PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Gourdon, P; Liu, XY; Skjorringe, T; Morth, JP; Moller, LB; Pedersen, BP; Nissen, P				Gourdon, Pontus; Liu, Xiang-Yu; Skjorringe, Tina; Morth, J. Preben; Moller, Lisbeth Birk; Pedersen, Bjorn Panyella; Nissen, Poul			Crystal structure of a copper-transporting PIB-type ATPase	NATURE			English	Article							P-TYPE-ATPASE; MENKES DISEASE; METAL-BINDING; CANDIDATE GENE; ACTUATOR DOMAIN; PUMP; CU+; MECHANISM; SODIUM; ORGANIZATION	Heavy-metal homeostasis and detoxification is crucial for cell viability. P-type ATPases of the class IB (PIB) are essential in these processes, actively extruding heavy metals from the cytoplasm of cells. Here we present the structure of a PIB-ATPase, a Legionella pneumophila CopA Cu+-ATPase, in a copper-free form, as determined by X-ray crystallography at 3.2 angstrom resolution. The structure indicates a three-stage copper transport pathway involving several conserved residues. A PIB-specific transmembrane helix kinks at a double-glycine motif displaying an amphipathic helix that lines a putative copper entry point at the intracellular interface. Comparisons to Ca2+-ATPase suggest an ATPase-coupled copper release mechanism from the binding sites in the membrane via an extracellular exit site. The structure also provides a framework to analyse missense mutations in the human ATP7A and ATP7B proteins associated with Menkes' and Wilson's diseases.	[Skjorringe, Tina; Moller, Lisbeth Birk] Kennedy Ctr, Ctr Appl Human Mol Genet, DK-2600 Glostrup, Denmark; [Gourdon, Pontus; Liu, Xiang-Yu; Morth, J. Preben; Pedersen, Bjorn Panyella; Nissen, Poul] Aarhus Univ, Ctr Membrane Pumps Cells & Dis PUMPKIN, Danish Natl Res Fdn, Dept Mol Biol, DK-8000 Aarhus C, Denmark; [Liu, Xiang-Yu] Peking Univ, Coll Life Sci, State Key Lab Prot & Plant Gene Res, Beijing 100871, Peoples R China	Aarhus University; Danmarks Grundforskningsfond; Peking University	Moller, LB (corresponding author), Kennedy Ctr, Ctr Appl Human Mol Genet, GI Landevej 7, DK-2600 Glostrup, Denmark.	lbm@kennedy.dk; pn@mb.au.dk	Nissen, Poul/D-5774-2014; Pedersen, Bjørn/H-4128-2017; Gourdon, Pontus/HCI-8898-2022; Gourdon, Pontus/E-1076-2014; Pedersen, Bjørn/AAT-2409-2021; Morth, Jens Preben/AAP-7834-2021; Morth, Jens Preben/G-4450-2013	Pedersen, Bjørn/0000-0001-7860-7230; Gourdon, Pontus/0000-0002-8631-3539; Pedersen, Bjørn/0000-0001-7860-7230; Morth, Jens Preben/0000-0003-4077-0192; Morth, Jens Preben/0000-0003-4077-0192; Nissen, Poul/0000-0003-0948-6628; Moller, Lisbeth/0000-0002-9524-4301	Danish Natural Science Research Council; Swedish Research Council; China Scholarship Council; Carlsberg Foundation; European Research Council; Novo Nordisk Foundation	Danish Natural Science Research Council(Danish Natural Science Research Council); Swedish Research Council(Swedish Research CouncilEuropean Commission); China Scholarship Council(China Scholarship Council); Carlsberg Foundation(Carlsberg Foundation); European Research Council(European Research Council (ERC)European Commission); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	We thank A. Pauluhn, C. Schulze-Briese,T. Tomizaki and V. Olieric (SLS), T. Ursby, M. Thunnissen, J. Unge and D. Haase (MAXLAB), and U. Muller, M. Weiss and K. Paithankar (BESSY) for assistance with synchrotron data collection. Support was provided by the Danscatt program of the Danish Natural Science Research Council. We also thank C. Buchrieser for supplying the L. pneumophila Philadelphia genome; X. D. Su for discussions, A. M. Nielsen for technical assistance and J. L. Karlsen for support on crystallographic computing. We are thankful to T. Deva and K. Faxen for preliminary functional analysis of the protein. P.G. was supported by the Swedish Research Council, X.-Y.L. by the China Scholarship Council and J.P.M. and B.P.P. by the Carlsberg Foundation. P.N. was supported by an advanced research grant (Biomemos) of the European Research Council and at earlier stages by a Hallas-Moller stipend of the Novo Nordisk Foundation.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ALBERS RW, 1967, ANNU REV BIOCHEM, V36, P727, DOI 10.1146/annurev.bi.36.070167.003455; Arguello JM, 2003, J MEMBRANE BIOL, V195, P93, DOI 10.1007/s00232-003-2048-2; Arguello JM, 2007, BIOMETALS, V20, P233, DOI 10.1007/s10534-006-9055-6; Arnesano F, 2001, BIOCHEMISTRY-US, V40, P1528, DOI 10.1021/bi0014711; Axelsen KB, 1998, J MOL EVOL, V46, P84, DOI 10.1007/PL00006286; Banci L, 2001, J BIOL CHEM, V276, P8415, DOI 10.1074/jbc.M008389200; Banci L, 2010, NATURE, V465, P645, DOI 10.1038/nature09018; Banci L, 2009, BIOCHEM J, V422, P37, DOI 10.1042/BJ20090422; Boal AK, 2009, J AM CHEM SOC, V131, P14196, DOI 10.1021/ja906363t; Cariani L, 2004, ANAL BIOCHEM, V324, P79, DOI 10.1016/j.ab.2003.09.008; CHELLY J, 1993, NAT GENET, V3, P14, DOI 10.1038/ng0193-14; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chintalapati S, 2008, J MOL BIOL, V378, P581, DOI 10.1016/j.jmb.2008.01.094; Daiho T, 2007, J BIOL CHEM, V282, P34429, DOI 10.1074/jbc.M707665200; de Bie P, 2007, J MED GENET, V44, P673, DOI 10.1136/jmg.2007.052746; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Forbes JR, 1999, J BIOL CHEM, V274, P12408, DOI 10.1074/jbc.274.18.12408; Gonzalez-Guerrero M, 2008, J BIOL CHEM, V283, P29753, DOI 10.1074/jbc.M803248200; Gonzalez-Guerrero M, 2008, P NATL ACAD SCI USA, V105, P5992, DOI 10.1073/pnas.0711446105; Gonzalez-Guerrero M, 2009, J BIOL CHEM, V284, P20804, DOI 10.1074/jbc.M109.016329; Gordon E, 2008, PROTEIN EXPRES PURIF, V62, P1, DOI 10.1016/j.pep.2008.07.005; Gourdon P, 2011, CRYST GROWTH DES, V11, P2098, DOI 10.1021/cg101360d; Guerrero SA, 2001, APPL MICROBIOL BIOT, V56, P718, DOI 10.1007/s002530100690; Hatori Y, 2007, J BIOL CHEM, V282, P25213, DOI 10.1074/jbc.M703520200; Inesi G, 2004, J BIOL CHEM, V279, P31629, DOI 10.1074/jbc.M403211200; Jones CE, 2003, J STRUCT BIOL, V143, P209, DOI 10.1016/j.jsb.2003.08.008; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kim EH, 2009, FEMS MICROBIOL LETT, V301, P164, DOI 10.1111/j.1574-6968.2009.01813.x; Kuhlbrandt W, 2004, NAT REV MOL CELL BIO, V5, P282, DOI 10.1038/nrm1354; Leonhardt K, 2009, J BIOL CHEM, V284, P7793, DOI 10.1074/jbc.M805145200; Long F, 2010, NATURE, V467, P484, DOI 10.1038/nature09395; LUTSENKO S, 1995, BIOCHEMISTRY-US, V34, P15607, DOI 10.1021/bi00048a001; MERCER JFB, 1993, NAT GENET, V3, P20, DOI 10.1038/ng0193-20; Moller AB, 2008, MOL PHYLOGENET EVOL, V46, P619, DOI 10.1016/j.ympev.2007.10.023; Morin I, 2009, FEBS J, V276, P4483, DOI 10.1111/j.1742-4658.2009.07155.x; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; Olesen C, 2004, SCIENCE, V306, P2251, DOI 10.1126/science.1106289; Olesen C, 2007, NATURE, V450, P1036, DOI 10.1038/nature06418; Pedersen BP, 2007, NATURE, V450, P1111, DOI 10.1038/nature06417; Pedersen BP, 2010, ACTA CRYSTALLOGR D, V66, P309, DOI 10.1107/S0907444909053244; Petrek M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-316; POST RL, 1972, J BIOL CHEM, V247, P6530; Sazinsky MH, 2006, BIOCHEMISTRY-US, V45, P9949, DOI 10.1021/bi0610045; Sazinsky MH, 2006, J BIOL CHEM, V281, P11161, DOI 10.1074/jbc.M510708200; Shinoda T, 2009, NATURE, V459, P446, DOI 10.1038/nature07939; SILVER S, 1989, TRENDS BIOCHEM SCI, V14, P76, DOI 10.1016/0968-0004(89)90048-0; Solioz M, 2010, J BIOL INORG CHEM, V15, P3, DOI 10.1007/s00775-009-0588-3; Sorensen TLM, 2004, SCIENCE, V304, P1672, DOI 10.1126/science.1099366; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Toyoshima C, 2004, NATURE, V432, P361, DOI 10.1038/nature02981; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; TOYOSHIMA C, 1993, NATURE, V362, P469, DOI 10.1038/362469a0; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; Tsuda T, 2009, EMBO J, V28, P1782, DOI 10.1038/emboj.2009.143; VONHEIJNE G, 1986, EMBO J, V5, P3021, DOI 10.1002/j.1460-2075.1986.tb04601.x; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; VULPE C, 1993, NAT GENET, V3, P7, DOI 10.1038/ng0193-7; Williams LE, 2005, TRENDS PLANT SCI, V10, P491, DOI 10.1016/j.tplants.2005.08.008; Wu CC, 2008, STRUCTURE, V16, P976, DOI 10.1016/j.str.2008.02.025; Zheng ZQ, 2010, J NEUROCHEM, V114, P1630, DOI 10.1111/j.1471-4159.2010.06888.x	63	235	241	3	104	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 7	2011	475	7354					59	U74		10.1038/nature10191	http://dx.doi.org/10.1038/nature10191			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	788RE	21716286				2022-12-24	WOS:000292461300044
J	Payne, D				Payne, David			RISK COMMUNICATION Watching the detectives: tracking the source of Europe's latest E coli outbreak	BRITISH MEDICAL JOURNAL			English	Editorial Material									BMJ, London WC1H 9JR, England		Payne, D (corresponding author), BMJ, London WC1H 9JR, England.	dpayne@bmj.com						[Anonymous], 2011, LANCET, V377, P1978; EVANS S, 2011, BBC NEWS        0607; *R KOCH I, 2011, INF UPD EHEC REC BAS	3	0	0	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 22	2011	342								d3884	10.1136/bmj.d3884	http://dx.doi.org/10.1136/bmj.d3884			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	785AT	21697228	Bronze, Green Submitted			2022-12-24	WOS:000292200500010
J	Shapses, SA; Manson, JE				Shapses, Sue A.; Manson, JoAnn E.			Vitamin D and Prevention of Cardiovascular Disease and Diabetes Why the Evidence Falls Short	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							RISK; 25-HYDROXYVITAMIN-D; SUPPLEMENTATION; CALCIUM		[Shapses, Sue A.] Rutgers State Univ, Dept Nutr Sci, Obes Grp, New Brunswick, NJ USA; [Manson, JoAnn E.] Harvard Univ, Sch Med, Dept Med, Brigham & Womens Hosp, Boston, MA USA	Rutgers State University New Brunswick; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Shapses, SA (corresponding author), Rutgers State Univ, Dept Nutr Sci, Obes Grp, 96 Lipman Dr, New Brunswick, NJ USA.	shapses@aesop.rutgers.edu		Shapses, Sue/0000-0002-3128-2325	NATIONAL INSTITUTE ON AGING [R01AG012161] Funding Source: NIH RePORTER; NIA NIH HHS [R01 AG012161] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Avenell A, 2009, AGE AGEING, V38, P606, DOI 10.1093/ageing/afp109; Chung M, 2009, 183 AG HEALTHC RES Q; Giovannucci E, 2008, ARCH INTERN MED, V168, P1174, DOI 10.1001/archinte.168.11.1174; Institute of Medicine, DIET REF INT CALC VI; Melamed ML, 2008, ARCH INTERN MED, V168, P1629, DOI 10.1001/archinte.168.15.1629; Pittas AG, 2007, J CLIN ENDOCR METAB, V92, P2017, DOI 10.1210/jc.2007-0298; Shankar A, 2011, DIABETES CARE, V34, P1114, DOI 10.2337/dc10-1203; Wang L, 2010, ANN INTERN MED, V152, P315, DOI 10.7326/0003-4819-152-5-201003020-00010; Wang TJ, 2008, CIRCULATION, V117, P503, DOI 10.1161/CIRCULATIONAHA.107.706127	9	62	65	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 22	2011	305	24					2565	2566		10.1001/jama.2011.881	http://dx.doi.org/10.1001/jama.2011.881			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	780MF	21693745	Green Accepted			2022-12-24	WOS:000291860400024
J	Laurance, J				Laurance, Jeremy			On Reflection Costing lives	LANCET			English	Editorial Material												j.laurance@independent.co.uk							0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 11	2011	377	9782					1996	1996		10.1016/S0140-6736(11)60852-0	http://dx.doi.org/10.1016/S0140-6736(11)60852-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	782LR	21665025	Bronze			2022-12-24	WOS:000292011700016
J	Kobayashi, T; Tsang, WY; Li, J; Lane, W; Dynlacht, BD				Kobayashi, Tetsuo; Tsang, William Y.; Li, Ji; Lane, William; Dynlacht, Brian David			Centriolar Kinesin Kif24 Interacts with CP110 to Remodel Microtubules and Regulate Ciliogenesis	CELL			English	Article							INTRACELLULAR-TRANSPORT; PROTEIN; CHLAMYDOMONAS; FLAGELLAR; TUBULIN; CELLS; DEPOLYMERIZATION; MECHANISM; DYNAMICS; BINDING	We have identified a protein, Kif24, that shares homology with the kinesin-13 subfamily of motor proteins and specifically interacts with CP110 and Cep97, centrosomal proteins that play a role in regulating centriolar length and ciliogenesis. Kif24 preferentially localizes to mother centrioles. Loss of Kif24 from cycling cells resulted in aberrant cilia assembly but did not promote growth of abnormally long centrioles, unlike CP110 and Cep97 depletion. We found that loss of Kif24 leads to the disappearance of CP110 from mother centrioles, specifically in cycling cells able to form cilia. Kif24 is able to bind and depolymerize microtubules in vitro. Remarkably, ectopically expressed Kif24 specifically remodels centriolar microtubules without significantly altering cytoplasmic microtubules. Thus, our studies have identified a centriolar kinesin that specifically remodels a subset of microtubules, thereby regulating cilia assembly. These studies also suggest mechanistic differences between the regulation of microtubule elongation associated with centrioles and cilia.	[Kobayashi, Tetsuo; Tsang, William Y.; Li, Ji; Dynlacht, Brian David] NYU, Sch Med, Dept Pathol, New York, NY 10016 USA; [Kobayashi, Tetsuo; Tsang, William Y.; Li, Ji; Dynlacht, Brian David] NYU, Sch Med, Inst Canc, Smilow Res Ctr, New York, NY 10016 USA; [Tsang, William Y.] Univ Montreal, Fac Med, Montreal, PQ H3C 3J7, Canada; [Tsang, William Y.] McGill Univ, Div Expt Med, Montreal, PQ H3A 1A3, Canada; [Lane, William] Harvard Univ, Mass Spectrometry & Prote Resource Lab, Ctr Syst Biol, Cambridge, MA 02138 USA	New York University; New York University; Universite de Montreal; McGill University; Harvard University	Dynlacht, BD (corresponding author), NYU, Sch Med, Dept Pathol, 522 1st Ave, New York, NY 10016 USA.	brian.dynlacht@med.nyu.edu	Li, Ji/J-6026-2014	Tsang, William/0000-0002-1584-616X	Irma T. Hirschl Career Scientist Award; March of Dimes research grant; DOD	Irma T. Hirschl Career Scientist Award; March of Dimes research grant(March of Dimes); DOD(United States Department of Defense)	We thank all members of the Dynlacht laboratory for constructive advice and encouragement. We thank M. Jelcic and I. Sanchez for assistance with baculoviral expression and thank J. Liu for experimental assistance. We thank J. Salisbury, E. Nigg, K. Lee, C. Janke, T. Katada, and K. Kontani for providing antibodies. B.D.D. was supported, in part, by an Irma T. Hirschl Career Scientist Award and March of Dimes research grant, for which he expresses his gratitude. J.L. was supported by a DOD Prostate Cancer pre-doctoral Training Award.	Bettencourt-Dias M, 2007, NAT REV MOL CELL BIO, V8, P451, DOI 10.1038/nrm2180; Blaineau C, 2007, CURR BIOL, V17, P778, DOI 10.1016/j.cub.2007.03.048; Chen ZH, 2002, DEV CELL, V3, P339, DOI 10.1016/S1534-5807(02)00258-7; Cole DG, 1998, J CELL BIOL, V141, P993, DOI 10.1083/jcb.141.4.993; Dawson SC, 2007, EUKARYOT CELL, V6, P2354, DOI 10.1128/EC.00128-07; Desai A, 1999, CELL, V96, P69, DOI 10.1016/S0092-8674(00)80960-5; Ems-McClung SC, 2010, SEMIN CELL DEV BIOL, V21, P276, DOI 10.1016/j.semcdb.2010.01.016; Endoh-Yamagami S, 2009, CURR BIOL, V19, P1320, DOI 10.1016/j.cub.2009.06.046; Hammond JW, 2008, CURR OPIN CELL BIOL, V20, P71, DOI 10.1016/j.ceb.2007.11.010; Hirokawa N, 2008, PHYSIOL REV, V88, P1089, DOI 10.1152/physrev.00023.2007; Hsu WB, 2008, EXP CELL RES, V314, P2591, DOI 10.1016/j.yexcr.2008.05.012; Jenkins PM, 2006, CURR BIOL, V16, P1211, DOI 10.1016/j.cub.2006.04.034; Kohlmaier G, 2009, CURR BIOL, V19, P1012, DOI 10.1016/j.cub.2009.05.018; KOZMINSKI KG, 1995, J CELL BIOL, V131, P1517, DOI 10.1083/jcb.131.6.1517; Lacroix B, 2010, J CELL BIOL, V189, P945, DOI 10.1083/jcb.201001024; Liem KF, 2009, P NATL ACAD SCI USA, V106, P13377, DOI 10.1073/pnas.0906944106; Moores CA, 2002, MOL CELL, V9, P903, DOI 10.1016/S1097-2765(02)00503-8; Moudjou M, 1996, J CELL SCI, V109, P875; Ogawa T, 2004, CELL, V116, P591, DOI 10.1016/S0092-8674(04)00129-1; Ou GS, 2005, NATURE, V436, P583, DOI 10.1038/nature03818; Ovechkina Y, 2002, J CELL BIOL, V159, P557, DOI 10.1083/jcb.200205089; Paoletti A, 1996, J CELL SCI, V109, P3089; Piao T, 2009, P NATL ACAD SCI USA, V106, P4713, DOI 10.1073/pnas.0808671106; Schmidt TI, 2009, CURR BIOL, V19, P1005, DOI 10.1016/j.cub.2009.05.016; Shipley K, 2004, EMBO J, V23, P1422, DOI 10.1038/sj.emboj.7600165; Spektor A, 2007, CELL, V130, P678, DOI 10.1016/j.cell.2007.06.027; Tang CJC, 2009, NAT CELL BIOL, V11, P825, DOI 10.1038/ncb1889; Tsang WY, 2008, DEV CELL, V15, P187, DOI 10.1016/j.devcel.2008.07.004; Tsang WY, 2007, J CELL BIOL, V178, P621, DOI 10.1083/jcb.200701166; Tsang WY, 2006, MOL BIOL CELL, V17, P3423, DOI 10.1091/mbc.E06-04-0371; Tsang WY, 2009, DEV CELL, V16, P649, DOI 10.1016/j.devcel.2009.03.004; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9	32	138	152	0	16	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 10	2011	145	6					914	925		10.1016/j.cell.2011.04.028	http://dx.doi.org/10.1016/j.cell.2011.04.028			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	775LS	21620453	Bronze			2022-12-24	WOS:000291461600018
J	Autran, D; Baroux, C; Raissig, MT; Lenormand, T; Wittig, M; Grob, S; Steimer, A; Barann, M; Klostermeier, UC; Leblanc, O; Vielle-Calzada, JP; Rosenstiel, P; Grimanelli, D; Grossniklaus, U				Autran, Daphne; Baroux, Celia; Raissig, Michael T.; Lenormand, Thomas; Wittig, Michael; Grob, Stefan; Steimer, Andrea; Barann, Matthias; Klostermeier, Ulrich C.; Leblanc, Olivier; Vielle-Calzada, Jean-Philippe; Rosenstiel, Phillip; Grimanelli, Daniel; Grossniklaus, Ueli			Maternal Epigenetic Pathways Control Parental Contributions to Arabidopsis Early Embryogenesis	CELL			English	Article							TO-ZYGOTIC TRANSITION; SEED DEVELOPMENT; SMALL-RNA; ENDOSPERM DEVELOPMENT; DNA METHYLATION; PATERNAL GENOME; HYBRID VIGOR; CHROMATIN; EMBRYO; MAINTENANCE	Defining the contributions and interactions of paternal and maternal genomes during embryo development is critical to understand the fundamental processes involved in hybrid vigor, hybrid sterility, and reproductive isolation. To determine the parental contributions and their regulation during Arabidopsis embryogenesis, we combined deep-sequencing-based RNA profiling and genetic analyses. At the 2-4 cell stage there is a strong, genome-wide dominance of maternal transcripts, although transcripts are contributed by both parental genomes. At the globular stage the relative paternal contribution is higher, largely due to a gradual activation of the paternal genome. We identified two antagonistic maternal pathways that control these parental contributions. Paternal alleles are initially downregulated by the chromatin siRNA pathway, linked to DNA and histone methylation, whereas transcriptional activation requires maternal activity of the histone chaperone complex CAF1. Our results define maternal epigenetic pathways controlling the parental contributions in plant embryos, which are distinct from those regulating genomic imprinting.	[Autran, Daphne; Leblanc, Olivier; Grimanelli, Daniel] Univ Montpellier, Inst Rech Dev, UMR 232, F-34394 Montpellier, France; [Baroux, Celia; Raissig, Michael T.; Grob, Stefan; Steimer, Andrea; Grossniklaus, Ueli] Univ Zurich, Inst Plant Biol, CH-8008 Zurich, Switzerland; [Baroux, Celia; Raissig, Michael T.; Grob, Stefan; Steimer, Andrea; Grossniklaus, Ueli] Univ Zurich, Zurich Basel Plant Sci Ctr, CH-8008 Zurich, Switzerland; [Lenormand, Thomas] Univ Montpellier, Ctr Ecol Fonct & Evolut, CNRS, UMR 5175, F-34293 Montpellier, France; [Wittig, Michael; Barann, Matthias; Klostermeier, Ulrich C.; Rosenstiel, Phillip] Univ Kiel, Inst Clin Mol Biol, D-24105 Kiel, Germany; [Vielle-Calzada, Jean-Philippe] CINVESTAV, Natl Lab Genom Biodivers, Guanajuato 36500, Mexico	Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; University of Zurich; University of Zurich; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier; University of Kiel; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional	Grimanelli, D (corresponding author), Univ Montpellier, Inst Rech Dev, UMR 232, F-34394 Montpellier, France.	daniel.grimanelli@ird.fr; grossnik@botinst.uzh.ch	Vielle-Calzada, Jean-Philippe/AAG-4036-2019; Lenormand, Thomas/A-5328-2012; Raissig, Michael T/AAO-9557-2020; Grob, Stefan/AAJ-3091-2020; Baroux, Célia/J-5359-2013; Grimanelli, Daniel/ABE-4777-2020; Grossniklaus, Ueli/A-2736-2012; Grossniklaus, Ueli/E-9995-2016; Raissig, Michael T/AGF-0291-2022; Autran, Daphné/AAV-4792-2021; Rosenstiel, Philip/A-5137-2009; Autran, Daphné/D-4846-2009	Lenormand, Thomas/0000-0001-8930-5393; Grob, Stefan/0000-0001-6199-7383; Baroux, Célia/0000-0001-6307-2229; Grossniklaus, Ueli/0000-0002-0522-8974; Autran, Daphné/0000-0002-5227-8966; Rosenstiel, Philip/0000-0002-9692-8828; Autran, Daphné/0000-0002-5227-8966; Vielle-Calzada, Jean-Philippe/0000-0002-3017-2490; Grimanelli, Daniel/0000-0001-5424-114X; Raissig, Michael/0000-0003-3179-9372	University of Zurich; Swiss National Science Foundation; European Union; Institut de Recherche pour le Developpement; Agence Nationale de la Recherche; CNRS; European Research Council; Clusters of Excellence; CONACyT	University of Zurich; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Union(European Commission); Institut de Recherche pour le Developpement; Agence Nationale de la Recherche(French National Research Agency (ANR)); CNRS(Centre National de la Recherche Scientifique (CNRS)); European Research Council(European Research Council (ERC)European Commission); Clusters of Excellence; CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	We thank the Arabidopsis Stock Centers (NASC/ABRC), J. Carrington, R. Gross-Hardt, R. Martienssen, F. Meins, T. Lagrange, J. Paszowski, and E. Richards for seeds; C. Michaud, N. Duran-Figueroa, and V. Olmedo-Monfil for technical support; T. Nawy for advice on embryo microdissection; S. Schreiber, L. Bossen, and M. Schilhabel for sequencing support at Kiel; and M. Schmid for help in GEO data submission. We are grateful to M. Arteaga-Vazquez, O. Hamant, and T. Lagrange for helpful comments on earlier versions of the manuscript and to S. Kessler and S. Gillmor for critical reading. C. B., M. R., S. G., and A. S. were supported by the University of Zurich and grants of Swiss National Science Foundation and the European Union (FP5 ApoTool Project) to U. G. D. A., O. L., and D. G. were supported by the Institut de Recherche pour le Developpement and the Agence Nationale de la Recherche, and T. L. by CNRS and a starting grant of the European Research Council. P. R. is supported by the Clusters of Excellence: "The Future Ocean" and "Inflammation at Interfaces." J.-P. V.-C. is supported by CONACyT and is an International Scholar of the Howard Hughes Medical Institute.	ANDEOL Y, 1994, ROUX ARCH DEV BIOL, V204, P3, DOI [10.1007/BF00744867, 10.1007/BF00189062]; Aw SJ, 2010, DEVELOPMENT, V137, P2683, DOI 10.1242/dev.052928; Baroux C, 2008, COLD SH Q B, V73, P89, DOI 10.1101/sqb.2008.73.053; Baroux C, 2001, FEBS LETT, V509, P11, DOI 10.1016/S0014-5793(01)03097-6; Baroux U, 2006, GENE DEV, V20, P1081, DOI 10.1101/gad.378106; Bayer M, 2009, SCIENCE, V323, P1485, DOI 10.1126/science.1167784; Borevitz JO, 2007, P NATL ACAD SCI USA, V104, P12057, DOI 10.1073/pnas.0705323104; Borges F, 2008, PLANT PHYSIOL, V148, P1168, DOI 10.1104/pp.108.125229; Bourc'his D, 2010, SCIENCE, V330, P617, DOI 10.1126/science.1194776; Brodersen P, 2006, TRENDS GENET, V22, P268, DOI 10.1016/j.tig.2006.03.003; Bushell C, 2003, PLANT CELL, V15, P1430, DOI 10.1105/tpc.010496; Chaudhury AM, 2001, SEMIN CELL DEV BIOL, V12, P381, DOI 10.1006/scdb.2001.0267; Chen ZJ, 2010, TRENDS PLANT SCI, V15, P57, DOI 10.1016/j.tplants.2009.12.003; De Renzis S, 2007, PLOS BIOL, V5, P1036, DOI 10.1371/journal.pbio.0050117; Feng SH, 2010, SCIENCE, V330, P622, DOI 10.1126/science.1190614; Gehring M, 2009, SCIENCE, V324, P1447, DOI 10.1126/science.1171609; Grimanelli D, 2005, PLANT CELL, V17, P1061, DOI 10.1105/tpc.104.029819; Groszmann M, 2011, P NATL ACAD SCI USA, V108, P2617, DOI 10.1073/pnas.1019217108; Hennig L, 2003, DEVELOPMENT, V130, P2555, DOI 10.1242/dev.00470; Hennig L, 2005, TRENDS CELL BIOL, V15, P295, DOI 10.1016/j.tcb.2005.04.004; Hsieh TF, 2011, P NATL ACAD SCI USA, V108, P1755, DOI 10.1073/pnas.1019273108; Hsieh TF, 2009, SCIENCE, V324, P1451, DOI [10.1126/science.1172417, 10.1126/science.112417]; Ingouff M, 2010, CURR BIOL, V20, P2137, DOI 10.1016/j.cub.2010.11.012; Jackson JP, 2002, NATURE, V416, P556, DOI 10.1038/nature731; Jahnke S, 2010, THEOR APPL GENET, V120, P389, DOI 10.1007/s00122-009-1207-y; Jullien PE, 2006, PLANT CELL, V18, P1360, DOI 10.1105/tpc.106.041178; Jullien PE, 2006, CURR BIOL, V16, P486, DOI 10.1016/j.cub.2006.01.020; Kaya H, 2001, CELL, V104, P131, DOI 10.1016/S0092-8674(01)00197-0; Kohler C, 2003, EMBO J, V22, P4804, DOI 10.1093/emboj/cdg444; Lu C, 2005, SCIENCE, V309, P1567, DOI 10.1126/science.1114112; Martienssen RA, 2010, NEW PHYTOL, V186, P46, DOI 10.1111/j.1469-8137.2010.03193.x; Meyer S, 2007, CURR BIOL, V17, P1686, DOI 10.1016/j.cub.2007.08.046; Mosher RA, 2009, NATURE, V460, P283, DOI 10.1038/nature08084; Ngo QA, 2007, DEVELOPMENT, V134, P4107, DOI 10.1242/dev.007310; Okada T, 2005, PLANT J, V44, P557, DOI 10.1111/j.1365-313X.2005.02554.x; Olmedo-Monfil V, 2010, NATURE, V464, P628, DOI 10.1038/nature08828; Ono T, 2006, GENES CELLS, V11, P153, DOI 10.1111/j.1365-2443.2006.00928.x; Ooi SL, 2006, PLOS GENET, V2, P883, DOI 10.1371/journal.pgen.0020097; Pahlavani MH, 2006, J APPL GENET, V47, P331, DOI 10.1007/BF03194642; Palancade B, 2003, EUR J BIOCHEM, V270, P3859, DOI 10.1046/j.1432-1033.2003.03794.x; Peiffer JA, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-43; Pillot M, 2010, PLANT SIGNAL BEHAV, V5, P1167, DOI 10.4161/psb.5.10.11905; Pillot M, 2010, PLANT CELL, V22, P307, DOI 10.1105/tpc.109.071647; Raissig MT, 2011, PLANT CELL, V23, P16, DOI 10.1105/tpc.110.081018; Ronceret A, 2005, PLANT J, V44, P223, DOI 10.1111/j.1365-313X.2005.02521.x; Ronceret A, 2008, PLANT J, V53, P776, DOI 10.1111/j.1365-313X.2007.03372.x; Scholten S, 2002, PLANT J, V32, P221, DOI 10.1046/j.1365-313X.2002.01418.x; Slotkin RK, 2009, CELL, V136, P461, DOI 10.1016/j.cell.2008.12.038; Tadros W, 2009, DEVELOPMENT, V136, P3033, DOI 10.1242/dev.033183; Tzafrir I, 2004, PLANT PHYSIOL, V135, P1206, DOI 10.1104/pp.104.045179; Vielle-Calzada JP, 2000, NATURE, V404, P91, DOI 10.1038/35003595; Weijers D, 2001, NATURE, V414, P709, DOI 10.1038/414709a; Wuest SE, 2010, CURR BIOL, V20, P506, DOI 10.1016/j.cub.2010.01.051	53	147	154	0	54	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 27	2011	145	5					707	719		10.1016/j.cell.2011.04.014	http://dx.doi.org/10.1016/j.cell.2011.04.014			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	769MR	21620136	Bronze, Green Submitted			2022-12-24	WOS:000291018600011
J	Wee, CC; Huskey, KW; Ngo, LH; Fowler-Brown, A; Leveille, SG; Mittlemen, MA; McCarthy, EP				Wee, Christina C.; Huskey, Karen W.; Ngo, Long H.; Fowler-Brown, Angela; Leveille, Suzanne G.; Mittlemen, Murray A.; McCarthy, Ellen P.			Obesity, Race, and Risk for Death or Functional Decline Among Medicare Beneficiaries A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							BODY-MASS INDEX; OLDER-ADULTS; WEIGHT-LOSS; US ADULTS; MORTALITY; OVERWEIGHT; DISABILITY; AMERICANS; PREVALENCE; MORBIDITY	Background: The adverse effect of obesity on health outcomes may be lower in older and African American adults than in the general U. S. population. Objective: To examine and compare the relationship between obesity and all-cause mortality and functional decline among older U. S. adults. Design: Longitudinal cohort study. Setting: Secondary analysis of data from the 1994 to 2000 Medicare Current Beneficiary Surveys, linked to Medicare enrollment files through 22 April 2008. Participants: 20 975 community-dwelling participants in the 1994 to 2000 Medicare Current Beneficiary Surveys who were aged 65 years or older. Measurements: All-cause mortality through 22 April 2008; new or worsening disability in performing activities of daily living (ADLs) and instrumental activities of daily living (IADLs) in 2 years. Results: 37% of the study sample were overweight (body mass index [BMI] of 25 to <30 kg/m(2)), 18% were obese (BMI >= 30 kg/m(2)), 48% died during the 14-year follow-up, and 27% had ADL and 43% had IADL disability at baseline. Among those without severe disability at baseline, 17% developed new or worsening ADL disability and 26% developed new or worsening IADL disabilor greater were the only group above the normal BMI range who had a higher risk for mortality (hazard ratio, 1.49 [95% CI, 1.20 to 1.85] in men and 1.21 [CI, 1.06 to 1.39] in women, compared with the reference group [BMI of 22.0 to 24.9 kg/m(2)]; P for BMI-sex interaction = 0.003). In contrast, both overweight and obesity were associated with new or progressive ADL and IADL disability in a dose-dependent manner, particularly for white men and women. Significant interactions were detected between BMI and sex but not between BMI and race for any outcome, although risk estimates for ADL disability seemed attenuated in African American relative to white respondents. Limitation: This was an observational study, baseline data were self-reported, and the study had limited power to detect differences between white and African American respondents. Conclusion: Among older U. S. adults, obesity was not associated with mortality, except for those with at least moderately severe obesity. However, lower levels of obesity were associated with new or worsening disability within 2 years. Efforts to prevent disability in older adults should target those who are overweight or obese.	[Wee, Christina C.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Gen Med & Primary Care, Boston, MA 02215 USA; Univ Massachusetts, Boston, MA 02125 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of Massachusetts System; University of Massachusetts Boston	Wee, CC (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Gen Med & Primary Care, 330 Brookline Ave, Boston, MA 02215 USA.	cwee@bidmc.harvard.edu	Leveille, Suzanne G/ACS-6588-2022	Leveille, Suzanne G/0000-0003-0427-1580; Mittleman, Murray/0000-0001-9788-7274	National Institute of Diabetes and Digestive and Kidney Diseases [R01 DK071083]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK087932, R01DK071083] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Grant Support: By the National Institute of Diabetes and Digestive and Kidney Diseases (R01 DK071083).	Adams KF, 2006, NEW ENGL J MED, V355, P763, DOI 10.1056/NEJMoa055643; Al Snih S, 2007, ARCH INTERN MED, V167, P774, DOI 10.1001/archinte.167.8.774; Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chen HL, 2008, J AM GERIATR SOC, V56, P689, DOI 10.1111/j.1532-5415.2007.01624.x; Department of Health and Human Services. National Heart Lung and Blood Institute, 1998, CLIN GUID ID EV TREA; Doshi JA, 2007, HEALTH AFFAIR, V26, P1111, DOI 10.1377/hlthaff.26.4.1111; Janssen I, 2007, OBES REV, V8, P41, DOI 10.1111/j.1467-789X.2006.00248.x; Jensen GL, 2002, J AM GERIATR SOC, V50, P918, DOI 10.1046/j.1532-5415.2002.50220.x; Jensen GL, 2010, CURR OPIN CLIN NUTR, V13, P46, DOI 10.1097/MCO.0b013e32833309cf; Kuk JL, 2009, J AM GERIATR SOC, V57, P2077, DOI 10.1111/j.1532-5415.2009.02486.x; Lang IA, 2008, J AM GERIATR SOC, V56, P1474, DOI 10.1111/j.1532-5415.2008.01813.x; Lenz M, 2009, DTSCH ARZTEBL INT, V106, P641, DOI 10.3238/arztebl.2009.0641; Liou TH, 2005, NUTR REV, V63, P321, DOI [10.1111/j.1753-4887.2005.tb00110.x, 10.1301/nr.2005.oct.321.331]; Manini TM, 2010, OBESITY, V18, P1168, DOI 10.1038/oby.2009.317; McTigue K, 2006, JAMA-J AM MED ASSOC, V296, P79, DOI 10.1001/jama.296.1.79; McTigue KM, 2006, OBESITY, V14, P1485, DOI 10.1038/oby.2006.171; Messier SP, 2004, ARTHRITIS RHEUM-US, V50, P1501, DOI 10.1002/art.20256; Moore SC, 2009, AM J CLIN NUTR, V89, P1003, DOI 10.3945/ajcn.2009.27598; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Peeters A, 2004, OBES RES, V12, P1145, DOI 10.1038/oby.2004.143; Rothman KJ, 2008, INT J OBESITY, V32, pS56, DOI 10.1038/ijo.2008.87; Shea MK, 2010, J GERONTOL A-BIOL, V65, P519, DOI 10.1093/gerona/glp217; Stevens J, 2000, NUTR REV, V58, P346, DOI 10.1111/j.1753-4887.2000.tb01832.x; Villanueva EV, 2001, BMC PUBLIC HEALTH, V1, DOI 10.1186/1471-2458-1-11; Walter S, 2009, INT J OBESITY, V33, P1410, DOI 10.1038/ijo.2009.176; Zamboni M, 2003, AGING CLIN EXP RES, V15, P321, DOI 10.1007/BF03324517; Zamboni M, 2005, INT J OBESITY, V29, P1011, DOI 10.1038/sj.ijo.0803005	28	51	53	1	11	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 17	2011	154	10					645	+		10.7326/0003-4819-154-10-201105170-00003	http://dx.doi.org/10.7326/0003-4819-154-10-201105170-00003			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	764HK	21576532	Green Accepted			2022-12-24	WOS:000290620300013
J	Horton, R; Dos, P				Horton, Richard; Dos, Pamela			The vaccine paradox	LANCET			English	Editorial Material							IMMUNIZATION; INITIATIVES; PROGRESS		[Horton, Richard; Dos, Pamela] The Lancet, London NW1 7BY, England		Horton, R (corresponding author), The Lancet, London NW1 7BY, England.							Black S, 2009, LANCET, V374, P2115, DOI 10.1016/S0140-6736(09)61877-8; Clemens J, 2010, NAT IMMUNOL, V11, P1069, DOI 10.1038/ni1210-1069; Lim SS, 2008, LANCET, V372, P2031, DOI 10.1016/S0140-6736(08)61869-3; Samb B, 2009, LANCET, V373, P2137, DOI 10.1016/S0140-6736(09)60919-3	4	5	5	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 23	2011	378	9788					296	298		10.1016/S0140-6736(11)60765-4	http://dx.doi.org/10.1016/S0140-6736(11)60765-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	803XL	21664684				2022-12-24	WOS:000293615800007
J	Bushey, D; Tononi, G; Cirelli, C				Bushey, Daniel; Tononi, Giulio; Cirelli, Chiara			Sleep and Synaptic Homeostasis: Structural Evidence in Drosophila	SCIENCE			English	Article							MENTAL-RETARDATION PROTEIN; MUSHROOM BODIES; DENDRITIC SPINES; CIRCADIAN CLOCK; PLASTICITY; INCREASES; NEURONS; NEED; WAKE; MICROSCOPY	The functions of sleep remain elusive, but a strong link exists between sleep need and neuronal plasticity. We tested the hypothesis that plastic processes during wake lead to a net increase in synaptic strength and sleep is necessary for synaptic renormalization. We found that, in three Drosophila neuronal circuits, synapse size or number increases after a few hours of wake and decreases only if flies are allowed to sleep. A richer wake experience resulted in both larger synaptic growth and greater sleep need. Finally, we demonstrate that the gene Fmr1 (fragile X mental retardation 1) plays an important role in sleep-dependent synaptic renormalization.	[Bushey, Daniel; Tononi, Giulio; Cirelli, Chiara] Univ Wisconsin, Dept Psychiat, Madison, WI 53719 USA	University of Wisconsin System; University of Wisconsin Madison	Cirelli, C (corresponding author), Univ Wisconsin, Dept Psychiat, Madison, WI 53719 USA.	ccirelli@wisc.edu			National Institute of General Medical Sciences [R01 GM075315]; NIH; Army Research Office [W911NF-08-1-0169]; Canadian Institutes of Health Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075315] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000579] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Army Research Office; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The study was supported by National Institute of General Medical Sciences (R01 GM075315 to C.C.), NIH Director's Pioneer award (to G.T.), Army Research Office (DURIP award W911NF-08-1-0169 to C.C.), and Canadian Institutes of Health Research (to D.B.). We thank G. Tavosanis for technical advice.	Appelbaum L, 2010, NEURON, V68, P87, DOI 10.1016/j.neuron.2010.09.006; BALLING A, 1987, J NEUROGENET, V4, P65, DOI 10.3109/01677068709102334; Bhatt DH, 2009, ANNU REV PHYSIOL, V71, P261, DOI 10.1146/annurev.physiol.010908.163140; Bushey D, 2009, J NEUROSCI, V29, P1948, DOI 10.1523/JNEUROSCI.4830-08.2009; Cirelli C, 2008, PLOS BIOL, V6, P1605, DOI 10.1371/journal.pbio.0060216; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Donlea JM, 2009, SCIENCE, V324, P105, DOI 10.1126/science.1166657; Feldman DE, 2009, ANNU REV NEUROSCI, V32, P33, DOI 10.1146/annurev.neuro.051508.135516; Ganguly-Fitzgerald I, 2006, SCIENCE, V313, P1775, DOI 10.1126/science.1130408; Gatto CL, 2009, FRONT NEURAL CIRCUIT, V3, DOI 10.3389/neuro.04.008.2009; Gilestro GF, 2009, SCIENCE, V324, P109, DOI 10.1126/science.1166673; HARRIS KM, 1989, J NEUROSCI, V9, P2982; Helfrich-Forster C, 2005, GENES BRAIN BEHAV, V4, P65, DOI 10.1111/j.1601-183X.2004.00092.X; Hendricks JC, 2000, NEURON, V25, P129, DOI 10.1016/S0896-6273(00)80877-6; Holtmaat A, 2009, NAT REV NEUROSCI, V10, P647, DOI 10.1038/nrn2699; Irwin SA, 2005, NEUROBIOL LEARN MEM, V83, P180, DOI 10.1016/j.nlm.2004.11.004; Joiner WJ, 2006, NATURE, V441, P757, DOI 10.1038/nature04811; Lee T, 1999, DEVELOPMENT, V126, P4065; Leiss F, 2009, DEV NEUROBIOL, V69, P221, DOI 10.1002/dneu.20699; Liu ZW, 2010, J NEUROSCI, V30, P8671, DOI 10.1523/JNEUROSCI.1409-10.2010; Maimon G, 2010, NAT NEUROSCI, V13, P393, DOI 10.1038/nn.2492; Mignot E, 2008, PLOS BIOL, V6, P661, DOI 10.1371/journal.pbio.0060106; Murthy VN, 2001, NEURON, V32, P673, DOI 10.1016/S0896-6273(01)00500-1; Pan LY, 2004, CURR BIOL, V14, P1863, DOI 10.1016/j.cub.2004.09.085; Parisky KM, 2008, NEURON, V60, P672, DOI 10.1016/j.neuron.2008.10.042; Pitman JL, 2006, NATURE, V441, P753, DOI 10.1038/nature04739; Redondo RL, 2011, NAT REV NEUROSCI, V12, P17, DOI 10.1038/nrn2963; Rodriguez A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001997; Shaw PJ, 2000, SCIENCE, V287, P1834, DOI 10.1126/science.287.5459.1834; Sigrist SJ, 2003, J NEUROSCI, V23, P6546; Tessier CR, 2009, FRONT MOL NEUROSCI, V2, DOI 10.3389/neuro.02.008.2009; Todd PK, 2000, MOL BRAIN RES, V80, P17, DOI 10.1016/S0169-328X(00)00098-X; Tononi G, 2006, SLEEP MED REV, V10, P49, DOI 10.1016/j.smrv.2005.05.002; Vyazovskiy VV, 2008, NAT NEUROSCI, V11, P200, DOI 10.1038/nn2035; Weiler IJ, 1997, P NATL ACAD SCI USA, V94, P5395, DOI 10.1073/pnas.94.10.5395; Zhang YQ, 2002, GENESIS, V34, P142, DOI 10.1002/gene.10144	36	230	235	0	63	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 24	2011	332	6037					1576	1581		10.1126/science.1202839	http://dx.doi.org/10.1126/science.1202839			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782EE	21700878	Green Accepted			2022-12-24	WOS:000291990000050
J	Gheorghiade, M; Peterson, ED				Gheorghiade, Mihai; Peterson, Eric D.			Improving Postdischarge Outcomes in Patients Hospitalized for Acute Heart Failure Syndromes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							MANAGEMENT		[Gheorghiade, Mihai] Northwestern Univ, Feinberg Sch Med, Ctr Cardiovasc Innovat, Chicago, IL 60611 USA; [Peterson, Eric D.] Duke Univ, Med Ctr, Duke Clin Res Inst, Durham, NC USA	Northwestern University; Feinberg School of Medicine; Duke University	Gheorghiade, M (corresponding author), Northwestern Univ, Feinberg Sch Med, Ctr Cardiovasc Innovat, 645 N Michigan Ave,Ste 1006, Chicago, IL 60611 USA.	m-gheorghiade@northwestern.edu	Peterson, Eric David/ABF-5033-2021					Albert NM, 2009, JAMA-J AM MED ASSOC, V302, P1658, DOI 10.1001/jama.2009.1493; Dunlay SM, 2010, EUR J HEART FAIL, V12, P367, DOI 10.1093/eurjhf/hfq019; Felker GM, 2011, NEW ENGL J MED, V364, P797, DOI 10.1056/NEJMoa1005419; Fonarow GC, 2011, CIRCULATION, V123, P1601, DOI 10.1161/CIRCULATIONAHA.110.989632; Gheorghiade M, 2006, JAMA-J AM MED ASSOC, V296, P2217, DOI 10.1001/jama.296.18.2217; Gheorghiade M, 2010, EUR J HEART FAIL, V12, P423, DOI 10.1093/eurjhf/hfq045; Gheorghiade M, 2009, JAMA-J AM MED ASSOC, V302, P2146, DOI 10.1001/jama.2009.1657; Metra M, 2010, CIRCULATION, V122, P1782, DOI 10.1161/CIRCULATIONAHA.110.982207; Pang PS, 2010, EUR HEART J, V31, P784, DOI 10.1093/eurheartj/ehq040; Shah SJ, 2008, JAMA-J AM MED ASSOC, V300, P431, DOI 10.1001/jama.300.4.431	10	35	36	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 15	2011	305	23					2456	2457		10.1001/jama.2011.836	http://dx.doi.org/10.1001/jama.2011.836			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	777EB	21673297				2022-12-24	WOS:000291597300026
J	Rabbani, P; Takeo, M; Chou, WC; Myung, P; Bosenberg, M; Chin, L; Taketo, MM; Ito, M				Rabbani, Piul; Takeo, Makoto; Chou, WeiChin; Myung, Peggy; Bosenberg, Marcus; Chin, Lynda; Taketo, M. Mark; Ito, Mayumi			Coordinated Activation of Wnt in Epithelial and Melanocyte Stem Cells Initiates Pigmented Hair Regeneration	CELL			English	Article							BETA-CATENIN; NEURAL CREST; FOLLICLE MORPHOGENESIS; TRANSCRIPTION FACTOR; SKIN; GROWTH; DIFFERENTIATION; EXPRESSION; NICHE; CYCLE	Melanocyte stem cells (McSCs) intimately interact with epithelial stem cells (EpSCs) in the hair follicle bulge and secondary hair germ (sHG). Together, they undergo activation and differentiation to regenerate pigmented hair. However, the mechanisms behind this coordinated stem cell behavior have not been elucidated. Here, we identified Wnt signaling as a key pathway that couples the behavior of the two stem cells. EpSCs and McSCs coordinately activate Wnt signaling at the onset of hair follicle regeneration within the sHG. Using genetic mouse models that specifically target either EpSCs or McSCs, we show that Wnt activation in McSCs drives their differentiation into pigment-producing melanocytes, while EpSC Wnt signaling not only dictates hair follicle formation but also regulates McSC proliferation during hair regeneration. Our data define a role for Wnt signaling in the regulation of McSCs and also illustrate a mechanism for regeneration of complex organs through collaboration between heterotypic stem cell populations.	[Rabbani, Piul; Takeo, Makoto; Chou, WeiChin; Ito, Mayumi] NYU, Sch Med, Dept Dermatol, New York, NY 10016 USA; [Rabbani, Piul; Takeo, Makoto; Chou, WeiChin; Ito, Mayumi] NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA; [Myung, Peggy] Univ Hosp Case Western Reserve, Dept Dermatol, Cleveland, OH USA; [Bosenberg, Marcus] Yale Univ, Sch Med, Dept Dermatol, New Haven, CT 06510 USA; [Chin, Lynda] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Taketo, M. Mark] Kyoto Univ, Dept Pharmacol, Grad Sch Med, Kyoto 6068501, Japan	New York University; New York University; Case Western Reserve University; Yale University; Harvard University; Dana-Farber Cancer Institute; Kyoto University	Ito, M (corresponding author), NYU, Sch Med, Dept Dermatol, New York, NY 10016 USA.	mayumi.ito@nyumc.org		Takeo, Makoto/0000-0002-5597-5994; Rabbani, Piul/0000-0001-8302-8225	Department of Dermatology; Helen and Martin Kimmel Center for Stem Cell Biology at New York University (NYU); Dermatology Foundation; Ellison Medical Foundation; Yan Deng; Microscopy Core of NYU [NCRR S10 RR023704-01A1, NCRR S10 RR024708]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024708, S10RR023704] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR059768] Funding Source: NIH RePORTER	Department of Dermatology; Helen and Martin Kimmel Center for Stem Cell Biology at New York University (NYU); Dermatology Foundation; Ellison Medical Foundation(Lawrence Ellison Foundation); Yan Deng; Microscopy Core of NYU; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank funds from the Department of Dermatology and the Helen and Martin Kimmel Center for Stem Cell Biology at New York University (NYU), the Dermatology Foundation Career Development Award, and the New Scholar Award in aging from the Ellison Medical Foundation to M.I. We thank Tung-Tien Sun for critical reading of the manuscript. We thank Seth Orlow and Prashiela Manga for providing Melan-a cells and helpful advice. We thank our mentors George Cotsarelis and Sarah Millar for their helpful advice and constant encouragement. We thank Radhika Atit for her input and collaboration for this work. We thank Yan Deng and the Microscopy Core of NYU for use of confocal microscopes (grants NCRR S10 RR023704-01A1 and NCRR S10 RR024708).	Andl T, 2002, DEV CELL, V2, P643, DOI 10.1016/S1534-5807(02)00167-3; Barker Nick, 2008, V468, P5, DOI 10.1007/978-1-59745-249-6_1; Blanpain C, 2009, NAT REV MOL CELL BIO, V10, P207, DOI 10.1038/nrm2636; Bosenberg M, 2006, GENESIS, V44, P262, DOI 10.1002/dvg.20205; Brault V, 2001, DEVELOPMENT, V128, P1253; Brockes JP, 2005, SCIENCE, V310, P1919, DOI 10.1126/science.1115200; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; Delmas V, 2007, GENE DEV, V21, P2923, DOI 10.1101/gad.450107; DORAN TI, 1980, CELL, V22, P17, DOI 10.1016/0092-8674(80)90150-6; Dorsky RI, 1998, NATURE, V396, P370, DOI 10.1038/24620; Dunn KJ, 2000, P NATL ACAD SCI USA, V97, P10050, DOI 10.1073/pnas.97.18.10050; Fu J, 2009, P NATL ACAD SCI USA, V106, P18598, DOI 10.1073/pnas.0904894106; Gat U, 1998, CELL, V95, P605, DOI 10.1016/S0092-8674(00)81631-1; Greco V, 2009, CELL STEM CELL, V4, P155, DOI 10.1016/j.stem.2008.12.009; Haegebarth A, 2009, AM J PATHOL, V174, P715, DOI 10.2353/ajpath.2009.080758; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Hari L, 2002, J CELL BIOL, V159, P867, DOI 10.1083/jcb.200209039; Huelsken J, 2001, CELL, V105, P533, DOI 10.1016/S0092-8674(01)00336-1; Ikeya M, 1997, NATURE, V389, P966, DOI 10.1038/40146; Imokawa G, 2004, PIGM CELL RES, V17, P96, DOI 10.1111/j.1600-0749.2003.00126.x; Inomata K, 2009, CELL, V137, P1088, DOI 10.1016/j.cell.2009.03.037; Ito M, 2005, NAT MED, V11, P1351, DOI 10.1038/nm1328; Ito M, 2004, DIFFERENTIATION, V72, P548, DOI 10.1111/j.1432-0436.2004.07209008.x; Ito M, 2007, NATURE, V447, P316, DOI 10.1038/nature05766; Kim TH, 2005, ONCOGENE, V24, P597, DOI 10.1038/sj.onc.1208237; Kirilly D, 2007, CELL RES, V17, P15, DOI 10.1038/sj.cr.7310123; Lang D, 2005, NATURE, V433, P884, DOI 10.1038/nature03292; Larue L, 2006, FRONT BIOSCI-LANDMRK, V11, P733, DOI 10.2741/1831; Liu YP, 2003, J INVEST DERMATOL, V121, P963, DOI 10.1046/j.1523-1747.2003.12600.x; Lowry WE, 2005, GENE DEV, V19, P1596, DOI 10.1101/gad.1324905; Moriyama M, 2006, J CELL BIOL, V173, P333, DOI 10.1083/jcb.200509084; Morris RJ, 2004, NAT BIOTECHNOL, V22, P411, DOI 10.1038/nbt950; Muller-Rover S, 2001, J INVEST DERMATOL, V117, P3, DOI 10.1046/j.0022-202x.2001.01377.x; Nishikawa SI, 2007, PIGM CELL RES, V20, P263, DOI 10.1111/j.1600-0749.2007.00388.x; Nishimura EK, 2005, SCIENCE, V307, P720, DOI 10.1126/science.1099593; Nishimura EK, 2002, NATURE, V416, P854, DOI 10.1038/416854a; Nishimura EK, 2010, CELL STEM CELL, V6, P130, DOI 10.1016/j.stem.2009.12.010; Nusse R, 2008, CELL RES, V18, P523, DOI 10.1038/cr.2008.47; O'Connell MP, 2009, PIGM CELL MELANOMA R, V22, P724, DOI 10.1111/j.1755-148X.2009.00627.x; Pellegrini G, 1997, LANCET, V349, P990, DOI 10.1016/S0140-6736(96)11188-0; RAWLES ME, 1947, PHYSIOL ZOOL, V20, P248, DOI 10.1086/physzool.20.3.30151958; Reddy S, 2001, MECH DEVELOP, V107, P69, DOI 10.1016/S0925-4773(01)00452-X; Rendl M, 2008, GENE DEV, V22, P543, DOI 10.1101/gad.1614408; SAKURAI T, 1990, NATURE, V348, P732, DOI 10.1038/348732a0; Saldana-Caboverde A, 2010, PIGM CELL MELANOMA R, V23, P160, DOI 10.1111/j.1755-148X.2010.00678.x; SCHOFIELD R, 1978, BLOOD CELLS, V4, P7; Schouwey K, 2007, DEV DYNAM, V236, P282, DOI 10.1002/dvdy.21000; Sharov A, 2005, J INVEST DERMATOL, V125, P1259, DOI 10.1111/j.0022-202X.2005.23959.x; Silva-Vargas V, 2005, DEV CELL, V9, P121, DOI 10.1016/j.devcel.2005.04.013; Takeda K, 2000, J BIOL CHEM, V275, P14013, DOI 10.1074/jbc.C000113200; Tanimura S, 2011, CELL STEM CELL, V8, P177, DOI 10.1016/j.stem.2010.11.029; Trempus CS, 2003, J INVEST DERMATOL, V120, P501, DOI 10.1046/j.1523-1747.2003.12088.x; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Van Mater D, 2003, GENE DEV, V17, P1219, DOI 10.1101/gad.1076103; Vasioukhin V, 1999, P NATL ACAD SCI USA, V96, P8551, DOI 10.1073/pnas.96.15.8551; Yamaguchi Y, 2004, J CELL BIOL, V165, P275, DOI 10.1083/jcb.200311122; Zhang YV, 2009, CELL STEM CELL, V5, P267, DOI 10.1016/j.stem.2009.06.004; Zhang Y, 2008, DEVELOPMENT, V135, P2161, DOI 10.1242/dev.017459	58	207	229	1	50	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 10	2011	145	6					941	955		10.1016/j.cell.2011.05.004	http://dx.doi.org/10.1016/j.cell.2011.05.004			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	775LS	21663796	Green Accepted, Bronze			2022-12-24	WOS:000291461600020
J	Reulen, RC; Frobisher, C; Winter, DL; Kelly, J; Lancashire, ER; Stiller, CA; Pritchard-Jones, K; Jenkinson, HC; Hawkins, MM				Reulen, Raoul C.; Frobisher, Clare; Winter, David L.; Kelly, Julie; Lancashire, Emma R.; Stiller, Charles A.; Pritchard-Jones, Kathryn; Jenkinson, Helen C.; Hawkins, Michael M.		British Childhood Canc Survivor St	Long-term Risks of Subsequent Primary Neoplasms Among Survivors of Childhood Cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							2ND MALIGNANT NEOPLASMS; COLORECTAL-CANCER; REGRESSION-MODELS; RELATIVE SURVIVAL; 5-YEAR SURVIVORS; FAMILY-HISTORY; SURVEILLANCE; METAANALYSIS; GUIDELINES; MORTALITY	Context Survivors of childhood cancer are at excess risk of developing subsequent primary neoplasms but the long-term risks are uncertain. Objectives To investigate long-term risks of subsequent primary neoplasms in survivors of childhood cancer, to identify the types that contribute most to long-term excess risk, and to identify subgroups of survivors at substantially increased risk of particular subsequent primary neoplasms that may require specific interventions. Design, Setting, and Participants British Childhood Cancer Survivor Study-a population-based cohort of 17 981 5-year survivors of childhood cancer diagnosed with cancer at younger than 15 years between 1940 and 1991 in Great Britain, followed up through December 2006. Main Outcome Measures Standardized incidence ratios (SIRs), absolute excess risks (AERs), and cumulative incidence of subsequent primary neoplasms. Results After a median follow-up time of 24.3 years (mean=25.6 years), 1354 subsequent primary neoplasms were ascertained; the most frequently observed being central nervous system (n=344), nonmelanoma skin cancer (n=278), digestive (n=105), genitourinary (n=100), breast (n=97), and bone (n=94). The overall SIR was 4 times more than expected (SIR, 3.9; 95% confidence interval [CI], 3.6-4.2; AER, 16.8 per 10 000 person-years). The AER at older than 40 years was highest for digestive and genitourinary subsequent primary neoplasms (AER, 5.9 [95% CI, 2.5-9.3]; and AER, 6.0 [95% CI, 2.3-9.6] per 10 000 person-years, respectively); 36% of the total AER was attributable to these 2 subsequent primary neoplasm sites. The cumulative incidence of colorectal cancer for survivors treated with direct abdominopelvic irradiation was 1.4% (95% CI, 0.7%-2.6%) by age 50 years, comparable with the 1.2% risk in individuals with at least 2 first-degree relatives affected by colorectal cancer. Conclusion Among a cohort of British childhood cancer survivors, the greatest excess risk associated with subsequent primary neoplasms at older than 40 years was for digestive and genitourinary neoplasms. JAMA. 2011;305(22):2311-2319 www.jama.com	[Reulen, Raoul C.; Frobisher, Clare; Winter, David L.; Kelly, Julie; Lancashire, Emma R.; Hawkins, Michael M.] Univ Birmingham, Sch Hlth & Populat Sci, Ctr Childhood Canc Survivor Studies, Birmingham B15 2TT, W Midlands, England; [Stiller, Charles A.] Univ Oxford, Childhood Canc Res Grp, Oxford, England; [Pritchard-Jones, Kathryn] Inst Canc Res, Dept Paediat Oncol, Surrey, England; [Jenkinson, Helen C.] Birmingham Childrens Hosp NHS Fdn Trust, Dept Paediat Oncol, Birmingham, W Midlands, England	University of Birmingham; University of Oxford; University of London; Institute of Cancer Research - UK; University of Birmingham	Reulen, RC (corresponding author), Univ Birmingham, Sch Hlth & Populat Sci, Ctr Childhood Canc Survivor Studies, Publ Hlth Bldg, Birmingham B15 2TT, W Midlands, England.	r.c.reulen@bham.ac.uk	Frobisher, Clare/AAC-5728-2020; Pritchard-Jones, Kathy/F-4286-2014; Reulen, Raoul/AAO-1033-2020	Frobisher, Clare/0000-0003-1099-163X; Pritchard-Jones, Kathy/0000-0002-2384-9475; Reulen, Raoul/0000-0002-7328-0467; Stiller, Charles/0000-0002-3006-7869; Kelly, Julie S/0000-0003-1155-735X	Cancer Research UK; Kay Kendall Leukaemia Fund; Department of Health; Scottish Ministers	Cancer Research UK(Cancer Research UK); Kay Kendall Leukaemia Fund; Department of Health; Scottish Ministers	This work was supported by Cancer Research UK and Kay Kendall Leukaemia Fund. The Childhood Cancer Research Group receives funding from the Department of Health and the Scottish Ministers.	Baglietto L, 2006, J CLIN EPIDEMIOL, V59, P114, DOI 10.1016/j.jclinepi.2005.07.018; BRESLOW NE, 1987, IARC SCI PUBLICATION, V82; Butterworth AS, 2006, EUR J CANCER, V42, P216, DOI 10.1016/j.ejca.2005.09.023; Cairns SR, 2010, GUT, V59, P666, DOI 10.1136/gut.2009.179804; Cancer Research UK, 2008, CANCERSTATS INC UK; Cardous-Ubbink MC, 2007, EUR J CANCER, V43, P351, DOI 10.1016/j.ejca.2006.10.004; Children's Oncology Group, 2008, LONG TERM FOLL UP GU; Cooper N, 2005, CANC ATLAS UK IRELAN, P39; Coviello V, 2004, STATA J, V4, P103, DOI 10.1177/1536867X0400400201; Dickman PW, 2004, STAT MED, V23, P51, DOI 10.1002/sim.1597; Friedman DL, 2010, JNCI-J NATL CANCER I, V102, P1083, DOI 10.1093/jnci/djq238; Fritz A, 2000, INT CLASSIFICATION D; Gooley TA, 1999, STAT MED, V18, P695, DOI 10.1002/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.3.CO;2-F; Hawkins MM, 2008, PEDIATR BLOOD CANCER, V50, P1018, DOI 10.1002/pbc.21335; Inskip PD, 2007, INT J CANCER, V121, P2233, DOI 10.1002/ijc.22827; Jenkinson HC, 2004, BRIT J CANCER, V91, P1905, DOI 10.1038/sj.bjc.6602226; Kroll ME, 2011, BRIT J CANCER, V104, P1227, DOI 10.1038/bjc.2011.70; Lambert PC, 2005, STAT MED, V24, P3871, DOI 10.1002/sim.2399; Magnani C, 1996, INT J CANCER, V67, P6; Nathan PC, 2010, ANN INTERN MED, V153, P442, DOI 10.7326/0003-4819-153-7-201010050-00007; National Health Service, CANC SCREEN PROGR; Neglia JP, 2001, J NATL CANCER I, V93, P618, DOI 10.1093/jnci/93.8.618; Office of National Statistics, 2006, CANC STAT REG MB1; Olsen JH, 2009, JNCI-J NATL CANCER I, V101, P806, DOI 10.1093/jnci/djp104; Reulen RC, 2010, JAMA-J AM MED ASSOC, V304, P172, DOI 10.1001/jama.2010.923; Shah A, 2008, BRIT J CANCER, V99, pS86, DOI 10.1038/sj.bjc.6604599; Thernau TM, 2000, MODELING SURVIVAL DA; Vincent TJ, 2007, CHILDHOOD CANC BRITA; Wilson CL, 2010, MED J AUSTRALIA, V193, P258, DOI 10.5694/j.1326-5377.2010.tb03902.x; Winawer S, 2003, GASTROENTEROLOGY, V124, P544, DOI 10.1053/gast.2003.50044	30	219	222	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 8	2011	305	22					2311	2319		10.1001/jama.2011.747	http://dx.doi.org/10.1001/jama.2011.747			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	773YV	21642683	Bronze			2022-12-24	WOS:000291349100024
J	Hibbs, RE; Gouaux, E				Hibbs, Ryan E.; Gouaux, Eric			Principles of activation and permeation in an anion-selective Cys-loop receptor	NATURE			English	Article							X-RAY-STRUCTURE; NICOTINIC ACETYLCHOLINE-RECEPTOR; GATED CHLORIDE CHANNEL; NEUROMUSCULAR-JUNCTION; CRYSTAL-STRUCTURE; BINDING PROTEIN; LIGAND-BINDING; ION CHANNELS; SUBUNIT; IVERMECTIN	Fast inhibitory neurotransmission is essential for nervous system function and is mediated by binding of inhibitory neurotransmitters to receptors of the Cys-loop family embedded in the membranes of neurons. Neurotransmitter binding triggers a conformational change in the receptor, opening an intrinsic chloride channel and thereby dampening neuronal excitability. Here we present the first three-dimensional structure, to our knowledge, of an inhibitory anion-selective Cys-loop receptor, the homopentameric Caenorhabditis elegans glutamate-gated chloride channel alpha (GluCl), at 3.3 angstrom resolution. The X-ray structure of the GluCl-Fab complex was determined with the allosteric agonist ivermectin and in additional structures with the endogenous neurotransmitter L-glutamate and the open-channel blocker picrotoxin. Ivermectin, used to treat river blindness, binds in the transmembrane domain of the receptor and stabilizes an open-pore conformation. Glutamate binds in the classical agonist site at subunit interfaces, and picrotoxin directly occludes the pore near its cytosolic base. GluCl provides a framework for understanding mechanisms of fast inhibitory neurotransmission and allosteric modulation of Cys-loop receptors.	[Hibbs, Ryan E.; Gouaux, Eric] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA; [Gouaux, Eric] Oregon Hlth & Sci Univ, Howard Hughes Med Inst, Portland, OR 97239 USA	Oregon Health & Science University; Howard Hughes Medical Institute; Oregon Health & Science University	Gouaux, E (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	gouauxe@ohsu.edu	Gouaux, Eric/Y-4370-2019	Gouaux, Eric/0000-0002-8549-2360	NIH [F32NS061404]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS061800, F32NS061404] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to H. Lester for providing the initial GluCl construct, to D. Cawley for monoclonal antibody production, to J. Michel for Fab fragment cloning and sequencing, to C. Alexander and D. C. Dawson for providing Xenopus oocytes, to M. Mayer for advice and equipment related to oocyte experiments, and to L. Vaskalis for help with illustrations. We thank the staff at the Advanced Photon Source beamline 24-ID-C for assistance with X-ray data collection. We are particularly appreciative of discussions with E.G. laboratory members and E. McCleskey. This work was supported by an individual NIH National Research Service Award (F32NS061404) to R.E.H. E.G. is an investigator with the Howard Hughes Medical Institute.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adelsberger H, 2000, EUR J PHARMACOL, V394, P163, DOI 10.1016/S0014-2999(00)00164-3; AKABAS MH, 1994, NEURON, V13, P919, DOI 10.1016/0896-6273(94)90257-7; Alexander C, 2009, BIOCHEMISTRY-US, V48, P10078, DOI 10.1021/bi901314c; ARENA JP, 1991, MOL PHARMACOL, V40, P368; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; AZIZ MA, 1982, LANCET, V2, P171; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Barrantes FJ, 2004, BRAIN RES REV, V47, P71, DOI 10.1016/j.brainresrev.2004.06.008; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; CAMPBELL WC, 1983, SCIENCE, V221, P823, DOI 10.1126/science.6308762; CamposCaro A, 1996, P NATL ACAD SCI USA, V93, P6118, DOI 10.1073/pnas.93.12.6118; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; Celie PHN, 2005, J BIOL CHEM, V280, P26457, DOI 10.1074/jbc.M414476200; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; COOMBS JS, 1955, J PHYSIOL-LONDON, V130, P326, DOI 10.1113/jphysiol.1955.sp005412; Corringer PJ, 2010, J PHYSIOL-LONDON, V588, P565, DOI 10.1113/jphysiol.2009.183160; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; CULLY DF, 1994, NATURE, V371, P707, DOI 10.1038/371707a0; DAMLE VN, 1980, BIOCHEMISTRY-US, V19, P3924, DOI 10.1021/bi00558a006; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Etter A, 1999, J NEUROCHEM, V72, P318, DOI 10.1111/jnc.1999.72.1.318; Etter A, 1996, J BIOL CHEM, V271, P16035, DOI 10.1074/jbc.271.27.16035; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; FATIMASHAD K, 1993, P ROY SOC B-BIOL SCI, V253, P69, DOI 10.1098/rspb.1993.0083; Garcia PS, 2010, CURR NEUROPHARMACOL, V8, P2, DOI 10.2174/157015910790909502; Gensler S, 2001, EUR J BIOCHEM, V268, P2209, DOI 10.1046/j.1432-1327.2001.02093.x; Hansen SB, 2005, EMBO J, V24, P3635, DOI 10.1038/sj.emboj.7600828; Harlow E., 1988, ANTIBODIES LAB MANUA; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Hilf RJC, 2009, CURR OPIN STRUC BIOL, V19, P418, DOI 10.1016/j.sbi.2009.07.006; Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; KAO PN, 1984, J BIOL CHEM, V259, P1662; Kawate T, 2006, STRUCTURE, V14, P673, DOI 10.1016/j.str.2006.01.013; Keramidas A, 2004, PROG BIOPHYS MOL BIO, V86, P161, DOI 10.1016/j.pbiomolbio.2003.09.002; Krause RM, 1998, MOL PHARMACOL, V53, P283, DOI 10.1124/mol.53.2.283; KUSAMA T, 1994, NEUROREPORT, V5, P1209, DOI 10.1097/00001756-199406020-00012; Lamla T, 2004, PROTEIN EXPRES PURIF, V33, P39, DOI 10.1016/j.pep.2003.08.014; Lee DJS, 2003, NEUROSCI LETT, V351, P196, DOI 10.1016/j.neulet.2003.08.005; Lee WY, 2005, NATURE, V438, P243, DOI 10.1038/nature04156; Leslie A. G. W., 1992, JOINT CCP4 ESF EAMCB; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Li P, 2002, FEBS LETT, V528, P77, DOI 10.1016/S0014-5793(02)03245-3; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; LYNCH JW, 1995, J BIOL CHEM, V270, P13799, DOI 10.1074/jbc.270.23.13799; Mancinelli R, 2007, J PHYS CHEM B, V111, P13570, DOI 10.1021/jp075913v; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miller PS, 2010, TRENDS PHARMACOL SCI, V31, P161, DOI 10.1016/j.tips.2009.12.005; Mukhtasimova N, 2005, J GEN PHYSIOL, V126, P23, DOI 10.1085/jgp.200509283; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Quiram PA, 2000, J BIOL CHEM, V275, P4889, DOI 10.1074/jbc.275.7.4889; RAJENDRA S, 1995, NEURON, V14, P169, DOI 10.1016/0896-6273(95)90251-1; Reeves DC, 2001, J BIOL CHEM, V276, P42035, DOI 10.1074/jbc.M106066200; Sauter NK, 2004, J APPL CRYSTALLOGR, V37, P399, DOI 10.1107/S0021889804005874; Shan Q, 2001, J BIOL CHEM, V276, P12556, DOI 10.1074/jbc.M011264200; Sherrington CS, 1906, INTEGRATIVE ACTION N, DOI 10.1037/13798-000; Silberberg SD, 2007, NEURON, V54, P263, DOI 10.1016/j.neuron.2007.03.020; Slimko EM, 2003, J NEUROSCI METH, V124, P75, DOI 10.1016/S0165-0270(02)00362-X; SMART OS, 1993, BIOPHYS J, V65, P2455, DOI 10.1016/S0006-3495(93)81293-1; SPRINGER JP, 1981, J AM CHEM SOC, V103, P4221, DOI 10.1021/ja00404a041; Sunesen M, 2006, J BIOL CHEM, V281, P14875, DOI 10.1074/jbc.M511657200; TAKEUCHI A, 1969, J PHYSIOL-LONDON, V205, P377, DOI 10.1113/jphysiol.1969.sp008972; Thompson AJ, 2010, Q REV BIOPHYS, V43, P449, DOI 10.1017/S0033583510000168; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Ueno S, 1999, BRIT J PHARMACOL, V127, P377, DOI 10.1038/sj.bjp.0702563; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Wada A, 1976, Adv Biophys, P1; Wilson GG, 2000, J GEN PHYSIOL, V115, P93, DOI 10.1085/jgp.115.2.93; Young GT, 2008, P NATL ACAD SCI USA, V105, P14686, DOI 10.1073/pnas.0804372105; Zhang Z, 2006, J APPL CRYSTALLOGR, V39, P112, DOI 10.1107/S0021889805040677	78	768	780	7	204	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 2	2011	474	7349					54	U80		10.1038/nature10139	http://dx.doi.org/10.1038/nature10139			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	771KV	21572436	Green Accepted			2022-12-24	WOS:000291156700035
J	Karim, SSA				Karim, Salim S. Abdool			Stigma impedes AIDS prevention	NATURE			English	Editorial Material							HIV		[Karim, Salim S. Abdool] Univ KwaZulu Natal, Ctr AIDS Programme Res S Africa, ZA-4001 Durban, South Africa; [Karim, Salim S. Abdool] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY 10032 USA	University of Kwazulu Natal; Columbia University	Karim, SSA (corresponding author), Univ KwaZulu Natal, Ctr AIDS Programme Res S Africa, ZA-4001 Durban, South Africa.	karims1@ukzn.ac.za	Karim, Salim Abdool/AAE-7118-2019; Karim, Salim Safurdeen Abdool/N-5947-2013; Karim, Salim Abdool/P-3117-2019	Karim, Salim Safurdeen Abdool/0000-0002-4986-2133; Karim, Salim Abdool/0000-0002-4986-2133				*BLOOMB, BLOOMB REP; Chigwedere P, 2008, JAIDS-J ACQ IMM DEF, V49, P410, DOI 10.1097/QAI.0b013e31818a6cd5; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2009, AIDS EP UPD 2009; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Karim SSA, 2007, NATURE, V449, P24, DOI 10.1038/449024c; Marks G, 2006, AIDS, V20, P1447, DOI 10.1097/01.aids.0000233579.79714.8d; SHIVANA O, 2009, S AFRICAN NATL HIV P; Smith A., 2010, Morbidity and Mortality Weekly Report, V59, P1201; Zhang FJ, 2011, LANCET INFECT DIS, V11, P516, DOI 10.1016/S1473-3099(11)70097-4	10	17	17	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 2	2011	474	7349					29	31		10.1038/474029a	http://dx.doi.org/10.1038/474029a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	771KV	21637237	Green Published, Bronze			2022-12-24	WOS:000291156700019
J	McCannon, J; Berwick, DM				McCannon, Joseph; Berwick, Donald M.			A New Frontier in Patient Safety	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Berwick, Donald M.] US Dept HHS, Ctr Medicare Serv, Washington, DC 20201 USA; US Dept HHS, Ctr Medicaid Serv, Washington, DC 20201 USA	Centers for Medicare & Medicaid Services; Centers for Medicare & Medicaid Services	Berwick, DM (corresponding author), US Dept HHS, Ctr Medicare Serv, 200 Independence Ave SW,Ste 314, Washington, DC 20201 USA.	donald.berwick@cms.hhs.gov						[Anonymous], 2010, OEI06Y0900090; Berenholtz SM, 2011, INFECT CONT HOSP EP, V32, P305, DOI 10.1086/658938; Haynes Alex B, 2009, N Engl J Med, V360, P491, DOI 10.1056/NEJMsa0810119; Interagency Working Group on Health Care Quality for the National Quality Strategy, NAT QUAL STRAT; Kohn LT, 2000, ERR IS HUMAN BUILDIN; Landrigan CP, 2010, NEW ENGL J MED, V363, P2124, DOI 10.1056/NEJMsa1004404; Pronovost PJ, 2011, HEALTH AFFAIR, V30, P628, DOI 10.1377/hlthaff.2011.0047; Srinivasan A., 2011, Morbidity and Mortality Weekly Report, V60, P243	8	32	32	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 1	2011	305	21					2221	2222		10.1001/jama.2011.742	http://dx.doi.org/10.1001/jama.2011.742			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	770RN	21632485				2022-12-24	WOS:000291106300025
J	Cooper, KL; Hu, JKH; ten Berge, D; Fernandez-Teran, M; Ros, MA; Tabin, CJ				Cooper, Kimberly L.; Hu, Jimmy Kuang-Hsien; ten Berge, Derk; Fernandez-Teran, Marian; Ros, Maria A.; Tabin, Clifford J.			Initiation of Proximal-Distal Patterning in the Vertebrate Limb by Signals and Growth	SCIENCE			English	Article							TISSUE INTERACTIONS; GENE-EXPRESSION; CELL FATE; WING-BUD; CHICK; SPECIFICATION; OUTGROWTH; AXIS; WNT	Two broad classes of models have been proposed to explain the patterning of the proximal-distal axis of the vertebrate limb (from the shoulder to the digit tips). Differentiating between them, we demonstrate that early limb mesenchyme in the chick is initially maintained in a state capable of generating all limb segments through exposure to a combination of proximal and distal signals. As the limb bud grows, the proximal limb is established through continued exposure to flank-derived signal(s), whereas the developmental program determining the medial and distal segments is initiated in domains that grow beyond proximal influence. In addition, the system we have developed, combining in vitro and in vivo culture, opens the door to a new level of analysis of patterning mechanisms in the limb.	[Cooper, Kimberly L.; Hu, Jimmy Kuang-Hsien; Tabin, Clifford J.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [ten Berge, Derk] Erasmus MC, Erasmus MC Stem Cell Inst, Dept Cell Biol, NL-3000 CA Rotterdam, Netherlands; [Fernandez-Teran, Marian; Ros, Maria A.] Univ Cantabria, Inst Biomed & Biotecnol CSIC UC IDICAN, E-39011 Santander, Spain	Harvard University; Harvard Medical School; Erasmus University Rotterdam; Erasmus MC; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Cantabria; CSIC - Instituto de Biomedicina y Biotecnologia de Cantabria (IBBTEC)	Tabin, CJ (corresponding author), Harvard Univ, Sch Med, Dept Genet, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	tabin@genetics.med.harvard.edu	Berge, David/P-2179-2017; Ros, Maria A./K-8160-2014; Berge, Derk ten/C-1967-2012; Berge, Derk ten/ABF-2591-2020	Berge, David/0000-0002-2918-1824; Ros, Maria A./0000-0002-1224-7671; Berge, Derk ten/0000-0002-5863-0860; Fernandez-Teran, M. Angeles/0000-0002-9019-1837; Hu, Jimmy/0000-0003-1035-0779	NIH [R37HD032443]; Spanish Ministry of Science and Innovation [BFU2008-00397]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD032443] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank R. Nusse for generously providing Wnt3a protein, G. Martin for helpful discussions, M. Torres for sharing data before publication, and J. Gros for assistance with confocal live imaging. This work was supported by an NIH grant, R37HD032443, to C. T. and by BFU2008-00397, from the Spanish Ministry of Science and Innovation to M.R.	AHRENS PB, 1977, DEV BIOL, V60, P69, DOI 10.1016/0012-1606(77)90110-5; Cunningham TJ, 2011, DEV DYNAM, V240, P1142, DOI 10.1002/dvdy.22583; Dudley AT, 2002, NATURE, V418, P539, DOI 10.1038/nature00945; Fernandez-Teran M, 1999, CELL TISSUE RES, V296, P121, DOI 10.1007/s004410051273; Galloway JL, 2009, NATURE, V460, P400, DOI 10.1038/nature08117; Hamburger H, 1951, J MORPHOL, V88, P49; Herrmann H, 1967, Natl Cancer Inst Monogr, V26, P303; KRABBENHOFT KM, 1989, DEV BIOL, V131, P373, DOI 10.1016/S0012-1606(89)80011-9; LEWIS JH, 1975, J EMBRYOL EXP MORPH, V33, P419; Mariani FV, 2008, NATURE, V453, P401, DOI 10.1038/nature06876; Mercader N, 2000, DEVELOPMENT, V127, P3961; Mic FA, 2003, P NATL ACAD SCI USA, V100, P7135, DOI 10.1073/pnas.1231422100; Nelson CE, 1996, DEVELOPMENT, V122, P1449; Pascoal S, 2007, J MOL BIOL, V368, P303, DOI 10.1016/j.jmb.2007.01.089; RAWLES ME, 1963, J EMBRYOL EXP MORPH, V11, P765; Ros MA, 2000, METH MOL B, V137, P245; Rosello-Diez A, 2011, SCIENCE, V332, P1086, DOI 10.1126/science.1199489; Sato K, 2007, DEVELOPMENT, V134, P1397, DOI 10.1242/dev.02822; SEARLS RL, 1971, DEV BIOL, V24, P198, DOI 10.1016/0012-1606(71)90095-9; SUMMERBELL D, 1973, NATURE, V244, P492, DOI 10.1038/244492a0; Tabin C, 2007, GENE DEV, V21, P1433, DOI 10.1101/gad.1547407; ten Berge D, 2008, DEVELOPMENT, V135, P3247, DOI 10.1242/dev.023176; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Zhao XL, 2009, CURR BIOL, V19, P1050, DOI 10.1016/j.cub.2009.04.059; ZWILLING E, 1964, DEV BIOL, V9, P20, DOI 10.1016/0012-1606(64)90012-0	25	111	113	0	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 27	2011	332	6033					1083	1086		10.1126/science.1199499	http://dx.doi.org/10.1126/science.1199499			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769FN	21617075	Green Accepted, Green Submitted			2022-12-24	WOS:000290996700044
J	Chew, EY				Chew, Emily Y.			Fatty Acids and Retinopathy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									NEI, Clin Trials Branch, Div Epidemiol & Clin Applicat, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Chew, EY (corresponding author), NEI, Clin Trials Branch, Div Epidemiol & Clin Applicat, NIH, Bethesda, MD 20892 USA.							Connor KM, 2007, NAT MED, V13, P868, DOI 10.1038/nm1591; SanGiovanni JP, 2008, ARCH OPHTHALMOL-CHIC, V126, P1274, DOI 10.1001/archopht.126.9.1274; Sapieha P, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001571; Stahl A, 2010, CIRC RES, V107, P495, DOI 10.1161/CIRCRESAHA.110.221317	4	7	8	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 19	2011	364	20					1970	1971		10.1056/NEJMcibr1101606	http://dx.doi.org/10.1056/NEJMcibr1101606			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	765PJ	21591950				2022-12-24	WOS:000290720700016
J	Prud'homme, B; Minervino, C; Hocine, M; Cande, JD; Aouane, A; Dufour, HD; Kassner, VA; Gompel, N				Prud'homme, Benjamin; Minervino, Caroline; Hocine, Melanie; Cande, Jessica D.; Aouane, Aicha; Dufour, Heloise D.; Kassner, Victoria A.; Gompel, Nicolas			Body plan innovation in treehoppers through the evolution of an extra wing-like appendage	NATURE			English	Article							BEETLE TRIBOLIUM-CASTANEUM; INSECT WINGS; GENE; CONSTRAINTS; ORIGIN	Body plans, which characterize the anatomical organization of animal groups of high taxonomic rank(1), often evolve by the reduction or loss of appendages (limbs in vertebrates and legs and wings in insects, for example). In contrast, the addition of new features is extremely rare and is thought to be heavily constrained, although the nature of the constraints remains elusive(2-4). Here we show that the treehopper (Membracidae) 'helmet' is actually an appendage, a wing serial homologue on the first thoracic segment. This innovation in the insect body plan is an unprecedented situation in 250 Myr of insect evolution. We provide evidence suggesting that the helmet arose by escaping the ancestral repression of wing formation imparted by a member of the Hox gene family, which sculpts the number and pattern of appendages along the body axis(5-8). Moreover, we propose that the exceptional morphological diversification of the helmet was possible because, in contrast to the wings, it escaped the stringent functional requirements imposed by flight. This example illustrates how complex morphological structures can arise by the expression of ancestral developmental potentials and fuel the morphological diversification of an evolutionary lineage.	[Prud'homme, Benjamin; Minervino, Caroline; Hocine, Melanie; Cande, Jessica D.; Aouane, Aicha; Gompel, Nicolas] CNRS, UMR 6216, Inst Biol Dev Marseille Luminy, F-13288 Marseille 9, France; [Dufour, Heloise D.; Kassner, Victoria A.] Univ Wisconsin, Madison, WI 53706 USA; [Dufour, Heloise D.; Kassner, Victoria A.] Howard Hughes Med Inst, Bock Labs, Madison, WI 53706 USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; University of Wisconsin System; University of Wisconsin Madison; Howard Hughes Medical Institute	Prud'homme, B (corresponding author), CNRS, UMR 6216, Inst Biol Dev Marseille Luminy, Case 907,Parc Sci Luminy, F-13288 Marseille 9, France.	benjamin.prudhomme@univmed.fr; nicolas.gompel@univmed.fr		Hocine, Melanie/0000-0003-2830-9918; Dufour, Heloise/0000-0001-7934-7549; Gompel, Nicolas/0000-0003-3358-7963	EURYI award; Human Frontier Science Program; CNRS	EURYI award(European Science Foundation (ESF)); Human Frontier Science Program(Human Frontier Science Program); CNRS(Centre National de la Recherche Scientifique (CNRS))	We are grateful to G. Moragues for inspiring the project and the loan of specimens. We thank S. B. Carroll for discussions and support during the early stage of the project; M. Morgan and S. Morgan for access to their field property; J. P. Chauvin for assistance with SEM; S. McKamey and C. Dietrich for help with bibliography; D. Milo for discussions; and D. Andrews, M. Averof, S. B. Carroll, A. Kopp, A. Salzberg and Y. Tomoyasu for sharing reagents. We used FlyBase for information support. We also thank F. Leulier, T. Lecuit, M. Averof, C. Desplan and S. B. Carroll for comments on the manuscript. This work was supported by a EURYI award, a Human Frontier Science Program Career Development Award and the CNRS. J.D.C. was supported by a Human Frontier Science Program Long-term fellowship.	Angelini DR, 2005, ANNU REV GENET, V39, P95, DOI 10.1146/annurev.genet.39.073003.112310; Averof M, 1997, NATURE, V385, P627, DOI 10.1038/385627a0; BEEMAN RW, 1989, DEV BIOL, V133, P196, DOI 10.1016/0012-1606(89)90311-4; Boulard M., 1973, Bulletin Mus Natn Hist nat Paris, V83, P145; Brakefield PM, 2006, TRENDS ECOL EVOL, V21, P362, DOI 10.1016/j.tree.2006.05.001; CARROLL SB, 1995, NATURE, V375, P58, DOI 10.1038/375058a0; Chesebro J, 2009, DEV BIOL, V329, P142, DOI 10.1016/j.ydbio.2009.01.032; Cifuentes FJ, 1997, P NATL ACAD SCI USA, V94, P11405, DOI 10.1073/pnas.94.21.11405; Cohn MJ, 1999, NATURE, V399, P474, DOI 10.1038/20944; Comstock JH, 1918, WINGS INSECTS; Darwin C., 1859, ORIGIN SPECIES MEANS; Di-Poi N, 2010, NATURE, V464, P99, DOI 10.1038/nature08789; Dietrich Christopher H., 2002, Denisia, V4, P155; Fowler W. W, 1894, BIOL CENTRALI AM, P1; Grimaldi David, 2005, pi; KUKALOVAPECK J, 1978, J MORPHOL, V156, P53, DOI 10.1002/jmor.1051560104; Moczek AP, 2006, DEV GENES EVOL, V216, P655, DOI 10.1007/s00427-006-0087-2; Pavlopoulos A, 2009, P NATL ACAD SCI USA, V106, P13897, DOI 10.1073/pnas.0902804106; Poinar Jr. G.O., 1999, AMBER FOREST; POULTON EB, 1903, MONOGRAPH MEMBRACIDA, P273; Raff R. A., 1996, SHAPE LIFE GENES DEV; Richter L., 1953, Lozania, Vno. 7, P1; RIEDL R, 1977, Q REV BIOL, V52, P351, DOI 10.1086/410123; Rogers BT, 1997, DEVELOPMENT, V124, P149; SMITH JM, 1985, Q REV BIOL, V60, P265, DOI 10.1086/414425; Snodgrass RE, 1935, PRINCIPLES INSECT MO; Snodgrass Robert Evans, 1909, Proceedings of the United States National Museum Smithsonian Institution Washington, V36; Stegmann UE, 1998, J MORPHOL, V238, P157, DOI 10.1002/(SICI)1097-4687(199811)238:2<157::AID-JMOR3>3.0.CO;2-H; Tomoyasu Y, 2005, NATURE, V433, P643, DOI 10.1038/nature03272	29	65	68	0	116	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 5	2011	473	7345					83	86		10.1038/nature09977	http://dx.doi.org/10.1038/nature09977			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759CQ	21544145				2022-12-24	WOS:000290218300035
J	Moxon, ER; Das, P; Greenwood, B; Heymann, DL; Horton, R; Levine, OS; Plotkin, S; Nossal, G				Moxon, E. Richard; Das, Pamela; Greenwood, Brian; Heymann, David L.; Horton, Richard; Levine, Orin S.; Plotkin, Stanley; Nossal, Gus			A call to action for the new decade of vaccines	LANCET			English	Editorial Material							PREVENTION		[Moxon, E. Richard] Univ Oxford, John Radcliffe Hosp, Dept Paediat, Oxford OX3 9DU, England; [Das, Pamela; Horton, Richard] The Lancet, London NW1 7BY, England; [Greenwood, Brian; Heymann, David L.] London Sch Hyg & Trop Med, London WC1, England; [Levine, Orin S.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Plotkin, Stanley] Univ Penn, Philadelphia, PA 19104 USA; [Nossal, Gus] Univ Melbourne, Dept Pathol, Melbourne, Vic 3010, Australia	University of Oxford; University of London; London School of Hygiene & Tropical Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Pennsylvania; University of Melbourne	Moxon, ER (corresponding author), Univ Oxford, John Radcliffe Hosp, Dept Paediat, Oxford OX3 9DU, England.	richard.moxon@paediatrics.ox.ac.uk						Barnighausen T, 2011, VACCINE, V29, P2371, DOI 10.1016/j.vaccine.2010.11.090; BLOOM DE, 2010, WORLD ECON, V6, P15; Chandran A, 2010, BIOL-TARGETS THER, V4, P213; Clemens J, 2005, NAT MED, V11, pS12, DOI 10.1038/nm1225; Coates TJ, 2008, LANCET, V372, P669, DOI 10.1016/S0140-6736(08)60886-7; *GAVI ALL, GAVI ALL STRAT BUS P; GAVI Alliance, FACTS FIG; Hargreaves JR, 2011, LANCET, V378, P1885, DOI 10.1016/S0140-6736(11)60687-9; Kersten G, 2007, EXPERT OPIN DRUG DEL, V4, P459, DOI 10.1517/17425247.4.5.459; LaForce FM, 2009, VACCINE, V27, pB13, DOI 10.1016/j.vaccine.2009.04.062; Larson HJ, 2011, LANCET, V378, P526, DOI 10.1016/S0140-6736(11)60678-8; Low N, 2008, VACCINE, V26, P383, DOI 10.1016/j.vaccine.2007.11.010; Moxon ER, 2011, LANCET, V378, P348, DOI 10.1016/S0140-6736(11)60407-8; NOSSAL GJV, PHIL T R B IN PRESS; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Padian NS, 2008, LANCET, V372, P585, DOI 10.1016/S0140-6736(08)60885-5; PLOTKIN SA, 2009, VACCINES, V16, P1709; Rappuoli R, 2011, LANCET, V378, P360, DOI 10.1016/S0140-6736(11)60440-6; Senouci K, 2010, VACCINE, V28, pA26, DOI 10.1016/j.vaccine.2010.02.028; Shiffman J, 2010, LANCET, V375, P2045, DOI 10.1016/S0140-6736(10)60710-6; SMITH J, 2011, LANCET	21	23	23	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 23	2011	378	9788					298	302		10.1016/S0140-6736(11)60766-6	http://dx.doi.org/10.1016/S0140-6736(11)60766-6			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	803XL	21664682				2022-12-24	WOS:000293615800008
J	Hart, CL; Gruer, L; Watt, GCM				Hart, Carole L.; Gruer, Laurence; Watt, Graham C. M.			Cause specific mortality, social position, and obesity among women who had never smoked: 28 year cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							LUNG-FUNCTION; BODY-MASS; SMOKING; MEN; DISEASE; HEALTH; RISK; INEQUALITIES; OVERWEIGHT; SCOTLAND	Objective To investigate the relations between causes of death, social position, and obesity in women who had never smoked. Design Prospective cohort study. Setting Renfrew and Paisley, Scotland. Participants 8353 women and 7049 men aged 45-64 were recruited to the Renfrew and Paisley Study in 1972-6. Of these, 3613 women had never smoked and were the focus of this study. They were categorised by occupational class (I and II, III non-manual, III manual, and IV and V) and body mass index groups (normal weight, overweight, moderately obese, and severely obese). Main outcome measures All cause and cause specific mortality during 28 years of follow-up by occupational class and body mass index, using Cox proportional hazards models adjusted for age and other confounders. Results The women in lower occupational classes who had never smoked were on average shorter and had poorer lung function and higher systolic blood pressure than women in the higher occupational classes. Overall, 43% (n=1555) were overweight, 14% (n=515) moderately obese, and 5% (n=194) severely obese. Obesity rates were higher in lower occupational classes and much higher in all occupational classes than in current smokers in the full cohort. Half the women died, 51% (n=916) from cardiovascular disease and 27% (n=487) from cancer. Relative to occupational class I and II, all cause mortality rates were more than a third higher in occupational classes III manual (relative rate 1.35, 95% confidence interval 1.16 to 1.57) and IV and V (1.34, 1.17 to 1.55) and largely explained by differences in obesity, systolic blood pressure, and lung function. Similar upward gradients were seen for cardiovascular disease and respiratory disease but not for cancer. Mortality rates were highest in severely obese women in the lowest occupational classes. Conclusions Women who had never smoked and were not obese had the lowest mortality rates, regardless of their social position. Where obesity is socially patterned as in this cohort, it may contribute to health inequalities and increase pressure on health and social services serving more disadvantaged populations.	[Hart, Carole L.; Watt, Graham C. M.] Univ Glasgow, Inst Hlth & Wellbeing, Glasgow G12 8RZ, Lanark, Scotland; [Gruer, Laurence] NHS Hlth Scotland, Glasgow, Lanark, Scotland	University of Glasgow	Hart, CL (corresponding author), Univ Glasgow, Inst Hlth & Wellbeing, Glasgow G12 8RZ, Lanark, Scotland.	carole.hart@glasgow.ac.uk		Gruer, Laurence/0000-0002-1089-2896	NHS Health Scotland; University of Glasgow	NHS Health Scotland; University of Glasgow	This research was supported by NHS Health Scotland. CLH and LG were funded by NHS Health Scotland and GCMW by the University of Glasgow. They had no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; and in the decision to submit the article for publication. The researchers were independent of the funders. All decisions relating to the study were made by the authors alone. The views expressed in the paper may not reflect those of the funding organisations.	Aekplakorn Wichai, 2004, Journal of the Medical Association of Thailand, V87, P685; [Anonymous], 1965, LANCET, V1, P775; Cavelaars AEJM, 2000, BRIT MED J, V320, P1102, DOI 10.1136/bmj.320.7242.1102; Corbett J, 2009, SCOTTISH HLTH SURVEY; DALLOSSO HM, 1984, INT J OBESITY, V8, P365; Flegal KM, 2007, JAMA-J AM MED ASSOC, V298, P2028, DOI 10.1001/jama.298.17.2028; General Register Office, 1966, CLASS OCC 1966, P1; Gruer L, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b480; Hart CL, 2005, INT J EPIDEMIOL, V34, P28, DOI 10.1093/ije/dyh348; Haslam D, 2006, BMJ-BRIT MED J, V333, P640, DOI 10.1136/bmj.333.7569.640; HAWTHORNE VM, 1995, SCOT MED J, V40, P102, DOI 10.1177/003693309504000402; Hole DJ, 1996, BRIT MED J, V313, P711; Hotchkiss JW, 2010, J EPIDEMIOL COMMUN H, V64, pA12, DOI 10.1136/jech.2010.120956.31; Huisman M, 2005, TOB CONTROL, V14, P106, DOI 10.1136/tc.2004.008573; Law MR, 1998, J EPIDEMIOL COMMUN H, V52, P344, DOI 10.1136/jech.52.6.344; Lawlor DA, 2006, OBESITY, V14, P2294, DOI 10.1038/oby.2006.269; Mackenbach JP, 2008, NEW ENGL J MED, V358, P2468, DOI 10.1056/NEJMsa0707519; Mannino DM, 2006, EUR RESPIR J, V27, P627, DOI 10.1183/09031936.06.00024605; Meyer HE, 2002, MED SCI SPORT EXER, V34, P1065, DOI 10.1097/00005768-200207000-00002; Nechuta SJ, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000339; ROSE GA, 1962, B WORLD HEALTH ORGAN, V27, P645; Sabia S, 2010, AM J EPIDEMIOL, V172, P1415, DOI 10.1093/aje/kwq294; Singh PN, 1998, EPIDEMIOLOGY, V9, P246, DOI 10.1097/00001648-199805000-00007; Stringhini S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000419; Stringhini S, 2010, JAMA-J AM MED ASSOC, V303, P1159, DOI 10.1001/jama.2010.297; World Health Organization Commission on Social Inequalities in Health, 2007, ACH HLTH EQ ROOT CAU	26	19	19	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 28	2011	342								d3785	10.1136/bmj.d3785	http://dx.doi.org/10.1136/bmj.d3785			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	788PY	21712337	Green Submitted, Green Accepted, hybrid, Green Published			2022-12-24	WOS:000292458100003
J	Cymes, GD; Grosman, C				Cymes, Gisela D.; Grosman, Claudio			Tunable pK(a) values and the basis of opposite charge selectivities in nicotinic-type receptors	NATURE			English	Article							CONGENITAL MYASTHENIC SYNDROME; GATED ION CHANNELS; ACETYLCHOLINE-RECEPTOR; SINGLE-CHANNEL; DIELECTRIC-CONSTANTS; CHLORIDE CHANNEL; M2 DOMAIN; MUTATIONS; PORE; SUBUNIT	Among ion channels, only the nicotinic-receptor superfamily has evolved to generate both cation-and anion-selective members. Although other, structurally unrelated, neurotransmitter-gated cation channels exist, no other type of neurotransmitter-gated anion channel, and thus no other source of fast synaptic inhibitory signals, has been described so far. In addition to the seemingly straightforward electrostatic effect of the presence (in the cation-selective members) or absence (in the anion-selective ones) of a ring of pore-facing carboxylates, mutational studies have identified other features of the amino-acid sequence near the intracellular end of the pore-lining transmembrane segments (M2) that are also required to achieve the high charge selectivity shown by native channels(1-10). However, the mechanism underlying this more subtle effect has remained elusive(11) and a subject of speculation. Here we show, using single-channel electrophysiological recordings to estimate the protonation state of native ionizable side chains, that anion-selective-type sequences favour whereas cation-selective-type sequences prevent the protonation of the conserved, buried basic residues at the intracellular entrance of the pore (the M2 0' position). We conclude that the previously unrecognized tunable charge state of the 0' ring of buried basic side chains is an essential feature of these channels' versatile charge-selectivity filter.	[Cymes, Gisela D.; Grosman, Claudio] Univ Illinois, Ctr Biophys & Computat Biol, Dept Mol & Integrat Physiol, Urbana, IL 61801 USA; [Cymes, Gisela D.; Grosman, Claudio] Univ Illinois, Neurosci Program, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Grosman, C (corresponding author), Univ Illinois, Ctr Biophys & Computat Biol, Dept Mol & Integrat Physiol, Urbana, IL 61801 USA.	grosman@illinois.edu		Grosman, Claudio/0000-0001-8093-8362; Cymes, Gisela/0000-0002-4155-585X	US National Institutes of Health [R01-NS042169]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042169] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank S. Sine for wild-type muscle AChR cDNA; M. Slaughter and D. Papke for wild-type alpha 1 GlyR cDNA; S. Elenes for critical advice on fast-perfusion experiments; E. Jakobsson and H. Robertson for discussions; and G. Papke, M. Maybaum, J. Pizarek and C. Staehlin for technical assistance. This work was supported by a grant from the US National Institutes of Health (R01-NS042169 to C.G.).	BARRY PH, 1991, J MEMBRANE BIOL, V121, P101, DOI 10.1007/BF01870526; Beg AA, 2003, NAT NEUROSCI, V6, P1145, DOI 10.1038/nn1136; Bocquet N, 2007, NATURE, V445, P116, DOI 10.1038/nature05371; Chimenti MS, 2011, J MOL BIOL, V405, P361, DOI 10.1016/j.jmb.2010.10.001; Corringer PJ, 1999, NEURON, V22, P831, DOI 10.1016/S0896-6273(00)80741-2; CULLY DF, 1994, NATURE, V371, P707, DOI 10.1038/371707a0; Cymes GD, 2005, NATURE, V438, P975, DOI 10.1038/nature04293; Cymes GD, 2008, NAT STRUCT MOL BIOL, V15, P389, DOI 10.1038/nsmb.1407; Elenes S, 2006, J GEN PHYSIOL, V128, P615, DOI 10.1085/jgp.200609570; Engel AG, 1996, HUM MOL GENET, V5, P1217, DOI 10.1093/hmg/5.9.1217; GALZI JL, 1992, NATURE, V359, P500, DOI 10.1038/359500a0; Grosman C, 2000, J GEN PHYSIOL, V115, P637, DOI 10.1085/jgp.115.5.637; Gunthorpe MJ, 2001, J BIOL CHEM, V276, P10977, DOI 10.1074/jbc.M009575200; Harms MJ, 2009, J MOL BIOL, V389, P34, DOI 10.1016/j.jmb.2009.03.039; Jensen ML, 2002, J BIOL CHEM, V277, P41438, DOI 10.1074/jbc.M205645200; Kamerlin SCL, 2009, J PHYS CHEM B, V113, P1253, DOI 10.1021/jp8071712; Karp DA, 2010, BIOCHEMISTRY-US, V49, P4138, DOI 10.1021/bi902114m; Keramidas A, 2000, BIOPHYS J, V79, P247, DOI 10.1016/S0006-3495(00)76287-4; Keramidas A, 2004, PROG BIOPHYS MOL BIO, V86, P161, DOI 10.1016/j.pbiomolbio.2003.09.002; Keramidas A, 2002, J GEN PHYSIOL, V119, P393, DOI 10.1085/jgp.20028552; Krishek BJ, 1996, MOL PHARMACOL, V49, P494; Lee DJS, 2003, NEUROSCI LETT, V351, P196, DOI 10.1016/j.neulet.2003.08.005; Menard C, 2005, J BIOL CHEM, V280, P27502, DOI 10.1074/jbc.M501624200; OHNO K, 1995, P NATL ACAD SCI USA, V92, P758, DOI 10.1073/pnas.92.3.758; Papke D, 2011, J PHYSIOL-LONDON, V589, P1571, DOI 10.1113/jphysiol.2010.203315; Qin F, 2004, BIOPHYS J, V86, P1488, DOI 10.1016/S0006-3495(04)74217-4; Qin F, 1996, BIOPHYS J, V70, P264, DOI 10.1016/S0006-3495(96)79568-1; Schutz CN, 2001, PROTEINS, V44, P400, DOI 10.1002/prot.1106; Sunesen M, 2006, J BIOL CHEM, V281, P14875, DOI 10.1074/jbc.M511657200; Thompson AJ, 2003, BRIT J PHARMACOL, V140, P359, DOI 10.1038/sj.bjp.0705424; van Nierop P, 2005, J NEUROSCI, V25, P10617, DOI 10.1523/JNEUROSCI.2015-05.2005; Wotring VE, 2003, J PHYSIOL-LONDON, V548, P527, DOI 10.1113/jphysiol.2002.032045	32	21	21	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 23	2011	474	7352					526	U160		10.1038/nature10015	http://dx.doi.org/10.1038/nature10015			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	781NJ	21602825	Green Accepted			2022-12-24	WOS:000291939700052
J	Hope, T; McMillan, J				Hope, Tony; McMillan, John			The art of medicine Advance decisions, chronic mental illness, and everyday care	LANCET			English	Editorial Material							DEMENTIA; CAPACITY		[Hope, Tony] Univ Oxford, Ethox Ctr, Oxford OX3 7LF, England; [McMillan, John] Flinders Med Ctr, Sch Med, Adelaide, SA 5001, Australia	University of Oxford; Flinders Medical Centre	Hope, T (corresponding author), Univ Oxford, Ethox Ctr, Oxford OX3 7LF, England.	tonyhope@doctors.org.uk	McMillan, John/S-9660-2018	McMillan, John/0000-0002-7507-1861				Agich G, 2003, DEPENDENCE AUTONOMY; David A., 2010, BRIT MED J, V341, P587; Dresser R, 1995, HASTINGS CENT REP, V25, P32, DOI 10.2307/3527839; Dworkin R., 1993, LIFES DOMINION; Hope T, 2009, J MED ETHICS, V35, P733, DOI 10.1136/jme.2009.030783; Jaworska A, 1999, PHILOS PUBLIC AFF, V28, P105, DOI 10.1111/j.1088-4963.1999.00105.x; Nuffield Council on Bioethics, DEM ETH ISS	7	1	1	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 18	2011	377	9783					2076	2077		10.1016/S0140-6736(11)60909-4	http://dx.doi.org/10.1016/S0140-6736(11)60909-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	783XI	21692228	Bronze			2022-12-24	WOS:000292117800016
J	Maekawa, M; Yamaguchi, K; Nakamura, T; Shibukawa, R; Kodanaka, I; Ichisaka, T; Kawamura, Y; Mochizuki, H; Goshima, N; Yamanaka, S				Maekawa, Momoko; Yamaguchi, Kei; Nakamura, Tomonori; Shibukawa, Ran; Kodanaka, Ikumi; Ichisaka, Tomoko; Kawamura, Yoshifumi; Mochizuki, Hiromi; Goshima, Naoki; Yamanaka, Shinya			Direct reprogramming of somatic cells is promoted by maternal transcription factor Glis1	NATURE			English	Article							PLURIPOTENT STEM-CELLS; GENERATION; PROTEIN; MOUSE; FIBROBLASTS	Induced pluripotent stem cells (iPSCs) are generated from somatic cells by the transgenic expression of three transcription factors collectively called OSK: Oct3/4 (also called Pou5f1), Sox2 and Klf4(1). However, the conversion to iPSCs is inefficient. The protooncogene Myc enhances the efficiency of iPSC generation by OSK but it also increases the tumorigenicity of the resulting iPSCs(2). Here we show that the Gli-like transcription factor Glis1 (Glis family zinc finger 1) markedly enhances the generation of iPSCs from both mouse and human fibroblasts when it is expressed together with OSK. Mouse iPSCs generated using this combination of transcription factors can form germline-competent chimaeras. Glis1 is enriched in unfertilized oocytes and in embryos at the one-cell stage. DNA microarray analyses show that Glis1 promotes multiple pro-reprogramming pathways, including Myc, Nanog, Lin28, Wnt, Essrb and the mesenchymal-epithelial transition. These results therefore show that Glis1 effectively promotes the direct reprogramming of somatic cells during iPSC generation.	[Maekawa, Momoko; Nakamura, Tomonori; Shibukawa, Ran; Kodanaka, Ikumi; Ichisaka, Tomoko; Yamanaka, Shinya] Kyoto Univ, Ctr iPS Cell Res & Applicat CiRA, Kyoto 6068507, Japan; [Maekawa, Momoko; Shibukawa, Ran; Kodanaka, Ikumi; Yamanaka, Shinya] JST, Yamanaka iPS Cell Special Project, Kawaguchi, Saitama 3320012, Japan; [Yamaguchi, Kei; Kawamura, Yoshifumi; Mochizuki, Hiromi] Japan Biol Informat Consortium, Tokyo 1350064, Japan; [Nakamura, Tomonori; Ichisaka, Tomoko; Yamanaka, Shinya] Kyoto Univ, Inst Integrated Cell Mat Sci, Kyoto 6068507, Japan; [Goshima, Naoki] Natl Inst Adv Ind Sci & Technol, Biomed Informat Res Ctr, Tokyo 1350064, Japan; [Yamanaka, Shinya] Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA	Kyoto University; Japan Science & Technology Agency (JST); Kyoto University; National Institute of Advanced Industrial Science & Technology (AIST); University of California System; University of California San Francisco; The J David Gladstone Institutes	Yamanaka, S (corresponding author), Kyoto Univ, Ctr iPS Cell Res & Applicat CiRA, Kyoto 6068507, Japan.	n-goshima@aist.go.jp; yamanaka@cira.kyoto-u.ac.jp	Nakamura, Tomonori/V-8828-2019	Nakamura, Tomonori/0000-0002-0173-0780	New Energy and Industrial Technology Development Organization (NEDO); Ministry of Education, Culture, Sports, Science and Technology (MEXT); Japanese Society for the Promotion of Science (JSPS); Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO)	New Energy and Industrial Technology Development Organization (NEDO)(New Energy and Industrial Technology Development Organization (NEDO)); Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO)(National Institute of Biomedical Innovation)	We thank T. Yamamoto, Y. Yamada and the members of our laboratory for valuable scientific discussions and administrative support. We thank M. Nakagawa, H. Seki, M. Murakami, A. Okada, M. Narita, M. Inoue, H. Shiga and T. Matsumoto for technical assistance and H. Suemori (Kyoto University) for human ES cells. This work was supported in part by grants from the New Energy and Industrial Technology Development Organization (NEDO), the Leading Project of the Ministry of Education, Culture, Sports, Science and Technology (MEXT), the Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program) of the Japanese Society for the Promotion of Science (JSPS), Grants-in-Aid for Scientific Research from JSPS and MEXT, and the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO). S.Y. is a member of scientific advisory boards of iPearian Inc. and iPS Academia Japan.	Egli D, 2007, NATURE, V447, P679, DOI 10.1038/nature05879; Feng B, 2009, NAT CELL BIOL, V11, P197, DOI 10.1038/ncb1827; Goshima N, 2008, NAT METHODS, V5, P1011, DOI 10.1038/nmeth.1273; Guo GJ, 2010, DEV CELL, V18, P675, DOI 10.1016/j.devcel.2010.02.012; Hashimoto J, 2009, J BIOMOL SCREEN, V14, P970, DOI 10.1177/1087057109341406; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Kim YS, 2002, J BIOL CHEM, V277, P30901, DOI 10.1074/jbc.M203563200; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; Marson A, 2008, CELL STEM CELL, V3, P132, DOI 10.1016/j.stem.2008.06.019; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Nakagawa M, 2010, P NATL ACAD SCI USA, V107, P14152, DOI 10.1073/pnas.1009374107; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Yamanaka S, 2007, CELL STEM CELL, V1, P39, DOI 10.1016/j.stem.2007.05.012; Yamanaka S, 2010, NATURE, V465, P704, DOI 10.1038/nature09229; Yamanaka S, 2009, NATURE, V460, P49, DOI 10.1038/nature08180; Yamanaka S, 2009, CELL, V137, P13, DOI 10.1016/j.cell.2009.03.034; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	25	277	323	0	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 9	2011	474	7350					225	U268		10.1038/nature10106	http://dx.doi.org/10.1038/nature10106			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774PE	21654807	Green Submitted			2022-12-24	WOS:000291397800053
J	Slimak, L; Svendsen, JI; Mangerud, J; Plisson, H; Heggen, HP; Brugere, A; Pavlov, PY				Slimak, Ludovic; Svendsen, John Inge; Mangerud, Jan; Plisson, Hugues; Heggen, Herbjorn Presthus; Brugere, Alexis; Pavlov, Pavel Yurievich			Late Mousterian Persistence near the Arctic Circle	SCIENCE			English	Article							NORTHERN EURASIA; LATE QUATERNARY; EASTERN-EUROPE; NEANDERTHALS; SIBERIA; SITE; KOSTENKI; HISTORY; MAMMOTH; CLIMATE	Palaeolithic sites in Russian high latitudes have been considered as Upper Palaeolithic and thus representing an Arctic expansion of modern humans. Here we show that at Byzovaya, in the western foothills of the Polar Urals, the technological structure of the lithic assemblage makes it directly comparable with Mousterian Middle Palaeolithic industries that so far have been exclusively attributed to the Neandertal populations in Europe. Radiocarbon and optical-stimulated luminescence dates on bones and sand grains indicate that the site was occupied during a short period around 28,500 carbon-14 years before the present (about 31,000 to 34,000 calendar years ago), at the time when only Upper Palaeolithic cultures occupied lower latitudes of Eurasia. Byzovaya may thus represent a late northern refuge for Neandertals, about 1000 km north of earlier known Mousterian sites.	[Slimak, Ludovic] Univ Toulouse Le Mirail, CNRS, UMR 5608, TRACES, F-31058 Toulouse 9, France; [Svendsen, John Inge; Mangerud, Jan; Heggen, Herbjorn Presthus] Univ Bergen, Dept Earth Sci, N-5007 Bergen, Norway; [Svendsen, John Inge; Mangerud, Jan; Heggen, Herbjorn Presthus] Univ Bergen, Bjerknes Ctr Climate Res, N-5007 Bergen, Norway; [Plisson, Hugues] Univ Bordeaux 1, CNRS, UMR 5199, PACEA,IPGQ, F-33405 Talence, France; [Brugere, Alexis] CNRS, USR 3225, F-92023 Nanterre, France; [Brugere, Alexis] ArScAn, UMR 7041, F-92023 Nanterre, France; [Pavlov, Pavel Yurievich] Russian Acad Sci, Komi Sci Ctr, Inst Language Literature & Hist, Dept Archaeol, Syktyvkar 167000, Komi, Russia	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Toulouse; Universite de Toulouse - Jean Jaures; University of Bergen; Bjerknes Centre for Climate Research; University of Bergen; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Humanities & Social Sciences (INSHS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Humanities & Social Sciences (INSHS); Russian Academy of Sciences; Institute of Language, Literature & History, Komi Scientific Centre of the RAS; Komi Science Centre of the Ural Branch of the Russian Academy of Sciences	Slimak, L (corresponding author), Univ Toulouse Le Mirail, CNRS, UMR 5608, TRACES, 5 Allees Antonio Machado, F-31058 Toulouse 9, France.	slimak@univ-tlse2.fr	Pavlov, Pavel Yu/S-3823-2016; Slimak, Ludovic/AAG-7890-2020	Pavlov, Pavel Yu/0000-0001-8827-5719; 	Fondation des Maisons des Sciences de l'Homme; French-Russian Center for Social and Human Sciences in Moscow; French Ministry of Foreign and European Affairs; Research Council of Norway; Russian Foundation for Humanitarian Research [08-01-94952a]	Fondation des Maisons des Sciences de l'Homme; French-Russian Center for Social and Human Sciences in Moscow; French Ministry of Foreign and European Affairs; Research Council of Norway(Research Council of Norway); Russian Foundation for Humanitarian Research	L.S., H. P., and A. B. analyzed the archaeological material; J.I.S, J.M., and H. P. H. performed the stratigraphic, paleoenvironmental, and chronological descriptions and interpretations; and P.Y.P. organized the archaeological field missions. All contributed to the writing of the paper. Supported by the Fondation des Maisons des Sciences de l'Homme, the French-Russian Center for Social and Human Sciences in Moscow, the French Ministry of Foreign and European Affairs, the Research Council of Norway, and Russian Foundation for Humanitarian Research grant 08-01-94952a. Kh. A. Arslanov and S. Gulliksen performed the radiocarbon dating and A. Murray the OSL dating. We thank the Komi Scientific Centre in Syktyvkar; the museums of Pechora and of Syktyvkar; and the Institute of History of Material Culture of St. Petersburg, especially A. A. Sinitsyn and A. E. Matjuhin for access to their collections and N. N. Skakun for her help. We also thank E. Bjorseth for preparing Figs. 1 and 2 and figs. S1 and S2 and J. E. Lewis for improving the English.	Anikovich MV, 2007, SCIENCE, V315, P223, DOI 10.1126/science.1133376; Bader O.N., 1978, SUNGIR UPPER PALAEOL; Barroso Ruiz C, 2003, ARQUEOLOGIA MONOGRAF, V15; Blockley SPE, 2008, J HUM EVOL, V55, P764, DOI 10.1016/j.jhevol.2008.08.009; Bordes F., 1961, TYPOLOGIE PALEOLITHI; BOSINSKI G, 2001, ZEPHYRUS, V53, P77; Bosinski G., 1967, FUNDAMERTA A, V4; Finlayson C, 2006, NATURE, V443, P850, DOI 10.1038/nature05195; Giaccio B, 2008, J VOLCANOL GEOTH RES, V177, P208, DOI 10.1016/j.jvolgeores.2007.10.007; GUENTHER EW, 1991, ALTSTEINZEITLICHE FU, P101; GUSLITSER BI, 1965, SOVETSKAYA ARKHEOLOG, V2, P112; Heggen HP, 2010, BOREAS, V39, P116, DOI 10.1111/j.1502-3885.2009.00109.x; Higham T, 2006, P NATL ACAD SCI USA, V103, P553, DOI 10.1073/pnas.0510005103; Hoffecker JF, 2010, J ARCHAEOL SCI, V37, P1073, DOI 10.1016/j.jas.2009.12.008; Hubberten HW, 2004, QUATERNARY SCI REV, V23, P1333, DOI 10.1016/j.quascirev.2003.12.012; Hublin JJ, 2009, CR PALEVOL, V8, P503, DOI 10.1016/j.crpv.2009.04.001; Hublin JJ, 2007, RETHINKING HUMAN REV, P235; Joris O., 2004, BERICHTE R MISCH GER, V84, P49; Krause J, 2007, NATURE, V449, P902, DOI 10.1038/nature06193; Krause J, 2010, NATURE, V464, P894, DOI 10.1038/nature08976; Mangerud J, 2010, BOREAS, V39, P328, DOI 10.1111/j.1502-3885.2009.00127.x; Pavlov P, 2004, J HUM EVOL, V47, P3, DOI 10.1016/j.jhevol.2004.05.002; Pavlov P, 2001, NATURE, V413, P64, DOI 10.1038/35092552; Pavlov P., 1986, EXCAVATION BYZOVAYA, P7; Pitulko VV, 2004, SCIENCE, V303, P52, DOI 10.1126/science.1085219; Reich D, 2010, NATURE, V468, P1053, DOI 10.1038/nature09710; Reimer PJ, 2009, RADIOCARBON, V51, P1111, DOI 10.1017/S0033822200034202; Simonet P., 1991, Quaternaire, V2, P5; Sinitsyn AA, 2006, QUATERN INT, V152, P164, DOI 10.1016/j.quaint.2005.12.007; Slimak L., 2004, THESIS U PROVENCE AI; Stringer C, 2002, PHILOS T R SOC B, V357, P563, DOI 10.1098/rstb.2001.1057; Svendsen I.G., 2003, CHRONOLOGY AURIGNACI, V33, P109; Svendsen JI, 2004, QUATERNARY SCI REV, V23, P1229, DOI 10.1016/j.quascirev.2003.12.008; Svendsen JI, 2010, QUATERNARY SCI REV, V29, P3138, DOI 10.1016/j.quascirev.2010.06.043; Velichko AA, 2005, QUATERN INT, V126, P137, DOI 10.1016/j.quaint.2004.04.019; Wojtal P, 2005, J ARCHAEOL SCI, V32, P193, DOI 10.1016/j.jas.2004.08.005; ZilhAo J., 2006, FARMING, V2006, P95, DOI DOI 10.3828/BFARM.2006.3.3	38	54	57	0	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 13	2011	332	6031					841	845		10.1126/science.1203866	http://dx.doi.org/10.1126/science.1203866			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	763CD	21566192				2022-12-24	WOS:000290529900046
J	Borden, WB; Redberg, RF; Mushlin, AI; Dai, D; Kaltenbach, LA; Spertus, JA				Borden, William B.; Redberg, Rita F.; Mushlin, Alvin I.; Dai, David; Kaltenbach, Lisa A.; Spertus, John A.			Patterns and Intensity of Medical Therapy in Patients Undergoing Percutaneous Coronary Intervention	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CARDIOVASCULAR-DATA-REGISTRY; ST-SEGMENT ELEVATION; ARTERY-DISEASE; MYOCARDIAL-INFARCTION; SECONDARY PREVENTION; PRACTICE GUIDELINES; QUALITY; CARE; PREVALENCE; TRENDS	Context The Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) study, which provided optimal medical therapy (OMT) to all patients and demonstrated no incremental advantage of percutaneous coronary intervention (PCI) on outcomes other than angina-related quality of life in stable coronary artery disease (CAD), suggests that a trial of OMT is warranted before PCI. It is unknown to what degree OMT is applied before PCI in routine practice or whether its use increased after the COURAGE trial. Objective To examine the use of OMT in patients with stable angina undergoing PCI before and after the publication of the COURAGE trial. Design, Setting, and Participants An observational study of patients with stable CAD undergoing PCI in the National Cardiovascular Data Registry between September 1, 2005, and June 30, 2009. Analysis compared use of OMT, both before PCI and at the time of discharge, before and after the publication of the COURAGE trial. Optimal medical therapy was defined as either being prescribed or having a documented contraindication to all medicines (antiplatelet agent, beta-blocker, and statin). Main Outcome Measures Rates of OMT before PCI and at discharge (following PCI) between the 2 study periods. Results Among all 467 211 patients (173 416 before [37.1%] and 293 795 after [62.9%] the COURAGE trial) meeting study criteria, OMT was used in 206 569 patients (44.2%; 95% confidence interval [CI], 44.1%-44.4%) before PCI and in 303 864 patients (65.0%; 95% CI, 64.9%-65.2%) at discharge following PCI (P<.001). Before PCI, OMT was applied in 75 381 patients (43.5%; 95% CI, 43.2%-43.7%) before the COURAGE trial and in 131 188 patients (44.7%; 95% CI, 44.5%-44.8%) after the COURAGE trial (P<.001). The use of OMT at discharge following PCI before and after the COURAGE trial was 63.5% (95% CI, 63.3%-63.7%) and 66.0% (95% CI, 65.8%-66.1%), respectively (P<.001). Conclusion Among patients with stable CAD undergoing PCI, less than half were receiving OMT before PCI and approximately two-thirds were receiving OMT at discharge following PCI, with relatively little change in these practice patterns after publication of the COURAGE trial. JAMA. 2011;305(18):1882-1889 www.jama.com	[Borden, William B.] Cornell Univ, Weill Cornell Med Coll, Dept Med, New York, NY 10021 USA; [Borden, William B.; Mushlin, Alvin I.] Cornell Univ, Weill Cornell Med Coll, Dept Publ Hlth, New York, NY 10021 USA; [Redberg, Rita F.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Dai, David; Kaltenbach, Lisa A.] Duke Univ, Duke Clin Res Inst, Durham, NC USA; [Spertus, John A.] Univ Missouri, St Lukes Mid Amer Heart Inst, Kansas City, MO 64110 USA	Cornell University; Cornell University; University of California System; University of California San Francisco; Duke University; Saint Luke's Mid America Heart Institute; University of Missouri System; University of Missouri Kansas City	Borden, WB (corresponding author), Cornell Univ, Weill Cornell Med Coll, Dept Med, 1305 York Ave,8th Floor, New York, NY 10021 USA.	wbb2001@med.cornell.edu	Spertus, John/ABD-3075-2021		NCDR; American College of Cardiology Foundation; Weill Cornell Medical College; Agency for Healthcare Research and Quality [U18 HS016075]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [U18HS016075] Funding Source: NIH RePORTER	NCDR; American College of Cardiology Foundation(General Electric); Weill Cornell Medical College; Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	This work was supported by the NCDR, an initiative of the American College of Cardiology Foundation. Dr Borden is funded through a Nanette Laitman Clinical Scholar in Public Health award at the Weill Cornell Medical College. Dr Mushlin is funded in part by cooperative agreement U18 HS016075 from the Agency for Healthcare Research and Quality.	Ahmed B, 2011, CIRC-CARDIOVASC QUAL, V4, P300, DOI 10.1161/CIRCOUTCOMES.110.957175; Anderson HV, 2007, AM J CARDIOL, V99, P189, DOI 10.1016/j.amjcard.2006.07.083; Association of Amercian Medical Colleges, 2008, IND FUND MED ED; Atwater Brett D, 2009, Clin Cardiol, V32, pE1, DOI 10.1002/clc.20524; Avorn J, 2010, HEALTH AFFAIR, V29, P1891, DOI 10.1377/hlthaff.2010.0696; Boden WE, 2007, NEW ENGL J MED, V356, P1503, DOI 10.1056/NEJMoa070829; Boden WE, 2009, AM J CARDIOL, V104, P1, DOI 10.1016/j.amjcard.2009.02.059; Bonham AC, 2010, HEALTH AFFAIR, V29, P1901, DOI 10.1377/hlthaff.2010.0790; Brindis R G, 2001, J Am Coll Cardiol, V37, P2240, DOI 10.1016/S0735-1097(01)01372-9; Bucher HC, 2000, BMJ-BRIT MED J, V321, P73, DOI 10.1136/bmj.321.7253.73; Butler J, 2002, J AM COLL CARDIOL, V40, P1589, DOI 10.1016/S0735-1097(02)02379-3; Cutler JA, 2008, HYPERTENSION, V52, P818, DOI 10.1161/HYPERTENSIONAHA.108.113357; Davis D, 1999, JAMA-J AM MED ASSOC, V282, P867, DOI 10.1001/jama.282.9.867; Davis DA, 1997, CAN MED ASSOC J, V157, P408; Fraker Theodore D Jr, 2007, Circulation, V116, P2762, DOI 10.1161/CIRCULATIONAHA.107.187930; Gattis WA, 2004, AM J CARDIOL, V93, p74B, DOI 10.1016/j.amjcard.2004.01.019; GRIMSHAW JM, 1993, LANCET, V342, P1317, DOI 10.1016/0140-6736(93)92244-N; Hyre AD, 2007, ANN EPIDEMIOL, V17, P548, DOI 10.1016/j.annepidem.2007.01.032; Katritsis DG, 2005, CIRCULATION, V111, P2906, DOI 10.1161/CIRCULATIONAHA.104.521864; Kereiakes DJ, 2007, J AM COLL CARDIOL, V50, P1598, DOI 10.1016/j.jacc.2007.07.063; Krone RJ, 2006, CATHETER CARDIO INTE, V68, P696, DOI 10.1002/ccd.20910; Krumholz HM, 1998, JAMA-J AM MED ASSOC, V280, P623, DOI 10.1001/jama.280.7.623; Lin GA, 2007, ARCH INTERN MED, V167, P1604, DOI 10.1001/archinte.167.15.1604; Lin GA, 2010, MED CARE, V48, P733, DOI 10.1097/MLR.0b013e3181e35b3a; Lloyd-Jones D, 2009, CIRCULATION, V119, pE21, DOI 10.1161/CIRCULATIONAHA.108.191261; Maddox TM, 2010, CIRC-CARDIOVASC QUAL, V3, P632, DOI 10.1161/CIRCOUTCOMES.109.906214; Maron David J, 2011, Curr Treat Options Cardiovasc Med, V13, P16, DOI 10.1007/s11936-010-0104-7; Maron DJ, 2010, J AM COLL CARDIOL, V55, P1348, DOI 10.1016/j.jacc.2009.10.062; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; Mehta RH, 2006, ARCH INTERN MED, V166, P2027, DOI 10.1001/archinte.166.18.2027; Riley RF, 2011, CIRC-CARDIOVASC QUAL, V4, P193, DOI 10.1161/CIRCOUTCOMES.110.958744; Roe MT, 2005, ARCH INTERN MED, V165, P1630, DOI 10.1001/archinte.165.14.1630; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Smith SC, 2006, CIRCULATION, V113, P2363, DOI 10.1161/CIRCULATIONAHA.106.174516; Stafford RS, 2010, ARCH INTERN MED, V170, P851, DOI 10.1001/archinternmed.2010.130; Stafford RS, 2003, J AM COLL CARDIOL, V41, P56, DOI 10.1016/S0735-1097(02)02670-0; Steinberg BA, 2007, AM J CARDIOL, V99, P1212, DOI 10.1016/j.amjcard.2006.12.039; *VET AFF, VET AFF COOP STUD PR; Weintraub WS, 2008, NEW ENGL J MED, V359, P677, DOI 10.1056/NEJMoa072771; Yan AT, 2007, AM HEART J, V154, P1108, DOI 10.1016/j.ahj.2007.07.040; ISI WEB KNOWLEDGE IT	41	137	142	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 11	2011	305	18					1882	1889		10.1001/jama.2011.601	http://dx.doi.org/10.1001/jama.2011.601			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	761YH	21558519	Bronze			2022-12-24	WOS:000290438800025
J	Eyler, CE; Wu, QL; Yan, K; MacSwords, JM; Chandler-Militello, D; Misuraca, KL; Lathia, JD; Forrester, MT; Lee, J; Stamler, JS; Goldman, SA; Bredel, M; McLendon, RE; Sloan, AE; Hjelmeland, AB; Rich, JN				Eyler, Christine E.; Wu, Qiulian; Yan, Kenneth; MacSwords, Jennifer M.; Chandler-Militello, Devin; Misuraca, Katherine L.; Lathia, Justin D.; Forrester, Michael T.; Lee, Jeongwu; Stamler, Jonathan S.; Goldman, Steven A.; Bredel, Markus; McLendon, Roger E.; Sloan, Andrew E.; Hjelmeland, Anita B.; Rich, Jeremy N.			Glioma Stem Cell Proliferation and Tumor Growth Are Promoted by Nitric Oxide Synthase-2	CELL			English	Article							LYMPHOCYTIC-LEUKEMIA CELLS; HIGHLY SELECTIVE INHIBITOR; ACUTE MYELOID-LEUKEMIA; ISCHEMIC BRAIN-INJURY; MICE LACKING; IN-VIVO; HUMAN GLIOBLASTOMA; INITIATING CELLS; SEPTIC SHOCK; SELF-RENEWAL	Malignant gliomas are aggressive brain tumors with limited therapeutic options, and improvements in treatment require a deeper molecular understanding of this disease. As in other cancers, recent studies have identified highly tumorigenic subpopulations within malignant gliomas, known generally as cancer stem cells. Here, we demonstrate that glioma stem cells (GSCs) produce nitric oxide via elevated nitric oxide synthase-2 (NOS2) expression. GSCs depend on NOS2 activity for growth and tumorigenicity, distinguishing them from non-GSCs and normal neural progenitors. Gene expression profiling identified many NOS2-regulated genes, including the cell-cycle inhibitor cell division autoantigen-1 (CDA1). Further, high NOS2 expression correlates with decreased survival in human glioma patients, and NOS2 inhibition slows glioma growth in a murine intracranial model. These data provide insight into how GSCs are mechanistically distinct from their less tumorigenic counterparts and suggest that NOS2 inhibition may be an efficacious approach to treating this devastating disease.	[Eyler, Christine E.; Wu, Qiulian; Yan, Kenneth; MacSwords, Jennifer M.; Lathia, Justin D.; Lee, Jeongwu; Hjelmeland, Anita B.; Rich, Jeremy N.] Cleveland Clin, Lerner Res Inst, Dept Stem Cell Biol & Regenerat Med, Cleveland, OH 44195 USA; [Eyler, Christine E.; Misuraca, Katherine L.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; [Eyler, Christine E.] Duke Univ, Med Ctr, Med Scientist Training Program, Durham, NC 27710 USA; [McLendon, Roger E.] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; [Chandler-Militello, Devin; Goldman, Steven A.] Univ Rochester, Med Ctr, Dept Neurol, Rochester, NY 14642 USA; [Forrester, Michael T.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Stamler, Jonathan S.] Case Western Reserve Univ, Sch Med, Inst Transformat Mol Med, Cleveland, OH 44106 USA; [Stamler, Jonathan S.] Case Western Reserve Univ, Sch Med, Dept Med, Cleveland, OH 44106 USA; [Sloan, Andrew E.] Case Western Reserve Univ, Sch Med, Dept Neurol Surg, Cleveland, OH 44106 USA; [Sloan, Andrew E.] Case Western Reserve Univ, Sch Med, Dept Pathol, Cleveland, OH 44106 USA; [Sloan, Andrew E.] Case Western Reserve Univ, Sch Med, Dept Translat Neurosci, Cleveland, OH 44106 USA; [Rich, Jeremy N.] Case Western Reserve Univ, Sch Med, Cleveland Clin Lerner Coll Med, Dept Mol Med, Cleveland, OH 44106 USA; Univ Hosp Cleveland, Cleveland, OH 44106 USA; [Bredel, Markus] Univ Alabama, Ctr Comprehens Canc, Dept Radiat Oncol, Birmingham, AL 35249 USA; [Bredel, Markus] Univ Freiburg, Neuroctr, Dept Neurosurg, D-79106 Freiburg, Germany; [Bredel, Markus] Univ Freiburg, Ctr Comprehens Canc, D-79106 Freiburg, Germany	Cleveland Clinic Foundation; Duke University; Duke University; Duke University; University of Rochester; Harvard University; Harvard Medical School; Massachusetts General Hospital; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Cleveland Clinic Foundation; University Hospitals of Cleveland; University of Alabama System; University of Alabama Birmingham; University of Freiburg; University of Freiburg	Hjelmeland, AB (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Stem Cell Biol & Regenerat Med, Cleveland, OH 44195 USA.	hjelmea@ccf.org; richj@ccf.org	Eyler, Christine E/A-2921-2010; Sloan, Andrew/AAE-9842-2020; Rich, Jeremy/AAM-1445-2021; Lathia, Justin/AHB-8296-2022	Stamler, Jonathan/0000-0002-6866-1572; Goldman, Steven/0000-0002-5498-4303	National Institutes of Health [F30NS063496, CA112958, CA116659, CA154130, CA151522, CA137443, NS063971, CA128269, CA101954, CA116257, CA142159, HL059130, HL091876,, HLO95463, CA108786, NS20023]; German Cancer Aid Grant Award [107714]; NATIONAL CANCER INSTITUTE [R01CA129958, P50CA108786, U01CA137443, UM1CA137443, R01CA151522, R42CA128269, R01CA154130, K08CA101954, F32CA142159, R01CA116257, R01CA116659] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059130, R01HL095463, R01HL091876] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007250] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS063971, R01NS075345, P50NS020023, F30NS063496, R01NS052534, R01NS054276] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Cancer Aid Grant Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the sources of our funding, including National Institutes of Health grant F30NS063496 for C.E.E.; CA112958, CA116659, and CA154130 for J.N.R.; CA151522 for A.B.H.; CA137443, NS063971, CA128269, CA101954, and CA116257 for A.E.S.; CA142159 for J.D.L.; HL059130, HL091876, and HLO95463 for J.S.S.; and CA108786 and NS20023 for R.E.M. We also thank the Adelson Medical Research Foundation (S.A.G.), American Brain Tumor Association (J.D.L.), National Brain Tumor Society (A.B.H.), Ben and Catherine Ivy Foundation (A. E. S.), Damon Runyon Cancer Research Foundation (J.N.R.), German Cancer Aid Grant Award 107714 (M.B.), Goldhirsh Foundation (J.N.R.), James S. McDonnell Foundation (J.N.R. and S.A.G.), New York State Stem Cell Science Board (S. A. G.), Ohio Department of Development Tech 09-071 (A.E.S.), and Pediatric Brain Tumor Foundation of the United States (R.E.M.). We appreciate critical manuscript review by H. Suh; animal support provided by T. Myshrall, Y. Parker, and D. Lindner; M. Cook, B. Harvat, C. Shemo, and S. O'Bryant for flow cytometry assistance; D. Satterfield, L. Ehinger, J. Funkhouser, and J. Faison for technical assistance; the tissue provided by the Cleveland Clinic Foundation Tissue Procurement Service and S. Staugatis, R. Weil, and M. McGraw; and microarray analysis completed by P. Faber and W. Jones.	Androutsellis-Theotokis A, 2006, NATURE, V442, P823, DOI 10.1038/nature04940; Avontuur JAM, 1998, CRIT CARE MED, V26, P660, DOI 10.1097/00003246-199804000-00012; Bakshi A, 1998, J NEUROL SCI, V155, P196, DOI 10.1016/S0022-510X(97)00315-8; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Bao SD, 2006, CANCER RES, V66, P7843, DOI 10.1158/0008-5472.CAN-06-1010; Bar EE, 2007, STEM CELLS, V25, P2524, DOI 10.1634/stemcells.2007-0166; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Brindicci C, 2009, CHEST, V135, P353, DOI 10.1378/chest.08-0964; Broadley KWR, 2011, STEM CELLS, V29, P452, DOI 10.1002/stem.582; Chai ZL, 2001, J BIOL CHEM, V276, P33665, DOI 10.1074/jbc.M007681200; Charles NA, 2010, CELL STEM CELL, V6, P6, DOI 10.1016/j.stem.2009.12.005; Clement V, 2007, CURR BIOL, V17, P165, DOI 10.1016/j.cub.2006.11.033; COBBS CS, 1995, CANCER RES, V55, P727; Dover AR, 2006, CLIN SCI, V111, P275, DOI 10.1042/CS20060104; Eissa NT, 1998, P NATL ACAD SCI USA, V95, P7625, DOI 10.1073/pnas.95.13.7625; Eissa NT, 1996, J BIOL CHEM, V271, P27184, DOI 10.1074/jbc.271.43.27184; Engels K, 2008, CANCER RES, V68, P5159, DOI 10.1158/0008-5472.CAN-08-0406; Fan X, 2006, CANCER RES, V66, P7445, DOI 10.1158/0008-5472.CAN-06-0858; Fetz V, 2009, INT J CANCER, V124, P2033, DOI 10.1002/ijc.24182; Forrester MT, 2011, BIOTECHNIQUES, V50, P41, DOI 10.2144/000113586; Fukumura D, 2006, NAT REV CANCER, V6, P521, DOI 10.1038/nrc1910; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Gardner PR, 1998, P NATL ACAD SCI USA, V95, P10378, DOI 10.1073/pnas.95.18.10378; Garvey EP, 1997, J BIOL CHEM, V272, P4959, DOI 10.1074/jbc.272.8.4959; Hausladen A, 2001, P NATL ACAD SCI USA, V98, P10108, DOI 10.1073/pnas.181199698; Hausladen A, 1998, P NATL ACAD SCI USA, V95, P14100, DOI 10.1073/pnas.95.24.14100; Hochman JS, 2007, JAMA-J AM MED ASSOC, V297, P1657; Iadecola C, 1997, J NEUROSCI, V17, P9157; Kandalaft LE, 2008, CARCINOGENESIS, V29, P1282, DOI 10.1093/carcin/bgn087; Kashiwagi S, 2008, NAT MED, V14, P255, DOI 10.1038/nm1730; Keyoung HM, 2001, NAT BIOTECHNOL, V19, P843, DOI 10.1038/nbt0901-843; Kojima H, 1998, ANAL CHEM, V70, P2446, DOI 10.1021/ac9801723; Lam-Himlin D, 2006, NEUROCHEM INT, V49, P764, DOI 10.1016/j.neuint.2006.07.001; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Levesque MC, 2003, LEUKEMIA, V17, P442, DOI 10.1038/sj.leu.2402783; Li F, 2007, MOL CELL, V26, P63, DOI 10.1016/j.molcel.2007.02.024; Li Z, 2009, CANCER CELL, V15, P501, DOI 10.1016/j.ccr.2009.03.018; Lim KH, 2008, NATURE, V452, P646, DOI 10.1038/nature06778; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Lopez A, 2004, CRIT CARE MED, V32, P21, DOI 10.1097/01.CCM.0000105581.01815.C6; Luo CX, 2007, J NEUROCHEM, V103, P1872, DOI 10.1111/j.1471-4159.2007.04915.x; MACMICKING JD, 1995, CELL, V81, P641, DOI 10.1016/0092-8674(95)90085-3; Martinez-Diaz H, 2003, ARCH PATHOL LAB MED, V127, P1187; Nakatsubo N, 1998, FEBS LETT, V427, P263, DOI 10.1016/S0014-5793(98)00440-2; Perry A, 2009, BRAIN PATHOL, V19, P81, DOI 10.1111/j.1750-3639.2008.00167.x; Rai RM, 1998, P NATL ACAD SCI USA, V95, P13829, DOI 10.1073/pnas.95.23.13829; REBELLO SS, 2002, AAPS PHARMSCI, V4; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Shackleton M, 2009, CELL, V138, P822, DOI 10.1016/j.cell.2009.08.017; Singh D, 2007, AM J RESP CRIT CARE, V176, P988, DOI 10.1164/rccm.200704-588OC; Singh SK, 2003, CANCER RES, V63, P5821; Sinz EH, 1999, J CLIN INVEST, V104, P647, DOI 10.1172/JCI6670; Son MJ, 2009, CELL STEM CELL, V4, P440, DOI 10.1016/j.stem.2009.03.003; Strub A, 2006, MOL PHARMACOL, V69, P328, DOI 10.1124/mol.105.017087; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Taylor MD, 2005, CANCER CELL, V8, P323, DOI 10.1016/j.ccr.2005.09.001; Thomsen LL, 1997, CANCER RES, V57, P3300; Tiscornia AC, 2004, LEUKEMIA, V18, P48, DOI 10.1038/sj.leu.2403169; Tu YG, 2007, J BIOL CHEM, V282, P11722, DOI 10.1074/jbc.M609623200; Visvader JE, 2011, NATURE, V469, P314, DOI 10.1038/nature09781; Wechsler-Reya RJ, 1999, NEURON, V22, P103, DOI 10.1016/S0896-6273(00)80682-0; WEI XQ, 1995, NATURE, V375, P408, DOI 10.1038/375408a0; Williams EL, 2005, BIOESSAYS, V27, P1228, DOI 10.1002/bies.20324; Yamaguchi S, 2002, BRIT J NEUROSURG, V16, P567; Yang DI, 2002, ANN NY ACAD SCI, V962, P8, DOI 10.1111/j.1749-6632.2002.tb04052.x; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; Yuan XP, 2004, ONCOGENE, V23, P9392, DOI 10.1038/sj.onc.1208311; Zhao HX, 1998, BLOOD, V92, P1031; Zhao XR, 2000, BRAIN RES, V872, P215, DOI 10.1016/S0006-8993(00)02459-8	72	229	236	1	38	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 8	2011	146	1					53	66		10.1016/j.cell.2011.06.006	http://dx.doi.org/10.1016/j.cell.2011.06.006			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	789TN	21729780	Bronze, Green Accepted			2022-12-24	WOS:000292539300006
J	Sanderson, K				Sanderson, Katharine			A chewy problem	NATURE			English	Editorial Material																		Binder JB, 2009, J AM CHEM SOC, V131, P1979, DOI 10.1021/ja808537j; Sergeev AG, 2011, SCIENCE, V332, P439, DOI 10.1126/science.1200437; Zhong SH, 2010, ENERG FUEL, V24, P2891, DOI 10.1021/ef901575a	3	251	266	4	106	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 23	2011	474	7352					S12	S14		10.1038/474S012a	http://dx.doi.org/10.1038/474S012a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	781NJ	21697834				2022-12-24	WOS:000291939700004
J	Wang, TY; Nallamothu, BK; Krumholz, HM; Li, S; Roe, MT; Jollis, JG; Jacobs, AK; Holmes, DR; Peterson, ED; Ting, HH				Wang, Tracy Y.; Nallamothu, Brahmajee K.; Krumholz, Harlan M.; Li, Shuang; Roe, Matthew T.; Jollis, James G.; Jacobs, Alice K.; Holmes, David R.; Peterson, Eric D.; Ting, Henry H.			Association of Door-In to Door-Out Time With Reperfusion Delays and Outcomes Among Patients Transferred for Primary Percutaneous Coronary Intervention	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ELEVATION MYOCARDIAL-INFARCTION; CARDIOVASCULAR DATA REGISTRY; LONGITUDINAL DATA-ANALYSIS; TO-BALLOON TIME; ST-ELEVATION; PRIMARY ANGIOPLASTY; INTERHOSPITAL TRANSFER; THROMBOLYTIC THERAPY; AMERICAN-COLLEGE; SYMPTOM-ONSET	Context Patients with ST-elevation myocardial infarction (STEMI) requiring inter-hospital transfer for primary percutaneous coronary intervention (PCI) often have prolonged overall door-to-balloon (DTB) times from first hospital presentation to second hospital PCI. Door-in to door-out (DIDO) time, defined as the duration of time from arrival to discharge at the first or STEMI referral hospital, is a new clinical performance measure, and a DIDO time of 30 minutes or less is recommended to expedite reperfusion care. Objective To characterize time to reperfusion and patient outcomes associated with a DIDO time of 30 minutes or less. Design, Setting, and Patients Retrospective cohort of 14 821 patients with STEMI transferred to 298 STEMI receiving centers for primary PCI in the ACTION Registry-Get With the Guidelines between January 2007 and March 2010. Main Outcome Measures Factors associated with a DIDO time greater than 30 minutes, overall DTB times, and risk-adjusted in-hospital mortality. Results Median DIDO time was 68 minutes (interquartile range, 43-120 minutes), and only 1627 patients (11%) had DIDO times of 30 minutes or less. Significant factors associated with a DIDO time greater than 30 minutes included older age, female sex, off-hours presentation, and non-emergency medical services transport to the first hospital. Patients with a DIDO time of 30 minutes or less were significantly more likely to have an overall DTB time of 90 minutes or less compared with patients with DIDO times greater than 30 minutes (60% [95% confidence interval {CI}, 57%-62%] vs 13% [95% CI, 12%-13%]; P < .001). Among patients with DIDO times greater than 30 minutes, only 0.6% (95% CI, 0.5%-0.8%) had an absolute contraindication to fibrinolysis. Observed in-hospital mortality was significantly higher among patients with DIDO times greater than 30 minutes vs patients with DIDO times of 30 minutes or less (5.9% [95% CI, 5.5%-6.3%] vs 2.7% [95% CI, 1.9%-3.5%]; P < .001; adjusted odds ratio for in-hospital mortality, 1.56 [95% CI, 1.15-2.12]). Conclusion A DIDO time of 30 minutes or less was observed in only a small proportion of patients transferred for primary PCI but was associated with shorter reperfusion delays and lower in-hospital mortality. JAMA. 2011;305(24):2540-2547	[Wang, Tracy Y.; Li, Shuang; Roe, Matthew T.; Jollis, James G.; Peterson, Eric D.] Duke Univ, Med Ctr, Duke Clin Res Inst, Durham, NC USA; [Nallamothu, Brahmajee K.] Univ Michigan, Sch Med, Dept Med, VA Hlth Serv Res & Dev Ctr Excellence, Ann Arbor, MI 48104 USA; [Krumholz, Harlan M.] Yale Univ, Sch Med, Robert Wood Johnson Clin Scholars Program, New Haven, CT USA; [Krumholz, Harlan M.] Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, New Haven, CT 06504 USA; [Jacobs, Alice K.] Boston Med Ctr, Dept Med, Cardiol Sect, Boston, MA USA; [Ting, Henry H.] Mayo Clin, Knowledge & Evaluat Res Unit, Rochester, MN USA; [Holmes, David R.] Mayo Clin, Div Cardiovasc Dis, Rochester, MN USA	Duke University; University of Michigan System; University of Michigan; Yale University; Yale University; Boston Medical Center; Mayo Clinic; Mayo Clinic	Wang, TY (corresponding author), 2400 Pratt St, Durham, NC 27705 USA.	tracy.wang@duke.edu	, Harlan/AAI-2875-2020; Peterson, Eric David/ABF-5033-2021	Jacobs, Alice/0000-0002-2428-2458	Bristol-Myers Squibb/Sanofi; Schering Plough/Merck; Medicines Co; Heartscape; Canyon Pharmaceuticals; Eli Lilly/Daiichi Sankyo Alliance; Eli Lilly; Novartis; Merck-Schering Plough; Bristol-Myers Squibb; American College of Cardiology; American Heart Association; Glaxo Smith Kline; KAI Pharmaceuticals; Sanofi-Aventis; Orexigen; Astra Zeneca; St Jude Inc; Bayer; Pfizer; ACC Foundation's NCDR; Society of Chest Pain Centers; American College of Emergency Physicians; Society of Hospital Medicine	Bristol-Myers Squibb/Sanofi(Bristol-Myers Squibb); Schering Plough/Merck(Merck & CompanySchering Plough Corporation); Medicines Co; Heartscape; Canyon Pharmaceuticals; Eli Lilly/Daiichi Sankyo Alliance(Eli Lilly); Eli Lilly(Eli Lilly); Novartis(Novartis); Merck-Schering Plough(Merck & CompanySchering Plough Corporation); Bristol-Myers Squibb(Bristol-Myers Squibb); American College of Cardiology(General Electric); American Heart Association(American Heart Association); Glaxo Smith Kline(GlaxoSmithKline); KAI Pharmaceuticals; Sanofi-Aventis(Sanofi-Aventis); Orexigen; Astra Zeneca(AstraZeneca); St Jude Inc; Bayer(Bayer AG); Pfizer(Pfizer); ACC Foundation's NCDR; Society of Chest Pain Centers; American College of Emergency Physicians(General Electric); Society of Hospital Medicine	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. All conflicts of interest are listed at http://www.dcri.org. Dr Wang reports receiving research grants to the Duke Clinical Research Institute from the Bristol-Myers Squibb/Sanofi Partnership, Schering Plough/Merck, The Medicines Co, Heartscape, Canyon Pharmaceuticals, and Eli Lilly/Daiichi Sankyo Alliance, as well as consulting fees/honoraria for Medco and Astra Zeneca. Dr Krumholz reports chairing a scientific advisory board for United Healthcare. Dr Roe reports receiving research funding from Eli Lilly, Novartis, Merck-Schering Plough, Bristol-Myers Squibb, the American College of Cardiology, and the American Heart Association; and consulting fees/honoraria from Glaxo Smith Kline, KAI Pharmaceuticals, Novartis, Eli Lilly, Bristol-Myers Squibb, Sanofi-Aventis, Orexigen, and Astra Zeneca. Dr Jacobs reports chairing the Mission: Lifeline Advisory Working Group. Dr Peterson reports receiving research grants from Bristol-Myers Squibb, Sanofi-Aventis, Eli Lilly, Schering Plough/Merck, and St Jude Inc and consultant fees from Bayer and Pfizer. No other disclosures were reported.; This research was supported by the ACC Foundation's NCDR. The ACTION Registry-GWTG is an initiative of the ACC Foundation and the AHA with partnering support from the Society of Chest Pain Centers, the American College of Emergency Physicians, and the Society of Hospital Medicine. The registry is sponsored in part by the Bristol-Myers Squibb/Sanofi Partnership.	American Hospital Association, 2005, ANN SURV HOSP DAT DO; Andersen HR, 2003, NEW ENGL J MED, V349, P733, DOI 10.1056/NEJMoa025142; [Anonymous], MEAS SUMM AC MYOC IN; Antman EM, 2008, CIRCULATION, V117, P296, DOI 10.1161/CIRCULATIONAHA.107.188209; Berger PB, 1999, CIRCULATION, V100, P14, DOI 10.1161/01.CIR.100.1.14; Bohmer E, 2010, J AM COLL CARDIOL, V55, P102, DOI 10.1016/j.jacc.2009.08.007; Bradley EH, 2009, J AM COLL CARDIOL, V54, P2423, DOI 10.1016/j.jacc.2009.11.003; Cantor WJ, 2009, NEW ENGL J MED, V360, P2705, DOI 10.1056/NEJMoa0808276; Chakrabarti A, 2008, J AM COLL CARDIOL, V51, P2442, DOI 10.1016/j.jacc.2008.02.071; Chin CT, 2011, AM HEART J, V161, DOI 10.1016/j.ahj.2010.10.004; De Luca G, 2003, J AM COLL CARDIOL, V42, P991, DOI 10.1016/S0735-1097(03)00919-7; Eagle KA, 2002, LANCET, V359, P373, DOI 10.1016/S0140-6736(02)07595-5; Ellrodt G, 2007, CIRCULATION, V116, pE49, DOI 10.1161/CIRCULATIONAHA.107.184048; Henry TD, 2007, CIRCULATION, V116, P721, DOI 10.1161/CIRCULATIONAHA.107.694141; Jacobs AK, 2006, CIRCULATION, V113, P1159, DOI 10.1161/CIRCULATIONAHA.105.610345; Jacobs AK, 2007, CIRCULATION, V116, P217, DOI 10.1161/CIRCULATIONAHA.107.184043; Jollis JG, 2007, JAMA-J AM MED ASSOC, V298, P2371, DOI 10.1001/jama.298.20.joc70124; Keeley EC, 2003, LANCET, V361, P13, DOI 10.1016/S0140-6736(03)12113-7; Krumholz HM, 2011, J AM COLL CARDIOL, V57, P637, DOI 10.1016/j.jacc.2010.12.010; Krumholz HM, 2008, JACC-CARDIOVASC INTE, V1, P97, DOI 10.1016/j.jcin.2007.10.006; Krumholz HM, 2008, J AM COLL CARDIOL, V52, P2046, DOI 10.1016/j.jacc.2008.10.012; Kushner, 2010, CIRCULATION, V121, pE257, DOI 10.1161/CIR.0b013e3181d7a65e; Kushner FG, 2009, CIRCULATION, V120, P2271, DOI 10.1161/CIRCULATIONAHA.109.192663; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Nallamothu BK, 2009, AM J CARDIOL, V103, P1051, DOI 10.1016/j.amjcard.2008.12.030; Newby LK, 1996, J AM COLL CARDIOL, V27, P1646; Peterson ED, 2010, J AM COLL CARDIOL, V55, P1923, DOI 10.1016/j.jacc.2010.02.005; Terkelsen CJ, 2010, JAMA-J AM MED ASSOC, V304, P763, DOI 10.1001/jama.2010.1139; Ting HH, 2007, CIRCULATION, V116, P729, DOI 10.1161/CIRCULATIONAHA.107.699934; Wang TY, 2011, AM HEART J, V161, DOI 10.1016/j.ahj.2010.10.001; Wang TY, 2011, AM HEART J, V161, pe1; Widimsky P, 2000, EUR HEART J, V21, P823, DOI 10.1053/euhj.1999.1993; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	33	123	125	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 22	2011	305	24					2540	2547		10.1001/jama.2011.862	http://dx.doi.org/10.1001/jama.2011.862			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	780MF	21693742	Bronze			2022-12-24	WOS:000291860400021
J	Alexander, GC; O'Connor, AB; Stafford, RS				Alexander, G. Caleb; O'Connor, Alec B.; Stafford, Randall S.			Enhancing Prescription Drug Innovation and Adoption	ANNALS OF INTERNAL MEDICINE			English	Article							SURROGATE END-POINTS; CLINICAL-TRIALS; FDA; RISK; INFORMATION	The adoption and use of a new drug would ideally be guided by its innovation and cost-effectiveness. However, information about the relative efficacy and safety of a drug is typically incomplete even well after market entry, and various other forces create a marketplace in which most new drugs are little better than their older counterparts. Five proposed mechanisms are considered for promoting innovation and reducing the use of therapies ultimately found to offer poor value or have unacceptable risks. These changes range from increasing the evidence required for U. S. Food and Drug Administration approval to modifying the structure of drug reimbursement. Despite the challenges of policy implementation, the United States has a long history of successfully improving the societal value and safe use of prescription medicines.	Univ Chicago, Univ Chicago Hosp, Chicago, IL 60637 USA; Univ Illinois, Sch Pharm, Chicago, IL USA; Univ Rochester, Sch Med & Dent, Rochester, NY USA; Stanford Univ, Sch Med, Stanford, CA 94305 USA	University of Chicago; University of Illinois System; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Rochester; Stanford University	Alexander, GC (corresponding author), Univ Chicago, Med Ctr, 5841 S Maryland Ave,MC 2007, Chicago, IL 60637 USA.	galexand@uchicago.edu	; Stafford, Randall/F-3974-2017	O'Connor, Alec/0000-0001-8181-5567; Stafford, Randall/0000-0003-1805-1271	Agency for Healthcare Research and Quality [K08 HS15699, RO1 HS0189960]; National Heart, Lung, and Blood Institute [K24 HL086703]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K08HS015699] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K24HL086703] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Grant Support: By grants K08 HS15699 and RO1 HS0189960 from the Agency for Healthcare Research and Quality (Dr. Alexander) and grant K24 HL086703 from the National Heart, Lung, and Blood Institute (Dr. Stafford).	Abraham J, 2005, SOC SCI MED, V61, P881, DOI 10.1016/j.socscimed.2005.01.004; Alexander GC, 2009, JAMA-J AM MED ASSOC, V301, P2488, DOI 10.1001/jama.2009.851; *ASTRAZENECA, 2010, 4 Q FULL YEAR RES 20; BACIU A, 2007, FUTURE DRUG SAFETY P; Barter PJ, 2007, NEW ENGL J MED, V357, P2109, DOI 10.1056/NEJMoa0706628; Berndt ER, 2005, NAT REV DRUG DISCOV, V4, P545, DOI 10.1038/nrd1774; Carpenter D, 2010, PRINC STUD AM POLIT, P1; Fleming TR, 1996, ANN INTERN MED, V125, P605, DOI 10.7326/0003-4819-125-7-199610010-00011; Fretheim Atle, 2003, BMC Fam Pract, V4, P19, DOI 10.1186/1471-2296-4-19; Green JA, 2007, PRESCRIBING NUMBERS; Hamburg MA, 2010, NEW ENGL J MED, V363, P2228, DOI 10.1056/NEJMsa1007467; Kesselheim AS, 2010, NEW ENGL J MED, V363, P1855, DOI 10.1056/NEJMhle1002961; Leidl R M, 1994, Int J Technol Assess Health Care, V10, P467; Lindstrom JA, 2009, DERMATOL THER, V22, P246, DOI 10.1111/j.1529-8019.2009.01238.x; Mintzes Barbara, 2005, Can J Clin Pharmacol, V12, pe22; O'Connor AB, 2010, JAMA-J AM MED ASSOC, V303, P979, DOI 10.1001/jama.2010.257; *OFF INSP GEN, OEI039400760 US DEP; Olson MK, 2008, J HEALTH ECON, V27, P175, DOI 10.1016/j.jhealeco.2007.10.007; Pearson SD, 2010, HEALTH AFFAIR, V29, P1796, DOI 10.1377/hlthaff.2010.0623; Polinski JM, 2007, HEALTH AFFAIR, V26, P750, DOI 10.1377/hlthaff.26.3.750; Psaty BM, 1999, JAMA-J AM MED ASSOC, V282, P786, DOI 10.1001/jama.282.8.786; Radley DC, 2006, ARCH INTERN MED, V166, P1021, DOI 10.1001/archinte.166.9.1021; RAO AR, 1989, J MARKETING RES, V26, P351, DOI 10.2307/3172907; Rogers, 1962, DIFFUSION INNOVATION; Schiff GD, 2009, JAMA-J AM MED ASSOC, V301, P865, DOI 10.1001/jama.2009.195; Schwartz LM, 2009, ANN INTERN MED, V150, P516, DOI 10.7326/0003-4819-150-8-200904210-00106; Stafford RS, 2009, NEW ENGL J MED, V361, P1230, DOI 10.1056/NEJMp0906490; Strom BL, 2006, JAMA-J AM MED ASSOC, V295, P2072, DOI 10.1001/jama.295.17.2072; Thomas CP, 2003, NEW ENGL J MED, V349, P2186, DOI 10.1056/NEJMp038172; *US FDA, 2010, FAST TRACK ACC APPR; *US GOV ACC OFF, 2002, GAO02958 US GOV ACC; Waber RL, 2008, JAMA-J AM MED ASSOC, V299, P1016, DOI 10.1001/jama.299.9.1016; Weinstein MC, 2010, NEW ENGL J MED, V362, P460, DOI 10.1056/NEJMsb0911104; WITTES J, 1989, STAT MED, V8, P415, DOI 10.1002/sim.4780080405; Wood AJJ, 2006, NEW ENGL J MED, V355, P618, DOI 10.1056/NEJMsb055203; Zhang YT, 2007, HEALTH AFFAIR, V26, P880, DOI 10.1377/hlthaff.26.3.880; 2001, PRESCRIRE INT, V10, P52	37	17	17	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 21	2011	154	12					833	839		10.7326/0003-4819-154-12-201106210-00012	http://dx.doi.org/10.7326/0003-4819-154-12-201106210-00012			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	779SA	21690598	Green Accepted			2022-12-24	WOS:000291800500020
J	Florence, C; Shepherd, J; Brennan, I; Simon, T				Florence, Curtis; Shepherd, Jonathan; Brennan, Iain; Simon, Thomas			Effectiveness of anonymised information sharing and use in health service, police, and local government partnership for preventing violence related injury: experimental study and time series analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ACCIDENT	Objective To evaluate the effectiveness of anonymised information sharing to prevent injury related to violence. Design Experimental study and time series analysis of a prototype community partnership between the health service, police, and local government partners designed to prevent violence. Setting Cardiff, Wales, and 14 comparison cities designated "most similar" by the Home Office in England and Wales. Intervention After a 33 month development period, anonymised data relevant to violence prevention (precise violence location, time, days, and weapons) from patients attending emergency departments in Cardiff and reporting injury from violence were shared over 51 months with police and local authority partners and used to target resources for violence prevention. Main outcome measures Health service records of hospital admissions related to violence and police records of woundings and less serious assaults in Cardiff and other cities after adjustment for potential confounders. Results Information sharing and use were associated with a substantial and significant reduction in hospital admissions related to violence. In the intervention city (Cardiff) rates fell from seven to five a month per 100 000 population compared with an increase from five to eight in comparison cities (adjusted incidence rate ratio 0.58, 95% confidence interval 0.49 to 0.69). Average rate of woundings recorded by the police changed from 54 to 82 a month per 100 000 population in Cardiff compared with an increase from 54 to 114 in comparison cities (adjusted incidence rate ratio 0.68, 0.61 to 0.75). There was a significant increase in less serious assaults recorded by the police, from 15 to 20 a month per 100 000 population in Cardiff compared with a decrease from 42 to 33 in comparison cities (adjusted incidence rate ratio 1.38, 1.13 to 1.70). Conclusion An information sharing partnership between health services, police, and local government in Cardiff, Wales, altered policing and other strategies to prevent violence based on information collected from patients treated in emergency departments after injury sustained in violence. This intervention led to a significant reduction in violent injury and was associated with an increase in police recording of minor assaults in Cardiff compared with similar cities in England and Wales where this intervention was not implemented.	[Shepherd, Jonathan] Cardiff Univ, Violence & Soc Res Grp, Sch Dent, Cardiff CF14 4XY, S Glam, Wales; [Florence, Curtis; Simon, Thomas] Ctr Dis Control & Prevent, Div Violence Prevent, Atlanta, GA USA; [Brennan, Iain] Univ Hull, Dept Social Sci, Kingston Upon Hull HU6 7RX, N Humberside, England	Cardiff University; Centers for Disease Control & Prevention - USA; University of Hull	Shepherd, J (corresponding author), Cardiff Univ, Violence & Soc Res Grp, Sch Dent, Cardiff CF14 4XY, S Glam, Wales.	shepherdjp@cardiff.ac.uk		Shepherd, Jonathan/0000-0001-6466-2298; Brennan, Iain/0000-0003-2131-1599	Home Office; Wales Office for Research and Development in Health and Social Care (WORD) [R/98/037]	Home Office; Wales Office for Research and Development in Health and Social Care (WORD)	The development of the prototype partnership was funded in part by a grant from the Home Office targeted policing fund. The study was funded in part by the Wales Office for Research and Development in Health and Social Care (WORD), grant No R/98/037.	[Anonymous], PREV VIOL GUID IMPL; Braga A. A., 2007, CAMPBELL SYST REV, V3, P1, DOI DOI 10.4073/CSR.2007.1; BULLOCK S, 2007, POLICE SERVICE STREN; Christopherson O., 2004, POLICE SERVICE STREN; Clarke R.V., 1994, CRIME PREVENTION STU, V2, P165; CLARKSON C, 1994, CRIM LAW REV, P4; Clegg M., 2006, POLICE SERVICE STREN; COTTON J, 2003, POLICE SERVICE STREN; *CTR STUD PREV VIO, BLUEPR VIOL PREV; Dahlberg Linda L, 2005, Int J Inj Contr Saf Promot, V12, P93, DOI 10.1080/15660970500086239; Dubourg R, 2005, EC SOCIAL COSTS CRIM; Faergemann Christian, 2007, J Forensic Leg Med, V14, P20, DOI 10.1016/j.jcfm.2006.01.001; FARRINGTON D, 2004, CROSS NATL STUDIES C; Giacopassi D, 2000, J CRIM JUST, V28, P397, DOI 10.1016/S0047-2352(00)00054-4; Goodwin V, 2000, J ACCID EMERG MED, V17, P196; Green L., 1995, JUSTICE Q, V12, P711, DOI DOI 10.1080/07418829500096261; HAHN H, 2007, MMWR RECOMM REP, V56, P1; HARPER G, 2002, FAMILY ORIGINS DEV G; Houry D, 2002, ANN EMERG MED, V39, P56, DOI 10.1067/mem.2002.117759; Kellermann AL, 2001, ANN EMERG MED, V38, P423, DOI 10.1067/mem.2001.117273; Mercy JA, 2006, INJURY PREV, V12, P1, DOI 10.1136/ip.2006.012542; Pinto R., 2005, POLICE SERVICE STREN; Povey D., 2001, POLICE SERVICE STREN; RITTERN, 2009, NATL I JUSTICE J, V264, P20; Sachs CJ, 1998, ANN EMERG MED, V31, P488, DOI 10.1016/S0196-0644(98)70259-8; Shepherd JP, 2001, LANCET, V358, P1717, DOI 10.1016/S0140-6736(01)06716-2; SHEPHERD JP, 1990, J ROY SOC MED, V83, P75, DOI 10.1177/014107689008300206; SHEPHERD JP, 1990, INJURY, V21, P139, DOI 10.1016/0020-1383(90)90081-5; Shepherd JP, 2001, ANN EMERG MED, V38, P430, DOI 10.1067/mem.2001.114317; SHEPHERD JP, 1993, J ROY SOC MED, V86, P87; Sherman L W, 1995, JUSTICE Q, V12, P625; Simmons J., 2003, NATL CRIME RECORDING; SISSON D, 2001, POLICE SERVICE STREN; Sivarajasingam V, 2004, INJURY, V35, P467, DOI 10.1016/S0020-1383(03)00241-9; Sivarajasingam V, 2003, INJURY PREV, V9, P312, DOI 10.1136/ip.9.4.312; SMITH C, 2002, POLICE SERVICE STREN; STPIERRE TL, 1992, AM J COMMUN PSYCHOL, V20, P673; Sutherland I, 2002, INJ PREV, V8, P246, DOI 10.1136/ip.8.3.246; The Crown Prosecution Service, OFF PERS INC CHARG S; Villaveces A, 2000, JAMA-J AM MED ASSOC, V283, P1205, DOI 10.1001/jama.283.9.1205; Walker A, 2009, CRIME ENGLAND WALES; Warburton AL, 2006, EMERG MED J, V23, P12, DOI 10.1136/emj.2004.023028; Warburton AL, 2004, EMERG MED J, V21, P473, DOI 10.1136/emj.2003.004978; WHO, 2022, GLOB BURD DIS 2004 U; World Health Organization, 2002, WORLD REPORT VIOLENC	45	88	88	1	31	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 16	2011	342								d3313	10.1136/bmj.d3313	http://dx.doi.org/10.1136/bmj.d3313			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	781LF	21680632	Green Submitted, Green Published, hybrid, Green Accepted			2022-12-24	WOS:000291933000004
J	Jurkovic, D; Wilkinson, H				Jurkovic, Davor; Wilkinson, Helen			Diagnosis and management of ectopic pregnancy	BMJ-BRITISH MEDICAL JOURNAL			English	Review							DOSE SYSTEMIC METHOTREXATE; EXPECTANT MANAGEMENT; LAPAROSCOPIC SURGERY; RANDOMIZED-TRIAL; ECONOMIC-EVALUATION; RISK-FACTORS; SONOGRAPHY		[Jurkovic, Davor] Univ Coll Hosp, Dept Obstet & Gynaecol, London NW1 2BU, England; [Wilkinson, Helen] Kings Coll Hosp London, Ectop Pregnancy Trust, London, England	University of London; University College London; King's College Hospital NHS Foundation Trust; King's College Hospital	Jurkovic, D (corresponding author), Univ Coll Hosp, Dept Obstet & Gynaecol, London NW1 2BU, England.	davor.jurkovic@uclh.nhs.uk						Agency for Healthcare Research and Quality, 2008, MED MAN ECT PREGN, P427; Ankum WM, 1996, FERTIL STERIL, V65, P1093, DOI 10.1016/S0015-0282(16)58320-4; Bouyer J, 2003, AM J EPIDEMIOL, V157, P185, DOI 10.1093/aje/kwf190; BROWN DL, 1994, J ULTRAS MED, V13, P259, DOI 10.7863/jum.1994.13.4.259; CACCIATORE B, 1989, OBSTET GYNECOL, V73, P770; Condous G, 2006, ULTRASOUND OBST GYN, V28, P121, DOI 10.1002/uog.2838; CORDINA M, 2011, BJOG; Dart RG, 1999, ANN EMERG MED, V33, P283, DOI 10.1016/S0196-0644(99)70364-1; Ehrenberg-Buchner S, 2009, CLIN OBSTET GYNECOL, V52, P372, DOI 10.1097/GRF.0b013e3181b0be24; Elson J, 2004, ULTRASOUND OBST GYN, V23, P552, DOI 10.1002/uog.1061; Hajenius PJ, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000324.pub2; Hajenius PJ, 1997, LANCET, V350, P774, DOI 10.1016/S0140-6736(97)05487-1; Helmy S, 2007, ULTRASOUND OBST GYN, V30, P988, DOI 10.1002/uog.5186; Huusom LD, 2011, BJOG-INT J OBSTET GY, V118, P1, DOI 10.1111/j.1471-0528.2010.02782.x; Kirk E, 2007, HUM REPROD, V22, P1744, DOI 10.1093/humrep/dem073; Kirk E, 2007, HUM REPROD, V22, P2824, DOI 10.1093/humrep/dem283; KOBAYASHI M, 1969, AM J OBSTET GYNECOL, V103, P1131, DOI 10.1016/0002-9378(69)90518-3; Korhonen J, 1996, OBSTET GYNECOL, V88, P775, DOI 10.1016/0029-7844(96)00293-1; LI TC, 1991, HUM REPROD, V6, P1002, DOI 10.1093/oxfordjournals.humrep.a137449; Lundorff P, 1991, ACTA OBSTET GYN SCAN, V70, P343, DOI 10.3109/00016349109007885; Moeller LBK, 2009, ACTA OBSTET GYN SCAN, V88, P1331, DOI 10.3109/00016340903188912; Mol BWJ, 1998, HUM REPROD, V13, P3220, DOI 10.1093/humrep/13.11.3220; Mol BWJ, 1999, FERTIL STERIL, V71, P155, DOI 10.1016/S0015-0282(98)00396-3; Mol F, 2008, HUM REPROD UPDATE, V14, P309, DOI 10.1093/humupd/dmn012; Murray H, 2005, CAN MED ASSOC J, V173, P905, DOI 10.1503/cmaj.050222; *ROYAL COLL OBST G, 2004, 21 ROYAL COLL OBST G; Royal College of Obstetricians and Gunecologists, 2009, UK MED EL CRIT CONTR; Sowter MC, 2001, BRIT J OBSTET GYNAEC, V108, P192, DOI 10.1111/j.1471-0528.2001.00038.x; Sowter MC, 2001, BRIT J OBSTET GYNAEC, V108, P204, DOI 10.1111/j.1471-0528.2001.00037.x; Stein JC, 2010, ANN EMERG MED, V56, P674, DOI 10.1016/j.annemergmed.2010.06.563; WANG R, 2011, ANN EMERG MED; Wedderburn CJ, 2010, HUM REPROD, V25, P328, DOI 10.1093/humrep/dep397	32	63	67	0	22	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 10	2011	342								d3397	10.1136/bmj.d3397	http://dx.doi.org/10.1136/bmj.d3397			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	777SS	21665933				2022-12-24	WOS:000291645900003
J	Eisenstein, M				Eisenstein, Michael			A moving target	NATURE			English	Editorial Material																		Brimacombe CL, 2011, J VIROL, V85, P596, DOI 10.1128/JVI.01592-10; Frey SE, 2010, VACCINE, V28, P6367, DOI 10.1016/j.vaccine.2010.06.084; Houghton M, 2011, IMMUNOL REV, V239, P99, DOI 10.1111/j.1600-065X.2010.00977.x; Soderholm J, 2006, GUT, V55, P266, DOI 10.1136/gut.2005.072231	4	12	12	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 9	2011	474	7350					S16	S17		10.1038/474S16a	http://dx.doi.org/10.1038/474S16a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	774PE	21666730	Bronze			2022-12-24	WOS:000291397800010
J	Baker, M				Baker, Monya			THE NEXT STEP FOR THE SYNTHETIC GENOME	NATURE			English	Editorial Material							CHEMICAL-SYNTHESIS; DNA; YEAST; CELL											Caruthers MH, 2011, BIOCHEM SOC T, V39, P575, DOI 10.1042/BST0390575; Danino T, 2010, NATURE, V463, P326, DOI 10.1038/nature08753; Ellis T, 2011, INTEGR BIOL-UK, V3, P109, DOI 10.1039/c0ib00070a; Gibson DG, 2010, NAT METHODS, V7, P901, DOI 10.1038/nmeth.1515; Gibson DG, 2010, SCIENCE, V329, P52, DOI 10.1126/science.1190719; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gibson DG, 2008, P NATL ACAD SCI USA, V105, P20404, DOI 10.1073/pnas.0811011106; Itaya M, 2005, P NATL ACAD SCI USA, V102, P15971, DOI 10.1073/pnas.0503868102; Kosuri S, 2010, NAT BIOTECHNOL, V28, P1295, DOI 10.1038/nbt.1716; Parenteau J, 2008, MOL BIOL CELL, V19, P1932, DOI 10.1091/mbc.E07-12-1254; Quan JY, 2011, NAT BIOTECHNOL, V29, P449, DOI 10.1038/nbt.1847; Ro DK, 2006, NATURE, V440, P940, DOI 10.1038/nature04640; Wang HH, 2009, NATURE, V460, P894, DOI 10.1038/nature08187	13	24	27	2	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 19	2011	473	7347					403	408		10.1038/473403a	http://dx.doi.org/10.1038/473403a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765QA	21593873	Bronze			2022-12-24	WOS:000290722400055
J	Lioy, DT; Garg, SK; Monaghan, CE; Raber, J; Foust, KD; Kaspar, BK; Hirrlinger, PG; Kirchhoff, F; Bissonnette, JM; Ballas, N; Mandel, G				Lioy, Daniel T.; Garg, Saurabh K.; Monaghan, Caitlin E.; Raber, Jacob; Foust, Kevin D.; Kaspar, Brian K.; Hirrlinger, Petra G.; Kirchhoff, Frank; Bissonnette, John M.; Ballas, Nurit; Mandel, Gail			A role for glia in the progression of Rett's syndrome	NATURE			English	Article							MECP2 DEFICIENCY; MOUSE MODEL; NEURONS; EXPRESSION; ASTROCYTES; ABNORMALITIES; DEFECTS; RELEASE	Rett's syndrome (RTT) is an X-chromosome-linked autism spectrum disorder caused by loss of function of the transcription factor methyl-CpG-binding protein 2 (MeCP2)(1). Although MeCP2 is expressed in most tissues(2), loss of MeCP2 expression results primarily in neurological symptoms(1,3,4). Earlier studies suggested the idea that RTT is due exclusively to loss of MeCP2 function in neurons(2,4-10). Although defective neurons clearly underlie the aberrant behaviours, we and others showed recently that the loss of MECP2 from glia negatively influences neurons in a non-cell-autonomous fashion(11-13). Here we show that in globally MeCP2-deficient mice, re-expression of Mecp2 preferentially in astrocytes significantly improved locomotion and anxiety levels, restored respiratory abnormalities to a normal pattern, and greatly prolonged lifespan compared to globally null mice. Furthermore, restoration of MeCP2 in the mutant astrocytes exerted a non-cell-autonomous positive effect on mutant neurons in vivo, restoring normal dendritic morphology and increasing levels of the excitatory glutamate transporter VGLUT1. Our study shows that glia, like neurons, are integral components of the neuropathology of RTT, and supports the targeting of glia as a strategy for improving the associated symptoms.	[Lioy, Daniel T.; Garg, Saurabh K.; Monaghan, Caitlin E.; Mandel, Gail] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA; [Lioy, Daniel T.; Garg, Saurabh K.; Monaghan, Caitlin E.; Mandel, Gail] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Raber, Jacob] Oregon Hlth & Sci Univ, Dept Behav Neurosci, Portland, OR 97239 USA; [Raber, Jacob] Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97239 USA; [Raber, Jacob] Oregon Hlth & Sci Univ, Div Neurosci, Oregon Natl Primate Res Ctr, Beaverton, OR 97006 USA; [Foust, Kevin D.; Kaspar, Brian K.] Ohio State Univ, Dept Pediat, Ctr Gene Therapy, Nationwide Childrens Hosp, Columbus, OH 43205 USA; [Hirrlinger, Petra G.] Paul Flechsig Inst Brain Res, D-04109 Leipzig, Germany; [Kirchhoff, Frank] Max Planck Inst Expt Med, Dept Neurogenet, D-37075 Gottingen, Germany; [Kirchhoff, Frank] Univ Saarland, Inst Pathol, D-37075 Homburg, Germany; [Bissonnette, John M.] Oregon Hlth & Sci Univ, Dept Cell & Dev Biol, Portland, OR 97202 USA; [Bissonnette, John M.] Oregon Hlth & Sci Univ, Dept Obstet & Gynecol, Portland, OR 97202 USA; [Ballas, Nurit] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA	Oregon Health & Science University; Howard Hughes Medical Institute; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon National Primate Research Center; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; Max Planck Society; Saarland University; Oregon Health & Science University; Oregon Health & Science University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Mandel, G (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA.	mandelg@ohsu.edu	Kaspar, Brian/E-3349-2011; Kirchhoff, Frank/B-9335-2008	Kirchhoff, Frank/0000-0002-2324-2761; Monaghan, Caitlin/0000-0001-7055-3610	National Institutes of Health; International Rett Syndrome Foundation; Rett Syndrome Research Trust; Oregon Brain Institute; OHSU; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD056503] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS061800] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International Rett Syndrome Foundation; Rett Syndrome Research Trust; Oregon Brain Institute; OHSU; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank P. Brehm, R. H. Goodman, C. Bond, M. McGinley and C. Mandel-Brehm for discussions; P. Micha, J. Eng, S. Knopp and T. Shaffer for technical support; and M. Murtha for generating the CBA/CMV-MECP2 construct. ViraPur, LLC generated the AAV9 virus. The work was supported by grants from the National Institutes of Health (G. M. and N.B.), International Rett Syndrome Foundation (N.B. and J. M. B.), Rett Syndrome Research Trust (G. M. and B. K. K.), Oregon Brain Institute (D. T. L.), and OHSU Cell and Developmental Biology Training Program (D. T. L.). G. M. is an Investigator of the Howard Hughes Medical Institute.	Armstrong DD, 2005, J CHILD NEUROL, V20, P747, DOI 10.1177/08830738050200082401; Ballas N, 2009, NAT NEUROSCI, V12, P311, DOI 10.1038/nn.2275; BAUMAN ML, 1995, NEUROLOGY, V45, P1581, DOI 10.1212/WNL.45.8.1581; BRENNER M, 1994, J NEUROSCI, V14, P1030, DOI 10.1523/JNEUROSCI.14-03-01030.1994; Casper KB, 2007, GENESIS, V45, P292, DOI 10.1002/dvg.20287; Chahrour M, 2007, NEURON, V56, P422, DOI 10.1016/j.neuron.2007.10.001; Chao HT, 2007, NEURON, V56, P58, DOI 10.1016/j.neuron.2007.08.018; Chao HT, 2010, NATURE, V468, P263, DOI 10.1038/nature09582; Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906; Chow LML, 2008, TRANSGENIC RES, V17, P919, DOI 10.1007/s11248-008-9185-4; Foust KD, 2009, NAT BIOTECHNOL, V27, P59, DOI 10.1038/nbt.1515; Fyffe SL, 2008, NEURON, V59, P947, DOI 10.1016/j.neuron.2008.07.030; Gemelli T, 2006, BIOL PSYCHIAT, V59, P468, DOI 10.1016/j.biopsych.2005.07.025; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; Guy J, 2007, SCIENCE, V315, P1143, DOI 10.1126/science.1138389; Hirrlinger PG, 2006, GLIA, V54, P11, DOI 10.1002/glia.20342; Ilieva H, 2009, J CELL BIOL, V187, P761, DOI 10.1083/jcb.200908164; Kishi N, 2004, MOL CELL NEUROSCI, V27, P306, DOI 10.1016/j.mcn.2004.07.006; Luikenhuis S, 2004, P NATL ACAD SCI USA, V101, P6033, DOI 10.1073/pnas.0401626101; Maezawa I, 2010, J NEUROSCI, V30, P5346, DOI 10.1523/JNEUROSCI.5966-09.2010; Maezawa I, 2009, J NEUROSCI, V29, P5051, DOI 10.1523/JNEUROSCI.0324-09.2009; Marchetto MCN, 2010, CELL, V143, P527, DOI 10.1016/j.cell.2010.10.016; McGill BE, 2006, P NATL ACAD SCI USA, V103, P18267, DOI 10.1073/pnas.0608702103; Pelka GJ, 2006, BRAIN, V129, P887, DOI 10.1093/brain/awl022; Samaco RC, 2009, P NATL ACAD SCI USA, V106, P21966, DOI 10.1073/pnas.0912257106; Shahbazian MD, 2002, HUM MOL GENET, V11, P115, DOI 10.1093/hmg/11.2.115; Stearns NA, 2007, NEUROSCIENCE, V146, P907, DOI 10.1016/j.neuroscience.2007.02.009; Viemari JC, 2005, J NEUROSCI, V25, P11521, DOI 10.1523/JNEUROSCI.4373-05.2005; Weese-Mayer DE, 2006, PEDIATR RES, V60, P443, DOI 10.1203/01.pdr.0000238302.84552.d0	29	341	354	1	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 28	2011	475	7357					497	U90		10.1038/nature10214	http://dx.doi.org/10.1038/nature10214			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	797ZA	21716289	Green Accepted			2022-12-24	WOS:000293167900040
J	Beaglehole, R; Bonita, R; Alleyne, G; Horton, R; Li, LM; Lincoln, P; Mbanya, JC; Mckee, M; Moodie, R; Nishtar, S; Piot, P; Reddy, KS; Stuckler, D				Beaglehole, Robert; Bonita, Ruth; Alleyne, George; Horton, Richard; Li, Liming; Lincoln, Paul; Mbanya, Jean Claude; McKee, Martin; Moodie, Rob; Nishtar, Sania; Piot, Peter; Reddy, K. Srinath; Stuckler, David		Lancet NCD Action Grp	UN High-Level Meeting on Non-Communicable Diseases: addressing four questions	LANCET			English	Article							CARDIOVASCULAR-DISEASE; LOW-INCOME; HEALTH; RISK; BURDEN	Non-communicable diseases (NCDs), principally heart disease, stroke, cancer, diabetes, and chronic respiratory diseases, are a global crisis and require a global response. Despite the threat to human development, and the availability of affordable, cost-effective, and feasible interventions, most countries, development agencies, and foundations neglect the crisis. The UN High-Level Meeting (UN HLM) on NCDs in September, 2011, is an opportunity to stimulate a coordinated global response to NCDs that is commensurate with their health and economic burdens. To achieve the promise of the UN HLM, several questions must be addressed. In this report, we present the realities of the situation by answering four questions: is there really a global crisis of NCDs; how is NCD a development issue; are affordable and cost-effective interventions available; and do we really need high-level leadership and accountability? Action against NCDs will support other global health and development priorities. A successful outcome of the UN HLM depends on the heads of states and governments attending the meeting, and endorsing and implementing the commitments to action. Long-term success requires inspired and committed national and international leadership.	[Beaglehole, Robert; Bonita, Ruth] Univ Auckland, Auckland 1, New Zealand; [Alleyne, George] Pan Amer Hlth Org, Washington, DC USA; [Horton, Richard] The Lancet, London NW1 7BY, England; Peking Union Med Coll, Beijing 100021, Peoples R China; [Lincoln, Paul] Natl Heart Forum, London, England; [Mbanya, Jean Claude] Univ Yaounde I, Fac Med & Biomed Sci, Yaounde, Cameroon; [McKee, Martin; Piot, Peter] London Sch Hyg & Trop Med, London WC1, England; [Moodie, Rob] Univ Melbourne, Melbourne, Vic, Australia; [Nishtar, Sania] HeartFile, Islamabad, Pakistan; [Reddy, K. Srinath] Publ Hlth Fdn India, New Delhi, India; [Stuckler, David] Harvard Univ, Boston, MA 02115 USA	University of Auckland; Pan American Health Organization; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; University of Yaounde I; University of London; London School of Hygiene & Tropical Medicine; University of Melbourne; Public Health Foundation of India; Harvard University	Beaglehole, R (corresponding author), 42 Albert Rd, Auckland 0624, New Zealand.	r.beaglehole@auckland.ac.nz	McKee, Marc D/E-2187-2011; Stuckler, David/H-2261-2012; Mbanya, Jean Claude N/T-5147-2018; McKee, Martin/E-6673-2018	McKee, Marc D/0000-0001-8349-965X; Stuckler, David/0000-0002-1288-8401; Moodie, Alan/0000-0002-8425-7975; Reddy, K Srinath/0000-0003-3416-3548; Mbanya, Jean Claude N/0000-0001-9651-8653; McKee, Martin/0000-0002-0121-9683				Abegunde DO, 2007, LANCET, V370, P1929, DOI 10.1016/S0140-6736(07)61696-1; Adeyi O, 2007, DIR DEV, P1, DOI 10.1596/978-0-8213-7044-5; [Anonymous], 2011, 1 GLOB MIN C HLTH LI; [Anonymous], 2010, HLTH NUTR POPUL SER; Asaria P, 2007, LANCET, V370, P2044, DOI 10.1016/S0140-6736(07)61698-5; Beaglehole R, 2011, LANCET, V377, P1438, DOI 10.1016/S0140-6736(11)60393-0; Bissell K, 2010, SMOKING CESSATION SM; Blanco F, 2010, AIDS REV, V12, P231; Burki TK, 2011, LANCET, V377, P1559, DOI 10.1016/S0140-6736(11)60626-0; Cecchini M, 2010, LANCET, V376, P1775, DOI 10.1016/S0140-6736(10)61514-0; Creswell J, 2011, EUR RESPIR J, V37, P1269, DOI 10.1183/09031936.00084310; Danaei G, 2011, LANCET, V377, P568, DOI 10.1016/S0140-6736(10)62036-3; Dherani M, 2008, B WORLD HEALTH ORGAN, V86, P390, DOI 10.2471/BLT.07.044529; Donnelly J, 2011, LANCET, V377, P1393, DOI 10.1016/S0140-6736(11)60559-X; Egeland GM, 2010, DIABETIC MED, V27, P257, DOI 10.1111/j.1464-5491.2010.02944.x; Farzadfar F, 2011, LANCET, V377, P578, DOI 10.1016/S0140-6736(10)62038-7; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; GLUCKMAN P, 2006, WHY OUR WORLD NO LON; Haines A, 2009, LANCET, V374, P2104, DOI 10.1016/S0140-6736(09)61759-1; Lee PT, 2010, LANCET, V376, P516, DOI 10.1016/S0140-6736(10)61254-8; Lim SS, 2007, LANCET, V370, P2054, DOI 10.1016/S0140-6736(07)61699-7; Manderbacka K, 2011, PHARMACOEPIDEM DR S, V20, P338, DOI 10.1002/pds.2072; MWATSAMA M, 2010, RAISING POLITICAL PR; *NCD ALL, 2010, NONC DIS PRIOR WOM H; *NCD ALL, PROP OUTC STAT UN HI; Oberg M, 2011, LANCET, V377, P139, DOI 10.1016/S0140-6736(10)61388-8; Piot Peter, 2010, BMJ, V341, pc4865, DOI 10.1136/bmj.c4865; Rabkin M, 2011, GLOB PUBLIC HEALTH, V6, P247, DOI 10.1080/17441692.2011.552068; Samb B, 2010, LANCET, V376, P1785, DOI 10.1016/S0140-6736(10)61353-0; Shi WX, 2011, HEALTH RES POLICY SY, V9, DOI 10.1186/1478-4505-9-16; Stahl T., 2006, HLTH ALL POLICIES PR; Strong K, 2005, LANCET, V366, P1578, DOI 10.1016/S0140-6736(05)67341-2; STUCKLER D, SICK SOC RE IN PRESS; Stuckler D, 2008, MILBANK Q, V86, P273, DOI 10.1111/j.1468-0009.2008.00522.x; Stuckler D, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000241; Suhrcke M., 2006, CHRONIC DIS EC PERSP; Suhrcke M, 2007, EC CONSEQUENCES NONC; *UN, 2010, PREV CONTR NONC DIS; *UN, 2001, UN GEN ASS SPEC SESS; WHO, 2011, GLOB STAT REP NONC D; WHO, 2010, MORT BURD DIS EST WH; Woodcock J, 2009, LANCET, V374, P1930, DOI 10.1016/S0140-6736(09)61714-1; World Economic Forum, 2011, GLOB RISKS 2011	43	256	271	0	43	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL-AUG	2011	378	9789					449	455		10.1016/S0140-6736(11)60879-9	http://dx.doi.org/10.1016/S0140-6736(11)60879-9			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	803XM	21665266				2022-12-24	WOS:000293615900036
J	Guilbaud, R; Butler, IB; Ellam, RM				Guilbaud, Romain; Butler, Ian B.; Ellam, Rob M.			Abiotic Pyrite Formation Produces a Large Fe Isotope Fractionation	SCIENCE			English	Article							IRON; REDOX; CONSTRAINTS; SEDIMENTS; MINERALS; OCEAN; REDUCTION; CHEMISTRY; FE(III); OXYGEN	The iron isotope composition of sedimentary pyrite has been proposed as a potential proxy to trace microbial metabolism and the redox evolution of the oceans. We demonstrate that Fe isotope fractionation accompanies abiotic pyrite formation in the absence of Fe(II) redox change. Combined fractionation factors between Fe(II)(aq), mackinawite, and pyrite permit the generation of pyrite with Fe isotope signatures that nearly encapsulate the full range of sedimentary delta(56)Fe(pyrite) recorded in Archean to modern sediments. We propose that Archean negative Fe isotope excursions reflect partial Fe(II)(aq) utilization during abiotic pyrite formation rather than microbial dissimilatory Fe(III) reduction. Late Proterozoic to modern sediments may reflect greater Fe(II)(aq) utilization and variations in source composition.	[Guilbaud, Romain; Butler, Ian B.] Univ Edinburgh, Sch Geosci, Grant Inst, Edinburgh EH9 3JW, Midlothian, Scotland; [Guilbaud, Romain; Butler, Ian B.; Ellam, Rob M.] Scottish Univ Environm Res Ctr, E Kilbride G75 0QF, Lanark, Scotland; [Ellam, Rob M.] ECOSSE, Edinburgh EH9 3JW, Midlothian, Scotland	University of Edinburgh; Scottish Universities Research & Reactor Center	Guilbaud, R (corresponding author), Univ Edinburgh, Sch Geosci, Grant Inst, Edinburgh EH9 3JW, Midlothian, Scotland.	R.Guilbaud@sms.ed.ac.uk	Ellam, Rob M/B-7878-2009; Guilbaud, Romain/R-1428-2017	Ellam, Rob M/0000-0001-8159-4864; Guilbaud, Romain/0000-0001-9701-9522	ECOSSE; Natural Environment Research Council [NE/E003958/1]; NERC [NE/E003958/1] Funding Source: UKRI	ECOSSE; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded by an ECOSSE Ph.D. studentship to R.G. and Natural Environment Research Council research grant NE/E003958/1 to I.B.B. We are thankful to K. Keefe, V. Gallagher, N. Odling, B. D. Roach, S. Mowbray, and C. Fricke for technical support and B. Ngwenya, A. Matthews, D. Rickard, A. McAnena, and M. Pekala for constructive discussions.	Anbar AD, 2000, SCIENCE, V288, P126, DOI 10.1126/science.288.5463.126; Anbar AD, 2007, ANNU REV EARTH PL SC, V35, P717, DOI 10.1146/annurev.earth.34.031405.125029; Archer C, 2006, GEOLOGY, V34, P153, DOI 10.1130/G22067.1; Butler IB, 2005, EARTH PLANET SC LETT, V236, P430, DOI 10.1016/j.epsl.2005.05.022; Butler IB, 2004, EARTH PLANET SC LETT, V228, P495, DOI 10.1016/j.epsl.2004.10.005; Canfield DE, 2005, ANNU REV EARTH PL SC, V33, P1, DOI 10.1146/annurev.earth.33.092203.122711; Canfield DE, 1998, NATURE, V396, P450, DOI 10.1038/24839; Czaja AD, 2010, EARTH PLANET SC LETT, V292, P170, DOI 10.1016/j.epsl.2010.01.032; Duan Y, 2010, EARTH PLANET SC LETT, V290, P244, DOI 10.1016/j.epsl.2009.11.052; Guilbaud R, 2011, GEOCHIM COSMOCHIM AC, V75, P2721, DOI 10.1016/j.gca.2011.02.023; ISLEY AE, 1995, J GEOL, V103, P169, DOI 10.1086/629734; Johnson CM, 2008, ANNU REV EARTH PL SC, V36, P457, DOI 10.1146/annurev.earth.36.031207.124139; Johnson CM, 2005, GEOCHIM COSMOCHIM AC, V69, P963, DOI 10.1016/j.gca.2004.06.043; Li C, 2010, SCIENCE, V328, P80, DOI 10.1126/science.1182369; Luther GW, 2005, J NANOPART RES, V7, P389, DOI 10.1007/s11051-005-4272-4; Matthews A, 2004, GEOCHIM COSMOCHIM AC, V68, P3107, DOI 10.1016/j.gca.2004.01.019; McAnena A, 2009, GEOCHIM COSMOCHIM AC, V73, pA854; Polyakov VB, 2007, GEOCHIM COSMOCHIM AC, V71, P3833, DOI 10.1016/j.gca.2007.05.019; Poulton SW, 2010, NAT GEOSCI, V3, P486, DOI 10.1038/NGEO889; Raiswell R, 1998, AM J SCI, V298, P219, DOI 10.2475/ajs.298.3.219; Rickard D, 1997, GEOCHIM COSMOCHIM AC, V61, P135, DOI 10.1016/S0016-7037(96)00322-5; Rickard D, 2007, CHEM REV, V107, P514, DOI 10.1021/cr0503658; Rouxel OJ, 2005, SCIENCE, V307, P1088, DOI 10.1126/science.1105692; Rouxel OJ, 2010, GEOSTAND GEOANAL RES, V34, P135, DOI 10.1111/j.1751-908X.2010.00063.x; Schauble EA, 2004, REV MINERAL GEOCHEM, V55, P65, DOI 10.2138/gsrmg.55.1.65; Severmann S, 2006, GEOCHIM COSMOCHIM AC, V70, P2006, DOI 10.1016/j.gca.2006.01.007; Severmann S, 2008, GEOLOGY, V36, P487, DOI 10.1130/G24670A.1; Skulan JL, 2002, GEOCHIM COSMOCHIM AC, V66, P2995, DOI 10.1016/S0016-7037(02)00902-X; Yamaguchi KE, 2005, CHEM GEOL, V218, P135, DOI 10.1016/j.chemgeo.2005.01.020	29	104	113	1	127	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 24	2011	332	6037					1548	1551		10.1126/science.1202924	http://dx.doi.org/10.1126/science.1202924			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782EE	21700871	Green Accepted			2022-12-24	WOS:000291990000042
J	Kenfield, SA; Stampfer, MJ; Chan, JM; Giovannucci, E				Kenfield, Stacey A.; Stampfer, Meir J.; Chan, June M.; Giovannucci, Edward			Smoking and Prostate Cancer Survival and Recurrence	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BODY-MASS INDEX; CIGARETTE-SMOKING; RADICAL PROSTATECTOMY; UNITED-STATES; HEALTH-PROFESSIONALS; EPITHELIAL-CELLS; MEN; RISK; CADMIUM; RADIOTHERAPY	Context Studies of smoking in relation to prostate cancer mortality or recurrence in prostate cancer patients are limited, with few prostate cancer-specific outcomes. Objective To assess the relation of cigarette smoking and smoking cessation with overall, prostate cancer-specific, and cardiovascular disease (CVD) mortality and biochemical recurrence among men with prostate cancer. Design, Setting, and Participants Prospective observational study of 5366 men diagnosed with prostate cancer between 1986 and 2006 in the Health Professionals Follow-Up Study. Main Outcome Measures Hazard ratios (HRs) for overall, prostate cancer-specific, and CVD mortality, and biochemical recurrence, defined by an increase in prostate-specific antigen (PSA) levels. Results There were 1630 deaths, 524 (32%) due to prostate cancer and 416 (26%) to CVD, and 878 biochemical recurrences. Absolute crude rates for prostate cancer-specific death for never vs current smokers were 9.6 vs 15.3 per 1000 person-years; for all-cause mortality, the corresponding rates were 27.3 and 53.0 per 1000 person-years. In multi-variable analysis, current vs never smokers had an increased risk of prostate cancer mortality (HR, 1.61; 95% confidence interval [CI], 1.11-2.32), as did current smokers with clinical stage T1 through T3 (HR, 1.80; 95% CI, 1.04-3.12). Current smokers also had increased risk of biochemical recurrence (HR, 1.61; 95% CI, 1.16-2.22), total mortality (HR, 2.28; 95% CI, 1.87-2.80), and CVD mortality (HR, 2.13; 95% CI, 1.39-3.26). After adjusting for clinical stage and grade (likely intermediates of the relation of smoking with prostate cancer recurrence and survival), current smokers had increased risk of prostate cancer mortality (HR, 1.38; 95% CI, 0.94-2.03), as did current smokers with clinical stage T1 through T3 (HR, 1.41; 95% CI, 0.80-2.49); they also had an increased risk of biochemical recurrence (HR, 1.47; 95% CI, 1.06-2.04). Greater number of pack-years was associated with significantly increased risk of prostate cancer mortality but not biochemical recurrence. Current smokers of 40 or more pack-years vs never smokers had increased prostate cancer mortality (HR, 1.82; 95% CI, 1.03-3.20) and biochemical recurrence (HR, 1.48; 95% CI, 0.88-2.48). Compared with current smokers, those who had quit smoking for 10 or more years (HR, 0.60; 95% CI, 0.42-0.87) or who have quit for less than 10 years but smoked less than 20 pack-years (HR, 0.64; 95% CI, 0.28-1.45) had prostate cancer mortality risks similar to never smokers (HR, 0.61; 95% CI, 0.42-0.88). Conclusions Smoking at the time of prostate cancer diagnosis is associated with increased overall and CVD mortality and prostate cancer-specific mortality and recurrence. Men who have quit for at least 10 years have prostate cancer-specific mortality risks similar to those who have never smoked. JAMA. 2011;305(24):2548-2555	[Kenfield, Stacey A.; Stampfer, Meir J.; Giovannucci, Edward] Channing Labs, Dept Med, Brigham & Womens Hosp, Boston, MA 02115 USA; [Kenfield, Stacey A.; Stampfer, Meir J.; Giovannucci, Edward] Harvard Univ, Sch Med, Boston, MA USA; [Kenfield, Stacey A.; Stampfer, Meir J.; Giovannucci, Edward] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Kenfield, Stacey A.; Giovannucci, Edward] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Chan, June M.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Chan, June M.] Univ Calif San Francisco, Dept Urol, San Francisco, CA 94143 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Kenfield, SA (corresponding author), Channing Labs, Dept Med, Brigham & Womens Hosp, 181 Longwood Ave,Room 452, Boston, MA 02115 USA.	skenfiel@hsph.harvard.edu		Chan, June/0000-0002-7620-569X	National Institutes of Health [CA055075, CA141298]; NATIONAL CANCER INSTITUTE [R01CA141298, T32CA009001, R25CA098566, R01CA090598, P01CA055075] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants CA055075 and CA141298 from the National Institutes of Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Achanzar WE, 2001, CANCER RES, V61, P455; Allen NE, 2002, CANCER CAUSE CONTROL, V13, P353, DOI 10.1023/A:1015238102830; Benbrahim-Tallaa L, 2007, PROSTATE, V67, P135, DOI 10.1002/pros.20479; Byrne MM, 2010, CANCER EPIDEMIOL, V34, P611, DOI 10.1016/j.canep.2010.06.017; Chan JM, 1999, CANCER EPIDEM BIOMAR, V8, P893; Chan JM, 2006, CANCER CAUSE CONTROL, V17, P199, DOI 10.1007/s10552-005-0413-4; DANIELL HW, 1995, J UROLOGY, V154, P153, DOI 10.1016/S0022-5347(01)67253-7; Enokida A, 2006, CANCER, V106, P79; Freedland SJ, 2003, UROLOGY, V61, P365, DOI 10.1016/S0090-4295(02)02268-9; Giovannucci E, 1999, CANCER EPIDEM BIOMAR, V8, P277; Giovannucci E, 2007, INT J CANCER, V121, P1571, DOI 10.1002/ijc.22788; Gong ZH, 2008, CANCER CAUSE CONTROL, V19, P25, DOI 10.1007/s10552-007-9066-9; Handa K, 1997, ATHEROSCLEROSIS, V130, P37, DOI 10.1016/S0021-9150(96)06041-8; Hecht SS, 2006, LANGENBECK ARCH SURG, V391, P603, DOI 10.1007/s00423-006-0111-z; Heeschen C, 2001, NAT MED, V7, P833, DOI 10.1038/89961; Heinonen OP, 1998, J NATL CANCER I, V90, P440, DOI 10.1093/jnci/90.6.440; Jager T, 2007, UROLOGE, V46, P397, DOI 10.1007/s00120-006-1252-y; Jain RK, 2001, NAT MED, V7, P775, DOI 10.1038/89889; Joshu CE, 2011, JNCI-J NATL CANCER I, V103, P835, DOI 10.1093/jnci/djr124; Kuban DA, 2006, INT J RADIAT ONCOL, V65, P1487, DOI 10.1016/j.ijrobp.2006.03.027; Kupelian PA, 2002, J CLIN ONCOL, V20, P3376, DOI 10.1200/JCO.2002.01.150; Ma J, 2008, LANCET ONCOL, V9, P1039, DOI 10.1016/S1470-2045(08)70235-3; Mai SK, 2007, HLTH CONS SMOK REP S, V2, P30; Merrick GS, 2004, INT J RADIAT ONCOL, V58, P1056, DOI 10.1016/j.ijrobp.2003.08.021; Moreira DM, 2010, UROLOGY, V76, P1218, DOI 10.1016/j.urology.2010.01.066; Nock NL, 2006, CANCER EPIDEM BIOMAR, V15, P756, DOI 10.1158/1055-9965.EPI-05-0826; Oefelein MG, 2004, J UROLOGY, V171, P2281, DOI 10.1097/01.ju.0000125123.46733.93; Pantarotto J, 2007, BJU INT, V99, P564, DOI 10.1111/j.1464-410X.2006.06656.x; Pickles T, 2004, J UROLOGY, V171, P1543, DOI 10.1097/01.ju.0000118292.25214.a4; POUR PM, 1983, CARCINOGENESIS, V4, P49, DOI 10.1093/carcin/4.1.49; RICHEDWARDS JW, 1994, AM J EPIDEMIOL, V140, P1016, DOI 10.1093/oxfordjournals.aje.a117191; Roach M, 2006, INT J RADIAT ONCOL, V65, P965, DOI 10.1016/j.ijrobp.2006.04.029; Shiels MS, 2009, CANCER CAUSE CONTROL, V20, P877, DOI 10.1007/s10552-009-9318-y; Svartberg J, 2007, INT J ANDROL, V30, P137, DOI 10.1111/j.1365-2605.2006.00720.x; Tamimi R, 2001, EUR J CANCER PREV, V10, P275, DOI 10.1097/00008469-200106000-00012; Villablanca AC, 1998, J APPL PHYSIOL, V84, P2089, DOI 10.1152/jappl.1998.84.6.2089; Vinceti M, 2007, SCI TOTAL ENVIRON, V373, P77, DOI 10.1016/j.scitotenv.2006.11.005; WAALKES MP, 1994, J TOXICOL ENV HEALTH, V43, P251, DOI 10.1080/15287399409531920; Wilson KM, 2011, JNCI-J NATL CANCER I, V103, P876, DOI 10.1093/jnci/djr151; Yu GP, 1997, CANCER DETECT PREV, V21, P497; Zeng XB, 2004, BIOMETALS, V17, P559, DOI 10.1023/B:BIOM.0000045739.89653.67; Zu K, 2009, CANCER CAUSE CONTROL, V20, P1799, DOI 10.1007/s10552-009-9387-y	42	177	179	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 22	2011	305	24					2548	2555		10.1001/jama.2011.879	http://dx.doi.org/10.1001/jama.2011.879			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	780MF	21693743	Green Accepted			2022-12-24	WOS:000291860400022
J	Rice, C				Rice, Charles			Miles to go before we sleep	NATURE			English	Editorial Material									Rockefeller Univ, Lab Virol & Infect Dis, New York, NY 10021 USA	Rockefeller University	Rice, C (corresponding author), Rockefeller Univ, Lab Virol & Infect Dis, 1230 York Ave, New York, NY 10021 USA.	ricec@mail.rockefeller.edu							0	17	17	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 9	2011	474	7350					S8	S8		10.1038/474S8a	http://dx.doi.org/10.1038/474S8a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	774PE	21666734	Bronze			2022-12-24	WOS:000291397800005
J	Yahia, M				Yahia, Mohammed			A uniquely Egyptian epidemic	NATURE			English	Editorial Material																		El-Zanaty F., 2009, EGYPT DEMOGRAPHIC HL, DOI DOI 10.1177/0049475514561330; Kamal SM, 2008, HEPATOLOGY, V47, P1371, DOI 10.1002/hep.22127; KAMEL MA, 1992, LANCET, V340, P427, DOI 10.1016/0140-6736(92)91508-6; Miller FD, 2010, P NATL ACAD SCI USA, V107, P14757, DOI 10.1073/pnas.1008877107	4	23	23	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 9	2011	474	7350					S12	S13		10.1038/474S12a	http://dx.doi.org/10.1038/474S12a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	774PE	21666728				2022-12-24	WOS:000291397800008
J	Larson, HJ; Ghinai, I				Larson, Heidi J.; Ghinai, Isaac			Lessons from polio eradication	NATURE			English	Editorial Material									[Larson, Heidi J.; Ghinai, Isaac] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1 7HT, England	University of London; London School of Hygiene & Tropical Medicine	Larson, HJ (corresponding author), London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, Keppel St, London WC1 7HT, England.	heidi.larson@lshtm.ac.uk	Ghinai, Isaac/AAI-7985-2021; Larson, Heidi J./N-1018-2017	Ghinai, Isaac/0000-0003-1322-1331; Larson, Heidi J./0000-0002-8477-7583				Anonymous, 2009, Morbidity and Mortality Weekly Report, V58, P357; Closser S, 2010, CHASING POLIO PAKIST; Donaldson L., 2011, REPORT INDEPENDENT M; Kaufmann JR, 2009, HEALTH AFFAIR, V28, P1091, DOI 10.1377/hlthaff.28.4.1091; Obregon R, 2009, B WORLD HEALTH ORGAN, V87, P624, DOI 10.2471/BLT.08.060863; Taylor S, 2010, J HEALTH COMMUN, V15, P48, DOI 10.1080/10810731003698585; Tebbens RJD, 2010, VACCINE, V29, P334, DOI 10.1016/j.vaccine.2010.10.026; Tool M., 2009, EVALUATION GLOBAL PO; UNICEF Regional Office for South Asia, 2004, EV CHILD COUNTS ENG; Yahya M., 2006, 261 IDS	10	45	47	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 26	2011	473	7348					446	447		10.1038/473446a	http://dx.doi.org/10.1038/473446a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	768QM	21614056	Bronze			2022-12-24	WOS:000290951300015
J	Smith, J; Humes, DJ; Spiller, RC				Smith, Janette; Humes, David J.; Spiller, Robin C.			Should we treat uncomplicated symptomatic diverticular disease with fibre?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							COLON; PATTERNS		[Spiller, Robin C.] Univ Nottingham, Nottingham Digest Dis Ctr, Nottingham NG7 2UH, England; [Smith, Janette; Humes, David J.] Univ Nottingham, Dept Surg, Nottingham NG7 2UH, England; [Spiller, Robin C.] Univ Nottingham, NIHR Biomed Res Ctr, Nottingham NG7 2UH, England	University of Nottingham; University of Nottingham; University of Nottingham	Spiller, RC (corresponding author), Univ Nottingham, Nottingham Digest Dis Ctr, Nottingham NG7 2UH, England.	robin.spiller@nottingham.ac.uk	spiller, robin/ABE-6690-2021	spiller, robin/0000-0001-6371-4500; Humes, David/0000-0002-7071-4098	National Institute for Health Research [CL-2006-12-002, NF-SI-0509-10005] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		Bijkerk CJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3154; BRODRIBB AJM, 1977, LANCET, V1, P664; Clemens CHM, 2004, GUT, V53, P717, DOI 10.1136/gut.2003.018093; CORTESINI C, 1991, DIS COLON RECTUM, V34, P339, DOI 10.1007/BF02050595; Etzioni DA, 2009, ANN SURG, V249, P210, DOI 10.1097/SLA.0b013e3181952888; Humes D, 2011, CLIN EVID, V3, P405; Kang JY, 2011, ALIMENT PHARM THER, V33, P487, DOI 10.1111/j.1365-2036.2010.04540.x; Longstreth GF, 2006, GASTROENTEROLOGY, V130, P1480, DOI 10.1053/j.gastro.2005.11.061; ORNSTEIN MH, 1981, BRIT MED J, V282, P1353, DOI 10.1136/bmj.282.6273.1353; PAINTER NS, 1982, S AFR MED J, V61, P1016; Rafferty J, 2006, DIS COLON RECTUM, V49, P939, DOI 10.1007/s10350-006-0578-2; Simpson J, 2003, EUR J GASTROEN HEPAT, V15, P1005, DOI 10.1097/00042737-200309000-00011; Simpson J, 2009, NEUROGASTROENT MOTIL, V21, P847, DOI 10.1111/j.1365-2982.2009.01308.x; SNOOK J, 1994, ALIMENT PHARM THERAP, V8, P511; Stollman NH, 1999, AM J GASTROENTEROL, V94, P3110, DOI 10.1111/j.1572-0241.1999.01501.x; Strate LL, 2009, GASTROENTEROLOGY, V136, P115, DOI 10.1053/j.gastro.2008.09.025; Tursi A, 2010, DIGEST LIVER DIS, V42, P458, DOI 10.1016/j.dld.2009.09.003	17	5	5	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 25	2011	342								d2951	10.1136/bmj.d2951	http://dx.doi.org/10.1136/bmj.d2951			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	771KE	21613363				2022-12-24	WOS:000291154800004
J	Kinross, JM; Holmes, E; Darzi, AW; Nicholson, JK				Kinross, James M.; Holmes, Elaine; Darzi, Ara W.; Nicholson, Jeremy K.			Metabolic phenotyping for monitoring surgical patients	LANCET			English	Editorial Material							IDENTIFICATION		[Holmes, Elaine; Nicholson, Jeremy K.] Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Surg & Canc, Sect Biomol Med, London SW7 2AZ, England; [Kinross, James M.; Darzi, Ara W.] Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Surg & Canc, Sect Biosurg & Surg Technol, London SW7 2AZ, England	Imperial College London; Imperial College London	Nicholson, JK (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Surg & Canc, Sect Biomol Med, London SW7 2AZ, England.	j.nicholson@imperial.ac.uk	Holmes, Elaine/A-2189-2015; Holmes, Elaine/ABE-6606-2020; Nicholson, Jeremy K/B-3395-2012	Holmes, Elaine/0000-0002-0556-8389; Nicholson, Jeremy K/0000-0002-8123-8349; Kinross, James/0000-0002-0427-7643				[Anonymous], 2010, LANCET, V376, P1025, DOI 10.1016/S0140-6736(10)61466-3; Balog J, 2010, ANAL CHEM, V82, P7343, DOI 10.1021/ac101283x; Can MF, 2008, WORLD J SURG, V32, P589, DOI 10.1007/s00268-007-9321-y; Chan ECY, 2009, J PROTEOME RES, V8, P352, DOI 10.1021/pr8006232; Clayton TA, 2009, P NATL ACAD SCI USA, V106, P14728, DOI 10.1073/pnas.0904489106; Clayton TA, 2006, NATURE, V440, P1073, DOI 10.1038/nature04648; Garcia-Miguel FJ, 2003, LANCET, V362, P1749, DOI 10.1016/S0140-6736(03)14857-X; Holmes E, 2008, CELL, V134, P714, DOI 10.1016/j.cell.2008.08.026; Holmes E, 2008, NATURE, V453, P396, DOI 10.1038/nature06882; Kinross JM, 2011, J PROTEOME RES, V10, P277, DOI 10.1021/pr1003278; Lindon JC, 2008, TRAC-TREND ANAL CHEM, V27, P194, DOI 10.1016/j.trac.2007.08.009; Miura D, 2010, ANAL CHEM, V82, P9789, DOI 10.1021/ac101998z; Nicholson JK, 2008, NATURE, V455, P1054, DOI 10.1038/4551054a	13	64	68	1	13	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY-JUN	2011	377	9780					1817	1819		10.1016/S0140-6736(11)60171-2	http://dx.doi.org/10.1016/S0140-6736(11)60171-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	774UI	21596428				2022-12-24	WOS:000291411700009
J	Chowdhury, BA; Seymour, SM; Levenson, MS				Chowdhury, Badrul A.; Seymour, Sally M.; Levenson, Mark S.			Assessing the Safety of Adding LABAs to Inhaled Corticosteroids for Treating Asthma	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ACTING BETA-AGONISTS		[Chowdhury, Badrul A.; Seymour, Sally M.] US FDA, Ctr Drug Evaluat & Res, Div Pulm Allergy & Rheumatol Prod, Off New Drugs, Silver Spring, MD USA; [Levenson, Mark S.] US FDA, Ctr Drug Evaluat & Res, Off Biostat, Silver Spring, MD USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA)	Chowdhury, BA (corresponding author), US FDA, Ctr Drug Evaluat & Res, Div Pulm Allergy & Rheumatol Prod, Off New Drugs, Silver Spring, MD USA.							Chowdhury BA, 2010, NEW ENGL J MED, V362, P1169, DOI 10.1056/NEJMp1002074; Drazen JM, 2009, NEW ENGL J MED, V360, P1671, DOI 10.1056/NEJMe0902057; *FDA, 2010, MARCH 10 11 2010 JOI; Fleming TR, 2008, NEW ENGL J MED, V359, P1400, DOI 10.1056/NEJMe0807372; Nelson HS, 2006, CHEST, V129, P15, DOI 10.1378/chest.129.1.15	5	84	87	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 30	2011	364	26					2473	2475		10.1056/NEJMp1104375	http://dx.doi.org/10.1056/NEJMp1104375			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	785AM	21714647				2022-12-24	WOS:000292199800001
J	Choi, J; Wang, DY; Kundu, S; Choliy, Y; Emge, TJ; Krogh-Jespersen, K; Goldman, AS				Choi, Jongwook; Wang, David Y.; Kundu, Sabuj; Choliy, Yuriy; Emge, Thomas J.; Krogh-Jespersen, Karsten; Goldman, Alan S.			Net Oxidative Addition of C(sp(3))-F Bonds to Iridium via Initial C-H Bond Activation	SCIENCE			English	Article							TRANSITION-METAL-COMPLEXES; REDUCTIVE ELIMINATION; FLUORINE; REACTIVITY; CHEMISTRY; MECHANISM; HYDROGEN	Carbon-fluorine bonds are the strongest known single bonds to carbon and as a consequence can prove very hard to cleave. Alhough vinyl and aryl C-F bonds can undergo oxidative addition to transition metal complexes, this reaction has appeared inoperable with aliphatic substrates. We report the addition of C(sp(3))-F bonds (including alkyl-F) to an iridium center via the initial, reversible cleavage of a C-H bond. These results suggest a distinct strategy for the development of catalysts and promoters to make and break C-F bonds, which are of strong interest in the context of both pharmaceutical and environmental chemistry.	[Choi, Jongwook; Wang, David Y.; Kundu, Sabuj; Choliy, Yuriy; Emge, Thomas J.; Krogh-Jespersen, Karsten; Goldman, Alan S.] Rutgers State Univ, Dept Chem & Chem Biol, New Brunswick, NJ 08903 USA	Rutgers State University New Brunswick	Krogh-Jespersen, K (corresponding author), Rutgers State Univ, Dept Chem & Chem Biol, New Brunswick, NJ 08903 USA.	krogh@rutchem.rutgers.edu; alan.goldman@rutgers.edu	Goldman, Alan/D-9521-2011	Goldman, Alan/0000-0002-2774-710X	NSF [CHE-0719307, CHE-0650456]	NSF(National Science Foundation (NSF))	We thank the NSF (grant CHE-0719307) for support of this work. R. Kondrat (University of California, Riverside) is thanked for obtaining LIFDI spectra and for related discussion. Analytical data were obtained from the Center for Enabling New Technologies Through Catalysis Elemental Analysis Facility at the University of Rochester, funded by NSF CHE-0650456. Metrical parameters for the structure of 4b are available free of charge from the Cambridge Crystallographic Data Centre under reference CCDC-823748.	Amii H, 2009, CHEM REV, V109, P2119, DOI 10.1021/cr800388c; Bourgeois CJ, 2006, ORGANOMETALLICS, V25, P3474, DOI 10.1021/om060267s; BROTHERS PJ, 1988, CHEM REV, V88, P1293, DOI 10.1021/cr00089a014; Cho EJ, 2010, SCIENCE, V328, P1679, DOI 10.1126/science.1190524; Choi J, 2009, J AM CHEM SOC, V131, P15627, DOI 10.1021/ja906930u; COLLMAN JP, 1968, ACCOUNTS CHEM RES, V1, P136, DOI 10.1021/ar50005a002; Cooper AC, 1997, ORGANOMETALLICS, V16, P505, DOI 10.1021/om9605488; de Meijere A., 2004, METAL CATALYZED CROS, V2nd, DOI 10.1002/9783527619535; Douvris C, 2008, SCIENCE, V321, P1188, DOI 10.1126/science.1159979; Dransfield TA, 2010, J FLUORINE CHEM, V131, P1213, DOI 10.1016/j.jfluchem.2010.05.008; Fawcett J, 2010, DALTON T, V39, P5827, DOI 10.1039/c0dt00066c; Furuya T, 2010, J AM CHEM SOC, V132, P3793, DOI 10.1021/ja909371t; Gomez-Benitez V., 2003, REV SOC QUIM MEX, V47, P124; HALPERN J, 1970, ACCOUNTS CHEM RES, V3, P386, DOI 10.1021/ar50035a004; Hartwig J. F, 2009, ORGANOTRANSITION MET; Huang DJ, 2000, J AM CHEM SOC, V122, P8916, DOI 10.1021/ja001646u; Hughes RP, 2005, J AM CHEM SOC, V127, P15020, DOI 10.1021/ja055166k; Hughes RP, 2009, EUR J INORG CHEM, P4591, DOI 10.1002/ejic.200900816; Jasim NA, 2000, J AM CHEM SOC, V122, P8685, DOI 10.1021/ja0010913; Kanzelberger M, 2000, J AM CHEM SOC, V122, P11017, DOI 10.1021/ja001626s; KIPLINGER JL, 1994, CHEM REV, V94, P373, DOI 10.1021/cr00026a005; Kraft BM, 2010, J FLUORINE CHEM, V131, P1122, DOI 10.1016/j.jfluchem.2010.05.003; McCulloch A, 2003, J FLUORINE CHEM, V123, P21, DOI 10.1016/S0022-1139(03)00105-2; MCMILLEN DF, 1982, ANNU REV PHYS CHEM, V33, P493, DOI 10.1146/annurev.pc.33.100182.002425; Muller K, 2007, SCIENCE, V317, P1881, DOI 10.1126/science.1131943; Northcutt TO, 2001, J AM CHEM SOC, V123, P7257, DOI 10.1021/ja003944x; Parkin G, 2009, ACCOUNTS CHEM RES, V42, P315, DOI 10.1021/ar800156h; Perutz RN., 2007, COMPREHENSIVE ORGANO, P725; RACHIDI IE, 1990, NEW J CHEM, V14, P671; Rybtchinski B, 1996, J AM CHEM SOC, V118, P12406, DOI 10.1021/ja962253r; STILLE JK, 1977, ACCOUNTS CHEM RES, V10, P434, DOI 10.1021/ar50120a002; Torrens H, 2005, COORDIN CHEM REV, V249, P1957, DOI 10.1016/j.ccr.2005.01.025; Veltheer JE, 1995, J AM CHEM SOC, V117, P12478, DOI 10.1021/ja00155a012; Vetter AJ, 2009, J AM CHEM SOC, V131, P10742, DOI 10.1021/ja9002316; Vigalok A, 2008, CHEM-EUR J, V14, P5102, DOI 10.1002/chem.200701738; Watson DA, 2009, SCIENCE, V325, P1661, DOI 10.1126/science.1178239; Werkema EL, 2005, J AM CHEM SOC, V127, P7781, DOI 10.1021/ja0504800	37	133	133	7	122	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 24	2011	332	6037					1545	1548		10.1126/science.1200514	http://dx.doi.org/10.1126/science.1200514			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	782EE	21700870				2022-12-24	WOS:000291990000041
J	Brotherton, JML; Fridman, M; May, CL; Chappell, G; Saville, AM; Gertig, DM				Brotherton, Julia M. L.; Fridman, Masha; May, Cathryn L.; Chappell, Genevieve; Saville, A. Marion; Gertig, Dorota M.			Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study	LANCET			English	Article							PREDICTED IMPACT; PAPILLOMAVIRUS; LESIONS	Background Australia introduced a human papillomavirus (HPV) vaccination programme with the quadrivalent HPV vaccine for all women aged 12-26 years between 2007 and 2009. We analysed trends in cervical abnormalities in women in Victoria, Australia, before and after introduction of the vaccination programme. Methods With data from the Victorian Cervical Cytology Registry between 2003 and 2009, we compared the incidence of histopathologically defined high-grade cervical abnormalities (HGAs, lesions coded as cervical intraepithelial neoplasia of grade 2 or worse or adenocarcinoma in situ; primary outcome) and low-grade cytological abnormalities (LGAs) in five age groups before (Jan 1, 2003, to March 31, 2007) and after (April 1, 2007, to Dec 31, 2009) the vaccination programme began. Binary comparisons between the two periods were done with Fisher's exact test. Poisson piecewise regression analysis was used to compare incident rate trends. Findings After the introduction of the vaccination programme, we recorded a decrease in the incidence of HGAs by 0.38% (95% CI 0.61-0.16) in girls younger than 18 years. This decrease was progressive and significantly different to the linear trend in incidence before introduction of the vaccination (incident rate ratio 1.14, 1.00-1.30, p=0.05). No similar temporal decline was recorded for LGAs or in older age groups. Interpretation This is the first report of a decrease in incidence of HGAs within 3 years after the implementation of a population-wide HPV vaccination programme. Linkage between vaccination and screening registers is needed to confirm that this ecological observation is attributable to vaccination and to monitor participation in screening among vaccinated women.	[Brotherton, Julia M. L.; May, Cathryn L.; Chappell, Genevieve; Saville, A. Marion; Gertig, Dorota M.] Victorian Cytol Serv, Victorian Cytol Serv Registries, Melbourne, Vic 8002, Australia; [Fridman, Masha] Dept Primary Ind, Biosci Res Div, Bundoora, Vic, Australia		Brotherton, JML (corresponding author), Victorian Cytol Serv, Victorian Cytol Serv Registries, POB 310, Melbourne, Vic 8002, Australia.	jbrother@vcs.org.au	Gertig, Dorota/Z-1087-2019		Australian Research Council; CSL Biotherapies; GlaxoSmithKline; Victorian Government	Australian Research Council(Australian Research Council); CSL Biotherapies; GlaxoSmithKline(GlaxoSmithKline); Victorian Government	JMLB, DMG, and MS are investigators on an Australian Research Council Linkage Grant, for which CSL Biotherapies is a partner organisation. JMLB was an investigator on a national HPV prevalence study that received partial, equal, and unrestricted funding from CSL Biotherapies and GlaxoSmithKline. GC, MF, and CLM declare that they have no conflicts of interest.; We thank Grace Zampogna (VCCR) for her assistance with variable definitions and appreciate the methodological advice received from Ian Gordon (Statistical Consulting Centre, University of Melbourne, Victoria, Australia), Karen Canfell (NSW Cancer Council, NSW, Australia), and Carolyn Nickson (University of Melbourne, Victoria, Australia). The VCCR is fully funded by the Victorian Government and operated by the Victorian Cytology Service.	Asghari S, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-62; [Australian Institute of Health and Welfare Australasian Association of Cancer Registries], 2008, CANC SER AIHW; Australian Institute of Health and Welfare, 2010, CANC SER AIHW; Australian Institute of Health and Welfare, 2008, NAT CERV SCREEN PROG; Brameld KJ, 2003, INT J EPIDEMIOL, V32, P617, DOI 10.1093/ije/dyg191; Brotherton JML, WILL YOUNG WOMEN HAV; Clifford GM, 2005, CANCER EPIDEM BIOMAR, V14, P1157, DOI 10.1158/1055-9965.EPI-04-0812; Constantine R, 2008, PSYCHIAT SERV, V59, P1162, DOI 10.1176/appi.ps.59.10.1162; Cuzick J, 2010, BRIT J CANCER, V102, P933, DOI 10.1038/sj.bjc.6605528; Fairley CK, 2009, SEX TRANSM INFECT, V85, P499, DOI 10.1136/sti.2009.037788; Frazer, 2020, GUIDELINES MANAGEMEN; Gertig DM, 2011, SEX HEALTH, V8, P171, DOI 10.1071/SH10001; Heley S, 2009, AUST FAM PHYSICIAN, V38, P977; Immunise Australia Program, HUM PAP HPV; Kreimer AR, PROOF OF PRINCIPLE E; Kurman RJ, 1994, BETHESDA SYSTEM REPO; Levy-Bruhl D, 2009, EUR J CANCER, V45, P2709, DOI 10.1016/j.ejca.2009.07.023; Mao C, 2006, OBSTET GYNECOL, V107, P1425; Muggeo VMR, 2003, STAT MED, V22, P3055, DOI 10.1002/sim.1545; Munoz N, 2010, JNCI-J NATL CANCER I, V102, P325, DOI 10.1093/jnci/djp534; Porras C, 2009, CANCER EPIDEM BIOMAR, V18, P863, DOI 10.1158/1055-9965.EPI-08-0951; Sellors J, HPV VACCINATION DEV; Smith JS, 2007, INT J CANCER, V121, P621, DOI 10.1002/ijc.22527; Smith MA, 2008, INT J CANCER, V123, P1854, DOI 10.1002/ijc.23633; Tota J, 2010, SEX HEALTH, V7, P376, DOI 10.1071/SH10022; [UCLA Academic Technology Services SCG], STAT FAQ CAN I RUN P; Victorian Cervical Cytology Registry, 2009, VICT CERV CYT REG ST; Winer RL, 2005, J INFECT DIS, V191, P731, DOI 10.1086/427557; World Health Organization, 2009, M HPV VACC COV IMP M	29	357	365	0	36	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 18	2011	377	9783					2085	2092		10.1016/S0140-6736(11)60551-5	http://dx.doi.org/10.1016/S0140-6736(11)60551-5			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	783XI	21684381				2022-12-24	WOS:000292117800030
J	Fujisaki, J; Wu, J; Carlson, AL; Silberstein, L; Putheti, P; Larocca, R; Gao, WD; Saito, TI; Lo Celso, C; Tsuyuzaki, H; Sato, T; Cote, D; Sykes, M; Strom, TB; Scadden, DT; Lin, CP				Fujisaki, Joji; Wu, Juwell; Carlson, Alicia L.; Silberstein, Lev; Putheti, Prabhakar; Larocca, Rafael; Gao, Wenda; Saito, Toshiki I.; Lo Celso, Cristina; Tsuyuzaki, Hitoshi; Sato, Tatsuyuki; Cote, Daniel; Sykes, Megan; Strom, Terry B.; Scadden, David T.; Lin, Charles P.			In vivo imaging of T-reg cells providing immune privilege to the haematopoietic stem-cell niche	NATURE			English	Article							BONE-MARROW NICHE; ENGRAFTMENT	Stem cells reside in a specialized regulatory microenvironment or niche(1,2), where they receive appropriate support for maintaining self-renewal and multi-lineage differentiation capacity(1-3). The niche may also protect stem cells from environmental insults(3) including cytotoxic chemotherapy and perhaps pathogenic immunity(4). The testis, hair follicle and placenta are all sites of residence for stem cells and are immune-suppressive environments, called immune-privileged sites, where multiple mechanisms cooperate to prevent immune attack, even enabling prolonged survival of foreign allografts without immunosuppression(4). We sought to determine if somatic stem-cell niches more broadly are immune-privileged sites by examining the haematopoietic stem/progenitor cell (HSPC) niche(1,2,5-7) in the bone marrow, a site where immune reactivity exists(8,9). We observed persistence of HSPCs from allogeneic donor mice (allo-HSPCs) in non-irradiated recipient mice for 30 days without immunosuppression with the same survival frequency compared to syngeneic HSPCs. These HSPCs were lost after the depletion of FoxP3 regulatory T (T-reg) cells. High-resolutionin vivo imaging over time demonstrated marked co-localization of HSPCs with T-reg cells that accumulated on the endosteal surface in the calvarial and trabecular bone marrow. T-reg cells seem to participate in creating a localized zone where HSPCs reside and where T-reg cells are necessary for allo-HSPC persistence. In addition to processes supporting stem-cell function, the niche will provide a relative sanctuary from immune attack.	[Fujisaki, Joji; Wu, Juwell; Carlson, Alicia L.; Lin, Charles P.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Syst Biol,Adv Microscopy Program, Boston, MA 02114 USA; [Fujisaki, Joji; Wu, Juwell; Carlson, Alicia L.; Lin, Charles P.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Wellman Ctr Photomed, Boston, MA 02114 USA; [Fujisaki, Joji; Wu, Juwell; Silberstein, Lev; Lo Celso, Cristina; Scadden, David T.; Lin, Charles P.] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Wu, Juwell] Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Silberstein, Lev; Scadden, David T.] Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA; [Putheti, Prabhakar; Larocca, Rafael; Gao, Wenda; Strom, Terry B.] Beth Israel Deaconess Med Ctr, Inst Transplantat, Boston, MA 02215 USA; [Putheti, Prabhakar; Larocca, Rafael; Gao, Wenda; Strom, Terry B.] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA; [Saito, Toshiki I.; Sykes, Megan] Massachusetts Gen Hosp E, Massachusetts Gen Hosp, Transplantat Biol Res Ctr, Bone Marrow Transplantat Sect, Boston, MA 02129 USA; [Tsuyuzaki, Hitoshi; Sato, Tatsuyuki] Univ Tokyo, Fac Med, Bunkyo Ku, Tokyo 1130033, Japan; [Cote, Daniel] Dept Phys Genie Phys & Opt, Quebec City, PQ G1J 2G3, Canada; [Cote, Daniel] Univ Laval Robert Giffard, Ctr Rech, Quebec City, PQ G1J 2G3, Canada	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard University; Harvard University; Massachusetts General Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Massachusetts General Hospital; University of Tokyo; Laval University	Fujisaki, J (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Syst Biol,Adv Microscopy Program, CPZN 8238,185 Cambridge St, Boston, MA 02114 USA.	jfujisaki@partners.org; lin@helix.mgh.harvard.edu	Côté, Daniel/D-5185-2011; Sato, Tatsuyuki/V-8183-2019; Assumpcao Larocca, Rafael/H-1655-2015; Larocca, Rafael/J-9557-2012	Sato, Tatsuyuki/0000-0002-9229-9016; Assumpcao Larocca, Rafael/0000-0002-9995-1804; Lo Celso, Cristina/0000-0002-1163-4207	Bullock fellowship; Harvard Stem Cell Institute; DoD [W81XWH-10-1-0217]; NIH [HL097748, HL97794, CA111519, AI041521]; EMBO; HFSP; philanthropic sources; Medical Research Council [G0600698B] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P01CA111519] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL097794, R01HL097748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI041521, P01AI073748] Funding Source: NIH RePORTER	Bullock fellowship; Harvard Stem Cell Institute; DoD(United States Department of Defense); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EMBO(European Molecular Biology Organization (EMBO)); HFSP(Human Frontier Science Program); philanthropic sources; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Bullock fellowship (to J.F.), the Harvard Stem Cell Institute and DoD W81XWH-10-1-0217 (to J.F. and C.P.L.), NIH HL097748 (to C.P.L.), HL97794 (to D.T.S.), CA111519 (to M.S.), AI041521 (to T.B.S), EMBO (to C.L.C.), HFSP (to C.L.C.), philanthropic sources (to D.T.S. and C.L.C.), and the National Institutes of Health. We acknowledge J. Zhao and D. Cao for cell sorting.	Adams GB, 2006, NAT IMMUNOL, V7, P333, DOI 10.1038/ni1331; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Feuerer M, 2003, NAT MED, V9, P1151, DOI 10.1038/nm914; Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7; Huang YM, 2004, BLOOD, V104, P873, DOI 10.1182/blood-2003-11-3910; Joffre O, 2008, NAT MED, V14, P88, DOI 10.1038/nm1688; Jung Y, 2006, BONE, V38, P497, DOI 10.1016/j.bone.2005.10.003; Li LH, 2005, ANNU REV CELL DEV BI, V21, P605, DOI 10.1146/annurev.cellbio.21.012704.131525; Lo Celso C, 2009, NATURE, V457, P92, DOI 10.1038/nature07434; Mazo IB, 1998, J EXP MED, V188, P465, DOI 10.1084/jem.188.3.465; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Niederkorn JY, 2006, NAT IMMUNOL, V7, P354, DOI 10.1038/ni1328; Sipkins DA, 2005, NATURE, V435, P969, DOI 10.1038/nature03703; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Welniak LA, 2007, ANNU REV IMMUNOL, V25, P139, DOI 10.1146/annurev.immunol.25.022106.141606; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041; Zou LH, 2004, CANCER RES, V64, P8451, DOI 10.1158/0008-5472.CAN-04-1987	19	388	402	2	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 9	2011	474	7350					216	U256		10.1038/nature10160	http://dx.doi.org/10.1038/nature10160			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774PE	21654805	Green Accepted			2022-12-24	WOS:000291397800051
J	Reichenheim, ME; de Souza, ER; Moraes, CL; Jorge, MHPD; da Silva, CMFP; Minayo, MCD				Reichenheim, Michael Eduardo; de Souza, Edinilsa Ramos; Moraes, Claudia Leite; Prado de Mello Jorge, Maria Helena; Furtado Passos da Silva, Cosme Marcelo; de Souza Minayo, Maria Cecilia			Health in Brazil 5 Violence and injuries in Brazil: the effect, progress made, and challenges ahead	LANCET			English	Article							INTIMATE PARTNER VIOLENCE; SEVERE PHYSICAL PUNISHMENT; DOMESTIC VIOLENCE; MENTAL-HEALTH; ELDER ABUSE; RISK-FACTORS; SAO-PAULO; CHILDREN; POPULATION; PREVALENCE	Although there are signs of decline, homicides and traffic-related injuries and deaths in Brazil account for almost two-thirds of all deaths from external causes. In 2007, the homicide rate was 26.8 per 100 000 people and traffic-related mortality was 23.5 per 100 000. Domestic violence might not lead to as many deaths, but its share of violence-related morbidity is large. These are important public health problems that lead to enormous individual and collective costs. Young, black, and poor men are the main victims and perpetrators of community violence, whereas poor black women and children are the main victims of domestic violence. Regional differentials are also substantial. Besides the sociocultural determinants, much of the violence in Brazil has been associated with the misuse of alcohol and illicit drugs, and the wide availability of firearms. The high traffic-related morbidity and mortality in Brazil have been linked to the chosen model for the transport system that has given priority to roads and private-car use without offering adequate infrastructure. The system is often poorly equipped to deal with violations of traffic rules. In response to the major problems of violence and injuries, Brazil has greatly advanced in terms of legislation and action plans. The main challenge is to assess these advances to identify, extend, integrate, and continue the successful ones.	[Reichenheim, Michael Eduardo; Moraes, Claudia Leite] Univ Estado Rio de Janeiro, Inst Social Med, Dept Epidemiol, BR-20559900 Rio De Janeiro, Brazil; [de Souza, Edinilsa Ramos; de Souza Minayo, Maria Cecilia] Fundacao Oswaldo Cruz, Natl Sch Publ Hlth, Latin Amer Ctr Studies Violence & Hlth CLAVES, Rio De Janeiro, Brazil; [Moraes, Claudia Leite] Estacio de Sa Univ, Rio De Janeiro, Brazil; [Prado de Mello Jorge, Maria Helena] Univ Sao Paulo, Publ Hlth Fac, Dept Epidemiol, Sao Paulo, Brazil; [Furtado Passos da Silva, Cosme Marcelo] Fundacao Oswaldo Cruz, Natl Sch Publ Hlth, Dept Epidemiol & Quantitat Methods Hlth, Rio De Janeiro, Brazil	Universidade do Estado do Rio de Janeiro; Fundacao Oswaldo Cruz; Universidade de Sao Paulo; Fundacao Oswaldo Cruz	Reichenheim, ME (corresponding author), Univ Estado Rio de Janeiro, Inst Social Med, Dept Epidemiol, Rua Sao Francisco Xavier 524,7 Andar, BR-20559900 Rio De Janeiro, Brazil.	michael@ims.uerj.br	Seguranca Publica, Inct/I-2423-2013; Moraes, claudia/AAK-9418-2020	Moraes, claudia/0000-0002-3223-1634	Brazilian National Research Council (CNPq) [PQ-301221/2009-0, PQ-300515/2009-0, PQ-302851/2008-9, PQ-310503/2009-4]; Rio de Janeiro State Research Foundation (FAPERJ) [E-26/101.461/2010]; Health Surveillance Secretariat (Secretaria de Vigilancia em Saude) of the Brazilian Ministry of Health; INCa	Brazilian National Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Rio de Janeiro State Research Foundation (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Health Surveillance Secretariat (Secretaria de Vigilancia em Saude) of the Brazilian Ministry of Health; INCa(Institut National du Cancer (INCA) France)	MER, ERS, CLM and MHPMJ were supported by the Brazilian National Research Council (CNPq), grants PQ-301221/2009-0, PQ-300515/2009-0, PQ-302851/2008-9 and PQ-310503/2009-4, respectively. CLM was also supported by grant E-26/101.461/2010 from the Rio de Janeiro State Research Foundation (FAPERJ). We are grateful to the National Cancer Institute (CONPREV/INCa) for providing data of the Household Survey on Risk Behaviors and Reported Morbidity from Non-Communicable Diseases used in some analyses (intimate-partner violence). This survey was financed by the Health Surveillance Secretariat (Secretaria de Vigilancia em Saude) of the Brazilian Ministry of Health, with counterpart funds from INCa. We thank Tatiana Ribeiro for her collaboration in organising the references and Christopher Peterson for his meticulous Portuguese-to-English translation.	Adorno S., 1993, BIB, V35, P3; ALFONSO R, 2003, PSIKHE, V8, P31; Anacleto AJ, 2009, CAD SAUDE PUBLICA, V25, P800, DOI 10.1590/S0102-311X2009000400011; [Anonymous], 1999, ENDING VIOLENCE WOME; ASSIS SG, 2003, VIOLENCIA SOB OLHAR, P163; Barata Rita Barradas, 2008, Rev. bras. epidemiol., V11, P3, DOI 10.1590/S1415-790X2008000100001; Beato CCFilho, 2007, HOMICIDIOS BRASIL, P177; Bordin IA, 2009, B WORLD HEALTH ORGAN, V87, P336, DOI 10.2471/BLT.07.043125; CAMARA P, 1999, REV ABRAMET, V30, P31; CAMPOS A, 2009, EVOLUCAO OCUPACAO SI; CANO I, 2007, BATITUCCI ECO, P51; CARDIA N, 1999, ATITUDES NORMAS CULT; Cecchetto F. R., 2004, VIOLENCIA ESTILOS MA; CERQUEIRA DRC, 2007, ANALISE CUSTOS CONSE; Comijs HC, 1998, J AM GERIATR SOC, V46, P885, DOI 10.1111/j.1532-5415.1998.tb02724.x; *CONS NAC DES CIEN, DIR GRUP PESQ COL DA; de Assis SG, 2009, CIENC SAUDE COLETIVA, V14, P349, DOI 10.1590/S1413-81232009000200002; De Micheli D, 2004, ADDICTION, V99, P570, DOI 10.1111/j.1360-0443.2003.00671.x; de Moraes CL, 2008, CAD SAUDE PUBLICA, V24, P2289, DOI 10.1590/S0102-311X2008001000010; de Souza ER, 2010, PSYCHOL RES PROG, P1; DUARTE PCA, 2000, ALCOOL VIOLENCIA EST, P61; FARIA L, 2006, CURINGA, V22, P183; Audi CAF, 2008, J PEDIAT-BRAZIL, V84, P60, DOI 10.2223/JPED.1744; FERRAZ SM, 2004, IMPULSO REV CIENCIAS, V15, P79; Galduróz José Carlos F, 2004, Rev. Bras. Psiquiatr., V26, P3, DOI 10.1590/S1516-44462004000500002; Gawryszewski VP, 2008, REV PANAM SALUD PUBL, V24, P400, DOI 10.1590/S1020-49892008001200004; Goncalves HS, 1999, REV SAUDE PUBL, V33, P547, DOI 10.1590/S0034-89101999000600005; *GOV RIO JAN, 2010, UN PAC; Hasselmann MH, 2006, PAEDIATR PERINAT EP, V20, P299, DOI 10.1111/j.1365-3016.2006.00735.x; Hasselmann Maria Helena, 2003, Cad. Saúde Pública, V19, P1083, DOI 10.1590/S0102-311X2003000400030; *I AVON, 2009, PESQ I AVON IBOPE PE; *I BRAS GEOGR EST, PESQ NAC AM DOM; *I NAC CANC COORD, 2003, INQ DOM COMP RISC MO; *I PESQ EC APL, 2006, IMP SOC EC AC TRANS; Silva MAI, 2007, REV LAT-AM ENFERM, V15, P275, DOI 10.1590/S0104-11692007000200013; JARDIM V, 2009, REV ABRAMET, V27, P48; Jewkes R, 2002, SOC SCI MED, V55, P1603, DOI 10.1016/S0277-9536(01)00294-5; JORGE MM, 2007, ACIDENTES TRANSITO B; KOIZUMI M, 2007, REV ABRAMET, V25, P12; Laurenti R, 1972, Rev Saude Publica, V6, P329, DOI 10.1590/S0034-89101972000400003; LIMA D, 2001, REV ABRAMET, V37, P44; Ludermir AB, 2008, SOC SCI MED, V66, P1008, DOI 10.1016/j.socscimed.2007.10.021; Ludermir AB, 2010, LANCET, V376, P903, DOI 10.1016/S0140-6736(10)60887-2; MALTA D, 2009, ATENDIMENTOS SAMU 19; Malta DC, 2010, EPIDEMIOL SERV SAUDE, V19, P77; MATIELO F, 2002, REV ABRAMET, V20, P14; Mello Jorge MHP, 2009, REV ABRAMET, V27, P16; Mello Jorge MHP, 1979, THESIS U SAO PAULO S; Melo Victor Lopes de, 2006, Rev. Bras. Saude Mater. Infant., V6, ps43, DOI 10.1590/S1519-38292006000500006; *MIN SAUD, SERV AT MOV URG SAMU; *MIN SAUD, 2010, PROGR SAUD FAM; *MIN SAUD, SIST VIG VIOL AC; *MIN SAUD, 2001, PORT GM MS 737 DE 16; *MIN SAUD, SIST INF HOSP; Minayo M C, 1993, Cad Saude Publica, V9, P65; Minayo Maria Cecília de Souza, 2003, Cad. Saúde Pública, V19, P783, DOI 10.1590/S0102-311X2003000300010; Ministerio da Saude, SIST INF MORT; Moraes CL, 2006, INT J GYNECOL OBSTET, V95, P254, DOI 10.1016/j.ijgo.2006.08.015; Moraes CL, 2002, INT J GYNECOL OBSTET, V79, P269, DOI 10.1016/S0020-7292(02)00250-3; Moraes CL, 2009, ACTA OBSTET GYN SCAN, V88, P1041, DOI 10.1080/00016340903128439; MORENO C, 2001, REV ABRAMET, V36, P17; Nadanovsky P, 2009, CAD SAUDE PUBLICA, V25, P1859, DOI 10.1590/S0102-311X2009000800022; Neri MC, 2008, NOVA CLASSE MEDIA MO; NETO GHF, 2004, J TROP MED, V50, P292; Nielsen A., 2009, CRIMINALIDADE AVANCA; O'Reilly R, 2007, CONTEMP NURSE, V25, P13, DOI 10.5172/conu.2007.25.1-2.13; OGG J, 1992, BRIT MED J, V305, P998, DOI 10.1136/bmj.305.6860.998; *PAHO, 2009, INF AN SAL SIT SAL A; Paixão Luiz Andrés Ribeiro, 2009, Econ. Apl., V13, P125, DOI 10.1590/S1413-80502009000100006; Paula CS, 2008, REV SAUDE PUBL, V42, P524, DOI 10.1590/S0034-89102008000300019; Peden M., 2004, WORLD REPORT ROAD TR; PERES M, 2006, AVALIACAO RAC REDESC; Peres MFT, 2005, REV SAUDE PUBL, V39, P58, DOI 10.1590/S0034-89102005000100008; PILLEMER K, 1988, GERONTOLOGIST, V28, P51, DOI 10.1093/geront/28.1.51; d'Oliveira AFPL, 2009, REV SAUDE PUBL, V43, P299, DOI 10.1590/S0034-89102009005000013; *PRES REP, 2006, LEI MAR PENH; RAMOS S, 2007, RESPOSTAS BRASILEIRA; Ramos Silvia, 2006, Physis, V16, P185, DOI 10.1590/S0103-73312006000200004; Rede Interagencial de Informacao para a Saude, 2008, IND BAS SAUD BRAS CO, V2a; Reichenheim ME, 2008, PUBLIC HEALTH, V122, P716, DOI 10.1016/j.puhe.2007.09.016; Reichenheim Michael Eduardo, 2006, Cad. Saúde Pública, V22, P425, DOI 10.1590/S0102-311X2006000200020; Reichenheim ME, 2006, REV SAUDE PUBL, V40, P595, DOI 10.1590/S0034-89102006000500007; Rickert VI, 2002, AM J OBSTET GYNECOL, V187, P1002, DOI 10.1067/mob.2002.126649; ROCHA PCX, CIEN SAUDE IN PRESS; Rondon V., 2003, ECONOMIA, V4, P223; Bordin IAS, 2006, REV BRAS PSIQUIATR, V28, P290, DOI 10.1590/S1516-44462006000700008; SANTOS VIM, 1978, REV ASSOC MED BRAS, V24, P255; *SECR ESP DIR HUM, 2010, OBS NAC ID; *SECR ESP POL MULH, 2007, ENFR VIOL MULH BAL A; *SECR ESP POL MULH, 2010, OBS BRAS IG GEN; Silva Iracema Viterbo, 2003, Cad. Saúde Pública, V19, pS263, DOI 10.1590/S0102-311X2003000800008; de Moura ATMS, 2008, CAD SAUDE PUBLICA, V24, P2926, DOI 10.1590/S0102-311X2008001200022; Souza Edinilsa Ramos de, 2005, Ciênc. saúde coletiva, V10, P59, DOI 10.1590/S1413-81232005000100012; SOUZA ER, 2001, CAD SAUDE PUBLICA, V17, P1291; SOUZA ER, 2005, IMPACTO VIOLENCIA SA, P279; SOUZA ER, 2006, AVALIACAO PROJETO LU; SOUZA ER, 2007, EPIDEMIOL SERV SAUDE, V16, P19, DOI DOI 10.5123/S1679-49742007000100003; Stefanello S, 2008, REV BRAS PSIQUIATR, V30, P139, DOI 10.1590/S1516-44462006005000063; STRAUS MA, 1979, J MARRIAGE FAM, V41, P75, DOI 10.2307/351733; Szwarcwald C L, 1998, Rev Panam Salud Publica, V4, P161; Taft AJ, 2004, AUST NZ J PUBL HEAL, V28, P324, DOI 10.1111/j.1467-842X.2004.tb00438.x; TEIXEIRA PAS, 2010, DOSSIE MULHER 2010; TOLEDO F, 2004, VERIFICACAO USO COCA; Peres MFT, 2008, REV PANAM SALUD PUBL, V23, P268; *UN, 2010, 11 UN SURV CRIM TREN; Vasconcelos MM, 2005, ARQ NEURO-PSIQUIAT, V63, P68, DOI 10.1590/S0004-282X2005000100013; Victora CG, 2011, LANCET, V377, P1863, DOI 10.1016/S0140-6736(11)60138-4; Vitolo YLC, 2005, REV SAUDE PUBL, V39, P716, DOI 10.1590/S0034-89102005000500004; WAISELFISZ JJ, 2010, MAPA VIOLENCIA BRASI; WAISELFISZ JJ, 2004, MAPA VIOLENCIA, V4; Waiselfisz JJ, 2008, MAPA VIOLENCIA MUNIC; *WHO, 2008, AG STAND MORT RAT CA; WONG L, 2009, REDS INTERAGENCIAL I, P36; World Health Organization, WHO MULT STUD WOM HL; World Health Organization, 2007, INT CLASS DIS; World Health Organization, 2002, WORLD REPORT VIOLENC; World Health Organization, 2009, GLOB STAT REP ROAD S; Ximenes LF, 2009, CIENC SAUDE COLETIVA, V14, P417, DOI 10.1590/S1413-81232009000200011; Zaleski M, 2010, J INTERPERS VIOLENCE, V25, P648, DOI 10.1177/0886260509334396; Zaluar Alba, 2007, Estud. av., V21, P31, DOI 10.1590/S0103-40142007000300003; Zaluar Alba, 2004, INTEGRACAO PERVERSA; 2008, LEI SECA 11705 08; 2010, GLOBO           0804; 1997, CODIGO TRANSITO BRAS	124	179	183	0	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 4	2011	377	9781					1962	1975		10.1016/S0140-6736(11)60053-6	http://dx.doi.org/10.1016/S0140-6736(11)60053-6			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	777LW	21561649				2022-12-24	WOS:000291623200033
J	Bell, AM; Robinson, GE				Bell, Alison M.; Robinson, Gene E.			Behavior and the Dynamic Genome	SCIENCE			English	Editorial Material							EVOLUTION; ACCOMMODATION; GENES; FOXP2; LINK		[Bell, Alison M.] Univ Illinois, Dept Anim Biol, Urbana, IL 61801 USA; [Robinson, Gene E.] Univ Illinois, Dept Entomol, Urbana, IL 61801 USA; [Bell, Alison M.; Robinson, Gene E.] Univ Illinois, Inst Genom Biol, Program Ecol Evolutionary Biol & Conservat, Neurosci Program, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Bell, AM (corresponding author), Univ Illinois, Dept Anim Biol, Urbana, IL 61801 USA.	generobi@life.uiuc.edu			NIGMS NIH HHS [R01 GM082937, R01 GM082937-01] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082937] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alaux C, 2009, P NATL ACAD SCI USA, V106, P15400, DOI 10.1073/pnas.0907043106; Arking DE, 2008, AM J HUM GENET, V82, P160, DOI 10.1016/j.ajhg.2007.09.015; Aubret F, 2009, CURR BIOL, V19, P1932, DOI 10.1016/j.cub.2009.09.061; Badyaev AV, 2009, PHILOS T R SOC B, V364, P1125, DOI 10.1098/rstb.2008.0285; Bakkaloglu B, 2008, AM J HUM GENET, V82, P165, DOI 10.1016/j.ajhg.2007.09.017; Baldwin J. M., 1902, DEV EVOLUTION; Bell AM, 2010, PHILOS T R SOC B, V365, P4001, DOI 10.1098/rstb.2010.0185; Enard W, 2002, NATURE, V418, P869, DOI 10.1038/nature01025; Haesler S, 2007, PLOS BIOL, V5, P2885, DOI 10.1371/journal.pbio.0050321; Konopka G, 2010, NEURON, V68, P231, DOI 10.1016/j.neuron.2010.10.012; Landry CR, 2007, SCIENCE, V317, P118, DOI 10.1126/science.1140247; McGuigan K, 2009, TRENDS ECOL EVOL, V24, P305, DOI 10.1016/j.tree.2009.02.001; Robinson GE, 2008, SCIENCE, V322, P896, DOI 10.1126/science.1159277; Shu WG, 2005, P NATL ACAD SCI USA, V102, P9643, DOI 10.1073/pnas.0503739102; Snell-Rood EC, 2011, EVOLUTION, V65, P231, DOI 10.1111/j.1558-5646.2010.01106.x; Tebbich S, 2010, PHILOS T R SOC B, V365, P1099, DOI 10.1098/rstb.2009.0291; WADDINGTON CH, 1953, EVOLUTION, V7, P118, DOI 10.2307/2405747; West-Eberhard Mary Jane, 2003, pi; Wund MA, 2008, AM NAT, V172, P449, DOI 10.1086/590966	19	41	41	0	75	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 3	2011	332	6034					1161	1162		10.1126/science.1203295	http://dx.doi.org/10.1126/science.1203295			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	772BO	21636765	Green Accepted			2022-12-24	WOS:000291205200037
J	Warensjo, E; Byberg, L; Melhus, H; Gedeborg, R; Mallmin, H; Wolk, A; Michaelsson, K				Warensjo, Eva; Byberg, Liisa; Melhus, Hakan; Gedeborg, Rolf; Mallmin, Hans; Wolk, Alicja; Michaelsson, Karl			Dietary calcium intake and risk of fracture and osteoporosis: prospective longitudinal cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							25-HYDROXYVITAMIN D LEVELS; TOTAL-ENERGY INTAKE; BREAST-CANCER RISK; VITAMIN-D; SUPPLEMENT USE; WOMEN; QUESTIONNAIRE; OLDER; METAANALYSIS; PREVENTION	Objective To investigate associations between long term dietary intake of calcium and risk of fracture of any type, hip fractures, and osteoporosis. Design A longitudinal and prospective cohort study, based on the Swedish Mammography Cohort, including a subcohort, the Swedish Mammography Cohort Clinical. Setting A population based cohort in Sweden established in 1987. Participants 61 433 women (born between 1914 and 1948) were followed up for 19 years. 5022 of these women participated in the subcohort. Main outcome measures Primary outcome measures were incident fractures of any type and hip fractures, which were identified from registry data. Secondary outcome was osteoporosis diagnosed by dual energy x ray absorptiometry in the subcohort. Diet was assessed by repeated food frequency questionnaires. Results During follow-up, 14 738 women (24%) experienced a first fracture of any type and among them 3871 (6%) a first hip fracture. Of the 5022 women in the subcohort, 1012 (20%) were measured as osteoporotic. The risk patterns with dietary calcium were non-linear. The crude rate of a first fracture of any type was 17.2/1000 person years at risk in the lowest quintile of calcium intake, and 14.0/1000 person years at risk in the third quintile, corresponding to a multivariable adjusted hazard ratio of 1.18 (95% confidence interval 1.12 to 1.25). The hazard ratio for a first hip fracture was 1.29 (1.17 to 1.43) and the odds ratio for osteoporosis was 1.47 (1.09 to 2.00). With a low vitamin D intake, the rate of fracture in the first calcium quintile was more pronounced. The highest quintile of calcium intake did not further reduce the risk of fractures of any type, or of osteoporosis, but was associated with a higher rate of hip fracture, hazard ratio 1.19 (1.06 to 1.32). Conclusion Gradual increases in dietary calcium intake above the first quintile in our female population were not associated with further reductions in fracture risk or osteoporosis.	[Warensjo, Eva; Byberg, Liisa; Mallmin, Hans; Michaelsson, Karl] Uppsala Univ, Dept Surg Sci, Sect Orthopaed, Uppsala, Sweden; [Melhus, Hakan] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Warensjo, Eva; Byberg, Liisa; Melhus, Hakan; Gedeborg, Rolf; Michaelsson, Karl] Uppsala Univ, UCR, Uppsala Clin Res Ctr, Uppsala, Sweden; [Wolk, Alicja] Karolinska Inst, Inst Environm Med, Div Nutr Epidemiol, S-10401 Stockholm, Sweden	Uppsala University; Uppsala University; Uppsala University; Karolinska Institutet	Warensjo, E (corresponding author), Uppsala Univ, Dept Surg Sci, Sect Orthopaed, Uppsala, Sweden.	eva.warensjo@surgsci.uu.se	Michaelsson, Karl/AAM-9094-2021; Gedeborg, Rolf/AAV-6702-2020	Gedeborg, Rolf/0000-0002-8850-7863; Michaelsson, Karl/0000-0003-2815-1217	Swedish Research Council [2008-2202, 2009-6281]	Swedish Research Council(Swedish Research CouncilEuropean Commission)	Supported by the Swedish Research Council, grant numbers 2008-2202 and 2009-6281. The funding source was not involved in the design, conduct or interpretation of the study, or in the writing of the submitted work.	[Anonymous], 2005, NORDIC NUTR RECOMMEN; Bergstrom L., 1991, Var Foda, V43, P439; Bischoff-Ferrari HA, 2007, AM J CLIN NUTR, V86, P1780; Bischoff-Ferrari HA, 2009, J BONE MINER RES, V24, P935, DOI [10.1359/JBMR.081242, 10.1359/jbmr.081242]; Bolland MJ, BMJ, V341, pc3691; Burgaz A, 2009, J INTERN MED, V266, P476, DOI 10.1111/j.1365-2796.2009.02125.x; Burgaz A, 2007, AM J CLIN NUTR, V86, P1399, DOI 10.1093/ajcn/86.5.1399; Calltorp J, 1996, LANCET, V347, P587, DOI 10.1016/S0140-6736(96)91278-7; Cashman KD, 2007, J NUTR, V137, p2507S, DOI 10.1093/jn/137.11.2507S; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cleves M., 2009, ANAL MULTIPLE FAILUR; Cumming RG, 1997, J BONE MINER RES, V12, P1321, DOI 10.1359/jbmr.1997.12.9.1321; Cumming RG, 1997, AM J EPIDEMIOL, V145, P926, DOI 10.1093/oxfordjournals.aje.a009052; Feskanich D, 2003, AM J CLIN NUTR, V77, P504, DOI 10.1093/ajcn/77.2.504; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Gedeborg R, 2008, EPIDEMIOLOGY, V19, P860, DOI 10.1097/EDE.0b013e318181319e; Griffith JF, 2010, ANN NY ACAD SCI, V1192, P45, DOI 10.1111/j.1749-6632.2009.05378.x; Hu FB, 1999, AM J EPIDEMIOL, V149, P531, DOI 10.1093/oxfordjournals.aje.a009849; Kaaks R, 2002, PUBLIC HEALTH NUTR, V5, P969, DOI 10.1079/PHN2002380; KANIS JA, 1994, OSTEOPOROSIS INT, V4, P368, DOI 10.1007/BF01622200; KANIS JA, 1989, BRIT MED J, V298, P205, DOI 10.1136/bmj.298.6668.205; Key TJ, 2007, PUBLIC HEALTH NUTR, V10, P1314, DOI 10.1017/S1368980007696402; Larsson SC, 2009, EUR J CANCER, V45, P3042, DOI 10.1016/j.ejca.2009.04.035; Larsson SC, 2009, AM J CLIN NUTR, V90, P556, DOI 10.3945/ajcn.2009.27480; Larsson SC, 2009, AM J CLIN NUTR, V89, P277, DOI 10.3945/ajcn.2008.26704; Lin DY, 1997, STAT MED, V16, P901, DOI 10.1002/(SICI)1097-0258(19970430)16:8<901::AID-SIM543>3.0.CO;2-M; Melhus H, 2010, J CLIN ENDOCR METAB, V95, P2637, DOI 10.1210/jc.2009-2699; Messerer M, 2004, J NUTR, V134, P1800, DOI 10.1093/jn/134.7.1800; Michaelsson K, 2003, BONE, V32, P694, DOI 10.1016/S8756-3282(03)00048-6; National Health and Medical Research Council, 2006, NUTR REF VAL AUSTR N; NHS Choices, VIT MIN CALC; Orsini N, 2008, EUR J EPIDEMIOL, V23, P661, DOI 10.1007/s10654-008-9273-z; Prentice A, 2004, PUBLIC HEALTH NUTR, V7, P227, DOI 10.1079/PHN2003590; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Reid IR, 2008, OSTEOPOROSIS INT, V19, P1119, DOI 10.1007/s00198-008-0563-9; Reid IR, 2006, AM J MED, V119, P777, DOI 10.1016/j.amjmed.2006.02.038; Sennerby U, 2009, JAMA-J AM MED ASSOC, V302, P1666, DOI 10.1001/jama.2009.1463; Serra-Majem L, 2009, BRIT J NUTR, V102, pS38, DOI 10.1017/S0007114509993138; Snellman G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007747; [STATA Corporation Stata Corporation], 2009, STAT REF MAN REL 11; Tang BMP, 2007, LANCET, V370, P657, DOI 10.1016/S0140-6736(07)61342-7; Willett WC, 1997, AM J CLIN NUTR, V65, P1220, DOI 10.1093/ajcn/65.4.1220S; Xu LZ, 2004, BRIT J NUTR, V91, P625, DOI 10.1079/BJN20031085; Yates AA, 1998, J AM DIET ASSOC, V98, P699, DOI 10.1016/S0002-8223(98)00160-6	44	123	125	1	29	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 24	2011	342								d1473	10.1136/bmj.d1473	http://dx.doi.org/10.1136/bmj.d1473			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	771KC	21610048	Green Published, Green Submitted, hybrid			2022-12-24	WOS:000291154600007
J	O'Neill, D				O'Neill, Desmond			The art of medicine The art of the demographic dividend	LANCET			English	Editorial Material									Adelaide & Meath Hosp, Trinity Ctr Hlth Sci, Ctr Ageing Neurosci & Humanities, Dublin 24, Ireland	Trinity College Dublin	O'Neill, D (corresponding author), Adelaide & Meath Hosp, Trinity Ctr Hlth Sci, Ctr Ageing Neurosci & Humanities, Dublin 24, Ireland.	doneill@tcd.ie	O'Neill, Desmond/D-1486-2013	O'Neill, Desmond/0000-0002-5542-9897				Clarfield A.M., 2007, BMJ, V334, P1225, DOI [10.1136/bmj.39237.488356.94, DOI 10.1136/BMJ.39237.488356.94]; Crutch SJ, 2001, LANCET, V357, P2129, DOI 10.1016/S0140-6736(00)05187-4; DORMANDY T, 2001, OLD MASTERS GREAT AR; HAKAMIESBLOMQVI.L, 2002, BEHAVIOUR, V5, P271; Murphy KM, 2006, J POLIT ECON, V114, P871, DOI 10.1086/508033; ONEILL D, 2010, BRIT MED J, V341, pE5975; Said Edward, 2006, LATE STYLE MUSIC LIT; SHAINBERG L, 1987, PARIS REV, P100; Sontag S., 1987, ILLNESS METAPHOR	9	18	18	0	15	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY-JUN	2011	377	9780					1828	1829		10.1016/S0140-6736(11)60612-0	http://dx.doi.org/10.1016/S0140-6736(11)60612-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	General & Internal Medicine	774UI	21630498				2022-12-24	WOS:000291411700015
J	Robinson, JK; Bigby, M				Robinson, June K.; Bigby, Michael			Prevention of Melanoma With Regular Sunscreen Use	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							RISK; SKIN; CELL		[Robinson, June K.] Northwestern Univ, Feinberg Sch Med, Dept Dermatol, Chicago, IL 60611 USA; [Bigby, Michael] Harvard Univ, Sch Med, Dept Dermatol, Boston, MA 02115 USA; [Bigby, Michael] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA	Northwestern University; Feinberg School of Medicine; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center	Robinson, JK (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Dermatol, 132 E Delaware Pl 5806, Chicago, IL 60611 USA.	june-robinson@northwestern.edu						[Anonymous], MEL SKIN CANC; Chang YM, 2009, INT J EPIDEMIOL, V38, P814, DOI 10.1093/ije/dyp166; Dennis LK, 2003, ANN INTERN MED, V139, P966, DOI 10.7326/0003-4819-139-12-200312160-00006; Green A, 1999, LANCET, V354, P723, DOI 10.1016/S0140-6736(98)12168-2; Green AC, 2011, J CLIN ONCOL, V29, P257, DOI 10.1200/JCO.2010.28.7078; Huncharek M, 2002, AM J PUBLIC HEALTH, V92, P1173, DOI 10.2105/AJPH.92.7.1173; IARC, 2001, IARC HDB CANC PREV, V5; *IARC, 1992, IARC MON EV CARC RIS, V55; Lin JS, 2011, ANN INTERN MED, V154, P190, DOI 10.7326/0003-4819-154-3-201102010-00009; van der Pols JC, 2006, CANCER EPIDEM BIOMAR, V15, P2546, DOI 10.1158/1055-9965.EPI-06-0352	10	10	10	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 20	2011	306	3					302	303		10.1001/jama.2011.990	http://dx.doi.org/10.1001/jama.2011.990			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	794BS	21712528				2022-12-24	WOS:000292870500023
J	Kabrhel, C; Varraso, R; Goldhaber, SZ; Rimm, E; Camargo, CA				Kabrhel, Christopher; Varraso, Raphaelle; Goldhaber, Samuel Z.; Rimm, Eric; Camargo, Carlos A., Jr.			Physical inactivity and idiopathic pulmonary embolism in women: prospective study	BRITISH MEDICAL JOURNAL			English	Article							DEEP-VEIN THROMBOSIS; CARDIOVASCULAR RISK-FACTORS; VENOUS-BLOOD FLOW; THROMBOEMBOLISM; EXERCISE; DISEASE; POPULATION; FIBRINOLYSIS; HEMOSTASIS; FIBRINOGEN	Objectives To determine the association between physical inactivity (that is, a sedentary lifestyle) and incident idiopathic pulmonary embolism. Design Prospective cohort study. Setting Nurses' Health Study. Participants 69 950 female nurses who completed biennial questionnaires from 1990 to 2008. Main outcome measures The primary outcome was idiopathic pulmonary embolism confirmed in medical records. Multivariable Cox proportional hazards models controlled for age, body mass index (BMI), energy intake, smoking, pack years, race, spouse's educational attainment, parity, menopause, non-aspirin non-steroidal anti-inflammatory drugs, warfarin, multivitamin supplements, hypertension, coronary heart disease, rheumatological disease, and dietary patterns. The primary exposure was physical inactivity, measured in hours of sitting each day. The secondary exposure was physical activity, measured in metabolic equivalents a day. Results Over the 18 year study period, there were 268 cases of incident idiopathic pulmonary embolism. There was an association between time of sitting and risk of idiopathic pulmonary embolism (41/104 720 v 16/14 565 cases in most inactive v least inactive in combined data; P<0.001 for trend). The risk of pulmonary embolism was more than twofold in women who spent the most time sitting compared with those who spent the least time sitting (multivariable hazard ratio 2.34, 95% confidence interval 1.30 to 4.20). There was no association between physical activity and pulmonary embolism (P=0.53 for trend). Conclusions Physical inactivity is associated with incident pulmonary embolism in women. Interventions that decrease time sitting could lower the risk of pulmonary embolism.	[Kabrhel, Christopher; Camargo, Carlos A., Jr.] Massachusetts Gen Hosp, Dept Emergency Med, Boston, MA 02114 USA; [Goldhaber, Samuel Z.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Cardiovasc,Dept Med, Boston, MA 02115 USA; [Varraso, Raphaelle] INSERM, CESP Ctr Res Epidemiol & Populat Hlth, U1018, Resp & Environm Epidemiol Team, F-94807 Villejuif, France; [Varraso, Raphaelle] Univ Paris 11, UMRS 1018, F-94807 Villejuif, France; [Rimm, Eric] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Rimm, Eric] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Rimm, Eric; Camargo, Carlos A., Jr.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Channing Lab,Dept Med, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Kabrhel, C (corresponding author), Massachusetts Gen Hosp, Dept Emergency Med, Zero Emerson Pl,Suite 3B, Boston, MA 02114 USA.	ckabrhel@partners.org	Varraso, Raphaelle/R-8740-2016; Camargo, Carlos A./C-2145-2008	Varraso, Raphaelle/0000-0002-3338-7825; Camargo, Carlos A./0000-0002-5071-7654; Kabrhel, Christopher/0000-0002-8699-7176	National Institute on Aging, National Institutes of Health, Bethesda, MD [R21AG031079, P01CA87969, R01HL034594]; NATIONAL CANCER INSTITUTE [P01CA087969] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL034594] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG031079] Funding Source: NIH RePORTER	National Institute on Aging, National Institutes of Health, Bethesda, MD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was funded by the National Institute on Aging, National Institutes of Health, Bethesda, MD (R21AG031079, P01CA87969, and R01HL034594). The funding source had no role in design or conduct of the study; collection, management, analysis, or interpretation of the data; preparation, review, or approval of the manuscript.	Arterburn DE, 2004, J AM GERIATR SOC, V52, P1907, DOI 10.1111/j.1532-5415.2004.52517.x; Bassett DR, 2010, MED SCI SPORT EXER, V42, P1819, DOI 10.1249/MSS.0b013e3181dc2e54; Centers for Disease Control and Prevention, 2007, US PHYS ACT STAT; Cushman M, 2004, JAMA-J AM MED ASSOC, V292, P1573, DOI 10.1001/jama.292.13.1573; El-Sayed MS, 2004, SPORTS MED, V34, P181, DOI 10.2165/00007256-200434030-00004; El-Sayed MS, 2000, MED SCI SPORT EXER, V32, P918; Eliasson M, 1996, INT J EPIDEMIOL, V25, P1182, DOI 10.1093/ije/25.6.1182; ElSayed MS, 1996, SPORTS MED, V22, P282, DOI 10.2165/00007256-199622050-00002; ElSayed MS, 1996, BLOOD COAGUL FIBRIN, V7, P484, DOI 10.1097/00001721-199606000-00009; Everett BM, 2009, J THROMB HAEMOST, V7, P588, DOI 10.1111/j.1538-7836.2009.03302.x; FOLSOM AR, 1991, ATHEROSCLEROSIS, V91, P191, DOI 10.1016/0021-9150(91)90167-2; Glynn RJ, 2005, AM J EPIDEMIOL, V162, P975, DOI 10.1093/aje/kwi309; Goldhaber SZ, 1999, LANCET, V353, P1386, DOI 10.1016/S0140-6736(98)07534-5; Goldhaber SZ, 1997, JAMA-J AM MED ASSOC, V277, P642, DOI 10.1001/jama.277.8.642; GOLDHABER SZ, 1983, AM J MED, V74, P1023, DOI 10.1016/0002-9343(83)90805-7; Heit JA, 2000, ARCH INTERN MED, V160, P809, DOI 10.1001/archinte.160.6.809; Heit JA, 2005, J THROMB HAEMOST, V3, P1611, DOI 10.1111/j.1538-7836.2005.01415.x; Heit JA, 2003, CLIN CHEST MED, V24, P1, DOI 10.1016/S0272-5231(02)00077-1; Hitos K, 2007, J THROMB HAEMOST, V5, P1890, DOI 10.1111/j.1538-7836.2007.02664.x; Jackson AS, 2009, ARCH INTERN MED, V169, P1781, DOI 10.1001/archinternmed.2009.312; Kabrhel C, 2009, OBESITY, V17, P2040, DOI 10.1038/oby.2009.92; Kline JA, 2004, J THROMB HAEMOST, V2, P1247, DOI 10.1111/j.1538-7836.2004.00790.x; Kucher N, 2005, THROMB HAEMOSTASIS, V93, P494, DOI 10.1160/TH04-09-0587; Kurkciyan I, 2000, ARCH INTERN MED, V160, P1529, DOI 10.1001/archinte.160.10.1529; McNally MA, 1997, J BONE JOINT SURG AM, V79A, P1198, DOI 10.2106/00004623-199708000-00012; Rimm E B, 1990, Epidemiology, V1, P466, DOI 10.1097/00001648-199011000-00009; Silverstein MD, 1998, ARCH INTERN MED, V158, P585, DOI 10.1001/archinte.158.6.585; Sochart DH, 1999, J BONE JOINT SURG BR, V81B, P700, DOI 10.1302/0301-620X.81B4.8909; STRATTON JR, 1991, CIRCULATION, V83, P1692, DOI 10.1161/01.CIR.83.5.1692; TROY LM, 1995, INT J OBESITY, V19, P570; Tsai AW, 2002, ARCH INTERN MED, V162, P1182, DOI 10.1001/archinte.162.10.1182; van Stralen KJ, 2007, J THROMB HAEMOST, V5, P2186, DOI 10.1111/j.1538-7836.2007.02732.x; van Stralen KJ, 2008, J AM GERIATR SOC, V56, P517, DOI 10.1111/j.1532-5415.2007.01588.x; van Stralen KJ, 2008, ARCH INTERN MED, V168, P21, DOI 10.1001/archinternmed.2007.5; Van Stralen KJ, 2005, J THROMB HAEMOST, V3, P2110, DOI 10.1111/j.1538-7836.2005.01482.x; Varraso R, 2007, AM J CLIN NUTR, V86, P488, DOI 10.1093/ajcn/86.2.488; Wells PS, 2000, THROMB HAEMOSTASIS, V83, P416; WILLETT W, 1983, AM J EPIDEMIOL, V117, P651, DOI 10.1093/oxfordjournals.aje.a113598; WILSON PWF, 1986, AM HEART J, V111, P1177, DOI 10.1016/0002-8703(86)90022-0; WOLF AM, 1994, INT J EPIDEMIOL, V23, P991, DOI 10.1093/ije/23.5.991	40	50	51	0	13	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 4	2011	343								d3867	10.1136/bmj.d3867	http://dx.doi.org/10.1136/bmj.d3867			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	791RR	21727169	Green Published, Green Submitted, hybrid			2022-12-24	WOS:000292682800005
J	Lee, MSY; Jago, JB; Garcia-Bellido, DC; Edgecombe, GD; Gehling, JG; Paterson, JR				Lee, Michael S. Y.; Jago, James B.; Garcia-Bellido, Diego C.; Edgecombe, Gregory D.; Gehling, James G.; Paterson, John R.			Modern optics in exceptionally preserved eyes of Early Cambrian arthropods from Australia	NATURE			English	Article							EMU BAY SHALE; SOUTH-AUSTRALIA; KANGAROO ISLAND; VISUAL-SYSTEM; LAGERSTATTE; TRILOBITES; EVOLUTION; TUZOIA	Despite the status of the eye as an "organ of extreme perfection"(1), theory suggests that complex eyes can evolve very rapidly(2). The fossil record has, until now, been inadequate in providing insight into the early evolution of eyes during the initial radiation of many animal groups known as the Cambrian explosion. This is surprising because Cambrian Burgess-Shale-type deposits are replete with exquisitely preserved animals, especially arthropods, that possess eyes(3-5). However, with the exception of biomineralized trilobite eyes, virtually nothing is known about the details of their optical design. Here we report exceptionally preserved fossil eyes from the Early Cambrian (similar to 515 million years ago) Emu Bay Shale of South Australia, revealing that some of the earliest arthropods possessed highly advanced compound eyes, each with over 3,000 large ommatidial lenses and a specialized 'bright zone'. These are the oldest non-biomineralized eyes known in such detail, with preservation quality exceeding that found in the Burgess Shale and Chengjiang deposits. Non-biomineralized eyes of similar complexity are otherwise unknown until about 85 million years later(6,7). The arrangement and size of the lenses indicate that these eyes belonged to an active predator that was capable of seeing in low light. The eyes are more complex than those known from contemporaneous trilobites and are as advanced as those of many living forms. They provide further evidence that the Cambrian explosion involved rapid innovation in fine-scale anatomy as well as gross morphology, and are consistent with the concept that the development of advanced vision helped to drive this great evolutionary event(8).	[Lee, Michael S. Y.; Jago, James B.; Gehling, James G.] S Australian Museum, Adelaide, SA 5000, Australia; [Lee, Michael S. Y.] Univ Adelaide, Sch Earth & Environm Sci, Adelaide, SA 5005, Australia; [Jago, James B.] Univ S Australia, Sch Nat & Built Environm, Mawson Lakes, SA 5095, Australia; [Garcia-Bellido, Diego C.] Inst Geociencias CSIC UCM, Inst Geol Econ, Dept Paleontol, Madrid 28040, Spain; [Edgecombe, Gregory D.] Nat Hist Museum, Dept Paleontol, London SW7 5BD, England; [Paterson, John R.] Univ New England, Sch Environm & Rural Sci, Div Earth Sci, Armidale, NSW 2351, Australia	University of Adelaide; University of South Australia; Complutense University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UCM - Instituto de Geociencias (IGEO); CSIC-UCM - Instituto de Geologia Economica (IGE); Natural History Museum London; University of New England	Lee, MSY (corresponding author), S Australian Museum, Adelaide, SA 5000, Australia.	mike.lee@samuseum.sa.gov.au; jpater20@une.edu.au	Garcia-Bellido, Diego/AAF-9043-2021	Paterson, John/0000-0003-2947-3912; Garcia-Bellido, Diego/0000-0003-1922-9836; Edgecombe, Gregory/0000-0002-9591-8011; Jago, James/0000-0002-3059-1572	Australian Research Council [LP0774959]; South Australian Museum; Spanish Ministry of Science [RYC2007-00090, CGL2009-07073]; Beach Energy and Sealink Pty Ltd	Australian Research Council(Australian Research Council); South Australian Museum; Spanish Ministry of Science(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Beach Energy and Sealink Pty Ltd	We thank P. and C. Buck for access to and assistance at the fossil site; N. Schroeder, M. Gemmell, R. Atkinson, M. A. Binnie and numerous others (Supplementary Table 3) for help with excavations and curatorial assistance; A. Netting, P. Hudson and Adelaide Microscopy for imaging; D. Birch and G. Brock for SEM-EDS analysis; A. Baonza and J. F. de Celis for discussions on arthropod eye development; R. Fortey and A. Parker for comments and the Australian Research Council (grant LP0774959), South Australian Museum, Spanish Ministry of Science (RYC2007-00090 and grant CGL2009-07073), Beach Energy and Sealink Pty Ltd for funding.	Briggs D.E.G., 1994, FOSSILS BURGESS SHAL; Briggs DEG, 1997, J PALEONTOL, V71, P22, DOI 10.1017/S0022336000038919; Clarkson E, 2006, ARTHROPOD STRUCT DEV, V35, P247, DOI 10.1016/j.asd.2006.08.002; Conway-Morris Simon., 1998, CRUCIBLE CREATION BU; Daley AC, 2009, SCIENCE, V323, P1597, DOI 10.1126/science.1169514; Darwin C., 1859, ORIGIN SPECIES MEANS; Freeman M, 1996, CELL, V87, P651, DOI 10.1016/S0092-8674(00)81385-9; Garcia-Bellido DC, 2009, PALAEONTOLOGY, V52, P1221, DOI 10.1111/j.1475-4983.2009.00914.x; Gehling JG, 2011, AUST J EARTH SCI, V58, P243, DOI 10.1080/08120099.2011.555487; Harzsch S, 2007, ORG DIVERS EVOL, V7, P20, DOI 10.1016/j.ode.2006.02.004; Harzsch S, 2006, ARTHROPOD STRUCT DEV, V35, P319, DOI 10.1016/j.asd.2006.08.009; Haug JT, 2009, PALAEONTOGR ABT A, V289, P1; Hou X. -G., 2004, CAMBRIAN FOSSILS CHE; Land MF, 2002, ANIMAL EYES; McCormick T, 1998, PALEOBIOLOGY, V24, P235; NILSSON DE, 1994, P ROY SOC B-BIOL SCI, V256, P53, DOI 10.1098/rspb.1994.0048; Oldham S, 2002, DEVELOPMENT, V129, P4103; Parker A., 2003, BLINK EYE CAUSE MOST; Parker AR, 2011, OPT LASER TECHNOL, V43, P323, DOI 10.1016/j.optlastec.2008.12.020; Paterson JR, 2010, PALAEONTOLOGY, V53, P377, DOI 10.1111/j.1475-4983.2010.00932.x; Plotnick RE, 2010, PALEOBIOLOGY, V36, P303, DOI 10.1666/08062.1; Ritchie A., 1985, Alcheringa, V9, P117, DOI 10.1080/03115518508618961; SCHOENEMANN B, 2010, LETHAIA         0930, DOI DOI 10.1111/J.1502-3931.2010.00239.X; Schoenemann B, 2008, ENTOMOL GEN, V31, P287; Snyder A. W., 1979, COMP PHYSL EVOLUTION, P225, DOI DOI 10.1007/978-3-642-66999-6_5; vanderBrugghen W, 1997, NATURE, V385, P589, DOI 10.1038/385589a0; Vannier J, 2007, J PALEONTOL, V81, P445, DOI 10.1666/pleo05070.1; Warrant E, 2006, INVERTEBRATE VISION, pXIX; WEHNER R, 1981, COMP PHYSL EVOLUTION, P287; ZHANG XG, 1990, PALAEONTOLOGY, V33, P911	30	58	60	1	82	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 30	2011	474	7353					631	634		10.1038/nature10097	http://dx.doi.org/10.1038/nature10097			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	785CF	21720369				2022-12-24	WOS:000292204300037
J	O'Brian, S; Onslow, M				O'Brian, Susan; Onslow, Mark			Clinical management of stuttering in children and adults	BRITISH MEDICAL JOURNAL			English	Review							LIDCOMBE PROGRAM; SOCIAL PHOBIA; TRIAL; ATTITUDES; IMPACT; INTERVENTION; ETIOLOGY; STAMMER; ONSET; AGE		[O'Brian, Susan; Onslow, Mark] Univ Sydney, Australian Stuttering Res Ctr, Lidcombe, NSW 2060, Australia	University of Sydney	Onslow, M (corresponding author), Univ Sydney, Australian Stuttering Res Ctr, Lidcombe, NSW 2060, Australia.	mark.onslow@sydney.edu.au		Onslow, Mark/0000-0003-2629-2390; O'Brian, Susan/0000-0002-0882-1909	University of Sydney	University of Sydney(University of Sydney)	Both authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: SO and MO have support from the University of Sydney for the submitted work; no financial relationships with any organisations that might have an interest in the submitted work in the previous three years; no other relationships or activities that could appear to have influenced the submitted work.	Blumgart E, 2010, DEPRESS ANXIETY, V27, P687, DOI 10.1002/da.20657; Carey B, 2010, INT J LANG COMM DIS, V45, P108, DOI 10.3109/13682820902763944; Chang SE, 2008, NEUROIMAGE, V39, P1333, DOI 10.1016/j.neuroimage.2007.09.067; CONTURE EG, 1991, J SPEECH HEAR RES, V34, P1041, DOI 10.1044/jshr.3405.1041; Craig A, 2009, J FLUENCY DISORD, V34, P61, DOI 10.1016/j.jfludis.2009.05.002; Cream A, 2010, J SPEECH LANG HEAR R, V53, P887, DOI 10.1044/1092-4388(2009/09-0080); Cykowski MD, 2010, NEUROIMAGE, V52, P1495, DOI 10.1016/j.neuroimage.2010.05.011; Davis S, 2002, J CHILD PSYCHOL PSYC, V43, P939, DOI 10.1111/1469-7610.00093; DeCarle AJ, 1996, AM J PSYCHIAT, V153, P1367; DENIL LF, 1991, J SPEECH HEAR RES, V34, P60; Ezrati-Vinacour R, 2001, J SPEECH LANG HEAR R, V44, P368, DOI 10.1044/1092-4388(2001/030); Felsenfeld S, 2000, BEHAV GENET, V30, P359, DOI 10.1023/A:1002765620208; Hayhow R, 2002, J FLUENCY DISORD, V27, P1, DOI 10.1016/S0094-730X(01)00102-4; Hugh-Jones S, 1999, BRIT J EDUC PSYCHOL, V69, P141, DOI 10.1348/000709999157626; HURST MI, 1983, J FLUENCY DISORD, V8, P1, DOI 10.1016/0094-730X(83)90017-7; Iverach L, 2010, J SPEECH LANG HEAR R, V53, P1178, DOI 10.1044/1092-4388(2010/09-0166); Iverach L, 2009, J FLUENCY DISORD, V34, P173, DOI 10.1016/j.jfludis.2009.09.001; Iverach L, 2009, J ANXIETY DISORD, V23, P928, DOI 10.1016/j.janxdis.2009.06.003; Iverach L, 2009, J FLUENCY DISORD, V34, P29, DOI 10.1016/j.jfludis.2009.02.002; Jones M, 2005, BMJ-BRIT MED J, V331, P659, DOI 10.1136/bmj.38520.451840.E0; Kingston M, 2003, INT J LANG COMM DIS, V38, P165, DOI 10.1080/1368282031000062882; Klein JF, 2004, J FLUENCY DISORD, V29, P255, DOI 10.1016/j.jfludis.2004.08.001; Langevin M., 1998, CONT ISSUES COMMUNIC, V25, P8, DOI 10.1044/cicsd_25_S_8; Langevin M, 2009, J FLUENCY DISORD, V34, P72, DOI 10.1016/j.jfludis.2009.05.001; Langevin M, 2009, AM J SPEECH-LANG PAT, V18, P264, DOI 10.1044/1058-0360(2009/07-0087); Lattermann C, 2008, J FLUENCY DISORD, V33, P52, DOI 10.1016/j.jfludis.2007.12.002; Lewis C, 2008, AM J SPEECH-LANG PAT, V17, P139, DOI 10.1044/1058-0360(2008/014); Menzies RG, 2008, J SPEECH LANG HEAR R, V51, P1451, DOI 10.1044/1092-4388(2008/07-0070); Onslow M., HDB EVIDENC IN PRESS; Reilly S, 2009, PEDIATRICS, V123, P270, DOI 10.1542/peds.2007-3219; Sommer M, 2002, LANCET, V360, P380, DOI 10.1016/S0140-6736(02)09610-1; Stein MB, 1996, AM J PSYCHIAT, V153, P278; Yairi E, 1999, J SPEECH LANG HEAR R, V42, P1097, DOI 10.1044/jslhr.4205.1097; YAIRI E, 1983, J SPEECH HEAR DISORD, V48, P171, DOI 10.1044/jshd.4802.171	34	5	5	0	27	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 24	2011	342								d3742	10.1136/bmj.d3742	http://dx.doi.org/10.1136/bmj.d3742			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	785AW	21705407				2022-12-24	WOS:000292200800002
J	Turner, SL; Li, N; Guda, T; Githure, J; Carde, RT; Ray, A				Turner, Stephanie Lynn; Li, Nan; Guda, Tom; Githure, John; Carde, Ring T.; Ray, Anandasankar			Ultra-prolonged activation of CO2-sensing neurons disorients mosquitoes	NATURE			English	Article							CARBON-DIOXIDE; AEDES-AEGYPTI; ANOPHELES-GAMBIAE; MAXILLARY PALP; DROSOPHILA; INSECT; DEET; RECEPTORS; RESPONSES; DIPTERA	Carbon dioxide (CO2) present in exhaled air is the most important sensory cue for female blood-feeding mosquitoes, causing activation of long-distance host-seeking flight, navigation towards the vertebrate host(1) and, in the case of Aedes aegypti, increased sensitivity to skin odours(2). The CO2 detection machinery is therefore an ideal target to disrupt host seeking. Here we use electrophysiological assays to identify a volatile odorant that causes an unusual, ultra-prolonged activation of CO2-detecting neurons in three major disease-transmitting mosquitoes: Anopheles gambiae, Culex quinquefasciatus and A. aegypti. Importantly, ultra-prolonged activation of these neurons severely compromises their ability subsequently to detect CO2 for several minutes. We also identify odours that strongly inhibit CO2-sensitive neurons as candidates for use in disruption of host-seeking behaviour, as well as an odour that evokes CO2-like activity and thus has potential use as a lure in trapping devices. Analysis of responses to panels of structurally related odours across the three mosquitoes and Drosophila, which have related CO2-receptor proteins, reveals a pattern of inhibition that is often conserved. We use video tracking in wind-tunnel experiments to demonstrate that the novel ultra-prolonged activators can completely disrupt CO2-mediated activation as well as source-finding behaviour in Aedes mosquitoes, even after the odour is no longer present. Lastly, semi-field studies demonstrate that use of ultra-prolonged activators disrupts CO2-mediated hut entry behaviour of Culex mosquitoes. The three classes of CO2-response-modifying odours offer powerful instruments for developing new generations of insect repellents and lures, which even in small quantities can interfere with the ability of mosquitoes to seek humans.	[Turner, Stephanie Lynn; Ray, Anandasankar] Univ Calif Riverside, Cellular Mol & Dev Biol Program, Riverside, CA 92521 USA; [Li, Nan; Carde, Ring T.; Ray, Anandasankar] Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA; [Guda, Tom; Githure, John] ICIPE, Human Hlth Div, Nairobi, Kenya	University of California System; University of California Riverside; University of California System; University of California Riverside; International Centre of Insect Physiology & Ecology (ICIPE)	Ray, A (corresponding author), Univ Calif Riverside, Cellular Mol & Dev Biol Program, Riverside, CA 92521 USA.	anand.ray@ucr.edu		Ray, Anandasankar/0000-0003-4133-2581	Bill & Melinda Gates Foundation through the Grand Challenges Exploration Initiative; NIAID (NIH) [R01AI087785]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI087785] Funding Source: NIH RePORTER	Bill & Melinda Gates Foundation through the Grand Challenges Exploration Initiative; NIAID (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank E. Lacey and S. McInally for help setting up behaviour experiments; the Malaria Group team members in ICIPE Mbita Point Research Station, Y. Afrane and G. Yan for logistical support; S. M. Boyle for help with Pharmacophores; K. Klingler for help with statistics; J. Perecko for building traps and excitorepellency chambers; A. Dahanukar and G. Tauxe for comments on the manuscript; W. Walton, P. Atkinson, P. Wirth and A. Khalon for mosquitoes. Part of this work was funded by a grant to A. Ray from the Bill & Melinda Gates Foundation through the Grand Challenges Exploration Initiative, and part supported by a grant to A. Ray, Award Number R01AI087785, from the NIAID (NIH). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIAID or NIH.	Bhandawat V, 2007, NAT NEUROSCI, V10, P1474, DOI 10.1038/nn1976; Bhandawat V, 2010, J EXP BIOL, V213, P3625, DOI 10.1242/jeb.040402; Carde RT, 2010, ECOL CONT VECTOR-BOR, V2, P115; Corbel V, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-47; de Bruyne M, 2001, NEURON, V30, P537, DOI 10.1016/S0896-6273(01)00289-6; Dekker T, 2005, J EXP BIOL, V208, P2963, DOI 10.1242/jeb.01736; Ditzen M, 2008, SCIENCE, V319, P1838, DOI 10.1126/science.1153121; GILLIES MT, 1980, B ENTOMOL RES, V70, P525, DOI 10.1017/S0007485300007811; Grant AJ, 1996, CIBA F SYMP, V200, P233; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Jones WD, 2007, NATURE, V445, P86, DOI 10.1038/nature05466; KAISSLING KE, 1989, J COMP PHYSIOL A, V165, P147, DOI 10.1007/BF00619189; Klun JA, 2004, J MED ENTOMOL, V41, P418, DOI 10.1603/0022-2585-41.3.418; Krajick K, 2006, SCIENCE, V313, P36, DOI 10.1126/science.313.5783.36; Kwon JY, 2007, P NATL ACAD SCI USA, V104, P3574, DOI 10.1073/pnas.0700079104; Lu T, 2007, CURR BIOL, V17, P1533, DOI 10.1016/j.cub.2007.07.062; MAFRANETO A, 1994, NATURE, V369, P142, DOI 10.1038/369142a0; Njiru BN, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-39; Noosidum A, 2008, J VECTOR ECOL, V33, P305, DOI 10.3376/1081-1710-33.2.305; Reeder NL, 2001, J ECON ENTOMOL, V94, P1584, DOI 10.1603/0022-0493-94.6.1584; Robertson HM, 2009, J INSECT SCI, V9, DOI 10.1673/031.009.1901; Rostelien T, 2000, CHEM SENSES, V25, P141, DOI 10.1093/chemse/25.2.141; Stanczyk NM, 2010, P NATL ACAD SCI USA, V107, P8575, DOI 10.1073/pnas.1001313107; Syed Z, 2008, P NATL ACAD SCI USA, V105, P13598, DOI 10.1073/pnas.0805312105; Syed Z, 2007, CHEM SENSES, V32, P727, DOI 10.1093/chemse/bjm040; Turner SL, 2009, NATURE, V461, P277, DOI 10.1038/nature08295; Yao CA, 2010, J NEUROSCI, V30, P4562, DOI 10.1523/JNEUROSCI.6357-09.2010; Zdobnov EM, 2002, SCIENCE, V298, P149, DOI 10.1126/science.1077061; Zollner GE, 2004, PHYSIOL ENTOMOL, V29, P381, DOI 10.1111/j.0307-6962.2004.00399.x; Zwiebel LJ, 2004, INSECT BIOCHEM MOLEC, V34, P645, DOI 10.1016/j.ibmb.2004.03.017	30	115	124	2	81	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 2	2011	474	7349					87	U114		10.1038/nature10081	http://dx.doi.org/10.1038/nature10081			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	771KV	21637258	Green Accepted, Green Submitted			2022-12-24	WOS:000291156700043
J	Spence, D				Spence, Des			FROM THE FRONTLINE Bad medicine: digital rectal examination	BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk							0	6	6	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 1	2011	342								d3421	10.1136/bmj.d3421	http://dx.doi.org/10.1136/bmj.d3421			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	774MK	21632663				2022-12-24	WOS:000291390500015
J	Rosello-Diez, A; Ros, MA; Torres, M				Rosello-Diez, Alberto; Ros, Maria A.; Torres, Miguel			Diffusible Signals, Not Autonomous Mechanisms, Determine the Main Proximodistal Limb Subdivision	SCIENCE			English	Article							VERTEBRATE LIMB; RETINOIC ACID; VITAMIN-A; GENE-EXPRESSION; MOUSE LIMB; CELL FATE; BUD; AXIS; FGF; REGENERATION	Vertebrate limbs develop three main proximodistal (PD) segments (upper arm, forearm, and hand) in a proximal-to-distal sequence. Despite extensive research into limb development, whether PD specification occurs through nonautonomous or autonomous mechanisms is not resolved. Heterotopic transplantation of intact and recombinant chicken limb buds identifies signals in the embryo trunk that proximalize distal limb cells to generate a complete PD axis. In these transplants, retinoic acid induces proximalization, which is counteracted by fibroblast growth factors from the distal limb bud; these related actions suggest that the first limb-bud PD regionalization results from the balance between proximal and distal signals. The plasticity of limb progenitor cell identity in response to diffusible signals provides a unifying view of PD patterning during vertebrate limb development and regeneration.	[Rosello-Diez, Alberto; Torres, Miguel] Inst Salud Carlos III, Ctr Nacl Invest Cardiovasc, Dept Desarrollo & Reparac Cardiovasc, E-28029 Madrid, Spain; [Ros, Maria A.] Inst Biomed & Biotecnol Cantabria CSIC UC SODERAN, E-39011 Santander, Spain; [Ros, Maria A.] Univ Cantabria, E-39011 Santander, Spain	Centro Nacional de Investigaciones Cardiovasculares (CNIC); Instituto de Salud Carlos III; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Cantabria; CSIC - Instituto de Biomedicina y Biotecnologia de Cantabria (IBBTEC); Universidad de Cantabria	Torres, M (corresponding author), Inst Salud Carlos III, Ctr Nacl Invest Cardiovasc, Dept Desarrollo & Reparac Cardiovasc, C Melchor Fernandez Almagro 3, E-28029 Madrid, Spain.	mtorres@cnic.es	Ros, Maria A./K-8160-2014; Roselló-Díez, Alberto/K-7295-2016; Torres, Miguel/CAG-0003-2022; Torres, Miguel/A-7388-2013	Ros, Maria A./0000-0002-1224-7671; Roselló-Díez, Alberto/0000-0002-5550-9846; Torres, Miguel/0000-0003-0906-4767; Torres, Miguel/0000-0003-0906-4767	Spanish Ministry of Science and Innovation (MICINN) [RD06/0010/0008, BFU2009-08331/BMC, BFU2008-00397]; Madrid's Regional Government (CAM) [CPI/0051/2007]; MICINN; Pro-CNIC Foundation	Spanish Ministry of Science and Innovation (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Madrid's Regional Government (CAM); MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); Pro-CNIC Foundation	We thank K. Storey and R. Diez del Corral for plasmids and C. Tabin for sharing unpublished results. Supported by grants RD06/0010/0008, BFU2009-08331/BMC (M. T.) and BFU2008-00397 (M. A. R.), from the Spanish Ministry of Science and Innovation (MICINN) and fellowship CPI/0051/2007 (A.R.-D.) from Madrid's Regional Government (CAM). The CNIC is supported by the MICINN and the Pro-CNIC Foundation.	Cooper KL, 2011, SCIENCE, V332, P1083, DOI 10.1126/science.1199499; Diez del Corral R, 2003, NEURON, V40, P65; Dudley AT, 2002, NATURE, V418, P539, DOI 10.1038/nature00945; Goldbeter A, 2007, DEV DYNAM, V236, P1495, DOI 10.1002/dvdy.21193; Gonzalez-Crespo S, 1998, NATURE, V394, P196, DOI 10.1038/28197; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; HAYAMIZU TF, 1994, DEV BIOL, V166, P123, DOI 10.1006/dbio.1994.1301; KIENY M, 1977, ROUX ARCH DEV BIOL, V183, P177, DOI 10.1007/BF00867319; MADEN M, 1983, J EMBRYOL EXP MORPH, V77, P273; MADEN M, 1983, DEV BIOL, V98, P409, DOI 10.1016/0012-1606(83)90370-6; Mariani FV, 2008, NATURE, V453, P401, DOI 10.1038/nature06876; Mercader N, 2000, DEVELOPMENT, V127, P3961; Mercader N, 1999, NATURE, V402, P425, DOI 10.1038/46580; Mercader N, 2009, INT J DEV BIOL, V53, P1483, DOI 10.1387/ijdb.072430nm; Nelson CE, 1996, DEVELOPMENT, V122, P1449; ROS MA, 1994, DEV BIOL, V166, P59, DOI 10.1006/dbio.1994.1296; SAXENA S, 1977, INDIAN J EXP BIOL, V15, P435; SUMMERBELL D, 1973, NATURE, V244, P492, DOI 10.1038/244492a0; SUMMERBELL D, 1977, J EMBRYOL EXP MORPH, V41, P137; SUMMERBELL D, 1975, J EMBRYOL EXP MORPH, V33, P621; Tabin C, 2007, GENE DEV, V21, P1433, DOI 10.1101/gad.1547407; ten Berge D, 2008, DEVELOPMENT, V135, P3247, DOI 10.1242/dev.023176; Vargesson N, 1997, DEVELOPMENT, V124, P1909; Yashiro K, 2004, DEV CELL, V6, P411, DOI 10.1016/S1534-5807(04)00062-0; Zhao XL, 2009, CURR BIOL, V19, P1050, DOI 10.1016/j.cub.2009.04.059	25	97	97	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 27	2011	332	6033					1086	1088		10.1126/science.1199489	http://dx.doi.org/10.1126/science.1199489			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769FN	21617076				2022-12-24	WOS:000290996700045
J	Gahl, WA; Tifft, CJ				Gahl, William A.; Tifft, Cynthia J.			The NIH Undiagnosed Diseases Program Lessons Learned	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							MUTATIONS		[Tifft, Cynthia J.] NHGRI, NIH, Undiagnosed Dis Program, Bethesda, MD 20892 USA; NHGRI, Off Clin Director, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Tifft, CJ (corresponding author), NHGRI, NIH, Undiagnosed Dis Program, 10 Ctr Dr,MSC 1205,Bldg 10,Room CRC3-2551, Bethesda, MD 20892 USA.	ctifft@nih.gov			NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000215] Funding Source: NIH RePORTER	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Amann K, 2008, CLIN J AM SOC NEPHRO, V3, P1599, DOI 10.2215/CJN.02120508; Bergen AAB, 2000, NAT GENET, V25, P228, DOI 10.1038/76109; Markello TC, 2011, MOL GENET METAB, V103, P44, DOI 10.1016/j.ymgme.2011.01.018; *NAT TECHN INF SER, 1989, PUBL NAT TECHN INF S, P17; *NIH OFF RAR DIS R, UND DIS PROGR; St Hilaire C, 2011, NEW ENGL J MED, V364, P432, DOI [10.1056/NEJMoa0912923, 10.1056/NEJMc1102515]	6	84	84	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 11	2011	305	18					1904	1905		10.1001/jama.2011.613	http://dx.doi.org/10.1001/jama.2011.613			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	761YH	21558523				2022-12-24	WOS:000290438800030
J	Hirose, S; Benabentos, R; Ho, HI; Kuspa, A; Shaulsky, G				Hirose, Shigenori; Benabentos, Rocio; Ho, Hsing-I; Kuspa, Adam; Shaulsky, Gad			Self-Recognition in Social Amoebae Is Mediated by Allelic Pairs of Tiger Genes	SCIENCE			English	Article							CELL-CELL ADHESION; DICTYOSTELIUM DEVELOPMENT; LAGC; GBF	Free-living cells of the social amoebae Dictyostelium discoideum can aggregate and develop into multicellular fruiting bodies in which many die altruistically as they become stalk cells that support the surviving spores. Dictyostelium cells exhibit kin discrimination-a potential defense against cheaters, which sporulate without contributing to the stalk. Kin discrimination depends on strain relatedness, and the polymorphic genes tgrB1 and tgrC1 are potential components of that mechanism. Here, we demonstrate a direct role for these genes in kin discrimination. We show that a matching pair of tgrB1 and tgrC1 alleles is necessary and sufficient for attractive self-recognition, which is mediated by differential cell-cell adhesion. We propose that TgrB1 and TgrC1 proteins mediate this adhesion through direct binding. This system is a genetically tractable ancient model of eukaryotic self-recognition.	[Hirose, Shigenori; Kuspa, Adam] Baylor Coll Med, Verna & Marrs Mclean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Benabentos, Rocio; Kuspa, Adam; Shaulsky, Gad] Baylor Coll Med, Cell & Mol Biol Grad Program, Houston, TX 77030 USA; [Benabentos, Rocio; Ho, Hsing-I; Kuspa, Adam; Shaulsky, Gad] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Kuspa, A (corresponding author), Baylor Coll Med, Verna & Marrs Mclean Dept Biochem & Mol Biol, Houston, TX 77030 USA.	akuspa@bcm.edu; gadi@bcm.edu		Shaulsky, Gad/0000-0002-0532-0551; Kuspa, Adam/0000-0002-9156-149X	NIH [R01 GM084992]; National Research Service from the NIH [F31 GM086131]; NSF [2006042535]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084992, F31GM086131] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Service from the NIH; NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Y. Wang and W. J. Cordill for useful discussions. This work was supported by grant no. R01 GM084992 from the NIH. R. B. was supported by National Research Service Award grant F31 GM086131 from the NIH and by an NSF fellowship 2006042535.	Benabentos R, 2009, CURR BIOL, V19, P567, DOI 10.1016/j.cub.2009.02.037; Boehm T, 2006, CELL, V125, P845, DOI 10.1016/j.cell.2006.05.017; BORK P, 1994, J MOL BIOL, V242, P309, DOI 10.1006/jmbi.1994.1582; BRAR SK, 1993, J BIOL CHEM, V268, P24902; De Tomaso AW, 2005, NATURE, V438, P454, DOI 10.1038/nature04150; HUGHES AL, 1988, NATURE, V335, P167, DOI 10.1038/335167a0; Iranfar N, 2006, DEV BIOL, V290, P460, DOI 10.1016/j.ydbio.2005.11.035; Kessin R.H., 2001, DICTYOSTELIUM EVOLUT; Matthews BJ, 2007, CELL, V129, P593, DOI 10.1016/j.cell.2007.04.013; Ostrowski EA, 2008, PLOS BIOL, V6, P2376, DOI 10.1371/journal.pbio.0060287; Rosa SFP, 2010, CURR BIOL, V20, P1122, DOI 10.1016/j.cub.2010.04.050; Rosengarten RD, 2011, MOL BIOL EVOL, V28, P933, DOI 10.1093/molbev/msq282; Shaulsky G, 2007, CURR BIOL, V17, pR684, DOI 10.1016/j.cub.2007.06.024; Siu CH, 2004, SEMIN CELL DEV BIOL, V15, P633, DOI 10.1016/j.semcdb.2004.09.004; Sukumaran S, 1998, DEV BIOL, V200, P16, DOI 10.1006/dbio.1998.8934; Wang J, 2000, DEV BIOL, V227, P734, DOI 10.1006/dbio.2000.9881	16	92	95	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 22	2011	333	6041					467	470		10.1126/science.1203903	http://dx.doi.org/10.1126/science.1203903			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	795FR	21700835	Green Accepted			2022-12-24	WOS:000292959600050
J	Lind, M; Bounias, I; Olsson, M; Gudbjornsdottir, S; Svensson, AM; Rosengren, A				Lind, Marcus; Bounias, Ioannis; Olsson, Marita; Gudbjornsdottir, Soffia; Svensson, Ann-Marie; Rosengren, Annika			Glycaemic control and incidence of heart failure in 20 985 patients with type 1 diabetes: an observational study	LANCET			English	Article							RISK-FACTORS; DISEASE; PREVALENCE; MORTALITY; REGISTER; SWEDEN; MEN	Background Poor glycaemic control is associated with microvascular and macrovascular complications in type 1 diabetes, but whether glycaemic control is associated with heart failure in such patients is not known. We aimed to assess this association in a large cohort of patients with type 1 diabetes identified from the Swedish national diabetes registry. Methods We identified all patients (aged >= 18 years) with type 1 diabetes and no known heart failure who were registered in the national diabetes registry between January, 1998, and December, 2003. These patients were followed up until hospital admission for heart failure, death, or end of follow-up on Dec 31, 2009. We calculated incidence categorised by glycated haemoglobin A(1c) (HbA(1c)) values, and we assessed the association between patients' characteristics, including HbA(1c), and heart failure. Findings In a cohort of 20 985 patients with mean age of 38.6 years (SD 13.3) at baseline, 635 patients (3%) were admitted to hospital with a primary or secondary diagnosis of heart failure during a median follow-up of 9.0 years (IQR 7.3-11.0), with an incidence of 3.38 events per 1000 patient-years (95% CI 3.12-3.65). Incidence increased monotonically with HbA(1c), with a range of 1.42-5.20 per 1000 patient-years between patients in the lowest (<6.5%) and highest (>= 10.5%) categories of HbA(1c). In a Cox regression analysis, with adjustment for age, sex, duration of diabetes, cardiovascular risk factors, and baseline or intervening acute myocardial infarction and other comorbidities, the hazard ratio for development of heart failure was 3.98 (95% CI 2.23-7.14) in patients with HbA(1c) of 10.5% or higher compared with a reference group of patients with HbA(1c) of less than 6.5%. Risk of heart failure increased with age and duration of diabetes. Other modifiable factors associated with increased risk of heart failure were smoking, high systolic blood pressure, and raised body-mass index. In a subgroup of 18 281 patients (87%) with data for blood lipids, higher HDL cholesterol was associated with lower risk of heart failure, but there was no association with LDL cholesterol. Interpretation The positive association between HbA(1c) and risk of heart failure in fairly young patients with type 1 diabetes indicates a potential for prevention of heart failure with improved glycaemic control.	[Lind, Marcus] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Mol & Clin Med, Gothenburg, Sweden; [Rosengren, Annika] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Emergency & Cardiovasc Med, Gothenburg, Sweden; [Lind, Marcus; Bounias, Ioannis] NU Hosp Org, Dept Med, Uddevalla, Sweden; [Olsson, Marita] Chalmers Univ Technol, Dept Math Sci, S-41296 Gothenburg, Sweden; [Gudbjornsdottir, Soffia] Univ Gothenburg, Sahlgrenska Univ Hosp, Inst Med, Dept Med, Gothenburg, Sweden; [Svensson, Ann-Marie] Ctr Registers Reg Vastra Gotaland, Gothenburg, Sweden	University of Gothenburg; University of Gothenburg; NU Hospital Group; Voestalpine AG; Chalmers University of Technology; Sahlgrenska University Hospital; University of Gothenburg	Lind, M (corresponding author), Uddevalla Cent Hosp, Dept Med, S-45180 Uddevalla, Sweden.	lind.marcus@telia.com	Lind, Marcus/AAI-6733-2021; Lind, Marcus/GRJ-4946-2022		AstzaZeneca; Novo Nordisk Scandinavia; Swedish Heart and Lung Foundation; Swedish Research Council; Abbot Scandinavia	AstzaZeneca; Novo Nordisk Scandinavia(Novo Nordisk); Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Abbot Scandinavia	AstzaZeneca, Novo Nordisk Scandinavia, Swedish Heart and Lung Foundation, and Swedish Research Council.; M L has received honoraria or served as consultant for Bayer, Eli Lilly, Novartis, Novo Nordisk Scandinavia, Medtronic Pfizer, and Sanofi-Aventis; and has been a member of an advisory board for Novo Nordisk Scandinavia. ML's institution (NU-Hospital Organisation) has received grants from AstraZeneca and Novo Nordisk Scandinavia related to studies of risk factors and diabetic complications, which were not drug specific, and from Abbot Scandinavia for assessments of continuous glucose monitoring. All other authors declare that they have no conflicts of interest.	Asif M, 2000, P NATL ACAD SCI USA, V97, P2809, DOI 10.1073/pnas.040558497; Avendano GF, 1999, DIABETES, V48, P1443, DOI 10.2337/diabetes.48.7.1443; Bauters C, 2003, CARDIOVASC DIABETOL, V2, DOI 10.1186/1475-2840-2-1; CLELAND JG, 1995, EUR HEART J, V16, P741; Di Cori A, 2007, AM J CARDIOL, V99, P84, DOI 10.1016/j.amjcard.2006.07.063; Eeg-Olofsson K, 2010, DIABETES CARE, V33, P1640, DOI 10.2337/dc10-0398; FRASER GE, 1995, AM J CARDIOL, V75, P141, DOI 10.1016/S0002-9149(00)80063-6; Gul K, 2009, EUR J ECHOCARDIOGR, V10, P841, DOI 10.1093/ejechocard/jep086; Hoelzel W, 2004, CLIN CHEM, V50, P166, DOI 10.1373/clinchem.2003.024802; Ingelsson E, 2005, EUR J HEART FAIL, V7, P787, DOI 10.1016/j.ejheart.2004.12.007; Iribarren C, 2001, CIRCULATION, V103, P2668; Kenchaiah S, 2002, NEW ENGL J MED, V347, P305, DOI 10.1056/NEJMoa020245; Laing SP, 2003, DIABETOLOGIA, V46, P760, DOI 10.1007/s00125-003-1116-6; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; Nichols GA, 2001, DIABETES CARE, V24, P1614, DOI 10.2337/diacare.24.9.1614; Rosen M, 2000, J INTERN MED, V248, P159, DOI 10.1046/j.1365-2796.2000.00716.x; Schaufelberger M, 2007, EUR HEART J, V28, P212, DOI 10.1093/eurheartj/ehl435; Shafazand M, 2009, EUR HEART J, V30, P671, DOI 10.1093/eurheartj/ehn541; Soedamah-Muthu SS, 2004, DIABETES CARE, V27, P530, DOI 10.2337/diacare.27.2.530; Steine K, 2007, EUR J HEART FAIL, V9, P1044, DOI 10.1016/j.ejheart.2007.07.013; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; Turnbull FM, 2009, DIABETOLOGIA, V52, P2288, DOI 10.1007/s00125-009-1470-0; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Wilhelmsen L, 2001, J INTERN MED, V249, P253, DOI 10.1046/j.1365-2796.2001.00801.x; Yazici D, 2013, ACTA DIABETOL, V50, P155, DOI 10.1007/s00592-010-0235-z	25	180	182	1	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 9	2011	378	9786					140	146		10.1016/S0140-6736(11)60471-6	http://dx.doi.org/10.1016/S0140-6736(11)60471-6			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	795CJ	21705065				2022-12-24	WOS:000292948800030
J	Heath, I				Heath, Iona			LIFE AND DEATH Seeming virtuous on chronic diseases	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Royal Coll Gen Practitioners, London, England		Heath, I (corresponding author), Royal Coll Gen Practitioners, London, England.	iona.heath22@yahoo.co.uk							0	9	9	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 6	2011	343								d4239	10.1136/bmj.d4239	http://dx.doi.org/10.1136/bmj.d4239			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	791SD	21734169				2022-12-24	WOS:000292684100009
J	de Boer, IH; Rue, TC; Hall, YN; Heagerty, PJ; Weiss, NS; Himmelfarb, J				de Boer, Ian H.; Rue, Tessa C.; Hall, Yoshio N.; Heagerty, Patrick J.; Weiss, Noel S.; Himmelfarb, Jonathan			Temporal Trends in the Prevalence of Diabetic Kidney Disease in the United States	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RENAL-INSUFFICIENCY; SERUM CREATININE; RISK; MICROALBUMINURIA; ALBUMINURIA; MORTALITY; NEPHROPATHY; PROTEINURIA; POPULATION; EPIDEMIOLOGY	Context Diabetes is the leading cause of kidney disease in the developed world. Over time, the prevalence of diabetic kidney disease (DKD) may increase due to the expanding size of the diabetes population or decrease due to the implementation of diabetes therapies. Objective To define temporal changes in DKD prevalence in the United States. Design, Setting, and Participants Cross-sectional analyses of the Third National Health and Nutrition Examination Survey (NHANES III) from 1988-1994 (N = 15 073), NHANES 1999-2004 (N = 13 045), and NHANES 2005-2008 (N = 9588). Participants with diabetes were defined by levels of hemoglobin A(1c) of 6.5% or greater, use of glucose-lowering medications, or both (n = 1431 in NHANES III; n = 1443 in NHANES 1999-2004; n = 1280 in NHANES 2005-2008). Main Outcome Measures Diabetic kidney disease was defined as diabetes with albuminuria (ratio of urine albumin to creatinine >= 30 mg/g), impaired glomerular filtration rate (<60 mL/min/1.73 m(2) estimated using the Chronic Kidney Disease Epidemiology Collaboration formula), or both. Prevalence of albuminuria was adjusted to estimate persistent albuminuria. Results The prevalence of DKD in the US population was 2.2% (95% confidence interval [CI], 1.8%-2.6%) in NHANES III, 2.8% (95% CI, 2.4%-3.1%) in NHANES 1999-2004, and 3.3% (95% CI, 2.8%-3.7%) in NHANES 2005-2008 (P < .001 for trend). The prevalence of DKD increased in direct proportion to the prevalence of diabetes, without a change in the prevalence of DKD among those with diabetes. Among persons with diabetes, use of glucose-lowering medications increased from 56.2% (95% CI, 52.1%-60.4%) in NHANES III to 74.2% (95% CI, 70.4%-78.0%) in NHANES 2005-2008 (P < .001); use of renin-angiotensin-aldosterone system inhibitors increased from 11.2% (95% CI, 9.0%-13.4%) to 40.6% (95% CI, 37.2%-43.9%), respectively (P < .001); the prevalence of impaired glomerular filtration rate increased from 14.9% (95% CI, 12.1%-17.8%) to 17.7% (95% CI, 15.2%-20.2%), respectively (P =. 03); and the prevalence of albuminuria decreased from 27.3% (95% CI, 22.0%-32.7%) to 23.7% (95% CI, 19.3%-28.0%), respectively, but this was not statistically significant (P =. 07). Conclusions Prevalence of DKD in the United States increased from 1988 to 2008 in proportion to the prevalence of diabetes. Among persons with diabetes, prevalence of DKD was stable despite increased use of glucose-lowering medications and renin-angiotensin-aldosterone system inhibitors. JAMA. 2011;305(24):2532-2539	[de Boer, Ian H.; Hall, Yoshio N.; Himmelfarb, Jonathan] Univ Washington, Kidney Res Inst, Seattle, WA 98104 USA; [de Boer, Ian H.; Hall, Yoshio N.; Himmelfarb, Jonathan] Univ Washington, Div Nephrol, Seattle, WA 98104 USA; [de Boer, Ian H.; Hall, Yoshio N.; Himmelfarb, Jonathan] Univ Washington, Dept Med, Seattle, WA 98104 USA; [Rue, Tessa C.; Heagerty, Patrick J.] Univ Washington, Dept Biostat, Seattle, WA 98104 USA; [de Boer, Ian H.; Weiss, Noel S.] Univ Washington, Dept Epidemiol, Seattle, WA 98104 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	de Boer, IH (corresponding author), Univ Washington, Kidney Res Inst, Box 359606,325 9th Ave, Seattle, WA 98104 USA.	deboer@u.washington.edu	Hall, Yoshio/AAP-5723-2021; de Boer, Ian/GYJ-3282-2022		Shire Scientific Advisory Board on Outcomes Studies in Hemodialysis Patients; Nephrion/Cytopheryx Medical Advisory Board; National Center for Research Resources [5KL2RR025015]; National Institutes of Health [UL1RR025014]; National Institute of Diabetes and Digestive and Kidney Diseases [1R01DK087726, 1R01DK088762]; Satellite Healthcare; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025014, KL2RR025015] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088762, R01DK087726, K23DK087900] Funding Source: NIH RePORTER	Shire Scientific Advisory Board on Outcomes Studies in Hemodialysis Patients; Nephrion/Cytopheryx Medical Advisory Board; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Satellite Healthcare; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Himmelfarb reported that all honoraria and consulting fees from serving on the Shire Scientific Advisory Board on Outcomes Studies in Hemodialysis Patients and the Nephrion/Cytopheryx Medical Advisory Board are donated to the Kidney Research Institute at the University of Washington; money is paid to his institution (University of Washington) for his consulting work for Genzyme, Lilly, and Thrasos. No other authors reported disclosures.; This publication was made possible by grant 5KL2RR025015 from the National Center for Research Resources, grant UL1RR025014 from the National Institutes of Health, grants 1R01DK087726 and 1R01DK088762 from the National Institute of Diabetes and Digestive and Kidney Diseases, and funding from the Satellite Healthcare's Norman S. Coplon Extramural Grant Program.	Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS11, DOI 10.2337/dc10-S011; BORCHJOHNSEN K, 1987, BMJ-BRIT MED J, V294, P1651, DOI 10.1136/bmj.294.6588.1651; Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; Caramori ML, 2003, DIABETES, V52, P1036, DOI 10.2337/diabetes.52.4.1036; Centers for Disease Control and Prevention, NAT HLTH NUTR EX SUR; Coresh J, 2002, AM J KIDNEY DIS, V39, P920, DOI 10.1053/ajkd.2002.32765; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Costacou T, 2007, AM J KIDNEY DIS, V50, P721, DOI 10.1053/j.ajkd.2007.08.005; Cowie CC, 2010, DIABETES CARE, V33, P562, DOI 10.2337/dc09-1524; de Boer IH, 2007, J AM SOC NEPHROL, V18, P235, DOI 10.1681/ASN.2006040394; de Boer IH, 2009, AM J KIDNEY DIS, V54, P1043, DOI 10.1053/j.ajkd.2009.07.018; de Boer IH, 2009, DIABETES CARE, V32, P1833, DOI 10.2337/dc09-0191; Diabet Control Complications DCCT Res Grp, 1995, KIDNEY INT, V47, P1703; Garg AX, 2002, KIDNEY INT, V61, P2165, DOI 10.1046/j.1523-1755.2002.00356.x; Gerstein HC, 2000, LANCET, V355, P253; GOODMAN LA, 1960, J AM STAT ASSOC, V55, P708, DOI 10.2307/2281592; Groop PH, 2009, DIABETES, V58, P1651, DOI 10.2337/db08-1543; Haller H, 2011, NEW ENGL J MED, V364, P907, DOI 10.1056/NEJMoa1007994; Hsu CY, 2006, ANN INTERN MED, V144, P21, DOI 10.7326/0003-4819-144-1-200601030-00006; Kramer HJ, 2003, JAMA-J AM MED ASSOC, V289, P3273, DOI 10.1001/jama.289.24.3273; Kunz R, 2008, ANN INTERN MED, V148, P30, DOI 10.7326/0003-4819-148-1-200801010-00190; Levey AS, 2009, AM J KIDNEY DIS, V54, P205, DOI 10.1053/j.ajkd.2009.04.029; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levin A, 2007, AM J KIDNEY DIS, V49, pS10, DOI 10.1053/j.ajkd.2006.12.004; Lewis EJ, 2001, NEW ENGL J MED, V345, P851, DOI 10.1056/NEJMoa011303; LEWIS EJ, 1993, NEW ENGL J MED, V329, P1456, DOI 10.1056/NEJM199311113292004; MOGENSEN CE, 1984, NEW ENGL J MED, V310, P356, DOI 10.1056/NEJM198402093100605; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; Nathan DM, 2009, ARCH INTERN MED, V169, P1307, DOI 10.1001/archinternmed.2009.193; Ninomiya T, 2009, J AM SOC NEPHROL, V20, P1813, DOI 10.1681/ASN.2008121270; Orchard TJ, 2010, DIABETOLOGIA, V53, P2312, DOI 10.1007/s00125-010-1860-3; PARVING HH, 1982, ACTA ENDOCRINOL-COP, V100, P550, DOI 10.1530/acta.0.1000550; Perkins BA, 2005, J AM SOC NEPHROL, V16, P1404, DOI 10.1681/ASN.2004100854; Retnakaran R, 2006, DIABETES, V55, P1832, DOI 10.2337/db05-1620; Rubin DB, 2004, MULTIPLE IMPUTATION; Selvin E, 2007, AM J KIDNEY DIS, V50, P918, DOI 10.1053/j.ajkd.2007.08.020; Steffes MW, 2003, JAMA-J AM MED ASSOC, V290, P2159, DOI 10.1001/jama.290.16.2159; Thompson ML, 1998, OCCUP ENVIRON MED, V55, P272, DOI 10.1136/oem.55.4.272; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; US Renal Data System, 2010, USRDS 2010 ANN DAT R; VIBERTI GC, 1982, LANCET, V1, P1430	41	630	640	4	43	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 22	2011	305	24					2532	2539		10.1001/jama.2011.861	http://dx.doi.org/10.1001/jama.2011.861			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	780MF	21693741	Green Accepted			2022-12-24	WOS:000291860400020
J	Hawkes, N				Hawkes, Nigel			MEDICAL RESEARCH Dangers of research into chronic fatigue syndrome	BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes1@btinternet.com						[Anonymous], 2011, LANCET, V377, P1808; NICE, CHRON FAT SYNDR MYAL; van Kuppeveld FJM, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1018; White PD, 2011, LANCET, V377, P823, DOI 10.1016/S0140-6736(11)60096-2	4	15	15	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 22	2011	342								d3780	10.1136/bmj.d3780	http://dx.doi.org/10.1136/bmj.d3780			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	785AT	21697226				2022-12-24	WOS:000292200500006
J	Miller, FG; Joffe, S				Miller, Franklin G.; Joffe, Steven			Balancing Access and Evaluation in the Approval of New Cancer Drugs	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ACCELERATED APPROVAL; CLINICAL-TRIALS		[Miller, Franklin G.] NIH, Dept Bioeth, Ctr Clin, Bethesda, MD 20892 USA; [Joffe, Steven] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Joffe, Steven] Childrens Hosp, Dept Med, Boston, MA 02115 USA	National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); Harvard University; Dana-Farber Cancer Institute; Harvard University; Boston Children's Hospital	Miller, FG (corresponding author), NIH, Dept Bioeth, Ctr Clin, Bldg 10,Room 1C118, Bethesda, MD 20892 USA.	fmiller@nih.gov	Joffe, Steven/H-3941-2019	Joffe, Steven/0000-0002-0667-7384				Adzick NS, 2011, NEW ENGL J MED, V364, P993, DOI 10.1056/NEJMoa1014379; Allison M, 2011, NAT BIOTECHNOL, V29, P13, DOI 10.1038/nbt.1746; Carpenter D, 2010, PRINC STUD AM POLIT, P1; Chabner BA, 2011, NEW ENGL J MED, V364, P1087, DOI 10.1056/NEJMp1100548; Ellenberg SS, 2011, J NATL CANCER I, V103, P616, DOI 10.1093/jnci/djr104; Fleming TR, 1996, ANN INTERN MED, V125, P605, DOI 10.7326/0003-4819-125-7-199610010-00011; Johnson JR, 2011, J NATL CANCER I, V103, P636, DOI 10.1093/jnci/djr062; Miller FG, 2011, NEW ENGL J MED, V364, P476, DOI 10.1056/NEJMsb1011301; Rawls John., 1999, THEORY JUSTICE, VRevised; Rettig R. A., 2007, FALSE HOPE BONE MARR	10	14	14	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 8	2011	305	22					2345	2346		10.1001/jama.2011.784	http://dx.doi.org/10.1001/jama.2011.784			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	773YV	21642688				2022-12-24	WOS:000291349100029
J	Alehagen, U; Dahlstrom, U; Rehfeld, JF; Goetze, JP				Alehagen, Urban; Dahlstroem, Ulf; Rehfeld, Jens F.; Goetze, Jens P.			Association of Copeptin and N-Terminal proBNP Concentrations With Risk of Cardiovascular Death in Older Patients With Symptoms of Heart Failure	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE MYOCARDIAL-INFARCTION; ARGININE-VASOPRESSIN INCREASES; LEFT-VENTRICULAR DYSFUNCTION; NATRIURETIC PEPTIDE; PROVASOPRESSIN COPEPTIN; PROGNOSTIC MARKER; DIAGNOSIS; PLASMA; BNP	Context Measurement of plasma concentrations of the biomarker copeptin may help identify patients with heart failure at high and low risk of mortality, although the value of copeptin measurement in elderly patients is not fully known. Objective To evaluate the association between plasma concentrations of copeptin, a surrogate marker of vasopressin, combined with concentrations of the N-terminal fragment of the precursor to B-type natriuretic peptide (NT-proBNP), and mortality in a cohort of elderly patients with symptoms of heart failure. Design, Setting, and Participants Primary health care population in Sweden enrolling 470 elderly patients with heart failure symptoms between January and December 1996. Clinical examination, echocardiography, and measurement of peptide concentrations were performed, with follow-up through December 2009. Main Outcome Measures All-cause mortality and cardiovascular mortality. Results After a median follow-up of 13 years, there were 226 deaths from all causes, including 146 deaths from cardiovascular causes. Increased concentration of copeptin was associated with increased risk of all-cause mortality (fourth quartile vs first quartile: 69.5% vs 38.5%, respectively; hazard ratio [HR], 2.04 [95% confidence interval {CI}, 1.38-3.02]) and cardiovascular mortality (fourth quartile vs first quartile: 46.6% vs 26.5%; HR, 1.94 [95% CI, 1.20-3.13]). The combination of elevated NT-proBNP concentrations and elevated copeptin concentrations also was associated with increased risk of all-cause mortality (copeptin fourth quartile: HR, 1.63 [95% CI, 1.08-2.47]; P=.01; NT-proBNP fourth quartile: HR, 3.17 [95% CI, 2.02-4.98]; P<.001). Using the 2 biomarkers simultaneously in the evaluation of cardiovascular mortality, there was a significant association for copeptin in the presence of NT-proBNP (log likelihood trend test, P=.048) and a significant association for NT-proBNP (fourth quartile: HR, 4.68 [95% CI 2.63-8.34]; P<.001). Conclusion Among elderly patients with symptoms of heart failure, elevated concentrations of copeptin and the combination of elevated concentrations of copeptin and NT-proBNP were associated with increased risk of all-cause mortality. JAMA. 2011; 305(20): 2088-2095	[Alehagen, Urban; Dahlstroem, Ulf] Linkoping Univ, Div Cardiovasc Med, Dept Med & Hlth Sci,Cty Council Ostergotland, Fac Hlth Sci,Dept Cardiol UHL, SE-58185 Linkoping, Sweden; [Rehfeld, Jens F.; Goetze, Jens P.] Univ Copenhagen, Rigshosp, Dept Clin Biochem, DK-2100 Copenhagen, Denmark	City Council Ostergotland; Linkoping University; Rigshospitalet; University of Copenhagen	Alehagen, U (corresponding author), Linkoping Univ, Dept Cardiol, Ctr Heart, SE-58185 Linkoping, Sweden.	urban.alehagen@liu.se		Goetze, Jens Peter/0000-0001-6356-3829	County Council of Ostergotland; Swedish Heart and Lung Foundation; University of Linkoping	County Council of Ostergotland; Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); University of Linkoping	This study was supported by grants from the County Council of Ostergotland, the Swedish Heart and Lung Foundation, and the University of Linkoping.	Alehagen U., 2002, HeartDrug, V2, P211, DOI 10.1159/000067723; Alehagen U, 2003, CLIN CHEM, V49, P1337, DOI 10.1373/49.8.1337; Apple FS, 2003, CLIN CHIM ACTA, V328, P191, DOI 10.1016/S0009-8981(02)00374-1; Chatterjee K, 2005, AM J CARDIOL, V95, p8B, DOI 10.1016/j.amjcard.2005.03.003; CHOY AMJ, 1994, BRIT HEART J, V72, P16; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Dieplinger B, 2009, HEART, V95, P1508, DOI 10.1136/hrt.2009.170696; EBERT TJ, 1986, J CLIN INVEST, V77, P1136, DOI 10.1172/JCI112413; Fan YH, 2007, LIFE SCI, V81, P327, DOI 10.1016/j.lfs.2007.05.018; Fukuzawa J, 1999, MOL CELL BIOCHEM, V195, P93, DOI 10.1023/A:1006980517557; Gegenhuber A, 2004, CLIN CHEM, V50, P454, DOI 10.1373/clinchem.2003.028712; Jensen-Urstad K, 1998, AM J CARDIOL, V81, P538, DOI 10.1016/S0002-9149(97)00964-8; Jochberger S, 2009, CRIT CARE MED, V37, P476, DOI 10.1097/CCM.0b013e3181957532; Keller T, 2010, J AM COLL CARDIOL, V55, P2096, DOI 10.1016/j.jacc.2010.01.029; Khan SQ, 2007, CIRCULATION, V115, P2103, DOI 10.1161/CIRCULATIONAHA.106.685503; McCullough PA, 2002, CIRCULATION, V106, P416, DOI 10.1161/01.CIR.0000025242.79963.4C; McDonagh TA, 1997, LANCET, V350, P829, DOI 10.1016/S0140-6736(97)03033-X; Mebazaa A, 2007, JAMA-J AM MED ASSOC, V297, P1883, DOI 10.1001/jama.297.17.1883; Morgenthaler NG, 2006, CLIN CHEM, V52, P112, DOI 10.1373/clinchem.2005.060038; Mosterd A, 1999, EUR HEART J, V20, P447, DOI 10.1053/euhj.1998.1239; MOYE LA, 1991, AM J CARDIOL, V68, pD70; Nakamura T, 2006, INT J CARDIOL, V106, P191, DOI 10.1016/j.ijcard.2005.01.043; Neuhold S, 2008, J AM COLL CARDIOL, V52, P266, DOI 10.1016/j.jacc.2008.03.050; Swedberg K, 1999, J Card Fail, V5, P276, DOI 10.1016/S1071-9164(99)90013-1; URETSKY BF, 1985, AM J PHYSIOL, V248, pH396, DOI 10.1152/ajpheart.1985.248.3.H396; vanRoyen N, 1996, AM J CARDIOL, V77, P843, DOI 10.1016/S0002-9149(97)89179-5; Voors AA, 2009, EUR HEART J, V30, P1187, DOI 10.1093/eurheartj/ehp098	27	109	129	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 25	2011	305	20					2088	2095		10.1001/jama.2011.666	http://dx.doi.org/10.1001/jama.2011.666			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	768AC	21610241				2022-12-24	WOS:000290901700022
J	Dyrbye, LN; Shanafelt, TD				Dyrbye, Liselotte N.; Shanafelt, Tait D.			Physician Burnout A Potential Threat to Successful Health Care Reform	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							AMERICAN SURGEONS		[Dyrbye, Liselotte N.; Shanafelt, Tait D.] Mayo Clin, Coll Med, Dept Med, Rochester, MN 55905 USA	Mayo Clinic	Dyrbye, LN (corresponding author), Mayo Clin, Coll Med, Dept Med, 200 1st St SW, Rochester, MN 55905 USA.	dyrbye.liselotte@mayo.edu						[Anonymous], REP PRES REAL FULL P; Association of American Medical Colleges, 2018, COMPL PHYS SUPPL DEM; Campbell DA, 2001, SURGERY, V130, P696, DOI 10.1067/msy.2001.116676; Dyrbye LN, 2011, ARCH SURG-CHICAGO, V146, P211, DOI 10.1001/archsurg.2010.310; Shanafelt TD, 2009, ANN SURG, V250, P463, DOI 10.1097/SLA.0b013e3181ac4dfd; SteelFisher GK, 2009, NEW ENGL J MED, V361, DOI 10.1056/NEJMp0909851; Taylor C, 2005, LANCET, V366, P742, DOI 10.1016/S0140-6736(05)67178-4; Wallace JE, 2009, LANCET, V374, P1714, DOI 10.1016/S0140-6736(09)61424-0; West CP, 2006, JAMA-J AM MED ASSOC, V296, P1071, DOI 10.1001/jama.296.9.1071; Wilson JF, 2008, ANN INTERN MED, V148, P489, DOI 10.7326/0003-4819-148-6-200803180-00029	10	230	233	1	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 18	2011	305	19					2009	2010		10.1001/jama.2011.652	http://dx.doi.org/10.1001/jama.2011.652			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	764WO	21586718				2022-12-24	WOS:000290665500027
J	Kirby, T				Kirby, Tony			Profile Rebecca Ivers: driving down the toll of injury	LANCET			English	Biographical-Item												tony.kirby@lancet.com							0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 7	2011	377	9777					1563	1563		10.1016/S0140-6736(11)60629-6	http://dx.doi.org/10.1016/S0140-6736(11)60629-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	763IJ	21550470				2022-12-24	WOS:000290549700013
J	Li, F; Martienssen, R; Cande, WZ				Li, Fei; Martienssen, Rob; Cande, W. Zacheus			Coordination of DNA replication and histone modification by the Rik1-Dos2 complex	NATURE			English	Article							FISSION YEAST; SCHIZOSACCHAROMYCES-POMBE; POLYMERASE-EPSILON; RNA INTERFERENCE; S-PHASE; HETEROCHROMATIN FORMATION; CHROMOSOMAL REPLICATION; EPIGENETIC INHERITANCE; CELL-CYCLE; CHROMATIN	Histone modification marks have an important role in many chromatin processes(1,2). During DNA replication, both heterochromatin and euchromatin are disrupted ahead of the replication fork and are then reassembled into their original epigenetic states behind the fork(3,4). How histone marks are accurately inherited from generation to generation is still poorly understood. In fission yeast (Schizosaccharomyces pombe), RNA interference (RNAi)-mediated histone methylation is cell cycle regulated. Centromeric repeats are transiently transcribed in the S phase of the cell cycle and are processed into short interfering RNAs (siRNAs) by the complexes RITS (RNA-induced initiation of transcriptional gene silencing) and RDRC (RNA-directed RNA polymerase complex)(5-7). The small RNAs together with silencing factors-including Dos1 (also known as Clr8 and Raf1), Dos2 (also known as Clr7 and Raf2), Rik1 and Lid2-promote heterochromatic methylation of histone H3 at lysine 9 (H3K9) by a histone methyltransferase, Clr4 (refs 8-13). The methylation of H3K9 provides a binding site for Swi6, a structural and functional homologue of metazoan heterochromatin protein 1 (HP1)(14). Here we characterize a silencing complex in fission yeast that contains Dos2, Rik1, Mms19 and Cdc20 (the catalytic subunit of DNA polymerase-e). This complex regulates RNA polymerase II (RNA Pol II) activity in heterochromatin and is required for DNA replication and heterochromatin assembly. Our findings provide a molecular link between DNA replication and histone methylation, shedding light on how epigenetic marks are transmitted during each cell cycle.	[Li, Fei] NYU, Dept Biol, New York, NY 10003 USA; [Martienssen, Rob] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Cande, W. Zacheus] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	New York University; Cold Spring Harbor Laboratory; University of California System; University of California Berkeley	Li, F (corresponding author), NYU, Dept Biol, New York, NY 10003 USA.	fl43@nyu.edu		Li, Fei/0000-0002-1206-9684	National Institutes of Health [RO1GM076396]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076396] Funding Source: NIH RePORTER; Direct For Biological Sciences [1025830] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank R. Allshire, P. Nurse, G. D'Urso and the Japan Yeast Genetic Resource Center for strains, E. Osborne and C. Hale for comments on the manuscript, Cold Spring Harbor Laboratory for mass spectrometry analysis, and members of the Cande and Li laboratories for their support and discussions. This work was supported by a grant from the National Institutes of Health (RO1GM076396) to W.Z.C. and R.M.	Allis C. D., 2006, EPIGENETICS; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Chen ES, 2008, NATURE, V451, P734, DOI 10.1038/nature06561; DUrso G, 1997, P NATL ACAD SCI USA, V94, P12491, DOI 10.1073/pnas.94.23.12491; Feng WY, 2001, MOL CELL BIOL, V21, P4495, DOI 10.1128/MCB.21.14.4495-4504.2001; Finnegan EJ, 2007, CURR BIOL, V17, P1978, DOI 10.1016/j.cub.2007.10.026; Fuss J, 2002, J BIOL CHEM, V277, P8658, DOI 10.1074/jbc.M110615200; Hall IM, 2003, P NATL ACAD SCI USA, V100, P193, DOI 10.1073/pnas.232688099; Hong Eun-Jin Erica, 2005, RNA Biol, V2, P106, DOI 10.4161/rna.2.3.2131; Horn PJ, 2005, GENE DEV, V19, P1705, DOI 10.1101/gad.1328005; Ito S, 2010, MOL CELL, V39, P632, DOI 10.1016/j.molcel.2010.07.029; Jia ST, 2004, SCIENCE, V304, P1971, DOI 10.1126/science.1099035; Kirchmaier AL, 2001, SCIENCE, V291, P646, DOI 10.1126/science.291.5504.646; Kloc A, 2008, CURR BIOL, V18, P490, DOI 10.1016/j.cub.2008.03.016; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lauder S, 1996, MOL CELL BIOL, V16, P6783; Li F, 2005, CURR BIOL, V15, P1448, DOI 10.1016/j.cub.2005.07.021; Li F, 2008, CELL, V135, P272, DOI 10.1016/j.cell.2008.08.036; Li YC, 2001, SCIENCE, V291, P650, DOI 10.1126/science.291.5504.650; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Motamedi MR, 2004, CELL, V119, P789, DOI 10.1016/j.cell.2004.11.034; Nakayama J, 2001, EMBO J, V20, P2857, DOI 10.1093/emboj/20.11.2857; Natsume T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002221; Pidoux A, 2004, METHODS, V33, P252, DOI 10.1016/j.ymeth.2003.11.021; Probst AV, 2009, NAT REV MOL CELL BIO, V10, P192, DOI 10.1038/nrm2640; SMITH JG, 1995, MOL CELL BIOL, V15, P5165; Thon G, 2005, GENETICS, V171, P1583, DOI 10.1534/genetics.105.048298; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Wallace J, 2005, CHROMOSOMA, V114, P389, DOI 10.1007/s00412-005-0024-6; White SA, 2008, CURR TOP MICROBIOL, V320, P157; Wu XY, 2001, J BIOL CHEM, V276, P23962, DOI 10.1074/jbc.M101041200; Yin HB, 2009, PLANT CELL, V21, P386, DOI 10.1105/tpc.108.061549	32	85	85	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 14	2011	475	7355					244	U2562		10.1038/nature10161	http://dx.doi.org/10.1038/nature10161			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791UA	21725325	Green Submitted, Green Accepted			2022-12-24	WOS:000292690500054
J	Theoret, MR; Ning, YM; Zhang, JJ; Justice, R; Keegan, P; Pazdur, R				Theoret, Marc R.; Ning, Yang-Min; Zhang, Jenny J.; Justice, Robert; Keegan, Patricia; Pazdur, Richard			The Risks and Benefits of 5 alpha-Reductase Inhibitors for Prostate-Cancer Prevention	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CHEMOPREVENTION		[Theoret, Marc R.; Ning, Yang-Min; Justice, Robert; Keegan, Patricia; Pazdur, Richard] US FDA, Off Oncol Drug Prod, Off New Drugs, Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA; [Zhang, Jenny J.] US FDA, Off Biostat, Off Translat Sci, Ctr Drug Evaluat & Res, Silver Spring, MD USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA)	Theoret, MR (corresponding author), US FDA, Off Oncol Drug Prod, Off New Drugs, Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA.		Zhang, Jenny/GXV-4980-2022					Andriole GL, 2010, NEW ENGL J MED, V362, P1192, DOI 10.1056/NEJMoa0908127; *FDA, 2010, DEC 1 M ONC DRUGS AD; Kramer BS, 2009, J CLIN ONCOL, V27, P1502, DOI 10.1200/JCO.2008.16.9599; Thompson IM, 2003, NEW ENGL J MED, V349, P215, DOI 10.1056/NEJMoa030660; Walsh PC, 2010, NEW ENGL J MED, V362, P1237, DOI 10.1056/NEJMe1001045	5	114	117	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 14	2011	365	2					97	99		10.1056/NEJMp1106783	http://dx.doi.org/10.1056/NEJMp1106783			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	791SP	21675880				2022-12-24	WOS:000292685500001
J	Izawa, Y; Pun, D; Stahl, SS				Izawa, Yusuke; Pun, Doris; Stahl, Shannon S.			Palladium-Catalyzed Aerobic Dehydrogenation of Substituted Cyclohexanones to Phenols	SCIENCE			English	Article							MOLECULAR-OXYGEN; OXIDATIVE AROMATIZATION; HYDRIDE; TRIFLUOROACETATE; COMPLEXES; TURNOVER; STRATEGY; AMINES; LIGAND; BOND	Aromatic molecules are key constituents of many pharmaceuticals, electronic materials, and commodity plastics. The utility of these molecules directly reflects the identity and pattern of substituents on the aromatic ring. Here, we report a palladium(II) catalyst system, incorporating an unconventional ortho-dimethylaminopyridine ligand, for the conversion of substituted cyclohexanones to the corresponding phenols. The reaction proceeds via successive dehydrogenation of two saturated carbon-carbon bonds of the six-membered ring and uses molecular oxygen as the hydrogen acceptor. This reactivity demonstrates a versatile and efficient strategy for the synthesis of substituted aromatic molecules with fundamentally different selectivity constraints from the numerous known synthetic methods that rely on substitution of a preexisting aromatic ring.	[Izawa, Yusuke; Pun, Doris; Stahl, Shannon S.] Univ Wisconsin, Dept Chem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Stahl, SS (corresponding author), Univ Wisconsin, Dept Chem, 1101 Univ Ave, Madison, WI 53706 USA.	stahl@chem.wisc.edu			NIH [RC1-GM091161]; Mitsubishi Chemical Corporation; NSF [CHE-1041934]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [RC1GM091161] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mitsubishi Chemical Corporation; NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to the NIH (RC1-GM091161), Mitsubishi Chemical Corporation, and NSF (CHE-1041934 to D.P.) for financial support of this work.	Ahuja R, 2011, NAT CHEM, V3, P167, DOI 10.1038/NCHEM.946; BAMFIELD P, 1984, CHEM SOC REV, V13, P441, DOI 10.1039/cs9841300441; Bercaw JE, 2008, J ORG CHEM, V73, P8654, DOI 10.1021/jo8016296; Bercaw JE, 2008, ANGEW CHEM INT EDIT, V47, P9941, DOI 10.1002/anie.200804455; Buckle D. R., 2010, ENCY REAGENTS ORGANI; Campbell AN, 2010, J AM CHEM SOC, V132, P15116, DOI 10.1021/ja105829t; Chen X, 2009, ANGEW CHEM INT EDIT, V48, P5094, DOI 10.1002/anie.200806273; Choi J, 2011, CHEM REV, V111, P1761, DOI 10.1021/cr1003503; Denney MC, 2006, J AM CHEM SOC, V128, P2508, DOI 10.1021/ja0562292; Dobereiner GE, 2010, CHEM REV, V110, P681, DOI 10.1021/cr900202j; FU PP, 1978, CHEM REV, V78, P317, DOI 10.1021/cr60314a001; Gligorich KM, 2009, CHEM COMMUN, P3854, DOI 10.1039/b902868d; Heitman LH, 2009, J MED CHEM, V52, P2036, DOI 10.1021/jm801561h; HORNING EC, 1947, J AM CHEM SOC, V69, P1359, DOI 10.1021/ja01198a035; Izawa Y, 2010, ADV SYNTH CATAL, V352, P3223, DOI 10.1002/adsc.201000771; Konnick MM, 2008, J AM CHEM SOC, V130, P5753, DOI 10.1021/ja7112504; LAROCK RC, 1993, J ORG CHEM, V58, P5298, DOI 10.1021/jo00072a004; Maleczka RE, 2003, J AM CHEM SOC, V125, P7792, DOI 10.1021/ja0349857; Moriuchi T, 2009, TETRAHEDRON LETT, V50, P7385, DOI 10.1016/j.tetlet.2009.10.070; MUZART J, 1982, J MOL CATAL, V15, P373, DOI 10.1016/0304-5102(82)80029-1; Muzart J, 2010, EUR J ORG CHEM, V2010, P3779, DOI 10.1002/ejoc.201000278; SCHUDA PF, 1987, J ORG CHEM, V52, P1972, DOI 10.1021/jo00386a014; SHELDON RA, 1991, J MOL CATAL, V68, P1, DOI 10.1016/0304-5102(91)80056-9; Stahl SS, 2004, ANGEW CHEM INT EDIT, V43, P3400, DOI 10.1002/anie.200300630; Tyman JHP., 1996, STUDIES ORGANIC CHEM; VANBENTHEM RATM, 1994, J CHEM SOC CHEM COMM, P357, DOI 10.1039/c39940000357; WENZEL TT, 1989, J CHEM SOC CHEM COMM, P932, DOI 10.1039/c39890000932; Ye XA, 2010, GREEN CHEM, V12, P1180, DOI 10.1039/c0gc00106f; Yi CS, 2009, ORGANOMETALLICS, V28, P947, DOI 10.1021/om8010883; Zhang XW, 2011, INORG CHIM ACTA, V369, P253, DOI 10.1016/j.ica.2010.11.016	30	350	354	4	183	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 8	2011	333	6039					209	213		10.1126/science.1204183	http://dx.doi.org/10.1126/science.1204183			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	789GG	21659567	Green Accepted			2022-12-24	WOS:000292502700046
J	Kowey, PR				Kowey, Peter R.			The Silent Majority	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							LIABILITY; REFORM		[Kowey, Peter R.] Main Line Hlth Syst, Lankenau Med Ctr, Wynnewood, PA USA; [Kowey, Peter R.] Main Line Hlth Syst, Inst Med Res, Wynnewood, PA USA; [Kowey, Peter R.] Thomas Jefferson Univ, Jefferson Med Coll, Philadelphia, PA 19107 USA	Lankenau Medical Center; Jefferson University	Kowey, PR (corresponding author), Main Line Hlth Syst, Lankenau Med Ctr, Wynnewood, PA USA.	koweyp@mlhs.org						Alpert JS, 2011, AM J MED, V124, P187, DOI 10.1016/j.amjmed.2010.10.010; BRUGADA P, 1992, J AM COLL CARDIOL, V20, P1391, DOI 10.1016/0735-1097(92)90253-J; Dove JT, 2010, J AM COLL CARDIOL, V55, P2801, DOI 10.1016/j.jacc.2010.03.028; *GOV ACC OFF, 2003, MED MALPR IMPL RIS P; Mello MM, 2009, NEW ENGL J MED, V361, P1, DOI 10.1056/NEJMp0903765; Shanafelt TD, 2011, ARCH SURG-CHICAGO, V146, P54, DOI 10.1001/archsurg.2010.292; Tu JV, 1997, NEW ENGL J MED, V336, P1500, DOI 10.1056/NEJM199705223362106	7	2	3	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 6	2011	306	1					18	19		10.1001/jama.2011.904	http://dx.doi.org/10.1001/jama.2011.904			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	787LV	21730231				2022-12-24	WOS:000292378700001
J	Hothorn, M; Belkhadir, Y; Dreux, M; Dabi, T; Noel, JP; Wilson, IA; Chory, J				Hothorn, Michael; Belkhadir, Youssef; Dreux, Marlene; Dabi, Tsegaye; Noel, Joseph. P.; Wilson, Ian A.; Chory, Joanne			Structural basis of steroid hormone perception by the receptor kinase BRI1	NATURE			English	Article							RICH REPEAT PROTEIN; EXTRACELLULAR DOMAIN; CRYSTAL-STRUCTURE; BRASSINOSTEROIDS; COMPLEX; BAK1; RECOGNITION; ACTIVATION; BRI1/BAK1; MUTANT	Polyhydroxylated steroids are regulators of body shape and size in higher organisms. In metazoans, intracellular receptors recognize these molecules. Plants, however, perceive steroids at membranes, using the membrane-integral receptor kinase BRASSINOSTEROID INSENSITIVE 1 (BRI1). Here we report the structure of the Arabidopsis thaliana BRI1 ligand-binding domain, determined by X-ray diffraction at 2.5 angstrom resolution. We find a superhelix of 25 twisted leucine-rich repeats (LRRs), an architecture that is strikingly different from the assembly of LRRs in animal Toll-like receptors. A 70-amino-acid island domain between LRRs 21 and 22 folds back into the interior of the superhelix to create a surface pocket for binding the plant hormone brassinolide. Known loss- and gain-of-function mutations map closely to the hormone-binding site. We propose that steroid binding to BRI1 generates a docking platform for a co-receptor that is required for receptor activation. Our findings provide insight into the activation mechanism of this highly expanded family of plant receptors that have essential roles in hormone, developmental and innate immunity signalling.	[Hothorn, Michael; Belkhadir, Youssef; Dabi, Tsegaye; Chory, Joanne] Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA; [Belkhadir, Youssef; Dabi, Tsegaye; Noel, Joseph. P.; Chory, Joanne] Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; [Dreux, Marlene] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Noel, Joseph. P.] Salk Inst Biol Studies, Jack H Skirball Ctr Chem Biol & Prote, La Jolla, CA 92037 USA; [Wilson, Ian A.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Wilson, Ian A.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Salk Institute; Howard Hughes Medical Institute; Salk Institute; Scripps Research Institute; Salk Institute; Scripps Research Institute; Scripps Research Institute	Chory, J (corresponding author), Salk Inst Biol Studies, Plant Biol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	chory@salk.edu	Dreux, Marlene/M-7295-2014; Belkhadir, Youssef/GXM-6743-2022; Noel, Joseph P/A-9459-2009; Hothorn, Michael/C-6807-2011	Dreux, Marlene/0000-0002-6607-4796; Belkhadir, Youssef/0000-0001-7149-7139; Hothorn, Michael/0000-0002-3597-5698	Howard Hughes Medical Institute; National Science Foundation [IOS-0649389]; European Molecular Biology Organisation; International Human Frontier Science Program Organisation; Philippe Foundation; NIH [AI042266]; Skaggs Institute for Chemical Biology; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI042266, R01AI042266] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Science Foundation(National Science Foundation (NSF)); European Molecular Biology Organisation; International Human Frontier Science Program Organisation; Philippe Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Skaggs Institute for Chemical Biology; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank J. Vanhnasy and W. Yu for maintaining insect cell stocks, M. Jinek and B. W. Han for advice, W. Kwiatowski for maintenance of the Salk X-ray equipment, Y. Jaillais for discussion, and F.V. Chisari for encouragement and support. This work was supported by the Howard Hughes Medical Institute and a grant from the National Science Foundation (IOS-0649389) to J.C. M.H. was supported by long-term fellowships from the European Molecular Biology Organisation and the International Human Frontier Science Program Organisation. Y.B. was a Howard Hughes Medical Institute fellow of the Life Sciences Research Foundation and also received support from the Philippe Foundation. I.A.W. was supported by NIH grant AI042266 and by the Skaggs Institute for Chemical Biology.	Back TG, 2003, J PLANT GROWTH REGUL, V22, P350, DOI 10.1007/s00344-003-0057-0; Belkhadir Y, 2006, SCIENCE, V314, P1410, DOI 10.1126/science.1134040; Bella J, 2008, CELL MOL LIFE SCI, V65, P2307, DOI 10.1007/s00018-008-8019-0; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Chinchilla D, 2009, TRENDS PLANT SCI, V14, P535, DOI 10.1016/j.tplants.2009.08.002; Choe J, 2005, SCIENCE, V309, P581, DOI 10.1126/science.1115253; Clark SE, 1997, CELL, V89, P575, DOI 10.1016/S0092-8674(00)80239-1; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Di Matteo A, 2003, P NATL ACAD SCI USA, V100, P10124, DOI 10.1073/pnas.1733690100; Dievarta A, 2006, FUNCT PLANT BIOL, V33, P723, DOI 10.1071/FP06080; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evdokimov AG, 2001, J MOL BIOL, V312, P807, DOI 10.1006/jmbi.2001.4973; Friedrichsen DM, 2000, PLANT PHYSIOL, V123, P1247, DOI 10.1104/pp.123.4.1247; Fujioka S, 1997, PLANT CELL, V9, P1951, DOI 10.1105/tpc.9.11.1951; Geldner N, 2007, GENE DEV, V21, P1598, DOI 10.1101/gad.1561307; Gomez-Gomez L, 2000, MOL CELL, V5, P1003, DOI 10.1016/S1097-2765(00)80265-8; Gruszka D, 2011, J APPL GENET, V52, P257, DOI 10.1007/s13353-011-0031-7; Han BW, 2008, SCIENCE, V321, P1834, DOI 10.1126/science.1162484; He K, 2007, CURR BIOL, V17, P1109, DOI 10.1016/j.cub.2007.05.036; He ZH, 2000, SCIENCE, V288, P2360, DOI 10.1126/science.288.5475.2360; Hink MA, 2008, BIOPHYS J, V94, P1052, DOI 10.1529/biophysj.107.112003; Jaillais Y, 2011, GENE DEV, V25, P232, DOI 10.1101/gad.2001911; Jin H, 2007, MOL CELL, V26, P821, DOI 10.1016/j.molcel.2007.05.015; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kajava AV, 1998, J MOL BIOL, V277, P519, DOI 10.1006/jmbi.1998.1643; Karlova R, 2006, PLANT CELL, V18, P626, DOI 10.1105/tpc.105.039412; Kim TW, 2010, ANNU REV PLANT BIOL, V61, P681, DOI 10.1146/annurev.arplant.043008.092057; Kinoshita T, 2005, NATURE, V433, P167, DOI 10.1038/nature03227; Li J, 2002, CELL, V110, P213, DOI 10.1016/S0092-8674(02)00812-7; Li JM, 1997, CELL, V90, P929, DOI 10.1016/S0092-8674(00)80357-8; Liu L, 2008, SCIENCE, V320, P379, DOI 10.1126/science.1155406; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Nadeau JA, 2002, SCIENCE, V296, P1697, DOI 10.1126/science.1069596; Nam KH, 2002, CELL, V110, P203, DOI 10.1016/S0092-8674(02)00814-0; Nishimura R, 2002, NATURE, V420, P426, DOI 10.1038/nature01231; Noguchi T, 1999, PLANT PHYSIOL, V121, P743, DOI 10.1104/pp.121.3.743; Ogawa M, 2008, SCIENCE, V319, P294, DOI 10.1126/science.1150083; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Russinova E, 2004, PLANT CELL, V16, P3216, DOI 10.1105/tpc.104.025387; Schubert WD, 2002, CELL, V111, P825, DOI 10.1016/S0092-8674(02)01136-4; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Shiu SH, 2001, P NATL ACAD SCI USA, V98, P10763, DOI 10.1073/pnas.181141598; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Vert G, 2005, ANNU REV CELL DEV BI, V21, P177, DOI 10.1146/annurev.cellbio.21.090704.151241; Wang XF, 2005, PLANT CELL, V17, P1685, DOI 10.1105/tpc.105.031393; Wang XF, 2008, DEV CELL, V15, P220, DOI 10.1016/j.devcel.2008.06.011; Wang XL, 2005, DEV CELL, V8, P855, DOI 10.1016/j.devcel.2005.05.001; Wang XL, 2006, SCIENCE, V313, P1118, DOI 10.1126/science.1127593; Wang ZY, 2001, NATURE, V410, P380, DOI 10.1038/35066597; Whippo CW, 2005, PLANT PHYSIOL, V139, P448, DOI 10.1104/pp.105.064444	50	269	295	0	96	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 23	2011	474	7352					467	U90		10.1038/nature10153	http://dx.doi.org/10.1038/nature10153			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	781NJ	21666665	Green Submitted, Green Accepted			2022-12-24	WOS:000291939700039
J	Anderson, E; Siegel, EH; Bliss-Moreau, E; Barrett, LF				Anderson, Eric; Siegel, Erika H.; Bliss-Moreau, Eliza; Barrett, Lisa Feldman			The Visual Impact of Gossip	SCIENCE			English	Article							BINOCULAR-RIVALRY; DOMINANCE DURATIONS; FACIAL EXPRESSIONS; PERCEPTION; ATTENTION; CONTRAST; EMOTION; FACES; RECOGNITION; PREDOMINATE	Gossip is a form of affective information about who is friend and who is foe. We show that gossip does not influence only how a face is evaluated-it affects whether a face is seen in the first place. In two experiments, neutral faces were paired with negative, positive, or neutral gossip and were then presented alone in a binocular rivalry paradigm (faces were presented to one eye, houses to the other). In both studies, faces previously paired with negative (but not positive or neutral) gossip dominated longer in visual consciousness. These findings demonstrate that gossip, as a potent form of social affective learning, can influence vision in a completely top-down manner, independent of the basic structural features of a face.	[Anderson, Eric; Siegel, Erika H.; Barrett, Lisa Feldman] Northeastern Univ, Dept Psychol, Boston, MA 02115 USA; [Bliss-Moreau, Eliza] Univ Calif Davis, Dept Psychiat & Behav Sci, Davis, CA 95616 USA; [Barrett, Lisa Feldman] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Psychiat, Charlestown, MA 02129 USA; [Barrett, Lisa Feldman] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Martinos Ctr Biomed Imaging, Charlestown, MA 02129 USA	Northeastern University; University of California System; University of California Davis; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Barrett, LF (corresponding author), Northeastern Univ, Dept Psychol, Boston, MA 02115 USA.	l.barrett@neu.edu	Barrett, Lisa Feldman/ABC-8157-2020	Anderson, Eric/0000-0002-4215-6308	NIH [DP1OD003312]; U.S. Army Research Institute for the Behavioral and Social Sciences [W91WAW-08-C-0018]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003312] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Army Research Institute for the Behavioral and Social Sciences; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Preparation of this manuscript was supported by the NIH Director's Pioneer Award (DP1OD003312) and by the U.S. Army Research Institute for the Behavioral and Social Sciences (contract W91WAW-08-C-0018) to L.F.B. The views, opinions, and/or findings contained in this article are solely those of the author(s) and should not be construed as an official Department of the Army or Department of Defense position, policy, or decision. We thank J. Shang and M. Norton for their help with data collection.	Abelson RP, 1997, PSYCHOL METHODS, V2, P315, DOI 10.1037/1082-989X.2.4.315; Alpers GW, 2007, EMOTION, V7, P495, DOI 10.1037/1528-3542.7.3.495; Alpers GW, 2006, COGNITION EMOTION, V20, P596, DOI 10.1080/02699930500282249; Alpers GW, 2005, INT J PSYCHOPHYSIOL, V57, P25, DOI 10.1016/j.ijpsycho.2005.01.008; Andrews TJ, 1997, P NATL ACAD SCI USA, V94, P9905, DOI 10.1073/pnas.94.18.9905; Bannerman RL, 2008, OPHTHAL PHYSL OPT, V28, P317, DOI 10.1111/j.1475-1313.2008.00568.x; Bar M, 2006, P NATL ACAD SCI USA, V103, P449, DOI 10.1073/pnas.0507062103; Barrett LF, 2009, PHILOS T R SOC B, V364, P1325, DOI 10.1098/rstb.2008.0312; Baumeister RF, 2004, REV GEN PSYCHOL, V8, P111, DOI 10.1037/1089-2680.8.2.111; Blake R., 2001, BRAIN MIND, V2, P5, DOI [https://doi.org/10.1023/A:1017925416289, DOI 10.1023/A:1017925416289, 10.1023/A:1017925416289]; Bliss-Moreau E, 2008, EMOTION, V8, P479, DOI 10.1037/1528-3542.8.4.479; Carmel D, 2010, CURR BIOL, V20, pR799, DOI 10.1016/j.cub.2010.07.036; Carter OL, 2005, CURR BIOL, V15, pR412, DOI 10.1016/j.cub.2005.05.043; Chong SC, 2005, J VISION, V5, P1004, DOI 10.1167/5.11.6; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; Delplanque S, 2007, J NEUROSCI METH, V165, P144, DOI 10.1016/j.jneumeth.2007.05.030; Dunbar RIM, 2004, REV GEN PSYCHOL, V8, P100, DOI 10.1037/1089-2680.8.2.100; Duncan S, 2007, COGNITION EMOTION, V21, P1184, DOI 10.1080/02699930701437931; HOLLINS M, 1980, PERCEPT PSYCHOPHYS, V27, P550, DOI 10.3758/BF03198684; Kakizaki S., 1960, JPN PSYCHOL RES, V2, P94, DOI [10.4992/psycholres1954.2.94, DOI 10.4992/PSYCHOLRES1954.2.94]; Knebel JF, 2008, BRAIN TOPOGR, V20, P284, DOI 10.1007/s10548-008-0046-5; Levelt W., 1965, BINOCULAR RIVALRY; Meng M, 2004, J VISION, V4, P539, DOI 10.1167/4.7.2; Nagamine M, 2007, PHYSIOL BEHAV, V91, P161, DOI 10.1016/j.physbeh.2007.02.016; Ohman A, 2001, J EXP PSYCHOL GEN, V130, P466, DOI 10.1037/0096-3445.130.3.466; Oliva A, 2007, TRENDS COGN SCI, V11, P520, DOI 10.1016/j.tics.2007.09.009; Olsson A, 2004, PSYCHOL SCI, V15, P822, DOI 10.1111/j.0956-7976.2004.00762.x; Phelps EA, 2006, PSYCHOL SCI, V17, P292, DOI 10.1111/j.1467-9280.2006.01701.x; PRATTO F, 1991, J PERS SOC PSYCHOL, V61, P380, DOI 10.1037/0022-3514.61.3.380; Schyns PG, 1999, COGNITION, V69, P243, DOI 10.1016/S0010-0277(98)00069-9; Tong F, 2006, TRENDS COGN SCI, V10, P502, DOI 10.1016/j.tics.2006.09.003; WHITTLE P, 1965, Q J EXP PSYCHOL, V17, P217, DOI 10.1080/17470216508416435; Yoon KL, 2009, EMOTION, V9, P172, DOI 10.1037/a0014714; YU K, 1992, J EXP PSYCHOL HUMAN, V18, P1158, DOI 10.1037/0096-1523.18.4.1158	34	99	104	7	79	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 17	2011	332	6036					1446	1448		10.1126/science.1201574	http://dx.doi.org/10.1126/science.1201574			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	778FT	21596956	Green Accepted			2022-12-24	WOS:000291689000046
J	Phan, G; Remaut, H; Wang, T; Allen, WJ; Pirker, KF; Lebedev, A; Henderson, NS; Geibel, S; Volkan, E; Yan, J; Kunze, MBA; Pinkner, JS; Ford, B; Kay, CWM; Li, HL; Hultgren, SJ; Thanassi, DG; Waksman, G				Phan, Gilles; Remaut, Han; Wang, Tao; Allen, William J.; Pirker, Katharina F.; Lebedev, Andrey; Henderson, Nadine S.; Geibel, Sebastian; Volkan, Ender; Yan, Jun; Kunze, Micha B. A.; Pinkner, Jerome S.; Ford, Bradley; Kay, Christopher W. M.; Li, Huilin; Hultgren, Scott J.; Thanassi, David G.; Waksman, Gabriel			Crystal structure of the FimD usher bound to its cognate FimC-FimH substrate	NATURE			English	Article							CHAPERONE-SUBUNIT COMPLEXES; BACTERIAL OUTER-MEMBRANE; PILUS BIOGENESIS; MOLECULAR REPLACEMENT; ADHESIN; RECOGNITION; DOMAIN; SITE	Type 1 pili are the archetypal representative of a widespread class of adhesive multisubunit fibres in Gram-negative bacteria. During pilus assembly, subunits dock as chaperone-bound complexes to an usher, which catalyses their polymerization and mediates pilus translocation across the outer membrane. Here we report the crystal structure of the full-length FimD usher bound to the FimC-FimH chaperone-adhesin complex and that of the unbound form of the FimD translocation domain. The FimD-FimC-FimH structure shows FimH inserted inside the FimD 24-stranded beta-barrel translocation channel. FimC-FimH is held in place through interactions with the two carboxy-terminal periplasmic domains of FimD, a binding mode confirmed in solution by electron paramagnetic resonance spectroscopy. To accommodate FimH, the usher plug domain is displaced from the barrel lumen to the periplasm, concomitant with a marked conformational change in the beta-barrel. The amino-terminal domain of FimD is observed in an ideal position to catalyse incorporation of a newly recruited chaperone-subunit complex. The FimD-FimC-FimH structure provides unique insights into the pilus subunit incorporation cycle, and captures the first view of a protein transporter in the act of secreting its cognate substrate.	[Phan, Gilles; Remaut, Han; Allen, William J.; Pirker, Katharina F.; Geibel, Sebastian; Yan, Jun; Kunze, Micha B. A.; Kay, Christopher W. M.; Waksman, Gabriel] UCL, Inst Struct & Mol Biol, London WC1E 7HX, England; [Phan, Gilles; Remaut, Han; Allen, William J.; Pirker, Katharina F.; Geibel, Sebastian; Yan, Jun; Kunze, Micha B. A.; Kay, Christopher W. M.; Waksman, Gabriel] Univ London Birkbeck Coll, London WC1E 7HX, England; [Remaut, Han] Vrije Univ Brussel VIB, B-1050 Brussels, Belgium; [Wang, Tao; Li, Huilin] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA; [Lebedev, Andrey] Univ York, Dept Chem, York YO10 5YW, N Yorkshire, England; [Henderson, Nadine S.; Thanassi, David G.] SUNY Stony Brook, Ctr Infect Dis, Stony Brook, NY 11794 USA; [Henderson, Nadine S.; Thanassi, David G.] SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA; [Volkan, Ender; Pinkner, Jerome S.; Ford, Bradley; Hultgren, Scott J.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Volkan, Ender; Pinkner, Jerome S.; Ford, Bradley; Hultgren, Scott J.] Washington Univ, Sch Med, Ctr Womens Infect Dis Res, St Louis, MO 63110 USA; [Ford, Bradley] Washington Univ, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Kay, Christopher W. M.] UCL, London Ctr Nanotechnol, London WC1H 0AH, England; [Kay, Christopher W. M.; Waksman, Gabriel] UCL, Res Dept Struct & Mol Biol, London WC1E 6BT, England; [Li, Huilin] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA	University of London; Birkbeck University London; University College London; University of London; Birkbeck University London; Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel; United States Department of Energy (DOE); Brookhaven National Laboratory; University of York - UK; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of London; University College London; University of London; University College London; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Waksman, G (corresponding author), UCL, Inst Struct & Mol Biol, Malet St, London WC1E 7HX, England.	david.thanassi@stonybrook.edu; g.waksman@ucl.ac.uk	VOLKAN, ENDER/GRF-1572-2022; Kay, Christopher William Michael/C-2467-2008; VOLKAN, ENDER/ABI-7302-2020; Geibel, Sebastian/B-5607-2015; VOLKAN, ENDER/AAJ-4583-2021	Kay, Christopher William Michael/0000-0002-5200-6004; Geibel, Sebastian/0000-0003-0068-680X; VOLKAN, ENDER/0000-0002-0071-5028; Frederiksen, Jun/0000-0003-0764-1831; Ford, Bradley/0000-0002-7871-7955; Remaut, Han/0000-0002-9775-4102; Kunze, Micha/0000-0001-8922-5510; Li, Huilin/0000-0001-8085-8928; Pinkner, Jerome/0000-0002-7389-7440	Medical Research Council [85602]; NIH [GM62987, 49950, 29549, 48689, GM74985]; BNL [10-16]; VIB; FWO-Vlaanderen; Austrian Science Fund [J 2959-N17]; Biotechnology and Biological Sciences Research Council [BB/F001134/1] Funding Source: researchfish; Medical Research Council [G0800002, G0100442] Funding Source: researchfish; BBSRC [BB/F001134/1] Funding Source: UKRI; MRC [G0800002, G0100442] Funding Source: UKRI; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062987, R01GM074985] Funding Source: NIH RePORTER	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BNL; VIB; FWO-Vlaanderen(FWO); Austrian Science Fund(Austrian Science Fund (FWF)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by Medical Research Council grant 85602 to G.W., NIH grant GM62987 to D.G.T., NIH grants 49950, 29549 and 48689 to S.J.H., and NIH grant GM74985 and BNL LDRD grant 10-16 to H.L.; H.R. is supported by a VIB Young PI project grant and the Odysseus program of the FWO-Vlaanderen. K.F.P. is supported by a Schrodinger Fellowship from the Austrian Science Fund, project J 2959-N17. We thank the staff of beamlines X25 and X29 at NSLS, the staff of beamline ID23-1 at ESRF, N. Cronin for technical assistance during data collection, and H. Saibil and E. Orlova for comments on the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barnhart MM, 2000, P NATL ACAD SCI USA, V97, P7709, DOI 10.1073/pnas.130183897; Chiu J, 2008, J MICROBIOL METH, V73, P195, DOI 10.1016/j.mimet.2008.02.013; Choudhury D, 1999, SCIENCE, V285, P1061, DOI 10.1126/science.285.5430.1061; Eidam O, 2008, FEBS LETT, V582, P651, DOI 10.1016/j.febslet.2008.01.030; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Ford B, 2010, J BACTERIOL, V192, P1824, DOI 10.1128/JB.01677-09; Hahn E, 2002, J MOL BIOL, V323, P845, DOI 10.1016/S0022-2836(02)01005-7; JACOBDUBUISSON F, 1994, J BIOL CHEM, V269, P12447; Jeschke G, 2006, APPL MAGN RESON, V30, P473, DOI 10.1007/BF03166213; JONES CH, 1995, P NATL ACAD SCI USA, V92, P2081, DOI 10.1073/pnas.92.6.2081; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Le Trong I, 2010, CELL, V141, P645, DOI 10.1016/j.cell.2010.03.038; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Li QQ, 2010, MOL MICROBIOL, V76, P159, DOI 10.1111/j.1365-2958.2010.07089.x; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Mulvey MA, 1998, SCIENCE, V282, P1494, DOI 10.1126/science.282.5393.1494; Munera D, 2007, MOL MICROBIOL, V64, P333, DOI 10.1111/j.1365-2958.2007.05657.x; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Ng TW, 2004, J BACTERIOL, V186, P5321, DOI 10.1128/JB.186.16.5321-5331.2004; Nishiyama M, 2005, EMBO J, V24, P2075, DOI 10.1038/sj.emboj.7600693; Nishiyama M, 2008, SCIENCE, V320, P376, DOI 10.1126/science.1154994; Nishlyama M, 2003, J MOL BIOL, V330, P513, DOI 10.1016/S0022-2836(03)00591-6; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pannier M, 2000, J MAGN RESON, V142, P331, DOI 10.1006/jmre.1999.1944; Pinkner JS, 2006, P NATL ACAD SCI USA, V103, P17897, DOI 10.1073/pnas.0606795103; Polyhach Y, 2011, PHYS CHEM CHEM PHYS, V13, P2356, DOI 10.1039/c0cp01865a; Remaut H, 2008, CELL, V133, P640, DOI 10.1016/j.cell.2008.03.033; Remaut H, 2006, MOL CELL, V22, P831, DOI 10.1016/j.molcel.2006.05.033; Rose RJ, 2008, P NATL ACAD SCI USA, V105, P12873, DOI 10.1073/pnas.0802177105; Sauer FG, 2004, BBA-MOL CELL RES, V1694, P259, DOI 10.1016/j.bbamcr.2004.02.010; Sauer FG, 2002, CELL, V111, P543, DOI 10.1016/S0092-8674(02)01050-4; Sauer FG, 1999, SCIENCE, V285, P1058, DOI 10.1126/science.285.5430.1058; Saulino ET, 1998, EMBO J, V17, P2177, DOI 10.1093/emboj/17.8.2177; So SSK, 2006, MOL MICROBIOL, V60, P364, DOI 10.1111/j.1365-2958.2006.052111.x; Vagin AA, 2001, ACTA CRYSTALLOGR D, V57, P1451, DOI 10.1107/S0907444901012409; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Verger D, 2008, STRUCTURE, V16, P1724, DOI 10.1016/j.str.2008.08.012; Verger D, 2006, EMBO REP, V7, P1228, DOI 10.1038/sj.embor.7400833; Vetsch M, 2004, NATURE, V431, P329, DOI 10.1038/nature02891; Waksman G, 2009, NAT REV MICROBIOL, V7, P765, DOI 10.1038/nrmicro2220; Zavialov AV, 2003, CELL, V113, P587, DOI 10.1016/S0092-8674(03)00351-9	44	137	138	0	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 2	2011	474	7349					49	U71		10.1038/nature10109	http://dx.doi.org/10.1038/nature10109			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	771KV	21637253	Green Accepted			2022-12-24	WOS:000291156700034
J	Wogelius, RA; Manning, PL; Barden, HE; Edwards, NP; Webb, SM; Sellers, WI; Taylor, KG; Larson, PL; Dodson, P; You, H; Da-Qing, L; Bergmann, U				Wogelius, R. A.; Manning, P. L.; Barden, H. E.; Edwards, N. P.; Webb, S. M.; Sellers, W. I.; Taylor, K. G.; Larson, P. L.; Dodson, P.; You, H.; Da-Qing, L.; Bergmann, U.			Trace Metals as Biomarkers for Eumelanin Pigment in the Fossil Record	SCIENCE			English	Article							MELANIN; COLOR; FEATHERS; MORPHOLOGY; CHEMISTRY; PRODUCTS; COPPER; EXAFS; BIRDS	Well-preserved fossils of pivotal early bird and nonavian theropod species have provided unequivocal evidence for feathers and/or downlike integuments. Recent studies have reconstructed color on the basis of melanosome structure; however, the chemistry of these proposed melanosomes has remained unknown. We applied synchrotron x-ray techniques to several fossil and extant organisms, including Confuciusornis sanctus, in order to map and characterize possible chemical residues of melanin pigments. Results show that trace metals, such as copper, are present in fossils as organometallic compounds most likely derived from original eumelanin. The distribution of these compounds provides a long-lived biomarker of melanin presence and density within a range of fossilized organisms. Metal zoning patterns may be preserved long after melanosome structures have been destroyed.	[Wogelius, R. A.; Manning, P. L.; Barden, H. E.; Edwards, N. P.; Larson, P. L.] Univ Manchester, Sch Earth Atmospher & Environm Sci, Manchester M13 9PL, Lancs, England; [Wogelius, R. A.; Manning, P. L.; Barden, H. E.; Edwards, N. P.] Univ Manchester, Williamson Res Ctr Mol Environm Sci, Manchester M13 9PL, Lancs, England; [Manning, P. L.; You, H.] Univ Penn, Dept Earth & Environm Sci, Philadelphia, PA 19104 USA; [Webb, S. M.] SSRL, SLAC Natl Accelerator Lab, Menlo Pk, CA 94025 USA; [Sellers, W. I.] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England; [Taylor, K. G.] Manchester Metropolitan Univ, Sch Sci & Environm, Manchester M1 5GD, Lancs, England; [Larson, P. L.] Black Hills Inst Geol Res, Hill City, SD 57745 USA; [Dodson, P.] Univ Penn, Sch Vet Med, Philadelphia, PA 19104 USA; [You, H.] Chinese Acad Geol Sci, Inst Geol, Beijing 100037, Peoples R China; [Da-Qing, L.] Gansu Geol Museum, Lanzhou 730030, Gansu, Peoples R China; [Bergmann, U.] Linac Coherent Light Source, SLAC Natl Accelerator Lab, Menlo Pk, CA 94025 USA	University of Manchester; University of Manchester; University of Pennsylvania; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; University of Manchester; Manchester Metropolitan University; University of Pennsylvania; Chinese Academy of Geological Sciences; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory	Wogelius, RA (corresponding author), Univ Manchester, Sch Earth Atmospher & Environm Sci, Manchester M13 9PL, Lancs, England.	roy.wogelius@manchester.ac.uk	Wogelius, Roy/C-4917-2008; Manning, Phillip/F-9966-2011; Sellers, William Irvin/Q-3843-2019; Webb, Samuel M/D-4778-2009	Manning, Phillip/0000-0002-7161-6246; Sellers, William Irvin/0000-0002-2913-5406; Webb, Samuel M/0000-0003-1188-0464; Taylor, Kevin/0000-0001-7024-5001; Wogelius, Roy/0000-0002-5781-2152; You, Hai-Lu/0000-0003-2203-6461	Natural Environment Research Council	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Samples were provided by the Black Hills Institute Museum and the Museum fur Naturkunde, Humboldt University, Berlin. We thank D. Schwarz-Wings for making the Archaeopteryx sample available. We also thank Perkin-Elmer, M. George, K. Palmer, E. Kaxiras, V. Vishnyakov, and R. Morton for technical assistance and additional data, and D. Vaughan, G. Brown, and three reviewers for helpful comments on the manuscript. Portions of this research were carried out at SSRL, a national user facility operated by Stanford University on behalf of the U. S. Department of Energy, Office of Basic Energy Sciences. Funding was provided in part by a Natural Environment Research Council Envirosync grant and by an anonymous private donor. R. Hartley provided the artist's drawing of C. sanctus. Data described in this paper are presented within the SOM. R. A. W. wrote the manuscript, analyzed the data, and supervised or assisted in all analyses. P. L. M. cowrote the manuscript and assisted in all analyses. H. E. B., N.P.E., and W. I. S. assisted in all analyses and contributed to the manuscript. S. M. W. performed the EXAFS analyses. K. G. T. provided and supervised VP-FEG-SEM analyses. P. L. L. provided specimen access and identification and also assisted with all x-ray measurements. P. D. consulted on the manuscript, and along with H.Y. and L. D. assisted in field collection, preparation, and identification of samples. U. B. supervised the SRS-XRF program and assisted in manuscript preparation.	Bergmann U, 2010, P NATL ACAD SCI USA, V107, P9060, DOI 10.1073/pnas.1001569107; BOWNESS JM, 1952, BIOCHEM J, V51, P530, DOI 10.1042/bj0510530; Cheah SF, 2000, AM MINERAL, V85, P118, DOI 10.2138/am-2000-0113; Clarke JA, 2010, SCIENCE, V330, P954, DOI 10.1126/science.1193604; EDWARDS NP, P R SOC B, DOI DOI 10.1098/RSPB.2011.0135; Frenkel AI, 1999, J SYNCHROTRON RADIAT, V6, P653, DOI 10.1107/S0909049598015180; HELZ GR, 1993, GEOCHIM COSMOCHIM AC, V57, P15, DOI 10.1016/0016-7037(93)90464-8; Hill G. E., 2006, BIRD COLORATION, VI; Hou LH, 1999, NATURE, V399, P679, DOI 10.1038/21411; Katsikini M, 2009, J PHYS CONF SER, V190, DOI 10.1088/1742-6596/190/1/012204; Kaxiras E, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.218102; LARSSON BS, 1993, PIGM CELL RES, V6, P127, DOI 10.1111/j.1600-0749.1993.tb00591.x; Li QG, 2010, SCIENCE, V327, P1369, DOI 10.1126/science.1186290; Liu Y, 2004, PIGM CELL RES, V17, P262, DOI 10.1111/j.1600-0749.2004.00140.x; Liu Y, 2003, PIGM CELL RES, V16, P72, DOI 10.1034/j.1600-0749.2003.00009.x; McGraw KJ, 2003, OIKOS, V102, P402; Niecke M, 1999, J ORNITHOL, V140, P355, DOI 10.1007/BF01651032; PALUMBO A, 1988, BIOCHIM BIOPHYS ACTA, V964, P193, DOI 10.1016/0304-4165(88)90166-3; RALPH CL, 1969, AM ZOOL, V9, P521; Simon JD, 2009, PIGM CELL MELANOMA R, V22, P563, DOI 10.1111/j.1755-148X.2009.00610.x; Stainsack J, 2003, INORG CHIM ACTA, V356, P243, DOI 10.1016/S0020-1693(03)00474-2; WILLIER B. H., 1940, PHYSIOLOGICAL ZOOLOGY, V13, P177; You HL, 2006, SCIENCE, V312, P1640, DOI 10.1126/science.1126377; Zhang FC, 2010, NATURE, V463, P1075, DOI 10.1038/nature08740	24	118	120	1	78	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 16	2011	333	6049					1622	1626		10.1126/science.1205748	http://dx.doi.org/10.1126/science.1205748			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	820JE	21719643				2022-12-24	WOS:000294900900041
J	Carpenter, D; Kesselheim, AS; Joffe, S				Carpenter, Daniel; Kesselheim, Aaron S.; Joffe, Steven			Reputation and Precedent in the Bevacizumab Decision	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Carpenter, Daniel] Harvard Univ, Dept Govt, Cambridge, MA 02138 USA; [Kesselheim, Aaron S.; Joffe, Steven] Harvard Univ, Sch Med, Boston, MA USA; [Kesselheim, Aaron S.] Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02115 USA; [Joffe, Steven] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Joffe, Steven] Childrens Hosp, Dept Med, Boston, MA 02115 USA	Harvard University; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Boston Children's Hospital	Carpenter, D (corresponding author), Harvard Univ, Dept Govt, Cambridge, MA 02138 USA.		Joffe, Steven/H-3941-2019	Joffe, Steven/0000-0002-0667-7384				Carpenter D, 2010, PRINC STUD AM POLIT, P1; Mckee AE, 2010, ONCOLOGIST, V15, P13, DOI 10.1634/theoncologist.2010-S1-13; O'Shaughnessy J, 2010, J CLIN ONCOL S, V28, p15s; Ocana A, 2011, J CLIN ONCOL, V29, P254, DOI 10.1200/JCO.2010.32.0275	4	53	54	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 14	2011	365	2							e3	10.1056/nejmp1107201	http://dx.doi.org/10.1056/nejmp1107201			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	791SP	21707383	Green Published			2022-12-24	WOS:000292685500006
J	Frankel, N; Erezyilmaz, DF; McGregor, AP; Wang, S; Payre, F; Stern, DL				Frankel, Nicolas; Erezyilmaz, Deniz F.; McGregor, Alistair P.; Wang, Shu; Payre, Francois; Stern, David L.			Morphological evolution caused by many subtle-effect substitutions in regulatory DNA	NATURE			English	Article							DROSOPHILA-SECHELLIA; ADAPTIVE EVOLUTION; NATURAL-SELECTION; GENE; PERSPECTIVE; DIVERGENCE; UNDERLIES; EPISTASIS; SEQUENCE; ORIGIN	Morphology evolves often through changes in developmental genes, but the causal mutations, and their effects, remain largely unknown. The evolution of naked cuticle on larvae of Drosophila sechellia resulted from changes in five transcriptional enhancers of shavenbaby (svb), a transcript of the ovo locus that encodes a transcription factor that governs morphogenesis of microtrichiae, hereafter called 'trichomes'. Here we show that the function of one of these enhancers evolved through multiple single-nucleotide substitutions that altered both the timing and level of svb expression. The consequences of these nucleotide substitutions on larval morphology were quantified with a novel functional assay. We found that each substitution had a relatively small phenotypic effect, and that many nucleotide changes account for this large morphological difference. In addition, we observed that the substitutions had non-additive effects. These data provide unprecedented resolution of the phenotypic effects of substitutions and show how individual nucleotide changes in a transcriptional enhancer have caused morphological evolution.	[Frankel, Nicolas; Erezyilmaz, Deniz F.; Wang, Shu; Stern, David L.] Princeton Univ, Howard Hughes Med Inst, Princeton, NJ 08544 USA; [Frankel, Nicolas; Erezyilmaz, Deniz F.; Wang, Shu; Stern, David L.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [McGregor, Alistair P.] Vet Med Univ Wien, Inst Populat Genet, A-1210 Vienna, Austria; [Payre, Francois] Univ Toulouse, F-31062 Toulouse, France; [Payre, Francois] Ctr Dev Biol, Ctr Natl Rech Sci, UMR5547, F-31062 Toulouse, France	Howard Hughes Medical Institute; Princeton University; Princeton University; University of Veterinary Medicine Vienna; Universite de Toulouse; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Stern, DL (corresponding author), Princeton Univ, Howard Hughes Med Inst, Princeton, NJ 08544 USA.	dstern@princeton.edu		PAYRE, Francois/0000-0002-8144-6711; Stern, David/0000-0002-1847-6483; McGregor, Alistair/0000-0002-2908-2420	Pew Charitable Trusts; Ruth L. Kirschstein National Research Service Award [F32 GM 83546-02]; Agence Nationale de la Recherche; NIH [GM063622-06A1]; NSF [IOS-0640339]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM083546, R01GM063622] Funding Source: NIH RePORTER	Pew Charitable Trusts; Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agence Nationale de la Recherche(French National Research Agency (ANR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank G. Davis, P. Parikh and P. Valenti for assistance with cloning and the Drosophila Species Stock Center for fly stocks. This work was supported by the Pew Charitable Trusts Latin American Fellows Program in the Biomedical Sciences Fellowship to N.F., a Ruth L. Kirschstein National Research Service Award to D. F. E. (F32 GM 83546-02), Agence Nationale de la Recherche (Blanc 2008, Netoshape) to F. P., and NIH (GM063622-06A1) and NSF (IOS-0640339) grants to D.L.S.	Akam M, 1998, INT J DEV BIOL, V42, P445; Andolfatto P, 2005, NATURE, V437, P1149, DOI 10.1038/nature04107; Baines JF, 2002, MOL BIOL EVOL, V19, P989, DOI 10.1093/oxfordjournals.molbev.a004179; Carroll S. B., 2001, DNA DIVERSITY MOL GE; CARROLL SB, 1995, NATURE, V376, P479, DOI 10.1038/376479a0; Carroll SB, 2008, CELL, V134, P25, DOI 10.1016/j.cell.2008.06.030; Casillas S, 2007, MOL BIOL EVOL, V24, P2222, DOI 10.1093/molbev/msm150; Chan YF, 2010, SCIENCE, V327, P302, DOI 10.1126/science.1182213; Chanut-Delalande H, 2006, PLOS BIOL, V4, P1549, DOI 10.1371/journal.pbio.0040290; Davidson EH, 2006, REG GEN GEN REG; Endo T, 1996, MOL BIOL EVOL, V13, P685, DOI 10.1093/oxfordjournals.molbev.a025629; Erezyilmaz DF, 2006, P NATL ACAD SCI USA, V103, P6925, DOI 10.1073/pnas.0509983103; Frankel N, 2010, NATURE, V466, P490, DOI 10.1038/nature09158; Gerke J, 2009, SCIENCE, V323, P498, DOI 10.1126/science.1166426; Gompel N, 2005, NATURE, V433, P481, DOI 10.1038/nature03235; Haygood R, 2010, P NATL ACAD SCI USA, V107, P7853, DOI 10.1073/pnas.0911249107; HOWARD KR, 1990, DEVELOPMENT, V110, P1223; Jeong S, 2008, CELL, V132, P783, DOI 10.1016/j.cell.2008.01.014; Kliman RM, 2000, GENETICS, V156, P1913; Klingler M, 1996, DEV BIOL, V177, P73, DOI 10.1006/dbio.1996.0146; Legrand D, 2009, GENETICS, V182, P1197, DOI 10.1534/genetics.108.092080; Ludwig MZ, 2005, PLOS BIOL, V3, P588, DOI 10.1371/journal.pbio.0030093; McGregor AP, 2007, NATURE, V448, P587, DOI 10.1038/nature05988; Monterio A, 2009, PLOS BIOL, V7, P209, DOI 10.1371/journal.pbio.1000037; Moses AM, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-286; Nadeau NJ, 2010, TRENDS GENET, V26, P484, DOI 10.1016/j.tig.2010.08.004; Nielsen R, 2005, ANNU REV GENET, V39, P197, DOI 10.1146/annurev.genet.39.073003.112420; Orr HA, 1998, GENETICS, V149, P2099; Payre F, 1999, NATURE, V400, P271, DOI 10.1038/22330; Phillips PC, 2008, NAT REV GENET, V9, P855, DOI 10.1038/nrg2452; Rebeiz M, 2009, SCIENCE, V326, P1663, DOI 10.1126/science.1178357; SMALL S, 1992, EMBO J, V11, P4047, DOI 10.1002/j.1460-2075.1992.tb05498.x; Stern D. L., 2010, EVOLUTION DEV PREDIC; Stern DL, 2008, EVOLUTION, V62, P2155, DOI 10.1111/j.1558-5646.2008.00450.x; Stern DL, 2000, EVOLUTION, V54, P1079, DOI 10.1554/0014-3820(2000)054[1079:PEDBAT]2.0.CO;2; Sucena E, 2000, P NATL ACAD SCI USA, V97, P4530, DOI 10.1073/pnas.97.9.4530; Swanson CI, 2010, DEV CELL, V18, P359, DOI 10.1016/j.devcel.2009.12.026; TAJIMA F, 1993, GENETICS, V135, P599; Weinreich DM, 2005, EVOLUTION, V59, P1165; Wilkins A.S., 2002, EVOLUTION DEV PATHWA; Williams TM, 2008, CELL, V134, P610, DOI 10.1016/j.cell.2008.06.052; Wittkopp PJ, 2006, HEREDITY, V97, P139, DOI 10.1038/sj.hdy.6800869; Wray GA, 2003, MOL BIOL EVOL, V20, P1377, DOI 10.1093/molbev/msg140; Yuh CH, 1998, SCIENCE, V279, P1896, DOI 10.1126/science.279.5358.1896	44	141	142	1	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 30	2011	474	7353					598	603		10.1038/nature10200	http://dx.doi.org/10.1038/nature10200			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	785CF	21720363	Green Submitted, Green Accepted			2022-12-24	WOS:000292204300030
J	Moraes, M				Moraes, Marcia			Lessons from Brazil	NATURE			English	Editorial Material									Univ Sao Paulo, BR-05508 Sao Paulo, Brazil	Universidade de Sao Paulo	Moraes, M (corresponding author), Univ Sao Paulo, BR-05508 Sao Paulo, Brazil.	mafdmora@esalq.usp.br							0	15	15	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 23	2011	474	7352					S25	S25		10.1038/474S025a	http://dx.doi.org/10.1038/474S025a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	781NJ	21697841	Green Published, Bronze			2022-12-24	WOS:000291939700010
J	Savage, N				Savage, Neil			The ideal biofuel	NATURE			English	Editorial Material																			0	117	119	1	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 23	2011	474	7352					S9	S11		10.1038/474S09a	http://dx.doi.org/10.1038/474S09a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	781NJ	21697843	Bronze			2022-12-24	WOS:000291939700003
J	Howard, DH				Howard, David H.			Realigning Incentives for Developing and Pricing New Anticancer Treatments	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Emory Univ, Dept Hlth Policy & Management, Atlanta, GA 30322 USA	Emory University	Howard, DH (corresponding author), Emory Univ, Dept Hlth Policy & Management, 1518 Clifton Rd NE, Atlanta, GA 30322 USA.	david.howard@emory.edu						Centers for Medicare and Medicaid Services, PROP DEC MEM AUT CEL; CMS HHS, 2011, FED REGISTER, V76, P19528; Congressional Budget Office, LONG TERM AN BUDG PR; Elkin EB, 2010, JAMA-J AM MED ASSOC, V303, P1086, DOI 10.1001/jama.2010.283; House Committee of the Budget, PATH PROSP REST AM C; Howard DH, 2010, ARCH INTERN MED, V170, P537, DOI 10.1001/archinternmed.2010.36; Stein R., 2010, WASH POST, pA01; Zajac A, 2001, LOS ANGELES TIM 0326, pA14	8	3	3	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 8	2011	305	22					2347	2348		10.1001/jama.2011.793	http://dx.doi.org/10.1001/jama.2011.793			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	773YV	21642689				2022-12-24	WOS:000291349100030
J	Kesselheim, AS; Myers, JA; Avorn, J				Kesselheim, Aaron S.; Myers, Jessica A.; Avorn, Jerry			Characteristics of Clinical Trials to Support Approval of Orphan vs Nonorphan Drugs for Cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACCELERATED APPROVAL; ONCOLOGY PRODUCTS; END-POINTS; EXPERIENCE; DISEASES	Context The Orphan Drug Act incentivizes medication development for rare diseases, offering substantial financial benefits to the manufacturer. Orphan products constitute most new drug approvals in oncology, but safety and efficacy questions have emerged about some of these agents. Objectives To define characteristics of orphan cancer drugs and their pivotal clinical trials and to compare these with nonorphan drugs. Design and Setting We identified all new orphan and nonorphan drugs approved between 2004 and 2010 to treat cancer. We then collected data on key development variables from publicly available information on the US Food and Drug Administration's Web site and in the Code of Federal Regulations. Main Outcome Measures We assessed clinical testing dates, approved indications, and regulatory characteristics (regular vs accelerated review, advisory committee review, postmarketing commitments). We then compared design features (randomization, blinding, primary end point) of pivotal trials supporting approval of orphan and nonorphan drugs and rates of adverse safety outcomes (deaths not attributed to disease progression, serious adverse events, dropouts) in pivotal trials. Results Fifteen orphan and 12 nonorphan drugs were approved between January 1, 2004, and December 31, 2010. Pivotal trials of orphan drugs had smaller participant numbers (median, 96 [interquartile range {IQR}, 66-152] vs 290 [IQR, 185-394] patients exposed to the drug; P<.001) and were less likely to be randomized (30% vs 80%; P=.007). Orphan and nonorphan pivotal trials varied in their blinding (P=.04), with orphan trials less likely to be double-blind (4% vs 33%). Primary study outcomes also varied (P=.04), with orphan trials more likely to assess disease response (68% vs 27%) rather than overall survival (8% vs 27%). More treated patients had serious adverse events in trials of orphan drugs vs trials of nonorphan drugs (48% vs 36%; odds ratio, 1.72; 95% confidence interval, 1.02-2.92; P=.04). Conclusion Compared with pivotal trials used to approve nonorphan cancer drugs, pivotal trials for recently approved orphan drugs for cancer were more likely to be smaller and to use nonrandomized, unblinded trial designs and surrogate end points to assess efficacy. JAMA. 2011;305(22):2320-2326 www.jama.com	[Kesselheim, Aaron S.] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02120 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Kesselheim, AS (corresponding author), Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, 1620 Tremont St,Ste 3030, Boston, MA 02120 USA.	akesselheim@partners.org	Kesselheim, Aaron/R-6793-2017	Kesselheim, Aaron/0000-0002-8867-2666	Agency for Healthcare Research and Quality [K08HS18465-01]; Robert Wood Johnson Foundation; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K08HS018465] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Dr Kesselheim is supported by career development award K08HS18465-01 from the Agency for Healthcare Research and Quality and a Robert Wood Johnson Foundation Investigator Award in Health Policy Research.	[Anonymous], SEARCH ORPH DRUG DES; [Anonymous], NME DRUG NEW BIOL AP; Avorn J, 2005, POWERFUL MED BENEFIT; Avorn J, 2007, NEW ENGL J MED, V356, P1697, DOI 10.1056/NEJMp078041; Bross PF, 2001, CLIN CANCER RES, V7, P1490; Buckley BM, 2008, LANCET, V371, P2051, DOI 10.1016/S0140-6736(08)60876-4; Chow WH, 2010, NAT REV UROL, V7, P245, DOI 10.1038/nrurol.2010.46; Cote T, 2010, NAT REV DRUG DISCOV, V9, P84, DOI 10.1038/nrd2546-c1; Dagher R, 2004, J NATL CANCER I, V96, P1500, DOI 10.1093/jnci/djh279; Haffner ME, 2006, NEW ENGL J MED, V354, P445, DOI 10.1056/NEJMp058317; Hirschler B, 2010, UK SAYS NOVARTIS BRI; Johnson JR, 2011, J NATL CANCER I, V103, P636, DOI 10.1093/jnci/djr062; Johnson JR, 2003, J CLIN ONCOL, V21, P1404, DOI 10.1200/JCO.2003.08.072; Kesselheim AS. B, 2010, RARE DIS ORPHAN PROD, P291; Mckee AE, 2010, ONCOLOGIST, V15, P13, DOI 10.1634/theoncologist.2010-S1-13; Miller FG, 2011, NEW ENGL J MED, V364, P476, DOI 10.1056/NEJMsb1011301; Mitsumoto J, 2009, ANN NEUROL, V66, P184, DOI 10.1002/ana.21676; National Cancer Institute, A Z LIST CANC; Office of the Inspector General, 2011, ORPH DRUG ACT IMPL I; Psaty BM, 2010, JAMA-J AM MED ASSOC, V304, P793, DOI 10.1001/jama.2010.1161; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Robert NJ, 2011, J CLIN ONCOL, V29, P1252, DOI 10.1200/JCO.2010.28.0982; SIMES RJ, 1986, BIOMETRIKA, V73, P751, DOI 10.2307/2336545; Tsimberidou AM, 2009, J CLIN ONCOL, V27, P6243, DOI 10.1200/JCO.2009.23.6018; U. S. Food Drug Adm. (FDA), 2011, DEV PROD RAR DIS CON; US Food and Drug Administration, 2011, POSTM REQ COMM; US Food and Drug Administration, 2010, MYL GEMT OZ MARK WIT; Wellman-Labadie O, 2010, HEALTH POLICY, V95, P216, DOI 10.1016/j.healthpol.2009.12.001; Yin W, 2009, J HEALTH ECON, V28, P950, DOI 10.1016/j.jhealeco.2009.06.011	29	155	159	0	20	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 8	2011	305	22					2320	2326		10.1001/jama.2011.769	http://dx.doi.org/10.1001/jama.2011.769			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	773YV	21642684	Bronze			2022-12-24	WOS:000291349100025
J	Souwer, IH; Lagro-Janssen, ALM				Souwer, I. H.; Lagro-Janssen, A. L. M.			10-MINUTE CONSULTATION Chronic chilblains	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Lagro-Janssen, A. L. M.] Radboud Univ Nijmegen, Med Ctr, Dept Primary & Community Care, Unit Womens Studies Med, NL-6500 HB Nijmegen, Netherlands	Radboud University Nijmegen	Souwer, IH (corresponding author), Middelie 91, NL-1472 GT Middelie, Netherlands.	IHSouweri.souwer@wxs.nl	Lagro, A.L.M./H-8066-2014					GOETTE DK, 1990, J AM ACAD DERMATOL, V23, P257, DOI 10.1016/0190-9622(90)70209-Z; JACOB JR, 1986, ARCH INTERN MED, V146, P1589, DOI 10.1001/archinte.146.8.1589; Morioka N, 1991, Nihon Hifuka Gakkai Zasshi, V101, P615; RUSTIN MHA, 1989, BRIT J DERMATOL, V120, P267; Souwer IH, 2009, INT J CLIN PRACT, V63, P282, DOI 10.1111/j.1742-1241.2008.01912.x; Souwer Ibo H, 2007, Eur J Gen Pract, V13, P159, DOI 10.1080/13814780701471068; Viguier M, 2001, MEDICINE, V80, P180, DOI 10.1097/00005792-200105000-00004	7	8	8	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	JUN 7	2011	342								d2708	10.1136/bmj.d2708	http://dx.doi.org/10.1136/bmj.d2708			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	777SL	21652748				2022-12-24	WOS:000291645200001
J	Copeland, SR; Sponheimer, M; de Ruiter, DJ; Lee-Thorp, JA; Codron, D; le Roux, PJ; Grimes, V; Richards, MP				Copeland, Sandi R.; Sponheimer, Matt; de Ruiter, Darryl J.; Lee-Thorp, Julia A.; Codron, Daryl; le Roux, Petrus J.; Grimes, Vaughan; Richards, Michael P.			Strontium isotope evidence for landscape use by early hominins	NATURE			English	Article							HUMAN-EVOLUTION; LIFE-HISTORY; RATIOS; BODY; AUSTRALOPITHECUS; SR-87/SR-86; PATTERNS; AFRICA; ORIGIN; HOMO	Ranging and residence patterns among early hominins have been indirectly inferred from morphology(1,2), stone-tool sourcing(3), referential models(4,5) and phylogenetic models(6-8). However, the highly uncertain nature of such reconstructions limits our understanding of early hominin ecology, biology, social structure and evolution. We investigated landscape use in Australopithecus africanus and Paranthropus robustus from the Sterkfontein and Swartkrans cave sites in South Africa using strontium isotope analysis, a method that can help to identify the geological substrate on which an animal lived during tooth mineralization. Here we show that a higher proportion of small hominins than large hominins had non-local strontium isotope compositions. Given the relatively high levels of sexual dimorphism in early hominins, the smaller teeth are likely to represent female individuals, thus indicating that females were more likely than males to disperse from their natal groups. This is similar to the dispersal pattern found in chimpanzees(9), bonobos(10) and many human groups(11), but dissimilar from that of most gorillas and other primates(12). The small proportion of demonstrably non-local large hominin individuals could indicate that male australopiths had relatively small home ranges, or that they preferred dolomitic landscapes.	[Copeland, Sandi R.; Grimes, Vaughan; Richards, Michael P.] Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, D-04103 Leipzig, Germany; [Copeland, Sandi R.; Sponheimer, Matt] Univ Colorado, Dept Anthropol, Boulder, CO 80309 USA; [de Ruiter, Darryl J.] Texas A&M Univ, Dept Anthropol, College Stn, TX 77843 USA; [Lee-Thorp, Julia A.] Univ Oxford, Res Lab Archaeol & Hist Art, Oxford OX1 3QY, England; [Lee-Thorp, Julia A.; le Roux, Petrus J.] Univ Cape Town, Dept Geol Sci, AEON EarthLAB, ZA-7701 Rondebosch, South Africa; [Codron, Daryl] Univ Zurich, Vetsuisse Fac, Clin Zoo Anim Exot Pets & Wildlife, CH-8057 Zurich, Switzerland; [Grimes, Vaughan] Mem Univ, Dept Archaeol, St John, NF A1C 5S7, Canada; [Richards, Michael P.] Univ British Columbia, Dept Anthropol, Vancouver, BC V6T 1Z1, Canada	Max Planck Society; University of Colorado System; University of Colorado Boulder; Texas A&M University System; Texas A&M University College Station; University of Oxford; University of Cape Town; University of Zurich; Memorial University Newfoundland; University of British Columbia	Copeland, SR (corresponding author), Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, Deutsch Pl 6, D-04103 Leipzig, Germany.	sandi.copeland@colorado.edu	Grimes, Vaughan/AAG-5174-2021; le Roux, Petrus J./AAD-4755-2021; Richards, Michael/A-9374-2008; Codron, Daryl/B-8867-2008; Sponheimer, Matt/A-6075-2013; Richards, Michael/O-3717-2016	Grimes, Vaughan/0000-0002-2177-3147; le Roux, Petrus J./0000-0002-5930-4995; Richards, Michael/0000-0001-5274-8887; Codron, Daryl/0000-0001-5223-9513; Sponheimer, Matt/0000-0002-8743-1123; Richards, Michael/0000-0001-5274-8887; de Ruiter, Darryl/0000-0003-1183-0352	National Science Foundation, USA [0609963]; Max Planck Society; University of Colorado	National Science Foundation, USA(National Science Foundation (NSF)); Max Planck Society(Max Planck SocietyFoundation CELLEX); University of Colorado	Funding for this project was provided by the National Science Foundation, USA (grant 0609963), the Max Planck Society, a University of Colorado LEAP Associate Professor Growth Grant and the University of Colorado Dean's Fund for Excellence. We are grateful to the Ditsong National Museum of Natural History (formerly the Transvaal Museum), including F. Thackeray, S. Potze and T. Kearny, for allowing us access to the Sterkfontein and Swartkrans fossil material and for granting permission for laser ablation MC-ICP-MS analysis. We thank S. Potze and T. Perregil for flying to Cape Town to allow laser ablation MC-ICP-MS sampling of the hominins. We also thank L. Berger, J. Brophy, J. Codron and J. Hancox for help in the field, J. Montgomery for useful discussions and J. Sealy and J. Lanham for help with plant preparation in the Archaeology Department, University of Cape Town. We thank A. Anderson, C. Campbell, B. Covert, D. Grimstead, F. Grine, J. Leichliter, O. Paine, J. Quade, P. Sandberg and P. Ungar for commenting on the manuscript. The research of A. Sillen and G. Hall inspired this study.	Ambrose SH, 2001, SCIENCE, V291, P1748, DOI 10.1126/science.1059487; Anton SC, 2002, J HUM EVOL, V43, P773, DOI 10.1006/jhev.2002.0602; BEYNON AD, 1988, NATURE, V335, P509, DOI 10.1038/335509a0; Charlier BLA, 2006, CHEM GEOL, V232, P114, DOI 10.1016/j.chemgeo.2006.02.015; Copeland SR, 2008, RAPID COMMUN MASS SP, V22, P3187, DOI 10.1002/rcm.3717; Copeland SR, 2010, J ARCHAEOL SCI, V37, P1437, DOI 10.1016/j.jas.2010.01.003; EMBER CR, 1978, ETHNOLOGY, V17, P439, DOI 10.2307/3773193; Faure G., 1972, STRONTIUM ISOTOPE GE; Foley R, 2009, PHILOS T R SOC B, V364, P3267, DOI 10.1098/rstb.2009.0136; FURUICHI T, 1989, INT J PRIMATOL, V10, P173, DOI 10.1007/BF02735199; GHIGLIERI MP, 1987, J HUM EVOL, V16, P319, DOI 10.1016/0047-2484(87)90065-0; Goodall J., 1986, CHIMPANZEES GOMBE PA; GOSZ JR, 1983, BIOSCIENCE, V33, P23, DOI 10.2307/1309240; Graustein W. C., 1989, STABLE ISOTOPES ECOL, V68, P491; HURST RW, 1981, ENVIRON GEOL, V3, P363, DOI 10.1007/BF02473525; Lockwood CA, 2007, SCIENCE, V318, P1443, DOI 10.1126/science.1149211; Mahler P.E., 1973, METRIC VARIATION PON; McHenry HM, 1998, J HUM EVOL, V35, P1, DOI 10.1006/jhev.1997.0197; McHenry HM, 2000, ANNU REV ANTHROPOL, V29, P125, DOI 10.1146/annurev.anthro.29.1.125; Moore Jim, 1996, P275, DOI 10.1017/CBO9780511752414.022; Plavcan JM, 1997, J HUM EVOL, V32, P345, DOI 10.1006/jhev.1996.0096; Price TD, 2002, ARCHAEOMETRY, V44, P117, DOI 10.1111/1475-4754.00047; Robbins MM, 2004, AM J PRIMATOL, V64, P145, DOI 10.1002/ajp.20069; RODMAN PS, 1980, AM J PHYS ANTHROPOL, V52, P103, DOI 10.1002/ajpa.1330520113; Sillen A, 1998, GEOCHIM COSMOCHIM AC, V62, P2463, DOI 10.1016/S0016-7037(98)00182-3; Tooby J., 1987, P183; WHEELER PE, 1992, J HUM EVOL, V23, P351, DOI 10.1016/0047-2484(92)90071-G; William C, 1981, WOMAN GATHERER, P35; Wrangham R.W., 1987, P51	29	135	138	1	76	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 2	2011	474	7349					76	U100		10.1038/nature10149	http://dx.doi.org/10.1038/nature10149			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	771KV	21637256				2022-12-24	WOS:000291156700040
J	Hartvigsen, J; Foster, NE; Croft, PR				Hartvigsen, Jan; Foster, Nadine E.; Croft, Peter R.			PERSONAL VIEW We need to rethink front line care for back pain	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Hartvigsen, Jan] Inst Sports Sci & Clin Biomech, Odense, Denmark; [Foster, Nadine E.; Croft, Peter R.] Keele Univ, Arthrit Res UK Primary Care Ctr, Keele, Staffs, England	University of Southern Denmark; Keele University	Hartvigsen, J (corresponding author), Inst Sports Sci & Clin Biomech, Odense, Denmark.	jhartvigsen@health.sdu.dk		Foster, Nadine/0000-0003-4429-9756; Hartvigsen, Jan/0000-0002-5876-7410	National Institute for Health Research [NF-SI-0509-10183] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))			0	12	12	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 25	2011	342								d3260	10.1136/bmj.d3260	http://dx.doi.org/10.1136/bmj.d3260			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	771KE	21613346				2022-12-24	WOS:000291154800010
J	Duke, T				Duke, Trevor			What the African fluid-bolus trial means	LANCET			English	Editorial Material							SEPTIC SHOCK; MENINGITIS; SECRETION; PNEUMONIA; CHILDREN; HORMONE		[Duke, Trevor] Royal Childrens Hosp, Dept Paediat, Ctr Int Child Hlth, Melbourne, Vic 3079, Australia; [Duke, Trevor] Royal Childrens Hosp, Intens Care Unit, Melbourne, Vic 3079, Australia; [Duke, Trevor] Univ Papua New Guinea, Sch Med & Hlth Sci, Port Moresby, Papua N Guinea	Royal Children's Hospital Melbourne; Royal Children's Hospital Melbourne; University of Papua New Guinea	Duke, T (corresponding author), Royal Childrens Hosp, Dept Paediat, Ctr Int Child Hlth, Melbourne, Vic 3079, Australia.	trevor.duke@rch.org.au						[Anonymous], 2005, HOSP CAR CHILDR GUID; CARCILLO JA, 1991, JAMA-J AM MED ASSOC, V266, P1242, DOI 10.1001/jama.266.9.1242; Carcillo JA, 2002, CRIT CARE MED, V30, P1365, DOI 10.1097/00003246-200206000-00040; DHAWAN A, 1992, ANN TROP PAEDIATR, V12, P455, DOI 10.1080/02724936.1992.11747614; DIXON BS, 1988, AM REV RESPIR DIS, V138, P512, DOI 10.1164/ajrccm/138.3.512; Duke T, 2002, ANN TROP PAEDIATR, V22, P145, DOI 10.1179/027249302125000878; Han YY, 2003, PEDIATRICS, V112, P793, DOI 10.1542/peds.112.4.793; JALAC SLR, 2010, PHILIPPINE J MICROBI, V39, P14; KAPLAN SL, 1978, J PEDIATR-US, V92, P758, DOI 10.1016/S0022-3476(78)80144-9; Maitland K, 2011, NEW ENGL J MED, V364, P2483, DOI 10.1056/NEJMoa1101549; Tibballs J, 2009, RESUSCITATION, V80, P61, DOI 10.1016/j.resuscitation.2008.10.002; [No title captured]	12	30	30	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV 12	2011	378	9804					1685	1687		10.1016/S0140-6736(11)60881-7	http://dx.doi.org/10.1016/S0140-6736(11)60881-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	846LB	21683436				2022-12-24	WOS:000296899800011
J	Armstrong, JB; Schindler, DE				Armstrong, Jonathan B.; Schindler, Daniel E.			Excess digestive capacity in predators reflects a life of feast and famine	NATURE			English	Article							BIOENERGETICS MODEL; FISHES; RUN	A central challenge for predators is achieving positive energy balance when prey are spatially and temporally heterogeneous. Ecological heterogeneity produces evolutionary trade-offs in the physiological design of predators; this is because the ability to capitalize on pulses of food abundance requires high capacity for food-processing, yet maintaining such capacity imposes energetic costs that are taxing during periods of food scarcity(1,2). Recent advances in physiology show that when variation in foraging opportunities is predictable, animals may adjust energetic tradeoffs by rapidly modulating their digestive system to track variation in foraging opportunities(1). However, it is increasingly recognized that foraging opportunities for animals are unpredictable(3), which should favour animals that maintain a capacity for food-processing that exceeds average levels of consumption (loads)(2,4). Despite this basic principle of quantitative evolutionary design, estimates of digestive load: capacity ratios in wild animals are virtually nonexistent(1). Here we provide an extensive assessment of load: capacity ratios for the digestive systems of predators in the wild, compiling 639 estimates across 38 species of fish. We found that piscine predators typically maintain the physiological capacity to feed at daily rates 2-3 times higher than what they experience on average. A numerical simulation of the trade-off between food-processing capacity and metabolic cost suggests that the observed level of physiological opportunism is profitable only if predator-prey encounters, and thus predator energy budgets, are far more variable in nature than currently assumed.	[Armstrong, Jonathan B.; Schindler, Daniel E.] Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Armstrong, JB (corresponding author), Univ Washington, Sch Aquat & Fishery Sci, Box 355020, Seattle, WA 98195 USA.	Jonny99@uw.edu			Gordon and Betty Moore Foundation; US National Science Foundation; University of Washington School of Aquatic and Fishery Sciences; Directorate For Geosciences [1114918] Funding Source: National Science Foundation	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); US National Science Foundation(National Science Foundation (NSF)); University of Washington School of Aquatic and Fishery Sciences(University of Washington); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank T. Essington, R. Huey, T. Reed, A. Walters, V. Sturtevant and A. Armstrong for comments on this manuscript. We also thank the following people for contributing to this project: J. Kitchell, O. Jensen, E. Ward, D. Beauchamp, B. Chasco, A. Farrell, P. Bisson and J. Kershner. This work was supported by the Gordon and Betty Moore Foundation, the US National Science Foundation and the University of Washington School of Aquatic and Fishery Sciences.	[Anonymous], 2010, R LANG ENV STAT COMP; [Anonymous], 1997, FISH BIOEN 3 0; Armstrong JB, 2010, ECOLOGY, V91, P1445, DOI 10.1890/09-0790.1; Arrington DA, 2002, ECOLOGY, V83, P2145, DOI 10.1890/0012-9658(2002)083[2145:HODFRO]2.0.CO;2; BEAUCHAMP DA, 1989, T AM FISH SOC, V118, P597, DOI 10.1577/1548-8659(1989)118<0597:COABMF>2.3.CO;2; BRECK JE, 1993, T AM FISH SOC, V122, P902, DOI 10.1577/1548-8659(1993)122<0902:FTAPFA>2.3.CO;2; Brodin Anders, 2007, P221; De Angelis D., 1992, INDIVIDUAL BASED MOD, DOI 10.1201/9781351073462; Diamond J, 2002, J PHYSIOL-LONDON, V542, P337, DOI 10.1113/jphysiol.2002.018366; Dupont-Prinet A, 2010, J EXP BIOL, V213, P1143, DOI 10.1242/jeb.037812; ELLIOTT JM, 1978, J ANIM ECOL, V47, P977, DOI 10.2307/3682; Essington TE, 2000, CAN J FISH AQUAT SCI, V57, P548, DOI 10.1139/cjfas-57-3-548; Farrell A. P., 2001, COMP BIOCH PHYSL A, V128, P549, DOI DOI 10.1016/S1095-6433(00)00335-4; GANS C, 1979, EVOLUTION, V33, P227, DOI 10.1111/j.1558-5646.1979.tb04677.x; HOFMANN RR, 1989, OECOLOGIA, V78, P443, DOI 10.1007/BF00378733; HOLLING C. S., 1959, CANADIAN ENT, V91, P293; Huey RB, 2001, ECOLOGY, V82, P1; Humphries NE, 2010, NATURE, V465, P1066, DOI 10.1038/nature09116; Jeschke JM, 2007, OECOLOGIA, V152, P357, DOI 10.1007/s00442-006-0654-2; Kauffman MJ, 2007, ECOL LETT, V10, P690, DOI 10.1111/j.1461-0248.2007.01059.x; Kersten M, 1996, FUNCT ECOL, V10, P440, DOI 10.2307/2389936; KITCHELL JF, 1977, J FISH RES BOARD CAN, V34, P1922, DOI 10.1139/f77-258; KITCHELL JF, 1994, J FISH BIOL, V45, P209, DOI 10.1006/jfbi.1994.1224; Klaassen M, 1997, PHYSIOL ZOOL, V70, P125, DOI 10.1086/639556; Piersma T., 2011, FLEXIBLE PHENOTYPE; RICE JA, 1984, ECOLOGY, V65, P732, DOI 10.2307/1938045; Ritchie EG, 2009, ECOL LETT, V12, P982, DOI 10.1111/j.1461-0248.2009.01347.x; Schindler DE, 1997, ECOLOGY, V78, P1816; Scott D. W., 1992, MULTIVARIATE DENSITY, DOI 10.1002/9780470316849; SECOR SM, 1994, AM J PHYSIOL, V266, pG695, DOI 10.1152/ajpgi.1994.266.4.G695; Stevens ED, 2000, J FISH BIOL, V56, P191, DOI 10.1111/j.1095-8649.2000.tb02094.x; Walters CJ., 2020, FISHERIES ECOLOGY MA, DOI [10.2307/j.ctv10vm1f6, DOI 10.2307/J.CTV10VM1F6]; WEIBEL ER, 1991, P NATL ACAD SCI USA, V88, P10357, DOI 10.1073/pnas.88.22.10357; WEINER J, 1992, TRENDS ECOL EVOL, V7, P384, DOI 10.1016/0169-5347(92)90009-Z; Yang LH, 2008, ECOLOGY, V89, P621, DOI 10.1890/07-0175.1; [No title captured]	36	111	112	0	71	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 4	2011	476	7358					84	+		10.1038/nature10240	http://dx.doi.org/10.1038/nature10240			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	801NR	21734659				2022-12-24	WOS:000293447300034
J	Connell, KA				Connell, Kathleen A.			Elastogenesis in the Vaginal Wall and Pelvic-Organ Prolapse	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Yale Univ, Sch Med, Dept Obstet Gynecol & Reprod Sci, Div Urogynecol & Reconstruct Pelv Surg, New Haven, CT 06520 USA	Yale University	Connell, KA (corresponding author), Yale Univ, Sch Med, Dept Obstet Gynecol & Reprod Sci, Div Urogynecol & Reconstruct Pelv Surg, New Haven, CT 06520 USA.							Budatha M, 2011, J CLIN INVEST, V121, P2048, DOI 10.1172/JCI45636; Olsen AL, 1997, OBSTET GYNECOL, V89, P501, DOI 10.1016/S0029-7844(97)00058-6; Subak LL, 2001, OBSTET GYNECOL, V98, P646, DOI 10.1016/S0029-7844(01)01472-7; Takacs P, 2009, INT UROGYNECOL J, V20, P207, DOI 10.1007/s00192-008-0757-x; Yanagisawa H, 2009, J CELL COMMUN SIGNAL, V3, P337, DOI 10.1007/s12079-009-0065-3	5	13	15	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 16	2011	364	24					2356	2358		10.1056/NEJMcibr1104976	http://dx.doi.org/10.1056/NEJMcibr1104976			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	777RZ	21675895				2022-12-24	WOS:000291643800016
J	Johnston, RJ; Otake, Y; Sood, P; Vogt, N; Behnia, R; Vasiliauskas, D; McDonald, E; Xie, BT; Koenig, S; Wolf, R; Cook, T; Gebelein, B; Kussell, E; Nakagoshi, H; Desplan, C				Johnston, Robert J., Jr.; Otake, Yoshiaki; Sood, Pranidhi; Vogt, Nina; Behnia, Rudy; Vasiliauskas, Daniel; McDonald, Elizabeth; Xie, Baotong; Koenig, Sebastian; Wolf, Reinhard; Cook, Tiffany; Gebelein, Brian; Kussell, Edo; Nakagoshi, Hideki; Desplan, Claude			Interlocked Feedforward Loops Control Cell-Type-Specific Rhodopsin Expression in the Drosophila Eye	CELL			English	Article							DEFECTIVE-PROVENTRICULUS; PHOTORECEPTOR CELLS; FATE SPECIFICATION; MOLECULAR SWITCH; ORTHODENTICLE; MORPHOGENESIS; PREFERENCE; OMMATIDIA; BEHAVIOR; SUBTYPES	How complex networks of activators and repressors lead to exquisitely specific cell-type determination during development is poorly understood. In the Drosophila eye, expression patterns of Rhodopsins define at least eight functionally distinct though related subtypes of photoreceptors. Here, we describe a role for the transcription factor gene defective proventriculus (dve) as a critical node in the network regulating Rhodopsin expression. dve is a shared component of two opposing, interlocked feedforward loops (FFLs). Orthodenticle and Dve interact in an incoherent FFL to repress Rhodopsin expression throughout the eye. In R7 and R8 photoreceptors, a coherent FFL relieves repression by Dve while activating Rhodopsin expression. Therefore, this network uses repression to restrict and combinatorial activation to induce cell-type-specific expression. Furthermore, Dve levels are finely tuned to yield cell-type-and region-specific repression or activation outcomes. This interlocked FFL motif may be a general mechanism to control terminal cell-fate specification.	[Otake, Yoshiaki; Nakagoshi, Hideki] Okayama Univ, Grad Sch Nat Sci & Technol, 3-1-1 Tsushima Naka, Okayama 7008530, Japan; [Johnston, Robert J., Jr.; Sood, Pranidhi; Vogt, Nina; Behnia, Rudy; Vasiliauskas, Daniel; Kussell, Edo; Desplan, Claude] NYU, Dept Biol, New York, NY 10003 USA; [McDonald, Elizabeth; Xie, Baotong; Cook, Tiffany; Gebelein, Brian] Cincinnati Childrens Hosp, Div Dev Biol, Cincinnati, OH 45229 USA; [Koenig, Sebastian; Wolf, Reinhard] Univ Wurzburg, Rudolf Virchow Zentrum, Deutsch Forschungsgemeinschaft Res Ctr Expt Biome, D-97080 Wurzburg, Germany	Okayama University; New York University; Cincinnati Children's Hospital Medical Center; University of Wurzburg	Nakagoshi, H (corresponding author), Okayama Univ, Grad Sch Nat Sci & Technol, 3-1-1 Tsushima Naka, Okayama 7008530, Japan.	goshi@cc.okayama-u.ac.jp; cd38@nyu.edu	NAKAGOSHI, Hideki/B-2145-2011; Vasiliauskas, Daniel/AAV-1981-2020	NAKAGOSHI, Hideki/0000-0003-0850-1814; Vasiliauskas, Daniel/0000-0002-0570-2322; Cook, Tiffany/0000-0002-3100-5248; Vogt, Nina/0000-0002-2658-9138; Desplan, Claude/0000-0002-6914-1413	Deutsche Forschungsgemeinschaft; European Molecular Biology Organization; Human Frontier Science Program; NIH [5F32EY016309-03, T32 HD046387, GM079428]; University of Cincinnati Research Council; Research to Prevent Blindness; Ziegler Foundation for the Blind; Burroughs Wellcome Fund Career Award at the Scientific Interface; National Eye Institute/NIH [R01 13010]; NCRR, NIH; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [T32HD046387] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [F32EY016309, R01EY013010] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079428] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [23570006] Funding Source: KAKEN	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Human Frontier Science Program(Human Frontier Science Program); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Cincinnati Research Council; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Ziegler Foundation for the Blind; Burroughs Wellcome Fund Career Award at the Scientific Interface(Burroughs Wellcome Fund); National Eye Institute/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NCRR, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We are very grateful to S. Britt, Y.N. Jan, C. Zuker, and the Bloomington Stock Center for reagents. We thank U. Alon, R. Carthew, O. Hobert, H. Johnston, P. O'Farrell, F. Payre, and E. Siggia for helpful comments on the manuscript. We thank all members of the Desplan laboratory for suggestions throughout the project. R.J.J. was supported by a Jane Coffin Childs Memorial Fund for Medical Research postdoctoral fellowship. N.V. was supported by Deutsche Forschungsgemeinschaft. R.B. was supported by the European Molecular Biology Organization and Human Frontier Science Program. D.V. was supported by NIH Grant 5F32EY016309-03. B.X. was supported by the University of Cincinnati Research Council. T.C. was supported by NIH Grant T32 HD046387 (ECM), Research to Prevent Blindness, and the Ziegler Foundation for the Blind. B.G. was supported by an NIH grant (GM079428). E.K. was supported by a Burroughs Wellcome Fund Career Award at the Scientific Interface. This work was funded by a grant from the National Eye Institute/NIH R01 13010 to C.D. and conducted in a facility constructed with the support of a Research Facilities Improvement Grant from the NCRR, NIH.	Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Briscoe AD, 2008, J EXP BIOL, V211, P1805, DOI 10.1242/jeb.013045; Carr M, 2005, DEV GENES EVOL, V215, P402, DOI 10.1007/s00427-005-0488-7; Chou WH, 1999, DEVELOPMENT, V126, P607; Cook T, 2003, DEV CELL, V4, P853, DOI 10.1016/S1534-5807(03)00156-4; FRANCESCHINI N, 1981, SCIENCE, V213, P1264, DOI 10.1126/science.7268434; Gao SY, 2008, NEURON, V60, P328, DOI 10.1016/j.neuron.2008.08.010; Goentoro L, 2009, MOL CELL, V36, P894, DOI 10.1016/j.molcel.2009.11.018; Hardie R.C., 1985, Progress in Sensory Physiology, V5, P1; Hornstein EP, 2000, P ROY SOC B-BIOL SCI, V267, P2111, DOI 10.1098/rspb.2000.1257; HOTTA Y, 1969, NATURE, V222, P354, DOI 10.1038/222354a0; Hu XB, 2009, J COMP NEUROL, V516, P334, DOI 10.1002/cne.22114; Johnston RJ, 2010, ANNU REV CELL DEV BI, V26, P689, DOI 10.1146/annurev-cellbio-100109-104113; Kaplan S, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.43; Kim D, 2008, BIOESSAYS, V30, P1204, DOI 10.1002/bies.20839; Li-Kroeger D, 2008, DEV CELL, V15, P298, DOI 10.1016/j.devcel.2008.06.001; Mangan S, 2003, P NATL ACAD SCI USA, V100, P11980, DOI 10.1073/pnas.2133841100; Mazzoni EO, 2008, PLOS BIOL, V6, P825, DOI 10.1371/journal.pbio.0060097; Mikeladze-Dvali T, 2005, CELL, V122, P775, DOI 10.1016/j.cell.2005.07.026; Mishra M, 2010, DEVELOPMENT, V137, P2895, DOI 10.1242/dev.051722; Mollereau B, 2001, NATURE, V412, P911, DOI 10.1038/35091076; Morey M, 2008, NATURE, V456, P795, DOI 10.1038/nature07419; Nakagoshi H, 2002, DEV BIOL, V249, P44, DOI 10.1006/dbio.2002.0746; Nakagoshi H, 1998, GENE DEV, V12, P2724, DOI 10.1101/gad.12.17.2724; ROSSEL S, 1982, P NATL ACAD SCI-BIOL, V79, P4451, DOI 10.1073/pnas.79.14.4451; Shirai T, 2007, DEV BIOL, V312, P147, DOI 10.1016/j.ydbio.2007.09.003; Stowers RS, 1999, GENETICS, V152, P1631; Tahayato A, 2003, DEV CELL, V5, P391, DOI 10.1016/S1534-5807(03)00239-9; Terriente J, 2008, DEV BIOL, V320, P102, DOI 10.1016/j.ydbio.2008.04.028; TREISMAN J, 1989, CELL, V59, P553; Vandendries ER, 1996, DEV BIOL, V173, P243, DOI 10.1006/dbio.1996.0020; Wakakuwa M, 2005, NATURWISSENSCHAFTEN, V92, P464, DOI 10.1007/s00114-005-0018-5; Wernet MF, 2006, NATURE, V440, P174, DOI 10.1038/nature04615; Wolff Tanya, 1993, P1277; Xie B, 2007, DEVELOPMENT, V134, P4243, DOI 10.1242/dev.012781; Yamaguchi S, 2008, P NATL ACAD SCI USA, V105, P4910, DOI 10.1073/pnas.0711484105; Yamaguchi S, 2010, P NATL ACAD SCI USA, V107, P5634, DOI 10.1073/pnas.0809398107; Zelhof AC, 2003, DEVELOPMENT, V130, P4383, DOI 10.1242/dev.00651	38	51	51	1	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 10	2011	145	6					956	968		10.1016/j.cell.2011.05.003	http://dx.doi.org/10.1016/j.cell.2011.05.003			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	775LS	21663797	Bronze, Green Accepted			2022-12-24	WOS:000291461600021
J	Cluver, L				Cluver, Lucie			Children of the AIDS pandemic	NATURE			English	Editorial Material							DISTRESS; ORPHANS; AFRICA		Univ Oxford, Dept Social Policy & Intervent, Oxford OX1 2ER, England	University of Oxford	Cluver, L (corresponding author), Univ Oxford, Dept Social Policy & Intervent, Oxford OX1 2ER, England.	lucie.cluver@spi.ox.ac.uk		Cluver, Lucie/0000-0002-0418-835X	Economic and Social Research Council [ES/H001743/1] Funding Source: researchfish; ESRC [ES/H001743/1] Funding Source: UKRI	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))		Bremner JD, 2003, AM J PSYCHIAT, V160, P924, DOI 10.1176/appi.ajp.160.5.924; Case A, 2004, DEMOGRAPHY, V41, P483, DOI 10.1353/dem.2004.0019; Cluver L, 2007, AIDS CARE, V19, P318, DOI 10.1080/09540120600986578; CLUVER L, 2011, 5 S AFR AIDS C DURB; Cluver L, 2007, J CHILD PSYCHOL PSYC, V48, P755, DOI 10.1111/j.1469-7610.2007.01757.x; Cluver L, 2009, SOC SCI MED, V69, P1186, DOI 10.1016/j.socscimed.2009.07.033; Kumakech E, 2009, SOC SCI MED, V68, P1038, DOI 10.1016/j.socscimed.2008.10.033; Nyamukapa CA, 2008, AM J PUBLIC HEALTH, V98, P133, DOI 10.2105/AJPH.2007.116038; RICHTER L, 2006, HEART IS; Zivin JG, 2009, J PUBLIC ECON, V93, P1008, DOI 10.1016/j.jpubeco.2009.03.003	10	18	18	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 2	2011	474	7349					27	29		10.1038/474027a	http://dx.doi.org/10.1038/474027a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	771KV	21637236	Bronze			2022-12-24	WOS:000291156700018
J	Finks, JF; Osborne, NH; Birkmeyer, JD				Finks, Jonathan F.; Osborne, Nicholas H.; Birkmeyer, John D.			Trends in Hospital Volume and Operative Mortality for High-Risk Surgery	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NATIONAL TRENDS; CARDIAC-SURGERY; CANCER-SURGERY; LUNG-CANCER; HEALTH-CARE; REGIONALIZATION; CENTERS; CALIFORNIA; RESECTION; OUTCOMES	Background There were numerous efforts in the United States during the previous decade to concentrate selected surgical procedures in high-volume hospitals. It remains unknown whether referral patterns for high-risk surgery have changed as a result and how operative mortality has been affected. Methods We used national Medicare data to study patients undergoing one of eight different cancer and cardiovascular operations from 1999 through 2008. For each procedure, we examined trends in hospital volume and market concentration, defined as the proportion of Medicare patients undergoing surgery in the top decile of hospitals by volume per year. We used regression-based techniques to assess the effects of volume and market concentration on mortality over time, adjusting for case mix. Results Median hospital volumes of four cancer resections (lung, esophagus, pancreas, and bladder) and of repair of abdominal aortic aneurysm (AAA) rose substantially. Depending on the procedure, higher hospital volumes were attributable to an increasing number of cases nationwide, an increasing market concentration, or both. Hospital volumes rose slightly for aortic-valve replacement but fell for coronary-artery bypass grafting and carotid endarterectomy. Operative mortality declined for all eight procedures, ranging from a relative decline of 8% for carotid endarterectomy (1.3% mortality in 1999 and 1.2% in 2008) to 36% for AAA repair (4.4% in 1999 and 2.8% in 2008). Higher hospital volumes explained a large portion of the decline in mortality for pancreatectomy (67% of the decline), cystectomy (37%), and esophagectomy (32%), but not for the other procedures. Conclusions Operative mortality with high-risk surgery fell substantially during the previous decade. Although increased market concentration and hospital volume have contributed to declining mortality with some high-risk cancer operations, declines in mortality with other procedures are largely attributable to other factors. (Funded by the National Institute on Aging.)	Univ Michigan, Ctr Healthcare Outcomes & Policy, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Surg, Sect Gen Surg, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Finks, JF (corresponding author), 2210F Taubman Ctr,1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	jfinks@umich.edu			National Institute on Aging [P01AG019783-07S1]; NATIONAL INSTITUTE ON AGING [P01AG019783] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Supported by a grant (P01AG019783-07S1) from the National Institute on Aging.	Bach PB, 2001, NEW ENGL J MED, V345, P181, DOI 10.1056/NEJM200107193450306; Birkmeyer JD, 2002, NEW ENGL J MED, V346, P1128, DOI 10.1056/NEJMsa012337; BLINDER AS, 1973, J HUM RESOUR, V8, P436, DOI 10.2307/144855; Chappel AR, 2006, J AM COLL SURGEONS, V203, P599, DOI 10.1016/j.jamcollsurg.2006.07.009; Cheung MC, 2009, ANN SURG ONCOL, V16, P3, DOI 10.1245/s10434-008-0025-9; *COMM QUAL HLTH CA, 2000, INT VOL OUTC REL CON; DIMICK JB, 2004, HLTH AFF MILLWOOD S, pVAR45; Dudley RA, 2000, JAMA-J AM MED ASSOC, V283, P1159, DOI 10.1001/jama.283.9.1159; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; FAIRLIE RW, 2003, 873 YAL U EC GROWTH; Ferguson TB, 2002, ANN THORAC SURG, V73, P480, DOI 10.1016/S0003-4975(01)03339-2; Finlayson E V, 2001, Eff Clin Pract, V4, P172; FINLAYSON EVA, 2001, EFF CLIN PRACT, V4, P235; Finlayson SRG, 1999, MED CARE, V37, P204, DOI 10.1097/00005650-199902000-00010; Gasper WJ, 2009, ANN SURG, V250, P472, DOI 10.1097/SLA.0b013e3181b47c79; Giles KA, 2009, J VASC SURG, V49, P543, DOI 10.1016/j.jvs.2008.09.067; Goodney PP, 2002, J AM COLL SURGEONS, V195, P219, DOI 10.1016/S1072-7515(02)01228-0; Hall BL, 2009, ANN SURG, V250, P363, DOI 10.1097/SLA.0b013e3181b4148f; Hill JS, 2008, J VASC SURG, V48, P29, DOI 10.1016/j.jvs.2008.02.048; Ho V, 2006, ANN SURG ONCOL, V13, P851, DOI 10.1245/ASO.2006.07.021; Hollenbeck BK, 2005, J UROLOGY, V174, P1385, DOI 10.1097/01.ju.0000173632.58991.a7; Holmes JS, 2007, HEALTH AFFAIR, V26, P169, DOI 10.1377/hlthaff.26.1.169; Kirby JB, 2006, MED CARE, V44, P64; Kohn KT, 1999, ERR IS HUMAN BUILDIN; *LEAPFR GROUP, EV BAS HOSP REF; Matsen SL, 2006, J VASC SURG, V44, P488, DOI 10.1016/j.jvs.2006.05.017; Milstein A, 2000, Eff Clin Pract, V3, P313; MILSTEIN A, 2001, EFF CLIN PRACT, V4, P94; Oaxaca R., 1973, INT EC REV, V14, P693, DOI DOI 10.2307/2525981; OConnor GT, 1996, JAMA-J AM MED ASSOC, V275, P841, DOI 10.1001/jama.275.11.841; Peterson ED, 2004, JAMA-J AM MED ASSOC, V291, P195, DOI 10.1001/jama.291.2.195; Roux AVD, 2001, NEW ENGL J MED, V345, P99, DOI 10.1056/NEJM200107123450205; Rowe JW, 2007, ANN INTERN MED, V146, P151, DOI 10.7326/0003-4819-146-11-200706050-00022; Rowe JW, 2006, ANN INTERN MED, V145, P695, DOI 10.7326/0003-4819-145-9-200611070-00013; Shahian DM, 2009, ANN THORAC SURG, V88, pS2, DOI 10.1016/j.athoracsur.2009.05.053; Steinbrook R, 2006, NEW ENGL J MED, V355, P1847, DOI 10.1056/NEJMp068222; Ward MM, 2004, J RURAL HEALTH, V20, P344, DOI 10.1111/j.1748-0361.2004.tb00048.x	37	953	972	0	49	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 2	2011	364	22					2128	2137		10.1056/NEJMsa1010705	http://dx.doi.org/10.1056/NEJMsa1010705			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	772AB	21631325	Green Accepted			2022-12-24	WOS:000291200700011
J	Chen, CY; Samuel, TK; Sinclair, J; Dailey, HA; Hamza, I				Chen, Caiyong; Samuel, Tamika K.; Sinclair, Jason; Dailey, Harry A.; Hamza, Iqbal			An Intercellular Heme-Trafficking Protein Delivers Maternal Heme to the Embryo during Development in C. elegans	CELL			English	Article							CAENORHABDITIS-ELEGANS; GENE FAMILY; HEMOPEXIN; EXPRESSION; FERROCHELATASE; PROTOPORPHYRIA; IDENTIFICATION; BIOSYNTHESIS; HOMEOSTASIS; INFECTIONS	Extracellular free heme can intercalate into membranes and promote damage to cellular macromolecules. Thus it is likely that specific intercellular pathways exist for the directed transport, trafficking, and delivery of heme to cellular destinations, although none have been found to date. Here we show that Caenorhabditis elegans HRG-3 is required for the delivery of maternal heme to developing embryos. HRG-3 binds heme and is exclusively secreted by maternal intestinal cells into the interstitial fluid for transport of heme to extraintestinal cells, including oocytes. HRG-3 deficiency results either in death during embryogenesis or in developmental arrest immediately post-hatching-phenotypes that are fully suppressed by maternal but not zygotic hrg-3 expression. Our results establish a role for HRG-3 as an intercellular heme-trafficking protein.	[Chen, Caiyong; Samuel, Tamika K.; Sinclair, Jason; Hamza, Iqbal] Univ Maryland, Dept Anim & Avian Sci, College Pk, MD 20742 USA; [Chen, Caiyong; Samuel, Tamika K.; Sinclair, Jason; Hamza, Iqbal] Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA; [Dailey, Harry A.] Univ Georgia, Biomed & Hlth Sci Inst, Dept Microbiol, Athens, GA 30602 USA; [Dailey, Harry A.] Univ Georgia, Biomed & Hlth Sci Inst, Dept Biochem & Mol Biol, Athens, GA 30602 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Hamza, I (corresponding author), Univ Maryland, Dept Anim & Avian Sci, College Pk, MD 20742 USA.	hamza@umd.edu		Hamza, Iqbal/0000-0003-0045-0610	National Institutes of Health [R01DK74797]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074797, R01DK032303] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank A. Golden and M. Krause for critical discussions and reading of the manuscript; B. Grant, D. Hall, and J. McGhee for insights into intestinal regulation in C. elegans; J. Lippincott-Schwartz for the FPP assay; B. Grant for RNAi clones and C. elegans strain RT1315; J. Hanover for use of the COPAS BioSort; T. Blumenthal for the SL2 ICS sequence; and National Bioresource Project and S. Mitani for the hrg-3 strain. This work was supported by funding from the National Institutes of Health R01DK74797 (I. H.). C. C., T. K. S., J. S., and I. H. designed studies and interpreted data. H. A. D. conducted the biochemical heme-binding studies. C. C. and I. H. wrote the manuscript. All authors discussed the results and commented on the manuscript.	Balklava Z, 2007, NAT CELL BIOL, V9, P1066, DOI 10.1038/ncb1627; BALLA G, 1991, LAB INVEST, V64, P648; Banci L, 2010, NATURE, V465, P645, DOI 10.1038/nature09018; BLUMENTHAL T, 1984, J MOL BIOL, V174, P1, DOI 10.1016/0022-2836(84)90361-9; BONKOVSKY HL, 1991, AM J GASTROENTEROL, V86, P1050; Brodigan TM, 2003, DEV BIOL, V254, P102, DOI 10.1016/S0012-1606(02)00032-5; CHAN MS, 1994, PARASITOLOGY, V109, P373, DOI 10.1017/S0031182000078410; Childs S, 2000, CURR BIOL, V10, P1001, DOI 10.1016/S0960-9822(00)00653-9; Chotard L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015662; Dailey HA, 2002, BIOCHEM SOC T, V30, P590, DOI 10.1042/bst0300590; Dooley KA, 2008, EXP HEMATOL, V36, P1132, DOI 10.1016/j.exphem.2008.04.008; Faller M, 2007, NAT STRUCT MOL BIOL, V14, P23, DOI 10.1038/nsmb1182; Fay DS, 2000, DEVELOPMENT, V127, P4049; Fuller VL, 2008, NEW PHYTOL, V180, P27, DOI 10.1111/j.1469-8137.2008.02508.x; Hardison RC, 1996, P NATL ACAD SCI USA, V93, P5675, DOI 10.1073/pnas.93.12.5675; HEDGECOCK EM, 1985, DEV BIOL, V107, P128, DOI 10.1016/0012-1606(85)90381-1; Held MR, 2006, INFECT IMMUN, V74, P289, DOI 10.1128/IAI.74.1.289-295.2006; Hotez PJ, 2008, J CLIN INVEST, V118, P1311, DOI 10.1172/JCI34261; HRKAL Z, 1974, EUR J BIOCHEM, V43, P73, DOI 10.1111/j.1432-1033.1974.tb03386.x; Hvidberg V, 2005, BLOOD, V106, P2572, DOI 10.1182/blood-2005-03-1185; Jasmer DP, 2003, ANNU REV PHYTOPATHOL, V41, P245, DOI 10.1146/annurev.phyto.41.052102.104023; Johnston WL, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-35; Kaasik K, 2004, NATURE, V430, P467, DOI 10.1038/nature02724; Keel SB, 2008, SCIENCE, V319, P825, DOI 10.1126/science.1151133; Kim AM, 2010, NAT CHEM BIOL, V6, P674, DOI [10.1038/NCHEMBIO.419, 10.1038/nchembio.419]; Kim BE, 2008, NAT CHEM BIOL, V4, P176, DOI 10.1038/nchembio.72; KIMBLE J, 1983, DEV BIOL, V96, P189, DOI 10.1016/0012-1606(83)90322-6; Knutson MD, 2005, P NATL ACAD SCI USA, V102, P1324, DOI 10.1073/pnas.0409409102; LI JM, 1988, J BACTERIOL, V170, P1021, DOI 10.1128/jb.170.2.1021-1025.1988; Lorenz H, 2006, NAT METHODS, V3, P205, DOI 10.1038/nmeth857; Magness ST, 2002, BLOOD, V100, P1470, DOI 10.1182/blood-2001-12-0283; McGhee James D, 2007, WormBook, P1; Oka T, 2001, J BIOL CHEM, V276, P33079, DOI 10.1074/jbc.M101652200; Okano S, 2010, GENES CELLS, V15, P77, DOI 10.1111/j.1365-2443.2009.01366.x; Puy H, 2010, LANCET, V375, P924, DOI 10.1016/S0140-6736(09)61925-5; Quigley JG, 2004, CELL, V118, P757, DOI 10.1016/j.cell.2004.08.014; Rajagopal A, 2008, NATURE, V453, P1127, DOI 10.1038/nature06934; Rao AU, 2005, P NATL ACAD SCI USA, V102, P4270, DOI 10.1073/pnas.0500877102; Rolls MM, 2002, MOL BIOL CELL, V13, P1778, DOI 10.1091/mbc.01-10-0514; Severance S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001044; Severance S, 2009, CHEM REV, V109, P4596, DOI 10.1021/cr9001116; Sinclair J, 2010, J BIOL CHEM, V285, P39536, DOI 10.1074/jbc.M110.167619; SPIETH J, 1985, MOL CELL BIOL, V5, P2495, DOI 10.1128/MCB.5.10.2495; Tolosano E, 1999, BLOOD, V94, P3906, DOI 10.1182/blood.V94.11.3906; Tolosano E, 2010, ANTIOXID REDOX SIGN, V12, P305, DOI 10.1089/ars.2009.2787; Uc A, 2004, AM J PHYSIOL-GASTR L, V287, pG1150, DOI 10.1152/ajpgi.00157.2004; Worthington MT, 2001, AM J PHYSIOL-GASTR L, V280, pG1172, DOI 10.1152/ajpgi.2001.280.6.G1172; Wu B, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000475; Yang ZT, 2010, J BIOL CHEM, V285, P28874, DOI 10.1074/jbc.M110.119131	49	42	44	1	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 27	2011	145	5					720	731		10.1016/j.cell.2011.04.025	http://dx.doi.org/10.1016/j.cell.2011.04.025			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	769MR	21620137	Green Accepted, Bronze			2022-12-24	WOS:000291018600012
J	Djulbegovic, B; Paul, A				Djulbegovic, Benjamin; Paul, Ash			From Efficacy to Effectiveness in the Face of Uncertainty Indication Creep and Prevention Creep	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Djulbegovic, Benjamin] Univ S Florida, Ctr Evidence Based Med & Hlth Outcomes Res, Tampa, FL 33612 USA; [Djulbegovic, Benjamin] Univ S Florida, Dept Med, Div Evidence Based Med & Hlth Outcomes Res, Tampa, FL 33612 USA; [Djulbegovic, Benjamin] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Hematol, Tampa, FL 33612 USA; [Djulbegovic, Benjamin] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Hlth Outcomes & Behav, Tampa, FL 33612 USA; [Paul, Ash] Natl Hlth Serv, Bedford, England	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; NHS Blood & Transplant (NHSBT)	Djulbegovic, B (corresponding author), Univ S Florida, Ctr Evidence Based Med & Hlth Outcomes Res, 12901 Bruce B Downs Blvd,MDC27,Room 3127-3126, Tampa, FL 33612 USA.	bdjulbeg@health.usf.edu	Djulbegovic, Benjamin/I-3661-2012	Djulbegovic, Benjamin/0000-0003-0671-1447				Abernethy AP, 2009, ANN INTERN MED, V150, P336, DOI 10.7326/0003-4819-150-5-200903030-00107; Brody H, 2011, AM J PUBLIC HEALTH, V101, P399, DOI 10.2105/AJPH.2010.199844; Djulbegovic B, 2007, PLOS MED, V4, P211, DOI 10.1371/journal.pmed.0040026; Djulbegovic B, 2011, HBK PHILOS SCI, V16, P299; Djulbegovic M, 2011, JAMA-J AM MED ASSOC, V305, P298, DOI 10.1001/jama.2010.2013; Hammond KR., 1996, HUMAN JUDGMENT SOCIA; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; Hebert PC, 2007, CAN MED ASSOC J, V177, P697, DOI 10.1503/cmaj.071223; Stafford RS, 2008, NEW ENGL J MED, V358, P1427, DOI 10.1056/NEJMp0802107	9	74	74	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 18	2011	305	19					2005	2006		10.1001/jama.2011.650	http://dx.doi.org/10.1001/jama.2011.650			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	764WO	21586716				2022-12-24	WOS:000290665500025
J	Skinner, J; Kay, P				Skinner, John; Kay, Peter			Commentary: Metal on metal hips	BRITISH MEDICAL JOURNAL			English	Editorial Material							RESURFACINGS; ARTHROPLASTY; FAILURE; BEARING		[Skinner, John] Royal Natl Orthopaed Hosp, Stanmore HA7 4LP, Middx, England; [Skinner, John] British Orthopaed Assoc, Joint Expert Advisory Grp Met Bearing Hips, British Hip Soc, London, England; [Kay, Peter] Wrightington Hosp, Wigan, England	University of London; University College London; Royal National Orthopaedic Hospital NHS Trust	Skinner, J (corresponding author), Royal Natl Orthopaed Hosp, Stanmore HA7 4LP, Middx, England.	john.skinner@ucl.ac.uk		Skinner, John/0000-0002-1901-9057				Berton C, 2010, J BONE JOINT SURG BR, V92B, P202, DOI 10.1302/0301-620X.92B2.22653; Bolland BJRF, 2011, J BONE JOINT SURG BR, V93B, P608, DOI 10.1302/0301-620X.93B5.26309; Bozic KJ, 2009, J BONE JOINT SURG AM, V91A, P1614, DOI 10.2106/JBJS.H.01220; Brodner W, 2003, J BONE JOINT SURG AM, V85A, P2168, DOI 10.2106/00004623-200311000-00017; Carrothers AD, 2010, J BONE JOINT SURG BR, V92B, P1344, DOI 10.1302/0301-620X.92B10.23504; CLOHISY JC, 2004, CLIN ORTHOP RELAT R, V429, P66; Grammatopoulos G, 2009, J BONE JOINT SURG BR, V91B, P1019, DOI 10.1302/0301-620X.91B8.22562; HADDAD FS, J BONE JOINT SURG BR, V93, P572; Hart AJ, 2009, J BONE JOINT SURG BR, V91B, P738, DOI 10.1302/0301-620X.91B6.21682; McMinn D, 2006, P I MECH ENG H, V220, P239, DOI 10.1243/095441105X68944; Medicines and Healthcare Products Regulatory Agency, 2010, MED DEV AL MDA 2010; Morlock MM, 2008, J BONE JOINT SURG AM, V90A, P89, DOI 10.2106/JBJS.H.00621; National Joint Registry for England and Wales, 2010, 7 NAT JOINT REG ENGL; Pandit H, 2008, J BONE JOINT SURG BR, V90B, P847, DOI 10.1302/0301-620X.90B7.20213; Sandiford NA, 2010, J ORTHOP SURG RES, V5, DOI 10.1186/1749-799X-5-88; Shimmin AJ, 2005, J BONE JOINT SURG BR, V87B, P463, DOI 10.1302/0301-620X.87B4	16	19	19	1	12	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 14	2011	342								d3009	10.1136/bmj.d3009	http://dx.doi.org/10.1136/bmj.d3009			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	765OV	21572137				2022-12-24	WOS:000290719100008
J	Dutko, JA; Mullins, MC				Dutko, James A.; Mullins, Mary C.			SnapShot: BMP Signaling in Development	CELL			English	Editorial Material									[Dutko, James A.; Mullins, Mary C.] Univ Penn, Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA	University of Pennsylvania	Dutko, JA (corresponding author), Univ Penn, Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA.				NICHD NIH HHS [5T32HD007516] Funding Source: Medline; NIGMS NIH HHS [R01-GM56326] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007516] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056326] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Blair SS, 2007, ANNU REV CELL DEV BI, V23, P293, DOI 10.1146/annurev.cellbio.23.090506.123606; Little SC, 2009, NAT CELL BIOL, V11, P637, DOI 10.1038/ncb1870; Liu AM, 2005, NAT REV NEUROSCI, V6, P945, DOI 10.1038/nrn1805; Miyazono K, 2010, J BIOCHEM, V147, P35, DOI 10.1093/jb/mvp148; Umulis D, 2009, DEVELOPMENT, V136, P3715, DOI 10.1242/dev.031534; Vuilleumier R, 2010, NAT CELL BIOL, V12, P611, DOI 10.1038/ncb2064; Wu MY, 2009, DEV CELL, V16, P329, DOI 10.1016/j.devcel.2009.02.012; Zakin L, 2010, DEV BIOL, V347, P204, DOI 10.1016/j.ydbio.2010.08.025	8	28	29	0	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 13	2011	145	4					636	U157		10.1016/j.cell.2011.05.001	http://dx.doi.org/10.1016/j.cell.2011.05.001			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	763MF	21565618	Bronze			2022-12-24	WOS:000290560800016
J	Short, PM; Lipworth, SIW; Elder, DHJ; Schembri, S; Lipworth, BJ				Short, Philip M.; Lipworth, Samuel I. W.; Elder, Douglas H. J.; Schembri, Stuart; Lipworth, Brian J.			Effect of beta blockers in treatment of chronic obstructive pulmonary disease: a retrospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							INHALED CORTICOSTEROIDS; MORTALITY; COPD; RISK; SELECTIVITY; REDUCTION; BLOCKADE; AIRWAYS; ASTHMA	Objective To examine the effect of beta blockers in the management of chronic obstructive pulmonary disease (COPD), assessing their effect on mortality, hospital admissions, and exacerbations of COPD when added to established treatment for COPD. Design Retrospective cohort study using a disease specific database of COPD patients (TARDIS) linked to the Scottish morbidity records of acute hospital admissions, the Tayside community pharmacy prescription records, and the General Register Office for Scotland death registry. Setting Tayside, Scotland (2001-2010) Population 5977 patients aged >50 years with a diagnosis of COPD. Main outcome measures Hazard ratios for all cause mortality, emergency oral corticosteroid use, and respiratory related hospital admissions calculated through Cox proportional hazard regression after correction for influential covariates. Results Mean follow-up was 4.35 years, mean age at diagnosis was 69.1 years, and 88% of beta blockers used were cardioselective. There was a 22% overall reduction in all cause mortality with beta blocker use. Furthermore, there were additive benefits of beta blockers on all cause mortality at all treatment steps for COPD. Compared with controls (given only inhaled therapy with either short acting beta agonists or short acting antimuscarinics), the adjusted hazard ratio for all cause mortality was 0.28 (95% CI 0.21 to 0.39) for treatment with inhaled corticosteroid, long acting beta agonist, and long acting antimuscarinic plus beta blocker versus 0.43 (0.38 to 0.48) without beta blocker. There were similar trends showing additive benefits of beta blockers in reducing oral corticosteroid use and hospital admissions due to respiratory disease. beta blockers had no deleterious impact on lung function at all treatment steps when given in conjunction with either a long acting beta agonist or antimuscarinic agent Conclusions beta blockers may reduce mortality and COPD exacerbations when added to established inhaled stepwise therapy for COPD, independently of overt cardiovascular disease and cardiac drugs, and without adverse effects on pulmonary function.	[Short, Philip M.; Lipworth, Brian J.] Univ Dundee, Ctr Cardiovasc & Lung Biol, Div Med Sci, Asthma & Allergy Res Grp, Dundee DD1 9SY, Scotland; [Lipworth, Samuel I. W.] Univ St Andrews, Bute Med Sch, St Andrews KY16 9UY, Fife, Scotland; [Schembri, Stuart] Perth Royal Infirm, Dept Resp Med, Perth PH1 1NX, Scotland	University of Dundee; University of St Andrews	Lipworth, BJ (corresponding author), Univ Dundee, Ctr Cardiovasc & Lung Biol, Div Med Sci, Asthma & Allergy Res Grp, Dundee DD1 9SY, Scotland.	brianlipworth@gmail.com	Hug, Balthasar L./G-1568-2010	Lipworth, Sam/0000-0001-5872-9214	University of Dundee	University of Dundee	This study was funded by the University of Dundee. The university had no influence over the design and conduct of the study; collection, management, analysis, and interpretation of the data; or preparation, review, or approval of the manuscript.	Agusti A, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-122; [Anonymous], 2009, GLOB STRAT DIAGN MAN; Chang CL, 2010, INTERN MED J, V40, P193, DOI 10.1111/j.1445-5994.2009.01943.x; Crim C, 2009, EUR RESPIR J, V34, P641, DOI 10.1183/09031936.00193908; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; FLETCHER C, 1977, BMJ-BRIT MED J, V1, P1645, DOI 10.1136/bmj.1.6077.1645; GAULD DR, 1979, MED J AUSTRALIA, V2, P88; Gottlieb SS, 1998, NEW ENGL J MED, V339, P489, DOI 10.1056/NEJM199808203390801; IND PW, 1989, AM REV RESPIR DIS, V139, P1390, DOI 10.1164/ajrccm/139.6.1390; LIPWORTH BJ, 1991, EUR J CLIN PHARMACOL, V40, P135; LIPWORTH BJ, 1989, BRIT J CLIN PHARMACO, V28, P95, DOI 10.1111/j.1365-2125.1989.tb03510.x; LIPWORTH BJ, 1991, EUR J CLIN PHARMACOL, V40, P467, DOI 10.1007/BF00315224; Lipworth BJ, 2009, LANCET, V373, P104, DOI 10.1016/S0140-6736(09)60018-0; Mancini GBJ, 2006, J AM COLL CARDIOL, V47, P2554, DOI 10.1016/j.jacc.2006.04.039; Olenchock BA, 2009, AM J CARDIOL, V103, P295, DOI 10.1016/j.amjcard.2008.09.081; RAINE JM, 1981, BRIT MED J, V282, P548, DOI 10.1136/bmj.282.6263.548; Rodrigo GJ, 2009, CHEST, V136, P1029, DOI 10.1378/chest.09-0821; Rutten FH, 2010, ARCH INTERN MED, V170, P880, DOI 10.1001/archinternmed.2010.112; Salpeter S, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003566.pub2; Salpeter SR, 2003, RESP MED, V97, P1094, DOI 10.1016/S0954-6111(03)00168-9; Schembri S, 2009, RESP MED, V103, P1461, DOI 10.1016/j.rmed.2009.04.021; Scottish Government, 2009, SCOTT IND MULT DEPR; Shah SM, 2008, BRIT J GEN PRACT, V58, P862, DOI 10.3399/bjgp08X376195; Sin DD, 2003, CIRCULATION, V107, P1514, DOI 10.1161/01.CIR.0000056767.69054.B3; Soyseth V, 2007, EUR RESPIR J, V29, P279, DOI 10.1183/09031936.00106406; Tashkin DP, 2008, NEW ENGL J MED, V359, P1543, DOI 10.1056/NEJMoa0805800; van der Woude HJ, 2005, CHEST, V127, P818, DOI 10.1378/chest.127.3.818; van Gestel YRBM, 2008, AM J RESP CRIT CARE, V178, P695, DOI 10.1164/rccm.200803-384OC; van Gestel Yvette R B M, 2009, Int J Chron Obstruct Pulmon Dis, V4, P177; WHEELDON NM, 1992, BRIT J CLIN PHARMACO, V34, P337, DOI 10.1111/j.1365-2125.1992.tb05640.x; WILLIAMS IP, 1980, THORAX, V35, P160, DOI 10.1136/thx.35.2.160; Zvezdin B, 2009, CHEST, V136, P376, DOI 10.1378/chest.08-2918	32	165	180	0	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 10	2011	342								d2549	10.1136/bmj.d2549	http://dx.doi.org/10.1136/bmj.d2549			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	765OM	21558357	Green Published, hybrid			2022-12-24	WOS:000290718100001
J	Hauri, EH; Weinreich, T; Saal, AE; Rutherford, MC; Van Orman, JA				Hauri, Erik H.; Weinreich, Thomas; Saal, Alberto E.; Rutherford, Malcolm C.; Van Orman, James A.			High Pre-Eruptive Water Contents Preserved in Lunar Melt Inclusions	SCIENCE			English	Article							OCEAN-RIDGE BASALT; VOLATILE CONTENT; SNC METEORITES; GLASSES; MANTLE; MOON; DEHYDRATION; CONSTRAINTS; ABUNDANCES; ISOTOPES	The Moon has long been thought to be highly depleted in volatiles such as water, and indeed published direct measurements of water in lunar volcanic glasses have never exceeded 50 parts per million (ppm). Here, we report in situ measurements of water in lunar melt inclusions; these samples of primitive lunar magma, by virtue of being trapped within olivine crystals before volcanic eruption, did not experience posteruptive degassing. The lunar melt inclusions contain 615 to 1410 ppm water and high correlated amounts of fluorine (50 to 78 ppm), sulfur (612 to 877 ppm), and chlorine (1.5 to 3.0 ppm). These volatile contents are very similar to primitive terrestrial mid-ocean ridge basalts and indicate that some parts of the lunar interior contain as much water as Earth's upper mantle.	[Hauri, Erik H.] Carnegie Inst Sci, Dept Terr Magnetism, Washington, DC 20015 USA; [Weinreich, Thomas; Saal, Alberto E.; Rutherford, Malcolm C.] Brown Univ, Dept Geol Sci, Providence, RI 02912 USA; [Van Orman, James A.] Case Western Reserve Univ, Dept Geol Sci, Cleveland, OH 44106 USA	Carnegie Institution for Science; Brown University; Case Western Reserve University	Hauri, EH (corresponding author), Carnegie Inst Sci, Dept Terr Magnetism, 5241 Broad Branch Rd NW, Washington, DC 20015 USA.	ehauri@ciw.edu		Van Orman, James/0000-0001-8741-0288	Carnegie Institution of Washington; NASA; NASA Lunar Science Institute; NASA Astrobiology Institute	Carnegie Institution of Washington; NASA(National Aeronautics & Space Administration (NASA)); NASA Lunar Science Institute; NASA Astrobiology Institute	This work was supported by the Carnegie Institution of Washington, the NASA LASER and Cosmochemistry programs, the NASA Lunar Science Institute, and the NASA Astrobiology Institute. We thank J. Wang for NanoSIMS assistance, and L. Nittler and Z. Peeters for help with image processing software.	Albarede F, 2009, NATURE, V461, P1227, DOI 10.1038/nature08477; Bombardieri DJ, 2005, METEORIT PLANET SCI, V40, P679, DOI 10.1111/j.1945-5100.2005.tb00973.x; Boyce JW, 2010, NATURE, V466, P466, DOI 10.1038/nature09274; Canup RM, 2004, ANNU REV ASTRON ASTR, V42, P441, DOI 10.1146/annurev.astro.41.082201.113457; Crotts APS, 2008, ASTROPHYS J, V687, P692, DOI 10.1086/591634; DELANO JW, 1986, J GEOPHYS RES-SOLID, V91, pD201, DOI 10.1029/JB091iB04p0D201; Dixon JE, 2002, NATURE, V420, P385, DOI 10.1038/nature01215; Feldman WC, 2001, J GEOPHYS RES-PLANET, V106, P23231, DOI 10.1029/2000JE001444; Greenwood JP, 2011, NAT GEOSCI, V4, P79, DOI 10.1038/NGEO1050; Hauri E, 2002, CHEM GEOL, V183, P115, DOI 10.1016/S0009-2541(01)00374-6; JAMBON A, 1990, EARTH PLANET SC LETT, V101, P323, DOI 10.1016/0012-821X(90)90163-R; Kelley KA, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2005JB003732; KLEIN N, 1998, LUNAR PLANET SCI, V29, P1448; Lassiter JC, 2002, EARTH PLANET SC LETT, V202, P525, DOI 10.1016/S0012-821X(02)00826-9; McCubbin FM, 2010, P NATL ACAD SCI USA, V107, P11223, DOI 10.1073/pnas.1006677107; MCSWEEN HY, 1993, SCIENCE, V259, P1890, DOI 10.1126/science.259.5103.1890; MICHAEL P, 1995, EARTH PLANET SC LETT, V131, P301, DOI 10.1016/0012-821X(95)00023-6; Pahlevan K, 2007, EARTH PLANET SC LETT, V262, P438, DOI 10.1016/j.epsl.2007.07.055; ROEDDER E, 1972, EARTH PLANET SC LETT, V13, P272, DOI 10.1016/0012-821X(72)90103-3; Roedder E., 1970, P APOLLO 11 LUNAR SC, P801; Roedder E., 1971, P LUNAR PLANET SCI C, V2, P507; Saal AE, 2002, NATURE, V419, P451, DOI 10.1038/nature01073; Saal AE, 2008, NATURE, V454, P192, DOI 10.1038/nature07047; Sharp ZD, 2010, SCIENCE, V329, P1050, DOI 10.1126/science.1192606; Shaw AM, 2008, EARTH PLANET SC LETT, V275, P138, DOI 10.1016/j.epsl.2008.08.015; Shaw AM, 2010, EARTH PLANET SC LETT, V289, P311, DOI 10.1016/j.epsl.2009.11.018; Shimizu N, 1998, PHYS EARTH PLANET IN, V107, P183, DOI 10.1016/S0031-9201(97)00133-7; WATSON LL, 1994, SCIENCE, V265, P86, DOI 10.1126/science.265.5168.86; Weitz CM, 1999, METEORIT PLANET SCI, V34, P527, DOI 10.1111/j.1945-5100.1999.tb01361.x; [No title captured]	30	246	256	4	105	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 8	2011	333	6039					213	215		10.1126/science.1204626	http://dx.doi.org/10.1126/science.1204626			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	789GG	21617039				2022-12-24	WOS:000292502700047
J	Borgia, MB; Borgia, A; Best, RB; Steward, A; Nettels, D; Wunderlich, B; Schuler, B; Clarke, J				Borgia, Madeleine B.; Borgia, Alessandro; Best, Robert B.; Steward, Annette; Nettels, Daniel; Wunderlich, Bengt; Schuler, Benjamin; Clarke, Jane			Single-molecule fluorescence reveals sequence-specific misfolding in multidomain proteins	NATURE			English	Article							FOLDING MECHANISM; DOMAIN; AGGREGATION; ENERGY; TITIN; INTERMEDIATE; SPECTROSCOPY; COLLAPSE	A large range of debilitating medical conditions(1) is linked to protein misfolding, which may compete with productive folding particularly in proteins containing multiple domains(2). Seventy-five per cent of the eukaryotic proteome consists of multidomain proteins, yet it is not understood how interdomain misfolding is avoided. It has been proposed that maintaining low sequence identity between covalently linked domains is a mechanism to avoid misfolding(3). Here we use single-molecule Forster resonance energy transfer(4,5) to detect and quantify rare misfolding events in tandem immunoglobulin domains from the I band of titin under native conditions. About 5.5 per cent of molecules with identical domains misfold during refolding in vitro and form an unexpectedly stable state with an unfolding half-time of several days. Tandem arrays of immunoglobulin-like domains in humans show significantly lower sequence identity between neighbouring domains than between non-adjacent domains(3). In particular, the sequence identity of neighbouring domains has been found to be preferentially below 40 per cent(3). We observe no misfolding for a tandem of naturally neighbouring domains with low sequence identity (24 per cent), whereas misfolding occurs between domains that are 42 per cent identical. Coarse-grained molecular simulations predict the formation of domain-swapped structures that are in excellent agreement with the observed transfer efficiency of the misfolded species. We infer that the interactions underlying misfolding are very specific and result in a sequence-specific domain-swapping mechanism. Diversifying the sequence between neighbouring domains seems to be a successful evolutionary strategy to avoid misfolding in multidomain proteins.	[Borgia, Madeleine B.; Best, Robert B.; Steward, Annette; Clarke, Jane] Univ Cambridge, Chem Lab, Cambridge CB2 1EW, England; [Borgia, Madeleine B.; Borgia, Alessandro; Nettels, Daniel; Wunderlich, Bengt; Schuler, Benjamin] Univ Zurich, Inst Biochem, CH-8057 Zurich, Switzerland	University of Cambridge; University of Zurich	Clarke, J (corresponding author), Univ Cambridge, Chem Lab, Lensfield Rd, Cambridge CB2 1EW, England.	schuler@bioc.uzh.ch; jc162@cam.ac.uk	Schuler, Benjamin/E-7342-2011; Borgia, Alessandro/AAF-9203-2019; Best, Robert/H-7588-2016	Schuler, Benjamin/0000-0002-5970-4251; Borgia, Alessandro/0000-0002-4701-8967; Best, Robert/0000-0002-7893-3543	Wellcome Trust [064417]; Swiss National Science Foundation; Swiss National Center of Competence in Research in Structural Biology; UK Medical Research Council; Marie Curie Intra-European Fellowship; Royal Society; MRC [MC_U105485808] Funding Source: UKRI; Medical Research Council [MC_U105485808] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss National Center of Competence in Research in Structural Biology(Swiss National Science Foundation (SNSF)); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Marie Curie Intra-European Fellowship(European Commission); Royal Society(Royal Society of London); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Wellcome Trust (grant number, 064417), the Swiss National Science Foundation (to B. S.) and the Swiss National Center of Competence in Research in Structural Biology (to B. S.). M. B. B. was supported by a UK Medical Research Council studentship. A. B. is supported by a Marie Curie Intra-European Fellowship. R. B. B. is supported by a Royal Society University Research Fellowship. J.C. is a Wellcome Trust Senior Research Fellow. We thank H. Hofmann, A. Soranno and A. Hoffmann for discussions and contributions to data analysis.	Arora P, 2006, BIOCHEMISTRY-US, V45, P12312, DOI 10.1021/bi060923s; Balamurali MM, 2008, PROTEIN SCI, V17, P1815, DOI 10.1110/ps.036376.108; Bennett MJ, 2006, STRUCTURE, V14, P811, DOI 10.1016/j.str.2006.03.011; Borgia A, 2008, ANGEW CHEM INT EDIT, V47, P6900, DOI 10.1002/anie.200801761; Borgia A, 2008, ANNU REV BIOCHEM, V77, P101, DOI 10.1146/annurev.biochem.77.060706.093102; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Capaldi AP, 2002, NAT STRUCT BIOL, V9, P209, DOI 10.1038/nsb757; Dahan M, 1999, CHEM PHYS, V247, P85, DOI 10.1016/S0301-0104(99)00132-9; Fedorov AN, 1997, J BIOL CHEM, V272, P32715, DOI 10.1074/jbc.272.52.32715; Fowler SB, 2001, STRUCTURE, V9, P355, DOI 10.1016/S0969-2126(01)00596-2; Gambin Y, 2009, P NATL ACAD SCI USA, V106, P10153, DOI 10.1073/pnas.0904461106; Gianni S, 2010, NAT STRUCT MOL BIOL, V17, P1431, DOI 10.1038/nsmb.1956; Gregersen N, 2006, ANNU REV GENOM HUM G, V7, P103, DOI 10.1146/annurev.genom.7.080505.115737; Hillger F, 2007, J FLUORESC, V17, P759, DOI 10.1007/s10895-007-0187-z; Hoffmann A, 2007, P NATL ACAD SCI USA, V104, P105, DOI 10.1073/pnas.0604353104; Hofmann H, 2010, P NATL ACAD SCI USA, V107, P11793, DOI 10.1073/pnas.1002356107; Improta S, 1996, STRUCTURE, V4, P323, DOI 10.1016/S0969-2126(96)00036-6; Ivarsson Y, 2008, J BIOL CHEM, V283, P8954, DOI 10.1074/jbc.M707424200; JAENICKE R, 1987, PROG BIOPHYS MOL BIO, V49, P117, DOI 10.1016/0079-6107(87)90011-3; Jaenicke R, 1997, ADV PROTEIN CHEM, V50, P1, DOI 10.1016/S0065-3233(08)60318-6; Joo C, 2008, ANNU REV BIOCHEM, V77, P51, DOI 10.1146/annurev.biochem.77.070606.101543; Karanicolas J, 2003, J MOL BIOL, V334, P309, DOI 10.1016/j.jmb.2003.09.047; Korzhnev DM, 2010, SCIENCE, V329, P1312, DOI 10.1126/science.1191723; Li HB, 2002, NATURE, V418, P998, DOI 10.1038/nature00938; Lu H, 1998, BIOPHYS J, V75, P662, DOI 10.1016/S0006-3495(98)77556-3; Mitraki A, 2010, ADV PROTEIN CHEM STR, V79, P89, DOI 10.1016/S1876-1623(10)79003-9; Nettels D, 2009, P NATL ACAD SCI USA, V106, P20740, DOI 10.1073/pnas.0900622106; Oberhauser AF, 1999, NAT STRUCT BIOL, V6, P1025; Schuler B, 2002, NATURE, V419, P743, DOI 10.1038/nature01060; Schuler B, 2008, CURR OPIN STRUC BIOL, V18, P16, DOI 10.1016/j.sbi.2007.12.003; Schuler Benjamin, 2007, V350, P115; Scott KA, 2002, J MOL BIOL, V315, P819, DOI 10.1006/jmbi.2001.5260; Steward A, 2002, PROTEIN SCI, V11, P2179, DOI 10.1110/ps.0212702; Straub JE, 2010, CURR OPIN STRUC BIOL, V20, P187, DOI 10.1016/j.sbi.2009.12.017; STRYER L, 1978, ANNU REV BIOCHEM, V47, P819, DOI 10.1146/annurev.bi.47.070178.004131; Wright CF, 2005, NATURE, V438, P878, DOI 10.1038/nature04195; Yang SC, 2004, P NATL ACAD SCI USA, V101, P13786, DOI 10.1073/pnas.0403724101	37	140	140	2	91	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 30	2011	474	7353					662	U142		10.1038/nature10099	http://dx.doi.org/10.1038/nature10099			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	785CF	21623368	Green Accepted			2022-12-24	WOS:000292204300044
J	Rosenthal, PJ				Rosenthal, Philip J.			Lessons from Sickle Cell Disease in the Treatment and Control of Malaria	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Calif San Francisco, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Rosenthal, PJ (corresponding author), Univ Calif San Francisco, San Francisco, CA 94143 USA.							de Souza JB, 2010, PARASITOLOGY, V137, P755, DOI 10.1017/S0031182009991715; Dondorp AM, 2010, LANCET, V376, P1647, DOI 10.1016/S0140-6736(10)61924-1; Ferreira A, 2011, CELL, V145, P398, DOI 10.1016/j.cell.2011.03.049; Roestenberg M, 2009, NEW ENGL J MED, V361, P468, DOI 10.1056/NEJMoa0805832; Williams TN, 2006, CURR OPIN MICROBIOL, V9, P388, DOI 10.1016/j.mib.2006.06.009	5	13	15	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 30	2011	364	26					2549	2551		10.1056/NEJMcibr1105118	http://dx.doi.org/10.1056/NEJMcibr1105118			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	785AM	21714653				2022-12-24	WOS:000292199800015
J	She, J; Han, ZF; Kim, TW; Wang, JJ; Cheng, W; Chang, JB; Shi, SA; Wang, JW; Yang, MJ; Wang, ZY; Chai, JJ				She, Ji; Han, Zhifu; Kim, Tae-Wuk; Wang, Jinjing; Cheng, Wei; Chang, Junbiao; Shi, Shuai; Wang, Jiawei; Yang, Maojun; Wang, Zhi-Yong; Chai, Jijie			Structural insight into brassinosteroid perception by BRI1	NATURE			English	Article							RECEPTOR KINASE BRI1; SIGNAL-TRANSDUCTION; TRANSCRIPTION FACTORS; ARABIDOPSIS-THALIANA; EXTRACELLULAR DOMAIN; PLANT-GROWTH; COMPLEX; PHOSPHORYLATION; ACTIVATION; BRI1/BAK1	Brassinosteroids are essential phytohormones that have crucial roles in plant growth and development. Perception of brassinosteroids requires an active complex of BRASSINOSTEROID-INSENSITIVE 1 (BRI1) and BRI1-ASSOCIATED KINASE 1 (BAK1). Recognized by the extracellular leucine-rich repeat (LRR) domain of BRI1, brassinosteroids induce a phosphorylation-mediated cascade to regulate gene expression. Here we present the crystal structures of BRI1(LRR) in free and brassinolide-bound forms. BRI1(LRR) exists as a monomer in crystals and solution independent of brassinolide. It comprises a helical solenoid structure that accommodates a separate insertion domain at its concave surface. Sandwiched between them, brassinolide binds to a hydrophobicity-dominating surface groove on BRI1(LRR). Brassinolide recognition by BRI1(LRR) is through an induced-fit mechanism involving stabilization of two interdomain loops that creates a pronounced non-polar surface groove for the hormone binding. Together, our results define the molecular mechanisms by which BRI1 recognizes brassinosteroids and provide insight into brassinosteroid-induced BRI1 activation.	[She, Ji; Han, Zhifu; Wang, Jiawei; Yang, Maojun; Chai, Jijie] Tsinghua Univ, Key Lab Prot Sci, Minist Educ, Sch Life Sci, Beijing 100084, Peoples R China; [She, Ji] Peking Univ, Coll Biol Sci, Beijing 100084, Peoples R China; [She, Ji; Wang, Jinjing; Cheng, Wei; Chai, Jijie] Natl Inst Biol Sci, Beijing 102206, Peoples R China; [Kim, Tae-Wuk; Wang, Zhi-Yong] Carnegie Inst Sci, Dept Plant Biol, Stanford, CA 94305 USA; [Chang, Junbiao; Shi, Shuai] Zhengzhou Univ, Dept Chem, Zhengzhou 450001, Peoples R China	Tsinghua University; Peking University; National Institute of Biological Sciences, Beijing; Carnegie Institution for Science; Zhengzhou University	Chai, JJ (corresponding author), Tsinghua Univ, Key Lab Prot Sci, Minist Educ, Sch Life Sci, Beijing 100084, Peoples R China.	chaijj@mail.tsinghua.edu.cn	Wang, Zhi-Yong/E-3810-2012; chang, junbiao/P-1095-2014; Wang, Jiawei/D-1144-2010; She, Ji/AAW-6150-2021	Wang, Zhi-Yong/0000-0003-4602-3390; chang, junbiao/0000-0001-6236-1256; Wang, Jiawei/0000-0001-9893-8539; Chai, Jijie/0000-0001-7591-3873; Yang, Maojun/0000-0002-6798-3094	National Outstanding Young Scholar Science Foundation of National Natural Science Foundation of China [20101331722]; NIH [R01GM066258]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066258] Funding Source: NIH RePORTER	National Outstanding Young Scholar Science Foundation of National Natural Science Foundation of China; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Huang and J. He at Shanghai Synchrotron Radiation Facility (SSRF) for assistance with data collection; J. Chory from the Salk Institute for providing the tritium-labelled brassinolide. This research was funded by the National Outstanding Young Scholar Science Foundation of National Natural Science Foundation of China grant no. 20101331722 to J. Chai and NIH R01GM066258 to Z.-Y.W.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Clouse SD, 1998, ANNU REV PLANT PHYS, V49, P427, DOI 10.1146/annurev.arplant.49.1.427; DeLano WL, 2002, PYMOL MOL; Di Matteo A, 2003, P NATL ACAD SCI USA, V100, P10124, DOI 10.1073/pnas.1733690100; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; He ZH, 2000, SCIENCE, V288, P2360, DOI 10.1126/science.288.5475.2360; Hink MA, 2008, BIOPHYS J, V94, P1052, DOI 10.1529/biophysj.107.112003; Jaillais Y, 2011, GENE DEV, V25, P232, DOI 10.1101/gad.2001911; Kajava AV, 1998, J MOL BIOL, V277, P519, DOI 10.1006/jmbi.1998.1643; Kim TW, 2010, ANNU REV PLANT BIOL, V61, P681, DOI 10.1146/annurev.arplant.043008.092057; Kinoshita T, 2005, NATURE, V433, P167, DOI 10.1038/nature03227; Li J, 2002, CELL, V110, P213, DOI 10.1016/S0092-8674(02)00812-7; Li J, 2001, P NATL ACAD SCI USA, V98, P5916, DOI 10.1073/pnas.091065998; Li JM, 1997, CELL, V90, P929, DOI 10.1016/S0092-8674(00)80357-8; Li JM, 2005, CURR OPIN PLANT BIOL, V8, P526, DOI 10.1016/j.pbi.2005.07.009; Li JM, 2002, SCIENCE, V295, P1299; Liu L, 2008, SCIENCE, V320, P379, DOI 10.1126/science.1155406; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nam KH, 2002, CELL, V110, P203, DOI 10.1016/S0092-8674(02)00814-0; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Russinova E, 2004, PLANT CELL, V16, P3216, DOI 10.1105/tpc.104.025387; Schubert WD, 2002, CELL, V111, P825, DOI 10.1016/S0092-8674(02)01136-4; Sheard LB, 2010, NATURE, V468, P400, DOI 10.1038/nature09430; Sheard LB, 2009, NATURE, V462, P575, DOI 10.1038/462575a; Shiu SH, 2004, PLANT CELL, V16, P1220, DOI 10.1105/tpc.020834; Sun Y, 2010, DEV CELL, V19, P765, DOI 10.1016/j.devcel.2010.10.010; Tang WQ, 2008, SCIENCE, V321, P557, DOI 10.1126/science.1156973; Vert G, 2005, ANNU REV CELL DEV BI, V21, P177, DOI 10.1146/annurev.cellbio.21.090704.151241; Wang XF, 2005, PLANT CELL, V17, P1685, DOI 10.1105/tpc.105.031393; Wang XF, 2008, DEV CELL, V15, P220, DOI 10.1016/j.devcel.2008.06.011; Wang XL, 2005, DEV CELL, V8, P855, DOI 10.1016/j.devcel.2005.05.001; Wang XL, 2006, SCIENCE, V313, P1118, DOI 10.1126/science.1127593; Whippo CW, 2005, PLANT PHYSIOL, V139, P448, DOI 10.1104/pp.105.064444; Yun HS, 2009, MOL CELLS, V27, P183, DOI 10.1007/s10059-009-0023-1; Zullo Marco António Teixeira, 2002, Braz. J. Plant Physiol., V14, P143, DOI 10.1590/S1677-04202002000300001	36	268	297	6	132	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 23	2011	474	7352					472	U96		10.1038/nature10178	http://dx.doi.org/10.1038/nature10178			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	781NJ	21666666	Green Accepted			2022-12-24	WOS:000291939700040
J	Aylward, B; Yamada, T				Aylward, Bruce; Yamada, Tadataka			The Polio Endgame	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							VACCINE; ERADICATION; TRIAL		[Aylward, Bruce] WHO, Geneva, Switzerland; [Yamada, Tadataka] Bill & Melinda Gates Fdn, Seattle, WA USA	World Health Organization; Bill & Melinda Gates Foundation	Aylward, B (corresponding author), WHO, Geneva, Switzerland.							Kew OM, 2005, ANNU REV MICROBIOL, V59, P587, DOI 10.1146/annurev.micro.58.030603.123625; Kreeftenberg H, 2006, BIOLOGICALS, V34, P155, DOI 10.1016/j.biologicals.2006.02.011; Resik S, 2010, J INFECT DIS, V201, P1344, DOI 10.1086/651611; Sutter RW, 2010, LANCET, V376, P1682, DOI 10.1016/S0140-6736(10)61230-5; Thompson KM, 2007, LANCET, V369, P1363, DOI 10.1016/S0140-6736(07)60532-7	5	35	36	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 16	2011	364	24					2273	2275		10.1056/NEJMp1104329	http://dx.doi.org/10.1056/NEJMp1104329			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	777RZ	21675884	Bronze			2022-12-24	WOS:000291643800001
J	Aliyu, F; Esegbona, G				Aliyu, Fatima; Esegbona, G.			A PATIENT'S JOURNEY Living with obstetric fistula	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Esegbona, G.] Specialist Hosp, Laure Fistula Ctr, Kano, Nigeria		Esegbona, G (corresponding author), Specialist Hosp, Laure Fistula Ctr, Kano, Nigeria.	gesegbona@aim.com							0	3	3	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 9	2011	342								d2881	10.1136/bmj.d2881	http://dx.doi.org/10.1136/bmj.d2881			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	777SR	21659374	Bronze			2022-12-24	WOS:000291645800001
J	Russell, HC; McDougall, V; Dutton, GN				Russell, Heather C.; McDougall, Valerie; Dutton, Gordon N.			EASILY MISSED? Congenital cataract	BRITISH MEDICAL JOURNAL			English	Editorial Material							SURGICAL-TREATMENT; PERIOD		[Russell, Heather C.] Princess Alexandra Eye Pavil, Edinburgh EH3 9HA, Midlothian, Scotland; [McDougall, Valerie] MacLean Med Practice, Glasgow G44 3QG, Lanark, Scotland; [Dutton, Gordon N.] Royal Hosp Sick Children, Glasgow G3 8SJ, Lanark, Scotland	University of Glasgow	Russell, HC (corresponding author), Princess Alexandra Eye Pavil, Edinburgh EH3 9HA, Midlothian, Scotland.	heatherrussell74@gmail.com		Dutton, Gordon N/0000-0003-2516-5795				Birch EE, 1996, INVEST OPHTH VIS SCI, V37, P1532; Birch EE, 2009, J AAPOS, V13, P67, DOI 10.1016/j.jaapos.2008.07.010; HALL DMB, 1996, HLTH ALL CHILDREN RE; Lambert SR, 2006, J AAPOS, V10, P30, DOI 10.1016/j.jaapos.2005.10.002; McLaughlin C, 2006, PEDIATR EMERG CARE, V22, P137, DOI 10.1097/01.pec.0000199567.87134.81; Morgan S, 1999, BRIT MED J, V319, P122, DOI 10.1136/bmj.319.7202.122; Rahi JS, 1999, BRIT MED J, V318, P362, DOI 10.1136/bmj.318.7180.362; Rahi JS, 2001, INVEST OPHTH VIS SCI, V42, P1444; *ROYAL COLL OPHTH, 1994, OPHTH SERV CHILDR RE; RUSSELL HC, 2010, J PEDIATR OPHTHALMOL, V46, pE1; Sotomi O, 2007, Ir Med J, V100, P398	11	3	3	1	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 27	2011	342								d3075	10.1136/bmj.d3075	http://dx.doi.org/10.1136/bmj.d3075			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	771KI	21622506				2022-12-24	WOS:000291155200003
J	Luz, PM; Vanni, T; Medlock, J; Paltiel, AD; Galvani, AP				Luz, Paula Mendes; Vanni, Tazio; Medlock, Jan; Paltiel, A. David; Galvani, Alison P.			Dengue vector control strategies in an urban setting: an economic modelling assessment	LANCET			English	Article							ADJUSTED LIFE YEARS; AEDES-AEGYPTI; COST-EFFECTIVENESS; INSECTICIDE; IMPACT; DISEASE; VIRUS; FEVER; POPULATIONS; CULICIDAE	Background An estimated 2.5 billion people are at risk of dengue. Incidence of dengue is especially high in resource-constrained countries, where control relies mainly on insecticides targeted at larval or adult mosquitoes. We did epidemiological and economic assessments of different vector control strategies. Methods We developed a dynamic model of dengue transmission that assesses the evolution of insecticide resistance and immunity in the human population, thus allowing for long-term evolutionary and immunological effects of decreased dengue transmission. We measured the dengue health burden in terms of disability-adjusted life-years (DALYs) lost. We did a cost-effectiveness analysis of 43 insecticide-based vector control strategies, including strategies targeted at adult and larval stages, at varying efficacies (high-efficacy [90% mortality], medium-efficacy [60% mortality], and low-efficacy [30% mortality]) and yearly application frequencies (one to six applications). To assess the effect of parameter uncertainty on the results, we did a probabilistic sensitivity analysis and a threshold analysis. Findings All interventions caused the emergence of insecticide resistance, which, with the loss of herd immunity, will increase the magnitude of future dengue epidemics. In our model, one or more applications of high-efficacy larval control reduced dengue burden for up to 2 years, whereas three or more applications of adult vector control reduced dengue burden for up to 4 years. The incremental cost-effectiveness ratios of the strategies for two high-efficacy adult vector control applications per year was US$615 per DALY saved and for six high-efficacy adult vector control applications per year was $1267 per DALY saved. Sensitivity analysis showed that if the cost of adult control was more than 8.2 times the cost of larval control then all strategies based on adult control became dominated. Interpretation Six high-efficacy adult vector control applications per year has a cost-effectiveness ratio that will probably meet WHO's standard for a cost-effective or very cost-effective intervention. Year-round larval control can be counterproductive, exacerbating epidemics in later years because of evolution of insecticide resistance and loss of herd immunity. We suggest the reassessment of vector control policies that are based on larval control only.	[Luz, Paula Mendes] Fundacao Oswaldo Cruz, Evandro Chagas Clin Res Inst, BR-21040360 Rio De Janeiro, Brazil; [Luz, Paula Mendes; Medlock, Jan; Paltiel, A. David; Galvani, Alison P.] Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06510 USA; [Vanni, Tazio] London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, London WC1, England; [Medlock, Jan] Clemson Univ, Dept Math Sci, Clemson, SC USA	Fundacao Oswaldo Cruz; Yale University; University of London; London School of Hygiene & Tropical Medicine; Clemson University	Luz, PM (corresponding author), Fundacao Oswaldo Cruz, Evandro Chagas Clin Res Inst, Ave Brasil 4365, BR-21040360 Rio De Janeiro, Brazil.	paula.luz@ipec.fiocruz.br	Vanni, Tazio P./B-7925-2018	Paltiel, A. David/0000-0002-4861-3290; Luz, Paula/0000-0001-9746-719X	Fulbright Programme; CAPES (Brazilian federal agency for post-graduate education); Miriam Burnett trust; Notsew Orm Sands Foundation; National Science Foundation [SBE-0624117]; NIH MIDAS [UO1 GM087719-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM087719] Funding Source: NIH RePORTER	Fulbright Programme; CAPES (Brazilian federal agency for post-graduate education)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Miriam Burnett trust; Notsew Orm Sands Foundation; National Science Foundation(National Science Foundation (NSF)); NIH MIDAS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	PML was funded by The Fulbright Programme, CAPES (Brazilian federal agency for post-graduate education), and the Miriam Burnett trust. APG was funded by Notsew Orm Sands Foundation and the Miriam Burnett trust. JM was supported by the National Science Foundation (grant SBE-0624117) and the Notsew Orm Sands Foundation. We gratefully acknowledge support from NIH MIDAS (grant UO1 GM087719-01).	Armien B, 2008, AM J TROP MED HYG, V79, P364, DOI 10.4269/ajtmh.2008.79.364; Balmaseda A, 2006, TROP MED INT HEALTH, V11, P935, DOI 10.1111/j.1365-3156.2006.01641.x; Bangs Michael J., 2006, Southeast Asian Journal of Tropical Medicine and Public Health, V37, P1103; Bartley LM, 2002, T ROY SOC TROP MED H, V96, P387, DOI 10.1016/S0035-9203(02)90371-8; Burattini MN, 2008, EPIDEMIOL INFECT, V136, P309, DOI 10.1017/S0950268807008667; Caldwell D, 2007, INT J EPIDEMIOL, V36, P476; Clark DV, 2005, AM J TROP MED HYG, V72, P786, DOI 10.4269/ajtmh.2005.72.786; Cordeiro MT, 2007, AM J TROP MED HYG, V77, P1128, DOI 10.4269/ajtmh.2007.77.1128; da-Cunha MP, 2005, MEM I OSWALDO CRUZ, V100, P441, DOI 10.1590/S0074-02762005000400017; De Simone TS, 2004, T ROY SOC TROP MED H, V98, P553, DOI 10.1016/j.trstmh.2003.09.003; Donalísio Maria Rita, 2002, Rev. bras. epidemiol., V5, P259, DOI 10.1590/S1415-790X2002000300005; Drummond MF., 2005, METHODS EC EVALUATIO, P55; FENWICK E, 2009, ENCY MED DECISION MA, P1; Fernandez EA, 1998, ACTA TROP, V70, P171, DOI 10.1016/S0001-706X(98)00033-3; FOCKS DA, 1995, AM J TROP MED HYG, V53, P489, DOI 10.4269/ajtmh.1995.53.489; Garg P, 2008, T ROY SOC TROP MED H, V102, P570, DOI 10.1016/j.trstmh.2008.02.015; Glasziou PP, 2001, DECISION MAKING HLTH; Gold MR, 1996, COST EFFECTIVENESS H; GRATZ NG, 1991, J AM MOSQUITO CONTR, V7, P353; GRATZ NG, 1994, AM J TROP MED HYG, V50, P11, DOI 10.4269/ajtmh.1994.50.6_Suppl.TM05006S0011; GUBLER DJ, 1989, AM J TROP MED HYG, V40, P571, DOI 10.4269/ajtmh.1989.40.571; Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0; Guzman MG, 2002, LANCET INFECT DIS, V2, P33, DOI 10.1016/S1473-3099(01)00171-2; Hemingway J, 2006, TRENDS PARASITOL, V22, P308, DOI 10.1016/j.pt.2006.05.003; *INT MON FUND, DAT STAT; Jakubczyk M, 2010, HEALTH ECON, V19, P955, DOI 10.1002/hec.1534; Koenraadt CJM, 2007, J MED ENTOMOL, V44, P65, DOI 10.1603/0022-2585(2007)44[65:SATPIT]2.0.CO;2; Kroeger A, 2006, BMJ-BRIT MED J, V332, P1247, DOI 10.1136/bmj.332.7552.1247; Lima José Bento Pereira, 2005, Rev. Inst. Med. trop. S. Paulo, V47, P7, DOI 10.1590/S0036-46652005000100002; Luz PM, 2009, EPIDEMIOL INFECT, V137, P1203, DOI 10.1017/S0950268808001799; Luz PM, 2009, TROP MED INT HEALTH, V14, P237, DOI 10.1111/j.1365-3156.2008.02203.x; McConnell K. John, 2003, Rev Panam Salud Publica, V14, P9, DOI 10.1590/S1020-49892003000600003; McGuire A, 2001, EC EVALUATION HLTH C, P172; Medlock J, 2009, AM NAT, V174, P565, DOI 10.1086/605403; Meltzer MI, 1998, AM J TROP MED HYG, V59, P265, DOI 10.4269/ajtmh.1998.59.265; Montella IR, 2007, AM J TROP MED HYG, V77, P467, DOI 10.4269/ajtmh.2007.77.467; Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042; MURRAY CJL, 1994, B WORLD HEALTH ORGAN, V72, P429; NEWTON EAC, 1992, AM J TROP MED HYG, V47, P709, DOI 10.4269/ajtmh.1992.47.709; Perich MJ, 2000, J MED ENTOMOL, V37, P541, DOI 10.1603/0022-2585-37.4.541; Pontes RJS, 2005, REV SOC BRAS MED TRO, V38, P316, DOI 10.1590/S0037-86822005000400007; Shepard DS, 2004, VACCINE, V22, P1275, DOI 10.1016/j.vaccine.2003.09.019; Suaya JA, 2007, TROP MED INT HEALTH, V12, P1026, DOI 10.1111/j.1365-3156.2007.01889.x; Teixeira M. da G., 2002, Dengue Bulletin, V26, P70; World Health Organization, 2001, MACR HLTH INV HLTH E	45	97	100	0	55	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 14	2011	377	9778					1673	1680		10.1016/S0140-6736(11)60246-8	http://dx.doi.org/10.1016/S0140-6736(11)60246-8			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	766JF	21546076	Green Accepted, Green Published			2022-12-24	WOS:000290777700032
J	Keown, P; Weich, S; Bhui, KS; Scott, J				Keown, Patrick; Weich, Scott; Bhui, Kamaldeep S.; Scott, Jan			Association between provision of mental illness beds and rate of involuntary admissions in the NHS in England 1988-2008: ecological study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RANDOMIZED CONTROLLED-TRIAL; PSYCHIATRIC ADMISSION; HEALTH-CARE; SERVICES; TEAM	Objective To examine the rise in the rate of involuntary admissions for mental illness in England that has occurred as community alternatives to hospital admission have been introduced. Design Ecological analysis. Setting England, 1988-2008. Data source Publicly available data on provision of beds for people with mental illness in the National Health Service from Hospital Activity Statistics and involuntary admission rates from the NHS Information Centre. Main outcome measures Association between annual changes in provision of mental illness beds in the NHS and involuntary admission rates, using cross correlation. Partial correlation coefficients were calculated and regression analysis carried out for the time lag (interval) over which the largest association between these variables was identified. Results The rate of involuntary admissions per annum in the NHS increased by more than 60%, whereas the provision of mental illness beds decreased by more than 60% over the same period; these changes seemed to be synchronous. The strongest association between these variables was observed when a time lag of one year was introduced, with bed reductions preceding increases in involuntary admissions (cross correlation -0.60, 95% confidence interval -1.06 to -0.15). This association increased in magnitude when analyses were restricted to civil (non-forensic) involuntary admissions and non-secure mental illness beds. Conclusion The annual reduction in provision of mental illness beds was associated with the rate of involuntary admissions over the short to medium term, with the closure of two mental illness beds leading to one additional involuntary admission in the subsequent year. This study provides a method for predicting rates of involuntary admissions and what may happen in the future if bed closures continue.	[Keown, Patrick] Queen Elizabeth Hosp, Tranwell Unit, Gateshead NE10 9R, Tyne & Wear, England; [Keown, Patrick; Scott, Jan] Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Weich, Scott] Warwick Med Sch, Hlth Sci Res Inst, Coventry, W Midlands, England; [Bhui, Kamaldeep S.] Queen Mary Univ London, Barts & London Sch Med & Dent, Wolfson Inst Prevent Med, London, England	Newcastle University - UK; University of Warwick; University of London; Queen Mary University London	Keown, P (corresponding author), Queen Elizabeth Hosp, Tranwell Unit, Gateshead NE10 9R, Tyne & Wear, England.	patrick.keown@ncl.ac.uk	Scott, Jan/F-2966-2010; Bhui, Kamaldeep/AAX-2576-2020	Scott, Jan/0000-0002-7203-8601; Bhui, Kamaldeep/0000-0002-9205-2144; Weich, Scott/0000-0002-7552-7697	SDO grant	SDO grant	All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: no support from any organisation for the submitted work; no financial relationships with any organisations that might have an interest in the submitted work in the previous three years. All authors are applicants for an SDO grant pending review to build on these analyses.	Bennewith O, 2010, BRIT J PSYCHIAT, V196, P75, DOI 10.1192/bjp.bp.109.068890; Bhui K, 2003, BRIT J PSYCHIAT, V182, P105, DOI 10.1192/bjp.182.2.105; Bindman J, 2002, SOC PSYCH PSYCH EPID, V37, P341, DOI 10.1007/s00127-002-0558-3; Craig TK, 2004, BMJ-BRIT MED J, V329, P1067, DOI 10.1136/bmj.38246.594873.7C; Davidge M., 1993, SURVEY ENGLISH MENTA; Dean C, 1993, BRIT MED J, V307, P642; Department of Health, 1988, IN PAT FORM DET HOSP; Department of Health, 2009, BED AV OCC; Glover G, 2006, BRIT J PSYCHIAT, V189, P441, DOI 10.1192/bjp.bp.105.020362; Information Centre (2009m), 2009, INP FORM DET HOSP ME; Johnson S, 2005, BRIT MED J, V331, P599, DOI 10.1136/bmj.38519.678148.8F; Keown P, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1837; NHSX, 2022, EL PRESCR MED ADM ME; Priebe S, 2005, BMJ-BRIT MED J, V330, P123, DOI 10.1136/bmj.38296.611215.AE; Rethink, 2005, FUT PERF OUTL ALT PA; Saxena S, 2007, LANCET, V370, P878, DOI 10.1016/S0140-6736(07)61239-2; VELLEMAN PF, 1980, J AM STAT ASSOC, V75, P609, DOI 10.2307/2287657; Wall S, 1999, BRIT MED J, V318, P1520, DOI 10.1136/bmj.318.7197.1520; Weich S, 2008, BRIT MED J, V337, P970; Weich S, 2010, SOC PSYCHIAT PSYCHIA	20	80	81	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 5	2011	343								d3736	10.1136/bmj.d3736	http://dx.doi.org/10.1136/bmj.d3736			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	791RV	21729994	hybrid, Green Submitted, Green Published			2022-12-24	WOS:000292683200001
J	Schousboe, JT; Kerlikowske, K; Loh, A; Cummings, SR				Schousboe, John T.; Kerlikowske, Karla; Loh, Andrew; Cummings, Steven R.			Personalizing Mammography by Breast Density and Other Risk Factors for Breast Cancer: Analysis of Health Benefits and Cost-Effectiveness	ANNALS OF INTERNAL MEDICINE			English	Article							CARCINOMA IN-SITU; NATURAL-HISTORY; FOLLOW-UP; MODEL; MORTALITY; WOMEN; STAGE; ACCURACY; THERAPY; STATES	Background: Current guidelines recommend mammography every 1 or 2 years starting at age 40 or 50 years, regardless of individual risk for breast cancer. Objective: To estimate the cost-effectiveness of mammography by age, breast density, history of breast biopsy, family history of breast cancer, and screening interval. Design: Markov microsimulation model. Data Sources: Surveillance, Epidemiology, and End Results program, Breast Cancer Surveillance Consortium, and the medical literature. Target Population: U. S. women aged 40 to 49, 50 to 59, 60 to 69, and 70 to 79 years with initial mammography at age 40 years and breast density of Breast Imaging Reporting and Data System (BI-RADS) categories 1 to 4. Time Horizon: Lifetime. Perspective: National health payer. Intervention: Mammography annually, biennially, or every 3 to 4 years or no mammography. Outcome Measures: Costs per quality-adjusted life-year (QALY) gained and number of women screened over 10 years to prevent 1 death from breast cancer. Results of Base-Case Analysis: Biennial mammography cost less than $100 000 per QALY gained for women aged 40 to 79 years with BI-RADS category 3 or 4 breast density or aged 50 to 69 years with category 2 density; women aged 60 to 79 years with category 1 density and either a family history of breast cancer or a previous breast biopsy; and all women aged 40 to 79 years with both a family history of breast cancer and a previous breast biopsy, regardless of breast density. Biennial mammography cost less than $50 000 per QALY gained for women aged 40 to 49 years with category 3 or 4 breast density and either a previous breast biopsy or a family history of breast cancer. Annual mammography was not cost-effective for any group, regardless of age or breast density. Results of Sensitivity Analysis: Mammography is expensive if the disutility of false-positive mammography results and the costs of detecting nonprogressive and nonlethal invasive cancer are considered. Limitation: Results are not applicable to carriers of BRCA1 or BRCA2 mutations. Conclusion: Mammography screening should be personalized on the basis of a woman's age, breast density, history of breast biopsy, family history of breast cancer, and beliefs about the potential benefit and harms of screening.	Pk Nicollet Hlth Serv, Minneapolis, MN USA; Univ Minnesota, Minneapolis, MN USA; Univ Calif San Francisco, San Francisco, CA 94143 USA; Calif Pacific Med Ctr, Res Inst, San Francisco Coordinating Ctr, San Francisco, CA USA	University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California San Francisco; California Pacific Medical Center; California Pacific Medical Center Research Institute	Schousboe, JT (corresponding author), Pk Nicollet Inst, 3800 Pk Nicollet Blvd, Minneapolis, MN 55416 USA.	scho0600@umn.edu			Eli Lilly; Da Costa Family Foundation for Research in Breast Cancer Prevention of the California Pacific Medical Center; Breast Cancer Surveillance Consortium; National Cancer Institute BCSC [U01CA63740, U01CA86076, U01CA86082, U01CA63736, U01CA70013, U01CA69976, U01CA63731, U01CA70040]; NATIONAL CANCER INSTITUTE [U01CA063731, U01CA063736, U01CA069976, U01CA086076, U01CA070013, U01CA086082, U01CA070040, U01CA063740] Funding Source: NIH RePORTER	Eli Lilly(Eli Lilly); Da Costa Family Foundation for Research in Breast Cancer Prevention of the California Pacific Medical Center; Breast Cancer Surveillance Consortium; National Cancer Institute BCSC; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Primary Funding Source: Eli Lilly, Da Costa Family Foundation for Research in Breast Cancer Prevention of the California Pacific Medical Center, and Breast Cancer Surveillance Consortium.r Grant Support: By an unrestricted grant from Eli Lilly and by the Da Costa Family Foundation for Research in Breast Cancer Prevention of the California Pacific Medical Center. Data collection for this work was supported by grants U01CA63740, U01CA86076, U01CA86082, U01CA63736, U01CA70013, U01CA69976, U01CA63731, and U01CA70040 from the National Cancer Institute BCSC. The collection of cancer incidence data used in this study was supported by several state public health departments and cancer registries throughout the United States; a full description of these sources can be found at http://breastscreening.cancer.gov/work/acknowledgement.html.	American Cancer Society, 2009, AM CANC SOC GUID EAR; Arias Elizabeth, 2006, Natl Vital Stat Rep, V54, P1; Arveux P, 2003, EUR J CANCER CARE, V12, P143, DOI 10.1046/j.1365-2354.2003.00373.x; Berg AO, 2002, ANN INTERN MED, V137, P344, DOI 10.7326/0003-4819-137-5_Part_1-200209030-00011; Berry DA, 2005, NEW ENGL J MED, V353, P1784, DOI 10.1056/NEJMoa050518; Boyd NF, 2007, NEW ENGL J MED, V356, P227, DOI 10.1056/NEJMoa062790; Breast Cancer Surveillance Consortium, 2004, NIH PUBL; Brett J, 2005, PSYCHO-ONCOLOGY, V14, P917, DOI 10.1002/pon.904; Bureau of Labor Statistics, 2009, CONS PRIC IND DET RE, V2009; Burstrom K, 2006, HEALTH POLICY, V76, P359, DOI 10.1016/j.healthpol.2005.06.011; Calonge N, 2009, ANN INTERN MED, V151, P716, DOI 10.7326/0003-4819-151-10-200911170-00008; Carney PA, 2003, ANN INTERN MED, V138, P168, DOI 10.7326/0003-4819-138-3-200302040-00008; Centers for Medicare & Medicaid Services, 2008, 2009 PHYS FEE SCHED; Chiu SYH, 2010, CANCER EPIDEM BIOMAR, V19, P1219, DOI 10.1158/1055-9965.EPI-09-1028; Ciatto S, 2005, BREAST, V14, P269, DOI 10.1016/j.breast.2004.12.004; EDDY DM, 1989, ANN INTERN MED, V111, P389, DOI 10.7326/0003-4819-111-5-389; Erbas B, 2006, BREAST CANCER RES TR, V97, P135, DOI 10.1007/s10549-005-9101-z; Ernster VL, 2000, ARCH INTERN MED, V160, P953, DOI 10.1001/archinte.160.7.953; Ernster VL, 2002, J NATL CANCER I, V94, P1546; Garuz R, 1997, EUR J PUBLIC HEALTH, V7, P68, DOI 10.1093/eurpub/7.1.68; Gotzsche PC, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001877.pub2; HALL J, 1992, SOC SCI MED, V34, P993, DOI 10.1016/0277-9536(92)90130-I; Jorgensen KJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2587; KATTLOVE H, 1995, JAMA-J AM MED ASSOC, V273, P142, DOI 10.1001/jama.273.2.142; Kerlikowske K, 2003, JNCI-J NATL CANCER I, V95, P1692, DOI 10.1093/jnci/djg097; Kerlikowske K, 1998, J NATL CANCER I, V90, P1801, DOI 10.1093/jnci/90.23.1801; Kerlikowske K, 2007, J NATL CANCER I, V99, P386, DOI 10.1093/jnci/djk066; Lee CH, 2002, RADIOL CLIN N AM, V40, P395, DOI 10.1016/S0033-8389(01)00015-X; Lidgren M, 2007, QUAL LIFE RES, V16, P1073, DOI 10.1007/s11136-007-9202-8; Mandelblatt JS, 2009, ANN INTERN MED, V151, P738, DOI 10.7326/0003-4819-151-10-200911170-00010; Nelson HD, 2009, ANN INTERN MED, V151, P727, DOI 10.7326/0003-4819-151-10-200911170-00009; Olsen AH, 2009, BRIT J CANCER, V100, P1205, DOI 10.1038/sj.bjc.6604989; Plevritis SK, 2007, STAT MED, V26, P581, DOI 10.1002/sim.2550; Ries L MD, 2008, SEER CANC STAT REV 1; Sirovich BE, 1999, SURG CLIN N AM, V79, P961, DOI 10.1016/S0039-6109(05)70056-6; Surveillance Epidemiology and End Results (SEER) Program, 2007, RES DAT 1973 2005; Szeto KL, 1996, HEALTH POLICY, V38, P101, DOI 10.1016/0168-8510(96)00843-3; TAPLIN SH, 1995, J NATL CANCER I, V87, P417, DOI 10.1093/jnci/87.6.417; Tice JA, 2008, ANN INTERN MED, V148, P337, DOI 10.7326/0003-4819-148-5-200803040-00004; Tosteson ANA, 2008, ANN INTERN MED, V148, P1, DOI 10.7326/0003-4819-148-1-200801010-00002; von Eschenbach AC, 2002, ONCOLOGIST, V7, P170, DOI 10.1634/theoncologist.7-3-170; Wang H, 2001, CANCER CAUSE CONTROL, V12, P39, DOI 10.1023/A:1008999403069; Yabroff KR, 2008, JNCI-J NATL CANCER I, V100, P630, DOI 10.1093/jnci/djn103; Zackrisson S, 2006, BRIT MED J, V332, P689, DOI 10.1136/bmj.38764.572569.7C; Zahl PH, 2008, ARCH INTERN MED, V168, P2311, DOI 10.1001/archinte.168.21.2311	45	231	235	0	39	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 5	2011	155	1					10	+		10.7326/0003-4819-155-1-201107050-00003	http://dx.doi.org/10.7326/0003-4819-155-1-201107050-00003			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	788MA	21727289	Green Accepted			2022-12-24	WOS:000292447800002
J	Marschner, K; Kollmann, K; Schweizer, M; Braulke, T; Pohl, S				Marschner, Katrin; Kollmann, Katrin; Schweizer, Michaela; Braulke, Thomas; Pohl, Sandra			A Key Enzyme in the Biogenesis of Lysosomes Is a Protease That Regulates Cholesterol Metabolism	SCIENCE			English	Article							ELEMENT-BINDING PROTEINS; UDP-N-ACETYLGLUCOSAMINE; SITE-1 PROTEASE; CLEAVAGE; CELLS; SUBUNIT; GLCNAC-1-PHOSPHOTRANSFERASE; PHOSPHOTRANSFERASE; IDENTIFICATION; CONVERTASE	Mucolipidosis II is a severe lysosomal storage disorder caused by defects in the alpha and beta subunits of the hexameric N-acetylglucosamine-1-phosphotransferase complex essential for the formation of the mannose 6-phosphate targeting signal on lysosomal enzymes. Cleavage of the membrane-bound alpha/beta-subunit precursor by an unknown protease is required for catalytic activity. Here we found that the alpha/beta-subunit precursor is cleaved by the site-1 protease (S1P) that activates sterol regulatory element-binding proteins in response to cholesterol deprivation. S1P-deficient cells failed to activate the alpha/beta-subunit precursor and exhibited a mucolipidosis II-like phenotype. Thus, S1P functions in the biogenesis of lysosomes, and lipid-independent phenotypes of S1P deficiency may be caused by lysosomal dysfunction.	[Marschner, Katrin; Kollmann, Katrin; Braulke, Thomas; Pohl, Sandra] Univ Med Ctr Hamburg Eppendorf, Childrens Hosp, Dept Biochem, Hamburg, Germany; [Schweizer, Michaela] Univ Hamburg, Ctr Mol Neurobiol, Dept Electron Microscopy, D-2000 Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg	Braulke, T (corresponding author), Univ Med Ctr Hamburg Eppendorf, Childrens Hosp, Dept Biochem, Hamburg, Germany.	braulke@uke.uni-hamburg.de	Pohl, Sandra/AAF-1943-2020; Braulke, Thomas/AAV-9121-2020	Braulke, Thomas/0000-0002-2336-8532; Pohl, Sandra/0000-0001-7409-7042	Deutsche Forschungsgemeinschaft [SFB877/B3, GRK1459]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank J. L. Goldstein for providing SRD-12B and CHO-7 cells. Lipoprotein-poor newborn calf serum and human LDL for selection of SRD-12B cells were provided by J. Heeren. We also thank J. Brand and C. Raithore for technical assistance. We are grateful to J. Bonifacino for critical reading of the manuscript and comments, and to K. Duncan for help in editing the manuscript. T. Braulke and S. Muller-Loennies hold a patent on the single-chain antibody fragment for the detection of M6P-containing proteins (International Patent no. PTC/EP2009/060224 and U.S./PTC Application no. 13/057,844). This work was supported by the Deutsche Forschungsgemeinschaft (SFB877/B3, GRK1459).	Bao M, 1996, J BIOL CHEM, V271, P31437, DOI 10.1074/jbc.271.49.31437; Braulke T, 2009, BBA-MOL CELL RES, V1793, P605, DOI 10.1016/j.bbamcr.2008.10.016; Brown MS, 1999, P NATL ACAD SCI USA, V96, P11041, DOI 10.1073/pnas.96.20.11041; Elagoz A, 2002, J BIOL CHEM, V277, P11265, DOI 10.1074/jbc.M109011200; Hawkins JL, 2008, J PHARMACOL EXP THER, V326, P801, DOI 10.1124/jpet.108.139626; Kollmann K, 2010, EUR J CELL BIOL, V89, P117, DOI 10.1016/j.ejcb.2009.10.008; Kornfeld S., 2001, METABOLIC MOL BASES, P3421; Kudo M, 2006, J BIOL CHEM, V281, P11761, DOI 10.1074/jbc.M513717200; Kudo M, 2005, J BIOL CHEM, V280, P36141, DOI 10.1074/jbc.m509008200; Mullerr-Loennies S, 2010, AM J PATHOL, V177, P240, DOI 10.2353/ajpath.2010.090954; Paik KH, 2005, HUM MUTAT, V26, P308, DOI 10.1002/humu.20205; Patra D, 2007, J CELL BIOL, V179, P687, DOI 10.1083/jcb.200708092; Pohl S, 2010, J BIOL CHEM, V285, P23936, DOI 10.1074/jbc.M110.129684; Rawson RB, 1998, J BIOL CHEM, V273, P28261, DOI 10.1074/jbc.273.43.28261; Rojek JM, 2008, J VIROL, V82, P6045, DOI 10.1128/JVI.02392-07; Rojek JM, 2010, J VIROL, V84, P573, DOI 10.1128/JVI.01697-09; Sakai J, 1998, MOL CELL, V2, P505, DOI 10.1016/S1097-2765(00)80150-1; Sakai J, 1998, J BIOL CHEM, V273, P5785, DOI 10.1074/jbc.273.10.5785; Saul RA, 2005, AM J MED GENET A, V135A, P328, DOI 10.1002/ajmg.a.30716; Schlombs K, 2003, P NATL ACAD SCI USA, V100, P14024, DOI 10.1073/pnas.2331794100; Seidah NG, 2007, J MOL MED, V85, P685, DOI 10.1007/s00109-007-0172-7; Seidah NG, 1999, P NATL ACAD SCI USA, V96, P1321, DOI 10.1073/pnas.96.4.1321; Stirling J, 2006, MOL BIOL CELL, V17, P413, DOI 10.1091/mbc.E05-06-0500; Tiede S, 2005, NAT MED, V11, P1109, DOI 10.1038/nm1305; Walkley SU, 2009, BBA-MOL CELL RES, V1793, P726, DOI 10.1016/j.bbamcr.2008.11.014	25	99	107	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 1	2011	333	6038					87	90		10.1126/science.1205677	http://dx.doi.org/10.1126/science.1205677			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	785UF	21719679				2022-12-24	WOS:000292255400055
J	Smart, N; Bollini, S; Dube, KN; Vieira, JM; Zhou, B; Davidson, S; Yellon, D; Riegler, J; Price, AN; Lythgoe, MF; Pu, WT; Riley, PR				Smart, Nicola; Bollini, Sveva; Dube, Karina N.; Vieira, Joaquim M.; Zhou, Bin; Davidson, Sean; Yellon, Derek; Riegler, Johannes; Price, Anthony N.; Lythgoe, Mark F.; Pu, William T.; Riley, Paul R.			De novo cardiomyocytes from within the activated adult heart after injury	NATURE			English	Article							EPICARDIAL PROGENITORS; SMOOTH-MUSCLE; NEOVASCULARIZATION; LINEAGE; CELLS; TBX18	A significant bottleneck in cardiovascular regenerative medicine is the identification of a viable source of stem/progenitor cells that could contribute new muscle after ischaemic heart disease and acute myocardial infarction(1). A therapeutic ideal-relative to cell transplantation-would be to stimulate a resident source, thus avoiding the caveats of limited graft survival, restricted homing to the site of injury and host immune rejection. Here we demonstrate in mice that the adult heart contains a resident stem or progenitor cell population, which has the potential to contribute bona fide terminally differentiated cardiomyocytes after myocardial infarction. We reveal a novel genetic label of the activated adult progenitors via re-expression of a key embryonic epicardial gene, Wilm's tumour 1 (Wt1), through priming by thymosin beta 4, a peptide previously shown to restore vascular potential to adult epicardium-derived progenitor cells(2) with injury. Cumulative evidence indicates an epicardial origin of the progenitor population, and embryonic reprogramming results in the mobilization of this population and concomitant differentiation to give rise to de novo cardiomyocytes. Cell transplantation confirmed a progenitor source and chromosome painting of labelled donor cells revealed transdifferentiation to a myocyte fate in the absence of cell fusion. Derived cardiomyocytes are shown here to structurally and functionally integrate with resident muscle; as such, stimulation of this adult progenitor pool represents a significant step towards resident-cell-based therapy in human ischaemic heart disease.	[Smart, Nicola; Bollini, Sveva; Dube, Karina N.; Vieira, Joaquim M.; Riley, Paul R.] UCL Inst Child Hlth, Mol Med Unit, London WC1N 1EH, England; [Zhou, Bin; Pu, William T.] Childrens Hosp, Harvard Stem Cell Inst, Boston, MA 02115 USA; [Zhou, Bin; Pu, William T.] Childrens Hosp, Dept Cardiol, Boston, MA 02115 USA; [Zhou, Bin; Pu, William T.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Zhou, Bin] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Beijing 20031, Peoples R China; [Davidson, Sean; Yellon, Derek] UCL, Hatter Cardiovasc Inst, London WC1E 6HX, England; [Riegler, Johannes; Lythgoe, Mark F.] UCL, Dept Med, Ctr Adv Biomed Imaging CABI, London WC1E 6DD, England; [Riegler, Johannes; Lythgoe, Mark F.] UCL, Inst Child Hlth, London WC1E 6DD, England; [Riegler, Johannes] UCL, Ctr Math & Phys Life Sci & Expt Biol CoMPLEX, London WC1E 6BT, England; [Price, Anthony N.] Univ London Imperial Coll Sci Technol & Med, MRC, Ctr Clin Sci, Fac Med, London W12 0NN, England	University of London; University College London; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London; Imperial College London	Riley, PR (corresponding author), UCL Inst Child Hlth, Mol Med Unit, London WC1N 1EH, England.	p.riley@ich.ucl.ac.uk	Pu, William/AAJ-8301-2020; Smart, Nicola/AAN-4011-2020; Bollini, Sveva/J-6004-2016; Smart, Nicola/AAD-3874-2020; Yellon, Derek M/ABD-5110-2021; Davidson, Sean M/F-5275-2010	Pu, William/0000-0002-4551-8079; Bollini, Sveva/0000-0003-1076-0823; Smart, Nicola/0000-0002-3501-7254; Davidson, Sean M/0000-0001-5182-4980; Yellon, Derek/0000-0001-7791-9320; Vieira, Joaquim/0000-0003-2023-6304; Zhou, Bin/0000-0001-5278-5522; Price, Anthony/0000-0002-6907-7554; Lythgoe, Mark/0000-0002-4945-0171	British Heart Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL100401] Funding Source: NIH RePORTER; EPSRC [EP/I014667/1] Funding Source: UKRI; MRC [G0700933] Funding Source: UKRI; British Heart Foundation [PG/10/005/28175, RG/08/015/26411, FS/08/004/23625, RG/08/003/25264] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/I014667/1] Funding Source: researchfish; Medical Research Council [G0700933] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by the British Heart Foundation. We are grateful to F. Costantini and S. Srinivas for providing the R26R-EYFP mouse strain, to B. Vernay for assistance with confocal microscopy and A. Eddaoudi, P. Chana and A. Angheluta for assistance in flow cytometry. We thank A. Taylor and V. Muthurangu for functional interpretation of MRI data and RegeneRx Biopharmaceuticals for provision of clinical grade T beta 4.	Bock-Marquette I, 2004, NATURE, V432, P466, DOI 10.1038/nature03000; Bock-Marquette I, 2009, J MOL CELL CARDIOL, V46, P728, DOI 10.1016/j.yjmcc.2009.01.017; Cai CL, 2008, NATURE, V454, P104, DOI 10.1038/nature06969; Chen J, 1998, DEVELOPMENT, V125, P1943; Christoffels VM, 2009, NATURE, V458, pE8, DOI 10.1038/nature07916; Heiberg E, 2005, COMPUT CARDIOL, V32, P599; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI DOI 10.2307/1390807; Laugwitz KL, 2005, NATURE, V433, P647, DOI 10.1038/nature03215; Limana F, 2010, J MOL CELL CARDIOL, V48, P609, DOI 10.1016/j.yjmcc.2009.11.008; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mahtab EAF, 2008, DEV DYNAM, V237, P847, DOI 10.1002/dvdy.21463; Moorman AFM, 2001, J HISTOCHEM CYTOCHEM, V49, P1, DOI 10.1177/002215540104900101; Moretti A, 2006, CELL, V127, P1151, DOI 10.1016/j.cell.2006.10.029; Prall OWJ, 2007, CELL, V128, P947, DOI 10.1016/j.cell.2007.01.042; Price A., 2010, J CARDIOVASC MAGN S1, V12, pP98; Rubart M, 2003, AM J PHYSIOL-CELL PH, V284, pC1654, DOI 10.1152/ajpcell.00469.2002; Smart N., 2009, CURR PROTOC STEM CEL; Smart N, 2007, NATURE, V445, P177, DOI 10.1038/nature05383; Smart N, 2010, ANN NY ACAD SCI, V1194, P97, DOI 10.1111/j.1749-6632.2010.05478.x; Wagner KD, 2002, FASEB J, V16, P1117, DOI 10.1096/fj.01-0986fje; Willems E, 2009, PEDIATR CARDIOL, V30, P635, DOI 10.1007/s00246-009-9409-2; Wu SM, 2006, CELL, V127, P1137, DOI 10.1016/j.cell.2006.10.028; Zhou B, 2008, NATURE, V454, P109, DOI 10.1038/nature07060	24	480	501	1	76	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 30	2011	474	7353					640	U117		10.1038/nature10188	http://dx.doi.org/10.1038/nature10188			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	785CF	21654746	Green Accepted, Bronze			2022-12-24	WOS:000292204300039
J	Iheanacho, I				Iheanacho, Ike			DRUG TALES AND OTHER STORIES Death of the silent witness: patients' reporting of adverse drug reactions	BRITISH MEDICAL JOURNAL			English	Editorial Material									Drug & Therapeut Bulletin, London, England		Iheanacho, I (corresponding author), Drug & Therapeut Bulletin, London, England.	iiheanacho@bmjgroup.com							0	0	0	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 29	2011	342								d4042	10.1136/bmj.d4042	http://dx.doi.org/10.1136/bmj.d4042			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	788PZ	21715457				2022-12-24	WOS:000292458200007
J	Wang, X; Ouyang, H; Yamamoto, Y; Kumar, PA; Wei, TS; Dagher, R; Vincent, M; Lu, X; Bellizzi, AM; Ho, KY; Crum, CP; Xian, W; McKeon, F				Wang, Xia; Ouyang, Hong; Yamamoto, Yusuke; Kumar, Pooja Ashok; Wei, Tay Seok; Dagher, Rania; Vincent, Matthew; Lu, Xin; Bellizzi, Andrew M.; Ho, Khek Yu; Crum, Christopher P.; Xian, Wa; McKeon, Frank			Residual Embryonic Cells as Precursors of a Barrett's-like Metaplasia	CELL			English	Article							INFLAMMATORY-BOWEL-DISEASE; ESOPHAGEAL ADENOCARCINOMA; INTESTINAL METAPLASIA; SQUAMOUS EPITHELIUM; COLUMNAR EPITHELIUM; GENE-EXPRESSION; GASTRIC-CANCER; STEM-CELLS; DYSPLASIA; P63	Barrett's esophagus is an intestine-like metaplasia and precursor of esophageal adenocarcinoma. Triggered by gastroesophageal reflux disease, the origin of this metaplasia remains unknown. p63-deficient mice, which lack squamous epithelia, may model acid-reflux damage. We show here that p63 null embryos rapidly develop intestine-like metaplasia with gene expression profiles similar to Barrett's metaplasia. We track its source to a unique embryonic epithelium that is normally undermined and replaced by p63-expressing cells. Significantly, we show that a discrete population of these embryonic cells persists in adult mice and humans at the squamocolumnar junction, the source of Barrett's metaplasia. We show that upon programmed damage to the squamous epithelium, these embryonic cells migrate toward adjacent, specialized squamous cells in a process that may recapitulate early Barrett's. Our findings suggest that certain precancerous lesions, such as Barrett's, initiate not from genetic alterations but from competitive interactions between cell lineages driven by opportunity.	[Wei, Tay Seok; Xian, Wa] ASTAR, Inst Med Biol, Singapore 138648, Singapore; [Wang, Xia; Ouyang, Hong; McKeon, Frank] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Yamamoto, Yusuke; Kumar, Pooja Ashok; McKeon, Frank] ASTAR, Genome Inst Singapore, Singapore 138672, Singapore; [Dagher, Rania] Univ Strasbourg, Inst Sci & Ingn Supramol, F-67081 Strasbourg, France; [Vincent, Matthew] Multiclonal Therapeut Inc, Newburyport, MA 01833 USA; [Lu, Xin] Univ Oxford, Ludwig Canc Inst, Oxford OX3 7DQ, England; [Bellizzi, Andrew M.; Crum, Christopher P.; Xian, Wa] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Ho, Khek Yu] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore 119077, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB); Harvard University; Harvard Medical School; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Ludwig Institute for Cancer Research; University of Oxford; Harvard University; Brigham & Women's Hospital; National University of Singapore	Xian, W (corresponding author), ASTAR, Inst Med Biol, Singapore 138648, Singapore.	wa.xian@imb.a-star.edu.sg; mckeonf@gis.a-star.edu.sg	Kumar, Pooja Ashok/K-6762-2019	Lu, Xin/0000-0002-6587-1152; Bellizzi, Andrew/0000-0002-8264-6379; Kumar, Pooja/0000-0002-6589-2447; Ouyang, Hong/0000-0002-7622-7733	National Institutes of Health [RO1-GM083348, R21CA124688]; European Research Council; Agence de Nationale; Biomedical Research Council; National Medical Research Council, Singapore; Institute of Medical Biology; Genome Institute of Singapore of the Agency for Science, Technology, and Research, Singapore; NATIONAL CANCER INSTITUTE [R21CA124688] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083348] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Research Council(European Research Council (ERC)European Commission); Agence de Nationale; Biomedical Research Council(Agency for Science Technology & Research (A*STAR)); National Medical Research Council, Singapore(National Medical Research Council, SingaporeUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Institute of Medical Biology(Agency for Science Technology & Research (A*STAR)); Genome Institute of Singapore of the Agency for Science, Technology, and Research, Singapore; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to Prof. Rod Bronson and the Rodent Pathology Core at Harvard Medical School for help with histology, the staff of the Nikon Imaging Center of the Harvard Medical School for their help with imaging, and Prof. Ed Cox of the Dana Farber Cancer Institute Microarray Facility. We thank Da-Kai Mu for assistance with genotyping. We thank Profs. Birgit Lane of the Institute of Medical Biology, Bernard Dallemagne of the IRCAD, University of Strasbourg, and Teh Ming of the National University of Singapore for helpful discussions. We thank all the members in the Xian-McKeon laboratory for helpful discussions and support and Profs. Edison Liu and Barbara Knowles for their critical review of the manuscript. This work was supported by grants from the National Institutes of Health (RO1-GM083348 and R21CA124688), the European Research Council, the Agence de Nationale, and the Biomedical Research Council and the National Medical Research Council, Singapore and intramural grants from the Institute of Medical Biology and the Genome Institute of Singapore of the Agency for Science, Technology, and Research, Singapore.	Antonioli DA, 1997, GASTROENTEROL CLIN N, V26, P495, DOI 10.1016/S0889-8553(05)70309-5; Badreddine RJ, 2010, NAT REV GASTRO HEPAT, V7, P369, DOI 10.1038/nrgastro.2010.78; Barr H, 1996, LANCET, V348, P584, DOI 10.1016/S0140-6736(96)03054-1; Bissell MJ, 2002, DIFFERENTIATION, V70, P537, DOI 10.1046/j.1432-0436.2002.700907.x; BLOT WJ, 1991, JAMA-J AM MED ASSOC, V265, P1287, DOI 10.1001/jama.265.10.1287; Botelho NK, 2010, CANCER BIOL THER, V10, P172, DOI 10.4161/cbt.10.2.12166; Chawengsaksophak K, 1997, NATURE, V386, P84, DOI 10.1038/386084a0; Coad RA, 2005, J PATHOL, V206, P388, DOI 10.1002/path.1804; CORREA P, 1994, CANCER SURV, V20, P55; Daniely Y, 2004, AM J PHYSIOL-CELL PH, V287, pC171, DOI 10.1152/ajpcell.00226.2003; Dixon J, 2001, AM J GASTROENTEROL, V96, P2575, DOI 10.1111/j.1572-0241.2001.04159.x; Farraye FA, 2010, GASTROENTEROLOGY, V138, P746, DOI [10.1053/j.gastro.2009.12.035, 10.1053/j.gastro.2009.12.037]; Glickman JN, 2001, AM J SURG PATHOL, V25, P569, DOI 10.1097/00000478-200105000-00002; Goldenring JR, 2010, GASTROENTEROLOGY, V138, P2207, DOI 10.1053/j.gastro.2010.04.023; HAGGITT RC, 1994, HUM PATHOL, V25, P982, DOI 10.1016/0046-8177(94)90057-4; Ivanova A, 2005, GENESIS, V43, P129, DOI 10.1002/gene.20162; Jankowski JA, 1999, AM J PATHOL, V154, P965, DOI 10.1016/S0002-9440(10)65346-1; Kimchi ET, 2005, CANCER RES, V65, P3146, DOI 10.1158/0008-5472.CAN-04-2490; Kiran RP, 2010, ANN SURG, V252, P330, DOI 10.1097/SLA.0b013e3181e61e69; Leedham SJ, 2008, GUT, V57, P1041, DOI 10.1136/gut.2007.143339; LEVINE DS, 1989, LAB INVEST, V60, P418; Maley CC, 2006, NAT GENET, V38, P468, DOI 10.1038/ng1768; Mutoh H, 2002, BIOCHEM BIOPH RES CO, V294, P470, DOI 10.1016/S0006-291X(02)00480-1; NAEF AP, 1975, J THORAC CARDIOV SUR, V70, P826; Piazuelo MB, 2004, MODERN PATHOL, V17, P62, DOI 10.1038/modpathol.3800016; RASKIND WH, 1992, CANCER RES, V52, P2946; REID BJ, 1991, GASTROENTEROL CLIN N, V20, P817; Reid BJ, 2010, NAT REV CANCER, V10, P87, DOI 10.1038/nrc2773; SAGAR PM, 1995, BRIT J SURG, V82, P806, DOI 10.1002/bjs.1800820628; Schetter AJ, 2010, CARCINOGENESIS, V31, P37, DOI 10.1093/carcin/bgp272; Senoo M, 2007, CELL, V129, P523, DOI 10.1016/j.cell.2007.02.045; Souza RF, 2008, AM J PHYSIOL-GASTR L, V295, pG211, DOI 10.1152/ajpgi.90250.2008; SPECHLER SJ, 1986, NEW ENGL J MED, V315, P362, DOI 10.1056/NEJM198608073150605; Stairs DB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003534; Strobel O, 2010, GASTROENTEROLOGY, V138, P1166, DOI 10.1053/j.gastro.2009.12.005; Suh E, 1996, MOL CELL BIOL, V16, P619; Tobey NA, 2007, AM J PHYSIOL-GASTR L, V293, pG264, DOI 10.1152/ajpgi.00047.2007; van Baal JWPM, 2008, SCAND J GASTROENTERO, V43, P132, DOI 10.1080/00365520701676575; Vasioukhin V, 1999, P NATL ACAD SCI USA, V96, P8551, DOI 10.1073/pnas.96.15.8551; Wang J, 2009, J GASTROENTEROL, V44, P897, DOI 10.1007/s00535-009-0082-2; Weimann A, 2010, VIRCHOWS ARCH, V457, P537, DOI 10.1007/s00428-010-0972-y; Wojcik SM, 2001, J CELL BIOL, V154, P619, DOI 10.1083/jcb.200102079; Wong P, 2003, J CELL BIOL, V163, P327, DOI 10.1083/jcb.200305032; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0	45	245	252	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 24	2011	145	7					1023	1035		10.1016/j.cell.2011.05.026	http://dx.doi.org/10.1016/j.cell.2011.05.026			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	782QV	21703447	Green Accepted, Bronze			2022-12-24	WOS:000292025700010
J	Martin, J				Martin, Jeremy			Don't foul the water	NATURE			English	Editorial Material									[Martin, Jeremy] Union Concerned Scientists, Cambridge, MA USA		Martin, J (corresponding author), Union Concerned Scientists, Cambridge, MA USA.	JMartin@ucsusa.org						EPA, 2008, TECH REP; *USDA, 2010, FEEDGR YB	2	11	13	1	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 23	2011	474	7352					S17	S17		10.1038/474S017a	http://dx.doi.org/10.1038/474S017a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	781NJ	21697836	Bronze			2022-12-24	WOS:000291939700006
J	Taveira-DaSilva, AM; Hathaway, O; Stylianou, M; Moss, J				Taveira-DaSilva, Angelo M.; Hathaway, Olanda; Stylianou, Mario; Moss, Joel			Changes in Lung Function and Chylous Effusions in Patients With Lymphangioleiomyomatosis Treated With Sirolimus	ANNALS OF INTERNAL MEDICINE			English	Article							TUBEROUS SCLEROSIS COMPLEX; PULMONARY LYMPHANGIOLEIOMYOMATOSIS; GENE-PRODUCTS; MOUSE MODELS; IFN-GAMMA; RAPAMYCIN; LAM; CHYLOTHORAX; DISEASE; WOMEN	Background: Lymphangioleiomyomatosis (LAM) is a disorder that affects women and is characterized by cystic lung destruction, chylous effusions, lymphangioleiomyomas, and angiomyolipomas. It is caused by proliferation of abnormal smooth muscle-like cells. Sirolimus is a mammalian target of rapamycin inhibitor that has been reported to decrease the size of neoplastic growths in animal models of tuberous sclerosis complex and to reduce the size of angiomyolipomas and stabilize lung function in humans. Objective: To assess whether sirolimus therapy is associated with improvement in lung function and a decrease in the size of chylous effusions and lymphangioleiomyomas in patients with LAM. Design: Observational study. Setting: The National Institutes of Health Clinical Center. Patients: 19 patients with rapidly progressing LAM or chylous effusions. Intervention: Treatment with sirolimus. Measurements: Lung function and the size of chylous effusions and lymphangioleiomyomas before and during sirolimus therapy. Results: Over a mean of 2.5 years before beginning sirolimus therapy, the mean (+/- SE) FEV1 decreased by 2.8% +/- 0.8% predicted and diffusing capacity of the lung for carbon monoxide (DLCO) decreased by 4.8% +/- 0.9% predicted per year. In contrast, over a mean of 2.6 years of sirolimus therapy, the mean (+/- SE) FEV1 increased by 1.8% +/- 0.5% predicted and DLCO increased by 0.8% +/- 0.5% predicted per year (P < 0.001). After beginning sirolimus therapy, 12 patients with chylous effusions and 11 patients with lymphangioleiomyomas experienced almost complete resolution of these conditions. In 2 of the 12 patients, sirolimus therapy enabled discontinuation of pleural fluid drainage. Limitations: This was an observational study. The resolution of effusions may have affected improvements in lung function. Conclusion: Sirolimus therapy is associated with improvement or stabilization of lung function and reduction in the size of chylous effusions and lymphangioleiomyomas in patients with LAM.	[Taveira-DaSilva, Angelo M.] NHLBI, Cardiovasc & Pulm Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Taveira-DaSilva, AM (corresponding author), NHLBI, Cardiovasc & Pulm Branch, NIH, Bldg 10,Room 6D05,MSC 1590, Bethesda, MD 20892 USA.	dasilvaa@nhlbi.nih.gov			NHLBI, NIH [95-H-0186]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL002541] Funding Source: NIH RePORTER	NHLBI, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Grant Support: By the Intramural Research Program, NHLBI, NIH (protocol 95-H-0186).	Almoosa KF, 2006, CLIN CHEST MED, V27, P355, DOI 10.1016/j.ccm.2006.01.005; Avila NA, 2000, RADIOLOGY, V216, P147, DOI 10.1148/radiology.216.1.r00jl42147; Bissler JJ, 2004, KIDNEY INT, V66, P924, DOI 10.1111/j.1523-1755.2004.00838.x; Bissler JJ, 2008, NEW ENGL J MED, V358, P140, DOI 10.1056/NEJMoa063564; Carsillo T, 2000, P NATL ACAD SCI USA, V97, P6085, DOI 10.1073/pnas.97.11.6085; Cohen MM, 2005, THORAX, V60, P875, DOI 10.1136/thx.2004.035154; Costello LC, 2000, MAYO CLIN PROC, V75, P591, DOI 10.4065/75.6.591; Davies DM, 2008, NEW ENGL J MED, V358, P200, DOI 10.1056/NEJMc072500; El-Hashemite N, 2004, CANCER RES, V64, P3436, DOI 10.1158/0008-5472.CAN-03-3609; Franz DN, 2001, AM J RESP CRIT CARE, V164, P661, DOI 10.1164/ajrccm.164.4.2011025; Glasgow Connie G., 2009, Lymphatic Research and Biology, V7, P221, DOI 10.1089/lrb.2009.0017; Goncharova EA, 2002, J BIOL CHEM, V277, P30958, DOI 10.1074/jbc.M202678200; Goncharova EA, 2008, J CELL BIOCHEM, V103, P369, DOI 10.1002/jcb.21419; Gupta Dipin, 2004, Ann Thorac Surg, V78, pe9, DOI 10.1016/j.athoracsur.2003.12.069; Hayashida M, 2007, RESPIROLOGY, V12, P523, DOI 10.1111/j.1440-1843.2007.01101.x; Jaiswal VR, 2003, ARCH PATHOL LAB MED, V127, P879; Johnson SR, 2004, THORAX, V59, P800, DOI 10.1136/thx.2004.023283; Kenerson H, 2005, PEDIATR RES, V57, P67, DOI 10.1203/01.PDR.0000147727.78571.07; Krueger DA, 2010, NEW ENGL J MED, V363, P1801, DOI 10.1056/NEJMoa1001671; Krymskaya VP, 2009, CELL CYCLE, V8, P403, DOI 10.4161/cc.8.3.7555; Lamb RF, 2000, NAT CELL BIOL, V2, P281, DOI 10.1038/35010550; Lazor R, 2004, RESP MED, V98, P536, DOI 10.1016/j.rmed.2003.11.013; Lee L, 2005, GENE CHROMOSOME CANC, V42, P213, DOI 10.1002/gcc.20118; Lu HC, 2003, CLIN IMAG, V27, P166, DOI 10.1016/S0899-7071(01)00349-7; MacIntyre N, 2005, EUR RESPIR J, V26, P720, DOI 10.1183/09031936.05.00034905; Makrilakis K, 2004, ANN INTERN MED, V141, P246, DOI 10.7326/0003-4819-141-3-200408030-00028; Matsui K, 2000, HUM PATHOL, V31, P1242, DOI 10.1053/hupa.2000.18500; McCormack FX, 2008, CHEST, V133, P507, DOI 10.1378/chest.07-0898; McCormack FX, 2011, NEW ENGL J MED, V364, P1595, DOI 10.1056/NEJMoa1100391; Mikroulis D, 2002, CHEST, V121, P2079, DOI 10.1378/chest.121.6.2079; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Moss J, 2001, AM J RESP CRIT CARE, V164, P669, DOI 10.1164/ajrccm.164.4.2101154; NELLIST M, 1993, CELL, V75, P1305; Ohara T, 2008, ANN THORAC SURG, V86, pE7, DOI 10.1016/j.athoracsur.2008.07.062; OSBORNE JP, 1991, ANN NY ACAD SCI, V615, P125; Ryu JH, 2006, AM J RESP CRIT CARE, V173, P105, DOI 10.1164/rccm.200409-1298OC; Ryu JH, 2003, CHEST, V123, P623, DOI 10.1378/chest.123.2.623; Smolarek TA, 1998, AM J HUM GENET, V62, P810, DOI 10.1086/301804; Sooriakumaran P, 2010, BJU INT, V105, P101, DOI 10.1111/j.1464-410X.2009.08649.x; Sugimoto R, 2008, J HEART LUNG TRANSPL, V27, P921, DOI 10.1016/j.healun.2008.05.012; Taille C, 2007, ANN INTERN MED, V146, P687, DOI 10.7326/0003-4819-146-9-200705010-00022; Taveira-DaSilva AM, 2004, CHEST, V126, P1867, DOI 10.1378/chest.126.6.1867; Tee AR, 2003, CURR BIOL, V13, P1259, DOI 10.1016/S0960-9822(03)00506-2; Tee AR, 2002, P NATL ACAD SCI USA, V99, P13571, DOI 10.1073/pnas.202476899; Wong YY, 2003, AM J ROENTGENOL, V181, P284, DOI 10.2214/ajr.181.1.1810284	45	138	142	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 21	2011	154	12					797	805		10.7326/0003-4819-154-12-201106210-00007	http://dx.doi.org/10.7326/0003-4819-154-12-201106210-00007			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	779SA	21690594	Green Accepted			2022-12-24	WOS:000291800500015
J	Smith, DL; Cohen, JM; Moonen, B; Tatem, AJ; Sabot, OJ; Ali, A; Mugheiry, SM				Smith, David L.; Cohen, Justin M.; Moonen, Bruno; Tatem, Andrew J.; Sabot, Oliver J.; Ali, Abdullah; Mugheiry, Sultan M.			Solving the Sisyphean Problem of Malaria in Zanzibar	SCIENCE			English	Editorial Material							ELIMINATION		[Smith, David L.; Tatem, Andrew J.] Univ Florida, Emerging Pathogens Inst, Gainesville, FL 32610 USA; [Smith, David L.] Univ Florida, Dept Biol, Gainesville, FL 32611 USA; [Cohen, Justin M.; Moonen, Bruno; Sabot, Oliver J.] Clinton Hlth Access Initiat, Boston, MA 02127 USA; [Tatem, Andrew J.] Univ Florida, Dept Geog, Gainesville, FL 32611 USA; [Ali, Abdullah] Zanzibar Malaria Control Programme, Zanzibar, Tanzania; [Mugheiry, Sultan M.] Hlth & Social Welf, Zanzibar, Tanzania	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Smith, DL (corresponding author), Univ Florida, Emerging Pathogens Inst, Gainesville, FL 32610 USA.	smitdave@gmail.com	Smith, David L/L-8850-2013	Smith, David L/0000-0003-4367-3849; Cohen, Justin/0000-0003-4481-6784; Tatem, Andrew/0000-0002-7270-941X				Cohen JM, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-213; Feachem RGA, 2009, SHRINKING MALARIA MA; Hay SI, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000048; Laxminarayan R, 2006, LANCET, V367, P1193, DOI 10.1016/S0140-6736(06)68440-7; MATOLA YG, 1984, CENT AFR J MED, V30, P95; Moonen B, 2010, LANCET, V376, P1592, DOI 10.1016/S0140-6736(10)61269-X; OAKES A, 1900, BRIT FOREIGN STATE P; RBMP, 2008, GLOB MAL ACT PLAN MA; Sabot O, 2010, LANCET, V376, P1604, DOI 10.1016/S0140-6736(10)61355-4; Smith DL, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-131; Snow RW, 2010, LANCET, V376, P137, DOI 10.1016/S0140-6736(10)60577-6; WHO, 2010, WORLD MALARIA REPORT 2010, P1; Zanzibar Malaria Control Programme (ZMCP), 2008, ROLL BACK MAL IND SU; *ZMCP, 2009, MAL EL ZANZ FEAS ASS; *ZMCP, 2011, ROLL BACK MAL IND SU	15	27	28	1	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 17	2011	332	6036					1384	1385		10.1126/science.1201398	http://dx.doi.org/10.1126/science.1201398			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	778FT	21680828				2022-12-24	WOS:000291689000024
J	Issigonis, M; Matunis, E				Issigonis, Melanie; Matunis, Erika			SnapShot: Stem Cell Niches of the Drosophila Testis and Ovary	CELL			English	Editorial Material							DIVISION		[Issigonis, Melanie; Matunis, Erika] Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA	Johns Hopkins University	Issigonis, M (corresponding author), Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA.				NCRR NIH HHS [S10 RR024550] Funding Source: Medline; NICHD NIH HHS [R01 HD040307] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD040307] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024550] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Ables ET, 2010, CELL STEM CELL, V7, P581, DOI 10.1016/j.stem.2010.10.001; Cheng J, 2011, DEVELOPMENT, V138, P831, DOI 10.1242/dev.057901; DECUEVAS M, 2011, DEV IN PRESS, V138, DOI DOI 10.1242/DEV.056242; Drummond-Barbosa D, 2008, GENETICS, V180, P1787, DOI 10.1534/genetics.108.098244; Fuller MT, 2007, SCIENCE, V316, P402, DOI 10.1126/science.1140861; Issigonis M, 2009, SCIENCE, V326, P153, DOI 10.1126/science.1176817; Leatherman JL, 2010, NAT CELL BIOL, V12, P806, DOI 10.1038/ncb2086; McLeod CJ, 2010, CURR BIOL, V20, P2100, DOI 10.1016/j.cub.2010.10.038; Ueishi S, 2009, CELL STRUCT FUNCT, V34, P61, DOI 10.1247/csf.08042; Yamashita YM, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001313	10	9	9	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 10	2011	145	6					994	U197		10.1016/j.cell.2011.05.037	http://dx.doi.org/10.1016/j.cell.2011.05.037			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	775LS	21663800	Bronze			2022-12-24	WOS:000291461600025
J	Scott, CT; McCormick, JB; DeRouen, MC; Owen-Smith, J				Scott, Christopher Thomas; McCormick, Jennifer B.; DeRouen, Mindy C.; Owen-Smith, Jason			Democracy Derived? New Trajectories in Pluripotent Stem Cell Research	CELL			English	Editorial Material								How has the development of human induced pluripotent stem cells (hiPSCs) modified the trajectory of stem cell research? Here, coauthorship networks of stem cell research articles and analysis of cell lines used in stem cell research indicate that hiPSCs are not replacing human embryonic stem cells, but instead, the two cell types are complementary, interdependent research tools. Thus, we conclude that a ban on funding for embryonic stem cell research could have unexpected negative ramifications on the nascent field of hiPSCs.	[Scott, Christopher Thomas; DeRouen, Mindy C.] Stanford Univ, Stanford Univ Ctr Biomed Eth Program Stem Cells &, Stanford, CA 94305 USA; [McCormick, Jennifer B.] Mayo Clin, Div Gen Internal Med, Rochester, MN 55905 USA; [McCormick, Jennifer B.] Mayo Clin, Div Hlth Care Policy Res, Rochester, MN 55905 USA; [Owen-Smith, Jason] Univ Michigan, Ann Arbor, MI 48109 USA	Stanford University; Mayo Clinic; Mayo Clinic; University of Michigan System; University of Michigan	Scott, CT (corresponding author), Stanford Univ, Stanford Univ Ctr Biomed Eth Program Stem Cells &, Stanford, CA 94305 USA.	cscott@stanford.edu; jdos@umich.edu	McBee, David J/F-3968-2012; Owen-Smith, Jason/B-3665-2012	DeRouen, Mindy/0000-0002-7198-7629; Owen-Smith, Jason/0000-0001-8007-1121	NCRR NIH HHS [UL1 RR024150-4, UL1 RR024150] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024150] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		FRUCHTERMAN TMJ, 1991, SOFTWARE PRACT EXPER, V21, P1129, DOI 10.1002/spe.4380211102; Hu BY, 2010, P NATL ACAD SCI USA, V107, P4335, DOI 10.1073/pnas.0910012107; KAMADA T, 1989, INFORM PROCESS LETT, V31, P7, DOI 10.1016/0020-0190(89)90102-6; Karmali RN, 2010, NAT BIOTECHNOL, V28, P1246, DOI 10.1038/nbt1210-1246; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Moody J, 2004, AM SOCIOL REV, V69, P213, DOI 10.1177/000312240406900204; Mosher JT, 2010, NEW ENGL J MED, V362, P183, DOI 10.1056/NEJMc0910371; Newman MEJ, 2001, P NATL ACAD SCI USA, V98, P404, DOI 10.1073/pnas.021544898; Pera MF, 2011, NATURE, V471, P46, DOI 10.1038/471046a; Scott CT, 2010, NAT METHODS, V7, P866, DOI 10.1038/nmeth1110-866; Scott CT, 2009, NAT BIOTECHNOL, V27, P696, DOI 10.1038/nbt0809-696; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhao TB, 2011, NATURE, V474, P212, DOI 10.1038/nature10135	14	33	34	7	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 10	2011	145	6					820	826		10.1016/j.cell.2011.05.032	http://dx.doi.org/10.1016/j.cell.2011.05.032			7	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	775LS	21663787	Green Accepted, Bronze			2022-12-24	WOS:000291461600009
J	Banwart, S				Banwart, Steve			Save our soils	NATURE			English	Editorial Material									[Banwart, Steve] Univ Sheffield, Kroto Res Inst, Sheffield S3 7HQ, S Yorkshire, England	University of Sheffield	Banwart, S (corresponding author), Univ Sheffield, Kroto Res Inst, Sheffield S3 7HQ, S Yorkshire, England.	s.a.banwart@sheffield.ac.uk	Banwart, Steven/B-3915-2016; Robinson, David A/A-6287-2010	Banwart, Steven/0000-0001-7223-6678; Robinson, David A/0000-0001-7290-4867				Alcamo J, 2007, AR4 CLIMATE CHANGE 2007: IMPACTS, ADAPTATION, AND VULNERABILITY, P541; Bellamy PH, 2005, NATURE, V437, P245, DOI 10.1038/nature04038; European Commission, 2006, COM2006231 EUR COMM; European Environmental Agency (EEA), 2006, URB SPRAWL EUR IGN C; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Montgomery DR, 2007, P NATL ACAD SCI USA, V104, P13268, DOI 10.1073/pnas.0611508104; Shein E.V., 2005, KURS FIZIKI POCHV UC	7	126	135	2	175	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 9	2011	474	7350					151	152		10.1038/474151a	http://dx.doi.org/10.1038/474151a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	774PE	21654781	Green Accepted			2022-12-24	WOS:000291397800025
J	Roeling, D; Morelli, LG; Ares, S; Julicher, F; Oates, AC				Roeling, Daniela; Morelli, Luis G.; Ares, Saul; Juelicher, Frank; Oates, Andrew C.			SnapShpt: The Segmentation Clock	CELL			English	Editorial Material							SOMITOGENESIS; NUMBER		[Roeling, Daniela; Morelli, Luis G.; Oates, Andrew C.] Max Planck Inst Cell Biol & Genet, D-01307 Dresden, Germany; [Ares, Saul; Juelicher, Frank] Max Planck Inst Phys Komplexer Syst, D-01187 Dresden, Germany	Max Planck Society; Max Planck Society	Roeling, D (corresponding author), Max Planck Inst Cell Biol & Genet, D-01307 Dresden, Germany.		Morelli, Luis G/A-6345-2009; Ares, Saúl/B-4082-2008; Julicher, Frank/B-1828-2009	Morelli, Luis G/0000-0001-5614-073X; Ares, Saúl/0000-0001-6214-4083; Julicher, Frank/0000-0003-4731-9185				Aulehla A, 2003, DEV CELL, V4, P395, DOI 10.1016/S1534-5807(03)00055-8; COOKE J, 1976, J THEOR BIOL, V58, P455, DOI 10.1016/S0022-5193(76)80131-2; Dubrulle J, 2001, CELL, V106, P219, DOI 10.1016/S0092-8674(01)00437-8; Gomez C, 2008, NATURE, V454, P335, DOI 10.1038/nature07020; Herrgen L, 2010, CURR BIOL, V20, P1244, DOI 10.1016/j.cub.2010.06.034; Horikawa K, 2006, NATURE, V441, P719, DOI 10.1038/nature04861; KROL AJ, 2011, IN PRESS; Lewis J, 2003, CURR BIOL, V13, P1398, DOI 10.1016/S0960-9822(03)00534-7; Masamizu Y, 2006, P NATL ACAD SCI USA, V103, P1313, DOI 10.1073/pnas.0508658103; Palmeirim I, 1997, CELL, V91, P639, DOI 10.1016/S0092-8674(00)80451-1; Riedel-Kruse IH, 2007, SCIENCE, V317, P1911, DOI 10.1126/science.1142538; Schroter C, 2010, CURR BIOL, V20, P1254, DOI 10.1016/j.cub.2010.05.071	12	5	5	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 27	2011	145	5					800	+		10.1016/j.cell.2011.05.007	http://dx.doi.org/10.1016/j.cell.2011.05.007			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	769MR	21620141	Bronze			2022-12-24	WOS:000291018600018
J	Astrow, AB; Popp, B				Astrow, Alan B.; Popp, Beth			The Palliative Care Information Act in Real Life	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Astrow, Alan B.; Popp, Beth] Maimonides Hosp, Brooklyn, NY 11219 USA	Maimonides Medical Center	Astrow, AB (corresponding author), Maimonides Hosp, Brooklyn, NY 11219 USA.								0	28	28	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 19	2011	364	20					1885	1887		10.1056/NEJMp1102392	http://dx.doi.org/10.1056/NEJMp1102392			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	765PJ	21591941				2022-12-24	WOS:000290720700001
J	Iheanacho, I				Iheanacho, Ike			DRUG TALES AND OTHER STORIES Take it like a man: pseudodrugs for man flu	BRITISH MEDICAL JOURNAL			English	Editorial Material												iiheanacho@bmjgroup.com							0	1	1	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 11	2011	342								d2863	10.1136/bmj.d2863	http://dx.doi.org/10.1136/bmj.d2863			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	765OP	21562005				2022-12-24	WOS:000290718400004
J	Li, HJ; Haurigot, V; Doyon, Y; Li, TJ; Wong, SNY; Bhagwat, AS; Malani, N; Anguela, XM; Sharma, R; Ivanciu, L; Murphy, SL; Finn, JD; Khazi, FR; Zhou, SZ; Paschon, DE; Rebar, EJ; Bushman, FD; Gregory, PD; Holmes, MC; High, KA				Li, Hojun; Haurigot, Virginia; Doyon, Yannick; Li, Tianjian; Wong, Sunnie Y.; Bhagwat, Anand S.; Malani, Nirav; Anguela, Xavier M.; Sharma, Rajiv; Ivanciu, Lacramiora; Murphy, Samuel L.; Finn, Jonathan D.; Khazi, Fayaz R.; Zhou, Shangzhen; Paschon, David E.; Rebar, Edward J.; Bushman, Frederic D.; Gregory, Philip D.; Holmes, Michael C.; High, Katherine A.			In vivo genome editing restores haemostasis in a mouse model of haemophilia	NATURE			English	Article							ZINC-FINGER NUCLEASES; LEBERS CONGENITAL AMAUROSIS; GENE-THERAPY; FACTOR-IX; CHIMERIC NUCLEASES; CELLS; TRANSDUCTION; VECTOR; DISRUPTION; DEFICIENCY	Editing of the human genome to correct disease-causing mutations is a promising approach for the treatment of genetic disorders. Genome editing improves on simple gene-replacement strategies by effecting in situ correction of a mutant gene, thus restoring normal gene function under the control of endogenous regulatory elements and reducing risks associated with random insertion into the genome. Gene-specific targeting has historically been limited to mouse embryonic stem cells. The development of zinc finger nucleases (ZFNs) has permitted efficient genome editing in transformed and primary cells that were previously thought to be intractable to such genetic manipulation(1). In vitro, ZFNs have been shown to promote efficient genome editing via homology-directed repair by inducing a site-specific double-strand break (DSB) at a target locus(2-4), but it is unclear whether ZFNs can induce DSBs and stimulate genome editing at a clinically meaningful level in vivo. Here we show that ZFNs are able to induce DSBs efficiently when delivered directly to mouse liver and that, when co-delivered with an appropriately designed gene-targeting vector, they can stimulate gene replacement through both homology-directed and homology-independent targeted gene insertion at the ZFN-specified locus. The level of gene targeting achieved was sufficient to correct the prolonged clotting times in a mouse model of haemophilia B, and remained persistent after induced liver regeneration. Thus, ZFN-driven gene correction can be achieved in vivo, raising the possibility of genome editing as a viable strategy for the treatment of genetic disease.	[Li, Hojun; Haurigot, Virginia; Bhagwat, Anand S.; Anguela, Xavier M.; Sharma, Rajiv; Ivanciu, Lacramiora; Murphy, Samuel L.; Finn, Jonathan D.; Khazi, Fayaz R.; Zhou, Shangzhen; High, Katherine A.] Childrens Hosp Philadelphia, CTRB 5000, Div Hematol, Philadelphia, PA 19104 USA; [Doyon, Yannick; Li, Tianjian; Wong, Sunnie Y.; Paschon, David E.; Rebar, Edward J.; Gregory, Philip D.; Holmes, Michael C.] Sangamo BioSci, Point Richmond Tech Ctr, Richmond, CA 94804 USA; [Malani, Nirav; Bushman, Frederic D.] Univ Penn, Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA; [High, Katherine A.] Howard Hughes Med Inst, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Sangamo Therapeutics, Inc.; University of Pennsylvania; Howard Hughes Medical Institute	High, KA (corresponding author), Childrens Hosp Philadelphia, CTRB 5000, Div Hematol, 3501 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	mholmes@sangamo.com; high@email.chop.edu	Anguela, Xavier M/D-3223-2013; High, Katherine A./AAB-9322-2020; Wilson, Matthew H/K-3193-2013; Anguela, Xavier/K-9594-2019; Huang, ZhiXin/H-5123-2017	Anguela, Xavier M/0000-0003-2430-8598; Anguela, Xavier/0000-0003-2430-8598; Huang, ZhiXin/0000-0003-0705-1970; Sharma, Rajiv/0000-0002-8147-5723; High, Katherine/0000-0002-0805-6223; Bushman, Frederic/0000-0003-4740-4056; Doyon, Yannick/0000-0002-3889-9563; Gregory, Philip/0000-0001-9249-2468; Haurigot, Virginia A./0000-0002-9772-2565	National Institutes of Health; Howard Hughes Medical Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL064190, T32HL007150] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by the National Institutes of Health and the Howard Hughes Medical Institute.	Aiuti A, 2009, NEW ENGL J MED, V360, P447, DOI 10.1056/NEJMoa0805817; Ayuso E, 2010, GENE THER, V17, P503, DOI 10.1038/gt.2009.157; Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268; Berry C, 2006, PLOS COMPUT BIOL, V2, P1450, DOI 10.1371/journal.pcbi.0020157; Bibikova M, 2001, MOL CELL BIOL, V21, P289, DOI 10.1128/MCB.21.1.289-297.2001; Cartier N, 2009, SCIENCE, V326, P818, DOI 10.1126/science.1171242; Cavazzana-Calvo M, 2010, NATURE, V467, P318, DOI 10.1038/nature09328; Cideciyan AV, 2008, P NATL ACAD SCI USA, V105, P15112, DOI 10.1073/pnas.0807027105; Doyon Y, 2008, NAT BIOTECHNOL, V26, P702, DOI 10.1038/nbt1409; GREEN PM, 2004, HAEMOPHILIA B MUTATI; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; Howe SJ, 2008, J CLIN INVEST, V118, P3143, DOI 10.1172/JCI35798; Li HJ, 2011, BLOOD, V117, P3311, DOI 10.1182/blood-2010-08-302729; Lin HF, 1997, BLOOD, V90, P3962, DOI 10.1182/blood.V90.10.3962; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Manno CS, 2006, NAT MED, V12, P342, DOI 10.1038/nm1358; Miao CH, 2000, MOL THER, V1, P522, DOI 10.1006/mthe.2000.0075; Miller DG, 2004, NAT GENET, V36, P767, DOI 10.1038/ng1380; Mitchell C, 2008, NAT PROTOC, V3, P1167, DOI 10.1038/nprot.2008.80; Moehle EA, 2007, P NATL ACAD SCI USA, V104, P3055, DOI 10.1073/pnas.0611478104; Nakai H, 2003, NAT GENET, V34, P297, DOI 10.1038/ng1179; Nakai H, 2001, J VIROL, V75, P6969, DOI 10.1128/JVI.75.15.6969-6976.2001; Perez EE, 2008, NAT BIOTECHNOL, V26, P808, DOI 10.1038/nbt1410; POLLAK ES, 2001, METABOLIC MOL BASES, P4393; Porteus MH, 2003, SCIENCE, V300, P763, DOI 10.1126/science.1078395; THOMPSON AR, 1994, HUM GENET, V94, P299; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; Zambrowicz BP, 1997, P NATL ACAD SCI USA, V94, P3789, DOI 10.1073/pnas.94.8.3789	30	394	480	1	92	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 14	2011	475	7355					217	U128		10.1038/nature10177	http://dx.doi.org/10.1038/nature10177			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791UA	21706032	Green Accepted			2022-12-24	WOS:000292690500048
J	Chiuve, SE; Fung, TT; Rexrode, KM; Spiegelman, D; Manson, JE; Stampfer, MJ; Albert, CM				Chiuve, Stephanie E.; Fung, Teresa T.; Rexrode, Kathryn M.; Spiegelman, Donna; Manson, JoAnn E.; Stampfer, Meir J.; Albert, Christine M.			Adherence to a Low-Risk, Healthy Lifestyle and Risk of Sudden Cardiac Death Among Women	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY-HEART-DISEASE; POLYUNSATURATED FATTY-ACIDS; BODY-MASS INDEX; MEDITERRANEAN DIET; MYOCARDIAL-INFARCTION; PRIMARY PREVENTION; PROSPECTIVE COHORT; PHYSICAL-ACTIVITY; MORTALITY; TIME	Context Sudden cardiac death (SCD) accounts for more than half of all cardiac deaths; the majority of SCD events occur as the first manifestation of heart disease, especially among women. Primary preventive strategies are needed to reduce SCD incidence. Objective To estimate the degree to which adherence to a healthy lifestyle may lower the risk of SCD among women. Design, Setting, and Participants A prospective cohort study of 81 722 US women in the Nurses' Health Study from June 1984 to June 2010. Lifestyle factors were assessed via questionnaires every 2 to 4 years. A low-risk lifestyle was defined as not smoking, body mass index of less than 25, exercise duration of 30 minutes/day or longer, and top 40% of the alternate Mediterranean diet score, which emphasizes high intake of vegetables, fruits, nuts, legumes, whole grains, and fish and moderate intake of alcohol. Main Outcome Measure Sudden cardiac death (defined as death occurring within 1 hour after symptom onset without evidence of circulatory collapse). Results There were 321 cases of SCD during 26 years of follow-up. Women were a mean age of 72 years at the time of the SCD event. All 4 low-risk lifestyle factors were significantly and independently associated with a lower risk of SCD. The absolute risks of SCD were 22 cases/100 000 person-years among women with 0 low-risk factors, 17 cases/100 000 person-years with 1 low-risk factor, 18 cases/100 000 person-years with 2 low-risk factors, 13 cases/100 000 person-years with 3 low-risk factors, and 16 cases/100 000 person-years with 4 low-risk factors. Compared with women with 0 low-risk factors, the multivariable relative risk of SCD was 0.54 (95% confidence interval [CI], 0.34-0.86) for women with 1 low-risk factor, 0.41 (95% CI, 0.25-0.65) for 2 low-risk factors, 0.33 (95% CI, 0.20-0.54) for 3 low-risk factors, and 0.08 (95% CI, 0.03-0.23) for 4 low-risk factors. The proportion of SCD attributable to smoking, inactivity, overweight, and poor diet was 81%(95% CI, 52%-93%). Among women without clinically diagnosed coronary heart disease, the percentage of population attributable risk was 79% (95% CI, 40%-93%). Conclusion Adherence to a low-risk lifestyle is associated with a low risk of SCD.	[Chiuve, Stephanie E.; Albert, Christine M.] Brigham & Womens Hosp, Dept Med, Ctr Arrhythmia Prevent, Boston, MA 02115 USA; [Chiuve, Stephanie E.; Rexrode, Kathryn M.; Manson, JoAnn E.; Stampfer, Meir J.; Albert, Christine M.] Brigham & Womens Hosp, Dept Med, Div Prevent Med, Boston, MA 02115 USA; [Albert, Christine M.] Brigham & Womens Hosp, Dept Med, Div Cardiovasc, Boston, MA 02115 USA; [Spiegelman, Donna; Stampfer, Meir J.] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA 02115 USA; [Chiuve, Stephanie E.; Fung, Teresa T.; Stampfer, Meir J.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Chiuve, Stephanie E.; Fung, Teresa T.; Stampfer, Meir J.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Spiegelman, Donna; Manson, JoAnn E.; Stampfer, Meir J.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Fung, Teresa T.] Simmons Coll, Dept Nutr, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Simmons University	Chiuve, SE (corresponding author), 900 Commonwealth Ave, Boston, MA 02215 USA.	schiuve@hsph.harvard.edu	Rexrode, Kathryn M/I-1177-2018	Albert, Christine/0000-0002-2081-1121; Rexrode, Kathryn/0000-0003-3387-8429; Chiuve, Stephanie/0000-0002-3524-8917	National Institutes of Health [CA 87969, HL 034594]; American Heart Association [K99 HL097068]; NATIONAL CANCER INSTITUTE [P01CA087969] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL097068, R01HL034594] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by grants CA 87969 and HL 034594 from the National Institutes of Health. Dr Chiuve was supported in part by grant K99 HL097068 and a Clinical Research Program Award from the American Heart Association. Dr Albert was supported in part by an Established Investigator Award from the American Heart Association.	Adams KF, 2006, NEW ENGL J MED, V355, P763, DOI 10.1056/NEJMoa055643; Ajani UA, 2004, ANN EPIDEMIOL, V14, P731, DOI 10.1016/j.annepidem.2003.10.008; Albert CM, 2002, NEW ENGL J MED, V346, P1113, DOI 10.1056/NEJMoa012918; Albert CM, 1998, JAMA-J AM MED ASSOC, V279, P23, DOI 10.1001/jama.279.1.23; Albert CM, 1999, CIRCULATION, V100, P944, DOI 10.1161/01.CIR.100.9.944; Albert CM, 2003, CIRCULATION, V107, P2096, DOI 10.1161/01.CIR.0000065223.21530.11; Albert CM, 2002, ARCH INTERN MED, V162, P1382, DOI 10.1001/archinte.162.12.1382; Baik I, 2000, AM J EPIDEMIOL, V152, P264, DOI 10.1093/aje/152.3.264; Chiuve SE, 2008, CIRCULATION, V118, P947, DOI 10.1161/CIRCULATIONAHA.108.781062; Chugh SS, 2009, J AM COLL CARDIOL, V54, P2006, DOI 10.1016/j.jacc.2009.07.038; Chugh SS, 2008, PROG CARDIOVASC DIS, V51, P213, DOI 10.1016/j.pcad.2008.06.003; COLDITZ GA, 1986, AM J EPIDEMIOL, V123, P48, DOI 10.1093/oxfordjournals.aje.a114223; COPELAND KT, 1977, AM J EPIDEMIOL, V105, P488, DOI 10.1093/oxfordjournals.aje.a112408; DAGOSTINO RB, 1990, STAT MED, V9, P1501, DOI 10.1002/sim.4780091214; de Gonzalez AB, 2010, NEW ENGL J MED, V363, P2211, DOI 10.1056/NEJMoa1000367; de Lorgeril M, 1999, CIRCULATION, V99, P779, DOI 10.1161/01.CIR.99.6.779; DURRLEMAN S, 1989, STAT MED, V8, P551, DOI 10.1002/sim.4780080504; FerroLuzzi A, 1995, WHO TECH REP SER, V854, P1; Ford ES, 2009, ARCH INTERN MED, V169, P1355, DOI 10.1001/archinternmed.2009.237; Forman JP, 2009, JAMA-J AM MED ASSOC, V302, P401, DOI 10.1001/jama.2009.1060; Fung TT, 2009, CIRCULATION, V119, P1093, DOI 10.1161/CIRCULATIONAHA.108.816736; Hildebrandt Mandy, 2006, BMC Med Res Methodol, V6, P32, DOI 10.1186/1471-2288-6-32; HINKLE LE, 1982, CIRCULATION, V65, P457, DOI 10.1161/01.CIR.65.3.457; Hu FB, 1999, AM J EPIDEMIOL, V149, P531, DOI 10.1093/oxfordjournals.aje.a009849; Hu FB, 2001, NEW ENGL J MED, V345, P790, DOI 10.1056/NEJMoa010492; Jouven X, 1999, CIRCULATION, V99, P1978, DOI 10.1161/01.CIR.99.15.1978; KANNEL WB, 1975, CIRCULATION, V51, P606, DOI 10.1161/01.CIR.51.4.606; Knoops KTB, 2004, JAMA-J AM MED ASSOC, V292, P1433, DOI 10.1001/jama.292.12.1433; Lemaitre RN, 1999, ARCH INTERN MED, V159, P686, DOI 10.1001/archinte.159.7.686; Lloyd-Jones DM, 2010, CIRCULATION, V121, P586, DOI 10.1161/CIRCULATIONAHA.109.192703; Marchioli R, 2002, CIRCULATION, V105, P1897, DOI 10.1161/01.CIR.0000014682.14181.F2; PETERS RW, 1995, J AM COLL CARDIOL, V26, P1287, DOI 10.1016/0735-1097(95)00328-2; Platz EA, 2000, CANCER CAUSE CONTROL, V11, P579, DOI 10.1023/A:1008999232442; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Roger VL, 2009, JAMA-J AM MED ASSOC, V302, P437, DOI 10.1001/jama.2009.1075; Schoenborn Charlotte A, 2010, Vital Health Stat 10, P1; SHEKELLE RB, 1982, AM J EPIDEMIOL, V115, P506, DOI 10.1093/oxfordjournals.aje.a113332; Shojania KG, 2003, JAMA-J AM MED ASSOC, V289, P2849, DOI 10.1001/jama.289.21.2849; SISCOVICK DS, 1995, JAMA-J AM MED ASSOC, V274, P1363, DOI 10.1001/jama.274.17.1363; SISCOVICK DS, 1986, AM J EPIDEMIOL, V123, P490, DOI 10.1093/oxfordjournals.aje.a114265; Sofi F, 2010, AM J CLIN NUTR, V92, P1189, DOI 10.3945/ajcn.2010.29673; Spiegelman D, 2007, CANCER CAUSE CONTROL, V18, P571, DOI 10.1007/s10552-006-0090-y; Stampfer MJ, 2000, NEW ENGL J MED, V343, P16, DOI 10.1056/NEJM200007063430103; Stecker EC, 2006, J AM COLL CARDIOL, V47, P1161, DOI 10.1016/j.jacc.2005.11.045; United States Department of Health and Human Services, 2008 PHYS ACT GUID A; US Department of Agriculture, 1963, COMP FOODS RAW PROC, V8; van Dam RM, 2008, BRIT MED J, V337, pa1440, DOI [DOI 10.1136/BMJ.A1440, 10.1136/bmj.a1440]; WACHOLDER S, 1994, AM J EPIDEMIOL, V140, P303, DOI 10.1093/oxfordjournals.aje.a117252; WANNAMETHEE G, 1995, CIRCULATION, V91, P1749, DOI 10.1161/01.CIR.91.6.1749; Whang W, 2006, JAMA-J AM MED ASSOC, V295, P1399, DOI 10.1001/jama.295.12.1399; Willett WC, 2010, AM J CLIN NUTR, V91, P829, DOI 10.3945/ajcn.2010.29347; WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086; WOLF AM, 1994, INT J EPIDEMIOL, V23, P991, DOI 10.1093/ije/23.5.991; Zheng ZJ, 2001, CIRCULATION, V104, P2158, DOI 10.1161/hc4301.098254	54	125	132	1	17	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 6	2011	306	1					62	69		10.1001/jama.2011.907	http://dx.doi.org/10.1001/jama.2011.907			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	787LV	21730242	Green Accepted, Bronze			2022-12-24	WOS:000292378700021
J	Usherwood, JR; Stavrou, M; Lowe, JC; Roskilly, K; Wilson, AM				Usherwood, James R.; Stavrou, Marinos; Lowe, John C.; Roskilly, Kyle; Wilson, Alan M.			Flying in a flock comes at a cost in pigeons	NATURE			English	Article							VORTEX THEORY; FLIGHT; FREQUENCY; BIRDS; DRAG	Flying birds often form flocks, with social(1), navigational(2) and antipredator(3) implications. Further, flying in a flock can result in aerodynamic benefits, thus reducing power requirements(4), as demonstrated by a reduction in heart rate and wingbeat frequency in pelicans flying in a V-formation(5). But how general is an aerodynamic power reduction due to group-flight? V-formation flocks are limited to moderately steady flight in relatively large birds, and may represent a special case. What are the aerodynamic consequences of flying in the more usual 'cluster'(6,7) flock? Here we use data from innovative back-mounted Global Positioning System (GPS) and 6-degrees-of-freedom inertial sensors to show that pigeons (1) maintain powered, banked turns like aircraft, imposing dorsal accelerations of up to 2g, effectively doubling body weight and quadrupling induced power requirements; (2) increase flap frequency with increases in all conventional aerodynamic power requirements; and (3) increase flap frequency when flying near, particularly behind, other birds. Therefore, unlike V-formation pelicans, pigeons do not gain an aerodynamic advantage from flying in a flock. Indeed, the increased flap frequency, whether due to direct aerodynamic interactions or requirements for increased stability or control, suggests a considerable energetic cost to flight in a tight cluster flock.	[Usherwood, James R.; Stavrou, Marinos; Lowe, John C.; Roskilly, Kyle; Wilson, Alan M.] Univ London, Struct & Mot Lab, Royal Vet Coll, Hatfield AL9 7TA, Herts, England	University of London; University of London Royal Veterinary College	Usherwood, JR (corresponding author), Univ London, Struct & Mot Lab, Royal Vet Coll, Hatfield AL9 7TA, Herts, England.	jusherwood@rvc.ac.uk		Wilson, Alan/0000-0001-9914-3455	Wellcome Trust; Royal Society; BBSRC; EPSRC; EPSRC [EP/H013016/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/H013016/1] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Royal Society(Royal Society of London); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We would like to thank T. Hubel, H. Chapman, V. Unt and T. Demes for practical assistance, and The Wellcome Trust (J.R.U.), The Royal Society (A.M.W.), BBSRC (K.R.) and EPSRC for funding.	Bilo D., 1984, BIONA REP, V3, P87; Dell'Ariccia G, 2008, ANIM BEHAV, V76, P1165, DOI 10.1016/j.anbehav.2008.05.022; ELLINGTON CP, 1984, PHILOS T ROY SOC B, V305, P115, DOI 10.1098/rstb.1984.0053; Greene P R, 1979, Physiologist, V22, pS35; Hedrick TL, 2004, J EXP BIOL, V207, P1689, DOI 10.1242/jeb.00933; Hedrick TL, 2009, SCIENCE, V324, P252, DOI 10.1126/science.1168431; HEPPNER FH, 1974, BIRD BANDING, V45, P160, DOI 10.2307/4512025; HIGDON JJL, 1978, AM NAT, V112, P727, DOI 10.1086/283314; Lilienthal O., 2001, BIRDFLIGHT BASIS AVI; LISSAMAN PB, 1970, SCIENCE, V168, P1003, DOI 10.1126/science.168.3934.1003; Nagy M, 2010, NATURE, V464, P890, DOI 10.1038/nature08891; Pennycuick C.J., 1989, BIRD FLIGHT PERFORMA; Pennycuick CJ, 1996, J EXP BIOL, V199, P2757; POMEROY H, 1992, AUK, V109, P256; RAYNER JMV, 1979, J FLUID MECH, V91, P697, DOI 10.1017/S0022112079000410; Schmidt-Wellenburg CA, 2007, J COMP PHYSIOL B, V177, P327, DOI 10.1007/s00360-006-0132-5; Spedding GR, 2010, J AIRCRAFT, V47, P120, DOI 10.2514/1.44247; Tinbergen, 1951, STUDY INSTINCT; Tobalske BW, 2003, NATURE, V421, P363, DOI 10.1038/nature01284; Usherwood JR, 2006, BIOL LETTERS, V2, P47, DOI 10.1098/rsbl.2005.0399; Usherwood JR, 2009, BIOINSPIR BIOMIM, V4, DOI 10.1088/1748-3182/4/1/015003; Usherwood JR, 2005, NATURE, V438, P753, DOI 10.1038/438753a; Weimerskirch H, 2001, NATURE, V413, P697, DOI 10.1038/35099670	23	81	86	2	68	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 23	2011	474	7352					494	497		10.1038/nature10164	http://dx.doi.org/10.1038/nature10164			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	781NJ	21697946	Green Accepted, Green Published			2022-12-24	WOS:000291939700045
J	Schlutter, J				Schluetter, Jana			New drugs hit the target	NATURE			English	Editorial Material																			0	50	57	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 9	2011	474	7350					S5	S7		10.1038/474S5a	http://dx.doi.org/10.1038/474S5a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	774PE	21666733	Bronze			2022-12-24	WOS:000291397800004
J	Powers, KA; Ghani, AC; Miller, WC; Hoffman, IF; Pettifor, AE; Kamanga, G; Martinson, FEA; Cohen, MS				Powers, Kimberly A.; Ghani, Azra C.; Miller, William C.; Hoffman, Irving F.; Pettifor, Audrey E.; Kamanga, Gift; Martinson, Francis E. A.; Cohen, Myron S.			The role of acute and early HIV infection in the spread of HIV and implications for transmission prevention strategies in Lilongwe, Malawi: a modelling study	LANCET			English	Article							SUB-SAHARAN AFRICA; ANTIRETROVIRAL THERAPY; HETEROSEXUAL TRANSMISSION; SEXUAL TRANSMISSION; PROSPECTIVE COHORT; UNITED-STATES; VIRAL LOAD; STAGE; RISK; PARTNERSHIPS	Background HIV transmission risk is higher during acute and early HIV infection than it is during chronic infection, but the contribution of early infection to the spread of HIV is controversial. We estimated the contribution of early infection to HIV incidence in Lilongwe, Malawi, and predict the future effect of hypothetical prevention interventions targeted at early infection only, chronic infection only, or both stages. Methods We developed a deterministic mathematical model describing heterosexual HIV transmission, informed by detailed behavioural and viral-load data collected in Lilongwe. We included sexual contact within and outside of steady pairs and divided the infectious period into intervals to allow for changes in transmissibility by infection stage. We used a Bayesian melding approach to fit the model to HIV prevalence data collected between 1987 and 2005 at Lilongwe antenatal clinics. We assessed interventions that reduced the per-contact transmission probability to 0.00003 in people receiving them, and varied the proportion of individuals receiving the intervention in each stage. Findings We estimated that 38.4% (95% credible interval 18-6-52.3) of HIV transmissions in Lilongwe are attributable to sexual contact with individuals with early infection. Interventions targeted at only early infection substantially reduced HIV prevalence, but did not lead to elimination, even with 100% coverage. Interventions targeted at only chronic infections also reduced HIV prevalence, but coverage levels of 95-99% were needed for the elimination of HIV. In scenarios with less than 95% coverage of interventions targeted at chronic infections, additional interventions reaching 25-75% of individuals with early infection reduced HIV prevalence substantially. Interpretation Our results suggest that early infection plays an important part in HIV transmission in this sub-Saharan African setting. Without near-complete coverage, interventions during chronic infection will probably have incomplete effectiveness unless complemented by strategies targeting individuals with early HIV infection.	[Powers, Kimberly A.; Miller, William C.; Hoffman, Irving F.; Cohen, Myron S.] Univ N Carolina, Dept Med, Chapel Hill, NC USA; [Powers, Kimberly A.; Miller, William C.; Pettifor, Audrey E.; Cohen, Myron S.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA; [Cohen, Myron S.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC USA; [Ghani, Azra C.] Univ London Imperial Coll Sci Technol & Med, MRC Ctr Outbreak Anal & Modelling, Dept Infect Dis Epidemiol, London SW7 2AZ, England; [Kamanga, Gift; Martinson, Francis E. A.] UNC Project Malawi, Lilongwe, Malawi	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Imperial College London	Powers, KA (corresponding author), Ctr Infect Dis, CB 7030,Bioinformat 2nd Floor, Chapel Hill, NC 27599 USA.	powersk@email.unc.edu	Miller, William C/H-4800-2014; Ghani, Azra/B-8560-2009; Pettifor, Audrey/H-6793-2019	Miller, William C/0000-0002-1934-7827; Pettifor, Audrey/0000-0002-3387-0817; Ghani, Azra/0000-0002-0007-4910	National Institutes of Health (NIH) [R01 MH068686, R37 DK049381, R01 AI083059, 5T32AI070114, P30 AI50410]; University of North Carolina Center for AIDS Research; University of North Carolina at Chapel Hill Center for AIDS Research (CFAR); Medical Research Council [G0600719B] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD050924] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083059, P30AI050410, T32AI070114] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK049381] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH068686] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of North Carolina Center for AIDS Research; University of North Carolina at Chapel Hill Center for AIDS Research (CFAR); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	National Institutes of Health, University of North Carolina Center for AIDS Research.; We thank Christophe Fraser for suggestions on the mathematical modelling methods, and Ward Cates, Jim Shelton, and David Burns for providing helpful comments on an earlier draft of this paper. We also thank four anonymous reviewers, whose comments on our work substantially improved this Article. This research was supported by the National Institutes of Health (NIH; grant numbers R01 MH068686, R37 DK049381, R01 AI083059, and 5T32AI070114) and the University of North Carolina at Chapel Hill Center for AIDS Research (CFAR), an NIH funded programme (grant number P30 AI50410).	Abu-Raddad LJ, 2008, AIDS, V22, P1055, DOI 10.1097/QAD.0b013e3282f8af84; Alkema L, 2008, SEX TRANSM INFECT, V84, pI11, DOI 10.1136/sti.2008.029991; Assefa Y, 2009, LANCET, V373, P1080, DOI 10.1016/S0140-6736(09)60647-4; Baggaley RF, 2006, PLOS MED, V3, P493, DOI 10.1371/journal.pmed.0030124; Bell SK, 2010, J INFECT DIS, V202, pS278, DOI 10.1086/655655; Boily MC, 2009, LANCET INFECT DIS, V9, P118, DOI 10.1016/S1473-3099(09)70021-0; Brenner BG, 2007, J INFECT DIS, V195, P951, DOI 10.1086/512088; Bunnell R, 2006, AIDS, V20, P85, DOI 10.1097/01.aids.0000196566.40702.28; Cates W, 1997, AM J PUBLIC HEALTH, V87, P1928, DOI 10.2105/AJPH.87.12.1928; Coates TJ, 2008, LANCET, V372, P669, DOI 10.1016/S0140-6736(08)60886-7; Cohen MS, 2007, ANN INTERN MED, V146, P591, DOI 10.7326/0003-4819-146-8-200704170-00010; Cohen MS, 2011, NEW ENGL J MED, V364, P1943, DOI 10.1056/NEJMra1011874; Cohen MS, 2010, J INFECT DIS, V202, pS270, DOI 10.1086/655651; Cohen MS, 2010, CLIN INFECT DIS, V50, pS85, DOI 10.1086/651478; Cohen MS, 2009, LANCET, V373, P1077, DOI 10.1016/S0140-6736(09)60640-1; Del Romero J, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2205; Dodd PJ, 2010, AIDS, V24, P729, DOI 10.1097/QAD.0b013e32833433fe; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; Dowdle W R, 1998, Bull World Health Organ, V76 Suppl 2, P22; Eaton JW, 2011, AIDS BEHAV, V15, P687, DOI 10.1007/s10461-010-9787-8; Epstein H, 2010, AIDS BEHAV, V14, P29, DOI 10.1007/s10461-009-9627-x; Epstein H, 2009, LANCET, V373, P1078, DOI 10.1016/S0140-6736(09)60643-7; Fiebig EW, 2003, AIDS, V17, P1871, DOI 10.1097/00002030-200309050-00005; Fiscus SA, 2007, J INFECT DIS, V195, P416, DOI 10.1086/510755; Garnett GP, 2009, LANCET, V373, P9, DOI 10.1016/S0140-6736(08)61698-0; Glynn JR, 2008, SEX TRANSM INFECT, V84, P356, DOI 10.1136/sti.2008.030056; Graham SM, 2007, AIDS, V21, P501, DOI 10.1097/QAD.0b013e32801424bd; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Hallett TB, 2009, EPIDEMICS-NETH, V1, P108, DOI 10.1016/j.epidem.2009.03.001; Hallett TB, 2008, PLOS MED, V5, P403, DOI 10.1371/journal.pmed.0050053; Hollingsworth TD, 2008, J INFECT DIS, V198, P687, DOI 10.1086/590501; Holtgrave DR, 2010, INT J CLIN PRACT, V64, P678, DOI 10.1111/j.1742-1241.2010.02381.x; HOSSEINIPOUR M, 2004, 11 C RETR OPP INF; Hsieh YH, 2009, LANCET, V373, P1079, DOI 10.1016/S0140-6736(09)60645-0; JACQUEZ JA, 1994, J ACQ IMMUN DEF SYND, V7, P1169; Jaffe H, 2009, LANCET, V373, P1080, DOI 10.1016/S0140-6736(09)60646-2; Jurgens R, 2009, LANCET, V373, P1079, DOI 10.1016/S0140-6736(09)60644-9; Kim JH, 2010, EPIDEMIOLOGY, V21, P676, DOI 10.1097/EDE.0b013e3181e6639f; Koopman JS, 1997, J ACQ IMMUN DEF SYND, V14, P249, DOI 10.1097/00042560-199703010-00009; Kretzschmar M, 1998, MATH BIOSCI, V148, P83, DOI 10.1016/S0025-5564(97)10008-6; Lewis F, 2008, PLOS MED, V5, P392, DOI 10.1371/journal.pmed.0050050; Lurie M, 2009, LANCET, V374, P1420, DOI 10.1016/S0140-6736(09)61860-2; Ma ZM, 2009, J VIROL, V83, P3288, DOI 10.1128/JVI.02423-08; Miller WC, 2010, CURR OPIN HIV AIDS, V5, P277, DOI 10.1097/COH.0b013e32833a0d3a; Miller WC, 2009, AIDS, V23, P835, DOI 10.1097/QAD.0b013e328326f55e; Morris M, 1997, AIDS, V11, P641, DOI 10.1097/00002030-199705000-00012; *NSO MAL, 2008, MAL POP HOUS CENS; Pao D, 2005, AIDS, V19, P85, DOI 10.1097/00002030-200501030-00010; Pettifor A, 2011, AIDS BEHAV, V15, P1243, DOI 10.1007/s10461-010-9839-0; Pilcher CD, 2001, JAMA-J AM MED ASSOC, V286, P1713, DOI 10.1001/jama.286.14.1713; Pilcher CD, 2004, AIDS, V18, P517, DOI 10.1097/00002030-200402200-00019; Pilcher CD, 2007, AIDS, V21, P1723, DOI 10.1097/QAD.0b013e3281532c82; Pinkerton SD, 1996, EVALUATION REV, V20, P516, DOI 10.1177/0193841X9602000502; PINKERTON SD, 2007, AIDS BEHAV, V7, P7; Pinkerton SD, 2007, AIDS, V21, P1625, DOI 10.1097/QAD.0b013e32826fb6a6; Powers KA, 2008, LANCET INFECT DIS, V8, P553, DOI 10.1016/S1473-3099(08)70156-7; Powers KA, 2007, AIDS, V21, P2237, DOI 10.1097/QAD.0b013e3282f08b4d; Powers KA, 2011, SEX TRANSM DIS, V38, P657, DOI 10.1097/OLQ.0b013e31820cb223; Prabhu VS, 2009, AIDS, V23, P1792, DOI 10.1097/QAD.0b013e32832e7d04; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Ruark A, 2009, LANCET, V373, P1078, DOI 10.1016/S0140-6736(09)60642-5; Schacker TW, 1998, ANN INTERN MED, V128, P613, DOI 10.7326/0003-4819-128-8-199804150-00001; Smith RJ, 2010, SCIENCE, V327, P697, DOI 10.1126/science.1180556; Taylor MM, 2007, CLIN INFECT DIS, V44, P301, DOI 10.1086/510487; *US BUR CENS, HIV AIDS SURV DAT; Vaidya NK, 2010, J VIROL, V84, P4302, DOI 10.1128/JVI.02284-09; Vernazza PL, 2000, AIDS, V14, P117, DOI 10.1097/00002030-200001280-00006; Wakabi W, 2008, LANCET INFECT DIS, V8, P285, DOI 10.1016/S1473-3099(08)70090-2; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411; Wilson DP, 2008, LANCET, V372, P314, DOI 10.1016/S0140-6736(08)61115-0; Wilson DP, 2009, LANCET, V373, P1077, DOI 10.1016/S0140-6736(09)60641-3; Xiridou M, 2004, AIDS, V18, P1311, DOI 10.1097/00002030-200406180-00010; Yerly S, 2001, AIDS, V15, P2287, DOI 10.1097/00002030-200111230-00010; 2004, MALAWI DEMOGRAPHIC H	74	246	252	1	33	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 16	2011	378	9787					256	268		10.1016/S0140-6736(11)60842-8	http://dx.doi.org/10.1016/S0140-6736(11)60842-8			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	798JD	21684591	Green Accepted			2022-12-24	WOS:000293201100033
J	Edelson, M; Sharot, T; Dolan, RJ; Dudai, Y				Edelson, Micah; Sharot, Tali; Dolan, Raymond J.; Dudai, Yadin			Following the Crowd: Brain Substrates of Long-Term Memory Conformity	SCIENCE			English	Article							FALSE MEMORIES; AMYGDALA; COGNITION; PREDICTS; EMOTION; CORTEX; MONKEY	Human memory is strikingly susceptible to social influences, yet we know little about the underlying mechanisms. We examined how socially induced memory errors are generated in the brain by studying the memory of individuals exposed to recollections of others. Participants exhibited a strong tendency to conform to erroneous recollections of the group, producing both long-lasting and temporary errors, even when their initial memory was strong and accurate. Functional brain imaging revealed that social influence modified the neuronal representation of memory. Specifically, a particular brain signature of enhanced amygdala activity and enhanced amygdala-hippocampus connectivity predicted long-lasting but not temporary memory alterations. Our findings reveal how social manipulation can alter memory and extend the known functions of the amygdala to encompass socially mediated memory distortions.	[Edelson, Micah; Dudai, Yadin] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; [Sharot, Tali; Dolan, Raymond J.] UCL, Inst Neurol, Wellcome Trust Ctr Neuroimaging, London, England	Weizmann Institute of Science; University of London; University College London	Edelson, M (corresponding author), Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel.	micah.edelson@weizmann.ac.il		Dolan, Ray/0000-0001-9356-761X; Edelson, Micah/0000-0001-6494-2871	Weizmann Institute-UK; British Academy; Wellcome Trust; Nella and Leon Benoziyo Center for Neurological Diseases	Weizmann Institute-UK; British Academy; Wellcome Trust(Wellcome TrustEuropean Commission); Nella and Leon Benoziyo Center for Neurological Diseases	M.E. was supported by a Weizmann Institute-UK Grant. T.S. is supported by a British Academy Postdoctoral Fellowship. R.J.D is supported by a Wellcome Trust Program Grant. Y.D. is supported by the Nella and Leon Benoziyo Center for Neurological Diseases. We thank A. Ben-Yakov, J. G. Edelson, T. Fitzgerald, O. Furman, S. Fleming, D. Levi, M. Guitart-Masip, A. Mendelsohn, U. Nili, A. Pine, J. S. Winston, and N. Wright for helpful comments and the support teams of the Norman and Helen Asher Center for Brain Imaging at the Weizmann Institute and the Imaging Neuroscience & Theoretical Neurobiology unit in the Wellcome Trust Center for Neuroimaging.	Adolphs R, 2003, NAT REV NEUROSCI, V4, P165, DOI 10.1038/nrn1056; Aggleton JP., 2000, AMYGDALA FUNCTIONAL; ALLEN VL, 1965, ADV EXP SOC PSYCHOL, V2, P133; Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Arndt J, 2010, J EXP PSYCHOL LEARN, V36, P66, DOI 10.1037/a0017394; Asch S. E., 1951, GROUPS LEADERSHIP ME, P39; Bartlett F. C., 1932, REMEMBERING; Bickart KC, 2011, NAT NEUROSCI, V14, P163, DOI 10.1038/nn.2724; Boyd R., 1988, P29; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/08989290051137585; Cardinal RN, 2002, NEUROSCI BIOBEHAV R, V26, P321, DOI 10.1016/S0149-7634(02)00007-6; Dolan RJ, 2002, SCIENCE, V298, P1191, DOI 10.1126/science.1076358; Dolcos F, 2004, NEURON, V42, P855, DOI 10.1016/S0896-6273(04)00289-2; Dudai Y, 2004, ANNU REV PSYCHOL, V55, P51, DOI 10.1146/annurev.psych.55.090902.142050; Dudai Y., 2002, MEMORY KEYWORDS CONC; Festinger L., 1957, THEOR COGNITIVE DIS, P99; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; Howe ML, 2008, PSYCHOL BULL, V134, P768, DOI 10.1037/0033-2909.134.5.768; Klucharev V, 2009, NEURON, V61, P140, DOI 10.1016/j.neuron.2008.11.027; Kluver H, 1938, J PSYCHOL, V5, P33; Kuhl BA, 2007, NAT NEUROSCI, V10, P908, DOI 10.1038/nn1918; Levy BJ, 2002, TRENDS COGN SCI, V6, P299, DOI 10.1016/S1364-6613(02)01923-X; Loftus EF, 2005, LEARN MEMORY, V12, P361, DOI 10.1101/lm.94705; Meade ML, 2002, MEM COGNITION, V30, P995, DOI 10.3758/BF03194318; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Mitchell JP, 2005, J COGNITIVE NEUROSCI, V17, P800, DOI 10.1162/0898929053747595; Nadel L, 1997, CURR OPIN NEUROBIOL, V7, P217, DOI 10.1016/S0959-4388(97)80010-4; Ochsner Kevin, 2006, SOC NEUROSCI-UK, P245; Okado Y, 2005, LEARN MEMORY, V12, P3, DOI 10.1101/lm.87605; Perkins HW, 2010, ADDICT BEHAV, V35, P866, DOI 10.1016/j.addbeh.2010.05.004; Phelps EA, 2006, ANNU REV PSYCHOL, V57, P27, DOI 10.1146/annurev.psych.56.091103.070234; REYNA VF, 1995, LEARN INDIVID DIFFER, V7, P1, DOI 10.1016/1041-6080(95)90031-4; Reysen MB, 2005, MEMORY, V13, P87, DOI 10.1080/09658210344000602; Richardson MP, 2004, NAT NEUROSCI, V7, P278, DOI 10.1038/nn1190; Roediger HL, 2001, PSYCHON B REV, V8, P385, DOI 10.3758/BF03196177; Schacter D. L., 2001, 7 SINS MEMORY MIND F; Shaw JS, 1997, LAW HUMAN BEHAV, V21, P503, DOI 10.1023/A:1024875723399; Sherif M., 1936, PSYCHOL SOCIAL NORMS; Smith E.R., 2007, SOC PSYCHOL-GERMANY, V3rd Ed.; Squire LR, 2004, NEUROBIOL LEARN MEM, V82, P171, DOI 10.1016/j.nlm.2004.06.005; Stefanacci L, 2002, J COMP NEUROL, V451, P301, DOI 10.1002/cne.10339; Wright DB, 2009, CURR DIR PSYCHOL SCI, V18, P174, DOI 10.1111/j.1467-8721.2009.01631.x	42	128	138	6	85	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 1	2011	333	6038					108	111		10.1126/science.1203557	http://dx.doi.org/10.1126/science.1203557			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	785UF	21719681	Green Published, Green Accepted			2022-12-24	WOS:000292255400061
J	Thiele, P; Blair, S				Thiele, Pauline; Blair, Simon			A PATIENT'S JOURNEY Destined to die	BRITISH MEDICAL JOURNAL			English	Editorial Material												liam194@gmail.com							0	2	2	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 1	2011	343								d3625	10.1136/bmj.d3625	http://dx.doi.org/10.1136/bmj.d3625			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	788QD	21724563	Bronze			2022-12-24	WOS:000292458600001
J	Klassen, T; Davis, C; Goldman, A; Burgess, D; Chen, T; Wheeler, D; McPherson, J; Bourquin, T; Lewis, L; Villasana, D; Morgan, M; Muzny, D; Gibbs, R; Noebels, J				Klassen, Tara; Davis, Caleb; Goldman, Alica; Burgess, Dan; Chen, Tim; Wheeler, David; McPherson, John; Bourquin, Traci; Lewis, Lora; Villasana, Donna; Morgan, Margaret; Muzny, Donna; Gibbs, Richard; Noebels, Jeffrey			Exome Sequencing of Ion Channel Genes Reveals Complex Profiles Confounding Personal Risk Assessment in Epilepsy	CELL			English	Article							SEVERE MYOCLONIC EPILEPSY; ORGANIZATION; MUTATIONS; MODELS; CHANNELOPATHIES; SUSCEPTIBILITY; PREVALENCE; MECHANISMS; EVOLUTION; ALIGNMENT	Ion channel mutations are an important cause of rare Mendelian disorders affecting brain, heart, and other tissues. We performed parallel exome sequencing of 237 channel genes in a well-characterized human sample, comparing variant profiles of unaffected individuals to those with the most common neuronal excitability disorder, sporadic idiopathic epilepsy. Rare missense variation in known Mendelian disease genes is prevalent in both groups at similar complexity, revealing that even deleterious ion channel mutations confer uncertain risk to an individual depending on the other variants with which they are combined. Our findings indicate that variant discovery via large scale sequencing efforts is only a first step in illuminating the complex allelic architecture underlying personal disease risk. We propose that in silico modeling of channel variation in realistic cell and network models will be crucial to future strategies assessing mutation profile pathogenicity and drug response in individuals with a broad spectrum of excitability disorders.	[Klassen, Tara; Davis, Caleb; Goldman, Alica; Burgess, Dan; Chen, Tim; Noebels, Jeffrey] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; [Noebels, Jeffrey] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [McPherson, John; Gibbs, Richard; Noebels, Jeffrey] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Wheeler, David; McPherson, John; Bourquin, Traci; Lewis, Lora; Villasana, Donna; Morgan, Margaret; Muzny, Donna; Gibbs, Richard] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Noebels, J (corresponding author), Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA.	jnoebels@bcm.edu	McPherson, John D/D-2633-2017; Resource Center, NINDS Human Genetics/AGF-2474-2022; Wheeler, David A/M-9740-2018; Sander-Effron, Samuel/AAX-2231-2020	McPherson, John D/0000-0001-8049-9347; Wheeler, David A/0000-0002-9056-6299; Davis, Caleb/0000-0002-5125-0494; Noebels, Jeffrey/0000-0002-2887-0839	NIH [NS 049130]; National Human Genome Research Institute; Gillson Longenbaugh Foundation; Blue Bird Circle Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS047304, R01NS049130] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Gillson Longenbaugh Foundation; Blue Bird Circle Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Melissa Lambeth and Marsha Hill for assistance with clinical recruitment, the Human Genome Sequencing Center sequencing team, and Colleen Clancy and Luay Nakhleh for valuable discussion. The authors acknowledge the support NIH NS 049130 (J.N.), the National Human Genome Research Institute (R. G.), the Gillson Longenbaugh Foundation (J.N. and R. G.), and the Blue Bird Circle Foundation.	Ackerman MJ, 2004, HEART RHYTHM, V1, P600, DOI 10.1016/j.hrthm.2004.07.013; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; [Anonymous], 1989, EPILEPSIA, V30, P389, DOI 10.1111/j.1528-1157.1989.tb05316.x; Bayes A, 2011, NAT NEUROSCI, V14, P19, DOI 10.1038/nn.2719; Bayes A, 2009, NAT REV NEUROSCI, V10, P635, DOI 10.1038/nrn2701; Berg AT, 2010, EPILEPSIA, V51, P676, DOI 10.1111/j.1528-1167.2010.02522.x; Bloodgood BL, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000190; Bower James M, 2007, Methods Mol Biol, V401, P103, DOI 10.1007/978-1-59745-520-6_7; Cahalan MD, 2009, IMMUNOL REV, V231, P59, DOI 10.1111/j.1600-065X.2009.00816.x; Catterall WA, 2008, J NEUROSCI, V28, P11768, DOI 10.1523/JNEUROSCI.3901-08.2008; Choi M, 2009, P NATL ACAD SCI USA, V106, P19096, DOI 10.1073/pnas.0910672106; Claes L, 2001, AM J HUM GENET, V68, P1327, DOI 10.1086/320609; Clancy CE, 1999, NATURE, V400, P566, DOI 10.1038/23034; Davis EE, 2011, NAT GENET, V43, P189, DOI 10.1038/ng.756; Demolombe S, 2005, CARDIOVASC RES, V67, P438, DOI 10.1016/j.cardiores.2005.04.021; Dougherty JD, 2010, NUCLEIC ACIDS RES, V38, P4218, DOI 10.1093/nar/gkq130; Drolet B, 2005, J CLIN INVEST, V115, P2209, DOI 10.1172/JCI23741; Dyhrfjeld-Johnsen J, 2007, J NEUROPHYSIOL, V97, P1566, DOI 10.1152/jn.00950.2006; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FRASER FC, 1976, TERATOLOGY, V14, P267, DOI 10.1002/tera.1420140302; Gargus JJ, 2003, AM J HUM GENET, V72, P785, DOI 10.1086/374317; Glasscock E, 2007, NAT NEUROSCI, V10, P1554, DOI 10.1038/nn1999; Goaillard JM, 2009, NAT NEUROSCI, V12, P1424, DOI 10.1038/nn.2404; Grashow R, 2009, P NATL ACAD SCI USA, V106, P11742, DOI 10.1073/pnas.0905614106; Gurkiewicz M, 2007, PLOS COMPUT BIOL, V3, P1633, DOI 10.1371/journal.pcbi.0030169; Harmar AJ, 2009, NUCLEIC ACIDS RES, V37, pD680, DOI 10.1093/nar/gkn728; Hawkins NA, 2011, NEUROBIOL DIS, V41, P655, DOI 10.1016/j.nbd.2010.11.016; Hiriart M, 2008, AM J PHYSIOL-ENDOC M, V295, pE1298, DOI 10.1152/ajpendo.90493.2008; Holmkvist J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005872; Huffaker SJ, 2009, NAT MED, V15, P509, DOI 10.1038/nm.1962; Jegla TJ, 2009, COMB CHEM HIGH T SCR, V12, P2, DOI 10.2174/138620709787047957; Kaczmarek LK, 2006, NAT REV NEUROSCI, V7, P761, DOI 10.1038/nrn1988; Kapplinger JD, 2009, HEART RHYTHM, V6, P1297, DOI 10.1016/j.hrthm.2009.05.021; Kellems AR, 2009, J COMPUT NEUROSCI, V27, P161, DOI 10.1007/s10827-008-0134-2; KNUDSON AG, 1975, P NATL ACAD SCI USA, V72, P5116, DOI 10.1073/pnas.72.12.5116; Liu G, 2003, NEUROPHARMACOLOGY, V44, P413, DOI 10.1016/S0028-3908(02)00400-8; Lupski JR, 2010, NEW ENGL J MED, V362, P1181, DOI 10.1056/NEJMoa0908094; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Marder E, 2010, NEURON, V66, P161, DOI 10.1016/j.neuron.2010.04.022; Martin MS, 2007, HUM MOL GENET, V16, P2892, DOI 10.1093/hmg/ddm248; Matzke AJM, 2010, MOL PLANT, V3, P642, DOI 10.1093/mp/ssq013; McDaniell R, 2010, SCIENCE, V328, P235, DOI 10.1126/science.1184655; Muller CS, 2010, P NATL ACAD SCI USA, V107, P14950, DOI 10.1073/pnas.1005940107; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Noebels JL, 2003, ANNU REV NEUROSCI, V26, P599, DOI 10.1146/annurev.neuro.26.010302.081210; Nusser Z, 2009, TRENDS NEUROSCI, V32, P267, DOI 10.1016/j.tins.2009.01.003; Ohmori I, 2006, EPILEPSIA, V47, P1636, DOI 10.1111/j.1528-1167.2006.00643.x; Okaty BW, 2009, J NEUROSCI, V29, P7040, DOI 10.1523/JNEUROSCI.0105-09.2009; Reid CA, 2009, PROG NEUROBIOL, V87, P41, DOI 10.1016/j.pneurobio.2008.09.016; Roepke TK, 2009, NAT MED, V15, P1186, DOI 10.1038/nm.2029; Rusconi R, 2007, J NEUROSCI, V27, P11037, DOI 10.1523/JNEUROSCI.3515-07.2007; Ryan DP, 2010, CELL, V140, P88, DOI 10.1016/j.cell.2009.12.024; Scheffer IE, 2007, BRAIN, V130, P100, DOI 10.1093/brain/awl272; Sheets MF, 2010, TRENDS CARDIOVAS MED, V20, P16, DOI 10.1016/j.tcm.2010.03.002; Singh NA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000649; Song I, 2004, J NEUROSCI, V24, P5249, DOI 10.1523/JNEUROSCI.5546-03.2004; Sontheimer H, 2008, EXP BIOL MED, V233, P779, DOI 10.3181/0711-MR-308; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Tang H, 2005, AM J HUM GENET, V76, P268, DOI 10.1086/427888; Thomas EA, 2009, ARCH NEUROL-CHICAGO, V66, P1225, DOI 10.1001/archneurol.2009.219; Tobin AE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006742; Toledo-Rodriguez M, 2005, TRENDS NEUROSCI, V28, P534, DOI 10.1016/j.tins.2005.08.001; Tomaselli GF, 2010, HEART RHYTHM, V7, P206, DOI 10.1016/j.hrthm.2009.10.029; TRAUB RD, 1991, J NEUROPHYSIOL, V66, P635, DOI 10.1152/jn.1991.66.2.635; Tsuji K, 2007, J MOL CELL CARDIOL, V42, P662, DOI 10.1016/j.yjmcc.2006.12.015; Tucker T, 2009, AM J HUM GENET, V85, P142, DOI 10.1016/j.ajhg.2009.06.022; Vacher H, 2008, PHYSIOL REV, V88, P1407, DOI 10.1152/physrev.00002.2008; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; Winden KD, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.46; Wray NR, 2010, GENOME MED, V2, DOI 10.1186/gm131; Wulff H, 2009, NAT REV DRUG DISCOV, V8, P982, DOI 10.1038/nrd2983; Xu J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002056; Yu FH, 2006, NAT NEUROSCI, V9, P1142, DOI 10.1038/nn1754; Zhang JH, 2005, PLOS COMPUT BIOL, V1, P395, DOI 10.1371/journal.pcbi.0010053	75	227	231	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 24	2011	145	7					1036	1048		10.1016/j.cell.2011.05.025	http://dx.doi.org/10.1016/j.cell.2011.05.025			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	782QV	21703448	Green Accepted, Bronze			2022-12-24	WOS:000292025700011
J	Duong, HA; Robles, MS; Knutti, D; Weitz, CJ				Duong, Hao A.; Robles, Maria S.; Knutti, Darko; Weitz, Charles J.			A Molecular Mechanism for Circadian Clock Negative Feedback	SCIENCE			English	Article							HISTONE ACETYLATION; TRANSCRIPTION; BINDING; PSF; COMPONENTS; REVEALS; FBXL3; MPER1; LOOP; LIMB	Circadian rhythms in mammals are generated by a feedback loop in which the three PERIOD (PER) proteins, acting in a large complex, inhibit the transcriptional activity of the CLOCK-BMAL1 dimer, which represses their own expression. Although fundamental, the mechanism of negative feedback in the mammalian clock, or any eukaryotic clock, is unknown. We analyzed protein constituents of PER complexes purified from mouse tissues and identified PSF (polypyrimidine tract-binding protein-associated splicing factor). Our analysis indicates that PSF within the PER complex recruits SIN3A, a scaffold for assembly of transcriptional inhibitory complexes and that the PER complex thereby rhythmically delivers histone deacetylases to the Per1 promoter, which repress Per1 transcription. These findings provide a function for the PER complex and a molecular mechanism for circadian clock negative feedback.	[Duong, Hao A.; Robles, Maria S.; Knutti, Darko; Weitz, Charles J.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Weitz, CJ (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA.	cweitz@hms.harvard.edu	Robles, Maria/ABH-1497-2020; Robles, Maria S/D-6307-2015	Robles, Maria/0000-0001-9149-8761; Robles, Maria S/0000-0001-9149-8761	G. Harold and Leila Y. Mathers Charitable Foundation; NIH; Edward R. and Anne G. Lefler Center; Swiss National Science Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007484] Funding Source: NIH RePORTER	G. Harold and Leila Y. Mathers Charitable Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Edward R. and Anne G. Lefler Center; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank M. Liu for technical assistance, P. Nakatani (Dana Farber Cancer Institute) for the FH tag, D. Weaver and S. Reppert (University of Massachusetts) for Per1<SUP>-/-</SUP>;Per2<SUP>-/-</SUP> mice, N. Copeland (Institute of Molecular and Cell Biology, Singapore) for reagents, and Y. Kurihara (Yokohama National University) for PSF plasmid. This work was supported by the G. Harold and Leila Y. Mathers Charitable Foundation (C.J.W.), NIH Training Grant in Fundamental Neurobiology fellowship (H.A.D.), an Edward R. and Anne G. Lefler Center fellowship (M.S.R.), and a Swiss National Science Foundation fellowship (D.K.).	Bae K, 2001, NEURON, V30, P525, DOI 10.1016/S0896-6273(01)00302-6; Belden WJ, 2007, MOL CELL, V25, P587, DOI 10.1016/j.molcel.2007.01.010; Brown SA, 2005, SCIENCE, V308, P693, DOI 10.1126/science.1107373; Chen RM, 2009, MOL CELL, V36, P417, DOI 10.1016/j.molcel.2009.10.012; Curtis AM, 2004, J BIOL CHEM, V279, P7091, DOI 10.1074/jbc.M311973200; Dong XS, 2007, MOL CELL BIOL, V27, P4863, DOI 10.1128/MCB.02144-06; Etchegaray JP, 2003, NATURE, V421, P177, DOI 10.1038/nature01314; Godinho SIH, 2007, SCIENCE, V316, P897, DOI 10.1126/science.1141138; Griffin EA, 1999, SCIENCE, V286, P768, DOI 10.1126/science.286.5440.768; Grzenda A, 2009, BBA-GENE REGUL MECH, V1789, P443, DOI 10.1016/j.bbagrm.2009.05.007; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Lamia KA, 2008, P NATL ACAD SCI USA, V105, P15172, DOI 10.1073/pnas.0806717105; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Mathur M, 2001, MOL CELL BIOL, V21, P2298, DOI 10.1128/MCB.21.7.2298-2311.2001; Nakahata Y, 2008, CELL, V134, P329, DOI 10.1016/j.cell.2008.07.002; Nakatani Y, 2003, METHOD ENZYMOL, V370, P430; Naruse Y, 2004, MOL CELL BIOL, V24, P6278, DOI 10.1128/MCB.24.14.6278-6287.2004; Padmanabhan K., UNPUB; Perales M, 2007, PLANT CELL, V19, P2111, DOI 10.1105/tpc.107.050807; Ripperger JRA, 2006, NAT GENET, V38, P369, DOI 10.1038/ng1738; Robles MS, 2010, SCIENCE, V327, P463, DOI 10.1126/science.1180067; Rundlett SE, 1996, P NATL ACAD SCI USA, V93, P14503, DOI 10.1073/pnas.93.25.14503; Sangoram AM, 1998, NEURON, V21, P1101, DOI 10.1016/S0896-6273(00)80627-3; Schibler U, 2003, J BIOL RHYTHM, V18, P250, DOI 10.1177/0748730403018003007; Shav-Tal Y, 2002, FEBS LETT, V531, P109, DOI 10.1016/S0014-5793(02)03447-6; Siepka SM, 2007, CELL, V129, P1011, DOI 10.1016/j.cell.2007.04.030; Storch KF, 2007, CELL, V130, P730, DOI 10.1016/j.cell.2007.06.045; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; Taylor P, 2008, MOL CELL BIOL, V28, P4642, DOI 10.1128/MCB.01612-07	29	194	202	1	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 17	2011	332	6036					1436	1439		10.1126/science.1196766	http://dx.doi.org/10.1126/science.1196766			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778FT	21680841	Green Accepted			2022-12-24	WOS:000291689000043
J	Sylvestre, D				Sylvestre, Diana			Recognizing resistance	NATURE			English	Editorial Material							ADHERENCE; MUTATIONS		Univ Calif San Francisco, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Sylvestre, D (corresponding author), Univ Calif San Francisco, San Francisco, CA 94143 USA.	diana.sylvestre@ucsf.edu						Ferrando SJ, 1996, AM J DRUG ALCOHOL AB, V22, P475, DOI 10.3109/00952999609001674; Foretier N, 2008, HEPATOLOGY, V48, p760A; Singh N, 1999, CLIN INFECT DIS, V29, P824, DOI 10.1086/520443; Tong X, 2008, ANTIVIR RES, V77, P177, DOI 10.1016/j.antiviral.2007.11.010; Tulsky JP, 2000, ARCH INTERN MED, V160, P697, DOI 10.1001/archinte.160.5.697; Yi MK, 2006, J BIOL CHEM, V281, P8205, DOI 10.1074/jbc.M510246200	6	2	2	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 9	2011	474	7350					S11	S11		10.1038/474S11a	http://dx.doi.org/10.1038/474S11a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	774PE	21666727	Bronze			2022-12-24	WOS:000291397800007
J	Keating, NL; Landrum, MB; Lamont, EB; Bozeman, SR; Krasnow, SH; Shulman, LN; Brown, JR; Earle, CC; Oh, WK; Rabin, M; McNeil, BJ				Keating, Nancy L.; Landrum, Mary Beth; Lamont, Elizabeth B.; Bozeman, Samuel R.; Krasnow, Steven H.; Shulman, Lawrence N.; Brown, Jennifer R.; Earle, Craig C.; Oh, William K.; Rabin, Michael; McNeil, Barbara J.			Quality of Care for Older Patients With Cancer in the Veterans Health Administration Versus the Private Sector A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							CELL LUNG-CANCER; III COLON-CANCER; PROSTATE-CANCER; ADJUVANT CHEMOTHERAPY; MYOCARDIAL-INFARCTION; PROPENSITY SCORE; ADVERSE EVENTS; SENSITIVITY; MEDICARE; SYSTEM	Background: The Veterans Health Administration (VHA) is the largest integrated health care system in the United States. Studies suggest that the VHA provides better preventive care and care for some chronic illnesses than does the private sector. Objective: To assess the quality of cancer care for older patients provided by the VHA versus fee-for-service Medicare. Design: Observational study of patients with cancer that was diagnosed between 2001 and 2004 who were followed through 2005. Setting: VHA and non-VHA hospitals and office-based practices. Patients: Men older than 65 years with incident colorectal, lung, or prostate cancer; lymphoma; or multiple myeloma. Measurements: Rates of processes of care for colorectal, lung, or prostate cancer; lymphoma; or multiple myeloma. Rates were adjusted by using propensity score weighting. Results: Compared with the fee-for-service Medicare population, the VHA population received diagnoses of colon (P < 0.001) and rectal (P = 0.007) cancer at earlier stages and had higher adjusted rates of curative surgery for colon cancer (92.7% vs. 90.5%; P < 0.010), standard chemotherapy for diffuse large B-cell non-Hodgkin lymphoma (71.1% vs. 59.3%; P < 0.001), and bisphosphonate therapy for multiple myeloma (62.1% vs. 50.4%; P < 0.001). The VHA population had lower adjusted rates of 3-dimensional conformal or intensity-modulated radiation therapy for prostate cancer treated with external-beam radiation therapy (61.6% vs. 86.0%; P < 0.001). Adjusted rates were similar for 9 other measures. Sensitivity analyses suggest that if patients with cancer in the VHA system have more severe comorbid illness than other patients, rates for most indicators would be higher in the VHA population than in the fee-for-service Medicare population. Limitation: This study included only older men and did not include information about performance status, severity of comorbid illness, or patient preferences. Conclusion: Care for older men with cancer in the VHA system was generally similar to or better than care for fee-for-service Medicare beneficiaries, although adoption of some expensive new technologies may be delayed in the VHA system.	Harvard Univ, Sch Med, Brigham & Womens Hosp, Massachusetts Gen Hosp,Ctr Canc, Boston, MA 02115 USA; Dana Farber Canc Inst, Boston, MA 02115 USA; Abt Associates Inc, Cambridge, MA USA; Vet Affairs Med Ctr, Washington, DC 20422 USA; Inst Clin Evaluat Sci, Toronto, ON, Canada; Mt Sinai Med Ctr, New York, NY 10029 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Massachusetts General Hospital; Harvard University; Dana-Farber Cancer Institute; ABT Associates; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Toronto; Icahn School of Medicine at Mount Sinai	Keating, NL (corresponding author), Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA.	keating@hcp.med.harvard.edu	Keating, Nancy L/I-9968-2019; Oh, William K/B-9163-2012	Keating, Nancy L/0000-0002-8274-4681; Oh, William K/0000-0001-5113-8147; Lamont, Elizabeth/0000-0001-6604-678X	Department of Veterans Affairs; Department of Veterans Affairs through the Office of Policy and Planning [101-35-04]	Department of Veterans Affairs(US Department of Veterans Affairs); Department of Veterans Affairs through the Office of Policy and Planning(US Department of Veterans Affairs)	Department of Veterans Affairs.r By contract 101-35-04 from the Department of Veterans Affairs through the Office of Policy and Planning.	Adib RS, 1997, BRIT J UROL, V79, P235; Asch SM, 2004, ANN INTERN MED, V141, P938, DOI 10.7326/0003-4819-141-12-200412210-00010; Baker LH, 2000, ONCOLOGY-NY, V14, P111; Berenson JR, 1996, NEW ENGL J MED, V334, P488, DOI 10.1056/NEJM199602223340802; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chrischilles EA, 2010, J CLIN ONCOL, V28, P620, DOI 10.1200/JCO.2009.23.8485; Coiffier B, 2002, NEW ENGL J MED, V346, P235, DOI 10.1056/NEJMoa011795; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; Dearnaley DP, 1999, LANCET, V353, P267, DOI 10.1016/S0140-6736(98)05180-0; FISHER RI, 1993, NEW ENGL J MED, V328, P1002, DOI 10.1056/NEJM199304083281404; Hortobagyi GN, 1996, NEW ENGL J MED, V335, P1785, DOI 10.1056/NEJM199612123352401; Huggins C, 1941, CANCER RES, V1, P293; Huggins C, 1941, ARCH SURG-CHICAGO, V43, P209, DOI 10.1001/archsurg.1941.01210140043004; Jha AK, 2003, NEW ENGL J MED, V348, P2218, DOI 10.1056/NEJMsa021899; Kahn KL, 2010, JAMA-J AM MED ASSOC, V303, P1037, DOI 10.1001/jama.2010.272; Keating NL, 2008, J CLIN ONCOL, V26, P2532, DOI 10.1200/JCO.2007.15.9434; Kizer KW, 2009, ANNU REV PUBL HEALTH, V30, P313, DOI 10.1146/annurev.publhealth.29.020907.090940; Kizer KW, 2000, MED CARE, V38, pS7; Klabunde CN, 2000, J CLIN EPIDEMIOL, V53, P1258, DOI 10.1016/S0895-4356(00)00256-0; Kurth T, 2006, AM J EPIDEMIOL, V163, P262, DOI 10.1093/aje/kwj047; Ladapo Pearson SJ., 2007, INTENSITY MODULATED; Lamont E, 2011, J GERIATRI IN PRESS; Lamont EB, 2003, JNCI-J NATL CANCER I, V95, P1370, DOI 10.1093/jnci/djg035; Lamont EB, 2010, J CLIN ONCOL, V28, P215, DOI 10.1200/JCO.2008.21.3652; Landrum MB, 2004, HEALTH SERV RES, V39, P1773, DOI 10.1111/j.1475-6773.2004.00317.x; Laurie SA, 2004, LUNG CANCER, V43, P223, DOI 10.1016/j.lungcan.2003.09.002; Lin DY, 1998, BIOMETRICS, V54, P948, DOI 10.2307/2533848; National Cancer Institute, SURV EP END RES OV S; National Comprehensive Cancer Network, 2001, CLIN PRACT GUID ONC; Petersen LA, 2003, NEW ENGL J MED, V348, P2209, DOI 10.1056/NEJMsa021725; Petersen LA, 2000, NEW ENGL J MED, V343, P1934, DOI 10.1056/NEJM200012283432606; Pisansky TM, 2006, NEW ENGL J MED, V355, P1583, DOI 10.1056/NEJMct055263; POTOSKY AL, 1993, MED CARE, V31, P732; Rogers SO, 2010, ANN SURG ONCOL, V17, P1581, DOI 10.1245/s10434-010-0946-y; ROSENBAUM PR, 1984, J AM STAT ASSOC, V79, P516, DOI 10.2307/2288398; ROSENBAUM PR, 1983, J ROY STAT SOC B MET, V45, P212; Sato T, 2003, EPIDEMIOLOGY, V14, P680, DOI 10.1097/01.EDE.0000081989.82616.7d; VanderWeele TJ, 2011, EPIDEMIOLOGY, V22, P42, DOI 10.1097/EDE.0b013e3181f74493; Wilson NJ, 1998, CANCER, V82, P2003, DOI 10.1002/(SICI)1097-0142(19980515)82:10+<2003::AID-CNCR5>3.3.CO;2-U; Wilt TJ, 2008, COMP EFFECTIVENESS R, V13	40	72	72	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 7	2011	154	11								10.7326/0003-4819-154-11-201106070-00004	http://dx.doi.org/10.7326/0003-4819-154-11-201106070-00004			90	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	773MV	21646556				2022-12-24	WOS:000291312300003
J	Debiec, H; Lefeu, F; Kemper, MJ; Niaudet, P; Deschenes, G; Remuzzi, G; Ulinski, T; Ronco, P				Debiec, Hanna; Lefeu, Florence; Kemper, Markus J.; Niaudet, Patrick; Deschenes, Georges; Remuzzi, Giuseppe; Ulinski, Tim; Ronco, Pierre			Early-Childhood Membranous Nephropathy Due to Cationic Bovine Serum Albumin	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							IMMUNE-RESPONSES; DIETARY ANTIGENS; IGG4 ANTIBODIES; PREVALENCE; COMPLEXES; PROTEINS; INFANTS; DISEASE; TARGET; CELLS	Background The M-type phospholipase A(2) receptor (PLA(2)R) was recently identified as a candidate antigen in 70% of cases of idiopathic membranous nephropathy, a common form of the nephrotic syndrome. The nature of antigens involved in other idiopathic and secondary membranous nephropathies remains unclear. Methods We searched for antibodies against bovine serum albumin and circulating bovine serum albumin by means of enzyme-linked immunosorbent assay and Western blotting in serum specimens obtained from 50 patients with membranous nephropathy and 172 controls. The properties of immunopurified circulating bovine serum albumin obtained from serum specimens were analyzed with the use of two-dimensional sodium dodecyl sulfate-polyacrylamide-gel electrophoresis. We detected bovine serum albumin in glomerular deposits and analyzed the reactivity of eluted IgG. Results Eleven patients, including four children, had high levels of circulating anti-bovine serum albumin antibodies, of both the IgG1 and IgG4 subclasses. These patients also had elevated levels of circulating bovine serum albumin, without an increase in circulating immune complex levels. Bovine serum albumin immunopurified from the serum specimens of these four children migrated in the basic range of pH, whereas the bovine serum albumin from adult patients migrated in neutral regions as native bovine serum albumin. Bovine serum albumin was detected in subepithelial immune deposits only in the children with both high levels of cationic circulating bovine serum albumin and bovine serum albumin-specific antibodies, and it colocalized with IgG in the absence of PLA(2)R. IgG eluted from such deposits was specific for bovine serum albumin. Conclusions Some patients with childhood membranous nephropathy have both circulating cationic bovine serum albumin and anti-bovine serum albumin antibodies. Bovine serum albumin is present in immune deposits, suggesting that cationic bovine serum albumin is pathogenic through binding to the anionic glomerular capillary wall and in situ formation of immune complexes, as shown in experimental models.	[Debiec, Hanna] Univ Paris 06, Tenon Hosp, AP HP, INSERM,Unite Mixte Rech Sci 702, F-75020 Paris, France; [Niaudet, Patrick] Univ Paris 05, Hop Necker Enfants Malad, AP HP, Dept Pediat Nephrol, Paris, France; [Deschenes, Georges] Univ Paris 07, Hop Robert Debre, AP HP, Dept Pediat Nephrol, Paris, France; [Ulinski, Tim] Armand Trousseau Childrens Hosp, AP HP, Pediat Nephrol Unit, Paris, France; [Kemper, Markus J.] Univ Med Ctr, Dept Pediat Nephrol, Hamburg, Germany; [Remuzzi, Giuseppe] Mario Negri Inst Pharmacol Res, Nephrol Unit, I-24100 Bergamo, Italy; [Remuzzi, Giuseppe] Mario Negri Inst Pharmacol Res, Unit Dialysis, I-24100 Bergamo, Italy	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; University of Hamburg; University Medical Center Hamburg-Eppendorf; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Istituto di Ricerche Farmacologiche Mario Negri IRCCS	Debiec, H (corresponding author), Univ Paris 06, Tenon Hosp, AP HP, INSERM,Unite Mixte Rech Sci 702, 4 Rue Chine, F-75020 Paris, France.	hanna.debiec@upmc.fr	Ronco, Pierre/AAC-8390-2022; Debiec, Hanna/AAL-8144-2021; Remuzzi, Giuseppe/V-9766-2017	Debiec, Hanna/0000-0002-8946-8245; Remuzzi, Giuseppe/0000-0002-6194-3446; deschenes, georges/0000-0002-5158-2915	Agence Nationale pour la Recherche [ANR-07-Physio-016-01]; European Community [HEALTH-F2-2007-201590]; Association pour l'Utilisation du Rein Artificiel; Amgen France; Fondation pour la Recherche Medicale; Assistance Publique-Hopitaux de Paris	Agence Nationale pour la Recherche(French National Research Agency (ANR)); European Community(European Commission); Association pour l'Utilisation du Rein Artificiel; Amgen France(Amgen); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Assistance Publique-Hopitaux de Paris	Supported by grants from Agence Nationale pour la Recherche (ANR-07-Physio-016-01), Coordination Theme 1 (Health) of the European Community's 7th Framework Program (HEALTH-F2-2007-201590), Association pour l'Utilisation du Rein Artificiel, Amgen France, and Fondation pour la Recherche Medicale, and by a Translational Research Contract from Assistance Publique-Hopitaux de Paris (to Dr. Debiec).	Aalberse RC, 2002, IMMUNOLOGY, V105, P9, DOI 10.1046/j.0019-2805.2001.01341.x; Alting AC, 1997, DIABETES CARE, V20, P875, DOI 10.2337/diacare.20.5.875; Beck LH, 2009, NEW ENGL J MED, V361, P11, DOI 10.1056/NEJMoa0810457; BORDER WA, 1982, J CLIN INVEST, V69, P451, DOI 10.1172/JCI110469; Briani C, 2008, AUTOIMMUN REV, V7, P644, DOI 10.1016/j.autrev.2008.05.006; Chen Ashton, 2007, BMC Nephrol, V8, P11, DOI 10.1186/1471-2369-8-11; Chen JS, 2004, NEPHROL DIAL TRANSPL, V19, P2721, DOI 10.1093/ndt/gfh419; Davis PJ, 1998, ALLERGY, V53, P102, DOI 10.1111/j.1398-9995.1998.tb04975.x; Debiec H, 2004, LANCET, V364, P1252, DOI 10.1016/S0140-6736(04)17142-0; FIOCCHI A, 1995, J AM COLL NUTR, V14, P239; Glassock RJ, 2010, AM J KIDNEY DIS, V56, P157, DOI 10.1053/j.ajkd.2010.01.008; Husby S, 2000, J PEDIATR GASTR NUTR, V30, pS13, DOI 10.1097/00005176-200001001-00003; KLETTER B, 1971, INT ARCH ALLER A IMM, V40, P656, DOI 10.1159/000230447; KOYAMA A, 1986, IMMUNOLOGY, V58, P535; Kuroki A, 2005, KIDNEY INT, V68, P302, DOI 10.1111/j.1523-1755.2005.00415.x; Kuroki A, 2002, INTERNAL MED, V41, P936, DOI 10.2169/internalmedicine.41.936; Lempainen J, 2009, J AUTOIMMUN, V33, P155, DOI 10.1016/j.jaut.2009.04.003; MALOSSE D, 1992, NEUROEPIDEMIOLOGY, V11, P304, DOI 10.1159/000110946; Menon S, 2010, PEDIATR NEPHROL, V25, P1419, DOI 10.1007/s00467-009-1324-5; Mogues T, 2005, J IMMUNOL METHODS, V300, P1, DOI 10.1016/j.jim.2005.01.022; Oliveira DBG, 1998, LANCET, V351, P670, DOI 10.1016/S0140-6736(97)04122-6; PEREZMACEDA B, 1991, CLIN CHIM ACTA, V203, P153, DOI 10.1016/0009-8981(91)90287-M; Ponticelli C, 2007, J NEPHROL, V20, P268; Ronco P, 2010, J AM SOC NEPHROL, V21, P564, DOI 10.1681/ASN.2009121220; Sanchez C, 2003, REV FR ALLERGOL, V43, P13, DOI 10.1016/S0335-7457(02)00003-5; Sathe SK, 2005, BIOTECHNOL ADV, V23, P423, DOI 10.1016/j.biotechadv.2005.05.008; SCHMIDT DG, 1995, CLIN EXP ALLERGY, V25, P1007, DOI 10.1111/j.1365-2222.1995.tb00404.x; Sreedharan R, 2004, PEDIATRICS, V113, P1044; Strobel S, 1998, IMMUNOL TODAY, V19, P173, DOI 10.1016/S0167-5699(97)01239-5; Tipping PG, 2005, CLIN EXP IMMUNOL, V142, P207, DOI 10.1111/j.1365-2249.2005.02842.x; Torente F, 2004, PEDIAT GASTROINTESTI, P944; van Elburg RM, 2003, ARCH DIS CHILD-FETAL, V88, P52; VANDERZEE JS, 1986, J IMMUNOL, V137, P3566; VANDERZEE JS, 1986, CLIN EXP IMMUNOL, V64, P415; Winer S, 2001, J IMMUNOL, V166, P4751, DOI 10.4049/jimmunol.166.7.4751	35	139	156	2	35	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 2	2011	364	22					2101	2110		10.1056/NEJMoa1013792	http://dx.doi.org/10.1056/NEJMoa1013792			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	772AB	21631322	Bronze			2022-12-24	WOS:000291200700008
J	Rios, AC; Serralbo, O; Salgado, D; Marcelle, C				Rios, Anne C.; Serralbo, Olivier; Salgado, David; Marcelle, Christophe			Neural crest regulates myogenesis through the transient activation of NOTCH	NATURE			English	Article							DERMOMYOTOME DORSOMEDIAL LIP; PROGENITOR CELLS; GENE-EXPRESSION; MUSCLE; DIFFERENTIATION; MAINTENANCE; POPULATION; INHIBITION; MOVEMENTS; MECHANISM	How dynamic signalling and extensive tissue rearrangements interact to generate complex patterns and shapes during embryogenesis is poorly understood(1-3). Here we characterize the signalling events taking place during early morphogenesis of chick skeletal muscles. We show that muscle progenitors present in somites require the transient activation of NOTCH signalling to undergo terminal differentiation. The NOTCH ligand Delta1 is expressed in a mosaic pattern in neural crest cells that migrate past the somites. Gain and loss of Delta1 function in neural crest modifies NOTCH signalling in somites, which results in delayed or premature myogenesis. Our results indicate that the neural crest regulates early muscle formation by a unique mechanism that relies on the migration of Delta1-expressing neural crest cells to trigger the transient activation of NOTCH signalling in selected muscle progenitors. This dynamic signalling guarantees a balanced and progressive differentiation of the muscle progenitor pool.	[Rios, Anne C.; Serralbo, Olivier; Salgado, David; Marcelle, Christophe] Monash Univ, EMBL Australia, Clayton, Vic 3800, Australia; [Rios, Anne C.; Serralbo, Olivier; Salgado, David; Marcelle, Christophe] Monash Univ, ARMI, Clayton, Vic 3800, Australia	European Molecular Biology Laboratory (EMBL); Monash University; Australian Regenerative Medicine Institute; Monash University	Marcelle, C (corresponding author), Monash Univ, EMBL Australia, Bldg 75, Clayton, Vic 3800, Australia.	christophe.marcelle@monash.edu	SALGADO, David/A-1417-2014	Serralbo, Olivier/0000-0003-0808-3464; Rios, Anne/0000-0002-9082-8068; Salgado, David/0000-0002-5905-3591	Agence Nationale pour le Recherche (ANR); EU	Agence Nationale pour le Recherche (ANR)(French National Research Agency (ANR)); EU(European Commission)	We thank N. Rosenthal and P. Currie for critical reading of the manuscript. This study was funded by grants from the Agence Nationale pour le Recherche (ANR), and by the EU 6th Framework Programme Network of Excellence MYORES. The help of P. Weber, S. Firth, C. Johnson and I. Harper from Imaging Facilities (IBDML, Marseille and MMI, Monash University) is acknowledged.	Ben-Yair R, 2005, DEVELOPMENT, V132, P689, DOI 10.1242/dev.01617; Cinnamon Y, 1999, DEVELOPMENT, V126, P4305; Das RM, 2006, DEV BIOL, V294, P554, DOI 10.1016/j.ydbio.2006.02.020; Daudet N, 2005, DEVELOPMENT, V132, P541, DOI 10.1242/dev.01589; De Calisto J, 2005, DEVELOPMENT, V132, P2587, DOI 10.1242/dev.01857; Denetclaw WF, 2001, DEVELOPMENT, V128, P1745; Fryer CJ, 2002, GENE DEV, V16, P1397, DOI 10.1101/gad.991602; Gros J, 2005, NATURE, V435, P954, DOI 10.1038/nature03572; Gros J, 2004, DEV CELL, V6, P875, DOI 10.1016/j.devcel.2004.05.006; Gros J, 2009, NATURE, V457, P589, DOI 10.1038/nature07564; HAMBURGER V, 1992, DEV DYNAM, V195, P231, DOI 10.1002/dvdy.1001950404; HENRIQUE D, 1995, NATURE, V375, P787, DOI 10.1038/375787a0; Henrique D, 1997, GENE DEV, V11, P603, DOI 10.1101/gad.11.5.603; Henrique D, 1997, CURR BIOL, V7, P661, DOI 10.1016/S0960-9822(06)00293-4; Hirsinger E, 2001, DEVELOPMENT, V128, P107; Iimura T, 2006, NATURE, V442, P568, DOI 10.1038/nature04838; Joubin K, 1999, CELL, V98, P559, DOI 10.1016/S0092-8674(00)80044-6; Jouve C, 2000, DEVELOPMENT, V127, P1421; Kahane N, 2002, DEVELOPMENT, V129, P2675; Kahane N, 1998, DEVELOPMENT, V125, P4259; Kahane N, 2001, DEVELOPMENT, V128, P2187; Kassar-Duchossoy L, 2005, GENE DEV, V19, P1426, DOI 10.1101/gad.345505; Manceau M, 2008, GENE DEV, V22, P668, DOI 10.1101/gad.454408; Marcelle C, 1997, DEVELOPMENT, V124, P3955; MAXWELL IH, 1986, CANCER RES, V46, P4660; Nagoshi E, 2004, CELL, V119, P693, DOI 10.1016/j.cell.2004.11.015; Ohtsuka T, 2006, MOL CELL NEUROSCI, V31, P109, DOI 10.1016/j.mcn.2005.09.006; Palmeirim I, 1997, CELL, V91, P639, DOI 10.1016/S0092-8674(00)80451-1; Relaix F, 2005, NATURE, V435, P948, DOI 10.1038/nature03594; Rios AC, 2010, DEV DYNAM, V239, P346, DOI 10.1002/dvdy.22174; Rothbacher U, 2000, EMBO J, V19, P1010, DOI 10.1093/emboj/19.5.1010; Schuster-Gossler K, 2007, P NATL ACAD SCI USA, V104, P537, DOI 10.1073/pnas.0608281104; Shimojo H, 2008, NEURON, V58, P52, DOI 10.1016/j.neuron.2008.02.014; Tobiume M, 2002, J VIROL, V76, P5959, DOI 10.1128/JVI.76.12.5959-5965.2002; Uchikawa M, 2003, DEV CELL, V4, P509, DOI 10.1016/S1534-5807(03)00088-1; Vasyutina E, 2007, CELL CYCLE, V6, P1451; Vasyutina E, 2007, P NATL ACAD SCI USA, V104, P4443, DOI 10.1073/pnas.0610647104; Venters SJ, 2002, DEVELOPMENT, V129, P3873; Wallingford JB, 2000, NATURE, V405, P81, DOI 10.1038/35011077; Weng AP, 2003, MOL CELL BIOL, V23, P655, DOI 10.1128/MCB.23.2.655-664.2003; Werner T, 2007, NUCLEIC ACIDS RES, V35, P6526, DOI 10.1093/nar/gkm727	41	111	112	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 26	2011	473	7348					532	U279		10.1038/nature09970	http://dx.doi.org/10.1038/nature09970			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	768QM	21572437				2022-12-24	WOS:000290951300045
J	Egan, A; Colman, E				Egan, Amy; Colman, Eric			Weighing the Benefits of High-Dose Simvastatin against the Risk of Myopathy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Egan, Amy; Colman, Eric] US FDA, Ctr Drug Evaluat & Res, Off New Drugs, Div Metab & Endocrinol Prod, Silver Spring, MD USA	US Food & Drug Administration (FDA)	Egan, A (corresponding author), US FDA, Ctr Drug Evaluat & Res, Off New Drugs, Div Metab & Endocrinol Prod, Silver Spring, MD USA.		Hug, Balthasar L./G-1568-2010					Armitage J, 2010, LANCET, V376, P1658, DOI 10.1016/S0140-6736(10)60310-8; Baigent C, 2008, LANCET, V371, P2084; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Link E, 2008, NEW ENGL J MED, V359, P789, DOI 10.1056/NEJMoa0801936; Smith MEB., 2009, DRUG CLASS REV HMG C	5	78	83	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 28	2011	365	4					285	287		10.1056/NEJMp1106689	http://dx.doi.org/10.1056/NEJMp1106689			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	798AJ	21675881	Bronze			2022-12-24	WOS:000293172200001
J	Heianza, Y; Hara, S; Arase, Y; Saito, K; Fujiwara, K; Tsuji, H; Kodama, S; Hsieh, SD; Mori, Y; Shimano, H; Yamada, N; Kosaka, K; Sone, H				Heianza, Yoriko; Hara, Shigeko; Arase, Yasuji; Saito, Kazumi; Fujiwara, Kazuya; Tsuji, Hiroshi; Kodama, Satoru; Hsieh, Shiun Dong; Mori, Yasumichi; Shimano, Hitoshi; Yamada, Nobuhiro; Kosaka, Kinori; Sone, Hirohito			HbA(1c) 5.7-6.4% and impaired fasting plasma glucose for diagnosis of prediabetes and risk of progression to diabetes in Japan (TOPICS 3): a longitudinal cohort study	LANCET			English	Article							GLYCATED HEMOGLOBIN; CARDIOVASCULAR RISK; INSULIN SENSITIVITY; CUT-POINTS; A1C; IMPACT; PREVALENCE; TOLERANCE; SECRETION; PEOPLE	Background The clinical relevance of the diagnostic criteria for prediabetes to prediction of progression to diabetes has been little studied. We aimed to compare the prevalence of prediabetes when assessed by the new glycated haemoglobin A(1c) (HbA(1c)) 5.7-6.4% criterion or by impaired fasting glucose, and assessed differences in progression rate to diabetes between these two criteria for prediabetes in a Japanese population. Methods Our longitudinal cohort study included 4670 men and 1571 women aged 24-82 years without diabetes at baseline (diabetes was defined as fasting plasma glucose >= 7.0 mmol/L, self-reported clinician-diagnosed diabetes, or HbA(1c) >= 6.5%) who attended Toranomon Hospital (Tokyo, Japan) for a routine health check between 1997 and 2003. Participants with a baseline diagnosis of prediabetes according to impaired fasting glucose (fasting plasma glucose 5.6-6.9 mmol/L) or HbA(1c) 5.7-6.4%, or both, were divided into four groups on the basis of baseline diagnosis of prediabetes. Rate of progression to diabetes was assessed annually. Findings Mean follow-up was 4.7 (SD 0.7) years. 412 (7%) of 6241 participants were diagnosed with prediabetes on the basis of the HbA(1c) 5.7-6.4% criterion. Screening by HbA(1c) alone missed 1270 (61%) of the 2092 prediabetic individuals diagnosed by a combination of impaired fasting glucose and HbA(1c) 5.7-6.4%. Overall cumulative probability of progression to diabetes did not differ significantly between participants with prediabetes discordantly diagnosed by either HbA(1c) or impaired fasting glucose alone (incidence was 7% for HbA(1c) alone [n=412 individuals and 30 incident cases] and 9% for impaired fasting glucose alone [n=1270,108 cases]; log-rank test, p=0.3317). Multivariate-adjusted hazard ratios for incident diabetes were 6.16 (95% CI 4.33-8.77) for those diagnosed with prediabetes by impaired fasting glucose alone and 6.00 (3.76-9.56) for diagnosis by HbA(1c) alone, and were substantially increased to 31.9 (22.6-45.0) for diagnosis by both impaired fasting glucose and HbA(1c) compared with normoglycaemic individuals. Interpretation Diagnosis of prediabetes by both the new HbA(1c) criterion and impaired fasting glucose identified individuals with an increased risk of progression to diabetes. Although the new HbA(1c) criterion identified fewer individuals at high risk than did impaired fasting glucose, the predictive value for progression to diabetes assessed by HbA(1c) 5.7-6.4% was similar to that assessed by impaired fasting glucose alone. The two tests used together could efficiently target people who are most likely to develop diabetes and allow for early intervention.	[Heianza, Yoriko; Hara, Shigeko; Arase, Yasuji; Saito, Kazumi; Tsuji, Hiroshi; Kodama, Satoru; Hsieh, Shiun Dong; Kosaka, Kinori; Sone, Hirohito] Toranomon Gen Hosp, Hlth Management Ctr, Tokyo 1058470, Japan; [Heianza, Yoriko; Saito, Kazumi; Fujiwara, Kazuya; Kodama, Satoru; Shimano, Hitoshi; Yamada, Nobuhiro; Sone, Hirohito] Univ Tsukuba, Inst Clin Med, Dept Internal Med, Ibaraki, Japan; [Hara, Shigeko; Arase, Yasuji; Tsuji, Hiroshi; Hsieh, Shiun Dong; Mori, Yasumichi; Kosaka, Kinori] Toranomon Gen Hosp, Okinaka Mem Inst Med Res, Tokyo 1058470, Japan	Toranomon Hospital; University of Tsukuba; Toranomon Hospital	Sone, H (corresponding author), Toranomon Gen Hosp, Hlth Management Ctr, Tokyo 1058470, Japan.	hsone@md.tsukuba.ac.jp	Heianza, Yoriko/M-5716-2017; Sone, Hirohito/ABC-9346-2021; Shimano, Hitoshi/AAI-5648-2020; Shimano, Hitoshi/V-1761-2019	Heianza, Yoriko/0000-0002-0957-9309; Sone, Hirohito/0000-0003-1263-2817; Shimano, Hitoshi/0000-0002-5562-5572	Japan Society for the Promotion of Science; Ministry of Health Labor and Welfare, Japan	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Health Labor and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan)	Japan Society for the Promotion of Science; Ministry of Health Labor and Welfare, Japan.	Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; Cederberg H, 2010, DIABETES CARE, V33, P2077, DOI 10.2337/dc10-0262; Chamnan P, 2011, DIABETES CARE, V34, P950, DOI 10.2337/dc09-2326; Chan JCN, 2009, JAMA-J AM MED ASSOC, V301, P2129, DOI 10.1001/jama.2009.726; Christensen DL, 2010, DIABETES CARE, V33, P580, DOI 10.2337/dc09-1843; Droumaguet C, 2006, DIABETES CARE, V29, P1619, DOI 10.2337/dc05-2525; Gerstein HC, 2007, DIABETES RES CLIN PR, V78, P305, DOI 10.1016/j.diabres.2007.05.004; Harano T, 1999, Rinsho Byori, V47, P215; Heianza Y, 2011, DIABETOLOGIA, V54, P762, DOI 10.1007/s00125-010-2029-9; Herman WH, 2007, DIABETES CARE, V30, P2453, DOI 10.2337/dc06-2003; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lorenzo C, 2010, DIABETES CARE, V33, P2104, DOI 10.2337/dc10-0679; Mann DM, 2010, DIABETES CARE, V33, P2190, DOI 10.2337/dc10-0752; Mohan V, 2010, DIABETES CARE, V33, P515, DOI 10.2337/dc09-1694; Mostafa SA, 2010, DIABETES RES CLIN PR, V90, P100, DOI 10.1016/j.diabres.2010.06.008; Mukai N, 2009, DIABETES CARE, V32, P2288, DOI 10.2337/dc09-0896; Nakagami T, 2010, DIABETES RES CLIN PR, V87, P126, DOI 10.1016/j.diabres.2009.11.001; *NAT DIAB INF CLEA, SICKL CELL TRAIT OTH; Nathan DM, 2007, DIABETES CARE, V30, P753, DOI 10.2337/dc07-9920; Nichols GA, 2007, DIABETES CARE, V30, P228, DOI 10.2337/dc06-1392; Olson DE, 2010, DIABETES CARE, V33, P2184, DOI 10.2337/dc10-0433; Seino Y., 2010, Journal of the Japan Diabetes Society, V53, P450, DOI 10.1111/j.2040-1124.2010.00074.x; Selvin E, 2011, DIABETES CARE, V34, P84, DOI 10.2337/dc10-1235; Selvin E, 2010, NEW ENGL J MED, V362, P800, DOI 10.1056/NEJMoa0908359; Tabak AG, 2009, LANCET, V373, P2215, DOI 10.1016/S0140-6736(09)60619-X; van 't Riet E, 2010, DIABETES CARE, V33, P61, DOI 10.2337/dc09-0677; Waki K, 2005, DIABETIC MED, V22, P323, DOI 10.1111/j.1464-5491.2004.01403.x; Wang WY, 2011, DIABETES CARE, V34, P363, DOI 10.2337/dc10-1680; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Zhang XP, 2010, DIABETES CARE, V33, P1665, DOI 10.2337/dc09-1939	30	167	171	0	25	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 9	2011	378	9786					147	155		10.1016/S0140-6736(11)60472-8	http://dx.doi.org/10.1016/S0140-6736(11)60472-8			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	795CJ	21705064				2022-12-24	WOS:000292948800031
J	Tamura, Y; Itoh, K; Sesaki, H				Tamura, Yasushi; Itoh, Kie; Sesaki, Hiromi			SnapShot: Mitochondrial Dynamics	CELL			English	Editorial Material							FISSION; FUSION; MECHANISMS; MITOPHAGY		[Tamura, Yasushi; Itoh, Kie; Sesaki, Hiromi] Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA	Johns Hopkins University	Tamura, Y (corresponding author), Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA.		Yasushi, TAMURA/I-7122-2014; Tamura, Yasushi/H-8270-2017; Tamura, Yasushi/A-9997-2013	Tamura, Yasushi/0000-0002-8462-0607; 	NIGMS NIH HHS [R01 GM089853, GM89853, R01 GM089853-02] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089853] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Campello S, 2010, EMBO REP, V11, P678, DOI 10.1038/embor.2010.115; Chang CR, 2010, ANN NY ACAD SCI, V1201, P34, DOI 10.1111/j.1749-6632.2010.05629.x; Chen HC, 2009, HUM MOL GENET, V18, pR169, DOI 10.1093/hmg/ddp326; Hoppins S, 2009, BBA-MOL CELL RES, V1793, P20, DOI 10.1016/j.bbamcr.2008.07.005; KAGEYAMA Y, 2011, CURR OPIN CELL BIOL; Kuroiwa T, 2010, P JPN ACAD B-PHYS, V86, P455, DOI 10.2183/pjab.86.455; McBride H, 2010, CURR BIOL, V20, pR274, DOI 10.1016/j.cub.2010.02.011; Palmer CS, 2011, EMBO REP, V12, P565, DOI 10.1038/embor.2011.54; Westermann B, 2010, SEMIN CELL DEV BIOL, V21, P542, DOI 10.1016/j.semcdb.2009.12.003; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028	10	42	43	0	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 24	2011	145	7							1158.e1	10.1016/j.cell.2011.06.018	http://dx.doi.org/10.1016/j.cell.2011.06.018			1	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	782QV	21703455	Green Accepted, Bronze			2022-12-24	WOS:000292025700021
J	Fairley, P				Fairley, Peter			Next generation biofuels	NATURE			English	Editorial Material																			0	128	134	1	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 23	2011	474	7352					S2	S5		10.1038/474S02a	http://dx.doi.org/10.1038/474S02a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	781NJ	21697838	Bronze			2022-12-24	WOS:000291939700001
J	Savage, N				Savage, Neil			The scum solution	NATURE			English	Editorial Material																			0	43	45	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 23	2011	474	7352					S15	S16		10.1038/474S015a	http://dx.doi.org/10.1038/474S015a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	781NJ	21697835	Bronze			2022-12-24	WOS:000291939700005
J	Cornes, O				Cornes, Ollie			Commentary: Living with CFS/ME	BRITISH MEDICAL JOURNAL			English	Editorial Material												ollie@cornes.org						ALTER HJ, 2010, BLOOD PRODUCTS ADVIS; 2009, NY TIMES        1015	2	2	2	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 22	2011	342								d3836	10.1136/bmj.d3836	http://dx.doi.org/10.1136/bmj.d3836			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	785AT	21697227				2022-12-24	WOS:000292200500009
J	McKhann, GM				McKhann, Guy M.			Changing Concepts of Alzheimer Disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21218 USA	Johns Hopkins University	McKhann, GM (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurol, 338 Krieger Hall,3400 N Charles St, Baltimore, MD 21218 USA.	guy.mckhann@jhu.edu						Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; Jack CR, 2011, ALZHEIMERS DEMENT, V7, P257, DOI 10.1016/j.jalz.2011.03.004; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; Jagust William, 2006, Alzheimers Dement, V2, P36, DOI 10.1016/j.jalz.2005.11.002; Kantarci K, 2003, NEUROIMAG CLIN N AM, V13, P197, DOI 10.1016/S1052-5149(03)00025-X; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Shaw LM, 2009, ANN NEUROL, V65, P403, DOI 10.1002/ana.21610; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003	9	67	67	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 15	2011	305	23					2458	2459		10.1001/jama.2011.810	http://dx.doi.org/10.1001/jama.2011.810			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	777EB	21673298				2022-12-24	WOS:000291597300027
J	Schmidt, M; Christiansen, CF; Mehnert, F; Rothman, KJ; Sorensen, HT				Schmidt, Morten; Christiansen, Christian F.; Mehnert, Frank; Rothman, Kenneth J.; Sorensen, Henrik Toft			Non-steroidal anti-inflammatory drug use and risk of atrial fibrillation or flutter: population based case-control study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CYCLOOXYGENASE-2 INHIBITORS; METAANALYSIS; COHORT; NSAIDS	Objectives To examine the risk of atrial fibrillation or flutter associated with use of non-selective non-steroidal anti-inflammatory drugs (NSAIDs) or selective cyclo-oxygenase (COX) 2 inhibitors. Design Population based case-control study using data from medical databases. Setting Northern Denmark (population 1.7 million). Participants 32 602 patients with a first inpatient or outpatient hospital diagnosis of atrial fibrillation or flutter between 1999 and 2008; 325 918 age matched and sex matched controls based on risk-set sampling. Main outcome measures Exposure to NSAID use at the time of admission (current use) or before (recent use). Current use was further classified as new use (first ever prescription redemption within 60 days before diagnosis date) or long term use. We used conditional logistic regression to compute odds ratios as unbiased estimates of the incidence rate ratios. Results 2925 cases (9%) and 21 871 controls (7%) were current users of either non-selective NSAIDs or COX 2 inhibitors. Compared with no use, the incidence rate ratio associating current drug use with atrial fibrillation or flutter was 1.33 (95% confidence interval 1.26 to 1.41) for non-selective NSAIDs and 1.50 (1.42 to 1.59) for COX 2 inhibitors. Adjustments for age, sex, and risk factors for atrial fibrillation or flutter reduced the incidence rate ratio to 1.17 (1.10 to 1.24) for non-selective NSAIDs and 1.27 (1.20 to 1.34) for COX 2 inhibitors. Among new users, the adjusted incidence rate ratio was 1.46 (1.33 to 1.62) for non-selective NSAIDs and 1.71 (1.56 to 1.88) for COX 2 inhibitors. Results for individual NSAIDs were similar. Conclusions Use of non-aspirin NSAIDs was associated with an increased risk of atrial fibrillation or flutter. Compared with non-users, the association was strongest for new users, with a 40-70% increase in relative risk (lowest for non-selective NSAIDs and highest for COX 2 inhibitors). Our study thus adds evidence that atrial fibrillation or flutter needs to be added to the cardiovascular risks to be considered when prescribing NSAIDs.	[Schmidt, Morten; Christiansen, Christian F.; Mehnert, Frank; Sorensen, Henrik Toft] Aarhus Univ Hosp, Dept Clin Epidemiol, DK-8200 Aarhus N, Denmark; [Rothman, Kenneth J.] Res Triangle Inst, RTI Hlth Solut, Res Triangle Pk, NC 27709 USA; [Rothman, Kenneth J.] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA	Aarhus University; Research Triangle Institute; Boston University	Schmidt, M (corresponding author), Aarhus Univ Hosp, Dept Clin Epidemiol, DK-8200 Aarhus N, Denmark.	msc@dce.au.dk	Christiansen, Christian/ABE-9423-2021; Sorensen, Henrik Toft/Z-6181-2019; Schmidt, Morten/F-5048-2013; Christiansen, Christian Fynbo/B-5870-2014	Christiansen, Christian/0000-0002-0727-953X; Sorensen, Henrik Toft/0000-0003-4299-7040; Christiansen, Christian Fynbo/0000-0002-0727-953X; Rothman, Kenneth/0000-0003-2398-1705; Schmidt, Morten/0000-0002-4935-4059; Mehnert, Frank/0000-0001-7639-7356	Danish Medical Research Council [271-05-0511]; Clinical Epidemiological Research Foundation, Denmark; Danish Heart Association; Aarhus University; Department of Clinical Epidemiology collaborates within the EU	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Clinical Epidemiological Research Foundation, Denmark; Danish Heart Association; Aarhus University; Department of Clinical Epidemiology collaborates within the EU	The study was supported by the Danish Medical Research Council (grant 271-05-0511), the Clinical Epidemiological Research Foundation, Denmark, the Danish Heart Association, and an Aarhus University scholarship. Department of Clinical Epidemiology collaborates within the EU Seventh Framework Programme: Arrhythmogenic potential of drugs (ARITMO). None of the funding sources had a role in the study design, conduct, analysis, or reporting.	Andersen TF, 1999, DAN MED BULL, V46, P263; [Anonymous], GUIDELINES TREATMENT; Aw TJ, 2005, ARCH INTERN MED, V165, P490, DOI 10.1001/archinte.165.5.IOI50013; Badhwar N, 2008, J CARDIOVASC ELECTR, V19, P1151, DOI 10.1111/j.1540-8167.2008.01238.x; BENJAMIN EJ, 1994, JAMA-J AM MED ASSOC, V271, P840, DOI 10.1001/jama.271.11.840; Capone ML, 2007, PROSTAG OTH LIPID M, V82, P85, DOI 10.1016/j.prostaglandins.2006.05.019; Christiansen CF, 2009, ARCH INTERN MED, V169, P1677, DOI 10.1001/archinternmed.2009.297; Cryer B, 1998, AM J MED, V104, P413, DOI 10.1016/S0002-9343(98)00091-6; *DAN MED AG, REIMB MED; De Caterina R, 2010, ARCH INTERN MED, V170, P1450, DOI 10.1001/archinternmed.2010.305; Ehrenstein Vera, 2010, Clin Epidemiol, V2, P273, DOI 10.2147/CLEP.S13458; Engelmann MDM, 2005, EUR HEART J, V26, P2083, DOI 10.1093/eurheartj/ehi350; Frost L, 2004, ARCH INTERN MED, V164, P1993, DOI 10.1001/archinte.164.18.1993; Greenland S, 2000, AM J EPIDEMIOL, V151, P531; Heeringa J, 2006, EUR HEART J, V27, P949, DOI 10.1093/eurheartj/ehi825; Kearney PM, 2006, BMJ-BRIT MED J, V332, P1302, DOI 10.1136/bmj.332.7553.1302; Laine L, 2002, SEMIN ARTHRITIS RHEU, V32, P25, DOI 10.1053/sarh.2002.37217; Pedersen CB, 2006, DAN MED BULL, V53, P441; Ray WA, 2003, AM J EPIDEMIOL, V158, P915, DOI 10.1093/aje/kwg231; ROTHMAN KJ, 2008, MODERN EPIDEMIOLOGY; Schneeweiss S, 2006, PHARMACOEPIDEM DR S, V15, P291, DOI 10.1002/pds.1200; Stevenson WG, 2004, NEW ENGL J MED, V351, P2437, DOI 10.1056/NEJMe048248; Thomsen RW, 2006, AM J GASTROENTEROL, V101, P2704, DOI 10.1111/j.1572-0241.2006.00825.x; Trelle S, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7086; van der Hooft CS, 2004, J AM COLL CARDIOL, V44, P2117, DOI 10.1016/j.jacc.2004.08.053; WACHOLDER S, 1992, AM J EPIDEMIOL, V135, P1019, DOI 10.1093/oxfordjournals.aje.a116396; Waldo AL, 2008, J AM COLL CARDIOL, V51, P779, DOI 10.1016/j.jacc.2007.08.066; Whelton A., 2001, AM J MED S1, V110, P33; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983; Zhang JJ, 2006, JAMA-J AM MED ASSOC, V296, P1619, DOI 10.1001/jama.296.13.jrv60015	30	80	87	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 4	2011	343								d3450	10.1136/bmj.d3450	http://dx.doi.org/10.1136/bmj.d3450			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	791RR	21727167	hybrid			2022-12-24	WOS:000292682800003
J	Graham-Rowe, D				Graham-Rowe, Duncan			Beyond food versus fuel	NATURE			English	Editorial Material																			0	155	159	0	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 23	2011	474	7352					S6	S8		10.1038/474S06a	http://dx.doi.org/10.1038/474S06a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	781NJ	21697842	Bronze			2022-12-24	WOS:000291939700002
J	McCartney, M				McCartney, Margaret			MEDICINE AND THE MEDIA An early warning for Alzheimer's disease?	BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358					0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 15	2011	342								d3732	10.1136/bmj.d3732	http://dx.doi.org/10.1136/bmj.d3732			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	781LC	21677015				2022-12-24	WOS:000291932700010
J	Edlin, BR				Edlin, Brian R.			Test and treat this silent killer	NATURE			English	Editorial Material							HEPATITIS-C VIRUS; INJECTION-DRUG USERS; UNITED-STATES; INFECTION		SUNY Downstate Coll Med, New York, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Edlin, BR (corresponding author), SUNY Downstate Coll Med, New York, NY USA.	brian.edlin@downstate.edu	Edlin, Brian R/F-2966-2018	Edlin, Brian R/0000-0001-8172-8797	NIDA NIH HHS [R01 DA029512, R01 DA016159, R01 DA021550] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA029512, R01DA016159, R01DA021550] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Armstrong GL, 2006, ANN INTERN MED, V144, P705, DOI 10.7326/0003-4819-144-10-200605160-00004; Edlin BR, 2006, CLIN INFECT DIS, V42, P673, DOI 10.1086/499960; Edlin BR, 2005, HEPATOLOGY, V42, p213A; *I MED, 2009, IN NAT PRIOR COMP EF, P126; Institute of Medicine, 2010, HEP LIV CANC NAT STR; McQuillan GM, 1997, J ACQ IMMUN DEF SYND, V14, P355, DOI 10.1097/00042560-199704010-00008; Onofrey Shauna, 2011, Morbidity and Mortality Weekly Report, V60, P537; Pyenson B., 2009, CONSEQUENCES HEPATIT; Tseng FC, 2007, HEPATOLOGY, V46, P666, DOI 10.1002/hep.21765	9	62	63	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 9	2011	474	7350					S18	S19		10.1038/474S18a	http://dx.doi.org/10.1038/474S18a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	774PE	21613999	Bronze, Green Accepted			2022-12-24	WOS:000291397800011
J	Ruthenburg, AJ; Li, HT; Milne, TA; Dewell, S; McGinty, RK; Yuen, M; Ueberheide, B; Dou, YL; Muir, TW; Patel, DJ; Allis, CD				Ruthenburg, Alexander J.; Li, Haitao; Milne, Thomas A.; Dewell, Scott; McGinty, Robert K.; Yuen, Melanie; Ueberheide, Beatrix; Dou, Yali; Muir, Tom W.; Patel, Dinshaw J.; Allis, C. David			Recognition of a Mononucleosomal Histone Modification Pattern by BPTF via Multivalent Interactions	CELL			English	Article							CHROMATIN REMODELING COMPLEX; PHD FINGER; MASS-SPECTROMETRY; NATIVE CHROMATIN; BINDING MODULES; HUMAN-CELLS; FACTOR NURF; BROMODOMAIN; METHYLATION; LYSINE-4	Little is known about how combinations of histone marks are interpreted at the level of nucleosomes. The second PHD finger of human BPTF is known to specifically recognize histone H3 when methylated on lysine 4 (H3K4me2/3). Here, we examine how additional heterotypic modifications influence BPTF binding. Using peptide surrogates, three acetyllysine ligands are indentified for a PHD-adjacent bromodomain in BPTF via systematic screening and biophysical characterization. Although the bromodomain displays limited discrimination among the three possible acetyllysines at the peptide level, marked selectivity is observed for only one of these sites, H4K16ac, in combination with H3K4me3 at the mononucleosome level. In support, these two histone marks constitute a unique trans-histone modification pattern that unambiguously resides within a single nucleosomal unit in human cells, and this module colocalizes with these marks in the genome. Together, our data call attention to nucleosomal patterning of covalent marks in dictating critical chromatin associations.	[Ruthenburg, Alexander J.; Milne, Thomas A.; Allis, C. David] Rockefeller Univ, Lab Chromatin Biol & Epigenet, New York, NY 10065 USA; [Dewell, Scott] Rockefeller Univ, Genom Resource Ctr, New York, NY 10065 USA; [McGinty, Robert K.; Yuen, Melanie; Muir, Tom W.] Rockefeller Univ, Lab Synthet Prot Chem, New York, NY 10065 USA; [Ueberheide, Beatrix] Rockefeller Univ, Lab Mass Spectrometry & Gaseous Ion Chem, New York, NY 10065 USA; [Li, Haitao; Patel, Dinshaw J.] Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10021 USA; [Dou, Yali] Univ Michigan, Dept Pathol, Sch Med, Ann Arbor, MI 48109 USA	Rockefeller University; Rockefeller University; Rockefeller University; Rockefeller University; Memorial Sloan Kettering Cancer Center; University of Michigan System; University of Michigan	Allis, CD (corresponding author), Rockefeller Univ, Lab Chromatin Biol & Epigenet, 1230 York Ave, New York, NY 10065 USA.	alliscd@rockefeller.edu	Milne, Tom/E-1872-2016; Li, Haitao/B-2668-2012; Muir, Tom/AHD-0860-2022; Ruthenburg, Alexander/F-3992-2015	Milne, Tom/0000-0002-0413-4271; Li, Haitao/0000-0001-6741-293X; Muir, Tom/0000-0001-9635-0344; Ruthenburg, Alexander/0000-0003-2709-4564; Ueberheide, Beatrix/0000-0003-2512-0204	National Center for Research Resources at the National Institutes of Health; Irvington Institute of the Cancer Research Institute; MSTP; NIH; Rockefeller University; Leukemia and Lymphoma Society; Starr Foundation; Abby Rockefeller Mauze Trust; Dewitt Wallace and Maloris Foundations; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040922, T32GM007739, R37GM053512, R01GM053512] Funding Source: NIH RePORTER	National Center for Research Resources at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Irvington Institute of the Cancer Research Institute; MSTP; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rockefeller University; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Starr Foundation; Abby Rockefeller Mauze Trust; Dewitt Wallace and Maloris Foundations; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank the staff at beamline 24ID-C of the Advanced Photon Source at the Argonne National Laboratory and the staff at beamline X29 of the National Synchrotron Light Source at Brookhaven National Laboratory, supported by the US Department of Energy, for assistance with data collection. This work is based upon research conducted at the Northeastern Collaborative Access Team (NE-CAT) beamlines of the Advanced Photon Source and the Macromolecular Crystallography Research Resource (PXRR) at the National Synchrotron Light Source, which are supported by the National Center for Research Resources at the National Institutes of Health. We would like to thank L. Liang for assistance in protein production and crystallization of BPTF H4 peptide complexes; H. A. Zebrowski for assistance in the preparation of the SPOT membrane; S. S. Yi of the Microchemistry and Proteomics Core at Memorial-Sloan Kettering Cancer Center for synthesis of peptides; Y. Wei of the Rockefeller Chemical Biology Spectroscopy center for use of their Biacore instrument; S. Yokoyama and H. Kurumizaka for an expression construct bearing codon optimized histone H4; K. Chiang for his 3_601_3_x32 repeat plasmid; M. Vila-Perello for HF cleavage of Boc-peptides; H. Dormann for HP1-chromodomain recombinantly produced protein; H. Yu of the Rockefeller Proteomics Core for MS assistance; C. Wu for the human BPTF cDNA; and L. Baker, F. Casadio, J. Denu, P. W. Lewis, K-M. Noh, R. G. Roeder, R. Sadeh, D. Shechter, T. Swigut, G. G. Wang, and J. Wysocka for valuable discussions and scientific input. A. J. R. is supported by Irvington Institute Fellowship Program of the Cancer Research Institute, and R. K. M. is supported by an MSTP grant. This work was supported by a MERIT grant from the NIH and funds from The Rockefeller University to C. D. A., as well as funds from the Leukemia and Lymphoma Society and Starr Foundation to C. D. A. and D. J. P. D. J. P. is supported by funds from the Abby Rockefeller Mauze Trust and the Dewitt Wallace and Maloris Foundations, and T. W. M. is supported by an award from the NIH. D. J. P. is a consultant in GlaxoSmithKline's epigenetic programs.	Badenhorst P, 2002, GENE DEV, V16, P3186, DOI 10.1101/gad.1032202; Badenhorst P, 2005, GENE DEV, V19, P2540, DOI 10.1101/gad.1342605; Bai X, 2007, GENETICS, V176, P1491, DOI 10.1534/genetics.107.071571; Barak O, 2003, EMBO J, V22, P6089, DOI 10.1093/emboj/cdg582; Basu A, 2009, P NATL ACAD SCI USA, V106, P13785, DOI 10.1073/pnas.0906801106; Becker PB, 2006, NATURE, V442, P31, DOI 10.1038/442031a; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Brand M, 2008, NAT PROTOC, V3, P398, DOI 10.1038/nprot.2008.8; Briggs SD, 2002, NATURE, V418, P498, DOI 10.1038/nature00970; Changeux JP, 2005, SCIENCE, V308, P1424, DOI 10.1126/science.1108595; CHOU PY, 1978, ANNU REV BIOCHEM, V47, P251, DOI 10.1146/annurev.bi.47.070178.001343; Clapier CR, 2001, MOL CELL BIOL, V21, P875, DOI 10.1128/MCB.21.3.875-883.2001; Dhalluin C, 1999, NATURE, V399, P491, DOI 10.1038/20974; Dou YL, 2005, CELL, V121, P873, DOI 10.1016/j.cell.2005.04.031; Eberharter A, 2004, EMBO J, V23, P4029, DOI 10.1038/sj.emboj.7600382; Grune T, 2003, MOL CELL, V12, P449, DOI 10.1016/S1097-2765(03)00273-9; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Hamiche A, 1999, CELL, V97, P833, DOI 10.1016/S0092-8674(00)80796-5; Hamiche A, 2001, P NATL ACAD SCI USA, V98, P14316, DOI 10.1073/pnas.251421398; Jacobson RH, 2000, SCIENCE, V288, P1422, DOI 10.1126/science.288.5470.1422; Kim J, 2009, CELL, V137, P459, DOI 10.1016/j.cell.2009.02.027; Krishnamurthy V.M., 2006, FRAGMENT BASED APPRO, P11, DOI DOI 10.1002/3527608761.CH2; Kwon SY, 2008, DEV BIOL, V316, P538, DOI 10.1016/j.ydbio.2008.01.033; Kwon SY, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000574; Landry J, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000241; Li B, 2007, SCIENCE, V316, P1050, DOI 10.1126/science.1139004; Li HT, 2006, NATURE, V442, P91, DOI 10.1038/nature04802; McGinty RK, 2008, NATURE, V453, P812, DOI 10.1038/nature06906; Milne TA, 2002, MOL CELL, V10, P1107, DOI 10.1016/S1097-2765(02)00741-4; Mizzen CA, 1999, METHOD ENZYMOL, V304, P675; Moriniere J, 2009, NATURE, V461, P664, DOI 10.1038/nature08397; Muir TW, 2003, ANNU REV BIOCHEM, V72, P249, DOI 10.1146/annurev.biochem.72.121801.161900; Mujtaba S, 2007, ONCOGENE, V26, P5521, DOI 10.1038/sj.onc.1210618; Nady N, 2008, TRENDS BIOCHEM SCI, V33, P305, DOI 10.1016/j.tibs.2008.04.014; O'Neill LP, 2003, METHODS, V31, P76, DOI 10.1016/S1046-2023(03)00090-2; Pena PV, 2006, NATURE, V442, P100, DOI 10.1038/nature04814; Pesavento JJ, 2008, J BIOL CHEM, V283, P14927, DOI 10.1074/jbc.M709796200; Pesavento JJ, 2006, ANAL CHEM, V78, P4271, DOI 10.1021/ac0600050; Ragvin A, 2004, J MOL BIOL, V337, P773, DOI 10.1016/j.jmb.2004.01.051; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; Schwanbeck R, 2004, J BIOL CHEM, V279, P39933, DOI 10.1074/jbc.M406060200; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Shin HJ, 2009, BIOINFORMATICS, V25, P2605, DOI 10.1093/bioinformatics/btp479; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; Shogren-Knaak MA, 2004, METHOD ENZYMOL, V375, P62; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Tsai WW, 2010, NATURE, V468, P927, DOI 10.1038/nature09542; TSUKIYAMA T, 1995, CELL, V83, P1011, DOI 10.1016/0092-8674(95)90216-3; Vermeulen M, 2007, CELL, V131, P58, DOI 10.1016/j.cell.2007.08.016; Verreault A, 1998, CURR BIOL, V8, P96, DOI 10.1016/S0960-9822(98)70040-5; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815; Xiao H, 2001, MOL CELL, V8, P531, DOI 10.1016/S1097-2765(01)00345-8; Zeng L, 2008, STRUCTURE, V16, P643, DOI 10.1016/j.str.2008.01.010; Zheng CY, 2004, METHOD ENZYMOL, V375, P179; Zhou YG, 2005, CURR BIOL, V15, P1434, DOI 10.1016/j.cub.2005.06.057	58	240	245	1	73	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 27	2011	145	5					692	706		10.1016/j.cell.2011.03.053	http://dx.doi.org/10.1016/j.cell.2011.03.053			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	769MR	21596426	Green Accepted, Bronze, Green Published			2022-12-24	WOS:000291018600010
J	Denham, BE				Denham, Bryan E.			Dietary Supplements-Regulatory Issues and Implications for Public Health	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Clemson Univ, Dept Commun Studies, Clemson, SC 29634 USA	Clemson University	Denham, BE (corresponding author), Clemson Univ, Dept Commun Studies, 412 Strode Tower, Clemson, SC 29634 USA.	bdenham@clemson.edu						Hill J.A., 2006, J FOOD L POL, V2, P361; *NAT CTR COMPL ALT, RES RES DIET HERB SU; US Food & Drug Administration, CURR GOOD MAN PRACT; *US GOV ACC OFF, 2009, PUBL US GOV ACC OFF; *US GOV ACC OFF, 2010, PUBL US GOV ACC OFF; *US GOV ACC OFF, 1993, PUBL US GOV ACC OFF	6	37	37	0	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 27	2011	306	4					428	429		10.1001/jama.2011.982	http://dx.doi.org/10.1001/jama.2011.982			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	797KL	21730229				2022-12-24	WOS:000293125800029
J	Amit, R; Garcia, HG; Phillips, R; Fraser, SE				Amit, Roee; Garcia, Hernan G.; Phillips, Rob; Fraser, Scott E.			Building Enhancers from the Ground Up: A Synthetic Biology Approach	CELL			English	Article							TET REPRESSOR; RNA-POLYMERASE; TRANSCRIPTIONAL REGULATION; THERMODYNAMIC ANALYSIS; GENE-REGULATION; TOGGLE SWITCH; IN-VIVO; EXPRESSION; PROMOTER; BINDING	A challenge of the synthetic biology approach is to use our understanding of a system to recreate a biological function with specific properties. We have applied this framework to bacterial enhancers, combining a driver, transcription factor binding sites, and a poised polymerase to create synthetic modular enhancers. Our findings suggest that enhancer-based transcriptional control depends critically and quantitatively on DNA looping, leading to complex regulatory effects when the enhancer cassettes contain additional transcription factor binding sites for TetR, a bacterial transcription factor. We show through a systematic interplay of experiment and thermodynamic modeling that the level of gene expression can be modulated to convert a variable inducer concentration input into discrete or step-like output expression levels. Finally, using a different DNA-binding protein (TraR), we show that the regulatory output is not a particular feature of the specific DNA-binding protein used for the enhancer but a general property of synthetic bacterial enhancers.	[Amit, Roee; Phillips, Rob; Fraser, Scott E.] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Garcia, Hernan G.] CALTECH, Dept Phys, Pasadena, CA 91125 USA; [Amit, Roee; Phillips, Rob; Fraser, Scott E.] CALTECH, Div Engn & Appl Sci, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology; California Institute of Technology	Amit, R (corresponding author), Technion Israel Inst Technol, Dept Biotechnol & Food Engn, IL-32000 Haifa, Israel.	roeeamit@technion.ac.il	Fraser, Scott/Y-3406-2019	Fraser, Scott/0000-0002-5377-0223; Garcia, Hernan G./0000-0002-5212-3649	NIH [ARRA R01 GM085286-01S, R01 GM085286, DP1 OD000217]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085286] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000217] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We would especially like to thank Prof. Frances H. Arnold for providing lab space and the forum to conduct thorough discussions as this project was evolving. We would also like to thank Eric H. Davidson for important early discussions and Alex J. Ninfa for plasmids and strains. R.A. was supported by a NIH Ruth L. Kirschstein fellowship, a Caltech CBCD grant, and the NIH through award NIH ARRA R01 GM085286-01S. R.P. and H.G.G. gratefully acknowledge awards NIH ARRA R01 GM085286-01S, R01 GM085286, and the NIH Director's PIONEER Award DP1 OD000217.	Atkinson MR, 2003, CELL, V113, P597, DOI 10.1016/S0092-8674(03)00346-5; Atkinson MR, 2002, MOL MICROBIOL, V46, P1247, DOI 10.1046/j.1365-2958.2002.03211.x; Basu S, 2005, NATURE, V434, P1130, DOI 10.1038/nature03461; Becker NA, 2005, J MOL BIOL, V349, P716, DOI 10.1016/j.jmb.2005.04.035; Bintu L, 2005, CURR OPIN GENET DEV, V15, P125, DOI 10.1016/j.gde.2005.02.006; Bintu L, 2005, CURR OPIN GENET DEV, V15, P116, DOI 10.1016/j.gde.2005.02.007; Buck M, 2000, J BACTERIOL, V182, P4129, DOI 10.1128/JB.182.15.4129-4136.2000; Davidson E.H., 2006, REGULATORY GENOME; Davidson E. H., 2001, DEV EVOLUTION; DRIEVER W, 1989, NATURE, V340, P363, DOI 10.1038/340363a0; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Friedland AE, 2009, SCIENCE, V324, P1199, DOI 10.1126/science.1172005; Garcia HG, 2011, P NATL ACAD SCI USA, V108, P12173, DOI 10.1073/pnas.1015616108; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Hervas AB, 2009, J BACTERIOL, V191, P6123, DOI 10.1128/JB.00744-09; HILLEN W, 1994, ANNU REV MICROBIOL, V48, P345, DOI 10.1146/annurev.mi.48.100194.002021; HILLEN W, 1984, J MOL BIOL, V172, P185, DOI 10.1016/S0022-2836(84)80037-6; Huo YX, 2006, MOL MICROBIOL, V59, P168, DOI 10.1111/j.1365-2958.2005.04943.x; JOUNG JK, 1993, P NATL ACAD SCI USA, V90, P3083, DOI 10.1073/pnas.90.7.3083; Kuhlman T, 2007, P NATL ACAD SCI USA, V104, P6043, DOI 10.1073/pnas.0606717104; LAW SM, 1993, J MOL BIOL, V230, P161, DOI 10.1006/jmbi.1993.1133; Lederer T, 1995, ANAL BIOCHEM, V232, P190, DOI 10.1006/abio.1995.0006; Lederer T, 1996, BIOCHEMISTRY-US, V35, P7439, DOI 10.1021/bi952683e; LEE DH, 1989, P NATL ACAD SCI USA, V86, P476, DOI 10.1073/pnas.86.2.476; Long T, 2009, PLOS BIOL, V7, P640, DOI 10.1371/journal.pbio.1000068; MAGASANIK B, 1993, J CELL BIOCHEM, V51, P34, DOI 10.1002/jcb.240510108; Mukherji S, 2009, NAT REV GENET, V10, P859, DOI 10.1038/nrg2697; Muller J, 1996, J MOL BIOL, V257, P21, DOI 10.1006/jmbi.1996.0143; Ninfa AJ, 2000, TRENDS MICROBIOL, V8, P172, DOI 10.1016/S0966-842X(00)01709-1; NINFA AJ, 1987, CELL, V50, P1039, DOI 10.1016/0092-8674(87)90170-X; Orth P, 2000, NAT STRUCT BIOL, V7, P215; Phillips R., 2009, PHYS BIOL CELL; Qin YP, 2009, MOL MICROBIOL, V74, P330, DOI 10.1111/j.1365-2958.2009.06865.x; Ramos JL, 2005, MICROBIOL MOL BIOL R, V69, P326, DOI 10.1128/MMBR.69.2.326-356.2005; Rappas M, 2007, CURR OPIN STRUC BIOL, V17, P110, DOI 10.1016/j.sbi.2006.11.002; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; Schulz A, 2000, J MOL BIOL, V300, P709, DOI 10.1006/jmbi.2000.3921; SU W, 1990, P NATL ACAD SCI USA, V87, P5504, DOI 10.1073/pnas.87.14.5504	38	40	40	0	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 8	2011	146	1					105	118		10.1016/j.cell.2011.06.024	http://dx.doi.org/10.1016/j.cell.2011.06.024			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	789TN	21729783	Green Accepted, Bronze			2022-12-24	WOS:000292539300010
J	Sim, MS; Bosak, T; Ono, S				Sim, Min Sub; Bosak, Tanja; Ono, Shuhei			Large Sulfur Isotope Fractionation Does Not Require Disproportionation	SCIENCE			English	Article							MICROBIAL SULFATE REDUCTION; ATMOSPHERIC OXYGEN; EVOLUTION; SEDIMENTS; OCEAN; BIOSPHERE; SULFIDE; BURIAL; CARBON; PYRITE	The composition of sulfur isotopes in sedimentary sulfides and sulfates traces the sulfur cycle throughout Earth's history. In particular, depletions of sulfur-34 ((34)S) in sulfide relative to sulfate exceeding 47 per mil (parts per thousand) often serve as a proxy for the disproportionation of intermediate sulfur species in addition to sulfate reduction. Here, we demonstrate that a pure, actively growing culture of a marine sulfate-reducing bacterium can deplete (34)S by up to 66 parts per thousand during sulfate reduction alone and in the absence of an extracellular oxidative sulfur cycle. Therefore, similar magnitudes of sulfur isotope fractionation in sedimentary rocks do not unambiguously record the presence of other sulfur-based metabolisms or the stepwise oxygenation of Earth's surface environment during the Proterozoic.	[Sim, Min Sub; Bosak, Tanja; Ono, Shuhei] MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Sim, MS (corresponding author), MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA.	mssim@mit.edu		Sim, Min Sub/0000-0002-3491-9002	NASA Astrobiology Institute [NNA08CN84A]	NASA Astrobiology Institute	We thank W. Olszewski, K. Donovan, S. Templer, J. Seewald, S. Sylva, B. Weiss, L. Kump, J. Grabenstatter, B. Bannon, P. Hedman, and Y. J. Joo. This work was partially supported by NASA Astrobiology Institute (#NNA08CN84A).	Berner RA, 1998, SCIENCE, V282, P1426, DOI 10.1126/science.282.5393.1426; Brunner B, 2005, GEOCHIM COSMOCHIM AC, V69, P4759, DOI 10.1016/j.gca.2005.04.015; CANFIELD DE, 1994, SCIENCE, V266, P1973, DOI 10.1126/science.11540246; Canfield DE, 1996, NATURE, V382, P127, DOI 10.1038/382127a0; Canfield DE, 2010, GEOLOGY, V38, P415, DOI 10.1130/G30723.1; Canfield DE, 2009, P NATL ACAD SCI USA, V106, P8123, DOI 10.1073/pnas.0902037106; D'Hondt S, 2002, SCIENCE, V295, P2067, DOI 10.1126/science.1064878; Farquhar J, 2003, GEOBIOLOGY, V1, P27, DOI 10.1046/j.1472-4669.2003.00007.x; Fike DA, 2006, NATURE, V444, P744, DOI 10.1038/nature05345; GARRELS RM, 1981, P NATL ACAD SCI USA, V78, P4652, DOI 10.1073/pnas.78.8.4652; Hayes J.M., 1992, PROTEROZOIC BIOSPHER, P129; Hurtgen MT, 2005, GEOLOGY, V33, P41, DOI 10.1130/G20923.1; Johnston DT, 2007, GEOCHIM COSMOCHIM AC, V71, P3929, DOI 10.1016/j.gca.2007.05.008; Johnston DT, 2005, SCIENCE, V310, P1477, DOI 10.1126/science.1117824; JORGENSEN BB, 1990, SCIENCE, V249, P152, DOI 10.1126/science.249.4965.152; Jorgensen BB, 2007, NAT REV MICROBIOL, V5, P770, DOI 10.1038/nrmicro1745; Kah LC, 2004, NATURE, V431, P834, DOI 10.1038/nature02974; Li XN, 2010, GEOCHIM COSMOCHIM AC, V74, P6764, DOI 10.1016/j.gca.2010.08.020; MOPPER K, 1980, MAR CHEM, V10, P55, DOI 10.1016/0304-4203(80)90058-4; NORTHROP DB, 1981, ANNU REV BIOCHEM, V50, P103, DOI 10.1146/annurev.bi.50.070181.000535; Otake T, 2008, CHEM GEOL, V249, P357, DOI 10.1016/j.chemgeo.2008.01.020; Parnell J, 2010, NATURE, V468, P290, DOI 10.1038/nature09538; PETERSON BJ, 1986, ECOLOGY, V67, P865, DOI 10.2307/1939809; REES CE, 1973, GEOCHIM COSMOCHIM AC, V37, P1141, DOI 10.1016/0016-7037(73)90052-5; ROSS GM, 1995, PRECAMBRIAN RES, V73, P71, DOI 10.1016/0301-9268(94)00072-Y; Rudnicki MD, 2001, GEOCHIM COSMOCHIM AC, V65, P777, DOI 10.1016/S0016-7037(00)00579-2; Sim MS, 2011, GEOCHIM COSMOCHIM AC, V75, P4244, DOI 10.1016/j.gca.2011.05.021; STAMS JM, 1983, ARCH MICROBIOL, V136, P54; Vu B, 2009, MOLECULES, V14, P2535, DOI 10.3390/molecules14072535; Wortmann UG, 2001, GEOLOGY, V29, P647, DOI 10.1130/0091-7613(2001)029<0647:HDBIES>2.0.CO;2; Wu NP, 2010, GEOCHIM COSMOCHIM AC, V74, P2053, DOI 10.1016/j.gca.2009.12.012; Zerkle AL, 2010, GEOCHIM COSMOCHIM AC, V74, P4953, DOI 10.1016/j.gca.2010.06.015	32	392	402	3	145	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 1	2011	333	6038					74	77		10.1126/science.1205103	http://dx.doi.org/10.1126/science.1205103			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	785UF	21719675				2022-12-24	WOS:000292255400051
J	Delamothe, T				Delamothe, Tony			ON THE CONTRARY Of swords, ploughshares, and climate change	BRITISH MEDICAL JOURNAL			English	Editorial Material												tdelamothe@bmj.com							0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 22	2011	342								d3806	10.1136/bmj.d3806	http://dx.doi.org/10.1136/bmj.d3806			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	785AT	21697215				2022-12-24	WOS:000292200500007
J	Conen, D; Everett, BM; Kurth, T; Creager, MA; Buring, JE; Ridker, PM; Pradhan, AD				Conen, David; Everett, Brendan M.; Kurth, Tobias; Creager, Mark A.; Buring, Julie E.; Ridker, Paul M.; Pradhan, Aruna D.			Smoking, Smoking Status, and Risk for Symptomatic Peripheral Artery Disease in Women A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							INTERMITTENT CLAUDICATION; CARDIOVASCULAR-DISEASE; PRIMARY PREVENTION; MORTALITY; CHOLESTEROL; POPULATION; PREVALENCE	Background: Smoking has a well-documented detrimental effect on risk for myocardial infarction and stroke, but less information is available regarding peripheral artery disease (PAD), particularly among women. Objective: To prospectively assess the association of current smoking status, cumulative smoking exposure, and smoking cessation with incident symptomatic PAD in women. Design: Prospective cohort study. Setting: U. S. female health care professionals in the Women's Health Study. Participants: 39 825 women with no cardiovascular disease who were prospectively followed for a median of 12.7 years. Measurements: Incidence of symptomatic PAD. Cox proportional hazards models were used to compare PAD risk across smoking categories. Results: 178 confirmed PAD events occurred. Across the 4 smoking categories (never, former, < 15 cigarettes/d, and >= 15 cigarettes/d), age-adjusted incidence rates were 0.12, 0.34, 0.95, and 1.63 per 1000 person-years of follow-up, respectively. Multivariate adjustment had little effect on this relationship (adjusted hazard ratios [HRs], 3.14 [95% CI, 2.01 to 4.90], 8.93 [CI, 5.02 to 15.89], and 16.95 [CI, 10.77 to 26.67], respectively, vs. women who never smoked). Additional adjustment for high-sensitivity C-reactive protein and soluble intercellular adhesion molecule-1 levels among women with available blood samples (28 314 participants, 117 events) attenuated risk estimates (HR, 5.58 [CI, 2.61 to 11.93] for smoking < 15 cigarettes/d and 9.52 [CI, 5.17 to 17.53] for smoking >= 15 cigarettes/d). Lifetime exposure showed a strong dose-response relationship; fully adjusted HRs for smoking abstinence of fewer than 10, 10 to 29, and 30 or more pack-years were 2.52 (CI, 1.49 to 4.25), 6.75 (CI, 4.33 to 10.52), and 11.09 (CI, 6.94 to 17.72), respectively. Compared with current smokers, the adjusted HRs for fewer than 10 years, 10 to 20 years, more than 20 years, or lifelong abstinence were 0.39 (CI, 0.24 to 0.66), 0.28 (CI, 0.17 to 0.46), 0.16 (CI, 0.10 to 0.26), and 0.08 (CI, 0.05 to 0.12), respectively. Limitation: The use of symptomatic PAD as the a priori primary end point excludes asymptomatic disease. Conclusion: Among initially healthy women, smoking is a potent risk factor for symptomatic PAD and was associated with subclinical inflammation. Smoking cessation substantially reduces risk for PAD, but an increased occurrence of PAD persists even among former smokers who maintain abstinence.	[Pradhan, Aruna D.] Harvard Univ, Brigham & Womens Hosp, Div Prevent Med, Med Sch,Sch Publ Hlth, Boston, MA 02215 USA; Univ Basel Hosp, CH-4031 Basel, Switzerland; Vet Affairs Boston Med Ctr, Boston, MA USA; INSERM, Neuroepidemiol U708, Paris, France; Univ Paris 06, Paris, France	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard T.H. Chan School of Public Health; University of Basel; Boston Medical Center; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Pradhan, AD (corresponding author), Harvard Univ, Brigham & Womens Hosp, Div Prevent Med, Med Sch,Sch Publ Hlth, 900 Commonwealth Ave E, Boston, MA 02215 USA.	apradhan@partners.org	Kurth, Tobias/A-9243-2012	Kurth, Tobias/0000-0001-7169-2620	The National Heart, Lung, and Blood Institute [HL-043851, HL-080467, HL-082740, HL-075771]; National Cancer Institute [CA-047988]; Donald W. Reynolds Foundation; NATIONAL CANCER INSTITUTE [R01CA047988] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL082740, R01HL080467, RC1HL099355, R01HL043851, R01HL075771] Funding Source: NIH RePORTER	The National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Donald W. Reynolds Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The National Heart, Lung, and Blood Institute and National Cancer Institute.r By the National Heart, Lung, and Blood Institute (grants HL-043851, HL-080467, HL-082740, and HL-075771), National Cancer Institute (grant CA-047988), and Donald W. Reynolds Foundation.	Aboyans V, 2007, J VASC SURG, V45, P319, DOI 10.1016/j.jvs.2006.10.032; CANTIN B, 1995, AM J CARDIOL, V75, P1224, DOI 10.1016/S0002-9149(99)80767-X; Conen D, 2009, CIRCULATION, V120, P1041, DOI 10.1161/CIRCULATIONAHA.109.863092; COX DR, 1972, J R STAT SOC B, V34, P187; Doll R, 2004, BMJ-BRIT MED J, V328, P1519, DOI 10.1136/bmj.38142.554479.AE; Ezzati M, 2003, LANCET, V362, P847, DOI 10.1016/S0140-6736(03)14338-3; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; Fowkes FGR, 2008, JAMA-J AM MED ASSOC, V300, P197, DOI 10.1001/jama.300.2.197; He Y, 2008, CIRCULATION, V118, P1535, DOI 10.1161/CIRCULATIONAHA.108.784801; Heyman KM, 2009, EARLY RELEASE SELECT; HIATT WR, 1995, CIRCULATION, V91, P1472, DOI 10.1161/01.CIR.91.5.1472; Hooi JD, 2001, AM J EPIDEMIOL, V153, P666, DOI 10.1093/aje/153.7.666; INGOLFSSON IO, 1994, J CLIN EPIDEMIOL, V47, P1237, DOI 10.1016/0895-4356(94)90128-7; Kenfield SA, 2008, JAMA-J AM MED ASSOC, V299, P2037, DOI 10.1001/jama.299.17.2037; Kollerits B, 2008, ATHEROSCLEROSIS, V198, P214, DOI 10.1016/j.atherosclerosis.2007.09.012; Lee IM, 2005, JAMA-J AM MED ASSOC, V294, P56, DOI 10.1001/jama.294.1.56; LENG GC, 1992, J CLIN EPIDEMIOL, V45, P1101, DOI 10.1016/0895-4356(92)90150-L; McDermott MM, 1999, ARCH INTERN MED, V159, P387; MCKINLAY SM, 1985, ANN INTERN MED, V103, P350, DOI 10.7326/0003-4819-103-3-350; Murabito JM, 1997, CIRCULATION, V96, P44; Pradhan AD, 2008, CIRCULATION, V117, P823, DOI 10.1161/CIRCULATIONAHA.107.719369; Price JF, 1999, EUR HEART J, V20, P344, DOI 10.1053/euhj.1998.1194; Rexrode KM, 2000, J WOMEN HEALTH GEN-B, V9, P19, DOI 10.1089/152460900318911; Ridker PM, 2005, JAMA-J AM MED ASSOC, V294, P326, DOI 10.1001/jama.294.3.326; Ridker PM, 2005, NEW ENGL J MED, V352, P1293, DOI 10.1056/NEJMoa050613; Tapp RJ, 2007, ATHEROSCLEROSIS, V190, P84, DOI 10.1016/j.atherosclerosis.2006.02.017; Teo KK, 2006, LANCET, V368, P647, DOI 10.1016/S0140-6736(06)69249-0; Vavra AK, 2009, WOMENS HEALTH, V5, P669, DOI 10.2217/WHE.09.60; World Health Organization, 2008, WHO REP GLOB TOB EP; World Health Organization Regional Office for Europe, 2010, TOB CONTR DAT	30	59	64	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 7	2011	154	11								10.7326/0003-4819-154-11-201106070-00003	http://dx.doi.org/10.7326/0003-4819-154-11-201106070-00003			104	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	773MV	21646555	Green Accepted			2022-12-24	WOS:000291312300002
J	Annas, GJ				Annas, George J.			Sudden Death for a Challenge to Federal Funding of Stem-Cell Research	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Boston Univ, Sch Publ Hlth, Dept Hlth Law Bioeth & Human Rights, Boston, MA 02215 USA	Boston University	Annas, GJ (corresponding author), Boston Univ, Sch Publ Hlth, Dept Hlth Law Bioeth & Human Rights, Boston, MA 02215 USA.			Annas, George/0000-0001-5836-7831				Annas GJ, 2010, NEW ENGL J MED, V363, P1687, DOI 10.1056/NEJMp1010466; [Anonymous], 2009, FED REGISTER, V74, P32170	2	4	4	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 2	2011	364	22								10.1056/NEJMp1105498	http://dx.doi.org/10.1056/NEJMp1105498			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	772AB	21591936				2022-12-24	WOS:000291200700005
J	Young, DA; Wright, AP; Roberts, JL; Warner, RC; Young, NW; Greenbaum, JS; Schroeder, DM; Holt, JW; Sugden, DE; Blankenship, DD; van Ommen, TD; Siegert, MJ				Young, Duncan A.; Wright, Andrew P.; Roberts, Jason L.; Warner, Roland C.; Young, Neal W.; Greenbaum, Jamin S.; Schroeder, Dustin M.; Holt, John W.; Sugden, David E.; Blankenship, Donald D.; van Ommen, Tas D.; Siegert, Martin J.			A dynamic early East Antarctic Ice Sheet suggested by ice-covered fjord landscapes	NATURE			English	Article							SOUTHERN VICTORIA LAND; EXOBIOLOGICAL IMPLICATIONS; ALTERNATIVE ORIGIN; NUMERICAL-MODEL; LAKE VOSTOK; MIOCENE; MOUNTAINS; EVOLUTION; ROUGHNESS; EROSION	The first Cenozoic ice sheets initiated in Antarctica from the Gamburtsev Subglacial Mountains(1) and other highlands as a result of rapid global cooling similar to 34 million years ago(2). In the subsequent 20 million years, at a time of declining atmospheric carbon dioxide concentrations(2) and an evolving Antarctic circumpolar current(2), sedimentary sequence interpretation(3) and numerical modelling(4) suggest that cyclical periods of ice-sheet expansion to the continental margin, followed by retreat to the subglacial highlands, occurred up to thirty times. These fluctuations were paced by orbital changes and were a major influence on global sea levels(5). Ice-sheet models show that the nature of such oscillations is critically dependent on the pattern and extent of Antarctic topographic lowlands. Here we show that the basal topography of the Aurora Subglacial Basin of East Antarctica, at present overlain by 2-4.5 km of ice, is characterized by a series of well-defined topographic channels within a mountain block landscape. The identification of this fjord landscape, based on new data from ice-penetrating radar, provides an improved understanding of the topography of the Aurora Subglacial Basin and its surroundings, and reveals a complex surface sculpted by a succession of ice-sheet configurations substantially different from today's. At different stages during its fluctuations, the edge of the East Antarctic Ice Sheet lay pinned along the margins of the Aurora Subglacial Basin, the upland boundaries of which are currently above sea level and the deepest parts of which are more than 1 km below sea level. Although the timing of the channel incision remains uncertain, our results suggest that the fjord landscape was carved by at least two ice-flow regimes of different scales and directions, each of which would have over-deepened existing topographic depressions, reversing valley floor slopes.	[Young, Duncan A.; Greenbaum, Jamin S.; Schroeder, Dustin M.; Holt, John W.; Blankenship, Donald D.] Univ Texas Austin, Inst Geophys, Jackson Sch Geosci, Austin, TX 78758 USA; [Wright, Andrew P.; Sugden, David E.; Siegert, Martin J.] Univ Edinburgh, Sch Geosci, Edinburgh EH9 3JW, Midlothian, Scotland; [Roberts, Jason L.; Warner, Roland C.; Young, Neal W.; van Ommen, Tas D.] Australian Antarctic Div, Kingston, Tas 7050, Australia; [Roberts, Jason L.; Warner, Roland C.; Young, Neal W.; van Ommen, Tas D.] Antarctic Climate & Ecosyst Cooperat Res Ctr, Hobart, Tas 7001, Australia	University of Texas System; University of Texas Austin; University of Edinburgh; Australian Antarctic Division; Antarctic Climate & Ecosystems Cooperative Research Centre (ACE CRC)	Young, DA (corresponding author), Univ Texas Austin, Inst Geophys, Jackson Sch Geosci, Austin, TX 78758 USA.	duncan@utig.ig.utexas.edu; m.j.siegert@ed.ac.uk	Siegert, Martin/M-9939-2019; Wright, Andrew/HDM-9615-2022; Roberts, Jason L/B-2235-2012; Siegert, Martin J/A-3826-2008; Holt, John/C-4896-2009; van Ommen, Tas D/B-5020-2012; Young, Duncan A./G-6256-2010	Siegert, Martin/0000-0002-0090-4806; Roberts, Jason L/0000-0002-3477-4069; Siegert, Martin J/0000-0002-0090-4806; van Ommen, Tas D/0000-0002-2463-1718; Young, Duncan A./0000-0002-6866-8176; Warner, Roland/0000-0002-9778-3544; Schroeder, Dustin/0000-0003-1916-3929	NSF [ANT-0733025]; NASA [NNX09AR52G]; NERC [NE/D003733/1]; Australian Antarctic Division [3103]; Jackson School of Geoscience; Jet Propulsion Laboratory; G. Unger Vetlesen Foundation; Antarctic Climate and Ecosystems Cooperative Research Centre; Natural Environment Research Council [NE/F016646/1, NE/E018254/1] Funding Source: researchfish; NERC [NE/F016646/1, NE/E018254/1] Funding Source: UKRI	NSF(National Science Foundation (NSF)); NASA(National Aeronautics & Space Administration (NASA)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Australian Antarctic Division; Jackson School of Geoscience; Jet Propulsion Laboratory; G. Unger Vetlesen Foundation; Antarctic Climate and Ecosystems Cooperative Research Centre(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by NSF grant ANT-0733025 and NASA grant NNX09AR52G to the University of Texas at Austin, NERC grant NE/D003733/1 to the University of Edinburgh, Australian Antarctic Division project 3103, the Jackson School of Geoscience, and the Jet Propulsion Laboratory, and the G. Unger Vetlesen Foundation. This research was also supported by the Antarctic Climate and Ecosystems Cooperative Research Centre. This is UTIG contribution 2344.	Alley RB, 2003, NATURE, V424, P758, DOI 10.1038/nature01839; Bo S, 2009, NATURE, V459, P690, DOI 10.1038/nature08024; DeConto RM, 2003, NATURE, V421, P245, DOI 10.1038/nature01290; DREWRY DJ, 1976, TECTONOPHYSICS, V36, P301, DOI 10.1016/0040-1951(76)90023-8; Duxbury NS, 2001, J GEOPHYS RES-PLANET, V106, P1453, DOI 10.1029/2000JE001254; Harwood DM, 2000, ANTARCT SCI, V12, P443; Holtedahl H., 1967, GEOGRAFISKA ANN A, V49, P188, DOI DOI 10.2307/520887; Huybrechts P., 1993, GEOGR ANN A, V75, P221, DOI [10.2307/521202, DOI 10.1080/04353676.1993.11880395, DOI 10.2307/521202]; Jamieson S. S. R., 2007, ANTARCTICA KEYSTONE, P39; Jamieson SSR, 2008, GEOMORPHOLOGY, V97, P91, DOI 10.1016/j.geomorph.2007.02.047; Kessler MA, 2008, NAT GEOSCI, V1, P365, DOI 10.1038/ngeo201; Kleman J, 2008, GEOMORPHOLOGY, V97, P73, DOI 10.1016/j.geomorph.2007.02.049; Le Brocq A. M., 2010, EARTH SYST SCI DATA, V2, P247, DOI [10.5194/essd-2-247-2010, DOI 10.5194/essd-2-247-2010, DOI 10.5194/ESSD-2-247-2010]; Lewis AR, 2007, GEOL SOC AM BULL, V119, P1449, DOI 10.1130/B26134; LOKEN OH, 1971, CAN J EARTH SCI, V8, P185, DOI 10.1139/e71-020; Lythe MB, 2001, J GEOPHYS RES-SOL EA, V106, P11335, DOI 10.1029/2000JB900449; Marchant DR, 2002, GEOL SOC AM BULL, V114, P718, DOI 10.1130/0016-7606(2002)114<0718:FOPGAS>2.0.CO;2; MERCER JH, 1978, NATURE, V271, P321, DOI 10.1038/271321a0; Naish TR, 2001, NATURE, V413, P719, DOI 10.1038/35099534; Pekar SF, 2006, PALAEOGEOGR PALAEOCL, V231, P101, DOI 10.1016/j.palaeo.2005.07.027; Peters ME, 2005, J GEOPHYS RES-SOL EA, V110, DOI 10.1029/2004JB003222; Roberts J. L., 2011, CRYOSPHERE DISCUSSIO, V5, P655; Shepard MK, 2001, J GEOPHYS RES-PLANET, V106, P32777, DOI 10.1029/2000JE001429; Sieger MJ, 2005, GLOBAL PLANET CHANGE, V45, P249, DOI 10.1016/j.gloplacha.2004.09.008; Siegert M. J., 2001, ICE SHEETS LATE QUAT, P131; Siegert MJ, 2004, J GEOPHYS RES-PLANET, V109, DOI 10.1029/2003JE002176; Sugden D.E., 1974, I BRIT GEOGRAPHERS S, V7, P177; Summerfield MA, 1999, GEOL SOC SPEC PUBL, V162, P255, DOI 10.1144/GSL.SP.1999.162.01.20; Watson D., 1992, CONTOURING GUIDE ANA, P67; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412	30	131	131	2	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 2	2011	474	7349					72	75		10.1038/nature10114	http://dx.doi.org/10.1038/nature10114			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	771KV	21637255				2022-12-24	WOS:000291156700039
J	Molgaard-Nielsen, D; Hviid, A				Molgaard-Nielsen, Ditte; Hviid, Anders			Newer-Generation Antiepileptic Drugs and the Risk of Major Birth Defects	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PREGNANCY-REGISTER; UK-EPILEPSY; PRELIMINARY EXPERIENCE; LAMOTRIGINE; WOMEN; MALFORMATIONS; REGISTRATION; METAANALYSIS; FREQUENCY; EXPOSURE	Context Epilepsy during pregnancy is a therapeutic challenge. Since the 1990s, the number of licensed antiepileptic drugs has substantially increased, but safety data on first-trimester use of newer-generation antiepileptic drugs and birth defects are limited. Objective To study the association between fetal exposure to newer-generation antiepileptic drugs during the first trimester of pregnancy and the risk of major birth defects. Design, Setting, and Participants Population-based cohort study of 837 795 live-born infants in Denmark from January 1, 1996, through September 30, 2008. Individual-level information on dispensed antiepileptic drugs to mothers, birth defect diagnoses, and potential confounders were ascertained from nationwide health registries. Main Outcome Measures Prevalence odds ratios (PORs) of any major birth defect diagnosed within the first year of life by fetal exposure to antiepileptic drugs. Results Of the 1532 infants exposed to lamotrigine, oxcarbazepine, topiramate, gabapentin, or levetiracetam during the first trimester, 49 were diagnosed with a major birth defect compared with 19 911 of the 836 263 who were not exposed to an antiepileptic drug (3.2% vs 2.4%, respectively; adjusted POR [APOR], 0.99; 95% confidence interval [CI], 0.72-1.36). A major birth defect was diagnosed in 38 of 1019 infants (3.7%) exposed to lamotrigine during the first trimester (APOR, 1.18; 95% CI, 0.83-1.68), in 11 of 393 infants (2.8%) exposed to oxcarbazepine (APOR, 0.86; 95% CI, 0.46-1.59), and in 5 of 108 infants (4.6%) exposed to topiramate (APOR, 1.44; 95% CI, 0.58-3.58). Gabapentin (n=59) and levetiracetam (n=58) exposure during the first trimester was uncommon, with only 1 (1.7%) and 0 infants diagnosed with birth defects, respectively. Conclusion Among live-born infants in Denmark, first-trimester exposure to lamotrigine, oxcarbazepine, topiramate, gabapentin, or levetiracetam compared with no exposure was not associated with an increased risk of major birth defects. JAMA. 2011; 305(19): 1996-2002	[Molgaard-Nielsen, Ditte; Hviid, Anders] Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen, Denmark	Statens Serum Institut	Molgaard-Nielsen, D (corresponding author), Artillerivej 5, DK-2300 Copenhagen S, Denmark.	dnl@ssi.dk	Hviid, Anders/AAH-4319-2020	Hviid, Anders/0000-0002-7509-9127	Danish Medical Research Council; Lundbeck Foundation	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Lundbeck Foundation(Lundbeckfonden)	The study was supported by the Danish Medical Research Council and the Lundbeck Foundation.	Agergaard Peter, 2011, Clin Epidemiol, V3, P61, DOI 10.2147/CLEP.S15627; Andersen TF, 1999, DAN MED BULL, V46, P263; Artama M, 2005, NEUROLOGY, V64, P1874, DOI 10.1212/01.WNL.0000163771.96962.1F; Clayton D, 2001, STAT MODELS EPIDEMIO, P227; Cunnington M, 2007, EPILEPSIA, V48, P1207, DOI 10.1111/j.1528-1167.2007.01021.x; CZEIZEL AE, 1992, EUR J EPIDEMIOL, V8, P122; *DAN MED AG, REG MED PROD STAT; Dolk H, 2010, ADV EXP MED BIOL, V686, P349, DOI 10.1007/978-90-481-9485-8_20; EUROCAT, MIN AN EXCL; EUROCAT, COD EUROCAT SUBGR CO; Fried S, 2004, DRUG SAFETY, V27, P197, DOI 10.2165/00002018-200427030-00004; Holmes LB, 2008, NEUROLOGY, V70, P2152, DOI 10.1212/01.wnl.0000304343.45104.d6; Honein MA, 1999, TERATOLOGY, V60, P356, DOI 10.1002/(SICI)1096-9926(199912)60:6<356::AID-TERA8>3.0.CO;2-B; Hunt S, 2008, NEUROLOGY, V71, P272, DOI 10.1212/01.wnl.0000318293.28278.33; Hunt S, 2006, NEUROLOGY, V67, P1876, DOI 10.1212/01.wnl.0000244491.48937.55; Jorgensen Finn Stener, 2003, Ugeskr Laeger, V165, P4409; Knudsen LB, 1998, DAN MED BULL, V45, P320; Kristensen J, 1996, J CLIN EPIDEMIOL, V49, P893, DOI 10.1016/0895-4356(96)00018-2; Larsen H, 2003, SCAND J PUBLIC HEALT, V31, P12, DOI 10.1080/14034940210134194; Malm H, 2003, EUR J CLIN PHARMACOL, V59, P127, DOI 10.1007/s00228-003-0584-4; Meador K, 2008, EPILEPSY RES, V81, P1, DOI 10.1016/j.eplepsyres.2008.04.022; Meador Kimford J, 2004, Cleve Clin J Med, V71 Suppl 2, pS38; Meador Kimford J, 2009, Epilepsy Behav, V15, P339, DOI 10.1016/j.yebeh.2009.04.026; Morrow J, 2006, J NEUROL NEUROSUR PS, V77, P193, DOI 10.1136/jnnp.2005.074203; Perucca E, 2005, LANCET NEUROL, V4, P781, DOI 10.1016/S1474-4422(05)70224-6; Sabers A, 2004, ACTA NEUROL SCAND, V109, P9, DOI 10.1034/j.1600-0404.2003.00200.x; Tomson T, 2007, CLIN PHARMACOKINET, V46, P209, DOI 10.2165/00003088-200746030-00002; Tomson T, 2009, NEUROL CLIN, V27, P993, DOI 10.1016/j.ncl.2009.06.006; Tsiropoulos I, 2006, ACTA NEUROL SCAND, V113, P405, DOI 10.1111/j.1600-0404.2006.00639.x; Vajda FJE, 2010, SEIZURE-EUR J EPILEP, V19, P558, DOI 10.1016/j.seizure.2010.07.019; WHO Collaborating Centre for Drug Statistics Methodology, ATC DDD IND 2011; Wide K, 2004, ACTA PAEDIATR, V93, P174, DOI 10.1080/08035250310021118	32	161	167	1	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 18	2011	305	19					1996	2002		10.1001/jama.2011.624	http://dx.doi.org/10.1001/jama.2011.624			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	764WO	21586715				2022-12-24	WOS:000290665500023
J	Sherman, RB; Woodcock, J; Norden, J; Grandinetti, C; Temple, RJ				Sherman, Rachel Behrman; Woodcock, Janet; Norden, Janet; Grandinetti, Cheryl; Temple, Robert J.			New FDA Regulation to Improve Safety Reporting in Clinical Trials	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Sherman, Rachel Behrman; Norden, Janet; Grandinetti, Cheryl] US FDA, Ctr Drug Evaluat & Res, Off Med Policy, Silver Spring, MD USA	US Food & Drug Administration (FDA)	Sherman, RB (corresponding author), US FDA, Ctr Drug Evaluat & Res, Off Med Policy, Silver Spring, MD USA.							[Anonymous], 1995, E2A ICH; Crowe BJ, 2009, CLIN TRIALS, V6, P430, DOI 10.1177/1740774509344101; *CTR DRUG EV RES, GUID IND INV SAF REP; Food and Drug Administration HHS, 2010, Fed Regist, V75, P59935	4	33	34	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 7	2011	365	1					3	5		10.1056/NEJMp1103464	http://dx.doi.org/10.1056/NEJMp1103464			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	788QL	21651388				2022-12-24	WOS:000292459400002
J	Noudoost, B; Moore, T				Noudoost, Behrad; Moore, Tirin			Control of visual cortical signals by prefrontal dopamine	NATURE			English	Article							FRONTAL EYE FIELD; ATTENTIONAL MODULATION; RECEPTOR ACTIONS; MESSENGER-RNAS; NEURONS; CORTEX; SELECTION; EXPRESSION	The prefrontal cortex is thought to modulate sensory signals in posterior cortices during top-down attention(1,2), but little is known about the underlying neural circuitry. Experimental and clinical evidence indicate that prefrontal dopamine has an important role in cognitive functions(3), acting predominantly through D1 receptors. Here we show that dopamine D1 receptors mediate prefrontal control of signals in the visual cortex of macaques (Macaca mulatta). We pharmacologically altered D1-receptor-mediated activity in the frontal eye field of the prefrontal cortex and measured the effect on the responses of neurons in area V4 of the visual cortex. This manipulation was sufficient to enhance the magnitude, the orientation selectivity and the reliability of V4 visual responses to an extent comparable with the known effects of top-down attention. The enhancement of V4 signals was restricted to neurons with response fields overlapping the part of visual space affected by the D1 receptor manipulation. Altering either D1- or D2-receptor-mediated frontal eye field activity increased saccadic target selection but the D2 receptor manipulation did not enhance V4 signals. Our results identify a role for D1 receptors in mediating the control of visual cortical signals by the prefrontal cortex and suggest how processing in sensory areas could be altered in mental disorders involving prefrontal dopamine.	[Noudoost, Behrad; Moore, Tirin] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Noudoost, Behrad; Moore, Tirin] Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University; Stanford University	Noudoost, B (corresponding author), Stanford Univ, Sch Med, Howard Hughes Med Inst, Fairchild Bldg,299 Campus Dr W, Stanford, CA 94305 USA.	behrad@stanford.edu			NATIONAL EYE INSTITUTE [R01EY014924, R56EY014924] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NEI NIH HHS [R01 EY014924-04, R01 EY014924, R01 EY014924-05, EY014924, R01 EY014924-06A2, R56 EY014924] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Armstrong KM, 2009, J NEUROSCI, V29, P15621, DOI 10.1523/JNEUROSCI.4465-09.2009; Awh E, 2006, TRENDS COGN SCI, V10, P124, DOI 10.1016/j.tics.2006.01.001; Bourne JA, 2001, CNS DRUG REV, V7, P399; Castellanos FX, 2002, NAT REV NEUROSCI, V3, P617, DOI 10.1038/nrn896; Durstewitz D, 2000, NAT NEUROSCI, V3, P1184, DOI 10.1038/81460; GOLDMANRAKIC PS, 1995, NEURON, V14, P477, DOI 10.1016/0896-6273(95)90304-6; Gregoriou GG, 2009, SCIENCE, V324, P1207, DOI 10.1126/science.1171402; Herrero JL, 2008, NATURE, V454, P1110, DOI 10.1038/nature07141; HUNTSMAN MM, 1994, J NEUROSCI, V14, P2236; LIDOW MS, 1991, NEUROSCIENCE, V40, P657, DOI 10.1016/0306-4522(91)90003-7; Lidow MS, 1998, SYNAPSE, V28, P10, DOI 10.1002/(SICI)1098-2396(199801)28:1<10::AID-SYN2>3.0.CO;2-F; McAdams CJ, 1999, J NEUROSCI, V19, P431, DOI 10.1523/JNEUROSCI.19-01-00431.1999; McAlonan K, 2008, NATURE, V456, P391, DOI 10.1038/nature07382; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Mitchell JF, 2007, NEURON, V55, P131, DOI 10.1016/j.neuron.2007.06.018; Monosov IE, 2009, J NEUROPHYSIOL, V102, P3656, DOI 10.1152/jn.00750.2009; Moore T, 2003, NATURE, V421, P370, DOI 10.1038/nature01341; Munoz DP, 2003, J NEUROPHYSIOL, V90, P503, DOI 10.1152/jn.00192.2003; Noudoost B, 2011, J NEUROSCI METH, V194, P218, DOI 10.1016/j.jneumeth.2010.10.009; Noudoost B, 2010, CURR OPIN NEUROBIOL, V20, P183, DOI 10.1016/j.conb.2010.02.003; Pouget P, 2009, FRONT NEUROANAT, V3, DOI 10.3389/neuro.05.002.2009; Reynolds JH, 2004, ANNU REV NEUROSCI, V27, P611, DOI 10.1146/annurev.neuro.26.041002.131039; Robbins TW, 2009, ANNU REV NEUROSCI, V32, P267, DOI 10.1146/annurev.neuro.051508.135535; Santana N, 2009, CEREB CORTEX, V19, P849, DOI 10.1093/cercor/bhn134; SCHALL JD, 1993, NATURE, V366, P467, DOI 10.1038/366467a0; Schiller PH, 2003, EUR J NEUROSCI, V18, P3127, DOI 10.1111/j.1460-9568.2003.03036.x; Thompson KG, 2005, J NEUROSCI, V25, P9479, DOI 10.1523/JNEUROSCI.0741-05.2005; Vijayraghavan S, 2007, NAT NEUROSCI, V10, P376, DOI 10.1038/nn1846; Wang M, 2004, SCIENCE, V303, P853, DOI 10.1126/science.1091162; WILLIAMS GV, 1995, NATURE, V376, P572, DOI 10.1038/376572a0	30	230	230	1	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 16	2011	474	7351					372	375		10.1038/nature09995	http://dx.doi.org/10.1038/nature09995			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777TD	21572439	Green Accepted			2022-12-24	WOS:000291647100044
J	Stacey, T; Thompson, JMD; Mitchell, EA; Ekeroma, AJ; Zuccollo, JM; McCowan, LME				Stacey, Tomasina; Thompson, John M. D.; Mitchell, Ed A.; Ekeroma, Alec J.; Zuccollo, Jane M.; McCowan, Lesley M. E.			Association between maternal sleep practices and risk of late stillbirth: a case-control study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							INFANT-DEATH; DAYTIME SLEEPINESS; FETAL-DEATH; PREGNANCY; OBESITY; ANTEPARTUM; POSITION; APNEA	Objectives To determine whether snoring, sleep position, and other sleep practices in pregnant women are associated with risk of late stillbirth. Design Prospective population based case-control study. Setting Auckland, New Zealand Participants Cases: 155 women with a singleton late stillbirth (>= 28 weeks' gestation) without congenital abnormality born between July 2006 and June 2009 and booked to deliver in Auckland. Controls: 310 women with single ongoing pregnancies and gestation matched to that at which the stillbirth occurred. Multivariable logistic regression adjusted for known confounding factors. Main outcome measure Maternal snoring, daytime sleepiness (measured with the Epworth sleepiness scale), and sleep position at the time of going to sleep and on waking (left side, right side, back, and other). Results The prevalence of late stillbirth in this study was 3.09/1000 births. No relation was found between snoring or daytime sleepiness and risk of late stillbirth. However, women who slept on their back or on their right side on the previous night (before stillbirth or interview) were more likely to experience a late stillbirth compared with women who slept on their left side (adjusted odds ratio for back sleeping 2.54 (95% CI 1.04 to 6.18), and for right side sleeping 1.74 (0.98 to 3.01)). The absolute risk of late stillbirth for women who went to sleep on their left was 1.96/1000 and was 3.93/1000 for women who did not go to sleep on their left. Women who got up to go to the toilet once or less on the last night were more likely to experience a late stillbirth compared with women who got up more frequently (adjusted odds ratio 2.28 (1.40 to 3.71)). Women who regularly slept during the day in the previous month were also more likely to experience a late stillbirth than those who did not (2.04 (1.26 to 3.27)). Conclusions This is the first study to report maternal sleep related practices as risk factors for stillbirth, and these findings require urgent confirmation in further studies.	[Stacey, Tomasina; Ekeroma, Alec J.; McCowan, Lesley M. E.] Univ Auckland, Dept Obstet & Gynaecol, Auckland 1142, New Zealand; [Thompson, John M. D.; Mitchell, Ed A.] Univ Auckland, Dept Paediat, Auckland 1142, New Zealand; [Zuccollo, Jane M.] Wellington Sch Med, Dept Obstet & Gynaecol, Wellington 6021, New Zealand	University of Auckland; University of Auckland; University of Otago	Stacey, T (corresponding author), Univ Auckland, Dept Obstet & Gynaecol, Private Bag 92019, Auckland 1142, New Zealand.	t.stacey@auckland.ac.nz	Ekeroma, Alec/H-4938-2019; Ekeroma, Alec/Y-3211-2019; McCowan, Lesley/C-2215-2009	Ekeroma, Alec/0000-0002-7581-8275; Stacey, Tomasina/0000-0003-2002-6200; McCowan, Lesley/0000-0001-9915-7873	Cure Kids; Nurture Foundation; Auckland District Health Board Trust	Cure Kids; Nurture Foundation; Auckland District Health Board Trust	Funding received from: Cure Kids, the Nurture Foundation, and the Auckland District Health Board Trust fund. EAM, JMDT, and TS are supported in part by Cure Kids. The authors were independent of the funders in all aspects of study design, data analysis, and writing of the manuscript.	AUSTIN H, 1994, EPIDEMIOL REV, V16, P65, DOI 10.1093/oxfordjournals.epirev.a036146; Brain KA, 2001, BRIT J OBSTET GYNAEC, V108, P543, DOI 10.1016/S0306-5456(00)00106-6; Carbonne B, 1996, OBSTET GYNECOL, V88, P797, DOI 10.1016/0029-7844(96)00298-0; Centre for Maternal and Child Enquiries (CMACE), 2011, PER MORT 2009 UK; Chen MY, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-59; Cousens S, 2011, LANCET, V377, P1319, DOI 10.1016/S0140-6736(10)62310-0; DREWS CD, 1990, INT J EPIDEMIOL, V19, P405, DOI 10.1093/ije/19.2.405; GIBBONS LE, 1993, AM J EPIDEMIOL, V137, P654, DOI 10.1093/oxfordjournals.aje.a116723; Gray R, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b3754; Haberman S, 2011, AM J OBSTET GYNECOL, V204, pS278; Izci B, 2006, EUR RESPIR J, V27, P321, DOI 10.1183/09031936.06.00148204; Izci B, 2005, SLEEP MED, V6, P163, DOI 10.1016/j.sleep.2004.12.007; Jeffreys RM, 2006, BJOG-INT J OBSTET GY, V113, P1239, DOI 10.1111/j.1471-0528.2006.01056.x; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; KINSELLA SM, 1994, OBSTET GYNECOL, V83, P774; Kuo CD, 1997, ANAESTHESIA, V52, P1161, DOI 10.1111/j.1365-2044.1997.254-az0387.x; Louis JM, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.10.867; Maasilta P, 2001, CHEST, V120, P1448, DOI 10.1378/chest.120.5.1448; Mador MJ, 2005, CHEST, V128, P2130, DOI 10.1378/chest.128.4.2130; MILSOM I, 1984, AM J OBSTET GYNECOL, V148, P764, DOI 10.1016/0002-9378(84)90563-5; New Zealand Ministry of Health, 2004, ETHN DAT PROT HLTH D; Nohr EA, 2005, OBSTET GYNECOL, V106, P250, DOI 10.1097/01.AOG.0000172422.81496.57; Olivarez SA, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.12.008; *PER SOC AUSTR NZ, 2009, PSANZ CLIN PRACT GUI; PMMRC, 2009, PER MAT MORT NZ 2006; Reddy UM, 2010, OBSTET GYNECOL, V116, P1119, DOI 10.1097/AOG.0b013e3181f903f8; Salihu HM, 2008, J OBSTET GYNAECOL RE, V34, P843, DOI 10.1111/j.1447-0756.2008.00855.x; Salihu HM, 2007, OBSTET GYNECOL, V110, P552, DOI 10.1097/01.AOG.0000270159.80607.10; Salmond C., 2007, NZDEP2006 INDEX DEPR; Spiegel K, 1999, LANCET, V354, P1435, DOI 10.1016/S0140-6736(99)01376-8; Stacey T, 2011, AUST NZ J OBSTET GYN, V51, P3, DOI 10.1111/j.1479-828X.2010.01254.x; Stacey T, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-3; Venkata C, 2009, J AM BOARD FAM MED, V22, P158, DOI 10.3122/jabfm.2009.02.080057; Willinger M, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.06.057; Youngstedt SD, 2004, SLEEP MED REV, V8, P159, DOI 10.1016/j.smrv.2003.10.002; [No title captured]	36	78	77	0	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 14	2011	342								d3403	10.1136/bmj.d3403	http://dx.doi.org/10.1136/bmj.d3403			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	781KY	21673002	Green Published			2022-12-24	WOS:000291932100007
J	Barnes, TRE; Paton, C				Barnes, Thomas R. E.; Paton, Carol			UNCERTAINTIES PAGE Do antidepressants improve negative symptoms in schizophrenia?	BRITISH MEDICAL JOURNAL			English	Editorial Material							PLACEBO-CONTROLLED TRIAL; COGNITIVE-BEHAVIOR THERAPY; ADD-ON THERAPY; DOUBLE-BLIND; PHARMACOLOGICAL-TREATMENT; MIRTAZAPINE ADD; METAANALYSIS; CLOZAPINE; ANTIPSYCHOTICS; AUGMENTATION		[Barnes, Thomas R. E.; Paton, Carol] Univ London Imperial Coll Sci Technol & Med, Ctr Mental Hlth, London W6 8RP, England	Imperial College London	Barnes, TRE (corresponding author), Univ London Imperial Coll Sci Technol & Med, Ctr Mental Hlth, London W6 8RP, England.	t.r.barnes@imperial.ac.uk			Department of Health [07/83/01] Funding Source: Medline; National Institute for Health Research [07/83/01] Funding Source: researchfish	Department of Health; National Institute for Health Research(National Institute for Health Research (NIHR))		Abbasi SH, 2010, SCHIZOPHR RES, V116, P101, DOI 10.1016/j.schres.2009.11.008; Barnes TRE, 2011, J PSYCHOPHARMACOL, V25, P567, DOI 10.1177/0269881110391123; Berk M, 2009, HUM PSYCHOPHARM CLIN, V24, P233, DOI 10.1002/hup.1017; Bobes J, 2010, J CLIN PSYCHIAT, V71, P280, DOI 10.4088/JCP.08m04250yel; Buchanan RW, 2007, SCHIZOPHRENIA BULL, V33, P1013, DOI 10.1093/schbul/sbl057; Buckley PF, 2007, ACTA PSYCHIAT SCAND, V115, P93, DOI 10.1111/j.1600-0447.2007.00992.x; CARPENTER WT, 1985, SCHIZOPHRENIA BULL, V11, P440, DOI 10.1093/schbul/11.3.440; Chang JS, 2008, J CLIN PSYCHIAT, V69, P720, DOI 10.4088/JCP.v69n0505; Cho SJ, 2011, PROG NEURO-PSYCHOPH, V35, P208, DOI 10.1016/j.pnpbp.2010.11.006; Erhart SM, 2006, SCHIZOPHRENIA BULL, V32, P234, DOI 10.1093/schbul/sbj055; Hofer A, 2005, EUR PSYCHIAT, V20, P386, DOI 10.1016/j.eurpsy.2005.02.005; Iancu I, 2010, PSYCHIAT RES, V179, P19, DOI 10.1016/j.psychres.2010.04.035; Lecrubier Y, 2007, EVID-BASED MENT HEAL, V10, DOI 10.1136/ebmh.10.4.113; Melle I, 2008, ARCH GEN PSYCHIAT, V65, P634, DOI 10.1001/archpsyc.65.6.634; Mulholland C, 2003, J PSYCHOPHARMACOL, V17, P107, DOI 10.1177/0269881103017001713; Paton C, 2007, J CLIN PSYCHOPHARM, V27, P198, DOI 10.1097/JCP.0b013e318036bfbb; Rosenheck R, 2006, AM J PSYCHIAT, V163, P411, DOI 10.1176/appi.ajp.163.3.411; RUMMEL C, 2006, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD005581.PUB2; Sepehry AA, 2007, J CLIN PSYCHIAT, V68, P604, DOI 10.4088/JCP.v68n0417; Silver H, 2000, INT CLIN PSYCHOPHARM, V15, P257, DOI 10.1097/00004850-200015050-00002; Singh SP, 2010, BRIT J PSYCHIAT, V197, P174, DOI 10.1192/bjp.bp.109.067710; Tiihonen J, 2009, SCHIZOPHR RES, V109, P10, DOI 10.1016/j.schres.2009.01.002; Turkington D, 2008, SCHIZOPHR RES, V98, P1, DOI 10.1016/j.schres.2007.09.026; Turkington D, 2006, BRIT J PSYCHIAT, V189, P36, DOI 10.1192/bjp.bp.105.010884; Weiner E, 2010, NEUROPSYCHOPHARMACOL, V35, P2274, DOI 10.1038/npp.2010.101; Wykes T, 2008, SCHIZOPHRENIA BULL, V34, P523, DOI 10.1093/schbul/sbm114	26	8	8	0	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 10	2011	342								d3371	10.1136/bmj.d3371	http://dx.doi.org/10.1136/bmj.d3371			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	777SS	21665932				2022-12-24	WOS:000291645900002
J	DeWeerdt, S				DeWeerdt, Sarah			A testing journey	NATURE			English	Editorial Material																		Duarte CAB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012822; Lee SR, 2011, J VIROL METHODS, V172, P27, DOI 10.1016/j.jviromet.2010.12.009; Shawky SM, 2010, CLIN BIOCHEM, V43, P1163, DOI 10.1016/j.clinbiochem.2010.07.001; Zuure F, 2010, EUROSURVEILLANCE, V15, P5; Zuure FR, 2011, AM J PREV MED, V40, P345, DOI 10.1016/j.amepre.2010.11.019	5	4	5	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 9	2011	474	7350					S20	S21		10.1038/474S20a	http://dx.doi.org/10.1038/474S20a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	774PE	21666732	Bronze			2022-12-24	WOS:000291397800012
J	Maxmen, A				Maxmen, Amy			Playing the odds	NATURE			English	Editorial Material							CHRONIC HEPATITIS-C; IL28B											Casrouge A, 2011, J CLIN INVEST, V121, P308, DOI 10.1172/JCI40594; Fellay J, 2010, NATURE, V464, P405, DOI 10.1038/nature08825; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Hitomi Y, 2011, GASTROENTEROLOGY, V140, P1314, DOI 10.1053/j.gastro.2010.12.038; Kelly C, 2011, GUT; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449	7	3	3	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 9	2011	474	7350					S9	S10		10.1038/474S9a	http://dx.doi.org/10.1038/474S9a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	774PE	21666735				2022-12-24	WOS:000291397800006
J	Dieffenbach, CW; Fauci, AS				Dieffenbach, Carl W.; Fauci, Anthony S.			Thirty Years of HIV and AIDS: Future Challenges and Opportunities	ANNALS OF INTERNAL MEDICINE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; NEUTRALIZING ANTIBODIES; POTENT NEUTRALIZATION; DISEASE PROGRESSION; DOUBLE-BLIND; T-CELLS; INFECTION; VACCINE; PREVENTION; TRANSMISSION	As the third decade since AIDS was first recognized comes to an end, extraordinary advances have occurred in the understanding, treatment, and prevention of HIV infection and AIDS. As a result of these successes, it is now time to focus on future challenges. Paramount among these is reaching the goal of truly controlling and ultimately ending the HIV and AIDS pandemic. To that end, AIDS researchers and public health personnel worldwide are aggressively pursuing 3 key areas of scientific research. Given the availability of highly effective therapeutic regimens for HIV infection, the first challenge is efficiently identifying a maximum number of HIV-infected persons through voluntary HIV testing and initiating antiretroviral therapy (ART). Second, scientists are trying to develop a cure for HIV infection, which would alleviate the need for lifelong ART. Finally, preventing new cases of HIV infection, which currently number approximately 2.6 million per year globally, is critical to any attempt to end this pandemic. This article addresses each of these challenges and provides directions for the future.	[Dieffenbach, Carl W.] NIAID, Div Aids, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Dieffenbach, CW (corresponding author), NIAID, Div Aids, NIH, 6700 Rockledge Dr,MSC 7620, Bethesda, MD 20892 USA.	cdieffenba@niaid.nih.gov						Allers K, 2011, BLOOD, V117, P2791, DOI 10.1182/blood-2010-09-309591; [Anonymous], 2010, NAT HIV AIDS STRAT U; [Anonymous], SAF EFF TEN 1 GEL TE; [Anonymous], 2009, AIDS EP UPD 2009; [Anonymous], STRAT TIM ANT TREATM; [Anonymous], US PRESIDENTS EMERGE; Bailey R. C., 2010, 18 INT AIDS C VIENN; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Centers for Disease Control (CDC), 1982, MMWR Morb Mortal Wkly Rep, V31, P305; Centers for Disease Control (CDC), 1981, MMWR Morb Mortal Wkly Rep, V30, P305; Centers for Disease Control (CDC), 1981, MMWR Morb Mortal Wkly Rep, V30, P250; CHUN TW, 1995, NAT MED, V1, P1284, DOI 10.1038/nm1295-1284; Chun TW, 1999, NATURE, V401, P874, DOI 10.1038/44755; Chun TW, 1997, P NATL ACAD SCI USA, V94, P13193, DOI 10.1073/pnas.94.24.13193; Chun TW, 1999, NAT MED, V5, P651, DOI 10.1038/9498; Costello C, 1999, AIDS, V13, P1990, DOI 10.1097/00002030-199910010-00031; Derdeyn CA, 2004, SCIENCE, V303, P2019, DOI 10.1126/science.1093137; DHHS Panel on Antiretroviral Guidelines for Adults and Adolescents, 2011, GUID US ANT AG HIV 1; Dieffenbach CW, 2009, JAMA-J AM MED ASSOC, V301, P2380, DOI 10.1001/jama.2009.828; Fauci AS, 2008, SCIENCE, V321, P530, DOI 10.1126/science.1161000; Fauci AS, 2009, HEALTH AFFAIR, V28, P1629, DOI 10.1377/hlthaff.28.6.1629; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; Flynn MN, 2005, J INFECT DIS, V191, P654, DOI 10.1086/428404; Folkers GK, 2010, JAMA-J AM MED ASSOC, V304, P350, DOI 10.1001/jama.2010.957; Gallo RC, 2003, NEW ENGL J MED, V349, P2283, DOI 10.1056/NEJMp038194; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Gray G, 2009, AIDS VACC 2009 PAR F; Hogg R, 2008, LANCET, V372, P293, DOI 10.1016/S0140-6736(08)61113-7; Hutter G, 2009, NEW ENGL J MED, V360, P692, DOI 10.1056/NEJMoa0802905; HYMES KB, 1981, LANCET, V2, P598; Joint United Nations Programme on HIV/AIDS, 2010, GLOB REP UNAIDS REP; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Lima VD, 2008, J INFECT DIS, V198, P59, DOI 10.1086/588673; Margolis DM, 2011, AIDS RES HUM RETROV, V27, P347, DOI 10.1089/aid.2011.0017; Mofenson LM, 2010, CLIN INFECT DIS, V50, pS130, DOI 10.1086/651484; Montero M, 2008, MICROBIOL MOL BIOL R, V72, P54, DOI 10.1128/MMBR.00020-07; Mouquet H, 2010, NATURE, V467, P591, DOI 10.1038/nature09385; Padian NS, 2008, LANCET, V372, P585, DOI 10.1016/S0140-6736(08)60885-5; Pejchal R, 2010, P NATL ACAD SCI USA, V107, P11483, DOI 10.1073/pnas.1004600107; Pietzsch J, 2010, J EXP MED, V207, P1995, DOI 10.1084/jem.20101176; Pitisuttithum P, 2006, J INFECT DIS, V194, P1661, DOI 10.1086/508748; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Richman DD, 2009, SCIENCE, V323, P1304, DOI 10.1126/science.1165706; Rodes B, 2004, AIDS, V18, P1109, DOI [10.1097/00002030-200405210-00004, 10.1097/01.aids.0000125962.16506.f9]; ROTHENBERG R, 1987, NEW ENGL J MED, V317, P1297, DOI 10.1056/NEJM198711193172101; Rotheram-Borus MJ, 2009, ANNU REV CLIN PSYCHO, V5, P143, DOI 10.1146/annurev.clinpsy.032408.153530; Stover J, 2002, LANCET, V360, P73, DOI 10.1016/S0140-6736(02)09339-X; Strain MC, 2005, J INFECT DIS, V191, P1410, DOI 10.1086/428777; Wagner BG, 2010, AIDS, V24, P775, DOI 10.1097/QAD.0b013e3283366782; Walker Bruce D, 2007, Top HIV Med, V15, P134; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; WHO, 2010, ANT THER HIV INF AD; Wong JK, 1997, SCIENCE, V278, P1291, DOI 10.1126/science.278.5341.1291; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819	58	113	117	0	10	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 7	2011	154	11					766	771		10.7326/0003-4819-154-11-201106070-00345	http://dx.doi.org/10.7326/0003-4819-154-11-201106070-00345			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	773MV	21628350				2022-12-24	WOS:000291312300008
J	Copertino, MD				Copertino, Margareth da Silva			Add coastal vegetation to the climate critical list	NATURE			English	Editorial Material									Fundacao Univ Fed Rio Grande, Inst Oceanog, Rio Grande, Brazil	Universidade Federal do Rio Grande	Copertino, MD (corresponding author), Fundacao Univ Fed Rio Grande, Inst Oceanog, Rio Grande, Brazil.	doccoper@furg.br	Copertino, Margareth/T-6873-2019; Fapesp, Biota/F-8655-2017; Copertino, Margareth S/C-9893-2013; da Silva Oliveira, Margareth/K-9670-2015	Copertino, Margareth/0000-0001-5771-829X; Fapesp, Biota/0000-0002-9887-8449; Copertino, Margareth S/0000-0001-5771-829X; da Silva Oliveira, Margareth/0000-0002-6490-5170					0	21	23	5	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 19	2011	473	7347					255	255		10.1038/473255a	http://dx.doi.org/10.1038/473255a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	765QA	21593818	Bronze			2022-12-24	WOS:000290722400004
J	Cohen-Bearak, A				Cohen-Bearak, Adena			Entering Data	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												adenacb@verizon.net							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 18	2011	305	19					1944	1944		10.1001/jama.2011.621	http://dx.doi.org/10.1001/jama.2011.621			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	764WO	21586704				2022-12-24	WOS:000290665500001
J	Sagiya, T; Kanamori, H; Yagi, Y; Yamada, M; Mori, J				Sagiya, Takeshi; Kanamori, Hiroo; Yagi, Yuji; Yamada, Masumi; Mori, Jim			Rebuilding seismology	NATURE			English	Editorial Material							JAPAN TRENCH		[Sagiya, Takeshi] Nagoya Univ, Nagoya, Aichi, Japan; [Kanamori, Hiroo] CALTECH, Pasadena, CA USA; [Yagi, Yuji] Univ Tsukuba, Tsukuba, Ibaraki, Japan; [Yamada, Masumi; Mori, Jim] Kyoto Univ, Disaster Prevent Res Inst, Kyoto, Japan	Nagoya University; California Institute of Technology; University of Tsukuba; Kyoto University	Sagiya, T (corresponding author), Nagoya Univ, Nagoya, Aichi, Japan.		Yagi, Yuji/D-8301-2014; Sagiya, Takeshi/N-8417-2018	Yagi, Yuji/0000-0001-5327-9277; Sagiya, Takeshi/0000-0001-7949-8048				Hashimoto C, 2009, NAT GEOSCI, V2, P141, DOI 10.1038/NGEO421; IKEDA Y, 1996, ACTIVE FAULT RES; Kawasaki I, 2001, TECTONOPHYSICS, V330, P267, DOI 10.1016/S0040-1951(00)00245-6; Nishimura T, 2004, GEOPHYS J INT, V157, P901, DOI 10.1111/j.1365-246X.2004.02159.x; NISHIMURA T, 2000, SPATIOTEMPORAL CHANG	5	31	32	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 12	2011	473	7346					146	148		10.1038/473146a	http://dx.doi.org/10.1038/473146a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	762NT	21562539				2022-12-24	WOS:000290487200046
J	Chen, Y; Graziano, JH; Parvez, F; Liu, ML; Slavkovich, V; Kalra, T; Argos, M; Islam, T; Ahmed, A; Rakibuz-Zaman, M; Hasan, R; Sarwar, G; Levy, D; van Geen, A; Ahsan, H				Chen, Yu; Graziano, Joseph H.; Parvez, Faruque; Liu, Mengling; Slavkovich, Vesna; Kalra, Tara; Argos, Maria; Islam, Tariqul; Ahmed, Alauddin; Rakibuz-Zaman, Muhammad; Hasan, Rabiul; Sarwar, Golam; Levy, Diane; van Geen, Alexander; Ahsan, Habibul			Arsenic exposure from drinking water and mortality from cardiovascular disease in Bangladesh: prospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							DOSE-RESPONSE RELATIONSHIP; PREMALIGNANT SKIN-LESIONS; ISCHEMIC-HEART-DISEASE; PERIPHERAL VASCULAR-DISEASE; CEREBROVASCULAR-DISEASE; HYPERENDEMIC VILLAGES; DIABETES-MELLITUS; BLADDER-CANCER; PULSE PRESSURE; LUNG-CANCER	Objective To evaluate the association between arsenic exposure and mortality from cardiovascular disease and to assess whether cigarette smoking influences the association. Design Prospective cohort study with arsenic exposure measured in drinking water from wells and urine. Setting General population in Araihazar, Bangladesh. Participants 11 746 men and women who provided urine samples in 2000 and were followed up for an average of 6. 6 years. Main outcome measure Death from cardiovascular disease. Results 198 people died from diseases of circulatory system, accounting for 43% of total mortality in the population. The mortality rate for cardiovascular disease was 214.3 per 100 000 person years in people drinking water containing <12.0 mu g/L arsenic, compared with 271.1 per 100 000 person years in people drinking water with >= 12.0 mu g/L arsenic. There was a dose-response relation between exposure to arsenic in well water assessed at baseline and mortality from ischaemic heart disease and other heart disease; the hazard ratios in increasing quarters of arsenic concentration in well water (0.1-12.0, 12.1-62.0, 62.1-148.0, and 148.1-864.0 mu g/L) were 1.00 (reference), 1.22 (0.65 to 2.32), 1.35 (0.71 to 2.57), and 1.92 (1.07 to 3.43) (P=0.0019 for trend), respectively, after adjustment for potential confounders including age, sex, smoking status, educational attainment, body mass index (BMI), and changes in urinary arsenic concentration since baseline. Similar associations were observed when baseline total urinary arsenic was used as the exposure variable and for mortality from ischaemic heart disease specifically. The data indicate a significant synergistic interaction between arsenic exposure and cigarette smoking in mortality from ischaemic heart disease and other heart disease. In particular, the hazard ratio for the joint effect of a moderate level of arsenic exposure (middle third of well arsenic concentration 25.3-114.0 mu g/L, mean 63.5 mu g/L) and cigarette smoking on mortality from heart disease was greater than the sum of the hazard ratios associated with their individual effect (relative excess risk for interaction 1.56, 0.05 to 3.14; P=0.010). Conclusions Exposure to arsenic in drinking water is adversely associated with mortality from heart disease, especially among smokers.	[Chen, Yu; Liu, Mengling] NYU, Sch Med, Dept Environm Med, New York, NY 10016 USA; [Graziano, Joseph H.; Parvez, Faruque; Slavkovich, Vesna; Levy, Diane] Columbia Univ, Dept Environm Hlth Sci, Mailman Sch Publ Hlth, New York, NY USA; [Kalra, Tara; Argos, Maria; Ahsan, Habibul] Univ Chicago, Dept Hlth Studies, Chicago, IL 60637 USA; [Kalra, Tara; Argos, Maria; Ahsan, Habibul] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Kalra, Tara; Argos, Maria; Ahsan, Habibul] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Kalra, Tara; Argos, Maria; Ahsan, Habibul] Univ Chicago, Ctr Comprehens Canc, Chicago, IL 60637 USA; [Islam, Tariqul; Ahmed, Alauddin; Rakibuz-Zaman, Muhammad; Hasan, Rabiul; Sarwar, Golam] Columbia Univ Res Project Off, Dhaka, Bangladesh; [van Geen, Alexander] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY USA	New York University; Columbia University; University of Chicago; University of Chicago; University of Chicago; Robert H. Lurie Comprehensive Cancer Center; University of Chicago; Columbia University	Chen, Y (corresponding author), NYU, Sch Med, Dept Environm Med, New York, NY 10016 USA.	yu.chen@nyumc.org; habib@uchicago.edu		Chen, Yu/0000-0002-1519-4894; Liu, Mengling/0000-0001-9758-8522	US National Institute of Health; National Institute of Environmental Health Sciences [P42ES010349, R01ES017541, R01CA102484, R01CA107431, R01ESO11601, P30ES09089, CA016087, ES000260, CA014599]; National Cancer Institute [P42ES010349, R01ES017541, R01CA102484, R01CA107431, R01ESO11601, P30ES09089, CA016087, ES000260, CA014599]; NATIONAL CANCER INSTITUTE [R01CA107431, R01CA102484, P30CA016087, P30CA014599] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES009089, P30ES000260, R01ES017541, P42ES010349] Funding Source: NIH RePORTER	US National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was supported by US National Institute of Health funding. The National Institute of Environmental Health Sciences and the National Cancer Institute provide support under the following grants: P42ES010349, R01ES017541, R01CA102484, R01CA107431, R01ES017541, R01ESO11601, P30ES09089, CA016087, ES000260, and CA014599. The views expressed in this paper are those of the authors and not necessarily those of any funding body or others whose support is acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHO K, 1980, B WORLD HEALTH ORGAN, V58, P113; Ahsan H, 2006, J EXPO SCI ENV EPID, V16, P191, DOI 10.1038/sj.jea.7500449; Ahsan H, 2007, CANCER EPIDEM BIOMAR, V16, P1270, DOI 10.1158/1055-9965.EPI-06-0676; Ahsan H, 2006, AM J EPIDEMIOL, V163, P1138, DOI 10.1093/aje/kwj154; [Anonymous], 2007, MAN INT CLASS DIS IN; Argos M, 2007, AM J PUBLIC HEALTH, V97, P825, DOI 10.2105/AJPH.2005.078816; Baqui AH, 1998, B WORLD HEALTH ORGAN, V76, P161; *BRIT GEOL SURV, 1999, GROUNDW STUD ARS CON; BRUZZI P, 1985, AM J EPIDEMIOL, V122, P904, DOI 10.1093/oxfordjournals.aje.a114174; Bunderson M, 2004, TOXICOL APPL PHARM, V201, P32, DOI 10.1016/j.taap.2004.04.008; Bunderson M, 2002, TOXICOL APPL PHARM, V184, P11, DOI 10.1006/taap.2002.9492; CHEN CJ, 1995, HYPERTENSION, V25, P53, DOI 10.1161/01.HYP.25.1.53; Chen CJ, 1996, ARTERIOSCL THROM VAS, V16, P504, DOI 10.1161/01.ATV.16.4.504; Chen CL, 2004, JAMA-J AM MED ASSOC, V292, P2984, DOI 10.1001/jama.292.24.2984; Chen Y, 2004, BRIT J NUTR, V92, P851, DOI 10.1079/BJN20041277; Chen Y, 2007, ENVIRON HEALTH PERSP, V115, P1415, DOI 10.1289/ehp.10277; Chen Y, 2007, ENVIRON HEALTH PERSP, V115, P917, DOI 10.1289/ehp.9833; Chen Y, 2007, AM J EPIDEMIOL, V165, P541, DOI 10.1093/aje/kwk037; Chen Y, 2006, EPIDEMIOLOGY, V17, P459, DOI 10.1097/01.ede.0000220554.50837.7f; Chen Y, 2010, ENVIRON HEALTH PERSP, V118, P1299, DOI 10.1289/ehp.0901559; Cheng Z, 2005, ENVIRON SCI TECHNOL, V39, P4759, DOI 10.1021/es048065f; Cheng Z, 2004, ANAL BIOANAL CHEM, V379, P512, DOI 10.1007/s00216-004-2618-x; Chiou HY, 1997, STROKE, V28, P1717, DOI 10.1161/01.STR.28.9.1717; Chowdhury UK, 2000, ENVIRON HEALTH PERSP, V108, P393, DOI 10.2307/3454378; Dart AM, 2001, J AM COLL CARDIOL, V37, P975, DOI 10.1016/S0735-1097(01)01108-1; ENGEL RR, 1994, ARCH ENVIRON HEALTH, V49, P418, DOI 10.1080/00039896.1994.9954996; Ferreccio C, 2000, EPIDEMIOLOGY, V11, P673, DOI 10.1097/00001648-200011000-00010; Gamble MV, 2005, ENVIRON HEALTH PERSP, V113, pA442, DOI 10.1289/ehp.113-a442a; GREENLAND S, 1994, AM J EPIDEMIOL, V139, P747, DOI 10.1093/oxfordjournals.aje.a117069; HopenhaynRich C, 1996, ENVIRON HEALTH PERSP, V104, P620, DOI 10.2307/3433091; HOSMER DW, 1992, EPIDEMIOLOGY, V3, P452, DOI 10.1097/00001648-199209000-00012; Hsueh YM, 1998, ATHEROSCLEROSIS, V141, P249, DOI 10.1016/S0021-9150(98)00178-6; Medrano MJ, 2010, ENVIRON RES, V110, P448, DOI 10.1016/j.envres.2009.10.002; Karagas MR, 2004, CANCER CAUSE CONTROL, V15, P465, DOI 10.1023/B:CACO.0000036452.55199.a3; Knol MJ, 2007, INT J EPIDEMIOL, V36, P1111, DOI 10.1093/ije/dym157; Lewis DR, 1999, ENVIRON HEALTH PERSP, V107, P359, DOI 10.2307/3434539; Li RL, 2007, ANN EPIDEMIOL, V17, P227, DOI 10.1016/j.annepidem.2006.10.009; Lindberg AL, 2010, ENVIRON HEALTH PERSP, V118, P533, DOI 10.1289/ehp.0900728; Meliker JR, 2007, ENVIRON HEALTH-GLOB, V6, DOI 10.1186/1476-069X-6-4; Melkonian S, 2011, AM J EPIDEMIOL, V173, P183, DOI 10.1093/aje/kwq357; Mudur G, 2000, BRIT MED J, V320, P822; Navas-Acien A, 2005, AM J EPIDEMIOL, V162, P1037, DOI 10.1093/aje/kwi330; NIXON DE, 1991, CLIN CHEM, V37, P1575; Parvez F, 2006, ENVIRON HEALTH PERSP, V114, P355, DOI 10.1289/ehp.7903; Pierce BL, 2010, INT J EPIDEMIOL, V39, P1037, DOI 10.1093/ije/dyp364; Rahman M, 1999, HYPERTENSION, V33, P74, DOI 10.1161/01.HYP.33.1.74; Ronsmans C, 1998, INT J EPIDEMIOL, V27, P660, DOI 10.1093/ije/27.4.660; Rothman K, 1986, MODERN EPIDEMIOLOGY; Safar ME, 2003, CIRCULATION, V107, P2864, DOI 10.1161/01.CIR.0000069826.36125.B4; Simeonova PP, 2004, TOXICOL APPL PHARM, V198, P444, DOI 10.1016/j.taap.2003.10.018; Simeonova PP, 2003, ENVIRON HEALTH PERSP, V111, P1744, DOI 10.1289/ehp.6332; SLOT C, 1965, SCAND J CLIN LAB INV, V17, P381, DOI 10.3109/00365516509077065; Sohel N, 2009, EPIDEMIOLOGY, V20, P824, DOI 10.1097/EDE.0b013e3181bb56ec; Srivastava S, 2009, TOXICOL APPL PHARM, V241, P90, DOI 10.1016/j.taap.2009.08.004; Steinmaus C, 2003, AM J EPIDEMIOL, V158, P1193, DOI 10.1093/aje/kwg281; Steinmaus C, 2009, EPIDEMIOLOGY, V20, P807, DOI 10.1097/EDE.0b013e3181b0fd29; Straub AC, 2009, AM J PATHOL, V174, P1949, DOI 10.2353/ajpath.2009.081016; Tseng CH, 2000, ENVIRON HEALTH PERSP, V108, P847, DOI 10.2307/3434992; Tseng CH, 1996, ATHEROSCLEROSIS, V120, P125, DOI 10.1016/0021-9150(95)05693-9; Tseng CH, 2003, TOXICOL LETT, V137, P15, DOI 10.1016/S0378-4274(02)00377-6; Tseng CH, 1997, ANGIOLOGY, V48, P321, DOI 10.1177/000331979704800405; *US EPA, 2009, 815F00015 EPA; van Geen A, 2003, WATER RESOUR RES, V39, DOI 10.1029/2002WR001617; van Geen A, 2002, B WORLD HEALTH ORGAN, V80, P732; Wang CH, 2002, CIRCULATION, V105, P1804, DOI 10.1161/01.CIR.0000015862.64816.B2; Wang CH, 2007, TOXICOL APPL PHARM, V222, P315, DOI 10.1016/j.taap.2006.12.022; WEI LJ, 1989, J AM STAT ASSOC, V84, P1065, DOI 10.2307/2290084; Willerson JT, 2004, CIRCULATION, V109, P2, DOI 10.1161/01.CIR.0000129535.04194.38; WU MM, 1989, AM J EPIDEMIOL, V130, P1123, DOI 10.1093/oxfordjournals.aje.a115439; Yuan Y, 2007, AM J EPIDEMIOL, V166, P1381, DOI 10.1093/aje/kwm238	70	260	268	4	49	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 5	2011	342								d2431	10.1136/bmj.d2431	http://dx.doi.org/10.1136/bmj.d2431			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	762MC	21546419	Green Published, hybrid			2022-12-24	WOS:000290481800003
J	West, S; Witt, J				West, Sophie; Witt, Johan			A PATIENT'S JOURNEY Bilateral developmental dysplasia of the hips	BRITISH MEDICAL JOURNAL			English	Editorial Material									[West, Sophie] London Deanery Sch Surg, London, England; [Witt, Johan] Univ Coll London Hosp, UCH Referrals Ctr, Orthopaed & Trauma Serv, London, England	University College London Hospitals NHS Foundation Trust; University of London; University College London	West, S (corresponding author), London Deanery Sch Surg, London, England.	sophie.pinder@doctors.org.uk							0	3	3	1	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 5	2011	342								d2152	10.1136/bmj.d2152	http://dx.doi.org/10.1136/bmj.d2152			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	762MC	21546421	Bronze			2022-12-24	WOS:000290481800001
J	Bhutta, ZA				Bhutta, Zulfiqar A.			The last mile in global poliomyelitis eradication	LANCET			English	Editorial Material							VACCINE-DERIVED POLIOVIRUS		Aga Khan Univ, Div Women & Child Hlth, Karachi 74800, Pakistan	Aga Khan University	Bhutta, ZA (corresponding author), Aga Khan Univ, Div Women & Child Hlth, Karachi 74800, Pakistan.	zulfiqar.bhutta@aku.edu		Mouw, Jolien/0000-0002-9336-6022				Anonymous, 2009, Morbidity and Mortality Weekly Report, V58, P357; Bonu S, 2003, SOC SCI MED, V57, P1807, DOI 10.1016/S0277-9536(03)00056-X; El-Sayed N, 2007, VACCINE, V25, P5062, DOI 10.1016/j.vaccine.2007.04.022; Global Polio Eradication Initiative, 2010, PROGRESS; Global Polio Eradication Initiative, 2011, POL THIS WEEK WEDN 1; Grassly NC, 2010, J INFECT DIS, V201, P1535, DOI 10.1086/651952; Grassly NC, 2009, J INFECT DIS, V200, P794, DOI 10.1086/605330; Hasan Azra S, 2004, Indian Pediatr, V41, P1040; Independent Monitoring Board of the Global Polio Eradication Initiative, 2011, REP GLOB POL ER IN; Jenkins HE, 2010, NEW ENGL J MED, V362, P2360, DOI 10.1056/NEJMoa0910074; McKenna MAJ, 2002, ATLANTA J CONST 1027; Mohammed AJ, 2010, NEW ENGL J MED, V362, P2351, DOI 10.1056/NEJMoa0909383; National Toxicology Program, 2011, Natl Toxicol Program Tech Rep Ser, P1; SABIN AB, 1979, PEDIATR RES, V13, P674, DOI 10.1203/00006450-197905001-00004; SALK D, 1980, REV INFECT DIS, V2, P243; Sutter RW, 2010, LANCET, V376, P1682, DOI 10.1016/S0140-6736(10)61230-5; Wassilak S, 2011, J INFECT DIS, V203, P898, DOI 10.1093/infdis/jiq140; World Health Assembly, 1993, GLOB ER POL YEAR 200	18	25	25	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 13	2011	378	9791					549	552		10.1016/S0140-6736(11)60744-7	http://dx.doi.org/10.1016/S0140-6736(11)60744-7			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	812UX	21664681				2022-12-24	WOS:000294319500008
J	Detsky, AS; Baerlocher, MO				Detsky, Allan S.; Baerlocher, Mark O.			Do Nice Patients Receive Better Care?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PHYSICIANS		[Detsky, Allan S.] Mt Sinai Hosp, Dept Med, Toronto, ON M5G 1X5, Canada; [Detsky, Allan S.] Univ Toronto, Dept Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Detsky, Allan S.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Detsky, Allan S.] Univ Hlth Network, Toronto, ON, Canada; [Baerlocher, Mark O.] Univ Calif San Diego, Dept Radiol, San Diego, CA 92103 USA	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of California System; University of California San Diego	Detsky, AS (corresponding author), Mt Sinai Hosp, Dept Med, 600 Univ Ave,Room 429, Toronto, ON M5G 1X5, Canada.	adetsky@mtsinai.on.ca						Atzema CL, 2011, CAN MED ASSOC J, V183, P663, DOI 10.1503/cmaj.100685; AYANIAN JZ, 1991, NEW ENGL J MED, V325, P221, DOI 10.1056/NEJM199107253250401; Bach PB, 1999, NEW ENGL J MED, V341, P1198, DOI 10.1056/NEJM199910143411606; Cain DM, 2008, JAMA-J AM MED ASSOC, V299, P2893, DOI 10.1001/jama.299.24.2893; Chapman KR, 2001, CHEST, V119, P1691, DOI 10.1378/chest.119.6.1691; GORLIN R, 1983, NEW ENGL J MED, V308, P1059, DOI 10.1056/NEJM198305053081804; Hahn SR, 1996, J GEN INTERN MED, V11, P1, DOI 10.1007/BF02603477; LEVINSON W, 1993, MED CARE, V31, P285, DOI 10.1097/00005650-199304000-00001; Lutfey K, 2005, AM J SOCIOL, V110, P1326, DOI 10.1086/428914; Pomm HA, 2004, FAM MED, V36, P467	10	6	6	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 6	2011	306	1					94	95		10.1001/jama.2011.883	http://dx.doi.org/10.1001/jama.2011.883			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	787LV	21730247				2022-12-24	WOS:000292378700028
J	Alley, JB				Alley, Joshua B.			Sleepless	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Alley, Joshua B.] Wilford Hall USAF Med Ctr, Dept Surg, Lackland Air Force Base, San Antonio, TX 78236 USA; [Alley, Joshua B.] Univ Texas Hlth Sci Ctr San Antonio, Dept Surg, San Antonio, TX USA; [Alley, Joshua B.] Uniformed Serv Univ Hlth Sci, F Edward Hebert Sch Med, Dept Def, Bethesda, MD 20814 USA	United States Department of Defense; United States Air Force; University of Texas System; University of Texas Health San Antonio; Uniformed Services University of the Health Sciences - USA; United States Department of Defense	Alley, JB (corresponding author), Wilford Hall USAF Med Ctr, Dept Surg, Lackland Air Force Base, San Antonio, TX 78236 USA.	joshalleymd@hotmail.com						[Anonymous], TIME	1	2	2	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 22	2011	305	24					2501	2502		10.1001/jama.2011.863	http://dx.doi.org/10.1001/jama.2011.863			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	780MF	21693732				2022-12-24	WOS:000291860400001
J	Spence, D				Spence, Des			FROM THE FRONTLINE Assisted dying: are doctors in denial?	BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk							0	2	2	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 22	2011	342								d3891	10.1136/bmj.d3891	http://dx.doi.org/10.1136/bmj.d3891			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	785AT	21697230				2022-12-24	WOS:000292200500012
J	Zeytinoglu, M				Zeytinoglu, Meltem			Talking It Out: Helping Our Patients Live Better While Dying	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							PALLIATIVE CARE; LIFE; ASSOCIATIONS; CANCER; HEALTH; COSTS; DEATH	Although dying is an inevitable part of the life cycle, there has been extensive political debate over end-of-life care. Participating in end-of-life care conversations can be emotionally challenging for everyone involved. Messages about serious or terminal illnesses can be very hard for patients and their families to hear, and physicians frequently struggle with the burden of delivering these messages. Still, evidence shows that conversations about end-of-life care options between physicians and patients can improve the quality of life of dying patients and help to relieve the emotional burden on surviving loved ones. Legislation to support these discussions by consistently reimbursing physicians for their time spent performing this service has been blocked on multiple occasions. More research on how to improve end-of-life care will enable health care providers to optimize treatment of their patients. Overcoming political divides to support end-of-life care conversations is needed to promote care that is consistent with patients' values and needs and is a key step in encouraging better quality of life for dying patients.	[Zeytinoglu, Meltem] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Zeytinoglu, M (corresponding author), Univ Chicago, NorthShore Programs, Dept Internal Med, 2650 Ridge Ave,Room 5319, Evanston, IL 60201 USA.	meltemz@gmail.com			American Cancer Society	American Cancer Society(American Cancer Society)	Grant Support: By the American Cancer Society Physician Training Award in Cancer Prevention and Control.	Billings ME, 2010, J PALLIAT MED, V13, P319, DOI 10.1089/jpm.2009.0293; Ferris FD, 2009, J CLIN ONCOL, V27, P3052, DOI 10.1200/JCO.2008.20.1558; Field MJ, 1997, APPROACHING DEATH IM; Hogan C, 2001, HEALTH AFFAIR, V20, P188, DOI 10.1377/hlthaff.20.4.188; Meier DE, 2009, J PALLIAT MED, V12, P291, DOI 10.1089/jpm.2009.9648; Morrison RS, 2004, NEW ENGL J MED, V350, P2582, DOI 10.1056/NEJMcp035232; Pear R., 2010, NY TIMES        1225; Peppercorn JM, 2011, J CLIN ONCOL, V29, P755, DOI 10.1200/JCO.2010.33.1744; Steinhauser KE, 2000, ANN INTERN MED, V132, P825, DOI 10.7326/0003-4819-132-10-200005160-00011; Sudore RL, 2010, ANN INTERN MED, V153, P256, DOI 10.7326/0003-4819-153-4-201008170-00008; Temel JS, 2010, NEW ENGL J MED, V363, P733, DOI 10.1056/NEJMoa1000678; Wright AA, 2008, JAMA-J AM MED ASSOC, V300, P1665, DOI 10.1001/jama.300.14.1665; Zhang BH, 2009, ARCH INTERN MED, V169, P480, DOI 10.1001/archinternmed.2008.587	13	3	4	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 21	2011	154	12					830	832		10.7326/0003-4819-154-12-201106210-00011	http://dx.doi.org/10.7326/0003-4819-154-12-201106210-00011			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	779SA	21690597				2022-12-24	WOS:000291800500019
J	Sadri-Ardekani, H; Akhondi, MA; van der Veen, F; Repping, S; van Pelt, AMM				Sadri-Ardekani, Hooman; Akhondi, Mohammad A.; van der Veen, Fulco; Repping, Sjoerd; van Pelt, Ans M. M.			In Vitro Propagation of Human Prepubertal Spermatogonial Stem Cells	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Sadri-Ardekani, Hooman; van der Veen, Fulco; Repping, Sjoerd; van Pelt, Ans M. M.] Univ Amsterdam, Acad Med Ctr, Ctr Reprod Med, NL-1105 AZ Amsterdam, Netherlands; [Akhondi, Mohammad A.] Avicenna Res Inst, Reprod Biotechnol Res Ctr, Tehran, Iran	University of Amsterdam; Academic Medical Center Amsterdam	Sadri-Ardekani, H (corresponding author), Univ Amsterdam, Acad Med Ctr, Ctr Reprod Med, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	s.repping@amc.uva.nl		van Pelt, Ans/0000-0001-9155-548X; Repping, Sjoerd/0000-0002-6959-149X; Akhondi, Mohammad mehdi/0000-0003-1707-3874				Brinster RL, 2007, SCIENCE, V316, P404, DOI 10.1126/science.1137741; He ZP, 2010, BIOL REPROD, V82, P363, DOI 10.1095/biolreprod.109.078550; Keros V, 2007, HUM REPROD, V22, P1384, DOI 10.1093/humrep/del508; Mizrak SC, 2010, HUM REPROD, V25, P158, DOI 10.1093/humrep/dep354; Sadri-Ardekani H, 2009, JAMA-J AM MED ASSOC, V302, P2127, DOI 10.1001/jama.2009.1689; Wu X, 2009, P NATL ACAD SCI USA, V106, P21672, DOI 10.1073/pnas.0912432106	6	141	149	0	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 15	2011	305	23					2416	2418		10.1001/jama.2011.791	http://dx.doi.org/10.1001/jama.2011.791			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	777EB	21673293	Bronze			2022-12-24	WOS:000291597300018
J	Jia, HJ; Wang, XY; Liu, F; Guenther, UP; Srinivasan, S; Anderson, JT; Jankowsky, E				Jia, Huijue; Wang, Xuying; Liu, Fei; Guenther, Ulf-Peter; Srinivasan, Sukanya; Anderson, James T.; Jankowsky, Eckhard			The RNA Helicase Mtr4p Modulates Polyadenylation in the TRAMP Complex	CELL			English	Article							SACCHAROMYCES-CEREVISIAE; RIBOSOMAL-RNA; NUCLEAR; SURVEILLANCE; DEGRADATION; EXOSOME; END; SUFFICIENT; TURNOVER; REVEALS	Many steps in nuclear RNA processing, surveillance, and degradation require TRAMP, a complex containing the poly(A) polymerase Trf4p, the Zn-knuckle protein Air2p, and the RNA helicase Mtr4p. TRAMP polyadenylates RNAs designated for decay or trimming by the nuclear exosome. It has been unclear how polyadenylation by TRAMP differs from polyadenylation by conventional poly(A) polymerase, which produces poly(A) tails that stabilize RNAs. Using reconstituted S. cerevisiae TRAMP, we show that TRAMP inherently suppresses poly(A) addition after only 3-4 adenosines. This poly(A) tail length restriction is controlled by Mtr4p. The helicase detects the number of 3'-terminal adenosines and, over several adenylation steps, elicits precisely tuned adjustments of ATP affinities and rate constants for adenylation and TRAMP dissociation. Our data establish Mtr4p as a critical regulator of polyadenylation by TRAMP and reveal that an RNA helicase can control the activity of another enzyme in a highly complex fashion and in response to features in RNA.	[Jia, Huijue; Liu, Fei; Guenther, Ulf-Peter; Srinivasan, Sukanya; Jankowsky, Eckhard] Case Western Reserve Univ, Ctr RNA Mol Biol, Cleveland, OH 44106 USA; [Jia, Huijue; Liu, Fei; Guenther, Ulf-Peter; Srinivasan, Sukanya; Jankowsky, Eckhard] Case Western Reserve Univ, Dept Biochem, Sch Med, Cleveland, OH 44106 USA; [Wang, Xuying; Anderson, James T.] Marquette Univ, Dept Biol Sci, Milwaukee, WI 53201 USA	Case Western Reserve University; Case Western Reserve University; Marquette University	Jankowsky, E (corresponding author), Case Western Reserve Univ, Ctr RNA Mol Biol, Cleveland, OH 44106 USA.	exj13@case.edu	Wang, Xuying/C-8053-2011; Jia, Huijue/M-3991-2015	Jia, Huijue/0000-0002-3592-126X; Jankowsky, Eckhard/0000-0001-7677-7412	NIH [GM067700, GM069949]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067700, R01GM069949] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the members of the Jankowsky and Anderson labs and Dr. Mike Harris (Case Western) for helpful discussions and Drs. Timothy Nilsen and Pat Maroney (Case Western) for advice on the determination of the poly(A) tail length of pre-tRNA<INF>i</INF><SUP>Met</SUP> in vivo. This work was supported by grants from the NIH to E.J. (GM067700) and J.T.A. (GM069949).	Ali JA, 1997, SCIENCE, V275, P377, DOI 10.1126/science.275.5298.377; Anderson JT, 2009, CRIT REV BIOCHEM MOL, V44, P16, DOI [10.1080/10409230802640218 , 10.1080/10409230802640218]; Bernstein J, 2008, J BIOL CHEM, V283, P4930, DOI 10.1074/jbc.M706677200; Bernstein J, 2010, BIOCHEMISTRY-US, V49, P10357, DOI 10.1021/bi101518x; Bonneau F, 2009, CELL, V139, P547, DOI 10.1016/j.cell.2009.08.042; Borowski LS, 2010, BBA-BIOENERGETICS, V1797, P1066, DOI 10.1016/j.bbabio.2010.01.028; Callahan KP, 2010, J BIOL CHEM, V285, P3540, DOI 10.1074/jbc.M109.058396; Carpousis AJ, 2009, PROG MOL BIOL TRANSL, V85, P91, DOI 10.1016/S0079-6603(08)00803-9; de la Cruz J, 1998, EMBO J, V17, P1128, DOI 10.1093/emboj/17.4.1128; Egecioglu DE, 2006, RNA, V12, P26, DOI 10.1261/rna.2207206; Grzechnik P, 2008, MOL CELL, V32, P247, DOI 10.1016/j.molcel.2008.10.003; Houseley J, 2006, EMBO REP, V7, P205, DOI 10.1038/sj.embor.7400612; Houseley J, 2008, BBA-GENE REGUL MECH, V1779, P239, DOI 10.1016/j.bbagrm.2007.12.008; Houseley J, 2009, CELL, V136, P763, DOI 10.1016/j.cell.2009.01.019; Jackson RN, 2010, EMBO J, V29, P2205, DOI 10.1038/emboj.2010.107; Jensen TH, 2005, CELL, V121, P660, DOI 10.1016/j.cell.2005.05.018; Kadaba S, 2006, RNA, V12, P508, DOI 10.1261/rna.2305406; Kadaba S, 2004, GENE DEV, V18, P1227, DOI 10.1101/gad.1183804; KELLER W, 1995, CELL, V81, P829, DOI 10.1016/0092-8674(95)90001-2; LaCava J, 2005, CELL, V121, P713, DOI 10.1016/j.cell.2005.04.029; Lebreton A, 2008, NATURE, V456, P993, DOI 10.1038/nature07480; Liu QS, 2006, CELL, V127, P1223, DOI 10.1016/j.cell.2006.10.037; Lucius AL, 2003, BIOPHYS J, V85, P2224, DOI 10.1016/S0006-3495(03)74648-7; Lykke-Andersen S, 2009, J CELL SCI, V122, P1487, DOI 10.1242/jcs.047399; Paolo SS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000555; Piccininni S, 2002, J BIOL CHEM, V277, P45670, DOI 10.1074/jbc.M204124200; SACHS AB, 1987, MOL CELL BIOL, V7, P3268, DOI 10.1128/MCB.7.9.3268; Scorilas A, 2002, CRIT REV CL LAB SCI, V39, P193, DOI 10.1080/10408360290795510; SENGER B, 1992, P NATL ACAD SCI USA, V89, P10768, DOI 10.1073/pnas.89.22.10768; Vanacova S, 2005, PLOS BIOL, V3, P986, DOI 10.1371/journal.pbio.0030189; Wang XY, 2008, RNA, V14, P107, DOI 10.1261/rna.808608; Weir JR, 2010, P NATL ACAD SCI USA, V107, P12139, DOI 10.1073/pnas.1004953107; Wilusz JE, 2010, RNA, V16, P259, DOI 10.1261/rna.1907510; Wlotzka W, 2011, EMBO J, V30, P1790, DOI 10.1038/emboj.2011.97; Wyers F, 2005, CELL, V121, P725, DOI 10.1016/j.cell.2005.04.030; Yang QS, 2005, BIOCHEMISTRY-US, V44, P13591, DOI 10.1021/bi0508946	36	77	78	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 10	2011	145	6					890	901		10.1016/j.cell.2011.05.010	http://dx.doi.org/10.1016/j.cell.2011.05.010			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	775LS	21663793	Bronze, Green Published, Green Accepted			2022-12-24	WOS:000291461600016
J	Konstantinopoulos, PA; Papavassiliou, AG				Konstantinopoulos, Panagiotis A.; Papavassiliou, Athanasios G.			Seeing the Future of Cancer-Associated Transcription Factor Drug Targets	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							BIOLOGY		[Konstantinopoulos, Panagiotis A.; Papavassiliou, Athanasios G.] Univ Athens, Sch Med, Dept Biol Chem, GR-11527 Athens, Greece; [Konstantinopoulos, Panagiotis A.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Hematol Oncol, Boston, MA 02215 USA	Athens Medical School; National & Kapodistrian University of Athens; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Papavassiliou, AG (corresponding author), Univ Athens, Sch Med, Dept Biol Chem, 75 M Asias St, GR-11527 Athens, Greece.	papavas@med.uoa.gr	Karamouzis, Michalis/AAD-2860-2020					Friend SH, 2006, CANCER CELL, V10, P349, DOI 10.1016/j.ccr.2006.10.011; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Imming P, 2006, NAT REV DRUG DISCOV, V5, P821, DOI 10.1038/nrd2132; Kaelin WG, 2009, GENOME MED, V1, DOI 10.1186/gm99; Leong PL, 2003, P NATL ACAD SCI USA, V100, P4138, DOI 10.1073/pnas.0534764100; PAPAVASSILIOU AG, 1995, NEW ENGL J MED, V332, P45, DOI 10.1056/NEJM199501053320108; Papavassiliou AG, 2001, EMBO REP, V2, P80, DOI 10.1093/embo-reports/kve033; Stegmaier K, 2007, PLOS MED, V4, P702, DOI 10.1371/journal.pmed.0040122; Strebhardt K, 2008, NAT REV CANCER, V8, P473, DOI 10.1038/nrc2394; van Montfort RLM, 2009, TRENDS BIOTECHNOL, V27, P315, DOI 10.1016/j.tibtech.2009.02.003	10	26	27	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 8	2011	305	22					2349	2350		10.1001/jama.2011.727	http://dx.doi.org/10.1001/jama.2011.727			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	773YV	21642690				2022-12-24	WOS:000291349100031
J	Cohen, IG; Adashi, EY				Cohen, I. Glenn; Adashi, Eli Y.			Human Embryonic Stem-Cell Research under Siege - Battle Won but Not the War	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Cohen, I. Glenn] Harvard Univ, Sch Law, Petrie Flom Ctr Hlth Law Policy Biotechnol & Bioe, Cambridge, MA 02138 USA; [Adashi, Eli Y.] Brown Univ, Alpert Med Sch, Providence, RI 02912 USA	Harvard University; Brown University	Cohen, IG (corresponding author), Harvard Univ, Sch Law, Petrie Flom Ctr Hlth Law Policy Biotechnol & Bioe, Cambridge, MA 02138 USA.							Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145	1	29	30	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 2	2011	364	22								10.1056/NEJMp1105088	http://dx.doi.org/10.1056/NEJMp1105088			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	772AB	21591937				2022-12-24	WOS:000291200700006
J	Dyson, C; Austin, T; Lees, C				Dyson, Charlotte; Austin, Topun; Lees, Christoph			Could routine cardiotocography reduce long term cognitive impairment?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							NEONATAL ENCEPHALOPATHY; SCHOOL-AGE; ASPHYXIA; SURVIVORS; SEIZURES; OUTCOMES		[Dyson, Charlotte; Lees, Christoph] Cambridge Univ Hosp NHS Fdn Trust, Addenbrookes Hosp, Div Maternal Fetal Med, Cambridge CB2 2QQ, England; [Austin, Topun] Addenbrookes Hosp, Div Neonatol, Cambridge, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Lees, C (corresponding author), Cambridge Univ Hosp NHS Fdn Trust, Addenbrookes Hosp, Div Maternal Fetal Med, Cambridge CB2 2QQ, England.	christoph.lees@addenbrookes.nhs.uk	Austin, Topun/ABG-1960-2021	Austin, Topun/0000-0002-8428-8624				Al-Macki N, 2009, PEDIATR NEUROL, V41, P399, DOI 10.1016/j.pediatrneurol.2009.06.001; Alfirevic Z, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006066; Chen HY, 2011, AM J OBSTET GYNECOL, V204, pS43, DOI 10.1016/j.ajog.2010.10.091; Edwards AD, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c363; Glass HC, 2009, J PEDIATR-US, V155, P318, DOI 10.1016/j.jpeds.2009.03.040; Graham EM, 2006, OBSTET GYNECOL, V108, P656, DOI 10.1097/01.AOG.0000230533.62760.ef; Graham EM, 2008, AM J OBSTET GYNECOL, V199, P587, DOI 10.1016/j.ajog.2008.06.094; Ingemarsson Ingemar, 2009, Neonatology, V95, P342, DOI 10.1159/000209299; Kurinczuk JJ, 2010, EARLY HUM DEV, V86, P329, DOI 10.1016/j.earlhumdev.2010.05.010; Lindstrom K, 2006, PEDIATR NEUROL, V35, P268, DOI 10.1016/j.pediatrneurol.2006.05.003; Marlow N, 2005, ARCH DIS CHILD-FETAL, V90, pF380, DOI 10.1136/adc.2004.067520; Morris JK, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b3794; Moster D, 2002, ARCH DIS CHILD-FETAL, V86, pF16, DOI 10.1136/fn.86.1.F16; National Institute for Health and Clinical Excellence, 2007, NICE CLIN GUID INTR; Office for National Statistics, 2005, LIV BIRTHS MULT GEST; Office for National Statistics, FERT; ROBERTSON CMT, 1989, J PEDIATR-US, V114, P753, DOI 10.1016/S0022-3476(89)80132-5; Silverstein FS, 2007, ANN NEUROL, V62, P112, DOI 10.1002/ana.21167; Tekgul H, 2006, PEDIATRICS, V117, P1270, DOI 10.1542/peds.2005-1178; TEMPLE CM, 1995, DEV MED CHILD NEUROL, V37, P109; van Handel M, 2007, EUR J PEDIATR, V166, P645, DOI 10.1007/s00431-007-0437-8	21	4	4	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 31	2011	342								d3120	10.1136/bmj.d3120	http://dx.doi.org/10.1136/bmj.d3120			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	774MG	21628365	Green Submitted			2022-12-24	WOS:000291390100003
J	Shi, FM; Lemmon, MA				Shi, Fumin; Lemmon, Mark A.			KSR Plays CRAF-ty	SCIENCE			English	Editorial Material							SCAFFOLD; KINASE; INHIBITORS; BINDING; BRAF; RAS; ATP		[Shi, Fumin] Univ Penn, Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Grad Grp Biochem & Mol Biophys, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Shi, FM (corresponding author), Univ Penn, Sch Med, Dept Biochem & Biophys, 422 Curie Blvd, Philadelphia, PA 19104 USA.	mlemmon@mail.med.upenn.edu	Shi, Fumin/H-3472-2013	Lemmon, Mark/0000-0002-3379-5319				Bollag G, 2010, NATURE, V467, P596, DOI 10.1038/nature09454; Brennan DF, 2011, NATURE, V472, P366, DOI 10.1038/nature09860; Cichowski K, 2010, NATURE, V464, P358, DOI 10.1038/464358a; Good MC, 2011, SCIENCE, V332, P680, DOI 10.1126/science.1198701; Hu JC, 2011, P NATL ACAD SCI USA, V108, P6067, DOI 10.1073/pnas.1102554108; Kolch W, 2005, NAT REV MOL CELL BIO, V6, P827, DOI 10.1038/nrm1743; McKay MM, 2011, CURR BIOL, V21, P563, DOI 10.1016/j.cub.2011.02.033; McKay MM, 2009, P NATL ACAD SCI USA, V106, P11022, DOI 10.1073/pnas.0901590106; Morrison DK, 2001, J CELL SCI, V114, P1609; Mukherjee K, 2008, CELL, V133, P328, DOI 10.1016/j.cell.2008.02.036; Poulikakos PI, 2011, CANCER CELL, V19, P11, DOI 10.1016/j.ccr.2011.01.008; Rajakulendran T, 2009, NATURE, V461, P542, DOI 10.1038/nature08314; Shi FM, 2010, P NATL ACAD SCI USA, V107, P7692, DOI 10.1073/pnas.1002753107; Udell CM, 2011, CELL MOL LIFE SCI, V68, P553, DOI 10.1007/s00018-010-0520-6; Zeqiraj E, 2010, CURR OPIN STRUC BIOL, V20, P772, DOI 10.1016/j.sbi.2010.10.001	15	4	4	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 27	2011	332	6033					1043	1044		10.1126/science.1208063	http://dx.doi.org/10.1126/science.1208063			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	769FN	21617065				2022-12-24	WOS:000290996700032
J	Conen, D; Chae, CU; Glynn, RJ; Tedrow, UB; Everett, BM; Buring, JE; Albert, CM				Conen, David; Chae, Claudia U.; Glynn, Robert J.; Tedrow, Usha B.; Everett, Brendan M.; Buring, Julie E.; Albert, Christine M.			Risk of Death and Cardiovascular Events in Initially Healthy Women With New-Onset Atrial Fibrillation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CONGESTIVE-HEART-FAILURE; FOLLOW-UP; ALCOHOL-CONSUMPTION; PREDICTING STROKE; NATURAL-HISTORY; SECULAR TRENDS; BLOOD-PRESSURE; MORTALITY; COMMUNITY; PREVALENCE	Context The risks associated with new-onset atrial fibrillation (AF) among middle-aged women and populations with a low comorbidity burden are poorly defined. Objectives To examine the association between incident AF and mortality in initially healthy women and to evaluate the influence of associated cardiovascular comorbidities on risk. Design, Setting, and Participants Between 1993 and March 16, 2010, 34 722 women participating in the Women's Health Study underwent prospective follow-up. Participants were 95% white, older than 45 years (median, 53 [interquartile range {IQR}, 49-59] years), and free of AF and cardiovascular disease at baseline. Cox proportional hazards models with time-varying covariates were used to determine the risk of events among women with incident AF. Secondary analyses were performed among women with paroxysmal AF. Main Outcome Measures Primary outcomes included all-cause, cardiovascular, and noncardiovascular mortality. Secondary outcomes included stroke, congestive heart failure, and myocardial infarction. Results During a median follow-up of 15.4 (IQR, 14.7-15.8) years, 1011 women developed AF. Incidence rates per 1000 person-years among women with and without AF were 10.8 (95% confidence interval [CI], 8.1-13.5) and 3.1 (95% CI, 2.9-3.2) for all-cause mortality, 4.3 (95% CI, 2.6-6.0) and 0.57 (95% CI, 0.5-0.6) for cardiovascular mortality, and 6.5 (95% CI, 4.4-8.6) and 2.5 (95% CI, 2.4-2.6) for noncardiovascular mortality, respectively. In multivariable models, hazard ratios (HRs) of new-onset AF for all-cause, cardiovascular, and noncardiovascular mortality were 2.14 (95% CI, 1.64-2.77), 4.18 (95% CI, 2.69-6.51), and 1.66 (95% CI, 1.19-2.30), respectively. Adjustment for nonfatal cardiovascular events potentially on the causal pathway to death attenuated these risks, but incident AF remained associated with all mortality components (all-cause: HR, 1.70 [95% CI, 1.30-2.22]; cardiovascular: HR, 2.57 [95% CI, 1.63-4.07]; and noncardiovascular: HR, 1.42 [95% CI, 1.02-1.98]). Among women with paroxysmal AF (n=656), the increase in mortality risk was limited to cardiovascular causes (HR, 2.94; 95% CI, 1.55-5.59). Conclusion Among a group of healthy women, new-onset AF was independently associated with all-cause, cardiovascular, and noncardiovascular mortality, with some of the risk potentially explained by nonfatal cardiovascular events. JAMA. 2011; 305(20): 2080-2087	[Conen, David] Univ Basel Hosp, Dept Med, CH-4031 Basel, Switzerland; [Conen, David; Tedrow, Usha B.; Albert, Christine M.] Harvard Univ, Sch Med, Dept Med, Ctr Arrhythmia Prevent,Brigham & Womens Hosp, Boston, MA USA; [Conen, David; Chae, Claudia U.; Glynn, Robert J.; Everett, Brendan M.; Buring, Julie E.; Albert, Christine M.] Harvard Univ, Sch Med, Dept Med, Div Prevent Med,Brigham & Womens Hosp, Boston, MA USA; [Tedrow, Usha B.; Everett, Brendan M.; Albert, Christine M.] Harvard Univ, Sch Med, Dept Med, Cardiovasc Div,Brigham & Womens Hosp, Boston, MA USA	University of Basel; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Conen, D (corresponding author), Univ Basel Hosp, Dept Med, Petersgraben 4, CH-4031 Basel, Switzerland.	conend@uhbs.ch	Tedrow, Usha/AFV-2528-2022	Albert, Christine/0000-0002-2081-1121	Boehringer Ingelheim; Sanofi-Aventis; Novartis; Swiss National Science Foundation [PP00P3_133681]; University of Basel; AstraZeneca; St Jude Medical; Biosense Webster; Medtronic Inc; National Institutes of Health/National Heart, Lung, and Blood Institute (NHLBI); American Heart Association; Siemens Healthcare Diagnostics; Boston Scientific; NHLBI [HL-093613, HL-043851, HL-080467, HL-099355]; National Cancer Institute [CA-047988]; NATIONAL CANCER INSTITUTE [R01CA047988] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL093613, R01HL043851, RC1HL099355, R01HL080467] Funding Source: NIH RePORTER	Boehringer Ingelheim(Boehringer Ingelheim); Sanofi-Aventis(Sanofi-Aventis); Novartis(Novartis); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); University of Basel; AstraZeneca(AstraZeneca); St Jude Medical(St. Jude Medical); Biosense Webster; Medtronic Inc(Medtronic); National Institutes of Health/National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); Siemens Healthcare Diagnostics; Boston Scientific(Boston Scientific); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Conen reports receiving research grants from Boehringer Ingelheim, Sanofi-Aventis, Novartis, the Swiss National Science Foundation (PP00P3_133681), and the University of Basel. Dr Glynn reports receiving an honorarium for an invited talk from Merck and research grants for data monitoring and analysis of clinical trials from AstraZeneca. Dr Tedrow reports receiving consultancy fees from St Jude Medical, research grants from Biosense Webster, and grants from Biosense Webster, St Jude Medical, and Medtronic Inc to support the fellows' program at Brigham and Women's Hospital that she directs. Dr Albert reports receiving grant and administrative support from the National Institutes of Health/National Heart, Lung, and Blood Institute (NHLBI), American Heart Association, Siemens Healthcare Diagnostics, and St Jude Medical, consultancy fees from Novartis, and speaker honorarium from Boston Scientific and St Jude Medical. No other conflict of interest disclosures were reported.; This study was supported by grant HL-093613 from the NHLBI to Dr Albert. The WHS was supported by grants HL-043851, HL-080467, and HL-099355 from the NHLBI and grant CA-047988 from the National Cancer Institute.	Benjamin EJ, 1998, CIRCULATION, V98, P946, DOI 10.1161/01.CIR.98.10.946; Conen D, 2008, JAMA-J AM MED ASSOC, V300, P2489, DOI 10.1001/jama.2008.755; Conen D, 2009, CIRCULATION, V119, P2146, DOI 10.1161/CIRCULATIONAHA.108.830042; Dagenais GR, 2006, LANCET, V368, P581, DOI 10.1016/S0140-6736(06)69201-5; Di Pasquale G, 2005, J THROMB HAEMOST, V3, P428, DOI 10.1111/j.1538-7836.2005.01182.x; Friberg J, 2004, AM J CARDIOL, V94, P889, DOI 10.1016/j.amjcard.2004.06.023; Friberg L, 2007, EUR HEART J, V28, P2346, DOI 10.1093/eurheartj/ehm308; Fried Linda P., 1991, Annals of Epidemiology, V1, P263; Fuster V, 2006, CIRCULATION, V114, pE257, DOI 10.1161/CIRCULATIONAHA.106.177292; Gage BF, 2001, JAMA-J AM MED ASSOC, V285, P2864, DOI 10.1001/jama.285.22.2864; Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370; Hart RG, 2007, ANN INTERN MED, V146, P857, DOI 10.7326/0003-4819-146-12-200706190-00007; Jahangir A, 2007, CIRCULATION, V115, P3050, DOI 10.1161/CIRCULATIONAHA.106.644484; Keating RJ, 2005, AM J CARDIOL, V96, P1420, DOI 10.1016/j.amjcard.2005.07.050; KRAHN AD, 1995, AM J MED, V98, P476, DOI 10.1016/S0002-9343(99)80348-9; MCKEE PA, 1971, NEW ENGL J MED, V285, P1441, DOI 10.1056/NEJM197112232852601; Miyasaka Y, 2007, J AM COLL CARDIOL, V49, P986, DOI 10.1016/j.jacc.2006.10.062; Miyasaka Y, 2006, CIRCULATION, V114, P119, DOI 10.1161/CIRCULATIONAHA.105.595140; Mukamal KJ, 2005, CIRCULATION, V112, P1736, DOI 10.1161/CIRCULATIONAHA.105.547844; Nieuwlaat R, 2005, EUR HEART J, V26, P2422, DOI 10.1093/eurheartj/ehi505; Ott A, 1997, STROKE, V28, P316, DOI 10.1161/01.STR.28.2.316; Psaty BM, 1997, CIRCULATION, V96, P2455; Rexrode KM, 2000, J WOMEN HEALTH GEN-B, V9, P19, DOI 10.1089/152460900318911; Ridker PM, 2005, NEW ENGL J MED, V352, P1293, DOI 10.1056/NEJMoa050613; Rockhill B, 1998, AM J PUBLIC HEALTH, V88, P15, DOI 10.2105/AJPH.88.1.15; Stewart S, 2002, AM J MED, V113, P359, DOI 10.1016/S0002-9343(02)01236-6; Tedrow UB, 2010, J AM COLL CARDIOL, V55, P2319, DOI 10.1016/j.jacc.2010.02.029; Turnbull F, 2003, LANCET, V362, P1527; Vidaillet H, 2002, AM J MED, V113, P365, DOI 10.1016/S0002-9343(02)01253-6; Wang TJ, 2004, JAMA-J AM MED ASSOC, V292, P2471, DOI 10.1001/jama.292.20.2471; Wang TJ, 2003, CIRCULATION, V107, P2920, DOI 10.1161/01.CIR.0000072767.89944.6E; Wang TJ, 2003, JAMA-J AM MED ASSOC, V290, P1049, DOI 10.1001/jama.290.8.1049; Wolf PA, 1996, AM HEART J, V131, P790, DOI 10.1016/S0002-8703(96)90288-4; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983	34	262	270	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 25	2011	305	20					2080	2087		10.1001/jama.2011.659	http://dx.doi.org/10.1001/jama.2011.659			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	768AC	21610240	Bronze, Green Accepted			2022-12-24	WOS:000290901700021
J	van Kuppeveld, FJM; van der Meer, JWM				van Kuppeveld, Frank J. M.; van der Meer, Jos W. M.			XMRV and CFS-the sad end of a story	LANCET			English	Editorial Material							CHRONIC-FATIGUE-SYNDROME; VIRUS-RELATED VIRUS; NO ASSOCIATION; RETROVIRUS; FAILURE; ABSENCE; DETECT; BLOOD		[van Kuppeveld, Frank J. M.] Radboud Univ Nijmegen, Med Ctr, Dept Med Microbiol, NL-6500 HB Nijmegen, Netherlands; [van der Meer, Jos W. M.] Radboud Univ Nijmegen, Med Ctr, Dept Med, NL-6500 HB Nijmegen, Netherlands; [van Kuppeveld, Frank J. M.; van der Meer, Jos W. M.] Radboud Univ Nijmegen, Med Ctr, Nijmegen Inst Infect Inflammat & Immun, NL-6500 HB Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen	van Kuppeveld, FJM (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Med Microbiol, NL-6500 HB Nijmegen, Netherlands.	f.vankuppeveld@ncmls.ru.nl	van der Meer, Jos W.M./C-8521-2013	van der Meer, Jos W.M./0000-0001-5120-3690; van Kuppeveld, Frank/0000-0001-5800-749X				Alberts B, 2011, SCIENCE, DOI [10.1126/science.1208542, DOI 10.1126/SCIENCE.1208542]; [Anonymous], 2011, LANCET, V377, P1808, DOI 10.1016/S0140-6736(11)60696-X; [Anonymous], PHOENIX RISING TREAT; Erlwein O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017592; Erlwein O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008519; Furuta RA, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-20; Groom HCT, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-10; Hong P, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-224; Knox K, 2011, SCIENCE, V333, P94, DOI 10.1126/science.1204963; Lloyd A, 2010, SCIENCE, V328, DOI 10.1126/science.1183706; Lo SC, 2010, P NATL ACAD SCI USA, V107, P15874, DOI 10.1073/pnas.1006901107; Lombardi VC, 2009, SCIENCE, V326, P585, DOI 10.1126/science.1179052; Marcus AD, 2011, WALL STREET J   0531, V31; Paprotka T, 2011, SCIENCE, V333, P97, DOI 10.1126/science.1205292; Satterfield BC, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-12; Schutzer SE, 2011, ANN NEUROL, V69, P735, DOI 10.1002/ana.22389; Shin CH, 2011, J VIROL, V85, P7195, DOI 10.1128/JVI.00693-11; Smith RA, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-112; Switzer WM, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-57; van Kuppeveld FJ, 2010, BMJ-BRIT MED J, V340, P1018; Weiss RA, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-124	21	11	11	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 4	2012	379	9814					E27	E28		10.1016/S0140-6736(11)60899-4	http://dx.doi.org/10.1016/S0140-6736(11)60899-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	891AF	21696817				2022-12-24	WOS:000300187800001
J	Rappuoli, R; Black, S; Lambert, PH				Rappuoli, Rino; Black, Steven; Lambert, Paul Henri			New Decade of Vaccines 2 Vaccine discovery and translation of new vaccine technology	LANCET			English	Article							PNEUMOCOCCAL CONJUGATE VACCINE; HEPATITIS-B-VACCINE; INFLUENZA VACCINES; SYSTEMS BIOLOGY; SAFETY; PREVENTION; EFFICACY; DIPHTHERIA; PERTUSSIS; DISEASE	An unprecedented increase in new vaccine development has occurred over the past three decades. This activity has resulted in vaccines that protect against an increased range of vaccine-preventable diseases, vaccines that reduce the number of required injections, and vaccines with improved safety and purity. New methods of discovery, such as reverse vaccinology, structural biology, and systems biology, promise new vaccines for different diseases and efficient development pathways for these vaccines. We expect development of vaccines not only for infectious diseases in children but also for healthy adults, pregnant women, and elderly people, and for new indications such as autoimmune disease and cancer. We have witnessed a concomitant development of new technology for assessment of vaccine safety to rapidly identify potential safety issues. Success of these new approaches will depend on effective implementation of vaccination programmes, creative thinking on the part of manufacturers and regulators as to how best to ensure that safe and effective vaccines are available in a timely manner, and improvement of public awareness about the benefits and risks of new vaccines in a way that encourages confidence in vaccines.	[Rappuoli, Rino] Novartis Vaccines, I-53100 Siena, Italy; [Black, Steven] Univ Cincinnati, Childrens Hosp, Ctr Global Hlth, Cincinnati, OH USA; [Lambert, Paul Henri] Univ Geneva, Ctr Vaccinol, Geneva, Switzerland	Novartis; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University of Geneva	Rappuoli, R (corresponding author), Novartis Vaccines, Via Fiorentina 1, I-53100 Siena, Italy.	rino.rappuoli@novartis.com						Alexander LN, 2004, JAMA-J AM MED ASSOC, V292, P1696, DOI 10.1001/jama.292.14.1696; [Anonymous], 2005, CUTTER INCIDENT AM 1; Balmer P, 2002, J MED MICROBIOL, V51, P717, DOI 10.1099/0022-1317-51-9-717; BELL JF, 1949, P SOC EXP BIOL MED, V70, P457, DOI 10.3181/00379727-70-16960; BISNO AL, 1991, NEW ENGL J MED, V325, P783, DOI 10.1056/NEJM199109123251106; Black S, 2000, PEDIATR INFECT DIS J, V19, P187, DOI 10.1097/00006454-200003000-00003; BLACK SB, 1988, PEDIATR INFECT DIS J, V7, P149, DOI 10.1097/00006454-198803000-00003; Bowden TA, 2010, BIOCHEM SOC T, V38, P1349, DOI 10.1042/BST0381349; Bringmann A, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/623687; Burch P, 1994, PROSTATE, V60, P197; Centers for Disease Control and Prevention, 2011, 2011 CHILD AD IMM SC; Centers for Disease Control and Prevention, 2009, PREL RES SURV GUILL; Centers for Disease Control and Prevention, CDC IMM SCHED; Centers for Disease Control and Prevention, ACT BACT COR SURV; Chen RT, 1997, PEDIATRICS, V99, P765, DOI 10.1542/peds.99.6.765; Clark TW, 2009, NEW ENGL J MED, V361, P1; Descamps D, 2009, HUM VACCINES, V5, P332, DOI 10.4161/hv.5.5.7211; Didierlaurent AM, 2009, J IMMUNOL, V183, P6186, DOI 10.4049/jimmunol.0901474; FARRINGTON P, 1995, LANCET, V345, P567, DOI 10.1016/S0140-6736(95)90471-9; FENNER F, 1982, REV INFECT DIS, V4, P916; Fulginiti VA, 2003, CLIN INFECT DIS, V37, P251, DOI 10.1086/375825; Galazka AM, 1996, VACCINE, V14, P845, DOI 10.1016/0264-410X(96)00021-7; Galli G, 2009, P NATL ACAD SCI USA, V106, P3877, DOI 10.1073/pnas.0813390106; Gilchrist M, 2006, NATURE, V441, P173, DOI 10.1038/nature04768; Goodman JL, M CHALLENGE PANDEMIC; Greco M, 2009, NEW GENERATION VACCI; HALLIDAY ML, 1990, ARCH INTERN MED, V150, P1195, DOI 10.1001/archinte.150.6.1195; Hausdorff WP, 2000, CLIN INFECT DIS, V30, P100, DOI 10.1086/313608; Hsu HE, 2009, NEW ENGL J MED, V360, P244, DOI 10.1056/NEJMoa0800836; Immunization Action Coalition, HIST DAT EV REL VACC; Kamath AT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005771; Kantoff PW, 2010, J CLIN ONCOL, V28, P1099, DOI 10.1200/JCO.2009.25.0597; Kaplan SL, 2004, PEDIATRICS, V113, P443, DOI 10.1542/peds.113.3.443; Kirkwood BR, 1995, B WORLD HEALTH ORGAN, V73, P793; Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492; Klein NP, 2010, PEDIATRICS, V126, pE1, DOI 10.1542/peds.2010-0665; MacDonald NE, 1998, JAMA-J AM MED ASSOC, V280, P1685, DOI 10.1001/jama.280.19.1685; Madhi SA, 2007, J INFECT DIS, V196, P1662, DOI 10.1086/522164; Mosca F, 2008, P NATL ACAD SCI USA, V105, P10501, DOI 10.1073/pnas.0804699105; Moxon ER, 2011, LANCET, V378, P348, DOI 10.1016/S0140-6736(11)60407-8; NEDELEC J, 1990, J NEUROIMMUNOL, V29, P49, DOI 10.1016/0165-5728(90)90146-E; PIALOUX G, 1995, AIDS RES HUM RETROV, V11, P875; Plotkin S., 2008, VACCINES, P1; Podda Audino, 2003, Expert Rev Vaccines, V2, P197, DOI 10.1586/14760584.2.2.197; Ramshaw IA, 2000, IMMUNOL TODAY, V21, P163, DOI 10.1016/S0167-5699(00)01612-1; Rappuoli R, 2001, VACCINE, V19, P2688, DOI 10.1016/S0264-410X(00)00554-5; Ray GT, 2006, PEDIATR INFECT DIS J, V25, P494, DOI 10.1097/01.inf.0000222403.42974.8b; Roberts L, 2008, SCIENCE, V320, P1712, DOI 10.1126/science.320.5884.1712; Rosenthal S, 1996, ARCH PEDIAT ADOL MED, V150, P457, DOI 10.1001/archpedi.1996.02170300011001; Serruto D, 2006, FEBS LETT, V580, P2985, DOI 10.1016/j.febslet.2006.04.084; STEVENS CE, 1987, JAMA-J AM MED ASSOC, V257, P2612, DOI 10.1001/jama.257.19.2612; Su LL, 2009, LANCET, V374, P1417, DOI 10.1016/S0140-6736(09)61854-7; Tree JA, 2001, VACCINE, V19, P3444, DOI 10.1016/S0264-410X(01)00053-6; Tsai T, 2010, VACCINE, V28, P1877, DOI 10.1016/j.vaccine.2009.11.077; Urwin R, 2003, TRENDS MICROBIOL, V11, P479, DOI 10.1016/j.tim.2003.08.006; Wenger JD, 1998, PEDIATR INFECT DIS J, V17, pS132, DOI 10.1097/00006454-199809001-00008; Wraith DC, 2003, LANCET, V362, P1659, DOI 10.1016/S0140-6736(03)14802-7; WYLE FA, 1972, J INFECT DIS, V126, P514, DOI 10.1093/infdis/126.5.514; Zepp F, 2010, VACCINE, V28, pC14, DOI 10.1016/j.vaccine.2010.07.020; Zhang QB, 2010, J INFECT DIS, V201, P1753, DOI 10.1086/652495; Zhu W, 2010, VACCINE, V28, P2865, DOI 10.1016/j.vaccine.2010.01.060	61	66	69	0	26	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 23	2011	378	9788					360	368		10.1016/S0140-6736(11)60440-6	http://dx.doi.org/10.1016/S0140-6736(11)60440-6			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	803XL	21664687				2022-12-24	WOS:000293615800034
J	McGraw, CM; Samaco, RC; Zoghbi, HY				McGraw, Christopher M.; Samaco, Rodney C.; Zoghbi, Huda Y.			Adult Neural Function Requires MeCP2	SCIENCE			English	Article							RETT-SYNDROME; MOUSE		[McGraw, Christopher M.; Zoghbi, Huda Y.] Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; [McGraw, Christopher M.; Samaco, Rodney C.; Zoghbi, Huda Y.] Jan & Dan Duncan Neurol Res Inst, Houston, TX 77030 USA; [McGraw, Christopher M.] Baylor Coll Med, Med Scientist Training Program, Houston, TX 77030 USA; [Samaco, Rodney C.; Zoghbi, Huda Y.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Zoghbi, Huda Y.] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Zoghbi, Huda Y.] Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute	Zoghbi, HY (corresponding author), Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA.	hzoghbi@bcm.edu		Zoghbi, Huda/0000-0002-0700-3349; Samaco, Rodney/0000-0001-5636-5314	NIH [NS057819, HD024064, F31-NS073317, T32-NS043124]; International Rett Syndrome Foundation; Simons Foundation; Rett Syndrome Research Trust; Baylor Research Advocates for Student Scientists; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS057819, F31NS073317, T32NS043124] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International Rett Syndrome Foundation; Simons Foundation; Rett Syndrome Research Trust; Baylor Research Advocates for Student Scientists; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank S. Baker, Y. Lee, A. Flora, and L. Chen for discussions and NIH (grants NS057819, HD024064 to H.Z.; F31-NS073317 to C.M.; T32-NS043124 to R.S.), Baylor Research Advocates for Student Scientists (C.M.), International Rett Syndrome Foundation, Simons Foundation, and Rett Syndrome Research Trust (H.Z.) for support.	Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Chahrour M, 2007, NEURON, V56, P422, DOI 10.1016/j.neuron.2007.10.001; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; Guy J, 2007, SCIENCE, V315, P1143, DOI 10.1126/science.1138389; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276	6	186	191	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 8	2011	333	6039					186	186		10.1126/science.1206593	http://dx.doi.org/10.1126/science.1206593			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	789GG	21636743	Green Accepted			2022-12-24	WOS:000292502700039
J	Ye, HF; Daoud-El Baba, M; Peng, RW; Fussenegger, M				Ye, Haifeng; Daoud-El Baba, Marie; Peng, Ren-Wang; Fussenegger, Martin			A Synthetic Optogenetic Transcription Device Enhances Blood-Glucose Homeostasis in Mice	SCIENCE			English	Article							GLUCAGON-LIKE PEPTIDE-1; ECTOPIC EXPRESSION; VISUAL FUNCTION; MELANOPSIN; LIGHT; CELLS; RESPONSES; ROD; SYSTEMS	Synthetic biology has advanced the design of genetic devices that can be used to reprogram metabolic activities in mammalian cells. By functionally linking the signal transduction of melanopsin to the control circuit of the nuclear factor of activated T cells, we have designed a synthetic signaling cascade enabling light-inducible transgene expression in different cell lines grown in culture or bioreactors or implanted into mice. In animals harboring intraperitoneal hollow-fiber or subcutaneous implants containing light-inducible transgenic cells, the serum levels of the human glycoprotein secreted alkaline phosphatase could be remote-controlled with fiber optics or transdermally regulated through direct illumination. Light-controlled expression of the glucagon-like peptide 1 was able to attenuate glycemic excursions in type II diabetic mice. Synthetic light-pulse-transcription converters may have applications in therapeutics and protein expression technology.	[Ye, Haifeng; Peng, Ren-Wang; Fussenegger, Martin] Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, CH-4058 Basel, Switzerland; [Daoud-El Baba, Marie] IUT, Dept Genie Biol, F-69622 Villeurbanne, France; [Fussenegger, Martin] Univ Basel, Fac Sci, CH-4058 Basel, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Basel	Fussenegger, M (corresponding author), Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, Mattenstr 26, CH-4058 Basel, Switzerland.	fussenegger@bsse.ethz.ch	Peng, Ren-Wang/AAM-8542-2021	Peng, Ren-Wang/0000-0003-1199-6520; Ye, Haifeng/0000-0002-5482-8116	Swiss National Science Foundation [31003A-126022]; EC	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); EC(European CommissionEuropean Commission Joint Research Centre)	We thank I. Provencio for providing pIRES<INF>2</INF>-OPN<INF>4</INF>AI and G. Charpin for skillful assistance with the animal study. This work was supported by the Swiss National Science Foundation (grant 31003A-126022) and in part by the EC Framework 7 (Persist).	Busskamp V, 2010, SCIENCE, V329, P413, DOI 10.1126/science.1190897; Crabtree GR, 2009, CELL, V138, DOI 10.1016/j.cell.2009.06.026; Culler SJ, 2010, SCIENCE, V330, P1251, DOI 10.1126/science.1192128; Do MTH, 2009, NATURE, V457, P281, DOI 10.1038/nature07682; Falkowski PG, 2008, SCIENCE, V320, P1034, DOI 10.1126/science.1153213; Fu YB, 2005, P NATL ACAD SCI USA, V102, P10339, DOI 10.1073/pnas.0501866102; Fussenegger M, 1998, NAT BIOTECHNOL, V16, P468, DOI 10.1038/nbt0598-468; Greber D, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn443; Guler AD, 2008, NATURE, V453, P102, DOI 10.1038/nature06829; Hankins MW, 2008, TRENDS NEUROSCI, V31, P27, DOI 10.1016/j.tins.2007.11.002; Hartwick ATE, 2007, J NEUROSCI, V27, P13468, DOI 10.1523/JNEUROSCI.3626-07.2007; Hattar S, 2003, NATURE, V424, P76, DOI 10.1038/nature01761; Hockberger PE, 1999, P NATL ACAD SCI USA, V96, P6255, DOI 10.1073/pnas.96.11.6255; HOLZ GG, 1993, NATURE, V361, P362, DOI 10.1038/361362a0; Kemmer C, 2010, NAT BIOTECHNOL, V28, P355, DOI 10.1038/nbt.1617; Khalil AS, 2010, NAT REV GENET, V11, P367, DOI 10.1038/nrg2775; Kielgast U, 2009, CURR DIABETES REV, V5, P266, DOI 10.2174/157339909789804413; Lagali PS, 2008, NAT NEUROSCI, V11, P667, DOI 10.1038/nn.2117; Levskaya A, 2009, NATURE, V461, P997, DOI 10.1038/nature08446; Lin B, 2008, P NATL ACAD SCI USA, V105, P16009, DOI 10.1073/pnas.0806114105; Lupi D, 2008, NAT NEUROSCI, V11, P1068, DOI 10.1038/nn.2179; Melyan Z, 2005, NATURE, V433, P741, DOI 10.1038/nature03344; Nagel G, 2002, SCIENCE, V296, P2395, DOI 10.1126/science.1072068; NELSON DE, 1991, BRAIN RES, V554, P272, DOI 10.1016/0006-8993(91)90200-F; Nelson N, 2006, ANNU REV PLANT BIOL, V57, P521, DOI 10.1146/annurev.arplant.57.032905.105350; O'Shaughnessy EC, 2011, CELL, V144, P119, DOI 10.1016/j.cell.2010.12.014; Panda S, 2005, SCIENCE, V307, P600, DOI 10.1126/science.1105121; Parsons GB, 2007, GENE THER, V14, P38, DOI 10.1038/sj.gt.3302842; Peisajovich SG, 2010, SCIENCE, V328, P368, DOI 10.1126/science.1182376; Ruby NF, 2002, SCIENCE, V298, P2211, DOI 10.1126/science.1076701; Storch KF, 2007, CELL, V130, P730, DOI 10.1016/j.cell.2007.06.045; Tigges M, 2009, NATURE, V457, P309, DOI 10.1038/nature07616; Umino Y, 2008, J NEUROSCI, V28, P189, DOI 10.1523/JNEUROSCI.3551-07.2008; Weber W, 2007, CURR OPIN BIOTECH, V18, P399, DOI 10.1016/j.copbio.2007.09.002; Wurm FM, 2004, NAT BIOTECHNOL, V22, P1393, DOI 10.1038/nbt1026	35	315	341	3	158	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 24	2011	332	6037					1565	1568		10.1126/science.1203535	http://dx.doi.org/10.1126/science.1203535			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782EE	21700876				2022-12-24	WOS:000291990000047
J	Snyder, SA; Gollner, A; Chiriac, MI				Snyder, Scott A.; Gollner, Andreas; Chiriac, Maria I.			Regioselective reactions for programmable resveratrol oligomer synthesis	NATURE			English	Article							CARAGANA-SINICA; STEM BARK; 4-HYDROXYSTILBENES; OLIGOSTILBENES; PRODUCTS; DIMERS; PLANTS	Although much attention has been devoted to resveratrol, a unique polyphenol produced by plants and credited as potentially being responsible for the 'French paradox'-the observation that French people have a relatively low incidence of coronary heart disease, even though their diet is high in saturated fats-the oligomers of resveratrol have been largely ignored despite their high biological activity. Challenges in achieving their isolation in sufficient quantity from natural sources, coupled with an inability to prepare them easily synthetically, are seen as the main obstacles. Here we report a programmable, controlled and potentially scalable synthesis of the resveratrol family via a three-stage design. The synthetic approach requires strategy- and reagent-guided chemical functionalizations to differentiate two distinct cores possessing multiple sites with the same or similar reactivity, ultimately leading to five higher-order natural products. This work demonstrates that challenging, positionally selective functionalizations of complex materials are possible where biosynthetic studies have indicated otherwise, it provides materials and tools with which to unlock the full biochemical potential of this family of natural products, and it affords an intellectual framework within which other oligomeric families could potentially be accessed.	[Snyder, Scott A.; Gollner, Andreas; Chiriac, Maria I.] Columbia Univ, Dept Chem, New York, NY 10027 USA	Columbia University	Snyder, SA (corresponding author), Columbia Univ, Dept Chem, Havemeyer Hall,3000 Broadway, New York, NY 10027 USA.	sas2197@columbia.edu		Gollner, Andreas/0000-0002-4347-8296; Snyder, Scott/0000-0003-3594-8769	Columbia University; National Institutes of Health [R01-GM84994]; Bristol-Myers Squibb; Eli Lilly; Research Corporation for Science Advancement; Austrian Science Fund (FWF) [J2986-N19]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084994] Funding Source: NIH RePORTER	Columbia University; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bristol-Myers Squibb(Bristol-Myers Squibb); Eli Lilly(Eli Lilly); Research Corporation for Science Advancement(Research Corporation for Science Advancement); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank G. Sukenick of The Memorial Sloan Kettering Cancer Research Institute and J. Decatur of Columbia University for NMR assistance, Y. Itagaki for mass spectrometric assistance, C. Stathakis for preliminary attempts to form dihydrofuran units on the pallidol core, A. ElSohly for theoretical calculations and discussions, and K. Shaw and J. Boyce for preparing some starting materials. Financial support was provided by Columbia University, the National Institutes of Health (R01-GM84994), Bristol-Myers Squibb, Eli Lilly, the Research Corporation for Science Advancement (Cottrell Scholar Award to S.A.S.), and the Austrian Science Fund (FWF, Schrodinger postdoctoral fellowship J2986-N19 to A.G.).	Abe N, 2010, J NAT PROD, V73, P1499, DOI 10.1021/np1002675; Atun S., 2008, J PHYS SCI, V19, P7; BACH NJ, 1980, J MED CHEM, V23, P481, DOI 10.1021/jm00179a003; BAKER R, 1987, CHEM COMMUN, P1102; Bertolini F, 2009, ORG PREP PROCED INT, V41, P385, DOI 10.1080/00304940903240836; BOGER DL, 1984, J ORG CHEM, V49, P4050, DOI 10.1021/jo00195a035; Burke MD, 2004, ANGEW CHEM INT EDIT, V43, P46, DOI 10.1002/anie.200300626; Chen K, 2009, NATURE, V459, P824, DOI 10.1038/nature08043; Christianson DW, 2006, CHEM REV, V106, P3412, DOI 10.1021/cr050286w; Corey E.J., 1995, LOGIC CHEM SYNTHESIS; COREY EJ, 1965, J AM CHEM SOC, V87, P1353, DOI 10.1021/ja01084a034; Fischbach MA, 2007, NAT CHEM BIOL, V3, P353, DOI 10.1038/nchembio0707-353; Gustafson JL, 2010, SCIENCE, V328, P1251, DOI 10.1126/science.1188403; He YH, 2006, HETEROCYCLES, V68, P93; Ito T, 2003, CARCINOGENESIS, V24, P1489, DOI 10.1093/carcin/bgg105; Jang MS, 1997, SCIENCE, V275, P218, DOI 10.1126/science.275.5297.218; Jeffrey JL, 2009, ORG LETT, V11, P5450, DOI 10.1021/ol902141z; Kim I, 2009, ORG BIOMOL CHEM, V7, P2788, DOI 10.1039/b901911a; Kraus GA, 2009, TETRAHEDRON LETT, V50, P7180, DOI 10.1016/j.tetlet.2009.10.040; Kurosawa W, 2004, TETRAHEDRON, V60, P9615, DOI 10.1016/j.tet.2004.06.144; LANGCAKE P, 1977, J CHEM SOC CHEM COMM, P208, DOI 10.1039/c39770000208; Lewis CA, 2006, ANGEW CHEM INT EDIT, V45, P5616, DOI 10.1002/anie.200601490; Li WL, 2006, ANGEW CHEM INT EDIT, V45, P7609, DOI 10.1002/anie.200603097; Li WL, 2010, SYNLETT, P1247, DOI 10.1055/s-0029-1219787; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Nicolaou KC, 2010, J AM CHEM SOC, V132, P7540, DOI 10.1021/ja102623j; OSHIMA Y, 1993, TETRAHEDRON, V49, P5801, DOI 10.1016/S0040-4020(01)87946-1; Quideau S, 2011, ANGEW CHEM INT EDIT, V50, P586, DOI 10.1002/anie.201000044; Sako M, 2004, J ORG CHEM, V69, P2598, DOI 10.1021/jo035791c; Sculimbrene BR, 2002, J AM CHEM SOC, V124, P11653, DOI 10.1021/ja027402m; Snyder SA, 2007, ANGEW CHEM INT EDIT, V46, P8186, DOI 10.1002/anie.200703333; Snyder SA, 2011, NAT PROD REP, V28, P897, DOI 10.1039/c1np00001b; Snyder SA, 2010, J AM CHEM SOC, V132, P14303, DOI 10.1021/ja106813s; Snyder SA, 2009, J AM CHEM SOC, V131, P1753, DOI 10.1021/ja806183r; SOTHEESWARAN S, 1993, PHYTOCHEMISTRY, V32, P1083, DOI 10.1016/S0031-9422(00)95070-2; Takaya Y, 2005, TETRAHEDRON, V61, P10285, DOI 10.1016/j.tet.2005.08.023; Takaya Y, 2002, TETRAHEDRON, V58, P9265, DOI 10.1016/S0040-4020(02)01191-2; Takaya Y, 2002, TETRAHEDRON, V58, P7259, DOI 10.1016/S0040-4020(02)00785-8; Tanaka T, 2000, PHYTOCHEMISTRY, V54, P63, DOI 10.1016/S0031-9422(00)00026-1; Tanaka T, 2001, HETEROCYCLES, V55, P729, DOI 10.3987/COM-01-9166; Tsukamoto T, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-46; Velu SS, 2008, CHEM-EUR J, V14, P11376, DOI 10.1002/chem.200801575; Wang SG, 2005, HELV CHIM ACTA, V88, P2315, DOI 10.1002/hlca.200590166; Wang SG, 2004, J ASIAN NAT PROD RES, V6, P241, DOI 10.1080/10286020310001653309; Yamada M, 2006, PHYTOCHEMISTRY, V67, P307, DOI 10.1016/j.phytochem.2005.11.001	45	161	162	1	81	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 23	2011	474	7352					461	466		10.1038/nature10197	http://dx.doi.org/10.1038/nature10197			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	781NJ	21697944	Green Accepted			2022-12-24	WOS:000291939700038
J	Passacquale, G; Ferro, A				Passacquale, Gabriella; Ferro, Albert			THERAPEUTICS Oral antiplatelet agents clopidogrel and prasugrel for the prevention of cardiovascular events	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PERCUTANEOUS CORONARY INTERVENTION; MYOCARDIAL-INFARCTION; COST-EFFECTIVENESS; ASPIRIN; THERAPY		[Passacquale, Gabriella; Ferro, Albert] Kings Coll London, Dept Clin Pharmacol, Div Cardiovasc, London SE1 9NH, England	University of London; King's College London	Ferro, A (corresponding author), Kings Coll London, Dept Clin Pharmacol, Div Cardiovasc, London SE1 9NH, England.	albert.ferro@kcl.ac.uk		Ferro, Albert/0000-0002-5486-9145				[Anonymous], 2009, PRAS TREATM AC COR S; Barnett H, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c1805; Bassand JP, 2007, EUR HEART J, V28, P1598, DOI 10.1093/eurheartj/ehm161; Bennett CL, 2000, NEW ENGL J MED, V342, P1773, DOI 10.1056/NEJM200006153422402; Berg J, 2008, CURR MED RES OPIN, V24, P2089, DOI 10.1185/03007990802222261 ; Bhatt DL, 2010, NEW ENGL J MED, V363, P1909, DOI 10.1056/NEJMoa1007964; Bhatt DL, 2006, NEW ENGL J MED, V354, P1706, DOI 10.1056/NEJMoa060989; Brandt JT, 2007, AM HEART J, V153, DOI 10.1016/j.ahj.2006.10.010; Chan FKL, 2005, NEW ENGL J MED, V352, P238, DOI 10.1056/NEJMoa042087; Chen ZM, 2005, LANCET, V366, P1607, DOI 10.1016/s0140-6736(05)67660-x; Collins R, 2009, LANCET, V373, P1849, DOI 10.1016/S0140-6736(09)60503-1; Diener HC, 2004, LANCET, V364, P331, DOI 10.1016/S0140-6736(04)16721-4; Farid NA, 2010, J CLIN PHARMACOL, V50, P126, DOI 10.1177/0091270009343005; Gent M, 1996, LANCET, V348, P1329, DOI 10.1016/s0140-6736(96)09457-3; Heeg BMS, 2007, PHARMACOECONOMICS, V25, P769, DOI 10.2165/00019053-200725090-00005; Jolly SS, 2009, EUR HEART J, V30, P900, DOI 10.1093/eurheartj/ehn417; McCarthy MW, 2003, ANN PHARMACOTHER, V37, P216; Mehta SR, 2010, LANCET, V376, P1233, DOI 10.1016/S0140-6736(10)61088-4; *NAT I HLTH CLIN E, AC COR SYND IN PRESS; National Institute for Health and Clinical Excellence, 2010, CLOP MOD REL DIP PRE; O'Donoghue ML, 2009, LANCET, V374, P989, DOI 10.1016/S0140-6736(09)61525-7; Peters RJG, 2003, CIRCULATION, V108, P1682, DOI 10.1161/01.CIR.0000091201.39590.CB; Sabatine MS, 2005, NEW ENGL J MED, V352, P1179, DOI 10.1056/NEJMoa050522; Sabatine MS, 2005, JAMA-J AM MED ASSOC, V294, P1224, DOI 10.1001/jama.294.10.1224; Sacco RL, 2008, NEW ENGL J MED, V359, P1238, DOI 10.1056/NEJMoa0805002; Serebruany VL, 2010, CIRCULATION, V122, pE436, DOI 10.1161/CIRCULATIONAHA.110.936757; Steinhubl SR, 2002, JAMA-J AM MED ASSOC, V288, P2411, DOI 10.1001/jama.288.19.2411; Van de Werf F, 2008, EUR HEART J, V29, P2909, DOI 10.1093/eurheartj/ehn416; WHO, 2000, WHO DRUG INFORM, V14; Williams ET, 2008, DRUG METAB DISPOS, V36, P1227, DOI 10.1124/dmd.107.020248; Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482; Wood D, 2005, HEART, V91, P1, DOI 10.1136/hrt.2005.079988	32	3	3	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 17	2011	342								d3488	10.1136/bmj.d3488	http://dx.doi.org/10.1136/bmj.d3488			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	781LH	21685436				2022-12-24	WOS:000291933200002
J	Raghavan, R; Nuila, R				Raghavan, Rajeev; Nuila, Ricardo			Survivors - Dialysis, Immigration, and U.S. Law	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Raghavan, Rajeev; Nuila, Ricardo] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Raghavan, Rajeev] Baylor Coll Med, Div Nephrol, Houston, TX 77030 USA; [Nuila, Ricardo] Baylor Coll Med, Dept Family & Community Med, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Raghavan, R (corresponding author), Baylor Coll Med, Dept Med, Houston, TX 77030 USA.							Campbell GA, 2010, AM J KIDNEY DIS, V55, P181, DOI 10.1053/j.ajkd.2009.06.039; Goldberg AM, 2007, TRANSPLANTATION, V83, P17, DOI 10.1097/01.tp.0000247795.41898.55; Raghavan R, 2011, DIALYSIS TRANSPLANT, V40, P78, DOI 10.1002/dat.20535; Sheikh-Hamad David, 2007, Tex Med, V103, P54; USRDS, 2008, ANN DAT REP ATL CHRO	5	23	23	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 9	2011	364	23					2183	2185		10.1056/NEJMp1101195	http://dx.doi.org/10.1056/NEJMp1101195			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	774NA	21651391				2022-12-24	WOS:000291392100004
J	Stiopkin, IV; Weeraman, C; Pieniazek, PA; Shalhout, FY; Skinner, JL; Benderskii, AV				Stiopkin, Igor V.; Weeraman, Champika; Pieniazek, Piotr A.; Shalhout, Fadel Y.; Skinner, James L.; Benderskii, Alexander V.			Hydrogen bonding at the water surface revealed by isotopic dilution spectroscopy	NATURE			English	Article							ULTRAFAST INFRARED-SPECTROSCOPY; SUM-FREQUENCY GENERATION; MOLECULAR-DYNAMICS SIMULATIONS; LIQUID WATER; VIBRATIONAL SPECTROSCOPY; LINE-SHAPES; INTERFACE; SPECTRUM; H2O; D2O	The air-water interface is perhaps the most common liquid interface. It covers more than 70 per cent of the Earth's surface and strongly affects atmospheric, aerosol and environmental chemistry. The air-water interface has also attracted much interest as a model system that allows rigorous tests of theory, with one fundamental question being just how thin it is. Theoretical studies have suggested a surprisingly short 'healing length' of about 3 angstroms (1 angstrom = 0.1 nm), with the bulk-phase properties of water recovered within the top few monolayers(1-3). However, direct experimental evidence has been elusive owing to the difficulty of depth-profiling the liquid surface on the angstrom scale. Most physical, chemical and biological properties of water, such as viscosity, solvation, wetting and the hydrophobic effect, are determined by its hydrogen-bond network. This can be probed by observing the lineshape of the OH-stretch mode, the frequency shift of which is related to the hydrogen-bond strength(4-6). Here we report a combined experimental and theoretical study of the air-water interface using surface-selective heterodyne-detected vibrational sum frequency spectroscopy to focus on the 'free OD' transition found only in the topmost water layer. By using deuterated water and isotopic dilution to reveal the vibrational coupling mechanism, we find that the free OD stretch is affected only by intramolecular coupling to the stretching of the other OD group on the same molecule. The other OD stretch frequency indicates the strength of one of the first hydrogen bonds encountered at the surface; this is the donor hydrogen bond of the water molecule straddling the interface, which we find to be only slightly weaker than bulk-phase water hydrogen bonds. We infer from this observation a remarkably fast onset of bulk-phase behaviour on crossing from the air into the water phase.	[Stiopkin, Igor V.; Weeraman, Champika; Shalhout, Fadel Y.; Benderskii, Alexander V.] Wayne State Univ, Dept Chem, Detroit, MI 48202 USA; [Pieniazek, Piotr A.; Skinner, James L.] Univ Wisconsin, Dept Chem, Madison, WI 53705 USA	Wayne State University; University of Wisconsin System; University of Wisconsin Madison	Benderskii, AV (corresponding author), Wayne State Univ, Dept Chem, Detroit, MI 48202 USA.	alex.benderskii@usc.edu			NSF [CHE-0449720, CHE-0750307]; DOE [DE-FG02-09ER16110]	NSF(National Science Foundation (NSF)); DOE(United States Department of Energy (DOE))	The experiments presented here were supported by the NSF CAREER grant number CHE-0449720 (I.V.S., C.W., F.Y.S. and A.V.B.). J.L.S. thanks the NSF and the DOE for support from grants CHE-0750307 and DE-FG02-09ER16110, respectively.	Auer BM, 2009, J PHYS CHEM B, V113, P4125, DOI 10.1021/jp806644x; Auer BM, 2008, J CHEM PHYS, V129, DOI 10.1063/1.3012568; Barker EF, 1935, J CHEM PHYS, V3, P660, DOI 10.1063/1.1749572; Corcelli SA, 2005, J PHYS CHEM A, V109, P6154, DOI 10.1021/jp0506540; Corcelli SA, 2004, J CHEM PHYS, V120, P8107, DOI 10.1063/1.1683072; DU Q, 1994, SCIENCE, V264, P826, DOI 10.1126/science.264.5160.826; DU Q, 1993, PHYS REV LETT, V70, P2313, DOI 10.1103/PhysRevLett.70.2313; Fecko CJ, 2003, SCIENCE, V301, P1698, DOI 10.1126/science.1087251; Gan W, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2179794; Ishiyama T, 2009, J PHYS CHEM C, V113, P16299, DOI 10.1021/jp9060957; Lawrence CP, 2003, CHEM PHYS LETT, V369, P472, DOI 10.1016/S0009-2614(02)02039-0; Lepetit L, 1995, J OPT SOC AM B, V12, P2467, DOI 10.1364/JOSAB.12.002467; Loparo JJ, 2007, CHEM PHYS, V341, P218, DOI 10.1016/j.chemphys.2007.06.056; Max JJ, 2002, J CHEM PHYS, V116, P4626, DOI 10.1063/1.1448286; Morita A, 2000, CHEM PHYS, V258, P371, DOI 10.1016/S0301-0104(00)00127-0; Nagata Y, 2010, J AM CHEM SOC, V132, P6434, DOI 10.1021/ja100508n; Nihonyanagi S, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3135147; Ostroverkhov V, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.046102; Raymond EA, 2003, J PHYS CHEM B, V107, P546, DOI 10.1021/jp021366w; Rey R, 2002, J PHYS CHEM A, V106, P11993, DOI 10.1021/jp026419o; Richmond GL, 2002, CHEM REV, V102, P2693, DOI 10.1021/cr0006876; Shimanouchi T, 1972, TABLES MOL VIBRATION, VI; Skinner JL, 2009, ADV CHEM PHYS, V142, P59, DOI 10.1002/9780470475935.ch2; Sovago M, 2009, CHEM PHYS LETT, V470, P7, DOI 10.1016/j.cplett.2009.01.009; Stiopkin IV, 2008, J AM CHEM SOC, V130, P2271, DOI 10.1021/ja076708w; Stiopkin IV, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3432776; Taylor RS, 1996, J PHYS CHEM-US, V100, P11720, DOI 10.1021/jp960615b; Tian CS, 2009, J AM CHEM SOC, V131, P2790, DOI 10.1021/ja809497y; TOWNSEND RM, 1985, J CHEM PHYS, V82, P4391, DOI 10.1063/1.448808; Woutersen S, 1999, NATURE, V402, P507, DOI 10.1038/990058	30	310	311	7	327	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 9	2011	474	7350					192	195		10.1038/nature10173	http://dx.doi.org/10.1038/nature10173			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774PE	21654801				2022-12-24	WOS:000291397800045
J	Wittner, M; Hamperl, S; Stockl, U; Seufert, W; Tschochner, H; Milkereit, P; Griesenbeck, J				Wittner, Manuel; Hamperl, Stephan; Stoeckl, Ulrike; Seufert, Wolfgang; Tschochner, Herbert; Milkereit, Philipp; Griesenbeck, Joachim			Establishment and Maintenance of Alternative Chromatin States at a Multicopy Gene Locus	CELL			English	Article							RIBOSOMAL-RNA GENES; POLYMERASE-I TRANSCRIPTION; SACCHAROMYCES-CEREVISIAE; CELL-CYCLE; ACTIVE GENES; PROTEIN HMO1; BOX PROTEIN; YEAST; RDNA; UBF	In eukaryotes, each of the more than 100 copies of ribosomal RNA (rRNA) genes exists in either an RNA polymerase I transcribed open chromatin state or a nucleosomal, closed chromatin state. Open rRNA genes guarantee the cell's supply with structural components of the ribosome, whereas closed rRNA genes ensure genomic integrity. We report that the observed balance between open and closed rRNA gene chromatin states in proliferating yeast cells is due to a dynamic equilibrium of transcription-dependent removal and replication-dependent assembly of nucleosomes. Pol I transcription is required for the association of the HMG box protein Hmo1 with open rRNA genes, counteracting replication-independent nucleosome deposition and maintaining the open rRNA gene chromatin state outside of S phase. The findings indicate that the opposing effects of replication and transcription lead to a de novo establishment of chromatin states for rRNA genes during each cell cycle.	[Wittner, Manuel; Hamperl, Stephan; Stoeckl, Ulrike; Tschochner, Herbert; Milkereit, Philipp; Griesenbeck, Joachim] Univ Regensburg, Inst Biochem Genet & Mikrobiol, Lehrstuhl Biochem 3, D-93053 Regensburg, Germany; [Seufert, Wolfgang] Univ Regensburg, Inst Biochem Genet & Mikrobiol, Lehrstuhl Genet, D-93053 Regensburg, Germany	University of Regensburg; University of Regensburg	Milkereit, P (corresponding author), Univ Regensburg, Inst Biochem Genet & Mikrobiol, Lehrstuhl Biochem 3, D-93053 Regensburg, Germany.	philipp.milkereit@vkl.uni-regensburg.de; joachim.griesenbeck@vkl.uni-regensburg.de	Seufert, Wolfgang/F-7136-2019	Seufert, Wolfgang/0000-0001-8938-9064; Griesenbeck, Joachim/0000-0002-7817-6095; Hamperl, Stephan/0000-0002-1658-7948	DFG research unit [FOR 1068]; Elitenetzwerk Bayern	DFG research unit(German Research Foundation (DFG)); Elitenetzwerk Bayern	We would like to thank Drs. M. Nomura and K. Yankulov for providing yeast strains and plasmids. We are grateful to colleagues at the department of Biochemistry III at the University of Regensburg for discussions. We thank Dr. H. Richter for help with flow cytometric analyses. We acknowledge Drs. A. Conconi and A. Ehrensberger for comments on the manuscript. This work was supported by a grant in the context of the DFG research unit FOR 1068 (J.G.). M. W. received a fellowship of the Elitenetzwerk Bayern.	Bermejo R, 2009, CELL, V138, P870, DOI 10.1016/j.cell.2009.06.022; Birch JL, 2008, BIOCHEM SOC T, V36, P619, DOI 10.1042/BST0360619; Birch JL, 2009, EMBO J, V28, P854, DOI 10.1038/emboj.2009.33; Brown SE, 2008, CELL CYCLE, V7, P382, DOI 10.4161/cc.7.3.5283; Cioci F, 2003, MOL CELL, V12, P135, DOI 10.1016/S1097-2765(03)00262-4; Claypool JA, 2004, MOL BIOL CELL, V15, P946, DOI 10.1091/mbc.E03-08-0594; CONCONI A, 1989, CELL, V57, P753, DOI 10.1016/0092-8674(89)90790-3; DAMMANN R, 1995, MOL CELL BIOL, V15, P5294; DAMMANN R, 1993, NUCLEIC ACIDS RES, V21, P2331, DOI 10.1093/nar/21.10.2331; DAVIS AH, 1983, J MOL BIOL, V167, P133, DOI 10.1016/S0022-2836(83)80038-2; Fahy D, 2005, EXP CELL RES, V305, P365, DOI 10.1016/j.yexcr.2005.01.016; French SL, 2003, MOL CELL BIOL, V23, P1558, DOI 10.1128/MCB.23.5.1558-1568.2003; Gadal O, 2002, EMBO J, V21, P5498, DOI 10.1093/emboj/cdf539; Gagnon-Kugler T, 2009, MOL CELL, V35, P414, DOI 10.1016/j.molcel.2009.07.008; GebraneYounes J, 1997, J CELL SCI, V110, P2429; Geil C, 2008, CURR BIOL, V18, P1001, DOI 10.1016/j.cub.2008.06.025; Goetze H, 2010, MOL CELL BIOL, V30, P2028, DOI 10.1128/MCB.01512-09; Ide S, 2010, SCIENCE, V327, P693, DOI 10.1126/science.1179044; Kamau E, 2004, J BIOL CHEM, V279, P55234, DOI 10.1074/jbc.M409459200; Kasahara K, 2007, MOL CELL BIOL, V27, P6686, DOI 10.1128/MCB.00876-07; Keener J, 1998, J BIOL CHEM, V273, P33795, DOI 10.1074/jbc.273.50.33795; Lu J, 1996, J BIOL CHEM, V271, P33678, DOI 10.1074/jbc.271.52.33678; Lucchini R, 2001, EMBO J, V20, P7294, DOI 10.1093/emboj/20.24.7294; LUCCHINI R, 1995, NATURE, V374, P276, DOI 10.1038/374276a0; McStay B, 2008, ANNU REV CELL DEV BI, V24, P131, DOI 10.1146/annurev.cellbio.24.110707.175259; Merz K, 2008, GENE DEV, V22, P1190, DOI 10.1101/gad.466908; MILLER OL, 1969, SCIENCE, V164, P955, DOI 10.1126/science.164.3882.955; MOLL T, 1991, CELL, V66, P743, DOI 10.1016/0092-8674(91)90118-I; Nemeth A, 2008, EPIGENETICS-US, V3, P243, DOI 10.4161/epi.3.5.6913; NOGI Y, 1991, P NATL ACAD SCI USA, V88, P3962, DOI 10.1073/pnas.88.9.3962; O'Sullivan AC, 2002, MOL CELL BIOL, V22, P657, DOI 10.1128/MCB.22.2.657-668.2002; Philippi A, 2010, NUCL ACIDS RES; Raska I, 2004, BIOL CELL, V96, P579, DOI 10.1016/j.biolcel.2004.04.015; Raska I, 2006, CURR OPIN CELL BIOL, V18, P325, DOI 10.1016/j.ceb.2006.04.008; Sanij E, 2008, J CELL BIOL, V183, P1259, DOI 10.1083/jcb.200805146; Schwab M, 1997, CELL, V90, P683, DOI 10.1016/S0092-8674(00)80529-2; Stancheva I, 1997, NUCLEIC ACIDS RES, V25, P1727, DOI 10.1093/nar/25.9.1727; Stefanovsky V, 2006, MOL CELL, V21, P629, DOI 10.1016/j.molcel.2006.01.023; Tan RZ, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.14; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; Yamamoto RT, 1996, EMBO J, V15, P3964, DOI 10.1002/j.1460-2075.1996.tb00770.x	41	55	55	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 13	2011	145	4					543	554		10.1016/j.cell.2011.03.051	http://dx.doi.org/10.1016/j.cell.2011.03.051			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	763MF	21565613	Bronze			2022-12-24	WOS:000290560800008
J	Karakas, E; Simorowski, N; Furukawa, H				Karakas, Erkan; Simorowski, Noriko; Furukawa, Hiro			Subunit arrangement and phenylethanolamine binding in GluN1/GluN2B NMDA receptors	NATURE			English	Article							AMINO-TERMINAL DOMAIN; D-ASPARTATE RECEPTOR; NR2B SUBUNIT; GLUTAMATE RECEPTORS; CRYSTAL-STRUCTURE; IFENPRODIL; MECHANISMS; SOFTWARE; PROTEIN; MODELS	Since it was discovered that the anti-hypertensive agent ifenprodil has neuroprotective activity through its effects on NMDA (N-methyl-D-aspartate) receptors(1), a determined effort has been made to understand the mechanism of action and to develop improved therapeutic compounds on the basis of this knowledge(2-4). Neurotransmission mediated by NMDA receptors is essential for basic brain development and function(5). These receptors form heteromeric ion channels and become activated after concurrent binding of glycine and glutamate to the GluN1 and GluN2 subunits, respectively. A functional hallmark of NMDA receptors is that their ion-channel activity is allosterically regulated by binding of small compounds to the amino-terminal domain (ATD) in a subtype-specific manner. Ifenprodil and related phenylethanolamine compounds, which specifically inhibit GluN1 and GluN2B NMDA receptors(6,7), have been intensely studied for their potential use in the treatment of various neurological disorders and diseases, including depression, Alzheimer's disease and Parkinson's disease(2,4). Despite considerable enthusiasm, mechanisms underlying the recognition of phenylethanolamines and ATD-mediated allosteric inhibition remain limited owing to a lack of structural information. Here we report that the GluN1 and GluN2B ATDs forma heterodimer and that phenylethanolamine binds at the interface between GluN1 and GluN2B, rather than within the GluN2B cleft. The crystal structure of the heterodimer formed between the GluN1b ATD from Xenopus laevis and the GluN2B ATD from Rattus norvegicus shows a highly distinct pattern of subunit arrangement that is different from the arrangements observed in homodimeric non-NMDA receptors and reveals the molecular determinants for phenylethanolamine binding. Restriction of domain movement in the bi-lobed structure of the GluN2B ATD, by engineering of an inter-subunit disulphide bond, markedly decreases sensitivity to ifenprodil, indicating that conformational freedom in the GluN2B ATD is essential for ifenprodil-mediated allosteric inhibition of NMDA receptors. These findings pave the way for improving the design of subtype-specific compounds with therapeutic value for neurological disorders and diseases.	[Karakas, Erkan; Simorowski, Noriko; Furukawa, Hiro] WM Keck Struct Biol Lab, Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory	Furukawa, H (corresponding author), WM Keck Struct Biol Lab, Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	furukawa@cshl.edu			NIH [MH085926]; Alzheimer's Association; Fox family; NARSAD; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH085926] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association(Alzheimer's Association); Fox family; NARSAD(NARSAD); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank the staff at X25 and X29 at the National Synchrotron Light Source for beamline support. M. Mayer is thanked for comments on this work. We also thank D. Raleigh for the use of analytical ultracentrifugation. GluN1 clones from Xenopus laevis were gifts from M. Hollmann and H. Cline. This work was supported by NIH MH085926, the Alzheimer's Association and a donation from the Fox family (to H.F.). H.F. was also funded by a scientist development grant from the American Heart Association. E.K. is supported by a NARSAD Lieber Young Investigator Award.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Clayton A, 2009, J MOL BIOL, V392, P1125, DOI 10.1016/j.jmb.2009.07.082; Cohen SX, 2004, ACTA CRYSTALLOGR D, V60, P2222, DOI 10.1107/S0907444904027556; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ewald RC, 2009, FRONT MOL NEUROSCI, V2, DOI 10.3389/neuro.02.004.2009; Fitzgerald DJ, 2006, NAT METHODS, V3, P1021, DOI 10.1038/nmeth983; Furukawa H, 2005, NATURE, V438, P185, DOI 10.1038/nature04089; Gallagher MJ, 1996, J BIOL CHEM, V271, P9603, DOI 10.1074/jbc.271.16.9603; Gielen M, 2009, NATURE, V459, P703, DOI 10.1038/nature07993; GOTTI B, 1988, J PHARMACOL EXP THER, V247, P1211; Hansen KB, 2010, MOL PHARMACOL, V78, P535, DOI 10.1124/mol.110.067157; Jin RS, 2009, EMBO J, V28, P1812, DOI 10.1038/emboj.2009.140; Karakas E, 2009, EMBO J, V28, P3910, DOI 10.1038/emboj.2009.338; Koller M, 2010, EXPERT OPIN THER PAT, V20, P1683, DOI 10.1517/13543776.2010.533656; Kumar J, 2009, NAT STRUCT MOL BIOL, V16, P631, DOI 10.1038/nsmb.1613; Lee C. H., 2011, PLOS ONE, V6, pe19181; Malherbe P, 2003, J PHARMACOL EXP THER, V307, P897, DOI 10.1124/jpet.103.056291; Masuko T, 1999, MOL PHARMACOL, V55, P957, DOI 10.1124/mol.55.6.957; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mony L, 2009, BRIT J PHARMACOL, V157, P1301, DOI 10.1111/j.1476-5381.2009.00304.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perin-Dureau F, 2002, J NEUROSCI, V22, P5955; Rachline J, 2005, J NEUROSCI, V25, P308, DOI 10.1523/JNEUROSCI.3967-04.2005; Schmidt C, 2009, MOL CELL NEUROSCI, V42, P116, DOI 10.1016/j.mcn.2009.06.004; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; WILLIAMS K, 1993, MOL PHARMACOL, V44, P851	29	247	255	1	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 14	2011	475	7355					249	U170		10.1038/nature10180	http://dx.doi.org/10.1038/nature10180			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791UA	21677647	Green Accepted			2022-12-24	WOS:000292690500055
J	Kozlov, AS; Baumgart, J; Risler, T; Versteegh, CPC; Hudspeth, AJ				Kozlov, Andrei S.; Baumgart, Johannes; Risler, Thomas; Versteegh, Corstiaen P. C.; Hudspeth, A. J.			Forces between clustered stereocilia minimize friction in the ear on a subnanometre scale	NATURE			English	Article							HAIR CELL STEREOCILIA; TRANSDUCTION CHANNELS; MECHANICAL AMPLIFICATION; COHERENT MOTION; BUNDLE; MEMBRANE	The detection of sound begins when energy derived from an acoustic stimulus deflects the hair bundles on top of hair cells(1). As hair bundles move, the viscous friction between stereocilia and the surrounding liquid poses a fundamental physical challenge to the ear's high sensitivity and sharp frequency selectivity. Part of the solution to this problem lies in the active process that uses energy for frequency-selective sound amplification(2,3). Here we demonstrate that a complementary part of the solution involves the fluid-structure interaction between the liquid within the hair bundle and the stereocilia. Using force measurement on a dynamically scaled model, finite-element analysis, analytical estimation of hydrodynamic forces, stochastic simulation and high-resolution interferometric measurement of hair bundles, we characterize the origin and magnitude of the forces between individual stereocilia during small hair-bundle deflections. We find that the close apposition of stereocilia effectively immobilizes the liquid between them, which reduces the drag and suppresses the relative squeezing but not the sliding mode of stereociliary motion. The obliquely oriented tip links couple the mechanotransduction channels to this least dissipative coherent mode, whereas the elastic horizontal top connectors that stabilize the structure further reduce the drag. As measured from the distortion products associated with channel gating at physiological stimulation amplitudes of tens of nanometres, the balance of viscous and elastic forces in a hair bundle permits a relative mode of motion between adjacent stereocilia that encompasses only a fraction of a nanometre. A combination of high-resolution experiments and detailed numerical modelling of fluid-structure interactions reveals the physical principles behind the basic structural features of hair bundles and shows quantitatively how these organelles are adapted to the needs of sensitive mechanotransduction.	[Kozlov, Andrei S.; Versteegh, Corstiaen P. C.; Hudspeth, A. J.] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA; [Kozlov, Andrei S.; Versteegh, Corstiaen P. C.; Hudspeth, A. J.] Rockefeller Univ, Lab Sensory Neurosci, New York, NY 10065 USA; [Baumgart, Johannes] Tech Univ Dresden, Dept Math, Inst Comp Sci, D-01062 Dresden, Germany; [Risler, Thomas] Inst Curie, Ctr Rech, F-75005 Paris, France; [Risler, Thomas] Univ Paris 06, UMR 168, F-75005 Paris, France; [Risler, Thomas] CNRS, UMR 168, F-75005 Paris, France; [Versteegh, Corstiaen P. C.] Wageningen Univ, Expt Zool Grp, NL-6709 PG Wageningen, Netherlands	Howard Hughes Medical Institute; Rockefeller University; Rockefeller University; Technische Universitat Dresden; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; UNICANCER; Institut Curie; Wageningen University & Research	Hudspeth, AJ (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, 1230 York Ave, New York, NY 10065 USA.	hudspaj@rockefeller.edu	Baumgart, Johannes/A-8547-2011; Risler, Thomas/E-6943-2011	Baumgart, Johannes/0000-0001-7384-5715; Risler, Thomas/0000-0003-1677-4636	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [F32DC000241, R01DC000241] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIDCD NIH HHS [F32 DC000241, R01 DC000241, DC000241, R01 DC000241-30] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Batchelor G. K., 2000, INTRO FLUID DYNAMICS, P353; BROERSMA S, 1981, J CHEM PHYS, V74, P6989, DOI 10.1063/1.441071; Cotton J, 2004, HEARING RES, V197, P105, DOI 10.1016/j.heares.2004.06.005; DENK W, 1989, P NATL ACAD SCI USA, V86, P5371, DOI 10.1073/pnas.86.14.5371; HOWARD J, 1988, NEURON, V1, P189, DOI 10.1016/0896-6273(88)90139-0; Hudspeth AJ, 2008, NEURON, V59, P530, DOI 10.1016/j.neuron.2008.07.012; Hudspeth AJ, 2010, J NEUROPHYSIOL, V104, P1219, DOI 10.1152/jn.00437.2010; HUDSPETH AJ, 1989, NATURE, V341, P397, DOI 10.1038/341397a0; JARAMILLO F, 1993, NATURE, V364, P527, DOI 10.1038/364527a0; Karavitaki KD, 2010, J NEUROSCI, V30, P9051, DOI 10.1523/JNEUROSCI.4864-09.2010; Kozlov AS, 2007, NAT NEUROSCI, V10, P87, DOI 10.1038/nn1818; Martin P, 2000, P NATL ACAD SCI USA, V97, P12026, DOI 10.1073/pnas.210389497; NEUGEBAUER DC, 1987, CELL TISSUE RES, V249, P199, DOI 10.1007/BF00215434; Perrin F, 1934, J PHYS-PARIS, V5, P497, DOI 10.1051/jphysrad:01934005010049700; PICKLES JO, 1993, HEARING RES, V68, P159, DOI 10.1016/0378-5955(93)90120-P; Stokes G. G., 1850, T CAMBRIDGE PHILOS S, V9, P1; Tamada K., 1957, Q J MECH APPL MATH, V10, P425, DOI DOI 10.1093/QJMAM/10.4.425; Verpy E, 2011, J COMP NEUROL, V519, P194, DOI 10.1002/cne.22509; Yeom J, 2009, J MICROMECH MICROENG, V19, DOI 10.1088/0960-1317/19/6/065025	19	51	51	1	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 16	2011	474	7351					376	379		10.1038/nature10073	http://dx.doi.org/10.1038/nature10073			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777TD	21602823	Green Accepted, Green Submitted			2022-12-24	WOS:000291647100045
J	Dorner, M; Horwitz, JA; Robbins, JB; Barry, WT; Feng, Q; Mu, K; Jones, CT; Schoggins, JW; Catanese, MT; Burton, DR; Law, M; Rice, CM; Ploss, A				Dorner, Marcus; Horwitz, Joshua A.; Robbins, Justin B.; Barry, Walter T.; Feng, Qian; Mu, Kathy; Jones, Christopher T.; Schoggins, John W.; Catanese, Maria Teresa; Burton, Dennis R.; Law, Mansun; Rice, Charles M.; Ploss, Alexander			A genetically humanized mouse model for hepatitis C virus infection	NATURE			English	Article							B TYPE-I; HUMAN LIVER; REPLICATION; RECEPTOR; ANTIBODIES; FIBROBLASTS; REVEALS; VITRO; MICE; CD81	Hepatitis C virus (HCV) remains a major medical problem. Antiviral treatment is only partially effective and a vaccine does not exist. Development of more effective therapies has been hampered by the lack of a suitable small animal model. Although xenotransplantation of immunodeficient mice with human hepatocytes has shown promise, these models are subject to important challenges. Building on the previous observation that CD81 and occludin comprise the minimal human factors required to render mouse cells permissive to HCV entry in vitro(4), we attempted murine humanization via a genetic approach. Here we show that expression of two human genes is sufficient to allow HCV infection of fully immunocompetent inbred mice. We establish a precedent for applying mouse genetics to dissect viral entry and validate the role of scavenger receptor type B class I for HCV uptake. We demonstrate that HCV can be blocked by passive immunization, as well as showing that a recombinant vaccinia virus vector induces humoral immunity and confers partial protection against heterologous challenge. This system recapitulates a portion of the HCV life cycle in an immunocompetent rodent for the first time, opening opportunities for studying viral pathogenesis and immunity and comprising an effective platform for testing HCV entry inhibitors in vivo.	[Dorner, Marcus; Horwitz, Joshua A.; Barry, Walter T.; Feng, Qian; Mu, Kathy; Jones, Christopher T.; Schoggins, John W.; Catanese, Maria Teresa; Rice, Charles M.; Ploss, Alexander] Rockefeller Univ, Ctr Study Hepatitis C, New York, NY 10021 USA; [Robbins, Justin B.; Burton, Dennis R.; Law, Mansun] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Burton, Dennis R.] Scripps Res Inst, IAVI Neutralizing Antibody Ctr, La Jolla, CA 92037 USA; [Burton, Dennis R.] Ragon Inst MGH MIT & Harvard, Boston, MA 02129 USA	Rockefeller University; Scripps Research Institute; International AIDS Vaccine Initiative; Scripps Research Institute; Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute	Ploss, A (corresponding author), Rockefeller Univ, Ctr Study Hepatitis C, 1230 York Ave, New York, NY 10021 USA.	aploss@rockefeller.edu	Feng, Qian/AAL-4323-2020; Ploss, Alexander/ABG-2330-2020	Ploss, Alexander/0000-0001-9322-7252; Law, Mansun/0000-0002-8934-9756; Dorner, Marcus/0000-0003-0321-4226; Dorner, Marcus/0000-0001-7936-1527	National Institute of Diabetes and Digestive and Kidney Diseases [RC1DK087193]; National Institute for Allergy and Infectious Disease [R01AI072613, R01AI079031, R01AI071084]; Starr Foundation; Greenberg Medical Institute; German Research Foundation (Deutsche Forschungsgesellschaft); Rockefeller University; National Institute of Health [F32DK082155, F32DK081193]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079031, R01AI071084, R01AI072613] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK081193, R01DK085713, RC1DK087193, F32DK082155] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute for Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Starr Foundation; Greenberg Medical Institute; German Research Foundation (Deutsche Forschungsgesellschaft)(German Research Foundation (DFG)); Rockefeller University; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank J. Sable, E. Castillo, A. Forrest, M. Panis, S. Pouzol, S. Shirley, A. Webson and E. Giang for laboratory support, L. Chiriboga and H. Yee for technical assistance, J. Bukh and Apath, LLC for providing the prototype intergenotypic HCV chimaeras and C. Murray for editing the manuscript. This study was supported in part by award number RC1DK087193 (to C.M.R. and A.P.) from the National Institute of Diabetes and Digestive and Kidney Diseases, R01AI072613 (to C.M.R.), R01AI079031 (to M.L.) and R01AI071084 (to D.R.B.) from the National Institute for Allergy and Infectious Disease, The Starr Foundation and the Greenberg Medical Institute. M.D. was supported by a postdoctoral fellowship from the German Research Foundation (Deutsche Forschungsgesellschaft) and M.T.C. by funds from The Rockefeller University's Women & Science Fellowship Program. J.W.S. and C.T.J are recipients of Ruth L. Kirschstein National Research Service Awards from the National Institute of Health (F32DK082155 to J.W.S., F32DK081193 to C.T.J.).	Awatramani R, 2001, NAT GENET, V29, P257, DOI 10.1038/ng1101-257; Bissig KD, 2010, J CLIN INVEST, V120, P924, DOI 10.1172/JCI40094; Catanese MT, 2007, J VIROL, V81, P8063, DOI 10.1128/JVI.00193-07; Chang KS, 2006, J VIROL, V80, P7364, DOI 10.1128/JVI.00586-06; Cooper S, 1999, IMMUNITY, V10, P439, DOI 10.1016/S1074-7613(00)80044-8; de Jong YP, 2010, J CLIN INVEST, V120, P650, DOI 10.1172/JCI42338; Evans MJ, 2007, NATURE, V446, P801, DOI 10.1038/nature05654; Flint M, 1999, J VIROL, V73, P6235, DOI 10.1128/JVI.73.8.6235-6244.1999; Gottwein JM, 2009, HEPATOLOGY, V49, P364, DOI 10.1002/hep.22673; Higginbottom A, 2000, J VIROL, V74, P3642, DOI 10.1128/JVI.74.8.3642-3649.2000; Jones CT, 2010, NAT BIOTECHNOL, V28, P167, DOI 10.1038/nbt.1604; Law M, 2008, NAT MED, V14, P25, DOI 10.1038/nm1698; Law Mansun, 2004, Methods Mol Biol, V269, P187; Liang YQ, 2009, GASTROENTEROLOGY, V137, P1448, DOI 10.1053/j.gastro.2009.07.050; Lin LT, 2010, J VIROL, V84, P9170, DOI 10.1128/JVI.00559-10; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Marukian S, 2008, HEPATOLOGY, V48, P1843, DOI 10.1002/hep.22550; McCaffrey AP, 2002, MOL THER, V5, P676, DOI 10.1006/mthe.2002.0600; Mercer DF, 2001, NAT MED, V7, P927, DOI 10.1038/90968; Meuleman P, 2005, HEPATOLOGY, V41, P847, DOI 10.1002/hep.20657; Meuleman P, 2008, HEPATOLOGY, V48, P1761, DOI 10.1002/hep.22547; Pileri P, 1998, SCIENCE, V282, P938, DOI 10.1126/science.282.5390.938; Ploss A, 2010, P NATL ACAD SCI USA, V107, P3141, DOI 10.1073/pnas.0915130107; Ploss A, 2009, NATURE, V457, P882, DOI 10.1038/nature07684; RALSTON R, 1993, J VIROL, V67, P6753, DOI 10.1128/JVI.67.11.6753-6761.1993; Rigotti A, 1997, P NATL ACAD SCI USA, V94, P12610, DOI 10.1073/pnas.94.23.12610; Safran Michal, 2003, Mol Imaging, V2, P297, DOI 10.1162/153535003322750637; Scarselli E, 2002, EMBO J, V21, P5017, DOI 10.1093/emboj/cdf529; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Schoggins JW, 2003, J VIROL, V77, P1039, DOI 10.1128/JVI.77.2.1039-1048.2003; Selby M, 1999, J IMMUNOL, V162, P669; Stoller JZ, 2008, GENESIS, V46, P200, DOI 10.1002/dvg.20384; Uprichard SL, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-89; Youn JW, 2008, J VIROL, V82, P10896, DOI 10.1128/JVI.01179-08; Zhu Q, 2003, J VIROL, V77, P9204, DOI 10.1128/JVI.77.17.9204-9210.2003	35	283	305	0	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 9	2011	474	7350					208	U246		10.1038/nature10168	http://dx.doi.org/10.1038/nature10168			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774PE	21654804	Green Accepted, Green Submitted			2022-12-24	WOS:000291397800049
J	Mukherjee, T; Kim, WS; Mandal, L; Banerjee, U				Mukherjee, Tina; Kim, William Sang; Mandal, Lolitika; Banerjee, Utpal			Interaction Between Notch and Hif-alpha in Development and Survival of Drosophila Blood Cells	SCIENCE			English	Article							HYPOXIA; HIF-1-ALPHA; SPECIFICATION; REQUIRES; PATHWAY; LINEAGE	A blood cell type termed crystal cell in Drosophila functions in clotting and wound healing and requires Notch for specification and maintenance. We report that crystal cells express elevated levels of Sima protein orthologous to mammalian hypoxia-inducible factor-alpha (Hif-alpha) even under conditions of normal oxygen availability. In these platelet-like crystal cells, Sima activates full-length Notch receptor signaling via a noncanonical, ligand-independent mechanism that promotes hemocyte survival during both normal hematopoietic development and hypoxic stress. This interaction initiates in early endosomes, is independent of Hif-beta (Tango in Drosophila), and does not activate hypoxia response targets. Studies in vertebrate myeloid cells have shown a similar up-regulation of Hif-alpha protein in well-oxygenated environments. This study provides a mechanistic paradigm for Hif-alpha/Notch interaction that may be conserved in mammals.	[Mukherjee, Tina; Kim, William Sang; Mandal, Lolitika; Banerjee, Utpal] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; [Banerjee, Utpal] Univ Calif Los Angeles, Dept Biol Chem, Inst Mol Biol, Los Angeles, CA 90095 USA; [Banerjee, Utpal] Univ Calif Los Angeles, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Banerjee, U (corresponding author), Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA.	banerjee@mbi.ucla.edu			NIH [R01HL067395]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067395] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank H. Bellen, C. Frei, S. Artavanis-Tsakonas, C. Delidakis, M. Guo, M. Regulski, B. Shilo, G. Struhl, P. Wappner, National Institute of Genetics, Vienna Drosophila RNAi Center, Flybase, and Bloomington for reagents and D. Walker, G. Weinmaster, and C. Evans for helpful discussion. Supported by NIH grant R01HL067395.	Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Bacon NCM, 1998, BIOCHEM BIOPH RES CO, V249, P811, DOI 10.1006/bbrc.1998.9234; Bidla G, 2007, J CELL SCI, V120, P1209, DOI 10.1242/jcs.03420; Centanin L, 2005, EMBO REP, V6, P1070, DOI 10.1038/sj.embor.7400528; Cramer T, 2003, CELL, V112, P645, DOI 10.1016/S0092-8674(03)00154-5; Duvic B, 2002, CURR BIOL, V12, P1923, DOI 10.1016/S0960-9822(02)01297-6; Evans CJ, 2003, DEV CELL, V5, P673, DOI 10.1016/S1534-5807(03)00335-6; Gerald D, 2004, CELL, V118, P781, DOI 10.1016/j.cell.2004.08.025; Gustafsson MV, 2005, DEV CELL, V9, P617, DOI 10.1016/j.devcel.2005.09.010; Hansson EM, 2004, SEMIN CANCER BIOL, V14, P320, DOI 10.1016/j.semcancer.2004.04.011; Jaekel R, 2006, DEV CELL, V11, P655, DOI 10.1016/j.devcel.2006.09.019; Jung SH, 2005, DEVELOPMENT, V132, P2521, DOI 10.1242/dev.01837; Kasivisvanathan V, 2011, CURR VASC PHARMACOL, V9, P333, DOI 10.2174/157016111795495602; Lavista-Llanos S, 2002, MOL CELL BIOL, V22, P6842, DOI 10.1128/MCB.22.19.6842-6853.2002; Lebestky T, 2003, GENE DEV, V17, P348, DOI 10.1101/gad.1052803; Lebestky T, 2000, SCIENCE, V288, P146, DOI 10.1126/science.288.5463.146; Li F, 2007, MOL CELL, V26, P63, DOI 10.1016/j.molcel.2007.02.024; MacDonald HR, 2001, TRENDS IMMUNOL, V22, P155; Markus R, 2009, P NATL ACAD SCI USA, V106, P4805, DOI 10.1073/pnas.0801766106; Moberg KH, 2005, DEV CELL, V9, P699, DOI 10.1016/j.devcel.2005.09.018; Nakamura H, 2005, J IMMUNOL, V174, P7592, DOI 10.4049/jimmunol.174.12.7592; Okajima T, 2003, J BIOL CHEM, V278, P42340, DOI 10.1074/jbc.M308687200; Owusu-Ansah E, 2009, NATURE, V461, P537, DOI 10.1038/nature08313; Panin VM, 1997, NATURE, V387, P908, DOI 10.1038/43191; Pitsouli C, 2005, DEVELOPMENT, V132, P4041, DOI 10.1242/dev.01979; Rizki R. R., 1981, GENETICS, V97, ps90; RIZKI TM, 1980, ROUX ARCH DEV BIOL, V188, P91, DOI 10.1007/BF00848799; Sandau KB, 2001, BLOOD, V97, P1009, DOI 10.1182/blood.V97.4.1009; Schofield CJ, 2005, BIOCHEM BIOPH RES CO, V338, P617, DOI 10.1016/j.bbrc.2005.08.111; Struhl G, 2001, P NATL ACAD SCI USA, V98, P229, DOI 10.1073/pnas.011530298; Vaccari T, 2005, DEV CELL, V9, P687, DOI 10.1016/j.devcel.2005.09.019; Wang WD, 2005, DEVELOPMENT, V132, P2883, DOI 10.1242/dev.01860	32	128	129	1	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 3	2011	332	6034					1210	1213		10.1126/science.1199643	http://dx.doi.org/10.1126/science.1199643			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	772BO	21636775	Green Accepted			2022-12-24	WOS:000291205200051
J	Black, ME				Black, Mary E.			THE BIGGER PICTURE Four burials and a funeral	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 25	2011	342								d3241	10.1136/bmj.d3241	http://dx.doi.org/10.1136/bmj.d3241			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	771KE	21613364				2022-12-24	WOS:000291154800009
J	Decramer, M				Decramer, Marc		European Resp Roadmap Initiative	The European Respiratory Roadmap	LANCET			English	Editorial Material									[Decramer, Marc; European Resp Roadmap Initiative] Katholieke Univ Leuven, Div Resp, B-3000 Louvain, Belgium	KU Leuven	Decramer, M (corresponding author), Katholieke Univ Leuven, Div Resp, B-3000 Louvain, Belgium.	Marc.Decramer@uzleuven.be		Nicod, Laurent P/0000-0002-0905-916X				[Anonymous], 2011, SMOK FREE LEG EU; Christensen CM, 2000, HARVARD BUS REV, V78, P102; Christensen K, 2009, LANCET, V374, P1196, DOI 10.1016/S0140-6736(09)61460-4; *EUR COMM, 2009, SURV TOB AN REP; Gerkens S, 2010, HEALT SYST TRANSIT, V12, P1; Jemal A, 2005, JAMA-J AM MED ASSOC, V294, P1255, DOI 10.1001/jama.294.10.1255; K Neubauer, 2010, INVESTING EUROPES HL; Kamel N, 2008, EUR RESPIR J, V31, P924, DOI 10.1183/09031936.00033208; Kane RL, 2007, MED CARE, V45, P1195, DOI 10.1097/MLR.0b013e3181468ca3; La Parra D, 2008, AGEING SOC, V28, P85, DOI 10.1017/S0144686X07006563; Loddenkemper R, 2008, EUR RESPIR J, V32, P538, DOI 10.1183/09031936.00090908; Oberg M, 2011, LANCET, V377, P139, DOI 10.1016/S0140-6736(10)61388-8; World Health Organization, WORLD HLTH STAT 2008	13	4	4	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 19	2011	378	9805					1765	1767		10.1016/S0140-6736(11)60619-3	http://dx.doi.org/10.1016/S0140-6736(11)60619-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	851IS	21703674				2022-12-24	WOS:000297262300010
J	Delebecque, CJ; Lindner, AB; Silver, PA; Aldaye, FA				Delebecque, Camille J.; Lindner, Ariel B.; Silver, Pamela A.; Aldaye, Faisal A.			Organization of Intracellular Reactions with Rationally Designed RNA Assemblies	SCIENCE			English	Article							DNA	The rules of nucleic acid base-pairing have been used to construct nanoscale architectures and organize biomolecules, but little has been done to apply this technology in vivo. We designed and assembled multidimensional RNA structures and used them as scaffolds for the spatial organization of bacterial metabolism. Engineered RNA modules were assembled into discrete, one-dimensional, and two-dimensional scaffolds with distinct protein-docking sites and used to control the spatial organization of a hydrogen-producing pathway. We increased hydrogen output as a function of scaffold architecture. Rationally designed RNA assemblies can thus be used to construct functional architectures in vivo.	[Delebecque, Camille J.; Lindner, Ariel B.] INSERM, U1001, F-75015 Paris, France; [Delebecque, Camille J.; Silver, Pamela A.; Aldaye, Faisal A.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Delebecque, Camille J.; Silver, Pamela A.; Aldaye, Faisal A.] Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA; [Delebecque, Camille J.; Lindner, Ariel B.] Paris Descartes Univ, Fac Med, F-75015 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Harvard University; Harvard Medical School; UDICE-French Research Universities; Universite Paris Cite	Lindner, AB (corresponding author), INSERM, U1001, F-75015 Paris, France.	ariel.lindner@inserm.fr; pamela_silver@hms.harvard.edu	Lindner, Ariel B/I-8503-2016; Lindner, Ariel/K-9247-2019	Lindner, Ariel B/0000-0001-5015-6511; Lindner, Ariel/0000-0001-5015-6511	Enerbio-Tuck Foundation; Institut Francais du Petrole Energies Nouvelles; Agence Nationale de la Recherche France; Institut National de la Sante et de la Recherche Medicale-Institut National de Recherche en Informatique et en Automatique projet d'envergure; Axa Foundation Chair on Longevity; Natural Sciences and Engineering Research Council of Canada; Wyss Institute for Biologically Inspired Engineering	Enerbio-Tuck Foundation; Institut Francais du Petrole Energies Nouvelles; Agence Nationale de la Recherche France(French National Research Agency (ANR)); Institut National de la Sante et de la Recherche Medicale-Institut National de Recherche en Informatique et en Automatique projet d'envergure; Axa Foundation Chair on Longevity(AXA Research Fund); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Wyss Institute for Biologically Inspired Engineering	This work was supported by from the Enerbio-Tuck Foundation and the Institut Francais du Petrole Energies Nouvelles (to C.J.D.); Agence Nationale de la Recherche France, Institut National de la Sante et de la Recherche Medicale-Institut National de Recherche en Informatique et en Automatique projet d'envergure, and Axa Foundation Chair on Longevity (to A. B. L.); Natural Sciences and Engineering Research Council of Canada (to F. A. A.); and the Wyss Institute for Biologically Inspired Engineering. We thank the Harvard Medical School Electron Microscopy Center for assistance in electron microscopy, and we thank the reviewers for their insight.	Barstow B, 2011, J BIOL ENG, V5, DOI 10.1186/1754-1611-5-7; Burack WR, 2000, CURR OPIN CELL BIOL, V12, P211, DOI 10.1016/S0955-0674(99)00078-2; Cayrol B, 2009, J AM CHEM SOC, V131, P17270, DOI 10.1021/ja906076e; Diestra E, 2009, J STRUCT BIOL, V165, P157, DOI 10.1016/j.jsb.2008.11.009; Dueber JE, 2009, NAT BIOTECHNOL, V27, P753, DOI 10.1038/nbt.1557; Guo PX, 2010, NAT NANOTECHNOL, V5, P833, DOI [10.1038/nnano.2010.231, 10.1038/NNANO.2010.231]; Isaacs FJ, 2006, NAT BIOTECHNOL, V24, P545, DOI 10.1038/nbt1208; Jaeger L, 2006, CURR OPIN STRUC BIOL, V16, P531, DOI 10.1016/j.sbi.2006.07.001; Lin C, 2009, BIOCHEMISTRY-US, V48, P1663, DOI 10.1021/bi802324w; Lin CX, 2008, P NATL ACAD SCI USA, V105, P17626, DOI 10.1073/pnas.0805416105; Liu HP, 2006, ANGEW CHEM INT EDIT, V45, P1942, DOI 10.1002/anie.200504022; Liu HP, 2005, BIOMACROMOLECULES, V6, P2943, DOI 10.1021/bm050632j; Park SH, 2003, SCIENCE, V299, P1061, DOI 10.1126/science.1076979; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; Savage DF, 2010, SCIENCE, V327, P1258, DOI 10.1126/science.1186090; Seeman NC, 2010, ANNU REV BIOCHEM, V79, P65, DOI 10.1146/annurev-biochem-060308-102244; Win MN, 2008, SCIENCE, V322, P456, DOI 10.1126/science.1160311; Winfree E, 1998, NATURE, V394, P539, DOI 10.1038/28998; Yin P, 2008, NATURE, V451, P318, DOI 10.1038/nature06451	19	454	489	7	278	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 22	2011	333	6041					470	474		10.1126/science.1206938	http://dx.doi.org/10.1126/science.1206938			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	795FR	21700839				2022-12-24	WOS:000292959600051
J	Cortellino, S; Xu, JF; Sannai, M; Moore, R; Caretti, E; Cigliano, A; Le Coz, M; Devarajan, K; Wessels, A; Soprano, D; Abramowitz, LK; Bartolomei, MS; Rambow, F; Bassi, MR; Bruno, T; Fanciulli, M; Renner, C; Klein-Szanto, AJ; Matsumoto, Y; Kobi, D; Davidson, I; Alberti, C; Larue, L; Bellacosa, A				Cortellino, Salvatore; Xu, Jinfei; Sannai, Mara; Moore, Robert; Caretti, Elena; Cigliano, Antonio; Le Coz, Madeleine; Devarajan, Karthik; Wessels, Andy; Soprano, Dianne; Abramowitz, Lara K.; Bartolomei, Marisa S.; Rambow, Florian; Bassi, Maria Rosaria; Bruno, Tiziana; Fanciulli, Maurizio; Renner, Catherine; Klein-Szanto, Andres J.; Matsumoto, Yoshihiro; Kobi, Dominique; Davidson, Irwin; Alberti, Christophe; Larue, Lionel; Bellacosa, Alfonso			Thymine DNA Glycosylase Is Essential for Active DNA Demethylation by Linked Deamination-Base Excision Repair	CELL			English	Article							MAMMALIAN DEVELOPMENT; EMBRYONIC LETHALITY; CANCER EPIGENETICS; PATERNAL GENOME; AID DEFICIENCY; METHYLATION; TRANSCRIPTION; 5-METHYLCYTOSINE; ACTIVATION; RECEPTORS	DNA methylation is a major epigenetic mechanism for gene silencing. Whereas methyltransferases mediate cytosine methylation, it is less clear how unmethylated regions in mammalian genomes are protected from de novo methylation and whether an active demethylating activity is involved. Here, we show that either knockout or catalytic inactivation of the DNA repair enzyme thymine DNA glycosylase (TDG) leads to embryonic lethality in mice. TDG is necessary for recruiting p300 to retinoic acid (RA)-regulated promoters, protection of CpG islands from hypermethylation, and active demethylation of tissue-specific developmentally and hormonally regulated promoters and enhancers. TDG interacts with the deaminase AID and the damage response protein GADD45a. These findings highlight a dual role for TDG in promoting proper epigenetic states during development and suggest a two-step mechanism for DNA demethylation in mammals, whereby 5-methylcytosine and 5-hydroxymethylcytosine are first deaminated by AID to thymine and 5-hydroxymethyluracil, respectively, followed by TDG-mediated thymine and 5-hydroxymethyluracil excision repair.	[Cortellino, Salvatore; Xu, Jinfei; Sannai, Mara; Moore, Robert; Caretti, Elena; Cigliano, Antonio; Le Coz, Madeleine; Bassi, Maria Rosaria; Bellacosa, Alfonso] Fox Chase Canc Ctr, Canc Biol Program, Philadelphia, PA 19111 USA; [Cortellino, Salvatore; Xu, Jinfei; Sannai, Mara; Moore, Robert; Caretti, Elena; Cigliano, Antonio; Le Coz, Madeleine; Bassi, Maria Rosaria; Bellacosa, Alfonso] Fox Chase Canc Ctr, Epigenet & Progenitor Cells Keystone Program, Philadelphia, PA 19111 USA; [Devarajan, Karthik] Fox Chase Canc Ctr, Dept Biostat, Philadelphia, PA 19111 USA; [Renner, Catherine; Klein-Szanto, Andres J.] Fox Chase Canc Ctr, Dept Pathol, Philadelphia, PA 19111 USA; [Wessels, Andy] Med Univ S Carolina, Dept Cell Biol & Anat, Charleston, SC 29425 USA; [Soprano, Dianne] Temple Univ, Sch Med, Dept Biochem, Philadelphia, PA 19140 USA; [Abramowitz, Lara K.; Bartolomei, Marisa S.] Univ Penn, Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; [Rambow, Florian; Alberti, Christophe; Larue, Lionel] Inst Curie, Ctr Rech, F-91405 Orsay, France; [Rambow, Florian; Alberti, Christophe; Larue, Lionel] CNRS, INSERM, U1021, UMR3347, F-91405 Orsay, France; [Bruno, Tiziana; Fanciulli, Maurizio] Regina Elena Canc Ctr, I-00158 Rome, Italy; [Matsumoto, Yoshihiro] E Stroudsburg Univ, Dept Biol Sci, E Stroudsburg, PA 18301 USA; [Kobi, Dominique; Davidson, Irwin] CNRS INSERM ULP, Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, France	Fox Chase Cancer Center; Fox Chase Cancer Center; Fox Chase Cancer Center; Fox Chase Cancer Center; Medical University of South Carolina; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Pennsylvania; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Saclay; Pennsylvania State System of Higher Education (PASSHE); East Stroudsburg University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Bellacosa, A (corresponding author), Fox Chase Canc Ctr, Canc Biol Program, Philadelphia, PA 19111 USA.	alfonso.bellacosa@fccc.edu	Cigliano, Antonio/J-4660-2017; Cortellino, Salvatore/AAH-8857-2019; Larue, Lionel/F-7355-2013; Larue, Lionel/I-6532-2016; Cortellino, Salvatore/GPW-6929-2022; bruno, tiziana/AAC-4913-2022; fanciulli, maurizio/ABH-6745-2020; cigliano, antonio/J-1836-2015	Cigliano, Antonio/0000-0002-6408-3613; bruno, tiziana/0000-0003-0352-4523; Bassi, Maria Rosaria/0000-0001-6736-6152; Davidson, Irwin/0000-0001-5533-1171; CORTELLINO, Salvatore/0000-0001-8331-3800; Matsumoto, Yoshihiro/0000-0001-6580-7188; Le Coz, Madeleine/0000-0003-4932-1342; rambow, florian/0000-0002-9727-8986	NIH [CA78412, CA06927, DK067558, T32GM008216]; Commonwealth of Pennsylvania; Italian Association for Cancer Research (AIRC); American-Italian Cancer Foundation; Epigenetics and Progenitor Cells Keystone Program Fellowship; NATIONAL CANCER INSTITUTE [R01CA078412, R29CA078412, P30CA006927] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067558] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008216] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Commonwealth of Pennsylvania; Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); American-Italian Cancer Foundation; Epigenetics and Progenitor Cells Keystone Program Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Drs. F. De Angelis, H.-Y. Fan, R. Katz, O. Segatto, K. Zaret, and R. Zhang for critical reading of the manuscript; Drs. P. K. Cooper, F. Roegiers, and K. Soprano for comments and advice; G. Albergo, K. Brewer, C. Garnier, B. Lurie, and M. Oliver for mouse genotyping; Dr. Z.P. Zhang for help with CAT assays; Dr. J. Kulkosky, A. Kowalski, T. Stulkivska, and W. Schroeder for Crabp2 and Oct4 methylation analysis; Dr. M. Xu for the targeting plasmid (with permission from Dr. G. Martin); Dr. A.J. Furnace for recombinant GADD45a; Dr. K. Sugasawa for anti-TDG antibody; Drs. L. Bagella and P.L. Puri for p300 reporters; Drs. S. Peri and Y. Zhou for ingenuity pathway analysis; Dr. F. Alt for AID cDNA; Dr. N. Davidson for Apobec-1 cDNA; Dr. W. Cui for human Oct4::EGFP reporter; Drs. C. Niehrs and A. Schafer for advice on transfected plasmid recovery; Dr. J. Thorvaldsen for advice on bisulfite modification of PGC DNA; and R. Sonlin for secretarial assistance. We thank the following core facilities at the Fox Chase Cancer Center: Genotyping, Cell Culture, Transgenic and Knock-out, Laboratory Animal, and Fannie E. Rippel Biotechnology Facility. Y.M. would like to thank Dr. Alan Tomkinson for providing hospitality to conduct some of the experiments in his laboratory. This study was supported by NIH grants CA78412, CA06927, and DK067558; an appropriation from the Commonwealth of Pennsylvania to the Fox Chase Cancer Center; and the Italian Association for Cancer Research (AIRC). S.C. was supported, in part, by an American-Italian Cancer Foundation Post-Doctoral Research Fellowship. M.L.C. was supported by an Epigenetics and Progenitor Cells Keystone Program Fellowship. L.K.A. was supported by NIH training grant T32GM008216. A. B. would like to dedicate this article to the memory of his father Pancrazio who taught him the importance of hard work, perseverance and dedication.	Baker D, 2002, CHEM RES TOXICOL, V15, P33, DOI 10.1021/tx010113b; Barreto G, 2007, NATURE, V445, P671, DOI 10.1038/nature05515; Bhutani N, 2010, NATURE, V463, P1042, DOI 10.1038/nature08752; BIRD A, 1992, CELL, V70, P5, DOI 10.1016/0092-8674(92)90526-I; Carrier F, 1999, MOL CELL BIOL, V19, P1673; Chen DS, 2003, J BIOL CHEM, V278, P38586, DOI 10.1074/jbc.M304286200; Cortazar D, 2007, DNA REPAIR, V6, P489, DOI 10.1016/j.dnarep.2006.10.013; Cortazar D, 2011, NATURE, V470, P419, DOI 10.1038/nature09672; Cortellino S, 2003, P NATL ACAD SCI USA, V100, P15071, DOI 10.1073/pnas.2334585100; Deb-Rinker P, 2005, J BIOL CHEM, V280, P6257, DOI 10.1074/jbc.C400479200; Feinberg AP, 2004, NAT REV CANCER, V4, P143, DOI 10.1038/nrc1279; Gaudet F, 2003, SCIENCE, V300, P489, DOI 10.1126/science.1083558; Gehring M, 2006, CELL, V124, P495, DOI 10.1016/j.cell.2005.12.034; Gehring M, 2009, TRENDS GENET, V25, P82, DOI 10.1016/j.tig.2008.12.001; Globisch D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015367; Guo JU, 2011, CELL, V145, P423, DOI 10.1016/j.cell.2011.03.022; Hajkova P, 2010, SCIENCE, V329, P78, DOI 10.1126/science.1187945; Hardeland U, 2000, J BIOL CHEM, V275, P33449, DOI 10.1074/jbc.M005095200; Haushalter KA, 1999, CURR BIOL, V9, P174, DOI 10.1016/S0960-9822(99)80087-6; Howard JH, 2009, CANCER BIOL THER, V8, P94, DOI 10.4161/cbt.8.1.7469; Illingworth RS, 2009, FEBS LETT, V583, P1713, DOI 10.1016/j.febslet.2009.04.012; Jin SG, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000013; Jones PA, 1999, NAT GENET, V21, P163, DOI 10.1038/5947; Kass SU, 1997, CURR BIOL, V7, P157, DOI 10.1016/S0960-9822(97)70086-1; Kim MS, 2009, NATURE, V461, P1007, DOI 10.1038/nature08456; Kress C, 2006, P NATL ACAD SCI USA, V103, P11112, DOI 10.1073/pnas.0601793103; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Li YQ, 2007, NUCLEIC ACIDS RES, V35, P390, DOI 10.1093/nar/gkl1052; Ma DK, 2009, SCIENCE, V323, P1074, DOI 10.1126/science.1166859; Mark M, 2006, ANNU REV PHARMACOL, V46, P451, DOI 10.1146/annurev.pharmtox.46.120604.141156; Mayer W, 2000, NATURE, V403, P501, DOI 10.1038/35000656; Metivier R, 2008, NATURE, V452, P45, DOI 10.1038/nature06544; Missero C, 2001, J BIOL CHEM, V276, P33569, DOI 10.1074/jbc.M104963200; Mohn F, 2008, MOL CELL, V30, P755, DOI 10.1016/j.molcel.2008.05.007; Morales-Ruiz T, 2006, P NATL ACAD SCI USA, V103, P6853, DOI 10.1073/pnas.0601109103; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Niehrs C, 2009, DIFFERENTIATION, V77, P1, DOI 10.1016/j.diff.2008.09.004; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Ooi SKT, 2008, CELL, V133, P1145, DOI 10.1016/j.cell.2008.06.009; Oswald J, 2000, CURR BIOL, V10, P475, DOI 10.1016/S0960-9822(00)00448-6; Pantoja C, 2005, CANCER RES, V65, P26; Popp C, 2010, NATURE, V463, P1101, DOI 10.1038/nature08829; Rai K, 2008, CELL, V135, P1201, DOI 10.1016/j.cell.2008.11.042; Reese KJ, 2006, CYTOGENET GENOME RES, V113, P153, DOI 10.1159/000090827; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Rideout WM, 2001, SCIENCE, V293, P1093, DOI 10.1126/science.1063206; Schmitz KM, 2009, MOL CELL, V33, P344, DOI 10.1016/j.molcel.2009.01.015; Siegfried Z, 1997, CURR BIOL, V7, pR305, DOI 10.1016/S0960-9822(06)00144-8; Surani MA, 2007, CELL, V128, P747, DOI 10.1016/j.cell.2007.02.010; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Tanaka Y, 2000, MECH DEVELOP, V95, P133, DOI 10.1016/S0925-4773(00)00360-9; Thomassin H, 2001, EMBO J, V20, P1974, DOI 10.1093/emboj/20.8.1974; Tini M, 2002, MOL CELL, V9, P265, DOI 10.1016/S1097-2765(02)00453-7; Um S, 1998, J BIOL CHEM, V273, P20728, DOI 10.1074/jbc.273.33.20728; Vermot J, 2003, P NATL ACAD SCI USA, V100, P1763, DOI 10.1073/pnas.0437920100; Wu SC, 2010, NAT REV MOL CELL BIO, V11, P607, DOI 10.1038/nrm2950; Xu J, 2007, P NATL ACAD SCI USA, V104, P12377, DOI 10.1073/pnas.0704579104; Yao TP, 1998, CELL, V93, P361, DOI 10.1016/S0092-8674(00)81165-4; Yi YW, 2000, BIOCHEM BIOPH RES CO, V272, P193; Zhu B, 2000, P NATL ACAD SCI USA, V97, P5135, DOI 10.1073/pnas.100107597	62	582	612	4	135	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 8	2011	146	1					67	79		10.1016/j.cell.2011.06.020	http://dx.doi.org/10.1016/j.cell.2011.06.020			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	789TN	21722948	Green Published, Bronze, Green Accepted			2022-12-24	WOS:000292539300007
J	Pfeffer, MA; Bowler, MB				Pfeffer, Marc A.; Bowler, Marianne B.			Access to Safety Data - Stockholders versus Prescribers	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Pfeffer, Marc A.] Brigham & Womens Hosp, Dept Med, Div Cardiovasc, Boston, MA 02115 USA; [Pfeffer, Marc A.] Harvard Univ, Sch Med, Boston, MA USA; [Bowler, Marianne B.] US Dist Court, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Pfeffer, MA (corresponding author), Brigham & Womens Hosp, Dept Med, Div Cardiovasc, Boston, MA 02115 USA.							BREYER STEPHEN, 2010, MAKING OUR DEMOCRACY; Curfman GD, 2006, NEW ENGL J MED, V354, P1193, DOI 10.1056/NEJMe068054; *FOOD DRUG ADM, SENT IN NAT STRAT MO	3	2	2	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 7	2011	365	1					1	3		10.1056/NEJMp1104699	http://dx.doi.org/10.1056/NEJMp1104699			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	788QL	21714642				2022-12-24	WOS:000292459400001
J	Fernandez, A; Lynch, M				Fernandez, Ariel; Lynch, Michael			Non-adaptive origins of interactome complexity	NATURE			English	Article							PROTEIN; DYNAMICS; ALGORITHMS; EVOLUTION	The boundaries between prokaryotes, unicellular eukaryotes and multicellular eukaryotes are accompanied by orders-of-magnitude reductions in effective population size, with concurrent amplifications of the effects of random genetic drift and mutation(1). The resultant decline in the efficiency of selection seems to be sufficient to influence a wide range of attributes at the genomic level in a non-adaptive manner(2). A key remaining question concerns the extent to which variation in the power of random genetic drift is capable of influencing phylogenetic diversity at the subcellular and cellular levels(2-4). Should this be the case, population size would have to be considered as a potential determinant of the mechanistic pathways underlying long-term phenotypic evolution. Here we demonstrate a phylogenetically broad inverse relation between the power of drift and the structural integrity of protein subunits. This leads to the hypothesis that the accumulation of mildly deleterious mutations in populations of small size induces secondary selection for protein-protein interactions that stabilize key gene functions. By this means, the complex protein architectures and interactions essential to the genesis of phenotypic diversity may initially emerge by non-adaptive mechanisms.	[Lynch, Michael] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; [Fernandez, Ariel] Univ Chicago, Dept Comp Sci, Chicago, IL 60637 USA; [Fernandez, Ariel] Rice Univ, Dept Bioengn, Houston, TX 77005 USA	Indiana University System; Indiana University Bloomington; University of Chicago; Rice University	Lynch, M (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN 47405 USA.	ariel@uchicago.edu; milynch@indiana.edu	Fernandez, Ariel/I-7925-2016	Fernandez, Ariel/0000-0002-5102-4294	National Institutes of Health [R01GM072614, R01GM036827]; Institute of Biophysical Dynamics; Department of Computer Science at The University of Chicago; National Science Foundation [EF-0827411]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072614, R01GM036827] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institute of Biophysical Dynamics; Department of Computer Science at The University of Chicago; National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	A.F. was supported by National Institutes of Health grant R01GM072614, and by the Institute of Biophysical Dynamics and the Department of Computer Science at The University of Chicago. M.L. was supported by National Institutes of Health grant R01GM036827 and National Science Foundation grant EF-0827411.	BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Canutescu AA, 2003, PROTEIN SCI, V12, P2001, DOI 10.1110/ps.03154503; Clackson T, 1998, J MOL BIOL, V277, P1111, DOI 10.1006/jmbi.1998.1669; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Fenimore PW, 2004, P NATL ACAD SCI USA, V101, P14408, DOI 10.1073/pnas.0405573101; Fernandez A, 2002, J MOL BIOL, V321, P659, DOI 10.1016/S0022-2836(02)00679-4; Fernandez A, 2010, J PROTEOME RES, V9, P2643, DOI 10.1021/pr100089t; Gabaldon T, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-403; Gray MW, 2010, SCIENCE, V330, P920, DOI 10.1126/science.1198594; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kuriyan J, 2007, NATURE, V450, P983, DOI 10.1038/nature06524; Levy ED, 2008, NATURE, V453, P1262, DOI 10.1038/nature06942; Levy ED, 2006, PLOS COMPUT BIOL, V2, P1395, DOI 10.1371/journal.pcbi.0020155; Li, 1999, Genome Inform Ser Workshop Genome Inform, V10, P30; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Lynch M, 2003, SCIENCE, V302, P1401, DOI 10.1126/science.1089370; Lynch M, 2007, ORIGINS GENOME ARCHI; Lynch M, 2007, P NATL ACAD SCI USA, V104, P8597, DOI 10.1073/pnas.0702207104; Moran NA, 1996, P NATL ACAD SCI USA, V93, P2873, DOI 10.1073/pnas.93.7.2873; Ostlund G, 2010, NUCLEIC ACIDS RES, V38, pD196, DOI 10.1093/nar/gkp931; Pietrosemoli N, 2007, J PROTEOME RES, V6, P3519, DOI 10.1021/pr070208k; Rizzo RC, 1999, J AM CHEM SOC, V121, P4827, DOI 10.1021/ja984106u; Rowlinson J. S., 1982, MOL THEORY CAPILLARI; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schutz CN, 2001, PROTEINS, V44, P400, DOI 10.1002/prot.1106; Scott R, 2004, J PHYS A-MATH GEN, V37, P9791, DOI 10.1088/0305-4470/37/41/012; Stoltzfus A, 1999, J MOL EVOL, V49, P169, DOI 10.1007/PL00006540; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Zhou HY, 2010, PROTEINS, V78, P2041, DOI 10.1002/prot.22717	30	90	93	1	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 23	2011	474	7352					502	U130		10.1038/nature09992	http://dx.doi.org/10.1038/nature09992			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	781NJ	21593762	Green Accepted			2022-12-24	WOS:000291939700047
J	Lynd, LR; Woods, J				Lynd, Lee R.; Woods, Jeremy			A new hope for Africa	NATURE			English	Editorial Material									[Lynd, Lee R.] Dartmouth Coll Thayer Sch Engn, Hanover, NH USA; [Woods, Jeremy] Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England	Dartmouth College; Imperial College London	Lynd, LR (corresponding author), Dartmouth Coll Thayer Sch Engn, Hanover, NH USA.	lee.r.lynd@Dartmouth.edu; Jeremy.woods@imperial.ac.uk	Lynd, Lee R/N-1260-2013	Lynd, Lee R/0000-0002-5642-668X; Woods, Jeremy/0000-0002-1542-8144					0	37	39	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 23	2011	474	7352					S20	S21		10.1038/474S020a	http://dx.doi.org/10.1038/474S020a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	781NJ	21697839	Bronze, Green Submitted			2022-12-24	WOS:000291939700008
J	Lovett, KM; Liang, BA				Lovett, Kimberly M.; Liang, Bryan A.			Direct-to-Consumer Cardiac Screening and Suspect Risk Evaluation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Lovett, Kimberly M.] Kaiser Permanente, San Diego, CA USA; [Liang, Bryan A.] UCSD Sch Med, San Diego Ctr Patient Safety, San Diego, CA USA; [Liang, Bryan A.] Calif Western Sch Law, Inst Hlth Law Studies, San Diego, CA USA	Kaiser Permanente; University of California System; University of California San Diego	Lovett, KM (corresponding author), Kaiser Permanente, 1630 E Main St, El Cajon, CA 92021 USA.	klovett@ucsd.edu		Liang, Bryan/0000-0001-7801-5673				FEINBERG WM, 1995, ARCH INTERN MED, V155, P469, DOI 10.1001/archinte.155.5.469; Greenland P, 2010, J AM COLL CARDIOL, V56, P2182, DOI 10.1016/j.jacc.2010.09.002; Health Fair, HLTH SCREEN TEST PAC; Healthy Life Screening, LV DYSF SUDD CARD DE; Lifeline Screening, ASS YOUR RISK CAR AR; U.S. Preventive Services Task Force (USPSTF), REC; US Department of Health and Human Services, 2011, MOL CLIN GEN PAN M M; *US FDA, DRAFT GUID IND CLIN; Vital Scanning Inc, ART STIFFN SCREEN; Wilson J JG, 1968, PUBLIC HLTH PAPERS, V34	10	18	18	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 22	2011	305	24					2567	2568		10.1001/jama.2011.865	http://dx.doi.org/10.1001/jama.2011.865			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	780MF	21693746				2022-12-24	WOS:000291860400025
J	Maciejewski, ML; Livingston, EH; Smith, VA; Kavee, AL; Kahwati, LC; Henderson, WG; Arterburn, DE				Maciejewski, Matthew L.; Livingston, Edward H.; Smith, Valerie A.; Kavee, Andrew L.; Kahwati, Leila C.; Henderson, William G.; Arterburn, David E.			Survival Among High-Risk Patients After Bariatric Surgery	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LONG-TERM MORTALITY; QUALITY IMPROVEMENT PROGRAM; TREATMENT SELECTION BIAS; AFFAIRS MEDICAL-CENTERS; GASTRIC BYPASS-SURGERY; VETERANS-AFFAIRS; PROPENSITY-SCORE; OBESITY; PERFORMANCE; PREVALENCE	Context Existing evidence of the survival associated with bariatric surgery is based on cohort studies of predominantly younger women with a low inherent obesity-related mortality risk. The association of survival and bariatric surgery for older men is less clear. Objective To determine whether bariatric surgery is associated with reduced mortality in a multisite cohort of predominantly older male patients who have a high baseline mortality rate. Design, Setting, and Participants Retrospective cohort study of bariatric surgery programs in Veterans Affairs medical centers. Mortality was examined for 850 veterans who had bariatric surgery in January 2000 to December 2006 (mean age 49.5 years; SD 8.3; mean body mass index [BMI] 47.4; SD 7.8) and 41 244 nonsurgical controls (mean age 54.7 years, SD 10.2; mean BMI 42.0, SD 5.0) from the same 12 Veteran Integrated Service Networks; the mean follow-up was 6.7 years. Four Cox proportional hazards models were assessed: unadjusted and controlled for baseline covariates on unmatched and propensity-matched cohorts. Main Outcome Measure All-cause mortality through December 2008. Results Among patients who had bariatric surgery, the 1-, 2-, and 6-year crude mortality rates were, respectively, 1.5%, 2.2%, and 6.8% compared with 2.2%, 4.6%, and 15.2% for nonsurgical controls. In unadjusted Cox regression, bariatric surgery was associated with reduced mortality (hazard ratio [HR], 0.64; 95% confidence interval [CI], 0.51-0.80). After covariate adjustment, bariatric surgery remained associated with reduced mortality (HR, 0.80; 95% CI, 0.63-0.995). In analysis of 1694 propensity-matched patients, bariatric surgery was no longer significantly associated with reduced mortality in unadjusted (HR, 0.83; 95% CI, 0.61-1.14) and time-adjusted (HR, 0.94; 95% CI, 0.64-1.39) Cox regressions. Conclusion In propensity score-adjusted analyses of older severely obese patients with high baseline mortality in Veterans Affairs medical centers, the use of bariatric surgery compared with usual care was not associated with decreased mortality during a mean 6.7 years of follow-up. JAMA. 2011;305(23):2419-2426 www.jama.com	[Maciejewski, Matthew L.; Smith, Valerie A.; Kavee, Andrew L.] Durham VA Med Ctr, Ctr Hlth Serv Res Primary Care, Durham, NC 27705 USA; [Maciejewski, Matthew L.] Duke Univ, Dept Med, Div Gen Internal Med, Durham, NC USA; [Livingston, Edward H.] Univ Texas SW Med Ctr Dallas, Div Gastrointestinal & Endocrine Surg, Dallas, TX 75390 USA; [Livingston, Edward H.] Vet Adm N Texas Hlth Care Syst, Dallas, TX USA; [Livingston, Edward H.] Univ Texas Arlington, Arlington, TX USA; [Kahwati, Leila C.] US Dept Vet Affairs, Natl Ctr Hlth Promot & Dis Prevent, Off Patient Care Serv, Durham, NC USA; [Henderson, William G.] Denver Vet Affairs Med Ctr, Denver, CO USA; [Henderson, William G.] Univ Colorado, Sch Publ Hlth, Dept Biostat & Informat, Aurora, CO USA; [Henderson, William G.] Univ Colorado, Colorado Hlth Outcomes Program, Aurora, CO USA; [Arterburn, David E.] Grp Hlth Res Inst, Seattle, WA USA; [Arterburn, David E.] Univ Washington, Dept Med, Div Gen Internal Med, Seattle, WA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center; Duke University; University of Texas System; University of Texas Southwestern Medical Center Dallas; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA North Texas Health Care System; University of Texas System; University of Texas Arlington; US Department of Veterans Affairs; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Denver; Colorado School of Public Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Washington; University of Washington Seattle	Maciejewski, ML (corresponding author), Durham VA Med Ctr, Ctr Hlth Serv Res Primary Care 152, 411 W Chapel Hill St,Ste 600, Durham, NC 27705 USA.	matthew.maciejewski@va.gov		Smith, Valerie/0000-0001-5170-9819; Kahwati, Leila/0000-0001-6963-2848	Takeda Pharmaceuticals; Novartis; Surgical Review Corporation; Research Data and Assistance Center at the University of Minnesota; Texas Instruments; Foundation for Informed Medical Decision Making [501[3]c]	Takeda Pharmaceuticals(Takeda Pharmaceutical Company Ltd); Novartis(Novartis); Surgical Review Corporation; Research Data and Assistance Center at the University of Minnesota; Texas Instruments; Foundation for Informed Medical Decision Making	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Maciejewski reports receiving consultation funds from Takeda Pharmaceuticals, Novartis, the Surgical Review Corporation, and the Research Data and Assistance Center at the University of Minnesota and owns stock in Amgen. Dr Livingston reports receiving consulting funds from Texas Instruments. Dr Arterburn reports receiving research funding and has received salary support as a medical editor for the not-for-profit (501[3]c) Foundation for Informed Medical Decision Making (http://www.fimdm.org), which develops content for patient education programs. The foundation has an arrangement with a for-profit company, Health Dialog, to coproduce and market these programs to health care organizations. Dr Arterburn was formerly with the Cincinnati Veterans Affairs and Dr Livingston was formerly with the Dallas Veterans Affairs. No other disclosures were reported.	Adams TD, 2007, NEW ENGL J MED, V357, P753, DOI 10.1056/NEJMoa066603; Arterburn D, 2009, ARCH SURG-CHICAGO, V144, P914, DOI 10.1001/archsurg.2009.134; Austin PC, 2008, J CLIN EPIDEMIOL, V61, P537, DOI 10.1016/j.jclinepi.2007.07.011; Austin PC, 2010, AM J EPIDEMIOL, V172, P1092, DOI 10.1093/aje/kwq224; Austin PC, 2010, J CLIN EPIDEMIOL, V63, P136, DOI 10.1016/j.jclinepi.2009.05.009; Austin PC, 2009, STAT MED, V28, P3083, DOI 10.1002/sim.3697; Beyersmann J, 2008, STAT MED, V27, P6439, DOI 10.1002/sim.3437; Buchwald H, 2007, SURGERY, V142, P621, DOI 10.1016/j.surg.2007.07.018; Christou NV, 2004, ANN SURG, V240, P416, DOI 10.1097/01.sla.0000137343.63376.19; Das SR, 2005, AM J PREV MED, V28, P291, DOI 10.1016/j.amepre.2004.12.007; Davis CL, 2007, J AM COLL SURGEONS, V204, P550, DOI 10.1016/j.jamcollsurg.2007.01.012; Fan VS, 2006, HEALTH SERV OUTCOME, V6, P21, DOI 10.1007/s10742-006-0004-1; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Flegal KM, 2005, JAMA-J AM MED ASSOC, V293, P1861, DOI 10.1001/jama.293.15.1861; Flum David R, 2006, Surg Obes Relat Dis, V2, P78, DOI 10.1016/j.soard.2006.02.008; Flum DR, 2009, NEW ENGL J MED, V361, P445, DOI 10.1056/NEJMoa0901836; Flum DR, 2005, JAMA-J AM MED ASSOC, V294, P1903, DOI 10.1001/jama.294.15.1903; Flum DR, 2004, J AM COLL SURGEONS, V199, P543, DOI 10.1016/j.jamcollsurg.2004.06.014; Fontaine KR, 2003, JAMA-J AM MED ASSOC, V289, P187, DOI 10.1001/jama.289.2.187; Hutter MM, 2009, OBESITY, V17, P924, DOI 10.1038/oby.2008.568; Lautz DB, 2007, J AM COLL SURGEONS, V204, P1261, DOI 10.1016/j.jamcollsurg.2007.04.003; Livingston EH, 2006, J AM COLL SURGEONS, V203, P625, DOI 10.1016/j.jamcollsurg.2006.07.006; Livingston EH, 2010, AM J SURG, V200, P378, DOI 10.1016/j.amjsurg.2009.11.007; Livingston EH, 2005, SURGERY, V137, P16, DOI 10.1016/j.surg.2004.05.049; Livingston EH, 2002, ANN SURG, V236, P576, DOI 10.1097/00000658-200211000-00007; MacDonald K G Jr, 1997, J Gastrointest Surg, V1, P213, DOI 10.1016/S1091-255X(97)80112-6; Maciejewski ML, 2010, SURG OBES RELAT DIS, V6, P601, DOI 10.1016/j.soard.2010.07.005; Maciejewski ML, 2010, MED CARE, V48, P989, DOI 10.1097/MLR.0b013e3181ef9cf7; Maciejewski ML, 2009, DIABETES CARE, V32, P75, DOI 10.2337/dc08-1099; Maciejewski ML, 2005, HEALTH SERV RES, V40, P887, DOI 10.1111/j.1475-6773.2005.00390.x; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Parsons, 2001, P 26 ANN SAS US GROU; Pope GC, 2004, HEALTH CARE FINANC R, V25, P119; Schauer PR, 2003, ANN SURG, V238, P467, DOI 10.1097/01.sla.0000089851.41115.1b; Sjostrom L, 2007, NEW ENGL J MED, V357, P741, DOI 10.1056/NEJMoa066254; Sohn Min-Woong, 2006, Popul Health Metr, V4, P2, DOI 10.1186/1478-7954-4-2; Stukel TA, 2007, JAMA-J AM MED ASSOC, V297, P278, DOI 10.1001/jama.297.3.278; Sturm R, 2007, PUBLIC HEALTH, V121, P492, DOI 10.1016/j.puhe.2007.01.006; *VET ADM, MAN OB OV	39	112	114	0	8	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 15	2011	305	23					2419	2426		10.1001/jama.2011.817	http://dx.doi.org/10.1001/jama.2011.817			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	777EB	21666276	Bronze			2022-12-24	WOS:000291597300021
J	George, TJ; Arnaoutakis, GJ; Merlo, CA; Kemp, CD; Baumgartner, WA; Conte, JV; Shah, AS				George, Timothy J.; Arnaoutakis, George J.; Merlo, Christian A.; Kemp, Clinton D.; Baumgartner, William A.; Conte, John V.; Shah, Ashish S.			Association of Operative Time of Day With Outcomes After Thoracic Organ Transplant	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							COMPLICATIONS; SURVIVAL; VOLUME; IMPACT	Context Recent emphasis on systems-based approaches to patient safety has led to several studies demonstrating worse outcomes associated with surgery at night. Objective To evaluate whether operative time of day was associated with thoracic organ transplant outcomes, hypothesizing that it would not be associated with increased morbidity or mortality. Design, Setting, and Participants We conducted a retrospective cohort study of adult heart and lung transplant recipients in the United Network for Organ Sharing database from January 2000 through June 2010. Primary stratification was by operative time of day (night, 7 PM-7 AM; day, 7 AM-7 PM). Main Outcome Measures Primary end points were short-term survival, assessed by the Kaplan-Meier method at 30, 90, and 365 days. Secondary end points encompassed common postoperative complications. Risk-adjusted multivariable Cox proportional hazards regression examined mortality. Results A total of 27 118 patients were included in the study population. Of the 16 573 who underwent a heart transplant, 8346 (50.36%) did so during the day and 8227 (49.64%) during the night. Of the 10 545 who underwent a lung transplant, 5179 (49.11%) did so during the day and 5366 (50.89%) during the night. During a median follow-up of 32.2 months (interquartile range, 11.2-61.1 months), 8061 patients (28.99%) died. Survival was similar for organ transplants performed during the day and night. Survival rates at 30 days for heart transplants during the day were 95.0% vs 95.2% during the night (hazard ratio [HR], 1.05; 95% confidence interval, 0.83-1.32; P=.67) and for lung transplants during the day were 96.0% vs 95.5% during the night (HR, 1.22; 95% CI, 0.97-1.55; P=.09). At 90 days, survival rates for heart transplants were 92.6% during the day vs 92.7% during the night (HR, 1.05; 95% CI, 0.88-1.26; P=.59) and for lung transplants during the day were 92.7% vs 91.7% during the night (HR, 1.23; 95% CI, 1.04-1.47; P=.02). At 1 year, survival rates for heart transplants during the day were 88.0% vs 87.7% during the night (HR, 1.05; 95% CI, 0.91-1.21; P=.47) and for lung transplants during the day were 83.8% vs 82.6% during the night (HR, 1.08; 95% CI, 0.96-1.22; P=.19). Among lung transplant recipients, there was a slightly higher rate of airway dehiscence associated with nighttime transplants (57 of 5022 [1.1%] vs 87 of 5224 [1.7%], P=.02). Conclusion Among patients who underwent thoracic organ transplants, there was no significant association between operative time of day and survival up to 1 year after organ transplant. JAMA. 2011;305(21):2193-2199 www.jama.com	[George, Timothy J.; Arnaoutakis, George J.; Kemp, Clinton D.; Baumgartner, William A.; Conte, John V.; Shah, Ashish S.] Johns Hopkins Med Inst, Div Cardiac Surg, Baltimore, MD 21205 USA; [Merlo, Christian A.] Johns Hopkins Med Inst, Div Pulm & Crit Care Med, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine	Shah, AS (corresponding author), Johns Hopkins Univ Hosp, Div Cardiac Surg, 600 N Wolfe St,Blalock 618, Baltimore, MD 21287 USA.	ashah29@jhmi.edu	Arnaoutakis, George/AAE-8796-2022	Shah, Ashish/0000-0002-1821-9110	Thoratec; Heartware; Medtronic; National Institutes of Health [T32 2T32DK007713-12]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007713] Funding Source: NIH RePORTER	Thoratec; Heartware; Medtronic(Medtronic); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Conte reported that he receives research support from Thoratec, Heartware, and Medtronic; otherwise no other conflicts of interest were reported.; This research was supported by grant T32 2T32DK007713-12 from the National Institutes of Health (Dr George). Dr George is the Hugh R. Sharp Cardiac Surgery Research Fellow. Dr Arnaoutakis is the Irene Piccinini Investigator in Cardiac Surgery.	Fechner G, 2008, TRANSPL P, V40, P1341, DOI 10.1016/j.transproceed.2008.02.072; Glaser R, 2008, JACC-CARDIOVASC INTE, V1, P681, DOI 10.1016/j.jcin.2008.08.020; Grantcharov TP, 2001, BRIT MED J, V323, P1222, DOI 10.1136/bmj.323.7323.1222; Iglehart JK, 2008, NEW ENGL J MED, V359, P2633, DOI 10.1056/NEJMp0808736; Kohn L.T., 2000, ERR IS HUMAN BUILDIN, VVolume 600; Komen N, 2009, INT J COLORECTAL DIS, V24, P789, DOI 10.1007/s00384-009-0692-4; Lonze BE, 2010, AM J TRANSPLANT, V10, P1842, DOI 10.1111/j.1600-6143.2010.03177.x; Peberdy MA, 2008, JAMA-J AM MED ASSOC, V299, P785, DOI 10.1001/jama.299.7.785; Ricci WM, 2009, J BONE JOINT SURG AM, V91A, P2067, DOI 10.2106/JBJS.H.00661; Seow YY, 2004, TRANSPLANTATION, V77, P1386, DOI 10.1097/01.TP.0000122230.46091.E2; Taffinder NJ, 1998, LANCET, V352, P1191, DOI 10.1016/S0140-6736(98)00034-8; Weiss ES, 2008, ANN THORAC SURG, V86, P1250, DOI 10.1016/j.athoracsur.2008.06.071; Weiss ES, 2009, ANN THORAC SURG, V88, P1062, DOI 10.1016/j.athoracsur.2009.06.005	13	53	54	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 1	2011	305	21					2193	2199		10.1001/jama.2011.726	http://dx.doi.org/10.1001/jama.2011.726			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	770RN	21632483	Bronze			2022-12-24	WOS:000291106300022
J	Saijo, K; Collier, JG; Li, AC; Katzenellenbogen, JA; Glass, CK				Saijo, Kaoru; Collier, Jana G.; Li, Andrew C.; Katzenellenbogen, John A.; Glass, Christopher K.			An ADIOL-ER beta-CtBP Transrepression Pathway Negatively Regulates Microglia-Mediated Inflammation	CELL			English	Article							ESTROGEN-RECEPTOR-BETA; T-CELLS; FRACTALKINE RECEPTOR; SELECTIVE LIGANDS; GENE-EXPRESSION; ALPHA; BRAIN; BINDING; ENCEPHALOMYELITIS; TRANSCRIPTION	Microglia and astrocytes play essential roles in the maintenance of homeostasis within the central nervous system, but mechanisms that control the magnitude and duration of responses to infection and injury remain poorly understood. Here, we provide evidence that 5-androsten-3 beta, 17 beta-diol (ADIOL) functions as a selective modulator of estrogen receptor (ER)beta to suppress inflammatory responses of microglia and astrocytes. ADIOL and a subset of synthetic ER beta-specific ligands, but not 17 beta-estradiol, mediate recruitment of CtBP corepressor complexes to AP-1-dependent promoters, thereby repressing genes that amplify inflammatory responses and activate Th17 T cells. Reduction of ADIOL or ER beta expression results in exaggerated inflammatory responses to TLR4 agonists. Conversely, the administration of ADIOL or synthetic ER beta-specific ligands that promote CtBP recruitment prevents experimental autoimmune encephalomyelitis in an ER beta-dependent manner. These findings provide evidence for an ADIOL/ER beta/CtBP-transrepression pathway that regulates inflammatory responses in microglia and can be targeted by selective ER beta modulators.	[Saijo, Kaoru; Collier, Jana G.; Glass, Christopher K.] Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Li, Andrew C.; Glass, Christopher K.] Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92093 USA; [Katzenellenbogen, John A.] Univ Illinois, Dept Chem, Urbana, IL 61801 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of Illinois System; University of Illinois Urbana-Champaign	Saijo, K (corresponding author), Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	ksaijo@ucsd.edu; ckg@ucsd.edu	Glass, Christopher/AAI-3933-2021	Glass, Christopher/0000-0003-4344-3592	NIH [CA52599, HL087391, DK015556]; NATIONAL CANCER INSTITUTE [R01CA052599] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087391] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK091183, R01DK015556, R37DK015556] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Benita Katzenellenbogen, Joshua Stender, and Christian Schmedt for the critical reading of this manuscript. We are grateful to Norio Yasui for the preparation of Indazole-Cl; and Mel Simon for retrovirus carrying shRNA against PKA catalytic subunits; the CMMW vivarium for taking care of animals; and Lynn Bautista for help with preparing figures. This work was supported by grants from the NIH (CA52599 to C. K. G., HL087391 to A. C. L., and DK015556 to J.A.K.).	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P942, DOI 10.1038/ni1496; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Baker AE, 2004, ENDOCRINOLOGY, V145, P5021, DOI 10.1210/en.2004-0619; Bhaskar K, 2010, NEURON, V68, P19, DOI 10.1016/j.neuron.2010.08.023; Bonetti A, 2009, J NEUROIMMUNOL, V208, P119, DOI 10.1016/j.jneuroim.2009.01.003; Cardona AE, 2006, NAT NEUROSCI, V9, P917, DOI 10.1038/nn1715; Chang EC, 2008, MOL ENDOCRINOL, V22, P1032, DOI 10.1210/me.2007-0356; De Angelis M, 2005, J MED CHEM, V48, P1132, DOI 10.1021/jm049223g; Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447; Glass CK, 2010, NAT REV IMMUNOL, V10, P365, DOI 10.1038/nri2748; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Gold SM, 2009, J NEUROL SCI, V286, P99, DOI 10.1016/j.jns.2009.05.028; Gold SM, 2009, LAB INVEST, V89, P1076, DOI 10.1038/labinvest.2009.79; Gottfried-Blackmore A, 2008, J STEROID BIOCHEM, V109, P96, DOI 10.1016/j.jsbmb.2007.12.013; Grober OMV, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-36; Heppner FL, 2005, NAT MED, V11, P146, DOI 10.1038/nm1177; Jellinck PH, 2007, J STEROID BIOCHEM, V107, P156, DOI 10.1016/j.jsbmb.2007.04.004; Koga K, 2009, IMMUNITY, V30, P372, DOI 10.1016/j.immuni.2008.12.021; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Krumbholz M, 2005, J EXP MED, V201, P195, DOI 10.1084/jem.20041674; Kuiper GGJM, 1996, P NATL ACAD SCI USA, V93, P5925, DOI 10.1073/pnas.93.12.5925; Kuiper GGJM, 1997, ENDOCRINOLOGY, V138, P863, DOI 10.1210/en.138.3.863; Laflamme N, 1998, J NEUROBIOL, V36, P357, DOI 10.1002/(SICI)1097-4695(19980905)36:3<357::AID-NEU5>3.0.CO;2-V; Lin SX, 2006, MOL CELL ENDOCRINOL, V248, P38, DOI 10.1016/j.mce.2005.11.035; Littman DR, 2010, CELL, V140, P845, DOI 10.1016/j.cell.2010.02.021; Lukacik P, 2007, BIOCHEM J, V402, P419, DOI 10.1042/BJ20061319; Mackay F, 2002, NAT REV IMMUNOL, V2, P465, DOI 10.1038/nri844; Malamas MS, 2004, J MED CHEM, V47, P5021, DOI 10.1021/jm049719y; Meyers MJ, 2001, J MED CHEM, V44, P4230, DOI 10.1021/jm010254a; MINUTOLO F, 2009, ESTROGEN RECEPTOR BE; Moeller G, 2009, MOL CELL ENDOCRINOL, V301, P7, DOI 10.1016/j.mce.2008.10.040; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Perry VH, 2010, NAT REV NEUROL, V6, P193, DOI 10.1038/nrneurol.2010.17; Pettersson K, 2001, ANNU REV PHYSIOL, V63, P165, DOI 10.1146/annurev.physiol.63.1.165; PIECHACZYK M, 1994, CRIT REV ONCOL HEMAT, V17, P93, DOI 10.1016/1040-8428(94)90021-3; Ransohoff RM, 2009, ANNU REV IMMUNOL, V27, P119, DOI 10.1146/annurev.immunol.021908.132528; Rogatsky I, 2002, P NATL ACAD SCI USA, V99, P16701, DOI 10.1073/pnas.262671599; Saijo K, 2009, CELL, V137, P47, DOI 10.1016/j.cell.2009.01.038; Schaeper U, 1998, J BIOL CHEM, V273, P8549, DOI 10.1074/jbc.273.15.8549; Simard J, 2005, ENDOCR REV, V26, P525, DOI 10.1210/er.2002-0050; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Spandidos A, 2010, NUCLEIC ACIDS RES, V38, pD792, DOI 10.1093/nar/gkp1005; Stauffer SR, 2000, J MED CHEM, V43, P4934, DOI 10.1021/jm000170m; Stossi F, 2009, MOL CELL BIOL, V29, P1749, DOI 10.1128/MCB.01476-08; Streit WJ, 2002, GLIA, V40, P133, DOI 10.1002/glia.10154; Stromnes IM, 2006, NAT PROTOC, V1, P1810, DOI 10.1038/nprot.2006.285; Tiwari-Woodruff S, 2007, P NATL ACAD SCI USA, V104, P14813, DOI 10.1073/pnas.0703783104; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Vegeto E, 2000, EXP GERONTOL, V35, P1309, DOI 10.1016/S0531-5565(00)00161-3; Vegeto E, 2008, FRONT NEUROENDOCRIN, V29, P507, DOI 10.1016/j.yfrne.2008.04.001; Wall EA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000202; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Wise LH, 1999, ANN HUM GENET, V63, P263, DOI 10.1046/j.1469-1809.1999.6330263.x; Yadav A, 2009, J NEUROIMMUNE PHARM, V4, P430, DOI 10.1007/s11481-009-9174-2	54	223	229	0	22	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 13	2011	145	4					584	595		10.1016/j.cell.2011.03.050	http://dx.doi.org/10.1016/j.cell.2011.03.050			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	763MF	21565615	Bronze, Green Accepted			2022-12-24	WOS:000290560800011
J	Wollmann, P; Cui, S; Viswanathan, R; Berninghausen, O; Wells, MN; Moldt, M; Witte, G; Butryn, A; Wendler, P; Beckmann, R; Auble, DT; Hopfner, KP				Wollmann, Petra; Cui, Sheng; Viswanathan, Ramya; Berninghausen, Otto; Wells, Melissa N.; Moldt, Manuela; Witte, Gregor; Butryn, Agata; Wendler, Petra; Beckmann, Roland; Auble, David T.; Hopfner, Karl-Peter			Structure and mechanism of the Swi2/Snf2 remodeller Mot1 in complex with its substrate TBP	NATURE			English	Article							TATA-BINDING PROTEIN; RNA-POLYMERASE-II; PREINITIATION COMPLEX; DNA; TRANSCRIPTION; CHROMATIN; SOFTWARE; PROMOTER; SYSTEM; NC2	Swi2/Snf2-type ATPases regulate genome-associated processes such as transcription, replication and repair by catalysing the disruption, assembly or remodelling of nucleosomes or other protein-DNA complexes(1,2). It has been suggested that ATP-driven motor activity along DNA disrupts target protein-DNA interactions in the remodelling reaction(3-5). However, the complex and highly specific remodelling reactions are poorly understood, mostly because of a lack of high-resolution structural information about how remodellers bind to their substrate proteins. Mot1 (modifier of transcription 1 in Saccharomyces cerevisiae, denoted BTAF1 in humans) is a Swi2/Snf2 enzyme that specifically displaces the TATA box binding protein (TBP) from the promoter DNA and regulates transcription globally by generating a highly dynamic TBP pool in the cell(6,7). As a Swi2/Snf2 enzyme that functions as a single polypeptide and interacts with a relatively simple substrate, Mot1 offers an ideal system from which to gain a better understanding of this important enzyme family. To reveal how Mot1 specifically disrupts TBP-DNA complexes, we combined crystal and electron microscopy structures of Mot1-TBP from Encephalitozoon cuni-culi with biochemical studies. Here we show that Mot1 wraps around TBP and seems to act like a bottle opener: a spring-like array of 16 HEAT(huntingtin, elongation factor 3, protein phosphatase 2A and lipid kinase TOR) repeats grips the DNA-distal side of TBP via loop insertions, and the Swi2/Snf2 domain binds to upstream DNA, positioned to weaken the TBP-DNA interaction by DNA translocation. A 'latch' subsequently blocks the DNA-binding groove of TBP, acting as a chaperone to prevent DNA re-association and ensure efficient promoter clearance. This work shows how a remodelling enzyme can combine both motor and chaperone activities to achieve functional specificity using a conserved Swi2/Snf2 translocase.	[Wollmann, Petra; Cui, Sheng; Berninghausen, Otto; Moldt, Manuela; Witte, Gregor; Butryn, Agata; Wendler, Petra; Beckmann, Roland; Hopfner, Karl-Peter] Univ Munich, Dept Biochem, D-81377 Munich, Germany; [Wollmann, Petra; Witte, Gregor; Hopfner, Karl-Peter] Gene Ctr Munich, Munich Ctr Adv Photon, D-81377 Munich, Germany; [Viswanathan, Ramya; Wells, Melissa N.; Auble, David T.] Univ Virginia Hlth Syst, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA; [Witte, Gregor; Beckmann, Roland; Hopfner, Karl-Peter] Gene Ctr Munich, Ctr Integrated Prot Sci, D-81377 Munich, Germany	University of Munich; University of Munich; University of Virginia; University of Munich	Hopfner, KP (corresponding author), Univ Munich, Dept Biochem, Feodor Lynen Str 25, D-81377 Munich, Germany.	auble@virginia.edu; hopfner@lmb.uni-muenchen.de	Sheng, CUI/M-6405-2013; Witte, Gregor/B-4635-2011; Cui, Sheng/AAQ-1721-2020; Wendler, Petra/C-9056-2014; Viswanathan, Ramya/L-5935-2019; Wendler, Petra/X-5799-2019; Hopfner, Karl-Peter/B-6864-2014	Sheng, CUI/0000-0001-6329-3582; Witte, Gregor/0000-0003-0313-0962; Wendler, Petra/0000-0002-8285-2199; Hopfner, Karl-Peter/0000-0002-4528-8357; Butryn, Agata/0000-0002-5227-4770	German Research Council [SFB 646, SFB/TR5]; Excellence Initiative (Center for Integrated Protein Science, Munich); DFG [WE4628/1]; NIH [GM55763]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055763, T32GM008136] Funding Source: NIH RePORTER	German Research Council(German Research Foundation (DFG)); Excellence Initiative (Center for Integrated Protein Science, Munich); DFG(German Research Foundation (DFG)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Max-Planck Crystallization Facility Martinsried. We thank M. Lucas, A. Schele, C. Ungewickell, J. Goetzl and Y. Hiruma for help with experimentation. We thank J.-P. Armache and M. Turk for help with electron microscopy data. We are grateful to G. Miller and S. Hahn for advice. We thank the staff at the SLS and ESRF for help with data collection. We thank P. Cramer and members of the Hopfner and Auble laboratories for discussions and comments on the manuscript. This work was supported by the German Research Council (SFB 646 and SFB/TR5) and Excellence Initiative (Center for Integrated Protein Science, Munich) to K.-P. H. and R. B., by DFG grant WE4628/1 to P. Wendler and by NIH grant GM55763 to D.T.A.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Auble DT, 2009, TRENDS BIOCHEM SCI, V34, P49, DOI 10.1016/j.tibs.2008.10.008; AUBLE DT, 1993, GENE DEV, V7, P844, DOI 10.1101/gad.7.5.844; Auble DT, 1997, MOL CELL BIOL, V17, P4842, DOI 10.1128/MCB.17.8.4842; Berger I, 2004, NAT BIOTECHNOL, V22, P1583, DOI 10.1038/nbt1036; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Cairns BR, 2009, NATURE, V461, P193, DOI 10.1038/nature08450; Chen HT, 2003, MOL CELL, V12, P437, DOI 10.1016/S1097-2765(03)00306-X; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Darst RP, 2003, J BIOL CHEM, V278, P13216, DOI 10.1074/jbc.M211445200; Darst RP, 2001, EMBO J, V20, P2028, DOI 10.1093/emboj/20.8.2028; Dasgupta A, 2002, P NATL ACAD SCI USA, V99, P2666, DOI 10.1073/pnas.052397899; de Graaf P, 2010, J CELL SCI, V123, P2663, DOI 10.1242/jcs.064097; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Durr H, 2005, CELL, V121, P363, DOI 10.1016/j.cell.2005.03.026; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gangaraju VK, 2009, MOL CELL, V35, P58, DOI 10.1016/j.molcel.2009.05.013; Geisberg JV, 2004, MOL CELL, V14, P479, DOI 10.1016/j.molcel.2004.05.003; Gkikopoulos T, 2009, MOL CELL BIOL, V29, P4057, DOI 10.1128/MCB.00400-09; Hsu JY, 2008, GENE DEV, V22, P2353, DOI 10.1101/gad.1681808; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kagawa R, 2004, EMBO J, V23, P2734, DOI 10.1038/sj.emboj.7600293; KIM YC, 1993, NATURE, V365, P512, DOI 10.1038/365512a0; Klejman MP, 2004, MOL CELL BIOL, V24, P10072, DOI 10.1128/MCB.24.22.10072-10082.2004; Kostrewa D, 2009, NATURE, V462, P323, DOI 10.1038/nature08548; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Liu X, 2010, SCIENCE, V327, P206, DOI 10.1126/science.1182015; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miller G, 2006, NAT STRUCT MOL BIOL, V13, P603, DOI 10.1038/nsmb1117; Mohibullah N, 2008, GENE DEV, V22, P2994, DOI 10.1101/gad.1724408; Pereira LA, 2004, J BIOL CHEM, V279, P21802, DOI 10.1074/jbc.M313519200; Pereira LA, 2001, MOL CELL BIOL, V21, P7523, DOI 10.1128/MCB.21.21.7523-7534.2001; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; POON D, 1994, J BIOL CHEM, V269, P23135; Pugh BF, 2000, GENE, V255, P1, DOI 10.1016/S0378-1119(00)00288-2; Racki LR, 2009, NATURE, V462, P1016, DOI 10.1038/nature08621; Saha A, 2002, GENE DEV, V16, P2120, DOI 10.1101/gad.995002; Schluesche P, 2007, NAT STRUCT MOL BIOL, V14, P1196, DOI 10.1038/nsmb1328; Sprouse RO, 2006, EMBO J, V25, P1492, DOI 10.1038/sj.emboj.7601050; TIMMERS HTM, 1992, P NATL ACAD SCI USA, V89, P8140, DOI 10.1073/pnas.89.17.8140; Trabuco LG, 2008, STRUCTURE, V16, P673, DOI 10.1016/j.str.2008.03.005; van Werven FJ, 2008, GENE DEV, V22, P2359, DOI 10.1101/gad.1682308; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004	44	56	56	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 21	2011	475	7356					403	U168		10.1038/nature10215	http://dx.doi.org/10.1038/nature10215			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794PA	21734658	Green Accepted			2022-12-24	WOS:000292911200048
J	Takahashi, H; Parmely, TJ; Sato, S; Tomomori-Sato, C; Banks, CAS; Kong, SE; Szutorisz, H; Swanson, SK; Martin-Brown, S; Washburn, MP; Florens, L; Seidel, CW; Lin, CQ; Smith, ER; Shilatifard, A; Conaway, RC; Conaway, JW				Takahashi, Hidehisa; Parmely, Tari J.; Sato, Shigeo; Tomomori-Sato, Chieri; Banks, Charles A. S.; Kong, Stephanie E.; Szutorisz, Henrietta; Swanson, Selene K.; Martin-Brown, Skylar; Washburn, Michael P.; Florens, Laurence; Seidel, Chris W.; Lin, Chengqi; Smith, Edwin R.; Shilatifard, Ali; Conaway, Ronald C.; Conaway, Joan W.			Human Mediator Subunit MED26 Functions as a Docking Site for Transcription Elongation Factors	CELL			English	Article							RNA-POLYMERASE-II; CARBOXYL-TERMINAL-DOMAIN; P-TEFB KINASE; HEAT-SHOCK; FACTOR ELL; HIV-1 TAT; COMPLEX; PROMOTER; ACTIVATION; BINDING	Promoter-proximal pausing by initiated RNA polymerase II (Pol II) and regulated release of paused polymerase into productive elongation has emerged as a major mechanism of transcription activation. Reactivation of paused Pol II correlates with recruitment of super-elongation complexes (SECs) containing ELL/EAF family members, P-TEFb, and other proteins, but the mechanism of their recruitment is an unanswered question. Here, we present evidence for a role of human Mediator subunit MED26 in this process. We identify in the conserved N-terminal domain of MED26 overlapping docking sites for SEC and a second ELL/EAF-containing complex, as well as general initiation factor TFIID. In addition, we present evidence consistent with the model that MED26 can function as a molecular switch that interacts first with TFIID in the Pol II initiation complex and then exchanges TFIID for complexes containing ELL/EAF and P-TEFb to facilitate transition of Pol II into the elongation stage of transcription.	[Takahashi, Hidehisa; Parmely, Tari J.; Sato, Shigeo; Tomomori-Sato, Chieri; Banks, Charles A. S.; Kong, Stephanie E.; Szutorisz, Henrietta; Swanson, Selene K.; Martin-Brown, Skylar; Washburn, Michael P.; Florens, Laurence; Seidel, Chris W.; Lin, Chengqi; Smith, Edwin R.; Shilatifard, Ali; Conaway, Ronald C.; Conaway, Joan W.] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Washburn, Michael P.] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66160 USA; [Conaway, Ronald C.; Conaway, Joan W.] Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS 66160 USA	Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center	Conaway, JW (corresponding author), Stowers Inst Med Res, Kansas City, MO 64110 USA.	jlc@stowers.org	Hidehisa, Takahashi/E-2175-2012	Washburn, Michael/0000-0001-7568-2585; Banks, Charles/0000-0002-0404-2940; Florens, Laurence/0000-0002-9310-6650; Tomomori-Sato, Chieri/0000-0002-2543-293X; Lin, Chengqi/0000-0002-2121-584X; Conaway, Joan/0000-0002-2786-0663	Stowers Institute; NIGMS, NIH [GM41628]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041628, R37GM041628] Funding Source: NIH RePORTER	Stowers Institute; NIGMS, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank T. Suganuma for helpful discussions, M. Thirman for a generous gift of the anti-EAF1 antibody, K. Zueckert-Gaudenz and A. Peak for help with microarray experiments, and M. Katt and V. Neubauer for tissue culture. C.L. is a PhD thesis student registered with the Open University. This work was supported by funds from the Stowers Institute and by Grant GM41628 from NIGMS, NIH to J.W.C. and R.C.C.	Adelman K, 2005, MOL CELL, V17, P103, DOI 10.1016/j.molcel.2004.11.028; Andrau JC, 2006, MOL CELL, V22, P179, DOI 10.1016/j.molcel.2006.03.023; Balamotis MA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.1164302; Banks CAS, 2007, J BIOL CHEM, V282, P5761, DOI 10.1074/jbc.M610393200; Bartkowiak B, 2010, GENE DEV, V24, P2303, DOI 10.1101/gad.1968210; Belakavadi M, 2010, MOL CELL BIOL, V30, P2437, DOI 10.1128/MCB.01541-09; Boehm AK, 2003, MOL CELL BIOL, V23, P7628, DOI 10.1128/MCB.23.21.7628-7637.2003; Booth V, 2000, J BIOL CHEM, V275, P31266, DOI 10.1074/jbc.M002595200; Bourbon HM, 2008, NUCLEIC ACIDS RES, V36, P3993, DOI 10.1093/nar/gkn349; Buratowski S, 2009, MOL CELL, V36, P541, DOI 10.1016/j.molcel.2009.10.019; Byun JS, 2009, P NATL ACAD SCI USA, V106, P19292, DOI 10.1073/pnas.0905469106; Cai G, 2010, NAT STRUCT MOL BIOL, V17, P273, DOI 10.1038/nsmb.1757; Cai Y, 2007, NAT STRUCT MOL BIOL, V14, P872, DOI 10.1038/nsmb1276; Core LJ, 2008, SCIENCE, V319, P1791, DOI 10.1126/science.1150843; Donner AJ, 2010, NAT STRUCT MOL BIOL, V17, P194, DOI 10.1038/nsmb.1752; Donner AJ, 2007, MOL CELL, V27, P121, DOI 10.1016/j.molcel.2007.05.026; Glover-Cutter K, 2009, MOL CELL BIOL, V29, P5455, DOI 10.1128/MCB.00637-09; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; He NH, 2010, MOL CELL, V38, P428, DOI 10.1016/j.molcel.2010.04.013; Johnson KM, 2002, GENE DEV, V16, P1852, DOI 10.1101/gad.995702; KIM YJ, 1994, CELL, V77, P599, DOI 10.1016/0092-8674(94)90221-6; Kim YK, 2002, MOL CELL BIOL, V22, P4622, DOI 10.1128/MCB.22.13.4622-4637.2002; Kininis M, 2009, MOL CELL BIOL, V29, P1123, DOI 10.1128/MCB.00841-08; KOLESKE AJ, 1994, NATURE, V368, P466, DOI 10.1038/368466a0; Kong SE, 2005, P NATL ACAD SCI USA, V102, P10094, DOI 10.1073/pnas.0503017102; Lariviere L, 2006, NAT STRUCT MOL BIOL, V13, P895, DOI 10.1038/nsmb1143; Lin CQ, 2010, MOL CELL, V37, P429, DOI 10.1016/j.molcel.2010.01.026; Lis J, 1998, COLD SPRING HARB SYM, V63, P347, DOI 10.1101/sqb.1998.63.347; Lis JT, 2000, GENE DEV, V14, P792; Marshall NF, 1996, J BIOL CHEM, V271, P27176, DOI 10.1074/jbc.271.43.27176; Martincic K, 2009, NAT IMMUNOL, V10, P1102, DOI 10.1038/ni.1786; Mittler G, 2001, EMBO REP, V2, P808, DOI 10.1093/embo-reports/kve186; Mo XM, 2004, MOL CELL, V13, P241, DOI 10.1016/S1097-2765(03)00521-5; Montanuy I, 2008, J BIOL CHEM, V283, P7368, DOI 10.1074/jbc.M706243200; Mueller D, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000249; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; Naar AM, 2002, GENE DEV, V16, P1339, DOI 10.1101/gad.987602; Nechaev S, 2010, SCIENCE, V327, P335, DOI 10.1126/science.1181421; Ni ZY, 2004, MOL CELL, V13, P55, DOI 10.1016/S1097-2765(03)00526-4; Park JM, 2001, MOL CELL, V8, P9, DOI 10.1016/S1097-2765(01)00296-9; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Ryu SJ, 1999, NATURE, V397, P446, DOI 10.1038/17141; Sato S, 2004, MOL CELL, V14, P685, DOI 10.1016/j.molcel.2004.05.006; Saunders A, 2006, NAT REV MOL CELL BIO, V7, P557, DOI 10.1038/nrm1981; SERIZAWA H, 1992, P NATL ACAD SCI USA, V89, P7476, DOI 10.1073/pnas.89.16.7476; Shilatifard A, 1996, SCIENCE, V271, P1873, DOI 10.1126/science.271.5257.1873; Shilatifard A, 1997, J BIOL CHEM, V272, P22355, DOI 10.1074/jbc.272.35.22355; Smith ER, 2008, P NATL ACAD SCI USA, V105, P8575, DOI 10.1073/pnas.0804379105; Sobhian B, 2010, MOL CELL, V38, P439, DOI 10.1016/j.molcel.2010.04.012; Taatjes DJ, 2002, SCIENCE, V295, P1058, DOI 10.1126/science.1065249; Taatjes DJ, 2010, TRENDS BIOCHEM SCI, V35, P315, DOI 10.1016/j.tibs.2010.02.004; Takahashi H, 2009, J BIOL CHEM, V284, P32405, DOI 10.1074/jbc.M109.017954; Wada T, 1998, GENE DEV, V12, P343, DOI 10.1101/gad.12.3.343; Wang G, 2005, MOL CELL, V17, P683, DOI 10.1016/j.molcel.2005.02.010; Wei P, 1998, CELL, V92, P451, DOI 10.1016/S0092-8674(00)80939-3; Yamaguchi Y, 1999, CELL, V97, P41, DOI 10.1016/S0092-8674(00)80713-8; Yokoyama A, 2010, CANCER CELL, V17, P198, DOI 10.1016/j.ccr.2009.12.040; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26; Zhang Y, 2010, ANAL CHEM, V82, P2272, DOI 10.1021/ac9023999; Zhu XF, 2006, MOL CELL, V22, P169, DOI 10.1016/j.molcel.2006.03.032	61	234	247	2	40	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 8	2011	146	1					92	104		10.1016/j.cell.2011.06.005	http://dx.doi.org/10.1016/j.cell.2011.06.005			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	789TN	21729782	Bronze, Green Accepted			2022-12-24	WOS:000292539300009
J	Greene, JA; Kesselheim, AS				Greene, Jeremy A.; Kesselheim, Aaron S.			Why Do the Same Drugs Look Different? Pills, Trade Dress, and Public Health	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							COLOR; PLACEBO; LITERACY		[Greene, Jeremy A.; Kesselheim, Aaron S.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon,Dept Med, Boston, MA 02120 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Greene, JA (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon,Dept Med, 1620 Tremont St,Suite 3030, Boston, MA 02120 USA.	greene@fas.harvard.edu			AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K08HS018465] Funding Source: NIH RePORTER	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		[Anonymous], 2010, CBS 60 MINUTES  1229; Berman Adrienne, 2004, J Med Syst, V28, P9, DOI 10.1023/B:JOMS.0000021518.60670.10; Cardenas-Valladolid J, 2010, DRUG AGING, V27, P641, DOI 10.2165/11537320-000000000-00000; CARPENTER D, B HIST MED IN PRESS; Cutler C, 2011, BIOL BLOOD MARROW TR, V17, P285, DOI 10.1016/j.bbmt.2010.11.006; Davit BM, 2009, ANN PHARMACOTHER, V43, P1583, DOI 10.1345/aph.1M141; deCraen AJM, 1996, BRIT MED J, V313, P1624, DOI 10.1136/bmj.313.7072.1624; Donohue JM, 2007, NEW ENGL J MED, V357, P673, DOI 10.1056/NEJMsa070502; FACCHINETTI NJ, 1982, AM J PUBLIC HEALTH, V72, P468, DOI 10.2105/AJPH.72.5.468; Frank RG, 2007, NEW ENGL J MED, V357, P1993, DOI 10.1056/NEJMp078193; Fritsch David, 2006, INTELLECTUAL PROPERT, V47, P171; Generic Pharmaceutical Association, FACTS GLANC; Gray S, NHS EVIDENCE RESP; Greene Jeremy A., 2007, PRESCRIBING NUMBERS; Greenslit Nathan, 2002, Mol Interv, V2, P342, DOI 10.1124/mi.2.6.342; HARRINGTON A, 1997, PLACEBO EFFECT; Hellier Elizabeth, 2010, J Patient Saf, V6, P158; HORN CR, 1986, LANCET, V1, P165; HUSKISSON EC, 1974, BMJ-BRIT MED J, V4, P196, DOI 10.1136/bmj.4.5938.196; JACOBS KW, 1979, PERCEPT MOTOR SKILL, V49, P367, DOI 10.2466/pms.1979.49.2.367; Kenagy JW, 2001, AM J HEALTH-SYST PH, V58, P2033, DOI 10.1093/ajhp/58.21.2033; Kesselheim AS, 2008, JAMA-J AM MED ASSOC, V300, P2514, DOI 10.1001/jama.2008.758; Khan A, 2010, PSYCHOPHARMACOLOGY, V211, P113, DOI 10.1007/s00213-010-1874-z; Kirsche ML, 2005, DRUG STORE NEWS 0822; Kohn LT, 2000, ERR IS HUMAN BUILDIN; Krieg M, 1967, BLACK MARKET MED; Lambert BL, 2005, DRUG SAFETY, V28, P495, DOI 10.2165/00002018-200528060-00003; Levinthal BR, 2008, J GEN INTERN MED, V23, P1172, DOI 10.1007/s11606-008-0612-2; LUCCHELLI PE, 1978, EUR J CLIN PHARMACOL, V13, P153, DOI 10.1007/BF00609760; Matheson Julia Anne, 2009, MED MARKET MEDIA, V44, P55; NEWMAN SJ, 1994, U CHICAGO LAW REV, V61, P1595, DOI 10.2307/1600127; Ngoh LN, 2009, J AM PHARM ASSOC, V49, pE132, DOI 10.1331/JAPhA.2009.07075; Sabate E., 2003, ADHERENCE LONG TERM; Schiff Gordon, 2004, J Med Syst, V28, P1, DOI 10.1023/B:JOMS.0000021517.51673.f3; Shrank WH, 2010, HEALTH AFFAIR, V29, P1383, DOI 10.1377/hlthaff.2009.0424; Stinson Nina, 1982, INDIANA LAW REV, V15, P733; Waber RL, 2008, JAMA-J AM MED ASSOC, V299, P1016, DOI 10.1001/jama.299.9.1016; Wolf MS, 2011, ARCH INTERN MED, V171, P300, DOI 10.1001/archinternmed.2011.39	38	55	55	0	19	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 7	2011	365	1					83	89		10.1056/NEJMhle1101722	http://dx.doi.org/10.1056/NEJMhle1101722			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	788QL	21732842				2022-12-24	WOS:000292459400016
J	Shimamoto, Y; Maeda, YT; Ishiwata, S; Libchaber, AJ; Kapoor, TM				Shimamoto, Yuta; Maeda, Yusuke T.; Ishiwata, Shin'ichi; Libchaber, Albert J.; Kapoor, Tarun M.			Insights into the Micromechanical Properties of the Metaphase Spindle	CELL			English	Article							MITOTIC SPINDLE; MICROTUBULE DYNAMICS; CELL-DIVISION; MECHANICAL-PROPERTIES; TUBULIN; KINESIN; LENGTH; MOTOR; ORGANIZATION; CHROMOSOMES	The microtubule-based metaphase spindle is subjected to forces that act in diverse orientations and over a wide range of timescales. Currently, we cannot explain how this dynamic structure generates and responds to forces while maintaining overall stability, as we have a poor understanding of its micromechanical properties. Here, we combine the use of force-calibrated needles, high-resolution microscopy, and biochemical perturbations to analyze the vertebrate metaphase spindle's timescale- and orientation-dependent viscoelastic properties. We find that spindle viscosity depends on microtubule crosslinking and density. Spindle elasticity can be linked to kinetochore and nonkinetochore microtubule rigidity, and also to spindle pole organization by kinesin-5 and dynein. These data suggest a quantitative model for the micromechanics of this cytoskeletal architecture and provide insight into how structural and functional stability is maintained in the face of forces, such as those that control spindle size and position, and can result from deformations associated with chromosome movement.	[Shimamoto, Yuta; Kapoor, Tarun M.] Rockefeller Univ, Lab Chem & Cell Biol, New York, NY 10065 USA; [Maeda, Yusuke T.; Libchaber, Albert J.] Rockefeller Univ, Lab Expt Condensed Matter Phys, New York, NY 10065 USA; [Ishiwata, Shin'ichi] Waseda Univ, Fac Sci & Engn, Dept Phys, Shinjuku Ku, Tokyo 1698555, Japan	Rockefeller University; Rockefeller University; Waseda University	Kapoor, TM (corresponding author), Rockefeller Univ, Lab Chem & Cell Biol, 1230 York Ave, New York, NY 10065 USA.	kapoor@rockefeller.edu	Shimamoto, Yuta/AAH-3281-2019	Shimamoto, Yuta/0000-0003-0935-2793	National Institutes of Health/National Institute of General Medical Sciences [GM065933]; Grants-in-Aid for Scientific Research [21000011, 22227005] Funding Source: KAKEN; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065933] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	T.M.K. acknowledges support from the National Institutes of Health/National Institute of General Medical Sciences (GM065933). We also thank the Uehara memorial foundation (Y.S.) and the Japan Society for the Promotion of Science (Y.S. and Y.T.M.).	ALEXANDER SP, 1991, J CELL BIOL, V113, P805, DOI 10.1083/jcb.113.4.805; Belmont LD, 1996, CELL, V84, P623, DOI 10.1016/S0092-8674(00)81037-5; Burbank KS, 2006, J CELL BIOL, V175, P369, DOI 10.1083/jcb.200511112; Chakravarty A, 2004, MOL BIOL CELL, V15, P2116, DOI 10.1091/mbc.E03-08-0579; Cowan CR, 2004, ANNU REV CELL DEV BI, V20, P427, DOI 10.1146/annurev.cellbio.19.111301.113823; Desai A, 1999, METHOD CELL BIOL, V61, P385; Dogterom M, 1997, SCIENCE, V278, P856, DOI 10.1126/science.278.5339.856; Dumont S, 2009, CURR BIOL, V19, P1086, DOI 10.1016/j.cub.2009.05.056; EVANS RM, 2009, SOFT MATTER PHYS, V80; Fletcher DA, 2010, NATURE, V463, P485, DOI 10.1038/nature08908; Gaetz J, 2004, J CELL BIOL, V166, P465, DOI 10.1083/jcb.200404015; Gardel ML, 2008, METHOD CELL BIOL, V89, P487, DOI 10.1016/S0091-679X(08)00619-5; Gatlin JC, 2010, J CELL BIOL, V188, P481, DOI 10.1083/jcb.200907110; Gennerich A, 2007, CELL, V131, P952, DOI 10.1016/j.cell.2007.10.016; GITTES F, 1993, J CELL BIOL, V120, P923, DOI 10.1083/jcb.120.4.923; Goshima G, 2010, ANNU REV CELL DEV BI, V26, P21, DOI 10.1146/annurev-cellbio-100109-104006; Hirokawa N, 1998, SCIENCE, V279, P519, DOI 10.1126/science.279.5350.519; Houghtaling BR, 2009, P NATL ACAD SCI USA, V106, P15338, DOI 10.1073/pnas.0902317106; Howard J., 2001, MECH MOTOR PROTEINS; Hughes SE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000348; INOUE S, 1995, MOL BIOL CELL, V6, P1619, DOI 10.1091/mbc.6.12.1619; Itabashi T, 2009, NAT METHODS, V6, P167, DOI [10.1038/NMETH.1297, 10.1038/nmeth.1297]; Janmey PA, 2007, METHOD CELL BIOL, V83, P3, DOI 10.1016/S0091-679X(07)83001-9; Kapoor TM, 2006, SCIENCE, V311, P388, DOI 10.1126/science.1122142; Karki S, 1999, CURR OPIN CELL BIOL, V11, P45, DOI 10.1016/S0955-0674(99)80006-4; KISHINO A, 1988, NATURE, V334, P74, DOI 10.1038/334074a0; Kwok BH, 2007, CURR OPIN CELL BIOL, V19, P36, DOI 10.1016/j.ceb.2006.12.003; LESLIE RJ, 1984, CELL, V36, P717, DOI 10.1016/0092-8674(84)90352-0; LIN Y, 1971, J CELL BIOL, V49, P468; McIntosh J R, 1975, Soc Gen Physiol Ser, V30, P31; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; Mitchison TJ, 2005, MOL BIOL CELL, V16, P3064, DOI 10.1091/mbc.E05-02-0174; Mogilner A, 2010, J CELL SCI, V123, P3435, DOI 10.1242/jcs.062208; Nedelec F, 2001, METH MOL B, V164, P213; Neumann B, 2010, NATURE, V464, P721, DOI 10.1038/nature08869; NICKLAS RB, 1983, J CELL BIOL, V97, P542, DOI 10.1083/jcb.97.2.542; NICKLAS RB, 1965, J CELL BIOL, V25, P119, DOI 10.1083/jcb.25.1.119; Ohi R, 2007, CURR BIOL, V17, P953, DOI 10.1016/j.cub.2007.04.057; SALMON ED, 1984, J CELL BIOL, V99, P2165, DOI 10.1083/jcb.99.6.2165; SATO M, 1988, J CELL BIOL, V106, P1205, DOI 10.1083/jcb.106.4.1205; SAWIN KE, 1991, J CELL BIOL, V112, P941, DOI 10.1083/jcb.112.5.941; TAWADA K, 1991, J THEOR BIOL, V150, P193, DOI 10.1016/S0022-5193(05)80331-5; Tirnauer JS, 2004, MOL BIOL CELL, V15, P1776, DOI 10.1091/mbc.E03-11-0824; Valentine MT, 2004, BIOPHYS J, V86, P4004, DOI 10.1529/biophysj.103.037812; Valentine MT, 2006, NAT CELL BIOL, V8, P470, DOI 10.1038/ncb1394; Walczak CE, 2008, INT REV CYTOL, V265, P111, DOI 10.1016/S0074-7696(07)65003-7; Waters JC, 1996, J CELL SCI, V109, P2823; Wittmann T, 1999, METHOD CELL BIOL, V61, P137; Yang G, 2007, NAT CELL BIOL, V9, P1233, DOI 10.1038/ncb1643; ZHAI Y, 1995, J CELL BIOL, V131, P721, DOI 10.1083/jcb.131.3.721	50	76	76	0	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 24	2011	145	7					1062	1074		10.1016/j.cell.2011.05.038	http://dx.doi.org/10.1016/j.cell.2011.05.038			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	782QV	21703450	Green Accepted, Bronze			2022-12-24	WOS:000292025700013
J	Bristow, TF; Bonifacie, M; Derkowski, A; Eiler, JM; Grotzinger, JP				Bristow, Thomas F.; Bonifacie, Magali; Derkowski, Arkadiusz; Eiler, John M.; Grotzinger, John P.			A hydrothermal origin for isotopically anomalous cap dolostone cements from south China	NATURE			English	Article							GAS HYDRATE; NEOPROTEROZOIC SEAWATER; DOUSHANTUO FORMATION; METHANE SEEPS; CARBONATE; EVOLUTION; OXYGEN; FRACTIONATION; TEMPERATURE; EARTH	The release of methane into the atmosphere through destabilization of clathrates is a positive feedback mechanism capable of amplifying global warming trends that may have operated several times in the geological past(1-3). Such methane release is a hypothesized cause or amplifier for one of the most drastic global warming events in Earth history, the end of the Marinoan 'snowball Earth' ice age, similar to 635 Myr ago(4-7). A key piece of evidence supporting this hypothesis is the occurrence of exceptionally depleted carbon isotope signatures (delta(13)C(PDB) down to -48 parts per thousand; ref. 8) in post-glacial cap dolostones (that is, dolostone overlying glacial deposits) from south China; these signatures have been interpreted as products of methane oxidation at the time of deposition(5,6,8). Here we show, on the basis of carbonate clumped isotope thermometry, (87)Sr/(86)Sr isotope ratios, trace element content and clay mineral evidence, that carbonates bearing the (13)C-depleted signatures crystallized more than 1.6 Myr after deposition of the cap dolostone. Our results indicate that highly (13)C-depleted carbonate cements grew from hydrothermal fluids and suggest that their carbon isotope signatures are a consequence of thermogenic methane oxidation at depth. This finding not only negates carbon isotope evidence for methane release during Marinoan deglaciation in south China, but also eliminates the only known occurrence of a Precambrian sedimentary carbonate with highly (13)C-depleted signatures related to methane oxidation in a seep environment. We propose that the capacity to form highly (13)C-depleted seep carbonates, through biogenic anaeorobic oxidation of methane using sulphate, was limited in the Precambrian period by low sulphate concentrations in sea water(9). As a consequence, although clathrate destabilization may or may not have had a role in the exit from the 'snowball' state, it would not have left extreme carbon isotope signals in cap dolostones.	[Bristow, Thomas F.; Bonifacie, Magali; Eiler, John M.; Grotzinger, John P.] CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; [Bonifacie, Magali] Univ Paris Diderot, Equipe Geochim Isotopes Stables, Inst Phys Globe Paris, CNRS,UMR 7154, F-75005 Paris, France; [Derkowski, Arkadiusz] Polish Acad Sci, Inst Geol Sci, PL-31002 Krakow, Poland	California Institute of Technology; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universite Paris Cite; Polish Academy of Sciences; Institute of Geological Sciences of the Polish Academy of Sciences	Bristow, TF (corresponding author), NASA, Ames Res Ctr, Moffett Field, CA 94035 USA.	thomas.f.bristow@nasa.gov	Bonifacie, Magali/P-7737-2019; Bonifacie, Magali/A-5656-2011	Bonifacie, Magali/0000-0002-4797-043X; Bonifacie, Magali/0000-0002-4797-043X	O.K. Earl Postdoctoral fellowship; NSF; INSU	O.K. Earl Postdoctoral fellowship; NSF(National Science Foundation (NSF)); INSU(Centre National de la Recherche Scientifique (CNRS))	We thank G. Jiang for guidance in the field and for providing samples, V. Orphan and W. Fischer for discussion and advice, M. Kennedy for supporting fieldwork and use of analytical equipment, and E. Peterman and K. Morrison for laboratory work. C. Ma and M. Anderson are thanked for analytical assistance and advice. This work was supported by an O.K. Earl Postdoctoral fellowship (to T.F.B.), by the NSF EAR and GEG programmes (to J.M.E.), and by INSU (to M.B.). Part of the work of M.B. is IPGP contribution 3138.	Bechtel A, 1999, CHEM GEOL, V156, P191, DOI 10.1016/S0009-2541(98)00185-5; Boles JR, 2004, AAPG BULL, V88, P947, DOI 10.1306/02090403040; Bristow TF, 2009, P NATL ACAD SCI USA, V106, P13190, DOI 10.1073/pnas.0901080106; Campbell KA, 2006, PALAEOGEOGR PALAEOCL, V232, P362, DOI 10.1016/j.palaeo.2005.06.018; Chen DZ, 2009, CHEM GEOL, V258, P168, DOI 10.1016/j.chemgeo.2008.10.016; Condon D, 2005, SCIENCE, V308, P95, DOI 10.1126/science.1107765; DICKENS GR, 1995, PALEOCEANOGRAPHY, V10, P965, DOI 10.1029/95PA02087; Eigenbrode JL, 2006, P NATL ACAD SCI USA, V103, P15759, DOI 10.1073/pnas.0607540103; FARVER JR, 1994, EARTH PLANET SC LETT, V121, P575, DOI 10.1016/0012-821X(94)90092-2; FRIEDMAN I, 1977, 444KK US GEOL SURV; Ghosh P, 2006, GEOCHIM COSMOCHIM AC, V70, P1439, DOI 10.1016/j.gca.2005.11.014; Grotzinger JP, 1995, PALAIOS, V10, P578, DOI 10.2307/3515096; Halverson GP, 2007, PALAEOGEOGR PALAEOCL, V256, P103, DOI 10.1016/j.palaeo.2007.02.028; Hesselbo SP, 2000, NATURE, V406, P392, DOI 10.1038/35019044; Hoffman PF, 2002, TERRA NOVA, V14, P129, DOI 10.1046/j.1365-3121.2002.00408.x; Horita J, 2008, GEOCHIM COSMOCHIM AC, V72, pA391; Huntington KW, 2009, J MASS SPECTROM, V44, P1318, DOI 10.1002/jms.1614; Jacobsen SB, 1999, CHEM GEOL, V161, P37, DOI 10.1016/S0009-2541(99)00080-7; Jiang GQ, 2006, J SEDIMENT RES, V76, P978, DOI 10.2110/jsr.2006.086; Jiang GQ, 2003, NATURE, V426, P822, DOI 10.1038/nature02201; Kah LC, 2004, NATURE, V431, P834, DOI 10.1038/nature02974; Kasting JF, 2005, PRECAMBRIAN RES, V137, P119, DOI 10.1016/j.precamres.2005.03.002; Kennedy M, 2008, NATURE, V453, P642, DOI 10.1038/nature06961; Kennedy MJ, 2001, GEOLOGY, V29, P443, DOI 10.1130/0091-7613(2001)029<0443:APCCAI>2.0.CO;2; Knauth LP, 2009, NATURE, V460, P728, DOI 10.1038/nature08213; MACDONALD GJ, 1990, CLIMATIC CHANGE, V16, P247, DOI 10.1007/BF00144504; Machel HG, 1996, GEOL SOC AM BULL, V108, P1108, DOI 10.1130/0016-7606(1996)108<1108:IEFCCA>2.3.CO;2; Maekawa T, 2004, GEOCHEM J, V38, P129, DOI 10.2343/geochemj.38.129; Meunier, 2005, CLAYS, P471; Orsini L., 1976, J B AFES, V4, P269; Passey BH, 2010, P NATL ACAD SCI USA, V107, P11245, DOI 10.1073/pnas.1001824107; ROSENBAUM J, 1986, GEOCHIM COSMOCHIM AC, V50, P1147, DOI 10.1016/0016-7037(86)90396-0; Sawaki Y, 2010, PRECAMBRIAN RES, V176, P46, DOI 10.1016/j.precamres.2009.10.006; SWART PK, 1991, CHEM GEOL, V86, P89, DOI 10.1016/0168-9622(91)90055-2; Wang JS, 2008, GEOLOGY, V36, P347, DOI 10.1130/G24513A.1; Wegener G, 2009, BIOGEOSCIENCES, V6, P867, DOI 10.5194/bg-6-867-2009; WELHAN JA, 1988, CHEM GEOL, V71, P183, DOI 10.1016/0009-2541(88)90114-3	37	109	113	3	111	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 2	2011	474	7349					68	U92		10.1038/nature10096	http://dx.doi.org/10.1038/nature10096			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	771KV	21613997				2022-12-24	WOS:000291156700038
J	Pankhania, M; Judd, O; Ward, A				Pankhania, Miran; Judd, Owen; Ward, Andy			10-MINUTE CONSULTATION Otorrhoea	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Pankhania, Miran] Milton Keynes Dist Gen Hosp, Dept ENT, Milton Keynes MK6 5LD, Bucks, England; [Judd, Owen] Leicester Royal Infirm, Dept ENT, Leicester LE1 5WW, Leics, England; [Ward, Andy] S Wigston Hlth Ctr, Leicester LE18 4SE, Leics, England	University of Leicester	Pankhania, M (corresponding author), Milton Keynes Dist Gen Hosp, Dept ENT, Milton Keynes MK6 5LD, Bucks, England.	pank@doctors.org.uk	Ward, Andy/AAH-8950-2021	Ward, Andy/0000-0002-4955-1984; Judd, Owen/0000-0003-3112-931X				Beers SL, 2004, PEDIATR EMERG CARE, V20, P250, DOI 10.1097/01.pec.0000121246.99242.f5; Grevers G, 2010, INT J PEDIATR OTORHI, V74, P572, DOI 10.1016/j.ijporl.2010.03.049; McHugh TP, 2007, J EMERG MED, V32, P375, DOI 10.1016/j.jemermed.2006.08.015; Phillips JS, 2007, CLIN OTOLARYNGOL, V32, P330, DOI 10.1111/j.1749-4486.2007.01532.x	4	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 20	2011	342								d2299	10.1136/bmj.d2299	http://dx.doi.org/10.1136/bmj.d2299			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	768QT	21602234				2022-12-24	WOS:000290952200001
J	Giuseppone, N; Lutz, JF				Giuseppone, Nicolas; Lutz, Jean-Francois			MATERIALS CHEMISTRY Catalytic accordions	NATURE			English	Editorial Material							ENCAPSULATION; SYSTEMS		[Giuseppone, Nicolas] Univ Strasbourg, Fac Chem, F-67034 Strasbourg, France; [Giuseppone, Nicolas] CNRS, Inst Charles Sadron, UPR22, F-67034 Strasbourg, France	UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Giuseppone, N (corresponding author), Univ Strasbourg, Fac Chem, F-67034 Strasbourg, France.	giuseppone@unistra.fr; jflutz@unistra.fr	Giuseppone, Nicolas/J-1300-2016; Lutz, Jean-François/C-3264-2009	Giuseppone, Nicolas/0000-0003-4093-3000; Lutz, Jean-François/0000-0002-3893-2458				Badi N, 2009, CHEM SOC REV, V38, P3383, DOI 10.1039/b806413j; BRESLOW R, 1982, SCIENCE, V218, P532, DOI 10.1126/science.7123255; Douglas T, 1998, NATURE, V393, P152, DOI 10.1038/30211; Dwars T, 2005, ANGEW CHEM INT EDIT, V44, P7174, DOI 10.1002/anie.200501365; Hecht S, 2001, ANGEW CHEM INT EDIT, V40, P74, DOI 10.1002/1521-3773(20010105)40:1<74::AID-ANIE74>3.0.CO;2-C; Kang JM, 1997, NATURE, V385, P50, DOI 10.1038/385050a0; Kent SBH, 2009, CHEM SOC REV, V38, P338, DOI 10.1039/b700141j; Ouchi M, 2009, CHEM REV, V109, P4963, DOI 10.1021/cr900234b; Terashima T, 2011, J AM CHEM SOC, V133, P4742, DOI 10.1021/ja2004494	9	37	37	0	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 5	2011	473	7345					40	41		10.1038/473040a	http://dx.doi.org/10.1038/473040a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759CQ	21544141				2022-12-24	WOS:000290218300026
J	Mombouli, JV; Ostroff, SM				Mombouli, Jean-Vivien; Ostroff, Stephen M.			The remaining smallpox stocks: the healthiest outcome	LANCET			English	Editorial Material							MONKEYPOX; CONGO		[Ostroff, Stephen M.] Penn Dept Hlth Harrisburg, Bur Epidemiol, Harrisburg, PA 17120 USA; [Mombouli, Jean-Vivien] Natl Publ Hlth Lab, Brazzaville, Rep Congo		Ostroff, SM (corresponding author), Penn Dept Hlth Harrisburg, Bur Epidemiol, Harrisburg, PA 17120 USA.	sostroff@state.pa.us						Advisory Group of Independent Experts to review the smallpox research programme (AGIES), 2010, ADV GROUP IND EXP RE; [Anonymous], 1999, SMALLP ER DESTR VAR; Damon IK, 2006, NEW ENGL J MED, V355, P962, DOI 10.1056/NEJMc060792; Henderson DA, 1998, EMERG INFECT DIS, V4, P488, DOI 10.3201/eid0403.980340; [Institute of Medicine National Acadamies of Sciences USA], 2009, LIV VAR VIR CONS CON; Khan AS, 2010, SCI REV VARIOLA VIRU; Learned LA, 2005, AM J TROP MED HYG, V73, P428, DOI 10.4269/ajtmh.2005.73.428; Rimoin AW, 2010, P NATL ACAD SCI USA, V107, P16262, DOI 10.1073/pnas.1005769107; WHO, 2007, SMALLP ER DESTR VAR	9	6	6	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 7	2012	379	9810					10	12		10.1016/S0140-6736(11)60694-6	http://dx.doi.org/10.1016/S0140-6736(11)60694-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	873WC	21601271				2022-12-24	WOS:000298913000011
J	Simon, A; Warszawski, J; Kariyawasam, D; Le Chenadec, J; Benhammou, V; Czernichow, P; Foissac, F; Laborde, K; Treluyer, JM; Firtion, G; Layouni, I; Munzer, M; Bavoux, F; Polak, M; Blanche, S				Simon, Albane; Warszawski, Josiane; Kariyawasam, Dulanjalee; Le Chenadec, Jerome; Benhammou, Valerie; Czernichow, Paul; Foissac, Frantz; Laborde, Kathleen; Treluyer, Jean-Marc; Firtion, Ghislaine; Layouni, Incs; Munzer, Martine; Bavoux, Francoise; Polak, Michel; Blanche, Stephane		ANRS French Perinatal Cohort Study	Association of Prenatal and Postnatal Exposure to Lopinavir-Ritonavir and Adrenal Dysfunction Among Uninfected Infants of HIV-Infected Mothers	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PARTIAL ALDOSTERONE RESISTANCE; LOPINAVIR/RITONAVIR; PHARMACOKINETICS; INSUFFICIENCY; HYPERPLASIA; BIRTH; AGE; INHIBITORS; PREGNANCY; CHILDREN	Context Lopinavir-ritonavir is a human immunodeficiency virus 1 (HIV-1) protease inhibitor boosted by ritonavir, a cytochrome p450 inhibitor. A warning about its tolerance in premature newborns was recently released, and transient elevation of 17-hydroxyprogesterone (17OHP) was noted in 2 newborns treated with lopinavir-ritonavir in France. Objective To evaluate adrenal function in newborns postnatally treated with lopinavir-ritonavir. Design, Setting, and Participants Retrospective cross-sectional analysis of the database from the national screening for congenital adrenal hyperplasia (CAH) and the French Perinatal Cohort. Comparison of HIV-1-uninfected newborns postnatally treated with lopinavir-ritonavir and controls treated with standard zidovudine. Main Outcome Measures Plasma 17OHP and dehydroepiandrosterone-sulfate (DHEA-S) concentrations during the first week of treatment. Clinical and biological symptoms compatible with adrenal deficiency. Results Of 50 HIV-1-uninfected newborns who received lopinavir-ritonavir at birth for a median of 30 days (interquartile range [IQR], 25-33), 7 (14%) had elevated 17OHP levels greater than 16.5 ng/mL for term infants (>23.1 ng/mL for preterm) on days 1 to 6 vs 0 of 108 controls having elevated levels. The median 17OHP concentration for 42 term newborns treated with lopinavir-ritonavir was 9.9 ng/mL (IQR, 3.9-14.1 ng/mL) vs 3.7 ng/mL (IQR, 2.6-5.3 ng/mL) for 93 term controls (P < .001). The difference observed in median 17OHP values between treated newborns and controls was higher in children also exposed in utero (11.5 ng/mL vs 3.7 ng/mL; P < .001) than not exposed in utero (6.9 ng/mL vs 3.3 ng/mL; P =. 03). The median DHEA-S concentration among 18 term newborns treated with lopinavir-ritonavir was 9242 ng/mL (IQR, 1347-25 986 ng/mL) compared with 484 ng/mL (IQR, 218-1308 ng/mL) among 17 term controls (P < .001). The 17OHP and DHEA-S concentrations were positively correlated (r = 0.53; P =. 001). All term newborns treated with lopinavir-ritonavir were asymptomatic, although 3 premature newborns experienced life-threatening symptoms compatible with adrenal insufficiency, including hyponatremia and hyperkalemia with, in 1 case, cardiogenic shock. All symptoms resolved following completion of the lopinavir-ritonavir treatment. Conclusion Among newborn children of HIV-1-infected mothers exposed in utero to lopinavir-ritonavir, postnatal treatment with a lopinavir-ritonavir-based regimen, compared with a zidovudine-based regimen, was associated with transient adrenal dysfunction.	[Blanche, Stephane] Hop Necker Enfants Malad, AP HP, Unite Immunol Hematol Pediat, F-75015 Paris, France; [Simon, Albane; Kariyawasam, Dulanjalee; Polak, Michel] Assoc Francaise Depistage & Prevent Handicaps Enf, Unite Endocrinol Pediat, Paris, France; [Foissac, Frantz; Treluyer, Jean-Marc] Hop Necker Enfants Malad, AP HP, Paris Ctr, Unite Rech Clin, F-75015 Paris, France; [Laborde, Kathleen] Hop Necker Enfants Malad, AP HP, Lab Explorat Fonct, F-75015 Paris, France; [Polak, Michel] Hop Necker Enfants Malad, AP HP, INSERM, U845, F-75015 Paris, France; [Foissac, Frantz; Treluyer, Jean-Marc; Blanche, Stephane] EA 3620, Paris, France; [Simon, Albane; Kariyawasam, Dulanjalee; Polak, Michel] Univ Paris 05, Paris, France; [Warszawski, Josiane; Le Chenadec, Jerome; Benhammou, Valerie] Equipe VIH & IST, INSERM, CESP U1018, Le Kremlin Bicetre, France; [Warszawski, Josiane] Univ & Fac Med Paris Sud, Le Kremlin Bicetre, France; [Warszawski, Josiane] Hop Bicetre, AP HP, Serv Epidemiol & Sante Publ, Le Kremlin Bicetre, France; [Firtion, Ghislaine] Hop Cochin Port Royal, AP HP, Serv Neonatol, Creteil, France; [Layouni, Incs] Hop Intercommunal Creteil, Serv Neonatol, Creteil, France; [Munzer, Martine] Ctr Hosp Univ Reims, Serv Pediat, Reims, France; [Bavoux, Francoise] Hop Cochin St Vincent Paul, AP HP, Unite Pharmacovigilance Pediat, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); CHI Creteil; CHU de Reims; Universite de Reims Champagne-Ardenne; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite	Blanche, S (corresponding author), Hop Necker Enfants Malad, AP HP, Unite Immunol Hematol Pediat, 149 Rue Sevres, F-75015 Paris, France.	stephane.blanche@nck.aphp.fr	kariyawasam, dulanjalee/AAH-1867-2021; Foix-L'Hélias, Laurence/AAH-4933-2019; treluyer, Jean-Marc/F-8036-2010; Matheron, Sophie/D-7420-2017	Foix-L'Hélias, Laurence/0000-0002-5699-4839; Matheron, Sophie/0000-0001-7879-6553	Abbott Laboratories; Pfizer; IPSEN; Sandoz-SAS Laboratories	Abbott Laboratories(Abbott Laboratories); Pfizer(Pfizer); IPSEN(Ipsen); Sandoz-SAS Laboratories(Randox Laboratories)	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Warszawski reported having obtained a research grant from Abbott Laboratories for another study concerning lopinavir-ritonavir in children. Dr Polak reported having received support for educational presentations and grant support from Pfizer, IPSEN, and Sandoz-SAS Laboratories. Dr Blanche reported having received support for travel to meetings from Abbott Laboratories and honoraria for lectures and for development of educational presentations from Astellas, Boehringer Ingelheim, GlaxoSmithKline, and Tibotec Laboratories. No other disclosures were reported.r This study was supported by the French Agence Nationale de Recherche sur le SIDA (ANRS) and Agence Francaise de Securite Sanitaire et des Produits de Sante (AFSSAPS).	[Anonymous], KAL LOP RIT LAB CHAN; [Anonymous], PRISE CHARGE MED PER; Beal B., 1992, NONMEM USERS GUIDE; Benhammou V, 2008, AIDS, V22, P2165, DOI 10.1097/QAD.0b013e328311d18b; BLANCHE S, 1989, NEW ENGL J MED, V320, P1643, DOI 10.1056/NEJM198906223202502; Bornstein SR, 2009, NEW ENGL J MED, V360, P2328, DOI 10.1056/NEJMra0804635; Cavarzere P, 2009, EUR J ENDOCRINOL, V161, P285, DOI 10.1530/EJE-09-0145; Chadwick EG, 2008, AIDS, V22, P249, DOI 10.1097/QAD.0b013e3282f2be1d; Chadwick EG, 2009, PEDIATR INFECT DIS J, V28, P215, DOI 10.1097/INF.0b013e31818cc053; Chiappini E, 2009, CLIN INFECT DIS, V49, P1618, DOI 10.1086/644774; Coovadia H, 2009, CURR OPIN HIV AIDS, V4, P319, DOI 10.1097/COH.0b013e32832a9a17; Croxtall JD, 2010, DRUGS, V70, P1885, DOI 10.2165/11204950-000000000-00000; DEPERETTI E, 1978, J CLIN ENDOCR METAB, V47, P572, DOI 10.1210/jcem-47-3-572; DHONDT JL, 1986, J INHERIT METAB DIS, V9, P147, DOI 10.1007/BF01800869; Fernandez EF, 2009, J PERINATOL, V29, pS44, DOI 10.1038/jp.2009.24; Foisy MM, 2008, HIV MED, V9, P389, DOI 10.1111/j.1468-1293.2008.00579.x; Forest MG., 2003, DIAGNOSTICS ENDOCRIN, V3, P372; Gingelmaier A, 2006, AIDS, V20, P1737, DOI 10.1097/01.aids.0000242820.67001.2c; Haile-Selassie H, HIV MED, DOI [10.1111/j.1468-1293.2010.00902, DOI 10.1111/J.1468-1293.2010.00902]; Jullien V, 2006, ANTIMICROB AGENTS CH, V50, P3548, DOI 10.1128/AAC.00943-05; Lopriore E, 2007, AIDS, V21, P2564, DOI 10.1097/QAD.0b013e3282f12060; Lyall E G, 2001, HIV Med, V2, P314, DOI 10.1046/j.1464-2662.2001.00082.x; Martinerie L, 2009, PEDIATR RES, V66, P323, DOI 10.1203/PDR.0b013e3181b1bbec; Martinerie L, 2009, ENDOCRINOLOGY, V150, P4414, DOI 10.1210/en.2008-1498; McArthur MA, 2009, PEDIATR INFECT DIS J, V28, P1127, DOI 10.1097/INF.0b013e3181acd17e; Neary N, 2010, CURR OPIN ENDOCRINOL, V17, P217, DOI 10.1097/MED.0b013e328338f608; Nielsen KN, 2011, 18 C RETR OPP INF CR; Ozturk IC, 2000, MOL DIAGN, V5, P47, DOI 10.2165/00066982-200005010-00011; Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission, REC US ANT DRUGS PRE; Shapiro RL, 2010, NEW ENGL J MED, V362, P2282, DOI 10.1056/NEJMoa0907736; Urien S, 2011, BRIT J CLIN PHARMACO, V71, P956, DOI 10.1111/j.1365-2125.2011.03926.x; Watterberg Kristi L, 2004, Semin Neonatol, V9, P13, DOI 10.1016/j.siny.2003.08.003; White PC, 2009, NAT REV ENDOCRINOL, V5, P490, DOI 10.1038/nrendo.2009.148; Yeh RF, 2009, ANTIMICROB AGENTS CH, V53, P2367, DOI 10.1128/AAC.01523-08	34	62	62	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 6	2011	306	1					70	78		10.1001/jama.2011.915	http://dx.doi.org/10.1001/jama.2011.915			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	787LV	21730243	Bronze			2022-12-24	WOS:000292378700022
J	Chow, EJ; Mueller, BA; Baker, KS; Cushing-Haugen, KL; Flowers, MED; Martin, PJ; Friedman, DL; Lee, SJ				Chow, Eric J.; Mueller, Beth A.; Baker, K. Scott; Cushing-Haugen, Kara L.; Flowers, Mary E. D.; Martin, Paul J.; Friedman, Debra L.; Lee, Stephanie J.			Cardiovascular Hospitalizations and Mortality Among Recipients of Hematopoietic Stem Cell Transplantation	ANNALS OF INTERNAL MEDICINE			English	Article							LONG-TERM SURVIVORS; BONE-MARROW-TRANSPLANTATION; VERSUS-HOST-DISEASE; ADMINISTRATIVE DATA; EUROPEAN-GROUP; VASCULAR ENDOTHELIUM; METABOLIC SYNDROME; KIDNEY-DISEASE; HEART-FAILURE; UNITED-STATES	Background: Hematopoietic stem cell transplantation (HSCT) is increasingly used to treat multiple malignant and nonmalignant conditions. The risk for cardiovascular disease after the procedure has not been well-described. Objective: To compare rates and hazards of cardiovascular-related hospitalization and death among persons who were still alive at least 2 years after HSCT with those in a population-based sample. Design: Retrospective cohort study. Setting: Comprehensive cancer center. Patients: 1491 patients who had survived 2 years or longer after HSCT received between 1985 and 2006, and frequency-matched persons who were randomly selected from drivers' license files in the state of Washington. Measurements: Cardiovascular hospitalizations and death, as determined from statewide hospital discharge records and death registries in Washington. Results: Compared with the general population, transplant recipients experienced increased cardiovascular death (adjusted incidence rate difference, 3.6 per 1000 person-years [95% CI, 1.7 to 5.5]). Recipients also had an increased cumulative incidence of ischemic heart disease, cardiomyopathy or heart failure, stroke, vascular diseases, and rhythm disorders and an increased incidence of related conditions that predispose toward more serious cardiovascular disease (hypertension, renal disease, dyslipidemia, and diabetes). No consistent differences in hazards were observed after total-body irradiation or receipt of an allogeneic versus an autologous graft, aside from an increased rate of hypertension among recipients of allogeneic grafts. Disease relapse after transplantation was associated with an increased hazard of cardiovascular death (hazard ratio, 2.3 [CI, 1.1 to 4.8]). Limitation: All patients received HSCT at a single institution, and no information was available on pretransplantation treatment and lifestyle factors that may influence risk for cardiovascular disease. Conclusion: Increased rates of cardiovascular disease should be taken into account when caring for patients who have received HSCT. Future efforts should be directed toward improved screening and controlling of factors that predispose toward cardiovascular disease.	[Chow, Eric J.] Seattle Childrens Hosp, Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA; Univ Washington, Seattle, WA 98195 USA; Vanderbilt Univ, Nashville, TN USA; Vanderbilt Ingram Canc Ctr, Nashville, TN USA	Fred Hutchinson Cancer Center; Seattle Children's Hospital; University of Washington; University of Washington Seattle; Vanderbilt University; Vanderbilt University	Chow, EJ (corresponding author), Seattle Childrens Hosp, Fred Hutchinson Canc Res Ctr, POB 19024,M4-C308, Seattle, WA 98109 USA.	ericchow@u.washington.edu	Chow, Eric/GWV-1056-2022; Chow, Eric/AAU-8380-2021	Chow, Eric/0000-0001-7712-961X; Chow, Eric/0000-0001-7712-961X	American Society for Blood and Marrow Transplantation; Leukemia and Lymphoma Society; Seattle Children's Research Institute; NATIONAL CANCER INSTITUTE [U54CA091408] Funding Source: NIH RePORTER	American Society for Blood and Marrow Transplantation; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Seattle Children's Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Primary Funding Source: The American Society for Blood and Marrow Transplantation, the Leukemia and Lymphoma Society, and the Seattle Children's Research Institute.	Annaloro C, 2008, BONE MARROW TRANSPL, V41, P797, DOI 10.1038/sj.bmt.1705972; Armenian SH, 2008, J CLIN ONCOL, V26, P5537, DOI 10.1200/JCO.2008.17.7428; Baker KS, 2007, BLOOD, V109, P1765, DOI 10.1182/blood-2006-05-022335; Bhatia S, 2005, BLOOD, V105, P4215, DOI 10.1182/blood-2005-01-0035; Bhatia S, 2007, BLOOD, V110, P3784, DOI 10.1182/blood-2007-03-082933; Biedermann BC, 2008, BEST PRACT RES CL HA, V21, P129, DOI 10.1016/j.beha.2008.02.003; Centers for Disease Control and Prevention, GROWTH CHARTS; Chao NJ, 2008, THOMAS HEMATOPOTETIC, P1257, DOI DOI 10.1016/J.BEHA.2008.02.002; Chow EJ, 2010, BIOL BLOOD MARROW TR, V16, P1674, DOI 10.1016/j.bbmt.2010.05.016; GIANNI L, 2008, BLOOD, V26, P3777; Gooley TA, 1999, STAT MED, V18, P695, DOI 10.1002/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.3.CO;2-F; Gooley TA, 2010, NEW ENGL J MED, V363, P2091, DOI 10.1056/NEJMoa1004383; Herman AA, 1997, PAEDIATR PERINAT EP, V11, P5, DOI 10.1046/j.1365-3016.11.s1.11.x; Hingorani S, 2007, BONE MARROW TRANSPL, V39, P223, DOI 10.1038/sj.bmt.1705573; Hoffmeister PA, 2004, J PEDIAT HEMATOL ONC, V26, P81, DOI 10.1097/00043426-200402000-00003; HOROWITZ MM, 2008, THOMAS HEMATOPOIETIC, P15; IVES DG, 2009, MED CARE, V57, P133; Kiyota Y, 2004, AM HEART J, V148, P99, DOI 10.1016/j.ahj.2004.02.013; Lee DS, 2005, MED CARE, V43, P182, DOI 10.1097/00005650-200502000-00012; Majhail NS, 2009, BONE MARROW TRANSPL, V43, P49, DOI 10.1038/bmt.2008.263; Martin PJ, 2010, J CLIN ONCOL, V28, P1011, DOI 10.1200/JCO.2009.25.6693; Meacham LR, 2010, CANCER EPIDEM BIOMAR, V19, P170, DOI 10.1158/1055-9965.EPI-09-0555; Mensah GA, 2005, CIRCULATION, V111, P1233, DOI 10.1161/01.CIR.0000158136.76824.04; *OFF FIN MAN STAT, AG SEX RAC HISP OR; *OFF FIN MAN STAT, MIGR, DOI DOI 10.1016/J.ANNEPIDEM.2003.09.016; Powell H, 2001, J CLIN EPIDEMIOL, V54, P687, DOI 10.1016/S0895-4356(00)00364-4; Quan H, 2004, MED CARE, V42, P801, DOI 10.1097/01.mlr.0000132391.59713.0d; Rizzo JD, 2006, BIOL BLOOD MARROW TR, V12, P138, DOI 10.1016/j.bbmt.2005.09.012; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Sarnak MJ, 2003, CIRCULATION, V108, P2154, DOI 10.1161/01.CIR.0000095676.90936.80; Saydah SH, 2004, ANN EPIDEMIOL, V14, P507, DOI 10.1016/j.annepidem.2003.09.016; Schmitz N, 2006, BLOOD, V108, P4288, DOI 10.1182/blood-2006-05-024042; Shankar SM, 2007, CANCER EPIDEM BIOMAR, V16, P834, DOI 10.1158/1055-9965.EPI-06-0714; Socie G, 2003, BLOOD, V101, P3373, DOI 10.1182/blood-2002-07-2231; SUN CL, 2010, CIRCULATION, V116, P3129; Taskinen M, 2000, LANCET, V356, P993, DOI 10.1016/S0140-6736(00)02717-3; Tichelli A, 2008, BEST PRACT RES CL HA, V21, P139, DOI 10.1016/j.beha.2008.02.002; Tichelli A, 2008, HAEMATOL-HEMATOL J, V93, P1203, DOI 10.3324/haematol.12949; Tirschwell DL, 2002, STROKE, V33, P2465, DOI 10.1161/01.STR.0000032240.28636.BD; Yeh ETH, 2004, CIRCULATION, V109, P3122, DOI 10.1161/01.CIR.0000133187.74800.B9	40	132	135	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 5	2011	155	1					21	+		10.7326/0003-4819-155-1-201107050-00004	http://dx.doi.org/10.7326/0003-4819-155-1-201107050-00004			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	788MA	21727290				2022-12-24	WOS:000292447800003
J	Ely, EW				Ely, E. Wesley			Cyanosis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Ely, E. Wesley] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA; [Ely, E. Wesley] VA GRECC, Nashville, TN USA	Vanderbilt University; Geriatric Research Education & Clinical Center	Ely, EW (corresponding author), Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA.	wes.ely@vanderbilt.edu	Adeyinka, Adebayo/K-7917-2019; Ely, E. Wesley/Z-2018-2019	Ely, E. Wesley/0000-0003-3957-2172					0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 15	2011	305	23					2388	2389		10.1001/jama.2011.816	http://dx.doi.org/10.1001/jama.2011.816			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	777EB	21673285				2022-12-24	WOS:000291597300001
J	Paeschke, K; Capra, JA; Zakian, VA				Paeschke, Katrin; Capra, John A.; Zakian, Virginia A.			DNA Replication through G-Quadruplex Motifs Is Promoted by the Saccharomyces cerevisiae Pif1 DNA Helicase	CELL			English	Article							FALSE DISCOVERY RATE; TELOMERE ELONGATION; FORK PROGRESSION; YEAST; RRM3P; INSTABILITY; SEQUENCES; PROTEIN; GENES; PAUSE	G-quadruplex (G4) DNA structures are extremely stable four-stranded secondary structures held together by noncanonical G-G base pairs. Genome-wide chromatin immunoprecipitation was used to determine the in vivo binding sites of the multifunctional Saccharomyces cerevisiae Pif1 DNA helicase, a potent unwinder of G4 structures in vitro. G4 motifs were a significant subset of the high-confidence Pif1-binding sites. Replication slowed in the vicinity of these motifs, and they were prone to breakage in Pif1-deficient cells, whereas non-G4 Pif1-binding sites did not show this behavior. Introducing many copies of G4 motifs caused slow growth in replication-stressed Pif1-deficient cells, which was relieved by spontaneous mutations that eliminated their ability to form G4 structures, bind Pif1, slow DNA replication, and stimulate DNA breakage. These data suggest that G4 structures form in vivo and that they are resolved by Pif1 to prevent replication fork stalling and DNA breakage.	[Paeschke, Katrin; Zakian, Virginia A.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Capra, John A.] Univ Calif San Francisco, Gladstone Inst, San Francisco, CA 94158 USA	Princeton University; University of California System; University of California San Francisco; The J David Gladstone Institutes	Zakian, VA (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.	vzakian@princeton.edu	Capra, Tony/C-7784-2013		NIH [GM26938]; Deutsche Forschungsgemeinschaft; NJCCR; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026938, R37GM026938] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NJCCR; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank B. A. Lenzmeier for strains and advice on the recombination assay and C. Webb, N. Sabouri, M. Bochman, and J. Broach for comments on the manuscript. This work was supported by NIH grant GM26938 (V.A.Z.) and postdoctoral fellowships from Deutsche Forschungsgemeinschaft and NJCCR (K.P.).	Azvolinsky A, 2006, GENE DEV, V20, P3104, DOI 10.1101/gad.1478906; Azvolinsky A, 2009, MOL CELL, V34, P722, DOI 10.1016/j.molcel.2009.05.022; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bochman ML, 2010, DNA REPAIR, V9, P237, DOI 10.1016/j.dnarep.2010.01.008; Boule JB, 2005, NATURE, V438, P57, DOI 10.1038/nature04091; Boule JB, 2007, NUCLEIC ACIDS RES, V35, P5809, DOI 10.1093/nar/gkm613; BREWER BJ, 1987, CELL, V51, P463, DOI 10.1016/0092-8674(87)90642-8; Buck MJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-11-r97; Capra JA, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000861; Cheung I, 2002, NAT GENET, V31, P405, DOI [10.1038/ng928, 10.1038/417405a]; Deshpande AM, 1996, SCIENCE, V272, P1030, DOI 10.1126/science.272.5264.1030; Downs JA, 2000, NATURE, V408, P1001, DOI 10.1038/35050000; FOURY F, 1985, EMBO J, V4, P3525, DOI 10.1002/j.1460-2075.1985.tb04112.x; Freudenreich CH, 1998, SCIENCE, V279, P853, DOI 10.1126/science.279.5352.853; Gasser R, 1996, J MOL BIOL, V258, P224, DOI 10.1006/jmbi.1996.0245; GREENFEDER SA, 1992, MOL CELL BIOL, V12, P4056, DOI 10.1128/MCB.12.9.4056; Hershman SG, 2008, NUCLEIC ACIDS RES, V36, P144, DOI 10.1093/nar/gkm986; Huppert JL, 2008, BIOCHIMIE, V90, P1140, DOI 10.1016/j.biochi.2008.01.014; Huppert JL, 2010, FEBS J, V277, P3452, DOI 10.1111/j.1742-4658.2010.07758.x; Ivessa AS, 2000, CELL, V100, P479, DOI 10.1016/S0092-8674(00)80683-2; Ivessa AS, 2003, MOL CELL, V12, P1525, DOI 10.1016/S1097-2765(03)00456-8; LEA DE, 1949, J GENET, V49, P264, DOI 10.1007/BF02986080; Lipps HJ, 2009, TRENDS CELL BIOL, V19, P414, DOI 10.1016/j.tcb.2009.05.002; London TBC, 2008, J BIOL CHEM, V283, P36132, DOI 10.1074/jbc.M808152200; Mateyak MK, 2006, CELL CYCLE, V5, P2796, DOI 10.4161/cc.5.23.3524; Myung K, 2001, NATURE, V411, P1073, DOI 10.1038/35082608; Nakken S, 2009, NUCLEIC ACIDS RES, V37, P5749, DOI 10.1093/nar/gkp590; Paeschke K, 2010, FEBS LETT, V584, P3760, DOI 10.1016/j.febslet.2010.07.007; Ribeyre C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000475; RUNGE KW, 1989, MOL CELL BIOL, V9, P1488, DOI 10.1128/MCB.9.4.1488; Sanders CM, 2010, BIOCHEM J, V430, P119, DOI 10.1042/BJ20100612; SCHULZ VP, 1994, CELL, V76, P145, DOI 10.1016/0092-8674(94)90179-1; SIKORSKI RS, 1989, GENETICS, V122, P19; Storey JD, 2003, ANN STAT, V31, P2013, DOI 10.1214/aos/1074290335; Vega LR, 2007, PLOS GENET, V3, P1065, DOI 10.1371/journal.pgen.0030105; Yamagata K, 1998, P NATL ACAD SCI USA, V95, P8733, DOI 10.1073/pnas.95.15.8733; Zhou JQ, 2000, SCIENCE, V289, P771, DOI 10.1126/science.289.5480.771	37	398	407	2	72	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 27	2011	145	5					678	691		10.1016/j.cell.2011.04.015	http://dx.doi.org/10.1016/j.cell.2011.04.015			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	769MR	21620135	Green Accepted, Bronze			2022-12-24	WOS:000291018600009
J	Xu, CR; Cole, PA; Meyers, DJ; Kormish, J; Dent, S; Zaret, KS				Xu, Cheng-Ran; Cole, Philip A.; Meyers, David J.; Kormish, Jay; Dent, Sharon; Zaret, Kenneth S.			Chromatin "Prepattern" and Histone Modifiers in a Fate Choice for Liver and Pancreas	SCIENCE			English	Article							TRANSCRIPTION FACTORS; STEM-CELLS; IN-VITRO; GENE; EXPRESSION; ENDODERM; PROMOTER; DISTINCT; ACETYLTRANSFERASE; DIFFERENTIATION	Transcriptionally silent genes can be marked by histone modifications and regulatory proteins that indicate the genes' potential to be activated. Such marks have been identified in pluripotent cells, but it is unknown how such marks occur in descendant, multipotent embryonic cells that have restricted cell fate choices. We isolated mouse embryonic endoderm cells and assessed histone modifications at regulatory elements of silent genes that are activated upon liver or pancreas fate choices. We found that the liver and pancreas elements have distinct chromatin patterns. Furthermore, the histone acetyltransferase P300, recruited via bone morphogenetic protein signaling, and the histone methyltransferase Ezh2 have modulatory roles in the fate choice. These studies reveal a functional "prepattern" of chromatin states within multipotent progenitors and potential targets to modulate cell fate induction.	[Xu, Cheng-Ran; Kormish, Jay; Zaret, Kenneth S.] Univ Penn, Sch Med, Dept Cell & Dev Biol, Inst Regenerat Med,Epigenet Program, Philadelphia, PA 19104 USA; [Cole, Philip A.; Meyers, David J.] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [Dent, Sharon] Univ Texas MD Anderson Canc Ctr, Dept Mol Carcinogenesis, Smithville, TX 78957 USA	University of Pennsylvania; Johns Hopkins University; University of Texas System; UTMD Anderson Cancer Center	Zaret, KS (corresponding author), Univ Penn, Sch Med, Dept Cell & Dev Biol, Inst Regenerat Med,Epigenet Program, Philadelphia, PA 19104 USA.	zaret@upenn.edu	Dent, Sharon YR/F-1746-2011	Dent, Sharon YR/0000-0002-4824-3269	FAMRI Foundation; NIH [U54MH084691, RO1 GM067718, R37GM36477, U01DK072503]; Acylin Therapeutics; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK072503] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067718, R37GM036477, R01GM062437] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH084691] Funding Source: NIH RePORTER	FAMRI Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Acylin Therapeutics; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank T. Jiang, R. Hardy, J. Oesterling, and W. DeMuth for assistance; Z. Zhang, J. Xu, and S. Hua for advice; P. Streeter and K. Kaestner for reagents; J. Epstein, E. Wandzioch, D. Metzger, A. Wecker, A. Hines, and D. Freedman-Cass for comments; and E. Pytko for preparing the manuscript. Supported by the FAMRI Foundation and NIH grant U54MH084691 (P.A.C. and D.J.M.), NIH grant RO1 GM067718 (S.D.), and NIH grants R37GM36477 and U01DK072503 (K.S.Z.). There is a patent on P300i: "Methods and compositions for modulating p300/CBP activity" (pub. WO/2008/157680; international application PCT/US2008/067477 to D.J.M. and P.A.C.). P.A.C. is co-founder, owns equity, and receives consulting fees as science advisor to Acylin Therapeutics, which is attempting the development of clinically useful HAT inhibitors and licenses from Johns Hopkins some of our discoveries related to C646.	Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bort R, 2004, DEVELOPMENT, V131, P797, DOI 10.1242/dev.00965; Bowers EM, 2010, CHEM BIOL, V17, P471, DOI 10.1016/j.chembiol.2010.03.006; Boyer DF, 2006, DEV BIOL, V298, P616, DOI 10.1016/j.ydbio.2006.07.020; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Chu GC, 2004, DEVELOPMENT, V131, P3501, DOI 10.1242/dev.01248; COSTA RH, 1989, MOL CELL BIOL, V9, P1415, DOI 10.1128/MCB.9.4.1415; Dahl JA, 2008, NAT PROTOC, V3, P1032, DOI 10.1038/nprot.2008.68; de Caestecker MP, 2000, J BIOL CHEM, V275, P2115, DOI 10.1074/jbc.275.3.2115; Deutsch G, 2001, DEVELOPMENT, V128, P871; FEUERMAN MH, 1989, MOL CELL BIOL, V9, P4204, DOI 10.1128/MCB.9.10.4204; Gadue P, 2009, STEM CELLS, V27, P2103, DOI 10.1002/stem.147; Gao N, 2008, GENE DEV, V22, P3435, DOI 10.1101/gad.1752608; Gerrish K, 2004, MOL ENDOCRINOL, V18, P533, DOI 10.1210/me.2003-0371; GORSKI K, 1986, CELL, V47, P767, DOI 10.1016/0092-8674(86)90519-2; Gualdi R, 1996, GENE DEV, V10, P1670, DOI 10.1101/gad.10.13.1670; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lee CS, 2005, NATURE, V435, P944, DOI 10.1038/nature03649; Lin WC, 2008, DEV DYNAM, V237, P928, DOI 10.1002/dvdy.21479; LIU JK, 1991, MOL CELL BIOL, V11, P773, DOI 10.1128/MCB.11.2.773; Pouponnot C, 1998, J BIOL CHEM, V273, P22865, DOI 10.1074/jbc.273.36.22865; Qiao LP, 2006, J BIOL CHEM, V281, P39915, DOI 10.1074/jbc.M607215200; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Roth SY, 2001, ANNU REV BIOCHEM, V70, P81, DOI 10.1146/annurev.biochem.70.1.81; Schiltz RL, 1999, J BIOL CHEM, V274, P1189, DOI 10.1074/jbc.274.3.1189; Seydel F, 2008, J AUTOIMMUN, V31, P377, DOI 10.1016/j.jaut.2008.08.010; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Su IH, 2003, NAT IMMUNOL, V4, P124, DOI 10.1038/ni876; van Arensbergen J, 2010, GENOME RES, V20, P722, DOI 10.1101/gr.101709.109; Wandzioch E, 2009, SCIENCE, V324, P1707, DOI 10.1126/science.1174497; Xu J, 2009, GENE DEV, V23, P2824, DOI 10.1101/gad.1861209; Xu WT, 2000, NAT GENET, V26, P229, DOI 10.1038/79973; Yamauchi T, 2000, P NATL ACAD SCI USA, V97, P11303, DOI 10.1073/pnas.97.21.11303; Yao TP, 1998, CELL, V93, P361, DOI 10.1016/S0092-8674(00)81165-4; Zaret KS, 2008, NAT REV GENET, V9, P329, DOI 10.1038/nrg2318	36	153	158	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 20	2011	332	6032					963	966		10.1126/science.1202845	http://dx.doi.org/10.1126/science.1202845			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766FO	21596989	Green Accepted			2022-12-24	WOS:000290766600043
J	Shekelle, PG; Pronovost, PJ; Wachter, RM; Taylor, SL; Dy, SM; Foy, R; Hempel, S; McDonald, KM; Ovretveit, J; Rubenstein, LV; Adams, AS; Angood, PB; Bates, DW; Bickman, L; Carayon, P; Donaldson, L; Duan, N; Farley, DO; Greenhalgh, T; Haughom, J; Lake, ET; Lilford, R; Lohr, KN; Meyer, GS; Miller, MR; Neuhauser, DV; Ryan, G; Saint, S; Shojania, KG; Shortell, SM; Stevens, DP; Walshe, K				Shekelle, Paul G.; Pronovost, Peter J.; Wachter, Robert M.; Taylor, Stephanie L.; Dy, Sydney M.; Foy, Robbie; Hempel, Susanne; McDonald, Kathryn M.; Ovretveit, John; Rubenstein, Lisa V.; Adams, Alyce S.; Angood, Peter B.; Bates, David W.; Bickman, Leonard; Carayon, Pascale; Donaldson, Liam; Duan, Naihua; Farley, Donna O.; Greenhalgh, Trisha; Haughom, John; Lake, Eileen T.; Lilford, Richard; Lohr, Kathleen N.; Meyer, Gregg S.; Miller, Marlene R.; Neuhauser, Duncan V.; Ryan, Gery; Saint, Sanjay; Shojania, Kaveh G.; Shortell, Stephen M.; Stevens, David P.; Walshe, Kieran			Advancing the Science of Patient Safety	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							EVIDENCE-BASED MEDICINE; PHYSICIAN ORDER ENTRY; QUALITY IMPROVEMENT; MEDICATION ERRORS; CARE; ACCOUNTABILITY; INTERVENTION; PUBLICATION	Despite a decade's worth of effort, patient safety has improved slowly, in part because of the limited evidence base for the development and widespread dissemination of successful patient safety practices. The Agency for Healthcare Research and Quality sponsored an international group of experts in patient safety and evaluation methods to develop criteria to improve the design, evaluation, and reporting of practice research in patient safety. This article reports the findings and recommendations of this group, which include greater use of theory and logic models, more detailed descriptions of interventions and their implementation, enhanced explanation of desired and unintended outcomes, and better description and measurement of context and of how context influences interventions. Using these criteria and measuring and reporting contexts will improve the science of patient safety.	RAND Hlth, Santa Monica, CA USA; RAND Hlth, Pittsburgh, PA USA; Vet Affairs Greater Los Angeles Healthcare Syst, Los Angeles, CA USA; Johns Hopkins Univ, Baltimore, MD USA; Univ Calif San Francisco, San Francisco, CA 94143 USA; Univ Leeds, Leeds, W Yorkshire, England; Stanford Univ, Stanford, CA 94305 USA; Karolinska Inst, Stockholm, Sweden; Kaiser Permanente, Oakland, CA USA; Natl Qual Forum, Washington, DC USA; Harvard Univ, Sch Med, Boston, MA USA; Massachusetts Gen Phys Org, Boston, MA USA; Vanderbilt Univ, Nashville, TN USA; Univ Wisconsin, Madison, WI USA; Dept Hlth, London SE1 6TE, England; UCL, London, England; New York State Psychiat Inst & Hosp, New York, NY 10032 USA; PeaceHealth, Bellevue, WA USA; Univ Penn, Sch Nursing, Philadelphia, PA 19104 USA; Univ Birmingham, Birmingham, W Midlands, England; RTI Int, Res Triangle Pk, NC USA; Case Western Reserve Univ, Cleveland, OH 44106 USA; Univ Michigan, Ann Arbor, MI 48109 USA; [Shojania, Kaveh G.] Univ Toronto, Toronto, ON, Canada; Univ Calif Berkeley, Berkeley, CA 94720 USA; Dartmouth Inst Hlth Policy & Clin Practice, Lebanon, NH USA; Univ Manchester, Manchester, Lancs, England	RAND Corporation; RAND Corporation; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; Johns Hopkins University; University of California System; University of California San Francisco; University of Leeds; Stanford University; Karolinska Institutet; Kaiser Permanente; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Vanderbilt University; University of Wisconsin System; University of Wisconsin Madison; University of London; University College London; New York State Psychiatry Institute; University of Pennsylvania; University of Birmingham; Research Triangle Institute; Case Western Reserve University; University of Michigan System; University of Michigan; University of Toronto; University of California System; University of California Berkeley; Dartmouth College; University of Manchester	Shekelle, PG (corresponding author), RAND Corp, 1776 Main St, Santa Monica, CA 90401 USA.	shekelle@rand.org	Saint, Sanjay/AAF-5126-2019; Bates, David/AAE-7283-2019; Chang, Shulan/H-2270-2011; TAYLOR, STEPHANIE/GYV-4768-2022; Greenhalgh, Trisha/B-1825-2015	Greenhalgh, Trisha/0000-0003-2369-8088; Foy, Robbie/0000-0003-0605-7713; Walshe, Kieran/0000-0002-0696-480X; ovretveit, john/0000-0002-5177-6613; Duan, Naihua/0000-0001-9411-2924; Lilford, Richard/0000-0002-0634-984X; Hempel, Susanne/0000-0003-1597-5110; Taylor, Stephanie/0000-0002-3266-1132; Bickman, Leonard/0000-0002-0746-3791; Lohr, Kathleen/0000-0002-3825-0713	AHRQ [HHSA-290-2009-10001C]	AHRQ(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Grant Support: By the AHRQ (contract HHSA-290-2009-10001C).	Auerbach AD, 2007, NEW ENGL J MED, V357, P608, DOI 10.1056/NEJMsb070738; Bates DW, 1998, JAMA-J AM MED ASSOC, V280, P1311, DOI 10.1001/jama.280.15.1311; Bosk CL, 2009, LANCET, V374, P444, DOI 10.1016/S0140-6736(09)61440-9; Chassin MR, 2010, NEW ENGL J MED, V363, P683, DOI 10.1056/NEJMsb1002320; Davidoff F, 2008, ANN INTERN MED, V149, P670, DOI 10.7326/0003-4819-149-9-200811040-00009; Glasziou P, 2010, BMJ-BRIT MED J, V341, pc3852; Haynes AB, 2009, NEW ENGL J MED, V360, P491, DOI 10.1056/NEJMsa0810119; Institute of Medicine, 2000, ERR IS HUM BUILD SAF; Koppel R, 2005, JAMA-J AM MED ASSOC, V293, P1197, DOI 10.1001/jama.293.10.1197; Landrigan CP, 2010, NEW ENGL J MED, V363, P2124, DOI 10.1056/NEJMsa1004404; Leape LL, 2002, JAMA-J AM MED ASSOC, V288, P501, DOI 10.1001/jama.288.4.501; Office of the Inspector General, 2010, ADVERSE EVENTS HOSP; Pronovost P, 2006, QUAL SAF HEALTH CARE, V15, P152, DOI 10.1136/qshc.2006.018432; Pronovost P, 2006, NEW ENGL J MED, V355, P2725, DOI 10.1056/NEJMoa061115; Pronovost PJ, 2008, J CRIT CARE, V23, P207, DOI 10.1016/j.jcrc.2007.09.002; Pronovost PJ, 2009, JAMA-J AM MED ASSOC, V302, P890, DOI 10.1001/jama.2009.1177; Pronovost PJ, 2010, BMJ-BRIT MED J, V340, pc309; Shekelle PG, 2010, AHRQ PUBLICATION; Shojania KG, 2010, CAN MED ASSOC J, V182, pE216, DOI 10.1503/cmaj.090578; Shojania KG, 2002, JAMA-J AM MED ASSOC, V288, P508, DOI 10.1001/jama.288.4.508; Smith GCS, 2003, BRIT MED J, V327, P1459, DOI 10.1136/bmj.327.7429.1459; Stelfox HT, 2003, JAMA-J AM MED ASSOC, V290, P1899, DOI 10.1001/jama.290.14.1899; Wachter RM, 2010, HEALTH AFFAIR, V29, P165, DOI 10.1377/hlthaff.2009.0785	23	134	134	2	32	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 17	2011	154	10					693	696		10.7326/0003-4819-154-10-201105170-00011	http://dx.doi.org/10.7326/0003-4819-154-10-201105170-00011			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	764HK	21576538				2022-12-24	WOS:000290620300019
J	Barnes, K				Barnes, Katherine			EUROPE'S TICKING TIME BOMB	NATURE			English	News Item							VESUVIUS											Baxter PJ, 2008, J VOLCANOL GEOTH RES, V178, P454, DOI 10.1016/j.jvolgeores.2008.08.015; Mastrolorenzo G, 2006, P NATL ACAD SCI USA, V103, P4366, DOI 10.1073/pnas.0508697103; Mastrolorenzo G, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2009JB006871; Pappalardo L, 2010, EARTH PLANET SC LETT, V296, P133, DOI 10.1016/j.epsl.2010.05.010; Rolandi G, 2010, J VOLCANOL GEOTH RES, V189, P347, DOI 10.1016/j.jvolgeores.2009.08.007; Scaillet B, 2008, NATURE, V455, P216, DOI 10.1038/nature07232	6	8	8	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 12	2011	473	7346					140	141		10.1038/473140a	http://dx.doi.org/10.1038/473140a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	762NT	21562537	Bronze			2022-12-24	WOS:000290487200012
J	Devaraneni, PK; Conti, B; Matsumura, Y; Yang, ZY; Johnson, AE; Skach, WR				Devaraneni, Prasanna K.; Conti, Brian; Matsumura, Yoshihiro; Yang, Zhongying; Johnson, Arthur E.; Skach, William R.			Stepwise Insertion and Inversion of a Type II Signal Anchor Sequence in the Ribosome-Sec61 Translocon Complex	CELL			English	Article							ENDOPLASMIC-RETICULUM MEMBRANE; ER MEMBRANE; PROTEIN TRANSLOCATION; TRANSMEMBRANE SEGMENTS; SECRETORY PROTEINS; TOPOGENESIS; RECOGNITION; INTEGRATION; REVEALS; CHANNEL	In eukaryotic cells, the ribosome-Sec61 translocon complex (RTC) establishes membrane protein topology by cotranslationally partitioning nascent polypeptides into the cytosol, ER lumen, and lipid bilayer. Using photocrosslinking, collisional quenching, cysteine accessibility, and protease protection, we show that a canonical type II signal anchor (SA) acquires its topology through four tightly coupled and mechanistically distinct steps: (1) head-first insertion into Sec61 alpha, (2) nascent chain accumulation within the RTC, (3) inversion from type I to type II topology, and (4) stable translocation of C-terminal flanking residues. Progression through each stage is induced by incremental increases in chain length and involves abrupt changes in the molecular environment of the SA. Importantly, type II SA inversion deviates from a type I SA at an unstable intermediate whose topology is controlled by dynamic interactions between the ribosome and translocon. Thus, the RTC coordinates SA topogenesis within a protected environment via sequential energetic transitions of the TM segment.	[Devaraneni, Prasanna K.; Conti, Brian; Matsumura, Yoshihiro; Yang, Zhongying; Skach, William R.] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA; [Johnson, Arthur E.] Texas A&M Univ, Texas A&M Univ Syst Hlth Sci Ctr, Dept Mol & Cellular Med, College Stn, TX 77843 USA; [Johnson, Arthur E.] Texas A&M Univ, Dept Chem, College Stn, TX 77843 USA; [Johnson, Arthur E.] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA	Oregon Health & Science University; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Skach, WR (corresponding author), Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA.	skachw@ohsu.edu	Johnson, Arthur E/G-3457-2012	Matsumura, Yoshihiro/0000-0002-3108-0440	US National Institutes of Health [GM53457, DK51818, GM26494, GM083568, HL083808]; NSF [EF-0623664]; Robert A. Welch Foundation Chair [BE-0017]; Manpei Suzuki Diabetes Foundation; American Heart Association; Cystic Fibrosis Foundation Therapeutics Inc.; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL083808] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051818] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053457, R01GM026494, F32GM083568] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Robert A. Welch Foundation Chair(The Welch Foundation); Manpei Suzuki Diabetes Foundation; American Heart Association(American Heart Association); Cystic Fibrosis Foundation Therapeutics Inc.; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. N. Alder for valuable assistance and advice with fluorescence quenching, K. Rusterholtz and B. Leighton for technical assistance, Drs. Soo Kim and Amardeep Khushoo for critically reading the manuscript, and Dr. R. Hegde for generously providing TRAM antisera. This work was supported by US National Institutes of Health grants GM53457 (W.R.S.), DK51818 (W.R.S.), GM26494 (A.E.J.), GM083568 (B.C.), HL083808 (B.C.), NSF grant EF-0623664 (A.E.J.), Robert A. Welch Foundation Chair grant BE-0017 (A.E.J.), the Manpei Suzuki Diabetes Foundation (Y.M.), the American Heart Association (W.R.S.), and the Cystic Fibrosis Foundation Therapeutics Inc. (W.R.S.).	Becker T, 2009, SCIENCE, V326, P1369, DOI 10.1126/science.1178535; Brambillasca S, 2006, J CELL BIOL, V175, P767, DOI 10.1083/jcb.200608101; Cannon KS, 2005, J CELL BIOL, V169, P219, DOI 10.1083/jcb.200412019; Cheng ZL, 2005, J CELL BIOL, V168, P67, DOI 10.1083/jcb.200408188; CROWLEY KS, 1993, CELL, V73, P1101, DOI 10.1016/0092-8674(93)90640-C; CROWLEY KS, 1994, CELL, V78, P461, DOI 10.1016/0092-8674(94)90424-3; Denzer AJ, 1995, EMBO J, V14, P6311, DOI 10.1002/j.1460-2075.1995.tb00321.x; Dowhan W, 2009, ANNU REV BIOCHEM, V78, P515, DOI 10.1146/annurev.biochem.77.060806.091251; Foster W, 2000, J BIOL CHEM, V275, P34157, DOI 10.1074/jbc.M000165200; Garrison JL, 2005, NATURE, V436, P285, DOI 10.1038/nature03821; Goder V, 1999, J CELL BIOL, V147, P257, DOI 10.1083/jcb.147.2.257; Goder V, 2003, EMBO J, V22, P3645, DOI 10.1093/emboj/cdg361; HEGDE K, 1996, CELL, V85, P217; Hessa T, 2007, NATURE, V450, P1026, DOI 10.1038/nature06387; HIGH S, 1993, J BIOL CHEM, V268, P26745; Higy M, 2004, BIOCHEMISTRY-US, V43, P12716, DOI 10.1021/bi048368m; Ismail N, 2008, BIOCHEM J, V411, P495, DOI 10.1042/BJ20071597; Johnson AE, 2005, TRAFFIC, V6, P1078, DOI 10.1111/j.1600-0854.2005.00340.x; Johnson AE, 1999, ANNU REV CELL DEV BI, V15, P799, DOI 10.1146/annurev.cellbio.15.1.799; JUNGNICKEL B, 1995, CELL, V82, P261, DOI 10.1016/0092-8674(95)90313-5; Junne T, 2010, MOL BIOL CELL, V21, P1662, DOI 10.1091/mbc.E10-01-0060; KALIES KU, 1994, J CELL BIOL, V126, P925, DOI 10.1083/jcb.126.4.925; Kida Y, 2007, J CELL BIOL, V179, P1441, DOI 10.1083/jcb.200707050; Kida Y, 2010, MOL BIOL CELL, V21, P418, DOI 10.1091/mbc.E09-08-0738; Kim SJ, 2002, DEV CELL, V2, P207, DOI 10.1016/S1534-5807(01)00120-4; King LS, 2004, NAT REV MOL CELL BIO, V5, P687, DOI 10.1038/nrm1469; Liao SR, 1997, CELL, V90, P31, DOI 10.1016/S0092-8674(00)80311-6; Lu JL, 2005, BIOCHEMISTRY-US, V44, P8230, DOI 10.1021/bi050372q; MATLACK KES, 1995, J BIOL CHEM, V270, P6170, DOI 10.1074/jbc.270.11.6170; McCormick PJ, 2003, MOL CELL, V12, P329, DOI 10.1016/S1097-2765(03)00304-6; Mingarro I, 2000, BMC Cell Biol, V1, P3, DOI 10.1186/1471-2121-1-3; MOTHES W, 1994, EMBO J, V13, P3973, DOI 10.1002/j.1460-2075.1994.tb06713.x; Pitonzo D, 2009, MOL BIOL CELL, V20, P685, DOI 10.1091/mbc.E08-09-0902; Plath K, 2004, MOL BIOL CELL, V15, P1, DOI 10.1091/mbc.E03-06-0390; Pool MR, 2009, J CELL BIOL, V185, P889, DOI 10.1083/jcb.200807066; Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384; ROTHMAN RE, 1988, J BIOL CHEM, V263, P10470; Rutkowski DT, 2001, P NATL ACAD SCI USA, V98, P7823, DOI 10.1073/pnas.141125098; Sadlish H, 2005, NAT STRUCT MOL BIOL, V12, P870, DOI 10.1038/nsmb994; SHAW AS, 1988, P NATL ACAD SCI USA, V85, P7592, DOI 10.1073/pnas.85.20.7592; Shibatani T, 2005, BIOCHEMISTRY-US, V44, P5982, DOI 10.1021/bi047328f; Skach WR, 2009, NAT STRUCT MOL BIOL, V16, P606, DOI 10.1038/nsmb.1600; Song WQ, 2000, CELL, V100, P333, DOI 10.1016/S0092-8674(00)80669-8; THRIFT RN, 1991, J CELL BIOL, V112, P809, DOI 10.1083/jcb.112.5.809; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; von Heijne G, 2006, NAT REV MOL CELL BIO, V7, P909, DOI 10.1038/nrm2063	46	77	78	0	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 8	2011	146	1					134	147		10.1016/j.cell.2011.06.004	http://dx.doi.org/10.1016/j.cell.2011.06.004			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	789TN	21729785	Bronze, Green Accepted			2022-12-24	WOS:000292539300012
J	Long, DT; Raschle, M; Joukov, V; Walter, JC				Long, David T.; Raeschle, Markus; Joukov, Vladimir; Walter, Johannes C.			Mechanism of RAD51-Dependent DNA Interstrand Cross-Link Repair	SCIENCE			English	Article							DOUBLE-STRAND BREAKS; FANCONI-ANEMIA; HOMOLOGOUS RECOMBINATION; JUNCTIONS; PROTEIN	DNA interstrand cross-links (ICLs) are toxic DNA lesions whose repair in S phase of eukaryotic cells is incompletely understood. In Xenopus egg extracts, ICL repair is initiated when two replication forks converge on the lesion. Dual incisions then create a DNA double-strand break (DSB) in one sister chromatid, whereas lesion bypass restores the other sister. We report that the broken sister chromatid is repaired via RAD51-dependent strand invasion into the regenerated sister. Recombination acts downstream of FANCI-FANCD2, yet RAD51 binds ICL-stalled replication forks independently of FANCI-FANCD2 and before DSB formation. Our results elucidate the functional link between the Fanconi anemia pathway and the recombination machinery during ICL repair. In addition, they demonstrate the complete repair of a DSB via homologous recombination in vitro.	[Long, David T.; Walter, Johannes C.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Raeschle, Markus] Max Planck Inst Biochem, Dept Prote & Signal Transduct, D-82152 Martinsried, Germany; [Joukov, Vladimir] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Max Planck Society; Harvard University; Dana-Farber Cancer Institute	Walter, JC (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	johannes_walter@hms.harvard.edu	Joukov, Vladimir/K-3525-2019	Walter, Johannes/0000-0002-4186-7570; Long, David/0000-0001-9232-0316	NIH [GM GM80676, HL098316]; Department of Defense Breast Cancer Research [W81XWH-04-1-0524]; American Cancer Society [PF-10-146-01-DMC]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098316] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080676] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense Breast Cancer Research(United States Department of Defense); American Cancer Society(American Cancer Society); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank V. Costanzo for the BRC<SUP>WT</SUP> expression construct; T. V. Ho and O. Scharer for instruction on pICL preparation; P. Knipscheer for reagents and helpful discussions; and A. D'Andrea, K. J. Patel, R. Scully, and P. Knipscheer for critical reading of the manuscript. This work was supported by NIH grants GM GM80676 and HL098316 and a John and Virginia Kaneb award to J.C.W., Department of Defense Breast Cancer Research Program Award W81XWH-04-1-0524 to V. J., and American Cancer Society postdoctoral fellowship PF-10-146-01-DMC to D.T.L. M. R. made initial observation of X-arcs; V. J. generated x.l.RAD51 antibodies; D.T.L. and J.C.W. designed and analyzed experiments; D.T.L. performed experiments; and D.T.L. and J.C.W. prepared the manuscript.	Bzymek M, 2010, NATURE, V464, P937, DOI 10.1038/nature08868; Carreira A, 2009, CELL, V136, P1032, DOI 10.1016/j.cell.2009.02.019; Deans AJ, 2009, MOL CELL, V36, P943, DOI 10.1016/j.molcel.2009.12.006; Hashimoto Y, 2010, NAT STRUCT MOL BIOL, V17, P1305, DOI 10.1038/nsmb.1927; Knipscheer P, 2009, SCIENCE, V326, P1698, DOI 10.1126/science.1182372; Lambert S, 2007, DNA REPAIR, V6, P1042, DOI 10.1016/j.dnarep.2007.02.024; Moldovan GL, 2009, ANNU REV GENET, V43, P223, DOI 10.1146/annurev-genet-102108-134222; Nakanishi K, 2005, P NATL ACAD SCI USA, V102, P1110, DOI 10.1073/pnas.0407796102; Nakanishi K, 2011, NAT STRUCT MOL BIOL, V18, P500, DOI 10.1038/nsmb.2029; Niedzwiedz W, 2004, MOL CELL, V15, P607, DOI 10.1016/j.molcel.2004.08.009; Raschle M, 2008, CELL, V134, P969, DOI 10.1016/j.cell.2008.08.030; Robinson NP, 2007, EMBO J, V26, P816, DOI 10.1038/sj.emboj.7601529; Thompson LH, 2009, MUTAT RES-FUND MOL M, V668, P54, DOI 10.1016/j.mrfmmm.2009.02.003; Wang WD, 2007, NAT REV GENET, V8, P735, DOI 10.1038/nrg2159; Yamamoto K, 2003, MOL CELL BIOL, V23, P5421, DOI 10.1128/MCB.23.15.5421-5430.2003; Yang YG, 2005, CARCINOGENESIS, V26, P1731, DOI 10.1093/carcin/bgi134; Zhang NX, 2007, DNA REPAIR, V6, P1670, DOI 10.1016/j.dnarep.2007.06.002	17	165	165	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 1	2011	333	6038					84	87		10.1126/science.1204258	http://dx.doi.org/10.1126/science.1204258			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	785UF	21719678	Green Accepted			2022-12-24	WOS:000292255400054
J	Trajkovski, M; Hausser, J; Soutschek, J; Bhat, B; Akin, A; Zavolan, M; Heim, MH; Stoffel, M				Trajkovski, Mirko; Hausser, Jean; Soutschek, Juergen; Bhat, Bal; Akin, Akinc; Zavolan, Mihaela; Heim, Markus H.; Stoffel, Markus			MicroRNAs 103 and 107 regulate insulin sensitivity	NATURE			English	Article							RESISTANCE; ADIPOSE; EXPRESSION; CAVEOLIN; RECEPTOR; MECHANISMS; STEATOSIS; HORMONE; OBESITY	Defects in insulin signalling are among the most common and earliest defects that predispose an individual to the development of type 2 diabetes(1-3). MicroRNAs have been identified as a new class of regulatory molecules that influence many biological functions, including metabolism(4,5). However, the direct regulation of insulin sensitivity by microRNAs in vivo has not been demonstrated. Here we show that the expression of microRNAs 103 and 107 (miR-103/107) is upregulated in obese mice. Silencing of miR-103/107 leads to improved glucose homeostasis and insulin sensitivity. In contrast, gain of miR-103/107 function in either liver or fat is sufficient to induce impaired glucose homeostasis. We identify caveolin-1, a critical regulator of the insulin receptor, as a direct target gene of miR-103/107. We demonstrate that caveolin-1 is upregulated upon miR-103/107 inactivation in adipocytes and that this is concomitant with stabilization of the insulin receptor, enhanced insulin signalling, decreased adipocyte size and enhanced insulin-stimulated glucose uptake. These findings demonstrate the central importance of miR-103/107 to insulin sensitivity and identify a new target for the treatment of type 2 diabetes and obesity.	[Trajkovski, Mirko; Hausser, Jean; Heim, Markus H.; Stoffel, Markus] ETH, Competence Ctr Syst Physiol & Metab Dis, CH-8093 Zurich, Switzerland; [Trajkovski, Mirko; Stoffel, Markus] ETH, Inst Mol Syst Biol, CH-8093 Zurich, Switzerland; [Hausser, Jean; Zavolan, Mihaela] Univ Basel, Biozentrum Basel, CH-4056 Basel, Switzerland; [Soutschek, Juergen; Bhat, Bal] Regulus Therapeut Inc, San Diego, CA 92121 USA; [Akin, Akinc] Alnylam Pharmaceut, Cambridge, MA 02142 USA; [Heim, Markus H.] Univ Basel Hosp, CH-4031 Basel, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Basel; Isis Pharmaceuticals Inc; University of Basel	Stoffel, M (corresponding author), ETH, Competence Ctr Syst Physiol & Metab Dis, Schafmattstr 18,HPM F 39-1, CH-8093 Zurich, Switzerland.	stoffel@imsb.biol.ethz.ch	Zavolan, Mihaela/S-3888-2016; Heim, Markus/A-7526-2008; Xie, Huangming/B-2260-2012	Heim, Markus/0000-0002-7523-4894; Hausser, Jean/0000-0002-3321-7199; Trajkovski, Mirko/0000-0002-3152-9551; Stoffel, Markus/0000-0003-1304-5817; Zavolan, Mihaela/0000-0002-8832-2041	Juvenile Diabetes Research Foundation International; Swiss National Science Foundation (SNF); European Community; Leducq Foundation	Juvenile Diabetes Research Foundation International(Juvenile Diabetes Research Foundation); Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); European Community(European Commission); Leducq Foundation(Leducq Foundation)	We would like to thank F. Preitner and B. Thorens for the hyperinsulinaemic euglycaemic clamp studies. M. T. was supported by a fellowship from the Juvenile Diabetes Research Foundation International. The work was supported in part by the Swiss National Science Foundation (SNF, LiverX), the European Community (SIROCCO, ERC and MetaboloMirs) and the Leducq Foundation.	Anderson N, 2008, PHARMACOL REV, V60, P311, DOI 10.1124/pr.108.00001; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Cohen AW, 2003, AM J PHYSIOL-ENDOC M, V285, pE1151, DOI 10.1152/ajpendo.00324.2003; Cohen AW, 2003, AM J PHYSIOL-CELL PH, V285, pC222, DOI 10.1152/ajpcell.00006.2003; Esau C, 2004, J BIOL CHEM, V279, P52361, DOI 10.1074/jbc.C400438200; Goossens GH, 2008, PHYSIOL BEHAV, V94, P206, DOI 10.1016/j.physbeh.2007.10.010; Hansen LH, 1998, MOL ENDOCRINOL, V12, P1140, DOI 10.1210/me.12.8.1140; Herrera BM, 2010, DIABETOLOGIA, V53, P1099, DOI 10.1007/s00125-010-1667-2; Kahn C Ronald, 2003, Exp Diabesity Res, V4, P169, DOI 10.1155/EDR.2003.169; Kajimoto K, 2006, RNA, V12, P1626, DOI 10.1261/rna.7228806; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Krutzfeldt J, 2006, CELL METAB, V4, P9, DOI 10.1016/j.cmet.2006.05.009; Minehira K, 2008, J LIPID RES, V49, P2038, DOI 10.1194/jlr.M800248-JLR200; Muoio DM, 2008, NAT REV MOL CELL BIO, V9, P193, DOI 10.1038/nrm2327; Nystrom FH, 1999, MOL ENDOCRINOL, V13, P2013, DOI 10.1210/me.13.12.2013; Ortega FJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009022; Otsu K, 2010, AM J PHYSIOL-CELL PH, V298, pC450, DOI 10.1152/ajpcell.00077.2009; Parton RG, 2007, NAT REV MOL CELL BIO, V8, P185, DOI 10.1038/nrm2122; Preitner F, 2009, AM J PHYSIOL-ENDOC M, V297, pE1420, DOI 10.1152/ajpendo.00362.2009; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; Semple SC, 2010, NAT BIOTECHNOL, V28, P172, DOI 10.1038/nbt.1602; Sun TW, 2009, MOL ENDOCRINOL, V23, P925, DOI 10.1210/me.2008-0298; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; TOZZO E, 1995, AM J PHYSIOL-ENDOC M, V268, pE956, DOI 10.1152/ajpendo.1995.268.5.E956; Xie HM, 2009, DIABETES, V58, P1050, DOI 10.2337/db08-1299; Yamamoto M, 1998, J BIOL CHEM, V273, P26962, DOI 10.1074/jbc.273.41.26962; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984	27	733	782	3	105	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 30	2011	474	7353					649	U127		10.1038/nature10112	http://dx.doi.org/10.1038/nature10112			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	785CF	21654750	Green Published			2022-12-24	WOS:000292204300041
J	Ma, DH; Taneja, TK; Hagen, BM; Kim, BY; Ortega, B; Lederer, WJ; Welling, PA				Ma, Donghui; Taneja, Tarvinder Kaur; Hagen, Brian M.; Kim, Bo-Young; Ortega, Bernardo; Lederer, W. Jonathan; Welling, Paul A.			Golgi Export of the Kir2.1 Channel Is Driven by a Trafficking Signal Located within Its Tertiary Structure	CELL			English	Article							ANDERSEN-TAWIL-SYNDROME; RECTIFIER POTASSIUM CHANNELS; CLATHRIN-COATED VESICLES; ENDOPLASMIC-RETICULUM; SORTING SIGNALS; CELL-SURFACE; TRANSMEMBRANE PROTEINS; PROTEOMIC ANALYSIS; MEMBRANE-PROTEINS; PLASMA-MEMBRANE	Mechanisms that are responsible for sorting newly synthesized proteins for traffic to the cell surface from the Golgi are poorly understood. Here, we show that the potassium channel Kir2.1, mutations in which are associated with Andersen-Tawil syndrome, is selected as cargo into Golgi export carriers in an unusual signal-dependent manner. Unlike conventional trafficking signals, which are typically comprised of short linear peptide sequences, Golgi exit of Kir2.1 is dictated by residues that are embedded within the confluence of two separate domains. This signal patch forms a recognition site for interaction with the AP1 adaptor complex, thereby marking Kir2.1 for incorporation into clathrin-coated vesicles at the trans-Golgi. The identification of a trafficking signal in the tertiary structure of Kir2.1 reveals a quality control step that couples protein conformation to Golgi export and provides molecular insight into how mutations in Kir2.1 arrest the channels at the Golgi.	[Ma, Donghui; Taneja, Tarvinder Kaur; Hagen, Brian M.; Kim, Bo-Young; Ortega, Bernardo; Lederer, W. Jonathan; Welling, Paul A.] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Welling, PA (corresponding author), Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA.	pwelling@umaryland.edu			NIH [P01 HL70709, R01 DK54231, R01 DK 63049, T32-HL-072751]; American Heart Association [0855321E]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL070709, T32HL072751] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063049, R01DK054231] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This project was supported by funds from the NIH (P01 HL70709, R01 DK54231, R01 DK 63049, and T32-HL-072751) and the American Heart Association (0855321E). We thank Drs. Ora Weisz and S. Kornberg for reagents, Dr. Terry Rogers for support and advice, and Dr. William R. Randall for help with adenovirus production.	ANDERSEN ED, 1971, ACTA PAEDIATR SCAND, V60, P559, DOI 10.1111/j.1651-2227.1971.tb06990.x; Ando R, 2004, SCIENCE, V306, P1370, DOI 10.1126/science.1102506; Baust T, 2006, P NATL ACAD SCI USA, V103, P3159, DOI 10.1073/pnas.0511062103; Bendahhou S, 2003, J BIOL CHEM, V278, P51779, DOI 10.1074/jbc.M310278200; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Campo C, 2005, REV PHYSIOL BIOCH P, V153, P47, DOI 10.1007/s10254-004-0037-1; Chaudhuri R, 2007, J VIROL, V81, P3877, DOI 10.1128/JVI.02725-06; Clarke OB, 2010, CELL, V141, P1018, DOI 10.1016/j.cell.2010.05.003; Costes SV, 2004, BIOPHYS J, V86, P3993, DOI [10.1529/biophysj.103.038422, 10.1529/biophysi.103.038422]; Crump CM, 2001, EMBO J, V20, P2191, DOI 10.1093/emboj/20.9.2191; De Matteis MA, 2008, NAT REV MOL CELL BIO, V9, P273, DOI 10.1038/nrm2378; Deborde S, 2008, NATURE, V452, P719, DOI 10.1038/nature06828; Donaldson MR, 2004, ANN MED, V36, P92, DOI 10.1080/17431380410032490; Doray B, 2002, SCIENCE, V297, P1700, DOI 10.1126/science.1075327; Doray B, 2007, MOL BIOL CELL, V18, P1887, DOI 10.1091/mbc.E07-01-0012; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Fischer-Lougheed J, 2001, J CELL BIOL, V153, P677, DOI 10.1083/jcb.153.4.677; Godi A, 2004, NAT CELL BIOL, V6, P393, DOI 10.1038/ncb1119; GRIFFITHS G, 1985, J CELL BIOL, V101, P949, DOI 10.1083/jcb.101.3.949; Habuchi S, 2005, P NATL ACAD SCI USA, V102, P9511, DOI 10.1073/pnas.0500489102; JACKSON MR, 1993, J CELL BIOL, V121, P317, DOI 10.1083/jcb.121.2.317; Janvier K, 2003, J CELL BIOL, V163, P1281, DOI 10.1083/jcb.200307157; Kohout TA, 1996, CIRC RES, V78, P971, DOI 10.1161/01.RES.78.6.971; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; KUBO Y, 1993, NATURE, V362, P127, DOI 10.1038/362127a0; LeBorgne R, 1996, J BIOL CHEM, V271, P2162; Lee I, 2008, J CELL BIOL, V180, P467, DOI 10.1083/jcb.200709037; LeMaout S, 1997, P NATL ACAD SCI USA, V94, P13329, DOI 10.1073/pnas.94.24.13329; Leonoudakis D, 2004, J BIOL CHEM, V279, P22331, DOI 10.1074/jbc.M400285200; Leonoudakis D, 2004, J BIOL CHEM, V279, P19051, DOI 10.1074/jbc.M400284200; LITTMAN DR, 1985, CELL, V40, P237, DOI 10.1016/0092-8674(85)90138-2; Liu YW, 2001, J CELL BIOL, V155, P27, DOI 10.1083/jcb.200103020; Lock JG, 2005, TRAFFIC, V6, P1142, DOI 10.1111/j.1600-0854.2005.00349.x; Lopes CMB, 2002, NEURON, V34, P933, DOI 10.1016/S0896-6273(02)00725-0; Lui WWY, 2003, MOL BIOL CELL, V14, P2385, DOI 10.1091/mbc.e02-11-0735; Ma D, 2002, NEURON, V33, P715, DOI 10.1016/S0896-6273(02)00614-1; Ma DK, 2001, SCIENCE, V291, P316, DOI 10.1126/science.291.5502.316; Ma DH, 2007, J BIOL CHEM, V282, P5781, DOI 10.1074/jbc.M608776200; Mancias JD, 2007, MOL CELL, V26, P403, DOI 10.1016/j.molcel.2007.03.017; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; MANDERS EMM, 1992, J CELL SCI, V103, P857; Melnyk P, 2002, AM J PHYSIOL-HEART C, V283, pH1123, DOI 10.1152/ajpheart.00934.2001; Miller SE, 2007, NATURE, V450, P570, DOI 10.1038/nature06353; Nakamura N, 1995, J CELL BIOL, V131, P1715, DOI 10.1083/jcb.131.6.1715; Nichols CG, 1997, ANNU REV PHYSIOL, V59, P171, DOI 10.1146/annurev.physiol.59.1.171; Nishida M, 2002, CELL, V111, P957, DOI 10.1016/S0092-8674(02)01227-8; O'Connell AD, 2005, P NATL ACAD SCI USA, V102, P9954, DOI 10.1073/pnas.0504332102; OHNO H, 1995, SCIENCE, V269, P1872, DOI 10.1126/science.7569928; Orzech E, 1999, J BIOL CHEM, V274, P2201, DOI 10.1074/jbc.274.4.2201; Pegan S, 2005, NAT NEUROSCI, V8, P279, DOI 10.1038/nn1411; Plaster NM, 2001, CELL, V105, P511, DOI 10.1016/S0092-8674(01)00342-7; Pogwizd SM, 2004, TRENDS CARDIOVAS MED, V14, P61, DOI 10.1016/j.tcm.2003.12.002; Prescott AR, 1997, EUR J CELL BIOL, V72, P238; Pryor PR, 2008, CELL, V134, P817, DOI 10.1016/j.cell.2008.07.023; Rahkila P, 1997, EXP CELL RES, V234, P452, DOI 10.1006/excr.1997.3633; RALSTON E, 1993, J CELL BIOL, V120, P399, DOI 10.1083/jcb.120.2.399; Rodriguez-Boulan E, 2005, BBA-MOL CELL RES, V1744, P455, DOI 10.1016/j.bbamcr.2005.04.007; Sampson LJ, 2003, J BIOL CHEM, V278, P41988, DOI 10.1074/jbc.M307479200; Sansone V, 1997, ANN NEUROL, V42, P305, DOI 10.1002/ana.410420306; SARASTE J, 1984, CELL, V38, P535, DOI 10.1016/0092-8674(84)90508-7; Shih W, 1995, J BIOL CHEM, V270, P31083, DOI 10.1074/jbc.270.52.31083; Stockklausner C, 2003, J BIOL CHEM, V278, P17000, DOI 10.1074/jbc.M212243200; Tristani-Firouzi M, 2002, J CLIN INVEST, V110, P381, DOI 10.1172/JCI200215183; Wang CW, 2006, J CELL BIOL, V174, P973, DOI 10.1083/jcb.200605106; Yoo D, 2005, J BIOL CHEM, V280, P35281, DOI 10.1074/jbc.M504836200; Yoo D, 2003, J BIOL CHEM, V278, P23066, DOI 10.1074/jbc.M212301200; Zaritsky JJ, 2001, J PHYSIOL-LONDON, V533, P697, DOI 10.1111/j.1469-7793.2001.t01-1-00697.x; Zerangue N, 2001, P NATL ACAD SCI USA, V98, P2431, DOI 10.1073/pnas.051630198	68	76	76	1	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 24	2011	145	7					1102	1115		10.1016/j.cell.2011.06.007	http://dx.doi.org/10.1016/j.cell.2011.06.007			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	782QV	21703452	Green Accepted, Bronze, Green Submitted			2022-12-24	WOS:000292025700016
J	Robbins, M				Robbins, Martin			Fuelling politics	NATURE			English	Editorial Material																			0	21	23	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 23	2011	474	7352					S22	S24		10.1038/474S022a	http://dx.doi.org/10.1038/474S022a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	781NJ	21697840	Bronze			2022-12-24	WOS:000291939700009
J	Vitari, AC; Leong, KG; Newton, K; Yee, C; O'Rourke, K; Liu, JF; Phu, LL; Vij, R; Ferrando, R; Couto, SS; Mohan, S; Pandita, A; Hongo, JA; Arnott, D; Wertz, IE; Gao, WQ; French, DM; Dixit, VM				Vitari, Alberto C.; Leong, Kevin G.; Newton, Kim; Yee, Cindy; O'Rourke, Karen; Liu, Jinfeng; Phu, Lilian; Vij, Rajesh; Ferrando, Ronald; Couto, Suzana S.; Mohan, Sankar; Pandita, Ajay; Hongo, Jo-Anne; Arnott, David; Wertz, Ingrid E.; Gao, Wei-Qiang; French, Dorothy M.; Dixit, Vishva M.			COP1 is a tumour suppressor that causes degradation of ETS transcription factors	NATURE			English	Article							UBIQUITIN LIGASE; PROSTATE-CANCER; GENE FUSIONS; C-MYC; BURKITTS-LYMPHOMA; REGULATED GENE; MOUSE MODELS; PEA3 GROUP; IN-VIVO; MUTATIONS	The proto-oncogenes ETV1, ETV4 and ETV5 encode transcription factors in the E26 transformation-specific (ETS) family, which includes the most frequently rearranged and overexpressed genes in prostate cancer(1-4). Despite being critical regulators of development, little is known about their post-translational regulation. Here we identify the ubiquitin ligase COP1 (also known as RFWD2) as a tumour suppressor that negatively regulates ETV1, ETV4 and ETV5. ETV1, which is mutated in prostate cancer more often, was degraded after being ubiquitinated by COP1. Truncated ETV1 encoded by prostate cancer translocation TMPRSS2:ETV1 lacks the critical COP1 binding motifs and was 50-fold more stable than wild-type ETV1. Almost all patient translocations render ETV1 insensitive to COP1, implying that this confers a selective advantage to prostate epithelial cells. Indeed, COP1 deficiency in mouse prostate elevated ETV1 and produced increased cell proliferation, hyperplasia, and early prostate intraepithelial neoplasia. Combined loss of COP1 and PTEN enhanced the invasiveness of mouse prostate adenocarcinomas. Finally, rare human prostate cancer samples showed hemizygous loss of the COP1 gene, loss of COP1 protein, and elevated ETV1 protein while lacking a translocation event. These findings identify COP1 as a tumour suppressor whose downregulation promotes prostatic epithelial cell proliferation and tumorigenesis.	[Vitari, Alberto C.; Newton, Kim; O'Rourke, Karen; Dixit, Vishva M.] Genentech Inc, Dept Physiol Chem, San Francisco, CA 94080 USA; [Leong, Kevin G.] Genentech Inc, Dept Res Oncol, San Francisco, CA 94080 USA; [Yee, Cindy; Gao, Wei-Qiang] Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA; [Liu, Jinfeng] Genentech Inc, Dept Bioinformat & Computat Biol, San Francisco, CA 94080 USA; [Phu, Lilian; Arnott, David] Genentech Inc, Dept Prot Chem, San Francisco, CA 94080 USA; [Vij, Rajesh; Hongo, Jo-Anne] Genentech Inc, Dept Antibody Engn, San Francisco, CA 94080 USA; [Ferrando, Ronald; Couto, Suzana S.; French, Dorothy M.] Genentech Inc, Dept Pathol, San Francisco, CA 94080 USA; [Mohan, Sankar; Pandita, Ajay] Genentech Inc, Dept Mol Diagnost & Canc Cell Biol, San Francisco, CA 94080 USA; [Wertz, Ingrid E.] Genentech Inc, Dept Early Discovery Biochem, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Dixit, VM (corresponding author), Genentech Inc, Dept Physiol Chem, 1 DNA Way, San Francisco, CA 94080 USA.	dixit@gene.com	dixit, vishva m/A-4496-2012; Gao, Wei/GXH-0380-2022	dixit, vishva m/0000-0001-6983-0326; Liu, Jinfeng/0000-0002-0343-8222				ALBERT T, 1994, ONCOGENE, V9, P759; Ali IU, 1999, JNCI-J NATL CANCER I, V91, P1922, DOI 10.1093/jnci/91.22.1922; Ang LH, 1998, MOL CELL, V1, P213, DOI 10.1016/S1097-2765(00)80022-2; Baert JL, 2010, ONCOGENE, V29, P1810, DOI 10.1038/onc.2009.471; Bartel FO, 2000, ONCOGENE, V19, P6443, DOI 10.1038/sj.onc.1204038; BHATIA K, 1993, NAT GENET, V5, P56, DOI 10.1038/ng0993-56; Bianchi E, 2003, J BIOL CHEM, V278, P19682, DOI 10.1074/jbc.M212681200; Cai CM, 2007, MOL ENDOCRINOL, V21, P1835, DOI 10.1210/me.2006-0480; Carver BS, 2009, NAT GENET, V41, P619, DOI 10.1038/ng.370; CLARK HM, 1994, CANCER RES, V54, P3383; Clark JP, 2009, NAT REV UROL, V6, P429, DOI 10.1038/nrurol.2009.127; CUNHA GR, 1978, J EXP ZOOL, V205, P181, DOI 10.1002/jez.1402050203; de Launoit Y, 2006, BBA-REV CANCER, V1766, P79, DOI 10.1016/j.bbcan.2006.02.002; Dentin R, 2007, NATURE, V449, P366, DOI 10.1038/nature06128; Gutierrez-Hartmann A, 2007, TRENDS ENDOCRIN MET, V18, P150, DOI 10.1016/j.tem.2007.03.002; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Hermans KG, 2008, CANCER RES, V68, P7541, DOI 10.1158/0008-5472.CAN-07-5930; Holm M, 2001, EMBO J, V20, P118, DOI 10.1093/emboj/20.1.118; Jubb Adrian M, 2006, Methods Mol Biol, V326, P255; Kayagaki N, 2007, SCIENCE, V318, P1628, DOI 10.1126/science.1145918; King JC, 2009, NAT GENET, V41, P524, DOI 10.1038/ng.371; Kumar-Sinha C, 2008, NAT REV CANCER, V8, P497, DOI 10.1038/nrc2402; Leong KG, 2008, NATURE, V456, P804, DOI 10.1038/nature07427; Mehra R, 2007, MODERN PATHOL, V20, P538, DOI 10.1038/modpathol.3800769; Newton K, 2008, CELL, V134, P668, DOI 10.1016/j.cell.2008.07.039; O'Brien C, 2008, CANCER RES, V68, P5380, DOI 10.1158/0008-5472.CAN-08-0234; Ouyang X, 2008, CANCER RES, V68, P2132, DOI 10.1158/0008-5472.CAN-07-6055; Pandita A, 2004, GENE CHROMOSOME CANC, V39, P29, DOI 10.1002/gcc.10300; Pickart CM, 2000, TRENDS BIOCHEM SCI, V25, P544, DOI 10.1016/S0968-0004(00)01681-9; Qi L, 2006, SCIENCE, V312, P1763, DOI 10.1126/science.1123374; Salghetti SE, 1999, EMBO J, V18, P717, DOI 10.1093/emboj/18.3.717; Seo HS, 2003, NATURE, V423, P995, DOI 10.1038/nature01696; Shappell SB, 2004, CANCER RES, V64, P2270, DOI 10.1158/0008-5472.CAN-03-0946; SHAULIAN E, 1992, MOL CELL BIOL, V12, P5581, DOI 10.1128/MCB.12.12.5581; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Tomlins SA, 2007, NATURE, V448, P595, DOI 10.1038/nature06024; Wang SY, 2003, CANCER CELL, V4, P209, DOI 10.1016/S1535-6108(03)00215-0; Wertz IE, 2004, SCIENCE, V303, P1371, DOI 10.1126/science.1093549; Whang YE, 1998, P NATL ACAD SCI USA, V95, P5246, DOI 10.1073/pnas.95.9.5246; Wu XT, 2001, MECH DEVELOP, V101, P61, DOI 10.1016/S0925-4773(00)00551-7; Xin L, 2003, P NATL ACAD SCI USA, V100, P11896, DOI 10.1073/pnas.1734139100; Yi CL, 2005, TRENDS CELL BIOL, V15, P618, DOI 10.1016/j.tcb.2005.09.007; Yi EC, 2003, RAPID COMMUN MASS SP, V17, P2093, DOI 10.1002/rcm.1150; Yoshimoto M, 2006, CANCER GENET CYTOGEN, V169, P128, DOI 10.1016/j.cancergencyto.2006.04.003	44	129	132	1	32	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 16	2011	474	7351					403	+		10.1038/nature10005	http://dx.doi.org/10.1038/nature10005			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777TD	21572435				2022-12-24	WOS:000291647100051
J	Shen, YC; Hsia, RY				Shen, Yu-Chu; Hsia, Renee Y.			Association Between Ambulance Diversion and Survival Among Patients With Acute Myocardial Infarction	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HOSPITAL CARDIAC-ARREST; LENGTH-OF-STAY; EMERGENCY-DEPARTMENTS; MORTALITY; IMPACT; DELAYS; TIMES; CARE	Context Ambulance diversion, a practice in which emergency departments (EDs) are temporarily closed to ambulance traffic, might be problematic for patients experiencing time-sensitive conditions, such as acute myocardial infarction (AMI). However, there is little empirical evidence to show whether diversion is associated with worse patient outcomes. Objective To analyze whether temporary ED closure on the day a patient experiences AMI, as measured by ambulance diversion hours of the nearest ED, is associated with increased mortality rates among patients with AMI. Design, Study, and Participants A case-crossover design of 13 860 Medicare patients with AMI from 508 zip codes within 4 California counties (Los Angeles, San Francisco, San Mateo, and Santa Clara) whose admission date was between 2000 and 2005. Data included 100% Medicare claims data that covered admissions between 2000 and 2005, linked with date of death until 2006, and daily ambulance diversion logs from the same 4 counties. Among the hospital universe, 149 EDs were identified as the nearest ED to these patients. Main Outcome Measures The percentage of patients with AMI who died within 7 days, 30 days, 90 days, 9 months, and 1 year from admission (when their nearest ED was not on diversion and when that same ED was exposed to <6, 6 to <12, and >= 12 hours of diversion out of 24 hours on the day of admission). Results Between 2000 and 2006, the mean (SD) daily diversion duration was 7.9 (6.1) hours. Based on analysis of 11 625 patients admitted to the ED between 2000 and 2005, and whose nearest ED had at least 3 diversion exposure levels (3541, 3357, 2667, and 2060 patients for no exposure, exposure to <6, 6 to <12, and >= 12 hours of diversion, respectively), there were no statistically significant differences in mortality rates between no diversion and exposure to less than 12 hours of diversion. Exposure to 12 or more hours of diversion was associated with higher 30-day mortality vs no diversion status (unadjusted mortality rate, 392 patients [19%] vs 545 patients [15%]; regression adjusted difference, 3.24 percentage points; 95% confidence interval [CI], 0.60-5.88); higher 90-day mortality (537 patients [26%] vs 762 patients [22%]; 2.89 percentage points; 95% CI, 0.13-5.64); higher 9-month mortality (680 patients [33%] vs 980 patients [28%]; 2.93 percentage points; 95% CI, 0.15-5.71); and higher 1-year mortality (731 patients [35%] vs 1034 patients [29%]; 3.04 percentage points; 95% CI, 0.33-5.75). Conclusion Among Medicare patients with AMI in 4 populous California counties, exposure to at least 12 hours of diversion by the nearest ED was associated with increased 30-day, 90-day, 9-month, and 1-year mortality. JAMA. 2011;305(23):2440-2447 www.jama.com	[Shen, Yu-Chu] USN, Postgrad Sch, Grad Sch Business & Publ Policy, Monterey, CA 93943 USA; [Shen, Yu-Chu] Natl Bur Econ Res, Cambridge, MA 02138 USA; [Hsia, Renee Y.] Univ Calif San Francisco, San Francisco Gen Hosp, Dept Emergency Med, San Francisco, CA USA	United States Department of Defense; United States Navy; Naval Postgraduate School; National Bureau of Economic Research; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco	Shen, YC (corresponding author), USN, Postgrad Sch, Grad Sch Business & Publ Policy, 555 Dyer Rd,Code GB, Monterey, CA 93943 USA.	yshen@nps.edu			Robert Wood Johnson Foundation's Changes in Health Care Financing and Organization initiative [63974]; National Institutes of Health/National Center for Research Resources, University of California, San Francisco Clinical and Translational Science [KL2 RR024130]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000143] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024130] Funding Source: NIH RePORTER	Robert Wood Johnson Foundation's Changes in Health Care Financing and Organization initiative(Robert Wood Johnson Foundation (RWJF)); National Institutes of Health/National Center for Research Resources, University of California, San Francisco Clinical and Translational Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)University of California System); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by grant 63974 from the Robert Wood Johnson Foundation's Changes in Health Care Financing and Organization initiative (Dr Shen), grant KL2 RR024130 from the National Institutes of Health/National Center for Research Resources, University of California, San Francisco Clinical and Translational Science (Dr Hsia), and the Robert Wood Johnson Foundation Physician Faculty Scholars (Dr Hsia).	ANDRULIS DP, 1991, ANN EMERG MED, V20, P980, DOI 10.1016/S0196-0644(05)82976-2; Auerbach J, 0807494 DHCQ; Bernstein SL, 2009, ACAD EMERG MED, V16, P1, DOI 10.1111/j.1553-2712.2008.00295.x; Buchmueller TC, 2006, J HEALTH ECON, V25, P740, DOI 10.1016/j.jhealeco.2005.10.006; Burke Laura, 2010, Virtual Mentor, V12, P483, DOI 10.1001/virtualmentor.2010.12.6.pfor2-1006; Burt Catharine W, 2006, Adv Data, P1; Burt Catharine W, 2004, Vital Health Stat 13, P1; Burt CW, 2006, ANN EMERG MED, V47, P317, DOI 10.1016/j.annemergmed.2005.12.001; Cameron Peter, 2002, Aust Health Rev, V25, P59; Castillo EM, 2011, J EMERG MED, V40, P300, DOI 10.1016/j.jemermed.2010.02.023; Cuong J, 2006, ACAD EMERG MED, V13, P1220, DOI 10.1197/j.aem.2006.05.024; Derlet RW, 2000, ANN EMERG MED, V35, P63, DOI 10.1016/S0196-0644(00)70105-3; Greene W., 2012, ECONOMETRIC ANAL, V7th; Health Economics Research Center, I EST TRAV COSTS; Horwitz JR, 2009, J HEALTH ECON, V28, P924, DOI 10.1016/j.jhealeco.2009.06.008; Institute of Medicine, 2007, HOSP BAS EM CAR BREA; Lambe S, 2003, ANN EMERG MED, V41, P35, DOI 10.1067/mem.2003.2; Maclure M, 2000, ANNU REV PUBL HEALTH, V21, P193, DOI 10.1146/annurev.publhealth.21.1.193; Magid DJ, 2004, ANN EMERG MED, V44, P586, DOI 10.1016/j.annemergmed.2004.07.449; Mailer's Software, 2006, MAIL SOFTW ZIP DAT; MCCLELLAN M, 1994, JAMA-J AM MED ASSOC, V272, P859, DOI 10.1001/jama.272.11.859; McConnell KJ, 2005, ANN EMERG MED, V45, P471, DOI 10.1016/j.annemergmed.2004.10.032; Millard WB, 2011, ANN EMERG MED, V57, p15A, DOI 10.1016/j.annemergmed.2011.03.015; National Association of State EMS Officials, IMPL STAT AMB NO DIV; Nichol G, 2008, JAMA-J AM MED ASSOC, V300, P1423, DOI 10.1001/jama.300.12.1423; Norris RM, 2005, HEART, V91, P1537, DOI 10.1136/hrt.2004.057018; Phibbs CS, 1995, MED CARE RES REV, V52, P532, DOI 10.1177/107755879505200406; Pines JM, 2008, ANN EMERG MED, V51, P1, DOI 10.1016/j.annemergmed.2007.07.008; Pines JM, 2007, ANN EMERG MED, V50, P510, DOI 10.1016/j.annemergmed.2007.07.021; Pines JM, 2010, ACAD EMERG MED, V17, P834, DOI 10.1111/j.1553-2712.2010.00780.x; Robert Wood Johnson Foundation, EM DEP UT CAP; Schafermeyer Robert W, 2003, Emerg Med (Fremantle), V15, P22, DOI 10.1046/j.1442-2026.2003.00403.x; Schneider S, 2001, ACAD EMERG MED, V8, P1044, DOI 10.1111/j.1553-2712.2001.tb01113.x; Schull MJ, 2004, ANN EMERG MED, V44, P577, DOI 10.1016/j.annemergmed.2004.05.004; Schull MJ, 2003, ACAD EMERG MED, V10, P709, DOI 10.1111/j.1553-2712.2003.tb00064.x; Shenoi RP, 2009, ACAD EMERG MED, V16, P116, DOI 10.1111/j.1553-2712.2008.00317.x; Skinner J, 2009, NBER TECHNICAL WORKI; Stock JH, 2006, NBER TECHNICAL WOR T; Tang N, 2010, JAMA-J AM MED ASSOC, V304, P664, DOI 10.1001/jama.2010.1112; WILSON M, 2004, BURSTING SEAMS IMPRO; Yankovic N, 2010, INQUIRY-J HEALTH CAR, V47, P81, DOI 10.5034/inquiryjrnl_47.01.81	41	63	63	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 15	2011	305	23					2440	2447		10.1001/jama.2011.811	http://dx.doi.org/10.1001/jama.2011.811			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	777EB	21666277	Green Accepted, Bronze			2022-12-24	WOS:000291597300024
J	Schwartlander, B; Stover, J; Hallett, T; Atun, R; Avila, C; Gouws, E; Bartos, M; Ghys, PD; Opuni, M; Barr, D; Alsallaq, R; Bollinger, L; de Freitas, M; Garnett, G; Holmes, C; Legins, K; Pillay, Y; Stanciole, AE; McClure, C; Hirnschall, G; Laga, M; Padian, N				Schwartlaender, Bernhard; Stover, John; Hallett, Timothy; Atun, Rifat; Avila, Carlos; Gouws, Eleanor; Bartos, Michael; Ghys, Peter D.; Opuni, Marjorie; Barr, David; Alsallaq, Ramzi; Bollinger, Lori; de Freitas, Marcelo; Garnett, Geoffrey; Holmes, Charles; Legins, Ken; Pillay, Yogan; Stanciole, Anderson Eduardo; McClure, Craig; Hirnschall, Gottfried; Laga, Marie; Padian, Nancy		Investment Framework Study Grp	Towards an improved investment approach for an effective response to HIV/AIDS	LANCET			English	Article							SUB-SAHARAN AFRICA; COMMUNITY-HEALTH WORKERS; ANTIRETROVIRAL THERAPY; HIV PREVENTION; TUBERCULOSIS-CONTROL; MALE CIRCUMCISION; SOUTH-AFRICA; TRANSMISSION; INTERVENTIONS; CHALLENGES	Substantial changes are needed to achieve a more targeted and strategic approach to investment in the response to the HIV/AIDS epidemic that will yield long-term dividends. Until now, advocacy for resources has been done on the basis of a commodity approach that encouraged scaling up of numerous strategies in parallel, irrespective of their relative effects. We propose a strategic investment framework that is intended to support better management of national and international HIV/AIDS responses than exists with the present system. Our framework incorporates major efficiency gains through community mobilisation, synergies between programme elements, and benefits of the extension of antiretroviral therapy for prevention of HIV transmission. It proposes three categories of investment, consisting of six basic programmatic activities, interventions that create an enabling environment to achieve maximum effectiveness, and programmatic efforts in other health and development sectors related to HIV/AIDS. The yearly cost of achievement of universal access to HIV prevention, treatment, care, and support by 2015 is estimated at no less than US$22 billion. Implementation of the new investment framework would avert 12.2 million new HIV infections and 7.4 million deaths from AIDS between 2011 and 2020 compared with continuation of present approaches, and result in 29.4 million life-years gained. The framework is cost effective at $1060 per life-year gained, and the additional investment proposed would be largely offset from savings in treatment costs alone.	[Schwartlaender, Bernhard] Joint United Nations Programme HIV AIDS UNAIDS, Evidence Strategy & Results Dept, Geneva, Switzerland; [Stover, John; Bollinger, Lori] Futures Inst, Glastonbury, CT USA; [Hallett, Timothy; Garnett, Geoffrey] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, London, England; [Atun, Rifat] Univ London Imperial Coll Sci Technol & Med, Imperial Coll Business Sch, London, England; [Atun, Rifat] Global Fund Fight AIDS TB & Malaria, Geneva, Switzerland; [Barr, David] Int Treatment Preparedness Coalit, New York, NY USA; [Alsallaq, Ramzi] Univ Washington, Int Clin Res Ctr, Dept Global Hlth, Seattle, WA 98195 USA; [de Freitas, Marcelo] Natl AIDS Programme, Brasilia, DF, Brazil; [Holmes, Charles; Padian, Nancy] Off US Global AIDS Coordinator, US Presidents Emergency Plan AIDS Relief, Washington, DC USA; [Padian, Nancy] Bill & Melinda Gates Fdn, Seattle, WA USA; [Legins, Ken] UNICEF, New York, NY USA; [Pillay, Yogan] Strateg Hlth Programmes, Dept Hlth, Johannesburg, South Africa; [Stanciole, Anderson Eduardo] World Bank, Global HIVAIDS Unit, Washington, DC 20433 USA; [McClure, Craig; Hirnschall, Gottfried] WHO, CH-1211 Geneva, Switzerland; [Laga, Marie] Inst Trop Med, B-2000 Antwerp, Belgium	UNAIDS; Imperial College London; Imperial College London; University of Washington; University of Washington Seattle; Bill & Melinda Gates Foundation; UNICEF; The World Bank; World Health Organization; Institute of Tropical Medicine (ITM)	Schwartlander, B (corresponding author), Joint United Nations Programme HIV AIDS UNAIDS, Evidence Strategy & Results Dept, 20 Ave Apia, Geneva, Switzerland.	schwartlanderb@unaids.org	Garnett, Geoffrey P/A-9312-2008; Atun, Rifat/AAH-5537-2021	Opuni, Marjorie/0000-0002-0939-7695; Atun, Rifat/0000-0002-1531-5983; Hallett, Timothy/0000-0002-9681-0424	Pangea Global AIDS Foundation; Wellcome Trust; GlaxoSmithKline; Merck; Sanofi Pasteur MSD for HPV vaccination works; Bill & Melinda Gates Foundation; MRC [G0600719] Funding Source: UKRI; Medical Research Council [G0600719, G0600719B] Funding Source: researchfish	Pangea Global AIDS Foundation; Wellcome Trust(Wellcome TrustEuropean Commission); GlaxoSmithKline(GlaxoSmithKline); Merck(Merck & Company); Sanofi Pasteur MSD for HPV vaccination works; Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	DB received consultation fees payment from Pangea Global AIDS Foundation and unrelated honoraria from UNAIDS, International Civil Society Support Project and Merck Foundation. GG received grant from the Wellcome Trust and was paid consultancy fees by GlaxoSmithKline, Merck and Sanofi Pasteur MSD for HPV vaccination works. TH received grant from Wellcome Trust for Fellowship and received grants and consultation fees from the Bill & Melinda Gates Foundation. NP received consultation fees from the Bill & Melinda Gates Foundation. The findings and conclusions in this paper are those of the authors and do not necessarily represent the views of the US Department of State.	*AIDS 2031 COSTS F, COSTS CHOIC FIN LONG; [Anonymous], REP GLOB AIDS EP 200; [Anonymous], 2010, NEW HIV INF MOD TRAN; Atun RA, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b2165; Atun R, 2010, INT J DRUG POLICY, V21, P103, DOI 10.1016/j.drugpo.2010.01.002; Atun R, 2010, HEALTH POLICY PLANN, V25, P104, DOI 10.1093/heapol/czp055; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Barth RE, 2010, LANCET INFECT DIS, V10, P155, DOI 10.1016/S1473-3099(09)70328-7; Bollinger LA, 2008, AIDS, V22, pS51, DOI 10.1097/01.aids.0000327623.31856.45; Brinkhof MWG, 2007, CLIN INFECT DIS, V45, P1518, DOI 10.1086/522986; Callaghan M, 2010, HUM RESOUR HEALTH, V8, DOI 10.1186/1478-4491-8-8; Commision on AIDS in Asia, 2008, RED AIDS AS CRAFT EF; DiClemente RJ, 2007, J PEDIATR PSYCHOL, V32, P888, DOI 10.1093/jpepsy/jsm056; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; Frumence G, 2010, SAHARA J-J SOC ASP H, V7, P9, DOI 10.1080/17290376.2010.9724964; Ghys PD, 2010, SEX TRANSM INFECT, V86, pI1, DOI [10.1136/sti.2010.047852, 10.1136/sti.2010.044933]; *GLOB FUND FIGHT A, 3 REPL 2011 13 FIN H; *GLOB FUND FIGHT A, 2008, 18 BOARD M NOV; *GLOB FUND FIGHT A, 2010, 22 BOARD M DEC; *GLOB FUND FIGHT A, GLOB FUND 2010 INN I; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Gregson S, 2006, SCIENCE, V311, P664, DOI 10.1126/science.1121054; GROWN C, FINANCIAL REQUIREMEN; Hallett T B, 2006, Sex Transm Infect, V82 Suppl 1, pi1; Halperin DT, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000414; Hayes R, 2010, AIDS, V24, pS81, DOI 10.1097/01.aids.0000390710.04255.2b; Hermann K, 2009, HUM RESOUR HEALTH, V7, DOI 10.1186/1478-4491-7-31; HESTER V, ASSESSING C IN PRESS; Hirnschall G, 2011, LANCET, V378, P209, DOI 10.1016/S0140-6736(11)60247-X; JOUQUET G, 2009, 5 INT AIDS SOC C CAP; Kenya National Aids Control Council, 2009, KEN HIV PREV RESP MO; Kunihira NR, 2010, AFR HEALTH SCI, V10, P120; Lawn SD, 2006, AIDS, V20, P1605, DOI 10.1097/01.aids.0000238406.93249.cd; Lewin S, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004015.pub3; LOEVINSOHN M, 2003, 157 FCND INT FOOD PO; Long EF, 2006, AIDS, V20, P2207, DOI 10.1097/QAD.0b013e328010c7d0; Low-Beer D., 2010, GLOB HLTH GOV, V4, P1; Macneil J, 2011, DRUG ALCOHOL REV, V30, P26, DOI 10.1111/j.1465-3362.2010.00188.x; Marconi VC, 2010, AIDS RES THER, V7, DOI 10.1186/1742-6405-7-14; Marseille E, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-108; Menzies NA, 2011, AIDS, V25, P1753, DOI 10.1097/QAD.0b013e3283463eec; Merson MH, 2008, LANCET, V372, P475, DOI 10.1016/S0140-6736(08)60884-3; Middelkoop K, 2011, JAIDS-J ACQ IMM DEF, V56, P263, DOI 10.1097/QAI.0b013e31820413b3; Mofenson LM, 2010, CLIN INFECT DIS, V50, pS130, DOI 10.1086/651484; Narayanan S, 2011, INT J DRUG POLICY, V22, P311, DOI 10.1016/j.drugpo.2011.01.002; *NAT I ALL INF DIS, QUEST ANSW HPTN 052; Nyamathi AM, 2011, HEALTH CARE WOMEN IN, V32, P300, DOI 10.1080/07399332.2010.536282; Oosterhoff P, 2008, REPROD HEALTH MATTER, V16, P162, DOI 10.1016/S0968-8080(08)32408-2; Padian NS, 2010, AIDS, V24, P621, DOI 10.1097/QAD.0b013e328337798a; PADIAN NS, LANCET IN PRESS; Palmer S, 2008, P NATL ACAD SCI USA, V105, P3879, DOI 10.1073/pnas.0800050105; *PEPFAR, 2011, PEPFAR MAK SMART INV; Philips M, 2008, LANCET, V371, P682, DOI 10.1016/S0140-6736(08)60307-4; Pronyk PM, 2006, LANCET, V368, P1973, DOI 10.1016/S0140-6736(06)69744-4; Reynolds SJ, 2011, AIDS, V25, P473, DOI 10.1097/QAD.0b013e3283437c2b; Reza-Paul S, 2008, AIDS, V22, pS91, DOI 10.1097/01.aids.0000343767.08197.18; Rhodes T., 2010, EMCDDA MONOGRAPHS HA; ROSEN S, 2011, PEPFAR SUPPORTED EVA; SABAPATHY K, 2011, J ACQ IMMUN DEF SYND, DOI DOI 10.1097/QA1.0B013E318218A713; Samb B, 2009, LANCET, V373, P2137, DOI 10.1016/S0140-6736(09)60919-3; Scalway T., 2010, PRESENTING EVIDENCE; Schneider H, 2008, HEALTH POLICY PLANN, V23, P179, DOI 10.1093/heapol/czn006; Schwartlander B, 2001, SCIENCE, V292, P2434, DOI 10.1126/science.1062876; Shin S, 2011, HEALTH SOC CARE COMM, V19, P261, DOI 10.1111/j.1365-2524.2010.00968.x; Sidibe M., 2010, GLOBAL HLTH GOVERNAN, V4, P1; STOVER J, 2010, FINANCIAL RESOURCES; Strathdee SA, 2010, LANCET, V376, P268, DOI 10.1016/S0140-6736(10)60743-X; Sweat M, 2011, LANCET INFECT DIS, V11, P525, DOI 10.1016/S1473-3099(11)70060-3; TEMIN M, HIV SENSITIVE SOCIAL; *UN, REP SECR GEN UN UN A; *UNAIDS, 2010, REP GLOB AIDS EP; UNAIDS, 2011, UNAIDS 2011 2015 STR; *UNAIDS, 2009, P THINK TANK EV METH; *UNAIDS, TREATM 2 0; *UNAIDS, 2011, AIDS 2011 PROGR OWN; UNAIDS, 2009, WHAT COUNTR NEED INV; *UNAIDS, FIN RESP AIDS LOW MI; UNICEF UNAIDS WHO UNFPA UNESCO, 2010, CHILDR AIDS 5 STOCKT; United Nations June, 2001, DECL COMM HIV AIDS U; Van Rie A, 2011, JAIDS-J ACQ IMM DEF, V56, P349, DOI 10.1097/QAI.0b013e3181f9fb39; Victora CG, 2004, AM J PUBLIC HEALTH, V94, P400, DOI 10.2105/AJPH.94.3.400; *WHO, 2010, COUNTR HLTH INF; Williams BG, 2003, SCIENCE, V301, P1535, DOI 10.1126/science.1086845; Williams BG, 2010, P NATL ACAD SCI USA, V107, P19485, DOI 10.1073/pnas.1005660107; World Health Organisation (WHO), 2009, WHO UNODC UNAIDS TEC; World Health Organization, 2003, WHO GUID COST EFF AN	87	355	358	1	61	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 11	2011	377	9782					2031	2041		10.1016/S0140-6736(11)60702-2	http://dx.doi.org/10.1016/S0140-6736(11)60702-2			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	782LR	21641026				2022-12-24	WOS:000292011700038
J	Lin, IH; Miller, DS; Bertics, PJ; Murphy, CJ; de Pablo, JJ; Abbott, NL				Lin, I-Hsin; Miller, Daniel S.; Bertics, Paul J.; Murphy, Christopher J.; de Pablo, Juan J.; Abbott, Nicholas L.			Endotoxin-Induced Structural Transformations in Liquid Crystalline Droplets	SCIENCE			English	Article							DEFECTS	The ordering of liquid crystals (LCs) is known to be influenced by surfaces and contaminants. Here, we report that picogram per milliliter concentrations of endotoxin in water trigger ordering transitions in micrometer-size LC droplets. The ordering transitions, which occur at surface concentrations of endotoxin that are less than 10(-5) Langmuir, are not due to adsorbate-induced changes in the interfacial energy of the LC. The sensitivity of the LC to endotoxin was measured to change by six orders of magnitude with the geometry of the LC (droplet versus slab), supporting the hypothesis that interactions of endotoxin with topological defects in the LC mediate the response of the droplets. The LC ordering transitions depend strongly on glycophospholipid structure and provide new designs for responsive soft matter.	[Lin, I-Hsin; Miller, Daniel S.; de Pablo, Juan J.; Abbott, Nicholas L.] Univ Wisconsin, Dept Chem & Biol Engn, Madison, WI 53706 USA; [Bertics, Paul J.] Univ Wisconsin, Dept Biomol Chem, Madison, WI 53706 USA; [Murphy, Christopher J.] Univ Calif Davis, Sch Med, Dept Ophthalmol & Vis Sci, Davis, CA 95616 USA; [Murphy, Christopher J.] Univ Calif Davis, Sch Vet Med, Dept Vet Surg & Radiol Sci, Davis, CA 95616 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of California System; University of California Davis; University of California System; University of California Davis	Abbott, NL (corresponding author), Univ Wisconsin, Dept Chem & Biol Engn, 1415 Engn Dr, Madison, WI 53706 USA.	abbott@engr.wisc.edu	Miller, Daniel/G-8578-2013; de Pablo, Juan/AAJ-9161-2021; Miller, Daniel S./AAH-3422-2020		NSF [DMR-0520527]; Army Research Office [W911NF-07-1-0446, W911NF-06-1-0314]; National Institutes of Health [CA108467, CA105730]; NATIONAL CANCER INSTITUTE [R01CA108467, R21CA105730] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI092004] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); Army Research Office; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was primarily supported by NSF through DMR-0520527 (Materials Research Science and Engineering Center), the Army Research Office (W911NF-07-1-0446 and W911NF-06-1-0314), and the National Institutes of Health (CA108467 and CA105730). The technical assistance of B. Carlton is gratefully acknowledged. A patent application based on this work has been filed by the Wisconsin Alumni Research Foundation (P09241US02). N.L.A. and C.J.M. are members of the board of directors of Platypus Technologies LLC, a startup company set up to develop analytic methods based on liquid crystals.	Brake JM, 2003, SCIENCE, V302, P2094, DOI 10.1126/science.1091749; Chen XM, 2008, LANGMUIR, V24, P541, DOI 10.1021/la701844s; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; Fernandez-Nieves A, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.157801; Gupta JK, 2009, ANGEW CHEM INT EDIT, V48, P1652, DOI 10.1002/anie.200804500; Hu DH, 2000, NATURE, V405, P1030, DOI 10.1038/35016520; Lavrentovich OD, 1998, LIQ CRYST, V24, P117, DOI 10.1080/026782998207640; Lee BW, 2001, SCIENCE, V291, P2576, DOI 10.1126/science.291.5513.2576; McCamley MK, 2007, PROC SPIE, V6441, DOI 10.1117/12.725767; McCamley MK, 2009, J APPL PHYS, V105, DOI 10.1063/1.3148861; Meli MV, 2008, J AM CHEM SOC, V130, P4326, DOI 10.1021/ja077379a; Musevic I, 2006, SCIENCE, V313, P954, DOI 10.1126/science.1129660; Poulin P, 1997, SCIENCE, V275, P1770, DOI 10.1126/science.275.5307.1770; Prischepa OO, 2004, JETP LETT+, V79, P257, DOI 10.1134/1.1759405; Queisser HJ, 1998, SCIENCE, V281, P945, DOI 10.1126/science.281.5379.945; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Ravnik M, 2010, FARADAY DISCUSS, V144, P159, DOI 10.1039/b908676e; Romalis M, 2008, NATURE, V455, P606, DOI 10.1038/455606a; Simon J, 2010, SCIENCE, V327, P60, DOI 10.1126/science.1183226; Sivakumar S, 2009, ADV FUNCT MATER, V19, P2260, DOI 10.1002/adfm.200900399; Skarabot M, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.031705; Volovik G. E., 1983, Soviet Physics - JETP, V58, P1159; Zapotocky M, 1999, SCIENCE, V283, P209, DOI 10.1126/science.283.5399.209	23	279	287	0	188	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 10	2011	332	6035					1297	1300		10.1126/science.1195639	http://dx.doi.org/10.1126/science.1195639			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	775EP	21596951	Green Accepted			2022-12-24	WOS:000291441700039
J	Luo, DG; Yue, WWS; Ala-Laurila, P; Yau, KW				Luo, Dong-Gen; Yue, Wendy W. S.; Ala-Laurila, Petri; Yau, King-Wai			Activation of Visual Pigments by Light and Heat	SCIENCE			English	Article							DARK NOISE; SPECTRAL PROPERTIES; THERMAL-ACTIVATION; ROD PHOTORECEPTORS; RETINAL CONES; TOAD RETINA; PHOTOTRANSDUCTION; PHOTOACTIVATION; CHROMOPHORE; RHODOPSIN	Vision begins with photoisomerization of visual pigments. Thermal energy can complement photon energy to drive photoisomerization, but it also triggers spontaneous pigment activation as noise that interferes with light detection. For half a century, the mechanism underlying this dark noise has remained controversial. We report here a quantitative relation between a pigment's photoactivation energy and its peak-absorption wavelength, lambda(max). Using this relation and assuming that pigment activations by light and heat go through the same ground-state isomerization energy barrier, we can predict the relative noise of diverse pigments with multi-vibrational-mode thermal statistics. The agreement between predictions and our measurements strongly suggests that pigment noise arises from canonical isomerization. The predicted high noise for pigments with lambda(max) in the infrared presumably explains why they apparently do not exist in nature.	[Luo, Dong-Gen; Yue, Wendy W. S.; Yau, King-Wai] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; [Yau, King-Wai] Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Baltimore, MD 21205 USA; [Luo, Dong-Gen; Yue, Wendy W. S.; Yau, King-Wai] Johns Hopkins Univ, Sch Med, Ctr Sensory Biol, Baltimore, MD 21205 USA; [Yue, Wendy W. S.] Johns Hopkins Univ, Sch Med, Biochem Cellular & Mol Biol Grad Program, Baltimore, MD 21205 USA; [Ala-Laurila, Petri] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Ala-Laurila, Petri] Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA; [Ala-Laurila, Petri] Univ Helsinki, Dept Biol & Environm Sci, FI-00014 Helsinki, Finland	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Helsinki	Luo, DG (corresponding author), Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA.	dgluo@jhmi.edu; kwyau@mail.jhmi.edu	Ala-Laurila, Petri/AAE-1203-2019; Luo, Donggen/D-5990-2011	Ala-Laurila, Petri/0000-0002-6139-6825; 	U.S. NIH [EY06837]; Antonio Champalimaud Vision Award; Academy of Finland [123231]; NATIONAL EYE INSTITUTE [R37EY006837, R01EY006837] Funding Source: NIH RePORTER	U.S. NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Antonio Champalimaud Vision Award; Academy of Finland(Academy of Finland); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by a U.S. NIH grant (EY06837) and the Antonio Champalimaud Vision Award (Portugal) to K.-W.Y and a grant (123231) from the Academy of Finland to P. A.-L. We thank R. S. Molday and J.-X. Ma for the antibodies against rhodopsin and blue cone pigment, respectively; J. Chen for the transgenic mouse line expressing mouse S-cone opsin in the rods; X. Lin for mathematical help; M. T. H. Do for critique; T. Xue and Y. P. Wang for computational help; and V. S. Batista, R. R. Birge, P. J. Dagdigian, T. Ebrey, B. Honig, M. Karplus, J. E. Kim, B. E. Knox, C. L. Makino, R. A. Mathies, J. Nathans, T. P. Sakmar, J. L. Schnapf, K. Schulten, T. G. Wensel, T. B. Woolf, and E. C. Y. Yan for discussions. D.-G. L. and K.-W.Y. designed the experiments, did the data analysis, developed the theory, and wrote the paper; D.-G. L. performed all of the electrophysiological experiments; W. W. S. Y did the retinal immunolabeling and participated in the measurement of thermal activity of Bufo red rods as well as writing; and P. A.-L. contributed to the theory and participated in discussion.	Ala-Laurila P, 2004, VISION RES, V44, P2153, DOI 10.1016/j.visres.2004.03.031; Ala-Laurila P, 2004, BIOPHYS J, V86, P3653, DOI 10.1529/biophysj.103.035626; Ala-Laurila P, 2003, VISUAL NEUROSCI, V20, P411, DOI 10.1017/S0952523803204065; Ala-Laurila P, 2002, VISUAL NEUROSCI, V19, P781, DOI 10.1017/S0952523802196088; Ala-Laurila P, 2007, J PHYSIOL-LONDON, V585, P57, DOI 10.1113/jphysiol.2007.142935; Atkins P., 2006, PHYS CHEM; BARLOW HB, 1957, NATURE, V179, P255, DOI 10.1038/179255b0; BARLOW RB, 1993, NATURE, V366, P64, DOI 10.1038/366064a0; BAYLOR DA, 1980, J PHYSIOL-LONDON, V309, P591, DOI 10.1113/jphysiol.1980.sp013529; BIRGE RR, 1990, BIOCHIM BIOPHYS ACTA, V1016, P293, DOI 10.1016/0005-2728(90)90163-X; COOPER A, 1979, NATURE, V282, P531, DOI 10.1038/282531a0; CRESCITELLI F, 1984, VISION RES, V24, P1551, DOI 10.1016/S0042-6989(84)80004-8; DONNER K, 1990, J PHYSIOL-LONDON, V428, P673, DOI 10.1113/jphysiol.1990.sp018234; Dukkipati A, 2002, BIOCHEMISTRY-US, V41, P9842, DOI 10.1021/bi025883g; Fu YB, 2008, NAT NEUROSCI, V11, P565, DOI 10.1038/nn.2110; Goodeve C. F., 1936, P ROY SOC LOND A MAT, V155, P664; Govardovskii VI, 2000, VISUAL NEUROSCI, V17, P509, DOI 10.1017/S0952523800174036; Gracheva EO, 2010, NATURE, V464, P1006, DOI 10.1038/nature08943; Hecht S, 1942, J GEN PHYSIOL, V25, P819, DOI 10.1085/jgp.25.6.819; Hinshelwood C. N., 1940, KINETICS CHEM CHANGE, p[39, 79]; Holbrook K. A., 1996, UNIMOLECULAR REACTIO, P1; Kefalov V, 2003, NATURE, V425, P526, DOI 10.1038/nature01992; Kefalov VJ, 2005, NEURON, V46, P879, DOI 10.1016/j.neuron.2005.05.009; LAMB TD, 1995, VISION RES, V35, P3083, DOI 10.1016/0042-6989(95)00114-F; Lorenz-Fonfria VA, 2010, J AM CHEM SOC, V132, P5693, DOI 10.1021/ja907756e; Luo DG, 2005, J GEN PHYSIOL, V126, P263, DOI 10.1085/jgp.200509342; Luo DG, 2008, P NATL ACAD SCI USA, V105, P9855, DOI 10.1073/pnas.0708405105; Makino CL, 1996, J GEN PHYSIOL, V108, P27, DOI 10.1085/jgp.108.1.27; MANSFIELD RJW, 1985, VISUAL SYSTEM, P89; Mathies R A, 1999, Novartis Found Symp, V224, P70; Mathies RA, 1999, NOVART FDN SYMP, V224, P84; MATSUMOTO H, 1975, BIOCHIM BIOPHYS ACTA, V404, P300, DOI 10.1016/0304-4165(75)90337-2; MATTHEWS G, 1984, J PHYSIOL-LONDON, V349, P607, DOI 10.1113/jphysiol.1984.sp015176; Nikonov SS, 2006, J GEN PHYSIOL, V127, P359, DOI 10.1085/jgp.200609490; Okada T, 2001, TRENDS BIOCHEM SCI, V26, P318, DOI 10.1016/S0968-0004(01)01799-6; Rieke F, 2000, NEURON, V26, P181, DOI 10.1016/S0896-6273(00)81148-4; Sakurai K, 2007, J GEN PHYSIOL, V130, P21, DOI 10.1085/jgp.200609729; Sampath AP, 2002, BIOPHYS J, V83, P184, DOI 10.1016/S0006-3495(02)75160-6; Shi G, 2007, J NEUROSCI, V27, P10084, DOI 10.1523/JNEUROSCI.2211-07.2007; STGEORGE RCC, 1952, J GEN PHYSIOL, V35, P495, DOI 10.1085/jgp.35.3.495; Stiles W. S., 1948, T OPTICAL CONVENTION, P97	41	91	94	1	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 10	2011	332	6035					1307	1312		10.1126/science.1200172	http://dx.doi.org/10.1126/science.1200172			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	775EP	21659602	Green Accepted			2022-12-24	WOS:000291441700042
J	Dolgin, E				Dolgin, Elie			The murine candidate	NATURE			English	Editorial Material							HEPATITIS-C; INFECTION; MODEL; MICE											Amako Y, 2010, J VIROL, V84, P303, DOI 10.1128/JVI.01448-09; Bissig KD, 2010, J CLIN INVEST, V120, P924, DOI 10.1172/JCI40094; Brenndorfer ED, 2010, HEPATOLOGY, V52, P1553, DOI 10.1002/hep.23870; Mercer DF, 2001, NAT MED, V7, P927, DOI 10.1038/90968; Ohara E, 2011, J HEPATOL, V54, P872, DOI 10.1016/j.jhep.2010.08.033; Ploss A, 2009, NATURE, V457, P882, DOI 10.1038/nature07684; Washburn ML, 2011, GASTROENTEROLOGY, V140, P1334, DOI 10.1053/j.gastro.2011.01.001	7	5	6	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 9	2011	474	7350					S14	S15		10.1038/474S14a	http://dx.doi.org/10.1038/474S14a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	774PE	21666729				2022-12-24	WOS:000291397800009
J	Tsukazaki, T; Mori, H; Echizen, Y; Ishitani, R; Fukai, S; Tanaka, T; Perederina, A; Vassylyev, DG; Kohno, T; Maturana, AD; Ito, K; Nureki, O				Tsukazaki, Tomoya; Mori, Hiroyuki; Echizen, Yuka; Ishitani, Ryuichiro; Fukai, Shuya; Tanaka, Takeshi; Perederina, Anna; Vassylyev, Dmitry G.; Kohno, Toshiyuki; Maturana, Andres D.; Ito, Koreaki; Nureki, Osamu			Structure and function of a membrane component SecDF that enhances protein export	NATURE			English	Article							ESCHERICHIA-COLI; PREPROTEIN TRANSLOCASE; CYTOPLASMIC MEMBRANE; CHANNEL; COMPLEX; MACHINERY; MECHANISM; MOVEMENT; DOMAIN	Protein translocation across the bacterial membrane, mediated by the secretory translocon SecYEG and the SecA ATPase(1-4), is enhanced by proton motive force(5,6) and membrane-integrated SecDF(7-9), which associates with SecYEG. The role of SecDF has remained unclear, although it is proposed to function in later stages of translocation as well as in membrane protein biogenesis(4,10-13). Here, we determined the crystal structure of Thermus thermophilus SecDF at 3.3 angstrom resolution, revealing a pseudo-symmetrical, 12-helix transmembrane domain belonging to the RND superfamily and two major periplasmic domains, P1 and P4. Higher-resolution analysis of the periplasmic domains suggested that P1, which binds an unfolded protein, undergoes functionally important conformational changes. In vitro analyses identified an ATP-independent step of protein translocation that requires both SecDF and proton motive force. Electrophysiological analyses revealed that SecDF conducts protons in a manner dependent on pH and the presence of an unfolded protein, with conserved Asp and Arg residues at the transmembrane interface between SecD and SecF playing essential roles in the movements of protons and preproteins. Therefore, we propose that SecDF functions as a membrane-integrated chaperone, powered by proton motive force, to achieve ATP-independent protein translocation.	[Tsukazaki, Tomoya; Echizen, Yuka; Ishitani, Ryuichiro; Nureki, Osamu] Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Bunkyo Ku, Tokyo 1130032, Japan; [Mori, Hiroyuki] Kyoto Univ, Inst Virus Res, Sakyo Ku, Kyoto 6068507, Japan; [Fukai, Shuya] Univ Tokyo, Synchrotron Radiat Res Org, Div Life Sci, Struct Biol Lab, Tokyo 1130032, Japan; [Fukai, Shuya] Univ Tokyo, Ctr Struct Biol Challenging Prot, Lab Macromol Complexes, Tokyo 1130032, Japan; [Tanaka, Takeshi; Kohno, Toshiyuki] Mitsubishi Kagaku Inst Life Sci, Machida, Tokyo 1948511, Japan; [Perederina, Anna; Vassylyev, Dmitry G.] Univ Alabama, Sch Med, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA; [Perederina, Anna; Vassylyev, Dmitry G.] Univ Alabama, Sch Dent, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA; [Maturana, Andres D.] Nagaoka Univ Technol, Dept Bioengn, Niigata 9402188, Japan; [Ito, Koreaki] Kyoto Sangyo Univ, Kita Ku, Kyoto 6038555, Japan	University of Tokyo; Kyoto University; University of Tokyo; University of Tokyo; Mitsubishi Kagaku Institute of Life Sciences (MITILS); University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Nagaoka University of Technology; Kyoto Sangyo University	Nureki, O (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Bunkyo Ku, Tokyo 1130032, Japan.	kito@cc.kyoto-su.ac.jp; nureki@ims.u-tokyo.ac.jp	Fukai, Shuya/X-4838-2018; Tsukazaki, Tomoya/N-2299-2019; NUREKI, OSAMU/G-4960-2014	Fukai, Shuya/0000-0002-1241-1443; Tsukazaki, Tomoya/0000-0002-6386-723X; Mori, Hiroyuki/0000-0002-0429-1269	Ministry of Education, Culture, Sports, Science and Technology (MEXT); JST; NIH; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074840] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [20247020, 22121003] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JST(Japan Science & Technology Agency (JST)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank Y. Akiyama, R. Suno, Y. Morimoto, T. Minamino, K. Namba, K. Inaba, M. Hattori and H. Nishimasu for suggestions; T. Sakamoto and A. Kurabayashi for assistance with sample preparation; R. Yamasaki, M. Sano, K. Mochizuki, K. Yoshikaie, K. Imayoshi and T. Adachi for technical support; M. Homma and S. Kojima for providing the Vibrio genomic DNA; the beamline staff members at BL41XU of SPring-8 (Hyogo, Japan) and at NW12 of KEK PF-AR (Tsukuba, Japan) for technical help during data collection and M. Ibba for comments on our manuscript. This work was supported by a Grant-in-Aid for Scientific Research (S) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) to O.N., by a CREST grant from JST to K.I., by a BIRD grant from JST to H.M. and R.I., by a grant for the National Project on Protein Structural and Functional Analyses to O.N., by NIH grants to D.G.V. and by grants from MEXT to T. Tsukazaki, H.M., R.I., S.F. and K.I.	ARKOWITZ RA, 1994, EMBO J, V13, P954, DOI 10.1002/j.1460-2075.1994.tb06340.x; DRIESSEN AJM, 1991, P NATL ACAD SCI USA, V88, P2471, DOI 10.1073/pnas.88.6.2471; Du Plessis DJF, 2011, BBA-BIOMEMBRANES, V1808, P851, DOI 10.1016/j.bbamem.2010.08.016; Duong F, 1997, EMBO J, V16, P4871, DOI 10.1093/emboj/16.16.4871; Economou A, 1995, CELL, V83, P1171, DOI 10.1016/0092-8674(95)90143-4; Hand NJ, 2006, J BACTERIOL, V188, P1251, DOI 10.1128/JB.188.4.1251-1259.2006; Hase CC, 2001, BBA-BIOENERGETICS, V1505, P169, DOI 10.1016/S0005-2728(00)00286-3; Hattori M, 2009, EMBO J, V28, P3602, DOI 10.1038/emboj.2009.288; Inaba K, 2006, CELL, V127, P789, DOI 10.1016/j.cell.2006.10.034; Matsuo E, 1998, J BIOL CHEM, V273, P18835, DOI 10.1074/jbc.273.30.18835; MATSUYAMA S, 1993, EMBO J, V12, P265, DOI 10.1002/j.1460-2075.1993.tb05652.x; Murakami S, 2006, NATURE, V443, P173, DOI 10.1038/nature05076; Nouwen N, 2005, J BACTERIOL, V187, P5857, DOI 10.1128/JB.187.16.5857-5860.2005; POGLIANO JA, 1994, EMBO J, V13, P554, DOI 10.1002/j.1460-2075.1994.tb06293.x; POGLIANO KJ, 1994, J BACTERIOL, V176, P804, DOI 10.1128/jb.176.3.804-814.1994; SAGARA K, 1994, J BACTERIOL, V176, P4111, DOI 10.1128/JB.176.13.4111-4116.1994; Sasaki M, 2006, SCIENCE, V312, P589, DOI 10.1126/science.1122352; SCHIEBEL E, 1991, CELL, V64, P927, DOI 10.1016/0092-8674(91)90317-R; Seeger MA, 2009, BIOCHEMISTRY-US, V48, P5801, DOI 10.1021/bi900446j; SHIOZUKA K, 1990, J BIOL CHEM, V265, P18843; Tseng Tsai-Tien, 1999, Journal of Molecular Microbiology and Biotechnology, V1, P107; Tsukazaki T, 2006, ACTA CRYSTALLOGR F, V62, P376, DOI 10.1107/S1744309106007779; Tsukazaki T, 2008, NATURE, V455, P988, DOI 10.1038/nature07421; Uchida K, 1995, J BIOL CHEM, V270, P30862, DOI 10.1074/jbc.270.52.30862; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; Vassylyev DG, 2007, NATURE, V448, P163, DOI 10.1038/nature05931; Zimmer J, 2008, NATURE, V455, P936, DOI 10.1038/nature07335	27	159	171	0	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 9	2011	474	7350					235	238		10.1038/nature09980	http://dx.doi.org/10.1038/nature09980			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774PE	21562494	Green Accepted			2022-12-24	WOS:000291397800055
J	Jha, P; Kesler, MA; Kumar, R; Ram, F; Ram, U; Aleksandrowicz, L; Bassani, DG; Chandra, S; Banthia, JK				Jha, Prabhat; Kesler, Maya A.; Kumar, Rajesh; Ram, Faujdar; Ram, Usha; Aleksandrowicz, Lukasz; Bassani, Diego G.; Chandra, Shailaja; Banthia, Jayant K.			Trends in selective abortions of girls in India: analysis of nationally representative birth histories from 1990 to 2005 and census data from 1991 to 2011	LANCET			English	Article							SEX-RATIOS; TECHNOLOGY; POPULATION; MORTALITY	Background India's 2011 census revealed a growing imbalance between the numbers of girls and boys aged 0-6 years, which we postulate is due to increased prenatal sex determination with subsequent selective abortion of female fetuses. We aimed to establish the trends in sex ratio by birth order from 1990 to 2005 with three nationally representative surveys and to quantify the totals of selective abortions of girls with census cohort data. Methods We assessed sex ratios by birth order in 0.25 million births in three rounds of the nationally representative National Family Health Survey covering the period from 1990 to 2005. We estimated totals of selective abortion of girls by assessing the birth cohorts of children aged 0-6 years in the 1991,2001, and 2011 censuses. Our main statistic was the conditional sex ratio of second-order births after a firstborn girl and we used 3-year rolling weighted averages to test for trends, with differences between trends compared by linear regression. Findings The conditional sex ratio for second-order births when the firstborn was a girl fell from 906 per 1000 boys (99% CI 798-1013) in 1990 to 836 (733-939) in 2005; an annual decline of 0.52% (p for trend=0.002). Declines were much greater in mothers with 10 or more years of education than in mothers with no education, and in wealthier households compared with poorer households. By contrast, we did not detect any significant declines in the sex ratio for second-order births if the firstborn was a boy, or for firstborns. Between the 2001 and 2011 censuses, more than twice the number of Indian districts (local administrative areas) showed declines in the child sex ratio as districts with no change or increases. After adjusting for excess mortality rates in girls, our estimates of number of selective abortions of girls rose from 0-2.0 million in the 1980s, to 1.2-4.1 million in the 1990s, and to 3.1-6.0 million in the 2000s. Each 1% decline in child sex ratio at ages 0-6 years implied 1.2-3.6 million more selective abortions of girls. Selective abortions of girls totalled about 4.2-12.1 million from 1980-2010, with a greater rate of increase in the 1990s than in the 2000s. Interpretation Selective abortion of girls, especially for pregnancies after a firstborn girl, has increased substantially in India. Most of India's population now live in states where selective abortion of girls is common.	[Jha, Prabhat; Kesler, Maya A.; Ram, Usha; Aleksandrowicz, Lukasz; Bassani, Diego G.] Univ Toronto, St Michaels Hosp, Li Ka Shing Knowledge Inst, Ctr Global Hlth Res, Toronto, ON M5B 2C5, Canada; [Jha, Prabhat; Kesler, Maya A.; Ram, Usha; Aleksandrowicz, Lukasz; Bassani, Diego G.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON M5B 2C5, Canada; [Kumar, Rajesh] Post Grad Inst Med Res & Educ, Sch Publ Hlth, Chandigarh, India; [Ram, Faujdar; Ram, Usha] Int Inst Populat Sci, Mumbai, Maharashtra, India; [Chandra, Shailaja] Govt India, Natl Populat Stabilisat Fund, New Delhi, India; [Banthia, Jayant K.] Govt Maharasthra, Mumbai, Maharashtra, India	University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; International Institute for Population Sciences	Jha, P (corresponding author), Univ Toronto, St Michaels Hosp, Li Ka Shing Knowledge Inst, Ctr Global Hlth Res, Toronto, ON M5B 2C5, Canada.	prabhat.jha@utoronto.ca	Ram, Usha/AAS-4140-2020; Bassani, Diego/G-2827-2015	Ram, Usha/0000-0001-6722-7347; Bassani, Diego/0000-0001-6704-3820; Aleksandrowicz, Lukasz/0000-0002-3644-1372	Fogarty International Centre of the US National Institutes of Health [R01 TW05991-01]; International Development Research Centre [102172]; Canadian Institute of Health Research (CIHR) [IEG-53506]; Li Ka Shing Knowledge Institute at St Michael's Hospital; University of Toronto; Canada Research Chair programme; FOGARTY INTERNATIONAL CENTER [R01TW005991, R01TW007939] Funding Source: NIH RePORTER	Fogarty International Centre of the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); International Development Research Centre; Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Li Ka Shing Knowledge Institute at St Michael's Hospital; University of Toronto(University of Toronto); Canada Research Chair programme(Canada Research Chairs); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	The Registrar-General of India first established the ongoing national census in 1881, and is presently collaborating with several of the authors on the Million Death Study. External funding is from the Fogarty International Centre of the US National Institutes of Health (grant R01 TW05991-01]), International Development Research Centre (grant 102172), Canadian Institute of Health Research (CIHR; IEG-53506), and the Li Ka Shing Knowledge Institute at St Michael's Hospital and University of Toronto (CGHR support). PJ is supported by the Canada Research Chair programme. The opinions expressed in this report are those of the authors and do not necessarily represent those of the Government of India. We thank Rahim Moineddin and Wilson Suraweera for statistical help, Vicky Hsiao and Brendon Pezzack for graphics, and Daniel Rosenblum and Ansely Wong for comments.	Agarwal Shonali, 2007, J Indian Med Assoc, V105, P132; Almond D, 2008, P NATL ACAD SCI USA, V105, P5681, DOI 10.1073/pnas.0800703105; Almond Jr D., 2009, 15391 NBER; [Anonymous], 2009, WORLD POP PROSP; [Anonymous], 2019, NATL FAMILY HLTH SUR; Bardia A, 2004, NATL MED J INDIA, V17, P207; Bassani DG, 2010, LANCET, V376, P1853, DOI 10.1016/S0140-6736(10)61461-4; BHAT M, 2007, WATERING NEIGHBOURS; COALE AJ, 1991, POPUL DEV REV, V17, P517, DOI 10.2307/1971953; George SM, 2006, PRENATAL DIAG, V26, P604, DOI 10.1002/pd.1475; *GOV IND, 2005, ANN REP IMPL PREC PR; Hatti N, 2004, LUND PAPERS EC HIST, V93; Hesketh T, 2006, P NATL ACAD SCI USA, V103, P13271, DOI 10.1073/pnas.0602203103; International Institute for Population Sciences, 2005, NAT FAM HLTH SURV NF; International Institute for Population Sciences, 1992, NAT FAM HLTH SURV NF; International Institute of Population Sciences, 2010, DISTR LEV HOUS SURV; Jha P, 2006, LANCET, V367, P211, DOI 10.1016/S0140-6736(06)67930-0; Jha P., 2009, CHOOSING HLTH ENTITL; Kulkarni P.M, 2007, ESTIMATION MISSING G; Miller R. G., 1981, SURVIVAL ANAL; Pallikadavath S, 2006, INT FAM PLAN PERSPEC, V32, P120, DOI 10.1363/3212006; *REG GEN IND, 2007, SAMPL REG SYST BAS S; *REG GEN IND, 2011, CENS IND 2011 INSTR; *REG GEN IND, 2001, CENS IND 2001 POST S; Registrar General India, 2009, SAMPL REG SYST STAT; Rodgers JL., 2001, CHANCE MAG, V14, P8, DOI DOI 10.1080/09332480.2001.10542293; Subramanian SV, 2009, J EPIDEMIOL COMMUN H, V63, P245, DOI 10.1136/jech.2008.078477; Teitelbaum M S, 1970, J Biosoc Sci Suppl, V2, P61; World Bank, 2009, WORLD DEV IND; Zhu WX, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1211	30	152	155	0	16	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 4	2011	377	9781					1921	1928		10.1016/S0140-6736(11)60649-1	http://dx.doi.org/10.1016/S0140-6736(11)60649-1			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	777LW	21612820	Green Accepted			2022-12-24	WOS:000291623200028
J	Cooley, RB; Rhoads, TW; Arp, DJ; Karplus, PA				Cooley, Richard B.; Rhoads, Timothy W.; Arp, Daniel J.; Karplus, P. Andrew			A Diiron Protein Autogenerates a Valine-Phenylalanine Cross-Link	SCIENCE			English	Article							MONOOXYGENASE; ACTIVATION; METHANE		[Arp, Daniel J.] Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA; [Cooley, Richard B.; Rhoads, Timothy W.; Karplus, P. Andrew] Oregon State Univ, Dept Biochem & Biophys, Corvallis, OR 97331 USA	Oregon State University; Oregon State University	Arp, DJ (corresponding author), Oregon State Univ, Dept Bot & Plant Pathol, 2082 Cordley Hall, Corvallis, OR 97331 USA.	Dan.J.Arp@oregonstate.edu; karplusp@science.oregonstate.edu	Rhoads, Tim/AAI-2483-2020	Rhoads, Tim/0000-0001-7364-1122; Cooley, Richard/0000-0003-3928-2757; Karplus, Paul/0000-0001-8725-6292	NIH [GM R01-083136]; Oregon Agricultural Experiment Station; National Institute of Environmental Health Sciences Environmental Health Sciences Center [ES00210]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000210] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083136] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oregon Agricultural Experiment Station; National Institute of Environmental Health Sciences Environmental Health Sciences Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by NIH grant GM R01-083136 (P.A.K.), the Oregon Agricultural Experiment Station (D.J.A.), and National Institute of Environmental Health Sciences Environmental Health Sciences Center grant ES00210. We thank J. M. Bollinger and C. Krebs for discussions. Coordinates and structure factors are deposited as Protein Data Bank entry 3QHB.	Andersson CS, 2009, P NATL ACAD SCI USA, V106, P5633, DOI 10.1073/pnas.0812971106; Bergman RG, 2007, NATURE, V446, P391, DOI 10.1038/446391a; Cooley RB, 2010, J MOL BIOL, V404, P232, DOI 10.1016/j.jmb.2010.09.034; Kopp DA, 2002, CURR OPIN CHEM BIOL, V6, P568, DOI 10.1016/S1367-5931(02)00366-6; Shu LJ, 1997, SCIENCE, V275, P515, DOI 10.1126/science.275.5299.515; Xie LL, 2001, P NATL ACAD SCI USA, V98, P12863, DOI 10.1073/pnas.231485998	6	9	10	1	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 20	2011	332	6032					929	929		10.1126/science.1205687	http://dx.doi.org/10.1126/science.1205687			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766FO	21596985	Green Accepted			2022-12-24	WOS:000290766600033
J	Frank, C; Werber, D; Cramer, JP; Askar, M; Faber, M; an der Heiden, M; Bernard, H; Fruth, A; Prager, R; Spode, A; Wadl, M; Zoufaly, A; Jordan, S; Kemper, MJ; Follin, P; Muller, L; King, LA; Rosner, B; Buchholz, U; Stark, K; Krause, G				Frank, Christina; Werber, Dirk; Cramer, Jakob P.; Askar, Mona; Faber, Mirko; an der Heiden, Matthias; Bernard, Helen; Fruth, Angelika; Prager, Rita; Spode, Anke; Wadl, Maria; Zoufaly, Alexander; Jordan, Sabine; Kemper, Markus J.; Follin, Per; Muller, Luise; King, Lisa A.; Rosner, Bettina; Buchholz, Udo; Stark, Klaus; Krause, Gerard		HUS Invest Team	Epidemic Profile of Shiga-Toxin-Producing Escherichia coli O104:H4 Outbreak in Germany	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HEMOLYTIC-UREMIC-SYNDROME; MULTISTATE OUTBREAK; BLOODY DIARRHEA; STRAINS; O157-H7; IDENTIFICATION; INFECTION; HUMANS; GENES	BACKGROUND We describe an outbreak of gastroenteritis and the hemolytic-uremic syndrome caused by Shiga-toxin-producing Escherichia coli in Germany in May, June, and July, 2011. The consumption of sprouts was identified as the most likely vehicle of infection. METHODS We analyzed data from reports in Germany of Shiga-toxin-producing E. coli gastroenteritis and the hemolytic-uremic syndrome and clinical information on patients presenting to Hamburg University Medical Center (HUMC). An outbreak case was defined as a reported case of the hemolytic-uremic syndrome or of gastroenteritis in a patient infected by Shiga-toxin-producing E. coli, serogroup O104 or serogroup unknown, with an onset of disease during the period from May 1 through July 4, 2011, in Germany. RESULTS A total of 3816 cases (including 54 deaths) were reported in Germany, 845 of which (22%) involved the hemolytic-uremic syndrome. The outbreak was centered in northern Germany and peaked around May 21 to 22. Most of the patients in whom the hemolytic-uremic syndrome developed were adults (88%; median age, 42 years), and women were overrepresented (68%). The estimated median incubation period was 8 days, with a median of 5 days from the onset of diarrhea to the development of the hemolytic-uremic syndrome. Among 59 patients prospectively followed at HUMC, the hemolytic-uremic syndrome developed in 12 (20%), with no significant differences according to sex or reported initial symptoms and signs. The outbreak strain was typed as an enteroaggregative Shiga-toxin-producing E. coli O104:H4, producing extended-spectrum beta-lactamase. CONCLUSIONS In this outbreak, caused by an unusual E. coli strain, cases of the hemolytic-uremic syndrome occurred predominantly in adults, with a preponderance of cases occurring in women. The hemolytic-uremic syndrome developed in more than 20% of the identified cases.	[Frank, Christina; Werber, Dirk; Faber, Mirko; an der Heiden, Matthias; Bernard, Helen; Wadl, Maria; Rosner, Bettina; Buchholz, Udo; Stark, Klaus; Krause, Gerard] Robert Koch Inst, Dept Infect Dis Epidemiol, D-1000 Berlin, Germany; [Fruth, Angelika; Prager, Rita] Robert Koch Inst, Dept Infect Dis, D-1000 Berlin, Germany; [Askar, Mona] Robert Koch Inst, Postgrad Training Appl Epidemiol Program, D-1000 Berlin, Germany; [Cramer, Jakob P.; Zoufaly, Alexander; Jordan, Sabine; Kemper, Markus J.] Univ Med Ctr Hamburg Eppendorf, Dept Internal Med, Hamburg, Germany; [Spode, Anke] Hamburg No Dist, Dept Hlth, Hamburg, Germany; [Follin, Per] Vastra Gotaland Reg, Dept Communicable Dis Control & Prevent, Gothenburg, Sweden; [Muller, Luise] Statens Serum Inst, DK-2300 Copenhagen, Denmark; [King, Lisa A.] Inst Veille Sanit, St Maurice, France	Robert Koch Institute; Robert Koch Institute; Robert Koch Institute; University of Hamburg; University Medical Center Hamburg-Eppendorf; Statens Serum Institut; Institute of Public Health Surveillance	Werber, D (corresponding author), Robert Koch Inst, Dept Infect Dis Epidemiol, D-1000 Berlin, Germany.	werberd@rki.de	Werber, Dirk/L-2264-2019; Schink, Susanne Barbara/F-7758-2015; Adlhoch, Cornelia/AAH-5888-2021; zhang, weidong/N-1070-2014; alzahrani, saud hamed/C-2014-2012; Schink, Susanne Barbara/A-2669-2017; Faber, MIrko/O-1191-2018; Richter, Martin Heinrich/AAB-1929-2022	Adlhoch, Cornelia/0000-0002-8842-0469; zhang, weidong/0000-0002-8079-1185; Schink, Susanne Barbara/0000-0001-7542-9416; Faber, MIrko/0000-0002-9196-570X; Richter, Martin Heinrich/0000-0002-8649-5248; an der Heiden, Matthias/0000-0001-5863-4549; Nielsen, Stine/0000-0002-5931-5379; Rieck, Thorsten/0000-0002-8799-8744; Werber, Dirk/0000-0002-8076-788X; Krause, Gerard/0000-0003-3328-8808; Frank, Christina/0000-0001-6776-8450; Marti, Melanie/0000-0002-6800-760X; Altmann, Mathias/0000-0002-8977-9270; Dudareva, Sandra/0000-0003-1803-704X; nachtnebel, matthias/0000-0001-7077-5694				[Anonymous], 2011, LAB INF REG STEC OUT; [Anonymous], GERM NAT INF DIS NOT; BELL BP, 1994, JAMA-J AM MED ASSOC, V272, P1349, DOI 10.1001/jama.272.17.1349; Bielaszewska M, 2006, CLIN INFECT DIS, V43, P1160, DOI 10.1086/508195; Buchholz U, 2011, NEW ENGL J MED, V365, P1763, DOI 10.1056/NEJMoa1106482; CEBULA TA, 1995, J CLIN MICROBIOL, V33, P248, DOI 10.1128/JCM.33.1.248-250.1995; CEBULA TA, 1995, J CLIN MICROBIOL, V33, P1048; European Food Safety Authority, 2011, TECHN REP SHIG TOX V; Friedrich AW, 2002, J INFECT DIS, V185, P74, DOI 10.1086/338115; Fukushima H, 1999, PEDIATR INT, V41, P213, DOI 10.1046/j.1442-200X.1999.4121041.x; GASSER C, 1955, Schweiz Med Wochenschr, V85, P905; Gerber A, 2002, J INFECT DIS, V186, P493, DOI 10.1086/341940; Gould LH, 2009, CLIN INFECT DIS, V49, P1480, DOI 10.1086/644621; Guh A, 2010, CLIN INFECT DIS, V51, P1411, DOI 10.1086/657304; Jenkins C, 2006, DIAGN MICR INFEC DIS, V55, P13, DOI 10.1016/j.diagmicrobio.2005.10.019; Karpac CA, 2008, BRIT J HAEMATOL, V141, P696, DOI 10.1111/j.1365-2141.2008.07116.x; Matsell DG, 2009, KIDNEY INT, V75, pS35, DOI 10.1038/ki.2008.628; Mead PS, 1998, LANCET, V352, P1207, DOI 10.1016/S0140-6736(98)01267-7; Mellmann A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022751; Prager R, 2003, INT J MED MICROBIOL, V292, P477, DOI 10.1078/1438-4221-00226; Prager R, 2007, EHEC WORKSH 2007 WIL; Rasko DA, 2011, NEW ENGL J MED, V365, P709, DOI 10.1056/NEJMoa1106920; Ribot EM, 2006, FOODBORNE PATHOG DIS, V3, P59, DOI 10.1089/fpd.2006.3.59; Rohde H, 2011, NEW ENGL J MED, V365, P718, DOI 10.1056/NEJMoa1107643; Scavia G, 2011, EMERG INFECT DIS, V17, P1957, DOI 10.3201/eid1710.111072; Scheutz F, 2011, EURO SURVEILL, V16; Soderstrom A, 2008, FOODBORNE PATHOG DIS, V5, P339, DOI 10.1089/fpd.2007.0065; Tarr PI, 2005, LANCET, V365, P1073, DOI 10.1016/S0140-6736(05)71144-2; Uber AP, 2006, FEMS MICROBIOL LETT, V256, P251, DOI 10.1111/j.1574-6968.2006.00124.x; Wendel AM, 2009, CLIN INFECT DIS, V48, P1079, DOI 10.1086/597399; World Health Organization, 2011, OUTBR E COL O104 H4	31	779	812	3	128	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 10	2011	365	19					1771	1780		10.1056/NEJMoa1106483	http://dx.doi.org/10.1056/NEJMoa1106483			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	844QQ	21696328				2022-12-24	WOS:000296762800006
J	Eagle, RA; Tutken, T; Martin, TS; Tripati, AK; Fricke, HC; Connely, M; Cifelli, RL; Eiler, JM				Eagle, Robert A.; Tuetken, Thomas; Martin, Taylor S.; Tripati, Aradhna K.; Fricke, Henry C.; Connely, Melissa; Cifelli, Richard L.; Eiler, John M.			Dinosaur Body Temperatures Determined from Isotopic (C-13-O-18) Ordering in Fossil Biominerals	SCIENCE			English	Article							ENDOTHERMY; GROWTH; THERMOREGULATION; HISTOLOGY; EVOLUTION	The nature of the physiology and thermal regulation of the nonavian dinosaurs is the subject of debate. Previously, arguments have been made for both endothermic and ectothermic metabolisms on the basis of differing methodologies. We used clumped isotope thermometry to determine body temperatures from the fossilized teeth of large Jurassic sauropods. Our data indicate body temperatures of 36 degrees to 38 degrees C, which are similar to those of most modern mammals. This temperature range is 4 degrees to 7 degrees C lower than predicted by a model that showed scaling of dinosaur body temperature with mass, which could indicate that sauropods had mechanisms to prevent excessively high body temperatures being reached because of their gigantic size.	[Eagle, Robert A.; Martin, Taylor S.; Eiler, John M.] CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; [Eagle, Robert A.; Tripati, Aradhna K.] Univ Calif Los Angeles, Dept Earth & Space Sci, Los Angeles, CA 90095 USA; [Tuetken, Thomas] Univ Bonn, Steinmann Inst Geol Mineral & Palaontol, D-53115 Bonn, Germany; [Tripati, Aradhna K.] Univ Calif Los Angeles, Inst Environm & Sustainabil, Inst Geophys & Planetary Phys, Dept Atmospher & Ocean Sci, Los Angeles, CA 90095 USA; [Fricke, Henry C.] Colorado Coll, Dept Geol, Colorado Springs, CO 80903 USA; [Connely, Melissa] Casper Coll, Tate Geol Museum, Casper, WY 82601 USA; [Cifelli, Richard L.] Univ Oklahoma, Oklahoma Museum Nat Hist, Norman, OK 73019 USA; [Cifelli, Richard L.] Univ Oklahoma, Dept Zool, Norman, OK 73019 USA	California Institute of Technology; University of California System; University of California Los Angeles; University of Bonn; University of California System; University of California Los Angeles; Colorado College; University of Oklahoma System; University of Oklahoma - Norman; University of Oklahoma System; University of Oklahoma - Norman	Eagle, RA (corresponding author), CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA.	rob.eagle@gmail.com	Tripati, Aradhna/C-9419-2011; Martin, Taylor/AAJ-8728-2020; Tütken, Thomas/E-4988-2010; Eagle, Robert/A-2679-2011	Tripati, Aradhna/0000-0002-1695-1754; Martin, Taylor/0000-0002-6242-6782; Eagle, Robert/0000-0003-0304-6111; Tutken, Thomas/0000-0002-2590-8600	National Science Foundation [EAR-1024929, EAR-0949191]; Deutsche Forschungsgemeinschaft (DFG) [TU 148/2-1, TU 148/4-1]; Division of Physical Sciences at UCLA	National Science Foundation(National Science Foundation (NSF)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Division of Physical Sciences at UCLA	R.A.E. and J.M.E. are funded by National Science Foundation grant EAR-1024929. T. T. is funded by Deutsche Forschungsgemeinschaft (DFG) grants TU 148/2-1 and TU 148/4-1. A. K. T. is supported by the Division of Physical Sciences at UCLA and National Science Foundation grant EAR-0949191. We thank the Utah Museum of Natural History, the Oklahoma Museum of Natural History, the Berlin Museum fur Naturkunde, the Aathal Dinosaurier Museum, D. Chure at Dinosaur National Monument, and the Wyoming Dinosaur International Society for the provision of specimens for analysis. We thank D. Schwarz-Wings for specimen identification and D. Goodreau for curatorial assistance. We also thank the stable isotope laboratories at Tubingen and Lyon for conducting phosphate delta<SUP>18</SUP>O measurements. Lastly, thanks to J. Gillooly for provision of published data. This is contribution number 113 of the DFG Research Unit 533 "Biology of the Sauropod Dinosaurs: The Evolution of Gigantism." R. A. E. designed the project and experiments, performed the experiments, analyzed the data, and wrote the manuscript. J. M. E. and A. K. T. assisted with experimental design and data interpretation. Clumped isotope analyses were conducted in the lab of J. M. E. T. T. provided samples for the study, conducted phosphate oxygen isotope analysis, and assisted with data interpretation. T. S. M. assisted with isotope measurements and petrographic analyses. H. C. F., M. C., and R. L. C. provided samples for analysis and insights into the provenance of samples and data interpretation.	Alexander RM, 1998, PALAEONTOLOGY, V41, P1231; Amiot R, 2006, EARTH PLANET SC LETT, V246, P41, DOI 10.1016/j.epsl.2006.04.018; [Anonymous], 1980, COLD LOOK WARM BLOOD; BAKKER RT, 1972, NATURE, V238, P81, DOI 10.1038/238081a0; BAKKER RT, 1980, COLD LOOK WARM BLOOD, P351; BARRICK RE, 1994, SCIENCE, V265, P222, DOI 10.1126/science.265.5169.222; CASE TJ, 1978, Q REV BIOL, V53, P243, DOI 10.1086/410622; Chinsamy A, 2004, DINOSAURIA, 2ND EDITION, P643; Clarke A, 2008, FUNCT ECOL, V22, P58, DOI 10.1111/j.1365-2435.2007.01341.x; COLBERT EH, 1993, AM J SCI, V293A, P1, DOI 10.2475/ajs.293.A.1; Dennis KJ, 2010, GEOCHIM COSMOCHIM AC, V74, P4110, DOI 10.1016/j.gca.2010.04.005; DUNHAM AE, 1989, GEOL S AM S, V238, P1; Eagle RA, 2010, P NATL ACAD SCI USA, V107, P10377, DOI 10.1073/pnas.0911115107; Erickson GM, 2005, TRENDS ECOL EVOL, V20, P677, DOI 10.1016/j.tree.2005.08.012; Farlow J.O., 1990, P43; Fricke HC, 2000, GEOLOGY, V28, P799, DOI 10.1130/0091-7613(2000)028<0799:MTMLAT>2.3.CO;2; Fricke HC, 2008, PALAEOGEOGR PALAEOCL, V266, P13, DOI 10.1016/j.palaeo.2008.03.030; Ghosh P, 2006, GEOCHIM COSMOCHIM AC, V70, P1439, DOI 10.1016/j.gca.2005.11.014; Gillooly JF, 2006, PLOS BIOL, V4, P1467, DOI 10.1371/journal.pbio.0040248; Klein N, 2008, PALEOBIOLOGY, V34, P247, DOI 10.1666/0094-8373(2008)034[0247:OSITLB]2.0.CO;2; Kohn MJ, 2002, REV MINERAL GEOCHEM, V48, P455, DOI 10.2138/rmg.2002.48.12; O'Connor MP, 1999, PALEOBIOLOGY, V25, P341, DOI 10.1017/S0094837300021321; Padian K, 2004, DINOSAURIA, 2ND EDITION, P660; PALADINO FV, 1990, NATURE, V344, P858, DOI 10.1038/344858a0; Pontzer H, 2009, PLOS ONE, V4, pA127, DOI 10.1371/journal.pone.0007783; Ricqles A. de, 1974, EVOL THEORY, V1, P51; Ruben John, 1997, P505; RUSSELL LORE S., 1965, J PALEONTOL, V39, P497; Sander PM, 2008, SCIENCE, V322, P200, DOI 10.1126/science.1160904; Sander PM, 2011, BIOL REV, V86, P117, DOI 10.1111/j.1469-185X.2010.00137.x; Sander PM, 2000, PALEOBIOLOGY, V26, P466, DOI 10.1666/0094-8373(2000)026<0466:LHOTTS>2.0.CO;2; Seebacher F, 1999, J EXP BIOL, V202, P77; Seebacher F, 2003, PHYSIOL BIOCHEM ZOOL, V76, P348, DOI 10.1086/375426; Seebacher F, 2003, PALEOBIOLOGY, V29, P105, DOI 10.1666/0094-8373(2003)029<0105:DBTTOO>2.0.CO;2; Spotila J.R., 1991, Modern Geology, V16, P203; Wedel MJ, 2003, PALEOBIOLOGY, V29, P243, DOI 10.1666/0094-8373(2003)029<0243:VPASAT>2.0.CO;2	36	107	112	2	156	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 22	2011	333	6041					443	445		10.1126/science.1206196	http://dx.doi.org/10.1126/science.1206196			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	795FR	21700837				2022-12-24	WOS:000292959600042
J	Tinetti, ME; Studenski, SA				Tinetti, Mary E.; Studenski, Stephanie A.			Comparative Effectiveness Research and Patients with Multiple Chronic Conditions	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							OLDER PERSONS		[Tinetti, Mary E.] Yale Univ, Sch Med, Dept Med, New Haven, CT 06510 USA; [Tinetti, Mary E.] Yale Univ, Sch Epidemiol & Publ Hlth, New Haven, CT 06510 USA; [Studenski, Stephanie A.] Univ Pittsburgh, Sch Med, Dept Med, Pittsburgh, PA USA; [Studenski, Stephanie A.] VA Pittsburgh Healthcare Syst, Pittsburgh, PA USA	Yale University; Yale University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System	Tinetti, ME (corresponding author), Yale Univ, Sch Med, Dept Med, New Haven, CT 06510 USA.							Alecxih L., 2010, INDIVIDUALS LIVING C; Fried TR, 2008, J AM GERIATR SOC, V56, P1839, DOI 10.1111/j.1532-5415.2008.01923.x; Gill TM, 2001, ANN INTERN MED, V135, P313, DOI 10.7326/0003-4819-135-5-200109040-00007; Manton KG, 2008, J GERONTOL B-PSYCHOL, V63, pS269, DOI 10.1093/geronb/63.5.S269; Van Spall HGC, 2007, JAMA-J AM MED ASSOC, V297, P1233, DOI 10.1001/jama.297.11.1233	5	107	108	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 30	2011	364	26					2478	2481		10.1056/NEJMp1100535	http://dx.doi.org/10.1056/NEJMp1100535			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	785AM	21696327				2022-12-24	WOS:000292199800003
J	Ezratty, EJ; Stokes, N; Chai, S; Shah, AS; Williams, SE; Fuchs, E				Ezratty, Ellen J.; Stokes, Nicole; Chai, Sophia; Shah, Alok S.; Williams, Scott E.; Fuchs, Elaine			A Role for the Primary Cilium in Notch Signaling and Epidermal Differentiation during Skin Development	CELL			English	Article							HAIR FOLLICLE MORPHOGENESIS; INTRAFLAGELLAR TRANSPORT; TERMINAL DIFFERENTIATION; CONDITIONAL ABLATION; KIDNEY-DISEASE; KIF3A SUBUNIT; CELL-DIVISION; STEM-CELLS; KINESIN-II; HEDGEHOG	Ciliogenesis precedes lineage-determining signaling in skin development. To understand why, we performed shRNA-mediated knockdown of seven intraflagellar transport proteins (IFTs) and conditional ablation of Ift-88 and Kif3a during embryogenesis. In both cultured keratinocytes and embryonic epidermis, all of these eliminated cilia, and many (not Kif3a) caused hyperproliferation. Surprisingly and independent of proliferation, ciliary mutants displayed defects in Notch signaling and commitment of progenitors to differentiate. Notch receptors and Notch-processing enzymes colocalized with cilia in wild-type epidermal cells. Moreover, differentiation defects in ciliary mutants were cell autonomous and rescued by activated Notch (NICD). By contrast, Shh signaling was neither operative nor required for epidermal ciliogenesis, Notch signaling, or differentiation. Rather, Shh signaling defects in ciliary mutants occurred later, arresting hair follicle morphogenesis in the skin. These findings unveil temporally and spatially distinct functions for primary cilia at the nexus of signaling, proliferation, and differentiation.	[Ezratty, Ellen J.; Stokes, Nicole; Chai, Sophia; Shah, Alok S.; Williams, Scott E.; Fuchs, Elaine] Rockefeller Univ, Howard Hughes Med Inst, Lab Mammalian Cell Biol & Dev, New York, NY 10065 USA	Howard Hughes Medical Institute; Rockefeller University	Fuchs, E (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab Mammalian Cell Biol & Dev, New York, NY 10065 USA.	fuchslb@rockefeller.edu	Fuchs, Elaine/G-1565-2016	Williams, Scott/0000-0001-9975-7334	National Institutes of Health; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R37AR027883] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank L. Goldstein (UCSD) for Kif3 fl/fl mice and Q. Zhang (University of Iowa) for Ift88 fl/fl mice; D. Oristan and L. Polak for their expertise and assistance in the mouse facility; A. North and the RU Bioimaging Resource Center for assistance with image acquisition; and M. Schober, D. Devenport, C. Luxenburg, M. Kadaja, and other Fuchs laboratory members for helpful discussions and critical reading of the manuscript. E.J.E. is a Jane Coffin Childs postdoctoral fellow, A. S. S. is a Marie Josee and Henry Kravis postdoctoral fellow, S. E. W. is an American Cancer Society postdoctoral fellow, and E. F. is an investigator in the Howard Hughes Medical Institute. This work was supported by a grant from the National Institutes of Health.	Baldari CT, 2010, CURR OPIN CELL BIOL, V22, P75, DOI 10.1016/j.ceb.2009.10.010; Beronja S, 2010, NAT MED, V16, P821, DOI 10.1038/nm.2167; Bershteyn M, 2010, DEV CELL, V19, P270, DOI 10.1016/j.devcel.2010.07.009; Blanpain C, 2006, GENE DEV, V20, P3022, DOI 10.1101/gad.1477606; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Chakrabarti A, 1998, CELL TISSUE RES, V293, P453, DOI 10.1007/s004410051137; Chiang C, 1999, DEV BIOL, V205, P1, DOI 10.1006/dbio.1998.9103; Croyle MJ, 2011, DEVELOPMENT, V138, P1675, DOI 10.1242/dev.060210; Duncan AW, 2005, NAT IMMUNOL, V6, P314, DOI 10.1038/ni1164; ELOFSSON R, 1984, J ULTRA MOL STRUCT R, V87, P212, DOI 10.1016/S0022-5320(84)80061-1; Fan SL, 2004, CURR BIOL, V14, P1451, DOI 10.1016/j.cub.2004.08.025; Finetti F, 2009, NAT CELL BIOL, V11, P1332, DOI 10.1038/ncb1977; FUCHS E, 1992, P NATL ACAD SCI USA, V89, P6906, DOI 10.1073/pnas.89.15.6906; Fuchs E, 2007, NATURE, V445, P834, DOI 10.1038/nature05659; Gao J, 2008, GENE DEV, V22, P2111, DOI 10.1101/gad.1689908; Gerdes JM, 2009, CELL, V137, P32, DOI 10.1016/j.cell.2009.03.023; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Gritli-Linde A, 2007, DEV CELL, V12, P99, DOI 10.1016/j.devcel.2006.12.006; Han YG, 2010, CURR OPIN NEUROBIOL, V20, P58, DOI 10.1016/j.conb.2009.12.002; Haraguchi K, 2006, J BIOL CHEM, V281, P4094, DOI 10.1074/jbc.M507028200; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; Jaulin F, 2010, J CELL BIOL, V190, P443, DOI 10.1083/jcb.201006044; Jonassen JA, 2008, J CELL BIOL, V183, P377, DOI 10.1083/jcb.200808137; KENNEDY JR, 1968, J ULTRA MOL STRUCT R, V22, P530, DOI 10.1016/S0022-5320(68)90039-7; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Lechler T, 2007, J CELL BIOL, V176, P147, DOI 10.1083/jcb.200609109; Lehman JM, 2009, J INVEST DERMATOL, V129, P438, DOI 10.1038/jid.2008.279; Lin FM, 2003, P NATL ACAD SCI USA, V100, P5286, DOI 10.1073/pnas.0836980100; Lowell S, 2000, CURR BIOL, V10, P491, DOI 10.1016/S0960-9822(00)00451-6; Luxenburg C, 2011, NAT CELL BIOL, V13, P203, DOI 10.1038/ncb2163; Marszalek JR, 1999, P NATL ACAD SCI USA, V96, P5043, DOI 10.1073/pnas.96.9.5043; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Mizutani K, 2007, NATURE, V449, P351, DOI 10.1038/nature06090; Morimoto M, 2010, J CELL SCI, V123, P213, DOI 10.1242/jcs.058669; Moriyama M, 2008, DEV CELL, V14, P594, DOI 10.1016/j.devcel.2008.01.017; Nguyen BC, 2006, GENE DEV, V20, P1028, DOI 10.1101/gad.1406006; Nigg EA, 2009, CELL, V139, P663, DOI 10.1016/j.cell.2009.10.036; Okuyama R, 2004, DEV CELL, V6, P551, DOI 10.1016/S1534-5807(04)00098-X; Oro AE, 2003, DEV BIOL, V255, P238, DOI 10.1016/S0012-1606(02)00042-8; Pan JM, 2007, CELL, V129, P1255, DOI 10.1016/j.cell.2007.06.018; Pedersen LB, 2008, CURR TOP DEV BIOL, V85, P23, DOI 10.1016/S0070-2153(08)00802-8; Pugacheva EN, 2007, CELL, V129, P1351, DOI 10.1016/j.cell.2007.04.035; Raghavan S, 2000, J CELL BIOL, V150, P1149, DOI 10.1083/jcb.150.5.1149; Santos N, 2010, DEV CELL, V19, P5, DOI 10.1016/j.devcel.2010.07.001; Satir P, 2010, J CELL SCI, V123, P499, DOI 10.1242/jcs.050377; Schneider L, 2005, CURR BIOL, V15, P1861, DOI 10.1016/j.cub.2005.09.012; Schober M, 2007, J CELL BIOL, V176, P667, DOI 10.1083/jcb.200608010; Seeley ES, 2010, J CELL SCI, V123, P511, DOI 10.1242/jcs.061093; Segre JA, 1999, NAT GENET, V22, P356, DOI 10.1038/11926; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Taulman PD, 2001, MOL BIOL CELL, V12, P589, DOI 10.1091/mbc.12.3.589; Tien AC, 2009, J CELL BIOL, V184, P621, DOI 10.1083/jcb.200811141; Vasioukhin V, 1999, P NATL ACAD SCI USA, V96, P8551, DOI 10.1073/pnas.96.15.8551; Vasioukhin V, 2001, CELL, V104, P605, DOI 10.1016/S0092-8674(01)00246-X; Wang X, 2008, J CELL BIOL, V183, P37, DOI 10.1083/jcb.200804030; Williams SE, 2011, NATURE, V470, P353, DOI 10.1038/nature09793; Wong SY, 2009, NAT MED, V15, P1055, DOI 10.1038/nm.2011; Yamashita YM, 2007, SCIENCE, V315, P518, DOI 10.1126/science.1134910; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yi R, 2006, NAT GENET, V38, P356, DOI 10.1038/ng1744	60	216	221	0	26	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 24	2011	145	7					1129	1141		10.1016/j.cell.2011.05.030	http://dx.doi.org/10.1016/j.cell.2011.05.030			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	782QV	21703454	Bronze, Green Accepted			2022-12-24	WOS:000292025700018
J	Ladeveze, S; de Muizon, C; Beck, RMD; Germain, D; Cespedes-Paz, R				Ladeveze, Sandrine; de Muizon, Christian; Beck, Robin M. D.; Germain, Damien; Cespedes-Paz, Ricardo			Earliest evidence of mammalian social behaviour in the basal Tertiary of Bolivia	NATURE			English	Article							SEXUAL-DIMORPHISM; SOUTH-AMERICA; MARSUPIALS; ORGANIZATION; DIDELPHIDAE; DASYURIDAE; PALEOCENE; HISTORY; ORIGIN	The vast majority of Mesozoic and early Cenozoic metatherian mammals (extinct relatives of modern marsupials) are known only from partial jaws or isolated teeth, which give insight into their probable diets and phylogenetic relationships but little else. The few skulls known are generally crushed, incomplete or both(1-4), and associated postcranial material is extremely rare. Here we report the discovery of an exceptionally large number of almost undistorted, nearly complete skulls and skeletons of a stem-metatherian, Pucadelphys andinus, in the early Palaeocene epoch(5) of Tiupampa in Bolivia(6-8). These give an unprecedented glimpse into early metatherian morphology, evolutionary relationships and, especially, ecology. The remains of 35 individuals have been collected, with 22 of these represented by nearly complete skulls and associated postcrania. These individuals were probably buried in a single catastrophic event, and so almost certainly belong to the same population(9). The preservation of multiple adult, sub-adult and juvenile individuals in close proximity (<1 m(2)) is indicative of gregarious social behaviour or at least a high degree of social tolerance and frequent interaction. Such behaviour is unknown in living didelphids, which are highly solitary and have been regarded, perhaps wrongly, as the most generalized living marsupials. The Tiupampan P. andinus population also exhibits strong sexual dimorphism, which, in combination with gregariousness, suggests strong male-male competition and polygyny. Our study shows that social interactions occurred in metatherians as early as the basal Palaeocene and that solitary behaviour may not be plesiomorphic for Metatheria as a whole.	[Ladeveze, Sandrine] Royal Belgian Inst Nat Sci, Dept Palaeontol, B-1000 Brussels, Belgium; [de Muizon, Christian; Germain, Damien] UPMC, MNHN, Dept Hist tERRE, CNRS,UMR7207,CR2P, F-75005 Paris, France; [Beck, Robin M. D.] Amer Museum Nat Hist, Dept Mammal, New York, NY 10024 USA; [Cespedes-Paz, Ricardo] Museo Hist Nat Alcide Orbigny, Cochabamba, Bolivia	Royal Belgian Institute of Natural Sciences; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; American Museum of Natural History (AMNH)	Ladeveze, S (corresponding author), Royal Belgian Inst Nat Sci, Dept Palaeontol, 29 Rue Vautier, B-1000 Brussels, Belgium.	sandrine.ladeveze@naturalsciences.be; muizon@mnhn.fr	germain, damien/I-5906-2012; De Muizon, Christian/P-4335-2017; De Muizon, Christian/Q-7986-2019	De Muizon, Christian/0000-0002-1247-8867; De Muizon, Christian/0000-0002-1247-8867; Beck, Robin/0000-0002-7050-7072; Germain, Damien/0000-0002-7608-2212	National Geographic Society [2908-84]; Institut Francais d'Etudes Andines; Belgian Federal Science Policy Office [MO/36/020]; NSF [DEB-0743039]	National Geographic Society(National Geographic Society); Institut Francais d'Etudes Andines; Belgian Federal Science Policy Office(Belgian Federal Science Policy Office); NSF(National Science Foundation (NSF))	Field expeditions were supported by the National Geographic Society (grants 2908-84) in 1985 and by the 'Institut Francais d'Etudes Andines' in 1997. The specimens collected are the property of the 'Museo de Historia Natural Alcide d'Orbigny' in Cochabamba, Bolivia. Additional financial support was provided by Research Project MO/36/020 of the Belgian Federal Science Policy Office (S. L.), and NSF grant DEB-0743039 (R. M.D.B., in collaboration with R. Voss at the American Museum of Natural History). Photographs are by C. Lemzaouda and P. Loubry, scanning electron microscope photographs are by J. Cillis and the reconstruction in Fig. 1 is by S. Fernandez. We thank E. Westwig for access to the AMNH collections, and O. Lambert, A. Pradel, and T. Soderquist for discussions.	Astua D, 2010, J MAMMAL, V91, P1011, DOI 10.1644/09-MAMM-A-018.1; ATRAMENTOWICZ M, 1986, BIOTROPICA, V18, P136, DOI 10.2307/2388756; Caceres NC, 2007, J NAT HIST, V41, P1979, DOI 10.1080/00222930701520835; Cifelli RL, 1998, CR ACAD SCI II A, V326, P215, DOI 10.1016/S1251-8050(00)89038-2; DE MUIZON C., 2003, PREDATORS POUCHES BI, P42; de Muizon C, ORIGINS EVO IN PRESS; de Muizon Christian, 1998, Geodiversitas, V20, P19; deMuizon C, 1997, NATURE, V389, P486, DOI 10.1038/39029; Fisher DO, 2006, BEHAV ECOL, V17, P164, DOI 10.1093/beheco/arj012; Gelfo JN, 2009, PALAEONTOLOGY, V52, P251, DOI 10.1111/j.1475-4983.2008.00835.x; Head JJ, 2009, NATURE, V457, P715, DOI 10.1038/nature07671; Hershkovitz P, 1997, FIELDIANA ZOOLOGY, V86, P1; Horovitz I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008278; Kraaijeveld K, 2003, P ROY SOC B-BIOL SCI, V270, pS251, DOI 10.1098/rsbl.2003.0082; LAZENBYCOHEN KA, 1988, BEHAV ECOL SOCIOBIOL, V22, P195, DOI 10.1007/BF00300569; Luo ZX, 2003, SCIENCE, V302, P1934, DOI 10.1126/science.1090718; Marshall Larry G., 1995, Memoires du Museum National d'Histoire Naturelle, V165, P21; Marshall LG, 1997, J S AM EARTH SCI, V10, P49, DOI 10.1016/S0895-9811(97)00005-9; MARSHALL LG, 1995, PUCADELPHYS ANDINUS; MORTON SR, 1978, J MAMMAL, V59, P569, DOI 10.2307/1380234; Muizon C., 1992, REV TECNICA YACIMIEN, V12, P575; Oakwood M, 2002, J ZOOL, V257, P237, DOI 10.1017/S0952836902000833; Plavcan JM, 2000, J HUM EVOL, V39, P327, DOI 10.1006/jhev.2000.0423; Rougier GW, 1998, NATURE, V396, P459, DOI 10.1038/24856; RUSSELL EM, 1984, MAMMAL REV, V14, P101, DOI 10.1111/j.1365-2907.1984.tb00343.x; SODERQUIST TR, 1995, J ZOOL, V237, P385, DOI 10.1111/j.1469-7998.1995.tb02769.x; Szalay FS, 1996, J VERTEBR PALEONTOL, V16, P474, DOI 10.1080/02724634.1996.10011335; TYNDALEBISCOE CH, 1976, J MAMMAL, V57, P249, DOI 10.2307/1379686	28	26	26	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 2	2011	474	7349					83	86		10.1038/nature09987	http://dx.doi.org/10.1038/nature09987			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	771KV	21552278				2022-12-24	WOS:000291156700042
J	Kelly, RP; Foley, MM; Fisher, WS; Feely, RA; Halpern, BS; Waldbusser, GG; Caldwell, MR				Kelly, R. P.; Foley, M. M.; Fisher, W. S.; Feely, R. A.; Halpern, B. S.; Waldbusser, G. G.; Caldwell, M. R.			Mitigating Local Causes of Ocean Acidification with Existing Laws	SCIENCE			English	Editorial Material							CLIMATE-CHANGE; IMPACTS; EUTROPHICATION; SATURATION; COASTAL; WATER		[Kelly, R. P.; Foley, M. M.; Caldwell, M. R.] Stanford Univ, Ctr Ocean Solut, Stanford, CA 94305 USA; [Fisher, W. S.] US EPA, Gulf Ecol Div, Gulf Breeze, FL 32561 USA; [Feely, R. A.] NOAA, Pacific Marine Environm Lab, Seattle, WA 98115 USA; [Halpern, B. S.] Natl Ctr Ecol Anal & Synth, Santa Barbara, CA 93101 USA; [Waldbusser, G. G.] Oregon State Univ, Coll Atmospher & Ocean Sci, Corvallis, OR 97331 USA	Stanford University; United States Environmental Protection Agency; National Oceanic Atmospheric Admin (NOAA) - USA; National Center for Ecological Analysis & Synthesis; Oregon State University	Kelly, RP (corresponding author), Stanford Univ, Ctr Ocean Solut, Stanford, CA 94305 USA.	rpk@stanford.edu	Feely, Richard A./ABI-5740-2020	Waldbusser, George/0000-0002-8334-580X; Kelly, Ryan/0000-0001-5037-2441				[Anonymous], 2009, FED REGISTER, V74, P15; Baron J.S., 2008, PRELIMINARY REV ADAP; Borges AV, 2010, LIMNOL OCEANOGR, V55, P346, DOI 10.4319/lo.2010.55.1.0346; Bradley P.A., 2010, EPA600R10054; Cheung WWL, 2010, GLOBAL CHANGE BIOL, V16, P24, DOI 10.1111/j.1365-2486.2009.01995.x; Cheung WWL, 2009, FISH FISH, V10, P235, DOI 10.1111/j.1467-2979.2008.00315.x; Cooley SR, 2009, ENVIRON RES LETT, V4, DOI 10.1088/1748-9326/4/2/024007; Costanza R, 1998, SCIENCE, V281, P198, DOI 10.1126/science.281.5374.198; Dentener F, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002672; Doney SC, 2007, P NATL ACAD SCI USA, V104, P14580, DOI 10.1073/pnas.0702218104; Doney SC, 2010, SCIENCE, V328, P1512, DOI 10.1126/science.1185198; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; Dove MC, 2007, J SHELLFISH RES, V26, P519, DOI 10.2983/0730-8000(2007)26[519:IOEAOS]2.0.CO;2; Feely RA, 2008, SCIENCE, V320, P1490, DOI 10.1126/science.1155676; Feely RA, 2010, ESTUAR COAST SHELF S, V88, P442, DOI 10.1016/j.ecss.2010.05.004; Feely RA, 2009, OCEANOGRAPHY, V22, P36, DOI 10.5670/oceanog.2009.95; Fore LS, 2008, SCIENCE, V322, P1788, DOI 10.1126/science.322.5909.1788a; Green MA, 2009, LIMNOL OCEANOGR, V54, P1037, DOI 10.4319/lo.2009.54.4.1037; Halpern BS, 2008, OCEAN COAST MANAGE, V51, P203, DOI 10.1016/j.ocecoaman.2007.08.002; Kemp WM, 2005, MAR ECOL PROG SER, V303, P1, DOI 10.3354/meps303001; Salisbury J., 2008, EOS T AM GEOPHYS UN, V89, P513, DOI [10.1029/2008EO500001, DOI 10.1029/2008EO500001]; Waldbusser GG, 2011, ESTUAR COAST, V34, P221, DOI 10.1007/s12237-010-9307-0	22	93	97	3	93	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 27	2011	332	6033					1036	1037		10.1126/science.1203815	http://dx.doi.org/10.1126/science.1203815			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	769FN	21617060				2022-12-24	WOS:000290996700027
J	Teglas, E; Vul, E; Girotto, V; Gonzalez, M; Tenenbaum, JB; Bonatti, LL				Teglas, Erno; Vul, Edward; Girotto, Vittorio; Gonzalez, Michel; Tenenbaum, Joshua B.; Bonatti, Luca L.			Pure Reasoning in 12-Month-Old Infants as Probabilistic Inference	SCIENCE			English	Article							SPEECH STREAM; OBJECT; PERCEPTION; COMPUTATIONS; SEGMENTATION; STATISTICS; SEQUENCES; BELIEFS	Many organisms can predict future events from the statistics of past experience, but humans also excel at making predictions by pure reasoning: integrating multiple sources of information, guided by abstract knowledge, to form rational expectations about novel situations, never directly experienced. Here, we show that this reasoning is surprisingly rich, powerful, and coherent even in preverbal infants. When 12-month-old infants view complex displays of multiple moving objects, they form time-varying expectations about future events that are a systematic and rational function of several stimulus variables. Infants' looking times are consistent with a Bayesian ideal observer embodying abstract principles of object motion. The model explains infants' statistical expectations and classic qualitative findings about object cognition in younger babies, not originally viewed as probabilistic inferences.	[Tenenbaum, Joshua B.] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Teglas, Erno] Cent European Univ, Cognit Dev Ctr, H-1015 Budapest, Hungary; [Teglas, Erno] Hungarian Acad Sci, H-1015 Budapest, Hungary; [Vul, Edward] Univ Calif San Diego, La Jolla, CA 92093 USA; [Girotto, Vittorio] Univ IUAV Venice, I-30135 Venice, Italy; [Girotto, Vittorio; Gonzalez, Michel] CNRS, F-13331 Marseille, France; [Girotto, Vittorio; Gonzalez, Michel] Aix Marseille Univ, F-13331 Marseille, France; [Bonatti, Luca L.] ICREA, Barcelona 08018, Spain; [Bonatti, Luca L.] Univ Pompeu Fabra, Barcelona 08018, Spain	Massachusetts Institute of Technology (MIT); Central European University; Hungarian Academy of Sciences; University of California System; University of California San Diego; IUAV University Venice; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; ICREA; Pompeu Fabra University	Tenenbaum, JB (corresponding author), MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA.	lucabonatti@mac.com; jbt@mit.edu	Bonatti, Luca Lorenzo/AAA-2410-2019	Bonatti, Luca Lorenzo/0000-0001-8624-9007; Teglas, Erno/0000-0003-4502-3639	Ministerio de Ciencia E Innovacion [PSI2009-08232PSIC]; James S. McDonnell Foundation; Office of Naval Research [N00014-09-0124, N00014-07-1-0937]; Army Research Office MURI [W911NF-08-1-0242]; Swiss and Global-Fondazione Ca' Foscari; Marie Curie 035975 Disorders and Coherence of the Embodied Self; ICREA Funding Source: Custom	Ministerio de Ciencia E Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); James S. McDonnell Foundation; Office of Naval Research(Office of Naval Research); Army Research Office MURI(MURI); Swiss and Global-Fondazione Ca' Foscari; Marie Curie 035975 Disorders and Coherence of the Embodied Self; ICREA(ICREA)	The research was supported by grants Friuli-Venezia-Giulia "PsyScope XL," Ministerio de Ciencia E Innovacion PSI2009-08232PSIC, the James S. McDonnell Foundation Causal Learning Research Collaborative grant, Office of Naval Research grants N00014-09-0124 and N00014-07-1-0937, Army Research Office MURI W911NF-08-1-0242, the Swiss and Global-Fondazione Ca' Foscari, and Marie Curie 035975 Disorders and Coherence of the Embodied Self. E. T. and L. L. B. designed the experiments and analyzed the data. E. T. ran the experiments. J.B.T. and E. V. conceived the model and the simulations. E. T., E. V., J.B.T., and L. L. B. wrote the paper. All authors discussed the research and revised the text and the analyses. We thank D. Amati, L. Filippin, F. Gandolfo, N. Goodman, A. Isaja, and N. Sebastian for support and suggestions. J. Mehler and the Language, Cognition, and Development Laboratory in Trieste, Italy made the experimental work possible. We are deeply grateful to them.	Aguiar A, 1999, COGNITIVE PSYCHOL, V39, P116, DOI 10.1006/cogp.1999.0717; Baillargeon R., 2009, LEARNING INFANT MIND, P66; Baker CL, 2009, COGNITION, V113, P329, DOI 10.1016/j.cognition.2009.07.005; Brown SD, 2009, COGNITIVE PSYCHOL, V58, P49, DOI 10.1016/j.cogpsych.2008.09.002; Cosmides L, 1996, COGNITION, V58, P1, DOI 10.1016/0010-0277(95)00664-8; Cover T. M., 2006, ELEMENTS INFORM THEO, p[xxiii, 74]; Creel SC, 2004, J EXP PSYCHOL LEARN, V30, P1119, DOI 10.1037/0278-7393.30.5.1119; Fiser J, 2002, J EXP PSYCHOL LEARN, V28, P458, DOI 10.1037//0278-7393.28.3.458; Fodor J. A., 1975, LANGUAGE THOUGHT; Gergely G, 2003, TRENDS COGN SCI, V7, P287, DOI 10.1016/S1364-6613(03)00128-1; GIGERENZER G, 1995, PSYCHOL REV, V102, P684, DOI 10.1037/0033-295X.102.4.684; Girotto V, 2006, NORMS IN HUMAN DEVELOPMENT, P220, DOI 10.1017/CBO9780511489778.010; Griffiths TL, 2006, PSYCHOL SCI, V17, P767, DOI 10.1111/j.1467-9280.2006.01780.x; Hauser MD, 2001, COGNITION, V78, pB53, DOI 10.1016/S0010-0277(00)00132-3; Johnson SP, 2003, CHILD DEV, V74, P94, DOI 10.1111/1467-8624.00523; Johnson-Laird PN, 1999, PSYCHOL REV, V106, P62, DOI 10.1037/0033-295X.106.1.62; KELLMAN PJ, 1983, COGNITIVE PSYCHOL, V15, P483, DOI 10.1016/0010-0285(83)90017-8; KEMP C, 2009, ADV NEURAL INFORM PR, V22, P925; Kersten D, 2004, ANNU REV PSYCHOL, V55, P271, DOI 10.1146/annurev.psych.55.090902.142005; Kovacs AM, 2010, SCIENCE, V330, P1830, DOI 10.1126/science.1190792; LEVY R, 2008, ADV NEURAL INFORM PR, V21, P937; Onishi KH, 2005, SCIENCE, V308, P255, DOI 10.1126/science.1107621; Pena M, 2002, SCIENCE, V298, P604, DOI 10.1126/science.1072901; Russell S, 2009, ARTIFICIAL INTELLIGE; Saffran JR, 1996, J MEM LANG, V35, P606, DOI 10.1006/jmla.1996.0032; SINHA P, 2009, OBJECT CATEGORIZATIO, P301; Spelke Elizabeth, 1986, PSYCHOL FR, V31, P67; Teglas E, 2007, P NATL ACAD SCI USA, V104, P19156, DOI 10.1073/pnas.0700271104; Tenenbaum JB, 2006, TRENDS COGN SCI, V10, P309, DOI 10.1016/j.tics.2006.05.009; Tenenbaum JB, 2011, SCIENCE, V331, P1279, DOI 10.1126/science.1192788; Toro JM, 2005, PERCEPT PSYCHOPHYS, V67, P867, DOI 10.3758/BF03193539; VUL E, 2009, ADV NEURAL INFORM PR, V22, P1955; Wilcox T, 2003, INFANT BEHAV DEV, V26, P253, DOI 10.1016/S0163-6383(03)00021-3; Woodward AL, 1998, COGNITION, V69, P1, DOI 10.1016/S0010-0277(98)00058-4; WYNN K, 1992, NATURE, V358, P749, DOI 10.1038/358749a0; Xu F, 1996, COGNITIVE PSYCHOL, V30, P111, DOI 10.1006/cogp.1996.0005; Xu F, 2008, P NATL ACAD SCI USA, V105, P5012, DOI 10.1073/pnas.0704450105	39	169	169	4	66	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 27	2011	332	6033					1054	1059		10.1126/science.1196404	http://dx.doi.org/10.1126/science.1196404			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	769FN	21617069				2022-12-24	WOS:000290996700036
J	Lakhani, M				Lakhani, Mayur			PERSONAL VIEW Let's talk about dying	BRITISH MEDICAL JOURNAL			English	Editorial Material												MK.Lakhani@GP-C82644.nhs.uk							0	2	2	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 17	2011	342								d3018	10.1136/bmj.d3018	http://dx.doi.org/10.1136/bmj.d3018			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	768QO	21586451				2022-12-24	WOS:000290951700007
J	Baker, M				Baker, Monya			TECHNOLOGY FEATURE Inside the minds of mice and men	NATURE			English	Editorial Material							MOUSE; BEHAVIORS; DEFECTS											Abazyan B, 2010, BIOL PSYCHIAT, V68, P1172, DOI 10.1016/j.biopsych.2010.09.022; Bissonette GB, 2008, J NEUROSCI, V28, P11124, DOI 10.1523/JNEUROSCI.2820-08.2008; Bussey TJ, 2012, NEUROPHARMACOLOGY, V62, P1191, DOI 10.1016/j.neuropharm.2011.04.011; Goulding EH, 2008, P NATL ACAD SCI USA, V105, P20575, DOI 10.1073/pnas.0809053106; Guy J, 2007, SCIENCE, V315, P1143, DOI 10.1126/science.1138389; Krueger DD, 2011, ANNU REV MED, V62, P411, DOI 10.1146/annurev-med-061109-134644; Langford DJ, 2010, NAT METHODS, V7, P447, DOI [10.1038/NMETH.1455, 10.1038/nmeth.1455]; Lutz C. M., J CLIN INVE IN PRESS; Peca J, 2011, NATURE, V472, P437, DOI 10.1038/nature09965; Spencer CM, 2011, AUTISM RES, V4, P40, DOI 10.1002/aur.168; Welch JM, 2007, NATURE, V448, P894, DOI 10.1038/nature06104; Yang M, 2011, AUTISM RES, V4, P17, DOI 10.1002/aur.163	12	49	49	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 7	2011	475	7354					123	128		10.1038/475123a	http://dx.doi.org/10.1038/475123a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	788RE	21734709	Bronze			2022-12-24	WOS:000292461300061
J	Gilbert, N				Gilbert, Natasha			The seeds of an economy	NATURE			English	Editorial Material									Nature, London, England		Gilbert, N (corresponding author), Nature, London, England.								0	14	15	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 23	2011	474	7352					S18	S19		10.1038/474S018a	http://dx.doi.org/10.1038/474S018a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	781NJ	21697837	Bronze			2022-12-24	WOS:000291939700007
J	Batista, LFZ; Pech, M; Zhong, FL; Nguyen, HN; Xie, KT; Zaug, AJ; Crary, SM; Choi, J; Sebastiano, V; Cherry, A; Giri, N; Wernig, M; Alter, BP; Cech, TR; Savage, SA; Pera, RAR; Artandi, SE				Batista, Luis F. Z.; Pech, MatthewF.; Zhong, Franklin L.; Nguyen, Ha Nam; Xie, Kathleen T.; Zaug, Arthur J.; Crary, Sharon M.; Choi, Jinkuk; Sebastiano, Vittorio; Cherry, Athena; Giri, Neelam; Wernig, Marius; Alter, Blanche P.; Cech, Thomas R.; Savage, Sharon A.; Pera, Renee A. Reijo; Artandi, Steven E.			Telomere shortening and loss of self-renewal in dyskeratosis congenita induced pluripotent stem cells	NATURE			English	Article							REVERSE-TRANSCRIPTASE; MOUSE; RNA; LOCALIZATION; ANTICIPATION; ELONGATION; GENERATION; MUTATIONS; LENGTH; LEADS	The differentiation of patient-derived induced pluripotent stem cells (iPSCs) to committed fates such as neurons, muscle and liver is a powerful approach for understanding key parameters of human development and disease(1-6). Whether undifferentiated iPSCs themselves can be used to probe disease mechanisms is uncertain. Dyskeratosis congenita is characterized by defective maintenance of blood, pulmonary tissue and epidermal tissues and is caused by mutations in genes controlling telomere homeostasis(7,8). Short telomeres, a hallmark of dyskeratosis congenita, impair tissue stem cell function in mouse models, indicating that a tissue stem cell defect may underlie the pathophysiology of dyskeratosis congenita(9,10). Here we show that even in the undifferentiated state, iPSCs from dyskeratosis congenita patients harbour the precise biochemical defects characteristic of each form of the disease and that the magnitude of the telomere maintenance defect in iPSCs correlates with clinical severity. In iPSCs from patients with heterozygous mutations in TERT, the telomerase reverse transcriptase, a 50% reduction in telomerase levels blunts the natural telomere elongation that accompanies reprogramming. In contrast, mutation of dyskerin (DKC1) in X-linked dyskeratosis congenita severely impairs telomerase activity by blocking telomerase assembly and disrupts telomere elongation during reprogramming. In iPSCs from a form of dyskeratosis congenita caused by mutations in TCAB1 (also known as WRAP53), telomerase catalytic activity is unperturbed, yet the ability of telomerase to lengthen telomeres is abrogated, because telomerase mislocalizes from Cajal bodies to nucleoli within the iPSCs. Extended culture of DKC1-mutant iPSCs leads to progressive telomere shortening and eventual loss of self-renewal, indicating that a similar process occurs in tissue stem cells in dyskeratosis congenita patients. These findings in iPSCs from dyskeratosis congenita patients reveal that undifferentiated iPSCs accurately recapitulate features of a human stem cell disease and may serve as a cell-culture-based system for the development of targeted therapeutics.	[Batista, Luis F. Z.; Pech, MatthewF.; Zhong, Franklin L.; Choi, Jinkuk; Artandi, Steven E.] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA; [Pech, MatthewF.; Zhong, Franklin L.; Choi, Jinkuk; Pera, Renee A. Reijo; Artandi, Steven E.] Stanford Univ, Sch Med, Canc Biol Program, Stanford, CA 94305 USA; [Nguyen, Ha Nam; Sebastiano, Vittorio; Wernig, Marius; Pera, Renee A. Reijo] Stanford Univ, Sch Med, Dept Obstet & Gynecol, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Xie, Kathleen T.] Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA; [Zaug, Arthur J.; Crary, Sharon M.; Cech, Thomas R.] Univ Colorado, Howard Hughes Med Inst, Dept Chem & Biochem, Boulder, CO 80309 USA; [Sebastiano, Vittorio; Cherry, Athena; Wernig, Marius] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; [Giri, Neelam; Alter, Blanche P.; Savage, Sharon A.] NCI, Clin Genet Branch, Div Canc Epidemiol & Genet, NIH,US Dept HHS, Bethesda, MD 20852 USA; [Artandi, Steven E.] Stanford Univ, Sch Med, Glenn Labs Biol Aging, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder; Stanford University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Stanford University	Artandi, SE (corresponding author), Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA.	sartandi@stanford.edu	Savage, Sharon A/B-9747-2015; Savage, Sharon/AAB-5160-2019	Savage, Sharon A/0000-0001-6006-0740; Savage, Sharon/0000-0001-6006-0740; Choi, Jinkuk/0000-0002-2449-8291; Batista, Luis/0000-0002-7538-3240; Reijo Pera, Renee/0000-0002-6487-1329; Xie, Kathleen/0000-0002-3178-8959	Howard Hughes Medical Institute Funding Source: Medline; Intramural NIH HHS Funding Source: Medline; NCI NIH HHS [T32 CA009302, R01 CA125453-05, R01 CA111691, R01 CA125453, R01 CA111691-05] Funding Source: Medline; NHLBI NIH HHS [RC1 HL100361-01, U01 HL100397, RC1 HL100361] Funding Source: Medline; NIA NIH HHS [R01 AG033747-02, R01 AG033747] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA125453, ZIACP010190, T32CA009302, R01CA111691] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL100397, RC1HL100361] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG033747] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Agarwal S, 2010, NATURE, V464, P292, DOI 10.1038/nature08792; Allsopp RC, 2003, BLOOD, V102, P517, DOI 10.1182/blood-2002-07-2334; Alter BP, 2007, BLOOD, V110, P1439, DOI 10.1182/blood-2007-02-075598; Alter BP, 2010, BRIT J HAEMATOL, V150, P179, DOI 10.1111/j.1365-2141.2010.08212.x; Armanios M, 2005, P NATL ACAD SCI USA, V102, P15960, DOI 10.1073/pnas.0508124102; Bessler M, 2010, FEBS LETT, V584, P3831, DOI 10.1016/j.febslet.2010.05.019; Byrne J. A., 2009, PLOS ONE, V4, pe7118; Cristofari G, 2006, EMBO J, V25, P565, DOI 10.1038/sj.emboj.7600952; Deb-Rinker P, 2005, J BIOL CHEM, V280, P6257, DOI 10.1074/jbc.C400479200; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Lee HW, 1998, NATURE, V392, P569, DOI 10.1038/33345; Lei M, 2005, J BIOL CHEM, V280, P20449, DOI 10.1074/jbc.M502212200; Liu G. H., 2011, NATURE          0223, DOI [10.1038/nature09879, DOI 10.1038/NATURE09879]; LUNDBLAD V, 1989, CELL, V57, P633, DOI 10.1016/0092-8674(89)90132-3; Maehr R, 2009, P NATL ACAD SCI USA, V106, P15768, DOI 10.1073/pnas.0906894106; Marion RM, 2009, CELL STEM CELL, V4, P141, DOI 10.1016/j.stem.2008.12.010; Matera AG, 2007, NAT REV MOL CELL BIO, V8, P209, DOI 10.1038/nrm2124; Middleman EJ, 2006, MOL CELL BIOL, V26, P2146, DOI 10.1128/MCB.26.6.2146-2159.2006; Mitchell JR, 1999, NATURE, V402, P551, DOI 10.1038/990141; Mochizuki Y, 2004, P NATL ACAD SCI USA, V101, P10756, DOI 10.1073/pnas.0402560101; Rashid ST, 2010, J CLIN INVEST, V120, P3127, DOI 10.1172/JCI43122; SEABRIGH.M, 1971, LANCET, V2, P971; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Sommer CA, 2009, STEM CELLS, V27, P543, DOI 10.1634/stemcells.2008-1075; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tomlinson RL, 2008, MOL BIOL CELL, V19, P3793, DOI 10.1091/mbc.E08-02-0184; Tycowski KT, 2009, MOL CELL, V34, P47, DOI 10.1016/j.molcel.2009.02.020; Venteicher AS, 2008, CELL, V132, P945, DOI 10.1016/j.cell.2008.01.019; Venteicher AS, 2009, SCIENCE, V323, P644, DOI 10.1126/science.1165357; Vulliamy T, 2004, NAT GENET, V36, P447, DOI 10.1038/ng1346; Walne AJ, 2009, BRIT J HAEMATOL, V145, P164, DOI 10.1111/j.1365-2141.2009.07598.x; Wang F, 2007, NATURE, V445, P506, DOI 10.1038/nature05454; Wong JMY, 2006, GENE DEV, V20, P2848, DOI 10.1101/gad.1476206; Yoshida Y, 2009, CELL STEM CELL, V5, P237, DOI 10.1016/j.stem.2009.08.001; Zaug AJ, 2010, GENE DEV, V24, P613, DOI 10.1101/gad.1881810; Zhong F, 2011, GENE DEV, V25, P11, DOI 10.1101/gad.2006411	37	180	186	1	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 16	2011	474	7351					399	+		10.1038/nature10084	http://dx.doi.org/10.1038/nature10084			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777TD	21602826	Green Accepted			2022-12-24	WOS:000291647100050
J	Clasquin, MF; Melamud, E; Singer, A; Gooding, JR; Xu, XH; Dong, AP; Cui, H; Campagna, SR; Savchenko, A; Yakunin, AF; Rabinowitz, JD; Caudy, AA				Clasquin, Michelle F.; Melamud, Eugene; Singer, Alexander; Gooding, Jessica R.; Xu, Xiaohui; Dong, Aiping; Cui, Hong; Campagna, Shawn R.; Savchenko, Alexei; Yakunin, Alexander F.; Rabinowitz, Joshua D.; Caudy, Amy A.			Riboneogenesis in Yeast	CELL			English	Article							PENTOSE-PHOSPHATE PATHWAY; SACCHAROMYCES-CEREVISIAE STRAINS; RED BLOOD CELL; HUMAN-ERYTHROCYTES; SEDOHEPTULOSE DIPHOSPHATE; METABOLOMIC ANALYSIS; OCTULOSE PHOSPHATES; F-TYPE; C-13; MUTANTS	Glucose is catabolized in yeast via two fundamental routes, glycolysis and the oxidative pentose phosphate pathway, which produces NADPH and the essential nucleotide component ribose-5-phosphate. Here, we describe riboneogenesis, a thermodynamically driven pathway that converts glycolytic intermediates into ribose-5-phosphate without production of NADPH. Riboneogenesis begins with synthesis, by the combined action of transketolase and aldolase, of the seven-carbon bisphosphorylated sugar sedoheptulose-1,7-bisphosphate. In the pathway's committed step, sedoheptulose bisphosphate is hydrolyzed to sedoheptulose-7-phosphate by the enzyme sedoheptulose-1,7-bisphosphatase (SHB17), whose activity we identified based on metabolomic analysis of the corresponding knockout strain. The crystal structure of Shb17 in complex with sedoheptulose-1,7-bisphosphate reveals that the substrate binds in the closed furan form in the active site. Sedoheptulose-7-phosphate is ultimately converted by known enzymes of the nonoxidative pentose phosphate pathway to ribose-5-phosphate. Flux through SHB17 increases when ribose demand is high relative to demand for NADPH, including during ribosome biogenesis in metabolically synchronized yeast cells.	[Clasquin, Michelle F.; Melamud, Eugene; Rabinowitz, Joshua D.; Caudy, Amy A.] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; [Clasquin, Michelle F.; Melamud, Eugene; Rabinowitz, Joshua D.] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA; [Singer, Alexander; Xu, Xiaohui; Dong, Aiping; Cui, Hong; Savchenko, Alexei; Yakunin, Alexander F.] Univ Toronto, Dept Chem Engn & Appl Chem, Banting & Best Dept Med Res, Toronto, ON M5G 1L6, Canada; [Gooding, Jessica R.; Campagna, Shawn R.] Univ Tennessee, Dept Chem, Knoxville, TN 37996 USA	Princeton University; Princeton University; University of Toronto; University of Tennessee System; University of Tennessee Knoxville	Rabinowitz, JD (corresponding author), Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA.	joshr@genomics.princeton.edu; amy.caudy@utoronto.ca	Rabinowitz, Joshua/GPP-4019-2022; Yakunin, Alexander/J-1519-2014	Rabinowitz, Joshua/0000-0002-1247-4727; Caudy, Amy/0000-0001-6307-8137; Campagna, Shawn/0000-0001-6809-3862; Yakunin, Alexander/0000-0003-0813-6490	NSF [MCB-0643859]; NIH [GM071508, AI078063]; Merck and Company; Lewis-Sigler Fellows program; Beckman Foundation; American Heart Association [0635188N]; DOE; government of Canada through Genome Canada; Ontario Genomics Institute [2009-OGI-ABC-1405]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI078063] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM071508] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Merck and Company(Merck & Company); Lewis-Sigler Fellows program; Beckman Foundation; American Heart Association(American Heart Association); DOE(United States Department of Energy (DOE)); government of Canada through Genome Canada(Genome Canada); Ontario Genomics Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by NSF Career Award MCB-0643859 to J.D.R. and NIH Grant GM071508 for the Center of Quantitative Biology at Princeton University. M.F.C. gratefully acknowledges financial support from Merck and Company through a Doctoral Research Fellowship and A.A.C. support through the Lewis-Sigler Fellows program. Additional support came from the Beckman Foundation, American Heart Association Grant 0635188N, NSF Career Award MCB-0643859, NIH Grant AI078063, the DOE Biohydrogen program (to J.D.R.), and the government of Canada through Genome Canada and the Ontario Genomics Institute (2009-OGI-ABC-1405) (to A.F.Y.). We thank Kate Kuznetsova for providing purified proteins, Wenyun Lu and Saw Kyin for assistance with mass spectrometry, and Dannie Durand and David Botstein for helpful discussions.	Allen J, 2003, NAT BIOTECHNOL, V21, P692, DOI 10.1038/nbt823; Amberg DC., 2005, METHODS YEAST GENETI; BARTLETT GR, 1968, BIOCHIM BIOPHYS ACTA, V156, P240, DOI 10.1016/0304-4165(68)90253-5; BARTLETT GR, 1960, BIOCHEM BIOPH RES CO, V3, P474, DOI 10.1016/0006-291X(60)90158-3; Bennett BD, 2008, NAT PROTOC, V3, P1299, DOI 10.1038/nprot.2008.107; BERTHON HA, 1993, BIOCHEM J, V296, P379, DOI 10.1042/bj2960379; Breslow DK, 2008, NAT METHODS, V5, P711, DOI 10.1038/nmeth.1234; Brown G, 2009, J BIOL CHEM, V284, P3784, DOI 10.1074/jbc.M808186200; BUCOLO G, 1960, BIOCHEM BIOPH RES CO, V3, P620, DOI 10.1016/0006-291X(60)90073-5; Daumke O, 2007, NATURE, V449, P923, DOI 10.1038/nature06173; DeBerardinis RJ, 2008, CURR OPIN GENET DEV, V18, P54, DOI 10.1016/j.gde.2008.02.003; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fendt SM, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.11; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Hegeman AD, 2007, ANAL CHEM, V79, P6912, DOI 10.1021/ac070346t; HORECKER BL, 1982, ANN NY ACAD SCI, V378, P215, DOI 10.1111/j.1749-6632.1982.tb31198.x; Jeppsson M, 2002, APPL ENVIRON MICROB, V68, P1604, DOI 10.1128/AEM.68.4.1604-1609.2002; Kleijn RJ, 2005, FEBS J, V272, P4970, DOI 10.1111/j.1742-4658.2005.04907.x; KOERNER TAW, 1973, BIOCHEM BIOPH RES CO, V51, P543, DOI 10.1016/0006-291X(73)91348-X; KUCHEL PW, 1990, BIOMED BIOCHIM ACTA, V49, pS105; Kudlicki A, 2007, BIOINFORMATICS, V23, P1559, DOI 10.1093/bioinformatics/btm126; Kuznetsova E, 2010, J BIOL CHEM, V285, P21049, DOI 10.1074/jbc.M110.118315; Lu W, 2008, J CHROMATOGR B, V871, P236, DOI 10.1016/j.jchromb.2008.04.031; Lu WY, 2010, ANAL CHEM, V82, P3212, DOI 10.1021/ac902837x; Luo B, 2007, J CHROMATOGR A, V1147, P153, DOI 10.1016/j.chroma.2007.02.034; MCINTYRE LM, 1989, EUR J BIOCHEM, V180, P399, DOI 10.1111/j.1432-1033.1989.tb14662.x; Meijer A E, 1984, Acta Histochem Suppl, V29, P141; Melamud E, 2010, ANAL CHEM, V82, P9818, DOI 10.1021/ac1021166; Nakahigashi K, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.65; PAOLETTI F, 1979, ARCH BIOCHEM BIOPHYS, V198, P620, DOI 10.1016/0003-9861(79)90539-3; Ralser M., 2007, J BIOL, V6, P10, DOI [DOI 10.1186/jbiol61, 10.1186/jbiol61]; Rutthard H, 2001, J BIOL CHEM, V276, P18728, DOI 10.1074/jbc.M102122200; Saghatelian A, 2005, LIFE SCI, V77, P1759, DOI 10.1016/j.lfs.2005.05.019; Saghatelian A, 2004, BIOCHEMISTRY-US, V43, P14332, DOI 10.1021/bi0480335; Saito N, 2006, J PROTEOME RES, V5, P1979, DOI 10.1021/pr0600576; SCHAAFFGERSTENS.GE, 1993, EUR J BIOCHEM, V217, P487; SGD Project, 2010, SACCH GEN DAT; SMYRNIOTIS PZ, 1956, J BIOL CHEM, V218, P745; Szyperski T, 1996, TRENDS BIOTECHNOL, V14, P453, DOI 10.1016/S0167-7799(96)10056-1; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Tu BP, 2005, SCIENCE, V310, P1152, DOI 10.1126/science.1120499; TYSON CB, 1979, J BACTERIOL, V138, P92, DOI 10.1128/JB.138.1.92-98.1979; VALENTIN ML, 1993, TETRAHEDRON LETT, V34, P8103, DOI 10.1016/S0040-4039(00)61463-6; Walther T, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2009.100; Wang LQ, 2006, METAB ENG, V8, P142, DOI 10.1016/j.ymben.2005.11.002; WEBB M, 1964, ENZYMES; WILLIAMS JF, 1987, INT J BIOCHEM, V19, P749, DOI 10.1016/0020-711X(87)90239-4; WINSTON F, 1995, YEAST, V11, P53, DOI 10.1002/yea.320110107; Yuan J, 2008, NAT PROTOC, V3, P1328, DOI 10.1038/nprot.2008.131; Zhang BL, 2000, J BIOL CHEM, V275, P25299, DOI 10.1074/jbc.M001027200; Zhao J, 2004, METAB ENG, V6, P164, DOI 10.1016/j.ymben.2004.02.004	51	81	82	2	48	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 10	2011	145	6					969	980		10.1016/j.cell.2011.05.022	http://dx.doi.org/10.1016/j.cell.2011.05.022			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	775LS	21663798	Bronze, Green Accepted			2022-12-24	WOS:000291461600022
J	Hotez, PJ; Mistry, N; Rubinstein, J; Sachs, JD				Hotez, Peter J.; Mistry, Neeraj; Rubinstein, Joanna; Sachs, Jeffrey D.			Integrating Neglected Tropical Diseases into AIDS, Tuberculosis, and Malaria Control	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							IMPACT		[Hotez, Peter J.; Mistry, Neeraj] Sabin Vaccine Inst, Washington, DC 20006 USA; [Hotez, Peter J.] Baylor Coll Med, Houston, TX 77030 USA; [Hotez, Peter J.] Texas Childrens Hosp, Houston, TX 77030 USA; [Rubinstein, Joanna; Sachs, Jeffrey D.] Columbia Univ, Earth Inst, New York, NY USA	Baylor College of Medicine; Baylor College of Medicine; Columbia University	Hotez, PJ (corresponding author), Sabin Vaccine Inst, Washington, DC 20006 USA.			Hotez, Peter/0000-0001-8770-1042				Brooker S, 2007, AM J TROP MED HYG, V77, P88, DOI 10.4269/ajtmh.2007.77.88; Kirwan P, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-277; Kjetland EF, 2006, AIDS, V20, P593, DOI 10.1097/01.aids.0000210614.45212.0a; Linehan M, 2011, AM J TROP MED HYG, V84, P5, DOI 10.4269/ajtmh.2011.10-0411; Walson JL, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006419.pub3	5	42	43	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 2	2011	364	22					2086	2089		10.1056/NEJMp1014637	http://dx.doi.org/10.1056/NEJMp1014637			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	772AB	21631320				2022-12-24	WOS:000291200700004
J	Robock, A				Robock, Alan			Nuclear winter is a real and present danger	NATURE			English	Editorial Material							CONSEQUENCES		Rutgers State Univ, Dept Environm Sci, New Brunswick, NJ 08901 USA	Rutgers State University New Brunswick	Robock, A (corresponding author), Rutgers State Univ, Dept Environm Sci, New Brunswick, NJ 08901 USA.	robock@envsci.rutgers.edu	Robock, Alan/B-6385-2016	Robock, Alan/0000-0002-6319-5656				Badash L, 2009, TRANSFORMATIONS-STUD, P1; Robock A, 2007, ATMOS CHEM PHYS, V7, P2003, DOI 10.5194/acp-7-2003-2007; Robock A, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD008235; SAGAN C, 1984, FOREIGN AFF, V62, P257; THOMPSON SL, 1986, FOREIGN AFF, V64, P981, DOI 10.2307/20042777; TURCO RP, 1983, SCIENCE, V222, P1283, DOI 10.1126/science.222.4630.1283	6	4	5	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 19	2011	473	7347					275	276		10.1038/473275a	http://dx.doi.org/10.1038/473275a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	765QA	21593838	Bronze			2022-12-24	WOS:000290722400013
J	Schlingmann, KP; Kaufmann, M; Weber, S; Irwin, A; Goos, C; John, U; Misselwitz, J; Klaus, G; Kuwertz-Broking, E; Fehrenbach, H; Wingen, AM; Guran, T; Hoenderop, JG; Bindels, RJ; Prosser, DE; Jones, G; Konrad, M				Schlingmann, Karl P.; Kaufmann, Martin; Weber, Stefanie; Irwin, Andrew; Goos, Caroline; John, Ulrike; Misselwitz, Joachim; Klaus, Guenter; Kuwertz-Broeking, Eberhard; Fehrenbach, Henry; Wingen, Anne M.; Gueran, Tuelay; Hoenderop, Joost G.; Bindels, Rene J.; Prosser, David E.; Jones, Glenville; Konrad, Martin			Mutations in CYP24A1 and Idiopathic Infantile Hypercalcemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SITE-DIRECTED MUTAGENESIS; VITAMIN-D; CALCITROIC ACID; METABOLISM; BONE; 1,25-DIHYDROXYVITAMIN-D3; PHARMACOKINETICS; INACTIVATION; MECHANISM; RESIDUES	BACKGROUND Vitamin D supplementation for the prevention of rickets is one of the oldest and most effective prophylactic measures in medicine, having virtually eradicated rickets in North America. Given the potentially toxic effects of vitamin D, the recommendations for the optimal dose are still debated, in part owing to the increased incidence of idiopathic infantile hypercalcemia in Britain in the 1950s during a period of high vitamin D supplementation in fortified milk products. We investigated the molecular basis of idiopathic infantile hypercalcemia, which is characterized by severe hypercalcemia, failure to thrive, vomiting, dehydration, and nephrocalcinosis. METHODS We used a candidate-gene approach in a cohort of familial cases of typical idiopathic infantile hypercalcemia with suspected autosomal recessive inheritance. Identified mutations in the vitamin D-metabolizing enzyme CYP24A1 were evaluated with the use of a mammalian expression system. RESULTS Sequence analysis of CYP24A1, which encodes 25-hydroxyvitamin D 24-hydroxylase, the key enzyme of 1,25-dihydroxyvitamin D-3 degradation, revealed recessive mutations in six affected children. In addition, CYP24A1 mutations were identified in a second cohort of infants in whom severe hypercalcemia had developed after bolus prophylaxis with vitamin D. Functional characterization revealed a complete loss of function in all CYP24A1 mutations. CONCLUSIONS The presence of CYP24A1 mutations explains the increased sensitivity to vitamin D in patients with idiopathic infantile hypercalcemia and is a genetic risk factor for the development of symptomatic hypercalcemia that may be triggered by vitamin D prophylaxis in otherwise apparently healthy infants.	[Konrad, Martin] Univ Childrens Hosp, Dept Gen Pediat, D-48149 Munster, Germany; [Schlingmann, Karl P.; Goos, Caroline] Univ Childrens Hosp, Marburg, Germany; [Weber, Stefanie; Wingen, Anne M.] Univ Childrens Hosp, Essen, Germany; [John, Ulrike; Misselwitz, Joachim] Univ Childrens Hosp, Jena, Germany; [Klaus, Guenter] Kuratorium Heimdialyse Pediat Kidney Ctr, Marburg, Germany; [Fehrenbach, Henry] Childrens Hosp, Memmingen, Germany; [Kaufmann, Martin; Irwin, Andrew; Prosser, David E.; Jones, Glenville] Queens Univ, Kingston, ON, Canada; [Gueran, Tuelay] Univ Childrens Hosp, Istanbul, Turkey; [Hoenderop, Joost G.; Bindels, Rene J.] Radboud Univ Nijmegen, NL-6525 ED Nijmegen, Netherlands	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Munster; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Duisburg Essen; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Queens University - Canada; Radboud University Nijmegen	Konrad, M (corresponding author), Univ Childrens Hosp, Dept Gen Pediat, Waldeyerstr 22, D-48149 Munster, Germany.	konradma@uni-muenster.de	Bindels, René JM/B-9824-2013; Hoenderop, Joost G.J./H-8047-2014	Bindels, René JM/0000-0003-1167-1339; Hoenderop, Joost G.J./0000-0002-1816-8544	Canadian Institutes of Health Research; Cytochroma	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Cytochroma	Supported by grants from the Canadian Institutes of Health Research and Cytochroma (to Dr. Jones).	Annalora AJ, 2007, ARCH BIOCHEM BIOPHYS, V460, P262, DOI 10.1016/j.abb.2006.11.018; [Anonymous], 1956, BRIT MED J, V2, P149; BEUREN AJ, 1962, CIRCULATION, V26, P1235, DOI 10.1161/01.CIR.26.6.1235; DeLuca HF, 2011, ARCH BIOCHEM BIOPHYS, V505, P226, DOI 10.1016/j.abb.2010.10.012; DELUCA HF, 1976, ANNU REV BIOCHEM, V45, P631, DOI 10.1146/annurev.bi.45.070176.003215; FANCONI G, 1951, SCHWEIZ MED WSCHR, V81, P908; FRASER DONALD, 1967, PEDIATRICS, V40, P1050; Hamamoto H, 2006, MOL PHARMACOL, V70, P120, DOI 10.1124/mol.106.023275; Hesse V, 1985, Kinderarztl Prax, V53, P383; Institute of Medicine, 2011, DIETARY REFERENCE IN; Jones G, 2008, AM J CLIN NUTR, V88, p582S, DOI 10.1093/ajcn/88.2.582S; LIGHTWOOD R, 1952, P ROY SOC MED, V45, P401; LIGHTWOOD R, 1953, LANCET, V265, P255; MAKIN G, 1989, BIOCHEM J, V262, P173, DOI 10.1042/bj2620173; Masuda S, 2005, ENDOCRINOLOGY, V146, P825, DOI 10.1210/en.2004-1116; Masuda S, 2007, ARCH BIOCHEM BIOPHYS, V460, P177, DOI 10.1016/j.abb.2006.11.030; Misselwitz J, 1986, Kinderarztl Prax, V54, P431; Nguyen M, 2010, J PEDIATR-US, V157, P296, DOI 10.1016/j.jpeds.2010.02.025; Pronicka E, 1997, PEDIATR NEPHROL, V11, P2, DOI 10.1007/s004670050221; Prosser DE, 2007, P NATL ACAD SCI USA, V104, P12673, DOI 10.1073/pnas.0702093104; Prosser DE, 2006, BIOPHYS J, V90, P3389, DOI 10.1529/biophysj.105.069369; Prosser DE, 2004, TRENDS BIOCHEM SCI, V29, P664, DOI 10.1016/j.tibs.2004.10.005; Quarles LD, 2008, J CLIN INVEST, V118, P3820, DOI 10.1172/JCI36479; REDDY GS, 1989, BIOCHEMISTRY-US, V28, P1763, DOI 10.1021/bi00430a051; RHANEY K, 1956, LANCET, V270, P1028; Ross AC, 2011, J CLIN ENDOCR METAB, V96, P53, DOI 10.1210/jc.2010-2704; SAMUEL H S, 1964, Br Med J, V1, P1659; SHEPARD RM, 1980, ARCH BIOCHEM BIOPHYS, V202, P43, DOI 10.1016/0003-9861(80)90404-X; SMITH DW, 1959, PEDIATRICS, V24, P258; St-Arnaud R, 1999, BONE, V25, P127, DOI 10.1016/S8756-3282(99)00118-0; St-Arnaud R, 2000, ENDOCRINOLOGY, V141, P2658, DOI 10.1210/en.141.7.2658; STAPLETON T, 1957, AM J CLIN NUTR, V5, P533, DOI 10.1093/ajcn/5.5.533; WEISMAN Y, 1979, MED HYPOTHESES, V5, P379, DOI 10.1016/0306-9877(79)90019-7; WILLIAMS JC, 1961, CIRCULATION, V24, P1311, DOI 10.1161/01.CIR.24.6.1311	34	383	407	0	36	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 4	2011	365	5					410	421		10.1056/NEJMoa1103864	http://dx.doi.org/10.1056/NEJMoa1103864			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	801NW	21675912	Bronze			2022-12-24	WOS:000293447800005
J	Liu, W; Wen, WY; Wei, ZY; Yu, J; Ye, F; Liu, CH; Hardie, RC; Zhang, MJ				Liu, Wei; Wen, Wenyu; Wei, Zhiyi; Yu, Jiang; Ye, Fei; Liu, Che-Hsiung; Hardie, Roger C.; Zhang, Mingjie			The INAD Scaffold Is a Dynamic, Redox-Regulated Modulator of Signaling in the Drosophila Eye	CELL			English	Article							PROTEIN-KINASE-C; PDZ-DOMAIN PROTEIN; PHOTORECEPTOR CELLS; LIGHT ADAPTATION; RETINAL DEGENERATION; VISUAL TRANSDUCTION; PHOSPHOLIPASE-C; TARGET BINDING; TRP CHANNELS; CA2+ CHANNEL	INAD is a scaffolding protein that regulates signaling in Drosophila photoreceptors. One of its PDZ domains, PDZ5, cycles between reduced and oxidized forms in response to light, but it is unclear how light affects its redox potential. Through biochemical and structural studies, we show that the redox potential of PDZ5 is allosterically regulated by its interaction with another INAD domain, PDZ4. Whereas isolated PDZ5 is stable in the oxidized state, formation of a PDZ45 "supramodule'' locks PDZ5 in the reduced state by raising the redox potential of its Cys606/Cys645 disulfide bond by similar to 330 mV. Acidification, potentially mediated via light and PLC beta-mediated hydrolysis of PIP(2), disrupts the interaction between PDZ4 and PDZ5, leading to PDZ5 oxidation and dissociation from the TRP Ca(2+) channel, a key component of fly visual signaling. These results show that scaffolding proteins can actively modulate the intrinsic redox potentials of their disulfide bonds to exert regulatory roles in signaling.	[Liu, Wei; Wei, Zhiyi; Yu, Jiang; Ye, Fei; Zhang, Mingjie] Hong Kong Univ Sci & Technol, Div Life Sci, Mol Neurosci Ctr, State Key Lab Mol Neurosci, Kowloon, Hong Kong, Peoples R China; [Wei, Zhiyi] Hong Kong Univ Sci & Technol, Inst Adv Studies, Kowloon, Hong Kong, Peoples R China; [Wen, Wenyu] Fudan Univ, Dept Chem, Shanghai 200032, Peoples R China; [Wen, Wenyu] Fudan Univ, Inst Biomed Sci, Shanghai 200032, Peoples R China; [Liu, Che-Hsiung; Hardie, Roger C.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 3DY, England	Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Fudan University; Fudan University; University of Cambridge	Zhang, MJ (corresponding author), Hong Kong Univ Sci & Technol, Div Life Sci, Mol Neurosci Ctr, State Key Lab Mol Neurosci, Kowloon, Hong Kong, Peoples R China.	mzhang@ust.hk	Wei, Zhiyi/N-9995-2019; Wei, Zhiyi/B-5001-2010; Yu, Jiang/C-6980-2012; Wei, Zhiyi/C-4315-2014	Wei, Zhiyi/0000-0002-4446-6502; Wei, Zhiyi/0000-0002-4446-6502; Wei, Zhiyi/0000-0002-4446-6502; Liu, Wei/0000-0001-8250-2562; Hardie, Roger/0000-0001-5531-3264; Zhang, Mingjie/0000-0001-9404-0190	Research Grants Council of Hong Kong [663808, 664009, 660709, 663610, CA07/08.SC01, HKUST6/CRF/10, SEG_HKUST06, AoE/B-15/01-II]; National Major Basic Research Program of China [2009CB918600]; Natural Science Foundation of China [30970574]; Shanghai Rising-Star Program [10QA1400700]; Biotechnology and Biological Sciences Research Council (BBSRC) [BB/G006865/1]; BBSRC [BB/G006865/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G006865/1] Funding Source: researchfish	Research Grants Council of Hong Kong(Hong Kong Research Grants Council); National Major Basic Research Program of China(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Rising-Star Program; Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank Drs. Quan Hao and Qun Liu for X-ray data collection, Dr. Zhenguo Wu and Dr. Yarui Diao for help in the protein kinase assays, and Mr. Anthony Zhang for critical reading of the manuscript. This work was supported by grants from the Research Grants Council of Hong Kong to M.Z. (663808, 664009, 660709, 663610, CA07/08.SC01, HKUST6/CRF/10, SEG_HKUST06, and AoE/B-15/01-II); the National Major Basic Research Program of China (2009CB918600), the Natural Science Foundation of China (30970574), and the Shanghai Rising-Star Program (10QA1400700) to W. W.; and BB/G006865/1 from the Biotechnology and Biological Sciences Research Council (BBSRC) to R.C.H.	Adamski FM, 1998, J BIOL CHEM, V273, P17713, DOI 10.1074/jbc.273.28.17713; Ago T, 2008, CELL, V133, P978, DOI 10.1016/j.cell.2008.04.041; Bhattacharyya RP, 2006, ANNU REV BIOCHEM, V75, P655, DOI 10.1146/annurev.biochem.75.103004.142710; Chevesich J, 1997, NEURON, V18, P95, DOI 10.1016/S0896-6273(01)80049-0; Feng W, 2003, NAT STRUCT BIOL, V10, P972, DOI 10.1038/nsb992; Feng W, 2009, NAT REV NEUROSCI, V10, P87, DOI 10.1038/nrn2540; Fox GC, 2007, NATURE, V447, P487, DOI 10.1038/nature05804; Gu YC, 2005, CURR BIOL, V15, P1228, DOI 10.1016/j.cub.2005.05.058; Hardie RC, 2002, NEURON, V36, P689, DOI 10.1016/S0896-6273(02)01048-6; Hardie RC, 2001, NATURE, V413, P186, DOI 10.1038/35093002; HARDIE RC, 2008, SENSES COMPREHENSIVE, V1, P77; Huang JH, 2010, CURR BIOL, V20, P189, DOI 10.1016/j.cub.2009.12.019; Huber A, 1996, J BIOL CHEM, V271, P11710, DOI 10.1074/jbc.271.20.11710; Huber A, 1996, EMBO J, V15, P7036, DOI 10.1002/j.1460-2075.1996.tb01095.x; Huber A, 2001, EUR J NEUROSCI, V14, P769, DOI 10.1046/j.0953-816x.2001.01704.x; Janssen-Heininger YMW, 2008, FREE RADICAL BIO MED, V45, P1, DOI 10.1016/j.freeradbiomed.2008.03.011; Juusola M, 2001, J GEN PHYSIOL, V117, P3, DOI 10.1085/jgp.117.1.3; Keese MA, 1999, FEBS LETT, V447, P135, DOI 10.1016/S0014-5793(99)00296-3; Kemble DJ, 2009, P NATL ACAD SCI USA, V106, P5070, DOI 10.1073/pnas.0806117106; Kimple ME, 2001, EMBO J, V20, P4414, DOI 10.1093/emboj/20.16.4414; Li HS, 2000, J CELL BIOL, V150, P1411, DOI 10.1083/jcb.150.6.1411; Liu CH, 2008, NEURON, V59, P778, DOI 10.1016/j.neuron.2008.07.007; Long JF, 2005, NAT STRUCT MOL BIOL, V12, P722, DOI 10.1038/nsmb958; Long JF, 2003, J MOL BIOL, V327, P203, DOI 10.1016/S0022-2836(03)00113-X; Long JF, 2008, J MOL BIOL, V375, P1457, DOI 10.1016/j.jmb.2007.11.088; Mishra P, 2007, CELL, V131, P80, DOI 10.1016/j.cell.2007.07.037; Montell C, 2005, J PHYSIOL-LONDON, V567, P45, DOI 10.1113/jphysiol.2005.092551; Montell C, 1999, ANNU REV CELL DEV BI, V15, P231, DOI 10.1146/annurev.cellbio.15.1.231; Montell C, 2003, CELL CALCIUM, V33, P409, DOI 10.1016/S0143-4160(03)00053-8; Ostergaard H, 2004, J CELL BIOL, V166, P337, DOI 10.1083/jcb.200402120; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; Peng L, 2008, J NEUROCHEM, V104, P1526, DOI 10.1111/j.1471-4159.2007.05096.x; Popescu DC, 2006, J NEUROSCI, V26, P8570, DOI 10.1523/JNEUROSCI.1478-06.2006; Rhee SG, 2006, SCIENCE, V312, P1882, DOI 10.1126/science.1130481; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Scott K, 1997, CELL, V91, P375, DOI 10.1016/S0092-8674(00)80421-3; Shieh BH, 1996, NEURON, V16, P991, DOI 10.1016/S0896-6273(00)80122-1; SMITH DP, 1991, SCIENCE, V254, P1478, DOI 10.1126/science.1962207; Tsunoda S, 1999, CELL CALCIUM, V26, P165, DOI 10.1054/ceca.1999.0070; Tsunoda S, 1997, NATURE, V388, P243, DOI 10.1038/40805; van Huizen R, 1998, EMBO J, V17, P2285, DOI 10.1093/emboj/17.8.2285; Wang T, 2007, PFLUG ARCH EUR J PHY, V454, P821, DOI 10.1007/s00424-007-0251-1; Xu XZS, 1998, J CELL BIOL, V142, P545, DOI 10.1083/jcb.142.2.545; Yau KW, 2009, CELL, V139, P246, DOI 10.1016/j.cell.2009.09.029; Zhang MJ, 2003, ACCOUNTS CHEM RES, V36, P530, DOI 10.1021/ar020210b	48	50	55	1	39	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 24	2011	145	7					1088	1101		10.1016/j.cell.2011.05.015	http://dx.doi.org/10.1016/j.cell.2011.05.015			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	782QV	21703451	Bronze			2022-12-24	WOS:000292025700015
J	Brownell, KD; Koplan, JP				Brownell, Kelly D.; Koplan, Jeffrey P.			Front-of-Package Nutrition Labeling - An Abuse of Trust by the Food Industry?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Brownell, Kelly D.] Yale Univ, New Haven, CT 06520 USA; [Koplan, Jeffrey P.] Emory Univ, Atlanta, GA 30322 USA	Yale University; Emory University	Brownell, KD (corresponding author), Yale Univ, New Haven, CT 06520 USA.							Koplan JP, 2010, JAMA-J AM MED ASSOC, V304, P1487, DOI 10.1001/jama.2010.1436; Pomeranz JL, 2011, AM J PREV MED, V40, P382, DOI 10.1016/j.amepre.2010.11.009; Scarborough P, 2007, PUBLIC HEALTH NUTR, V10, P330, DOI 10.1017/S1368980007223870; Sharma LL, 2010, AM J PUBLIC HEALTH, V100, P240, DOI 10.2105/AJPH.2009.160960	4	63	64	0	21	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 23	2011	364	25					2373	2375		10.1056/NEJMp1101033	http://dx.doi.org/10.1056/NEJMp1101033			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	781MG	21696305				2022-12-24	WOS:000291936100001
J	Solomon, DH; Massarotti, E; Garg, R; Liu, J; Canning, C; Schneeweiss, S				Solomon, Daniel H.; Massarotti, Elena; Garg, Rajesh; Liu, Jun; Canning, Claire; Schneeweiss, Sebastian			Association Between Disease-Modifying Antirheumatic Drugs and Diabetes Risk in Patients With Rheumatoid Arthritis and Psoriasis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INSULIN-RESISTANCE; ANKYLOSING-SPONDYLITIS; MELLITUS; HYDROXYCHLOROQUINE; ATHEROSCLEROSIS; INFLAMMATION; DATABASES; ACCURACY; MARKERS; COHORT	Context Rheumatoid arthritis (RA) and psoriasis have been linked with insulin resistance and diabetes mellitus (DM). Prior investigations suggest that systemic immunosuppressive drugs may improve insulin resistance and reduce the risk of DM. Objective To compare the risk of newly recorded DM among participants diagnosed with RA or psoriasis based on use of a variety of disease-modifying antirheumatic drugs (DMARDs). Design, Setting, and Participants A retrospective cohort study among 121 280 patients with a diagnosis of either RA or psoriasis on at least 2 visits. The analyses were conducted in the context of 2 large health insurance programs, 1 in Canada and 1 in the United States, using administrative data. The mean follow-up was 5.8 months and began with the first prescription for a DMARD after study eligibility was met. Drug regimens were categorized into 4 mutually exclusive groups: (1) tumor necrosis factor (TNF) inhibitors with or without other DMARDs; (2) methotrexate without TNF inhibitors or hydroxychloroquine; (3) hydroxychloroquine without TNF inhibitors or methotrexate; or (4) other nonbiologic DMARDs without TNF inhibitors, methotrexate, or hydroxychloroquine (reference exposure). Main Outcome Measure Newly recorded DM as evidenced by a new diagnosis of DM with use of a DM-specific medication. Results The study cohort consisted of 13 905 participants with 22 493 treatment episodes starting 1 of the categories of DMARD regimens between January 1996 and June 2008. New diabetes cases and respective incidence rates per 1000 person-years were: other nonbiologic DMARDs (55 cases among 3993 treatment episodes; rate, 50.2; 95% confidence interval [CI], 47.3-53.2); TNF inhibitors (80 cases among 4623 treatment episodes; rate, 19.7; 95% CI, 19.1-20.3); methotrexate (82 cases among 8195 treatment episodes; rate, 23.8; 95% CI, 23.0-24.6); and hydroxychloroquine (50 cases among 5682 treatment episodes; rate, 22.2; 95% CI, 21.3-23.1). The multivariate adjusted hazard ratios for DM were 0.62 (95% CI, 0.42-0.91) for TNF inhibitors, 0.77 (95% CI, 0.53-1.13) for methotrexate, and 0.54 (95% CI, 0.36-0.80) for hydroxychloroquine compared with other nonbiologic DMARDS. Conclusion Among patients with RA or psoriasis, the adjusted risk of DM was lower for individuals starting a TNF inhibitor or hydroxychloroquine compared with initiation of other nonbiologic DMARDs. JAMA. 2011;305(24):2525-2531	[Solomon, Daniel H.; Massarotti, Elena] Brigham & Womens Hosp, Div Rheumatol, Dept Med, Boston, MA 02115 USA; [Solomon, Daniel H.; Liu, Jun; Canning, Claire; Schneeweiss, Sebastian] Brigham & Womens Hosp, Div Pharmacoepidemiol, Dept Med, Boston, MA 02115 USA; [Garg, Rajesh] Brigham & Womens Hosp, Div Endocrinol, Dept Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital	Solomon, DH (corresponding author), Brigham & Womens Hosp, Div Rheumatol, Dept Med, 75 Francis St,PBB B3, Boston, MA 02115 USA.	dsolomon@partners.org	Schneeweiss, Sebastian/C-2125-2013	Schneeweiss, Sebastian/0000-0003-2575-467X	Abbott; Bristol-Myers Squibb; Pfizer; EMD-Serono; UCB; Human Genome Sciences; Ampimmune; Policy Analysis Inc.; sanofi-aventis; Novartis; Biogen Idec; Teva; Agency for Healthcare Research and Quality; FDA; Amgen; Brigham and Women's Hospital	Abbott(Abbott Laboratories); Bristol-Myers Squibb(Bristol-Myers Squibb); Pfizer(Pfizer); EMD-Serono; UCB(UCB Pharma SA); Human Genome Sciences(GlaxoSmithKline); Ampimmune; Policy Analysis Inc.; sanofi-aventis(Sanofi-Aventis); Novartis(Novartis); Biogen Idec(Biogen); Teva(Teva Pharmaceutical Industries); Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); FDA(United States Department of Health & Human Services); Amgen(Amgen); Brigham and Women's Hospital	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Solomon reports having received support through a research grant from Abbott, directing an educational course supported by Bristol-Myers Squibb, and serving in an unpaid role on 2 Pfizer-sponsored trials. Dr Massarotti reports being a clinical investigator for an RA therapeutics trial sponsored by Bristol-Myers Squibb, and for 2 sponsored systemic lupus erythematosus trials, 1 funded by EMD-Serono, and the second as part of the Autoimmune Centers of Excellence through the National Institutes of Health; and receiving consulting fees from UCB, Human Genome Sciences, Pfizer, Ampimmune, and Policy Analysis Inc. Dr Garg (or spouse) reports having received consultant fees from sanofi-aventis, Pfizer, Novartis, Biogen Idec, Teva, and EMD Serono. Dr Schneeweiss is principal investigator of the Brigham and Women's Hospital DEcIDE Center on Comparative Effectiveness Research and the DEcIDE Methods Center both funded by Agency for Healthcare Research and Quality and of the Harvard-Brigham Drug Safety and Risk Management Research Center funded by the FDA. Dr Schneeweiss reports being a paid member of the scientific advisory board of HealthCore; a consultant to HealthCore and WHISCON; and a recipient of investigator-initiated grants from Pfizer and Novartis.; Amgen paid for the research through a research contract with the Brigham and Women's Hospital. Amgen reviewed the study protocol and reviewed a draft manuscript but had no editorial control.	Birman-Deych E, 2005, MED CARE, V43, P480, DOI 10.1097/01.mlr.0000160417.39497.a9; del Rincon I, 2005, ARTHRITIS RHEUM-US, V52, P3413, DOI 10.1002/art.21397; Emami J, 1998, LIFE SCI, V64, P325, DOI 10.1016/S0024-3205(98)00568-2; Festa A, 2002, DIABETES, V51, P1131, DOI 10.2337/diabetes.51.4.1131; Gabriel SE, 2008, AM J MED, V121, P9, DOI 10.1016/j.amjmed.2008.06.011; GARCIAWEBB P, 1985, BIOCHEM BIOPH RES CO, V128, P487, DOI 10.1016/0006-291X(85)90073-7; Garg R, 2003, CURR DRUG TARGETS, V4, P487, DOI 10.2174/1389450033490920; Gelfand JM, 2003, ARCH DERMATOL, V139, P1425, DOI 10.1001/archderm.139.11.1425; Gelfand JM, 2006, JAMA-J AM MED ASSOC, V296, P1735, DOI 10.1001/jama.296.14.1735; Gerstein HC, 2002, DIABETES RES CLIN PR, V55, P209, DOI 10.1016/S0168-8227(01)00325-4; Gonzalez-Gay MA, 2006, CLIN EXP RHEUMATOL, V24, P83; Han CL, 2006, J RHEUMATOL, V33, P2167; Kiortsis DN, 2005, ANN RHEUM DIS, V64, P765, DOI 10.1136/ard.2004.026534; Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; LIN DY, 1993, BIOMETRIKA, V80, P557, DOI 10.2307/2337177; Liu S, 2007, ARCH INTERN MED, V167, P1676, DOI 10.1001/archinte.167.15.1676; Maradit-Kremers H, 2005, ARTHRITIS RHEUM-US, V52, P722, DOI 10.1002/art.20878; Meigs JB, 2006, DIABETES, V55, P530, DOI 10.2337/diabetes.55.02.06.db05-1041; O'Connor PJ, 1998, AM J MANAG CARE, V4, P335; Pradhan AD, 2001, JAMA-J AM MED ASSOC, V286, P327, DOI 10.1001/jama.286.3.327; QUATRARO A, 1990, ANN INTERN MED, V112, P678, DOI 10.7326/0003-4819-112-9-678; Qureshi AA, 2009, ARCH DERMATOL, V145, P379, DOI 10.1001/archdermatol.2009.48; Ray WA, 2003, AM J EPIDEMIOL, V158, P915, DOI 10.1093/aje/kwg231; ROMANO PS, 1993, J CLIN EPIDEMIOL, V46, P1075, DOI 10.1016/0895-4356(93)90103-8; Sattar N, 2003, CIRCULATION, V108, P2957, DOI 10.1161/01.CIR.0000099844.31524.05; Schneeweiss S, 2007, CLIN PHARMACOL THER, V82, P143, DOI 10.1038/sj.clpt.6100249; Schneeweiss S, 2005, J CLIN EPIDEMIOL, V58, P323, DOI 10.1016/j.jclinepi.2004.10.012; Schneeweiss S, 2010, PHARMACOEPIDEM DR S, V19, P858, DOI 10.1002/pds.1926; Singh JA, 2004, ARTHRIT RHEUM-ARTHR, V51, P952, DOI 10.1002/art.20827; Solomon DH, 2010, ANN RHEUM DIS, V69, P2114, DOI 10.1136/ard.2009.125476; Solomon DH, 2010, ANN RHEUM DIS, V69, P1920, DOI 10.1136/ard.2009.122226; Solomon DH, 2003, CIRCULATION, V107, P1303, DOI 10.1161/01.CIR.0000054612.26458.B2; Tam LS, 2007, CLIN RHEUMATOL, V26, P1495, DOI 10.1007/s10067-007-0539-8; Wasko MCM, 2007, JAMA-J AM MED ASSOC, V298, P187, DOI 10.1001/jama.298.2.187; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102	36	281	293	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 22	2011	305	24					2525	2531		10.1001/jama.2011.878	http://dx.doi.org/10.1001/jama.2011.878			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	780MF	21693740	Bronze			2022-12-24	WOS:000291860400019
J	Cole, M				Cole, Mike			Poison in party pills is too much to swallow	NATURE			English	Editorial Material									Anglia Ruskin Univ, Cambridge, England	Anglia Ruskin University	Cole, M (corresponding author), Anglia Ruskin Univ, Cambridge, England.	Michael.cole@anglia.ac.uk							0	6	6	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 16	2011	474	7351					253	253		10.1038/474253a	http://dx.doi.org/10.1038/474253a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	777TD	21677705	Bronze			2022-12-24	WOS:000291647100004
J	Mishra, SK; Ammon, T; Popowicz, GM; Krajewski, M; Nagel, RJ; Ares, M; Holak, TA; Jentsch, S				Mishra, Shravan Kumar; Ammon, Tim; Popowicz, Grzegorz M.; Krajewski, Marcin; Nagel, Roland J.; Ares, Manuel, Jr.; Holak, Tad A.; Jentsch, Stefan			Role of the ubiquitin-like protein Hub1 in splice-site usage and alternative splicing	NATURE			English	Article							GENE-EXPRESSION; MESSENGER-RNAS; YEAST GENES; MODIFIER; INTRON; SENSITIVITY; DESIGN; SRC1; STEP; UBL5	Alternative splicing of pre-messenger RNAs diversifies gene products in eukaryotes and is guided by factors that enable spliceosomes to recognize particular splice sites. Here we report that alternative splicing of Saccharomyces cerevisiae SRC1 pre-mRNA is promoted by the conserved ubiquitin-like protein Hub1. Structural and biochemical data show that Hub1 binds non-covalently to a conserved element termed HIND, which is present in the spliceosomal protein Snu66 in yeast and mammals, and Prp38 in plants. Hub1 binding mildly alters spliceosomal protein interactions and barely affects general splicing in S. cerevisiae. However, spliceosomes that lack Hub1, or are defective in Hub1-HIND interaction, cannot use certain non-canonical 59 splice sites and are defective in alternative SRC1 splicing. Hub1 confers alternative splicing not only when bound to HIND, but also when experimentally fused to Snu66, Prp38, or even the core splicing factor Prp8. Our study indicates a novel mechanism for splice site utilization that is guided by non-covalent modification of the spliceosome by an unconventional ubiquitin-like modifier.	[Mishra, Shravan Kumar; Ammon, Tim; Jentsch, Stefan] Max Planck Inst Biochem, Dept Mol Cell Biol, D-82152 Martinsried, Germany; [Popowicz, Grzegorz M.; Krajewski, Marcin; Holak, Tad A.] Max Planck Inst Biochem, NMR Spect, D-82152 Martinsried, Germany; [Nagel, Roland J.; Ares, Manuel, Jr.] Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Ctr Mol Biol RNA, Santa Cruz, CA 95064 USA	Max Planck Society; Max Planck Society; University of California System; University of California Santa Cruz	Jentsch, S (corresponding author), Max Planck Inst Biochem, Dept Mol Cell Biol, Klopferspitz 18, D-82152 Martinsried, Germany.	Jentsch@biochem.mpg.de	Popowicz, Grzegorz/G-4769-2017	Popowicz, Grzegorz/0000-0003-2818-7498; Ares, Manny/0000-0002-2552-9168; Mishra, Shravan Kumar/0000-0003-3899-0495	Max Planck Society; Deutsche Forschungsgemeinschaft; Fonds der chemischen Industrie; Center for Integrated Protein Science Munich; RUBICON EU Network of Excellence; NIH [GM040478]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040478] Funding Source: NIH RePORTER	Max Planck Society(Max Planck SocietyFoundation CELLEX); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fonds der chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); Center for Integrated Protein Science Munich; RUBICON EU Network of Excellence; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank U. Cramer and M. Kost for technical assistance, G. Dittmar, C. Guthrie, M. Konarska, K. Matuschewski, O. Nielsen, M. Rosbash and H. Yashiroda for materials, S. Uebel and C. Boulegue for mass spectrometric analysis and help, K. Hofmann for pointing out putative HIND elements in Prp38 proteins of plants, and M. Singh for initiating structural work. S.J. is supported by the Max Planck Society, Deutsche Forschungsgemeinschaft, Fonds der chemischen Industrie, Center for Integrated Protein Science Munich and RUBICON EU Network of Excellence; T.A.H. by the Max Planck Society; M.A. by NIH (GM040478).	ANSARI A, 1995, EMBO J, V14, P4001, DOI 10.1002/j.1460-2075.1995.tb00071.x; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bayer P, 1998, J MOL BIOL, V280, P275, DOI 10.1006/jmbi.1998.1839; Benedetti C, 2006, GENETICS, V174, P229, DOI 10.1534/genetics.106.061580; Burckin T, 2005, NAT STRUCT MOL BIOL, V12, P175, DOI 10.1038/nsmb891; Chen M, 2009, NAT REV MOL CELL BIO, V10, P741, DOI 10.1038/nrm2777; Clark TA, 2002, SCIENCE, V296, P907, DOI 10.1126/science.1069415; Davis CA, 2000, NUCLEIC ACIDS RES, V28, P1700, DOI 10.1093/nar/28.8.1700; Dikic I, 2009, NAT REV MOL CELL BIO, V10, P659, DOI 10.1038/nrm2767; Dittmar GAG, 2002, SCIENCE, V295, P2442, DOI 10.1126/science.1069989; Fabrizio P, 2009, MOL CELL, V36, P593, DOI 10.1016/j.molcel.2009.09.040; Friedmann JS, 2001, GENOMICS, V71, P252, DOI 10.1006/geno.2000.6439; Grund SE, 2008, J CELL BIOL, V182, P897, DOI 10.1083/jcb.200803098; Hagan IM, 2000, PRACT APPROACH SER, V218, P179; Hazbun TR, 2003, MOL CELL, V12, P1353, DOI 10.1016/S1097-2765(03)00476-3; Hochstrasser M, 2009, NATURE, V458, P422, DOI 10.1038/nature07958; JACQUIER A, 1985, CELL, V43, P423, DOI 10.1016/0092-8674(85)90172-2; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Keren H, 2010, NAT REV GENET, V11, P345, DOI 10.1038/nrg2776; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; Kress TL, 2008, MOL CELL, V32, P727, DOI 10.1016/j.molcel.2008.11.013; Kuhn AN, 2003, CURR GENET, V42, P241, DOI 10.1007/s00294-002-0355-2; LAMZIN VS, 1993, ACTA CRYSTALLOGR D, V49, P129, DOI 10.1107/S0907444992008886; LESSER CF, 1993, GENETICS, V133, P851; Liu ML, 1998, J MAGN RESON, V132, P125, DOI 10.1006/jmre.1998.1405; Luders J, 2003, EMBO REP, V4, P1169, DOI 10.1038/sj.embor.7400025; Makarova OV, 2001, EMBO J, V20, P2553, DOI 10.1093/emboj/20.10.2553; McNally T, 2003, PROTEIN SCI, V12, P1562, DOI 10.1110/ps.0382803; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; MORI S, 1995, J MAGN RESON SER B, V108, P94, DOI 10.1006/jmrb.1995.1109; Okazaki K, 2000, DNA RES, V7, P27, DOI 10.1093/dnares/7.1.27; Pervushin KV, 1998, J BIOMOL NMR, V12, P345, DOI 10.1023/A:1008268930690; RAMAGE R, 1994, BIOCHEM J, V299, P151, DOI 10.1042/bj2990151; Ramelot Theresa A., 2003, Journal of Structural and Functional Genomics, V4, P25, DOI 10.1023/A:1024674220425; Rodriguez-Navarro S, 2002, YEAST, V19, P43, DOI 10.1002/yea.803; Song J, 2005, J BIOL CHEM, V280, P40122, DOI 10.1074/jbc.M507059200; Steen H, 2004, NAT REV MOL CELL BIO, V5, P699, DOI 10.1038/nrm1468; Stevens SW, 1999, P NATL ACAD SCI USA, V96, P7226, DOI 10.1073/pnas.96.13.7226; Stevens SW, 2002, MOL CELL, V9, P31, DOI 10.1016/S1097-2765(02)00436-7; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Wilkinson CRM, 2004, CURR BIOL, V14, P2283, DOI 10.1016/j.cub.2004.11.058; Yashiroda H, 2004, GENES CELLS, V9, P1189, DOI 10.1111/j.1365-2443.2004.00807.x; Zhu G, 1999, J BIOMOL NMR, V13, P77, DOI 10.1023/A:1008398227519	44	60	62	2	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 9	2011	474	7350					173	U205		10.1038/nature10143	http://dx.doi.org/10.1038/nature10143			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774PE	21614000	Green Accepted			2022-12-24	WOS:000291397800041
J	Davis, MM; Dayoub, EJ				Davis, Matthew M.; Dayoub, Elias J.			A Strategic Approach to Therapeutic Cancer Vaccines in the 21st Century	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Davis, Matthew M.] Univ Michigan, Div Gen Med, Div Gen Pediat, Child Hlth Evaluat & Res Unit, Ann Arbor, MI 48109 USA; [Davis, Matthew M.] Univ Michigan, Gerald R Ford Sch Publ Policy, Ann Arbor, MI 48109 USA; [Dayoub, Elias J.] Univ Michigan, Sch Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Davis, MM (corresponding author), Univ Michigan, Div Gen Med, Div Gen Pediat, Child Hlth Evaluat & Res Unit, Ann Arbor, MI 48109 USA.	mattdav@med.umich.edu						Brower V, 2010, J NATL CANCER I, V102, P1108, DOI 10.1093/jnci/djq295; Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P243; Davis MM, 2010, HUM VACCINES, V6, P689, DOI 10.4161/hv.6.9.13496; Howlader N, 2011, SEER CANC STAT UNPUB; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kantoff PW, 2010, NEW ENGL J MED, V363, P411, DOI 10.1056/NEJMoa1001294	6	4	4	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 8	2011	305	22					2343	2344		10.1001/jama.2011.814	http://dx.doi.org/10.1001/jama.2011.814			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	773YV	21642687				2022-12-24	WOS:000291349100028
J	Stefer, S; Reitz, S; Wang, F; Wild, K; Pang, YY; Schwarz, D; Bomke, J; Hein, C; Lohr, F; Bernhard, F; Denic, V; Dotsch, V; Sinning, I				Stefer, Susanne; Reitz, Simon; Wang, Fei; Wild, Klemens; Pang, Yin-Yuin; Schwarz, Daniel; Bomke, Joerg; Hein, Christopher; Loehr, Frank; Bernhard, Frank; Denic, Vladimir; Doetsch, Volker; Sinning, Irmgard			Structural Basis for Tail-Anchored Membrane Protein Biogenesis by the Get3-Receptor Complex	SCIENCE			English	Article							SIGNAL RECOGNITION PARTICLE; PHOSPHOLIPID-BILAYERS; ER MEMBRANE; INSERTION; GET3; TRANSLOCATION; MECHANISM; PATHWAY; BINDING	Tail-anchored (TA) proteins are involved in cellular processes including trafficking, degradation, and apoptosis. They contain a C-terminal membrane anchor and are posttranslationally delivered to the endoplasmic reticulum (ER) membrane by the Get3 adenosine triphosphatase interacting with the hetero-oligomeric Get1/2 receptor. We have determined crystal structures of Get3 in complex with the cytosolic domains of Get1 and Get2 in different functional states at 3.0, 3.2, and 4.6 angstrom resolution. The structural data, together with biochemical experiments, show that Get1 and Get2 use adjacent, partially overlapping binding sites and that both can bind simultaneously to Get3. Docking to the Get1/2 complex allows for conformational changes in Get3 that are required for TA protein insertion. These data suggest a molecular mechanism for nucleotide-regulated delivery of TA proteins.	[Wang, Fei; Denic, Vladimir] Harvard Univ, Dept Mol & Cellular Biol, Northwest Labs, Cambridge, MA 02138 USA; [Stefer, Susanne; Hein, Christopher; Loehr, Frank; Bernhard, Frank; Doetsch, Volker] Goethe Univ Frankfurt, Inst Biophys Chem, Ctr Biomol Magnet Resonance, D-60325 Frankfurt, Germany; [Reitz, Simon; Wild, Klemens; Pang, Yin-Yuin; Sinning, Irmgard] Univ Heidelberg, Biochem Ctr BZH, D-69120 Heidelberg, Germany; [Schwarz, Daniel; Bomke, Joerg] Merck KGaA, Merck Serono, Mol Interact & Biophys, D-64293 Darmstadt, Germany	Harvard University; Goethe University Frankfurt; Ruprecht Karls University Heidelberg; Merck KGaA; EMD Serono Inc.	Denic, V (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Northwest Labs, Cambridge, MA 02138 USA.	vdenic@mcb.harvard.edu; vdoetsch@em.uni-frankfurt.de; irmi.sinning@bzh.uni-heidelberg.de		Bernhard, Frank/0000-0002-4860-1783; Dotsch, Volker/0000-0001-5720-212X	Deutsche Forschungsgemeinschaft (DFG) [SFB 807, SFB 638]; Centre for Biomolecular Magnetic Resonance (BMRZ); Cluster of Excellence Frankfurt (Macromolecular Complexes); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099943] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Centre for Biomolecular Magnetic Resonance (BMRZ); Cluster of Excellence Frankfurt (Macromolecular Complexes); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	V.D. would like to thank M. Frech for his support of the project and acknowledges funding by the Deutsche Forschungsgemeinschaft (DFG) (SFB 807), the Centre for Biomolecular Magnetic Resonance (BMRZ), and the Cluster of Excellence Frankfurt (Macromolecular Complexes). I. S. thanks J. Kopp und C. Siegmann from the crystallization platform of the Biochemiezentrum and the Cluster of Excellence Heidelberg (CellNetworks), the European Synchrotron Radiation Facility for access to data collection, B. Dobberstein for generous support and stimulating discussions, and acknowledges funding by the DFG (SFB 638). Coordinates and structure factors have been deposited in the Research Collaboratory for Structural Bioinformatics Protein Data Bank (PDB) with accession nos. 3SJA, 3SJB, 3SJC, and 3SJD.	Abell BM, 2007, J CELL SCI, V120, P1743, DOI 10.1242/jcs.002410; BLOBEL G, 1975, J CELL BIOL, V67, P835, DOI 10.1083/jcb.67.3.835; Borgese N, 2007, CURR OPIN CELL BIOL, V19, P368, DOI 10.1016/j.ceb.2007.04.019; Borgese N, 2011, BBA-BIOMEMBRANES, V1808, P937, DOI 10.1016/j.bbamem.2010.07.010; Bozkurt G, 2009, P NATL ACAD SCI USA, V106, P21131, DOI 10.1073/pnas.0910223106; Brambillasca S, 2006, J CELL BIOL, V175, P767, DOI 10.1083/jcb.200608101; Colombo SF, 2009, J CELL SCI, V122, P2383, DOI 10.1242/jcs.049460; Cross BCS, 2009, NAT REV MOL CELL BIO, V10, P255, DOI 10.1038/nrm2657; Egea PF, 2005, CURR OPIN STRUC BIOL, V15, P213, DOI 10.1016/j.sbi.2005.03.007; Favaloro V, 2008, J CELL SCI, V121, P1832, DOI 10.1242/jcs.020321; Favaloro V, 2010, J CELL SCI, V123, P1522, DOI 10.1242/jcs.055970; High S, 2004, BIOCHEM SOC T, V32, P659, DOI 10.1042/BST0320659; Hollenstein K, 2007, CURR OPIN STRUC BIOL, V17, P412, DOI 10.1016/j.sbi.2007.07.003; Hu JB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008061; Mateja A, 2009, NATURE, V461, P361, DOI 10.1038/nature08319; Meineke B, 2008, FEBS LETT, V582, P855, DOI 10.1016/j.febslet.2008.02.009; Osborne AR, 2005, ANNU REV CELL DEV BI, V21, P529, DOI 10.1146/annurev.cellbio.21.012704.133214; Rabu C, 2009, J CELL SCI, V122, P3605, DOI 10.1242/jcs.041210; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Schuldiner M, 2008, CELL, V134, P634, DOI 10.1016/j.cell.2008.06.025; Shan SO, 2005, FEBS LETT, V579, P921, DOI 10.1016/j.febslet.2004.11.049; Stefanovic S, 2007, CELL, V128, P1147, DOI 10.1016/j.cell.2007.01.036; Suloway CJM, 2009, P NATL ACAD SCI USA, V106, P14849, DOI 10.1073/pnas.0907522106; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Vilardi F, 2011, J CELL SCI, V124, P1301, DOI 10.1242/jcs.084277; Wattenberg B, 2001, TRAFFIC, V2, P66, DOI 10.1034/j.1600-0854.2001.20108.x; Yamagata A, 2010, GENES CELLS, V15, P29, DOI 10.1111/j.1365-2443.2009.01362.x; Zaitseva J, 2006, EMBO J, V25, P3432, DOI 10.1038/sj.emboj.7601208	28	78	82	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 5	2011	333	6043					758	762		10.1126/science.1207125	http://dx.doi.org/10.1126/science.1207125			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LH	21719644	Green Accepted			2022-12-24	WOS:000293512100044
J	Pope, PB; Smith, W; Denman, SE; Tringe, SG; Barry, K; Hugenholtz, P; McSweeney, CS; McHardy, AC; Morrison, M				Pope, P. B.; Smith, W.; Denman, S. E.; Tringe, S. G.; Barry, K.; Hugenholtz, P.; McSweeney, C. S.; McHardy, A. C.; Morrison, M.			Isolation of Succinivibrionaceae Implicated in Low Methane Emissions from Tammar Wallabies	SCIENCE			English	Article							ANAEROBIOSPIRILLUM-SUCCINICIPRODUCENS; MACROPUS-EUGENII; BOVINE RUMEN; FERMENTATION; FORESTOMACH; COMMUNITY; NITROGEN	The Tammar wallaby (Macropus eugenii) harbors unique gut bacteria and produces only one-fifth the amount of methane produced by ruminants per unit of digestible energy intake. We have isolated a dominant bacterial species (WG-1) from the wallaby microbiota affiliated with the family Succinivibrionaceae and implicated in lower methane emissions from starch-containing diets. This was achieved by using a partial reconstruction of the bacterium's metabolism from binned metagenomic data (nitrogen and carbohydrate utilization pathways and antibiotic resistance) to devise cultivation-based strategies that produced axenic WG-1 cultures. Pure-culture studies confirm that the bacterium is capnophilic and produces succinate, further explaining a microbiological basis for lower methane emissions from macropodids. This knowledge also provides new strategic targets for redirecting fermentation and reducing methane production in livestock.	[Pope, P. B.; Smith, W.; Denman, S. E.; McSweeney, C. S.; Morrison, M.] CSIRO Livestock Ind, Queensland Biosci Precinct, St Lucia, Qld 4067, Australia; [Pope, P. B.] Norwegian Univ Life Sci, Dept Chem Biotechnol & Food Sci, N-1432 As, Norway; [Tringe, S. G.; Barry, K.; Hugenholtz, P.] US DOE, Joint Genome Inst, Walnut Creek, CA 94598 USA; [Hugenholtz, P.] Australian Ctr Ecogenom, Sch Chem & Mol Biosci, St Lucia, Qld 4072, Australia; [Hugenholtz, P.] Australian Ctr Ecogenom, Inst Mol Biosci, St Lucia, Qld 4072, Australia; [McHardy, A. C.] Max Planck Inst Informat, Max Planck Res Grp Computat Genom & Epidemiol, D-66123 Saarbrucken, Germany; [McHardy, A. C.] Univ Dusseldorf, Dept Algorithm Bioinformat, D-40225 Dusseldorf, Germany; [Morrison, M.] Ohio State Univ, Dept Anim Sci, Columbus, OH 43210 USA	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Norwegian University of Life Sciences; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; University of Queensland; University of Queensland; Max Planck Society; Heinrich Heine University Dusseldorf; University System of Ohio; Ohio State University	Morrison, M (corresponding author), CSIRO Livestock Ind, Queensland Biosci Precinct, St Lucia, Qld 4067, Australia.	mark.morrison@csiro.au	McHardy, Alice/ABF-2322-2020; Morrison, Mark/C-9707-2013; Hugenholtz, Philip/AAD-9138-2019; Denman, Stuart E/A-5823-2011; McHardy, Alice C/K-9377-2018; McSweeney, Chris S/C-3688-2012; Pope, Phillip/AAQ-2251-2021	McHardy, Alice/0000-0003-2370-3430; Morrison, Mark/0000-0001-9257-9133; Hugenholtz, Philip/0000-0001-5386-7925; Denman, Stuart E/0000-0002-9910-3709; McHardy, Alice C/0000-0003-2370-3430; Pope, Phillip/0000-0002-2067-4059; McSweeney, Chris/0000-0002-0114-5151	Commonwealth Scientific and Industrial Research Organisation's (CSIRO's) Office of the Chief Executive (OCE); U.S. Department of Energy-Joint Genome Institute Community Sequencing Program; Office of Science of the U.S. Department of Energy [DE-AC02-05CH11231]	Commonwealth Scientific and Industrial Research Organisation's (CSIRO's) Office of the Chief Executive (OCE); U.S. Department of Energy-Joint Genome Institute Community Sequencing Program; Office of Science of the U.S. Department of Energy(United States Department of Energy (DOE))	The Tammar wallaby project is partially supported by the Commonwealth Scientific and Industrial Research Organisation's (CSIRO's) Office of the Chief Executive (OCE) Science Leader and Transformational Biology Capability Platform grant programs (awarded to M. M.), a CSIRO OCE Postdoctoral Fellowship (awarded to P. B. P.), and the U.S. Department of Energy-Joint Genome Institute Community Sequencing Program. We are especially grateful for the support from L. Hinds (CSIRO Ecosystem Sciences), A.-D. Wright (University of Vermont), and P. Evans (CSIRO Livestock Industries), who assisted in sample collections. The work conducted by the U.S. Department of Energy-Joint Genome Institute is supported by the Office of Science of the U.S. Department of Energy under contract no. DE-AC02-05CH11231. The whole-metagenome shotgun project and whole-genome shotgun project (for the WG-1 isolate) has been deposited at DDBJ/EMBL/GenBank under accession numbers ADGC00000000 and AFAK00000000, respectively. 16S rRNA gene sequences are deposited under accession numbers GQ358225 to GQ358517.	Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Delcher AL, 2002, NUCLEIC ACIDS RES, V30, P2478, DOI 10.1093/nar/30.11.2478; Evans PN, 2009, APPL ENVIRON MICROB, V75, P2598, DOI 10.1128/AEM.02436-08; Gagen EJ, 2010, APPL ENVIRON MICROB, V76, P7785, DOI 10.1128/AEM.01679-10; HAMLIN LJ, 1956, J BACTERIOL, V72, P548, DOI 10.1128/JB.72.4.548-554.1956; HUME ID, 1984, BIOSCIENCE, V34, P435, DOI 10.2307/1309633; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; KEMPTON TJ, 1976, AUST J BIOL SCI, V29, P209, DOI 10.1071/BI9760209; KENNEDY PM, 1978, COMP BIOCHEM PHYS A, V61, P117, DOI 10.1016/0300-9629(78)90286-4; Lee PC, 1999, ENZYME MICROB TECH, V24, P549, DOI 10.1016/S0141-0229(98)00156-2; Markowitz VM, 2008, NUCLEIC ACIDS RES, V36, pD534, DOI 10.1093/nar/gkm869; McHardy AC, 2007, NAT METHODS, V4, P63, DOI 10.1038/NMETH976; McKinlay JB, 2007, METAB ENG, V9, P177, DOI 10.1016/j.ymben.2006.10.006; Omsland A, 2009, P NATL ACAD SCI USA, V106, P4430, DOI 10.1073/pnas.0812074106; Ouwerkerk D, 2009, ANIM PROD SCI, V49, P1043, DOI 10.1071/EA08294; Patil KR, 2011, NAT METHODS, V8, P191, DOI 10.1038/nmeth0311-191; Pope PB, 2010, P NATL ACAD SCI USA, V107, P14793, DOI 10.1073/pnas.1005297107; RUSSELL JB, 1989, APPL ENVIRON MICROB, V55, P1; Samuelov NS, 1999, APPL ENVIRON MICROB, V65, P2260; Tyson GW, 2005, APPL ENVIRON MICROB, V71, P6319, DOI 10.1128/AEM.71.10.6319-6324.2005; von Engelhardt W., 1978, Comparative Biochemistry and Physiology A, V60, P309, DOI 10.1016/0300-9629(78)90254-2	21	118	127	5	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 29	2011	333	6042					646	648		10.1126/science.1205760	http://dx.doi.org/10.1126/science.1205760			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798PI	21719642				2022-12-24	WOS:000293222400066
J	Yong, E				Yong, Ed			EMERGING DISEASES Disease trackers	BRITISH MEDICAL JOURNAL			English	Editorial Material												edyong209@googlemail.com						KARESH WB, 2005, EMERG INFECT DIS JUL	1	2	2	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 5	2011	343								d4117	10.1136/bmj.d4117	http://dx.doi.org/10.1136/bmj.d4117			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	791RV	21729998				2022-12-24	WOS:000292683200003
J	Knox, K; Carrigan, D; Simmons, G; Teque, F; Zhou, YC; Hackett, J; Qiu, XX; Luk, KC; Schochetman, G; Knox, A; Kogelnik, AM; Levy, JA				Knox, Konstance; Carrigan, Donald; Simmons, Graham; Teque, Fernando; Zhou, Yanchen; Hackett, John, Jr.; Qiu, Xiaoxing; Luk, Ka-Cheung; Schochetman, Gerald; Knox, Allyn; Kogelnik, Andreas M.; Levy, Jay A.			No Evidence of Murine-Like Gammaretroviruses in CFS Patients Previously Identified as XMRV-Infected	SCIENCE			English	Article							CHRONIC-FATIGUE-SYNDROME; VIRUS-RELATED VIRUS; AIDS-ASSOCIATED RETROVIRUS; VIRAL GENOME; HUMAN-SERUM; MOUSE DNA; CONTAMINATION; INACTIVATION; SEQUENCES; BLOOD	Members of the gammaretroviruses-such as murine leukemia viruses (MLVs), most notably XMRV [xenotropic murine leukemia virus (X-MLV)-related virus-have been reported to be present in the blood of patients with chronic fatigue syndrome (CFS). We evaluated blood samples from 61 patients with CFS from a single clinical practice, 43 of whom had previously been identified as XMRV-positive. Our analysis included polymerase chain reaction and reverse transcription polymerase chain reaction procedures for detection of viral nucleic acids and assays for detection of infectious virus and virus-specific antibodies. We found no evidence of XMRV or other MLVs in these blood samples. In addition, we found that these gammaretroviruses were strongly (X-MLV) or partially (XMRV) susceptible to inactivation by sera from CFS patients and healthy controls, which suggested that establishment of a successful MLV infection in humans would be unlikely. Consistent with previous reports, we detected MLV sequences in commercial laboratory reagents. Our results indicate that previous evidence linking XMRV and MLVs to CFS is likely attributable to laboratory contamination.	[Teque, Fernando; Levy, Jay A.] Univ Calif San Francisco, Dept Med, Div Hematol Oncol, San Francisco, CA 94143 USA; [Knox, Konstance; Carrigan, Donald; Knox, Allyn] Wisconsin Viral Res Grp, Milwaukee, WI 53226 USA; [Knox, Konstance; Carrigan, Donald; Kogelnik, Andreas M.] Open Med Inst, Mountain View, CA 94040 USA; [Simmons, Graham; Zhou, Yanchen] Blood Syst Res Inst, San Francisco, CA 94118 USA; [Simmons, Graham; Zhou, Yanchen] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Hackett, John, Jr.; Qiu, Xiaoxing; Luk, Ka-Cheung; Schochetman, Gerald] Abbott Labs, Abbott Pk, IL 60064 USA	University of California System; University of California San Francisco; Vitalant; Vitalant Research Institute; University of California System; University of California San Francisco; Abbott Laboratories	Levy, JA (corresponding author), Univ Calif San Francisco, Dept Med, Div Hematol Oncol, San Francisco, CA 94143 USA.	jay.levy@ucsf.edu	Simmons, Graham/G-3523-2012	Simmons, Graham/0000-0002-9615-7023				Baliji S, 2010, J VIROL, V84, P12841, DOI 10.1128/JVI.01863-10; BANAPOUR B, 1986, VIROLOGY, V152, P268, DOI 10.1016/0042-6822(86)90392-2; Erlwein O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008519; FUKUDA K, 1994, ANN INTERN MED, V121, P953, DOI 10.7326/0003-4819-121-12-199412150-00009; Groom HCT, 2010, P NATL ACAD SCI USA, V107, P5166, DOI 10.1073/pnas.0913650107; Groom HCT, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-10; Henrich TJ, 2010, J INFECT DIS, V202, P1478, DOI 10.1086/657168; HOFFMAN AD, 1985, VIROLOGY, V147, P326, DOI 10.1016/0042-6822(85)90135-7; Hong P, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-224; Hue S, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-111; LANDAY AL, 1991, LANCET, V338, P707, DOI 10.1016/0140-6736(91)91440-6; Levy J A, 1978, Curr Top Microbiol Immunol, V79, P111; LEVY JA, 1973, SCIENCE, V182, P1151, DOI 10.1126/science.182.4117.1151; Lo SC, 2010, P NATL ACAD SCI USA, V107, P15874, DOI 10.1073/pnas.1006901107; Lombardi VC, 2009, SCIENCE, V326, P585, DOI 10.1126/science.1179052; Oakes B, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-109; Paprotka T, 2010, J VIROL, V84, P5719, DOI 10.1128/JVI.00134-10; Qiu XX, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-68; Robinson MJ, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-108; ROTHER RP, 1995, J EXP MED, V182, P1345, DOI 10.1084/jem.182.5.1345; Sato E, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-110; Simmons G, 2011, TRANSFUSION, V51, P643, DOI 10.1111/j.1537-2995.2011.03063.x; Switzer WM, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-57; Takefman DM, 2002, J VIROL, V76, P1999, DOI 10.1128/JVI.76.4.1999-2002.2002; TAKEUCHI Y, 1994, J VIROL, V68, P8001, DOI 10.1128/JVI.68.12.8001-8007.1994; Urisman A, 2006, PLOS PATHOG, V2, P211, DOI 10.1371/journal.ppat.0020025; van Kuppeveld FJM, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1018; VARNIER OE, 1984, VIROLOGY, V132, P79, DOI 10.1016/0042-6822(84)90093-X; VARNIER OE, 1983, J GEN VIROL, V64, P425, DOI 10.1099/0022-1317-64-2-425; Weiss RA, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-124	30	86	88	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 1	2011	333	6038					94	97		10.1126/science.1204963	http://dx.doi.org/10.1126/science.1204963			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	785UF	21628393				2022-12-24	WOS:000292255400057
J	[Anonymous]				[Anonymous]			Global response to non-communicable disease	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CARDIOVASCULAR-DISEASE						Prabhakaran, Dorairaj/B-4147-2011; Miranda, J. Jaime/A-8482-2008; Niessen, Louis/F-6254-2015	Prabhakaran, Dorairaj/0000-0002-3172-834X; Miranda, J. Jaime/0000-0002-4738-5468; Niessen, Louis/0000-0002-8639-5191; Levitt, Naomi/0000-0001-6480-8066; Ghannem, Hassen/0000-0002-9417-6837				American Cancer Society, 2010, GLOB EC COST CANC; [Anonymous], 2005, PREV CHRON DIS VIT I; Beaglehole R, 2011, LANCET, V377, P1438, DOI 10.1016/S0140-6736(11)60393-0; First Global Ministerial Conference on Healthy Lifestyles and Noncommunicable Disease Control, 2011, 1 GLOBAL MINISTERIAL; NCD Alliance, 2011, PROP OUTC DOC UN HIG; Nugent RA, 2010, 228 CTR GLOB DEV; Rodgers A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019857; Smith R, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d2796; SRIDHAR D, 2011, GETTING POLITICS RIG; Wald NJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018742; Wald NJ, 2003, BMJ-BRIT MED J, V326, P1419, DOI 10.1136/bmj.326.7404.1419; WHO, 2010, WORLD MALARIA REPORT 2010, P1; WHO, 2011, GLOB STAT REP NONC D; *WHO, 2008, GLOB STRAT HARMF US; World Health Organization, 2011, PRIOR RES AG PREV CO; World Health Organization, 2008, ACT PLAN GLOB STRAT; World Health Organization, 2003, WHO FRAM CONV TOB CO; World Health Organization, 2004, GLOB STRAT DIET PHYS; Yusuf S, 2009, LANCET, V373, P1341, DOI 10.1016/S0140-6736(09)60611-5; GLOBAL ALLIANCE CHRO	20	21	22	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 30	2011	342								d3823	10.1136/bmj.d3823	http://dx.doi.org/10.1136/bmj.d3823			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	788QB	21724543				2022-12-24	WOS:000292458400002
J	Girgis, A; Stacey, F; Lee, T; Black, D; Kilbreath, S				Girgis, Afaf; Stacey, Fiona; Lee, Teresa; Black, Deborah; Kilbreath, Sharon			Priorities for women with lymphoedema after treatment for breast cancer: population based cohort study	BRITISH MEDICAL JOURNAL			English	Article							RISK-FACTORS; PSYCHOLOGICAL DISTRESS; EARLY-DIAGNOSIS; ARM LYMPHEDEMA; SURGERY; NEEDS; MORBIDITY; SURVIVORS; PERCEPTIONS; CARE	Objective To explore the perceived unmet needs among women treated for breast cancer and in whom symptoms and signs indicate the presence of lymphoedema. Design Population based cross sectional survey with a purpose designed questionnaire (60 items). Setting Cancer registries of New South Wales, Victoria, and South Australia. Participants 237 women with symptoms and signs indicative of lymphoedema from an initial 1930 eligible women. Main outcome measure Unmet needs in the previous month across psychological, health system and information, physical and daily living, patient care and support, sexuality needs, body image, and financial domains. Results The 10 items most commonly identified as a "moderate to high current need" included having their doctor and allied health workers being fully informed about lymphoedema, acknowledge the seriousness of the condition, and be willing to treat it. Women also wanted access to up to date treatments, both mainstream and alternative, and financial assistance for their garments. The three factors that explained most of the variance were: information and support (11 items), which accounted for 49% of the variance; body image and self esteem (seven items; 7% variance); and health system (seven items; 5% variance). Examination of these three factors showed that while the levels of need were generally low, they were common. Conclusion To address the needs of women with lymphoedema and perhaps to prevent progression of lymphoedema, it is important that practitioners do not dismiss mild symptoms and that women are referred to an appropriate specialist.	[Black, Deborah; Kilbreath, Sharon] Univ Sydney, Fac Hlth Sci, Lidcombe, NSW 2141, Australia; [Stacey, Fiona] Univ Newcastle, Sch Med & Publ Hlth, Callaghan, NSW 2308, Australia; [Lee, Teresa] Royal N Shore Hosp, Canc Serv, St Leonards, NSW 2065, Australia	University of Sydney; University of Newcastle; Royal North Shore Hospital	Kilbreath, S (corresponding author), Univ Sydney, Fac Hlth Sci, Lidcombe, NSW 2141, Australia.	sharon.kilbreath@sydney.edu.au	black, deborah/C-2829-2017; Girgis, Afaf/G-8660-2011; Stacey, Fiona/G-7715-2013	black, deborah/0000-0001-9174-1565; Girgis, Afaf/0000-0003-4101-4006; Kilbreath, Sharon/0000-0002-8024-8641	National Breast Cancer Foundation	National Breast Cancer Foundation	This study was funded by a grant in aid from the National Breast Cancer Foundation; SK is funded by the National Breast Cancer Foundation.	Armer Jane M, 2009, J Lymphoedema, V4, P14; Bonevski B, 2000, CANCER, V88, P217, DOI 10.1002/(SICI)1097-0142(20000101)88:1<217::AID-CNCR29>3.0.CO;2-Y; Brorson Hakan, 2009, Lymphatic Research and Biology, V7, P3, DOI 10.1089/lrb.2008.1022; Carter B J, 1997, Oncol Nurs Forum, V24, P875; Collins LG, 2004, SUPPORT CARE CANCER, V12, P106, DOI 10.1007/s00520-003-0554-5; Cormier JN, 2009, LYMPHOLOGY, V42, P161; Cornish BH, 1996, BREAST CANCER RES TR, V38, P169, DOI 10.1007/BF01806671; Cornish BH, 2000, ANN NY ACAD SCI, V904, P571; DUNN SM, 1993, J CLIN ONCOL, V11, P2279, DOI 10.1200/JCO.1993.11.11.2279; Gergich NLS, 2008, CANCER-AM CANCER SOC, V112, P2809, DOI 10.1002/cncr.23494; Girgis A, 2000, AUST NZ J PUBL HEAL, V24, P166, DOI 10.1111/j.1467-842X.2000.tb00137.x; Goldberg JI, 2010, ANN SURG ONCOL, V17, P3278, DOI 10.1245/s10434-010-1155-4; Greenslade M Victoria, 2006, Can Oncol Nurs J, V16, P165; Hayes S, 2008, LYMPHOLOGY, V41, P18; Hayes SC, 2008, J CLIN ONCOL, V26, P3536, DOI 10.1200/JCO.2007.14.4899; Johansson K, 2003, SCAND J CARING SCI, V17, P35, DOI 10.1046/j.1471-6712.2003.00119.x; Kilbreath SL, 2010, BREAST CANCER RES TR, V120, P649, DOI 10.1007/s10549-010-0793-3; Lacomba MT, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b5396; Lawenda BD, 2009, CA-CANCER J CLIN, V59, P8, DOI 10.3322/caac.20001; Lee TS, 2010, ONCOL NURS FORUM, V37, P85, DOI 10.1188/10.ONF.85-91; Lee TS, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-75; Lee TS, 2009, ONCOL NURS FORUM, V36, P454, DOI 10.1188/09.ONF.454-462; MAUNSELL E, 1993, CAN J SURG, V36, P315; McNeely ML, 2011, CANCER-AM CANCER SOC, V117, P1136, DOI 10.1002/cncr.25513; Meeske KA, 2009, BREAST CANCER RES TR, V113, P383, DOI 10.1007/s10549-008-9940-5; Newman ML, 1996, J PAIN SYMPTOM MANAG, V12, P376, DOI 10.1016/S0885-3924(96)00187-X; Norman SA, 2009, J CLIN ONCOL, V27, P390, DOI 10.1200/JCO.2008.17.9291; Oliveri Jill M, 2008, J Cancer Surviv, V2, P233, DOI 10.1007/s11764-008-0065-y; Passik SD, 1998, CANCER, V83, P2817, DOI 10.1002/(SICI)1097-0142(19981215)83:12B+<2817::AID-CNCR32>3.0.CO;2-2; Sanson-Fisher R, 2000, CANCER, V88, P226, DOI 10.1002/(SICI)1097-0142(20000101)88:1<226::AID-CNCR30>3.0.CO;2-P; Schmitz KH, 2009, NEW ENGL J MED, V361, P664, DOI 10.1056/NEJMoa0810118; Shih YCT, 2009, J CLIN ONCOL, V27, P2007, DOI 10.1200/JCO.2008.18.3517; Stanton A W B, 2003, Lymphat Res Biol, V1, P121, DOI 10.1089/153968503321642615; TOBIN MB, 1993, CANCER-AM CANCER SOC, V72, P3248, DOI 10.1002/1097-0142(19931201)72:11<3248::AID-CNCR2820721119>3.0.CO;2-Z; Towers A, 2008, J PALLIAT CARE, V24, P134, DOI 10.1177/082585970802400302; Woods M, 1995, CANCER NURS, V18, P467	36	26	26	0	7	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 21	2011	342								d3442	10.1136/bmj.d3442	http://dx.doi.org/10.1136/bmj.d3442			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	785AO	21693532	Green Submitted, Green Published, hybrid			2022-12-24	WOS:000292200000002
J	Seibert, D; Hong, CH; Takeuchi, F; Olsen, C; Hathaway, O; Moss, J; Darling, TN				Seibert, Diane; Hong, Chien-Hui; Takeuchi, Fumiko; Olsen, Cara; Hathaway, Olonda; Moss, Joel; Darling, Thomas N.			Recognition of Tuberous Sclerosis in Adult Women: Delayed Presentation With Life-Threatening Consequences	ANNALS OF INTERNAL MEDICINE			English	Article							PULMONARY LYMPHANGIOLEIOMYOMATOSIS; CLINICAL CHARACTERISTICS; RENAL ANGIOMYOLIPOMA; CONSENSUS CONFERENCE; FORME-FRUSTE; COMPLEX; PREVALENCE; DIAGNOSIS; MUTATION; ASSOCIATION	Background: Tuberous sclerosis complex (TSC) is associated with tumor development in the brain, retina, kidney, skin, heart, and lung. Seizures, intellectual disability, and characteristic skin lesions commonly manifest in early childhood, but some findings, notably renal angiomyolipomas and pulmonary lymphangioleiomyomatosis (LAM), emerge later, placing adults with undiagnosed TSC at increased risk for morbidity and mortality. Objective: To describe the clinical presentation and severity of TSC in adult women. Design: Retrospective cohort study. Setting: National Institutes of Health Clinical Center, Bethesda, Maryland, 1995 to 2010. Patients: 79 women aged 18 years or older who were enrolled in an observational cohort study of TSC to evaluate disease manifestations. Measurements: History, physical examination, pulmonary function testing, chest radiography, abdominal computed tomography, high-resolution chest computed tomography, and brain magnetic resonance imaging were used to evaluate patients. Results: Among the 45 patients who received a diagnosis of TSC in adulthood, 21 presented with symptoms due to LAM, 19 with renal angiomyolipomas, and 10 with seizures. Of the 45 patients, 30 met clinical criteria for TSC in childhood that remained undiagnosed for a median of 21.5 years and 15 were older than 18 years before meeting the clinical criteria for TSC. Patients diagnosed in adulthood and those diagnosed in childhood had similar occurrences of pneumothorax, shortness of breath, hemoptysis, nephrectomy, and death. Limitation: No men were included in the study, and selection was biased toward patients having pulmonary LAM. Conclusion: Women who received a TSC diagnosis in adulthood had minimal morbidity during childhood but were still at risk for life-threatening pulmonary and renal manifestations.	[Darling, Thomas N.] Uniformed Serv Univ Hlth Sci, Dept Dermatol, Bethesda, MD 20814 USA; NHLBI, Bethesda, MD 20892 USA; Kaohsiung Vet Gen Hosp, Kaohsiung, Taiwan	Uniformed Services University of the Health Sciences - USA; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Kaohsiung Veterans General Hospital	Darling, TN (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Dermatol, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	mossj@nhlbi.nih.gov; tdarling@usuhs.mil	Seibert, Diane/S-9611-2019	Darling, Thomas/0000-0002-5161-1974	National Institutes of Health, National Heart, Lung, and Blood Institute; National Cancer Institute [R01 CA100907]; Congressionally Directed Medical Research Programs [TS080064]; NATIONAL CANCER INSTITUTE [R01CA100907] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL002541] Funding Source: NIH RePORTER	National Institutes of Health, National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Congressionally Directed Medical Research Programs(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Grant Support: From the Intramural Research Program, National Institutes of Health, National Heart, Lung, and Blood Institute, and grants from the National Cancer Institute (R01 CA100907; Dr. Darling) and the Congressionally Directed Medical Research Programs (TS080064; Dr. Darling).	Aldrich SL, 2010, J AM ACAD DERMATOL, V63, P244, DOI 10.1016/j.jaad.2009.08.042; An KS, 2004, J CHILD NEUROL, V19, P699, DOI 10.1177/08830738040190091101; Avila NA, 2010, RADIOLOGY, V254, P851, DOI 10.1148/radiol.09090227; Bissler JJ, 2008, NEW ENGL J MED, V358, P140, DOI 10.1056/NEJMoa063564; Camposano SE, 2009, ANN HUM GENET, V73, P141, DOI 10.1111/j.1469-1809.2008.00496.x; Chu-Shore CJ, 2010, EPILEPSIA, V51, P1236, DOI 10.1111/j.1528-1167.2009.02474.x; Costello LC, 2000, MAYO CLIN PROC, V75, P591, DOI 10.4065/75.6.591; Curatolo P, 2008, LANCET, V372, P657, DOI 10.1016/S0140-6736(08)61279-9; Dabora SL, 2002, AM J HUM GENET, V71, P750, DOI 10.1086/342718; Devlin LA, 2006, DEV MED CHILD NEUROL, V48, P495, DOI 10.1017/S0012162206001058; Ewalt DH, 2005, J UROLOGY, V174, P1764, DOI 10.1097/01.ju.0000177497.31986.64; Franz DN, 2001, AM J RESP CRIT CARE, V164, P661, DOI 10.1164/ajrccm.164.4.2011025; Gomez MR, 1988, TUBEROUS SCLEROSIS; Hancock E, 2002, RESP MED, V96, P7, DOI 10.1053/rmed.2001.1206; HUNT A, 1984, J MED GENET, V21, P272, DOI 10.1136/jmg.21.4.272; Jansen AC, 2006, ANN NEUROL, V60, P528, DOI 10.1002/ana.21037; Johnson SR, 2010, RESP MED, V104, pS33, DOI 10.1016/j.rmed.2010.03.015; KERR LA, 1993, UROLOGY, V41, P440, DOI 10.1016/0090-4295(93)90504-4; Krueger DA, 2010, NEW ENGL J MED, V363, P1801, DOI 10.1056/NEJMoa1001671; Lendvay TS, 2003, J UROLOGY, V169, P1635, DOI 10.1097/01.ju.0000058253.40352.60; McCormack FX, 2011, NEW ENGL J MED, V364, P1595, DOI 10.1056/NEJMoa1100391; Moss J, 2001, AM J RESP CRIT CARE, V164, P669, DOI 10.1164/ajrccm.164.4.2101154; Moss J, 2001, JAMA-J AM MED ASSOC, V286, P1879, DOI 10.1001/jama.286.15.1879; Muzykewicz DA, 2009, J MED GENET, V46, P465, DOI 10.1136/jmg.2008.065342; Neumann H P, 1998, Semin Pediatr Neurol, V5, P269, DOI 10.1016/S1071-9091(98)80005-3; O'Callaghan FJ, 2004, BJU INT, V94, P853, DOI 10.1111/j.1464-410X.2004.05046.x; O'Callaghan FJ, 2000, ARCH DIS CHILD, V83, P140, DOI 10.1136/adc.83.2.140; O'Callaghan FJK, 1998, LANCET, V351, P1490, DOI 10.1016/S0140-6736(05)78872-3; Pulsifer MB, 2007, EPILEPSY BEHAV, V10, P402, DOI 10.1016/j.yebeh.2007.02.004; Qin W, 2010, HUM GENET, V127, P573, DOI 10.1007/s00439-010-0801-z; Quist SR, 2010, J AM ACAD DERMATOL, V62, P159, DOI 10.1016/j.jaad.2009.01.021; Roach ES, 1999, J CHILD NEUROL, V14, P401, DOI 10.1177/088307389901400610; Roach ES, 1998, J CHILD NEUROL, V13, P624, DOI 10.1177/088307389801301206; SAMPSON JR, 1989, J MED GENET, V26, P28, DOI 10.1136/jmg.26.1.28; Seyam RM, 2008, UROLOGY, V72, P1077, DOI 10.1016/j.urology.2008.07.049; SHEPHERD CW, 1991, MAYO CLIN PROC, V66, P792, DOI 10.1016/S0025-6196(12)61196-3; SHEPHERD CW, 1991, ARCH NEUROL-CHICAGO, V48, P400, DOI 10.1001/archneur.1991.00530160068015; SIEGEL JM, 1974, ARCH DERMATOL, V110, P476; Sparling MJD, 2007, J AM ACAD DERMATOL, V56, P786, DOI 10.1016/j.jaad.2006.11.019; Staley BA, 2011, PEDIATRICS, V127, pE117, DOI 10.1542/peds.2010-0192; Taveira-DaSilva AM, 2011, ANN INTERN MED, V154, P797, DOI 10.7326/0003-4819-154-12-201106210-00007; Vail EA, 2009, CLIN GENET, V75, P282, DOI 10.1111/j.1399-0004.2008.01129.x; Webb DW, 1996, DEV MED CHILD NEUROL, V38, P146	43	43	45	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 21	2011	154	12					806	813		10.7326/0003-4819-154-12-201106210-00008	http://dx.doi.org/10.7326/0003-4819-154-12-201106210-00008			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	779SA	21690595	Green Accepted			2022-12-24	WOS:000291800500016
J	Karijolich, J; Yu, YT				Karijolich, John; Yu, Yi-Tao			Converting nonsense codons into sense codons by targeted pseudouridylation	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; U2 SNRNA; RNA; SITE; GENE; RECOGNITION; TERMINATION; TURNOVER	All three translation termination codons, or nonsense codons, contain a uridine residue at the first position of the codon(1-3). Here, we demonstrate that pseudouridylation (conversion of uridine into pseudouridine (Psi), ref. 4) of nonsense codons suppresses translation termination both in vitro and in vivo. In vivo targeting of nonsense codons is accomplished by the expression of an H/ACA RNA capable of directing the isomerization of uridine to Psi within the nonsense codon. Thus, targeted pseudouridylation represents a novel approach for promoting nonsense suppression in vivo. Remarkably, we also show that pseudouridylated nonsense codons code for amino acids with similar properties. Specifically, Psi AA and Psi AG code for serine and threonine, whereas Psi GA codes for tyrosine and phenylalanine, thus suggesting a new mode of decoding. Our results also suggest that RNA modification, as a naturally occurring mechanism, may offer a new way to expand the genetic code.	[Karijolich, John; Yu, Yi-Tao] Univ Rochester, Med Ctr, Dept Biochem & Biophys, Rochester, NY 14642 USA	University of Rochester	Yu, YT (corresponding author), Univ Rochester, Med Ctr, Dept Biochem & Biophys, 601 Elmwood Ave, Rochester, NY 14642 USA.	yitao_yu@urmc.rochester.edu			NIGMS NIH HHS [R01 GM062937-09, R21 GM078223-02, R01 GM062937, R21 GM078223] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062937, R21GM078223] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agris PF, 2004, NUCLEIC ACIDS RES, V32, P223, DOI 10.1093/nar/gkh185; Agris PF, 1996, PROG NUCLEIC ACID RE, V53, P79, DOI 10.1016/S0079-6603(08)60143-9; ATKINS JF, 1979, CELL, V18, P1119, DOI 10.1016/0092-8674(79)90225-3; Auffinger P, 1997, J MOL BIOL, V269, P326, DOI 10.1006/jmbi.1997.1022; BRENNER S, 1967, NATURE, V213, P449, DOI 10.1038/213449a0; BRENNER S, 1965, NATURE, V206, P994, DOI 10.1038/206994a0; Charette M, 2000, IUBMB LIFE, V49, P341; Chernyakov I, 2008, GENE DEV, V22, P1369, DOI 10.1101/gad.1654308; COHN WE, 1959, BIOCHIM BIOPHYS ACTA, V32, P569, DOI 10.1016/0006-3002(59)90644-4; Davis DR, 1995, NUCLEIC ACIDS RES, V23, P5020, DOI 10.1093/nar/23.24.5020; Frischmeyer PA, 1999, HUM MOL GENET, V8, P1893, DOI 10.1093/hmg/8.10.1893; Ganot P, 1997, CELL, V89, P799, DOI 10.1016/S0092-8674(00)80263-9; Gelperin DM, 2005, GENE DEV, V19, P2816, DOI 10.1101/gad.1362105; HAMER DH, 1985, SCIENCE, V228, P685, DOI 10.1126/science.3887570; LEEDS P, 1991, GENE DEV, V5, P2303, DOI 10.1101/gad.5.12a.2303; LEEDS P, 1992, MOL CELL BIOL, V12, P2165, DOI 10.1128/MCB.12.5.2165; LESSER CF, 1993, GENETICS, V133, P851; Ma XJ, 2005, EMBO J, V24, P2403, DOI 10.1038/sj.emboj.7600718; Ni JW, 1997, CELL, V89, P565, DOI 10.1016/S0092-8674(00)80238-X; Song HW, 2000, CELL, V100, P311, DOI 10.1016/S0092-8674(00)80667-4; WEIGERT MG, 1965, NATURE, V206, P992, DOI 10.1038/206992a0; Wilusz CJ, 2001, GENE DEV, V15, P2781; Wu GW, 2011, EMBO J, V30, P79, DOI 10.1038/emboj.2010.316; Yu YT, 2000, METHOD ENZYMOL, V318, P71; Zebarjadian Y, 1999, MOL CELL BIOL, V19, P7461; Zhao XL, 2004, RNA, V10, P996, DOI 10.1261/rna.7110804; Zhao XL, 2004, RNA, V10, P681, DOI 10.1261/rna.5159504	27	209	224	2	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 16	2011	474	7351					395	+		10.1038/nature10165	http://dx.doi.org/10.1038/nature10165			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777TD	21677757	Green Accepted			2022-12-24	WOS:000291647100049
J	Woods, LM; Coleman, MP; Lawrence, G; Rashbass, J; Berrino, F; Rachet, B				Woods, Laura M.; Coleman, Michel P.; Lawrence, Gill; Rashbass, Jem; Berrino, Franco; Rachet, Bernard			Evidence against the proposition that "UK cancer survival statistics are misleading": simulation study with National Cancer Registry data	BMJ-BRITISH MEDICAL JOURNAL			English	Article							BREAST-CANCER; RADIOTHERAPY; COUNTRIES; AUSTRALIA; EUROCARE; ENGLAND; EUROPE	Objectives To simulate each of two hypothesised errors in the National Cancer Registry (recording of the date of recurrence of cancer, instead of the date of diagnosis, for registrations initiated from a death certificate; long term survivors who are never notified to the registry), to estimate their possible effect on relative survival, and to establish whether lower survival in the UK might be due to one or both of these errors. Design Simulation study. Setting National Cancer Registry of England and Wales. Population Patients diagnosed as having breast (women), lung, or colorectal cancer during 1995-2007 in England and Wales, with follow-up to 31 December 2007. Main outcome measure Mean absolute percentage change in one year and five year relative survival associated with each simulated error. Results To explain the differences in one year survival after breast cancer between England and Sweden, under the first hypothesis, date of diagnosis would have to have been incorrectly recorded by an average of more than a year for more than 70% of women known to be dead. Alternatively, under the second hypothesis, failure to register even 40% of long term survivors would explain less than half the difference in one year survival. Results were similar for lung and colorectal cancers. Conclusions Even implausibly extreme levels of the hypothesised errors in the cancer registry data could not explain the international differences in survival observed between the UK and other European countries.	[Woods, Laura M.; Coleman, Michel P.; Rachet, Bernard] Univ London London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, Canc Res UK Canc Survival Grp, London WC1E 7HT, England; [Lawrence, Gill] Univ Birmingham, W Midlands Canc Intelligence Unit, Birmingham BT5 2TT, W Midlands, England; [Rashbass, Jem] Eastern Canc Registry & Informat Ctr, Cambridge CB22 3AD, England; [Berrino, Franco] Ist Nazl Tumori, Fdn IRCCS, Dept Predict & Prevent Med, I-20133 Milan, Italy	Cancer Research UK; University of London; London School of Hygiene & Tropical Medicine; University of Birmingham; Fondazione IRCCS Istituto Nazionale Tumori Milan	Woods, LM (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, Canc Res UK Canc Survival Grp, Keppel St, London WC1E 7HT, England.	laura.woods@lshtm.ac.uk	Coleman, Michel/AAA-9543-2020; Berrino, Franco/AAC-2364-2020; Woods, Laura M/Q-1714-2017	Coleman, Michel/0000-0001-8940-3807; Berrino, Franco/0000-0002-4858-1866; Woods, Laura M/0000-0002-2178-1577; Rachet, Bernard/0000-0001-5837-7773	Cancer Research UK [11700, 11415] Funding Source: Medline	Cancer Research UK(Cancer Research UK)		Anderson GF, 2007, HEALTH AFFAIR, V26, P1481, DOI 10.1377/hlthaff.26.5.1481; Autier P, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3620; Bentzen SM, 2005, RADIOTHER ONCOL, V75, P355, DOI 10.1016/j.radonc.2004.12.007; Beral V, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c4112; Berrino F, 2003, ANN ONCOL, V14, pV9, DOI 10.1093/annonc/mdg750; Berrino F, 1999, SURVIVAL CANC PATIEN; Berrino F, 2007, LANCET ONCOL, V8, P773, DOI 10.1016/S1470-2045(07)70245-0; Bray F, 2009, EUR J CANCER, V45, P747, DOI 10.1016/j.ejca.2008.11.032; Brenner H, 1997, J CLIN EPIDEMIOL, V50, P211, DOI 10.1016/S0895-4356(97)00280-1; Brenner H, 2009, INT J CANCER, V125, P432, DOI 10.1002/ijc.24344; *CANC RES UK CANC, 2006, STREL COMP PROGR VER, V5; Coleman MP, 2003, ANN ONCOL, V14, pV128, DOI 10.1093/annonc/mdg756; Coleman MP, 2011, LANCET, V377, P127, DOI 10.1016/S0140-6736(10)62231-3; Coleman MP, 2008, LANCET ONCOL, V9, P730, DOI 10.1016/S1470-2045(08)70179-7; Curado MP, 2007, CANC INCIDENCE 5 CON, VIX; Department of Health, 2000, NHS CANC PLAN; Department of Health, 2007, CANC REF STRAT; EDERER FRED, 1961, NATL CANCER INST MONOGR, V6, P101; ESTEVE J, 1990, STAT MED, V9, P529, DOI 10.1002/sim.4780090506; Kaye JA, 2000, BRIT J CANCER, V83, P1556, DOI 10.1054/bjoc.2000.1493; Laurenti R, 2000, DEATH CERTIFICATION; Maudsley G, 1996, J PUBLIC HEALTH MED, V18, P59, DOI 10.1093/oxfordjournals.pubmed.a024463; *OFF NAT STAT, 2008, SER MB1 OFF NAT STAT, V37; Organisation for Economic Co Operation and Development, 2009, HLTH GLANC 2009; Rachet B, 2009, LANCET ONCOL, V10, P351, DOI 10.1016/S1470-2045(09)70028-2; Rooney C, 1999, HLTH STAT Q, P21; Sant M, 2003, INT J CANCER, V106, P416, DOI 10.1002/ijc.11226; Sant M., 1995, SURVIVAL CANC PATIEN; Stotter A, 2000, BRIT MED J, V321, P214, DOI 10.1136/bmj.321.7255.214; UK Association of Cancer Registries, 2010, UKACR QUAL PERF IND; Wilkinson E, 2009, LANCET, V374, P964, DOI 10.1016/S0140-6736(09)61648-2; Williams MV, 2007, CLIN ONCOL-UK, V19, P273, DOI 10.1016/j.clon.2007.03.011; Williams MV, 2009, CLIN ONCOL-UK, V21, P575, DOI 10.1016/j.clon.2009.07.003; Woods LM, 2009, INT J CANCER, V124, P2391, DOI 10.1002/ijc.24233; 2011, EUROCARE 4 DATABASE	35	38	38	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 9	2011	342								d3399	10.1136/bmj.d3399	http://dx.doi.org/10.1136/bmj.d3399			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	777SR	21659366	Green Published, hybrid, Green Accepted			2022-12-24	WOS:000291645800003
J	Kamerow, D				Kamerow, Douglas			YANKEE DOODLING AIDS at 30: a chance to treat is now a chance to prevent	BRITISH MEDICAL JOURNAL			English	Editorial Material									RTI Int, Res Triangle Pk, NC 27709 USA	Research Triangle Institute	Kamerow, D (corresponding author), RTI Int, Res Triangle Pk, NC 27709 USA.	dkamerow@rti.org		Kamerow, Douglas/0000-0001-7000-9957				BROWN D, 2011, WASHINGTON POST 0530; *CDC, 1981, MMWR-MORBID MORTAL W, V30, P1; FAUCI AS, 2011, WASHINGTON POST 0528	3	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 7	2011	342								d3512	10.1136/bmj.d3512	http://dx.doi.org/10.1136/bmj.d3512			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	777SL	21652746				2022-12-24	WOS:000291645200007
J	Remorino, A; Korendovych, IV; Wu, YB; DeGrado, WF; Hochstrasser, RM				Remorino, Amanda; Korendovych, Ivan V.; Wu, Yibing; DeGrado, William F.; Hochstrasser, Robin M.			Residue-Specific Vibrational Echoes Yield 3D Structures of a Transmembrane Helix Dimer	SCIENCE			English	Article							2-DIMENSIONAL INFRARED-SPECTROSCOPY; MOLECULAR-STRUCTURE DETERMINATION; 2D IR; XPLOR-NIH; PROTEINS; DYNAMICS; WATER; CONFORMATION; SIMULATIONS; PEPTIDES	Two-dimensional (2D) vibrational echo spectroscopy has previously been applied to structural determination of small peptides. Here we extend the technique to a more complex, biologically important system: the homodimeric transmembrane dimer from the alpha chain of the integrin alpha(IIb)beta(3). We prepared micelle suspensions of the pair of 30-residue chains that span the membrane in the native structure, with varying levels of heavy ((13)C=(18)O) isotopes substituted in the backbone of the central 10th through 20th positions. The constraints derived from vibrational coupling of the precisely spaced heavy residues led to determination of an optimized structure from a range of model candidates: Glycine residues at the 12th, 15th, and 16th positions form a tertiary contact in parallel right-handed helix dimers with crossing angles of -58 degrees +/- 9 degrees and interhelical distances of 7.7 +/- 0.5 angstroms. The frequency correlation established the dynamical model used in the analysis, and it indicated the absence of mobile water associated with labeled residues. Delocalization of vibrational excitations between the helices was also quantitatively established.	[Remorino, Amanda; Hochstrasser, Robin M.] Univ Penn, Dept Chem, Philadelphia, PA 19104 USA; [Korendovych, Ivan V.; Wu, Yibing; DeGrado, William F.] Univ Penn, Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Hochstrasser, RM (corresponding author), Univ Penn, Dept Chem, Philadelphia, PA 19104 USA.	hochstra@sas.upenn.edu			NSFCHE [NIH-GM12592, NIH-RR01348]; NSF-MRSEC [NIH-GM54616, NIH-GM60610, NIH-GM56423]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001348] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM012592, R01GM060610, R01GM054616, R01GM056423, R37GM012592, R37GM054616] Funding Source: NIH RePORTER	NSFCHE(National Science Foundation (NSF)); NSF-MRSEC(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The research was supported by grants NIH-GM12592, NIH-RR01348, and NSFCHE (to R.M.H.) and NIH-GM54616, NIH-GM60610, NSF-MRSEC, and NIH-GM56423 (to W.F.D.). We thank C. Schwieters and M. Clore for providing us with the Xplor-NIH source code.	Berger BW, 2010, P NATL ACAD SCI USA, V107, P703, DOI 10.1073/pnas.0910873107; Ernst R. R., 1987, PRINCIPLES NUCL MAGN; Fang C, 2003, CHEM PHYS LETT, V382, P586, DOI 10.1016/j.cplett.2003.10.111; Fang C, 2006, P NATL ACAD SCI USA, V103, P16740, DOI 10.1073/pnas.0608243103; Ghosh A, 2011, P NATL ACAD SCI USA, V108, P6115, DOI 10.1073/pnas.1103027108; Hamm P, 1998, J PHYS CHEM B, V102, P6123, DOI 10.1021/jp9813286; Hamm P, 1999, P NATL ACAD SCI USA, V96, P2036, DOI 10.1073/pnas.96.5.2036; Kim YS, 2005, J PHYS CHEM B, V109, P7511, DOI 10.1021/jp044989d; Kim YS, 2009, P NATL ACAD SCI USA, V106, P17751, DOI 10.1073/pnas.0909888106; Kolano C, 2006, NATURE, V444, P469, DOI 10.1038/nature05352; KRIMM S, 1986, ADV PROTEIN CHEM, V38, P181, DOI 10.1016/S0065-3233(08)60528-8; Kwac K, 2003, J CHEM PHYS, V119, P2256, DOI 10.1063/1.1580808; Li RH, 2004, J BIOL CHEM, V279, P26666, DOI 10.1074/jbc.M314168200; MacKenzie KR, 1997, SCIENCE, V276, P131, DOI 10.1126/science.276.5309.131; Marecek J, 2007, ORG LETT, V9, P4935, DOI 10.1021/ol701913p; Mukamel S., 1995, PRINCIPLES NONLINEAR; Mukherjee P, 2006, P NATL ACAD SCI USA, V103, P3528, DOI 10.1073/pnas.0508833103; Rubtsov IV, 2002, J PHYS CHEM B, V106, P9165, DOI 10.1021/jp020837b; Schwieters CD, 2006, PROG NUCL MAG RES SP, V48, P47, DOI 10.1016/j.pnmrs.2005.10.001; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Sul S, 2006, J PHYS CHEM B, V110, P19891, DOI 10.1021/jp062039h; TORII H, 1992, J CHEM PHYS, V96, P3379, DOI 10.1063/1.461939; Walters RFS, 2006, P NATL ACAD SCI USA, V103, P13658, DOI 10.1073/pnas.0605878103; Wang JP, 2004, CHEM PHYS, V297, P195, DOI 10.1016/j.chemphys.2003.10.013; WERTHEIMER R, 1980, CHEM PHYS LETT, V75, P243, DOI 10.1016/0009-2614(80)80505-7; Woutersen S, 2000, J PHYS CHEM B, V104, P11316, DOI 10.1021/jp001546a; Woys AM, 2010, J AM CHEM SOC, V132, P2832, DOI 10.1021/ja9101776; Zhuang W, 2009, ANGEW CHEM INT EDIT, V48, P3750, DOI 10.1002/anie.200802644	28	89	89	3	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 3	2011	332	6034					1206	1209		10.1126/science.1202997	http://dx.doi.org/10.1126/science.1202997			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	772BO	21636774	Green Accepted			2022-12-24	WOS:000291205200050
J	Carter, PJ; Taylor, BJ; Williams, SM; Taylor, RW				Carter, Philippa J.; Taylor, Barry J.; Williams, Sheila M.; Taylor, Rachael W.			Longitudinal analysis of sleep in relation to BMI and body fat in children: the FLAME study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MASS INDEX; RISK-FACTORS; CHILDHOOD OVERWEIGHT; CIRCADIAN-RHYTHMS; DURATION; OBESITY; ADOLESCENTS; AGE; ACCELEROMETERS; ASSOCIATION	Objectives To determine whether reduced sleep is associated with differences in body composition and the risk of becoming overweight in young children. Design Longitudinal study with repeated annual measurements. Setting Dunedin, New Zealand. Participants 244 children recruited from a birth cohort and followed from age 3 to 7. Main outcome measures Body mass index (BMI), fat mass (kg), and fat free mass (kg) measured with bioelectrical impedance; dual energy x ray absorptiometry; physical activity and sleep duration measured with accelerometry; dietary intake (fruit and vegetables, non-core foods), television viewing, and family factors (maternal BMI and education, birth weight, smoking during pregnancy) measured with questionnaire. Results After adjustment for multiple confounders, each additional hour of sleep at ages 3-5 was associated with a reduction in BMI of 0.48 (95% confidence interval 0.01 to 0.96) and a reduced risk of being overweight (BMI >= 85th centile) of 0.39 (0.24 to 0.63) at age 7. Further adjustment for BMI at age 3 strengthened these relations. These differences in BMI were explained by differences in fat mass index (-0.43, -0.82 to -0.03) more than by differences in fat free mass index (-0.21, -0.41 to -0.00). Conclusions Young children who do not get enough sleep are at increased risk of becoming overweight, even after adjustment for initial weight status and multiple confounding factors. This weight gain is a result of increased fat deposition in both sexes rather than additional accumulation of fat free mass.	[Carter, Philippa J.; Taylor, Barry J.] Univ Otago, Dept Womens & Childrens Hlth, Dunedin, New Zealand; [Williams, Sheila M.] Univ Otago, Dept Prevent & Social Med, Dunedin, New Zealand; [Taylor, Rachael W.] Univ Otago, Dept Med & Surg Sci, Edgar Natl Ctr Diabet & Obes Res, Dunedin, New Zealand	University of Otago; University of Otago; University of Otago	Taylor, RW (corresponding author), Dept Human Nutr, POB 56, Dunedin 9054, New Zealand.	rachael.taylor@otago.ac.nz	Williams, Sheila/L-4028-2019; Taylor, Barry j/G-1410-2010	Taylor, Barry/0000-0002-6450-8677	University of Otago; Child Health Research Foundation; New Zealand Heart Foundation; Bequest-AAW Jones Trust	University of Otago; Child Health Research Foundation; New Zealand Heart Foundation; Bequest-AAW Jones Trust	This study was funded by the University of Otago, the Child Health Research Foundation, the New Zealand Heart Foundation, and the Dean's Bequest-AAW Jones Trust. The funders had no role in study design; or in the collection, analysis, and interpretation of data; or in the writing of the report or the decision to submit the article for publication.	Acebo C, 1999, SLEEP, V22, P95, DOI 10.1093/sleep/22.1.95; Agras WS, 2004, J PEDIATR-US, V145, P20, DOI 10.1016/j.jpeds.2004.03.023; Balding DJ, 2004, APPL LONGITUDINAL AN; Bayer O, 2009, SLEEP, V32, P1183, DOI 10.1093/sleep/32.9.1183; Cappuccio FP, 2008, SLEEP, V31, P619, DOI 10.1093/sleep/31.5.619; Chen XL, 2008, OBESITY, V16, P265, DOI 10.1038/oby.2007.63; Cliff DP, 2009, J SCI MED SPORT, V12, P557, DOI 10.1016/j.jsams.2008.10.008; Crabtree VM, 2009, CHILD ADOL PSYCH CL, V18, P799, DOI 10.1016/j.chc.2009.04.013; Dollman I, 2007, ACTA PAEDIATR, V96, P1011, DOI 10.1111/j.1651-2227.2007.00278.x; Gangwisch JE, 2009, OBES REV, V10, P37, DOI 10.1111/j.1467-789X.2009.00663.x; Hart CN, 2008, BEHAV SLEEP MED, V6, P251, DOI 10.1080/15402000802371379; Hitze B, 2009, EUR J CLIN NUTR, V63, P739, DOI 10.1038/ejcn.2008.41; Horlick M, 2002, AM J CLIN NUTR, V76, P991, DOI 10.1093/ajcn/76.5.991; Iglowstein I, 2003, PEDIATRICS, V111, P302, DOI 10.1542/peds.111.2.302; Keith SW, 2006, INT J OBESITY, V30, P1585, DOI 10.1038/sj.ijo.0803326; Kuczmarski RJ, 2002, SERIES-J SPAN ECON, V11, P1, DOI DOI 10.1016/J.BBRC.2015.06.114; Landhuis CE, 2008, PEDIATRICS, V122, P955, DOI 10.1542/peds.2007-3521; Littner M, 2003, SLEEP, V26, P337, DOI 10.1093/sleep/26.3.337; Lumeng JC, 2007, PEDIATRICS, V120, P1020, DOI 10.1542/peds.2006-3295; Marshall NS, 2008, SLEEP MED REV, V12, P289, DOI 10.1016/j.smrv.2008.03.001; Ministry of Health, 2008, PORTR HLTH KEY RES 2; Must A, 2009, INT J OBESITY, V33, pS82, DOI 10.1038/ijo.2009.23; Nixon GM, 2008, SLEEP, V31, P71, DOI 10.1093/sleep/31.1.71; Ogden CL, 2010, JAMA-J AM MED ASSOC, V303, P242, DOI 10.1001/jama.2009.2012; Padez C, 2009, AM J HUM BIOL, V21, P371, DOI 10.1002/ajhb.20884; Patel SR, 2009, OBES REV, V10, P61, DOI 10.1111/j.1467-789X.2009.00664.x; Patel SR, 2008, OBESITY, V16, P643, DOI 10.1038/oby.2007.118; Pfeiffer KA, 2006, MED SCI SPORT EXER, V38, P152, DOI 10.1249/01.mss.0000183219.44127.e7; Puyau MR, 2004, MED SCI SPORT EXER, V36, P1625, DOI 10.1249/01.MSS.0000139898.30804.60; Reilly JJ, 2005, BMJ-BRIT MED J, V330, P1357, DOI 10.1136/bmj.38470.670903.E0; Roche A., 1996, HUMAN BODY COMPOSITI, P167; Rose G., 1992, STRATEGY PREVENTIVE; Sadeh A, 2002, SLEEP MED REV, V6, P113, DOI 10.1053/smrv.2001.0182; Sadeh A, 2008, J PEDIATR PSYCHOL, V33, P406, DOI 10.1093/jpepsy/jsn018; Sadeh A, 2009, SLEEP, V32, P1602, DOI 10.1093/sleep/32.12.1602; Sazonov E, 2004, PHYSIOL MEAS, V25, P1291, DOI 10.1088/0967-3334/25/5/018; Snell EK, 2007, CHILD DEV, V78, P309, DOI 10.1111/j.1467-8624.2007.00999.x; Sugimori H, 2004, PEDIATR INT, V46, P302, DOI 10.1111/j.1442-200x.2004.01895.x; Sundblom E, 2008, INT J OBESITY, V32, P1525, DOI 10.1038/ijo.2008.104; Swartz AM, 2000, MED SCI SPORT EXER, V32, pS450, DOI 10.1097/00005768-200009001-00003; Taveras EM, 2008, ARCH PEDIAT ADOL MED, V162, P305, DOI 10.1001/archpedi.162.4.305; Taylor RW, 2007, AM J CLIN NUTR, V86, P735, DOI 10.1093/ajcn/86.3.735; Taylor RW, 2009, MED SCI SPORT EXER, V41, P96, DOI 10.1249/MSS.0b013e3181849d81; Taylor RW, 2002, AM J CLIN NUTR, V76, P1416, DOI 10.1093/ajcn/76.6.1416; Touchette E, 2008, SLEEP, V31, P1507, DOI 10.1093/sleep/31.11.1507; von Kries R, 2002, INT J OBESITY, V26, P710, DOI 10.1038/sj.ijo.0801980; Wells JCK, 1999, AM J CLIN NUTR, V69, P904; Yu YX, 2007, SLEEP, V30, P1688, DOI 10.1093/sleep/30.12.1688	48	124	131	0	21	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 26	2011	342								d2712	10.1136/bmj.d2712	http://dx.doi.org/10.1136/bmj.d2712			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	771KG	21622518	hybrid, Green Published			2022-12-24	WOS:000291155000002
J	McCartney, M				McCartney, Margaret			MEDICINE AND THE MEDIA What GPs know about asthma	BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358					0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 18	2011	342								d2972	10.1136/bmj.d2972	http://dx.doi.org/10.1136/bmj.d2972			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	768QQ	21593089				2022-12-24	WOS:000290951900005
J	Smith, J; Lipsitch, M; Almond, JW				Smith, Jon; Lipsitch, Marc; Almond, Jeffrey W.			New Decade of Vaccines 3 Vaccine production, distribution, access, and uptake	LANCET			English	Article							INFLUENZA VACCINE; PANDEMIC INFLUENZA; VIRUS; PROTECTION; EPIDEMIC; SPREAD; INTERVENTIONS; STRATEGIES; MORTALITY; PERTUSSIS	For human vaccines to be available on a global scale, complex production methods, meticulous quality control, and reliable distribution channels are needed to ensure that the products are potent and effective at the point of use. The technologies used to manufacture different types of vaccines can strongly affect vaccine cost, ease of industrial scale-up, stability, and, ultimately, worldwide availability. The complexity of manufacturing is compounded by the need for different formulations in different countries and age-groups. Reliable vaccine production in appropriate quantities and at affordable prices is the cornerstone of developing global vaccination policies. However, to ensure, optimum access and uptake, strong partnerships are needed between private manufacturers, regulatory authorities, and national and international public health services. For vaccines whose supply is insufficient to meet demand, prioritisation of target groups can increase the effect of these vaccines. In this report, we draw from our experience of vaccine development and focus on influenza vaccines as an example to consider production, distribution, access, and other factors that affect vaccine uptake and population-level effectiveness.	[Smith, Jon; Almond, Jeffrey W.] Sanofi Pasteur, F-69280 Marcy Letoile, France; [Lipsitch, Marc] Harvard Univ, Sch Publ Hlth, Ctr Communicable Dis Dynam, Dept Epidemiol, Boston, MA 02115 USA; [Lipsitch, Marc] Harvard Univ, Sch Publ Hlth, Ctr Communicable Dis Dynam, Dept Immunol & Infect Dis, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Almond, JW (corresponding author), Sanofi Pasteur, 1541 Ave Marcel Merieux, F-69280 Marcy Letoile, France.	jeffrey.almond@sanofipasteur.com		Lipsitch, Marc/0000-0003-1504-9213	National Institute of General Medical Sciences [U54GM088558]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM088558] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	ML's work on this report was supported by the National Institute of General Medical Sciences (award number U54GM088558). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of General Medical Sciences or the National Institutes of Health.	Abramson JS, 2000, PEDIATRICS, V106, P362; Allgaier S, 2009, BIOLOGICALS, V37, P128, DOI 10.1016/j.biologicals.2009.02.006; Almond JW, 2007, NAT REV MICROBIOL, V5, P478, DOI 10.1038/nrmicro1702; ANDERSON R M, 1991; Andreasen V, 2008, J INFECT DIS, V197, P270, DOI 10.1086/524065; [Anonymous], 2011, US PHARM NAT FORM 20, P3132; [Anonymous], 2011, US PHARM NAT FORM 20, P4377; [Anonymous], 2009, GLOB AL RESP PAND H1; [Anonymous], 2011, US PHARM NAT FORM 20, P3384; [Anonymous], WHO GLOB INFL SURV N; [Anonymous], 2011, US PHARM NAT FORM 20, P3570; [Anonymous], 2011, US PHARM NAT FORM 20, P3949; [Anonymous], 2011, US PHARM NAT FORM 20, P1993; [Anonymous], 2011, US PHARM NAT FORM 20, P4187; Barrett PN, 2009, EXPERT REV VACCINES, V8, P607, DOI [10.1586/erv.09.19, 10.1586/ERV.09.19]; Cassone A, 2010, MBIO, V1, DOI 10.1128/mBio.00042-10; D'Aoust MA, 2010, PLANT BIOTECHNOL J, V8, P607, DOI 10.1111/j.1467-7652.2009.00496.x; Doroshenko A, 2009, EXPERT REV VACCINES, V8, P679, DOI 10.1586/ERV.09.31; Dushoff J, 2007, PLOS MED, V4, P921, DOI 10.1371/journal.pmed.0040174; European Agency for the Evaluation of Medicinal Products (EMEA), CPMPBWP21496 EUR AG; European Council, COMM PROC AUTH SUP M; European Medicines Agency, EMEACPMPVEG47172003R; European Medicines Agency, ANN 1 SUMM PROD CHAR; Fedson DS, 2005, J PUBLIC HEALTH POL, V26, P4, DOI 10.1057/palgrave.jphp.3200008; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Fidler DP, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000247; Fraser C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000758; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; G-Con, 2010, TEX BAS CONS ANN PRO; GAVI Alliance, WHAT YOU CAN APPL; GAVI Alliance, KEY IND MEAS ALL PRO; GAVI Alliance, INN FIN; GAVI Alliance, FACTS FIG; GAVI Alliance, EL COUNTR; GAVI Alliance, INV IMM GAVI ALL EV; Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103; Goldstein E, 2010, J R SOC INTERFACE, V7, P755, DOI 10.1098/rsif.2009.0393; Goldstein E, 2009, MATH BIOSCI, V221, P11, DOI 10.1016/j.mbs.2009.06.002; Ivers LC, 2010, LANCET, V376, P2048, DOI 10.1016/S0140-6736(10)62243-X; Kahn JA, 2009, NEW ENGL J MED, V361, P271, DOI 10.1056/NEJMct0806938; Keyserling H, 2005, ARCH PEDIAT ADOL MED, V159, P907, DOI 10.1001/archpedi.159.10.907; Koudstaal W, 2009, VACCINE, V27, P2588, DOI 10.1016/j.vaccine.2009.02.033; Lessler J, 2010, EPIDEMICS-NETH, V2, P132, DOI 10.1016/j.epidem.2010.07.001; Levine OS, 2011, LANCET, V378, P439, DOI 10.1016/S0140-6736(11)60406-6; Lipsitch M, 1999, EMERG INFECT DIS, V5, P336, DOI 10.3201/eid0503.990304; Loeb M, 2010, JAMA-J AM MED ASSOC, V303, P943, DOI 10.1001/jama.2010.250; Longini IM, 2005, AM J EPIDEMIOL, V161, P303, DOI 10.1093/aje/kwi053; McNeil C, 2006, J NATL CANCER I, V98, P433, DOI 10.1093/jnci/djj144; Meghrous J, 2009, VACCINE, V28, P309, DOI 10.1016/j.vaccine.2009.10.048; Mills CE, 2004, NATURE, V432, P904, DOI 10.1038/nature03063; Minor PD, 2009, VACCINE, V27, P2907, DOI 10.1016/j.vaccine.2009.02.064; Modlin JF, 2010, NEW ENGL J MED, V362, P2346, DOI 10.1056/NEJMp1005405; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Moxon ER, 2011, LANCET, V378, P348, DOI 10.1016/S0140-6736(11)60407-8; Nabel GJ, 2010, NAT MED, V16, P1389, DOI 10.1038/nm1210-1389; NIELSEN A, 1994, INT J EPIDEMIOL, V23, P1300, DOI 10.1093/ije/23.6.1300; Nishiura H, 2009, EUROSURVEILLANCE, V14; Novavax, RES DEV PROGR; Pan American Health Organization, 2006, POL ER FIELD GUID; Simonsen L, 1998, J INFECT DIS, V178, P53, DOI 10.1086/515616; Simonsen L, 2007, LANCET INFECT DIS, V7, P658, DOI 10.1016/S1473-3099(07)70236-0; SLEPUSHKIN VA, 1995, VACCINE, V13, P1399, DOI 10.1016/0264-410X(95)92777-Y; Song JM, 2011, P NATL ACAD SCI USA, V108, P757, DOI 10.1073/pnas.1012199108; Steel J, 2010, MBIO, V1, DOI 10.1128/mBio.00018-10; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Thompson WW, 2009, INFLUENZA OTHER RESP, V3, P37, DOI 10.1111/j.1750-2659.2009.00073.x; UK Health Protection Agency, ROUT CHILDH IMM SCHE; UNICEF, SUPPL LOG GAVI; US Centers for Disease Control and Prevention, IMM SCHED; Waldor MK, 2010, NEW ENGL J MED, V363, P2279, DOI 10.1056/NEJMp1012300; Wallinga J, 2010, P NATL ACAD SCI USA, V107, P923, DOI 10.1073/pnas.0908491107; Wang TT, 2010, P NATL ACAD SCI USA, V107, P18979, DOI 10.1073/pnas.1013387107; Ward JI, 2005, NEW ENGL J MED, V353, P1555, DOI 10.1056/NEJMoa050824; Weinberger DM, 2011, LANCET, V378, P1962, DOI 10.1016/S0140-6736(10)62225-8; White LF, 2009, INFLUENZA OTHER RESP, V3, P267, DOI 10.1111/j.1750-2659.2009.00106.x; WHO, GLOB AL RESP CONF HU; WHO, 2006, UN PREQ VACC WHO LIS; WHO, WHO AFR RG ROUT EPI; WHO, 2009, UPD H1N1 PAND SEAS V; WHO, CHOL FACT SHEET; WHO, SYST PREQ VACC UN SU; Wolfson LJ, 2008, B WORLD HEALTH ORGAN, V86, P27, DOI 10.2471/BLT.07.045096	83	54	55	0	18	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL-AUG	2011	378	9789					428	438		10.1016/S0140-6736(11)60478-9	http://dx.doi.org/10.1016/S0140-6736(11)60478-9			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	803XM	21664680	Green Accepted			2022-12-24	WOS:000293615900034
J	Bonaguidi, MA; Wheeler, MA; Shapiro, JS; Stadel, RP; Sun, GJ; Ming, GL; Song, HJ				Bonaguidi, Michael A.; Wheeler, Michael A.; Shapiro, Jason S.; Stadel, Ryan P.; Sun, Gerald J.; Ming, Guo-li; Song, Hongjun			In Vivo Clonal Analysis Reveals Self-Renewing and Multipotent Adult Neural Stem Cell Characteristics	CELL			English	Article							RADIAL GLIAL-CELLS; HIPPOCAMPAL NEUROGENESIS; SUBVENTRICULAR ZONE; NEURONS; ASTROCYTES; LINEAGE; PTEN; QUIESCENT; DIFFERENTIATION; PROGENITOR	Neurogenesis and gliogenesis continue in discrete regions of the adult mammalian brain. A fundamental question remains whether cell genesis occurs from distinct lineage-restricted progenitors or from self-renewing and multipotent neural stem cells in the adult brain. Here, we developed a genetic marking strategy for lineage tracing of individual, quiescent, and nestin-expressing radial glia-like (RGL) precursors in the adult mouse dentate gyrus. Clonal analysis identified multiple modes of RGL activation, including asymmetric and symmetric self-renewal. Long-term lineage tracing in vivo revealed a significant percentage of clones that contained RGL(s), neurons, and astrocytes, indicating capacity of individual RGLs for both self-renewal and multilineage differentiation. Furthermore, conditional Pten deletion in RGLs initially promotes their activation and symmetric self-renewal but ultimately leads to terminal astrocytic differentiation and RGL depletion in the adult hippocampus. Our study identifies RGLs as self-renewing and multipotent neural stem cells and provides novel insights into in vivo properties of adult neural stem cells.	[Bonaguidi, Michael A.; Wheeler, Michael A.; Shapiro, Jason S.; Stadel, Ryan P.; Sun, Gerald J.; Ming, Guo-li; Song, Hongjun] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21205 USA; [Bonaguidi, Michael A.; Ming, Guo-li; Song, Hongjun] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Stadel, Ryan P.; Song, Hongjun] Johns Hopkins Univ, Sch Med, Human Genet Predoctoral Training Program, Baltimore, MD 21205 USA; [Sun, Gerald J.; Ming, Guo-li; Song, Hongjun] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Ming, GL (corresponding author), Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21205 USA.	gming1@jhmi.edu; shongju1@jhmi.edu	Ming, Guo-li/J-7880-2013	Ming, Guo-li/0000-0002-2517-6075	NIH [NS047344, AG024984, NS048271, HD069184]; NARSAD; MSCRF; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD069184] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS047344, R01NS047344, R01NS048271, R56NS047344] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG024984] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NARSAD(NARSAD); MSCRF; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank D. Lee and members of Song and Ming laboratories for discussion; G. Fishell for sharing nestin-CreER<SUP>T2</SUP> mice; L. DeBiase for NG2 antibodies; J. Song, S. Danzer, C. Song, Y. Namgung, X. Duan and K. Sailor for help; and Q. Hussaini, Y. Cai, and L. Liu for technical support. This work was supported by grants from NIH (NS047344, AG024984) and NARSAD to H. S. and from NIH (NS048271, HD069184) and MSCRF to G.-l. M. M. A. B. was a MSCRF fellow.	ALTMAN J, 1965, NATURE, V207, P953, DOI 10.1038/207953a0; Balordi F, 2007, J NEUROSCI, V27, P14248, DOI 10.1523/JNEUROSCI.4531-07.2007; BRONNERFRASER M, 1991, DEVELOPMENT, P17; Brunne B, 2010, GLIA, V58, P1553, DOI 10.1002/glia.21029; Carlen M, 2009, NAT NEUROSCI, V12, P259, DOI 10.1038/nn.2268; DAVIS AA, 1994, NATURE, V372, P263, DOI 10.1038/372263a0; Dhaliwal J, 2011, EUR J NEUROSCI, V33, P1025, DOI 10.1111/j.1460-9568.2011.07600.x; Doe CQ, 2008, DEVELOPMENT, V135, P1575, DOI 10.1242/dev.014977; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Encinas JM, 2011, CELL STEM CELL, V8, P566, DOI 10.1016/j.stem.2011.03.010; Gabay L, 2003, NEURON, V40, P485, DOI 10.1016/S0896-6273(03)00637-8; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Gregorian C, 2009, J NEUROSCI, V29, P1874, DOI 10.1523/JNEUROSCI.3095-08.2009; Hill R, 2009, J BIOL CHEM, V284, P11755, DOI 10.1074/jbc.R800071200; Kang SH, 2010, NEURON, V68, P668, DOI 10.1016/j.neuron.2010.09.009; Kim JY, 2009, NEURON, V63, P761, DOI 10.1016/j.neuron.2009.08.008; Kondo T, 2000, SCIENCE, V289, P1754, DOI 10.1126/science.289.5485.1754; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Li LH, 2005, ANNU REV CELL DEV BI, V21, P605, DOI 10.1146/annurev.cellbio.21.012704.131525; Li LH, 2010, SCIENCE, V327, P542, DOI 10.1126/science.1180794; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; Lugert S, 2010, CELL STEM CELL, V6, P445, DOI 10.1016/j.stem.2010.03.017; Ma DK, 2009, CELL RES, V19, P672, DOI 10.1038/cr.2009.56; Maslov AY, 2004, J NEUROSCI, V24, P1726, DOI 10.1523/JNEUROSCI.4608-03.2004; Merkle FT, 2007, SCIENCE, V317, P381, DOI 10.1126/science.1144914; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Morshead CM, 1998, DEVELOPMENT, V125, P2251; MORSHEAD CM, 1994, NEURON, V13, P1071, DOI 10.1016/0896-6273(94)90046-9; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Palmer TD, 1999, J NEUROSCI, V19, P8487; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; SANES JR, 1986, EMBO J, V5, P3133, DOI 10.1002/j.1460-2075.1986.tb04620.x; Seri B, 2001, J NEUROSCI, V21, P7153, DOI 10.1523/JNEUROSCI.21-18-07153.2001; Sierra A, 2010, CELL STEM CELL, V7, P483, DOI 10.1016/j.stem.2010.08.014; Snippert HJ, 2011, EMBO REP, V12, P113, DOI 10.1038/embor.2010.216; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Steiner B, 2004, GLIA, V46, P41, DOI 10.1002/glia.10337; Suh H, 2007, CELL STEM CELL, V1, P515, DOI 10.1016/j.stem.2007.09.002; Temple S, 2001, NATURE, V414, P112, DOI 10.1038/35102174; TURNER DL, 1987, NATURE, V328, P131, DOI 10.1038/328131a0; Weissman IL, 2001, ANNU REV CELL DEV BI, V17, P387, DOI 10.1146/annurev.cellbio.17.1.387; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; Zhang JW, 2006, NATURE, V441, P518, DOI 10.1038/nature04747; Zong H, 2005, CELL, V121, P479, DOI 10.1016/j.cell.2005.02.012	48	565	586	2	51	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 24	2011	145	7					1142	1155		10.1016/j.cell.2011.05.024	http://dx.doi.org/10.1016/j.cell.2011.05.024			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	782QV	21664664	Green Accepted, Bronze			2022-12-24	WOS:000292025700019
J	Unal, E; Kinde, B; Amon, A				Unal, Elcin; Kinde, Benyam; Amon, Angelika			Gametogenesis Eliminates Age-Induced Cellular Damage and Resets Life Span in Yeast	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; BUDDING YEAST; MEIOSIS-I; PROTEIN; GENE; MUTANTS; SEGREGATION; DIVISION; NDT80; RDNA	Eukaryotic organisms age, yet detrimental age-associated traits are not passed on to progeny. How life span is reset from one generation to the next is not known. We show that in budding yeast resetting of life span occurs during gametogenesis. Gametes (spores) generated by aged cells show the same replicative potential as gametes generated by young cells. Age-associated damage is no longer detectable in mature gametes. Furthermore, transient induction of a transcription factor essential for later stages of gametogenesis extends the replicative life span of aged cells. Our results indicate that gamete formation brings about rejuvenation by eliminating age-induced cellular damage.	[Unal, Elcin; Amon, Angelika] MIT, David H Koch Inst Integrat Canc Res, Howard Hughes Med Inst, Cambridge, MA 02139 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Amon, A (corresponding author), MIT, David H Koch Inst Integrat Canc Res, Howard Hughes Med Inst, E76-543,500 Main St, Cambridge, MA 02139 USA.	angelika@mit.edu		Amon, Angelika/0000-0001-9837-0314; Unal, Elcin/0000-0002-6768-609X	NIH [GM62207]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056800, R01GM062207] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank B. Alpert, M. Boselli, A. Thompson, and J. Chen for technical help; D. Koshland for reagents; and T. Orr-Weaver, F. Solomon, and members of the Amon laboratory for comments on the manuscript. Research was supported by NIH grant GM62207 to A.A. A.A. is also an HHMI investigator. E.U. is a fellow of the Jane Coffin Childs Memorial Fund. The authors declare no competing financial interests.	Benjamin KR, 2003, GENE DEV, V17, P1524, DOI 10.1101/gad.1101503; Boselli M, 2009, DEV CELL, V16, P844, DOI 10.1016/j.devcel.2009.05.013; Carlile TM, 2008, CELL, V133, P280, DOI 10.1016/j.cell.2008.02.032; Chu S, 1998, SCIENCE, V282, P699, DOI 10.1126/science.282.5389.699; Chu S, 1998, MOL CELL, V1, P685, DOI 10.1016/S1097-2765(00)80068-4; Curran SP, 2009, NATURE, V459, P1079, DOI 10.1038/nature08106; Erjavec N, 2007, GENE DEV, V21, P2410, DOI 10.1101/gad.439307; Fuchs J, 2004, CHROMOSOME RES, V12, P427, DOI 10.1023/B:CHRO.0000034726.05374.db; Ganley ARD, 2009, MOL CELL, V35, P683, DOI 10.1016/j.molcel.2009.07.012; Jaskelioff M, 2011, NATURE, V469, P102, DOI 10.1038/nature09603; KASSIR Y, 1988, CELL, V52, P853, DOI 10.1016/0092-8674(88)90427-8; KLAPHOLZ S, 1980, GENETICS, V96, P567; Kobayashi T, 1996, GENES CELLS, V1, P465, DOI 10.1046/j.1365-2443.1996.d01-256.x; Lee BH, 2003, SCIENCE, V300, P482, DOI 10.1126/science.1081846; Lee DH, 1996, J BIOL CHEM, V271, P27280, DOI 10.1074/jbc.271.44.27280; LENZ AG, 1984, ARCH MICROBIOL, V137, P104, DOI 10.1007/BF00414448; Liu BD, 2010, CELL, V140, P257, DOI 10.1016/j.cell.2009.12.031; Nachman I, 2007, CELL, V131, P544, DOI 10.1016/j.cell.2007.09.044; Neiman AM, 2005, MICROBIOL MOL BIOL R, V69, P565, DOI 10.1128/MMBR.69.4.565-584.2005; Scherthan H, 2007, P NATL ACAD SCI USA, V104, P16934, DOI 10.1073/pnas.0704860104; Sinclair D, 1998, ANNU REV MICROBIOL, V52, P533, DOI 10.1146/annurev.micro.52.1.533; Sinclair DA, 1997, CELL, V91, P1033, DOI 10.1016/S0092-8674(00)80493-6; Sinclair DA, 1997, SCIENCE, V277, P1313, DOI 10.1126/science.277.5330.1313; Smeal T, 1996, CELL, V84, P633, DOI 10.1016/S0092-8674(00)81038-7; XU LZ, 1995, MOL CELL BIOL, V15, P6572	25	85	87	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 24	2011	332	6037					1554	1557		10.1126/science.1204349	http://dx.doi.org/10.1126/science.1204349			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782EE	21700873	Green Submitted, Green Accepted			2022-12-24	WOS:000291990000044
J	Lebon, G; Warne, T; Edwards, PC; Bennett, K; Langmead, CJ; Leslie, AGW; Tate, CG				Lebon, Guillaume; Warne, Tony; Edwards, Patricia C.; Bennett, Kirstie; Langmead, Christopher J.; Leslie, Andrew G. W.; Tate, Christopher G.			Agonist-bound adenosine A(2A) receptor structures reveal common features of GPCR activation	NATURE			English	Article							PROTEIN-COUPLED RECEPTORS; CRYSTAL-STRUCTURE; BINDING; THERMOSTABILIZATION; STABILITY; RHODOPSIN; MODELS	Adenosine receptors and beta-adrenoceptors are G-protein-coupled receptors (GPCRs) that activate intracellular G proteins on binding the agonists adenosine(1) or noradrenaline(2), respectively. GPCRs have similar structures consisting of seven transmembrane helices that contain well-conserved sequence motifs, indicating that they are probably activated by a common mechanism(3,4). Recent structures of beta-adrenoceptors highlight residues in transmembrane region 5 that initially bind specifically to agonists rather than to antagonists, indicating that these residues have an important role in agonist-induced activation of receptors(5-7). Here we present two crystal structures of the thermostabilized human adenosine A(2A) receptor (A(2A)R-GL31) bound to its endogenous agonist adenosine and the synthetic agonist NECA. The structures represent an intermediate conformation between the inactive and active states, because they share all the features of GPCRs that are thought to be in a fully activated state, except that the cytoplasmic end of transmembrane helix 6 partially occludes the G-protein-binding site. The adenine substituent of the agonists binds in a similar fashion to the chemically related region of the inverse agonist ZM241385 (ref. 8). Both agonists contain a ribose group, not found in ZM241385, which extends deep into the ligand-binding pocket where it makes polar interactions with conserved residues in H7 (Ser 277(7.42) and His 278(7.43); superscripts refer to Ballesteros-Weinstein numbering(9)) and non-polar interactions with residues in H3. In contrast, the inverse agonist ZM241385 does not interact with any of these residues and comparison with the agonist-bound structures indicates that ZM241385 sterically prevents the conformational change in H5 and therefore it acts as an inverse agonist. Comparison of the agonist-bound structures of A(2A)R with the agonist-bound structures of beta-adrenoceptors indicates that the contraction of the ligand-binding pocket caused by the inward motion of helices 3, 5 and 7 may be a common feature in the activation of all GPCRs.	[Lebon, Guillaume; Warne, Tony; Edwards, Patricia C.; Leslie, Andrew G. W.; Tate, Christopher G.] MRC, Mol Biol Lab, Cambridge CB2 0QH, England; [Bennett, Kirstie; Langmead, Christopher J.] BioPark, Heptares Therapeut, Welwyn Garden City AL7 3AX, Herts, England	MRC Laboratory Molecular Biology; Heptares Therapeutics Ltd.	Tate, CG (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 0QH, England.	cgt@mrc-lmb.cam.ac.uk	Lebon, Guillaume/AAZ-4486-2020	Tate, Christopher/0000-0002-2008-9183; Guillaume, Lebon/0000-0003-1162-5148; Langmead, Christopher/0000-0003-3483-1120; Warne, Tony/0000-0001-9646-6080	Medical Research Council; Heptares Therapeutics Ltd; Biotechnology and Biological Sciences Research Council [BB/G003653/1]; Medical Research Council [MC_U105197215, MC_U105184325] Funding Source: researchfish; BBSRC [BB/G003653/1] Funding Source: UKRI; MRC [MC_U105197215, MC_U105184325] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Heptares Therapeutics Ltd; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by core funding from the Medical Research Council, and grants from Heptares Therapeutics Ltd and from the Biotechnology and Biological Sciences Research Council (BB/G003653/1). We would like to thank F. Magnani for technical help at the start of the project and F. Gorrec for developing the crystallization screen. We also thank the beamline staff at the European Synchrotron Radiation Facility, particularly at (beamline ID23-2; D. Flot and A. Popov), the Swiss Light Source (beamline X06SA) and at the Diamond Light Source (beamline I24; G. Evans, D. Axford and R. Owen). F. Marshall, M. Weir, M. Congreve and R. Henderson are thanked for their comments on the manuscript.	Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Chien EYT, 2010, SCIENCE, V330, P1091, DOI 10.1126/science.1197410; Dal Ben D, 2010, CURR TOP MED CHEM, V10, P993, DOI 10.2174/156802610791293145; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans BA, 2010, BRIT J PHARMACOL, V159, P1022, DOI 10.1111/j.1476-5381.2009.00602.x; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fredholm BB, 2011, PHARMACOL REV, V63, P1, DOI 10.1124/pr.110.003285; Gorrec F, 2011, ACTA CRYSTALLOGR D, V67, P463, DOI 10.1107/S0907444911008754; Hofmann KP, 2009, TRENDS BIOCHEM SCI, V34, P540, DOI 10.1016/j.tibs.2009.07.005; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kim SK, 2003, J MED CHEM, V46, P4847, DOI 10.1021/jm0300431; Kobilka BK, 2007, TRENDS PHARMACOL SCI, V28, P397, DOI 10.1016/j.tips.2007.06.003; Lebon G, 2011, J MOL BIOL, V409, P298, DOI 10.1016/j.jmb.2011.03.075; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Li J, 2004, J MOL BIOL, V343, P1409, DOI 10.1016/j.jmb.2004.08.090; Magnani F, 2008, P NATL ACAD SCI USA, V105, P10744, DOI 10.1073/pnas.0804396105; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; Murphree LJ, 2002, MOL PHARMACOL, V61, P455, DOI 10.1124/mol.61.2.455; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Robertson N, 2011, NEUROPHARMACOLOGY, V60, P36, DOI 10.1016/j.neuropharm.2010.07.001; Rosenbaum DM, 2011, NATURE, V469, P236, DOI 10.1038/nature09665; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; SCHAFFNE.W, 1973, ANAL BIOCHEM, V56, P502, DOI 10.1016/0003-2697(73)90217-0; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Serrano-Vega MJ, 2008, P NATL ACAD SCI USA, V105, P877, DOI 10.1073/pnas.0711253105; Shibata Y, 2009, J MOL BIOL, V390, P262, DOI 10.1016/j.jmb.2009.04.068; Vauquelin G, 2005, FUND CLIN PHARMACOL, V19, P45, DOI 10.1111/j.1472-8206.2005.00319.x; Wacker D, 2010, J AM CHEM SOC, V132, P11443, DOI 10.1021/ja105108q; Warne T, 2003, BBA-BIOMEMBRANES, V1610, P133, DOI 10.1016/S0005-2736(02)00716-2; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Warne T, 2011, NATURE, V469, P241, DOI 10.1038/nature09746; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Xu F., 2011, SCIENCE; Yao XJ, 2009, P NATL ACAD SCI USA, V106, P9501, DOI 10.1073/pnas.0811437106	44	644	657	1	130	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 23	2011	474	7352					521	U154		10.1038/nature10136	http://dx.doi.org/10.1038/nature10136			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	781NJ	21593763	Green Accepted			2022-12-24	WOS:000291939700051
J	Oakhill, JS; Steel, R; Chen, ZP; Scott, JW; Ling, N; Tam, S; Kemp, BE				Oakhill, Jonathan S.; Steel, Rohan; Chen, Zhi-Ping; Scott, John W.; Ling, Naomi; Tam, Shanna; Kemp, Bruce E.			AMPK Is a Direct Adenylate Charge-Regulated Protein Kinase	SCIENCE			English	Article							NUCLEAR-MAGNETIC-RESONANCE; ACETYL-COA CARBOXYLASE; SKELETAL-MUSCLE; ENERGY-CHARGE; 3-HYDROXY-3-METHYLGLUTARYL-COA REDUCTASE; ADP; PHOSPHORYLATION; INACTIVATION; METABOLISM; EXERCISE	The adenosine monophosphate (AMP)-activated protein kinase (AMPK) regulates whole-body and cellular energy balance in response to energy demand and supply. AMPK is an alpha beta gamma heterotrimer activated by decreasing concentrations of adenosine triphosphate (ATP) and increasing AMP concentrations. AMPK activation depends on phosphorylation of the alpha catalytic subunit on threonine-172 (Thr(172)) by kinases LKB1 or CaMKK beta, and this is promoted by AMP binding to the gamma subunit. AMP sustains activity by inhibiting dephosphorylation of alpha-Thr(172), whereas ATP promotes dephosphorylation. Adenosine diphosphate (ADP), like AMP, bound to gamma sites 1 and 3 and stimulated alpha-Thr(172) phosphorylation. However, in contrast to AMP, ADP did not directly activate phosphorylated AMPK. In this way, both ADP/ATP and AMP/ATP ratios contribute to AMPK regulation.	[Oakhill, Jonathan S.; Steel, Rohan; Chen, Zhi-Ping; Scott, John W.; Ling, Naomi; Tam, Shanna; Kemp, Bruce E.] Univ Melbourne, St Vincents Inst Med Res, Dept Prot Chem & Metab, Fitzroy, Vic 3065, Australia	St. Vincent's Institute of Medical Research; University of Melbourne	Oakhill, JS (corresponding author), Univ Melbourne, St Vincents Inst Med Res, Dept Prot Chem & Metab, 41 Victoria Parade, Fitzroy, Vic 3065, Australia.	joakhill@svi.edu.au	Scott, John W/AAA-2676-2021; Kemp, Bruce/G-9602-2019; Oakhill, Jonathan S/F-5724-2011; Kemp, Bruce E/L-2633-2014; Scott, John W/P-1170-2018	Scott, John W/0000-0002-1896-9798; Kemp, Bruce/0000-0001-6735-5082; Oakhill, Jonathan S/0000-0002-9475-1440; Kemp, Bruce E/0000-0001-6735-5082; Scott, John W/0000-0002-1896-9798; /0000-0002-0423-6120; Ling, Naomi/0000-0001-6240-4092	Australian Research Council; National Health and Medical Research Council (NHMRC); Victorian Government	Australian Research Council(Australian Research Council); National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government	We thank F. Katsis for the preparation of antibodies and L. Macaulay at Commonwealth Scientific and Industrial Research Organisation Parkville, Victoria, Australia, for CaMKK beta expression constructs. We are most grateful to S. Gamblin and D. Carling and their colleagues at Medical Research Council National Institute of Medical Research and Hammersmith Hospital, respectively, for generously sharing with us the observation that ADP inhibited the dephosphorylation of AMPK by PP2c (30), which prompted us to test whether ADP also controlled the kinase kinase reaction. This work was supported by grants from the Australian Research Council, the National Health and Medical Research Council (NHMRC), and the Victorian Government Operational Infrastructure Support Scheme. B. E. K. is an NHMRC Fellow.	ADAMS JA, 1992, BIOCHEMISTRY-US, V31, P8516, DOI 10.1021/bi00151a019; Atkinson D E, 1979, Methods Enzymol, V55, P229; ATKINSON DE, 1968, BIOCHEMISTRY-US, V7, P4030, DOI 10.1021/bi00851a033; BROWN MS, 1975, J BIOL CHEM, V250, P2502; CARLING D, 1989, EUR J BIOCHEM, V186, P129, DOI 10.1111/j.1432-1033.1989.tb15186.x; Davies SP, 1995, FEBS LETT, V377, P421, DOI 10.1016/0014-5793(95)01368-7; DAWSON MJ, 1978, NATURE, V274, P861, DOI 10.1038/274861a0; Hancock CR, 2005, AM J PHYSIOL-CELL PH, V288, pC1298, DOI 10.1152/ajpcell.00621.2004; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hardie DG, 2001, BIOESSAYS, V23, P1112, DOI 10.1002/bies.10009; HARDIE DG, 1989, TRENDS BIOCHEM SCI, V14, P20; HARWOOD HJ, 1984, J BIOL CHEM, V259, P2810; JANSSON E, 1987, CLIN PHYSIOL, V7, P337, DOI 10.1111/j.1475-097X.1987.tb00177.x; Jin XS, 2007, STRUCTURE, V15, P1285, DOI 10.1016/j.str.2007.07.017; KREBS H, 1964, PROC R SOC SER B-BIO, V159, P545, DOI 10.1098/rspb.1964.0019; KUSHMERICK MJ, 1992, P NATL ACAD SCI USA, V89, P7521, DOI 10.1073/pnas.89.16.7521; MEYER RA, 1985, AM J PHYSIOL, V248, pC279, DOI 10.1152/ajpcell.1985.248.3.C279; MEYER RA, 1979, AM J PHYSIOL, V237, pC111, DOI 10.1152/ajpcell.1979.237.3.C111; Oakhill JS, 2010, P NATL ACAD SCI USA, V107, P19237, DOI 10.1073/pnas.1009705107; SAHLIN K, 1989, ACTA PHYSIOL SCAND, V136, P193, DOI 10.1111/j.1748-1716.1989.tb08652.x; SERAYDARIAN K, 1962, BIOCHIM BIOPHYS ACTA, V65, P443, DOI 10.1016/0006-3002(62)90447-X; SHERBAN DG, 1985, J BIOL CHEM, V260, P2579; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; Townley R, 2007, SCIENCE, V315, P1726, DOI 10.1126/science.1137503; Xiao B, 2007, NATURE, V449, P496, DOI 10.1038/nature06161; Xiao B, 2011, NATURE, V472, P230, DOI 10.1038/nature09932; YEH LA, 1980, J BIOL CHEM, V255, P2308	27	403	428	5	77	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 17	2011	332	6036					1433	1435		10.1126/science.1200094	http://dx.doi.org/10.1126/science.1200094			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778FT	21680840				2022-12-24	WOS:000291689000042
J	Thomson, M; Liu, SJ; Zou, LN; Smith, Z; Meissner, A; Ramanathan, S				Thomson, Matt; Liu, Siyuan John; Zou, Ling-Nan; Smith, Zack; Meissner, Alexander; Ramanathan, Sharad			Pluripotency Factors in Embryonic Stem Cells Regulate Differentiation into Germ Layers	CELL			English	Article							SELF-RENEWAL; ES CELLS; MOUSE EPIBLAST; NEURAL DIFFERENTIATION; IN-VITRO; FATE; SOX2; EXPRESSION; NETWORK; COMPLEX	Cell fate decisions are fundamental for development, but we do not know how transcriptional networks reorganize during the transition from a pluripotent to a differentiated cell state. Here, we asked how mouse embryonic stem cells (ESCs) leave the pluripotent state and choose between germ layer fates. By analyzing the dynamics of the transcriptional circuit that maintains pluripotency, we found that Oct4 and Sox2, proteins that maintain ESC identity, also orchestrate germ layer fate selection. Oct4 suppresses neural ectodermal differentiation and promotes mesendodermal differentiation; Sox2 inhibits mesendodermal differentiation and promotes neural ectodermal differentiation. Differentiation signals continuously and asymmetrically modulate Oct4 and Sox2 protein levels, altering their binding pattern in the genome, and leading to cell fate choice. The same factors that maintain pluripotency thus also integrate external signals and control lineage selection. Our study provides a framework for understanding how complex transcription factor networks control cell fate decisions in progenitor cells.	[Thomson, Matt; Liu, Siyuan John; Zou, Ling-Nan; Ramanathan, Sharad] Harvard Univ, FAS Ctr Syst Biol, Cambridge, MA 02138 USA; [Thomson, Matt; Ramanathan, Sharad] Harvard Univ, Biophys Program, Cambridge, MA 02138 USA; [Thomson, Matt; Zou, Ling-Nan; Meissner, Alexander; Ramanathan, Sharad] Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Smith, Zack; Meissner, Alexander] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Ramanathan, Sharad] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Liu, Siyuan John; Ramanathan, Sharad] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University; Harvard University; Harvard University; Harvard University; Harvard University; Harvard University	Ramanathan, S (corresponding author), Harvard Univ, FAS Ctr Syst Biol, Cambridge, MA 02138 USA.	sharad@post.harvard.edu			Harvard Stem Cell Institute; Massachusetts Life Science Center;  [NIH-P50-NS40828];  [NIH-P30-HD18655]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [DP1MH099906] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS040828] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD008197] Funding Source: NIH RePORTER	Harvard Stem Cell Institute; Massachusetts Life Science Center; ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Doug Melton, Sean Eddy, Areez Mody, and Alexander Schier for scientific discussions and Rene Maehr, Masa Yamagata, and Dawen Cai for discussions and technical assistance. We thank Manfred Baetscher and the Harvard Genome Modification Facility for assistance with the cell line generation. We thank Bodo Stern, Nicole Francis, and in particular Sean Eddy and three anonymous referees for extensive comments on the manuscript. We thank the Harvard Stem Cell Institute Seed Grant (S.R.) and the Massachusetts Life Science Center (A.M.) for support. Microarray hybridization and measurements were performed by the Molecular Genetics Core Facility at Children's Hospital Boston supported by NIH-P50-NS40828, and NIH-P30-HD18655. M.T. and S.R. conceived the project. M.T. established the experimental system and performed the immunofluorescence and perturbation experiments. S.J.L. and M.T. built the cell lines and performed microarray experiments. L.N.Z. performed the FACS experiments and established techniques for long term microscopy of ESCs on glass. M.T. and S.J.L. performed the time-lapse microscopy experiments. Z.S. and A.M. did the ChIP for Oct4 and Sox2. S.J.L., M.T., and S.R. performed the tiling qPCR experiments. M.T., S.R., and S.J.L. performed the data and mathematical analyses and wrote the manuscript.	Abranches E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006286; Anderson DJ, 2001, NEURON, V30, P19, DOI 10.1016/S0896-6273(01)00260-4; Briscoe J, 2000, CELL, V101, P435, DOI 10.1016/S0092-8674(00)80853-3; Cantor AB, 2001, CURR OPIN GENET DEV, V11, P513, DOI 10.1016/S0959-437X(00)00226-4; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Chew JL, 2005, MOL CELL BIOL, V25, P6031, DOI 10.1128/MCB.25.14.6031-6046.2005; Davidson EH, 2002, SCIENCE, V295, P1669, DOI 10.1126/science.1069883; Ema M, 2008, CELL STEM CELL, V3, P555, DOI 10.1016/j.stem.2008.09.003; Greber B, 2010, CELL STEM CELL, V6, P215, DOI 10.1016/j.stem.2010.01.003; Han JY, 2010, NATURE, V463, P1096, DOI 10.1038/nature08735; Hu G, 2009, GENE DEV, V23, P837, DOI 10.1101/gad.1769609; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Jackson SA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010706; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; Li JY, 2007, MOL CELL BIOL, V27, P8748, DOI 10.1128/MCB.01380-07; Lu R, 2009, NATURE, V462, P358, DOI 10.1038/nature08575; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; Masui S, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-45; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Miyagi S, 2006, J BIOL CHEM, V281, P13374, DOI 10.1074/jbc.M512669200; Nishikawa SI, 2007, NAT REV MOL CELL BIO, V8, P502, DOI 10.1038/nrm2189; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 2007, DEVELOPMENT, V134, P635, DOI 10.1242/dev.02787; Niwa H, 2010, DEV GROWTH DIFFER, V52, P275, DOI 10.1111/j.1440-169X.2009.01166.x; Novershtern N, 2011, CELL, V144, P296, DOI 10.1016/j.cell.2011.01.004; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; Pasini D, 2010, NATURE, V464, P306, DOI 10.1038/nature08788; Peng JC, 2009, CELL, V139, P1290, DOI 10.1016/j.cell.2009.12.002; Sachs K, 2005, SCIENCE, V308, P523, DOI 10.1126/science.1105809; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Schuettengruber B, 2009, DEVELOPMENT, V136, P3531, DOI 10.1242/dev.033902; Shen XH, 2008, MOL CELL, V32, P491, DOI 10.1016/j.molcel.2008.10.016; Sikorska M, 2008, J NEUROSCI RES, V86, P1680, DOI 10.1002/jnr.21635; Silva J, 2008, CELL, V132, P532, DOI 10.1016/j.cell.2008.02.006; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; ten Berge D, 2008, CELL STEM CELL, V3, P508, DOI 10.1016/j.stem.2008.09.013; ten Berge D, 2008, DEVELOPMENT, V135, P3247, DOI 10.1242/dev.023176; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Tomioka M, 2002, NUCLEIC ACIDS RES, V30, P3202, DOI 10.1093/nar/gkf435; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Yamaguchi TP, 1999, GENE DEV, V13, P3185, DOI 10.1101/gad.13.24.3185; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Ying QL, 2003, METHOD ENZYMOL, V365, P327; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X	49	374	385	2	53	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 10	2011	145	6					875	889		10.1016/j.cell.2011.05.017	http://dx.doi.org/10.1016/j.cell.2011.05.017			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	775LS	21663792	Green Accepted, hybrid			2022-12-24	WOS:000291461600015
J	Elinav, E; Strowig, T; Kau, AL; Henao-Mejia, J; Thaiss, CA; Booth, CJ; Peaper, DR; Bertin, J; Eisenbarth, SC; Gordon, JI; Flavell, RA				Elinav, Eran; Strowig, Till; Kau, Andrew L.; Henao-Mejia, Jorge; Thaiss, Christoph A.; Booth, Carmen J.; Peaper, David R.; Bertin, John; Eisenbarth, Stephanie C.; Gordon, Jeffrey I.; Flavell, Richard A.			NLRP6 Inflammasome Regulates Colonic Microbial Ecology and Risk for Colitis	CELL			English	Article							NF-KAPPA-B; INTESTINAL MICROBIOTA; DIVISION TM7; BACTERIA; PREVALENCE; ACTIVATION; RECOGNITION; CASPASE-1; STRAINS; MUCIN	Inflammasomes are multiprotein complexes that function as sensors of endogenous or exogenous damage-associated molecular patterns. Here, we show that deficiency of NLRP6 in mouse colonic epithelial cells results in reduced IL-18 levels and altered fecal microbiota characterized by expanded representation of the bacterial phyla Bacteroidetes (Prevotellaceae) and TM7. NLRP6 inflammasome-deficient mice were characterized by spontaneous intestinal hyperplasia, inflammatory cell recruitment, and exacerbation of chemical colitis induced by exposure to dextran sodium sulfate (DSS). Cross-fostering and cohousing experiments revealed that the colitogenic activity of this microbiota is transferable to neonatal or adult wild-type mice, leading to exacerbation of DSS colitis via induction of the cytokine, CCL5. Antibiotic treatment and electron microscopy studies further supported the role of Prevotellaceae as a key representative of this microbiota-associated phenotype. Altogether, perturbations in this inflammasome pathway, including NLRP6, ASC, caspase-1, and IL-18, may constitute a predisposing or initiating event in some cases of human IBD.	[Elinav, Eran; Strowig, Till; Henao-Mejia, Jorge; Thaiss, Christoph A.; Eisenbarth, Stephanie C.; Flavell, Richard A.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Booth, Carmen J.] Yale Univ, Sch Med, Comparat Med Sect, New Haven, CT 06520 USA; [Peaper, David R.; Eisenbarth, Stephanie C.] Yale Univ, Sch Med, Dept Lab Med, New Haven, CT 06520 USA; [Kau, Andrew L.; Gordon, Jeffrey I.] Washington Univ, Sch Med, Ctr Genome Sci & Syst Biol, St Louis, MO 63108 USA; [Kau, Andrew L.] Washington Univ, Sch Med, Dept Internal Med, Div Allergy & Immunol, St Louis, MO 63108 USA; [Bertin, John] GlaxoSmithKline, Pattern Recognit Receptor Discovery Performance U, Collegeville, PA 19426 USA; [Flavell, Richard A.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Yale University; Yale University; Yale University; Washington University (WUSTL); Washington University (WUSTL); GlaxoSmithKline; Howard Hughes Medical Institute	Flavell, RA (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, 333 Cedar St, New Haven, CT 06520 USA.	richard.flavell@yale.edu	Elinav, Eran/ABE-8881-2020; Kau, Andrew/AGX-9881-2022	Elinav, Eran/0000-0002-5775-2110; Kau, Andrew/0000-0002-9386-3766; Strowig, Till/0000-0003-0185-1459; Eisenbarth, Stephanie/0000-0002-1244-208X	Cancer Research Institute; Israel-US educational foundation; American Physicians for Medicine in Israel Foundation; W.M Keck Foundation; LLS; Howard Hughes Medical Institute; Crohn's and Colitis Foundation of America; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007974] Funding Source: NIH RePORTER	Cancer Research Institute; Israel-US educational foundation; American Physicians for Medicine in Israel Foundation; W.M Keck Foundation(W.M. Keck Foundation); LLS; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Crohn's and Colitis Foundation of America; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We would like to thank A Hafemann, S. Campton, E. Eynon, J. Alderman, W. Philbrick, C. Zorca, M. Musaheb, J. Stein, A. Ferrandino, F. Manzo, and the members of the Flavell lab for technical help and helpful discussions; K. Fitzgerald for providing AIM2<SUP>-/-</SUP> deficient mice; M. Graham and C. Rahner, CCMI EM Core Facility, Yale School of Medicine; J. Manchester and S. Deng for their assistance with DNA sequencing; V. Nagy for discussion and help with figure preparation; and H. Elinav for important discussions, suggestions, and critique. E. E. is supported by Cancer Research Institute (2010-2012) and the Israel-US educational foundation (2009) and is the recipient of the Claire and Emmanuel G. Rosenblatt award from the American Physicians for Medicine in Israel Foundation. A. L. K. is the recipient of a postdoctoral fellowship from the W.M Keck Foundation. J. H.-M. is supported by a LLS Postdoctoral Fellowship. This work was supported, in part, by Howard Hughes Medical Institute (R. A. F.) and the Crohn's and Colitis Foundation of America (J.I.G.).	Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Allen IC, 2010, J EXP MED, V207, P1045, DOI 10.1084/jem.20100050; Arthur JC, 2010, J IMMUNOL, V185, P4515, DOI 10.4049/jimmunol.1002227; Bauer C, 2010, GUT, V59, P1192, DOI 10.1136/gut.2009.197822; Becker C, 2006, NAT PROTOC, V1, P2900, DOI 10.1038/nprot.2006.446; Berube J, 2009, CELL SIGNAL, V21, P448, DOI 10.1016/j.cellsig.2008.12.001; Bjorksten B, 1999, ALLERGY, V54, P17, DOI 10.1111/j.1398-9995.1999.tb04383.x; BREBAN MA, 1993, CLIN EXP RHEUMATOL, V11, P61; Brinig MM, 2003, APPL ENVIRON MICROB, V69, P1687, DOI 10.1128/AEM.69.3.1687-1694.2003; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Darfeuille-Michaud A, 2004, GASTROENTEROLOGY, V127, P412, DOI 10.1053/j.gastro.2004.04.061; Dupaul-Chicoine J, 2010, IMMUNITY, V32, P367, DOI 10.1016/j.immuni.2010.02.012; Geijtenbeek TBH, 2004, ANNU REV IMMUNOL, V22, P33, DOI 10.1146/annurev.immunol.22.012703.104558; Grenier JM, 2002, FEBS LETT, V530, P73, DOI 10.1016/S0014-5793(02)03416-6; Hirota SA, 2011, INFLAMM BOWEL DIS, V17, P1359, DOI 10.1002/ibd.21478; Hu B, 2010, P NATL ACAD SCI USA, V107, P21635, DOI 10.1073/pnas.1016814108; Hugenholtz P, 2001, APPL ENVIRON MICROB, V67, P411, DOI 10.1128/AEM.67.1.411-419.2001; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Kempster SL, 2011, AM J PHYSIOL-GASTR L, V300, pG253, DOI 10.1152/ajpgi.00397.2010; Kleessen B, 2002, SCAND J GASTROENTERO, V37, P1034, DOI 10.1080/003655202320378220; Kuehbacher T, 2008, J MED MICROBIOL, V57, P1569, DOI 10.1099/jmm.0.47719-0; Kufer TA, 2011, NAT IMMUNOL, V12, P121, DOI 10.1038/ni.1985; Kumar PS, 2003, J DENT RES, V82, P338, DOI 10.1177/154405910308200503; Lee YK, 2011, P NATL ACAD SCI USA, V108, P4615, DOI 10.1073/pnas.1000082107; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lucke K, 2006, J MED MICROBIOL, V55, P617, DOI 10.1099/jmm.0.46198-0; Macpherson AJ, 2004, SCIENCE, V303, P1662, DOI 10.1126/science.1091334; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Marcy Y, 2007, P NATL ACAD SCI USA, V104, P11889, DOI 10.1073/pnas.0704662104; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Matzinger P, 2007, NAT IMMUNOL, V8, P11, DOI 10.1038/ni0107-11; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; Niess JH, 2005, SCIENCE, V307, P254, DOI 10.1126/science.1102901; Ouverney CC, 2003, APPL ENVIRON MICROB, V69, P6294, DOI 10.1128/AEM.69.10.6294-6298.2003; Penders J, 2007, ALLERGY, V62, P1223, DOI 10.1111/j.1398-9995.2007.01462.x; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Siegmund B, 2001, P NATL ACAD SCI USA, V98, P13249, DOI 10.1073/pnas.231473998; Siegmund B, 2010, IMMUNITY, V32, P300, DOI 10.1016/j.immuni.2010.03.010; Sinkorova Z, 2008, HUM IMMUNOL, V69, P845, DOI 10.1016/j.humimm.2008.08.296; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Suzuki K, 2004, P NATL ACAD SCI USA, V101, P1981, DOI 10.1073/pnas.0307317101; TSAI HH, 1995, GUT, V36, P570, DOI 10.1136/gut.36.4.570; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Vaahtovuo J, 2008, J RHEUMATOL, V35, P1500; Vaishnava S, 2008, P NATL ACAD SCI USA, V105, P20858, DOI 10.1073/pnas.0808723105; Wang L, 2002, J BIOL CHEM, V277, P29874, DOI 10.1074/jbc.M203915200; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; Werts C, 2007, EUR J IMMUNOL, V37, P2499, DOI 10.1002/eji.200737069; Wright DP, 2000, FEMS MICROBIOL LETT, V190, P73, DOI 10.1016/S0378-1097(00)00324-4; Wu HJ, 2010, IMMUNITY, V32, P815, DOI 10.1016/j.immuni.2010.06.001; Zaki MH, 2010, IMMUNITY, V32, P379, DOI 10.1016/j.immuni.2010.03.003	54	1363	1424	11	305	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 27	2011	145	5					745	757		10.1016/j.cell.2011.04.022	http://dx.doi.org/10.1016/j.cell.2011.04.022			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	769MR	21565393	Bronze, Green Accepted			2022-12-24	WOS:000291018600014
J	Mikolajczyk, RT; Zhang, J; Betran, AP; Souza, JP; Mori, R; Gulmezoglu, AM; Merialdi, M				Mikolajczyk, Rafael T.; Zhang, Jun; Betran, Ana Pilar; Souza, Joao Paulo; Mori, Rintaro; Guelmezoglu, A. Metin; Merialdi, Mario			A global reference for fetal-weight and birthweight percentiles	LANCET			English	Article							INTRAUTERINE GROWTH-RETARDATION; STANDARDS; DEFINITION; OUTCOMES; INFANTS; BORN	Background Definition of small for gestational age in various populations worldwide remains a challenge. References based on birthweight are deficient for preterm births, those derived from ultrasound estimates might not be applicable to all populations, and the individualised reference can be too complex to use in developing countries. Our aim was to create a generic reference for fetal weight and birthweight that overcame these deficiencies and could be readily adapted to local populations. Methods We used the fetal-weight reference developed by Hadlock and colleagues and the notion of proportionality proposed by Gardosi and colleagues and made the weight reference easily adjustable according to the mean birthweight at 40 weeks of gestation for any local population. For application and validation, we used data from 24 countries in Africa, Latin America, and Asia that participated in the 2004-08 WHO Global Survey on Maternal and Perinatal Health (237025 births). We compared our reference with that of Hadlock and colleagues (non-customised) and with that of Gardosi and colleagues (individualised). For every reference, the odds ratio (OR) of adverse perinatal outcomes (stillbirths, neonatal deaths, referral to higher-level or special care unit, or Apgar score lower than 7 at 5 min) for infants who were small for gestational age versus those who were not was estimated with multilevel logistic regression. Findings OR of adverse outcomes for infants small for gestational age versus those not small for gestational age was 1.59 (95% CI 1.53-1.66) for the non-customised fetal-weight reference compared with 2.87 (2.73-3.01) for our country-specific reference, and 2.84 (2.71-2.99) for the fully individualised reference. Interpretation Our generic reference for fetal-weight and birthweight percentiles can be easily adapted to local populations. It has a better ability to predict adverse perinatal outcomes than has the non-customised fetal-weight reference, and is simpler to use than the individualised reference without loss of predictive ability.	[Zhang, Jun] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, MOE, Shanghai 200092, Peoples R China; [Zhang, Jun] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Shanghai Key Lab Childrens Environm Hlth, Shanghai 200092, Peoples R China; [Mikolajczyk, Rafael T.] Bremen Inst Prevent Res & Social Med, Dept Clin Epidemiol, Bremen, Germany; [Mikolajczyk, Rafael T.] Univ Bielefeld, Sch Publ Hlth, Dept Publ Hlth Med, Bielefeld, Germany; [Zhang, Jun] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Epidemiol Branch, NIH, Bethesda, MD USA; [Betran, Ana Pilar; Souza, Joao Paulo; Guelmezoglu, A. Metin; Merialdi, Mario] WHO, Dept Reprod Hlth & Res, CH-1211 Geneva, Switzerland; [Mori, Rintaro] Univ Tokyo, Grad Sch Med, Dept Global Hlth Policy, Tokyo, Japan	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Leibniz Institute for Prevention Research & Epidemiology (BIPS); University of Bielefeld; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); World Health Organization; University of Tokyo	Zhang, J (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, MOE, Shanghai 200092, Peoples R China.	junjimzhang@gmail.com	Mikolajczyk, Rafael/ABB-5259-2021; Souza, João Paulo/G-1982-2010	Souza, João Paulo/0000-0002-2288-4244; Mori, Rintaro/0000-0001-7656-6156; Mikolajczyk, Rafael/0000-0003-1271-7204	UNDP/UNFPA/WHO/World Bank; WHO; United States Agency for International Development (USAID); Ministry of Health, Labour and Welfare of Japan; Ministry of Public Health of the People's Republic of China; Indian Council of Medical Research, India; Eunice Shriver Kennedy National Institute of Child Health and Human Development, National Institutes of Health, USA; Grants-in-Aid for Scientific Research [23406035] Funding Source: KAKEN	UNDP/UNFPA/WHO/World Bank(World Health Organization); WHO(World Health Organization); United States Agency for International Development (USAID)(United States Agency for International Development (USAID)); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Public Health of the People's Republic of China; Indian Council of Medical Research, India(Indian Council of Medical Research (ICMR)); Eunice Shriver Kennedy National Institute of Child Health and Human Development, National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The 2004-08 WHO Global Survey on Maternal and Perinatal Health (WHOGS) was a research project implemented by the WHO in a global network of health facilities between 2004 and 2008. The authors of this secondary analysis are grateful to all those who contributed to the project design and implementation, including researchers, study coordinators, data collectors, data clerks, and other partners such as the staff from the Ministries of Health and WHO offices. The WHOGS project was financially supported by the UNDP/UNFPA/WHO/World Bank Special Programme of Research, Development, and Research Training in Human Reproduction (HRP); WHO; United States Agency for International Development (USAID); Ministry of Health, Labour and Welfare of Japan; Ministry of Public Health of the People's Republic of China; and the Indian Council of Medical Research, India. JZ was supported by the Intramural Programme of Eunice Shriver Kennedy National Institute of Child Health and Human Development, National Institutes of Health, USA. The named authors alone are responsible for the views expressed in this manuscript, which does not necessarily represent the decisions or the stated policy of the WHO.	Alexander GR, 1996, OBSTET GYNECOL, V87, P163, DOI 10.1016/0029-7844(95)00386-X; [Anonymous], 2004, MEDLINE DATA CHANGES; Chauhan SP, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.11.025; Clausson B, 2001, BRIT J OBSTET GYNAEC, V108, P830, DOI 10.1111/j.1471-0528.2001.00205.x; Doctor BA, 2001, AM J OBSTET GYNECOL, V185, P652, DOI 10.1067/mob.2001.116749; Figueras F, 2008, EUR J OBSTET GYN R B, V136, P20, DOI 10.1016/j.ejogrb.2006.12.015; Figueras F, 2009, FETAL DIAGN THER, V25, P297, DOI 10.1159/000235875; Gardosi J, 2007, BJOG-INT J OBSTET GY, V114, P1301, DOI 10.1111/j.1471-0528.2007.01432.x; Gardosi J, 2006, HORM RES, V65, P15, DOI 10.1159/000091501; Gardosi J, 2005, ULTRASOUND OBST GYN, V26, P112, DOI 10.1002/uog.1971; GARDOSI J, 1995, ULTRASOUND OBST GYN, V6, P73, DOI 10.1046/j.1469-0705.1995.06020073.x; Gardosi J, 2009, BJOG-INT J OBSTET GY, V116, P1356, DOI 10.1111/j.1471-0528.2009.02245.x; GARDOSI J, 1995, ULTRASOUND OBST GYN, V6, P168, DOI 10.1046/j.1469-0705.1995.06030168.x; Gardosi J, 2009, AM J OBSTET GYNECOL, V201; HADLOCK FP, 1991, RADIOLOGY, V181, P129, DOI 10.1148/radiology.181.1.1887021; Hutcheon JA, 2011, AM J EPIDEMIOL, V173, P459, DOI 10.1093/aje/kwq399; McCowan L, 2004, AUST NZ J OBSTET GYN, V44, P428, DOI 10.1111/j.1479-828X.2004.00272.x; Mongelli M, 2007, AUST NZ J OBSTET GYN, V47, P128, DOI 10.1111/j.1479-828X.2007.00698.x; Neta G, 2011, ULTRASOUND OBST GYN, V38, P62, DOI 10.1002/uog.8902; OTT WJ, 1995, AM J PERINAT, V12, P396, DOI 10.1055/s-2007-994506; Shah A, 2008, B WORLD HEALTH ORGAN, V86, P126, DOI 10.2471/BLT.06.039842; SMEDLER AC, 1992, ACTA PAEDIATR, V81, P197, DOI 10.1111/j.1651-2227.1992.tb12203.x; SUNG IK, 1993, J PEDIATR-US, V123, P618, DOI 10.1016/S0022-3476(05)80965-5; Verkauskiene R, 2008, HORM RES, V70, P309, DOI 10.1159/000157878; von Ehrenstein OS, 2009, AM J EPIDEMIOL, V170, P1388, DOI 10.1093/aje/kwp296; WILLIAMS RL, 1982, OBSTET GYNECOL, V59, P624; Zhang J, 2011, AM J EPIDEMIOL, V173, P539, DOI 10.1093/aje/kwq411; Zhang J, 2010, AM J OBSTET GYNECOL, V202, P522, DOI 10.1016/j.ajog.2009.10.889; Zhang X, 2007, BJOG-INT J OBSTET GY, V114, P474, DOI 10.1111/j.1471-0528.2007.01273.x	29	321	340	0	60	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY-JUN	2011	377	9780					1855	1861		10.1016/S0140-6736(11)60364-4	http://dx.doi.org/10.1016/S0140-6736(11)60364-4			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	774UI	21621717				2022-12-24	WOS:000291411700031
J	Neunuebel, MR; Chen, Y; Gaspar, AH; Backlund, PS; Yergey, A; Machner, MP				Neunuebel, M. Ramona; Chen, Yang; Gaspar, Andrew H.; Backlund, Peter S., Jr.; Yergey, Alfred; Machner, Matthias P.			De-AMPylation of the Small GTPase Rab1 by the Pathogen Legionella pneumophila	SCIENCE			English	Article							EFFECTOR PROTEIN DRRA; ENDOPLASMIC-RETICULUM; VESICULAR TRANSPORT; BINDING; SYSTEM; MUTANTS	The bacterial pathogen Legionella pneumophila exploits host cell vesicle transport by transiently manipulating the activity of the small guanosine triphosphatase (GTPase) Rab1. The effector protein SidM recruits Rab1 to the Legionella-containing vacuole (LCV), where it activates Rab1 and then AMPylates it by covalently adding adenosine monophosphate (AMP). L. pneumophila GTPase-activating protein LepB inactivates Rab1 before its removal from LCVs. Because LepB cannot bind AMPylated Rab1, the molecular events leading to Rab1 inactivation are unknown. We found that the effector protein SidD from L. pneumophila catalyzed AMP release from Rab1, generating de-AMPylated Rab1 accessible for inactivation by LepB. L. pneumophila mutants lacking SidD were defective for Rab1 removal from LCVs, identifying SidD as the missing link connecting the processes of early Rab1 accumulation and subsequent Rab1 removal during infection.	[Neunuebel, M. Ramona; Chen, Yang; Gaspar, Andrew H.; Machner, Matthias P.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Cell Biol & Metab Program, NIH, Bethesda, MD 20892 USA; [Backlund, Peter S., Jr.; Yergey, Alfred] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Biomed Mass Spectrometry Facil, NIH, Bethesda, MD 20892 USA; [Chen, Yang] Peking Univ, Ctr Hlth Sci, Beijing 100191, Peoples R China	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Peking University	Machner, MP (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Cell Biol & Metab Program, NIH, Bethesda, MD 20892 USA.	machnerm@mail.nih.gov	Machner, Matthias/G-2758-2015	Machner, Matthias/0000-0002-6971-7451	NIH; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008893, ZICHD001421] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank G. Storz, S. Gottesman, J. Bonifacino, J. Neunuebel, and M. Barzik for critical reading and insightful discussion and R. Isberg and V. Losick for kindly providing reagents. This work was supported by the Intramural Research Program of the NIH.	ANDERSON WB, 1970, BIOCHEM BIOPH RES CO, V41, P704, DOI 10.1016/0006-291X(70)90070-7; BACON RA, 1989, J CELL BIOL, V109, P1015, DOI 10.1083/jcb.109.3.1015; Byrne B, 1998, INFECT IMMUN, V66, P3029, DOI 10.1128/IAI.66.7.3029-3034.1998; Derre I, 2005, INFECT IMMUN, V73, P4370, DOI 10.1128/IAI.73.7.4370-4380.2005; Derre I, 2004, INFECT IMMUN, V72, P3048, DOI 10.1128/IAI.72.5.3048-3053.2004; Ensminger AW, 2009, CURR OPIN MICROBIOL, V12, P67, DOI 10.1016/j.mib.2008.12.004; Ingmundson A, 2007, NATURE, V450, P365, DOI 10.1038/nature06336; Kagan JC, 2004, J EXP MED, V199, P1201, DOI 10.1084/jem.20031706; Luo ZQ, 2004, P NATL ACAD SCI USA, V101, P841, DOI 10.1073/pnas.0304916101; Machner MP, 2007, SCIENCE, V318, P974, DOI 10.1126/science.1149121; Machner MP, 2006, DEV CELL, V11, P47, DOI 10.1016/j.devcel.2006.05.013; MANTEL M, 1970, P NATL ACAD SCI USA, V65, P660, DOI 10.1073/pnas.65.3.660; Muller MP, 2010, SCIENCE, V329, P946, DOI 10.1126/science.1192276; Murata T, 2006, NAT CELL BIOL, V8, P971, DOI 10.1038/ncb1463; PLUTNER H, 1991, J CELL BIOL, V115, P31, DOI 10.1083/jcb.115.1.31; Roy CR, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.262pe14; Spirin V, 2003, P NATL ACAD SCI USA, V100, P12123, DOI 10.1073/pnas.2032324100; TISDALE EJ, 1992, J CELL BIOL, V119, P749, DOI 10.1083/jcb.119.4.749; Worby CA, 2009, MOL CELL, V34, P93, DOI 10.1016/j.molcel.2009.03.008; Yarbrough ML, 2009, SCIENCE, V323, P269, DOI 10.1126/science.1166382	20	161	167	1	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 22	2011	333	6041					453	456		10.1126/science.1207193	http://dx.doi.org/10.1126/science.1207193			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	795FR	21680813	Green Accepted			2022-12-24	WOS:000292959600046
J	Ceccarelli, DF; Tang, XJ; Pelletier, B; Orlicky, S; Xie, WL; Plantevin, V; Neculai, D; Chou, YC; Ogunjimi, A; Al-Hakim, A; Varelas, X; Koszela, J; Wasney, GA; Vedadi, M; Dhe-Paganon, S; Cox, S; Xu, SC; Lopez-Girona, A; Mercurio, F; Wrana, J; Durocher, D; Meloche, S; Webb, DR; Tyers, M; Sicheri, F				Ceccarelli, Derek F.; Tang, Xiaojing; Pelletier, Benoit; Orlicky, Stephen; Xie, Weilin; Plantevin, Veronique; Neculai, Dante; Chou, Yang-Chieh; Ogunjimi, Abiodun; Al-Hakim, Abdallah; Varelas, Xaralabos; Koszela, Joanna; Wasney, Gregory A.; Vedadi, Masoud; Dhe-Paganon, Sirano; Cox, Sarah; Xu, Shuichan; Lopez-Girona, Antonia; Mercurio, Frank; Wrana, Jeff; Durocher, Daniel; Meloche, Sylvain; Webb, David R.; Tyers, Mike; Sicheri, Frank			An Allosteric Inhibitor of the Human Cdc34 Ubiquitin-Conjugating Enzyme	CELL			English	Article							F-BOX PROTEINS; CELL-DIVISION; LIGASE; ACTIVATION; SUBSTRATE; E2; PROTEOLYSIS; P27(KIP1); COMPLEX; E3	In the ubiquitin-proteasome system (UPS), E2 enzymes mediate the conjugation of ubiquitin to substrates and thereby control protein stability and interactions. The E2 enzyme hCdc34 catalyzes the ubiquitination of hundreds of proteins in conjunction with the cullin-RING (CRL) superfamily of E3 enzymes. We identified a small molecule termed CC0651 that selectively inhibits hCdc34. Structure determination revealed that CC0651 inserts into a cryptic binding pocket on hCdc34 distant from the catalytic site, causing subtle but wholesale displacement of E2 secondary structural elements. CC0651 analogs inhibited proliferation of human cancer cell lines and caused accumulation of the SCFSkp2 substrate p27(Kip1). CC0651 does not affect hCdc34 interactions with E1 or E3 enzymes or the formation of the ubiquitin thioester but instead interferes with the discharge of ubiquitin to acceptor lysine residues. E2 enzymes are thus susceptible to noncatalytic site inhibition and may represent a viable class of drug target in the UPS.	[Xie, Weilin; Plantevin, Veronique; Cox, Sarah; Xu, Shuichan; Lopez-Girona, Antonia; Mercurio, Frank; Webb, David R.] Celgene Signal Res Div, San Diego, CA 92121 USA; [Ceccarelli, Derek F.; Tang, Xiaojing; Orlicky, Stephen; Neculai, Dante; Chou, Yang-Chieh; Ogunjimi, Abiodun; Al-Hakim, Abdallah; Varelas, Xaralabos; Wrana, Jeff; Durocher, Daniel; Tyers, Mike; Sicheri, Frank] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Ctr Syst Biol, Toronto, ON M5G 1X5, Canada; [Meloche, Sylvain] Univ Montreal, Program Mol Biol, Montreal, PQ H3C 3J7, Canada; [Meloche, Sylvain] Univ Montreal, Dept Pharmacol, Montreal, PQ H3C 3J7, Canada; [Neculai, Dante; Wasney, Gregory A.; Vedadi, Masoud; Dhe-Paganon, Sirano] Struct Genom Consortium, Toronto, ON M5G 1L7, Canada; [Koszela, Joanna; Tyers, Mike] Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland; [Tyers, Mike; Sicheri, Frank] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Pelletier, Benoit; Meloche, Sylvain] Univ Montreal, Inst Rech Immunol & Cancerol, Montreal, PQ H3C 3J7, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Universite de Montreal; Universite de Montreal; University of Toronto; Structural Genomics Consortium; University of Edinburgh; University of Toronto; Universite de Montreal	Webb, DR (corresponding author), Celgene Signal Res Div, 4550 Towne Ctr Court, San Diego, CA 92121 USA.	dwebb@celgene.com; m.tyers@ed.ac.uk; sicheri@lunenfeld.ca	Wrana, Jeffrey/F-8857-2013; Neculai, Dante/A-9923-2011; Tyers, Michael/ABE-3194-2021; Varelas, Xaralabos/ABB-9141-2020; Sicheri, Frank/F-8856-2013; Neculai, Dante/M-2884-2013; 高, 雨莉/HGU-8187-2022; Durocher, Daniel/A-7733-2010	Neculai, Dante/0000-0001-8887-9168; Durocher, Daniel/0000-0003-3863-8635; Varelas, Xaralabos/0000-0002-2882-4541; Orlicky, Stephen/0000-0002-8172-2042; Ceccarelli, Derek/0000-0002-2674-9234	National Center for Research Resources at the National Institutes of Health [RR-15301]; U.S. Department of Energy [DE-AC02-06CH11357]; Canadian Institutes of Health Research [MOP-57795, MOP-14339, MOP-14168]; National Cancer Institute of Canada; Canada Research Chair in Cellular Signaling; Research Chair of the Scottish Universities Life Sciences Alliance; Royal Society; Canada Research Chair in Structural Biology; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015301] Funding Source: NIH RePORTER	National Center for Research Resources at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); U.S. Department of Energy(United States Department of Energy (DOE)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Cancer Institute of Canada(Canadian Cancer Society (CCS)); Canada Research Chair in Cellular Signaling; Research Chair of the Scottish Universities Life Sciences Alliance; Royal Society(Royal Society of London); Canada Research Chair in Structural Biology; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank Jean O'Donoghue and Ted Hupp for cell culture advice, Michele Pagano for SCF reagents, and Thimo Kurz for MLN4924. We also thank I. Kourinov and staff at Argonne National Laboratory for assistance with micro-diffraction experiments at the Advanced Photon Source on the Northeastern Collaborative Access Team beamlines, as supported by award RR-15301 from the National Center for Research Resources at the National Institutes of Health and contract DE-AC02-06CH11357 from the U.S. Department of Energy. This work was supported by grants to F. S., M. T., J.W., and S. M. from the Canadian Institutes of Health Research (MOP-57795, MOP-14339, and MOP-14168). B. P. is recipient of a fellowship from the National Cancer Institute of Canada. S. M. is supported by a Canada Research Chair in Cellular Signaling, M. T. by a Research Chair of the Scottish Universities Life Sciences Alliance and a Royal Society Wolfson Research Merit Award, and F. S. by a Canada Research Chair in Structural Biology.	Aghajan M, 2010, NAT BIOTECHNOL, V28, P738, DOI 10.1038/nbt.1645; Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; Brzovic PS, 2006, MOL CELL, V21, P873, DOI 10.1016/j.molcel.2006.02.008; Bussing I, 2008, TRENDS MOL MED, V14, P400, DOI 10.1016/j.molmed.2008.07.001; Burroughs AM, 2008, J STRUCT BIOL, V162, P205, DOI 10.1016/j.jsb.2007.12.006; Butz N, 2005, EXP CELL RES, V303, P482, DOI 10.1016/j.yexcr.2004.10.008; Chauhan D, 2004, ONCOGENE, V23, P3597, DOI 10.1038/sj.onc.1207458; Chen Q, 2008, BLOOD, V111, P4690, DOI 10.1182/blood-2007-09-112904; Cohen P, 2010, CELL, V143, P686, DOI 10.1016/j.cell.2010.11.016; Duda DM, 2008, CELL, V134, P995, DOI 10.1016/j.cell.2008.07.022; Eliseeva E, 2001, CELL GROWTH DIFFER, V12, P427; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feldman RMR, 1997, CELL, V91, P221, DOI 10.1016/S0092-8674(00)80404-3; Frescas D, 2008, NAT REV CANCER, V8, P438, DOI 10.1038/nrc2396; Gazdoiu S, 2007, MOL CELL BIOL, V27, P7041, DOI 10.1128/MCB.00812-07; Hamilton KS, 2001, STRUCTURE, V9, P897, DOI 10.1016/S0969-2126(01)00657-8; Huang DT, 2007, NATURE, V445, P394, DOI 10.1038/nature05490; Kamura T, 2004, NAT CELL BIOL, V6, P1229, DOI 10.1038/ncb1194; Kleiger G, 2009, CELL, V139, P957, DOI 10.1016/j.cell.2009.10.030; Legesse-Miller A, 2009, J BIOL CHEM, V284, P6605, DOI 10.1074/jbc.C900002200; Li W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001487; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakada S, 2010, NATURE, V466, P941, DOI 10.1038/nature09297; Nalepa G, 2006, NAT REV DRUG DISCOV, V5, P596, DOI 10.1038/nrd2056; Orlicky S, 2003, CELL, V112, P243, DOI 10.1016/S0092-8674(03)00034-5; Orlicky S, 2010, NAT BIOTECHNOL, V28, P733, DOI 10.1038/nbt.1646; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ozkan E, 2005, P NATL ACAD SCI USA, V102, P18890, DOI 10.1073/pnas.0509418102; Patton EE, 1998, GENE DEV, V12, P692, DOI 10.1101/gad.12.5.692; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Pierce NW, 2009, NATURE, V462, P615, DOI 10.1038/nature08595; Ravid T, 2008, NAT REV MOL CELL BIO, V9, P679, DOI 10.1038/nrm2468; Saha A, 2011, MOL CELL, V42, P75, DOI 10.1016/j.molcel.2011.03.016; Scaglione KM, 2007, MOL CELL BIOL, V27, P5860, DOI 10.1128/MCB.01555-06; Seol JH, 1999, GENE DEV, V13, P1614, DOI 10.1101/gad.13.12.1614; Servant MJ, 2000, J CELL BIOL, V148, P543, DOI 10.1083/jcb.148.3.543; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Tang X, 2007, CELL, V129, P1165, DOI 10.1016/j.cell.2007.04.042; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Voisin L, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-337; Wang YS, 1999, CURR BIOL, V9, P1191, DOI 10.1016/S0960-9822(00)80024-X; Welcker M, 2008, NAT REV CANCER, V8, P83, DOI 10.1038/nrc2290; Wenzel DM, 2011, BIOCHEM J, V433, P31, DOI 10.1042/BJ20100985; Wickliffe KE, 2011, CELL, V144, P769, DOI 10.1016/j.cell.2011.01.035; Willems AR, 1996, CELL, V86, P453, DOI 10.1016/S0092-8674(00)80118-X; Wu PY, 2003, EMBO J, V22, P5241, DOI 10.1093/emboj/cdg501; Ye YH, 2009, NAT REV MOL CELL BIO, V10, P755, DOI 10.1038/nrm2780; Yen HCS, 2008, SCIENCE, V322, P923, DOI 10.1126/science.1160462; Yunus AA, 2006, NAT STRUCT MOL BIOL, V13, P491, DOI 10.1038/nsmb1104; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X	52	163	170	1	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 24	2011	145	7					1075	1087		10.1016/j.cell.2011.05.039	http://dx.doi.org/10.1016/j.cell.2011.05.039			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	782QV	21683433	Bronze			2022-12-24	WOS:000292025700014
J	Leask, J				Leask, Julie			Target the fence-sitters	NATURE			English	Editorial Material							VACCINATION		Univ Sydney, Sch Publ Hlth, Discipline Paediat & Child Hlth, Natl Ctr Immunisat Res & Surveillance, Sydney, NSW 2006, Australia	University of Sydney	Leask, J (corresponding author), Univ Sydney, Sch Publ Hlth, Discipline Paediat & Child Hlth, Natl Ctr Immunisat Res & Surveillance, Sydney, NSW 2006, Australia.	JulieL3@chw.edu.au	Leask, Julie/ABE-2077-2020	Leask, Julie/0000-0001-5095-1443				[Anonymous], 2010, HLTH PROTECTION REPO, V4; Gangarosa EJ, 1998, LANCET, V351, P356, DOI 10.1016/S0140-6736(97)04334-1; Hull BP, 2010, COMMUN DIS INTELL, V34, P241; Leach M., 2007, VACCINE ANXIETIES GL; National Committee for Quality Assurance, 2010, STAT HLTH CAR QUAL; Nicoll A, 1998, BMJ-BRIT MED J, V316, P715, DOI 10.1136/bmj.316.7133.715; Petrovic M, 2001, BRIT MED J, V322, P82, DOI 10.1136/bmj.322.7278.82; *ROYAL COLL GEN PR, 1981, BMJ-BRIT MED J, V282, P23; Stefanoff P, 2010, VACCINE, V28, P5731, DOI 10.1016/j.vaccine.2010.06.009; Wooten K. G., 2010, Morbidity and Mortality Weekly Report, V59, P1171	10	120	122	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 26	2011	473	7348					443	445		10.1038/473443a	http://dx.doi.org/10.1038/473443a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	768QM	21614055	Bronze, Green Submitted			2022-12-24	WOS:000290951300014
J	Vijaykrishna, D; Smith, GJD; Pybus, OG; Zhu, HC; Bhatt, S; Poon, LLM; Riley, S; Bahl, J; Ma, SK; Cheung, CL; Perera, RAPM; Chen, HL; Shortridge, KF; Webby, RJ; Webster, RG; Guan, Y; Peiris, JSM				Vijaykrishna, Dhanasekaran; Smith, Gavin J. D.; Pybus, Oliver G.; Zhu, Huachen; Bhatt, Samir; Poon, Leo L. M.; Riley, Steven; Bahl, Justin; Ma, Siu K.; Cheung, Chung L.; Perera, Ranawaka A. P. M.; Chen, Honglin; Shortridge, Kennedy F.; Webby, Richard J.; Webster, Robert G.; Guan, Yi; Peiris, J. S. Malik			Long-term evolution and transmission dynamics of swine influenza A virus	NATURE			English	Article							PIGS; REASSORTMENT; EMERGENCE; ORIGINS; CHINA; H9N2	Swine influenza A viruses (SwIV) cause significant economic losses in animal husbandry as well as instances of human disease(1) and occasionally give rise to human pandemics(2), including that caused by the H1N1/2009 virus(3,4). The lack of systematic and longitudinal influenza surveillance in pigs has hampered attempts to reconstruct the origins of this pandemic(4). Most existing swine data were derived from opportunistic samples collected from diseased pigs in disparate geographical regions, not from prospective studies in defined locations, hence the evolutionary and transmission dynamics of SwIV are poorly understood. Here we quantify the epidemiological, genetic and antigenic dynamics of SwIV in Hong Kong using a data set of more than 650 SwIV isolates and more than 800 swine sera from 12 years of systematic surveillance in this region, supplemented with data stretching back 34 years. Intercontinental virus movement has led to reassortment and lineage replacement, creating an antigenically and genetically diverse virus population whose dynamics are quantitatively different from those previously observed for human influenza viruses. Our findings indicate that increased antigenic drift is associated with reassortment events and offer insights into the emergence of influenza viruses with epidemic potential in swine and humans.	[Vijaykrishna, Dhanasekaran; Smith, Gavin J. D.; Zhu, Huachen; Poon, Leo L. M.; Bahl, Justin; Ma, Siu K.; Cheung, Chung L.; Perera, Ranawaka A. P. M.; Chen, Honglin; Shortridge, Kennedy F.; Webster, Robert G.; Guan, Yi; Peiris, J. S. Malik] Univ Hong Kong, Li Ka Shing Fac Med, State Key Lab Emerging Infect Dis, Pokfulam, Hong Kong, Peoples R China; [Vijaykrishna, Dhanasekaran; Smith, Gavin J. D.; Zhu, Huachen; Poon, Leo L. M.; Bahl, Justin; Ma, Siu K.; Cheung, Chung L.; Perera, Ranawaka A. P. M.; Chen, Honglin; Shortridge, Kennedy F.; Webster, Robert G.; Guan, Yi; Peiris, J. S. Malik] Univ Hong Kong, Li Ka Shing Fac Med, Dept Microbiol, Pokfulam, Hong Kong, Peoples R China; [Vijaykrishna, Dhanasekaran; Smith, Gavin J. D.; Zhu, Huachen; Bahl, Justin; Chen, Honglin; Shortridge, Kennedy F.; Guan, Yi] Shantou Univ, Coll Med, Int Inst Infect & Immun, Shantou, Guangdong, Peoples R China; [Vijaykrishna, Dhanasekaran; Smith, Gavin J. D.; Bahl, Justin] Duke NUS Grad Med Sch, Program Emerging Infect Dis, Lab Virus Evolut, Singapore 169857, Singapore; [Pybus, Oliver G.; Bhatt, Samir] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Riley, Steven] Univ Hong Kong, Li Ka Shing Fac Med, Dept Community Med, Pokfulam, Hong Kong, Peoples R China; [Riley, Steven] Univ Hong Kong, Li Ka Shing Fac Med, Sch Publ Hlth, Pokfulam, Hong Kong, Peoples R China; [Webby, Richard J.; Webster, Robert G.] St Jude Childrens Res Hosp, Dept Infect Dis, Div Virol, Memphis, TN 38015 USA; [Peiris, J. S. Malik] Univ Hong Kong, HKU Pasteur Res Ctr, Pokfulam, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; Shantou University; National University of Singapore; University of Oxford; University of Hong Kong; University of Hong Kong; St Jude Children's Research Hospital; University of Hong Kong	Guan, Y (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, State Key Lab Emerging Infect Dis, 21 Sassoon Rd, Pokfulam, Hong Kong, Peoples R China.	yguan@hkucc.hku.hk; malik@hkucc.hku.hk	Zhu, Huachen/A-8252-2017; Webby, Richard J/N-5657-2018; Perera, Dr. Ranawaka A.P.M Perera/N-8263-2015; Poon, Leo Lit Man/C-4382-2009; Cheung, Yiu Man/T-2708-2019; Poon, Leo/AAP-6887-2020; Dhanasekaran, Vijaykrishna/D-1011-2010; Chen, Honglin/C-4224-2009; Vijaykrishna, Dhanasekaran/AAG-2077-2020; Bahl, Justin/A-4728-2011; Pybus, Oliver G/B-2640-2012; Bhatt, Samir/ABE-7938-2020	Zhu, Huachen/0000-0003-2711-0501; Perera, Dr. Ranawaka A.P.M Perera/0000-0003-3936-1535; Poon, Leo Lit Man/0000-0002-9101-7953; Dhanasekaran, Vijaykrishna/0000-0003-3293-6279; Chen, Honglin/0000-0001-5108-8338; Vijaykrishna, Dhanasekaran/0000-0003-3293-6279; Bahl, Justin/0000-0001-7572-4300; Pybus, Oliver G/0000-0002-8797-2667; Smith, Gavin JD/0000-0001-5031-468X; Bhatt, Samir/0000-0002-0891-4611; Riley, Steven/0000-0001-7904-4804; Guan, Yi/0000-0001-6057-9243	National Institute of Allergy and Infectious Diseases (NIAID) [HHSN26600700005C]; University Grants Commission of the Hong Kong SAR Government [AoE/M-12/06]; Royal Society of London; UK COSI; Agency for Science, Technology and Research; Ministry of Health, Singapore; BBSRC [BB/H014306/1] Funding Source: UKRI; MRC [MC_G0902096] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H014306/1] Funding Source: researchfish; Medical Research Council [G0600719B, MC_G0902096] Funding Source: researchfish	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); University Grants Commission of the Hong Kong SAR Government; Royal Society of London(Royal Society of London); UK COSI; Agency for Science, Technology and Research(Agency for Science Technology & Research (A*STAR)); Ministry of Health, Singapore(Ministry of Health-Singapore); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This research was supported in part by the National Institute of Allergy and Infectious Diseases (NIAID) contract HHSN26600700005C and the Area of Excellence Scheme of the University Grants Commission (grant AoE/M-12/06) of the Hong Kong SAR Government. We acknowledge the Food and Environmental Hygiene Department of Hong Kong for facilitating the study. We acknowledge support from The Royal Society of London (O.G.P.), UK COSI (S.B.), NIAID (G.J.D.S.), the Agency for Science, Technology and Research and the Ministry of Health, Singapore (D.V., G.J.D.S and J.B.). We thank C. Y. H. Leung for producing some of the ferret antisera used in this study.	Clements ACA, 2002, PREV VET MED, V56, P19, DOI 10.1016/S0167-5877(02)00121-6; Cong YL, 2007, J GEN VIROL, V88, P2035, DOI 10.1099/vir.0.82783-0; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Dunham EJ, 2009, J VIROL, V83, P5485, DOI 10.1128/JVI.02565-08; Finkelstein DB, 2007, J VIROL, V81, P10292, DOI 10.1128/JVI.00921-07; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Guan Y, 1996, J VIROL, V70, P8041, DOI 10.1128/JVI.70.11.8041-8046.1996; [李海燕 Li Haiyan], 2004, [中国预防兽医学报, Chinase Journal of Preventive Veterinary Medicine], V26, P1; Loeffen WLA, 2003, VET IMMUNOL IMMUNOP, V92, P23, DOI 10.1016/S0165-2427(03)00019-9; Lorusso A, 2011, J GEN VIROL, V92, P919, DOI 10.1099/vir.0.027557-0; Moreno A, 2011, VET MICROBIOL, V149, P472, DOI 10.1016/j.vetmic.2010.12.011; Nidom CA, 2010, EMERG INFECT DIS, V16, P1515, DOI 10.3201/eid1610.100508; Obenauer JC, 2006, SCIENCE, V311, P1576, DOI 10.1126/science.1121586; Peiris JSM, 2001, J VIROL, V75, P9679, DOI 10.1128/JVI.75.20.9679-9686.2001; PENSAERT M, 1981, B WORLD HEALTH ORGAN, V59, P75; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Poon LLM, 2010, CLIN CHEM, V56, P1340, DOI 10.1373/clinchem.2010.149179; Rambaut A, 2008, NATURE, V453, P615, DOI 10.1038/nature06945; REED L. J., 1938, AMER JOUR HYG, V27, P493; Russell CA, 2008, SCIENCE, V320, P340, DOI 10.1126/science.1154137; Scholtissek C., 1998, TXB INFLUENZA, P137; Shinde V, 2009, NEW ENGL J MED, V360, P2616, DOI 10.1056/NEJMoa0903812; Smith GJD, 2009, P NATL ACAD SCI USA, V106, P11709, DOI 10.1073/pnas.0904991106; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; Taubenberger JK, 2005, NATURE, V437, P889, DOI 10.1038/nature04230; Vijaykrishna D, 2010, SCIENCE, V328, P1529, DOI 10.1126/science.1189132; Wang RuoJun, 2006, Banff Pork Seminar Proceedings 2006. The Pork Wars - Internal & External Threats, 17-20 January, 2006, Banff, Alberta, Canada, P33; Webby RJ, 2000, J VIROL, V74, P8243, DOI 10.1128/JVI.74.18.8243-8251.2000; Wolfe ND, 2007, NATURE, V447, P279, DOI 10.1038/nature05775; Yu H, 2008, J CLIN MICROBIOL, V46, P1067, DOI 10.1128/JCM.01257-07; Zhang J., 2008, PEOPLES REPUBLIC CHI	32	170	191	2	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 26	2011	473	7348					519	U263		10.1038/nature10004	http://dx.doi.org/10.1038/nature10004			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	768QM	21614079	Bronze			2022-12-24	WOS:000290951300042
J	Boly, M; Garrido, MI; Gosseries, O; Bruno, MA; Boveroux, P; Schnakers, C; Massimini, M; Litvak, V; Laureys, S; Friston, KJ				Boly, Melanie; Garrido, Marta Isabel; Gosseries, Olivia; Bruno, Marie-Aurelie; Boveroux, Pierre; Schnakers, Caroline; Massimini, Marcello; Litvak, Vladimir; Laureys, Steven; Friston, Karl J.			Preserved Feedforward But Impaired Top-Down Processes in the Vegetative State	SCIENCE			English	Article							MINIMALLY CONSCIOUS STATE; MISMATCH NEGATIVITY; RESPONSES; MMN; POTENTIALS; EEG	Frontoparietal cortex is involved in the explicit processing (awareness) of stimuli. Frontoparietal activation has also been found in studies of subliminal stimulus processing. We hypothesized that an impairment of top-down processes, involved in recurrent neuronal message-passing and the generation of long-latency electrophysiological responses, might provide a more reliable correlate of consciousness in severely brain-damaged patients, than frontoparietal responses. We measured effective connectivity during a mismatch negativity paradigm and found that the only significant difference between patients in a vegetative state and controls was an impairment of backward connectivity from frontal to temporal cortices. This result emphasizes the importance of top-down projections in recurrent processing that involve high-order associative cortices for conscious perception.	[Boly, Melanie; Gosseries, Olivia; Bruno, Marie-Aurelie; Schnakers, Caroline; Laureys, Steven] Univ Liege, Coma Sci Grp, Cyclotron Res Ctr, B-4000 Liege, Belgium; [Boly, Melanie; Gosseries, Olivia; Bruno, Marie-Aurelie; Schnakers, Caroline; Laureys, Steven] Univ Liege, Dept Neurol, B-4000 Liege, Belgium; [Boly, Melanie; Gosseries, Olivia; Bruno, Marie-Aurelie; Boveroux, Pierre; Schnakers, Caroline; Laureys, Steven] CHU Sart Tilman Hosp, B-4000 Liege, Belgium; [Boly, Melanie; Garrido, Marta Isabel; Litvak, Vladimir; Friston, Karl J.] UCL, Wellcome Trust Ctr Neuroimaging, Inst Neurol, London WC1N 1PJ, England; [Boveroux, Pierre] Univ Liege, Dept Anesthesiol, B-4000 Liege, Belgium; [Massimini, Marcello] Univ Milan, Dept Clin Sci, I-20157 Milan, Italy	University of Liege; University of Liege; University of Liege; University of London; University College London; University of Liege; University of Milan	Boly, M (corresponding author), Univ Liege, Coma Sci Grp, Cyclotron Res Ctr, B-4000 Liege, Belgium.	mboly@ulg.ac.be	Gosseries, Olivia/AAB-6469-2020; Litvak, Vladimir/C-1533-2008; Friston, Karl/D-9230-2011; Laureys, Steven/A-3349-2011; Garrido, Marta I/B-7372-2013; Laureys, Steven/AAN-2097-2021; Massimini, Marcello/T-8115-2017	Gosseries, Olivia/0000-0001-9011-7496; Litvak, Vladimir/0000-0001-8535-7452; Friston, Karl/0000-0001-7984-8909; Laureys, Steven/0000-0002-3096-3807; Boly, Melanie/0000-0001-9584-0907; Bekinschtein, Tristan/0000-0001-5501-8628; Garrido, Marta/0000-0003-0679-4959; Massimini, Marcello/0000-0003-2271-957X	Belgian Fonds National de la Recherche Scientifique (FNRS); European Commission; Mind Science Foundation; McDonnell Foundation; French-Speaking Community Concerted Research Action [ARC 06/11-340]; Fondation Leon Fredericq; National Institutes of Health; Wellcome Trust	Belgian Fonds National de la Recherche Scientifique (FNRS)(Fonds de la Recherche Scientifique - FNRS); European Commission(European CommissionEuropean Commission Joint Research Centre); Mind Science Foundation; McDonnell Foundation; French-Speaking Community Concerted Research Action; Fondation Leon Fredericq; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Belgian Fonds National de la Recherche Scientifique (FNRS), European Commission, Mind Science Foundation, McDonnell Foundation, French-Speaking Community Concerted Research Action (ARC 06/11-340), Fondation Leon Fredericq, and National Institutes of Health. M.-A. B. and O.G. are Research Fellows, M. B. and C. S. Postdoctoral Fellows, and S. L. Senior Research Associate at the FNRS. M. I. G., V. L., and K. F. are supported by the Wellcome Trust.	Balduzzi D, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000091; Boly M, 2004, ARCH NEUROL-CHICAGO, V61, P233, DOI 10.1001/archneur.61.2.233; David O, 2005, NEUROIMAGE, V25, P756, DOI 10.1016/j.neuroimage.2004.12.030; David O, 2006, NEUROIMAGE, V30, P1255, DOI 10.1016/j.neuroimage.2005.10.045; Dehaene S, 2006, TRENDS COGN SCI, V10, P204, DOI 10.1016/j.tics.2006.03.007; Del Cul A, 2007, PLOS BIOL, V5, P2408, DOI 10.1371/journal.pbio.0050260; Diaz MT, 2007, J COGNITIVE NEUROSCI, V19, P1768, DOI 10.1162/jocn.2007.19.11.1768; Fischer C, 2010, CLIN NEUROPHYSIOL, V121, P1032, DOI 10.1016/j.clinph.2010.02.005; Friston KJ, 2010, NAT REV NEUROSCI, V11, P127, DOI 10.1038/nrn2787; Friston KJ, 2009, SCIENCE, V326, P399, DOI 10.1126/science.1174521; Friston KJ, 2003, NEUROIMAGE, V19, P1273, DOI 10.1016/S1053-8119(03)00202-7; Garrido MI, 2008, NEUROIMAGE, V42, P936, DOI 10.1016/j.neuroimage.2008.05.018; Garrido MI, 2007, P NATL ACAD SCI USA, V104, P20961, DOI 10.1073/pnas.0706274105; Garrido MI, 2007, NEUROIMAGE, V36, P571, DOI 10.1016/j.neuroimage.2007.03.014; Garrido MI, 2009, NEUROIMAGE, V48, P269, DOI 10.1016/j.neuroimage.2009.06.034; Garrido MI, 2009, CLIN NEUROPHYSIOL, V120, P453, DOI 10.1016/j.clinph.2008.11.029; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Heinke W, 2004, ANESTHESIOLOGY, V100, P617, DOI 10.1097/00000542-200403000-00023; Kiebel SJ, 2009, HUM BRAIN MAPP, V30, P1866, DOI 10.1002/hbm.20775; Lamme VAF, 2006, TRENDS COGN SCI, V10, P494, DOI 10.1016/j.tics.2006.09.001; Laureys S, 2005, TRENDS COGN SCI, V9, P556, DOI 10.1016/j.tics.2005.10.010; Laureys S, 2004, LANCET NEUROL, V3, P537, DOI 10.1016/S1474-4422(04)00852-X; Luo Q, 2009, CEREB CORTEX, V19, P1896, DOI 10.1093/cercor/bhn216; Naatanen R, 2007, CLIN NEUROPHYSIOL, V118, P2544, DOI 10.1016/j.clinph.2007.04.026; Rees G, 2002, NAT REV NEUROSCI, V3, P261, DOI 10.1038/nrn783; ROTH M, 1956, ELECTROEN CLIN NEURO, V8, P385, DOI 10.1016/0013-4694(56)90004-9; Ruby P, 2008, J COGNITIVE NEUROSCI, V20, P296, DOI 10.1162/jocn.2008.20023; Schnakers C, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-35; Wijnen VJM, 2007, CLIN NEUROPHYSIOL, V118, P597, DOI 10.1016/j.clinph.2006.11.020	29	323	336	0	76	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 13	2011	332	6031					858	862		10.1126/science.1202043	http://dx.doi.org/10.1126/science.1202043			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763CD	21566197	Green Submitted			2022-12-24	WOS:000290529900051
J	Schlacher, K; Christ, N; Siaud, N; Egashira, A; Wu, H; Jasin, M				Schlacher, Katharina; Christ, Nicole; Siaud, Nicolas; Egashira, Akinori; Wu, Hong; Jasin, Maria			Double-Strand Break Repair-Independent Role for BRCA2 in Blocking Stalled Replication Fork Degradation by MRE11	CELL			English	Article							WERNER-SYNDROME PROTEIN; DNA-REPLICATION; HOMOLOGOUS RECOMBINATION; CANCER SUSCEPTIBILITY; GENOMIC STABILITY; ATP HYDROLYSIS; HUMAN RAD51; CELLS; COMPLEX; HYPERSENSITIVITY	Breast cancer suppressor BRCA2 is critical for maintenance of genomic integrity and resistance to agents that damage DNA or collapse replication forks, presumably through homology-directed repair of double-strand breaks (HDR). Using single-molecule DNA fiber analysis, we show here that nascent replication tracts created before fork stalling with hydroxyurea are degraded in the absence of BRCA2 but are stable in wild-type cells. BRCA2 mutational analysis reveals that a conserved C-terminal site involved in stabilizing RAD51 filaments, but not in loading RAD51 onto DNA, is essential for this fork protection but dispensable for HDR. RAD51 filament disruption in wild-type cells phenocopies BRCA2 deficiency. BRCA2 prevents chromosomal aberrations on replication stalling, which are alleviated by inhibition of MRE11, the nuclease responsible for this form of fork instability. Thus, BRCA2 prevents rather than repairs nucleolytic lesions at stalled replication forks to maintain genomic integrity and hence likely suppresses tumorigenesis through this replication-specific function.	[Schlacher, Katharina; Christ, Nicole; Siaud, Nicolas; Egashira, Akinori; Jasin, Maria] Mem Sloan Kettering Canc Ctr, Dev Biol Program, New York, NY 10065 USA; [Schlacher, Katharina; Wu, Hong] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Wu, Hong] Univ Calif Los Angeles, Inst Mol Med, Los Angeles, CA 90095 USA	Memorial Sloan Kettering Cancer Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Schlacher, K (corresponding author), Mem Sloan Kettering Canc Ctr, Dev Biol Program, New York, NY 10065 USA.	schlachk@mskcc.org; m-jasin@ski.mskcc.org		SCHLACHER, KATHARINA/0000-0001-7226-6391	Susan G. Komen grant [BCTR122106]; NIH [R01CA121110, R01GM54668, P01CA94060]; NATIONAL CANCER INSTITUTE [R01CA121110, P01CA094060] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054668] Funding Source: NIH RePORTER	Susan G. Komen grant(Susan G. Komen Breast Cancer Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Francesca Cole, Jeannine LaRocque, Koji Nakanishi, Yu Zhang, and other members of the Jasin lab and for reagents and discussions, Marie-Emilie Terret (MSKCC) and Margaret Leversha (MSKCC) for technical assistance, Julia Sidorova (Seattle) for critical discussions along with Duncan Wright (MSKCC) and Reginald Hill (UCLA), and Toshiyasu Taniguchi (Seattle), Ouathek Ouerfelli (MSKCC), and Berry Sleckman (St. Louis) for reagents. K. S. is the Berger Foundation Fellow of the Damon Runyon Cancer Research Foundation (DRG 1957-07). This work was supported by Susan G. Komen grant BCTR122106 (M.J.) and NIH grants R01CA121110 (H. W.) and R01GM54668 and P01CA94060 (M.J.).	Ayoub Nabieh, 2009, Curr Biol, V19, P1075, DOI 10.1016/j.cub.2009.05.057; BENSON FE, 1994, EMBO J, V13, P5764, DOI 10.1002/j.1460-2075.1994.tb06914.x; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Budzowska M, 2009, CELL BIOCHEM BIOPHYS, V53, P17, DOI 10.1007/s12013-008-9039-y; Cheng WH, 2004, J BIOL CHEM, V279, P21169, DOI 10.1074/jbc.M312770200; Cotta-Ramusino C, 2005, MOL CELL, V17, P153, DOI 10.1016/j.molcel.2004.11.032; Davies AA, 2001, MOL CELL, V7, P273, DOI 10.1016/S1097-2765(01)00175-7; Davies OR, 2007, NAT STRUCT MOL BIOL, V14, P475, DOI 10.1038/nsmb1251; Donoho G, 2003, GENE CHROMOSOME CANC, V36, P317, DOI 10.1002/gcc.10148; Dupre A, 2008, NAT CHEM BIOL, V4, P119, DOI 10.1038/nchembio.63; Edwards SL, 2008, NATURE, V451, P1111, DOI 10.1038/nature06548; Esashi F, 2005, NATURE, V434, P598, DOI 10.1038/nature03404; Esashi F, 2007, NAT STRUCT MOL BIOL, V14, P468, DOI 10.1038/nsmb1245; Essers J, 1997, CELL, V89, P195, DOI 10.1016/S0092-8674(00)80199-3; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; FISHMANLOBELL J, 1992, MOL CELL BIOL, V12, P1292, DOI 10.1128/MCB.12.3.1292; Foiani M, 2000, MUTAT RES-FUND MOL M, V451, P187, DOI 10.1016/S0027-5107(00)00049-X; Franchitto A, 2004, CELL CYCLE, V3, P1331, DOI 10.4161/cc.3.10.1185; Goggins M, 1996, CANCER RES, V56, P5360; Gu YS, 1997, P NATL ACAD SCI USA, V94, P8076, DOI 10.1073/pnas.94.15.8076; Gudmundsdottir K, 2006, ONCOGENE, V25, P5864, DOI 10.1038/sj.onc.1209874; Hanada K, 2007, NAT STRUCT MOL BIOL, V14, P1096, DOI 10.1038/nsmb1313; Hashimoto Y, 2010, NAT STRUCT MOL BIOL, V17, P1305, DOI 10.1038/nsmb.1927; Hay T, 2005, BIOCHEM SOC T, V33, P715, DOI 10.1042/BST0330715; Heyer WD, 2006, NUCLEIC ACIDS RES, V34, P4115, DOI 10.1093/nar/gkl481; Jackson DA, 1998, J CELL BIOL, V140, P1285, DOI 10.1083/jcb.140.6.1285; Jensen RB, 2010, NATURE, V467, P678, DOI 10.1038/nature09399; Kass EM, 2010, FEBS LETT, V584, P3703, DOI 10.1016/j.febslet.2010.07.057; Lomonosov M, 2003, GENE DEV, V17, P3017, DOI 10.1101/gad.279003; Mazloum N, 2009, MOL CELL, V36, P620, DOI 10.1016/j.molcel.2009.09.033; McAllister KA, 2002, CANCER RES, V62, P990; Mimitou EP, 2009, DNA REPAIR, V8, P983, DOI 10.1016/j.dnarep.2009.04.017; Morimatsu M, 1998, CANCER RES, V58, P3441; Morrison C, 1999, MOL CELL BIOL, V19, P6891; Moynahan ME, 2010, NAT REV MOL CELL BIO, V11, P196, DOI 10.1038/nrm2851; Moynahan ME, 2001, MOL CELL, V7, P263, DOI 10.1016/S1097-2765(01)00174-5; Moynahan ME, 2002, ONCOGENE, V21, P8994, DOI 10.1038/sj.onc.1206177; Nagaraju G, 2007, DNA REPAIR, V6, P1018, DOI 10.1016/j.dnarep.2007.02.020; Navarro S, 2006, MOL THER, V14, P525, DOI 10.1016/j.ymthe.2006.05.018; Negrini S, 2010, NAT REV MOL CELL BIO, V11, P220, DOI 10.1038/nrm2858; Petermann E, 2010, MOL CELL, V37, P492, DOI 10.1016/j.molcel.2010.01.021; Pierce AJ, 2001, GENE DEV, V15, P3237, DOI 10.1101/gad.946401; Postow L, 2001, P NATL ACAD SCI USA, V98, P8219, DOI 10.1073/pnas.111006998; Saeki H, 2006, P NATL ACAD SCI USA, V103, P8768, DOI 10.1073/pnas.0600298103; Sakai W, 2008, NATURE, V451, P1116, DOI 10.1038/nature06633; Schlacher K, 2007, NAT REV MOL CELL BIO, V8, P587, DOI 10.1038/nrm2198; Sogo JM, 2002, SCIENCE, V297, P599, DOI 10.1126/science.1074023; Stark JM, 2002, J BIOL CHEM, V277, P20185, DOI 10.1074/jbc.M112132200; Su X, 2008, NAT STRUCT MOL BIOL, V15, P1049, DOI 10.1038/nsmb.1490; van Mameren J, 2009, NATURE, V457, P745, DOI 10.1038/nature07581; Wang Y, 2000, GENE DEV, V14, P927; Wiegant WW, 2006, MUTAT RES-FUND MOL M, V600, P79, DOI 10.1016/j.mrfmmm.2006.03.001; Williams RS, 2008, CELL, V135, P97, DOI 10.1016/j.cell.2008.08.017	53	792	802	1	57	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 13	2011	145	4					529	542		10.1016/j.cell.2011.03.041	http://dx.doi.org/10.1016/j.cell.2011.03.041			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	763MF	21565612	Bronze, Green Accepted			2022-12-24	WOS:000290560800007
J	Allison, KR; Brynildsen, MP; Collins, JJ				Allison, Kyle R.; Brynildsen, Mark P.; Collins, James J.			Metabolite-enabled eradication of bacterial persisters by aminoglycosides	NATURE			English	Article							ESCHERICHIA-COLI; PSEUDOMONAS-AERUGINOSA; ANTIBIOTIC TOLERANCE; CELLS; RESISTANCE; MECHANISM; BIOFILMS; ROLES; DEATH; ANTIMICROBIALS	Bacterial persistence is a state in which a sub-population of dormant cells, or 'persisters', tolerates antibiotic treatment(1-4). Bacterial persisters have been implicated in biofilms and in chronic and recurrent infections(5-7). Despite this clinical relevance, there are currently no viable means for eradicating persisters. Here we show that specific metabolic stimuli enable the killing of both Gram-negative (Escherichia coli) and Gram-positive (Staphylococcus aureus) persisters with aminoglycosides. This potentiation is aminoglycoside-specific, it does not rely on growth resumption and it is effective in both aerobic and anaerobic conditions. It proceeds by the generation of a proton-motive force which facilitates aminoglycoside uptake. Our results demonstrate that persisters, although dormant, are primed for metabolite uptake, central metabolism and respiration. We show that aminoglycosides can be used in combination with specific metabolites to treat E. coli and S. aureus biofilms. Furthermore, we demonstrate that this approach can improve the treatment of chronic infections in a mouse urinary tract infection model. This work establishes a strategy for eradicating bacterial persisters that is based on metabolism, and highlights the importance of the metabolic environment to antibiotic treatment.	[Allison, Kyle R.; Brynildsen, Mark P.; Collins, James J.] Boston Univ, Howard Hughes Med Inst, Dept Biomed Engn, Ctr Biodynam, Boston, MA 02215 USA; [Collins, James J.] Boston Univ, Sch Med, Boston, MA 02118 USA; [Collins, James J.] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02118 USA	Boston University; Howard Hughes Medical Institute; Boston University; Harvard University	Collins, JJ (corresponding author), Boston Univ, Howard Hughes Med Inst, Dept Biomed Engn, Ctr Biodynam, Boston, MA 02215 USA.	jcollins@bu.edu			NIH; Howard Hughes Medical Institute; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003644] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank A. Slee and T. Murphy from ViviSource Laboratories for assistance with the in vivo mouse studies and T. K. Lu for guidance with the biofilm experiments. This work was supported by the NIH Director's Pioneer Award Program and the Howard Hughes Medical Institute.	Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; BRYAN LE, 1983, ANTIMICROB AGENTS CH, V23, P835, DOI 10.1128/AAC.23.6.835; DAVIS BD, 1987, MICROBIOL REV, V51, P341, DOI 10.1128/MMBR.51.3.341-350.1987; Dhar N, 2007, CURR OPIN MICROBIOL, V10, P30, DOI 10.1016/j.mib.2006.12.007; Dwyer DJ, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100135; FRAIMOW HS, 1991, J BACTERIOL, V173, P2800, DOI 10.1128/JB.173.9.2800-2808.1991; Gefen O, 2008, P NATL ACAD SCI USA, V105, P6145, DOI 10.1073/pnas.0711712105; Gefen O, 2009, FEMS MICROBIOL REV, V33, P704, DOI 10.1111/j.1574-6976.2008.00156.x; Govantes F, 2000, MOL MICROBIOL, V37, P1456, DOI 10.1046/j.1365-2958.2000.02100.x; Hansen S, 2008, ANTIMICROB AGENTS CH, V52, P2718, DOI 10.1128/AAC.00144-08; HILL S, 1990, J BACTERIOL, V172, P2071, DOI 10.1128/jb.172.4.2071-2078.1990; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Keren I, 2004, J BACTERIOL, V186, P8172, DOI 10.1128/JB.186.24.8172-8180.2004; Keren I, 2004, FEMS MICROBIOL LETT, V230, P13, DOI 10.1016/S0378-1097(03)00856-5; Kohanski MA, 2008, CELL, V135, P679, DOI 10.1016/j.cell.2008.09.038; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Levin BR, 2006, NAT REV MICROBIOL, V4, P556, DOI 10.1038/nrmicro1445; Lewis K, 2007, NAT REV MICROBIOL, V5, P48, DOI 10.1038/nrmicro1557; Lu TK, 2007, P NATL ACAD SCI USA, V104, P11197, DOI 10.1073/pnas.0704624104; Magnet S, 2005, CHEM REV, V105, P477, DOI 10.1021/cr0301088; Majerczyk CD, 2010, J BACTERIOL, V192, P2861, DOI 10.1128/JB.00220-10; MATES SM, 1982, P NATL ACAD SCI-BIOL, V79, P6693, DOI 10.1073/pnas.79.21.6693; Sandoval R, 1998, J AM SOC NEPHROL, V9, P167; Shah D, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-53; Smith PA, 2007, NAT CHEM BIOL, V3, P549, DOI 10.1038/nchembio.2007.27; Spoering AL, 2001, J BACTERIOL, V183, P6746, DOI 10.1128/JB.183.23.6746-6751.2001; TABER HW, 1987, MICROBIOL REV, V51, P439, DOI 10.1128/MMBR.51.4.439-457.1987; Vakulenko SB, 2003, CLIN MICROBIOL REV, V16, P430, DOI 10.1128/CMR.16.3.430-450.2003; Walters MC, 2003, ANTIMICROB AGENTS CH, V47, P317, DOI 10.1128/AAC.47.1.317-323.2003; WEISBLUM B, 1968, BACTERIOL REV, V32, P493, DOI 10.1128/MMBR.32.4_Pt_2.493-528.1968	30	594	625	15	269	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 12	2011	473	7346					216	+		10.1038/nature10069	http://dx.doi.org/10.1038/nature10069			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	762NT	21562562	Green Accepted			2022-12-24	WOS:000290487200039
J	Lucanic, M; Held, JM; Vantipalli, MC; Klang, IM; Graham, JB; Gibson, BW; Lithgow, GJ; Gill, MS				Lucanic, Mark; Held, Jason M.; Vantipalli, Maithili C.; Klang, Ida M.; Graham, Jill B.; Gibson, Bradford W.; Lithgow, Gordon J.; Gill, Matthew S.			N-acylethanolamine signalling mediates the effect of diet on lifespan in Caenorhabditis elegans	NATURE			English	Article							RESTRICTION-INDUCED LONGEVITY; C-ELEGANS; ENDOCANNABINOID SYSTEM; EVOLUTIONARY ORIGINS; DAUER FORMATION; FOOD-INTAKE; EXTENSION; ACID; MECHANISMS; EXPRESSION	Dietary restriction is a robust means of extending adult lifespan and postponing age-related disease in many species, including yeast, nematode worms, flies and rodents(1,2). Studies of the genetic requirements for lifespan extension by dietary restriction in the nematode Caenorhabditis elegans have implicated a number of key molecules in this process(3-5), including the nutrient-sensing target of rapamycin (TOR) pathway(6) and the Foxa transcription factor PHA-4 (ref. 7). However, little is known about the metabolic signals that coordinate the organismal response to dietary restriction and maintain homeostasis when nutrients are limited. The endocannabinoid system is an excellent candidate for such a role given its involvement in regulating nutrient intake and energy balance(8). Despite this, a direct role for endocannabinoid signalling in dietary restriction or lifespan determination has yet to be demonstrated, in part due to the apparent absence of endocannabinoid signalling pathways in model organisms that are amenable to lifespan analysis(9). N-acylethanolamines (NAEs) are lipid-derived signalling molecules, which include the mammalian endocannabinoid arachidonoyl ethanolamide. Here we identify NAEs in C. elegans, show that NAE abundance is reduced under dietary restriction and that NAE deficiency is sufficient to extend lifespan through a dietary restriction mechanism requiring PHA-4. Conversely, dietary supplementation with the nematode NAE eicosapentaenoyl ethanolamide not only inhibits dietary-restriction-induced lifespan extension in wild-type worms, but also suppresses lifespan extension in a TOR pathway mutant. This demonstrates a role for NAE signalling in ageing and indicates that NAEs represent a signal that coordinates nutrient status with metabolic changes that ultimately determine lifespan.	[Lucanic, Mark; Held, Jason M.; Vantipalli, Maithili C.; Klang, Ida M.; Graham, Jill B.; Gibson, Bradford W.; Lithgow, Gordon J.; Gill, Matthew S.] Buck Inst Res Aging, Novato, CA 94945 USA; [Klang, Ida M.] Karolinska Inst, Ctr Biosci, Novum, Dept Biosci & Nutr, S-14183 Huddinge, Sweden	Buck Institute for Research on Aging; Karolinska Institutet	Gill, MS (corresponding author), Scripps Res Inst Scripps Florida, 130 Scripps Way,3B3, Jupiter, FL 33458 USA.	mgill@scripps.edu		Held, Jason/0000-0001-8024-2736; lucanic, mark/0000-0003-1511-1013; Gill, Matthew/0000-0003-0818-8792	NIH National Center for Research Resources (NCRR); NIH [T32 AG000266, R01 AG029631, PL1-AG032118, UL1 DE019608, R21 AG030192, R01 AG036992]; Larry L. Hillblom Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024917] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [UL1DE019608] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG036992, T32AG000266, R21AG030192, R01AG029631, PL1AG032118] Funding Source: NIH RePORTER	NIH National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Larry L. Hillblom Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Some nematode strains used in this work were provided by the Caenorhabditis Genetics Center, which is funded by the NIH National Center for Research Resources (NCRR). We would like to thank N. J. Harrison, A. Olsen and P. Kapahi. M.L. was supported by NIH training grant T32 AG000266 and NIH grant R01 AG029631. GC-MS analysis was made possible through the Mass Spectrometry and Imaging Technologies Core supported by NIH grant PL1-AG032118. This work was supported by a Larry L. Hillblom Foundation grant and NIH grants to G.J.L. (UL1 DE019608, supporting the Interdisciplinary Research Consortium on Geroscience and R01 AG029631) and by NIH grants R21 AG030192 and R01 AG036992 to M.S.G.	Banni S, 2010, MOL NUTR FOOD RES, V54, P82, DOI 10.1002/mnfr.200900516; Bishop NA, 2007, NAT REV GENET, V8, P835, DOI 10.1038/nrg2188; Bishop NA, 2007, NATURE, V447, P545, DOI 10.1038/nature05904; Breunig E, 2010, J NEUROSCI, V30, P8965, DOI 10.1523/JNEUROSCI.4030-09.2010; Carrano AC, 2009, NATURE, V460, P396, DOI 10.1038/nature08130; Chen D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000486; De Petrocellis L, 1999, NEUROSCIENCE, V92, P377, DOI 10.1016/S0306-4522(98)00749-0; Di Marzo V, 2004, NAT REV DRUG DISCOV, V3, P771, DOI 10.1038/nrd1495; Di Marzo V, 2005, NAT NEUROSCI, V8, P585, DOI 10.1038/nn1457; Dupuy D, 2007, NAT BIOTECHNOL, V25, P663, DOI 10.1038/nbt1305; Elphick MR, 2007, GENE, V399, P65, DOI 10.1016/j.gene.2007.04.025; Elphick MR, 2005, HANDB EXP PHARMACOL, V168, P283; FABIAN TJ, 1994, J GERONTOL, V49, pB145, DOI 10.1093/geronj/49.4.B145; Fielenbach N, 2008, GENE DEV, V22, P2149, DOI 10.1101/gad.1701508; Hardison S, 2006, PROSTAG OTH LIPID M, V81, P106, DOI 10.1016/j.prostaglandins.2006.08.002; Held JM, 2006, AGING CELL, V5, P283, DOI 10.1111/j.1474-9726.2006.00218.x; Hobert O, 2002, BIOTECHNIQUES, V32, P728, DOI 10.2144/02324bm01; Honjoh S, 2009, NATURE, V457, P726, DOI 10.1038/nature07583; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Izzo AA, 2010, OBESITY, V18, P55, DOI 10.1038/oby.2009.186; Kaeberlein TL, 2006, AGING CELL, V5, P487, DOI 10.1111/j.1474-9726.2006.00238.x; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kapahi P, 2010, CELL METAB, V11, P453, DOI 10.1016/j.cmet.2010.05.001; Kirkham TC, 2002, BRIT J PHARMACOL, V136, P550, DOI 10.1038/sj.bjp.0704767; Knight CG, 2002, EVOL DEV, V4, P16, DOI 10.1046/j.1525-142x.2002.01058.x; Lehtonen M, 2008, CHEM BIODIVERS, V5, P2431, DOI 10.1002/cbdv.200890208; Leung D, 2006, BIOCHEMISTRY-US, V45, P4720, DOI 10.1021/bi060163l; LITHGOW GJ, 1995, P NATL ACAD SCI USA, V92, P7540, DOI 10.1073/pnas.92.16.7540; Mair W, 2008, ANNU REV BIOCHEM, V77, P727, DOI 10.1146/annurev.biochem.77.061206.171059; Mair W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004535; McPartland JM, 2006, GENE, V370, P64, DOI 10.1016/j.gene.2005.11.004; McPartland JM, 2003, GENE, V312, P297, DOI 10.1016/S0378-1119(03)00638-3; Panowski SH, 2007, NATURE, V447, P550, DOI 10.1038/nature05837; Soderstrom K, 2004, J NEUROSCI, V24, P10013, DOI 10.1523/JNEUROSCI.3298-04.2004; Sulston J., 1988, NEMATODE CAENORHABDI, P587; Sultana T, 2006, J CHROMATOGR A, V1101, P278, DOI 10.1016/j.chroma.2005.10.027; Timmons L, 2003, MOL BIOL CELL, V14, P2972, DOI 10.1091/mbc.E03-01-0858; Valenti M, 2005, J NEUROCHEM, V95, P662, DOI 10.1111/j.1471-4159.2005.03406.x; Watts JL, 2002, P NATL ACAD SCI USA, V99, P5854, DOI 10.1073/pnas.092064799	39	104	111	6	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 12	2011	473	7346					226	+		10.1038/nature10007	http://dx.doi.org/10.1038/nature10007			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	762NT	21562563	Green Accepted			2022-12-24	WOS:000290487200041
J	Kim, HJ; Ruszczycky, MW; Choi, SH; Liu, YN; Liu, HW				Kim, Hak Joong; Ruszczycky, Mark W.; Choi, Sei-hyun; Liu, Yung-nan; Liu, Hung-wen			Enzyme-catalysed [4+2] cycloaddition is a key step in the biosynthesis of spinosyn A	NATURE			English	Article							DIELS-ALDER REACTION; MACROPHOMATE SYNTHASE; SACCHAROPOLYSPORA-SPINOSA; SUGAR BIOSYNTHESIS; MECHANISM	The Diels-Alder reaction is a [4+2] cycloaddition reaction in which a cyclohexene ring is formed between a 1,3-diene and an electron-deficient alkene via a single pericyclic transition state(1). This reaction has been proposed as a key transformation in the biosynthesis of many cyclohexene-containing secondary metabolites(2-5). However, only four purified enzymes have thus far been implicated in biotransformations that are consistent with a Diels-Alder reaction, namely solanapyrone synthase(6), LovB(7,8), macrophomate synthase(9,10), and riboflavin synthase(11,12). Although the stereochemical outcomes of these reactions indicate that the product formation could be enzyme-guided in each case, these enzymes typically demonstrate more than one catalytic activity, leaving their specific influence on the cycloaddition step uncertain. In our studies of the biosynthesis of spinosyn A, a tetracyclic polyketide-derived insecticide from Saccharopolyspora spinosa(13,14), we identified a cyclase, SpnF, that catalyses a transannular [4+2] cycloaddition to form the cyclohexene ring in spinosyn A. Kinetic analysis demonstrates that SpnF specifically accelerates the ring formation reaction with an estimated 500-fold rate enhancement. A second enzyme, SpnL, was also identified as responsible for the final cross-bridging step that completes the tetracyclic core of spinosyn A in a manner consistent with a Rauhut-Currier reaction(15). This work is significant because SpnF represents the first example characterized in vitro of a standalone enzyme solely committed to the catalysis of a [4+2] cycloaddition reaction. In addition, the mode of formation of the complex perhydro-as-indacene moiety in spinosyn A is now fully established.	[Kim, Hak Joong; Choi, Sei-hyun; Liu, Hung-wen] Univ Texas Austin, Dept Chem & Biochem, Austin, TX 78712 USA; [Ruszczycky, Mark W.; Liu, Yung-nan; Liu, Hung-wen] Univ Texas Austin, Coll Pharm, Div Med Chem, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Liu, HW (corresponding author), Univ Texas Austin, Dept Chem & Biochem, Austin, TX 78712 USA.	h.w.liu@mail.utexas.edu	Kim, Hak Joong/D-1117-2013		National Institutes of Health [GM035906, F32AI082906]; Texas Higher Education Coordination Board [ARP-003658-0093-2007]; Welch Foundation [F-1511]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI082906] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040541, R01GM035906, R37GM035906] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Texas Higher Education Coordination Board; Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. Whitman for review of the manuscript, L. Hong for carrying out the early cloning work, B. Shoulders and S. Sorey for assistance with the interpretation of the NMR spectra, and S. Mansoorabadi and E. Isiorho for discussions on the reaction mechanisms and structural modelling of SpnF. This work is supported in part by grants from the National Institutes of Health (GM035906, F32AI082906), the Texas Higher Education Coordination Board (ARP-003658-0093-2007), and the Welch Foundation (F-1511).	Aroyan CE, 2009, TETRAHEDRON, V65, P4069, DOI 10.1016/j.tet.2009.02.066; Auclair K, 2000, J AM CHEM SOC, V122, P11519, DOI 10.1021/ja003216+; Chen YL, 2009, J BIOL CHEM, V284, P7352, DOI 10.1074/jbc.M808441200; Draper N.R., 1998, WILEY SERIES PROBABI, V326; Eberhardt S, 2001, EUR J BIOCHEM, V268, P4315, DOI 10.1046/j.1432-1327.2001.02351.x; FRIEDEN C, 1994, METHOD ENZYMOL, V240, P311; Guimaraes CRW, 2005, J AM CHEM SOC, V127, P3577, DOI 10.1021/ja043905b; HUISGEN R, 1968, ANGEW CHEM INT EDIT, V7, P321, DOI 10.1002/anie.196803211; Kelly WL, 2008, ORG BIOMOL CHEM, V6, P4483, DOI 10.1039/b814552k; Kim HJ, 2007, J AM CHEM SOC, V129, P14582, DOI 10.1021/ja076580i; Kim HJ, 2010, J AM CHEM SOC, V132, P2901, DOI 10.1021/ja910223x; Kim RR, 2010, J AM CHEM SOC, V132, P2983, DOI 10.1021/ja908395r; KIRST HA, 1991, TETRAHEDRON LETT, V32, P4839, DOI 10.1016/S0040-4039(00)93474-9; Kirst HA, 2010, J ANTIBIOT, V63, P101, DOI 10.1038/ja.2010.5; Ma SM, 2009, SCIENCE, V326, P589, DOI 10.1126/science.1175602; Martin CJ, 2003, ORG BIOMOL CHEM, V1, P4144, DOI 10.1039/b310740j; Mergott DJ, 2004, P NATL ACAD SCI USA, V101, P11955, DOI 10.1073/pnas.0401247101; Oikawa H, 2005, B CHEM SOC JPN, V78, P537, DOI 10.1246/bcsj.78.537; Oikawa H, 2003, J ORG CHEM, V68, P3552, DOI 10.1021/jo0267596; OIKAWA H, 1995, J CHEM SOC CHEM COMM, P1321, DOI 10.1039/c39950001321; Oikawa H, 2010, COMPREHENSIVE NATURAL PRODUCTS II: CHEMISTRY AND BIOLOGY, VOL 8: ENZYMES AND ENZYME MECHANISMS, P277; Ose T, 2003, NATURE, V422, P185, DOI 10.1038/nature01454; Serafimov JM, 2008, J AM CHEM SOC, V130, P7798, DOI 10.1021/ja8017994; Stocking EM, 2003, ANGEW CHEM INT EDIT, V42, P3078, DOI 10.1002/anie.200200534; Tenenbaum M., 1985, ORDINARY DIFFERENTIA; Thibodeaux CJ, 2007, NATURE, V446, P1008, DOI 10.1038/nature05814; Thibodeaux CJ, 2008, ANGEW CHEM INT EDIT, V47, P9814, DOI 10.1002/anie.200801204; Waldron C, 2001, CHEM BIOL, V8, P487, DOI 10.1016/S1074-5521(01)00029-1; Watanabe K, 2000, J BIOL CHEM, V275, P38393, DOI 10.1074/jbc.M003119200	29	223	223	8	179	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 5	2011	473	7345					109	112		10.1038/nature09981	http://dx.doi.org/10.1038/nature09981			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759CQ	21544146	Green Accepted			2022-12-24	WOS:000290218300041
J	OCarroll, DC; Bidwell, NJ; Laughlin, SB; Warrant, EJ				OCarroll, DC; Bidwell, NJ; Laughlin, SB; Warrant, EJ			Insect motion detectors matched to visual ecology	NATURE			English	Article							SENSITIVE NEURON; DETECTION SYSTEM; ADAPTATION; SELECTIVITY	To detect motion, primates, birds and insects all use local detectors to correlate signals sampled at one location in the image with those sampled after a delay at adjacent locations(1-10) These detectors can adapt to high image velocities by shortening the delay(11-13). To investigate whether they use long delays for detecting low velocities, we compared motion-sensitive neurons in ten species of fast-flying insects, some of which encounter low velocities while hovering. Neurons of bee-flies and hawkmoths, which hover, are tuned to lower temporal frequencies than those of butterflies and bumblebees, which do not. Tuning to low frequencies indicates longer delays and extends sensitivity to lower velocities, Hoverflies retain fast temporal tuning but use their high spatial acuity for sensing low-velocity motion. Thus an unexpectedly wide range of spatio-temporal tuning matches motion detection to visual ecology.	UNIV SUSSEX,CTR NEUROSCI,BRIGHTON BN1 9QG,E SUSSEX,ENGLAND; LUND UNIV,DEPT ZOOL,S-22362 LUND,SWEDEN	University of Sussex; Lund University	OCarroll, DC (corresponding author), UNIV CAMBRIDGE,DEPT ZOOL,DOWNING ST,CAMBRIDGE CB2 3EJ,ENGLAND.		O'Carroll, David C/C-4320-2008	O'Carroll, David C/0000-0002-2352-4320; Warrant, Eric/0000-0001-7480-7016				ANDERSON SJ, 1985, VISION RES, V25, P1147, DOI 10.1016/0042-6989(85)90104-X; BARLOW HB, 1965, J PHYSIOL-LONDON, V178, P477, DOI 10.1113/jphysiol.1965.sp007638; BIDWELL NJ, 1993, APIDOLOGIE, V24, P333, DOI 10.1051/apido:19930311; BORST A, 1989, TRENDS NEUROSCI, V12, P297, DOI 10.1016/0166-2236(89)90010-6; Buchner E, 1984, PLENUM, P561, DOI DOI 10.1007/978-1-4613-2743-1_16; BURR DC, 1982, VISION RES, V22, P479, DOI 10.1016/0042-6989(82)90196-1; COLLETT TS, 1975, J COMP PHYSIOL, V99, P1, DOI 10.1007/BF01464710; EGELHAAF M, 1989, J OPT SOC AM A, V6, P1070, DOI 10.1364/JOSAA.6.001070; FARINA WM, 1994, J COMP PHYSIOL A, V174, P239; HASSENSTEIN B, 1956, Z NATURFORSCH PT B, V11, P513; Hausen K., 1989, P391; IBBOTSON MR, 1990, J EXP BIOL, V148, P255; KELLY DH, 1979, J OPT SOC AM, V69, P1340, DOI 10.1364/JOSA.69.001340; MADDESS T, 1985, PROC R SOC SER B-BIO, V225, P251, DOI 10.1098/rspb.1985.0061; MADDESS T, 1991, J EXP BIOL, V161, P171; MORGAN MJ, 1995, NATURE, V378, P380, DOI 10.1038/378380a0; REICHARDT W, 1957, Z NATURFORSCH PT B, V12, P448, DOI 10.1515/znb-1957-0707; Reichardt W., 1961, S PRINC SENS COMM, P303; SANTEN JPH, 1985, J OPT SOC AM A, V2, P300; VANSTEVENINCK RRD, 1986, BIOL CYBERN, V54, P223, DOI 10.1007/BF00318418; WILSON HR, 1985, BIOL CYBERN, V51, P213, DOI 10.1007/BF00337147; WOLFOBERHOLLENZER F, 1994, J NEUROPHYSIOL, V71, P1559, DOI 10.1152/jn.1994.71.4.1559	22	113	115	2	45	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	JUL 4	1996	382	6586					63	66		10.1038/382063a0	http://dx.doi.org/10.1038/382063a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UV473	21638927				2022-12-24	WOS:A1996UV47300053
J	Huang, PY; He, ZY; Ji, SY; Sun, HW; Xiang, D; Liu, CC; Hu, YP; Wang, X; Hui, LJ				Huang, Pengyu; He, Zhiying; Ji, Shuyi; Sun, Huawang; Xiang, Dao; Liu, Changcheng; Hu, Yiping; Wang, Xin; Hui, Lijian			Induction of functional hepatocyte-like cells from mouse fibroblasts by defined factors	NATURE			English	Article							ENRICHED TRANSCRIPTION FACTORS; EMBRYONIC STEM-CELLS; TYROSINEMIA TYPE-I; PANCREAS PROGENITORS; HEPATIC-DYSFUNCTION; DIRECT CONVERSION; GENE-EXPRESSION; FACTOR NETWORK; LIVER-FUNCTION; MURINE MODEL	The generation of functional hepatocytes independent of donor liver organs is of great therapeutic interest with regard to regenerative medicine and possible cures for liver disease(1). Induced hepatic differentiation has been achieved previously using embryonic stem cells or induced pluripotent stem cells(2-8). Particularly, hepatocytes generated froma patient's own induced pluripotent stem cells could theoretically avoid immunological rejection. However, the induction of hepatocytes frominduced pluripotent stem cells is a complicated process that would probably be replaced with the arrival of improved technology. Overexpression of lineage-specific transcription factors directly converts terminally differentiated cells into some other lineages(9-12), including neurons(13), cardiomyocytes(14) and blood progenitors(15); however, it remains unclear whether these lineage-converted cells could repair damaged tissues in vivo. Here we demonstrate the direct induction of functional hepatocytelike (iHep) cells from mouse tail-tip fibroblasts by transduction of Gata4, Hnf1 alpha and Foxa3, and inactivation of p19(Arf). iHep cells show typical epithelial morphology, express hepatic genes and acquire hepatocyte functions. Notably, transplanted iHep cells repopulate the livers of fumarylacetoacetate-hydrolase-deficient (Fah(-/-)) mice and rescue almost half of recipients from death by restoring liver functions. Our study provides a novel strategy to generate functional hepatocyte-like cells for the purpose of liver engineering and regenerative medicine.	[Huang, Pengyu; He, Zhiying; Ji, Shuyi; Sun, Huawang; Liu, Changcheng; Hu, Yiping; Wang, Xin; Hui, Lijian] Chinese Acad Sci, Lab Mol Cell Biol, Inst Biochem & Cell Biol, Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China; [He, Zhiying; Xiang, Dao; Liu, Changcheng; Hu, Yiping] Second Mil Med Univ, Dept Cell Biol, Shanghai 200433, Peoples R China; [Wang, Xin] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; [Wang, Xin] Univ Minnesota, Stem Cell Inst, Minneapolis, MN 55455 USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Naval Medical University; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Hui, LJ (corresponding author), Chinese Acad Sci, Lab Mol Cell Biol, Inst Biochem & Cell Biol, Shanghai Inst Biol Sci, Yueyang Rd 320, Shanghai 200031, Peoples R China.	ljhui@sibs.ac.cn	Huang, Pengyu/ABH-1721-2021; Huang, Pengyu/ABF-5330-2021	Huang, Pengyu/0000-0001-8394-7280; 	National Science Foundation of China [91019014, 30801115]; Chinese Academy of Sciences [KSCX2-YW-R-241, XDA01010402]; Chinese National 863 Plan Project [2006AA02Z474]; National Key Basic Research and Development Program of China [2007CB947102, 2009CB941100]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Chinese National 863 Plan Project(National High Technology Research and Development Program of China); National Key Basic Research and Development Program of China(National Basic Research Program of China)	We would like to thank X. Chen, J. Cen, L. Zhang and J. Yuan for technical support, and F. Tang and D. Li for comments. The laboratory of L. H. is funded by the National Science Foundation of China (91019014) and the Chinese Academy of Sciences (KSCX2-YW-R-241, XDA01010402 and the Hundred Talents Program). The laboratory of X. W. is supported by the National Science Foundation of China (30801115), Chinese National 863 Plan Project (2006AA02Z474) and National Key Basic Research and Development Program of China (2007CB947102 and 2009CB941100).	Basma H, 2009, GASTROENTEROLOGY, V136, P990, DOI 10.1053/j.gastro.2008.10.047; Cirillo LA, 2002, MOL CELL, V9, P279, DOI 10.1016/S1097-2765(02)00459-8; Duan YY, 2007, STEM CELLS, V25, P3058, DOI 10.1634/stemcells.2007-0291; Feng R, 2008, P NATL ACAD SCI USA, V105, P6057, DOI 10.1073/pnas.0711961105; Gouon-Evans V, 2006, NAT BIOTECHNOL, V24, P1402, DOI 10.1038/nbt1258; GROMPE M, 1993, GENE DEV, V7, P2298, DOI 10.1101/gad.7.12a.2298; GROMPE M, 1995, NAT GENET, V10, P453, DOI 10.1038/ng0895-453; Hui LJ, 2007, NAT GENET, V39, P741, DOI 10.1038/ng2033; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Kyrmizi I, 2006, GENE DEV, V20, P2293, DOI 10.1101/gad.390906; Li FM, 2010, GASTROENTEROLOGY, V139, P2158, DOI 10.1053/j.gastro.2010.08.042; Li H, 2009, NATURE, V460, P1136, DOI 10.1038/nature08290; Mikula M, 2004, HEPATOLOGY, V39, P628, DOI 10.1002/hep.20084; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; Overturf K, 1996, NAT GENET, V12, P266, DOI 10.1038/ng0396-266; Schrem H, 2004, PHARMACOL REV, V56, P291, DOI 10.1124/pr.56.2.5; Schrem H, 2002, PHARMACOL REV, V54, P129, DOI 10.1124/pr.54.1.129; Shen CN, 2000, NAT CELL BIOL, V2, P879, DOI 10.1038/35046522; Si-Tayeb K, 2010, HEPATOLOGY, V51, P297, DOI 10.1002/hep.23354; Soto-Gutierrez A, 2006, NAT BIOTECHNOL, V24, P1412, DOI 10.1038/nbt1257; Sullivan GJ, 2010, HEPATOLOGY, V51, P329, DOI 10.1002/hep.23335; Szabo E, 2010, NATURE, V468, P521, DOI 10.1038/nature09591; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Wang X, 2003, P NATL ACAD SCI USA, V100, P11881, DOI 10.1073/pnas.1734199100; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2; Zaret KS, 2008, COLD SH Q B, V73, P119, DOI 10.1101/sqb.2008.73.040; Zaret KS, 2008, NAT REV GENET, V9, P329, DOI 10.1038/nrg2318; Zern MA, 2009, GASTROENTEROLOGY, V136, P767, DOI 10.1053/j.gastro.2009.01.019; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	29	610	691	9	213	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 21	2011	475	7356					386	U142		10.1038/nature10116	http://dx.doi.org/10.1038/nature10116			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794PA	21562492				2022-12-24	WOS:000292911200044
J	Shimamura, T; Shiroishi, M; Weyand, S; Tsujimoto, H; Winter, G; Katritch, V; Abagyan, R; Cherezov, V; Liu, W; Han, GW; Kobayashi, T; Stevens, RC; Iwata, S				Shimamura, Tatsuro; Shiroishi, Mitsunori; Weyand, Simone; Tsujimoto, Hirokazu; Winter, Graeme; Katritch, Vsevolod; Abagyan, Ruben; Cherezov, Vadim; Liu, Wei; Han, Gye Won; Kobayashi, Takuya; Stevens, Raymond C.; Iwata, So			Structure of the human histamine H-1 receptor complex with doxepin	NATURE			English	Article							SITE-DIRECTED MUTAGENESIS; STRUCTURE-BASED DISCOVERY; CRYSTAL-STRUCTURE; BINDING-SITE; MUTATIONAL ANALYSIS; ANTIDEPRESSANTS; PURIFICATION; MEMBRANE; AFFINITY; MODELS	The biogenic amine histamine is an important pharmacological mediator involved in pathophysiological processes such as allergies and inflammations. Histamine H-1 receptor (H1R) antagonists are very effective drugs alleviating the symptoms of allergic reactions. Here we show the crystal structure of the H1R complex with. doxepin, a first-generation H1R antagonist. Doxepin sits deep in the ligand-binding pocket and directly interacts with Trp 428(6,48), a highly conserved key residue G -protein-coupled-receptor activation. This well-conserved pocket with mostly hydrophobic nature contributes to the low selectivity of the first-generation compounds. The pocket is associated with an anion-binding region occupied by a phosphate ion. Docking of various second-generation H1R antagonists reveals that the unique carboxyl group present in this class of compounds interacts with Lys191(5.39) and/or Lys 179(ECL2), both of which form part of the anion-binding region. This region is not conserved in other aminergic receptors, demonstrating how minor differences in receptors lead to pronounced selectivity differences with small molecules. Our study sheds light on the molecular basis of H1R antagonist specificity against H1R.	[Shimamura, Tatsuro; Cherezov, Vadim; Liu, Wei; Han, Gye Won; Stevens, Raymond C.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Shimamura, Tatsuro; Shiroishi, Mitsunori; Weyand, Simone; Tsujimoto, Hirokazu; Kobayashi, Takuya; Iwata, So] Japan Sci & Technol Agcy, ERATO, Human Receptor Crystallog Project, Sakyo Ku, Kyoto 6068501, Japan; [Shimamura, Tatsuro; Shiroishi, Mitsunori; Tsujimoto, Hirokazu; Kobayashi, Takuya; Iwata, So] Kyoto Univ, Grad Sch Med, Dept Cell Biol, Sakyo Ku, Kyoto 6068501, Japan; [Shiroishi, Mitsunori] Kyushu Univ, Grad Sch Pharmaceut Sci, Higashi Ku, Fukuoka 8128582, Japan; [Weyand, Simone; Iwata, So] Univ London Imperial Coll Sci Technol & Med, Membrane Prot Crystallog Grp, Div Mol Biosci, London SW7 2AZ, England; [Weyand, Simone; Winter, Graeme; Iwata, So] Diamond Light Source, Didcot OX11 0DE, Oxon, England; [Katritch, Vsevolod; Abagyan, Ruben] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Katritch, Vsevolod; Abagyan, Ruben] Univ Calif San Diego, San Diego Supercomp Ctr, La Jolla, CA 92093 USA; [Iwata, So] RIKEN, Syst & Struct Biol Ctr, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan	Scripps Research Institute; Japan Science & Technology Agency (JST); Kyoto University; Kyushu University; Imperial College London; Diamond Light Source; University of California System; University of California San Diego; University of California System; University of California San Diego; RIKEN	Stevens, RC (corresponding author), Scripps Res Inst, Dept Mol Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	t-coba@mfour.med.kyoto-u.ac.jp; stevens@scripps.edu; so_iwata@me.com	soler, martha maricel m gomez/L-6025-2014; Han, Gye Won/GLQ-8673-2022; Katritch, Vsevolod/Y-2721-2019; Liu, Wei/F-1820-2011; Cherezov, Vadim/L-9812-2013; Han, Gye Won/GLQ-8724-2022; Han, Gye Won/GLT-1531-2022; Katritch, Vsevolod/Q-8357-2016; Stevens, Raymond/K-7272-2015	soler, martha maricel m gomez/0000-0002-4412-8108; Cherezov, Vadim/0000-0002-5265-3914; Han, Gye Won/0000-0003-4107-835X; Katritch, Vsevolod/0000-0003-3883-4505; Stevens, Raymond/0000-0002-4522-8725; Shiroishi, Mitsunori/0000-0002-3133-157X	Japan Science and Technology Agency; MEXT, Japan; NIH [P50 GM073197, R01 GM071872, GM075915]; NIH PSI [U54 GM094618]; Biotechnology and Biological Sciences Research Council (BBSRC) [BB/G023425/1]; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Takeda Scientific Foundation; Sumitomo Foundation; Wellcome Trust at the Diamond Light Source Limited [062164/7/00/Z]; Scripps Research Institute; National Science Foundation [HS0308078]; Science Foundation Ireland [02-IN1-B266]; Biotechnology and Biological Sciences Research Council [BB/G023425/1] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM073197, R01GM089857, R01GM071872, U54GM094618] Funding Source: NIH RePORTER; BBSRC [BB/G023425/1] Funding Source: UKRI	Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH PSI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Takeda Scientific Foundation(Takeda Science Foundation (TSF)); Sumitomo Foundation; Wellcome Trust at the Diamond Light Source Limited(Wellcome Trust); Scripps Research Institute; National Science Foundation(National Science Foundation (NSF)); Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the ERATO Human Receptor Crystallography Project from the Japan Science and Technology Agency and by the Targeted Proteins Research Program of MEXT (S.I.), Japan; the NIH Common Fund grant P50 GM073197 for technology development (R.C.S.) and NIH PSI:Biology grant U54 GM094618 (R.C.S., V.C., V.K. and R.A.); R.A. was also partly funded by NIH R01 GM071872. The work was also partly funded by the Biotechnology and Biological Sciences Research Council (BBSRC) BB/G023425/1 (SI), Grant-in-Aid for challenging Exploratory Research (T.S.), the Mochida Memorial Foundation for Medical and Pharmaceutical Research (T.S. and T.K.), Takeda Scientific Foundation (M.S.) and the Sumitomo Foundation (T K.). A part of the work was performed in the Membrane Protein Laboratory funded by the Wellcome Trust (grant 062164/7/00/Z) at the Diamond Light Source Limited and at The Scripps Research Institute. We thank D. Axford, R. Owen and G. Evans for help with data collection at 124 of the Diamond Light Source Limited, H. Wu for help with the preparation of Supplementary Fig. 1 and Q. Xu for help on validation of data processing and A. Walker for assistance with manuscript preparation. The authors acknowledge Y. Zheng (The Ohio State University) and M. Caffrey, Trinity College (Dublin, Ireland), for the loan of the in meso robot (built with support from the NIH (GM075915), the National Science Foundation (HS0308078), and Science Foundation Ireland (02-IN1-B266)). S.I. is thankful for the help of L E Johnson, a co-founder of the Diamond-MPL Project and R. Tanaka, the technical coordinator of the ERATO Human Receptor Crystallography Project.	ABAGYAN R, 1994, J MOL BIOL, V235, P983, DOI 10.1006/jmbi.1994.1052; Abagyan R., 2011, ICM MANUAL V 3 0; Aishima J, 2010, ACTA CRYSTALLOGR D, V66, P1032, DOI 10.1107/S0907444910028192; Bakker RA, 2004, MOL PHARMACOL, V65, P538, DOI 10.1124/mol.65.3.538; Bakker RA, 2000, EUR J PHARMACOL, V387, pR5, DOI 10.1016/S0014-2999(99)00803-1; Bakker RA, 2001, MOL PHARMACOL, V60, P1133, DOI 10.1124/mol.60.5.1133; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Bruysters M, 2004, EUR J PHARMACOL, V487, P55, DOI 10.1016/j.ejphar.2004.01.028; Cherezov V, 2004, ACTA CRYSTALLOGR D, V60, P1795, DOI 10.1107/S0907444904019109; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Chien EYT, 2010, SCIENCE, V330, P1091, DOI 10.1126/science.1197410; CUSACK B, 1994, PSYCHOPHARMACOLOGY, V114, P559, DOI 10.1007/BF02244985; de Graaf C, 2009, CURR PHARM DESIGN, V15, P4026, DOI 10.2174/138161209789824786; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Gillard M, 2003, INFLAMM RES, V52, pS49, DOI 10.1007/s000110300050; Gillard M, 2002, MOL PHARMACOL, V61, P391, DOI 10.1124/mol.61.2.391; Hill SJ, 1997, PHARMACOL REV, V49, P253; HILL SJ, 1990, PHARMACOL REV, V42, P45; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Jongejan A, 2005, ARCH PHARM, V338, P248, DOI 10.1002/ardp.200400998; Katritch V, 2011, NEUROPHARMACOLOGY, V60, P108, DOI 10.1016/j.neuropharm.2010.07.009; Katritch V, 2010, J MED CHEM, V53, P1799, DOI 10.1021/jm901647p; Katritch V, 2009, J MOL RECOGNIT, V22, P307, DOI 10.1002/jmr.949; Kiss R, 2004, EUR J MED CHEM, V39, P959, DOI 10.1016/j.ejmech.2004.07.009; Klabunde T, 2002, CHEMBIOCHEM, V3, P929, DOI 10.1002/1439-7633(20021004)3:10<928::AID-CBIC928>3.0.CO;2-5; Kolb P, 2009, P NATL ACAD SCI USA, V106, P6843, DOI 10.1073/pnas.0812657106; Leslie AGW, 1992, JOINT CCP4 ESF EACMB; LEURS R, 1995, BIOCHEM BIOPH RES CO, V214, P110, DOI 10.1006/bbrc.1995.2263; Matsumoto Y, 2008, PHARMACOLOGY, V81, P266, DOI 10.1159/000115970; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murakami M, 2008, NATURE, V453, P363, DOI 10.1038/nature06925; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Newstead S, 2007, P NATL ACAD SCI USA, V104, P13936, DOI 10.1073/pnas.0704546104; Nonaka H, 1998, EUR J PHARMACOL, V345, P111, DOI 10.1016/S0014-2999(97)01620-8; OHTA K, 1994, BIOCHEM BIOPH RES CO, V203, P1096, DOI 10.1006/bbrc.1994.2295; Okamura N, 2000, BRIT J PHARMACOL, V129, P115, DOI 10.1038/sj.bjp.0702994; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Peeters MC, 2011, TRENDS PHARMACOL SCI, V32, P35, DOI 10.1016/j.tips.2010.10.001; Qanbar R, 2003, PHARMACOL THERAPEUT, V97, P1, DOI 10.1016/S0163-7258(02)00300-5; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Ratnala VRP, 2004, EUR J BIOCHEM, V271, P2636, DOI 10.1111/j.1432-1033.2004.04192.x; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Sarker S, 2010, MOL PHARMACOL, V78, P1026, DOI 10.1124/mol.110.067538; SCHWARTZ JC, 1991, PHYSIOL REV, V71, P1, DOI 10.1152/physrev.1991.71.1.1; Simons FER, 2004, NEW ENGL J MED, V351, P2203, DOI 10.1056/NEJMra033121; Skubak P, 2004, ACTA CRYSTALLOGR D, V60, P2196, DOI 10.1107/S0907444904019079; Tashiro M, 2009, HUM PSYCHOPHARM CLIN, V24, P540, DOI 10.1002/hup.1051; Totrov M, 1997, PROTEINS, P215; Totrov M. M., 1999, P 3 ANN INT C COMP M, P312, DOI DOI 10.1145/299432.299509; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Wieland K, 1999, J BIOL CHEM, V274, P29994, DOI 10.1074/jbc.274.42.29994; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701; WOOSLEY RL, 1993, JAMA-J AM MED ASSOC, V269, P1532, DOI 10.1001/jama.269.12.1532; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Xu F, 2011, SCIENCE, V332, P322, DOI 10.1126/science.1202793; YAMASHITA M, 1991, P NATL ACAD SCI USA, V88, P11515, DOI 10.1073/pnas.88.24.11515; Yap Yee Guan, 2002, Clin Allergy Immunol, V17, P389	59	597	609	6	160	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 7	2011	475	7354					65	U82		10.1038/nature10236	http://dx.doi.org/10.1038/nature10236			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	788RE	21697825	Green Accepted, Green Published			2022-12-24	WOS:000292461300045
J	Laguette, N; Sobhian, B; Casartelli, N; Ringeard, M; Chable-Bessia, C; Segeral, E; Yatim, A; Emiliani, S; Schwartz, O; Benkirane, M				Laguette, Nadine; Sobhian, Bijan; Casartelli, Nicoletta; Ringeard, Mathieu; Chable-Bessia, Christine; Segeral, Emmanuel; Yatim, Ahmad; Emiliani, Stephane; Schwartz, Olivier; Benkirane, Monsef			SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx	NATURE			English	Article							GAMMA-INDUCED PROTEIN; INNATE IMMUNITY; INFECTION; INHIBITION; TARGET; DOMAIN	The primate lentivirus auxiliary protein Vpx counteracts an unknown restriction factor that renders human dendritic and myeloid cells largely refractory to HIV-1 infection(1-6). Here we identify SAMHD1 as this restriction factor. SAMHD1 is a protein involved in Aicardi-Goutieres syndrome, a genetic encephalopathy with symptoms mimicking congenital viral infection, that has been proposed to act as a negative regulator of the interferon response(7). We show that Vpx induces proteasomal degradation of SAMHD1. Silencing of SAMHD1 in non-permissive cell lines alleviates HIV-1 restriction and is associated with a significant accumulation of viral DNA in infected cells. Concurrently, overexpression of SAMHD1 in sensitive cells inhibits HIV-1 infection. The putative phosphohydrolase activity of SAMHD1 is probably required for HIV-1 restriction. Vpx-mediated relief of restriction is abolished in SAMHD1-negative cells. Finally, silencing of SAMHD1 markedly increases the susceptibility of monocytic-derived dendritic cells to infection. Our results demonstrate that SAMHD1 is an antiretroviral protein expressed in cells of the myeloid lineage that inhibits an early step of the viral life cycle.	[Laguette, Nadine; Sobhian, Bijan; Ringeard, Mathieu; Chable-Bessia, Christine; Yatim, Ahmad; Benkirane, Monsef] CNRS, Inst Genet Humaine, Lab Virol Mol, UPR1142, F-34000 Montpellier, France; [Casartelli, Nicoletta; Schwartz, Olivier] CNRS, Inst Pasteur, Virus & Immun Unit, URA 3015, Paris, France; [Segeral, Emmanuel; Emiliani, Stephane] Univ Paris 05, CNRS, Inst Cochin, UMR 8104,INSERM,U567, Paris, France	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Benkirane, M (corresponding author), CNRS, Inst Genet Humaine, Lab Virol Mol, UPR1142, F-34000 Montpellier, France.	nadine.laguette@igh.cnrs.fr; monsef.benkirane@igh.cnrs.fr	Casartelli, Nicoletta/L-4798-2015; Laguette, Nadine/A-2764-2019; Casartelli, Nicoletta/AAD-5583-2021; Schwartz, Olivier/AAZ-3765-2021	Schwartz, Olivier/0000-0002-0729-1475; Sobhian, Bijan/0000-0001-7255-6006; Laguette, Nadine/0000-0001-8072-5607	ERC [250333]; Sidaction; ANRS; FRM 'equipe labellisee'; CNRS/region Languedoc Roussillon; European FP7 [201412]; Institut Pasteur	ERC(European Research Council (ERC)European Commission); Sidaction; ANRS(ANRSFrench National Research Agency (ANR)); FRM 'equipe labellisee'; CNRS/region Languedoc Roussillon(Centre National de la Recherche Scientifique (CNRS)Region Occitanie); European FP7; Institut Pasteur(European Commission)	We wish to thank members of the Molecular Virology laboratory for critical reading of the manuscript, N. Manel for SIV3<SUP>+</SUP> molecular clone and J. Luban for SIV delta Vpx and Vpx mutants. This work was supported by grants from the ERC (250333), Sidaction, ANRS and FRM 'equipe labellisee' to M. B. N. L was supported by ANRS and SIDACTION fellowships; B. S. by ANRS fellowship; M. R. by CNRS/region Languedoc Roussillon fellowship. O.S. and N. C. are supported by grants from ANRS, Sidaction, ANR, European FP7 contract 201412 and Institut Pasteur.	Altfeld M, 2011, NAT REV IMMUNOL, V11, P176, DOI 10.1038/nri2935; Ayinde D, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-35; Bergamaschi A, 2009, J VIROL, V83, P4854, DOI 10.1128/JVI.00187-09; Blanchet FP, 2010, IMMUNITY, V32, P654, DOI 10.1016/j.immuni.2010.04.011; Borrow P, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-84; Cobb A, 2011, J IMMUNOL METHODS, V365, P27, DOI 10.1016/j.jim.2010.11.002; Goujon C, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-2; Goujon C, 2008, J VIROL, V82, P12335, DOI 10.1128/JVI.01181-08; Gramberg T, 2010, J VIROL, V84, P1387, DOI 10.1128/JVI.01437-09; Hirsch VM, 1998, NAT MED, V4, P1401, DOI 10.1038/3992; Kaushik R, 2009, CELL HOST MICROBE, V6, P68, DOI 10.1016/j.chom.2009.05.022; Kumar D, 2009, MOL BIOL CELL, V20, P3170, DOI 10.1091/mbc.E08-12-1185; Lepelley A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001284; Li N, 2000, IMMUNOL LETT, V74, P221, DOI 10.1016/S0165-2478(00)00276-5; Liao WP, 2008, PROTEOMICS, V8, P2640, DOI 10.1002/pmic.200700954; Manel N, 2010, NATURE, V467, P214, DOI 10.1038/nature09337; Nakatani Y, 2003, METHOD ENZYMOL, V370, P430; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Rice GI, 2009, NAT GENET, V41, P829, DOI 10.1038/ng.373; Sharova N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000057; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Sobhian B, 2010, MOL CELL, V38, P439, DOI 10.1016/j.molcel.2010.04.012; Srivastava S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000059; Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343; Yan N, 2011, CURR OPIN IMMUNOL, V23, P21, DOI 10.1016/j.coi.2010.11.004; Zhao DC, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-114; Zimmerman MD, 2008, J MOL BIOL, V378, P215, DOI 10.1016/j.jmb.2008.02.036	27	1082	1112	2	78	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 30	2011	474	7353					654	U132		10.1038/nature10117	http://dx.doi.org/10.1038/nature10117			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	785CF	21613998	Green Accepted			2022-12-24	WOS:000292204300042
J	Settembre, C; Di Malta, C; Polito, VA; Garcia-Arencibia, M; Vetrini, F; Erdin, S; Erdin, SU; Huynh, T; Medina, D; Colella, P; Sardiello, M; Rubinsztein, DC; Ballabio, A				Settembre, Carmine; Di Malta, Chiara; Polito, Vinicia Assunta; Garcia-Arencibia, Moises; Vetrini, Francesco; Erdin, Serkan; Erdin, Serpil Uckac; Huynh, Tuong; Medina, Diego; Colella, Pasqualina; Sardiello, Marco; Rubinsztein, David C.; Ballabio, Andrea			TFEB Links Autophagy to Lysosomal Biogenesis	SCIENCE			English	Article							IN-VIVO; PHOSPHORYLATION SITES; PROTEIN-DEGRADATION; PREDICTION; PATHWAYS; ULK1	Autophagy is a cellular catabolic process that relies on the cooperation of autophagosomes and lysosomes. During starvation, the cell expands both compartments to enhance degradation processes. We found that starvation activates a transcriptional program that controls major steps of the autophagic pathway, including autophagosome formation, autophagosome-lysosome fusion, and substrate degradation. The transcription factor EB (TFEB), a master gene for lysosomal biogenesis, coordinated this program by driving expression of autophagy and lysosomal genes. Nuclear localization and activity of TFEB were regulated by serine phosphorylation mediated by the extracellular signal-regulated kinase 2, whose activity was tuned by the levels of extracellular nutrients. Thus, a mitogen-activated protein kinase-dependent mechanism regulates autophagy by controlling the biogenesis and partnership of two distinct cellular organelles.	[Settembre, Carmine; Di Malta, Chiara; Polito, Vinicia Assunta; Medina, Diego; Colella, Pasqualina; Ballabio, Andrea] TIGEM, I-80131 Naples, Italy; [Settembre, Carmine; Polito, Vinicia Assunta; Vetrini, Francesco; Erdin, Serkan; Erdin, Serpil Uckac; Huynh, Tuong; Sardiello, Marco; Ballabio, Andrea] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Settembre, Carmine; Polito, Vinicia Assunta; Erdin, Serkan; Erdin, Serpil Uckac; Huynh, Tuong; Sardiello, Marco; Ballabio, Andrea] Texas Childrens Hosp, Jan & Dan Duncan Neurol Res Inst, Houston, TX 77030 USA; [Garcia-Arencibia, Moises; Rubinsztein, David C.] Addenbrookes Hosp, Cambridge Inst Med Res, Cambridge CB2 0XY, England; [Ballabio, Andrea] Univ Naples Federico 2, Dept Pediat, I-80131 Naples, Italy	Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); Baylor College of Medicine; Baylor College of Medicine; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Naples Federico II	Ballabio, A (corresponding author), TIGEM, Via Pietro Castellino 111, I-80131 Naples, Italy.	ballabio@tigem.it	Erdin, Serkan/AAE-4288-2019; Garcia-Arencibia, Moises/B-5538-2012; BALLABIO, Andrea/AAL-2672-2020; Erdin, Serkan/B-4988-2008; Polito, Vinicia Assunta/AAA-5219-2020; Rubinsztein, David C/C-3472-2011; Di Malta, Chiara/AAX-6395-2020; Settembre, Carmine/AIA-9170-2022; Garcia-Arencibia, Moises/K-9920-2013; COLELLA, PASQUALINA/I-5478-2017; Medina, Diego/AAC-9622-2020	BALLABIO, Andrea/0000-0003-1381-4604; Erdin, Serkan/0000-0001-6587-2625; Garcia-Arencibia, Moises/0000-0002-1618-4487; COLELLA, PASQUALINA/0000-0002-4268-2391; Medina, Diego/0000-0002-7347-2645; Polito, Vinicia Assunta/0000-0002-5698-7778; SETTEMBRE, Carmine/0000-0002-5829-8589	Italian Telethon Foundation; Beyond Batten Disease Foundation; European Research Council [250154]; European Molecular Biology Organization; Wellcome Trust; U.K. Medical Research Council; Intellectual and Developmental Disabilities Research Center at the Baylor College of Medicine [5 P30 HD024064]; MRC [G0600194] Funding Source: UKRI; Medical Research Council [G0600194] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS078072] Funding Source: NIH RePORTER	Italian Telethon Foundation(Fondazione Telethon); Beyond Batten Disease Foundation; European Research Council(European Research Council (ERC)European Commission); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Wellcome Trust(Wellcome TrustEuropean Commission); U.K. Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Intellectual and Developmental Disabilities Research Center at the Baylor College of Medicine; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank H. Bellen, A. De Matteis, G. Diez-Roux, M. Ferron, G. Karsenty, A. Luini, and H. Zoghbi for critical reading of the manuscript; R. Polishchuck for technical advice with the electron microscopy; K. Moreau, M. Renna, A. Ronza, and M. Palmieri for their contribution; and L. Naldini for the lentivirus production. We acknowledge the support of the Italian Telethon Foundation (C.S., C.D.M., V.P., M.S., and A.B.); the Beyond Batten Disease Foundation (C.S., C.D.M., V.P., S.U.E., T.H., M.S., and A.B.); European Research Council Advanced Investigator grant no. 250154 (A.B.); a European Molecular Biology Organization long-term fellowship (C.S.); a Wellcome Trust Senior Research Fellowship (D.C.R.); and a U.K. Medical Research Council program grant (D.C.R.). We wish to thank Cherie and James C. Flores for their generous donation. We also thank S. Tooze for GFP-LC3 cells, T. Yoshimori for the RFP-GFP, and P. Pandolfi for the HA-ERK2 and ca-MEK; M. Krentz for the CAG-lox-LacZ plasmid and for the useful suggestions during transgene generation; and the TIGEM AAV vector core for virus production. Confocal microscopy was supported by the Intellectual and Developmental Disabilities Research Center at the Baylor College of Medicine (5 P30 HD024064).	Amanchy R, 2007, NAT BIOTECHNOL, V25, P285, DOI 10.1038/nbt0307-285; Bauvy C, 2009, METHOD ENZYMOL, V452, P47, DOI 10.1016/S0076-6879(08)03604-5; Behrends C, 2010, NATURE, V466, P68, DOI 10.1038/nature09204; Dang TH, 2008, BIOINFORMATICS, V24, P2857, DOI 10.1093/bioinformatics/btn546; Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371; Gnad F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r250; He CC, 2010, CURR OPIN CELL BIOL, V22, P140, DOI 10.1016/j.ceb.2010.01.001; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Hemesath TJ, 1998, NATURE, V391, P298, DOI 10.1038/34681; Hidvegi T, 2010, SCIENCE, V329, P229, DOI 10.1126/science.1190354; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Kolch W, 2005, NAT REV MOL CELL BIO, V6, P827, DOI 10.1038/nrm1743; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Linding R, 2007, CELL, V129, P1415, DOI 10.1016/j.cell.2007.05.052; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Rabinowitz JD, 2010, SCIENCE, V330, P1344, DOI 10.1126/science.1193497; Ravikumar B, 2004, NEUROREPORT, V15, P2443, DOI 10.1097/00001756-200411150-00001; Sardiello M, 2009, SCIENCE, V325, P473, DOI 10.1126/science.1174447; Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026; Settembre C, 2008, GENE DEV, V22, P2645, DOI 10.1101/gad.1711308; Settembre C, 2008, HUM MOL GENET, V17, P119, DOI 10.1093/hmg/ddm289; Wong E, 2010, NAT NEUROSCI, V13, P805, DOI 10.1038/nn.2575; Xue Y, 2008, MOL CELL PROTEOMICS, V7, P1598, DOI 10.1074/mcp.M700574-MCP200; Yang JY, 2008, NAT CELL BIOL, V10, P138, DOI 10.1038/ncb1676; Zhao J, 2007, CELL METAB, V6, P472, DOI 10.1016/j.cmet.2007.11.004	29	1900	1952	15	240	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 17	2011	332	6036					1429	1433		10.1126/science.1204592	http://dx.doi.org/10.1126/science.1204592			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778FT	21617040	Green Accepted			2022-12-24	WOS:000291689000041
J	Jirawatnotai, S; Hu, YD; Michowski, W; Elias, JE; Becks, L; Bienvenu, F; Zagozdzon, A; Goswami, T; Wang, YYE; Clark, AB; Kunkel, TA; van Harn, T; Xia, B; Correll, M; Quackenbush, J; Livingston, DM; Gygi, SP; Sicinski, P				Jirawatnotai, Siwanon; Hu, Yiduo; Michowski, Wojciech; Elias, Joshua E.; Becks, Lisa; Bienvenu, Frederic; Zagozdzon, Agnieszka; Goswami, Tapasree; Wang, Yaoyu E.; Clark, Alan B.; Kunkel, Thomas A.; van Harn, Tanja; Xia, Bing; Correll, Mick; Quackenbush, John; Livingston, David M.; Gygi, Steven P.; Sicinski, Piotr			A function for cyclin D1 in DNA repair uncovered by protein interactome analyses in human cancers	NATURE			English	Article							HUMAN RAD51 PROTEIN; DOUBLE-STRAND BREAK; PHOSPHORYLATION; DAMAGE; OVEREXPRESSION; ABSENCE; CELLS	Cyclin D1 is a component of the core cell cycle machinery(1). Abnormally high levels of cyclin D1 are detected in many human cancer types(2). To elucidate the molecular functions of cyclin D1 in human cancers, we performed a proteomic screen for cyclin D1 protein partners in several types of human tumours. Analyses of cyclin D1 interactors revealed a network of DNA repair proteins, including RAD51, a recombinase that drives the homologous recombination process(3). We found that cyclin D1 directly binds RAD51, and that cyclin D1-RAD51 interaction is induced by radiation. Like RAD51, cyclin D1 is recruited to DNA damage sites in a BRCA2-dependent fashion. Reduction of cyclin D1 levels in human cancer cells impaired recruitment of RAD51 to damaged DNA, impeded the homologous recombination-mediated DNA repair, and increased sensitivity of cells to radiation in vitro and in vivo. This effect was seen in cancer cells lacking the retinoblastoma protein, which do not require D-cyclins for proliferation(4,5). These findings reveal an unexpected function of a core cell cycle protein in DNA repair and suggest that targeting cyclin D1 may be beneficial also in retinoblastoma-negative cancers which are currently thought to be unaffected by cyclin D1 inhibition.	[Jirawatnotai, Siwanon; Hu, Yiduo; Michowski, Wojciech; Becks, Lisa; Bienvenu, Frederic; Zagozdzon, Agnieszka; van Harn, Tanja; Livingston, David M.; Sicinski, Piotr] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02215 USA; [Jirawatnotai, Siwanon; Hu, Yiduo; Michowski, Wojciech; Becks, Lisa; Bienvenu, Frederic; Zagozdzon, Agnieszka; van Harn, Tanja; Livingston, David M.; Sicinski, Piotr] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02215 USA; [Jirawatnotai, Siwanon] Mahidol Univ, Inst Mol Biosci, Salaya 73170, Nakhon Prathom, Thailand; [Elias, Joshua E.; Goswami, Tapasree; Gygi, Steven P.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Becks, Lisa] Massachusetts Coll Pharm & Hlth Sci, Dept Pharmacol, Boston, MA 02115 USA; [Wang, Yaoyu E.; Correll, Mick; Quackenbush, John] Dana Farber Canc Inst, Ctr Canc Computat Biol, Boston, MA 02215 USA; [Clark, Alan B.; Kunkel, Thomas A.] NIEHS, Mol Genet Lab, NIH, US Dept HHS, Res Triangle Pk, NC 27709 USA; [Clark, Alan B.; Kunkel, Thomas A.] NIEHS, Struct Biol Lab, NIH, US Dept HHS, Res Triangle Pk, NC 27709 USA; [Xia, Bing] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Canc Inst New Jersey, Dept Radiat Oncol, New Brunswick, NJ 08903 USA; [Quackenbush, John] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02215 USA; [Quackenbush, John] Harvard Univ, Sch Publ Hlth, Boston, MA 02215 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Mahidol University; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard T.H. Chan School of Public Health	Sicinski, P (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02215 USA.	peter_sicinski@dfci.harvard.edu	Kunkel, Thomas A./D-5088-2019	Kunkel, Thomas A./0000-0002-9900-1788; Quackenbush, John/0000-0002-2702-5879	NIH [R01 CA083688, P01 CA080111, P01 CA109901]; Thailand Research Fund [MRG5280248]; Foundation for Polish Science; CCCB; Dana-Farber Strategic Plan Initiative; Division of Intramural Research of the NIH, NIEHS [Z01 ES065089]; NATIONAL CANCER INSTITUTE [P01CA109901, R01CA083688, R01CA138804, P01CA080111] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI060354] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES065089, ZIAES065089] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Thailand Research Fund(Thailand Research Fund (TRF)); Foundation for Polish Science(Foundation for Polish ScienceEuropean Commission); CCCB; Dana-Farber Strategic Plan Initiative; Division of Intramural Research of the NIH, NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank the members of the Sicinski lab for help and advice, N. Li for help with initial experiments, S Panyim and Y. Geng for discussions and reading the manuscript, P. Nakatani for pOZ-FH-N construct, M. Jasin for DR-GFP system, D. Bulavin and E. Appella for anti-phospho-CDC25A antibodies, A. Smogorzewska for anti-FANCI antibody, A. Venkitaraman and M. Lee for GST-BRCA2 fragments, and DFCI Confocal and Light Microscopy Core Facility for assisting with confocal microscopy. This work was supported by R01 CA083688, P01 CA080111 and P01 CA109901 grants from NIH (to P.S.). S.J. is supported by The Thailand Research Fund MRG5280248, W.M. by Foundation for Polish Science, Y.E.W. through the CCCB and the Dana-Farber Strategic Plan Initiative, A.B.C. and T.A.K. by Project Z01 ES065089 (to T.A.K.) from the Division of Intramural Research of the NIH, NIEHS.	Agami R, 2000, CELL, V102, P55, DOI 10.1016/S0092-8674(00)00010-6; BARTKOVA J, 1995, CANCER RES, V55, P949; BATES S, 1994, ONCOGENE, V9, P1633; Baumann P, 1996, CELL, V87, P757, DOI 10.1016/S0092-8674(00)81394-X; Baumann P, 1998, TRENDS BIOCHEM SCI, V23, P247, DOI 10.1016/S0968-0004(98)01232-8; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bienvenu F, 2010, NATURE, V463, P374, DOI 10.1038/nature08684; Deshpande A, 2005, ONCOGENE, V24, P2909, DOI 10.1038/sj.onc.1208618; Ek S, 2005, LEUKEMIA RES, V29, P205, DOI 10.1016/j.leukres.2004.06.009; HINDS PW, 1994, P NATL ACAD SCI USA, V91, P709, DOI 10.1073/pnas.91.2.709; Hosokawa Y, 1998, GENE CHROMOSOME CANC, V22, P66, DOI 10.1002/(SICI)1098-2264(199805)22:1<66::AID-GCC9>3.0.CO;2-5; Kozar K, 2004, CELL, V118, P477, DOI 10.1016/j.cell.2004.07.025; Landis MW, 2006, CANCER CELL, V9, P13, DOI 10.1016/j.ccr.2005.12.019; Lee M, 2004, ONCOGENE, V23, P865, DOI 10.1038/sj.onc.1207223; Li ZP, 2010, CANCER RES, V70, P8802, DOI 10.1158/0008-5472.CAN-10-0312; Lin DI, 2006, MOL CELL, V24, P355, DOI 10.1016/j.molcel.2006.09.007; Lord CJ, 2008, CURR OPIN PHARMACOL, V8, P363, DOI 10.1016/j.coph.2008.06.016; LUKAS J, 1995, NATURE, V375, P503, DOI 10.1038/375503a0; Martin JMC, 1999, CANCER RES, V59, P1134; Nakatani Y, 2003, METHOD ENZYMOL, V370, P430; OSTLING O, 1984, BIOCHEM BIOPH RES CO, V123, P291, DOI 10.1016/0006-291X(84)90411-X; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Pontano LL, 2008, MOL CELL BIOL, V28, P7245, DOI 10.1128/MCB.01085-08; Rodrigue A, 2006, EMBO J, V25, P222, DOI 10.1038/sj.emboj.7600914; Sherr CJ, 2004, GENE DEV, V18, P2699, DOI 10.1101/gad.1256504; Sugawara N, 2003, MOL CELL, V12, P209, DOI 10.1016/S1097-2765(03)00269-7; Toogood PL, 2005, J MED CHEM, V48, P2388, DOI 10.1021/jm049354h; West SC, 2003, NAT REV MOL CELL BIO, V4, P435, DOI 10.1038/nrm1127; Wolner B, 2003, MOL CELL, V12, P221, DOI 10.1016/S1097-2765(03)00242-9	29	245	250	0	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 9	2011	474	7350					230	234		10.1038/nature10155	http://dx.doi.org/10.1038/nature10155			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774PE	21654808	Green Accepted			2022-12-24	WOS:000291397800054
J	Ofstad, TA; Zuker, CS; Reiser, MB				Ofstad, Tyler A.; Zuker, Charles S.; Reiser, Michael B.			Visual place learning in Drosophila melanogaster	NATURE			English	Article							MUSHROOM BODIES; CENTRAL COMPLEX; SPATIAL MEMORY; FRUIT-FLY; BEHAVIOR; SYSTEM; EXPRESSION; PARADIGM; CELLS; HEAD	The ability of insects to learn and navigate to specific locations in the environment has fascinated naturalists for decades. The impressive navigational abilities of ants, bees, wasps and other insects demonstrate that insects are capable of visual place learning(1-4), but little is known about the underlying neural circuits that mediate these behaviours. Drosophila melanogaster (common fruit fly) is a powerful model organism for dissecting the neural circuitry underlying complex behaviours, from sensory perception to learning and memory. Drosophila can identify and remember visual features such as size, colour and contour orientation(5,6). However, the extent to which they use vision to recall specific locations remains unclear. Here we describe a visual place learning platform and demonstrate that Drosophila are capable of forming and retaining visual place memories to guide selective navigation. By targeted genetic silencing of small subsets of cells in the Drosophila brain, we show that neurons in the ellipsoid body, but not in the mushroom bodies, are necessary for visual place learning. Together, these studies reveal distinct neuroanatomical substrates for spatial versus non-spatial learning, and establish Drosophila as a powerful model for the study of spatial memories. [GRAPHICS] .	[Ofstad, Tyler A.; Zuker, Charles S.; Reiser, Michael B.] Howard Hughes Med Inst, Ashburn, VA 20147 USA; [Ofstad, Tyler A.; Zuker, Charles S.] Univ Calif San Diego, Howard Hughes Med Inst, Dept Neurosci, La Jolla, CA 92093 USA; [Zuker, Charles S.] Univ Calif San Diego, Howard Hughes Med Inst, Dept Neurobiol, La Jolla, CA 92093 USA; [Zuker, Charles S.] Columbia Univ, Columbia Coll Phys & Surg, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Zuker, Charles S.] Columbia Univ, Columbia Coll Phys & Surg, Howard Hughes Med Inst, Dept Neurosci, New York, NY 10032 USA	Howard Hughes Medical Institute; Howard Hughes Medical Institute; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego; Columbia University; Howard Hughes Medical Institute; Columbia University; Howard Hughes Medical Institute	Zuker, CS (corresponding author), Howard Hughes Med Inst, Janelia Farm Res Campus,19700 Helix Dr, Ashburn, VA 20147 USA.	cz2195@columbia.edu; reiserm@janelia.hhmi.org		Reiser, Michael/0000-0002-4108-4517	HHMI	HHMI(Howard Hughes Medical Institute)	We particularly thank M. Gallio for help with thermosensation and the development of temperature behavioural tests. We also thank G. Rubin for providing GAL4 lines before publication, A. Jenett for their anatomical annotation and M. Dickinson for discussions and advice. Brain images were provided by the Janelia Fly Light Project. T. Laverty and the Janelia Fly Core assisted with Drosophila maintenance. Additional support was provided by J. Osborne, C. Werner, D. Olbris and M. Bolstad. We also thank V. Jayaraman, members of the Reiser and Zuker labs, Janelia Farm colleagues and the Janelia Fly Olympiad Project. This project was supported through the HHMI Janelia Farm Research Campus visitor programmed (T.A.O. and C.S.Z., hosted by M.B.R.). C.S.Z. is a HHMI investigator and a Senior Fellow at Janelia Farm.	Baines RA, 2001, J NEUROSCI, V21, P1523, DOI 10.1523/JNEUROSCI.21-05-01523.2001; BERNSTEIN S, 1969, BRAIN RES, V16, P85, DOI 10.1016/0006-8993(69)90087-0; Branson K, 2009, NAT METHODS, V6, P451, DOI [10.1038/nmeth.1328, 10.1038/NMETH.1328]; Capaldi EA, 1999, J EXP BIOL, V202, P1655; CARTWRIGHT BA, 1982, NATURE, V295, P560, DOI 10.1038/295560a0; deBelle JS, 1996, P NATL ACAD SCI USA, V93, P9875, DOI 10.1073/pnas.93.18.9875; DEBELLE JS, 1994, SCIENCE, V263, P692, DOI 10.1126/science.8303280; Dickinson MH, 1999, PHILOS T ROY SOC B, V354, P903, DOI 10.1098/rstb.1999.0442; Diegelmann S, 2006, LEARN MEMORY, V13, P72, DOI 10.1101/lm.45506; Dombeck DA, 2010, NAT NEUROSCI, V13, P1433, DOI 10.1038/nn.2648; Ernst R, 1999, VISION RES, V39, P3920, DOI 10.1016/S0042-6989(99)00114-5; Fahrbach SE, 1995, LEARN MEMORY, V2, P199, DOI 10.1101/lm.2.5.199; Foucaud J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015231; Heisenberg M, 2003, NAT REV NEUROSCI, V4, P266, DOI 10.1038/nrn1074; Martin JR, 1999, J COMP PHYSIOL A, V185, P277, DOI 10.1007/s003590050387; MCGUIRE SE, 2004, SCI STKE, pPL6; Mizunami M, 1998, J COMP NEUROL, V402, P520; MORRIS RGM, 1990, EUR J NEUROSCI, V2, P1016, DOI 10.1111/j.1460-9568.1990.tb00014.x; MORRIS RGM, 1981, LEARN MOTIV, V12, P239, DOI 10.1016/0023-9690(81)90020-5; Moser EI, 2008, ANNU REV NEUROSCI, V31, P69, DOI 10.1146/annurev.neuro.31.061307.090723; Neuser K, 2008, NATURE, V453, P1244, DOI 10.1038/nature07003; Pfeiffer BD, 2008, P NATL ACAD SCI USA, V105, P9715, DOI 10.1073/pnas.0803697105; Putz G, 2002, LEARN MEMORY, V9, P349, DOI 10.1101/lm.50402; Reiser MB, 2008, J NEUROSCI METH, V167, P127, DOI 10.1016/j.jneumeth.2007.07.019; Sayeed O, 1996, P NATL ACAD SCI USA, V93, P6079, DOI 10.1073/pnas.93.12.6079; Seelig JD, 2010, NAT METHODS, V7, P535, DOI [10.1038/NMETH.1468, 10.1038/nmeth.1468]; STOCKER RF, 1994, CELL TISSUE RES, V275, P3, DOI 10.1007/BF00305372; Strauss R, 2002, CURR OPIN NEUROBIOL, V12, P633, DOI 10.1016/S0959-4388(02)00385-9; Strauss R, 1997, J EXP BIOL, V200, P1281; Tang SM, 2001, SCIENCE, V294, P1543, DOI 10.1126/science.1058237; TULLY T, 1985, J COMP PHYSIOL A, V157, P263, DOI 10.1007/BF01350033; Waddell S, 2001, TRENDS GENET, V17, P719, DOI 10.1016/S0168-9525(01)02526-4; WEHNER R, 1979, EXPERIENTIA, V35, P1569, DOI 10.1007/BF01953197; Wessnitzer J, 2008, P ROY SOC B-BIOL SCI, V275, P915, DOI 10.1098/rspb.2007.1647; Wolf R, 1998, LEARN MEMORY, V5, P166; Wustmann G, 1996, J COMP PHYSIOL A, V179, P429, DOI 10.1007/BF00194996; Wustmann G, 1997, LEARN MEMORY, V4, P328, DOI 10.1101/lm.4.4.328; Zars T, 2000, LEARN MEMORY, V7, P18, DOI 10.1101/lm.7.1.18; Zars T, 2001, J COMP PHYSIOL A, V187, P235, DOI 10.1007/s003590100194; Zars T, 2009, J NEUROGENET, V23, P104, DOI 10.1080/01677060802441364	40	260	265	2	99	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 9	2011	474	7350					204	U240		10.1038/nature10131	http://dx.doi.org/10.1038/nature10131			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774PE	21654803	Green Accepted, Green Published			2022-12-24	WOS:000291397800048
J	Pastor, WA; Pape, UJ; Huang, Y; Henderson, HR; Lister, R; Ko, M; McLoughlin, EM; Brudno, Y; Mahapatra, S; Kapranov, P; Tahiliani, M; Daley, GQ; Liu, XS; Ecker, JR; Milos, PM; Agarwal, S; Rao, A				Pastor, William A.; Pape, Utz J.; Huang, Yun; Henderson, Hope R.; Lister, Ryan; Ko, Myunggon; McLoughlin, Erin M.; Brudno, Yevgeny; Mahapatra, Sahasransu; Kapranov, Philipp; Tahiliani, Mamta; Daley, George Q.; Liu, X. Shirley; Ecker, Joseph R.; Milos, Patrice M.; Agarwal, Suneet; Rao, Anjana			Genome-wide mapping of 5-hydroxymethylcytosine in embryonic stem cells	NATURE			English	Article							DEVELOPMENTAL REGULATORS; MYELOID CANCERS; DNA METHYLATION; 5-METHYLCYTOSINE; HYDROXYLATION; TET1; QUANTIFICATION; SPECIFICATION; PLURIPOTENT; CONVERSION	5-hydroxymethylcytosine (5hmC) is a modified base present at low levels in diverse cell types in mammals(1-5). 5hmC is generated by the TET family of Fe(II) and 2-oxoglutarate-dependent enzymes through oxidation of 5-methylcytosine (5mC)(1,2,4-7). 5hmC and TET proteins have been implicated in stem cell biology and cancer(1,4,5,8,9), but information on the genome-wide distribution of 5hmC is limited. Here we describe two novel and specific approaches to profile the genomic localization of 5hmC. The first approach, termed GLIB (glucosylation, periodate oxidation, biotinylation) uses a combination of enzymatic and chemical steps to isolate DNA fragments containing as few as a single 5hmC. The second approach involves conversion of 5hmC to cytosine 5-methylenesulphonate (CMS) by treatment of genomic DNA with sodium bisulphite, followed by immunoprecipitation of CMS-containing DNA with a specific antiserum to CMS5. High-throughput sequencing of 5hmC-containing DNA from mouse embryonic stem (ES) cells showed strong enrichment within exons and near transcriptional start sites. 5hmC was especially enriched at the start sites of genes whose promoters bear dual histone 3 lysine 27 trimethylation (H3K27me3) and histone 3 lysine 4 trimethylation (H3K4me3) marks. Our results indicate that 5hmC has a probable role in transcriptional regulation, and suggest a model in which 5hmC contributes to the 'poised' chromatin signature found at developmentally-regulated genes in ES cells.	[McLoughlin, Erin M.; Daley, George Q.; Agarwal, Suneet] Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA; [Pape, Utz J.; Liu, X. Shirley] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [McLoughlin, Erin M.; Daley, George Q.; Agarwal, Suneet] Harvard Stem Cell Inst, Boston, MA 02115 USA; [Pastor, William A.; Pape, Utz J.; Henderson, Hope R.; Tahiliani, Mamta; Rao, Anjana] Harvard Univ, Sch Med, Immune Dis Inst, Boston, MA 02115 USA; [Pastor, William A.; Pape, Utz J.; Henderson, Hope R.; Tahiliani, Mamta; Rao, Anjana] Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA; [Pastor, William A.; Huang, Yun; Henderson, Hope R.; Ko, Myunggon; Mahapatra, Sahasransu; Rao, Anjana] La Jolla Inst Allergy & Immunol, La Jolla, CA 92037 USA; [Pape, Utz J.; Liu, X. Shirley] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Lister, Ryan; Ecker, Joseph R.] Salk Inst Biol Studies, Genom Anal Lab, La Jolla, CA 92037 USA; [Brudno, Yevgeny] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Kapranov, Philipp; Milos, Patrice M.] Helicos BioSci Corp, Cambridge, MA 02139 USA	Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); La Jolla Institute for Immunology; Harvard University; Harvard T.H. Chan School of Public Health; Salk Institute; Harvard University	Agarwal, S (corresponding author), Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA.	Suneet.Agarwal@childrens.harvard.edu; arao@idi.harvard.edu	Ecker, Joseph R/B-9144-2008; Lister, Ryan/B-5168-2012	Ecker, Joseph R/0000-0001-5799-5895; Lister, Ryan/0000-0001-6637-7239; Ko, Myunggon/0000-0002-6007-2570; Kapranov, Philipp/0000-0003-2647-4856; Henderson, Hope/0000-0002-1373-296X; Brudno, Yevgeny/0000-0003-2963-3293; Huang, Yun/0000-0001-5950-9168	National Science Foundation; Leukemia and Lymphoma Society; California Institute for Regenerative Medicine; National Institute of Health [RC1 DA028422, R01 AI44432, 1 R01 HD065812-01A1, NIH K08 HL089150]; Harvard Catalyst, The Harvard Clinical and Translational Science Center (NIH) [1 UL1 RR 025758-02]; Mary. K. Chapman Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD065812] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025758] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL089150] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044432] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [RC1DA028422] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Catalyst, The Harvard Clinical and Translational Science Center (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mary. K. Chapman Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank B. Ren for assistance in next generation sequencing using the Illumina platform. We thank M. Guttman for making his RNASeq data set available to us. W. A. P. is supported by a predoctoral graduate research fellowship from the National Science Foundation, and Y.H. by a postdoctoral fellowship from the Leukemia and Lymphoma Society. R. L. is supported by a California Institute for Regenerative Medicine Training Grant. This study was supported by the National Institute of Health grants RC1 DA028422, R01 AI44432 and 1 R01 HD065812-01A1 and a grant from the California Institute of Regenerative Medicine (to A. R.), a pilot grant from Harvard Catalyst, The Harvard Clinical and Translational Science Center (NIH Grant 1 UL1 RR 025758-02) and NIH K08 HL089150 (to S. A.), and a grant from the Mary. K. Chapman Foundation (to J.R.E.).	Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bowers J, 2009, NAT METHODS, V6, P593, DOI 10.1038/nmeth.1354; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Delhommeau F, 2009, NEW ENGL J MED, V360, P2289, DOI 10.1056/NEJMoa0810069; Feng SH, 2010, P NATL ACAD SCI USA, V107, P8689, DOI 10.1073/pnas.1002720107; Fouse SD, 2008, CELL STEM CELL, V2, P160, DOI 10.1016/j.stem.2007.12.011; Guttman M, 2010, NAT BIOTECHNOL, V28, P503, DOI 10.1038/nbt.1633; Harris TD, 2008, SCIENCE, V320, P106, DOI 10.1126/science.1150427; HAYATSU H, 1979, BIOCHEMISTRY-US, V18, P632, DOI 10.1021/bi00571a013; Huang Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008888; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Iyer LM, 2009, CELL CYCLE, V8, P1698, DOI 10.4161/cc.8.11.8580; Ko M, 2010, NATURE, V468, P839, DOI 10.1038/nature09586; Koh KP, 2011, CELL STEM CELL, V8, P200, DOI 10.1016/j.stem.2011.01.008; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Ku M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000242; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Loenarz C, 2009, CHEM BIOL, V16, P580, DOI 10.1016/j.chembiol.2009.06.002; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Saxonov S, 2006, P NATL ACAD SCI USA, V103, P1412, DOI 10.1073/pnas.0510310103; Song CX, 2011, NAT BIOTECHNOL, V29, P68, DOI 10.1038/nbt.1732; Szwagierczak A, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq684; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Zhang H, 2003, NAT BIOTECHNOL, V21, P660, DOI 10.1038/nbt827; Zhang HK, 2010, CELL RES, V20, P1390, DOI 10.1038/cr.2010.156	28	614	659	2	144	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 19	2011	473	7347					394	397		10.1038/nature10102	http://dx.doi.org/10.1038/nature10102			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765QA	21552279	Green Accepted, Green Published			2022-12-24	WOS:000290722400053
J	Jeon, Y; Lee, JT				Jeon, Yesu; Lee, Jeannie T.			YY1 Tethers Xist RNA to the Inactive X Nucleation Center	CELL			English	Article							CHROMOSOME INACTIVATION; DOSAGE COMPENSATION; IN-VIVO; CELL-DIFFERENTIATION; BINDING PROTEIN; POLYMERASE-II; CTCF BINDING; POLYCOMB; GENE; MOUSE	The long noncoding Xist RNA inactivates one X chromosome in the female mammal. Current models posit that Xist induces silencing as it spreads along X and recruits Polycomb complexes. However, the mechanisms for Xist loading and spreading are currently unknown. Here, we define the nucleation center for Xist RNA and show that YY1 docks Xist particles onto the X chromosome. YY1 is a "bivalent'' protein, capable of binding both RNA and DNA through different sequence motifs. Xist's exclusive attachment to the inactive X is determined by an epigenetically regulated trio of YY1 sites as well as allelic origin. Specific YY1-to-RNA and YY1-to-DNA contacts are required to load Xist particles onto X. YY1 interacts with Xist RNA through Repeat C. We propose that YY1 acts as adaptor between regulatory RNA and chromatin targets.	[Jeon, Yesu; Lee, Jeannie T.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Howard Hughes Med Inst,Dept Mol Biol, Boston, MA 02114 USA; [Jeon, Yesu; Lee, Jeannie T.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Howard Hughes Medical Institute; Harvard University; Harvard Medical School	Lee, JT (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, Howard Hughes Med Inst,Dept Mol Biol, Boston, MA 02114 USA.	lee@molbio.mgh.harvard.edu			Korean Research Foundation; MGH ECOR Fund; NIH [RO1-GM090278]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM090278] Funding Source: NIH RePORTER	Korean Research Foundation(National Research Foundation of Korea); MGH ECOR Fund; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	lWe thank K. Sarma, B. Del Rosario, and B. Payer for reading of the manuscript and all lab members for many helpful suggestions. We acknowledge K. Hochedlinger for Rosa26-M2rtTA mice, Y. Shi for His-YY1, and B. Del Rosario for purified His-GFP. This work was supported by a Korean Research Foundation grant and the MGH ECOR Fund to Y.J. and NIH RO1-GM090278 to J.T.L. J.T.L. is an Investigator of the Howard Hughes Medical Institute.	Atchison L, 2003, EMBO J, V22, P1347, DOI 10.1093/emboj/cdg124; Bhadra MP, 2006, GENETICS, V174, P1151, DOI 10.1534/genetics.106.060541; BROCKDORFF N, 1992, CELL, V71, P515, DOI 10.1016/0092-8674(92)90519-I; BROWN CJ, 1992, CELL, V71, P527, DOI 10.1016/0092-8674(92)90520-M; Chow JC, 2007, P NATL ACAD SCI USA, V104, P10104, DOI 10.1073/pnas.0610946104; Chureau C, 2002, GENOME RES, V12, P894, DOI 10.1101/gr.152902; Clemson CM, 1996, J CELL BIOL, V132, P259, DOI 10.1083/jcb.132.3.259; Clemson CM, 1998, J CELL BIOL, V142, P13, DOI 10.1083/jcb.142.1.13; Csankovszki G, 1999, NAT GENET, V22, P323, DOI 10.1038/11887; Do Kim J, 2006, GENOME RES, V16, P901, DOI 10.1101/gr.5091406; Do Kim J, 2009, NUCLEIC ACIDS RES, V37, P5656, DOI 10.1093/nar/gkp613; Donohoe ME, 2007, MOL CELL, V25, P43, DOI 10.1016/j.molcel.2006.11.017; Donohoe ME, 2009, NATURE, V460, P128, DOI 10.1038/nature08098; Essien K, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r131; GARTLER SM, 1983, ANNU REV GENET, V17, P155, DOI 10.1146/annurev.ge.17.120183.001103; GILL G, 1988, NATURE, V334, P721, DOI 10.1038/334721a0; HARIHARAN N, 1991, P NATL ACAD SCI USA, V88, P9799, DOI 10.1073/pnas.88.21.9799; HENDRICH BD, 1993, HUM MOL GENET, V2, P663, DOI 10.1093/hmg/2.6.663; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; Iuchi S, 2001, CELL MOL LIFE SCI, V58, P625, DOI 10.1007/PL00000885; Johnston CM, 1998, CELL, V94, P809, DOI 10.1016/S0092-8674(00)81739-0; Jonkers I, 2008, MOL CELL BIOL, V28, P5583, DOI 10.1128/MCB.02269-07; Kohlmaier A, 2004, PLOS BIOL, V2, P991, DOI 10.1371/journal.pbio.0020171; Landeira D, 2010, NAT CELL BIOL, V12, P618, DOI 10.1038/ncb2065; Laverty C, 2010, CURR OPIN GENET DEV, V20, P171, DOI 10.1016/j.gde.2010.01.007; Lee JT, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003749; Lee JT, 2009, GENE DEV, V23, P1831, DOI 10.1101/gad.1811209; Lee JT, 2000, CELL, V103, P17, DOI 10.1016/S0092-8674(00)00101-X; Lee JT, 1999, P NATL ACAD SCI USA, V96, P3836, DOI 10.1073/pnas.96.7.3836; Lee JT, 1999, CELL, V99, P47, DOI 10.1016/S0092-8674(00)80061-6; Lee JT, 1996, CELL, V86, P83, DOI 10.1016/S0092-8674(00)80079-3; Li G, 2010, GENE DEV, V24, P368, DOI 10.1101/gad.1886410; LOBANENKOV VV, 1990, ONCOGENE, V5, P1743; Lucchesi JC, 2005, ANNU REV GENET, V39, P615, DOI 10.1146/annurev.genet.39.073003.094210; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; Marahrens Y, 1997, GENE DEV, V11, P156, DOI 10.1101/gad.11.2.156; Mendenhall EM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001244; Meyer BJ, 2010, CURR OPIN GENET DEV, V20, P179, DOI 10.1016/j.gde.2010.03.008; Nesterova TB, 2001, GENOME RES, V11, P833, DOI 10.1101/gr.174901; Ogawa Y, 2003, MOL CELL, V11, P731, DOI 10.1016/S1097-2765(03)00063-7; Ogawa Y, 2008, SCIENCE, V320, P1336, DOI 10.1126/science.1157676; PARK K, 1991, P NATL ACAD SCI USA, V88, P9804, DOI 10.1073/pnas.88.21.9804; Park Y, 2003, MOL CELL, V11, P977, DOI 10.1016/S1097-2765(03)00147-3; Payer B, 2008, ANNU REV GENET, V42, P733, DOI 10.1146/annurev.genet.42.110807.091711; Penny GD, 1996, NATURE, V379, P131, DOI 10.1038/379131a0; Pillet N, 1995, P NATL ACAD SCI USA, V92, P12515, DOI 10.1073/pnas.92.26.12515; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; Pugacheva EM, 2005, HUM MOL GENET, V14, P953, DOI 10.1093/hmg/ddi089; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Sado T, 2001, DEVELOPMENT, V128, P1275; Sarma Kavitha, 2010, Proc Natl Acad Sci U S A, V107, P22196, DOI 10.1073/pnas.1009785107; Schoeftner S, 2006, EMBO J, V25, P3110, DOI 10.1038/sj.emboj.7601187; Schwartz YB, 2008, CURR OPIN CELL BIOL, V20, P266, DOI 10.1016/j.ceb.2008.03.002; SETO E, 1991, NATURE, V354, P241, DOI 10.1038/354241a0; SHI Y, 1991, CELL, V67, P377, DOI 10.1016/0092-8674(91)90189-6; Silva J, 2003, DEV CELL, V4, P481, DOI 10.1016/S1534-5807(03)00068-6; Stavropoulos N, 2005, MOL CELL BIOL, V25, P2757, DOI 10.1128/MCB.25.7.2757-2769.2005; Sun BK, 2006, MOL CELL, V21, P617, DOI 10.1016/j.molcel.2006.01.028; Takahashi Y, 2000, GENE DEV, V14, P804; Tian D, 2010, CELL, V143, P390, DOI 10.1016/j.cell.2010.09.049; WASSENEGGER M, 1994, CELL, V76, P567, DOI 10.1016/0092-8674(94)90119-8; Wilkinson FH, 2006, P NATL ACAD SCI USA, V103, P19296, DOI 10.1073/pnas.0603564103; Woo CJ, 2010, CELL, V140, P99, DOI 10.1016/j.cell.2009.12.022; Wutz A, 2000, MOL CELL, V5, P695, DOI 10.1016/S1097-2765(00)80248-8; Wutz A, 2002, NAT GENET, V30, P167, DOI 10.1038/ng820; Wutz A, 2007, CURR OPIN GENET DEV, V17, P387, DOI 10.1016/j.gde.2007.08.001; Xu N, 2007, NAT GENET, V39, P1390, DOI 10.1038/ng.2007.5; Zhang LF, 2007, CELL, V129, P693, DOI 10.1016/j.cell.2007.03.036; Zhao J, 2008, SCIENCE, V322, P750, DOI 10.1126/science.1163045; Zhao J, 2010, MOL CELL, V40, P939, DOI 10.1016/j.molcel.2010.12.011	70	361	393	0	38	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 8	2011	146	1					119	133		10.1016/j.cell.2011.06.026	http://dx.doi.org/10.1016/j.cell.2011.06.026			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	789TN	21729784	Green Accepted, Bronze			2022-12-24	WOS:000292539300011
J	Mazzulli, JR; Xu, YH; Sun, Y; Knight, AL; McLean, PJ; Caldwell, GA; Sidransky, E; Grabowski, GA; Krainc, D				Mazzulli, Joseph R.; Xu, You-Hai; Sun, Ying; Knight, Adam L.; McLean, Pamela J.; Caldwell, Guy A.; Sidransky, Ellen; Grabowski, Gregory A.; Krainc, Dimitri			Gaucher Disease Glucocerebrosidase and alpha-Synuclein Form a Bidirectional Pathogenic Loop in Synucleinopathies	CELL			English	Article							PARKINSONS-DISEASE; MOUSE MODELS; MUTATIONS; DEFICIENCY; MECHANISM; OLIGOMERS; CATECHOLS; ENZYME	Parkinson's disease (PD), an adult neurodegenerative disorder, has been clinically linked to the lysosomal storage disorder Gaucher disease (GD), but the mechanistic connection is not known. Here, we show that functional loss of GD-linked glucocerebrosidase (GCase) in primary cultures or human iPS neurons compromises lysosomal protein degradation, causes accumulation of alpha-synuclein (alpha-syn), and results in neurotoxicity through aggregation-dependent mechanisms. Glucosylceramide (GlcCer), the GCase substrate, directly influenced amyloid formation of purified alpha-syn by stabilizing soluble oligomeric intermediates. We further demonstrate that alpha-syn inhibits the lysosomal activity of normal GCase in neurons and idiopathic PD brain, suggesting that GCase depletion contributes to the pathogenesis of sporadic synucleinopathies. These findings suggest that the bidirectional effect of alpha-syn and GCase forms a positive feedback loop that may lead to a self-propagating disease. Therefore, improved targeting of GCase to lysosomes may represent a specific therapeutic approach for PD and other synucleinopathies.	[Mazzulli, Joseph R.; McLean, Pamela J.; Krainc, Dimitri] Harvard Univ, Sch Med, Massachusetts Gen Hosp, MassGen Inst Neurodegenerat Dis,Dept Neurol, Charlestown, MA 02129 USA; [Xu, You-Hai; Sun, Ying; Grabowski, Gregory A.] Cincinnati Childrens Hosp, Med Ctr, Div Human Genet, Cincinnati, OH 45229 USA; [Xu, You-Hai; Sun, Ying; Grabowski, Gregory A.] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH 45229 USA; [Knight, Adam L.; Caldwell, Guy A.] Univ Alabama, Dept Biol Sci, Tuscaloosa, AL 35487 USA; [Caldwell, Guy A.] Univ Alabama Birmingham, Ctr Neurodegenerat & Expt Therapeut, Dept Neurol, Birmingham, AL 35294 USA; [Caldwell, Guy A.] Univ Alabama Birmingham, Ctr Neurodegenerat & Expt Therapeut, Dept Neurobiol, Birmingham, AL 35294 USA; [Sidransky, Ellen] NHGRI, Sect Mol Neurogenet, Med Genet Branch, NIH, Bethesda, MD 20892 USA	Harvard University; Massachusetts General Hospital; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University of Alabama System; University of Alabama Tuscaloosa; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Krainc, D (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, MassGen Inst Neurodegenerat Dis,Dept Neurol, Charlestown, MA 02129 USA.	krainc@mgh.helix.harvard.edu	Mazzulli, joseph/AAS-4480-2020	McLean, Pamela/0000-0003-4870-5715; Caldwell, Guy/0000-0002-8283-9090	National Institutes of Health [R01NS051303, F32NS066730]; National Institute of Neurological Disorders and Stroke [R01DK36729]; National Human Genome Research Institute; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200336] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK036729] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS070168, F32NS066730, R01NS051303] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Harry Ischiropoulos for pCDNA3.1 human alpha-syn plasmids and syn303 antibody, Benoit I. Giasson for the SNL-1 antibody, and Kimberly Kegel for technical advice on liposome formation. This work was supported by National Institutes of Health grants R01NS051303 (D.K.) and F32NS066730 (J.R.M.) from the National Institute of Neurological Disorders and Stroke, R01DK36729 (G.A.G.), and the Intramural Programs of the National Human Genome Research Institute and the National Institutes of Health (E.S.).	Auluck PK, 2002, SCIENCE, V295, P865, DOI 10.1126/science.1067389; BRADY RO, 1965, J BIOL CHEM, V240, P39; Bultron G, 2010, J INHERIT METAB DIS, V33, P167, DOI 10.1007/s10545-010-9055-0; Chandra S, 2005, CELL, V123, P383, DOI 10.1016/j.cell.2005.09.028; Conway KA, 1998, NAT MED, V4, P1318, DOI 10.1038/3311; Cooper AA, 2006, SCIENCE, V313, P324, DOI 10.1126/science.1129462; Duda JE, 2002, ANN NEUROL, V52, P205, DOI 10.1002/ana.10279; ERICKSON AH, 1985, J BIOL CHEM, V260, P4319; Giasson BI, 2002, NEURON, V34, P521, DOI 10.1016/S0896-6273(02)00682-7; Giasson BI, 2001, J BIOL CHEM, V276, P2380, DOI 10.1074/jbc.M008919200; Goker-Alpan O, 2004, J MED GENET, V41, P937, DOI 10.1136/jmg.2004.024455; GOKERALPAN O, 2008, LANCET, V372, P1263; Hodara R, 2004, J BIOL CHEM, V279, P47746, DOI 10.1074/jbc.M408906200; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; LEE RE, 1968, P NATL ACAD SCI USA, V61, P484, DOI 10.1073/pnas.61.2.484; LILL CM, 2008, PDGENE DATABASE ALZH; Manning-Bog AB, 2009, NEUROTOXICOLOGY, V30, P1127, DOI 10.1016/j.neuro.2009.06.009; MAROTEAUX L, 1988, J NEUROSCI, V8, P2804; Martinez Z, 2007, BIOCHEMISTRY-US, V46, P1868, DOI 10.1021/bi061749a; Mazzulli JR, 2007, J BIOL CHEM, V282, P31621, DOI 10.1074/jbc.M704737200; Mazzulli JR, 2006, J NEUROSCI, V26, P10068, DOI 10.1523/JNEUROSCI.0896-06.2006; Neudorfer O, 1996, QJM-MON J ASSOC PHYS, V89, P691; Neumann J, 2009, BRAIN, V132, P1783, DOI 10.1093/brain/awp044; Seibler P, 2011, J NEUROSCI, V31, P5970, DOI 10.1523/JNEUROSCI.4441-10.2011; Sidransky E, 2005, MOL GENET METAB, V84, P302, DOI 10.1016/j.ymgme.2004.11.007; Sidransky E, 2009, NEW ENGL J MED, V361, P1651, DOI 10.1056/NEJMoa0901281; STRYER LUBERT, 1965, J MOL BIOL, V13, P482; Sun Y, 2005, J LIPID RES, V46, P2102, DOI 10.1194/jlr.M500202-JLR200; Tayebi N, 2003, MOL GENET METAB, V79, P104, DOI 10.1016/S1096-7192(03)00071-4; Tayebi N, 2001, MOL GENET METAB, V73, P313, DOI 10.1006/mgme.2001.3201; Thayanidhi N, 2010, MOL BIOL CELL, V21, P1850, DOI 10.1091/mbc.E09-09-0801; Trojanowski JQ, 2002, NEUROTOXICOLOGY, V23, P457, DOI 10.1016/S0161-813X(02)00065-7; Tsika E, 2010, J NEUROSCI, V30, P3409, DOI 10.1523/JNEUROSCI.4977-09.2010; Volles MJ, 2003, BIOCHEMISTRY-US, V42, P7871, DOI 10.1021/bi030086j; Wong KD, 2004, MOL GENET METAB, V82, P192, DOI 10.1016/j.ymgme.2004.04.011; Xu YH, 2011, MOL GENET METAB, V102, P436, DOI 10.1016/j.ymgme.2010.12.014; Xu YH, 2003, AM J PATHOL, V163, P2093, DOI 10.1016/S0002-9440(10)63566-3; Zala D, 2005, NEUROBIOL DIS, V20, P785, DOI 10.1016/j.nbd.2005.05.017	38	886	915	1	76	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 8	2011	146	1					37	52		10.1016/j.cell.2011.06.001	http://dx.doi.org/10.1016/j.cell.2011.06.001			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	789TN	21700325	Green Accepted, Bronze			2022-12-24	WOS:000292539300005
J	De Nicola, GM; Karreth, FA; Humpton, TJ; Gopinathan, A; Wei, C; Frese, K; Mangal, D; Yu, KH; Yeo, CJ; Calhoun, ES; Scrimieri, F; Winter, JM; Hruban, RH; Iacobuzio-Donahue, C; Kern, SE; Blair, IA; Tuveson, DA				De Nicola, Gina M.; Karreth, Florian A.; Humpton, Timothy J.; Gopinathan, Aarthi; Wei, Cong; Frese, Kristopher; Mangal, Dipti; Yu, Kenneth H.; Yeo, Charles J.; Calhoun, Eric S.; Scrimieri, Francesca; Winter, Jordan M.; Hruban, Ralph H.; Iacobuzio-Donahue, Christine; Kern, Scott E.; Blair, Ian A.; Tuveson, David A.			Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis	NATURE			English	Article							PANCREATIC-CANCER; HEME OXYGENASE-1; K-RAS; ACTIVATION; EXPRESSION; PATHWAY; INHIBITION; MUTATIONS; INDUCTION; ELEMENTS	Reactive oxygen species (ROS) are mutagenic and may thereby promote cancer(1). Normally, ROS levels are tightly controlled by an inducible antioxidant program that responds to cellular stressors and is predominantly regulated by the transcription factor Nrf2 (also known as Nfe212) and its repressor protein Keap1 (refs 2-5). In contrast to the acute physiological regulation of Nrf2, in neoplasia there is evidence for increased basal activation of Nrf2. Indeed, somatic mutations that disrupt the Nrf2-Keap1 interaction to stabilize Nrf2 and increase the constitutive transcription of Nrf2 target genes were recently identified, indicating that enhanced ROS detoxification and additional Nrf2 functions may in fact be pro-tumorigenic(6). Here, we investigated ROS metabolism in primary murine cells following the expression of endogenous oncogenic alleles of Kras, Braf and Myc, and found that ROS are actively suppressed by these oncogenes. K-Ras(G12D), B-Raf(V619E) and Myc(ERT2) each increased the transcription of Nrf2 to stably elevate the basal Nrf2, antioxidant program and thereby lower intracellular ROS and confer a more reduced intracellular environment. Oncogene-directed increased expression of Nrf2 is a new mechanism for the activation of the Nrf2 antioxidant program, and is evident in primary cells and tissues of mice expressing K-Ras(G12D) up and B-Raf(V619E), and in human pancreatic cancer. Furthermore, genetic targeting of the Nrf2 pathway impairs K-Ras(G12D)-induced proliferation and tumorigenesis in vivo. Thus, the Nrf2 antioxidant and cellular detoxification program represents a previously unappreciated mediator of oncogenesis.	[De Nicola, Gina M.; Karreth, Florian A.; Humpton, Timothy J.; Gopinathan, Aarthi; Frese, Kristopher; Tuveson, David A.] Cancer Res UK Cambridge Inst, Li Ka Shing Ctr, Cambridge CB2 0RE, England; [De Nicola, Gina M.; Gopinathan, Aarthi] Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [Karreth, Florian A.] Univ Vienna, A-1030 Vienna, Austria; [Wei, Cong; Mangal, Dipti; Yu, Kenneth H.; Blair, Ian A.] Univ Penn, Ctr Canc Pharmacol, Philadelphia, PA 19104 USA; [Yeo, Charles J.] Thomas Jefferson Univ, Jefferson Med Coll, Dept Surg, Philadelphia, PA 19107 USA; [Calhoun, Eric S.] Alma Coll, Dept Biol, Alma, MI 48801 USA; [Scrimieri, Francesca; Hruban, Ralph H.; Iacobuzio-Donahue, Christine; Kern, Scott E.] Johns Hopkins Med Inst, Sol Goldman Pancreat Canc Res Ctr, Dept Oncol, Baltimore, MD 21287 USA; [Winter, Jordan M.] Johns Hopkins Med Inst, Sol Goldman Pancreat Canc Res Ctr, Dept Surg, Baltimore, MD 21287 USA; [Hruban, Ralph H.; Iacobuzio-Donahue, Christine; Kern, Scott E.] Johns Hopkins Med Inst, Sol Goldman Pancreat Canc Res Ctr, Dept Pathol, Baltimore, MD 21287 USA	Cancer Research UK; CRUK Cambridge Institute; University of Pennsylvania; Pennsylvania Medicine; University of Vienna; University of Pennsylvania; Pennsylvania Medicine; Jefferson University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine	Tuveson, DA (corresponding author), Cancer Res UK Cambridge Inst, Li Ka Shing Ctr, Robinson Way, Cambridge CB2 0RE, England.	david.tuveson@cancer.org.uk	Iacobuzio-Donahue, Christine/ABF-1295-2020; Humpton, Timothy/AAV-5501-2020	Iacobuzio-Donahue, Christine/0000-0002-4672-3023; Humpton, Timothy/0000-0002-8030-9539; DeNicola, Gina/0000-0001-6611-6696; Wei, Cong/0000-0003-2310-9255	University of Cambridge; Cancer Research UK; The Li Ka Shing Foundation; Hutchison Whampoa Limited; NIHR Cambridge Biomedical Research Centre; NIH [CA101973, CA111294, CA084291, CA105490, CA62924, CA128920, CA106610]; Abramson Cancer Center of the University of Pennsylvania [IRG 78-002-26]; Emerald Foundation; Marjorie Kovler Fund; Ruth L. Kirschstein National Research Service Award [F32CA123887-01]; NATIONAL CANCER INSTITUTE [U01CA084291, R01CA101973, K08CA106610, P50CA062924, U01CA105490, U01CA111294, F32CA123887, R01CA128920] Funding Source: NIH RePORTER	University of Cambridge(University of Cambridge); Cancer Research UK(Cancer Research UK); The Li Ka Shing Foundation; Hutchison Whampoa Limited; NIHR Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Abramson Cancer Center of the University of Pennsylvania; Emerald Foundation; Marjorie Kovler Fund; Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank J. Johnson for providing the Nrf2<SUP>-/-</SUP> mice; G. Evan, O. Sansom, C. Murtaugh, J.-J. Ventura and E. Wagner for MEFs; E Schmidt for Nrf2 antiserum; E. Jaffee,A. Maitra and A. Hors for human PDAcell lines; B. Haynes, S. Davies and N. Cook for human PDA tissue samples; C. Ross-Innes, K Holmes and J. Carroll for advice with the ChIP assay; and the ENCODE Consortium for ChIP-seq studies. We thank F. Connor, C. Martins arid other members of the Tuveson lab for assistance arid advice, and the animal carestaff and histology core at CRI. This research was supported by the University of Cambridge and Cancer Research UK, The Li Ka Shing Foundation and Hutchison Whampoa Limited, the NIHR Cambridge Biomedical Research Centre, arid the NIH (grants CA101973, CA111294, CA084291 and CA105490 to D.A.T.: CA62924 and CA128920 to S.E.K. and C.I.-D.; and CA106610 to C.I.-D.). Additional support was obtained from the Abramson Cancer Center of the University of Pennsylvania Pilot Grant IRG 78-002-26 (D.A.T.), Emerald Foundation (E.S.C.), the Marjorie Kovler Fund (S.E.K) and the Ruth L. Kirschstein National Research Service Award F32CA123887-01 (K.F) We regret that many primary references have been omitted due to space limitations.	Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Cakir Y, 2005, ANTIOXID REDOX SIGN, V7, P726, DOI 10.1089/ars.2005.7.726; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; Chan KM, 1996, P NATL ACAD SCI USA, V93, P13943, DOI 10.1073/pnas.93.24.13943; HAHN SA, 1995, CANCER RES, V55, P4670; Hayes JD, 2009, TRENDS BIOCHEM SCI, V34, P176, DOI 10.1016/j.tibs.2008.12.008; He XQ, 2006, J BIOL CHEM, V281, P23620, DOI 10.1074/jbc.M604120200; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Irani K, 1997, SCIENCE, V275, P1649, DOI 10.1126/science.275.5306.1649; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Karreth FA, 2009, MOL CELL, V36, P477, DOI 10.1016/j.molcel.2009.10.017; Kawaguchi Y, 2002, NAT GENET, V32, P128, DOI 10.1038/ng959; Keum YS, 2006, CANCER RES, V66, P8804, DOI 10.1158/0008-5472.CAN-05-3513; Kwak MK, 2002, MOL CELL BIOL, V22, P2883, DOI 10.1128/MCB.22.9.2883-2892.2002; Lee AC, 1999, J BIOL CHEM, V274, P7936, DOI 10.1074/jbc.274.12.7936; Mitsushita J, 2004, CANCER RES, V64, P3580, DOI 10.1158/0008-5472.CAN-03-3909; Murphy DJ, 2008, CANCER CELL, V14, P447, DOI 10.1016/j.ccr.2008.10.018; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; Park JH, 2008, P NATL ACAD SCI USA, V105, P6846, DOI 10.1073/pnas.0802776105; Rasband W., 2006, IMAGEJ; Recktenwald CV, 2008, CANCER RES, V68, P10086, DOI 10.1158/0008-5472.CAN-08-0360; SHIBUTANI S, 1991, NATURE, V349, P431, DOI 10.1038/349431a0; Sun CL, 2001, ONCOL REP, V8, P89; Sun JY, 2002, EMBO J, V21, P5216, DOI 10.1093/emboj/cdf516; Suvorova ES, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006158; Tanaka H, 2002, MOL CELL, V9, P1017, DOI 10.1016/S1097-2765(02)00522-1; Tuveson DA, 2004, CANCER CELL, V5, P375, DOI 10.1016/S1535-6108(04)00085-6; Venugopal R, 1998, ONCOGENE, V17, P3145, DOI 10.1038/sj.onc.1202237; Wakabayashi N, 2003, NAT GENET, V35, P238, DOI 10.1038/ng1248; Zhu PJ, 2008, RAPID COMMUN MASS SP, V22, P432, DOI 10.1002/rcm.3380	31	1441	1489	14	329	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 7	2011	475	7354					106	U128		10.1038/nature10189	http://dx.doi.org/10.1038/nature10189			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	788RE	21734707	Green Accepted, Green Submitted			2022-12-24	WOS:000292461300054
J	Faith, JJ; McNulty, NP; Rey, FE; Gordon, JI				Faith, Jeremiah J.; McNulty, Nathan P.; Rey, Federico E.; Gordon, Jeffrey I.			Predicting a Human Gut Microbiota's Response to Diet in Gnotobiotic Mice	SCIENCE			English	Article							MICROBES	The interrelationships between our diets and the structure and operations of our gut microbial communities are poorly understood. A model community of 10 sequenced human gut bacteria was introduced into gnotobiotic mice, and changes in species abundance and microbial gene expression were measured in response to randomized perturbations of four defined ingredients in the host diet. From the responses, we developed a statistical model that predicted over 60% of the variation in species abundance evoked by diet perturbations, and we were able to identify which factors in the diet best explained changes seen for each community member. The approach is generally applicable, as shown by a follow-up study involving diets containing various mixtures of pureed human baby foods.	[Faith, Jeremiah J.; McNulty, Nathan P.; Rey, Federico E.; Gordon, Jeffrey I.] Washington Univ, Sch Med, Ctr Genome Sci & Syst Biol, St Louis, MO 63108 USA	Washington University (WUSTL)	Gordon, JI (corresponding author), Washington Univ, Sch Med, Ctr Genome Sci & Syst Biol, St Louis, MO 63108 USA.	jgordon@wustl.edu			NIH [DK30292, DK70977]; Crohn's and Colitis Foundation of America; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK030292, R01DK030292, R01DK070977] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation of America; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We are indebted to D. O'Donnell, M. Karlsson, and S. Wagoner for their help with various aspects of gnotobiotic mouse husbandry and to B. Mickelson, I. Mogno, A. Goodman, N. Griffin, H. Seedorf, G. Simon, J. Chase, and B. Cohen for their many helpful suggestions during the course of this work. This work was supported by grants from NIH (DK30292 and DK70977) and the Crohn's and Colitis Foundation of America. COPRO-seq and microbial RNA-seq data are available in the Gene Expression Omnibus (accession GSE26687). Processed data can be obtained at http://gordonlab.wustl.edu/modeling_microbiota/.	Chase J.M., 2009, ECOLOGICAL NICHES LI; Clayton TA, 2009, P NATL ACAD SCI USA, V106, P14728, DOI 10.1073/pnas.0904489106; Faith JJ, 2010, ISME J, V4, P1094, DOI 10.1038/ismej.2010.110; Fu X, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-161; Goodman AL, 2009, CELL HOST MICROBE, V6, P279, DOI 10.1016/j.chom.2009.08.003; Handelsman J, 2008, DNA CELL BIOL, V27, P219, DOI 10.1089/dna.2008.1503; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Mahowald MA, 2009, P NATL ACAD SCI USA, V106, P5859, DOI 10.1073/pnas.0901529106; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Muegge BD, 2011, SCIENCE, V332, P970, DOI 10.1126/science.1198719; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rey FE, 2010, J BIOL CHEM, V285, P22082, DOI 10.1074/jbc.M110.117713; Turnbaugh PJ, 2010, P NATL ACAD SCI USA, V107, P7503, DOI 10.1073/pnas.1002355107; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005	15	347	361	9	157	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 1	2011	333	6038					101	104		10.1126/science.1206025	http://dx.doi.org/10.1126/science.1206025			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	785UF	21596954	Green Accepted			2022-12-24	WOS:000292255400059
J	Shattock, RJ; Warren, M; McCormack, S; Hankins, CA				Shattock, Robin J.; Warren, Mitchell; McCormack, Sheena; Hankins, Catherine A.			Turning the Tide Against HIV	SCIENCE			English	Editorial Material							TRANSMISSION; PREVENTION		[Shattock, Robin J.; McCormack, Sheena] Univ London Imperial Coll Sci Technol & Med, London W2 1PG, England; [Warren, Mitchell] AVAC Global Advocacy HIV Prevent, New York, NY 10027 USA; [McCormack, Sheena] MRC, Clin Trials Unit, London NW1 2DA, England; [Hankins, Catherine A.] Joint United Nations Programme HIV AIDS, Programme Branch, Off Deputy Execut Director, CH-1211 Geneva, Switzerland	Imperial College London; Medical Research Council Clinical Trials Unit	Shattock, RJ (corresponding author), Univ London Imperial Coll Sci Technol & Med, London W2 1PG, England.	r.shattock@imperial.ac.uk		Hankins, Catherine/0000-0002-1642-8592	MRC [MC_U122861322] Funding Source: UKRI; Medical Research Council [MC_U122861322] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Attia S, 2009, AIDS, V23, P1397, DOI 10.1097/QAD.0b013e32832b7dca; Cranage M, 2008, PLOS MED, V5, P1238, DOI 10.1371/journal.pmed.0050157; Excler JL, 2011, AIDS RES HUM RETROV, V27, P669, DOI [10.1089/aid.2010.0206, 10.1089/AID.2010.0206]; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Hankins CA, 2010, AIDS, V24, pS70, DOI 10.1097/01.aids.0000390709.04255.fd; Hecht R, 2010, LANCET, V376, P1254, DOI 10.1016/S0140-6736(10)61255-X; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Keele BF, 2011, BLOOD, V118, P839, DOI 10.1182/blood-2010-12-325860; Kersh EN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019295; Matthews LT, 2010, AIDS, V24, P1975, DOI 10.1097/QAD.0b013e32833bedeb; Patterson K. P. H., 2010, 18 INT AIDS C VIENN, P18; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Roehr B., 2011, BRIT MED J, V342, pd2613; Siegfried N, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003362.pub2; UNAIDS, 2011, AIDS 30 NAT CROSSR; van't Klooster G, 2008, 15 C RETR OPP INF CR; Whaley KJ, 2010, ANTIVIR RES, V88, pS55, DOI 10.1016/j.antiviral.2010.09.006	17	64	64	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 1	2011	333	6038					42	43		10.1126/science.1206399	http://dx.doi.org/10.1126/science.1206399			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	785UF	21719662				2022-12-24	WOS:000292255400037
J	Mao, ZY; Hine, C; Tian, X; Van Meter, M; Au, M; Vaidya, A; Seluanov, A; Gorbunova, V				Mao, Zhiyong; Hine, Christopher; Tian, Xiao; Van Meter, Michael; Au, Matthew; Vaidya, Amita; Seluanov, Andrei; Gorbunova, Vera			SIRT6 Promotes DNA Repair Under Stress by Activating PARP1	SCIENCE			English	Article							DOUBLE-STRAND BREAKS; HOMOLOGOUS RECOMBINATION; PROTEIN SIR2; DEACETYLASE; STABILITY; CHROMATIN; POLY(ADP-RIBOSYL)ATION; LONGEVITY; KINASE; SITES	Sirtuin 6 (SIRT6) is a mammalian homolog of the yeast Sir2 deacetylase. Mice deficient for SIRT6 exhibit genome instability. Here, we show that in mammalian cells subjected to oxidative stress SIRT6 is recruited to the sites of DNA double-strand breaks (DSBs) and stimulates DSB repair, through both nonhomologous end joining and homologous recombination. Our results indicate that SIRT6 physically associates with poly[adenosine diphosphate (ADP)-ribose] polymerase 1 (PARP1) and mono-ADP-ribosylates PARP1 on lysine residue 521, thereby stimulating PARP1 poly-ADP-ribosylase activity and enhancing DSB repair under oxidative stress.	[Mao, Zhiyong; Hine, Christopher; Tian, Xiao; Van Meter, Michael; Au, Matthew; Vaidya, Amita; Seluanov, Andrei; Gorbunova, Vera] Univ Rochester, Dept Biol, Rochester, NY 14627 USA	University of Rochester	Seluanov, A (corresponding author), Univ Rochester, Dept Biol, Rochester, NY 14627 USA.	andrei.seluanov@rochester.edu; vera.gorbunova@rochester.edu	Tian, Xiao/E-3998-2017	Tian, Xiao/0000-0001-5300-3596; Hine, Christopher/0000-0003-1926-7939; Gorbunova, Vera/0000-0001-8979-0333; Seluanov, Andrei/0000-0003-3400-538X; Mao, Zhiyong/0000-0002-5298-1918	NIH; Ellison Medical Foundation; NATIONAL INSTITUTE ON AGING [F31AG041603, R01AG027237] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants from the NIH (to V.G.) and the Ellison Medical Foundation (to V.G. and A.S.). Z.M. performed DNA repair assays, immunoblots, coimmunoprecipitations, in situ staining, and biochemical assays; C.H. and A.V. performed ChIP; X.T. analyzed PARP1 mutants; M.V.M. analyzed DNA damage foci; M.A. performed comet assays; and Z.M., C.H., A.S., and V.G. designed the study, analyzed data, and wrote the manuscript.	Ahel D, 2009, SCIENCE, V325, P1240, DOI 10.1126/science.1177321; Altmeyer M, 2009, NUCLEIC ACIDS RES, V37, P3723, DOI 10.1093/nar/gkp229; Audebert M, 2006, J MOL BIOL, V356, P257, DOI 10.1016/j.jmb.2005.11.028; Burkle A, 2000, BIOGERONTOLOGY, V1, P41, DOI 10.1023/A:1010089924898; di Fagagna FD, 1999, NAT GENET, V23, P76; Dioum EM, 2009, SCIENCE, V324, P1289, DOI 10.1126/science.1169956; El-Khamisy SF, 2003, NUCLEIC ACIDS RES, V31, P5526, DOI 10.1093/nar/gkg761; Frye RA, 1999, BIOCHEM BIOPH RES CO, V260, P273, DOI 10.1006/bbrc.1999.0897; Gorbunova V, 2005, MECH AGEING DEV, V126, P621, DOI 10.1016/j.mad.2005.02.008; Hassa PO, 2006, MICROBIOL MOL BIOL R, V70, P789, DOI 10.1128/MMBR.00040-05; Hochegger H, 2006, EMBO J, V25, P1305, DOI 10.1038/sj.emboj.7601015; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Jeggo PA, 1998, CURR BIOL, V8, pR49, DOI 10.1016/S0960-9822(98)70032-6; Kaidi A, 2010, SCIENCE, V329, P1348, DOI 10.1126/science.1192049; Landry J, 2000, P NATL ACAD SCI USA, V97, P5807, DOI 10.1073/pnas.110148297; Mao ZY, 2007, P NATL ACAD SCI USA, V104, P13068, DOI 10.1073/pnas.0702410104; McCord RA, 2009, AGING-US, V1, P109, DOI 10.18632/aging.100011; Michishita E, 2005, MOL BIOL CELL, V16, P4623, DOI 10.1091/mbc.E05-01-0033; Mostoslavsky R, 2006, CELL, V124, P315, DOI 10.1016/J.CEL.2005.11.044; Oberdoerffer P, 2008, CELL, V135, P907, DOI 10.1016/j.cell.2008.10.025; Paddock MN, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000428; Saunders LR, 2009, SCIENCE, V323, P1021, DOI 10.1126/science.1170007; Tao ZH, 2009, J AM CHEM SOC, V131, P14258, DOI 10.1021/ja906135d; Wang ML, 2006, NUCLEIC ACIDS RES, V34, P6170, DOI 10.1093/nar/gkl840; Westerheide SD, 2009, SCIENCE, V323, P1063, DOI 10.1126/science.1165946	25	556	580	4	90	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 17	2011	332	6036					1443	1446		10.1126/science.1202723	http://dx.doi.org/10.1126/science.1202723			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778FT	21680843	Green Accepted			2022-12-24	WOS:000291689000045
J	Shi, ML; Zhu, JH; Wang, R; Chen, X; Mi, LZ; Walz, T; Springer, TA				Shi, Minlong; Zhu, Jianghai; Wang, Rui; Chen, Xing; Mi, Lizhi; Walz, Thomas; Springer, Timothy A.			Latent TGF-beta structure and activation	NATURE			English	Article							GROWTH-FACTOR-BETA; BINDING-PROTEIN; CRYSTAL-STRUCTURE; SECRETION; MATURE; TGF-BETA-1; DOMAIN; FACTOR-BETA-1; INFLAMMATION; REQUIREMENT	Transforming growth factor (TGF)-beta is stored in the extracellular matrix as a latent complex with its prodomain. Activation of TGF-beta 1 requires the binding of alpha(v) integrin to an RGD sequence in the prodomain and exertion of force on this domain, which is held in the extracellular matrix by latent TGF-beta binding proteins. Crystals of dimeric porcine proTGF-beta 1 reveal a ring-shaped complex, a novel fold for the prodomain, and show how the prodomain shields the growth factor from recognition by receptors and alters its conformation. Complex formation between alpha(v)beta(6) integrin and the prodomain is insufficient for TGF-beta 1 release. Force-dependent activation requires unfastening of a 'straitjacket' that encircles each growth-factor monomer at a position that can be locked by a disulphide bond. Sequences of all 33 TGF-beta family members indicate a similar prodomain fold. The structure provides insights into the regulation of a family of growth and differentiation factors of fundamental importance in morphogenesis and homeostasis.	[Shi, Minlong; Zhu, Jianghai; Wang, Rui; Chen, Xing; Mi, Lizhi; Springer, Timothy A.] Childrens Hosp, Immune Dis Inst, Boston, MA 02115 USA; [Shi, Minlong; Zhu, Jianghai; Wang, Rui; Chen, Xing; Mi, Lizhi; Springer, Timothy A.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Walz, Thomas] Howard Hughes Med Inst, Boston, MA 02115 USA; [Walz, Thomas] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School	Springer, TA (corresponding author), Childrens Hosp, Immune Dis Inst, Boston, MA 02115 USA.	springer@idi.harvard.edu	Zhu, Jianghai/B-7339-2014; Mi, Li-Zhi/B-1371-2016; shi, minlong/G-8734-2013	Mi, Li-Zhi/0000-0001-9907-5245; Walz, Thomas/0000-0003-2606-2835	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL103526] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NHLBI NIH HHS [P01 HL103526] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Aluwihare P, 2009, J CELL SCI, V122, P227, DOI 10.1242/jcs.035246; Anderson SB, 2008, J BIOL CHEM, V283, P7027, DOI 10.1074/jbc.M706678200; Annes JP, 2004, J CELL BIOL, V165, P723, DOI 10.1083/jcb.200312172; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Belville C, 2004, MOL ENDOCRINOL, V18, P708, DOI 10.1210/me.2003-0358; Blanchet MH, 2008, EMBO J, V27, P2580, DOI 10.1038/emboj.2008.174; Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807; BRUNNER AM, 1992, MOL ENDOCRINOL, V6, P1691, DOI 10.1210/me.6.10.1691; Chen X, 2010, P NATL ACAD SCI USA, V107, P14727, DOI 10.1073/pnas.1008663107; Chen Y, 2005, J MOL BIOL, V345, P175, DOI 10.1016/j.jmb.2004.10.039; Cowtan K, 2010, ACTA CRYSTALLOGR D, V66, P470, DOI 10.1107/S090744490903947X; Cui YZ, 2001, GENE DEV, V15, P2797; DAOPIN S, 1992, SCIENCE, V257, P369, DOI 10.1126/science.1631557; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Derynck Rik, 2008, P29; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Forman JR, 2007, CURR OPIN STRUC BIOL, V17, P58, DOI 10.1016/j.sbi.2007.01.006; GENTRY LE, 1987, MOL CELL BIOL, V7, P3418, DOI 10.1128/MCB.7.10.3418; GENTRY LE, 1990, BIOCHEMISTRY-US, V29, P6851, DOI 10.1021/bi00481a014; GRAY AM, 1990, SCIENCE, V247, P1328, DOI 10.1126/science.2315700; Heras B, 2005, ACTA CRYSTALLOGR D, V61, P1173, DOI 10.1107/S0907444905019451; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Janssens K, 2006, J MED GENET, V43, P1, DOI 10.1136/jmg.2005.033522; Kabsch W., 2001, INT TABLES CRYSTALLO, P730, DOI [10.1107/97809553602060000001, DOI 10.1107/97809553602060000001]; Keefe AD, 2001, PROTEIN EXPRES PURIF, V23, P440, DOI 10.1006/prep.2001.1515; Lack J, 2003, J MOL BIOL, V334, P281, DOI 10.1016/j.jmb.2003.09.053; Little SC, 2009, NAT CELL BIOL, V11, P637, DOI 10.1038/ncb1870; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Munger JS, 1999, CELL, V96, P319, DOI 10.1016/S0092-8674(00)80545-0; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Radaev S, 2010, J BIOL CHEM, V285, P14806, DOI 10.1074/jbc.M109.079921; Ramirez F, 2010, CELL TISSUE RES, V339, P71, DOI 10.1007/s00441-009-0822-x; SCHLUNEGGER MP, 1992, NATURE, V358, P430, DOI 10.1038/358430a0; Sengle G, 2008, J BIOL CHEM, V283, P13874, DOI 10.1074/jbc.M707820200; Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2; Ulloa L, 2001, J BIOL CHEM, V276, P21387, DOI 10.1074/jbc.M006933200; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Walton KL, 2010, J BIOL CHEM, V285, P17029, DOI 10.1074/jbc.M110.110288; Walton KL, 2009, J BIOL CHEM, V284, P9311, DOI 10.1074/jbc.M808763200; WILSON CA, 1993, MOL ENDOCRINOL, V7, P247, DOI 10.1210/me.7.2.247; Wipff PJ, 2008, EUR J CELL BIOL, V87, P601, DOI 10.1016/j.ejcb.2008.01.012; Wu MY, 2009, DEV CELL, V16, P329, DOI 10.1016/j.devcel.2009.02.012; Yang ZW, 2007, J CELL BIOL, V176, P787, DOI 10.1083/jcb.200611044; Yoshinaga K, 2008, P NATL ACAD SCI USA, V105, P18758, DOI 10.1073/pnas.0805411105; Zou ZC, 2004, PROTEIN EXPRES PURIF, V37, P265, DOI 10.1016/j.pep.2003.06.001	46	648	673	6	76	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 16	2011	474	7351					343	U370		10.1038/nature10152	http://dx.doi.org/10.1038/nature10152			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777TD	21677751	Green Accepted			2022-12-24	WOS:000291647100038
J	Borgonie, G; Garcia-Moyano, A; Litthauer, D; Bert, W; Bester, A; van Heerden, E; Moller, C; Erasmus, M; Onstott, TC				Borgonie, G.; Garcia-Moyano, A.; Litthauer, D.; Bert, W.; Bester, A.; van Heerden, E.; Moeller, C.; Erasmus, M.; Onstott, T. C.			Nematoda from the terrestrial deep subsurface of South Africa	NATURE			English	Article							WITWATERSRAND BASIN; EVOLUTION; WATER	Since its discovery over two decades ago, the deep subsurface biosphere has been considered to be the realm of single-cell organisms, extending over three kilometres into the Earth's crust and comprising a significant fraction of the global biosphere(1-4). The constraints of temperature, energy, dioxygen and space seemed to preclude the possibility of more-complex, multicellular organisms from surviving at these depths. Here we report species of the phylum Nematoda that have been detected in or recovered from 0.9-3.6-kilometre-deep fracture water in the deep mines of South Africa but have not been detected in the mining water. These subsurface nematodes, including a new species, Halicephalobus mephisto, tolerate high temperature, reproduce asexually and preferentially feed upon subsurface bacteria. Carbon-14 data indicate that the fracture water in which the nematodes reside is 3,000-12,000-year-old palaeometeoric water. Our data suggest that nematodes should be found in other deep hypoxic settings where temperature permits, and that they may control the microbial population density by grazing on fracture surface biofilm patches. Our results expand the known metazoan biosphere and demonstrate that deep ecosystems are more complex than previously accepted. The discovery of multicellular life in the deep subsurface of the Earth also has important implications for the search for subsurface life on other planets in our Solar System.	[Borgonie, G.; Bert, W.] Univ Ghent, Dept Biol, Nematol Sect, B-9000 Ghent, Belgium; [Garcia-Moyano, A.; Litthauer, D.; Bester, A.; van Heerden, E.; Moeller, C.; Erasmus, M.] Univ Free State, Dept Microbial Biochem & Food Biotechnol, ZA-9300 Bloemfontein, South Africa; [Bert, W.] Wageningen Univ, Dept Plant Sci, Nematol Lab, NL-6708 Wageningen, Netherlands; [Onstott, T. C.] Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA	Ghent University; University of the Free State; Wageningen University & Research; Princeton University	Borgonie, G (corresponding author), Univ Ghent, Dept Biol, Nematol Sect, Ledeganckstr 35, B-9000 Ghent, Belgium.	gborgonie@gmail.com; tullis@princeton.edu	Bert, Wim/D-4511-2013; Erasmus, Mariana/AAE-9823-2019; Garcia-Moyano, Antonio/O-4791-2014; Garcia-Moyano, Antonio/AAI-8647-2020	Bert, Wim/0000-0002-5864-412X; Erasmus, Mariana/0000-0003-2191-762X; Garcia-Moyano, Antonio/0000-0003-1997-8589; Garcia-Moyano, Antonio/0000-0003-1997-8589; Onstott, Tullis/0000-0002-2898-3374	FWO; BOF; UFS; National Science Foundation [EAR 0409605]; BioPAD/UFS; Directorate For Geosciences [0948659] Funding Source: National Science Foundation	FWO(FWO); BOF; UFS; National Science Foundation(National Science Foundation (NSF)); BioPAD/UFS; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	G.B. is grateful to the University of Ghent for allowing a year-long sabbatical, and for grants from the FWO, BOF and UFS. We express our recognition of the support provided by Tau Tona gold mine (AngloGold Ashanti Limited), Driefontein gold mine (Gold Fields Limited), Beatrix gold mine (Gold Fields Limited), Zondereinde mine (Northern Platinum Ltd) and Star Diamonds mine (Petra Diamonds), and by the many people without whom this work would have been impossible. In particular, we are grateful to F. Rheeder, H. Moller, T. Lineque, A. Thwala, K. Sokhela, C. Rose, R. Fynn, B. Visser, O. Holovachev, T. Moens, M. Couvreur and A. Vierstraete. We are grateful to E. Botes and K. Albertyn of the University of the Free State for their contributions to the data analysis. T.C.O. acknowledges support from a National Science Foundation Continental Dynamics Program grant (EAR 0409605). E.v.H. acknowledges support from a BioPAD/UFS Metagenomics Platform grant.	Amend JP, 2005, PALAEOGEOGR PALAEOCL, V219, P131, DOI 10.1016/j.palaeo.2004.10.018; Danovaro R, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-30; Dorris M, 1999, PARASITOL TODAY, V15, P188, DOI 10.1016/S0169-4758(99)01439-8; Edwards KJ, 2005, TRENDS MICROBIOL, V13, P449, DOI 10.1016/j.tim.2005.07.005; Ekendahl S, 2003, MICROB ECOL, V46, P416, DOI 10.1007/s00248-003-2008-5; Engel AS, 2007, J CAVE KARST STUD, V69, P187; Ferris H, 1997, SOIL BIOL BIOCHEM, V29, P1183, DOI 10.1016/S0038-0717(97)00035-7; Foll RL, 1999, COMP BIOCHEM PHYS B, V124, P269, DOI 10.1016/S0305-0491(99)00130-3; Gihring TM, 2006, GEOMICROBIOL J, V23, P415, DOI 10.1080/01490450600875696; HEIP C, 1985, OCEANOGR MAR BIOL, V23, P399; HOEPPLI R., 1932, HONG KONG NATURALIST SUPPL, V1, P15; Holterman M, 2006, MOL BIOL EVOL, V23, P1792, DOI 10.1093/molbev/msl044; JANA BB, 1973, HYDROBIOLOGIA, V41, P291, DOI 10.1007/BF00016623; Lambshead PJD, 2004, NEMATOLOGY: ADVANCES AND PERSPECTIVES, VOL 1: NEMATODE MORPHOLOGY, PHYSIOLOGY AND ECOLOGY, P438, DOI 10.1079/9780851996455.0438; Lippmann J, 2003, GEOCHIM COSMOCHIM AC, V67, P4597, DOI 10.1016/S0016-7037(03)00414-9; Michel RL, 2005, ISOTOPES IN THE WATER CYCLE: PAST, PRESENT AND FUTURE OF A DEVELOPING SCIENCE, P53, DOI 10.1007/1-4020-3023-1_5; Moser DP, 2005, APPL ENVIRON MICROB, V71, P8773, DOI 10.1128/AEM.71.12.8773-8783.2005; Neher D. A., 2004, ENCY SOILS ENV, V3, P1; Ocana A., 1991, Nematologia Mediterranea, V19, P25; Onstott TC, 2006, GEOMICROBIOL J, V23, P369, DOI 10.1080/01490450600875688; Onstott T. C., 1998, ENIGMATIC MICROORGAN, P487; PEDERSEN K, 1993, EARTH-SCI REV, V34, P243, DOI 10.1016/0012-8252(93)90058-F; PHELPS TJ, 1994, MICROBIAL ECOL, V28, P335, DOI 10.1007/BF00662027; SINCLAIR JL, 1989, GEOMICROBIOL J, V7, P15, DOI 10.1080/01490458909377847; Van Voorhies WA, 1999, P NATL ACAD SCI USA, V96, P11399, DOI 10.1073/pnas.96.20.11399; Van Voorhies WA, 2000, J EXP BIOL, V203, P2467; Wanger G, 2006, GEOMICROBIOL J, V23, P443, DOI 10.1080/01490450600875746; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; YEATES GW, 1993, J NEMATOL, V25, P315	29	125	135	0	123	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 2	2011	474	7349					79	82		10.1038/nature09974	http://dx.doi.org/10.1038/nature09974			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	771KV	21637257	Green Published			2022-12-24	WOS:000291156700041
J	Wang, B; Moya, N; Niessen, S; Hoover, H; Mihaylova, MM; Shaw, RJ; Yates, JR; Fischer, WH; Thomas, JB; Montminy, M				Wang, Biao; Moya, Noel; Niessen, Sherry; Hoover, Heather; Mihaylova, Maria M.; Shaw, Reuben J.; Yates, John R., III; Fischer, Wolfgang H.; Thomas, John B.; Montminy, Marc			A Hormone-Dependent Module Regulating Energy Balance	CELL			English	Article							CREB COACTIVATOR TORC2; TRANSCRIPTION FACTOR; CLASS IIHDAC; DROSOPHILA; INSULIN; EXPRESSION; KINASE; PHOSPHORYLATION; METABOLISM; PROTEIN	Under fasting conditions, metazoans maintain energy balance by shifting from glucose to fat burning. In the fasted state, SIRT1 promotes catabolic gene expression by deacetylating the forkhead factor FOXO in response to stress and nutrient deprivation. The mechanisms by which hormonal signals regulate FOXO deacetylation remain unclear, however. We identified a hormone-dependent module, consisting of the Ser/Thr kinase SIK3 and the class IIa deacetylase HDAC4, which regulates FOXO activity in Drosophila. During feeding, HDAC4 is phosphorylated and sequestered in the cytoplasm by SIK3, whose activity is upregulated in response to insulin. SIK3 is inactivated during fasting, leading to the dephosphorylation and nuclear translocation of HDAC4 and to FOXO deacetylation. SIK3 mutant flies are starvation sensitive, reflecting FOXO-dependent increases in lipolysis that deplete triglyceride stores; reducing HDAC4 expression restored lipid accumulation. Our results reveal a hormone-regulated pathway that functions in parallel with the nutrient-sensing SIRT1 pathway to maintain energy balance.	[Wang, Biao; Thomas, John B.] Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA; [Wang, Biao; Moya, Noel; Fischer, Wolfgang H.; Montminy, Marc] Salk Inst Biol Studies, Peptide Biol Labs, La Jolla, CA 92037 USA; [Mihaylova, Maria M.; Shaw, Reuben J.] Salk Inst Biol Studies, Mol & Cellular Biol Lab, La Jolla, CA 92037 USA; [Niessen, Sherry; Hoover, Heather; Yates, John R., III] Scripps Res Inst, Ctr Physiol Prote, La Jolla, CA 92037 USA	Salk Institute; Salk Institute; Salk Institute; Scripps Research Institute	Thomas, JB (corresponding author), Salk Inst Biol Studies, Mol Neurobiol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	jthomas@salk.edu; montminy@salk.edu	Mihaylova, Maria M./ACZ-4949-2022	Mihaylova, Maria M./0000-0002-2725-767X	NIH [R01-DK049777, R01-DK083834, R01-DK077979, R01 DK080425, P01CA120964]; American Diabetes Association [1-08-JF-47]; Keickhefer Foundation; Clayton Foundation for Medical Research; Leona M. and Harry B. Helmsley Charitable Trust; NATIONAL CANCER INSTITUTE [P01CA120964] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080425, R01DK083834, R01DK077979, R37DK083834, R56DK077979, R01DK049777] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084947, R01GM040613] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS031249, R01NS040963, R21NS056316] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Keickhefer Foundation; Clayton Foundation for Medical Research; Leona M. and Harry B. Helmsley Charitable Trust; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by NIH grants (R01-DK049777 and R01-DK083834 to M. M.; R01-DK077979 to J.B.T.; R01 DK080425 and P01CA120964 to R.J.S.), an American Diabetes Association Junior Faculty Award (1-08-JF-47 to R.J.S.), The Keickhefer Foundation, The Clayton Foundation for Medical Research, and The Leona M. and Harry B. Helmsley Charitable Trust. We thank Y. Imai and A. Fukamizu (Tsukuba) for the gift of antisera. We also thank E. Hafen, J. Chung, R. Kulnlein, J. Scott, J. Park, Bloomington Stock Center, VDRC, Exelixis, and TRiP at Harvard Medical School (NIH/NIGMS R01-GM084947) for fly stocks used in this study.	Baker KD, 2007, CELL METAB, V6, P257, DOI 10.1016/j.cmet.2007.09.002; Barthel A, 2005, TRENDS ENDOCRIN MET, V16, P183, DOI 10.1016/j.tem.2005.03.010; Bassel-Duby R, 2006, ANNU REV BIOCHEM, V75, P19, DOI 10.1146/annurev.biochem.75.103004.142622; Berdeaux R, 2007, NAT MED, V13, P597, DOI 10.1038/nm1573; Bohni R, 1999, CELL, V97, P865, DOI 10.1016/S0092-8674(00)80799-0; Brazil DP, 2001, TRENDS BIOCHEM SCI, V26, P657, DOI 10.1016/S0968-0004(01)01958-2; Brent MM, 2008, STRUCTURE, V16, P1407, DOI 10.1016/j.str.2008.06.013; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Clancy DJ, 2001, SCIENCE, V292, P104, DOI 10.1126/science.1057991; Daitoku H, 2004, P NATL ACAD SCI USA, V101, P10042, DOI 10.1073/pnas.0400593101; Dentin R, 2007, NATURE, V449, P366, DOI 10.1038/nature06128; Fischle W, 2002, MOL CELL, V9, P45, DOI 10.1016/S1097-2765(01)00429-4; Frescas D, 2005, J BIOL CHEM, V280, P20589, DOI 10.1074/jbc.M412357200; Fukuoka M, 2003, INT J MOL MED, V12, P503; Gronke S, 2007, PLOS BIOL, V5, P1248, DOI 10.1371/journal.pbio.0050137; Gronke S, 2005, CELL METAB, V1, P323, DOI 10.1016/j.cmet.2005.04.003; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Horike N, 2003, J BIOL CHEM, V278, P18440, DOI 10.1074/jbc.M211770200; Ikeya T, 2002, CURR BIOL, V12, P1293, DOI 10.1016/S0960-9822(02)01043-6; Junger Martin A, 2003, J Biol, V2, P20, DOI 10.1186/1475-4924-2-20; Kim JK, 2004, J CLIN INVEST, V114, P823, DOI 10.1172/JCI200422230; Kim SK, 2004, NATURE, V431, P316, DOI 10.1038/nature02897; Kitamura T, 1999, MOL CELL BIOL, V19, P6286; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; Matsuzaki H, 2005, P NATL ACAD SCI USA, V102, P11278, DOI 10.1073/pnas.0502738102; Mihaylova MM, 2011, CELL, V145, P607, DOI 10.1016/j.cell.2011.03.043; Okamoto M, 2004, TRENDS ENDOCRIN MET, V15, P21, DOI 10.1016/j.tem.2003.11.002; Palanker L, 2009, CELL METAB, V9, P228, DOI 10.1016/j.cmet.2009.01.009; Reiter Lawrence T, 2002, Expert Opin Ther Targets, V6, P387; Screaton RA, 2004, CELL, V119, P61, DOI 10.1016/j.cell.2004.09.015; Teleman AA, 2008, CELL METAB, V7, P21, DOI 10.1016/j.cmet.2007.11.010; van der Linden AM, 2007, EMBO J, V26, P358, DOI 10.1038/sj.emboj.7601479; Verdu J, 1999, NAT CELL BIOL, V1, P500, DOI 10.1038/70293; Wagner BL, 2000, J BIOL CHEM, V275, P8263, DOI 10.1074/jbc.275.12.8263; Wang B, 2008, CELL METAB, V7, P434, DOI 10.1016/j.cmet.2008.02.010; Williams SR, 2010, AM J HUM GENET, V87, P219, DOI 10.1016/j.ajhg.2010.07.011	37	166	177	2	34	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 13	2011	145	4					596	606		10.1016/j.cell.2011.04.013	http://dx.doi.org/10.1016/j.cell.2011.04.013			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	763MF	21565616	Green Accepted, Bronze			2022-12-24	WOS:000290560800012
J	Park, E; Rapoport, TA				Park, Eunyong; Rapoport, Tom A.			Preserving the membrane barrier for small molecules during bacterial protein translocation	NATURE			English	Article							ESCHERICHIA-COLI; ENDOPLASMIC-RETICULUM; SECY PROTEIN; CONDUCTING CHANNEL; TRANSLATION ARREST; SIGNAL SEQUENCE; RIBOSOME; PERMEABILITY; MAINTAINS; COMPLEX	Many proteins are translocated through the SecY channel in bacteria and archaea and through the related Sec61 channel in eukaryotes(1). The channel has an hourglass shape with a narrow constriction approximately halfway across the membrane, formed by a pore ring of amino acids(2). While the cytoplasmic cavity of the channel is empty, the extracellular cavity is filled with a short helix called the plug(2), which moves out of the way during protein translocation(3,4). The mechanism by which the channel transports large polypeptides and yet prevents the passage of small molecules, such as ions or metabolites, has been controversial(2,5-8). Here, we have addressed this issue in intact Escherichia coli cells by testing the permeation of small molecules through wild-type and mutant SecY channels, which are either in the resting state or contain a defined translocating polypeptide chain. We show that in the resting state, the channel is sealed by both the pore ring and the plug domain. During translocation, the pore ring forms a 'gasket-like' seal around the polypeptide chain, preventing the permeation of small molecules. The structural conservation of the channel in all organisms indicates that this may be a universal mechanism by which the membrane barrier is maintained during protein translocation.	[Park, Eunyong; Rapoport, Tom A.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; [Park, Eunyong; Rapoport, Tom A.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School	Rapoport, TA (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, 240 Longwood Ave, Boston, MA 02115 USA.	tom_rapoport@hms.harvard.edu			NIH [GM052586]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052586] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank P. Walter, H. Bernstein and G. Phillips for materials, D. Boyd for advice, C. Akey for discussions and C. Akey, A. Osborne and A. Salic for critical reading of the manuscript. The work was supported by a grant from the NIH (GM052586). T.A.R. is a Howard Hughes Medical Institute investigator.	AKIYAMA Y, 1990, BIOCHEM BIOPH RES CO, V167, P711, DOI 10.1016/0006-291X(90)92083-C; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Becker T, 2009, SCIENCE, V326, P1369, DOI 10.1126/science.1178535; BIEKER KL, 1990, J BIOENERG BIOMEMBR, V22, P291, DOI 10.1007/BF00763169; Dalal K, 2009, EMBO REP, V10, P762, DOI 10.1038/embor.2009.87; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DERMAN AI, 1993, EMBO J, V12, P879, DOI 10.1002/j.1460-2075.1993.tb05728.x; Hamman BD, 1998, CELL, V92, P747, DOI 10.1016/S0092-8674(00)81403-8; Harris CR, 1999, J BACTERIOL, V181, P3438, DOI 10.1128/JB.181.11.3438-3444.1999; HELLER KB, 1980, J BACTERIOL, V144, P274, DOI 10.1128/JB.144.1.274-278.1980; Heritage D, 2001, J BIOL CHEM, V276, P22655, DOI 10.1074/jbc.M102409200; Junne T, 2010, MOL BIOL CELL, V21, P1662, DOI 10.1091/mbc.E10-01-0060; Le Gall S, 2004, MOL BIOL CELL, V15, P447, DOI 10.1091/mbc.E03-05-0325; Li WK, 2007, MOL CELL, V26, P511, DOI 10.1016/j.molcel.2007.05.002; Liao SR, 1997, CELL, V90, P31, DOI 10.1016/S0092-8674(00)80311-6; Menetret JF, 2008, STRUCTURE, V16, P1126, DOI 10.1016/j.str.2008.05.003; Nakatogawa H, 2002, CELL, V108, P629, DOI 10.1016/S0092-8674(02)00649-9; Nakatogawa H, 2001, MOL CELL, V7, P185, DOI 10.1016/S1097-2765(01)00166-6; Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384; Roy A, 2003, J BIOL CHEM, V278, P4397, DOI 10.1074/jbc.M207295200; Saparov SM, 2007, MOL CELL, V26, P501, DOI 10.1016/j.molcel.2007.03.022; SCHIEBEL E, 1992, J BIOL CHEM, V267, P7505; Schierle CF, 2003, J BACTERIOL, V185, P5706, DOI 10.1128/JB.185.19.5706-5713.2003; SIMON SM, 1991, CELL, V65, P371, DOI 10.1016/0092-8674(91)90455-8; Smith MA, 2005, J BACTERIOL, V187, P6454, DOI 10.1128/JB.187.18.6454-6465.2005; Tam PCK, 2005, EMBO J, V24, P3380, DOI 10.1038/sj.emboj.7600804; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; WADA A, 1990, P NATL ACAD SCI USA, V87, P2657, DOI 10.1073/pnas.87.7.2657; Woolhead CA, 2006, MOL CELL, V22, P587, DOI 10.1016/j.molcel.2006.05.021; Zhang W, 2003, J BIOL CHEM, V278, P50128, DOI 10.1074/jbc.M309840200	30	73	74	1	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 12	2011	473	7346					239	+		10.1038/nature10014	http://dx.doi.org/10.1038/nature10014			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	762NT	21562565	Green Accepted			2022-12-24	WOS:000290487200044
J	Liu, C; Sage, JC; Miller, MR; Verhaak, RGW; Hippenmeyer, S; Vogel, H; Foreman, O; Bronson, RT; Nishiyama, A; Luo, LQ; Zong, H				Liu, Chong; Sage, Jonathan C.; Miller, Michael R.; Verhaak, Roel G. W.; Hippenmeyer, Simon; Vogel, Hannes; Foreman, Oded; Bronson, Roderick T.; Nishiyama, Akiko; Luo, Liqun; Zong, Hui			Mosaic Analysis with Double Markers Reveals Tumor Cell of Origin in Glioma	CELL			English	Article							NEURAL STEM-CELLS; INTEGRATED GENOMIC ANALYSIS; PROGENITOR CELLS; SUBVENTRICULAR ZONE; SUPPRESSOR GENE; WHITE-MATTER; HUMAN BRAIN; NG2 CELLS; GROWTH; GLIOBLASTOMA	Cancer cell of origin is difficult to identify by analyzing cells within terminal stage tumors, whose identity could be concealed by the acquired plasticity. Thus, an ideal approach to identify the cell of origin is to analyze proliferative abnormalities in distinct lineages prior to malignancy. Here, we use mosaic analysis with double markers (MADM) in mice to model gliomagenesis by initiating concurrent p53/Nf1 mutations sporadically in neural stem cells (NSCs). Surprisingly, MADM-based lineage tracing revealed significant aberrant growth prior to malignancy only in oligodendrocyte precursor cells (OPCs), but not in any other NSC-derived lineages or NSCs themselves. Upon tumor formation, phenotypic and transcriptome analyses of tumor cells revealed salient OPC features. Finally, introducing the same p53/Nf1 mutations directly into OPCs consistently led to gliomagenesis. Our findings suggest OPCs as the cell of origin in this model, even when initial mutations occur in NSCs, and highlight the importance of analyzing premalignant stages to identify the cancer cell of origin.	[Liu, Chong; Sage, Jonathan C.; Miller, Michael R.; Zong, Hui] Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA; [Verhaak, Roel G. W.] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA; [Hippenmeyer, Simon; Luo, Liqun] Stanford Univ, HHMI, Stanford, CA 94305 USA; [Hippenmeyer, Simon; Luo, Liqun] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Vogel, Hannes] Stanford Univ, Sch Med, Dept Neuropathol, Stanford, CA 94305 USA; [Foreman, Oded] Jackson Lab, Sacramento, CA 95838 USA; [Bronson, Roderick T.] Tufts Cummings Sch Vet Med, Dept Biomed Sci, North Grafton, MA 01536 USA; [Nishiyama, Akiko] Univ Connecticut, Dept Physiol & Neurobiol, Storrs, CT 06269 USA	University of Oregon; University of Texas System; UTMD Anderson Cancer Center; Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University; Jackson Laboratory; University of Connecticut	Zong, H (corresponding author), Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA.	hzong@uoregon.edu	Messier, Claude/A-2322-2008; Liu, Chong/J-4826-2014; Verhaak, Roel/ABE-7058-2020; Liu, Chong/G-3514-2011	Messier, Claude/0000-0002-4791-1763; Vogel, Otto Hannes/0000-0002-0960-3508; Liu, Chong/0000-0001-6578-5919; Luo, Liqun/0000-0001-5467-9264; Hippenmeyer, Simon/0000-0003-2279-1061	NIH [R55-CA136495, R01-CA136495]; NSF; European Molecular Biology Organization [ALTF 851-2005]; Human Frontier Science Program Organization [LT00805/2006-L]; Swiss National Science Foundation [PA00P3_124160]; Pew Charitable Trusts; NATIONAL CANCER INSTITUTE [R55CA136495, R01CA136495] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050835] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Human Frontier Science Program Organization(Human Frontier Science Program); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Pew Charitable Trusts; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank A. Henner and M. Valle for technical support; J. Dugas for his help with the immunopanning method; and B. Bowerman, C. Doe, R. Galvao, W. Hong, M. Kohwi, M. Raff, R. Read, B. Tasic, X. Wu, and Y. Zhu for critical comments on the manuscript. This work is supported by NIH grants (R55-CA136495, R01-CA136495). M.R.M was supported by an NSF predoctoral fellowship. S.H. was supported by postdoctoral fellowships from the European Molecular Biology Organization (ALTF 851-2005), Human Frontier Science Program Organization (LT00805/2006-L), and Swiss National Science Foundation (PA00P3_124160). H.Z. is a Pew Scholar in Biomedical Sciences, supported by The Pew Charitable Trusts.	Assanah M, 2006, J NEUROSCI, V26, P6781, DOI 10.1523/JNEUROSCI.0514-06.2006; Bachoo RM, 2002, CANCER CELL, V1, P269, DOI 10.1016/S1535-6108(02)00046-6; Bennett MR, 2003, J NEUROSCI, V23, P7207, DOI 10.1523/JNEUROSCI.23-18-07207.2003; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Collier LS, 2005, NATURE, V436, P272, DOI 10.1038/nature03681; Dawson MRL, 2003, MOL CELL NEUROSCI, V24, P476, DOI 10.1016/S1044-7431(03)00210-0; Ding S, 2005, CELL, V122, P473, DOI 10.1016/j.cell.2005.07.013; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Geha S, 2010, BRAIN PATHOL, V20, P399, DOI 10.1111/j.1750-3639.2009.00295.x; Genove G, 2005, NAT MED, V11, P450, DOI 10.1038/nm1208; Hippenmeyer S, 2010, NEURON, V68, P695, DOI 10.1016/j.neuron.2010.09.027; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Komitova M, 2009, J COMP NEUROL, V512, P702, DOI 10.1002/cne.21917; Kondo T, 2000, SCIENCE, V289, P1754, DOI 10.1126/science.289.5485.1754; Lee JS, 2010, HUM MOL GENET, V19, P4643, DOI 10.1093/hmg/ddq395; Ligon KL, 2007, NEURON, V53, P503, DOI 10.1016/j.neuron.2007.01.009; Lindberg N, 2009, ONCOGENE, V28, P2266, DOI 10.1038/onc.2009.76; Llaguno SA, 2009, CANCER CELL, V15, P45, DOI 10.1016/j.ccr.2008.12.006; Nunes MC, 2003, NAT MED, V9, P439, DOI 10.1038/nm837; Pagliarini RA, 2003, SCIENCE, V302, P1227, DOI 10.1126/science.1088474; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Persson AI, 2010, CANCER CELL, V18, P669, DOI 10.1016/j.ccr.2010.10.033; Petersen PH, 2002, NATURE, V419, P929, DOI 10.1038/nature01124; Potter CJ, 2001, CELL, V105, P357, DOI 10.1016/S0092-8674(01)00333-6; Reilly KM, 2000, NAT GENET, V26, P109, DOI 10.1038/79075; Schuller U, 2008, CANCER CELL, V14, P123, DOI 10.1016/j.ccr.2008.07.005; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Tapon N, 2001, CELL, V105, P345, DOI 10.1016/S0092-8674(01)00332-4; The WHO, 2020, CLASSIFICATION TUMOU; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Visvader JE, 2011, NATURE, V469, P314, DOI 10.1038/nature09781; Wang Y, 2009, CANCER CELL, V15, P514, DOI 10.1016/j.ccr.2009.04.001; Yang ZJ, 2008, CANCER CELL, V14, P135, DOI 10.1016/j.ccr.2008.07.003; Zhu XQ, 2008, DEVELOPMENT, V135, P145, DOI 10.1242/dev.004895; Zhu Y, 2005, CANCER CELL, V8, P119, DOI 10.1016/j.ccr.2005.07.004; Zhuo L, 2001, GENESIS, V31, P85, DOI 10.1002/gene.10008; Zong H, 2005, CELL, V121, P479, DOI 10.1016/j.cell.2005.02.012	38	424	435	5	55	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 22	2011	146	2					209	221		10.1016/j.cell.2011.06.014	http://dx.doi.org/10.1016/j.cell.2011.06.014			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	795XS	21737130	Bronze, Green Accepted			2022-12-24	WOS:000293013000005
J	Pang, ZPP; Yang, N; Vierbuchen, T; Ostermeier, A; Fuentes, DR; Yang, TQ; Citri, A; Sebastiano, V; Marro, S; Sudhof, TC; Wernig, M				Pang, Zhiping P.; Yang, Nan; Vierbuchen, Thomas; Ostermeier, Austin; Fuentes, Daniel R.; Yang, Troy Q.; Citri, Ami; Sebastiano, Vittorio; Marro, Samuele; Suedhof, Thomas C.; Wernig, Marius			Induction of human neuronal cells by defined transcription factors	NATURE			English	Article							PLURIPOTENT STEM-CELLS; NEURAL DEVELOPMENT; DIFFERENTIATION; FIBROBLASTS; BLASTOCYST; PAX6	Somatic cell nuclear transfer, cell fusion, or expression of lineage-specific factors have been shown to induce cell-fate changes in diverse somatic cell types(1-12). We recently observed that forced expression of a combination of three transcription factors, Brn2 (also known as Pou3f2), Ascl1 and Myt1l, can efficiently convert mouse fibroblasts into functional induced neuronal (iN) cells(13). Here we show that the same three factors can generate functional neurons from human pluripotent stem cells as early as 6 days after transgene activation. When combined with the basic helix-loop-helix transcription factor NeuroD1, these factors could also convert fetal and postnatal human fibroblasts into iN cells showing typical neuronal morphologies and expressing multiple neuronal markers, even after downregulation of the exogenous transcription factors. Importantly, the vast majority of human iN cells were able to generate action potentials and many matured to receive synaptic contacts when co-cultured with primary mouse cortical neurons. Our data demonstrate that non-neural human somatic cells, as well as pluripotent stem cells, can be converted directly into neurons by lineage-determining transcription factors. These methods may facilitate robust generation of patient-specific human neurons for in vitro disease modelling or future applications in regenerative medicine.	[Yang, Nan; Vierbuchen, Thomas; Ostermeier, Austin; Fuentes, Daniel R.; Yang, Troy Q.; Sebastiano, Vittorio; Marro, Samuele; Wernig, Marius] Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Dept Pathol, Stanford, CA 94305 USA; [Pang, Zhiping P.; Suedhof, Thomas C.] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Vierbuchen, Thomas; Ostermeier, Austin; Wernig, Marius] Stanford Univ, Sch Med, Program Canc Biol, Stanford, CA 94305 USA; [Citri, Ami] Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Suedhof, Thomas C.] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University	Wernig, M (corresponding author), Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Dept Pathol, 265 Campus Dr, Stanford, CA 94305 USA.	wernig@stanford.edu	Marro, Samuele G./I-4493-2014; Yang, Nan/H-3174-2012; Citri, Ami/R-8973-2019; Pang, Zhiping/AAF-5757-2020	Marro, Samuele G./0000-0002-9326-6945; Citri, Ami/0000-0002-9914-0278; Vierbuchen, Thomas/0000-0002-5690-5680; Fuentes, Daniel/0000-0002-0412-6933; Yang, Nan/0000-0003-3663-1288; Pang, Zhiping/0000-0002-6183-1233	Institute for Stem Cell Biology and Regenerative Medicine at Stanford; Ellison Medical Foundation; Stinehard-Reed Foundation; Donald E. and Delia B. Baxter Foundation; NIH [1R01MH092931, RC4NS073015]; New York Stem Cell Foundation; NARSAD Young Investigator Awards; Ruth and Robert Halperin Stanford Graduate Fellowship; AXA research fund; BioX Undergraduate Fellowship; NATIONAL CANCER INSTITUTE [T32CA009302] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH092931] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [RC4NS073015] Funding Source: NIH RePORTER	Institute for Stem Cell Biology and Regenerative Medicine at Stanford; Ellison Medical Foundation(Lawrence Ellison Foundation); Stinehard-Reed Foundation; Donald E. and Delia B. Baxter Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York Stem Cell Foundation; NARSAD Young Investigator Awards(NARSAD); Ruth and Robert Halperin Stanford Graduate Fellowship; AXA research fund(AXA Research Fund); BioX Undergraduate Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank Y. Kokubu for technical assistance in molecular cloning and Y. Zhang for assistance in iPS cell induced neuron culture. We also thank Y. Sun for providing the microRNAs expression lentiviral vectors and S. Majumder for the REST-VP16 construct. This work was enabled by start-up funds from the Institute for Stem Cell Biology and Regenerative Medicine at Stanford (M. W.), the Ellison Medical Foundation (M. W.), the Stinehard-Reed Foundation (M. W.), the Donald E. and Delia B. Baxter Foundation (M. W.), the NIH grants 1R01MH092931 (M. W. and T. C. S.) and RC4NS073015 (M. W.), and a Robertson Investigator Award from the New York Stem Cell Foundation. Z.P.P. is supported by 2008 and 2010 NARSAD Young Investigator Awards. T. V. is supported by the Ruth and Robert Halperin Stanford Graduate Fellowship. A. C. is supported by the AXA research fund and D. R. F. is supported by BioX Undergraduate Fellowship.	BLAU HM, 1985, SCIENCE, V230, P758, DOI 10.1126/science.2414846; BOTTENSTEIN JE, 1979, P NATL ACAD SCI USA, V76, P514, DOI 10.1073/pnas.76.1.514; Graf T, 2009, NATURE, V462, P587, DOI 10.1038/nature08533; Guo GJ, 2010, DEV CELL, V18, P675, DOI 10.1016/j.devcel.2010.02.012; Gurdon JB, 2006, ANNU REV CELL DEV BI, V22, P1, DOI 10.1146/annurev.cellbio.22.090805.140144; Hansen DV, 2010, NATURE, V464, P554, DOI 10.1038/nature08845; Heins N, 2002, NAT NEUROSCI, V5, P308, DOI 10.1038/nn828; Hu BY, 2010, P NATL ACAD SCI USA, V107, P4335, DOI 10.1073/pnas.0910012107; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Johnson MA, 2007, J NEUROSCI, V27, P3069, DOI 10.1523/JNEUROSCI.4562-06.2007; Koch P, 2009, P NATL ACAD SCI USA, V106, P3225, DOI 10.1073/pnas.0808387106; Kriegstein A, 2006, NAT REV NEUROSCI, V7, P883, DOI 10.1038/nrn2008; Marchetto MCN, 2010, CELL, V143, P527, DOI 10.1016/j.cell.2010.10.016; Maximov A, 2007, J NEUROSCI METH, V161, P75, DOI 10.1016/j.jneumeth.2006.10.009; Shen CN, 2000, NAT CELL BIOL, V2, P879, DOI 10.1038/35046522; Somers A, 2010, STEM CELLS, V28, P1728, DOI 10.1002/stem.495; Tada M, 2001, CURR BIOL, V11, P1553, DOI 10.1016/S0960-9822(01)00459-6; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Wong CC, 2010, NAT BIOTECHNOL, V28, P1115, DOI 10.1038/nbt.1686; Wu H, 2007, P NATL ACAD SCI USA, V104, P13821, DOI 10.1073/pnas.0706199104; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2; Xu Y, 2010, P NATL ACAD SCI USA, V107, P8129, DOI 10.1073/pnas.1002024107; Zhang XQ, 2010, CELL STEM CELL, V7, P90, DOI 10.1016/j.stem.2010.04.017; Zhou Q, 2008, CELL STEM CELL, V3, P382, DOI 10.1016/j.stem.2008.09.015; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	27	866	925	5	159	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 11	2011	476	7359					220	U122		10.1038/nature10202	http://dx.doi.org/10.1038/nature10202			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	805MU	21617644	Green Accepted			2022-12-24	WOS:000293731900039
J	Lobell, DB; Schlenker, W; Costa-Roberts, J				Lobell, David B.; Schlenker, Wolfram; Costa-Roberts, Justin			Climate Trends and Global Crop Production Since 1980	SCIENCE			English	Article							YIELD; TEMPERATURE; FOOD	Efforts to anticipate how climate change will affect future food availability can benefit from understanding the impacts of changes to date. We found that in the cropping regions and growing seasons of most countries, with the important exception of the United States, temperature trends from 1980 to 2008 exceeded one standard deviation of historic year-to-year variability. Models that link yields of the four largest commodity crops to weather indicate that global maize and wheat production declined by 3.8 and 5.5%, respectively, relative to a counterfactual without climate trends. For soybeans and rice, winners and losers largely balanced out. Climate trends were large enough in some countries to offset a significant portion of the increases in average yields that arose from technology, carbon dioxide fertilization, and other factors.	[Lobell, David B.; Costa-Roberts, Justin] Stanford Univ, Dept Environm Earth Syst Sci, Stanford, CA 94305 USA; [Lobell, David B.; Costa-Roberts, Justin] Stanford Univ, Program Food Secur & Environm, Stanford, CA 94305 USA; [Schlenker, Wolfram] Columbia Univ, Dept Econ, New York, NY 10027 USA; [Schlenker, Wolfram] Columbia Univ, Sch Int & Publ Affairs, New York, NY 10027 USA; [Schlenker, Wolfram] Natl Bur Econ Res, New York, NY 10016 USA	Stanford University; Stanford University; Columbia University; Columbia University; National Bureau of Economic Research	Lobell, DB (corresponding author), Stanford Univ, Dept Environm Earth Syst Sci, Stanford, CA 94305 USA.	dlobell@stanford.edu		Lobell, David/0000-0002-5969-3476	Rockefeller Foundation; NASA [NNX08AV25G]; NSF [SES-0962625]	Rockefeller Foundation; NASA(National Aeronautics & Space Administration (NASA)); NSF(National Science Foundation (NSF))	We thank five anonymous reviewers for helpful comments. Supported by a grant from the Rockefeller Foundation, NASA new investigator grant NNX08AV25G (D.B.L.), and NSF grant SES-0962625.	Ainsworth EA, 2008, NEW PHYTOL, V179, P5, DOI 10.1111/j.1469-8137.2008.02500.x; Brisson N, 2010, FIELD CROP RES, V119, P201, DOI 10.1016/j.fcr.2010.07.012; Cassman KG, 1999, P NATL ACAD SCI USA, V96, P5952, DOI 10.1073/pnas.96.11.5952; Easterling W, 2007, AR4 CLIMATE CHANGE 2007: IMPACTS, ADAPTATION, AND VULNERABILITY, P273; Estrella N, 2007, GLOBAL CHANGE BIOL, V13, P1737, DOI 10.1111/j.1365-2486.2007.01374.x; Goswami BN, 2006, SCIENCE, V314, P1442, DOI 10.1126/science.1132027; Hertel TW, 2010, GLOBAL ENVIRON CHANG, V20, P577, DOI 10.1016/j.gloenvcha.2010.07.001; Kalra N, 2008, CURR SCI INDIA, V94, P82; Ladha JK, 2003, FIELD CROP RES, V81, P159, DOI 10.1016/S0378-4290(02)00219-8; Leakey ADB, 2009, P ROY SOC B-BIOL SCI, V276, P2333, DOI 10.1098/rspb.2008.1517; Lin E., 2007, PHYS SCI BASIS WORKI, V3, P6; Liu YA, 2010, GLOBAL CHANGE BIOL, V16, P2287, DOI 10.1111/j.1365-2486.2009.02077.x; Lobell DB, 2007, ENVIRON RES LETT, V2, DOI 10.1088/1748-9326/2/1/014002; Lobell DB, 2008, ENVIRON RES LETT, V3, DOI 10.1088/1748-9326/3/3/034007; Meehl GA, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P747; Reilly J, 2000, CLIMATIC CHANGE, V45, P253, DOI 10.1023/A:1005669807945; Reilly J, 1996, CLIMATE CHANGE 1995, P429; Roberts M J, 2010, 15921 NBER; ROSENZWEIG C, 1994, NATURE, V367, P133, DOI 10.1038/367133a0; Schlenker W, 2010, ENVIRON RES LETT, V5, DOI 10.1088/1748-9326/5/1/014010; Schlenker W, 2009, P NATL ACAD SCI USA, V106, P15594, DOI 10.1073/pnas.0906865106; Welch JR, 2010, P NATL ACAD SCI USA, V107, P14562, DOI 10.1073/pnas.1001222107	22	2204	2363	84	1411	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 29	2011	333	6042					616	620		10.1126/science.1204531	http://dx.doi.org/10.1126/science.1204531			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798PI	21551030				2022-12-24	WOS:000293222400058
J	Sanderson, MJ; McMahon, MM; Steel, M				Sanderson, Michael J.; McMahon, Michelle M.; Steel, Mike			Terraces in Phylogenetic Tree Space	SCIENCE			English	Article							MIXED MODELS; ALGORITHMS; INFERENCE	A key step in assembling the tree of life is the construction of species-rich phylogenies from multilocus-but often incomplete-sequence data sets. We describe previously unknown structure in the landscape of solutions to the tree reconstruction problem, comprising sometimes vast "terraces" of trees with identical quality, arranged on islands of phylogenetically similar trees. Phylogenetic ambiguity within a terrace can be characterized efficiently and then ameliorated by new algorithms for obtaining a terrace's maximum-agreement subtree or by identifying the smallest set of new targets for additional sequencing. Algorithms to find optimal trees or estimate Bayesian posterior tree distributions may need to navigate strategically in the neighborhood of large terraces in tree space.	[Sanderson, Michael J.] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA; [McMahon, Michelle M.] Univ Arizona, Sch Plant Sci, Tucson, AZ 85721 USA; [Steel, Mike] Univ Canterbury, Allan Wilson Ctr Mol Ecol & Evolut, Christchurch 1, New Zealand	University of Arizona; University of Arizona; University of Canterbury	Sanderson, MJ (corresponding author), Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA.	sanderm@email.arizona.edu		Steel, Mike/0000-0001-7015-4644	NSF [0829674]	NSF(National Science Foundation (NSF))	Thanks to C. Ane, M. Bordewich, D. Bryant, D. Fernandez-Baca, M. Nachman, B. O'Meara, and C. Semple for helpful comments. This work was supported by NSF award 0829674 (to M.J.S. and M. M. M.). All data used in this paper were obtained from GenBank or TreeBASE and are detailed in the Supporting Online Material.	AHO AV, 1981, SIAM J COMPUT, V10, P405, DOI 10.1137/0210030; Amir A, 1997, SIAM J COMPUT, V26, P1656, DOI 10.1137/S0097539794269461; Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634; Bordewich M, 2003, THESIS U OXFORD; Bouchenak-Khelladi Y, 2008, MOL PHYLOGENET EVOL, V47, P488, DOI 10.1016/j.ympev.2008.01.035; Bryant D., 2003, BIOCONSENSUS, P163; CONSTANTINESCU M, 1995, J CLASSIF, V12, P101, DOI 10.1007/BF01202270; DAY WHE, 1985, J CLASSIF, V2, P7, DOI 10.1007/BF01908061; Felsenstein J., 2004, INFERRING PHYLOGENIE, VVolume 2; MADDISON DR, 1991, SYST ZOOL, V40, P315, DOI 10.2307/2992325; McDade LA, 2008, AM J BOT, V95, P1136, DOI 10.3732/ajb.0800096; Meusemann K, 2010, MOL BIOL EVOL, V27, P2451, DOI 10.1093/molbev/msq130; Mossel E, 2005, MATHEMATICS OF EVOLUTION AND PHYLOGENY, P384; Pyron RA, 2011, MOL PHYLOGENET EVOL, V58, P329, DOI 10.1016/j.ympev.2010.11.006; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Salter LA, 2001, SYST BIOL, V50, P970, DOI 10.1080/106351501753462902; Sanderson MJ, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-155; Semple C, 2003, DISCRETE APPL MATH, V127, P489, DOI 10.1016/S0166-218X(02)00250-0; Smith SA, 2011, AM J BOT, V98, P404, DOI 10.3732/ajb.1000481; Stamatakis A, 2008, PHILOS T R SOC B, V363, P3977, DOI 10.1098/rstb.2008.0163; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Vanderpoorten A, 2006, SYSTEMATIC BIOL, V55, P957, DOI 10.1080/10635150601088995; Whelan S, 2010, MOL BIOL EVOL, V27, P2674, DOI 10.1093/molbev/msq163	23	73	73	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 22	2011	333	6041					448	450		10.1126/science.1206357	http://dx.doi.org/10.1126/science.1206357			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	795FR	21680810				2022-12-24	WOS:000292959600044
J	Goetz, JG; Minguet, S; Navarro-Lerida, I; Lazcano, JJ; Samaniego, R; Calvo, E; Tello, M; Osteso-Ibanez, T; Pellinen, T; Echarri, A; Cerezo, A; Klein-Szanto, AJP; Garcia, R; Keely, PJ; Sanchez-Mateos, P; Cukierman, E; Del Pozo, MA				Goetz, Jacky G.; Minguet, Susana; Navarro-Lerida, Inmaculada; Jose Lazcano, Juan; Samaniego, Rafael; Calvo, Enrique; Tello, Marta; Osteso-Ibanez, Teresa; Pellinen, Teijo; Echarri, Asier; Cerezo, Ana; Klein-Szanto, Andres J. P.; Garcia, Ricardo; Keely, Patricia J.; Sanchez-Mateos, Paloma; Cukierman, Edna; Del Pozo, Miguel A.			Biomechanical Remodeling of the Microenvironment by Stromal Caveolin-1 Favors Tumor Invasion and Metastasis	CELL			English	Article							CELL-MIGRATION; RHO; CANCER; MORPHOGENESIS; FIBROBLASTS; PROGRESSION; EXPRESSION; DEFECTS; ABSENCE; GROWTH	Mechanotransduction is a key determinant of tissue homeostasis and tumor progression. It is driven by intercellular adhesions, cell contractility, and forces generated within the microenvironment and is dependent on extracellular matrix composition, organization, and compliance. We show that caveolin-1 (Cav1) favors cell elongation in three-dimensional cultures and promotes Rho- and force-dependent contraction, matrix alignment, and microenvironment stiffening through regulation of p190RhoGAP. In turn, microenvironment remodeling by Cav1 fibroblasts forces cell elongation. Cav1-deficient mice have disorganized stromal tissue architecture. Stroma associated with human carcinomas and melanoma metastases is enriched in Cav1-expressing carcinoma-associated fibroblasts (CAFs). Cav1 expression in breast CAFs correlates with low survival, and Cav1 depletion in CAFs decreases CAF contractility. Consistently, fibroblast expression of Cav1, through p190RhoGAP regulation, favors directional migration and invasiveness of carcinoma cells in vitro. In vivo, stromal Cav1 remodels peri- and intratumoral microenvironments to facilitate tumor invasion, correlating with increased metastatic potency. Thus, Cav1 modulates tissue responses through force-dependent architectural regulation of the microenvironment.	[Calvo, Enrique] CNIC, Prote Unit, Madrid 28029, Spain; [Samaniego, Rafael; Sanchez-Mateos, Paloma] Hosp Gen Univ Gregorio Maranon, Unidad Microscopi Confocal, Lab Inmunooncol, Madrid 28007, Spain; [Tello, Marta; Garcia, Ricardo] CSIC, Forcetool Grp, Inst Microelect Madrid, Tres Cantos 28760, Spain; [Keely, Patricia J.] Univ Wisconsin, Dept Pharmacol, Mol Biol Lab, Madison, WI 53706 USA; [Klein-Szanto, Andres J. P.; Cukierman, Edna] Canc Biol Program, Philadelphia, PA 19111 USA; [Goetz, Jacky G.; Minguet, Susana; Navarro-Lerida, Inmaculada; Jose Lazcano, Juan; Osteso-Ibanez, Teresa; Pellinen, Teijo; Echarri, Asier; Cerezo, Ana; Del Pozo, Miguel A.] CNIC, Integrin Signaling Lab, Dept Vasc Biol & Inflammat, Madrid 28029, Spain	Centro Nacional de Investigaciones Cardiovasculares (CNIC); General University Gregorio Maranon Hospital; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Microelectronica de Madrid (IMM); University of Wisconsin System; University of Wisconsin Madison; Centro Nacional de Investigaciones Cardiovasculares (CNIC)	Goetz, JG (corresponding author), Inst Genet & Mol & Cellular Biol, F-67404 Illkirch Graffenstaden, France.	jgoetz@igbmc.fr; madelpozo@cnic.es	Echarri, Asier/GZL-8132-2022; Samaniego, Rafa/ABE-3558-2021; Garcia, Ricardo/B-3124-2013; Echarri, Asier/J-5333-2016; del Pozo, Miguel Angel/L-2861-2014; Osteso, Teresa/AAD-6364-2021; Cerezo, Ana/F-4403-2011; Sanchez-Mateos, Paloma/E-8931-2013; cukierman, edna/AAU-8932-2020; GOETZ, Jacky/AAT-1746-2021; Cukierman, Edna/A-3951-2013	Garcia, Ricardo/0000-0002-7115-1928; Echarri, Asier/0000-0002-7314-8087; del Pozo, Miguel Angel/0000-0001-9077-391X; cukierman, edna/0000-0002-1452-9576; GOETZ, Jacky/0000-0003-2842-8116; Samaniego, Rafael/0000-0002-3081-7332; Cerezo Montemayor, Ana/0000-0003-0275-0844; Sanchez-Mateos, Paloma/0000-0001-6589-4445; Osteso-Ibanez, Teresa/0000-0003-4247-8734; Navarro-Lerida, Inmaculada/0000-0001-9994-8069; Minguet, Susana/0000-0001-8211-5538; Microelectronica de Madrid, Instituto de/0000-0003-4211-9045	MICINN (Spanish Ministry of Science and Innovation) [SAF2008-02100, RTICC RD06/0020/1033, CSD2009-00016, SAF2010-1602, MAT2009-08650, CSD2010-00024]; EMBO; European Heads of Research Councils; ESF; NIH/NCI [CA113451]; MICINN; Pro-CNIC Foundation; NATIONAL CANCER INSTITUTE [R01CA114462, R01CA142833, R01CA113451] Funding Source: NIH RePORTER	MICINN (Spanish Ministry of Science and Innovation)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); EMBO(European Molecular Biology Organization (EMBO)); European Heads of Research Councils; ESF(European Commission); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); Pro-CNIC Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Wethank J. Massague and R. Gomis for luciferase-expressing TCs; F. Sirotnak, M. Kolonin, and A. Schrum for E0771 cells; M. Morente, the CNIO Tumor Bank, and the Spanish National Tumor Bank Network for colon carcinoma TMA; the CNIC Viral Vector Unit for lentivirus; P. Martin and R. Mota for intravenous injection; I. Trevino for help with immunohistochemistry; K. Devarajan for breast TMA statistical analysis; V. Gupta, R. Castello-Cros, and D. Bassi for renal and breast CAF harvesting and immunohistochemistry; A. Alfranca for luciferase vector and advice; M. Montoya for advice on SHG and helpful discussion; F. Sanchez-Cabo for help with statistical analysis; A. U. for brainstorming; X. Bustelo, I.R. Nabi, G. Scita, and P.P. di Fiore for critical reading of the manuscript; and S. Bartlett for editing. This work was supported by grants from the MICINN (Spanish Ministry of Science and Innovation) to M.A.D.P. (SAF2008-02100, RTICC RD06/0020/1033, and CSD2009-00016), P.S.-M. (SAF2010-1602), and R.G. (MAT2009-08650 and CSD2010-00024); by EMBO Young Investigator Programme to M.A.D.P., and by the European Heads of Research Councils and the ESF through a European Young Investigator (EURYI) award to M.A.D.P.; and by NIH/NCI CA113451 and FCCC Kidney Keystone Program grants to E.C. J.G.G. and T.P. are CNIC postdoctoral fellows. S.M. and A.E. are Ramon y Cajal fellows. A.C. is a AECC (Spanish Association against Cancer) fellow. The CNIC is supported by the MICINN and the Pro-CNIC Foundation.	Amatangelo MD, 2005, AM J PATHOL, V167, P475, DOI 10.1016/S0002-9440(10)62991-4; Bershadsky AD, 2003, ANNU REV CELL DEV BI, V19, P677, DOI 10.1146/annurev.cellbio.19.111301.153011; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Bustos RI, 2008, CURR BIOL, V18, P1606, DOI 10.1016/j.cub.2008.09.019; Cerezo A, 2009, MOL CELL BIOL, V29, P5046, DOI 10.1128/MCB.00315-09; Chang SH, 2009, AM J PATHOL, V175, P1768, DOI 10.2353/ajpath.2009.090171; Conklin MW, 2011, AM J PATHOL, V178, P1221, DOI 10.1016/j.ajpath.2010.11.076; Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829; del Pozo MA, 2005, NAT CELL BIOL, V7, P901, DOI 10.1038/ncb1293; Doyle AD, 2009, J CELL BIOL, V184, P481, DOI 10.1083/jcb.200810041; Drab M, 2001, SCIENCE, V293, P2449, DOI 10.1126/science.1062688; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Engler AJ, 2009, SCIENCE, V324, P208, DOI 10.1126/science.1170107; Friedl P, 2009, NAT REV MOL CELL BIO, V10, P445, DOI 10.1038/nrm2720; Gaggioli C, 2007, NAT CELL BIOL, V9, P1392, DOI 10.1038/ncb1658; Goetz JG, 2008, CANCER METAST REV, V27, P715, DOI 10.1007/s10555-008-9160-9; Goetz JG, 2008, J CELL BIOL, V180, P1261, DOI 10.1083/jcb.200709019; Gonzalez-Munoz E, 2009, ENDOCRINOLOGY, V150, P3493, DOI 10.1210/en.2008-1520; Grande-Garcia A, 2007, J CELL BIOL, V177, P683, DOI 10.1083/jcb.200701006; Gratton JP, 2003, CANCER CELL, V4, P31, DOI 10.1016/S1535-6108(03)00168-5; Hinz B, 2010, J BIOMECH, V43, P146, DOI 10.1016/j.jbiomech.2009.09.020; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Krieg M, 2008, NAT CELL BIOL, V10, P429, DOI 10.1038/ncb1705; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Mammoto A, 2007, J CELL SCI, V120, P456, DOI 10.1242/jcs.03353; Mammoto T, 2007, J BIOL CHEM, V282, P23910, DOI 10.1074/jbc.M702169200; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Parton RG, 2007, NAT REV MOL CELL BIO, V8, P185, DOI 10.1038/nrm2122; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Provenzano PP, 2008, BIOPHYS J, V95, P5374, DOI 10.1529/biophysj.108.133116; Provenzano PP, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-38; Razani B, 2001, J BIOL CHEM, V276, P38121; Ronnov-Jessen L, 2009, TRENDS MOL MED, V15, P5, DOI 10.1016/j.molmed.2008.11.001; Sloan EK, 2009, AM J PATHOL, V174, P2035, DOI 10.2353/ajpath.2009.080924; Sordella R, 2003, CELL, V113, P147, DOI 10.1016/S0092-8674(03)00271-X; Williams TM, 2006, AM J PATHOL, V169, P1784, DOI 10.2353/ajpath.2006.060590; Witkiewicz AK, 2008, CELL CYCLE, V7, P3021, DOI 10.4161/cc.7.19.6719; Witkiewicz AK, 2009, AM J PATHOL, V174, P2023, DOI 10.2353/ajpath.2009.080873; Yamada KM, 2007, CELL, V130, P601, DOI 10.1016/j.cell.2007.08.006; Yang G, 2008, EXP MOL PATHOL, V84, P131, DOI 10.1016/j.yexmp.2007.08.004; Zhao XH, 2007, J CELL SCI, V120, P1801, DOI 10.1242/jcs.001586; Zhao YY, 2002, P NATL ACAD SCI USA, V99, P11375, DOI 10.1073/pnas.172360799; Zhong CL, 1998, J CELL BIOL, V141, P539, DOI 10.1083/jcb.141.2.539	44	496	506	6	115	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 8	2011	146	1					148	163		10.1016/j.cell.2011.05.040	http://dx.doi.org/10.1016/j.cell.2011.05.040			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	789TN	21729786	Green Accepted, Bronze			2022-12-24	WOS:000292539300013
J	Zhou, Y; Cashman, TJ; Nevis, KR; Obregon, P; Carney, SA; Liu, Y; Gu, AH; Mosimann, C; Sondalle, S; Peterson, RE; Heideman, W; Burns, CE; Burns, CG				Zhou, Yong; Cashman, Timothy J.; Nevis, Kathleen R.; Obregon, Pablo; Carney, Sara A.; Liu, Yan; Gu, Aihua; Mosimann, Christian; Sondalle, Samuel; Peterson, Richard E.; Heideman, Warren; Burns, Caroline E.; Burns, C. Geoffrey			Latent TGF-beta binding protein 3 identifies a second heart field in zebrafish	NATURE			English	Article							ARTERIAL POLE; OUTFLOW TRACT; GROWTH; CELLS; DIFFERENTIATION; ORIGIN	The four-chambered mammalian heart develops from two fields of cardiac progenitor cells distinguished by their spatiotemporal patterns of differentiation and contributions to the definitive heart(1-3). The first heart field differentiates earlier in lateral plate mesoderm, generates the linear heart tube and ultimately gives rise to the left ventricle. The second heart field (SHF) differentiates later in pharyngeal mesoderm, elongates the heart tube, and gives rise to the outflow tract and much of the right ventricle. Because hearts in lower vertebrates contain a rudimentary outflow tract but not a right ventricle(4), the existence and function of SHF-like cells in these species has remained a topic of speculation(4-10). Here we provide direct evidence from Cre/Lox-mediated lineage tracing and loss-of-function studies in zebrafish, a lower vertebrate with a single ventricle, that latent TGF-beta binding protein 3 (ltbp3) transcripts mark a field of cardiac progenitor cells with defining characteristics of the anterior SHF in mammals. Specifically, ltbp3(+) cells differentiate in pharyngeal mesoderm after formation of the heart tube, elongate the heart tube at the outflow pole, and give rise to three cardiovascular lineages in the outflow tract and myocardium in the distal ventricle. In addition to expressing Ltbp3, a protein that regulates the bioavailability of TGF-beta ligands(11), zebrafish SHF cells co-express nkx2.5, an evolutionarily conserved marker of cardiac progenitor cells in both fields(4). Embryos devoid of ltbp3 lack the same cardiac structures derived from ltbp3(+) cells due to compromised progenitor proliferation. Furthermore, small-molecule inhibition of TGF-beta signalling phenocopies the ltbp3-morphant phenotype whereas expression of a constitutively active TGF-beta type I receptor rescues it. Taken together, our findings uncover a requirement for ltbp3-TGF-beta signalling during zebrafish SHF development, a process that serves to enlarge the single ventricular chamber in this species.	[Zhou, Yong; Cashman, Timothy J.; Nevis, Kathleen R.; Obregon, Pablo; Gu, Aihua; Sondalle, Samuel; Burns, Caroline E.; Burns, C. Geoffrey] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Charlestown, MA 02129 USA; [Zhou, Yong; Cashman, Timothy J.; Nevis, Kathleen R.; Obregon, Pablo; Liu, Yan; Gu, Aihua; Mosimann, Christian; Sondalle, Samuel; Burns, Caroline E.; Burns, C. Geoffrey] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Carney, Sara A.; Peterson, Richard E.; Heideman, Warren] Univ Wisconsin, Sch Pharm, Div Pharmaceut Sci, Madison, WI 53705 USA; [Liu, Yan] Massachusetts Gen Hosp, Div Nephrol, Charlestown, MA 02129 USA; [Gu, Aihua] Nanjing Med Univ, Sch Publ Hlth, Nanjing 210029, Peoples R China; [Mosimann, Christian] Childrens Hosp, Stem Cell Program, Boston, MA 02115 USA; [Mosimann, Christian] Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA; [Sondalle, Samuel; Burns, Caroline E.] Harvard Stem Cell Inst, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Wisconsin System; University of Wisconsin Madison; Harvard University; Massachusetts General Hospital; Nanjing Medical University; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University	Burns, CE (corresponding author), Massachusetts Gen Hosp, Cardiovasc Res Ctr, Charlestown, MA 02129 USA.	cburns6@partners.org; gburns@cvrc.mgh.harvard.edu	Sondalle, Samuel/C-1283-2014; Cashman, Tim/M-7738-2019	Sondalle, Samuel/0000-0002-4144-9897; Cashman, Timothy/0000-0001-6238-129X; Mosimann, Christian/0000-0002-0749-2576	NIH, National Institute of Environmental Health Sciences [R01 ES012716]; EMBO long-term fellowship; HFSP long-term fellowship; Cardiovascular Research Center at Massachusetts General Hospital; Claflin Distinguished Scholar Award; Harvard Stem Cell Institute; National Heart Lung and Blood Institute [5R01HL096816]; American Heart Association [10GRNT4270021]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096816] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES012716] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007205] Funding Source: NIH RePORTER	NIH, National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); EMBO long-term fellowship(European Molecular Biology Organization (EMBO)); HFSP long-term fellowship; Cardiovascular Research Center at Massachusetts General Hospital; Claflin Distinguished Scholar Award; Harvard Stem Cell Institute; National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Whitman for advice on pSmad2 staining, D. Hami and M. Kirby for providing Eln2 antisera and their immunohistochemistry protocol, R. Cornell for providing tfAP2a and tfAP2c morpholinos, M. Whitman, A. Srinivasan, D. Langenau, E. Provost, S. Leach, R. Anderson, D. Stainier, I. Woods, and A. Schier for providing plasmids. J. W. Xiong for providing clo<SUP>m39</SUP> fish, B. Barut and L. Zon for providing bacterial artificial chromosomes (BACs), and the MGH Nephrology Division for access to their confocal microscopy facilities. S. C., R. E. P. and W. H. were supported by NIH grant R01 ES012716 from the National Institute of Environmental Health Sciences. C. M. received support through an EMBO long-term fellowship and an HFSP long-term fellowship. This work was funded by the Cardiovascular Research Center at Massachusetts General Hospital, a Claflin Distinguished Scholar Award and Harvard Stem Cell Institute Seed Grant to C. E. B., and by awards from the National Heart Lung and Blood Institute (5R01HL096816), American Heart Association (Grant in Aid no. 10GRNT4270021), and Harvard Stem Cell Institute (Seed Grant) to C. G. B.	Brade T, 2007, DEV BIOL, V311, P297, DOI 10.1016/j.ydbio.2007.08.004; Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; Chen JN, 1997, DEVELOPMENT, V124, P4373; de Pater E, 2009, DEVELOPMENT, V136, P1633, DOI 10.1242/dev.030924; Dyer LA, 2009, DEV BIOL, V336, P137, DOI 10.1016/j.ydbio.2009.10.009; Grimes AC, 2006, DEV BIOL, V290, P265, DOI 10.1016/j.ydbio.2005.11.042; Grimes AC, 2010, EVOL DEV, V12, P552, DOI 10.1111/j.1525-142X.2010.00441.x; Ilagan R, 2006, DEVELOPMENT, V133, P2435, DOI 10.1242/dev.02408; Kang J, 2009, DEV BIOL, V334, P513, DOI 10.1016/j.ydbio.2009.06.041; Kelly RG, 2001, DEV CELL, V1, P435, DOI 10.1016/S1534-5807(01)00040-5; Li HY, 2006, J MED CHEM, V49, P2138, DOI 10.1021/jm058209g; Meilhac SM, 2004, DEV CELL, V6, P685, DOI 10.1016/S1534-5807(04)00133-9; Miao M, 2007, MATRIX BIOL, V26, P115, DOI 10.1016/j.matbio.2006.09.011; Mjaatvedt CH, 2001, DEV BIOL, V238, P97, DOI 10.1006/dbio.2001.0409; Mosimann C, 2011, DEVELOPMENT, V138, P169, DOI 10.1242/dev.059345; Olson EN, 2006, SCIENCE, V313, P1922, DOI 10.1126/science.1132292; Prall OWJ, 2007, CELL, V128, P947, DOI 10.1016/j.cell.2007.01.042; Rifkin DB, 2005, J BIOL CHEM, V280, P7409, DOI 10.1074/jbc.R400029200; Rochais F, 2009, CIRC RES, V104, P933, DOI 10.1161/CIRCRESAHA.109.194464; Todorovic V, 2007, DEVELOPMENT, V134, P3723, DOI 10.1242/dev.008599; Vincent SD, 2010, CURR TOP DEV BIOL, V90, P1, DOI 10.1016/S0070-2153(10)90001-X; von Both I, 2004, DEV CELL, V7, P331, DOI 10.1016/j.devcel.2004.07.023; Waldo KL, 2001, DEVELOPMENT, V128, P3179; Zaffran S, 2004, CIRC RES, V95, P261, DOI 10.1161/01.RES.0000136815.73623.BE	24	173	173	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 30	2011	474	7353					645	648		10.1038/nature10094	http://dx.doi.org/10.1038/nature10094			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	785CF	21623370	Green Accepted			2022-12-24	WOS:000292204300040
J	Bell, G; Gonzalez, A				Bell, Graham; Gonzalez, Andrew			Adaptation and Evolutionary Rescue in Metapopulations Experiencing Environmental Deterioration	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; EXTINCTION; POPULATIONS; GENETICS; RANGES	It is not known whether evolution will usually be rapid enough to allow a species to adapt and persist in a deteriorating environment. We tracked the eco-evolutionary dynamics of metapopulations with a laboratory model system of yeast exposed to salt stress. Metapopulations experienced environmental deterioration at three different rates and their component populations were either unconnected or connected by local dispersal or by global dispersal. We found that adaptation was favored by gradual deterioration and local dispersal. After further abrupt deterioration, the frequency of evolutionary rescue depended on both the prior rate of deterioration and the rate of dispersal. Adaptation was surprisingly frequent and rapid in small peripheral populations. Thus, evolutionary dynamics affect both the persistence and the range of a species after environmental deterioration.	[Bell, Graham; Gonzalez, Andrew] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada	McGill University	Gonzalez, A (corresponding author), McGill Univ, Dept Biol, 1205 Ave Docteur Penfield, Montreal, PQ H3A 1B1, Canada.	andrew.gonzalez@mcgill.ca	Gonzalez, Andrew/F-2247-2010	Gonzalez, Andrew/0000-0001-6075-8081	Natural Sciences and Engineering Research Council of Canada; Canadian Foundation for Innovation; Canada Research Chair Program	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Foundation for Innovation(Canada Foundation for Innovation); Canada Research Chair Program(Canada Research Chairs)	The robot was programmed and operated by Z. M. Wang, assisted by A.-M. LeHeureux. G. B. and A. G. are supported by funding from the Natural Sciences and Engineering Research Council of Canada and by the Canadian Foundation for Innovation. A. G. is supported by the Canada Research Chair Program. We thank two anonymous reviewers for comments that improved the manuscript.	Bell G, 2008, EVOL APPL, V1, P3, DOI 10.1111/j.1752-4571.2007.00011.x; Bell G, 2009, ECOL LETT, V12, P942, DOI 10.1111/j.1461-0248.2009.01350.x; Case TJ, 2000, AM NAT, V155, P583, DOI 10.1086/303351; Ceballos G, 2002, SCIENCE, V296, P904, DOI 10.1126/science.1069349; Channell R, 2000, NATURE, V403, P84, DOI 10.1038/47487; Dhar R, 2011, J EVOLUTION BIOL, V24, P1135, DOI 10.1111/j.1420-9101.2011.02249.x; Doak DF, 2010, NATURE, V467, P959, DOI 10.1038/nature09439; Eckert CG, 2008, MOL ECOL, V17, P1170, DOI 10.1111/j.1365-294X.2007.03659.x; Forde SE, 2004, NATURE, V431, P841, DOI 10.1038/nature02906; Gerrish PJ, 1998, GENETICA, V102-3, P127, DOI 10.1023/A:1017067816551; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; GILLESPIE JH, 1984, EVOLUTION, V38, P1116, DOI 10.1111/j.1558-5646.1984.tb00380.x; GOMULKIEWICZ R, 1995, EVOLUTION, V49, P201, DOI 10.1111/j.1558-5646.1995.tb05971.x; Gomulkiewicz R, 1999, THEOR POPUL BIOL, V55, P283, DOI 10.1006/tpbi.1998.1405; Greig D, 2002, SCIENCE, V298, P1773, DOI 10.1126/science.1076374; Hughes JB, 1997, SCIENCE, V278, P689, DOI 10.1126/science.278.5338.689; Orr HA, 2008, AM NAT, V172, P160, DOI 10.1086/589460; Orr HA, 2002, EVOLUTION, V56, P1317, DOI 10.1111/j.0014-3820.2002.tb01446.x; Replansky T, 2008, TRENDS ECOL EVOL, V23, P494, DOI 10.1016/j.tree.2008.05.005; Sagarin RD, 2006, TRENDS ECOL EVOL, V21, P524, DOI 10.1016/j.tree.2006.06.008; Samani P, 2010, J EVOLUTION BIOL, V23, P791, DOI 10.1111/j.1420-9101.2010.01945.x; Sexton JP, 2009, ANNU REV ECOL EVOL S, V40, P415, DOI 10.1146/annurev.ecolsys.110308.120317; Warringer J, 2003, P NATL ACAD SCI USA, V100, P15724, DOI 10.1073/pnas.2435976100	23	241	242	3	216	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 10	2011	332	6035					1327	1330		10.1126/science.1203105	http://dx.doi.org/10.1126/science.1203105			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	775EP	21659606				2022-12-24	WOS:000291441700046
J	De Stefani, D; Raffaello, A; Teardo, E; Szabo, I; Rizzuto, R				De Stefani, Diego; Raffaello, Anna; Teardo, Enrico; Szabo, Ildiko; Rizzuto, Rosario			A forty-kilodalton protein of the inner membrane is the mitochondrial calcium uniporter	NATURE			English	Article							ENDOPLASMIC-RETICULUM; INDUCED APOPTOSIS; CA2+ CHANNELS; COLOCALIZATION; PROPAGATION; ACTIVATION; DYNAMICS; CONTACTS; FEEDBACK; SIGNALS	Mitochondrial Ca(2+) homeostasis has a key role in the regulation of aerobic metabolism and cell survival(1), but the molecular identity of the Ca(2+) channel, the mitochondrial calcium uniporter(2), is still unknown. Here we have identified in silico a protein (named MCU) that shares tissue distribution with MICU1 (also known as CBARA1), a recently characterized uniporter regulator(3), is present in organisms in which mitochondrial Ca(2+) uptake was demonstrated and whose sequence includes two transmembrane domains. Short interfering RNA (siRNA) silencing of MCU in HeLa cells markedly reduced mitochondrial Ca(2+) uptake. MCU overexpression doubled the matrix Ca(2+) concentration increase evoked by inositol 1,4,5-trisphosphate-generating agonists, thus significantly buffering the cytosolic elevation. The purified MCU protein showed channel activity in planar lipid bilayers, with electrophysiological properties and inhibitor sensitivity of the uniporter. A mutant MCU, in which two negatively charged residues of the putative pore-forming region were replaced, had no channel activity and reduced agonist-dependent matrix Ca(2+) concentration transients when overexpressed in HeLa cells. Overall, these data demonstrate that the 40-kDa protein identified is the channel responsible for ruthenium-red-sensitive mitochondrial Ca(2+) uptake, thus providing a molecular basis for this process of utmost physiological and pathological relevance.	[De Stefani, Diego; Raffaello, Anna; Rizzuto, Rosario] Univ Padua, Dept Biomed Sci, I-35121 Padua, Italy; [De Stefani, Diego; Raffaello, Anna; Rizzuto, Rosario] Univ Padua, Inst Neurosci, CNR, I-35121 Padua, Italy; [Teardo, Enrico; Szabo, Ildiko] Univ Padua, Dept Biol, Padua, Italy	University of Padua; Consiglio Nazionale delle Ricerche (CNR); University of Padua; University of Padua	Rizzuto, R (corresponding author), Univ Padua, Dept Biomed Sci, I-35121 Padua, Italy.	rosario.rizzuto@unipd.it	Padova, Ildiko/K-5344-2016; De Stefani, Diego/I-7715-2015; Raffaello, Anna/K-7052-2016; Szabo, Ildiko/AAW-5972-2021	De Stefani, Diego/0000-0003-3796-8907; Szabo, Ildiko/0000-0002-3637-3947; RAFFAELLO, ANNA/0000-0002-8344-6459; Rizzuto, Rosario/0000-0001-7044-5097	Italian Ministry of Education, University and Research; European Commission [223576]; National Institutes of Health [1P01AG025532-01A1]; Cariparo Foundation (Padua); Italian Association for Cancer Research (AIRC); Telethon-Italy [GPP1005]; NATIONAL INSTITUTE ON AGING [P01AG025532] Funding Source: NIH RePORTER	Italian Ministry of Education, University and Research(Ministry of Education, Universities and Research (MIUR)); European Commission(European CommissionEuropean Commission Joint Research Centre); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cariparo Foundation (Padua)(Fondazione Cariparo); Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); Telethon-Italy(Fondazione Telethon); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank M. Zoratti for help in the analysis of electrophysiological data, G. Merli for carrying out some of the experiments and P. Bernardi, T. Pozzan and L. Cendron for helpful discussions and for the N33-D1cpV expression plasmid (T. Pozzan). This research was supported by grants from the Italian Ministry of Education, University and Research, European Commission (FP7 "MyoAGE", no. 223576), National Institutes of Health (Grant #1P01AG025532-01A1), Cariparo Foundation (Padua), the Italian Association for Cancer Research (AIRC) and Telethon-Italy (GPP1005).	BENAIM G, 1990, MOL BIOCHEM PARASIT, V39, P61, DOI 10.1016/0166-6851(90)90008-A; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Boitier E, 1999, J CELL BIOL, V145, P795, DOI 10.1083/jcb.145.4.795; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Carafoli E, 2003, TRENDS BIOCHEM SCI, V28, P175, DOI 10.1016/S0968-0004(03)00053-7; Costes SV, 2004, BIOPHYS J, V86, P3993, DOI [10.1529/biophysj.103.038422, 10.1529/biophysi.103.038422]; Csordas G, 1999, EMBO J, V18, P96, DOI 10.1093/emboj/18.1.96; Csordas G, 2010, MOL CELL, V39, P121, DOI 10.1016/j.molcel.2010.06.029; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; Giacomello M, 2010, MOL CELL, V38, P280, DOI 10.1016/j.molcel.2010.04.003; Hajnoczky G, 1999, J BIOL CHEM, V274, P14157, DOI 10.1074/jbc.274.20.14157; HAJNOCZKY G, 1995, CELL, V82, P415, DOI 10.1016/0092-8674(95)90430-1; Hajnoczky G, 2000, CELL CALCIUM, V28, P349, DOI 10.1054/ceca.2000.0169; Jouaville LS, 1999, P NATL ACAD SCI USA, V96, P13807, DOI 10.1073/pnas.96.24.13807; Kirichok Y, 2004, NATURE, V427, P360, DOI 10.1038/nature02246; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Michels G, 2009, CIRCULATION, V119, P2435, DOI 10.1161/CIRCULATIONAHA.108.835389; Nicholls DG, 2005, CELL CALCIUM, V38, P311, DOI 10.1016/j.ceca.2005.06.011; Pacher P, 2001, EMBO J, V20, P4107, DOI 10.1093/emboj/20.15.4107; Perocchi F, 2010, NATURE, V467, P291, DOI 10.1038/nature09358; Pinton P, 2001, EMBO J, V20, P2690, DOI 10.1093/emboj/20.11.2690; Pinton P, 2007, METHOD CELL BIOL, V80, P297, DOI 10.1016/S0091-679X(06)80015-4; Rizzuto R, 1998, SCIENCE, V280, P1763, DOI 10.1126/science.280.5370.1763; RIZZUTO R, 1993, SCIENCE, V262, P744, DOI 10.1126/science.8235595; SCHOENMAKERS TJM, 1992, BIOTECHNIQUES, V12, P870; Szabadkai G, 2008, PHYSIOLOGY, V23, P84, DOI 10.1152/physiol.00046.2007; Szabo I, 2011, CELL DEATH DIFFER, V18, P427, DOI 10.1038/cdd.2010.112; Teardo E, 2010, CELL PHYSIOL BIOCHEM, V26, P253, DOI 10.1159/000320525; Tinel H, 1999, EMBO J, V18, P4999, DOI 10.1093/emboj/18.18.4999; URIBE S, 1992, CELL CALCIUM, V13, P211, DOI 10.1016/0143-4160(92)90009-H; Wieckowski MR, 2009, NAT PROTOC, V4, P1582, DOI 10.1038/nprot.2009.151; Xiong ZH, 1997, J BIOL CHEM, V272, P31022, DOI 10.1074/jbc.272.49.31022	32	1276	1290	2	124	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 18	2011	476	7360					336	U104		10.1038/nature10230	http://dx.doi.org/10.1038/nature10230			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811JV	21685888	Green Accepted			2022-12-24	WOS:000294206500039
J	Sekiya, S; Suzuki, A				Sekiya, Sayaka; Suzuki, Atsushi			Direct conversion of mouse fibroblasts to hepatocyte-like cells by defined factors	NATURE			English	Article							HEPATIC PROGENITOR CELLS; CLONAL IDENTIFICATION; STEM-CELLS; IN-VIVO; LIVER; DIFFERENTIATION; CARDIOMYOCYTES; NORMALIZATION; EXPRESSION; NEURONS	The location and timing of cellular differentiation must be stringently controlled for proper organ formation. Normally, hepatocytes differentiate from hepatic progenitor cells to form the liver during development(1,2). However, previous studies have shown that the hepatic program can also be activated in non-hepatic lineage cells after exposure to particular stimuli or fusion with hepatocytes(3-9). These unexpected findings suggest that factors critical to hepatocyte differentiation exist and become activated to induce hepatocyte-specific properties in different cell types. Here, by screening the effects of twelve candidate factors, we identify three specific combinations of two transcription factors, comprising Hnf4 alpha plus Foxa1, Foxa2 or Foxa3, that can convert mouse embryonic and adult fibroblasts into cells that closely resemble hepatocytes in vitro. The induced hepatocyte-like (iHep) cells have multiple hepatocyte-specific features and reconstitute damaged hepatic tissues after transplantation. The generation of iHep cells may provide insights into the molecular nature of hepatocyte differentiation and potential therapies for liver diseases.	[Sekiya, Sayaka; Suzuki, Atsushi] Kyushu Univ, Div Organogenesis & Regenerat, Med Inst Bioregulat, Higashi Ku, Fukuoka 8128582, Japan; [Suzuki, Atsushi] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol PRESTO, Kawaguchi, Saitama 3320012, Japan	Kyushu University; Japan Science & Technology Agency (JST)	Suzuki, A (corresponding author), Kyushu Univ, Div Organogenesis & Regenerat, Med Inst Bioregulat, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	suzukicks@bioreg.kyushu-u.ac.jp		Suzuki, Atsushi/0000-0002-6347-5498	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; Japan Science and Technology Agency	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	We thank A. Iwama, H. Miyoshi and R. M. Tanguay for sharing reagents, F. Costantini for providing the R26R<SUP>YFP</SUP> mice and E. Gunshima, A. Kaneyuki and H. Kuboyama for excellent technical assistance. This work was supported in part by the Program for Improvement of the Research Environment for Young Researchers from the Special Coordination Funds for Promoting Science and Technology commissioned by the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan, a Grant-in-Aid for Scientific Research from the MEXT of Japan and the Precursory Research for Embryonic Science and Technology Program of the Japan Science and Technology Agency.	Alvarez-Dolado M, 2003, NATURE, V425, P968, DOI 10.1038/nature02069; Banas A, 2007, HEPATOLOGY, V46, P219, DOI 10.1002/hep.21704; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; Feng R, 2008, P NATL ACAD SCI USA, V105, P6057, DOI 10.1073/pnas.0711961105; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Kaneko S, 2001, HUM GENE THER, V12, P35, DOI 10.1089/104303401450942; Lee KD, 2004, HEPATOLOGY, V40, P1275, DOI 10.1002/hep.20469; Overturf K, 1996, NAT GENET, V12, P266, DOI 10.1038/ng0396-266; Quackenbush J, 2002, NAT GENET, V32, P496, DOI 10.1038/ng1032; REDDY JK, 1984, J CELL BIOL, V98, P2082, DOI 10.1083/jcb.98.6.2082; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; SCARPELLI DG, 1981, P NATL ACAD SCI-BIOL, V78, P2577, DOI 10.1073/pnas.78.4.2577; SEGLEN PO, 1979, J TOXICOL ENV HEALTH, V5, P551, DOI 10.1080/15287397909529766; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Suzuki A, 2000, HEPATOLOGY, V32, P1230, DOI 10.1053/jhep.2000.20349; Suzuki A, 2003, P NATL ACAD SCI USA, V100, P5034, DOI 10.1073/pnas.0936260100; Suzuki A, 2002, J CELL BIOL, V156, P173, DOI 10.1083/jcb.200108066; Suzuki A, 2003, DEVELOPMENT, V130, P2513, DOI 10.1242/dev.00459; Suzuki A, 2008, HEPATOLOGY, V48, P1964, DOI 10.1002/hep.22558; Szabo E, 2010, NATURE, V468, P521, DOI 10.1038/nature09591; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Vassilopoulos G, 2003, NATURE, V422, P901, DOI 10.1038/nature01539; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Wang X, 2003, NATURE, V422, P897, DOI 10.1038/nature01531; Wang X, 2001, AM J PATHOL, V158, P571, DOI 10.1016/S0002-9440(10)63999-5; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2; Zaret KS, 2008, SCIENCE, V322, P1490, DOI 10.1126/science.1161431; Zaret KS, 2002, NAT REV GENET, V3, P499, DOI 10.1038/nrg837; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	31	594	646	4	103	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 21	2011	475	7356					390	U148		10.1038/nature10263	http://dx.doi.org/10.1038/nature10263			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794PA	21716291				2022-12-24	WOS:000292911200045
J	Jenkins, SJ; Ruckerl, D; Cook, PC; Jones, LH; Finkelman, FD; van Rooijen, N; MacDonald, AS; Allen, JE				Jenkins, Stephen J.; Ruckerl, Dominik; Cook, Peter C.; Jones, Lucy H.; Finkelman, Fred D.; van Rooijen, Nico; MacDonald, Andrew S.; Allen, Judith E.			Local Macrophage Proliferation, Rather than Recruitment from the Blood, Is a Signature of T(H)2 Inflammation	SCIENCE			English	Article							CD4(+) T-CELLS; ALTERNATIVE ACTIVATION; HELMINTH INFECTION; IL-4; MONOCYTES; MICE; MECHANISMS; INJURY; REPAIR; LIFE	A defining feature of inflammation is the accumulation of innate immune cells in the tissue that are thought to be recruited from the blood. We reveal that a distinct process exists in which tissue macrophages undergo rapid in situ proliferation in order to increase population density. This inflammatory mechanism occurred during T helper 2 (T(H)2)-related pathologies under the control of the archetypal T(H)2 cytokine interleukin-4 (IL-4) and was a fundamental component of T(H)2 inflammation because exogenous IL-4 was sufficient to drive accumulation of tissue macrophages through self-renewal. Thus, expansion of innate cells necessary for pathogen control or wound repair can occur without recruitment of potentially tissue-destructive inflammatory cells.	[Jenkins, Stephen J.; Ruckerl, Dominik; Cook, Peter C.; Jones, Lucy H.; MacDonald, Andrew S.; Allen, Judith E.] Univ Edinburgh, Sch Biol Sci, Ctr Immun Infect & Evolut, Edinburgh EH9 3JT, Midlothian, Scotland; [Jenkins, Stephen J.; Ruckerl, Dominik; Cook, Peter C.; Jones, Lucy H.; MacDonald, Andrew S.; Allen, Judith E.] Univ Edinburgh, Sch Biol Sci, Inst Immunol & Infect Res, Edinburgh EH9 3JT, Midlothian, Scotland; [Finkelman, Fred D.] Cincinnati Vet Affairs Med Ctr, Dept Med, Cincinnati, OH 45220 USA; [Finkelman, Fred D.] Univ Cincinnati, Coll Med, Dept Internal Med, Div Immunol Allergy & Rheumatol, Cincinnati, OH 45267 USA; [Finkelman, Fred D.] Cincinnati Childrens Hosp, Med Ctr, Div Immunobiol, Cincinnati, OH 45229 USA; [Finkelman, Fred D.] Cincinnati Childrens Hosp, Med Ctr, Div Rheumatol, Cincinnati, OH 45229 USA; [van Rooijen, Nico] Free Univ Med Ctr, Dept Mol & Cell Biol, Amsterdam, Netherlands	University of Edinburgh; University of Edinburgh; US Department of Veterans Affairs; Veterans Health Administration (VHA); Cincinnati VA Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; Vrije Universiteit Amsterdam	Allen, JE (corresponding author), Univ Edinburgh, Sch Biol Sci, Ctr Immun Infect & Evolut, Edinburgh EH9 3JT, Midlothian, Scotland.	j.allen@ed.ac.uk	Van Rooijen, Nico/Z-1578-2019; Allen, Judith E/C-9198-2011; Cook, Peter/E-6731-2015	Allen, Judith E/0000-0002-3829-066X; Cook, Peter/0000-0002-5208-4985; Jackson-Jones, Lucy/0000-0003-0608-8966; Jenkins, Stephen/0000-0002-0233-5424; Ruckerl, Dominik/0000-0002-0206-1451	Medical Research Council (MRC) UK [G0600818, G0701437]; European Union [INCO-CT-2006-03232]; U.S. Department of Veterans Affairs; National Institutes of Health [RO1 AI070300]; Wellcome Trust; MRC [G0701437, G0600818] Funding Source: UKRI; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070300] Funding Source: NIH RePORTER; Medical Research Council [G0600818, G0701437] Funding Source: researchfish	Medical Research Council (MRC) UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union(European Commission); U.S. Department of Veterans Affairs(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank R. Zamoyska, F. Brombacher, and D. Gray for critical reading of the manuscript, and A. Fulton and S. Duncan for expert technical assistance. This study was funded by the Medical Research Council (MRC) UK (G0600818 to J.E.A.), with additional support from the European Union ("SCOOTT"; INCO-CT-2006-03232), MRC UK (G0701437 to A. S. M.), the U.S. Department of Veterans Affairs (Merit Award to F. D. F.), and the National Institutes of Health (RO1 AI070300 to F. D. F.). L.H.J. was funded by a Wellcome Trust Ph.D. studentship.	Allen JE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002003; Anthony RM, 2007, NAT REV IMMUNOL, V7, P975, DOI 10.1038/nri2199; Anthony RM, 2006, NAT MED, V12, P955, DOI 10.1038/nm1451; Ashcroft GS, 2003, J CLIN INVEST, V111, P1309, DOI 10.1172/KCO200316288; Auffray C, 2009, ANNU REV IMMUNOL, V27, P669, DOI 10.1146/annurev.immunol.021908.132557; Ghosn EEB, 2010, P NATL ACAD SCI USA, V107, P2568, DOI 10.1073/pnas.0915000107; Chorro L, 2009, J EXP MED, V206, P3089, DOI 10.1084/jem.20091586; DAEMS WT, 1982, IMMUNOBIOLOGY, V161, P204, DOI 10.1016/S0171-2985(82)80075-2; Eming SA, 2007, J INVEST DERMATOL, V127, P514, DOI 10.1038/sj.jid.5700701; Fine JS, 2003, INFLAMMATION, V27, P161, DOI 10.1023/A:1025076111950; Getts DR, 2008, J EXP MED, V205, P2319, DOI 10.1084/jem.20080421; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Kuziel WA, 1997, P NATL ACAD SCI USA, V94, P12053, DOI 10.1073/pnas.94.22.12053; Le Goff L, 2002, INT J PARASITOL, V32, P1277, DOI 10.1016/S0020-7519(02)00125-X; Loke P, 2007, J IMMUNOL, V179, P3926, DOI 10.4049/jimmunol.179.6.3926; Loke P'ng, 2002, BMC Immunol, V3, P7, DOI 10.1186/1471-2172-3-7; Lucas T, 2010, J IMMUNOL, V184, P3964, DOI 10.4049/jimmunol.0903356; MacDonald AS, 2003, MED MICROBIOL IMMUN, V192, P33, DOI 10.1007/s00430-002-0156-8; Merad M, 2002, NAT IMMUNOL, V3, P1135, DOI 10.1038/ni852; Milner JD, 2010, BLOOD, V116, P2476, DOI 10.1182/blood-2009-11-255174; Munder M, 1998, J IMMUNOL, V160, P5347; Murphy J, 2008, AM J RESP CELL MOL, V38, P380, DOI 10.1165/rcmb.2007-0224RC; Ruffell D, 2009, P NATL ACAD SCI USA, V106, P17475, DOI 10.1073/pnas.0908641106; Serbina NV, 2008, ANNU REV IMMUNOL, V26, P421, DOI 10.1146/annurev.immunol.26.021607.090326; Siracusa MC, 2008, J LEUKOCYTE BIOL, V84, P1422, DOI 10.1189/jlb.0308199; Smith P, 2007, J IMMUNOL, V178, P4557, DOI 10.4049/jimmunol.178.7.4557; Soehnlein O, 2010, NAT REV IMMUNOL, V10, P427, DOI 10.1038/nri2779; Sunderkotter C, 2004, J IMMUNOL, V172, P4410, DOI 10.4049/jimmunol.172.7.4410; Vats D, 2006, CELL METAB, V4, P13, DOI 10.1016/j.cmet.2006.05.011; Voehringer D, 2004, IMMUNITY, V20, P267, DOI 10.1016/S1074-7613(04)00026-3	30	959	993	0	111	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 10	2011	332	6035					1284	1288		10.1126/science.1204351	http://dx.doi.org/10.1126/science.1204351			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	775EP	21566158	Green Accepted			2022-12-24	WOS:000291441700035
J	Davis, M; Chew, MK; Hobbs, RJ; Lugo, AE; Ewel, JJ; Vermeij, GJ; Brown, JH; Rosenzweig, ML; Gardener, MR; Carroll, SP; Thompson, K; Pickett, STA; Stromberg, JC; Del Tredici, P; Suding, KN; Ehrenfeld, JG; Grime, JP; Mascaro, J; Briggs, JC				Davis, Mark; Chew, Matthew K.; Hobbs, Richard J.; Lugo, Ariel E.; Ewel, John J.; Vermeij, Geerat J.; Brown, James H.; Rosenzweig, Michael L.; Gardener, Mark R.; Carroll, Scott P.; Thompson, Ken; Pickett, Steward T. A.; Stromberg, Juliet C.; Del Tredici, Peter; Suding, Katharine N.; Ehrenfeld, Joan G.; Grime, J. Philip; Mascaro, Joseph; Briggs, John C.			Don't judge species on their origins	NATURE			English	Editorial Material							SCIENTISTS; MANAGEMENT		[Davis, Mark] Macalester Coll, St Paul, MN 55105 USA	Macalester College	Davis, M (corresponding author), Macalester Coll, St Paul, MN 55105 USA.	davis@macalester.edu	Hobbs, Richard J/F-5883-2010; Suding, Katharine/O-6290-2017	Hobbs, Richard J/0000-0003-4047-3147; Suding, Katharine/0000-0002-5357-0176; Carroll, Scott/0000-0003-2094-9398				Aukema JE, 2010, BIOSCIENCE, V60, P886, DOI 10.1525/bio.2010.60.11.5; Carroll SP, 2011, EVOL APPL, V4, P184, DOI 10.1111/j.1752-4571.2010.00180.x; Chew MK, 2011, FIFTY YEARS OF INVASION ECOLOGY: THE LEGACY OF CHARLES ELTON, P35; Chew MK, 2009, J HIST BIOL, V42, P231, DOI 10.1007/s10739-009-9181-4; Davis M. A., 2009, INVASION BIOL; Fleishman E, 2011, BIOSCIENCE, V61, P290, DOI 10.1525/bio.2011.61.4.9; Gardener MR, 2010, RANGELAND J, V32, P407, DOI 10.1071/RJ10029; Gleditsch JM, 2011, DIVERS DISTRIB, V17, P244, DOI 10.1111/j.1472-4642.2010.00733.x; Stromberg JC, 2009, RESTOR ECOL, V17, P177, DOI 10.1111/j.1526-100X.2008.00514.x; Wilcove DS, 1998, BIOSCIENCE, V48, P607, DOI 10.2307/1313420	10	630	654	7	583	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 9	2011	474	7350					153	154		10.1038/474153a	http://dx.doi.org/10.1038/474153a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	774PE	21654782				2022-12-24	WOS:000291397800026
J	Jones, MDM; Forn, I; Gadelha, C; Egan, MJ; Bass, D; Massana, R; Richards, TA				Jones, Meredith D. M.; Forn, Irene; Gadelha, Catarina; Egan, Martin J.; Bass, David; Massana, Ramon; Richards, Thomas A.			Discovery of novel intermediate forms redefines the fungal tree of life	NATURE			English	Article							OLIGONUCLEOTIDE PROBES; MOLECULAR PHYLOGENY; RIBOSOMAL-RNA; SEQUENCE DATA; LAND PLANTS; DIVERSITY; EVOLUTION; COMMUNITY; EUKARYOTES; ROZELLA	Fungi are the principal degraders of biomass in terrestrial ecosystems and establish important interactions with plants and animals(1-3). However, our current understanding of fungal evolutionary diversity is incomplete(4) and is based upon species amenable to growth in culture(1). These culturable fungi are typically yeast or filamentous forms, bound by a rigid cell wall rich in chitin. Evolution of this body plan was thought critical for the success of the Fungi, enabling them to adapt to heterogeneous habitats and live by osmotrophy: extracellular digestion followed by nutrient uptake(5). Here we investigate the ecology and cell biology of a previously undescribed and highly diverse form of eukaryotic life that branches with the Fungi, using environmental DNA analyses combined with fluorescent detection via DNA probes. This clade is present in numerous ecosystems including soil, freshwater and aquatic sediments. Phylogenetic analyses using multiple ribosomal RNA genes place this clade with Rozella, the putative primary branch of the fungal kingdom(1). Tyramide signal amplification coupled with group-specific fluorescence in situ hybridization reveals that the target cells are small eukaryotes of 3-5 mm in length, capable of forming a microtubule-based flagellum. Co-staining with cell wall markers demonstrates that representatives from the clade do not produce a chitin-rich cell wall during any of the life cycle stages observed and therefore do not conform to the standard fungal body plan(5). We name this highly diverse clade the cryptomycota in anticipation of formal classification.	[Jones, Meredith D. M.; Egan, Martin J.; Richards, Thomas A.] Univ Exeter, Sch Biosci, Exeter EX4 4QD, Devon, England; [Jones, Meredith D. M.; Bass, David; Richards, Thomas A.] Nat Hist Museum, Dept Zool, London SW7 5BD, England; [Forn, Irene; Massana, Ramon] CSIC, Inst Ciencies Mar, Dept Marine Biol & Oceanog, E-08003 Barcelona, Catalonia, Spain; [Gadelha, Catarina] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England; [Egan, Martin J.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	University of Exeter; Natural History Museum London; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM); University of Cambridge; Harvard University; Harvard Medical School	Richards, TA (corresponding author), Univ Exeter, Sch Biosci, Exeter EX4 4QD, Devon, England.	thomr@nhm.ac.uk	Massana, Ramon/F-4205-2016; Gadelha, Catarina/ABD-5623-2021	Gadelha, Catarina/0000-0001-5016-3682; Massana, Ramon/0000-0001-9172-5418; Richards, Thomas/0000-0002-9692-0973	Leverhulme Trust; Natural Environment Research Council, UK [NE/F011709/1]; Systematics Association; Linnean Society; MICINN [CGL2010-16304]; ERA; NERC [NE/F011709/1] Funding Source: UKRI; Natural Environment Research Council [NE/F011709/1] Funding Source: researchfish	Leverhulme Trust(Leverhulme Trust); Natural Environment Research Council, UK(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Systematics Association; Linnean Society; MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); ERA; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank: N. J. Talbot for advice, K. Gull for the TAT1 antibody, L. Guillou for access to curated SSU database and the Broad Institute of the Massachusetts Institute of Technology and Harvard for making their Rhizopus and Batrachochytrium genome sequence data publicly available. T.A.R. thanks the Leverhulme Trust for fellowship support. This work was primarily supported by a Natural Environment Research Council grant UK (NE/F011709/1). Additional support came from the Systematic Research Fund (awarded by the Systematics Association and the Linnean Society) to T.A.R., project FLAME (CGL2010-16304, MICINN) to R. M. and the BioMarKs project (European Funding Agencies from the ERA-net program BiodivERsA) to T.A.R. and R.M.	BARTNICKIGARCIA S, 1987, EVOLUTIONARY BIOL FU, P389; Baschien C, 2001, INT REV HYDROBIOL, V86, P371, DOI 10.1002/1522-2632(200107)86:4/5<371::AID-IROH371>3.0.CO;2-P; Bass D, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-162; Bass D, 2007, P ROY SOC B-BIOL SCI, V274, P3069, DOI 10.1098/rspb.2007.1067; Benson DA, 2006, NUCLEIC ACIDS RES, V34, pD16, DOI 10.1093/nar/gkj157; BULAWA CE, 1993, ANNU REV MICROBIOL, V47, P505, DOI 10.1146/annurev.micro.47.1.505; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Foster PG, 1999, J MOL EVOL, V48, P284, DOI 10.1007/PL00006471; Fuchs BM, 2000, APPL ENVIRON MICROB, V66, P3603, DOI 10.1128/AEM.66.8.3603-3607.2000; Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hawksworth DL, 2001, MYCOL RES, V105, P1422, DOI 10.1017/S0953756201004725; HELD AA, 1975, CAN J BOT, V53, P2212, DOI 10.1139/b75-245; HELD AA, 1981, BOT REV, V47, P451, DOI 10.1007/BF02860539; James TY, 2006, MYCOLOGIA, V98, P860, DOI 10.3852/mycologia.98.6.860; James TY, 2006, NATURE, V443, P818, DOI 10.1038/nature05110; Keane TM, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-29; Kim E, 2011, P NATL ACAD SCI USA, V108, P1496, DOI 10.1073/pnas.1013337108; LANAVE C, 1984, J MOL EVOL, V20, P86, DOI 10.1007/BF02101990; Lara E, 2010, PROTIST, V161, P116, DOI 10.1016/j.protis.2009.06.005; Lefevre E, 2007, ENVIRON MICROBIOL, V9, P61, DOI 10.1111/j.1462-2920.2006.01111.x; Lepere C, 2008, APPL ENVIRON MICROB, V74, P2940, DOI 10.1128/AEM.01156-07; LOCKHART PJ, 1994, MOL BIOL EVOL, V11, P605; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Mangot JF, 2009, APPL ENVIRON MICROB, V75, P6373, DOI 10.1128/AEM.00607-09; Massana R, 2008, CURR OPIN MICROBIOL, V11, P213, DOI 10.1016/j.mib.2008.04.004; PIROZYNSKI KA, 1975, BIOSYSTEMS, V6, P153, DOI 10.1016/0303-2647(75)90023-4; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Swofford D.L., 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/j.0014-3820.2002.tb00191.x; van Hannen EJ, 1999, APPL ENVIRON MICROB, V65, P2478; Vandenkoornhuyse P, 2002, SCIENCE, V295, P2051, DOI 10.1126/science.295.5562.2051; Wang B, 2006, MYCORRHIZA, V16, P299, DOI 10.1007/s00572-005-0033-6; Webster J., 2007, INTRO FUNGI, V3rd; WOODS A, 1989, J CELL SCI, V93, P491; Zettler LAA, 2001, J EUKARYOT MICROBIOL, V48, P293, DOI 10.1111/j.1550-7408.2001.tb00317.x	36	285	307	4	178	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 9	2011	474	7350					200	U234		10.1038/nature09984	http://dx.doi.org/10.1038/nature09984			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774PE	21562490				2022-12-24	WOS:000291397800047
J	Roppolo, D; De Rybel, B; Tendon, VD; Pfister, A; Alassimone, J; Vermeer, JEM; Yamazaki, M; Stierhof, YD; Beeckman, T; Geldner, N				Roppolo, Daniele; De Rybel, Bert; Tendon, Valerie Denervaud; Pfister, Alexandre; Alassimone, Julien; Vermeer, Joop E. M.; Yamazaki, Misako; Stierhof, York-Dieter; Beeckman, Tom; Geldner, Niko			A novel protein family mediates Casparian strip formation in the endodermis	NATURE			English	Article							ASYMMETRIC CELL-DIVISION; ARABIDOPSIS ROOT; PLANT; TRANSPORT; MOVEMENT; POLARITY	Polarized epithelia are fundamental to multicellular life. In animal epithelia, conserved junctional complexes establish membrane diffusion barriers, cellular adherence and sealing of the extracellular space(1). Plant cellular barriers are of independent evolutionary origin. The root endodermis strongly resembles a polarized epithelium and functions in nutrient uptake and stress resistance(2). Its defining features are the Casparian strips, belts of specialized cell wall material that generate an extracellular diffusion barrier(2). The mechanisms localizing Casparian strips are unknown. Here we identify and characterize a family of transmembrane proteins of previously unknown function. These 'CASPs' (Casparian strip membrane domain proteins) specifically mark a membrane domain that predicts the formation of Casparian strips. CASP1 displays numerous features required for a constituent of a plant junctional complex: it forms complexes with other CASPs; it becomes immobile upon localization; and it sediments like a large polymer. CASP double mutants display disorganized Casparian strips, demonstrating a role for CASPs in structuring and localizing this cell wall modification. To our knowledge, CASPs are the first molecular factors that are shown to establish a plasma membrane and extracellular diffusion barrier in plants, and represent a novel way of epithelial barrier formation in eukaryotes.	[Roppolo, Daniele; Tendon, Valerie Denervaud; Pfister, Alexandre; Alassimone, Julien; Vermeer, Joop E. M.; Yamazaki, Misako; Geldner, Niko] Univ Lausanne, UNIL Sorge, Dept Plant Mol Biol, CH-1015 Lausanne, Switzerland; [De Rybel, Bert; Beeckman, Tom] Univ Ghent, Dept Plant Biotechnol & Genet, B-9052 Ghent, Belgium; [De Rybel, Bert; Beeckman, Tom] VIB, Dept Plant Syst Biol, B-9052 Ghent, Belgium; [Stierhof, York-Dieter] Univ Tubingen, ZMBP, D-72076 Tubingen, Germany	University of Lausanne; Ghent University; Flanders Institute for Biotechnology (VIB); Eberhard Karls University of Tubingen	Geldner, N (corresponding author), Univ Lausanne, UNIL Sorge, Dept Plant Mol Biol, CH-1015 Lausanne, Switzerland.	niko.geldner@unil.ch	Beeckman, Tom/ABI-1703-2020; Vermeer, Joop E.M./J-2232-2014; Beeckman, Tom/ABA-1164-2020; Geldner, Niko/Y-2481-2019	Beeckman, Tom/0000-0001-8656-2060; Vermeer, Joop E.M./0000-0001-8876-5873; Alassimone, Julien/0000-0002-8118-2605; De Rybel, Bert/0000-0002-9551-042X; Geldner, Niko/0000-0002-2300-9644	Swiss National Science Foundation; European Research Council (ERC); Belgian Interuniversity Attraction Poles program [IUAP VI/33]; Ghent University; Roche Research Foundation; Marie-Curie IEF grant	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Research Council (ERC)(European Research Council (ERC)European Commission); Belgian Interuniversity Attraction Poles program(Belgian Federal Science Policy Office); Ghent University(Ghent University); Roche Research Foundation; Marie-Curie IEF grant	We thank the Central Imaging Facility (CIF) and the Protein Analysis Facility (PAF) of the University of Lausanne for technical support, G. Jurgens, W. Michalke, J. Chory for antibodies, T. W. J. Gadella for mTurquoise and J. Takano for mutant BOR1 clone. We thank J. Chory, E. M. N. Dohmann, Y. Lee and G. Jurgens for comments and critical reading of the manuscript. This work was supported by grants of the Swiss National Science Foundation and the European Research Council (ERC) to N.G., the Belgian Interuniversity Attraction Poles program (IUAP VI/33) and the Special Research Fund of Ghent University to B.D.R. and T.B., the Roche Research Foundation to D.R. and a Marie-Curie IEF grant to J.E.M.V.	Alassimone J, 2010, P NATL ACAD SCI USA, V107, P5214, DOI 10.1073/pnas.0910772107; Birnbaum K, 2003, SCIENCE, V302, P1956, DOI 10.1126/science.1090022; BONNETT HT, 1968, J CELL BIOL, V37, P199, DOI 10.1083/jcb.37.1.199; Carlsbecker A, 2010, NATURE, V465, P316, DOI 10.1038/nature08977; Caspary R., 1865, JB WISSENSCHAFTLICHE, V4, P101; Chiba H, 2008, BBA-BIOMEMBRANES, V1778, P588, DOI 10.1016/j.bbamem.2007.08.017; CLARKSON DT, 1984, PLANT CELL ENVIRON, V7, P449, DOI 10.1111/j.1365-3040.1984.tb01435.x; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; DiLaurenzio L, 1996, CELL, V86, P423, DOI 10.1016/S0092-8674(00)80115-4; Enstone DE, 2002, J PLANT GROWTH REGUL, V21, P335, DOI 10.1007/s00344-003-0002-2; Geldner N, 2003, CELL, V112, P219, DOI 10.1016/S0092-8674(03)00003-5; Geldner N, 2009, PLANT J, V59, P169, DOI 10.1111/j.1365-313X.2009.03851.x; Heidstra R, 2004, GENE DEV, V18, P1964, DOI 10.1101/gad.305504; KARAHARA I, 1992, PLANT CELL PHYSIOL, V33, P555; Ma JF, 2007, NATURE, V448, P209, DOI 10.1038/nature05964; Men SZ, 2008, NAT CELL BIOL, V10, P237, DOI 10.1038/ncb1686; NAGAHASHI G, 1974, SCIENCE, V183, P670, DOI 10.1126/science.183.4125.670; Nakajima K, 2001, NATURE, V413, P307, DOI 10.1038/35095061; Reichardt L, 2007, CURR BIOL, V17, P2047, DOI 10.1016/j.cub.2007.10.040; Rufz de Lavison J. d., 1910, REV GEN BOT, V22, P225; Schreiber L, 1996, PLANTA, V199, P596, DOI 10.1007/BF00195192; Sriranganadane D, 2010, J PROTEOME RES, V9, P3511, DOI 10.1021/pr901202z; Steudle E, 2000, PLANT SOIL, V226, P45, DOI 10.1023/A:1026439226716; Takano Junpei, 2010, Proc Natl Acad Sci U S A, V107, P5220, DOI 10.1073/pnas.0910744107; TOKUYASU KT, 1989, HISTOCHEM J, V21, P163, DOI 10.1007/BF01007491; VANFLEET DS, 1961, BOT REV, V27, P165, DOI 10.1007/BF02860082; VASSE J, 1995, MOL PLANT MICROBE IN, V8, P241, DOI 10.1094/MPMI-8-0241	27	249	266	5	117	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 19	2011	473	7347					380	U564		10.1038/nature10070	http://dx.doi.org/10.1038/nature10070			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765QA	21593871				2022-12-24	WOS:000290722400050
J	Baughman, JM; Perocchi, F; Girgis, HS; Plovanich, M; Belcher-Timme, CA; Sancak, Y; Bao, XR; Strittmatter, L; Goldberger, O; Bogorad, RL; Koteliansky, V; Mootha, VK				Baughman, Joshua M.; Perocchi, Fabiana; Girgis, Hany S.; Plovanich, Molly; Belcher-Timme, Casey A.; Sancak, Yasemin; Bao, X. Robert; Strittmatter, Laura; Goldberger, Olga; Bogorad, Roman L.; Koteliansky, Victor; Mootha, Vamsi K.			Integrative genomics identifies MCU as an essential component of the mitochondrial calcium uniporter	NATURE			English	Article							RAT KIDNEY MITOCHONDRIA; OXIDATIVE-PHOSPHORYLATION; RNAI THERAPEUTICS; PROTEIN TOPOLOGY; TRANSPORT; DELIVERY; RESPIRATION; INHIBITION; LIBRARY; COMPLEX	Mitochondria from diverse organisms are capable of transporting large amounts of Ca(2+) via a ruthenium-red-sensitive, membrane-potential-dependent mechanism called the uniporter(1-4). Although the uniporter's biophysical properties have been studied extensively, its molecular composition remains elusive. We recently used comparative proteomics to identify MICU1 (also known as CBARA1), an EF-hand-containing protein that serves as a putative regulator of the uniporter(5). Here, we use whole-genome phylogenetic profiling, genome-wide RNA co-expression analysis and organelle-wide protein coexpression analysis to predict proteins functionally related to MICU1. All three methods converge on a novel predicted transmembrane protein, CCDC109A, that we now call 'mitochondrial calcium uniporter' (MCU). MCU forms oligomers in the mitochondrial inner membrane, physically interacts with MICU1, and resides within a large molecular weight complex. Silencing MCU in cultured cells or in vivo in mouse liver severely abrogates mitochondrial Ca(2+) uptake, whereas mitochondrial respiration and membrane potential remain fully intact. MCU has two predicted transmembrane helices, which are separated by a highly conserved linker facing the intermembrane space. Acidic residues in this linker are required for its full activity. However, an S259A point mutation retains function but confers resistance to Ru360, the most potent inhibitor of the uniporter. Our genomic, physiological, biochemical and pharmacological data firmly establish MCU as an essential component of the mitochondrial Ca(2+) uniporter.	[Baughman, Joshua M.; Perocchi, Fabiana; Girgis, Hany S.; Plovanich, Molly; Belcher-Timme, Casey A.; Sancak, Yasemin; Bao, X. Robert; Strittmatter, Laura; Goldberger, Olga; Mootha, Vamsi K.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02114 USA; [Baughman, Joshua M.; Perocchi, Fabiana; Girgis, Hany S.; Plovanich, Molly; Belcher-Timme, Casey A.; Sancak, Yasemin; Bao, X. Robert; Strittmatter, Laura; Goldberger, Olga; Mootha, Vamsi K.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02114 USA; [Baughman, Joshua M.; Perocchi, Fabiana; Girgis, Hany S.; Plovanich, Molly; Belcher-Timme, Casey A.; Sancak, Yasemin; Bao, X. Robert; Strittmatter, Laura; Goldberger, Olga; Mootha, Vamsi K.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Baughman, Joshua M.; Perocchi, Fabiana; Girgis, Hany S.; Plovanich, Molly; Belcher-Timme, Casey A.; Sancak, Yasemin; Bao, X. Robert; Strittmatter, Laura; Goldberger, Olga; Mootha, Vamsi K.] Broad Inst, Cambridge, MA 02142 USA; [Bogorad, Roman L.] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Koteliansky, Victor] Alnylam Pharmaceut Inc, Cambridge, MA 02142 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT)	Mootha, VK (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02114 USA.	vamsi@hms.harvard.edu	Bogorad, Roman/G-2609-2011	perocchi, fabiana/0000-0002-1102-6500; Bao, Xiaoyan/0000-0001-7931-2944	National Science Foundation; National Institutes of Health [GM0077465, DK080261]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK080261] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077465] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Nilsson, J. Engreitz and S. Calvo for bioinformatics assistance; D. Root and S. Silver for assistance in lentiviral RNAi; B. R. Bettencourt, K. Charisse, S. Kuchimanchi and L. Speciner for siRNA design, synthesis and formulation; M. Blower, J. Avruch and R. Ward for advice; and members of the Mootha laboratory for valuable feedback. J. M. B. and L. S. were supported by graduate student fellowships from the National Science Foundation. This work was supported by grants from the National Institutes of Health (GM0077465, DK080261) awarded to V.K.M.	Akinc A, 2008, NAT BIOTECHNOL, V26, P561, DOI 10.1038/nbt1402; Akinc A, 2010, MOL THER, V18, P1357, DOI 10.1038/mt.2010.85; Bernardi P, 1999, PHYSIOL REV, V79, P1127, DOI 10.1152/physrev.1999.79.4.1127; Bernsel A, 2009, NUCLEIC ACIDS RES, V37, pW465, DOI 10.1093/nar/gkp363; CARAFOLI E, 1971, BIOCHEM J, V122, P681, DOI 10.1042/bj1220681; CHANCE B, 1955, J BIOL CHEM, V217, P383; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; DELUCA HF, 1961, P NATL ACAD SCI USA, V47, P1744, DOI 10.1073/pnas.47.11.1744; DENTON R M, 1980, Biochemical Society Transactions, V8, P266; Gohil VM, 2010, NAT BIOTECHNOL, V28, P249, DOI 10.1038/nbt.1606; GUNTER KK, 1994, J BIOENERG BIOMEMBR, V26, P471, DOI 10.1007/BF00762732; Kirichok Y, 2004, NATURE, V427, P360, DOI 10.1038/nature02246; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lattin Jane E, 2008, Immunome Res, V4, P5, DOI 10.1186/1745-7580-4-5; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; MOORE CL, 1971, BIOCHEM BIOPH RES CO, V42, P298, DOI 10.1016/0006-291X(71)90102-1; Musunuru K, 2010, NATURE, V466, P714, DOI 10.1038/nature09266; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Pellegrini M, 1999, P NATL ACAD SCI USA, V96, P4285, DOI 10.1073/pnas.96.8.4285; Perocchi F, 2010, NATURE, V467, P291, DOI 10.1038/nature09358; Rebres RA, 2011, J BIOL CHEM, V286, P942, DOI 10.1074/jbc.M110.198200; RIZZUTO R, 1992, NATURE, V358, P325, DOI 10.1038/358325a0; Ryan MT, 2001, METHOD CELL BIOL, V65, P189, DOI 10.1016/S0091-679X(01)65012-X; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Semple SC, 2010, NAT BIOTECHNOL, V28, P172, DOI 10.1038/nbt.1602; Territo PR, 2000, AM J PHYSIOL-CELL PH, V278, pC423, DOI 10.1152/ajpcell.2000.278.2.C423; VASINGTON FD, 1962, J BIOL CHEM, V237, P2670; YING WL, 1991, BIOCHEMISTRY-US, V30, P4949, DOI 10.1021/bi00234a016	28	1265	1289	2	135	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 18	2011	476	7360					341	U111		10.1038/nature10234	http://dx.doi.org/10.1038/nature10234			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811JV	21685886	Green Accepted			2022-12-24	WOS:000294206500040
J	Block, BA; Jonsen, ID; Jorgensen, SJ; Winship, AJ; Shaffer, SA; Bograd, SJ; Hazen, EL; Foley, DG; Breed, GA; Harrison, AL; Ganong, JE; Swithenbank, A; Castleton, M; Dewar, H; Mate, BR; Shillinger, GL; Schaefer, KM; Benson, SR; Weise, MJ; Henry, RW; Costa, DP				Block, B. A.; Jonsen, I. D.; Jorgensen, S. J.; Winship, A. J.; Shaffer, S. A.; Bograd, S. J.; Hazen, E. L.; Foley, D. G.; Breed, G. A.; Harrison, A. -L.; Ganong, J. E.; Swithenbank, A.; Castleton, M.; Dewar, H.; Mate, B. R.; Shillinger, G. L.; Schaefer, K. M.; Benson, S. R.; Weise, M. J.; Henry, R. W.; Costa, D. P.			Tracking apex marine predator movements in a dynamic ocean	NATURE			English	Article							PACIFIC-OCEAN; BLUEFIN TUNA; MORTALITY; HABITAT; SHARKS; FISH; POPULATION; RESOURCES; MIGRATION; TURTLES	Pelagic marine predators face unprecedented challenges and uncertain futures. Overexploitation and climate variability impact the abundance and distribution of top predators in ocean ecosystems(1-4). Improved understanding of ecological patterns, evolutionary constraints and ecosystem function is critical for preventing extinctions, loss of biodiversity and disruption of ecosystem services. Recent advances in electronic tagging techniques have provided the capacity to observe the movements and long-distance migrations of animals in relation to ocean processes across a range of ecological scales(5,6). Tagging of Pacific Predators, a field programme of the Census of Marine Life, deployed 4,306 tags on 23 species in the North Pacific Ocean, resulting in a tracking data set of unprecedented scale and species diversity that covers 265,386 tracking days from 2000 to 2009. Here we report migration pathways, link ocean features to multispecies hotspots and illustrate niche partitioning within and among congener guilds. Our results indicate that the California Current large marine ecosystem and the North Pacific transition zone attract and retain a diverse assemblage of marine vertebrates. Within the California Current large marine ecosystem, several predator guilds seasonally undertake north-south migrations that may be driven by oceanic processes, species-specific thermal tolerances and shifts in prey distributions. We identify critical habitats across multinational boundaries and show that top predators exploit their environment in predictable ways, providing the foundation for spatial management of large marine ecosystems.	[Block, B. A.; Jorgensen, S. J.; Ganong, J. E.; Swithenbank, A.; Castleton, M.; Shillinger, G. L.] Stanford Univ, Hopkins Marine Stn, Dept Biol, Pacific Grove, CA 93950 USA; [Jonsen, I. D.; Winship, A. J.; Breed, G. A.] Dalhousie Univ, Dept Biol, Halifax, NS B3H 4J1, Canada; [Shaffer, S. A.] San Jose State Univ, Dept Biol Sci, San Jose, CA 95192 USA; [Bograd, S. J.; Hazen, E. L.; Foley, D. G.] NOAA, SW Fisheries Sci Ctr, Div Environm Res, Pacific Grove, CA 93950 USA; [Breed, G. A.; Harrison, A. -L.; Weise, M. J.; Henry, R. W.; Costa, D. P.] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Long Marine Lab, Santa Cruz, CA 95060 USA; [Dewar, H.] NOAA, SW Fisheries Sci Ctr, Fisheries Res Div, La Jolla, CA 92037 USA; [Mate, B. R.] Oregon State Univ, Hatfield Marine Sci Ctr, Newport, OR 97365 USA; [Schaefer, K. M.] Interamer Trop Tuna Commiss, La Jolla, CA 92037 USA; [Benson, S. R.] NOAA, SW Fisheries Sci Ctr, Protected Resources Div, La Jolla, CA 92037 USA	Stanford University; Dalhousie University; California State University System; San Jose State University; National Oceanic Atmospheric Admin (NOAA) - USA; University of California System; University of California Santa Cruz; National Oceanic Atmospheric Admin (NOAA) - USA; Oregon State University; National Oceanic Atmospheric Admin (NOAA) - USA	Block, BA (corresponding author), Stanford Univ, Hopkins Marine Stn, Dept Biol, Pacific Grove, CA 93950 USA.	bblock@stanford.edu	Bograd, Steven/AAA-4824-2021; Hazen, Elliott/G-4149-2014; Shaffer, Scott A/D-5015-2009; Costa, Daniel/E-2616-2013	Hazen, Elliott/0000-0002-0412-7178; Shaffer, Scott A/0000-0002-7751-5059; Costa, Daniel/0000-0002-0233-5782; Harrison, Autumn-Lynn/0000-0002-6213-1765; Jonsen, Ian/0000-0001-5423-6076	Sloan Foundation; Packard Foundation; Moore Foundation; Office of Naval Research; NOAA; E&P Sound and Marine Life JIP under the OGP; Monterey Bay Aquarium Foundation	Sloan Foundation(Alfred P. Sloan Foundation); Packard Foundation(The David & Lucile Packard Foundation); Moore Foundation(Gordon and Betty Moore Foundation); Office of Naval Research(Office of Naval Research); NOAA(National Oceanic Atmospheric Admin (NOAA) - USA); E&P Sound and Marine Life JIP under the OGP; Monterey Bay Aquarium Foundation	This manuscript is the culmination of a Census of Marine Life cross project synthesis between TOPP and Future of Marine Animal Populations (FMAP). Funding for this work was provided by the Sloan Foundation's Census of Marine Life programme. TOPP research was funded by the Sloan, Packard and Moore foundations. FMAP was funded by the Sloan Foundation. Electronic tagging and tracking in TOPP was also supported by the Office of Naval Research, the NOAA, the E&P Sound and Marine Life JIP under contract from the OGP, and the Monterey Bay Aquarium Foundation. We thank the TOPP scientific teams and all those who supported animal tagging efforts, R. Kochevar and D. Kohrs for their dedication and their effort on behalf of the Census of Marine Life. We are grateful to the numerous captains and crews who provided ship time and logistical support and to the US Fish and Wildlife Service in Hawaii for further logistical support. We thank the Mexican authorities and collaborating TOPP partners (O. Sosa-Nishizki) for permitting and assisting in research in their waters. All animal research was conducted in accordance with IACUC protocols from Stanford University and the University of California.	Bailey Helen, 2010, Endangered Species Research, V10, P93, DOI 10.3354/esr00239; Berman-Kowalewski M, 2010, AQUAT MAMM, V36, P59, DOI 10.1578/AM.36.1.2010.59; Campana SE, 2002, N AM J FISH MANAGE, V22, P106, DOI 10.1577/1548-8675(2002)022<0106:PDOTPI>2.0.CO;2; Chavez FP, 2003, SCIENCE, V299, P217, DOI 10.1126/science.1075880; Costa DP, 2010, INTEGR COMP BIOL, V50, P1018, DOI 10.1093/icb/icq054; Halpern BS, 2009, CONSERV LETT, V2, P138, DOI 10.1111/j.1755-263X.2009.00058.x; Hays GC, 2003, MAR ECOL PROG SER, V262, P305, DOI 10.3354/meps262305; Heupel MR, 2002, CAN J FISH AQUAT SCI, V59, P624, DOI 10.1139/F02-036; Jonsen ID, 2005, ECOLOGY, V86, P2874, DOI 10.1890/04-1852; Jorgensen SJ, 2010, P ROY SOC B-BIOL SCI, V277, P679, DOI 10.1098/rspb.2009.1155; Kurota H, 2009, CAN J FISH AQUAT SCI, V66, P321, DOI 10.1139/F08-197; Lewison RL, 2003, ECOL APPL, V13, P743, DOI 10.1890/1051-0761(2003)013[0743:EFBAEO]2.0.CO;2; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; Peckham SH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001041; PICES, 2004, PICES SPEC PUBL, V1; Polovina JJ, 2001, PROG OCEANOGR, V49, P469, DOI 10.1016/S0079-6611(01)00036-2; Prince ED, 2006, FISH OCEANOGR, V15, P451, DOI 10.1111/j.1365-2419.2005.00393.x; Robinson Robert A., 2009, Endangered Species Research, V7, P87, DOI 10.3354/esr00095; Scheffer M, 2005, TRENDS ECOL EVOL, V20, P579, DOI 10.1016/j.tree.2005.08.018; Shaffer SA, 2006, P NATL ACAD SCI USA, V103, P12799, DOI 10.1073/pnas.0603715103; Shiels HA, 2011, P ROY SOC B-BIOL SCI, V278, P18, DOI 10.1098/rspb.2010.1274; Shillinger GL, 2008, PLOS BIOL, V6, P1408, DOI 10.1371/journal.pbio.0060171; Sibert J, 2006, SCIENCE, V314, P1773, DOI 10.1126/science.1135347; Springer AM, 2003, P NATL ACAD SCI USA, V100, P12223, DOI 10.1073/pnas.1635156100; STEELE JH, 1994, PHILOS T ROY SOC B, V343, P5, DOI 10.1098/rstb.1994.0001; Swain DP, 2008, CAN J FISH AQUAT SCI, V65, P2315, DOI 10.1139/F08-175; Tittensor DP, 2010, NATURE, V466, P1098, DOI 10.1038/nature09329; Weng KC, 2005, SCIENCE, V310, P104, DOI 10.1126/science.1114616; Whitehead H, 2008, ECOL LETT, V11, P1198, DOI 10.1111/j.1461-0248.2008.01234.x; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279	30	852	868	10	587	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 7	2011	475	7354					86	90		10.1038/nature10082	http://dx.doi.org/10.1038/nature10082			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	788RE	21697831				2022-12-24	WOS:000292461300050
J	Stefater, JA; Lewkowich, I; Rao, S; Mariggi, G; Carpenter, AC; Burr, AR; Fan, JQ; Ajima, R; Molkentin, JD; Williams, BO; Wills-Karp, M; Pollard, JW; Yamaguchi, T; Ferrara, N; Gerhardt, H; Lang, RA				Stefater, James A., III; Lewkowich, Ian; Rao, Sujata; Mariggi, Giovanni; Carpenter, April C.; Burr, Adam R.; Fan, Jieqing; Ajima, Rieko; Molkentin, Jeffery D.; Williams, Bart O.; Wills-Karp, Marsha; Pollard, Jeffrey W.; Yamaguchi, Terry; Ferrara, Napoleone; Gerhardt, Holger; Lang, Richard A.			Regulation of angiogenesis by a non-canonical Wnt-Flt1 pathway in myeloid cells	NATURE			English	Article							ENDOTHELIAL GROWTH-FACTOR; RETINAL NEOVASCULARIZATION; MOUSE; MECHANISM; VASCULATURE; MACROPHAGES; TUMORIGENESIS; HETEROGENEITY; INHIBITION; RECEPTOR-1	Myeloid cells are a feature of most tissues. Here we show that during development, retinal myeloid cells (RMCs) produce Wnt ligands to regulate blood vessel branching. In the mouse retina, where angiogenesis occurs postnatally(1), somatic deletion in RMCs of the Wnt ligand transporter Wntless(2,3) results in increased angiogenesis in the deeper layers. We also show that mutation of Wnt5a and Wnt11 results in increased angiogenesis and that these ligands elicit RMC responses via a non-canonical Wnt pathway. Using cultured myeloid-like cells and RMC somatic deletion of Flt1, we show that an effector of Wnt-dependent suppression of angiogenesis by RMCs is Flt1, a naturally occurring inhibitor of vascular endothelial growth factor (VEGF)(4-6). These findings indicate that resident myeloid cells can use a non-canonical, Wnt-Flt1 pathway to suppress angiogenic branching.	[Stefater, James A., III; Rao, Sujata; Carpenter, April C.; Fan, Jieqing; Lang, Richard A.] Cincinnati Childrens Hosp, Visual Syst Grp, Div Pediat Ophthalmol, Med Ctr, Cincinnati, OH 45229 USA; [Stefater, James A., III; Rao, Sujata; Carpenter, April C.; Fan, Jieqing; Lang, Richard A.] Cincinnati Childrens Hosp, Div Dev Biol, Med Ctr, Cincinnati, OH 45229 USA; [Stefater, James A., III; Rao, Sujata] Univ Cincinnati, Dept Ophthalmol, Cincinnati, OH 45229 USA; [Lewkowich, Ian; Wills-Karp, Marsha] Cincinnati Childrens Hosp, Div Immunobiol, Med Ctr, Cincinnati, OH 45229 USA; [Mariggi, Giovanni; Gerhardt, Holger] Canc Res UK, Vasc Biol Lab, London Res Inst, London WC2 3PX, England; [Burr, Adam R.; Molkentin, Jeffery D.] Univ Cincinnati, Div Mol Cardiovasc Biol, Cincinnati Childrens Hosp, Med Ctr, Cincinnati, OH 45229 USA; [Ajima, Rieko; Yamaguchi, Terry] NCI, Canc & Dev Biol Lab, Frederick, MD 21701 USA; [Molkentin, Jeffery D.] Univ Cincinnati, Med Ctr, Howard Hughes Med Inst, Cincinnati Childrens Hosp, Cincinnati, OH 45229 USA; [Williams, Bart O.] Van Andel Res Inst, Ctr Skeletal Dis Res, Grand Rapids, MI 49503 USA; [Pollard, Jeffrey W.] Yeshiva Univ, Albert Einstein Coll Med, Bronx, NY 10461 USA; [Ferrara, Napoleone] Genentech Inc, San Francisco, CA 94080 USA; [Gerhardt, Holger] VIB, Vasc Patterning Lab, Vesalius Res Ctr, B-3000 Louvain, Belgium	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cancer Research UK; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Cincinnati Children's Hospital Medical Center; Howard Hughes Medical Institute; University System of Ohio; University of Cincinnati; Van Andel Institute; Yeshiva University; Albert Einstein College of Medicine; Roche Holding; Genentech; Flanders Institute for Biotechnology (VIB)	Lang, RA (corresponding author), Cincinnati Childrens Hosp, Visual Syst Grp, Div Pediat Ophthalmol, Med Ctr, Cincinnati, OH 45229 USA.	richard.lang@cchmc.org	Lang, Richard/E-5578-2011; Burr, Adam/AAU-2980-2020; Williams, Bart/A-3539-2013; Gerhardt, Holger/G-4610-2011; Gerhardt, Holger/G-4610-2011	Williams, Bart/0000-0002-5261-5301; Gerhardt, Holger/0000-0002-3030-0384; Gerhardt, Holger/0000-0001-9228-7472; Lang, Richard/0000-0002-5212-254X; Molkentin, Jeffery/0000-0002-3558-6529	NIH; HHMI; Cancer Research UK; MRC [G1002033] Funding Source: UKRI; Medical Research Council [G1002033] Funding Source: researchfish; NATIONAL EYE INSTITUTE [R01EY015766] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053293] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI(Howard Hughes Medical Institute); Cancer Research UK(Cancer Research UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank P. Speeg for technical assistance and A. P. McMahon for the Wnt11 mice. This work was supported by the NIH (J.A.S., M.W-K., J.W.P., J.D.M., T.Y., B.O.W., R.A.L.) by the HHMI (J.D.M.) and Cancer Research UK (H.G.).	Ambati BK, 2006, NATURE, V443, P993, DOI 10.1038/nature05249; Behringer R, 2003, MANIPULATING MOUSE E, P371; Blumenthal A, 2006, BLOOD, V108, P965, DOI 10.1182/blood-2005-12-5046; Bryja V, 2009, MOL BIOL CELL, V20, P924, DOI 10.1091/mbc.E08-07-0711; Carpenter AC, 2010, GENESIS, V48, P554, DOI 10.1002/dvg.20651; Chan CK, 2005, LAB INVEST, V85, P721, DOI 10.1038/labinvest.3700277; Chan CK, 2004, INVEST OPHTH VIS SCI, V45, P441, DOI 10.1167/iovs.03-0869; Chappell JC, 2009, DEV CELL, V17, P377, DOI 10.1016/j.devcel.2009.07.011; Ching W, 2006, CELL, V125, P432, DOI 10.1016/j.cell.2006.04.018; Deng L, 2010, AM J PATHOL, V176, P952, DOI 10.2353/ajpath.2010.090622; Fantin A, 2010, BLOOD, V116, P829, DOI 10.1182/blood-2009-12-257832; Gao GQ, 2002, DIABETES, V51, P1218, DOI 10.2337/diabetes.51.4.1218; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Grumolato L, 2010, GENE DEV, V24, P2517, DOI 10.1101/gad.1957710; Grunewald M, 2006, CELL, V124, P175, DOI 10.1016/j.cell.2005.10.036; Haigh JJ, 2003, DEV BIOL, V262, P225, DOI 10.1016/S0012-1606(03)00356-7; KENDALL RL, 1993, P NATL ACAD SCI USA, V90, P10705, DOI 10.1073/pnas.90.22.10705; Kubota Y, 2009, J EXP MED, V206, P1089, DOI 10.1084/jem.20081605; Lichtenberger BM, 2010, CELL, V140, P268, DOI 10.1016/j.cell.2009.12.046; Lin EY, 2007, CANCER RES, V67, P5064, DOI 10.1158/0008-5472.CAN-07-0912; Lin SL, 2010, P NATL ACAD SCI USA, V107, P4194, DOI 10.1073/pnas.0912228107; Lobov IB, 2005, NATURE, V437, P417, DOI 10.1038/nature03928; Machnik A, 2009, NAT MED, V15, P545, DOI 10.1038/nm.1960; Majumdar A, 2003, DEVELOPMENT, V130, P3175, DOI 10.1242/dev.00520; Martin P, 2003, CURR BIOL, V13, P1122, DOI 10.1016/S0960-9822(03)00396-8; Mendes-Jorge L, 2009, INVEST OPHTH VIS SCI, V50, P5997, DOI 10.1167/iovs.09-3515; Novak A, 2000, GENESIS, V28, P147, DOI 10.1002/1526-968X(200011/12)28:3/4<147::AID-GENE90>3.0.CO;2-G; Pipp F, 2003, CIRC RES, V92, P378, DOI 10.1161/01.RES.0000057997.77714.72; Rohan RM, 2000, FASEB J, V14, P871, DOI 10.1096/fasebj.14.7.871; Saint-Geniez M, 2004, INT J DEV BIOL, V48, P1045, DOI 10.1387/ijdb.041895ms; Seifert JRK, 2007, NAT REV GENET, V8, P126, DOI 10.1038/nrg2042; Shibuya M, 2001, INT J BIOCHEM CELL B, V33, P409, DOI 10.1016/S1357-2725(01)00026-7; Stockmann C, 2008, NATURE, V456, P814, DOI 10.1038/nature07445; Tauber AI, 2003, NAT REV MOL CELL BIO, V4, P897, DOI 10.1038/nrm1244; Yamaguchi TP, 1999, DEVELOPMENT, V126, P1211	35	195	198	1	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 23	2011	474	7352					511	515		10.1038/nature10085	http://dx.doi.org/10.1038/nature10085			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	781NJ	21623369	Green Accepted			2022-12-24	WOS:000291939700049
J	Cotta-Ramusino, C; McDonald, ER; Hurov, K; Sowa, ME; Harper, JW; Elledge, SJ				Cotta-Ramusino, Cecilia; McDonald, E. Robert, III; Hurov, Kristen; Sowa, Mathew E.; Harper, J. Wade; Elledge, Stephen J.			A DNA Damage Response Screen Identifies RHINO, a 9-1-1 and TopBP1 Interacting Protein Required for ATR Signaling	SCIENCE			English	Article							REPAIR; PARTICIPATE; CHECKPOINT; COMPLEXES	The DNA damage response (DDR) is brought about by a protein kinase cascade that orchestrates DNA repair through transcriptional and posttranslational mechanisms. Cell cycle arrest is a hallmark of the DDR. We screened for cells that lacked damage-induced cell cycle arrest and uncovered a critical role for Fanconi anemia and homologous recombination proteins in ATR (ataxia telangiectasia and Rad3-related) signaling. Three DDR candidates, the RNA processing protein INTS7, the circadian transcription factor CLOCK, and a previously uncharacterized protein RHINO, were recruited to sites of DNA damage. RHINO independently bound the Rad9-Rad1-Hus1 complex (9-1-1) and the ATR activator TopBP1. RHINO was recruited to sites of DNA damage by the 9-1-1 complex to promote Chk1 activation. We suggest that RHINO functions together with the 9-1-1 complex and TopBP1 to fully activate ATR.	[Cotta-Ramusino, Cecilia; McDonald, E. Robert, III; Hurov, Kristen; Elledge, Stephen J.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Howard Hughes Med Inst,Div Genet,Dept Genet, Boston, MA 02115 USA; [Sowa, Mathew E.; Harper, J. Wade] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School	Elledge, SJ (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Howard Hughes Med Inst,Div Genet,Dept Genet, Boston, MA 02115 USA.	selledge@genetics.med.harvard.edu		Harper, Jeffrey/0000-0002-6944-7236	NIH; European Molecular Biology Organization; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054137, R37GM044664] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG011085] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank the Institute of Chemistry and Cell Biology-Longwood for screening assistance. We also thank K. Hofmann, A. Ciccia, A. Bredemeyer, B. Adamson, A. Burrows, A. Smogorzewska, and A. Brass for helpful discussions. This work was supported by NIH grants to S.J.E. and J.W.H. C. C. R. is the recipient of a long-term European Molecular Biology Organization fellowship. S.J.E. is a Howard Hughes Medical Institute investigator. W. H. is a paid consultant for Millennium Pharmaceuticals and its program in oncology.	Adamo A, 2010, MOL CELL, V39, P25, DOI 10.1016/j.molcel.2010.06.026; Baillat D, 2005, CELL, V123, P265, DOI 10.1016/j.cell.2005.08.019; Bartek J, 2007, CURR OPIN CELL BIOL, V19, P238, DOI 10.1016/j.ceb.2007.02.009; Bouwman P, 2010, NAT STRUCT MOL BIOL, V17, P688, DOI 10.1038/nsmb.1831; Bunting SF, 2010, CELL, V141, P243, DOI 10.1016/j.cell.2010.03.012; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Collis SJ, 2007, CHROMOSOMA, V116, P331, DOI 10.1007/s00412-007-0108-6; Delacroix S, 2007, GENE DEV, V21, P1472, DOI 10.1101/gad.1547007; Gorbacheva VY, 2005, P NATL ACAD SCI USA, V102, P3407, DOI 10.1073/pnas.0409897102; Huang J, 2009, MOL CELL, V35, P384, DOI 10.1016/j.molcel.2009.06.011; Iyer LM, 2002, GENOME BIOL, V3; Kumagai A, 2006, CELL, V124, P943, DOI 10.1016/j.cell.2005.12.041; Lee J, 2010, MOL BIOL CELL, V21, P926, DOI 10.1091/mbc.E09-11-0958; Li YJ, 2009, J BIOL CHEM, V284, P23525, DOI 10.1074/jbc.C109.039586; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Pace P, 2010, SCIENCE, V329, P219, DOI 10.1126/science.1192277; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Stokes MP, 2007, P NATL ACAD SCI USA, V104, P19855, DOI 10.1073/pnas.0707579104; Yarden RI, 2002, NAT GENET, V30, P285, DOI 10.1038/ng837	21	145	161	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 10	2011	332	6035					1313	1317		10.1126/science.1203430	http://dx.doi.org/10.1126/science.1203430			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	775EP	21659603	Green Accepted			2022-12-24	WOS:000291441700043
J	Hayden, EJ; Ferrada, E; Wagner, A				Hayden, Eric J.; Ferrada, Evandro; Wagner, Andreas			Cryptic genetic variation promotes rapid evolutionary adaptation in an RNA enzyme	NATURE			English	Article							GROUP-I RIBOZYME; PROTEIN; EVOLVABILITY; STABILITY; EPISTASIS; MECHANISM; AZOARCUS; INTRON; VITRO; CORE	Cryptic variation is caused by the robustness of phenotypes to mutations(1). Cryptic variation has no effect on phenotypes in a given genetic or environmental background, but it can have effects after mutations or environmental change(2-5). Because evolutionary adaptation by natural selection requires phenotypic variation, phenotypically revealed cryptic genetic variation may facilitate evolutionary adaptation(6-8). This is possible if the cryptic variation happens to be pre-adapted, or "exapted"(9), to a new environment, and is thus advantageous once revealed. However, this facilitating role for cryptic variation has not been proven, partly because most pertinent work focuses on complex phenotypes of whole organisms whose genetic basis is incompletely understood. Here we show that populations of RNA enzymes with accumulated cryptic variation adapt more rapidly to a new substrate than a population without cryptic variation. A detailed analysis of our evolving RNA populations in genotype space shows that cryptic variation allows a population to explore new genotypes that become adaptive only in a new environment. Our observations show that cryptic variation contains new genotypes pre-adapted to a changed environment. Our results highlight the positive role that robustness and epistasis can have in adaptive evolution(10,11).	[Hayden, Eric J.; Ferrada, Evandro; Wagner, Andreas] Univ Zurich, Inst Evolutionary Biol & Environm Studies, CH-8057 Zurich, Switzerland; [Hayden, Eric J.; Ferrada, Evandro; Wagner, Andreas] Swiss Inst Bioinformat, CH-1015 Lausanne, Switzerland; [Wagner, Andreas] Santa Fe Inst, Santa Fe, NM 87501 USA	University of Zurich; Swiss Institute of Bioinformatics; The Santa Fe Institute	Wagner, A (corresponding author), Univ Zurich, Inst Evolutionary Biol & Environm Studies, CH-8057 Zurich, Switzerland.	andreas.wagner@ieu.uzh.ch		Ferrada, Evandro/0000-0003-3242-1726	Swiss National Science Foundation [315200-116814, 315200-119697, 315230-129708]; SystemsX.ch; University of Zurich	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); SystemsX.ch; University of Zurich	We thank R. Dhar and N. de la Chaux for bioinformatic support. We thank the Functional Genomics Center, Zurich, for collecting sequence data. We acknowledge support from Swiss National Science Foundation grants 315200-116814, 315200-119697 and 315230-129708, from the YeastX program of SystemsX.ch, and from the Research Priority Program in Systems Biology at the University of Zurich.	Aharoni A, 2005, NAT GENET, V37, P73, DOI 10.1038/ng1482; BEAUDRY AA, 1992, SCIENCE, V257, P635, DOI 10.1126/science.1496376; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blake RD, 1996, NUCLEIC ACIDS RES, V24, P2095, DOI 10.1093/nar/24.11.2095; Bloom JD, 2006, P NATL ACAD SCI USA, V103, P5869, DOI 10.1073/pnas.0510098103; BREAKER RR, 1994, TRENDS BIOTECHNOL, V12, P268, DOI 10.1016/0167-7799(94)90138-4; Cadwell R C, 1992, PCR Methods Appl, V2, P28, DOI 10.1101/gr.2.1.28; Eckert K A, 1991, PCR Methods Appl, V1, P17; Gibson G, 2004, NAT REV GENET, V5, P681, DOI 10.1038/nrg1426; GOULD SJ, 1982, PALEOBIOLOGY, V8, P4, DOI 10.1017/S0094837300004310; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hanczyc MM, 1998, RNA, V4, P268; Hartl D.L., 1997, PRINCIPLES POPULATIO, V3rd ed.; Hermisson J, 2004, GENETICS, V168, P2271, DOI 10.1534/genetics.104.029173; Kondrashov FA, 2001, P NATL ACAD SCI USA, V98, P12089, DOI 10.1073/pnas.211214298; Kuo LY, 1999, BBA-GENE STRUCT EXPR, V1489, P281, DOI 10.1016/S0167-4781(99)00200-6; Lawrence MS, 2005, RNA, V11, P1173, DOI 10.1261/rna.2110905; Le Rouzic A, 2008, TRENDS ECOL EVOL, V23, P33, DOI 10.1016/j.tree.2007.09.014; LEHMAN N, 1993, NATURE, V361, P182, DOI 10.1038/361182a0; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Masel J, 2006, GENETICS, V172, P1985, DOI 10.1534/genetics.105.051649; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; O'Brien PJ, 1999, CHEM BIOL, V6, pR91, DOI 10.1016/S1074-5521(99)80033-7; Ouellet J, 2009, RNA, V15, P1822, DOI 10.1261/rna.1759009; Pan J, 1998, J MOL BIOL, V280, P597, DOI 10.1006/jmbi.1998.1901; Rangan P, 2003, P NATL ACAD SCI USA, V100, P1574, DOI 10.1073/pnas.0337743100; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Rutherford SL, 2000, BIOESSAYS, V22, P1095, DOI 10.1002/1521-1878(200012)22:12&lt;1095::AID-BIES7&gt;3.0.CO;2-A; Rydzanicz R, 2005, NUCLEIC ACIDS RES, V33, pW521, DOI 10.1093/nar/gki380; Stahley MR, 2005, SCIENCE, V309, P1587, DOI 10.1126/science.1114994; Tanner MA, 1996, RNA, V2, P74; True HL, 2000, NATURE, V407, P477, DOI 10.1038/35035005; WADDINGTON CH, 1953, EVOLUTION, V7, P118, DOI 10.2307/2405747; Wagner A., 2005, ROBUSTNESS EVOLVABIL; Weinreich DM, 2006, SCIENCE, V312, P111, DOI 10.1126/science.1123539; Wilke CO, 2003, BMC EVOL BIOL, V3, DOI 10.1186/1471-2148-3-3; Yu W, 2006, BIOTECHNIQUES, V40, P499, DOI 10.2144/000112124	37	158	163	0	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 2	2011	474	7349					92	U120		10.1038/nature10083	http://dx.doi.org/10.1038/nature10083			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	771KV	21637259	Green Accepted			2022-12-24	WOS:000291156700044
J	Mac Donald, CL; Johnson, AM; Cooper, D; Nelson, EC; Werner, NJ; Shimony, JS; Snyder, AZ; Raichle, ME; Witherow, JR; Fang, R; Flaherty, SF; Brody, DL				Mac Donald, Christine L.; Johnson, Ann M.; Cooper, Dana; Nelson, Elliot C.; Werner, Nicole J.; Shimony, Joshua S.; Snyder, Abraham Z.; Raichle, Marcus E.; Witherow, John R.; Fang, Raymond; Flaherty, Stephen F.; Brody, David L.			Detection of Blast-Related Traumatic Brain Injury in U.S. Military Personnel	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DIFFUSE AXONAL INJURY; AMYLOID PRECURSOR PROTEIN; WHITE-MATTER INJURY; CLOSED-HEAD INJURY; MILD; VETERANS; MEMORY; MODEL; TIME; IRAQ	Background Blast-related traumatic brain injuries have been common in the Iraq and Afghanistan wars, but fundamental questions about the nature of these injuries remain unanswered. Methods We tested the hypothesis that blast-related traumatic brain injury causes traumatic axonal injury, using diffusion tensor imaging (DTI), an advanced form of magnetic resonance imaging that is sensitive to axonal injury. The subjects were 63 U. S. military personnel who had a clinical diagnosis of mild, uncomplicated traumatic brain injury. They were evacuated from the field to the Landstuhl Regional Medical Center in Landstuhl, Germany, where they underwent DTI scanning within 90 days after the injury. All the subjects had primary blast exposure plus another, blast-related mechanism of injury (e. g., being struck by a blunt object or injured in a fall or motor vehicle crash). Controls consisted of 21 military personnel who had blast exposure and other injuries but no clinical diagnosis of traumatic brain injury. Results Abnormalities revealed on DTI were consistent with traumatic axonal injury in many of the subjects with traumatic brain injury. None had detectible intracranial injury on computed tomography. As compared with DTI scans in controls, the scans in the subjects with traumatic brain injury showed marked abnormalities in the middle cerebellar peduncles (P<0.001), in cingulum bundles (P=0.002), and in the right orbitofrontal white matter (P=0.007). In 18 of the 63 subjects with traumatic brain injury, a significantly greater number of abnormalities were found on DTI than would be expected by chance (P<0.001). Follow-up DTI scans in 47 subjects with traumatic brain injury 6 to 12 months after enrollment showed persistent abnormalities that were consistent with evolving injuries. Conclusions DTI findings in U. S. military personnel support the hypothesis that blast-related mild traumatic brain injury can involve axonal injury. However, the contribution of primary blast exposure as compared with that of other types of injury could not be determined directly, since none of the subjects with traumatic brain injury had isolated primary blast injury. Furthermore, many of these subjects did not have abnormalities on DTI. Thus, traumatic brain injury remains a clinical diagnosis. (Funded by the Congressionally Directed Medical Research Program and the National Institutes of Health; ClinicalTrials.gov number, NCT00785304.)	[Brody, David L.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Witherow, John R.; Fang, Raymond; Flaherty, Stephen F.] Landstuhl Reg Med Ctr, Landstuhl, Germany; [Flaherty, Stephen F.] Walter Reed Army Med Ctr, Washington, DC 20307 USA	Washington University (WUSTL); Landstuhl Regional Medical Center; United States Department of Defense; United States Army; Walter Reed National Military Medical Center	Brody, DL (corresponding author), Washington Univ, Sch Med, Dept Neurol, Biotech Bldg,Rm 201,660 S Euclid Ave,Box 8111, St Louis, MO 63110 USA.	brodyd@neuro.wustl.edu			Congressionally Directed Medical Research Program [W81XWH-08-2-0061]; National Institutes of Health [F32NS062529, 5K23HD053212, P30NS048056, P50NS06833, 5K08NS49237]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K23HD053212] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS006833, F32NS062529, P30NS048056, K08NS049237] Funding Source: NIH RePORTER	Congressionally Directed Medical Research Program(United States Department of Defense); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by a grant from the Congressionally Directed Medical Research Program (W81XWH-08-2-0061, to Dr. Brody) and the National Institutes of Health (F32NS062529, to Dr. Mac Donald; 5K23HD053212, to Dr. Shimony; P30NS048056, to Dr. Snyder; P50NS06833, to Drs. Raichle and Snyder; and 5K08NS49237, to Dr. Brody.)	ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Bauman RA, 2009, J NEUROTRAUM, V26, P841, DOI [10.1089/neu.2008.0898, 10.1089/neu.2009-0898]; Benzinger TLS, 2009, J NEUROTRAUM, V26, P2127, DOI [10.1089/neu.2009.0885, 10.1089/neu.2009-0885]; BLUMBERGS PC, 1989, J NEUROL NEUROSUR PS, V52, P838, DOI 10.1136/jnnp.52.7.838; BLUMBERGS PC, 1994, LANCET, V344, P1055, DOI 10.1016/S0140-6736(94)91712-4; BLUMBERGS PC, 1995, J NEUROTRAUM, V12, P565, DOI 10.1089/neu.1995.12.565; Carlson KF, 2011, J HEAD TRAUMA REHAB, V26, P103, DOI 10.1097/HTR.0b013e3181e50ef1; Carlson KF, 2010, J TRAUMA STRESS, V23, P17, DOI 10.1002/jts.20483; Casscells S.W., 2007, TRAUMATIC BRAIN INJU; Chafi MS, 2010, ANN BIOMED ENG, V38, P490, DOI 10.1007/s10439-009-9813-z; Chemtob CM, 1998, J NERV MENT DIS, V186, P701, DOI 10.1097/00005053-199811000-00007; Dempsey Kenneth E, 2009, J Trauma Nurs, V16, P6, DOI 10.1097/01.JTN.0000348063.41099.a7; Geary EK, 2010, J INT NEUROPSYCH SOC, V16, P506, DOI 10.1017/S135561771000010X; GURDJIAN ES, 1976, J TRAUMA, V16, P35, DOI 10.1097/00005373-197601000-00005; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Jones E, 2007, AM J PSYCHIAT, V164, P1641, DOI 10.1176/appi.ajp.2007.07071180; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Levin HS, 2010, J NEUROTRAUM, V27, P683, DOI 10.1089/neu.2009.1073; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; Lipton ML, 2008, J NEUROTRAUM, V25, P1335, DOI 10.1089/neu.2008.0547; Luethcke CA, 2011, J INT NEUROPSYCH SOC, V17, P36, DOI 10.1017/S1355617710001207; Mac Donald CL, 2007, EXP NEUROL, V205, P116, DOI 10.1016/j.expneurol.2007.01.035; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; Mori S.W., 2005, MRI ATLAS HUMAN WHIT; Mott FW, 1917, J ROY ARMY MED CORPS, V29, P662; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Niogi SN, 2008, BRAIN, V131, P3209, DOI 10.1093/brain/awn247; Perlbarg V, 2009, HUM BRAIN MAPP, V30, P3924, DOI 10.1002/hbm.20817; Peskind ER, 2011, NEUROIMAGE, V54, pS76, DOI 10.1016/j.neuroimage.2010.04.008; Pierpaoli C, 1996, RADIOLOGY, V201, P637, DOI 10.1148/radiology.201.3.8939209; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Singh M, 2010, MAGN RESON IMAGING, V28, P22, DOI 10.1016/j.mri.2009.05.049; STRICH SJ, 1956, J NEUROL NEUROSUR PS, V19, P163, DOI 10.1136/jnnp.19.3.163; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Taylor PA, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3118765; Vasterling JJ, 2000, J TRAUMA STRESS, V13, P441, DOI 10.1023/A:1007781107513; Wang JY, 2008, ARCH NEUROL-CHICAGO, V65, P619, DOI 10.1001/archneur.65.5.619; Warden DL, 2009, NEUROIMAGE, V47, pT152, DOI 10.1016/j.neuroimage.2009.01.060; Wilde EA, 2010, DEV NEUROPSYCHOL, V35, P333, DOI 10.1080/87565641003696940; Wu TC, 2010, J NEUROTRAUM, V27, P303, DOI 10.1089/neu.2009.1110	43	446	449	2	77	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 2	2011	364	22					2091	2100		10.1056/NEJMoa1008069	http://dx.doi.org/10.1056/NEJMoa1008069			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	772AB	21631321	Green Accepted, Bronze, Green Published			2022-12-24	WOS:000291200700007
J	Smith, TJ; Hillner, BE				Smith, Thomas J.; Hillner, Bruce E.			Bending the Cost Curve in Cancer Care	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CELL LUNG-CANCER; 2006 UPDATE; FEBRILE NEUTROPENIA; PALLIATIVE CARE; ONCOLOGY; LIFE; CHEMOTHERAPY; END; GUIDELINES; HEALTH		[Smith, Thomas J.] Virginia Commonwealth Univ, Div Hematol Oncol & Palliat Care, Richmond, VA 23284 USA; [Hillner, Bruce E.] Virginia Commonwealth Univ, Div Gen Internal Med, Richmond, VA 23284 USA; [Smith, Thomas J.; Hillner, Bruce E.] Virginia Commonwealth Univ, Massey Canc Ctr, Richmond, VA 23284 USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University	Smith, TJ (corresponding author), Virginia Commonwealth Univ, Div Hematol Oncol & Palliat Care, Richmond, VA 23284 USA.			Smith, Thomas/0000-0003-3040-6434	NCI NIH HHS [P30 CA006973] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA006973] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aaron HJ, 2009, HEALTH AFFAIR, V28, P1260, DOI 10.1377/hlthaff.28.5.1260; [Anonymous], 1996, J CLIN ONCOL, V14, P671; Azzoli CG, 2009, J CLIN ONCOL, V27, P6251, DOI 10.1200/JCO.2009.23.5622; Bach PB, 2009, NEW ENGL J MED, V360, P626, DOI 10.1056/NEJMhpr0807774; Blayney DW, 2009, J CLIN ONCOL, V27, P3802, DOI 10.1200/JCO.2008.21.6770; Bodenheimer T, 2007, ANN INTERN MED, V146, P301, DOI 10.7326/0003-4819-146-4-200702200-00011; Bohlius J., 2008, COCHRANE DB SYST REV, V4; Brickates Kennedy V, 2010, MARKETWATCH     1025; Brody H, 2010, NEW ENGL J MED, V362, P283, DOI 10.1056/NEJMp0911423; Brumley R, 2007, J AM GERIATR SOC, V55, P993, DOI 10.1111/j.1532-5415.2007.01234.x; Cardoso F, 2009, JNCI-J NATL CANCER I, V101, P1174, DOI 10.1093/jnci/djp235; Carlson RW, 2009, J NATL COMPR CANC NE, V7, P122, DOI 10.6004/jnccn.2009.0012; Carrick S, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003372.pub3; Chiew KS, 2008, HEALTH EXPECT, V11, P35, DOI 10.1111/j.1369-7625.2007.00470.x; Clement FM, 2009, JAMA-J AM MED ASSOC, V302, P1437, DOI 10.1001/jama.2009.1409; Connor SR, 2007, J PAIN SYMPTOM MANAG, V33, P238, DOI 10.1016/j.jpainsymman.2006.10.010; Donovan RJ, 2006, LANCET ONCOL, V7, P668, DOI 10.1016/S1470-2045(06)70794-X; Dow LA, 2010, J CLIN ONCOL, V28, P299, DOI 10.1200/JCO.2009.24.6397; Eastern Cooperative Oncology Group, ECOG PERF STAT; Elkin EB, 2010, JAMA-J AM MED ASSOC, V303, P1086, DOI 10.1001/jama.2010.283; Ettinger DS, 2010, J NATL COMPR CANC NE, V8, P740, DOI 10.6004/jnccn.2010.0056; Finn JW, 2002, P AN M AM SOC CLIN, V21, P1452; Fojo T, 2009, JNCI-J NATL CANCER I, V101, P1044, DOI 10.1093/jnci/djp177; Gade G, 2008, J PALLIAT MED, V11, P180, DOI 10.1089/jpm.2007.0055; Harrington SE, 2008, JAMA-J AM MED ASSOC, V299, P2667, DOI 10.1001/jama.299.22.2667; Hillner BE, 2009, J CLIN ONCOL, V27, P2111, DOI 10.1200/JCO.2008.21.0534; Hortobagyi GN, 2007, J CLIN ONCOL, V25, P1468, DOI 10.1200/JCO.2007.10.9397; Huskamp HA, 2009, ARCH INTERN MED, V169, P954, DOI 10.1001/archinternmed.2009.127; Jackson VA, 2008, J PALLIAT MED, V11, P893, DOI 10.1089/jpm.2007.2480; Jacobson JO, 2008, J CLIN ONCOL, V26, P1893, DOI 10.1200/JCO.2007.14.2992; Jacobson M, 2006, HEALTH AFFAIR, V25, P437, DOI 10.1377/hlthaff.25.2.437; Jacobson M, 2010, HEALTH AFFAIR, V29, P1391, DOI 10.1377/hlthaff.2009.0563; Johnson A, 2010, WALL STREET J   1019; Keating NL, 2010, CANCER-AM CANCER SOC, V116, P998, DOI 10.1002/cncr.24761; Kelly K, 2011, 1 LINE CHEMOTHERAPY; Khatcheressian JL, 2006, J CLIN ONCOL, V24, P5091, DOI 10.1200/JCO.2006.08.8575; Kuderer NM, 2007, J CLIN ONCOL, V25, P3158, DOI 10.1200/JCO.2006.08.8823; Levy AR, 2010, PHARMACOECONOMICS, V28, P813, DOI 10.2165/11536150-000000000-00000; Locker GY, 2006, J CLIN ONCOL, V24, P5313, DOI 10.1200/JCO.2006.08.2644; Loprinzi Charles L, 2003, J Clin Oncol, V21, p108s, DOI 10.1200/JCO.2003.01.190; Mariotto AB, 2011, JNCI-J NATL CANCER I, V103, P117, DOI 10.1093/jnci/djq495; Matsuyama R, 2006, J CLIN ONCOL, V24, P3490, DOI 10.1200/JCO.2005.03.6236; National Cancer Institute, CANC TRENDS PROGR RE; Neubauer MA, 2010, J ONCOL PRACT, V6, P12, DOI 10.1200/JOP.091058; Pearson SD, 2010, HEALTH AFFAIR, V29, P1796, DOI 10.1377/hlthaff.2010.0623; Peppercorn JM, 2011, J CLIN ONCOL, V29, P755, DOI 10.1200/JCO.2010.33.1744; Pyenson B, 2004, J PAIN SYMPTOM MANAG, V28, P200, DOI 10.1016/j.jpainsymman.2004.05.003; Rustin GJS, 2010, LANCET, V376, P1155, DOI 10.1016/S0140-6736(10)61268-8; SCHAPIRA DV, 1991, JAMA-J AM MED ASSOC, V265, P380, DOI 10.1001/jama.265.3.380; Sepucha KR, 2009, MED DECIS MAKING, V29, P475, DOI 10.1177/0272989X09333124; Smith TJ, 2006, J CLIN ONCOL, V24, P3187, DOI 10.1200/JCO.2006.06.4451; Smith Thomas J, 2011, J Support Oncol, V9, P79; Smith TJ, 2010, ONCOLOGY-NY, V24, P521; Smith TJ, 2010, ONCOLOGIST, V15, P65, DOI 10.1634/theoncologist.2010-S1-65; Smith TJ, 2010, J CLIN ONCOL, V28, pE128, DOI 10.1200/JCO.2009.26.8243; SMITH TJ, 1995, J CLIN ONCOL, V13, P2464, DOI 10.1200/JCO.1995.13.9.2464; Smith TJ, 2005, J CLIN ONCOL, V23, P6807, DOI 10.1200/JCO.2005.01.5545; Spettell CM, 2009, J PALLIAT MED, V12, P827, DOI 10.1089/jpm.2009.0089; Temel JS, 2010, NEW ENGL J MED, V363, P733, DOI 10.1056/NEJMoa1000678; Timmer-Bonte JNH, 2008, J CLIN ONCOL, V26, P290, DOI 10.1200/JCO.2007.13.0898; Wright AA, 2008, JAMA-J AM MED ASSOC, V300, P1665, DOI 10.1001/jama.300.14.1665; Yabroff KR, 2008, JNCI-J NATL CANCER I, V100, P630, DOI 10.1093/jnci/djn103; Zhang BH, 2009, ARCH INTERN MED, V169, P480, DOI 10.1001/archinternmed.2008.587	63	306	308	1	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 26	2011	364	21					2060	2065		10.1056/NEJMsb1013826	http://dx.doi.org/10.1056/NEJMsb1013826			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	768QR	21612477	Green Accepted			2022-12-24	WOS:000290952000015
J	Mihaylova, MM; Vasquez, DS; Ravnskjaer, K; Denechaud, PD; Yu, RT; Alvarez, JG; Downes, M; Evans, RM; Montminy, M; Shaw, RJ				Mihaylova, Maria M.; Vasquez, Debbie S.; Ravnskjaer, Kim; Denechaud, Pierre-Damien; Yu, Ruth T.; Alvarez, Jacqueline G.; Downes, Michael; Evans, Ronald M.; Montminy, Marc; Shaw, Reuben J.			Class IIa Histone Deacetylases Are Hormone-Activated Regulators of FOXO and Mammalian Glucose Homeostasis	CELL			English	Article							CREB COACTIVATOR TORC2; STEM-CELL HOMEOSTASIS; PROTEIN-KINASE; TRANSCRIPTION FACTOR; METABOLIC SYNDROME; GENE-EXPRESSION; CLASS IIHDAC; PHOSPHORYLATION; ACETYLATION; DISEASE	Class IIa histone deacetylases (HDACs) are signal-dependent modulators of transcription with established roles in muscle differentiation and neuronal survival. We show here that in liver, class IIa HDACs (HDAC4, 5, and 7) are phosphorylated and excluded from the nucleus by AMPK family kinases. In response to the fasting hormone glucagon, class IIa HDACs are rapidly dephosphorylated and translocated to the nucleus where they associate with the promoters of gluconeogenic enzymes such as G6Pase. In turn, HDAC4/5 recruit HDAC3, which results in the acute transcriptional induction of these genes via deacetylation and activation of FOXO family transcription factors. Loss of class IIa HDACs in murine liver results in inhibition of FOXO target genes and lowers blood glucose, resulting in increased glycogen storage. Finally, suppression of class IIa HDACs in mouse models of type 2 diabetes ameliorates hyperglycemia, suggesting that inhibitors of class I/II HDACs may be potential therapeutics for metabolic syndrome.	[Mihaylova, Maria M.; Vasquez, Debbie S.; Denechaud, Pierre-Damien; Shaw, Reuben J.] Salk Inst Biol Studies, Mol & Cell Biol Lab, La Jolla, CA 92037 USA; [Ravnskjaer, Kim; Montminy, Marc] Salk Inst Biol Studies, Clayton Labs Peptide Biol, La Jolla, CA 92037 USA; [Yu, Ruth T.; Alvarez, Jacqueline G.; Downes, Michael; Evans, Ronald M.] Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA; [Evans, Ronald M.; Shaw, Reuben J.] Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; [Mihaylova, Maria M.; Vasquez, Debbie S.; Ravnskjaer, Kim; Denechaud, Pierre-Damien; Yu, Ruth T.; Alvarez, Jacqueline G.; Downes, Michael; Evans, Ronald M.; Montminy, Marc; Shaw, Reuben J.] Salk Inst Biol Studies, Leona & Harry Helmsley Ctr Nutr Genom, La Jolla, CA 92037 USA	Salk Institute; Salk Institute; Salk Institute; Howard Hughes Medical Institute; Salk Institute; Salk Institute	Shaw, RJ (corresponding author), Salk Inst Biol Studies, Mol & Cell Biol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	shaw@salk.edu	Evans, Ronald/AAF-4001-2019; Pierre-Damien, Denechaud/M-5650-2016; Mihaylova, Maria M./ACZ-4949-2022; Ravnskjaer, Kim/GRJ-3065-2022	Evans, Ronald/0000-0002-9986-5965; Pierre-Damien, Denechaud/0000-0003-3502-4814; Mihaylova, Maria M./0000-0002-2725-767X; Ravnskjaer, Kim/0000-0002-5322-3887; Yu, Ruth/0000-0002-9527-9627	NIH [HD027183, DK062434, R01 DK049777, R01DK083834, R01 DK080425, P01CA120964]; American Diabetes Association [1-08-JF-47];  [T32 CMG]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD027183] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P01CA120964, P30CA014195] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK090962, R01DK049777, R01DK080425, R37DK083834, R01DK083834, U19DK062434] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	M.M.M. performed all cell and biochemistry experiments, designed shRNAs, generated and large-scale purified all adenoviruses utilized, characterized all antisera utilized, and with assistance from D. S. V. performed all mouse experiments. M. M. M. and R.J.S. designed the study, analyzed the data, and wrote the paper. In addition, K. R. in the lab of M. M. performed ChIP in Figure 3, Figure 5, and Figure S3; P.-D.D. in the lab of R.J.S. assisted with hepatocyte generation for Figure S2. R.T.Y. in the lab of R. M. E. performed microarray analysis in Figure 3A. J.G.A. and M. D. in the lab of R. M. E. performed qPCR in Figure 3B and Figure 6D. We thank A. Fukamizu (U. of Tsukuba) and A. Brunet (Stanford) for Foxo1 antibodies; M. Karin (UCSD) and P. Chambon (IGBMC) for the Albumin-creERT2 mice; B. Wang and S. Hedrick for sharing reagents and assistance; H. Juguilon for technical assistance; D. Shackelford for assistance with the in vivo mouse imaging studies; R. Dentin for initial help with hepatocytes; L. Gerken for genotyping; R. Kohnz for initial characterization of Alb-creERT2 LKB1 mice; J. Fitzpatrick for confocal imaging assistance; and K. Lamia for comments on the manuscript. We apologize to many investigators whose primary studies in the HDAC and FOXO fields could not be cited due to space limitations. M. M. M. was supported through the T32 CMG training grant to UCSD/Salk. R. M. E. is funded by the NIH HD027183 and DK062434. M. M. is funded by the NIH R01 DK049777 and R01DK083834. R. J. S. is funded by the NIH R01 DK080425 and P01CA120964 and the American Diabetes Association Junior Faculty Award 1-08-JF-47. We thank the Leona M. and Harry B. Helmsley Charitable Trust for their generous support.	Berdeaux R, 2007, NAT MED, V13, P597, DOI 10.1038/nm1573; Biddinger SB, 2006, ANNU REV PHYSIOL, V68, P123, DOI 10.1146/annurev.physiol.68.040104.124723; Brent MM, 2008, STRUCTURE, V16, P1407, DOI 10.1016/j.str.2008.06.013; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; Canettieri G, 2010, NAT CELL BIOL, V12, P132, DOI 10.1038/ncb2013; Canto C, 2010, CELL MOL LIFE SCI, V67, P3407, DOI 10.1007/s00018-010-0454-z; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Cool B, 2006, CELL METAB, V3, P403, DOI 10.1016/j.cmet.2006.05.005; Creemers EE, 2006, DEVELOPMENT, V133, P4245, DOI 10.1242/dev.02610; Dansen TB, 2004, J LIPID RES, V45, P81, DOI 10.1194/jlr.M300111-JLR200; Dentin R, 2007, NATURE, V449, P366, DOI 10.1038/nature06128; Dequiedt F, 2006, MOL CELL BIOL, V26, P7086, DOI 10.1128/MCB.00231-06; Djouder N, 2010, EMBO J, V29, P469, DOI 10.1038/emboj.2009.339; Dong XC, 2006, J CLIN INVEST, V116, P101, DOI 10.1172/JCI25735; Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371; Fischle W, 2002, MOL CELL, V9, P45, DOI 10.1016/S1097-2765(01)00429-4; Gregoire S, 2007, MOL CELL BIOL, V27, P1280, DOI 10.1128/MCB.00882-06; Gross DN, 2009, CURR DIABETES REP, V9, P208, DOI 10.1007/s11892-009-0034-5; Guarente L, 2006, NATURE, V444, P868, DOI 10.1038/nature05486; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Haeusler RA, 2010, J BIOL CHEM, V285, P35245, DOI 10.1074/jbc.C110.175851; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; Houtkooper RH, 2010, ENDOCR REV, V31, P194, DOI 10.1210/er.2009-0026; Hurley RL, 2006, J BIOL CHEM, V281, P36662, DOI 10.1074/jbc.M606676200; Hutton JC, 2009, J BIOL CHEM, V284, P29241, DOI 10.1074/jbc.R109.025544; Imai T, 2000, GENESIS, V26, P147, DOI 10.1002/(SICI)1526-968X(200002)26:2<147::AID-GENE15>3.0.CO;2-3; Jing EX, 2007, CELL METAB, V6, P105, DOI 10.1016/j.cmet.2007.07.003; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; Lahm A, 2007, P NATL ACAD SCI USA, V104, P17335, DOI 10.1073/pnas.0706487104; Matsumoto M, 2007, CELL METAB, V6, P208, DOI 10.1016/j.cmet.2007.08.006; Matsuzaki H, 2005, P NATL ACAD SCI USA, V102, P11278, DOI 10.1073/pnas.0502738102; Mcgee SL, 2008, DIABETES, V57, P860, DOI 10.2337/db07-0843; Montminy M, 2004, ANN ENDOCRINOL-PARIS, V65, P73, DOI 10.1016/S0003-4266(04)95634-X; Paik JH, 2009, CELL STEM CELL, V5, P540, DOI 10.1016/j.stem.2009.09.013; Peng WT, 2009, GENESIS, V47, P590, DOI 10.1002/dvg.20538; Qiang L, 2010, J BIOL CHEM, V285, P27396, DOI 10.1074/jbc.M110.140228; Renault VM, 2009, CELL STEM CELL, V5, P527, DOI 10.1016/j.stem.2009.09.014; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Salganik SV, 2009, LAB INVEST, V89, P1032, DOI 10.1038/labinvest.2009.64; Schuetz A, 2008, J BIOL CHEM, V283, P11355, DOI 10.1074/jbc.M707362200; Screaton RA, 2004, CELL, V119, P61, DOI 10.1016/j.cell.2004.09.015; Shackelford DB, 2009, NAT REV CANCER, V9, P563, DOI 10.1038/nrc2676; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; van der Linden AM, 2007, EMBO J, V26, P358, DOI 10.1038/sj.emboj.7601479; Vander Kooi BT, 2003, J BIOL CHEM, V278, P11782, DOI 10.1074/jbc.M212570200; Viollet B, 2009, ACTA PHYSIOL, V196, P81, DOI 10.1111/j.1748-1716.2009.01970.x; Wang B, 2011, CELL, V145, P596, DOI 10.1016/j.cell.2011.04.013; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Wen YD, 2000, P NATL ACAD SCI USA, V97, P7202, DOI 10.1073/pnas.97.13.7202; Witt O, 2009, CANCER LETT, V277, P8, DOI 10.1016/j.canlet.2008.08.016; Zhang XM, 2005, P NATL ACAD SCI USA, V102, P4459, DOI 10.1073/pnas.0501076102	54	406	423	1	53	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 13	2011	145	4					607	621		10.1016/j.cell.2011.03.043	http://dx.doi.org/10.1016/j.cell.2011.03.043			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	763MF	21565617	Bronze, Green Accepted			2022-12-24	WOS:000290560800013
J	Meinema, AC; Laba, JK; Hapsari, RA; Otten, R; Mulder, FAA; Kralt, A; van den Bogaart, G; Lusk, CP; Poolman, B; Veenhoff, LM				Meinema, Anne C.; Laba, Justyna K.; Hapsari, Rizqiya A.; Otten, Renee; Mulder, Frans A. A.; Kralt, Annemarie; van den Bogaart, Geert; Lusk, C. Patrick; Poolman, Bert; Veenhoff, Liesbeth M.			Long Unfolded Linkers Facilitate Membrane Protein Import Through the Nuclear Pore Complex	SCIENCE			English	Article							INTRACELLULAR TRAFFICKING; ARCHITECTURE; TRANSPORT; DOMAIN	Active nuclear import of soluble cargo involves transport factors that shuttle cargo through the nuclear pore complex (NPC) by binding to phenylalanine-glycine (FG) domains. How nuclear membrane proteins cross through the NPC to reach the inner membrane is presently unclear. We found that at least a 120-residue-long intrinsically disordered linker was required for the import of membrane proteins carrying a nuclear localization signal for the transport factor karyopherin-a. We propose an import mechanism for membrane proteins in which an unfolded linker slices through the NPC scaffold to enable binding between the transport factor and the FG domains in the center of the NPC.	[Meinema, Anne C.; Laba, Justyna K.; Hapsari, Rizqiya A.; Otten, Renee; Mulder, Frans A. A.; van den Bogaart, Geert; Poolman, Bert; Veenhoff, Liesbeth M.] Univ Groningen, Dept Biochem, Groningen Biomol Sci & Biotechnol Inst, Zernike Inst Adv Mat,Netherlands Prote Ctr, NL-9747 AG Groningen, Netherlands; [Meinema, Anne C.; Laba, Justyna K.; Hapsari, Rizqiya A.; Otten, Renee; Mulder, Frans A. A.; van den Bogaart, Geert; Poolman, Bert; Veenhoff, Liesbeth M.] Univ Groningen, Dept Biophys Chem, Groningen Biomol Sci & Biotechnol Inst, Zernike Inst Adv Mat,Netherlands Prote Ctr, NL-9747 AG Groningen, Netherlands; [Kralt, Annemarie; Veenhoff, Liesbeth M.] Univ Med Ctr Groningen, European Res Inst Biol Ageing, Dept Neurosci, NL-9713 AV Groningen, Netherlands; [Lusk, C. Patrick] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06519 USA	University of Groningen; University of Groningen; University of Groningen; Yale University	Veenhoff, LM (corresponding author), Univ Groningen, Dept Biochem, Groningen Biomol Sci & Biotechnol Inst, Zernike Inst Adv Mat,Netherlands Prote Ctr, Nijenborgh 4, NL-9747 AG Groningen, Netherlands.	l.m.veenhoff@rug.nl	Institute, Zernike/W-7033-2019; van den Bogaart, Geert/A-1089-2014; van den Bogaart, Geert/GLV-3283-2022; Poolman, Bert/D-1882-2012; Mulder, Frans AA/C-7158-2017	van den Bogaart, Geert/0000-0003-2180-6735; van den Bogaart, Geert/0000-0003-2180-6735; Mulder, Frans AA/0000-0001-9427-8406; Veenhoff, Liesbeth/0000-0002-0158-4728; Lusk, C. Patrick/0000-0003-4703-0533; Otten, Renee/0000-0001-7342-6131	Netherlands Organization for Scientific Research [700.56.302]	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	We thank M. C. King, M. P. Rout, and D. J. Slotboom for discussion; V. Krasnikov for help with confocal microscopy; and M. Graham for assistance with immunoelectron microscopy. We thank S. R. Wente, U. K. Laemmli, and M. P. Rout for reagents and strains. This work was supported by funding from the Netherlands Organization for Scientific Research (VIDI fellowship to L.M.V. and F.A.A.M.; Top-subsidy grant 700.56.302 to B.P.). L.M.V. conceived the project. Experiments were performed and analyzed by A.C.M., J.K.L., R.A.H., C.P.L., and A. K. NMR was performed by R.O. and F.A.A.M. G.v.d.B. helped with image analysis. Experiments were designed and the manuscript was written by A.C.M., C.P.L., B.P., and L.M.V.	Alber F, 2007, NATURE, V450, P695, DOI 10.1038/nature06405; Bailer SM, 2001, MOL CELL BIOL, V21, P7944, DOI 10.1128/MCB.21.23.7944-7955.2001; Ellenberg J, 1997, J CELL BIOL, V138, P1193, DOI 10.1083/jcb.138.6.1193; Frenkiel-Krispin D, 2010, J MOL BIOL, V395, P578, DOI 10.1016/j.jmb.2009.11.010; Frey S, 2006, SCIENCE, V314, P815, DOI 10.1126/science.1132516; Haruki H, 2008, MOL CELL, V31, P925, DOI 10.1016/j.molcel.2008.07.020; HINSHAW JE, 1992, CELL, V69, P1133, DOI 10.1016/0092-8674(92)90635-P; King MC, 2006, NATURE, V442, P1003, DOI 10.1038/nature05075; Lusk CP, 2007, NAT REV MOL CELL BIO, V8, P414, DOI 10.1038/nrm2165; Malik P, 2010, CELL MOL LIFE SCI, V67, P1353, DOI 10.1007/s00018-010-0257-2; Ohba T, 2004, J CELL BIOL, V167, P1051, DOI 10.1083/jcb.200409149; Ostlund C, 1999, J CELL SCI, V112, P1709; Peters R, 2009, BIOESSAYS, V31, P466, DOI 10.1002/bies.200800159; Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635; Schrader N, 2008, MOL CELL, V29, P46, DOI 10.1016/j.molcel.2007.10.022; SOULLAM B, 1995, J CELL BIOL, V130, P15, DOI 10.1083/jcb.130.1.15; Strawn LA, 2004, NAT CELL BIOL, V6, P197, DOI 10.1038/ncb1097; Turgay Y, 2010, EMBO J, V29, P2262, DOI 10.1038/emboj.2010.119; Wente SR, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000562; Wu W, 2002, J CELL SCI, V115, P1361; Yang Q, 1998, MOL CELL, V1, P223, DOI 10.1016/S1097-2765(00)80023-4; Zuleger N, 2008, BIOCHEM SOC T, V36, P1373, DOI 10.1042/BST0361373	22	94	95	1	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 1	2011	333	6038					90	93		10.1126/science.1205741	http://dx.doi.org/10.1126/science.1205741			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	785UF	21659568	Bronze			2022-12-24	WOS:000292255400056
J	van Dijk, EL; Chen, CL; d'Aubenton-Carafa, Y; Gourvennec, S; Kwapisz, M; Roche, V; Bertrand, C; Silvain, M; Legoix-Ne, P; Loeillet, S; Nicolas, A; Thermes, C; Morillon, A				van Dijk, E. L.; Chen, C. L.; d'Aubenton-Carafa, Y.; Gourvennec, S.; Kwapisz, M.; Roche, V.; Bertrand, C.; Silvain, M.; Legoix-Ne, P.; Loeillet, S.; Nicolas, A.; Thermes, C.; Morillon, A.			XUTs are a class of Xrn1-sensitive antisense regulatory non-coding RNA in yeast	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; PERVASIVE TRANSCRIPTION; BIDIRECTIONAL PROMOTERS; EUKARYOTIC GENOME; S. CEREVISIAE; METHYLATION; POLYMERASE; CHROMATIN; DECAY; XRN1	Non-coding (nc)RNAs are key players in numerous biological processes such as gene regulation, chromatin domain formation and genome stability(1,2). Large ncRNAs interact with histone modifiers' and are involved in cancer development(6), X-chromosome inactivation(7) and autosomal gene imprinting(8). However, despite recent evidence showing that pervasive transcription is more widespread than previously thought(9), only a few examples mediating gene regulation in eukaryotes have been described(10). In Saccharomyces cerevisiae, the bona-fide regulatory ncRNAs are destabilized by the Xrn1 5'-3' RNA exonudease(11,12) (also known as Kem1), but the genome-wide characterization of the entire regulatory ncRNA family remains elusive. Here, using strand-specific RNA sequencing (RNA-seq), we identify a novel class of 1,658 Xrn1-sensitive unstable transcripts (XUTs) in which 66% are antisense to open reading frames. These transcripts are polyadenylated and RNA polymerase II (RNAPII)-dependent. The majority of XUTs strongly accumulate in lithium-containing media, indicating that they might have a role in adaptive responses to changes in growth conditions. Notably, RNAP II chromatin immunoprecipitation followed by DNA sequencing (ChIP-seq) analysis of Xrn1-deficient strains revealed a significant decrease of RNAPII occupancy over 273 genes with antisense XUTs. These genes show an unusual bias for H3K4me3 marks and require the Set1 histone H3 lysine 4 methyl-transferase for silencing. Furthermore, abolishing H3K4me3 triggers the silencing of other genes with antisense XUTs, supporting a model in which H3K4me3 antagonizes antisense ncRNA repressive activity. Our results demonstrate that antisense ncRNA-mediated regulation is a general regulatory pathway for gene expression in S. cerevisiae.	[van Dijk, E. L.; Chen, C. L.; d'Aubenton-Carafa, Y.; Silvain, M.; Thermes, C.; Morillon, A.] CNRS, Ctr Genet Mol, UPR 3404, F-91198 Gif Sur Yvette, France; [Gourvennec, S.; Kwapisz, M.; Roche, V.; Bertrand, C.; Morillon, A.] Univ Paris 06, CNRS, UMR3244, Inst Curie,ncRNA,Ctr Rech, F-75248 Paris 05, France; [Legoix-Ne, P.] Inst Curie, NGS Platform, F-75248 Paris 05, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	Morillon, A (corresponding author), CNRS, Ctr Genet Mol, UPR 3404, Ave Terrasse, F-91198 Gif Sur Yvette, France.	thermes@cgm.cnrs-gif.fr; antonin.morillon@curie.fr	CHEN, Chunlong/D-7096-2011; Thermes, Claude/GNP-6416-2022; Morillon, Antonin/M-4751-2017	CHEN, Chunlong/0000-0002-4795-0295; Thermes, Claude/0000-0002-0023-5294; Morillon, Antonin/0000-0002-0575-5264; Roche, Veronique/0000-0001-8064-0507	Canceropole Ile de France; ANR "REGULncRNA"; ERC "EPIncRNA"; FRM fellowship	Canceropole Ile de France(Region Ile-de-France); ANR "REGULncRNA"(French National Research Agency (ANR)); ERC "EPIncRNA"; FRM fellowship(Fondation pour la Recherche Medicale)	We thank B. Seraphin, L. Benard and J. O'Sullivan for support and advice; B. Dichtl for insights into lithium treatment data normalization; M. Wery and A. Taddei for helpful discussions: A. Johnson, T. Kouzarides and V. Geli for generous gift of plasmids and strains. Special thanks to M. Descrimes, C. Jubin and S. Lair for technical assistance. We thank L. Steinmetz and M. Chodder for sharing unpublished results. E.L.V.D. benefits from an FRM fellowship. This work has benefited from facilities and expertise of the IMAGIF sequencing platform (Centre de Recherche de Gif). This work was financially supported by the Canceropole Ile de France, the ANR "REGULncRNA" and ERC "EPIncRNA" starting grant.	Amaral PP, 2008, SCIENCE, V319, P1787, DOI 10.1126/science.1155472; Aravind L, 2000, P NATL ACAD SCI USA, V97, P11319, DOI 10.1073/pnas.200346997; Bernstein E, 2005, GENE DEV, V19, P1635, DOI 10.1101/gad.1324305; Berretta J, 2008, GENE DEV, V22, P615, DOI 10.1101/gad.458008; Berretta J, 2009, EMBO REP, V10, P973, DOI 10.1038/embor.2009.181; Camblong J, 2007, CELL, V131, P706, DOI 10.1016/j.cell.2007.09.014; Camblong J, 2009, GENE DEV, V23, P1534, DOI 10.1101/gad.522509; Chernyakov I, 2008, GENE DEV, V22, P1369, DOI 10.1101/gad.1654308; Chow J, 2009, CURR OPIN CELL BIOL, V21, P359, DOI 10.1016/j.ceb.2009.04.012; Dichtl B, 1997, EMBO J, V16, P7184, DOI 10.1093/emboj/16.23.7184; Dichtl E, 2004, RNA, V10, P965, DOI 10.1261/rna.7090104; Fatica A, 2000, EMBO J, V19, P6218, DOI 10.1093/emboj/19.22.6218; Huarte M, 2010, HUM MOL GENET, V19, pR152, DOI 10.1093/hmg/ddq353; Jacquier A, 2009, NAT REV GENET, V10, P833, DOI 10.1038/nrg2683; Johnson AW, 1997, MOL CELL BIOL, V17, P6122, DOI 10.1128/MCB.17.10.6122; Kirmizis A, 2007, NATURE, V449, P928, DOI 10.1038/nature06160; Long RM, 2003, MOL CELL, V11, P1126, DOI 10.1016/S1097-2765(03)00198-9; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Matsuda E, 2009, P NATL ACAD SCI USA, V106, P15657, DOI 10.1073/pnas.0908305106; Moazed D, 2009, NATURE, V457, P413, DOI 10.1038/nature07756; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Nagano T, 2008, SCIENCE, V322, P1717, DOI 10.1126/science.1163802; Neil H, 2009, NATURE, V457, P1038, DOI 10.1038/nature07747; NONET M, 1987, MOL CELL BIOL, V7, P1602, DOI 10.1128/MCB.7.5.1602; Pinskaya M, 2009, EPIGENETICS-US, V4, P302, DOI 10.4161/epi.4.5.9369; Pinskaya M, 2009, EMBO J, V28, P1697, DOI 10.1038/emboj.2009.108; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Swiezewski S, 2009, NATURE, V462, P799, DOI 10.1038/nature08618; Thompson DM, 2007, MOL CELL BIOL, V27, P92, DOI 10.1128/MCB.01023-06; Wyers F, 2005, CELL, V121, P725, DOI 10.1016/j.cell.2005.04.030; Xu ZY, 2009, NATURE, V457, P1033, DOI 10.1038/nature07728; Yap KL, 2010, MOL CELL, V38, P662, DOI 10.1016/j.molcel.2010.03.021; Yassour M, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r87; Yu WQ, 2008, NATURE, V451, P202, DOI 10.1038/nature06468	35	257	259	1	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 7	2011	475	7354					114	U139		10.1038/nature10118	http://dx.doi.org/10.1038/nature10118			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	788RE	21697827				2022-12-24	WOS:000292461300056
J	Pierce, M; Kurinczuk, JJ; Spark, P; Brocklehurst, P; Knight, M				Pierce, Matthias; Kurinczuk, Jennifer J.; Spark, Patsy; Brocklehurst, Peter; Knight, Marian		UKOSS	Perinatal outcomes after maternal 2009/H1N1 infection: national cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							2009 H1N1 INFLUENZA; PREGNANT-WOMEN; HOSPITALIZATIONS; STILLBIRTH; INTERVAL; ILLNESS; RISK	Objectives To follow up a UK national cohort of women admitted to hospital with confirmed 2009/H1N1 influenza in pregnancy in order to obtain a complete picture of pregnancy outcomes and estimate the risks of adverse fetal and infant outcomes. Design National cohort study. Setting 221 hospitals with obstetrician led maternity units in the UK. Participants 256 women admitted to hospital with confirmed 2009/H1N1 in pregnancy during the second wave of pandemic infection between September 2009 and January 2010; 1220 pregnant women for comparison. Main outcome measures Rates of stillbirth, perinatal mortality, and neonatal mortality; odds ratios for infected versus comparison women. Results Perinatal mortality was higher in infants born to infected women (10 deaths among 256 infants; rate 39 (95% confidence interval 19 to 71) per 1000 total births) than in infants of uninfected women (9 deaths among 1233 infants; rate 7 (3 to 13) per 1000 total births) (P<0.001). This was principally explained by an increase in the rate of stillbirth (27 per 1000 total births v 6 per 1000 total births; P=0.001). Infants of infected women were also more likely to be born prematurely than were infants of comparison women (adjusted odds ratio 4.0, 95% confidence interval 2.7 to 5.9). Infected women who delivered preterm were more likely to be infected in their third trimester (P=0.046), to have been admitted to an intensive care unit (P<0.001), and to have a secondary pneumonia (P=0.001) than were those who delivered at term. Conclusions This study suggests an increase in the risk of poor outcomes of pregnancy in women infected with 2009/H1N1, which reinforces the message from studies of maternal risk alone. The health of pregnant women is an important public health priority in future waves of this and other influenza pandemics.	[Pierce, Matthias; Kurinczuk, Jennifer J.; Spark, Patsy; Brocklehurst, Peter; Knight, Marian; UKOSS] Univ Oxford, Natl Perinatal Epidemiol Unit, Oxford OX3 7LF, England	University of Oxford	Knight, M (corresponding author), Univ Oxford, Natl Perinatal Epidemiol Unit, Oxford OX3 7LF, England.	marian.knight@npeu.ox.ac.uk	Knight, Marian/B-6225-2009; Pierce, Matthias/D-8561-2011	Knight, Marian/0000-0002-1984-4575; Pierce, Matthias/0000-0003-2182-0369	National Institute for Health Research [09/84/47]; NIHR National Coordinating Centre for Research Capacity Development	National Institute for Health Research(National Institute for Health Research (NIHR)); NIHR National Coordinating Centre for Research Capacity Development	The research presented here was funded by a grant from the National Institute for Health Research Health Technology Assessment Programme, grant reference 09/84/47. MK was funded by a personal award from the NIHR National Coordinating Centre for Research Capacity Development. All researchers are independent of the funders.	Australian and New Zealand Intensive Care Influenza Investigators, 2010, BRIT MED J, V340, pc1279; Centre for Maternal and Child Enquiries, 2010, PER MORT 2008 UK; Centre for Maternal and Child Enquiries (CMACE), 2010, PER MORT 2008 UK; COFFEY VP, 1959, LANCET, V2, P935; Cox S, 2006, OBSTET GYNECOL, V107, P1315, DOI 10.1097/01.AOG.0000218702.92005.bb; Creanga AA, 2010, OBSTET GYNECOL, V115, P717, DOI 10.1097/AOG.0b013e3181d57947; Department of Health, 2010, CLIN MAN GUID PREGN; DOLL R, 1960, Br J Prev Soc Med, V14, P167; Dubar G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013112; Edwards MJ, 2006, BIRTH DEFECTS RES A, V76, P507, DOI 10.1002/bdra.20277; Goldenberg RL, 2007, ACTA OBSTET GYN SCAN, V86, P1303, DOI 10.1080/00016340701644876; GRIFFITH GW, 1972, BMJ-BRIT MED J, V3, P553, DOI 10.1136/bmj.3.5826.553; HARDY JM, 1961, AM J PUBLIC HEALTH N, V51, P1182, DOI 10.2105/AJPH.51.8.1182; Harris JW, 1919, J AMER MED ASSOC, V72, P978, DOI 10.1001/jama.1919.02610140008002; Hartert TV, 2003, AM J OBSTET GYNECOL, V189, P1705, DOI 10.1016/S0002-9378(03)00857-3; Hewagama S, 2010, CLIN INFECT DIS, V50, P686, DOI 10.1086/650460; Information Services Division Scotland, 2010, BIRTHS SCOTT HOSP; Jamieson DJ, 2009, LANCET, V374, P451, DOI 10.1016/S0140-6736(09)61304-0; Knight M, 2005, BJOG-INT J OBSTET GY, V112, P263, DOI 10.1111/j.1471-0528.2005.00609.x; Knight M, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b542; Laibl VR, 2005, CLIN PERINATOL, V32, P727, DOI 10.1016/j.clp.2005.04.009; Louie JK, 2010, NEW ENGL J MED, V362, P27, DOI 10.1056/NEJMoa0910444; NHS Information Centre, 2010, HOSP EP STAT MAT DAT; Nishiura H, 2009, EUR J OBSTET GYN R B, V147, P115, DOI 10.1016/j.ejogrb.2009.07.009; Office for National Statistics, 2008, STAT REV NOT CONG AN; Office for National Statistics, 2010, BIRTH STAT 2008 SER, V37; Rogers VL, 2010, OBSTET GYNECOL, V115, P924, DOI 10.1097/AOG.0b013e3181da0c5e; Royal College of Obstetricians and Gynaecologists, UPD INFL H1N1 2009 P; Royston P, 2007, STATA J, V7, P445, DOI 10.1177/1536867X0700700401; Rubin DB, 2004, MULTIPLE IMPUTATION; Siston AM, 2010, JAMA-J AM MED ASSOC, V303, P1517, DOI 10.1001/jama.2010.479; Smith GCS, 2003, LANCET, V362, P1779, DOI 10.1016/S0140-6736(03)14896-9; Smith GCS, 2003, BRIT MED J, V327, P313, DOI 10.1136/bmj.327.7410.313; Stanwell-Smith R, 1994, Commun Dis Rep CDR Rev, V4, pR28; Yates L, 2010, HEALTH TECHNOL ASSES, V14, P121	35	177	180	1	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 14	2011	342								d3214	10.1136/bmj.d3214	http://dx.doi.org/10.1136/bmj.d3214			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	781KY	21672992	Green Published, hybrid, Green Submitted			2022-12-24	WOS:000291932100002
J	Pelet, S; Rudolf, F; Nadal-Ribelles, M; de Nadal, E; Posas, F; Peter, M				Pelet, Serge; Rudolf, Fabian; Nadal-Ribelles, Mariona; de Nadal, Eulalia; Posas, Francesc; Peter, Matthias			Transient Activation of the HOG MAPK Pathway Regulates Bimodal Gene Expression	SCIENCE			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; SINGLE-CELL; TRANSCRIPTION; ADAPTATION; KINASE; OSMOREGULATION; NOISE	Mitogen-activated protein kinase (MAPK) cascades are conserved signaling modules that control many cellular processes by integrating intra- and extracellular cues. The p38/Hog1 MAPK is transiently activated in response to osmotic stress, leading to rapid translocation into the nucleus and induction of a specific transcriptional program. When investigating the dynamic interplay between Hog1 activation and Hog1-driven gene expression, we found that Hog1 activation increases linearly with stimulus, whereas the transcriptional output is bimodal. Modeling predictions, corroborated by single-cell experiments, established that a slow stochastic transition from a repressed to an activated transcriptional state in conjunction with transient Hog1 activation generates this behavior. Together, these findings provide a molecular mechanism by which a cell can impose a transcriptional threshold in response to a linear signaling behavior.	[Pelet, Serge; Rudolf, Fabian; Peter, Matthias] ETH, Dept Biol, Inst Biochem, CH-8093 Zurich, Switzerland; [Nadal-Ribelles, Mariona; de Nadal, Eulalia; Posas, Francesc] Univ Pompeu Fabra, Dept Ciencies Expt & Salut, Cell Signaling Unit, E-08003 Barcelona, Spain	Swiss Federal Institutes of Technology Domain; ETH Zurich; Pompeu Fabra University	Pelet, S (corresponding author), ETH, Dept Biol, Inst Biochem, Schafmattstr 18, CH-8093 Zurich, Switzerland.	serge.pelet@bc.biol.ethz.ch; matthias.peter@bc.biol.ethz.ch	Nadal-Ribelles, Mariona/T-7540-2017; Posas, Francesc/K-1364-2013; de Nadal, Eulàlia/J-8178-2014; Nadal-Ribelles, Mariona/ABE-4295-2021	Nadal-Ribelles, Mariona/0000-0003-3314-6711; Posas, Francesc/0000-0002-4164-7076; de Nadal, Eulàlia/0000-0003-0039-5607; Nadal-Ribelles, Mariona/0000-0003-3314-6711; Peter, Matthias/0000-0002-2160-6824; Pelet, Serge/0000-0002-0245-049X	ICREA Academia (Generalitat de Catalunya); Fundacion Marcelino Botin (FMB); Ministerio de Ciencia y Innovacion [BFU2008-00530, BIO2009-07762]; Swiss National Science Foundation; ETHZ;  [155111]	ICREA Academia (Generalitat de Catalunya)(ICREAGeneralitat de Catalunya); Fundacion Marcelino Botin (FMB); Ministerio de Ciencia y Innovacion(Spanish Government); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); ETHZ(ETH Zurich); 	We thank R. Dechant, C. Schuller, G. Ammerer, A Colman-Lerner, and A. Smith for strains, plasmids, and helpful discussions, and S.-S. Lee and H. Koeppl fur help with flow chamber experiments and model design, respectively. We are grateful to C. Rupp and D. Conde for technical assistance. This work was supported by QUASI, UNICELLSYS, the SystemsX.ch organization, and the Competence Centre "Systems Physiology and Metabolic Disease" (CC-SPMD). M.N.-R. is supported by 155111, and F.P is recipient of an ICREA Academia (Generalitat de Catalunya) award. Work in the Posas and de Nadal laboratories is funded by the Fundacion Marcelino Botin (FMB) and the Ministerio de Ciencia y Innovacion (BFU2008-00530 to E.N. and BIO2009-07762 to F.P.). The Peter Laboratory is supported by the Swiss National Science Foundation and ETHZ. The authors declare that they have no competing financial interests.	Alepuz PM, 2003, EMBO J, V22, P2433, DOI 10.1093/emboj/cdg243; Bar-Even A, 2006, NAT GENET, V38, P636, DOI 10.1038/ng1807; Capaldi AP, 2008, NAT GENET, V40, P1300, DOI 10.1038/ng.235; Chen RE, 2007, BBA-MOL CELL RES, V1773, P1311, DOI 10.1016/j.bbamcr.2007.05.003; Colman-Lerner A, 2005, NATURE, V437, P699, DOI 10.1038/nature03998; de Nadal E, 2003, MOL CELL BIOL, V23, P229, DOI 10.1128/MCB.23.1.229-237.2003; de Nadal E, 2010, EMBO J, V29, P4, DOI 10.1038/emboj.2009.346; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Ferrigno P, 1998, EMBO J, V17, P5606, DOI 10.1093/emboj/17.19.5606; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Hersen P, 2008, P NATL ACAD SCI USA, V105, P7165, DOI 10.1073/pnas.0710770105; Hohmann S, 2007, METHOD ENZYMOL, V428, P29, DOI 10.1016/S0076-6879(07)28002-4; Klopf E, 2009, MOL CELL BIOL, V29, P4994, DOI 10.1128/MCB.01858-08; Loewer A, 2010, CELL, V142, P89, DOI 10.1016/j.cell.2010.05.031; Lopez-Maury L, 2008, NAT REV GENET, V9, P583, DOI 10.1038/nrg2398; Macia J, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000056; Mas G, 2009, EMBO J, V28, P326, DOI 10.1038/emboj.2008.299; Muzzey D, 2009, CELL, V138, P160, DOI 10.1016/j.cell.2009.04.047; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; Oehlen LJWM, 1996, MOL CELL BIOL, V16, P2830; Strickfaden SC, 2007, CELL, V128, P519, DOI 10.1016/j.cell.2006.12.032; Weake VM, 2010, NAT REV GENET, V11, P426, DOI 10.1038/nrg2781; Westfall PJ, 2008, P NATL ACAD SCI USA, V105, P12212, DOI 10.1073/pnas.0805797105; Yu RC, 2008, NATURE, V456, P755, DOI 10.1038/nature07513; Zapater M, 2007, MOL CELL BIOL, V27, P3900, DOI 10.1128/MCB.00089-07	25	104	105	1	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 6	2011	332	6030					732	735		10.1126/science.1198851	http://dx.doi.org/10.1126/science.1198851			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759RK	21551064	Green Accepted			2022-12-24	WOS:000290265800047
J	de Lau, W; Barker, N; Low, TY; Koo, BK; Li, VSW; Teunissen, H; Kujala, P; Haegebarth, A; Peters, PJ; van de Wetering, M; Stange, DE; van Es, JE; Guardavaccaro, D; Schasfoort, RBM; Mohri, Y; Nishimori, K; Mohammed, S; Heck, AJR; Clevers, H				de Lau, Wim; Barker, Nick; Low, Teck Y.; Koo, Bon-Kyoung; Li, Vivian S. W.; Teunissen, Hans; Kujala, Pekka; Haegebarth, Andrea; Peters, Peter J.; van de Wetering, Marc; Stange, Daniel E.; van Es, Johan E.; Guardavaccaro, Daniele; Schasfoort, Richard B. M.; Mohri, Yasuaki; Nishimori, Katsuhiko; Mohammed, Shabaz; Heck, Albert J. R.; Clevers, Hans			Lgr5 homologues associate with Wnt receptors and mediate R-spondin signalling	NATURE			English	Article							PANETH CELL-DIFFERENTIATION; STEM-CELLS; SMALL-INTESTINE; PEPTIDE IDENTIFICATION; HAIR FOLLICLE; REPORTER GENE; NULL MICE; IN-VITRO; EXPRESSION; R-SPONDIN1	The adult stem cell marker Lgr5 and its relative Lgr4 are often co-expressed in Wnt-driven proliferative compartments. We find that conditional deletion of both genes in the mouse gut impairs Wnt target gene expression and results in the rapid demise of intestinal crypts, thus phenocopying Wnt pathway inhibition. Mass spectrometry demonstrates that Lgr4 and Lgr5 associate with the Frizzled/Lrp Wnt receptor complex. Each of the four R-spondins, secreted Wnt pathway agonists, can bind to Lgr4, -5 and -6. In HEK293 cells, RSPO1 enhances canonical WNT signals initiated by WNT3A. Removal of LGR4 does not affect WNT3A signalling, but abrogates the RSPO1-mediated signal enhancement, a phenomenon rescued by re-expression of LGR4, -5 or -6. Genetic deletion of Lgr4/5 in mouse intestinal crypt cultures phenocopies withdrawal of Rspo1 and can be rescued by Wnt pathway activation. Lgr5 homologues are facultative Wnt receptor components that mediate Wnt signal enhancement by soluble R-spondin proteins. These results will guide future studies towards the application of R-spondins for regenerative purposes of tissues expressing Lgr5 homologues.	[de Lau, Wim; Barker, Nick; Koo, Bon-Kyoung; Li, Vivian S. W.; Teunissen, Hans; Haegebarth, Andrea; van de Wetering, Marc; Stange, Daniel E.; van Es, Johan E.; Guardavaccaro, Daniele; Clevers, Hans] Univ Med Ctr, NL-3584 CX Utrecht, Netherlands; [de Lau, Wim; Barker, Nick; Koo, Bon-Kyoung; Li, Vivian S. W.; Teunissen, Hans; Haegebarth, Andrea; van de Wetering, Marc; Stange, Daniel E.; van Es, Johan E.; Guardavaccaro, Daniele; Clevers, Hans] Hubrecht Inst, NL-3584 CX Utrecht, Netherlands; [Low, Teck Y.; Mohammed, Shabaz; Heck, Albert J. R.] Univ Utrecht, Biomol Mass Spectrometry & Prote Grp, Bijvoet Ctr Biomol Res, NL-3584 CH Utrecht, Netherlands; [Low, Teck Y.; Mohammed, Shabaz; Heck, Albert J. R.] Univ Utrecht, Utrecht Inst Pharmaceut Sci, NL-3584 CH Utrecht, Netherlands; [Kujala, Pekka; Peters, Peter J.] Antoni van Leeuwenhoek Hosp, Netherlands Canc Inst, NL-1066 CX Amsterdam, Netherlands; [Schasfoort, Richard B. M.] Univ Twente, Med Cell Biophys MIRA Inst, NL-7500 AE Enschede, Netherlands; [Mohri, Yasuaki; Nishimori, Katsuhiko] Tohoku Univ, Sendai, Miyagi 9818555, Japan	Utrecht University; Utrecht University Medical Center; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University; Netherlands Cancer Institute; University of Twente; Tohoku University	Clevers, H (corresponding author), Univ Med Ctr, NL-3584 CX Utrecht, Netherlands.	h.clevers@hubrecht.eu	Barker, Nick/A-5535-2011; Low, Teck Yew/Q-5946-2019; Heck, Albert/D-7098-2011; Barker, Nick/AAS-2774-2020; Stange, Daniel E/O-1837-2015; Barker, Nick/AAE-9833-2021; Mohammed, Shabaz/D-1042-2010; van+Es, Johan/ABD-5411-2021; Mohammed, Shabaz/AAY-6313-2020; Koo, Bon-Kyoung/V-5219-2017; Low, Teck Yew/J-4403-2014	Low, Teck Yew/0000-0001-7878-7534; Heck, Albert/0000-0002-2405-4404; Stange, Daniel E/0000-0003-4246-2230; Barker, Nick/0000-0003-3566-4475; Mohammed, Shabaz/0000-0003-2640-9560; Mohammed, Shabaz/0000-0003-2640-9560; Koo, Bon-Kyoung/0000-0002-4134-8033; Low, Teck Yew/0000-0001-7878-7534; Schasfoort, Richard/0000-0003-1601-3853; Guardavaccaro, Daniele/0000-0002-4517-1765; Li, Vivian/0000-0003-2041-0085				Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2010, GASTROENTEROLOGY, V138, P1681, DOI 10.1053/j.gastro.2010.03.002; Barker N, 2010, CELL STEM CELL, V6, P25, DOI 10.1016/j.stem.2009.11.013; Binnerts ME, 2007, P NATL ACAD SCI USA, V104, P14700, DOI 10.1073/pnas.0702305104; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Flanagan CA, 2005, MOL PHARMACOL, V68, P1, DOI 10.1124/mol.105.014183; Frese CK, 2011, J PROTEOME RES, V10, P2377, DOI 10.1021/pr1011729; Garcia MI, 2009, DEV BIOL, V331, P58, DOI 10.1016/j.ydbio.2009.04.020; Glinka A, 1998, NATURE, V391, P357, DOI 10.1038/34848; Ireland H, 2005, DEV DYNAM, V233, P1332, DOI 10.1002/dvdy.20446; Jaks V, 2008, NAT GENET, V40, P1291, DOI 10.1038/ng.239; Kato S, 2007, FEBS LETT, V581, P4685, DOI 10.1016/j.febslet.2007.08.064; Kazanskaya O, 2004, DEV CELL, V7, P525, DOI 10.1016/j.devcel.2004.07.019; Kim KA, 2005, SCIENCE, V309, P1256, DOI 10.1126/science.1112521; Kim KA, 2008, MOL BIOL CELL, V19, P2588, DOI 10.1091/mbc.E08-02-0187; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; Kuhnert F, 2004, P NATL ACAD SCI USA, V101, P266, DOI 10.1073/pnas.2536800100; Morita H, 2004, MOL CELL BIOL, V24, P9736, DOI 10.1128/MCB.24.22.9736-9743.2004; Muncan V, 2006, MOL CELL BIOL, V26, P8418, DOI 10.1128/MCB.00821-06; Mustata RC, 2011, EMBO REP, V12, P558, DOI 10.1038/embor.2011.52; Nakatani Y, 2003, METHOD ENZYMOL, V370, P430; Nam JS, 2006, J BIOL CHEM, V281, P13247, DOI 10.1074/jbc.M508324200; Ng SS, 2009, J BIOL CHEM, V284, P35308, DOI 10.1074/jbc.M109.078261; Ohkawara B, 2011, DEV CELL, V20, P303, DOI 10.1016/j.devcel.2011.01.006; Pinto D, 2003, GENE DEV, V17, P1709, DOI 10.1101/gad.267103; Raijmakers R, 2008, MOL CELL PROTEOMICS, V7, P1755, DOI 10.1074/mcp.M800093-MCP200; ROBINE S, 1993, J BIOL CHEM, V268, P11426; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sansom OJ, 2007, NATURE, V446, P676, DOI 10.1038/nature05674; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Snippert HJ, 2010, SCIENCE, V327, P1385, DOI 10.1126/science.1184733; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Van der Flier LG, 2009, GASTROENTEROLOGY, V137, P15, DOI 10.1053/j.gastro.2009.05.035; van der Flier LG, 2009, CELL, V136, P903, DOI 10.1016/j.cell.2009.01.031; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; Van Schoore G, 2005, HISTOCHEM CELL BIOL, V124, P35, DOI 10.1007/s00418-005-0002-3; Wei Q, 2007, J BIOL CHEM, V282, P15903, DOI 10.1074/jbc.M701927200; Zhao JS, 2007, GASTROENTEROLOGY, V132, P1331, DOI 10.1053/j.gastro.2007.02.001	42	856	903	4	135	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 18	2011	476	7360					293	U57		10.1038/nature10337	http://dx.doi.org/10.1038/nature10337			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811JV	21727895				2022-12-24	WOS:000294206500030
J	Alaynick, WA; Jessell, TM; Pfaff, SL				Alaynick, William A.; Jessell, Thomas M.; Pfaff, Samuel L.			Snapshot: Spinal Cord Development	CELL			English	Editorial Material							CIRCUITS; SPECIFICATION; NETWORKS		[Alaynick, William A.; Pfaff, Samuel L.] Salk Inst Biol Studies, HHMI, La Jolla, CA 92037 USA; [Jessell, Thomas M.] Columbia Univ, HHMI, New York, NY 10032 USA	Howard Hughes Medical Institute; Salk Institute; Columbia University; Howard Hughes Medical Institute	Alaynick, WA (corresponding author), Salk Inst Biol Studies, HHMI, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054172, P01NS031249, R37NS037116, R01NS037116] Funding Source: NIH RePORTER; NINDS NIH HHS [P01 NS031249, R01 NS037116-10, R01 NS054172-02, R01 NS037116-03, R01 NS054172-05, R01 NS037116-08S1, R01 NS037116-05, R01 NS037116-04S1, R01 NS037116-07, R01 NS054172-03, R01 NS037116-06A1, R01 NS054172-04, R01 NS037116-08, P01 NS031249-14A1, R01 NS037116-09, P01 NS031249-15, P01 NS031249-17, R01 NS054172, R01 NS054172-01A2, R01 NS037116-04, P01 NS031249-16, R37 NS037116, R01 NS037116, P01 NS031249-18, R01 NS037116-07S1] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Dasen JS, 2009, CURR TOP DEV BIOL, V88, P169, DOI 10.1016/S0070-2153(09)88006-X; Goulding M, 2005, CURR OPIN NEUROBIOL, V15, P14, DOI 10.1016/j.conb.2005.01.017; Goulding M, 2009, NAT REV NEUROSCI, V10, P507, DOI 10.1038/nrn2608; Grillner S, 2009, CURR OPIN NEUROBIOL, V19, P572, DOI 10.1016/j.conb.2009.10.011; Helms AW, 2003, CURR OPIN NEUROBIOL, V13, P42, DOI 10.1016/S0959-4388(03)00010-2; Jankowska E, 2001, J PHYSIOL-LONDON, V533, P31, DOI 10.1111/j.1469-7793.2001.0031b.x; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Kiehn O, 2006, ANNU REV NEUROSCI, V29, P279, DOI 10.1146/annurev.neuro.29.051605.112910; Ladle DR, 2007, NEURON, V56, P270, DOI 10.1016/j.neuron.2007.09.026; Lee SK, 2001, NAT NEUROSCI, V4, P1183, DOI 10.1038/nn750	10	186	189	2	31	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 8	2011	146	1					178	U19		10.1016/j.cell.2011.06.038	http://dx.doi.org/10.1016/j.cell.2011.06.038			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	789TN	21729788	Green Accepted, Bronze			2022-12-24	WOS:000292539300015
J	Hachet, O; Berthelot-Grosjean, M; Kokkoris, K; Vincenzetti, V; Moosbrugger, J; Martin, SG				Hachet, Olivier; Berthelot-Grosjean, Martine; Kokkoris, Kyriakos; Vincenzetti, Vincent; Moosbrugger, Josselin; Martin, Sophie G.			A Phosphorylation Cycle Shapes Gradients of the DYRK Family Kinase Pom1 at the Plasma Membrane	CELL			English	Article							FISSION YEAST; CELL POLARITY; PROTEIN-KINASES; DIVISION PLANE; GROWTH; TEA1; DETERMINANTS; CYTOSKELETON; ACTIVATION; MITOSIS	Concentration gradients regulate many cell biological and developmental processes. In rod-shaped fission yeast cells, polar cortical gradients of the DYRK family kinase Pom1 couple cell length with mitotic commitment by inhibiting a mitotic inducer positioned at midcell. However, how Pom1 gradients are established is unknown. Here, we show that Tea4, which is normally deposited at cell tips by microtubules, is both necessary and, upon ectopic cortical localization, sufficient to recruit Pom1 to the cell cortex. Pom1 then moves laterally at the plasma membrane, which it binds through a basic region exhibiting direct lipid interaction. Pom1 autophosphorylates in this region to lower lipid affinity and promote membrane release. Tea4 triggers Pom1 plasma membrane association by promoting its dephosphorylation through the protein phosphatase 1 Dis2. We propose that local dephosphorylation induces Pom1 membrane association and nucleates a gradient shaped by the opposing actions of lateral diffusion and autophosphorylation-dependent membrane detachment.	[Hachet, Olivier; Berthelot-Grosjean, Martine; Kokkoris, Kyriakos; Vincenzetti, Vincent; Moosbrugger, Josselin; Martin, Sophie G.] Univ Lausanne, Fac Biol & Med, Dept Fundamental Microbiol, CH-1015 Lausanne, Switzerland	University of Lausanne	Martin, SG (corresponding author), Univ Lausanne, Fac Biol & Med, Dept Fundamental Microbiol, CH-1015 Lausanne, Switzerland.	sophie.martin@unil.ch		Berthelot-Grosjean, Martine/0000-0002-7168-2622; Martin, Sophie/0000-0002-5317-2557	Human Frontiers Science Program (HFSP) long-term fellowship [LT00595/2005-L]; Roche [67-2008]; Swiss National Science Foundation [PP00A-114936]; HFSP Career Development Award [CDA0016/2008]; European Research Council [260493]	Human Frontiers Science Program (HFSP) long-term fellowship(Human Frontier Science Program); Roche(Roche Holding); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); HFSP Career Development Award; European Research Council(European Research Council (ERC)European Commission)	We would like to thank Patrice Waridel and Manfredo Quadroni at the Protein Analysis Facility for the mass spectrometry, Philippe Kircher for technical help, Jurg Bahler, Iain Hagan, and Stuart MacNeill for strains and reagents, Yves Barral, Felipe Bendezu, and Richard Benton for comments on the manuscript, and all members of the lab for advice and discussion. O.H. was supported by a Human Frontiers Science Program (HFSP) long-term fellowship (LT00595/2005-L) and K. K. by a Roche research fellowship (67-2008). Research in S. G. M.'s laboratory is supported by a Swiss National Science Foundation Professorship grant (PP00A-114936), an HFSP Career Development Award (CDA0016/2008), and a European Research Council Starting Grant (260493). We also extend our thanks to the Center for Integrative Genomics at the University of Lausanne, where a large part of this work was conducted, for generous support.	Almonacid M, 2009, CURR BIOL, V19, P961, DOI 10.1016/j.cub.2009.04.024; Alvarez-Tabares I, 2007, J CELL SCI, V120, P3589, DOI 10.1242/jcs.007567; Aranda S, 2011, FASEB J, V25, P449, DOI 10.1096/fj.10-165837; Bahler J, 1998, GENE DEV, V12, P1356, DOI 10.1101/gad.12.9.1356; Bahler J, 2001, EMBO J, V20, P1064, DOI 10.1093/emboj/20.5.1064; Bicho CC, 2010, CURR BIOL, V20, P1752, DOI 10.1016/j.cub.2010.08.035; Bretscher MS, 1996, CELL, V87, P601, DOI 10.1016/S0092-8674(00)81380-X; Campbell LE, 2002, FEBS LETT, V510, P31, DOI 10.1016/S0014-5793(01)03221-5; Celton-Morizur S, 2006, J CELL SCI, V119, P4710, DOI 10.1242/jcs.03261; CHANG F, 2009, PERSPECT BIOL, V1; Fuller BG, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-5; GREENBERG ML, 1993, J MEMBRANE BIOL, V131, P115, DOI 10.1007/BF02791320; Himpel S, 2000, J BIOL CHEM, V275, P2431, DOI 10.1074/jbc.275.4.2431; Huang YY, 2007, DEV CELL, V12, P987, DOI 10.1016/j.devcel.2007.03.015; Kerppola TK, 2006, NAT REV MOL CELL BIO, V7, P449, DOI 10.1038/nrm1929; Knaus M, 2005, EMBO J, V24, P3000, DOI 10.1038/sj.emboj.7600783; KOUKOU AI, 1990, J GEN MICROBIOL, V136, P1271, DOI 10.1099/00221287-136-7-1271; Lochhead PA, 2005, CELL, V121, P925, DOI 10.1016/j.cell.2005.03.034; Lutkenhaus J, 2007, ANNU REV BIOCHEM, V76, P539, DOI 10.1146/annurev.biochem.75.103004.142652; Martin SG, 2005, DEV CELL, V8, P479, DOI 10.1016/j.devcel.2005.02.008; Martin SG, 2009, NATURE, V459, P852, DOI 10.1038/nature08054; Mata J, 1997, CELL, V89, P939, DOI 10.1016/S0092-8674(00)80279-2; Morrell JL, 2004, J CELL SCI, V117, P5293, DOI 10.1242/jcs.01409; Moseley JB, 2009, NATURE, V459, P857, DOI 10.1038/nature08074; Padte NN, 2006, CURR BIOL, V16, P2480, DOI 10.1016/j.cub.2006.11.024; Snaith HA, 2005, EMBO J, V24, P3690, DOI 10.1038/sj.emboj.7600838; Tatebe H, 2005, CURR BIOL, V15, P1006, DOI 10.1016/j.cub.2005.04.061; Tatebe H, 2008, CURR BIOL, V18, P322, DOI 10.1016/j.cub.2008.02.005; Valdez-Taubas J, 2003, CURR BIOL, V13, P1636, DOI 10.1016/j.cub.2003.09.001; WARTLICK O, 2009, PERSPECT BIOL, V1	30	90	91	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 24	2011	145	7					1116	1128		10.1016/j.cell.2011.05.014	http://dx.doi.org/10.1016/j.cell.2011.05.014			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	782QV	21703453	Green Published, Bronze			2022-12-24	WOS:000292025700017
J	Hsu, PP; Kang, SA; Rameseder, J; Zhang, Y; Ottina, KA; Lim, D; Peterson, TR; Choi, YM; Gray, NS; Yaffe, MB; Marto, JA; Sabatini, DM				Hsu, Peggy P.; Kang, Seong A.; Rameseder, Jonathan; Zhang, Yi; Ottina, Kathleen A.; Lim, Daniel; Peterson, Timothy R.; Choi, Yongmun; Gray, Nathanael S.; Yaffe, Michael B.; Marto, Jarrod A.; Sabatini, David M.			The mTOR-Regulated Phosphoproteome Reveals a Mechanism of mTORC1-Mediated Inhibition of Growth Factor Signaling	SCIENCE			English	Article							MESSENGER-RNA TRANSLATION; P-BODIES; PROTEIN; KINASE; GRB10; DISRUPTION; AUTOPHAGY; SPECIFICITY; ACTIVATION; REPRESSION	The mammalian target of rapamycin (mTOR) protein kinase is a master growth promoter that nucleates two complexes, mTORC1 and mTORC2. Despite the diverse processes controlled by mTOR, few substrates are known. We defined the mTOR-regulated phosphoproteome by quantitative mass spectrometry and characterized the primary sequence motif specificity of mTOR using positional scanning peptide libraries. We found that the phosphorylation response to insulin is largely mTOR dependent and that mTOR exhibits a unique preference for proline, hydrophobic, and aromatic residues at the +1 position. The adaptor protein Grb10 was identified as an mTORC1 substrate that mediates the inhibition of phosphoinositide 3-kinase typical of cells lacking tuberous sclerosis complex 2 (TSC2), a tumor suppressor and negative regulator of mTORC1. Our work clarifies how mTORC1 inhibits growth factor signaling and opens new areas of investigation in mTOR biology.	[Hsu, Peggy P.; Kang, Seong A.; Ottina, Kathleen A.; Peterson, Timothy R.; Sabatini, David M.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Hsu, Peggy P.; Peterson, Timothy R.; Yaffe, Michael B.; Sabatini, David M.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Rameseder, Jonathan] MIT, Computat & Syst Biol Initiat, Cambridge, MA 02139 USA; [Rameseder, Jonathan; Lim, Daniel; Yaffe, Michael B.; Sabatini, David M.] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Zhang, Yi; Choi, Yongmun; Gray, Nathanael S.; Marto, Jarrod A.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Zhang, Yi; Marto, Jarrod A.] DFCI, Blais Prote Ctr, Boston, MA 02115 USA; [Ottina, Kathleen A.; Sabatini, David M.] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Choi, Yongmun; Gray, Nathanael S.; Marto, Jarrod A.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School	Sabatini, DM (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	sabatini@wi.mit.edu		/0000-0002-1446-7256	National Institutes of Health [CA103866, AI47389, ES015339, GM68762, CA112967]; Department of Defense [W81XWH-07-0448]; W.M. Keck Foundation; LAM Foundation; Dana-Farber Cancer Institute; International Fulbright Science and Technology Award; American Cancer Society; NATIONAL CANCER INSTITUTE [R01CA129105, R01CA103866, U54CA112967] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI047389, R01AI047389] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015339] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753, P50GM068762] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); W.M. Keck Foundation(W.M. Keck Foundation); LAM Foundation; Dana-Farber Cancer Institute; International Fulbright Science and Technology Award; American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Sabatini Lab for helpful discussion, especially B. Joughin, G. Bell, H. Keys, K. Birsoy, N. Kory, C. Thoreen, J. Claessen, and D. Wagner for assistance with technical or conceptual aspects of this project. This work was supported by the National Institutes of Health (grants CA103866 and AI47389 to D. M. S.; ES015339, GM68762, and CA112967 to M.B.Y.), Department of Defense (W81XWH-07-0448 to D. M. S.), the W.M. Keck Foundation (D. M. S.), LAM Foundation (D. M. S.), Dana-Farber Cancer Institute (N. S. G, J. M), the International Fulbright Science and Technology Award (J. R.), and American Cancer Society (S. A. K.). D. M. S. is an investigator of the Howard Hughes Medical Institute. Torin1, the drug used in this paper, is part of a Whitehead-DFCI patent application on which N. S. G. and D. M. S. are inventors. Shared reagents are subject to a Materials Transfer Agreement.	Cao XR, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1160940; Charalambous M, 2003, P NATL ACAD SCI USA, V100, P8292, DOI 10.1073/pnas.1532175100; Choi JH, 2002, EMBO REP, V3, P988, DOI 10.1093/embo-reports/kvf197; Choo AY, 2008, P NATL ACAD SCI USA, V105, P17414, DOI 10.1073/pnas.0809136105; Coller J, 2005, CELL, V122, P875, DOI 10.1016/j.cell.2005.07.012; Dowling RJO, 2010, BBA-PROTEINS PROTEOM, V1804, P433, DOI 10.1016/j.bbapap.2009.12.001; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; Ganley IG, 2009, J BIOL CHEM, V284, P12297, DOI 10.1074/jbc.M900573200; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Holt LJ, 2005, BIOCHEM J, V388, P393, DOI 10.1042/BJ20050216; Hosokawa N, 2009, MOL BIOL CELL, V20, P1981, DOI 10.1091/mbc.E08-12-1248; Huber A, 2009, GENE DEV, V23, P1929, DOI 10.1101/gad.532109; Hutti JE, 2004, NAT METHODS, V1, P27, DOI 10.1038/NMETH708; Jung CH, 2009, MOL BIOL CELL, V20, P1992, DOI 10.1091/mbc.E08-12-1249; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; Mok J, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000482; Morrione A, 1999, J BIOL CHEM, V274, P24094, DOI 10.1074/jbc.274.34.24094; Nykamp K, 2008, RNA, V14, P1378, DOI 10.1261/rna.1066008; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; Pearce LR, 2010, BIOCHEM J, V431, P245, DOI 10.1042/BJ20101024; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; Polson HEJ, 2010, AUTOPHAGY, V6, P506, DOI 10.4161/auto.6.4.11863; Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200; Shah OJ, 2004, CURR BIOL, V14, P1650, DOI 10.1016/j.cub.2004.08.026; Smith FM, 2007, MOL CELL BIOL, V27, P5871, DOI 10.1128/MCB.02087-06; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Wan X, 2007, ONCOGENE, V26, P1932, DOI 10.1038/sj.onc.1209990; Wang L, 2007, MOL CELL BIOL, V27, P6497, DOI 10.1128/MCB.00679-07; Yip CK, 2010, MOL CELL, V38, P768, DOI 10.1016/j.molcel.2010.05.017; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	31	768	795	1	92	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 10	2011	332	6035					1317	1322		10.1126/science.1199498	http://dx.doi.org/10.1126/science.1199498			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	775EP	21659604	Green Submitted, Green Accepted			2022-12-24	WOS:000291441700044
J	Scheel, C; Eaton, EN; Li, SHJ; Chaffer, CL; Reinhardt, F; Kah, KJ; Bell, G; Guo, W; Rubin, J; Richardson, AL; Weinberg, RA				Scheel, Christina; Eaton, Elinor Ng; Li, Sophia Hsin-Jung; Chaffer, Christine L.; Reinhardt, Ferenc; Kah, Kong-Jie; Bell, George; Guo, Wenjun; Rubin, Jeffrey; Richardson, Andrea L.; Weinberg, Robert A.			Paracrine and Autocrine Signals Induce and Maintain Mesenchymal and Stem Cell States in the Breast	CELL			English	Article							STEM/PROGENITOR CELLS; CANCER-CELLS; IN-VITRO; TRANSITION; METASTASIS; PROPAGATION; EXPRESSION; PATHWAYS; DISEASE; LINES	The epithelial-mesenchymal transition (EMT) has been associated with the acquisition of motility, invasiveness, and self-renewal traits. During both normal development and tumor pathogenesis, this change in cell phenotype is induced by contextual signals that epithelial cells receive from their microenvironment. The signals that are responsible for inducing an EMT and maintaining the resulting cellular state have been unclear. We describe three signaling pathways, involving transforming growth factor (TGF)-beta and canonical and noncanonical Wnt signaling, that collaborate to induce activation of the EMT program and thereafter function in an autocrine fashion to maintain the resulting mesenchymal state. Downregulation of endogenously synthesized inhibitors of autocrine signals in epithelial cells enables the induction of the EMT program. Conversely, disruption of autocrine signaling by added inhibitors of these pathways inhibits migration and self-renewal in primary mammary epithelial cells and reduces tumorigenicity and metastasis by their transformed derivatives.	[Scheel, Christina; Eaton, Elinor Ng; Li, Sophia Hsin-Jung; Chaffer, Christine L.; Reinhardt, Ferenc; Kah, Kong-Jie; Bell, George; Guo, Wenjun; Weinberg, Robert A.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Li, Sophia Hsin-Jung; Kah, Kong-Jie; Weinberg, Robert A.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Richardson, Andrea L.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Weinberg, Robert A.] MIT Ludwig Ctr Mol Oncol, Cambridge, MA 02139 USA; [Rubin, Jeffrey] NCI, Bethesda, MD 20892 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Harvard University; Brigham & Women's Hospital; Massachusetts Institute of Technology (MIT); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Scheel, C (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	scheel@wi.mit.edu; weinberg@wi.mit.edu		Li, Sophia Hsin-Jung/0000-0001-8972-6921	National Institutes of Health/National Cancer Institute [CA12515, DE020817]; Massachusetts Institute of Technology Ludwig Center for Molecular Oncology; Ludwig Fellowship for Metastasis Research; Breast Cancer Research Foundation; Harvard Breast Cancer SPORE; Department of Defense; Samuel Waxman Foundation; NATIONAL CANCER INSTITUTE [U54CA126515, F32CA144404, ZIABC010251] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [RC1DE020817] Funding Source: NIH RePORTER	National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Massachusetts Institute of Technology Ludwig Center for Molecular Oncology; Ludwig Fellowship for Metastasis Research; Breast Cancer Research Foundation; Harvard Breast Cancer SPORE; Department of Defense(United States Department of Defense); Samuel Waxman Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We thank Brian Bierie, Thijn Brummelkamp, Sunny Gupta, Katharina Leuchte, Julia Rastelli, Andreas Scheel, Scott Valastyan, and Irene Wuethrich for critical reading of the manuscript, members of the Weinberg lab for discussion, John Stingl for protocols, the Whitehead Microarray and Flow Cytometry Cores, and the W.M. Keck Microscopy Facility for technical support. This research was supported by the National Institutes of Health/National Cancer Institute (R.A.W.; CA12515 and DE020817), Massachusetts Institute of Technology Ludwig Center for Molecular Oncology (R.A.W.), Ludwig Fellowship for Metastasis Research (C.S.), Breast Cancer Research Foundation (A.L.R. and R.A.W.), Harvard Breast Cancer SPORE (A.L.R. and R.A.W.), Department of Defense Breast Cancer Research Program Idea Award (R.A.W.), and Samuel Waxman Foundation (R.A.W.). C.S. and R.A.W. are inventors on a patent application in part based on findings detailed in this manuscript.	Abou-Khalil R, 2009, CELL STEM CELL, V5, P298, DOI 10.1016/j.stem.2009.06.001; Acloque H, 2009, J CLIN INVEST, V119, P1438, DOI 10.1172/JCI38019; Bafico A, 2004, CANCER CELL, V6, P497, DOI 10.1016/j.ccr.2004.09.032; Brabletz T, 2005, NAT REV CANCER, V5, P744, DOI 10.1038/nrc1694; Brown KA, 2004, BREAST CANCER RES, V6, pR215, DOI 10.1186/bcr778; Casas E, 2011, CANCER RES, V71, P245, DOI 10.1158/0008-5472.CAN-10-2330; CHAFFER CL, 2011, P NATL ACAD IN PRESS; Dissanayake SK, 2007, J BIOL CHEM, V282, P17259, DOI 10.1074/jbc.M700075200; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Eirew P, 2008, NAT MED, V14, P1384, DOI 10.1038/nm.1791; Elenbaas B, 2001, GENE DEV, V15, P50, DOI 10.1101/gad.828901; Fillmore CM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1982; Guo X, 2009, CELL RES, V19, P71, DOI 10.1038/cr.2008.302; Kuhnert F, 2004, P NATL ACAD SCI USA, V101, P266, DOI 10.1073/pnas.2536800100; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; Oft M, 1996, GENE DEV, V10, P2462, DOI 10.1101/gad.10.19.2462; Ogawa K, 2007, J CELL SCI, V120, P55, DOI 10.1242/jcs.03296; Onder TT, 2008, CANCER RES, V68, P3645, DOI 10.1158/0008-5472.CAN-07-2938; Pukrop T, 2006, P NATL ACAD SCI USA, V103, P5454, DOI 10.1073/pnas.0509703103; Rider DA, 2008, STEM CELLS, V26, P1598, DOI 10.1634/stemcells.2007-0480; Singh A, 2010, ONCOGENE, V29, P4741, DOI 10.1038/onc.2010.215; Suzuki H, 2004, NAT GENET, V36, P417, DOI 10.1038/ng1330; Taube JH, 2010, P NATL ACAD SCI USA, V107, P15449, DOI 10.1073/pnas.1004900107; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Toda H, 2003, J BIOL CHEM, V278, P35491, DOI 10.1074/jbc.M305342200; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Zeisberg M, 2003, NAT MED, V9, P964, DOI 10.1038/nm888	29	661	691	6	129	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 10	2011	145	6					926	940		10.1016/j.cell.2011.04.029	http://dx.doi.org/10.1016/j.cell.2011.04.029			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	775LS	21663795	Bronze, Green Accepted, Green Published			2022-12-24	WOS:000291461600019
J	Malovannaya, A; Lanz, RB; Jung, SY; Bulynko, Y; Le, NT; Chan, DW; Ding, C; Shi, Y; Yucer, N; Krenciute, G; Kim, BJ; Li, CS; Chen, R; Li, W; Wang, Y; O'Malley, BW; Qin, J				Malovannaya, Anna; Lanz, Rainer B.; Jung, Sung Yun; Bulynko, Yaroslava; Le, Nguyen T.; Chan, Doug W.; Ding, Chen; Shi, Yi; Yucer, Nur; Krenciute, Giedre; Kim, Beom-Jun; Li, Chunshu; Chen, Rui; Li, Wei; Wang, Yi; O'Malley, Bert W.; Qin, Jun			Analysis of the Human Endogenous Coregulator Complexome	CELL			English	Article							NUCLEAR RECEPTOR COREGULATORS; CUL3-BASED E3 LIGASE; COFACTOR COMPLEX; PROTEIN; COACTIVATOR; BRCA1; SRC-3/AIB1; DEGRADATION; ADAPTER; BREAST	Elucidation of endogenous cellular protein-protein interactions and their networks is most desirable for biological studies. Here we report our study of endogenous human coregulator protein complex networks obtained from integrative mass spectrometry-based analysis of 3290 affinity purifications. By preserving weak protein interactions during complex isolation and utilizing high levels of reciprocity in the large dataset, we identified many unreported protein associations, such as a transcriptional network formed by ZMYND8, ZNF687, and ZNF592. Furthermore, our work revealed a tiered interplay within networks that share common proteins, providing a conceptual organization of a cellular proteome composed of minimal endogenous modules (MEMOs), complex isoforms (uniCOREs), and regulatory complex-complex interaction networks (CCIs). This resource will effectively fill a void in linking correlative genomic studies with an understanding of transcriptional regulatory protein functions within the proteome for formulation and testing of future hypotheses.	[Malovannaya, Anna; Lanz, Rainer B.; Jung, Sung Yun; Bulynko, Yaroslava; Chan, Doug W.; Li, Wei; Wang, Yi; O'Malley, Bert W.; Qin, Jun] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Malovannaya, Anna; Jung, Sung Yun; Le, Nguyen T.; Chan, Doug W.; Ding, Chen; Shi, Yi; Yucer, Nur; Krenciute, Giedre; Kim, Beom-Jun; Li, Chunshu; Wang, Yi; Qin, Jun] Baylor Coll Med, Ctr Mol Discovery, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Chen, Rui] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	O'Malley, BW (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.	berto@bcm.edu; jqin@bcm.edu	Krenciute, Giedre/N-8094-2018; Shi, Yi/P-7972-2018	Krenciute, Giedre/0000-0003-4335-0644; Shi, Yi/0000-0002-2761-8324; Li, Wei/0000-0001-9931-5990; Jung, Sung Yun/0000-0003-1521-7977	NURSA [U19-DK62434]; Proteomics Strand; Collaborative Bridging Project; Center for Molecular Discovery; McLean Foundation at Baylor College of Medicine.; NIH [HD08188, DK059820, CA84199, GM080703]; CPRIT [RP101499]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD007857, R01HD008188] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [F32HD008188] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA084199] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK059820, U19DK062434] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080703] Funding Source: NIH RePORTER	NURSA; Proteomics Strand; Collaborative Bridging Project; Center for Molecular Discovery; McLean Foundation at Baylor College of Medicine.; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CPRIT; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported partially by the NURSA grant U19-DK62434 including the Proteomics Strand funding to B.W.O. and J.Q. and the Collaborative Bridging Project funding to R. B. L. We acknowledge the significant financial support of the Center for Molecular Discovery and the McLean Foundation at Baylor College of Medicine. NIH grants HD08188 and DK059820 to B.W.O., CA84199 to J.Q., GM080703 to Y.W., and CPRIT RP101499 fellowship to N.Y. are also acknowledged.	Alberts B, 1998, CELL, V92, P291, DOI 10.1016/S0092-8674(00)80922-8; Anzick SL, 1997, SCIENCE, V277, P965, DOI 10.1126/science.277.5328.965; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Brown LA, 2010, BREAST CANCER RES TR, V121, P347, DOI 10.1007/s10549-009-0479-x; Cai Y, 2010, J BIOL CHEM, V285, P4268, DOI 10.1074/jbc.C109.087981; Coste A, 2008, P NATL ACAD SCI USA, V105, P17187, DOI 10.1073/pnas.0808207105; Cullinan SB, 2004, MOL CELL BIOL, V24, P8477, DOI 10.1128/MCB.24.19.8477-8486.2004; de Mora JF, 2000, MOL CELL BIOL, V20, P5041, DOI 10.1128/MCB.20.14.5041-5047.2000; Feng L, 2009, GENE DEV, V23, P719, DOI 10.1101/gad.1770609; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Gianni M, 2006, EMBO J, V25, P739, DOI 10.1038/sj.emboj.7600981; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Glaros S, 2007, ONCOGENE, V26, P7058, DOI 10.1038/sj.onc.1210514; Gu W, 1999, MOL CELL, V3, P97, DOI 10.1016/S1097-2765(00)80178-1; Guenther MG, 2000, GENE DEV, V14, P1048; Hakimi MA, 2002, P NATL ACAD SCI USA, V99, P7420, DOI 10.1073/pnas.112008599; Ishikawa H, 2006, FEBS LETT, V580, P4784, DOI 10.1016/j.febslet.2006.07.066; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Kaeser MD, 2008, J BIOL CHEM, V283, P32254, DOI 10.1074/jbc.M806061200; Kim HT, 2008, MOL CELLS, V25, P457; Kim H, 2007, SCIENCE, V316, P1202, DOI 10.1126/science.1139621; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Kocher T, 2007, NAT METHODS, V4, P807, DOI 10.1038/NMETH1093; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Kuang SQ, 2004, CANCER RES, V64, P1875, DOI 10.1158/0008-5472.CAN-03-3745; Lanz RB, 2006, NUCLEIC ACIDS RES, V34, pD221, DOI 10.1093/nar/gkj029; Lanz RB, 2010, MOL ENDOCRINOL, V24, P859, DOI 10.1210/me.2009-0499; Li C, 2008, MOL CELL, V31, P835, DOI 10.1016/j.molcel.2008.07.019; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; Lonard DM, 2007, MOL CELL, V27, P691, DOI 10.1016/j.molcel.2007.08.012; Lonard DM, 2007, ENDOCR REV, V28, P575, DOI 10.1210/er.2007-0012; Louet JF, 2006, P NATL ACAD SCI USA, V103, P17868, DOI 10.1073/pnas.0608711103; Malovannaya A, 2010, P NATL ACAD SCI USA, V107, P2431, DOI 10.1073/pnas.0912599106; McKenna NJ, 1999, ENDOCR REV, V20, P321, DOI 10.1210/er.20.3.321; Mendjan S, 2006, MOL CELL, V21, P811, DOI 10.1016/j.molcel.2006.02.007; O'Malley BW, 2008, CURR OPIN CELL BIOL, V20, P310, DOI 10.1016/j.ceb.2008.04.005; Poleshko A, 2010, J BIOL CHEM, V285, P422, DOI 10.1074/jbc.M109.064667; Raouf A, 2005, JNCI-J NATL CANCER I, V97, P1302, DOI 10.1093/jnci/dji254; Ruepp A, 2010, NUCLEIC ACIDS RES, V38, pD497, DOI 10.1093/nar/gkp914; Santarius T, 2010, NAT REV CANCER, V10, P59, DOI 10.1038/nrc2771; Shao G, 2009, GENE DEV, V23, P740, DOI 10.1101/gad.1739609; Shao G, 2009, P NATL ACAD SCI USA, V106, P3166, DOI 10.1073/pnas.0807485106; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Torres-Arzayus MI, 2004, CANCER CELL, V6, P263, DOI 10.1016/j.ccr.2004.06.027; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Wang B, 2007, SCIENCE, V316, P1194, DOI 10.1126/science.1139476; Wang B, 2009, GENE DEV, V23, P729, DOI 10.1101/gad.1770309; Wang GG, 2009, NATURE, V459, P847, DOI 10.1038/nature08036; Wang WD, 1996, EMBO J, V15, P5370, DOI 10.1002/j.1460-2075.1996.tb00921.x; Wang Y, 2000, GENE DEV, V14, P927; Weake VM, 2010, NAT REV GENET, V11, P426, DOI 10.1038/nrg2781; Wu RC, 2004, MOL CELL, V15, P937, DOI 10.1016/j.molcel.2004.08.019; Xue YT, 1998, MOL CELL, V2, P851, DOI 10.1016/S1097-2765(00)80299-3; Yan J, 2006, ACTA PHARMACOL SIN, V27, P387, DOI 10.1111/j.1745-7254.2006.00315.x; Yan J, 2008, CANCER RES, V68, P5460, DOI 10.1158/0008-5472.CAN-08-0955; Yan J, 2007, CANCER RES, V67, P6647, DOI 10.1158/0008-5472.CAN-07-0924; Yi P, 2008, MOL CELL, V29, P465, DOI 10.1016/j.molcel.2007.12.030; York B, 2010, P NATL ACAD SCI USA, V107, P11122, DOI 10.1073/pnas.1005262107; Yu CD, 2007, MOL CELL, V25, P765, DOI 10.1016/j.molcel.2007.01.025; Zeng WL, 2010, BIOCHEM BIOPH RES CO, V394, P1024, DOI 10.1016/j.bbrc.2010.03.115; Zhang DD, 2004, MOL CELL BIOL, V24, P10941, DOI 10.1128/MCB.24.24.10941-10953.2004; Zhang F, 2009, MOL CANCER RES, V7, P1110, DOI 10.1158/1541-7786.MCR-09-0123	63	303	312	0	44	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 27	2011	145	5					787	799		10.1016/j.cell.2011.05.006	http://dx.doi.org/10.1016/j.cell.2011.05.006			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	769MR	21620140	Bronze, Green Accepted			2022-12-24	WOS:000291018600017
J	Hah, N; Danko, CG; Core, L; Waterfall, JJ; Siepel, A; Lis, JT; Kraus, WL				Hah, Nasun; Danko, Charles G.; Core, Leighton; Waterfall, Joshua J.; Siepel, Adam; Lis, John T.; Kraus, W. Lee			A Rapid, Extensive, and Transient Transcriptional Response to Estrogen Signaling in Breast Cancer Cells	CELL			English	Article							DIVERGENT TRANSCRIPTION; ACTIVE PROMOTERS; GENE-EXPRESSION; RECEPTOR; RNA; ELEMENTS; ACTIVATION; DISEASE; ALPHA	We report the immediate effects of estrogen signaling on the transcriptome of breast cancer cells using global run-on and sequencing (GRO-seq). The data were analyzed using a new bioinformatic approach that allowed us to identify transcripts directly from the GRO-seq data. We found that estrogen signaling directly regulates a strikingly large fraction of the transcriptome in a rapid, robust, and unexpectedly transient manner. In addition to protein-coding genes, estrogen regulates the distribution and activity of all three RNA polymerases and virtually every class of noncoding RNA that has been described to date. We also identified a large number of previously undetected estrogen-regulated intergenic transcripts, many of which are found proximal to estrogen receptor binding sites. Collectively, our results provide the most comprehensive measurement of the primary and immediate estrogen effects to date and a resource for understanding rapid signal-dependent transcription in other systems.	[Hah, Nasun; Danko, Charles G.; Core, Leighton; Waterfall, Joshua J.; Lis, John T.; Kraus, W. Lee] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA; [Hah, Nasun; Lis, John T.; Kraus, W. Lee] Cornell Univ, Grad Field Biochem Mol & Cell Biol, Ithaca, NY 14853 USA; [Danko, Charles G.; Siepel, Adam] Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY 14853 USA; [Kraus, W. Lee] Univ Texas SW Med Ctr Dallas, Cecil H & Ida Green Ctr Reprod Biol Sci, Dallas, TX 75390 USA; [Kraus, W. Lee] Univ Texas SW Med Ctr Dallas, Basic Res Div, Dept Obstet & Gynecol, Dallas, TX 75390 USA	Cornell University; Cornell University; Cornell University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Kraus, WL (corresponding author), Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA.	lee.kraus@utsouthwestern.edu		Siepel, Adam/0000-0002-3557-7219; Hah, Nasun/0000-0003-1509-2799; Danko, Charles/0000-0002-1999-7125; Waterfall, Joshua/0000-0002-3762-5050	NIH [T32HD052471, GM25232, HG04845]; PhRMA Foundation; NIH/NIDDK [DK058110]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD052471] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004845] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058110] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM025232, R37GM025232] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PhRMA Foundation; NIH/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Andre Martins for helpful insights and suggestions and Xin Luo and Shrikanth Gadad for critical comments on this manuscript. This work was supported by an NIH training award (T32HD052471) and a postdoctoral fellowship from the PhRMA Foundation to C. G. D., grants from the NIH (GM25232 and HG04845) to J.T.L., and a grant from the NIH/NIDDK (DK058110) to W.L.K.	Acevedo ML, 2004, ESSAYS BIOCHEM, V40, P73, DOI 10.1042/bse0400073; Beissbarth T, 2004, BIOINFORMATICS, V20, P1464, DOI 10.1093/bioinformatics/bth088; Boettiger AN, 2009, SCIENCE, V325, P471, DOI 10.1126/science.1173976; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; Cheung E, 2010, ANNU REV PHYSIOL, V72, P191, DOI 10.1146/annurev-physiol-021909-135840; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Danko CG, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-31; Deroo BJ, 2006, J CLIN INVEST, V116, P561, DOI 10.1172/JCI27987; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Frasor J, 2003, ENDOCRINOLOGY, V144, P4562, DOI 10.1210/en.2003-0567; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Kininis Miltiadis, 2008, Nucl Recept Signal, V6, pe005, DOI 10.1621/nrs.06005; Kininis M, 2009, MOL CELL BIOL, V29, P1123, DOI 10.1128/MCB.00841-08; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Lin CY, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r66; Lis J, 1998, COLD SPRING HARB SYM, V63, P347, DOI 10.1101/sqb.1998.63.347; Liu FQ, 2010, SCIENCE, V327, P94, DOI 10.1126/science.1180278; Mitchison, 1998, BIOLOGICAL SEQUENCE; Morris KV, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000258; Pan YF, 2008, J BIOL CHEM, V283, P32977, DOI 10.1074/jbc.M802024200; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Ruhl DD, 2009, PROG MOL BIOL TRANSL, V87, P137, DOI 10.1016/S1877-1173(09)87005-1; Seila AC, 2009, CELL CYCLE, V8, P2557, DOI 10.4161/cc.8.16.9305; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; Stadtman TC, 1996, ANNU REV BIOCHEM, V65, P83, DOI 10.1146/annurev.bi.65.070196.000503; Theodorou V, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2470; Warner M, 1999, CURR OPIN OBSTET GYN, V11, P249, DOI 10.1097/00001703-199906000-00003; Welboren WJ, 2009, EMBO J, V28, P1418, DOI 10.1038/emboj.2009.88; Werner A, 2009, RNA BIOL, V6, P43, DOI 10.4161/rna.6.1.7568; WIDELITZ RB, 1987, EXP CELL RES, V168, P539, DOI 10.1016/0014-4827(87)90026-7	36	351	355	0	35	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 13	2011	145	4					622	634		10.1016/j.cell.2011.03.042	http://dx.doi.org/10.1016/j.cell.2011.03.042			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	763MF	21549415	Bronze, Green Accepted			2022-12-24	WOS:000290560800014
J	Charleston, B; Bankowski, BM; Gubbins, S; Chase-Topping, ME; Schley, D; Howey, R; Barnett, PV; Gibson, D; Juleff, ND; Woolhouse, MEJ				Charleston, Bryan; Bankowski, Bartlomies M.; Gubbins, Simon; Chase-Topping, Margo E.; Schley, David; Howey, Richard; Barnett, Paul V.; Gibson, Debi; Juleff, Nicholas D.; Woolhouse, Mark E. J.			Relationship Between Clinical Signs and Transmission of an Infectious Disease and the Implications for Control	SCIENCE			English	Article							MOUTH-DISEASE; VIRUS TRANSMISSION; INFLUENZA; DYNAMICS; OUTBREAK	Control of many infectious diseases relies on the detection of clinical cases and the isolation, removal, or treatment of cases and their contacts. The success of such "reactive" strategies is influenced by the fraction of transmission occurring before signs appear. We performed experimental studies of foot-and-mouth disease transmission in cattle and estimated this fraction at less than half the value expected from detecting virus in body fluids, the standard proxy measure of infectiousness. This is because the infectious period is shorter (mean 1.7 days) than currently realized, and animals are not infectious until, on average, 0.5 days after clinical signs appear. These results imply that controversial preemptive control measures may be unnecessary; instead, efforts should be directed at early detection of infection and rapid intervention.	[Charleston, Bryan; Bankowski, Bartlomies M.; Gubbins, Simon; Schley, David; Barnett, Paul V.; Gibson, Debi; Juleff, Nicholas D.] AFRC, Inst Anim Hlth, Pirbright Lab, Woking GU24 0NF, Surrey, England; [Chase-Topping, Margo E.; Howey, Richard; Woolhouse, Mark E. J.] Univ Edinburgh, Ashworth Labs, Ctr Immun Infect & Evolut, Edinburgh EH9 3JT, Midlothian, Scotland	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; Pirbright Institute; University of Edinburgh	Charleston, B (corresponding author), AFRC, Inst Anim Hlth, Pirbright Lab, Ash Rd, Woking GU24 0NF, Surrey, England.	bryan.charleston@bbsrc.ac.uk		Charleston, Bryan/0000-0002-6952-9338; Gubbins, Simon/0000-0003-0538-4173	Biotechnology and Biological Sciences Research Council, UK [BBSB00549]; Biotechnology and Biological Sciences Research Council [BBSEI00001444]; Wellcome Trust; Biotechnology and Biological Sciences Research Council [BBS/B/00549, BBS/B/01480, BBS/E/I/00001444] Funding Source: researchfish; BBSRC [BBS/E/I/00001444] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council, UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank L. Fitzpatrick, C. Randal, and M. Jenkins for their assistance with the handling and management of experimental animals; P. Hamblin and P. Keel for help and advice with serology assays; L. Reid, M. Windsor, and S. Cox for assistance with laboratory assays; S. Alexandersen, D. Paton, and N. Savill for valuable advice on study design; and B. Grenfell, M. Keeling, M. de Jong, A. Graham, C. Dye, and four anonymous referees fur insightful comments. The work was funded by the Biotechnology and Biological Sciences Research Council (grant BBSB00549), UK. B.C. and P.V.B. are Jenner Investigators. S.G. and D.S. acknowledge funding from the Biotechnology and Biological Sciences Research Council (grant BBSEI00001444). M.E.C.T. is partly supported by the Wellcome Trust.	Carrat F, 2008, AM J EPIDEMIOL, V167, P775, DOI 10.1093/aje/kwm375; Chinsangaram J, 1999, J VIROL, V73, P9891, DOI 10.1128/JVI.73.12.9891-9898.1999; Fraser C, 2004, P NATL ACAD SCI USA, V101, P6146, DOI 10.1073/pnas.0307506101; Howey R, 2009, J R SOC INTERFACE, V6, P835, DOI 10.1098/rsif.2008.0434; King DA, 2006, SCIENCE, V313, P1392, DOI 10.1126/science.1129134; Lau LLH, 2010, J INFECT DIS, V201, P1509, DOI 10.1086/652241; Lipsitch M, 2003, SCIENCE, V300, P1966, DOI 10.1126/science.1086616; Mardones F, 2010, VET RES, V41, DOI 10.1051/vetres/2010017; Orsel K, 2009, PREV VET MED, V88, P158, DOI 10.1016/j.prevetmed.2008.09.001; Orsel K, 2007, VACCINE, V25, P327, DOI 10.1016/j.vaccine.2006.07.030; Paton DJ, 2010, VET REC, V166, P569, DOI 10.1136/vr.c2300; Paton DJ, 2009, PHILOS T R SOC B, V364, P2657, DOI 10.1098/rstb.2009.0100; Patrozou E, 2009, PUBLIC HEALTH REP, V124, P193, DOI 10.1177/003335490912400205; SCOTT GR, 1981, VIRUS DISEASES FOOD, V2, P401; Tildesley MJ, 2009, P ROY SOC B-BIOL SCI, V276, P3239, DOI 10.1098/rspb.2009.0427; Tracy CS, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-470; *WHO, WHO FACTSH; WILLIAMS GC, 1991, Q REV BIOL, V66, P1, DOI 10.1086/417048; Yamagishi T, 2010, JPN J INFECT DIS, V63, P327; Zinsstag J, 2001, SCIENCE, V294, P477, DOI 10.1126/science.294.5542.477	20	107	112	3	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 6	2011	332	6030					726	729		10.1126/science.1199884	http://dx.doi.org/10.1126/science.1199884			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759RK	21551063	Green Accepted			2022-12-24	WOS:000290265800045
J	Deutsch, C; Brix, H; Ito, T; Frenzel, H; Thompson, L				Deutsch, Curtis; Brix, Holger; Ito, Taka; Frenzel, Hartmut; Thompson, LuAnne			Climate-Forced Variability of Ocean Hypoxia	SCIENCE			English	Article							NORTH PACIFIC; ARABIAN SEA; DENITRIFICATION; NITROGEN; RATIOS; WATERS	Oxygen (O-2) is a critical constraint on marine ecosystems. As oceanic O-2 falls to hypoxic concentrations, habitability for aerobic organisms decreases rapidly. We show that the spatial extent of hypoxia is highly sensitive to small changes in the ocean's O-2 content, with maximum responses at suboxic concentrations where anaerobic metabolisms predominate. In model-based reconstructions of historical oxygen changes, the world's largest suboxic zone, in the Pacific Ocean, varies in size by a factor of 2. This is attributable to climate-driven changes in the depth of the tropical and subtropical thermocline that have multiplicative effects on respiration rates in low-O-2 water. The same mechanism yields even larger fluctuations in the rate of nitrogen removal by denitrification, creating a link between decadal climate oscillations and the nutrient limitation of marine photosynthesis.	[Deutsch, Curtis; Brix, Holger; Frenzel, Hartmut] Univ Calif Los Angeles, Dept Atmospher & Ocean Sci, Los Angeles, CA 90095 USA; [Ito, Taka] Colorado State Univ, Dept Atmospher Sci, Ft Collins, CO 80523 USA; [Thompson, LuAnne] Univ Washington, Sch Oceanog, Seattle, WA 98195 USA	University of California System; University of California Los Angeles; Colorado State University; University of Washington; University of Washington Seattle	Deutsch, C (corresponding author), Univ Calif Los Angeles, Dept Atmospher & Ocean Sci, Los Angeles, CA 90095 USA.	cdeutsch@atmos.ucla.edu	Thompson, LuAnne/AAA-1000-2020; Ito, Takamitsu/F-3856-2010	Thompson, LuAnne/0000-0001-8295-0533; Ito, Takamitsu/0000-0001-9873-099X; Brix, Holger/0000-0003-4229-6164	Gordon and Betty Moore Foundation; NSF [OCE-0851483, OCE-0851497]	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); NSF(National Science Foundation (NSF))	Supported by a grant from the Gordon and Betty Moore Foundation (C. D.) and NSF grants OCE-0851483 (C. D.) and OCE-0851497 (T.I.).	ALTABET MA, 1995, NATURE, V373, P506, DOI 10.1038/373506a0; ANDERSON LA, 1994, GLOBAL BIOGEOCHEM CY, V8, P65, DOI 10.1029/93GB03318; Bograd SJ, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034185; Bopp L, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001445; Carton JA, 2008, MON WEATHER REV, V136, P2999, DOI 10.1175/2007MWR1978.1; Castro CG, 2001, GLOBAL BIOGEOCHEM CY, V15, P819, DOI 10.1029/2000GB001324; Chan F, 2008, SCIENCE, V319, P920, DOI 10.1126/science.1149016; Codispoti LA, 2001, SCI MAR, V65, P85, DOI 10.3989/scimar.2001.65s285; CODISPOTI LA, 1989, LIFE SCI R, V44, P377; Deutsch C, 2001, GLOBAL BIOGEOCHEM CY, V15, P483, DOI 10.1029/2000GB001291; Emerson S, 2004, J OCEANOGR, V60, P139, DOI 10.1023/B:JOCE.0000038323.62130.a0; GANESHRAM RS, 1995, NATURE, V376, P755, DOI 10.1038/376755a0; Garcia H., 2006, NOAA ATLAS NESDROS I, V63; Hallberg R, 2006, J PHYS OCEANOGR, V36, P2232, DOI 10.1175/JPO2980.1; Ito T, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL041595; Karstensen J, 2008, PROG OCEANOGR, V77, P331, DOI 10.1016/j.pocean.2007.05.009; Keeling RF, 2010, ANNU REV MAR SCI, V2, P199, DOI 10.1146/annurev.marine.010908.163855; Keeling RF, 2002, P NATL ACAD SCI USA, V99, P7848, DOI 10.1073/pnas.122154899; Mantua NJ, 1997, B AM METEOROL SOC, V78, P1069, DOI 10.1175/1520-0477(1997)078<1069:APICOW>2.0.CO;2; Martinez E, 2009, SCIENCE, V326, P1253, DOI 10.1126/science.1177012; McClatchie S, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044497; Mecking S, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB003101; Stramma L, 2010, DEEP-SEA RES PT I, V57, P587, DOI 10.1016/j.dsr.2010.01.005; van Geen A, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2003PA000911; Vaquer-Sunyer R, 2008, P NATL ACAD SCI USA, V105, P15452, DOI 10.1073/pnas.0803833105; Ward BB, 2009, NATURE, V461, P78, DOI 10.1038/nature08276; Whitney FA, 2007, PROG OCEANOGR, V75, P179, DOI 10.1016/j.pocean.2007.08.007	27	234	239	3	168	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 15	2011	333	6040					336	339		10.1126/science.1202422	http://dx.doi.org/10.1126/science.1202422			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	792HF	21659566				2022-12-24	WOS:000292732000041
J	Xiao, T; Staub, W; Robles, E; Gosse, NJ; Cole, GJ; Baier, H				Xiao, Tong; Staub, Wendy; Robles, Estuardo; Gosse, Nathan J.; Cole, Gregory J.; Baier, Herwig			Assembly of Lamina-Specific Neuronal Connections by Slit Bound to Type IV Collagen	CELL			English	Article							HEPARAN-SULFATE PROTEOGLYCANS; AXON GUIDANCE; OPTIC TECTUM; ROBO RECEPTORS; RETINAL AXONS; RETINOTECTAL PROJECTION; EMBRYONIC ZEBRAFISH; BASEMENT-MEMBRANE; LATERAL POSITION; EXPRESSION	The mechanisms that generate specific neuronal connections in the brain are under intense investigation. In zebrafish, retinal ganglion cells project their axons into at least six layers within the neuropil of the midbrain tectum. Each axon elaborates a single, planar arbor in one of the target layers and forms synapses onto the dendrites of tectal neurons. We show that the laminar specificity of retinotectal connections does not depend on self-sorting interactions among RGC axons. Rather, tectum-derived Slit1, signaling through axonal Robo2, guides neurites to their target layer. Genetic and biochemical studies indicate that Slit binds to Dragnet (Col4a5), a type IV Collagen, which forms the basement membrane on the surface of the tectum. We further show that radial glial endfeet are required for the basement-membrane anchoring of Slit. We propose that Slit1 signaling, perhaps in the form of a superficial-to-deep gradient, presents laminar positional cues to ingrowing retinal axons.	[Xiao, Tong; Staub, Wendy; Robles, Estuardo; Gosse, Nathan J.; Baier, Herwig] Univ Calif San Francisco, Dept Physiol, Program Neurosci, San Francisco, CA 94158 USA; [Xiao, Tong; Staub, Wendy; Robles, Estuardo; Gosse, Nathan J.; Baier, Herwig] Univ Calif San Francisco, Dept Physiol, Genet Program, San Francisco, CA 94158 USA; [Xiao, Tong; Staub, Wendy; Robles, Estuardo; Gosse, Nathan J.; Baier, Herwig] Univ Calif San Francisco, Dept Physiol, Program Dev Biol, San Francisco, CA 94158 USA; [Cole, Gregory J.] N Carolina Cent Univ, Julius L Chambers Biomed Biotechnol Res Inst, Durham, NC 27707 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of North Carolina; North Carolina Central University	Baier, H (corresponding author), Max Planck Inst Neurobiol, Klopferspitz 18, D-82152 Martinsried, Germany.	herwig.baier@ucsf.edu		Robles, Estuardo/0000-0002-1202-2050	NIH [R01 EY013855, EY012406]; NATIONAL EYE INSTITUTE [R01EY013855, R01EY012406] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank Hitoshi Okamoto, Marc Ekker, Chi-Bin Chien and members of our laboratory for reagents and fish lines. This work was funded by NIH R01 EY013855 and EY012406.	Arrenberg AB, 2009, P NATL ACAD SCI USA, V106, P17968, DOI 10.1073/pnas.0906252106; Baier H, 1996, DEVELOPMENT, V123, P415; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Campbell DS, 2007, NEURON, V55, P231, DOI 10.1016/j.neuron.2007.06.034; Chen Z, 2008, NEURON, V58, P325, DOI 10.1016/j.neuron.2008.02.016; Curado S, 2008, NAT PROTOC, V3, P948, DOI 10.1038/nprot.2008.58; Dalkic E, 2006, DEV GENES EVOL, V216, P555, DOI 10.1007/s00427-006-0070-y; Davison JM, 2007, DEV BIOL, V304, P811, DOI 10.1016/j.ydbio.2007.01.033; Erskine L, 2000, J NEUROSCI, V20, P4975; Fricke C, 2001, SCIENCE, V292, P507, DOI 10.1126/science.1059496; Ghanem N, 2003, GENOME RES, V13, P533, DOI 10.1101/gr.716103; Goodhill GJ, 2003, NEURAL COMPUT, V15, P549, DOI 10.1162/089976603321192077; Gosse NJ, 2008, NATURE, V452, P892, DOI 10.1038/nature06816; Halfter W, 1998, J COMP NEUROL, V397, P105, DOI 10.1002/(SICI)1096-9861(19980720)397:1<105::AID-CNE8>3.0.CO;2-4; Halfter W, 2002, J NEUROSCI, V22, P6029; Haubst N, 2006, DEVELOPMENT, V133, P3245, DOI 10.1242/dev.02486; Hong KS, 1999, CELL, V97, P927, DOI 10.1016/S0092-8674(00)80804-1; Hu HY, 2001, NAT NEUROSCI, V4, P695, DOI 10.1038/89482; Huberman AD, 2008, NEURON, V59, P425, DOI 10.1016/j.neuron.2008.07.018; Huberman AD, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001743; Huberman AD, 2009, NEURON, V62, P327, DOI 10.1016/j.neuron.2009.04.014; Hussain SA, 2006, J BIOL CHEM, V281, P39693, DOI 10.1074/jbc.M609384200; Hutson LD, 2002, NEURON, V33, P205, DOI 10.1016/S0896-6273(01)00579-7; Inoue A, 1997, SCIENCE, V276, P1428, DOI 10.1126/science.276.5317.1428; Johnson KG, 2004, CURR BIOL, V14, P499, DOI 10.1016/j.cub.2004.02.005; Kay JN, 2005, DEVELOPMENT, V132, P2573, DOI 10.1242/dev.01831; Kay JN, 2001, NEURON, V30, P725, DOI 10.1016/S0896-6273(01)00312-9; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Lee JS, 2001, DEV DYNAM, V221, P216, DOI 10.1002/dvdy.1136; Lee JS, 2004, NEURON, V44, P947, DOI 10.1016/j.neuron.2004.11.029; Lemke G, 2005, ANNU REV CELL DEV BI, V21, P551, DOI 10.1146/annurev.cellbio.20.022403.093702; Li HS, 1999, CELL, V96, P807, DOI 10.1016/S0092-8674(00)80591-7; Matsuoka RL, 2011, NATURE, V470, P259, DOI 10.1038/nature09675; May PJ, 2006, PROG BRAIN RES, V151, P321, DOI 10.1016/S0079-6123(05)51011-2; Nevin LM, 2011, DEVELOPMENT, V138, P2457, DOI 10.1242/dev.060335; Nevin LM, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-126; Nevin LM, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-36; Plump AS, 2002, NEURON, V33, P219, DOI 10.1016/S0896-6273(01)00586-4; Poggi L, 2005, J CELL BIOL, V171, P991, DOI 10.1083/jcb.200509098; Rajagopalan S, 2000, CELL, V103, P1033, DOI 10.1016/S0092-8674(00)00207-5; Rakic P, 2003, GLIA, V43, P19, DOI 10.1002/glia.10244; Robles E, 2011, FRONT NEURAL CIRCUIT, V5, DOI 10.3389/fncir.2011.00001; Sanes JR, 2009, ANNU REV CELL DEV BI, V25, P161, DOI 10.1146/annurev.cellbio.24.110707.175402; Scott EK, 2007, NAT METHODS, V4, P323, DOI 10.1038/NMETH1033; Scott EK, 2009, FRONT NEURAL CIRCUIT, V3, DOI 10.3389/neuro.04.013.2009; Simpson JH, 2000, CELL, V103, P1019, DOI 10.1016/S0092-8674(00)00206-3; Spitzweck B, 2010, CELL, V140, P409, DOI 10.1016/j.cell.2010.01.002; Steigemann P, 2004, CURR BIOL, V14, P225, DOI 10.1016/j.cub.2004.01.006; Tie J, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000879; Van Vactor D, 2006, CURR OPIN NEUROBIOL, V16, P40, DOI 10.1016/j.conb.2006.01.011; Wang KH, 1999, CELL, V96, P771, DOI 10.1016/S0092-8674(00)80588-7; Wang XM, 2008, NATURE, V455, P72, DOI 10.1038/nature07214; Xiao T, 2003, J NEUROSCI, V23, P4190; Xiao T, 2005, DEVELOPMENT, V132, P2955, DOI 10.1242/dev.01861; Xiao T, 2007, NAT NEUROSCI, V10, P1529, DOI 10.1038/nn2002; YAMAGATA M, 1995, DEVELOPMENT, V121, P189; YAMAGATA M, 1995, DEVELOPMENT, V121, P3763; Yebra M, 2003, DEV CELL, V5, P695, DOI 10.1016/S1534-5807(03)00330-7; Yeo SY, 2004, MECH DEVELOP, V121, P315, DOI 10.1016/j.mod.2004.03.006; Yeo SY, 2001, DEV BIOL, V230, P1, DOI 10.1006/dbio.2000.0105	60	75	75	1	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 8	2011	146	1					164	176		10.1016/j.cell.2011.06.016	http://dx.doi.org/10.1016/j.cell.2011.06.016			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	789TN	21729787	Green Accepted, Bronze			2022-12-24	WOS:000292539300014
J	Keck, JM; Jones, MH; Wong, CCL; Binkley, J; Chen, DC; Jaspersen, SL; Holinger, EP; Xu, T; Niepel, M; Rout, MP; Vogel, J; Sidow, A; Yates, JR; Winey, M				Keck, Jamie M.; Jones, Michele H.; Wong, Catherine C. L.; Binkley, Jonathan; Chen, Daici; Jaspersen, Sue L.; Holinger, Eric P.; Xu, Tao; Niepel, Mario; Rout, Michael P.; Vogel, Jackie; Sidow, Arend; Yates, John R., III; Winey, Mark			A Cell Cycle Phosphoproteome of the Yeast Centrosome	SCIENCE			English	Article							SPINDLE POLE BODY; BUDDING YEAST; PHOSPHORYLATION SITES; PROTEIN; DUPLICATION; KINASE; COMPLEX; CDK1	Centrosomes organize the bipolar mitotic spindle, and centrosomal defects cause chromosome instability. Protein phosphorylation modulates centrosome function, and we provide a comprehensive map of phosphorylation on intact yeast centrosomes (18 proteins). Mass spectrometry was used to identify 297 phosphorylation sites on centrosomes from different cell cycle stages. We observed different modes of phosphoregulation via specific protein kinases, phosphorylation site clustering, and conserved phosphorylated residues. Mutating all eight cyclin-dependent kinase (Cdk)-directed sites within the core component, Spc42, resulted in lethality and reduced centrosomal assembly. Alternatively, mutation of one conserved Cdk site within gamma-tubulin (Tub4-S360D) caused mitotic delay and aberrant anaphase spindle elongation. Our work establishes the extent and complexity of this prominent posttranslational modification in centrosome biology and provides specific examples of phosphorylation control in centrosome function.	[Keck, Jamie M.; Jones, Michele H.; Holinger, Eric P.; Winey, Mark] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA; [Wong, Catherine C. L.; Xu, Tao; Yates, John R., III] Scripps Res Inst, Dept Chem Physiol, La Jolla, CA 92037 USA; [Binkley, Jonathan; Sidow, Arend] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; [Binkley, Jonathan; Sidow, Arend] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; [Chen, Daici; Vogel, Jackie] McGill Univ, Dept Biol, Montreal, PQ H3G 0B1, Canada; [Jaspersen, Sue L.] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Jaspersen, Sue L.] Univ Kansas, Dept Mol & Integrat Physiol, Med Ctr, Kansas City, KS 66160 USA; [Niepel, Mario] Harvard Univ, Dept Syst Biol, Sch Med, Boston, MA 02115 USA; [Rout, Michael P.] Rockefeller Univ, Lab Cellular & Struct Biol, New York, NY 10065 USA	University of Colorado System; University of Colorado Boulder; Scripps Research Institute; Stanford University; Stanford University; McGill University; Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center; Harvard University; Harvard Medical School; Rockefeller University	Winey, M (corresponding author), Univ Colorado, Dept Mol Cellular & Dev Biol, UCB 347, Boulder, CO 80309 USA.	mark.winey@colorado.edu	Rout, Michael/Y-7090-2018; Chen, Daici/AAI-7285-2020; Niepel, Mario/G-5443-2011	Chen, Daici/0000-0002-8872-0592; Niepel, Mario/0000-0003-1415-6295; Wong, Catherine CL/0000-0001-7270-980X; Rout, Michael/0000-0003-2010-706X	NIH [U54 RR022220, R01 GM062427, R01 HG003039, P41 RR011823, GM51312, F32 GM086038, T32 GM008759]; CIHR [MOP-64404]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823, U54RR022220] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003039] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051312, T32GM008759, R01GM062427, F32GM086038] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIHR(Canadian Institutes of Health Research (CIHR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. Pearson, A. Stemm-Wolf, and T. Su for comments on the manuscript; T. Davis and the Winey lab for helpful discussions; E. O'Toole for the electron micrograph; E. Nazarova for assisting with spindle dynamics analysis; M. Riffle for Yeast Resource Center assistance; and D. D'amours for the Cdc28 purification protocol. This work was supported by NIH U54 RR022220 and R01 GM062427 (M.P.R.), NIH R01 HG003039 (A.S.), NIH P41 RR011823 (J.R.Y. III, T.N. Davis, principal investigator), CIHR MOP-64404 (J.V.), and NIH GM51312 (M. W.). J.M.K. was supported by NIH F32 GM086038, and E.P.H. was supported by NIH T32 GM008759. Mass spectrometry data are provided at the Yeast Resource Center (www.yeastrc.org/pdr/pages/front.jsp).	Alvarado-Kristensson M, 2009, NAT CELL BIOL, V11, P1081, DOI 10.1038/ncb1921; Araki Y, 2010, J CELL BIOL, V189, P41, DOI 10.1083/jcb.200910027; Ba ANN, 2010, MOL BIOL EVOL, V27, P2027, DOI 10.1093/molbev/msq090; Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240; Binkley J, 2010, GENOME RES, V20, P142, DOI 10.1101/gr.097121.109; Crasta K, 2008, NAT CELL BIOL, V10, P665, DOI 10.1038/ncb1729; Friedman DB, 2001, J BIOL CHEM, V276, P17958, DOI 10.1074/jbc.M010461200; Holinger EP, 2009, J BIOL CHEM, V284, P12949, DOI 10.1074/jbc.M900088200; Holt LJ, 2009, SCIENCE, V325, P1682, DOI 10.1126/science.1172867; Jaspersen SL, 2004, ANNU REV CELL DEV BI, V20, P1, DOI 10.1146/annurev.cellbio.20.022003.114106; KAHANA JA, 1995, P NATL ACAD SCI USA, V92, P9707, DOI 10.1073/pnas.92.21.9707; Kimura MA, 1985, NEUTRAL THEORY MOL E; Kollman JM, 2010, NATURE, V466, P879, DOI 10.1038/nature09207; Lu BW, 2007, ANAL CHEM, V79, P1301, DOI 10.1021/ac061334v; Mayrose I, 2004, MOL BIOL EVOL, V21, P1781, DOI 10.1093/molbev/msh194; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; Niepel M, 2005, J CELL BIOL, V170, P225, DOI 10.1083/jcb.200504140; Schweiger R, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-6; Snead JL, 2007, CHEM BIOL, V14, P1261, DOI 10.1016/j.chembiol.2007.09.011; Vinh DBN, 2002, MOL BIOL CELL, V13, P1144, DOI 10.1091/mbc.02-01-0607; Visintin R, 2001, MOL BIOL CELL, V12, P2961, DOI 10.1091/mbc.12.10.2961; Vogel J, 2001, DEV CELL, V1, P621, DOI 10.1016/S1534-5807(01)00073-9; Winey M, 2001, NAT CELL BIOL, V3, pE23, DOI 10.1038/35050663	23	77	81	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 24	2011	332	6037					1557	1561		10.1126/science.1205193	http://dx.doi.org/10.1126/science.1205193			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782EE	21700874	Green Accepted			2022-12-24	WOS:000291990000045
J	Rappuoli, R; Aderem, A				Rappuoli, Rino; Aderem, Alan			A 2020 vision for vaccines against HIV, tuberculosis and malaria	NATURE			English	Article							CELL-MEDIATED-IMMUNITY; YELLOW-FEVER VACCINE; DOUBLE-BLIND; SYSTEMS BIOLOGY; EFFICACY; DESIGN; ANTIBODIES; TRIAL; IMMUNOGENICITY; IMMUNIZATION	Acquired immune deficiency syndrome (AIDS), malaria and tuberculosis collectively cause more than five million deaths per year, but have nonetheless eluded conventional vaccine development; for this reason they represent one of the major global public health challenges as we enter the second decade of the twenty-first century. Recent trials have provided evidence that it is possible to develop vaccines that can prevent infection by human immunodeficiency virus (HIV) and malaria. Furthermore, advances in vaccinology, including novel adjuvants, prime-boost regimes and strategies for intracellular antigen presentation, have led to progress in developing a vaccine against tuberculosis. Here we discuss these advances and suggest that new tools such as systems biology and structure-based antigen design will lead to a deeper understanding of mechanisms of protection which, in turn, will lead to rational vaccine development. We also argue that new and innovative approaches to clinical trials will accelerate the availability of these vaccines.	[Rappuoli, Rino] Novartis Vaccines & Diagnost, I-53100 Siena, Italy; [Aderem, Alan] Seattle Biomed Res Inst, Seattle, WA 98109 USA	Novartis; Center for Infectious Disease Research	Rappuoli, R (corresponding author), Novartis Vaccines & Diagnost, I-53100 Siena, Italy.	rino.rappuoli@novartis.com	Rivet, Catherine A/M-7978-2014					Aagaard C, 2011, NAT MED, V17, P189, DOI 10.1038/nm.2285; Alonso PL, 2004, LANCET, V364, P1411, DOI 10.1016/S0140-6736(04)17223-1; [Anonymous], 1927, VACCINATION PREVENTI; [Anonymous], 2010, MILL DEV GOALS REP; Aponte JJ, 2007, LANCET, V370, P1543, DOI 10.1016/S0140-6736(07)61542-6; Behr MA, 1999, SCIENCE, V284, P1520, DOI 10.1126/science.284.5419.1520; Bejon P, 2008, NEW ENGL J MED, V359, P2521, DOI 10.1056/NEJMoa0807381; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Bertholet S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001094; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Burton DR, 2004, SCIENCE, V303, P316, DOI 10.1126/science.1094620; Campbell H, 2009, VACCINE, V27, pB20, DOI 10.1016/j.vaccine.2009.04.067; Corey L, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001863; Dormitzer PR, 2008, TRENDS BIOTECHNOL, V26, P659, DOI 10.1016/j.tibtech.2008.08.002; Dutta S, 2007, P NATL ACAD SCI USA, V104, P12488, DOI 10.1073/pnas.0701464104; Fitzgerald DW, 2011, J INFECT DIS, V203, P765, DOI 10.1093/infdis/jiq114; Flynn MN, 2005, J INFECT DIS, V191, P654, DOI 10.1086/428404; Freidlin B, 2005, CLIN CANCER RES, V11, P7872, DOI 10.1158/1078-0432.CCR-05-0605; Galli G, 2009, P NATL ACAD SCI USA, V106, P3877, DOI 10.1073/pnas.0813390106; Garcon N, 2007, EXPERT REV VACCINES, V6, P723, DOI 10.1586/14760584.6.5.723; Gaucher D, 2008, J EXP MED, V205, P3119, DOI 10.1084/jem.20082292; Good MF, 2010, IMMUNITY, V33, P555, DOI 10.1016/j.immuni.2010.10.005; GORDON DM, 1995, J INFECT DIS, V171, P1576, DOI 10.1093/infdis/171.6.1576; Hoffman SL, 2002, J INFECT DIS, V185, P1155, DOI 10.1086/339409; Hoffman SL, 2010, HUM VACCINES, V6, P97, DOI 10.4161/hv.6.1.10396; HORWITZ MA, 2010, NEW GENERATION VACCI; Johnston MI, 2007, NEW ENGL J MED, V356, P2073, DOI 10.1056/NEJMra066267; Kaufmann SHE, 2010, IMMUNITY, V33, P567, DOI 10.1016/j.immuni.2010.09.015; Kaufmann SHE, 2010, LANCET, V375, P2110, DOI 10.1016/S0140-6736(10)60393-5; Koup RA, 2011, NAT REV IMMUNOL, V11, P65, DOI 10.1038/nri2890; Kusi KA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008110; Langhorne J, 2008, NAT IMMUNOL, V9, P725, DOI 10.1038/ni.f.205; Maertzdorf J, 2011, GENES IMMUN, V12, P15, DOI 10.1038/gene.2010.51; Mascola JR, 2010, ANNU REV IMMUNOL, V28, P413, DOI 10.1146/annurev-immunol-030409-101256; Masignani V, 2003, VACCINE, V21, pS110, DOI 10.1016/S0264-410X(03)00209-3; McElrath MJ, 2010, IMMUNITY, V33, P542, DOI 10.1016/j.immuni.2010.09.011; NUSSENZWEIG RS, 1967, NATURE, V216, P160, DOI 10.1038/216160a0; O'Hallahan J, 2009, NEW ZEAL MED J, V122, P48; Olotu A, 2011, LANCET INFECT DIS, V11, P102, DOI 10.1016/S1473-3099(10)70262-0; Palermo RE, 2011, J VIROL, V85, P1099, DOI 10.1128/JVI.01522-10; Pitisuttithum P, 2006, J INFECT DIS, V194, P1661, DOI 10.1086/508748; Pulendran B, 2010, IMMUNITY, V33, P516, DOI 10.1016/j.immuni.2010.10.006; Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688; Remarque EJ, 2008, INFECT IMMUN, V76, P2660, DOI 10.1128/IAI.00170-08; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Richie TL, 2002, NATURE, V415, P694, DOI 10.1038/415694a; Sauerwein RW, 2011, NAT REV IMMUNOL, V11, P57, DOI 10.1038/nri2902; SCARSELLI M, SCI TRANSL IN PRESS; Skeiky YAW, 2006, NAT REV MICROBIOL, V4, P469, DOI 10.1038/nrmicro1419; Stoute JA, 1997, NEW ENGL J MED, V336, P86, DOI 10.1056/NEJM199701093360202; Struik SS, 2004, IMMUNOL REV, V201, P268, DOI 10.1111/j.0105-2896.2004.00181.x; UNAIDS, 2010, REP GLOB AIDS EP; Wei CJ, 2010, SCIENCE, V329, P1060, DOI 10.1126/science.1192517; WHO, 2010, WORLD MALARIA REPORT 2010, P1; *WHO, 2010, MDG6 COMB HIV AIDS M; WHO, 2010, GLOB TUB CONTR 2010; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Zak DE, 2009, IMMUNOL REV, V227, P264, DOI 10.1111/j.1600-065X.2008.00721.x	58	193	201	0	57	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 26	2011	473	7348					463	469		10.1038/nature10124	http://dx.doi.org/10.1038/nature10124			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	768QM	21614073	Bronze			2022-12-24	WOS:000290951300031
J	Schwanhausser, B; Busse, D; Li, N; Dittmar, G; Schuchhardt, J; Wolf, J; Chen, W; Selbach, M				Schwanhaeusser, Bjoern; Busse, Dorothea; Li, Na; Dittmar, Gunnar; Schuchhardt, Johannes; Wolf, Jana; Chen, Wei; Selbach, Matthias			Global quantification of mammalian gene expression control	NATURE			English	Article							QUANTITATIVE PROTEOMICS; NUCLEOTIDE RESOLUTION; REGULATORY NETWORKS; IN-VIVO; PROTEIN; DYNAMICS; TRANSLATION; TRANSCRIPTION; STABILITY; CELLS	Gene expression is a multistep process that involves the transcription, translation and turnover of messenger RNAs and proteins. Although it is one of the most fundamental processes of life, the entire cascade has never been quantified on a genome-wide scale. Here we simultaneously measured absolute mRNA and protein abundance and turnover by parallel metabolic pulse labelling for more than 5,000 genes in mammalian cells. Whereas mRNA and protein levels correlated better than previously thought, corresponding half-lives showed no correlation. Using a quantitative model we have obtained the first genome-scale prediction of synthesis rates of mRNAs and proteins. We find that the cellular abundance of proteins is predominantly controlled at the level of translation. Genes with similar combinations of mRNA and protein stability shared functional properties, indicating that half-lives evolved under energetic and dynamic constraints. Quantitative information about all stages of gene expression provides a rich resource and helps to provide a greater understanding of the underlying design principles.	[Schwanhaeusser, Bjoern; Busse, Dorothea; Li, Na; Dittmar, Gunnar; Wolf, Jana; Chen, Wei; Selbach, Matthias] Max Delbruck Ctr Mol Med, D-13092 Berlin, Germany; [Schuchhardt, Johannes] MicroDiscovery GmbH, D-10405 Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine	Wolf, J (corresponding author), Max Delbruck Ctr Mol Med, Robert Rossle Str 10, D-13092 Berlin, Germany.	jana.wolf@mdc-berlin.de; wei.chen@mdc-berlin.de; matthias.selbach@mdc-berlin.de	Chen, Wei/C-1273-2011; Dittmar, Gunnar/C-6333-2019; Dittmar, Gunnar/B-6383-2016; Selbach, Matthias/C-5988-2008	Dittmar, Gunnar/0000-0003-3647-8623; Dittmar, Gunnar/0000-0003-3647-8623; Chen, Wei/0000-0003-3263-1627; Li, Na/0000-0001-6163-1648	Helmholtz Association; German Ministry of Education and Research (BMBF); Senate of Berlin by Berlin Institute of Medical Systems Biology (BIMSB) [315362A]; German Ministry of Education and Research [315289]; Helmholtz Alliance on Systems Biology/MSBN; China Scholarship Council CSC	Helmholtz Association(Helmholtz Association); German Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Senate of Berlin by Berlin Institute of Medical Systems Biology (BIMSB); German Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Helmholtz Alliance on Systems Biology/MSBN; China Scholarship Council CSC(China Scholarship Council)	We thank N. Rajewsky and L. Dolken for fruitful discussions and C. Sommer for technical assistance. M.S. and W.C. are supported by the Helmholtz Association, the German Ministry of Education and Research (BMBF) and the Senate of Berlin by funds aimed at establishing the Berlin Institute of Medical Systems Biology (BIMSB) (grant number 315362A). J.W. is supported by the ForSys-programme of the German Ministry of Education and Research (grant number 315289); D.B. by the Helmholtz Alliance on Systems Biology/MSBN; and N.L. by the China Scholarship Council CSC.	Abreu RD, 2009, MOL BIOSYST, V5, P1512, DOI 10.1039/b908315d; Arava Y, 2005, NUCLEIC ACIDS RES, V33, P2421, DOI 10.1093/nar/gki331; Belle A, 2006, P NATL ACAD SCI USA, V103, P13004, DOI 10.1073/pnas.0605420103; Beynon RJ, 2005, MOL CELL PROTEOMICS, V4, P857, DOI 10.1074/mcp.R400010-MCP200; Churchman LS, 2011, NATURE, V469, P368, DOI 10.1038/nature09652; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Darzacq X, 2007, NAT STRUCT MOL BIOL, V14, P796, DOI 10.1038/nsmb1280; de-Leon SBT, 2009, DEV BIOL, V325, P317, DOI 10.1016/j.ydbio.2008.10.043; Doherty MK, 2009, J PROTEOME RES, V8, P104, DOI 10.1021/pr800641v; Friedel CC, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp542; Gebauer F, 2004, NAT REV MOL CELL BIO, V5, P827, DOI 10.1038/nrm1488; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Gouw JW, 2010, MOL CELL PROTEOMICS, V9, P11, DOI 10.1074/mcp.R900001-MCP200; Hao SL, 2009, NAT IMMUNOL, V10, P281, DOI 10.1038/ni.1699; Hentze MW, 2004, CELL, V117, P285, DOI 10.1016/S0092-8674(04)00343-5; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hogan DJ, 2008, PLOS BIOL, V6, P2297, DOI 10.1371/journal.pbio.0060255; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; King RW, 1996, SCIENCE, V274, P1652, DOI 10.1126/science.274.5293.1652; Kirkpatrick DS, 2005, NAT CELL BIOL, V7, P750, DOI 10.1038/ncb0805-750; Komili S, 2008, NAT REV GENET, V9, P38, DOI 10.1038/nrg2223; Lam YW, 2007, CURR BIOL, V17, P749, DOI 10.1016/j.cub.2007.03.064; Legewie S, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.29; Lu P, 2007, NAT BIOTECHNOL, V25, P117, DOI 10.1038/nbt1270; Lu R, 2009, NATURE, V462, P358, DOI 10.1038/nature08575; Maier T, 2009, FEBS LETT, V583, P3966, DOI 10.1016/j.febslet.2009.10.036; Malmstrom J, 2009, NATURE, V460, P762, DOI 10.1038/nature08184; Mann M, 2006, NAT REV MOL CELL BIO, V7, P952, DOI 10.1038/nrm2067; Milner E, 2006, MOL CELL PROTEOMICS, V5, P357, DOI 10.1074/mcp.M500241-MCP200; Mittal N, 2009, P NATL ACAD SCI USA, V106, P20300, DOI 10.1073/pnas.0906940106; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Pedraza JM, 2008, SCIENCE, V319, P339, DOI 10.1126/science.1144331; Price JC, 2010, P NATL ACAD SCI USA, V107, P14508, DOI 10.1073/pnas.1006551107; Rabani M, 2011, NAT BIOTECHNOL, V29, P436, DOI 10.1038/nbt.1861; Rosenfeld N, 2002, J MOL BIOL, V323, P785, DOI 10.1016/S0022-2836(02)00994-4; Schwanhausser B, 2009, PROTEOMICS, V9, P205, DOI 10.1002/pmic.200800275; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Vogel C, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.59; Wagner A, 2005, MOL BIOL EVOL, V22, P1365, DOI 10.1093/molbev/msi126; Wu CC, 2004, ANAL CHEM, V76, P4951, DOI 10.1021/ac049208j; Wu G, 2008, CURR MICROBIOL, V57, P18, DOI 10.1007/s00284-008-9145-5; Yang E, 2003, GENOME RES, V13, P1863, DOI 10.1101/gr.1272403; Yen HCS, 2008, SCIENCE, V322, P918, DOI 10.1126/science.1160489	44	3889	3968	15	674	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 19	2011	473	7347					337	342		10.1038/nature10098	http://dx.doi.org/10.1038/nature10098			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765QA	21593866	Green Accepted			2022-12-24	WOS:000290722400040
J	Dolmans, GH; Werker, PM; Hennies, HC; Furniss, D; Festen, EA; Franke, L; Becker, K; van der Vlies, P; Wolffenbuttel, BH; Tinschert, S; Toliat, MR; Nothnagel, M; Franke, A; Klopp, N; Wichmann, HE; Nurnberg, P; Giele, H; Ophoff, RA; Wijmenga, C				Dolmans, Guido H.; Werker, Paul M.; Hennies, Hans C.; Furniss, Dominic; Festen, Eleonora A.; Franke, Lude; Becker, Kerstin; van der Vlies, Pieter; Wolffenbuttel, Bruce H.; Tinschert, Sigrid; Toliat, Mohammad R.; Nothnagel, Michael; Franke, Andre; Klopp, Norman; Wichmann, H-Erich; Nuernberg, Peter; Giele, Henk; Ophoff, Roel A.; Wijmenga, Cisca		Dutch Dupuytren Study Grp; German Dupuytren Study Grp; LifeLines Cohort Study; BSSH-GODD Consortium	Wnt Signaling and Dupuytren's Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GENETIC SUSCEPTIBILITY; CONTRACTURE; CATENIN; ASSOCIATION; VARIANTS	BACKGROUND Dupuytren's disease is a benign fibromatosis of the hands and fingers that leads to flexion contractures. We hypothesized that multiple genetic and environmental factors influence susceptibility to this disease and sought to identify susceptibility genes to better understand its pathogenesis. METHODS We conducted a genomewide association study of 960 Dutch persons with Dupuytren's disease and 3117 controls (the discovery set) to test for association between the disease and genetic markers. We tested the 35 single-nucleotide polymorphisms (SNPs) most strongly associated with Dupuytren's disease (P< 1x10-4) in the discovery set in three additional, independent case series comprising a total of 1365 affected persons and 8445 controls from Germany, the United Kingdom, and the Netherlands. RESULTS Initially, we observed a significant genomewide association between Dupuytren's disease and 8 SNPs at three loci. Tests of replication and joint analysis of all data from 2325 patients with Dupuytren's disease and 11,562 controls yielded an association with 11 SNPs from nine different loci (P< 5.0x10(-8)). Six of these loci contain genes known to be involved in the Wnt-signaling pathway: WNT4 (rs7524102) (P = 2.8x10(-9); odds ratio, 1.28), SFRP4 (rs16879765) (P = 5.6x10-39; odds ratio, 1.98), WNT2 (rs4730775) (P = 3.0x10(-8); odds ratio, 0.83), RSPO2 (rs611744) (P = 7.9x10(-15); odds ratio, 0.75), SULF1 (rs2912522) (P = 2.0x10(-13); odds ratio, 0.72), and WNT7B (rs6519955) (P = 3.2x10(-33); odds ratio, 1.54). CONCLUSIONS This study implicates nine different loci involved in genetic susceptibility to Dupuytren's disease. The fact that six of these nine loci harbor genes encoding proteins in the Wnt-signaling pathway suggests that aberrations in this pathway are key to the process of fibromatosis in Dupuytren's disease.	[Dolmans, Guido H.; Festen, Eleonora A.; Franke, Lude; van der Vlies, Pieter; Wijmenga, Cisca] Univ Med Ctr Groningen, Dept Genet, NL-9700 RB Groningen, Netherlands; [Dolmans, Guido H.; Werker, Paul M.] Univ Med Ctr Groningen, Dept Plast Surg, NL-9700 RB Groningen, Netherlands; [Festen, Eleonora A.] Univ Med Ctr Groningen, Dept Gastroenterol, NL-9700 RB Groningen, Netherlands; [Wolffenbuttel, Bruce H.] Univ Med Ctr Groningen, Dept Endocrinol, NL-9700 RB Groningen, Netherlands; Univ Groningen, Groningen, Netherlands; [Ophoff, Roel A.] Univ Med Ctr Utrecht, Dept Med Genet, Utrecht, Netherlands; [Ophoff, Roel A.] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Utrecht, Netherlands; [Hennies, Hans C.; Becker, Kerstin; Toliat, Mohammad R.; Nuernberg, Peter] Univ Cologne, Cologne Ctr Genom, Div Dermatogenet, Cologne, Germany; [Hennies, Hans C.; Nuernberg, Peter] Univ Cologne, Ctr Mol Med, Cologne, Germany; [Tinschert, Sigrid] Tech Univ Dresden, Fac Med Carl Gustav Carus, Inst Clin Genet, D-8027 Dresden, Germany; [Nothnagel, Michael] Univ Kiel, Inst Med Informat & Stat, Kiel, Germany; [Franke, Andre] Univ Kiel, Inst Clin Mol Biol, Kiel, Germany; [Klopp, Norman; Wichmann, H-Erich] Helmholtz Zentrum Munchen, Inst Epidemiol, Neuherberg, Germany; [Wichmann, H-Erich] Univ Munich, Inst Med Informat Biometry & Epidemiol, Munich, Germany; [Wichmann, H-Erich] Univ Munich, Klinikum Grosshadern, D-8000 Munich, Germany; [Furniss, Dominic; Giele, Henk] Univ Oxford, Nuffield Dept Surg Sci, Oxford, England; [Furniss, Dominic; Giele, Henk] John Radcliffe Hosp, Dept Plast & Reconstruct Surg, Oxford OX3 9DU, England; [Ophoff, Roel A.] Univ Calif Los Angeles, Ctr Neurobehav Genet, Los Angeles, CA USA	University of Groningen; University of Groningen; University of Groningen; University of Groningen; University of Groningen; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Cologne; University of Cologne; Technische Universitat Dresden; University of Kiel; University of Kiel; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; University of Munich; University of Oxford; University of Oxford; University of California System; University of California Los Angeles	Wijmenga, C (corresponding author), Univ Med Ctr Groningen, Dept Genet, POB 30001, NL-9700 RB Groningen, Netherlands.	ophoff@ucla.edu; cisca.wijmenga@med.umcg.nl	Wolffenbuttel, Bruce/A-8419-2011; Wichmann, Heinz Erich/AAA-5695-2022; Wijmenga, Cisca/AAE-7719-2019; Furniss, Dominic/AAH-4447-2019; Franke, Lude/P-7036-2016	Wolffenbuttel, Bruce/0000-0001-9262-6921; Wijmenga, Cisca/0000-0002-5635-1614; Nothnagel, Michael/0000-0001-8305-7114; Giele, Henk/0000-0003-2017-5193; Franke, Lude/0000-0002-5159-8802	University Medical Center Groningen; University of Groningen, the Netherlands; German Ministry of Education and Research through the German National Genome Research Network; German Research Foundation Cluster of Excellence Inflammation at Interfaces; Academy of Medical Sciences; Wellcome Trust; Oxford University [MRF/2009/HT/1932]; Netherlands Organization of Scientific Research [NWO 175.010.2007.006]; Dutch government; Ministries of Economic Affairs, Education, Culture and Science, and Health, Welfare and Sports; Northern Netherlands Collaboration of Provinces; Province of Groningen; Dutch Kidney Foundation; Dutch Diabetes Research Foundation; Helmholtz Center Munich; German Research Center for Environmental Health; Munich Center of Health Sciences; WTCCC [076113, 085475]	University Medical Center Groningen; University of Groningen, the Netherlands(Netherlands Government); German Ministry of Education and Research through the German National Genome Research Network; German Research Foundation Cluster of Excellence Inflammation at Interfaces; Academy of Medical Sciences(Academy of Medical Sciences (AMS)); Wellcome Trust(Wellcome TrustEuropean Commission); Oxford University; Netherlands Organization of Scientific Research(Netherlands Organization for Scientific Research (NWO)); Dutch government; Ministries of Economic Affairs, Education, Culture and Science, and Health, Welfare and Sports; Northern Netherlands Collaboration of Provinces; Province of Groningen; Dutch Kidney Foundation; Dutch Diabetes Research Foundation; Helmholtz Center Munich(Helmholtz Association); German Research Center for Environmental Health; Munich Center of Health Sciences; WTCCC	Supported by grants from the University Medical Center Groningen and the University of Groningen, the Netherlands, and in part by grants from the German Ministry of Education and Research through the German National Genome Research Network (NGFN-2 and NGFNplus) and the German Research Foundation Cluster of Excellence Inflammation at Interfaces; the Academy of Medical Sciences, Wellcome Trust Starter Grants for Clinical Lecturers, and the Oxford University Medical Research Fund (MRF/2009/HT/1932) (all to Dr. Furniss); data generated by the LifeLines Cohort Study, the KORA research platform, and the Wellcome Trust Case Control Consortium (WTCCC); a grant to the LifeLines Cohort Study from the Netherlands Organization of Scientific Research (NWO 175.010.2007.006); the Dutch government's Economic Structure Enhancing Fund; the Ministries of Economic Affairs, Education, Culture and Science, and Health, Welfare and Sports; the Northern Netherlands Collaboration of Provinces; the Province of Groningen; the Dutch Kidney Foundation; the Dutch Diabetes Research Foundation; the KORA research platform, initiated and financed by the Helmholtz Center Munich and the German Research Center for Environmental Health and supported by the Munich Center of Health Sciences as part of LMUinnovativ; and the WTCCC (awards 076113 and 085475).	Anthony Shawn G, 2008, Hand (N Y), V3, P87, DOI 10.1007/s11552-007-9076-9; Armstrong JR, 2000, J BONE JOINT SURG BR, V82B, P90, DOI 10.1302/0301-620X.82B1.9808; Bayat A, 2003, BRIT J PLAST SURG, V56, P328, DOI 10.1016/S0007-1226(03)00176-0; Bayat A, 2003, PLAST RECONSTR SURG, V111, P2133, DOI 10.1097/01.PRS.0000060531.98180.32; Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; Blank V, 1997, TRENDS BIOCHEM SCI, V22, P437, DOI 10.1016/S0968-0004(97)01105-5; Bowley E, 2007, J SURG RES, V138, P141, DOI 10.1016/j.jss.2006.07.026; Burge P, 1999, HAND CLIN, V15, P63; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Degreef I, 2009, SCAND J PLAST RECONS, V43, P36, DOI 10.1080/02844310802489806; Dias JJ, 2006, J HAND SURG-BRIT EUR, V31B, P514, DOI 10.1016/j.jhsb.2006.05.005; Dubois PCA, 2010, NAT GENET, V42, P465, DOI 10.1038/ng0510-465; Dubois PCA, 2010, NAT GENET, V42, P295, DOI 10.1038/ng.543; Eychene A, 2008, NAT REV CANCER, V8, P683, DOI 10.1038/nrc2460; Freeman SD, 2008, DEV BIOL, V320, P436, DOI 10.1016/j.ydbio.2008.05.554; Hindocha S, 2006, J HAND SURG-AM, V31A, P204, DOI 10.1016/j.jhsa.2005.09.018; Hindocha Sandip, 2009, Hand (N Y), V4, P256, DOI 10.1007/s11552-008-9160-9; Hu FZ, 2005, CLIN GENET, V68, P424, DOI 10.1111/j.1399-0004.2005.00504.x; Hurst LC, 2009, NEW ENGL J MED, V361, P968, DOI 10.1056/NEJMoa0810866; Kim KA, 2006, CELL CYCLE, V5, P23, DOI 10.4161/cc.5.1.2305; Lam WL, 2010, J HAND SURG-EUR VOL, V35E, P312, DOI 10.1177/1753193410362848; Lee LC, 2006, J HAND SURG-AM, V31A, P211, DOI 10.1016/j.jhsa.2005.09.007; LUCK JV, 1959, J BONE JOINT SURG AM, V41, P635, DOI 10.2106/00004623-195941040-00008; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Mosakhani N, 2010, MODERN PATHOL, V23, P1544, DOI 10.1038/modpathol.2010.146; Rao TP, 2010, CIRC RES, V106, P1798, DOI 10.1161/CIRCRESAHA.110.219840; Raychaudhuri S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000534; Ross DC, 1999, HAND CLIN, V15, P53; Sahota AP, 2009, EXP CELL RES, V315, P2752, DOI 10.1016/j.yexcr.2009.06.029; Stolk RP, 2008, EUR J EPIDEMIOL, V23, P67, DOI 10.1007/s10654-007-9204-4; van Heel DA, 2007, NAT GENET, V39, P827, DOI 10.1038/ng2058; Van Rijssen AL, 2006, J HAND SURG-BRIT EUR, V31B, P498, DOI 10.1016/j.jhsb.2006.03.174	32	140	140	0	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 28	2011	365	4					307	317		10.1056/NEJMoa1101029	http://dx.doi.org/10.1056/NEJMoa1101029			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	798AJ	21732829	Bronze, Green Published			2022-12-24	WOS:000293172200009
J	Heller, RC; Kang, S; Lam, WM; Chen, S; Chan, CS; Bell, SP				Heller, Ryan C.; Kang, Sukhyun; Lam, Wendy M.; Chen, Shuyan; Chan, Clara S.; Bell, Stephen P.			Eukaryotic Origin-Dependent DNA Replication In Vitro Reveals Sequential Action of DDK and S-CDK Kinases	CELL			English	Article							CHROMATIN ASSOCIATION; COMPLEX-FORMATION; MCM2-7 HELICASE; ATP-HYDROLYSIS; INITIATION; SLD3; CDC45; MCM10; GINS; PHOSPHORYLATION	Proper eukaryotic DNA replication requires temporal separation of helicase loading from helicase activation and replisome assembly. Using an in vitro assay for eukaryotic origin-dependent replication initiation, we investigated the control of these events. After helicase loading, we found that the Dbf4-dependent Cdc7 kinase (DDK) but not S phase cyclin-dependent kinase (S-CDK) is required for the initial origin recruitment of Sld3 and the Cdc45 helicase-activating protein. Likewise, in vivo, DDK drives early-firing-origin recruitment of Cdc45 before activation of S-CDK. After S-CDK activation, a second helicase-activating protein (GINS) and the remainder of the replisome are recruited to the origin. Finally, recruitment of lagging but not leading strand DNA polymerases depends on Mcm10 and DNA unwinding. Our studies identify distinct roles for DDK and S-CDK during helicase activation and support a model in which the leading strand DNA polymerase is recruited prior to origin DNA unwinding and RNA primer synthesis.	[Heller, Ryan C.; Kang, Sukhyun; Lam, Wendy M.; Chen, Shuyan; Chan, Clara S.; Bell, Stephen P.] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Bell, SP (corresponding author), MIT, Howard Hughes Med Inst, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	spbell@mit.edu		Kang, Sukhyun/0000-0002-7567-0231; Bell, Stephen/0000-0002-2876-610X	NIH [GM52339]; Damon Runyon Cancer Research Foundation (DRG) [1959-07]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052339] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Damon Runyon Cancer Research Foundation (DRG); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Amon, I. Cheeseman, D. MacAlpine, and T. Takara for comments on the manuscript. Rfa1 antibodies were a gift from S. Brill. We thank R. Sinapius and J. Randell for reagents and K. Galani and H. Blitzblau for help with microarrays. This work was supported by NIH grant GM52339 (S.P.B.). S.P.B., S.C., and S.K. are Howard Hughes Medical Institute employees. R.C.H. was a Damon Runyon Fellow supported by the Damon Runyon Cancer Research Foundation (DRG-# 1959-07).	Aparicio OM, 1999, P NATL ACAD SCI USA, V96, P9130, DOI 10.1073/pnas.96.16.9130; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Bowers JL, 2004, MOL CELL, V16, P967, DOI 10.1016/j.molcel.2004.11.038; BRAMHILL D, 1988, CELL, V52, P743, DOI 10.1016/0092-8674(88)90412-6; Burgers PMJ, 2009, J BIOL CHEM, V284, P4041, DOI 10.1074/jbc.R800062200; Cadoret JC, 2010, CHROMOSOME RES, V18, P79, DOI 10.1007/s10577-009-9094-2; Cayrou C, 2010, CHROMOSOME RES, V18, P137, DOI 10.1007/s10577-009-9105-3; Edwards MC, 2002, J BIOL CHEM, V277, P33049, DOI 10.1074/jbc.M204438200; Evrin C, 2009, P NATL ACAD SCI USA, V106, P20240, DOI 10.1073/pnas.0911500106; Gambus A, 2011, J BIOL CHEM, V286, P11855, DOI 10.1074/jbc.M110.199521; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Gregan J, 2003, MOL BIOL CELL, V14, P3876, DOI 10.1091/mbc.E03-02-0090; Homesley L, 2000, GENE DEV, V14, P913; Ilves I, 2010, MOL CELL, V37, P247, DOI 10.1016/j.molcel.2009.12.030; Jares P, 2000, GENE DEV, V14, P1528; Kamimura Y, 2001, EMBO J, V20, P2097, DOI 10.1093/emboj/20.8.2097; Kanemaki M, 2006, EMBO J, V25, P1753, DOI 10.1038/sj.emboj.7601063; Kubota Y, 2003, GENE DEV, V17, P1141, DOI 10.1101/gad.1070003; LABIB K, 2010, GENE DEV, V24, P1028; Lopez-Mosqueda J, 2010, NATURE, V467, P479, DOI 10.1038/nature09377; Masumoto H, 2000, MOL CELL BIOL, V20, P2809, DOI 10.1128/MCB.20.8.2809-2817.2000; Muramatsu S, 2010, GENE DEV, V24, P602, DOI 10.1101/gad.1883410; Nougarede R, 2000, MOL CELL BIOL, V20, P3795, DOI 10.1128/MCB.20.11.3795-3806.2000; Pasero P, 2002, METHOD ENZYMOL, V351, P184; Randell JCW, 2006, MOL CELL, V21, P29, DOI 10.1016/j.molcel.2005.11.023; Randell JCW, 2010, MOL CELL, V40, P353, DOI 10.1016/j.molcel.2010.10.017; Remus D, 2009, CURR OPIN CELL BIOL, V21, P771, DOI 10.1016/j.ceb.2009.08.002; Remus D, 2009, CELL, V139, P719, DOI 10.1016/j.cell.2009.10.015; Ricke RM, 2004, MOL CELL, V16, P173, DOI 10.1016/j.molcel.2004.09.017; Sawyer SL, 2004, J MOL BIOL, V340, P195, DOI 10.1016/j.jmb.2004.04.066; Sclafani RA, 2007, ANNU REV GENET, V41, P237, DOI 10.1146/annurev.genet.41.110306.130308; Seki T, 2000, P NATL ACAD SCI USA, V97, P14115, DOI 10.1073/pnas.97.26.14115; Sheu YJ, 2010, NATURE, V463, P113, DOI 10.1038/nature08647; STINCHCOMB DT, 1979, NATURE, V282, P39, DOI 10.1038/282039a0; Takayama Y, 2003, GENE DEV, V17, P1153, DOI 10.1101/gad.1065903; Tanaka S, 2007, NATURE, V445, P328, DOI 10.1038/nature05465; Tanaka TU, 1998, EMBO J, V17, P5182, DOI 10.1093/emboj/17.17.5182; Tsakraklides V, 2010, J BIOL CHEM, V285, P9437, DOI 10.1074/jbc.M109.072504; Ubersax JA, 2003, NATURE, V425, P859, DOI 10.1038/nature02062; Walter J, 2000, MOL CELL, V5, P617, DOI 10.1016/S1097-2765(00)80241-5; Walter J, 1998, MOL CELL, V1, P519, DOI 10.1016/S1097-2765(00)80052-0; Walter JC, 2000, J BIOL CHEM, V275, P39773, DOI 10.1074/jbc.M008107200; Wohlschlegel JA, 2002, MOL CELL, V9, P233, DOI 10.1016/S1097-2765(02)00456-2; Yabuuchi H, 2006, EMBO J, V25, P4663, DOI 10.1038/sj.emboj.7601347; Ying CY, 2005, EMBO J, V24, P4334, DOI 10.1038/sj.emboj.7600892; Zegerman P, 2007, NATURE, V445, P281, DOI 10.1038/nature05432; Zegerman P, 2010, NATURE, V467, P474, DOI 10.1038/nature09373; Zhu WG, 2007, GENE DEV, V21, P2288, DOI 10.1101/gad.1585607	48	217	219	1	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 8	2011	146	1					80	91		10.1016/j.cell.2011.06.012	http://dx.doi.org/10.1016/j.cell.2011.06.012			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	789TN	21729781	Green Accepted, Bronze, Green Published			2022-12-24	WOS:000292539300008
J	Qu, XH; Wen, JD; Lancaster, L; Noller, HF; Bustamante, C; Tinoco, I				Qu, Xiaohui; Wen, Jin-Der; Lancaster, Laura; Noller, Harry F.; Bustamante, Carlos; Tinoco, Ignacio, Jr.			The ribosome uses two active mechanisms to unwind messenger RNA during translation	NATURE			English	Article							SECONDARY STRUCTURE; SINGLE-MOLECULE; TRANSLOCATION; HELICASES; TIME; STABILITY; MOVEMENT; DYNAMICS; RECEPTOR	The ribosome translates the genetic information encoded in messenger RNA into protein. Folded structures in the coding region of an mRNA represent a kinetic barrier that lowers the peptide elongation rate, as the ribosome must disrupt structures it encounters in the mRNA at its entry site to allow translocation to the next codon. Such structures are exploited by the cell to create diverse strategies for translation regulation, such as programmed frameshifting(1,2), the modulation of protein expression levels-(3,4), ribosome localization(5) and co-translational protein folding(6). Although strand separation activity is inherent to the ribosome, requiring no exogenous helicases(7), its mechanism is still unknown. Here, using a single-molecule optical tweezers assay on mRNA hairpins, we find that the translation rate of identical codons at the decoding centre is greatly influenced by the GC content of folded structures at the mRNA entry site. Furthermore, force applied to the ends of the hairpin to favour its unfolding significantly speeds translation. Quantitative analysis of the force dependence of its helicase activity reveals that the ribosome, unlike previously studied helicases, uses two distinct active mechanisms to unwind mRNA structure: it destabilizes the helical junction at the mRNA entry site by biasing its thermal fluctuations towards the open state, increasing the probability of the ribosome translocating unhindered; and it mechanically pulls apart the mRNA single strands of the closed junction during the conformational changes that accompany ribosome translocation. The second of these mechanisms ensures a minimal basal rate of translation in the cell; specialized, mechanically stable structures are required to stall the ribosome temporarily(1,2). Our results establish a quantitative mechanical basis for understanding the mechanism of regulation of the elongation rate of translation by structured mRNAs.	[Qu, Xiaohui; Wen, Jin-Der; Bustamante, Carlos; Tinoco, Ignacio, Jr.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Qu, Xiaohui; Wen, Jin-Der; Bustamante, Carlos] Univ Calif Berkeley, Jason L Choy Lab Single Mol Biophys, Berkeley, CA 94720 USA; [Qu, Xiaohui; Wen, Jin-Der; Bustamante, Carlos] Univ Calif Berkeley, QB3 Inst, Berkeley, CA 94720 USA; [Lancaster, Laura; Noller, Harry F.] Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA; [Lancaster, Laura; Noller, Harry F.] Univ Calif Santa Cruz, Ctr Mol Biol RNA, Santa Cruz, CA 95064 USA; [Bustamante, Carlos] Univ Calif Berkeley, Dept Phys, Dept Mol & Cellular Biol, Berkeley, CA 94720 USA; [Bustamante, Carlos] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley	Tinoco, I (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	carlos@alice.berkeley.edu; intinoco@lbl.gov	; Wen, Jin-Der/A-3159-2014	Qu, Xiaohui/0000-0001-7756-307X; Wen, Jin-Der/0000-0001-8317-4329; Bustamante, Carlos/0000-0002-2970-0073	National Institutes of Health; Human Frontiers Science Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM010840] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontiers Science Program(Human Frontier Science Program); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank rnembers of the Tinoco and Bustamante labs for helpful discussions, especially S. B. Smith for his help with the optical tweezers, J. Moffitt for advice on data analysis arid C. Kaiser for suggestions. Our work was supported by grants from the National Institutes of Health (to IT., C.B. and H.F.N.) and the Human Frontiers Science Program (to I.T. and H.F.N).	Betterton MD, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.011904; Chen G, 2009, P NATL ACAD SCI USA, V106, P12706, DOI 10.1073/pnas.0905046106; Cukras AR, 2003, MOL CELL, V12, P321, DOI 10.1016/S1097-2765(03)00275-2; Duan JB, 2003, HUM MOL GENET, V12, P205, DOI 10.1093/hmg/ddg055; Fischer N, 2010, NATURE, V466, P329, DOI 10.1038/nature09206; Frank J, 2000, NATURE, V406, P318, DOI 10.1038/35018597; Giedroc DP, 2009, VIRUS RES, V139, P193, DOI 10.1016/j.virusres.2008.06.008; Johnson DS, 2007, CELL, V129, P1299, DOI 10.1016/j.cell.2007.04.038; Keller D, 2000, BIOPHYS J, V78, P541, DOI 10.1016/S0006-3495(00)76615-X; Kim S, 2010, J MOL BIOL, V395, P995, DOI 10.1016/j.jmb.2009.11.072; Lionnet T, 2007, P NATL ACAD SCI USA, V104, P19790, DOI 10.1073/pnas.0709793104; Lohman TM, 2008, NAT REV MOL CELL BIO, V9, P391, DOI 10.1038/nrm2394; Manosas M, 2010, NUCLEIC ACIDS RES, V38, P5518, DOI 10.1093/nar/gkq273; MOAZED D, 1989, NATURE, V342, P142, DOI 10.1038/342142a0; Nackley AG, 2006, SCIENCE, V314, P1930, DOI 10.1126/science.1131262; Patel SS, 2006, J BIOL CHEM, V281, P18265, DOI 10.1074/jbc.R600008200; Peske F, 2000, MOL CELL, V6, P501, DOI 10.1016/S1097-2765(00)00049-6; Rodnina MV, 2000, BIOL CHEM, V381, P377, DOI 10.1515/BC.2000.050; Schuwirth BS, 2005, SCIENCE, V310, P827, DOI 10.1126/science.1117230; Takyar S, 2005, CELL, V120, P49, DOI 10.1016/j.cell.2004.11.042; Tinoco I, 2002, BIOPHYS CHEM, V101, P513, DOI 10.1016/S0301-4622(02)00177-1; Tinoco I, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/2/025006; TSUCHIHASHI Z, 1991, NUCLEIC ACIDS RES, V19, P2457, DOI 10.1093/nar/19.9.2457; Uemura S, 2007, NATURE, V446, P454, DOI 10.1038/nature05625; Valle M, 2003, CELL, V114, P123, DOI 10.1016/S0092-8674(03)00476-8; Watts JM, 2009, NATURE, V460, P711, DOI 10.1038/nature08237; Wen JD, 2008, NATURE, V452, P598, DOI 10.1038/nature06716; Young JC, 1996, EMBO J, V15, P172, DOI 10.1002/j.1460-2075.1996.tb00345.x; Yusupova GZ, 2001, CELL, V106, P233, DOI 10.1016/S0092-8674(01)00435-4; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	30	219	221	1	74	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 7	2011	475	7354					118	121		10.1038/nature10126	http://dx.doi.org/10.1038/nature10126			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	788RE	21734708	Green Accepted			2022-12-24	WOS:000292461300057
J	Medenbach, J; Seiler, M; Hentze, MW				Medenbach, Jan; Seiler, Markus; Hentze, Matthias W.			Translational Control via Protein-Regulated Upstream Open Reading Frames	CELL			English	Article							MSL-2 MESSENGER-RNA; SEX-LETHAL; DOSAGE COMPENSATION; BINDING PROTEIN; DROSOPHILA; INITIATION; MECHANISM; GENE; RECOGNITION; REPRESSION	Analysis of the regulation of msl-2 mRNA by Sex lethal (SXL), which is critical for dosage compensation in Drosophila, has uncovered a mode of translational control based on common 50 untranslated region elements, upstream open reading frames (uORFs), and interaction sites for RNA-binding proteins. We show that SXL binding downstream of a short uORF imposes a strong negative effect on major reading frame translation. The underlying mechanism involves increasing initiation of scanning ribosomes at the uORF and augmenting its impediment to downstreamtranslation. Our analyses reveal that SXL exerts its effect controlling initiation, not elongation or termination, at the uORF. Probing the generality of the underlying mechanism, we show that the regulatorymodule that we define experimentally functions in a heterologous context, and we identify natural Drosophila mRNAs that are regulated via this module. We propose that protein-regulated uORFs constitute a systematic principle for the regulation of protein synthesis.	[Medenbach, Jan; Seiler, Markus; Hentze, Matthias W.] European Mol Biol Lab, D-69117 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL)	Hentze, MW (corresponding author), European Mol Biol Lab, Meyerhofstr 1, D-69117 Heidelberg, Germany.	hentze@embl.de	Seiler, Markus/HHR-8348-2022; Medenbach, Jan/B-6877-2018; Hentze, Matthias W/V-3980-2017	Seiler, Markus/0000-0002-9600-6620; Medenbach, Jan/0000-0003-0749-7788; Hentze, Matthias W/0000-0002-4023-7876	Deutsche Forschungsgemeinschaft [FOR855 He 1442/13-1, FOR855 He 1442/13-2]; EMBO; NGFN DiGtoP	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); EMBO(European Molecular Biology Organization (EMBO)); NGFN DiGtoP	We thank Anne Ephrussi for kindly providing a Drosophila PTB plasmid, Toby Gibson for generous support, the EMBL Protein Expression and Purification Core Facility for recombinant proteases, and members of the Hentze lab for useful discussions. We also thank an anonymous reviewer for insightful comments that enlightened our mechanistic model. This work was supported by Deutsche Forschungsgemeinschaft Grants FOR855 He 1442/13-1 and /13-2 to M.W.H. J.M. acknowledges a long-term postdoctoral fellowship from EMBO. M.S. was funded by the NGFN DiGtoP grant.	Abaza I, 2006, GENE DEV, V20, P380, DOI 10.1101/gad.371906; BASHAW GJ, 1995, DEVELOPMENT, V121, P3245; Bashaw GJ, 1997, CELL, V89, P789, DOI 10.1016/S0092-8674(00)80262-7; Beckmann K, 2005, CELL, V122, P529, DOI 10.1016/j.cell.2005.06.011; Besse F, 2009, GENE DEV, V23, P195, DOI 10.1101/gad.505709; Bopp D, 1996, DEVELOPMENT, V122, P971; CAVENER DR, 1987, NUCLEIC ACIDS RES, V15, P1353, DOI 10.1093/nar/15.4.1353; Chatterjee S, 2009, BIOL CELL, V101, P251, DOI 10.1042/BC20080104; Cuchalova L, 2010, MOL CELL BIOL, V30, P4671, DOI 10.1128/MCB.00430-10; Duncan K, 2006, GENE DEV, V20, P368, DOI 10.1101/gad.371406; Duncan KE, 2009, MOL CELL, V36, P571, DOI 10.1016/j.molcel.2009.09.042; Gebauer F, 2003, MOL CELL, V11, P1397, DOI 10.1016/S1097-2765(03)00176-X; Gebauer F, 1999, EMBO J, V18, P6146, DOI 10.1093/emboj/18.21.6146; GRAY NK, 1993, EUR J BIOCHEM, V218, P657, DOI 10.1111/j.1432-1033.1993.tb18420.x; Grskovic M, 2003, EMBO J, V22, P5571, DOI 10.1093/emboj/cdg539; Hayden CA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-61; Hinnebusch AG, 2005, ANNU REV MICROBIOL, V59, P407, DOI 10.1146/annurev.micro.59.031805.133833; Hood HM, 2009, ANNU REV MICROBIOL, V63, P385, DOI 10.1146/annurev.micro.62.081307.162835; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; KELLEY RL, 1995, CELL, V81, P867, DOI 10.1016/0092-8674(95)90007-1; Kelley RL, 1997, NATURE, V387, P195, DOI 10.1038/387195a0; Kim TH, 2004, PLANT CELL, V16, P3341, DOI 10.1105/tpc.104.026880; KOZAK M, 1987, J MOL BIOL, V196, P947, DOI 10.1016/0022-2836(87)90418-9; KOZAK M, 1990, P NATL ACAD SCI USA, V87, P8301, DOI 10.1073/pnas.87.21.8301; Morris DR, 2000, MOL CELL BIOL, V20, P8635, DOI 10.1128/MCB.20.23.8635-8642.2000; Nanda JS, 2009, J MOL BIOL, V394, P268, DOI 10.1016/j.jmb.2009.09.017; Oberstrass FC, 2005, SCIENCE, V309, P2054, DOI 10.1126/science.1114066; Passmore LA, 2007, MOL CELL, V26, P41, DOI 10.1016/j.molcel.2007.03.018; Pestova TV, 2007, TRANSLATIONAL CONTRO, V4, P87; Roy B, 2010, RNA, V16, P748, DOI 10.1261/rna.2056010; Ruiz-Echevarria MJ, 2000, CELL, V101, P741, DOI 10.1016/S0092-8674(00)80886-7; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Seiler M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-144; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Tweedie S, 2009, NUCLEIC ACIDS RES, V37, pD555, DOI 10.1093/nar/gkn788	35	98	105	1	20	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 10	2011	145	6					902	913		10.1016/j.cell.2011.05.005	http://dx.doi.org/10.1016/j.cell.2011.05.005			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	775LS	21663794	Bronze			2022-12-24	WOS:000291461600017
J	Mummery, C				Mummery, Christine			Induced Pluripotent Stem Cells - A Cautionary Note	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Leiden Univ, Dept Anat & Embryol, Med Ctr, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Mummery, C (corresponding author), Leiden Univ, Dept Anat & Embryol, Med Ctr, Leiden, Netherlands.			Mummery, Christine/0000-0002-4549-6535				Dambrot C, 2011, BIOCHEM J, V434, P25, DOI 10.1042/BJ20101707; Gore A, 2011, NATURE, V471, P63, DOI 10.1038/nature09805; Hussein SM, 2011, NATURE, V471, P58, DOI 10.1038/nature09871; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Pera MF, 2011, NATURE, V471, P46, DOI 10.1038/471046a	5	42	45	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 2	2011	364	22					2160	2162		10.1056/NEJMcibr1103052	http://dx.doi.org/10.1056/NEJMcibr1103052			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	772AB	21631331				2022-12-24	WOS:000291200700018
J	Reisch, CR; Stoudemayer, MJ; Varaljay, VA; Amster, IJ; Moran, MA; Whitman, WB				Reisch, Chris R.; Stoudemayer, Melissa J.; Varaljay, Vanessa A.; Amster, I. Jonathan; Moran, Mary Ann; Whitman, William B.			Novel pathway for assimilation of dimethylsulphoniopropionate widespread in marine bacteria	NATURE			English	Article							ACYL-COENZYME-A; DIMETHYL SULFIDE; DIMETHYLSULFONIOPROPIONATE; SULFUR; DMSP; METHANETHIOL; DEGRADATION; METHIONINE; ABUNDANT; ENZYME	Dimethylsulphoniopropionate (DMSP) accounts for up to 10% of carbon fixed by marine phytoplankton in ocean surface waters(1,2), producing an estimated 11.7-103 T mol S per year(3), most of which is processed by marine bacteria through the demethylation/demethiolation pathway(4). This pathway releases methanethiol (MeSH) instead of the climatically active gas dimethylsulphide (DMS) and enables marine microorganisms to assimilate the reduced sulphur(5-7). Despite recognition of this critical microbial transformation for over two decades, the biochemical pathway and enzymes responsible have remained unidentified. Here we show that three new enzymes related to fatty acid beta-oxidation constitute the pathway that assimilates methylmercaptopropionate (MMPA), the first product of DMSP demethylation/demethiolation, and that two previously unknown coenzyme A (CoA) derivatives, 3-methylmercaptopropionyl-CoA (MMPA-CoA) and methylthioacryloyl-CoA (MTA-CoA), are formed as novel intermediates. A member of the marine roseobacters, Ruegeria pomeroyi DSS-3, requires the MMPA-CoA pathway for MMPA assimilation and MeSH production. This pathway and the ability to produce MeSH from MMPA are present in diverse bacteria, and the ubiquitous SAR11 clade bacterium Pelagibacter ubique possesses enzymes for at least the first two steps. Analysis of marine metagenomic data indicates that the pathway is widespread among bacterioplankton in the ocean surface waters, making it one of the most important known routes for acquisition of reduced carbon and sulphur by surface ocean heterotrophs.	[Reisch, Chris R.; Varaljay, Vanessa A.; Whitman, William B.] Univ Georgia, Dept Microbiol, Athens, GA 30602 USA; [Moran, Mary Ann] Univ Georgia, Dept Marine Sci, Athens, GA 30602 USA; [Stoudemayer, Melissa J.; Amster, I. Jonathan] Univ Georgia, Dept Chem, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Whitman, WB (corresponding author), Univ Georgia, Dept Microbiol, Athens, GA 30602 USA.	whitman@uga.edu	Whitman, William/AAC-5896-2020; Moran, Mary Ann/B-6939-2012; Amster, Jon/D-6957-2011	Amster, Jon/0000-0001-7523-5144; Whitman, William/0000-0003-1229-0423; Moran, Mary Ann/0000-0002-0702-8167; Stoudemayer, Melissa/0000-0002-2967-9948	National Science Foundation [MCB-0702125, OCE-0724017]; Gordon and Betty Moore Foundation	National Science Foundation(National Science Foundation (NSF)); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation)	We thank G. Wylie for assistance with NMR spectroscopy, S. Sharma, S. Sun and H. Luo for bioinformatics assistance, S. Gifford for technical advice, C. Smith and W. Crabb for technical assistance, and C. English for assistance with graphics. Funding for this research was provided by the National Science Foundation (MCB-0702125 and OCE-0724017) and the Gordon and Betty Moore Foundation.	ANDREAE MO, 1990, MAR CHEM, V30, P1, DOI 10.1016/0304-4203(90)90059-L; Archer SD, 2001, AQUAT MICROB ECOL, V24, P225, DOI 10.3354/ame024225; BELL RP, 1949, PROC R SOC LON SER-A, V197, P141, DOI 10.1098/rspa.1949.0055; Bentley R, 2004, CHEMOSPHERE, V55, P291, DOI 10.1016/j.chemosphere.2003.12.017; BRETSCHER AP, 1978, J BACTERIOL, V133, P763, DOI 10.1128/JB.133.2.763-768.1978; CHAMBERS ST, 1987, J BACTERIOL, V169, P4845, DOI 10.1128/jb.169.10.4845-4847.1987; CHARLSON RJ, 1987, NATURE, V326, P655, DOI 10.1038/326655a0; Curson ARJ, 2008, ENVIRON MICROBIOL, V10, P1099, DOI 10.1111/j.1462-2920.2008.01592.x; DEUTSCH J, 1994, ANAL BIOCHEM, V220, P321, DOI 10.1006/abio.1994.1344; Gonzalez JM, 2003, INT J SYST EVOL MICR, V53, P1261, DOI 10.1099/ijs.0.02491-0; Gonzalez JM, 1999, APPL ENVIRON MICROB, V65, P3810; GUPTA N K, 1970, Archives of Biochemistry and Biophysics, V141, P632, DOI 10.1016/0003-9861(70)90183-9; HENRIKSEN JR, 2008, THESIS U GEORGIA; Howard EC, 2008, ENVIRON MICROBIOL, V10, P2397, DOI 10.1111/j.1462-2920.2008.01665.x; Howard EC, 2006, SCIENCE, V314, P649, DOI 10.1126/science.1130657; KEEN NT, 1988, GENE, V70, P191, DOI 10.1016/0378-1119(88)90117-5; Kiene RP, 2000, J SEA RES, V43, P209, DOI 10.1016/S1385-1101(00)00023-X; KIENE RP, 1988, APPL ENVIRON MICROB, V54, P2208, DOI 10.1128/AEM.54.9.2208-2212.1988; Kiene RP, 1999, APPL ENVIRON MICROB, V65, P4549; Kiene RP, 1996, MAR CHEM, V54, P69, DOI 10.1016/0304-4203(96)00006-0; Koch Arthur L., 1994, P248; Ledyard KM, 1996, LIMNOL OCEANOGR, V41, P33, DOI 10.4319/lo.1996.41.1.0033; Li MZ, 2007, NAT METHODS, V4, P251, DOI 10.1038/NMETH1010; MYERS RW, 1993, J BIOL CHEM, V268, P24785; Neidhardt FC, 1990, PHYSL BACTERIAL CELL; Reisch CR, 2008, J BACTERIOL, V190, P8018, DOI 10.1128/JB.00770-08; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Simo R, 2002, LIMNOL OCEANOGR, V47, P53, DOI 10.4319/lo.2002.47.1.0053; STADTMAN ER, 1957, METHOD ENZYMOL, V3, P931, DOI 10.1016/S0076-6879(57)03481-3; Taylor BF, 1996, BIOLOGICAL AND ENVIRONMENTAL CHEMISTRY OF DMSP AND RELATED SULFONIUM COMPOUNDS, P265; TAYLOR BF, 1991, APPL ENVIRON MICROB, V57, P3581, DOI 10.1128/AEM.57.12.3581-3584.1991; Todd JD, 2009, ENVIRON MICROBIOL, V11, P1376, DOI 10.1111/j.1462-2920.2009.01864.x; Todd JD, 2007, SCIENCE, V315, P666, DOI 10.1126/science.1135370; Todd JD, 2011, ENVIRON MICROBIOL, V13, P427, DOI 10.1111/j.1462-2920.2010.02348.x; Todd JD, 2010, ENVIRON MICROBIOL, V12, P327, DOI 10.1111/j.1462-2920.2009.02071.x; Tripp HJ, 2008, NATURE, V452, P741, DOI 10.1038/nature06776; van Duyl FC, 1998, J SEA RES, V40, P221, DOI 10.1016/S1385-1101(98)00024-0; Venkateswaran A, 2000, APPL ENVIRON MICROB, V66, P2620, DOI 10.1128/AEM.66.6.2620-2626.2000	38	94	104	1	85	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 12	2011	473	7346					208	+		10.1038/nature10078	http://dx.doi.org/10.1038/nature10078			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	762NT	21562561				2022-12-24	WOS:000290487200037
J	Papadopoulou, M; Cassenaer, S; Nowotny, T; Laurent, G				Papadopoulou, Maria; Cassenaer, Stijn; Nowotny, Thomas; Laurent, Gilles			Normalization for Sparse Encoding of Odors by a Wide-Field Interneuron	SCIENCE			English	Article							MUSHROOM BODY; OLFACTORY SYSTEM; ANTENNAL LOBE; LOCUST; CORTEX; REPRESENTATIONS; NEURONS; OSCILLATIONS; SEQUENCES; SYNAPSES	Sparse coding presents practical advantages for sensory representations and memory storage. In the insect olfactory system, the representation of general odors is dense in the antennal lobes but sparse in the mushroom bodies, only one synapse downstream. In locusts, this transformation relies on the oscillatory structure of antennal lobe output, feed-forward inhibitory circuits, intrinsic properties of mushroom body neurons, and connectivity between antennal lobe and mushroom bodies. Here we show the existence of a normalizing negative-feedback loop within the mushroom body to maintain sparse output over a wide range of input conditions. This loop consists of an identifiable "giant" nonspiking inhibitory interneuron with ubiquitous connectivity and graded release properties.	[Papadopoulou, Maria; Cassenaer, Stijn; Laurent, Gilles] CALTECH, Div Biol, Computat & Neural Syst Program, Pasadena, CA 91125 USA; [Cassenaer, Stijn] CALTECH, Broad Fellows Program Brain Circuitry, Pasadena, CA 91125 USA; [Nowotny, Thomas] Univ Sussex, Sch Informat, CCNR, Brighton BN1 9QJ, E Sussex, England; [Laurent, Gilles] Max Planck Inst Brain Res, D-60528 Frankfurt, Germany	California Institute of Technology; California Institute of Technology; University of Sussex; Max Planck Society	Laurent, G (corresponding author), CALTECH, Div Biol, Computat & Neural Syst Program, Pasadena, CA 91125 USA.	gilles.laurent@brain.mpg.de	Nowotny, Thomas/C-3883-2012; Laurent, Gilles/A-4583-2012	Laurent, Gilles/0000-0002-2296-114X; Nowotny, Thomas/0000-0002-4451-915X	National Institute for Deafness and Communications Disorders; Lawrence Hanson Fund; Max Planck Society; Office of Naval Research [N00014-07-1-0741, N00014-10-1-0735]; Evolved Machines, Inc.; Research Council of UK; Biotechnology and Biological Sciences Research Council (UK) [BB/F005113/1]; Biotechnology and Biological Sciences Research Council [BB/F005113/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/E500315/1] Funding Source: researchfish; BBSRC [BB/F005113/1] Funding Source: UKRI	National Institute for Deafness and Communications Disorders; Lawrence Hanson Fund; Max Planck Society(Max Planck SocietyFoundation CELLEX); Office of Naval Research(Office of Naval Research); Evolved Machines, Inc.; Research Council of UK; Biotechnology and Biological Sciences Research Council (UK)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank G. Turner fur help with early locust experiments; V. Jayaraman, G. Turner, and G. Jefferis for help with the Drosophila recordings (fig. S9); and the Caltech Imaging Center for use of a confocal microscope. This work was funded by the National Institute for Deafness and Communications Disorders (G.L.), the Lawrence Hanson Fund (G.L.), the Max Planck Society the Office of Naval Research (grants N00014-07-1-0741 and N00014-10-1-0735 to G.L. and S.C.), a grant from Evolved Machines, Inc. (G.L. and M.P.), a Research Council of UK Academic Fellowship, and a grant from the Biotechnology and Biological Sciences Research Council (UK grant number BB/F005113/1) (T.N.).	Broome BM, 2006, NEURON, V51, P467, DOI 10.1016/j.neuron.2006.07.018; BURROWS M, 1978, J PHYSIOL-LONDON, V285, P231, DOI 10.1113/jphysiol.1978.sp012569; Cassenaer S, 2007, NATURE, V448, P709, DOI 10.1038/nature05973; DeWeese MR, 2003, J NEUROSCI, V23, P7940; Hahnloser RHR, 2002, NATURE, V419, P65, DOI 10.1038/nature00974; Jortner RA, 2007, J NEUROSCI, V27, P1659, DOI 10.1523/JNEUROSCI.4171-06.2007; Kanerva P., 1988, SPARSE DISTRIBUTED M; LAURENT G, 1994, J NEUROSCI, V14, P2993; Leitch B, 1996, J COMP NEUROL, V372, P487; Li YS, 1997, J COMP NEUROL, V387, P631; Liu X, 2009, NAT NEUROSCI, V12, P53, DOI 10.1038/nn.2235; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; Mazor O, 2005, NEURON, V48, P661, DOI 10.1016/j.neuron.2005.09.032; Olshausen BA, 2004, CURR OPIN NEUROBIOL, V14, P481, DOI 10.1016/j.conb.2004.07.007; Perez-Orive J, 2002, SCIENCE, V297, P359, DOI 10.1126/science.1070502; Poo C, 2009, NEURON, V62, P850, DOI 10.1016/j.neuron.2009.05.022; Stopfer M, 2003, NEURON, V39, P991, DOI 10.1016/j.neuron.2003.08.011; Turner GC, 2008, J NEUROPHYSIOL, V99, P734, DOI 10.1152/jn.01283.2007; Vinje WE, 2000, SCIENCE, V287, P1273, DOI 10.1126/science.287.5456.1273; WATSON AHD, 1985, J COMP NEUROL, V240, P219, DOI 10.1002/cne.902400302; YOUNG MP, 1992, SCIENCE, V256, P1327, DOI 10.1126/science.1598577	21	132	132	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 6	2011	332	6030					721	725		10.1126/science.1201835	http://dx.doi.org/10.1126/science.1201835			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759RK	21551062	Green Accepted			2022-12-24	WOS:000290265800044
J	Das, SK; Eder, S; Schauer, S; Diwoky, C; Temmel, H; Guertl, B; Gorkiewicz, G; Tamilarasan, KP; Kumari, P; Trauner, M; Zimmermann, R; Vesely, P; Haemmerle, G; Zechner, R; Hoefler, G				Das, Suman K.; Eder, Sandra; Schauer, Silvia; Diwoky, Clemens; Temmel, Hannes; Guertl, Barbara; Gorkiewicz, Gregor; Tamilarasan, Kuppusamy P.; Kumari, Pooja; Trauner, Michael; Zimmermann, Robert; Vesely, Paul; Haemmerle, Guenter; Zechner, Rudolf; Hoefler, Gerald			Adipose Triglyceride Lipase Contributes to Cancer-Associated Cachexia	SCIENCE			English	Article							WHOLE-BODY LIPOLYSIS; ENERGY-METABOLISM; SKELETAL-MUSCLE; WEIGHT-LOSS; FATTY-ACID; MICE; TISSUE; INFLAMMATION; DEFINITION; MECHANISMS	Cachexia is a multifactorial wasting syndrome most common in patients with cancer that is characterized by the uncontrolled loss of adipose and muscle mass. We show that the inhibition of lipolysis through genetic ablation of adipose triglyceride lipase (Atgl) or hormone-sensitive lipase (Hsl) ameliorates certain features of cancer-associated cachexia (CAC). In wild-type C57BL/6 mice, the injection of Lewis lung carcinoma or B16 melanoma cells causes tumor growth, loss of white adipose tissue (WAT), and a marked reduction of gastrocnemius muscle. In contrast, Atgl-deficient mice with tumors resisted increased WAT lipolysis, myocyte apoptosis, and proteasomal muscle degradation and maintained normal adipose and gastrocnemius muscle mass. Hsl-deficient mice with tumors were also protected although to a lesser degree. Thus, functional lipolysis is essential in the pathogenesis of CAC. Pharmacological inhibition of metabolic lipases may help prevent cachexia.	[Eder, Sandra; Zimmermann, Robert; Haemmerle, Guenter; Zechner, Rudolf] Graz Univ, Inst Mol Biosci, A-8010 Graz, Austria; [Das, Suman K.; Schauer, Silvia; Temmel, Hannes; Guertl, Barbara; Gorkiewicz, Gregor; Tamilarasan, Kuppusamy P.; Kumari, Pooja; Vesely, Paul; Hoefler, Gerald] Med Univ Graz, Inst Pathol, A-8036 Graz, Austria; [Diwoky, Clemens] Graz Univ Technol, Inst Med Engn, A-8010 Graz, Austria; [Kumari, Pooja; Trauner, Michael] Med Univ Graz, Div Gastroenterol & Hepatol, Dept Internal Med, A-8036 Graz, Austria	University of Graz; Medical University of Graz; Graz University of Technology; Medical University of Graz	Zechner, R (corresponding author), Graz Univ, Inst Mol Biosci, A-8010 Graz, Austria.	rudolf.zechner@uni-graz.at; gerald.hoefler@medunigraz.at	Das, Suman kumar/E-1270-2015; Hoefler, Gerald/B-7006-2008; Gorkiewicz, Gregor/ABF-1602-2021; Vesely, Paul/AAO-1286-2020; Hoefler, Gerald/H-1796-2016	Das, Suman kumar/0000-0002-0539-5174; Gorkiewicz, Gregor/0000-0003-1149-4782; Zechner, Rudolf/0000-0001-5483-1182; Green, Tami/0000-0002-4070-6214; Haemmerle, Guenter/0000-0001-9900-5896; Vesely, Paul Willibald/0000-0003-3608-1060; Trauner, Michael/0000-0002-1275-6425; Hoefler, Gerald/0000-0002-9056-3063; Zimmermann, Robert/0000-0002-7354-870X; Green, Tami/0000-0003-0485-0363; Jha, Pooja/0000-0002-0293-9287	Medical University of Graz; Forschungsforderungsgesellschaft; Bundesministerium fur Wissenschaft und Forschung; SFB LIPOTOX [F30]; Austrian Fonds zur Forderung der Wissenschaftlichen Forschung [Z136]; Austrian Science Fund (FWF) [F 3002, F 3008, Z 136] Funding Source: researchfish	Medical University of Graz; Forschungsforderungsgesellschaft; Bundesministerium fur Wissenschaft und Forschung; SFB LIPOTOX(German Research Foundation (DFG)); Austrian Fonds zur Forderung der Wissenschaftlichen Forschung(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	We thank E. Zechner and C. Schober-Trummler for reviewing the manuscript. The research was supported by the doctoral program Molecular Medicine of the Medical University of Graz (S. D.); GOLD, Genomics of Lipid-Associated Disorders as part of the Austrian Genome Project GEN-AU funded by Forschungsforderungsgesellschaft and Bundesministerium fur Wissenschaft und Forschung (Ru.Ze.); SFB LIPOTOX grant no. F30 (Ru.Ze., G. H.), the Wittgenstein Award 2007 grant no. Z136 funded by the Austrian Fonds zur Forderung der Wissenschaftlichen Forschung (Ru.Ze.). S. K. D., Ro.Zi., G. H., and Ru.Ze. hold a patent related to the modulation of ATGL for prevention and treatment of cachexia.	Agustsson T, 2007, CANCER RES, V67, P5531, DOI 10.1158/0008-5472.CAN-06-4585; Argiles Josep M, 2009, Curr Opin Support Palliat Care, V3, P263, DOI 10.1097/SPC.0b013e3283311d09; Belizario JE, 2001, BRIT J CANCER, V84, P1135, DOI 10.1054/bjoc.2001.1700; Bing C, 2004, P NATL ACAD SCI USA, V101, P2500, DOI 10.1073/pnas.0308647100; Busquets S, 2007, CLIN NUTR, V26, P239, DOI 10.1016/j.clnu.2006.12.001; Deans C, 2005, CURR OPIN CLIN NUTR, V8, P265, DOI 10.1097/01.mco.0000165004.93707.88; DEWYS WD, 1980, AM J MED, V69, P491, DOI 10.1016/S0149-2918(05)80001-3; Evans WJ, 2008, CLIN NUTR, V27, P793, DOI 10.1016/j.clnu.2008.06.013; FEARON KCH, 1992, P NUTR SOC, V51, P251, DOI 10.1079/PNS19920036; Fearon KCH, 2002, INT J CARDIOL, V85, P73, DOI 10.1016/S0167-5273(02)00235-8; Fouladiun M, 2005, CANCER-AM CANCER SOC, V103, P2189, DOI 10.1002/cncr.21013; Haemmerle G, 2002, J BIOL CHEM, V277, P4806, DOI 10.1074/jbc.M110355200; Haemmerle G, 2006, SCIENCE, V312, P734, DOI 10.1126/science.1123965; Hyltander A, 2000, EUR J CANCER, V36, P330, DOI 10.1016/S0959-8049(99)00273-7; JEEVANANDAM M, 1986, METABOLISM, V35, P304, DOI 10.1016/0026-0495(86)90145-9; Kawamura I, 1999, ANTICANCER RES, V19, P341; Khal J, 2005, INT J BIOCHEM CELL B, V37, P2196, DOI 10.1016/j.biocel.2004.10.017; KLEIN S, 1990, J CLIN INVEST, V86, P1403, DOI 10.1172/JCI114854; Lainscak M, 2008, AM J CARDIOL, V101, p8E, DOI 10.1016/j.amjcard.2008.02.065; Laurencikiene J, 2008, CANCER RES, V68, P9247, DOI 10.1158/0008-5472.CAN-08-1343; LEGASPI A, 1987, METABOLISM, V36, P958, DOI 10.1016/0026-0495(87)90132-6; Morley JE, 2006, AM J CLIN NUTR, V83, P735, DOI 10.1093/ajcn/83.4.735; RENNIE MJ, 1983, CLIN PHYSIOL, V3, P387, DOI 10.1111/j.1475-097X.1983.tb00847.x; Ryden M, 2008, CANCER-AM CANCER SOC, V113, P1695, DOI 10.1002/cncr.23802; SHAW JHF, 1987, ANN SURG, V205, P368, DOI 10.1097/00000658-198704000-00005; Tisdale MJ, 2009, PHYSIOL REV, V89, P381, DOI 10.1152/physrev.00016.2008; Tisdale MJ, 2002, NAT REV CANCER, V2, P862, DOI 10.1038/nrc927; van Royen M, 2000, BIOCHEM BIOPH RES CO, V270, P533, DOI 10.1006/bbrc.2000.2462; Zechner R, 2009, J LIPID RES, V50, P3, DOI 10.1194/jlr.R800031-JLR200; Zhou XL, 2010, CELL, V142, P531, DOI 10.1016/j.cell.2010.07.011	30	365	381	3	87	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 8	2011	333	6039					233	238		10.1126/science.1198973	http://dx.doi.org/10.1126/science.1198973			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	789GG	21680814				2022-12-24	WOS:000292502700053
J	Seong, KH; Li, D; Shimizu, H; Nakamura, R; Ishii, S				Seong, Ki-Hyeon; Li, Dong; Shimizu, Hideyuki; Nakamura, Ryoichi; Ishii, Shunsuke			Inheritance of Stress-Induced, ATF-2-Dependent Epigenetic Change	CELL			English	Article							POSITION-EFFECT VARIEGATION; DROSOPHILA-MELANOGASTER; TRANSPOSABLE ELEMENTS; RNA-POLYMERASE; GENE; P38; PARAMUTATION; ACTIVATION; EXPRESSION; RESPONSES	Atf1, the fission yeast homolog of activation transcription factor-2 (ATF-2), contributes to heterochromatin formation. However, the role of ATF-2 in chromatin assembly in higher organisms remains unknown. This study reveals that Drosophila ATF-2 (dATF-2) is required for heterochromatin assembly, whereas the stress-induced phosphorylation of dATF-2, via Mekk1-p38, disrupts heterochromatin. The dATF-2 protein colocalized with HP1, not only on heterochromatin but also at specific loci in euchromatin. Heat shock or osmotic stress induced phosphorylation of dATF-2 and resulted in its release from heterochromatin. This heterochromatic disruption was an epigenetic event that was transmitted to the next generation in a non-Mendelian fashion. When embryos were exposed to heat stress over multiple generations, the defective chromatin state was maintained over multiple successive generations, though it gradually returned to the normal state. The results suggest a mechanism by which the effects of stress are inherited epigenetically via the regulation of a tight chromatin structure.	[Seong, Ki-Hyeon; Li, Dong; Shimizu, Hideyuki; Nakamura, Ryoichi; Ishii, Shunsuke] RIKEN Tsukuba Inst, Mol Genet Lab, Tsukuba, Ibaraki 3050074, Japan	RIKEN	Ishii, S (corresponding author), RIKEN Tsukuba Inst, Mol Genet Lab, 3-1-1 Koyadai, Tsukuba, Ibaraki 3050074, Japan.	sishii@rtc.riken.jp	Ishii, Shunsuke/A-5271-2016	Ishii, Shunsuke/0000-0002-6530-2478; Seong, Ki-Hyeon/0000-0002-0606-8896; Li, Dong/0000-0002-7268-657X	Ministry of Education, Culture, Sports, Science, and Technology; Grants-in-Aid for Scientific Research [23370079] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We are grateful to Y. Iijima and T. Nomura for technical assistance, the staff of the Research Resources Center of the RIKEN Brain Science Institute for microarray analysis, L. L. Wallrath, the Exelixis collection at Harvard Medical School, T. Ide, T. Adachi-Yamada, and J. Eissenberg, and the Bloomington Stock Center for Drosophila strains. This work was supported in part by a Grant-in-Aid for Scientific Research on Innovative Areas from the Ministry of Education, Culture, Sports, Science, and Technology.	Alleman M, 2006, NATURE, V442, P295, DOI 10.1038/nature04884; Aravin AA, 2001, CURR BIOL, V11, P1017, DOI 10.1016/S0960-9822(01)00299-8; Carone BR, 2010, CELL, V143, P1084, DOI 10.1016/j.cell.2010.12.008; Chandler VL, 2007, CELL, V128, P641, DOI 10.1016/j.cell.2007.02.007; Craig CR, 2004, EMBO REP, V5, P1058, DOI 10.1038/sj.embor.7400282; Gowen JW, 1933, SCIENCE, V77, P312, DOI 10.1126/science.77.1995.312; GUPTA S, 1995, SCIENCE, V267, P389, DOI 10.1126/science.7824938; HAI TW, 1989, GENE DEV, V3, P2083, DOI 10.1101/gad.3.12b.2083; Hall IM, 2002, SCIENCE, V297, P2232, DOI 10.1126/science.1076466; Han SJ, 1998, J BIOL CHEM, V273, P369, DOI 10.1074/jbc.273.1.369; Inoue H, 2001, EMBO J, V20, P5421, DOI 10.1093/emboj/20.19.5421; Jia ST, 2004, SCIENCE, V304, P1971, DOI 10.1126/science.1099035; Kavi HH, 2009, EPIGENET CHROMATIN, V2, DOI 10.1186/1756-8935-2-15; Kennerdell JR, 2002, GENE DEV, V16, P1884, DOI 10.1101/gad.990802; Khurana JS, 2010, J CELL BIOL, V191, P905, DOI 10.1083/jcb.201006034; Lloyd VK, 2003, GENOME, V46, P1104, DOI 10.1139/G03-070; Lu BY, 1996, EMBO J, V15, P1323, DOI 10.1002/j.1460-2075.1996.tb00474.x; MAEKAWA T, 1989, EMBO J, V8, P2023, DOI 10.1002/j.1460-2075.1989.tb03610.x; Maekawa T, 2007, MOL CELL BIOL, V27, P1730, DOI 10.1128/MCB.01579-06; Maekawa T, 2010, EMBO J, V29, P184, DOI 10.1038/emboj.2009.318; Molinier J, 2006, NATURE, V442, P1046, DOI 10.1038/nature05022; Ng SF, 2010, NATURE, V467, P963, DOI 10.1038/nature09491; Okamura T, 2007, MOL BIOL CELL, V18, P1519, DOI 10.1091/mbc.E06-10-0909; RABINOW L, 1991, GENETICS, V129, P463; REUTER G, 1982, CHROMOSOMA, V85, P539, DOI 10.1007/BF00327349; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Sano Y, 2005, MOL BIOL CELL, V16, P2934, DOI 10.1091/mbc.E04-11-1008; Shimizu H, 2008, MOL CELL BIOL, V28, P6278, DOI 10.1128/MCB.02242-07; SPOFFORD JB, 1976, GENETICS BIOL DROS C, V1, P955; TARTOF KD, 1984, CELL, V37, P869, DOI 10.1016/0092-8674(84)90422-7; Thibault ST, 2004, NAT GENET, V36, P283, DOI 10.1038/ng1314; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Wagschal A, 2007, CSH PROTOC; WALLRATH LL, 1995, GENE DEV, V9, P1263, DOI 10.1101/gad.9.10.1263; Wang HB, 2003, MOL CELL, V12, P475, DOI 10.1016/j.molcel.2003.08.007; Waterland RA, 2003, MOL CELL BIOL, V23, P5293, DOI 10.1128/MCB.23.15.5293-5300.2003; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276	37	214	221	0	59	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 24	2011	145	7					1049	1061		10.1016/j.cell.2011.05.029	http://dx.doi.org/10.1016/j.cell.2011.05.029			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	782QV	21703449	Bronze			2022-12-24	WOS:000292025700012
J	Tada, K; Susumu, H; Sakuno, T; Watanabe, Y				Tada, Kenji; Susumu, Hiroaki; Sakuno, Takeshi; Watanabe, Yoshinori			Condensin association with histone H2A shapes mitotic chromosomes	NATURE			English	Article							AURORA-B KINASE; FISSION YEAST; MEIOSIS-I; BUDDING YEAST; SCHIZOSACCHAROMYCES-POMBE; MONOPOLAR ATTACHMENT; GENE-TRANSCRIPTION; H3 PHOSPHORYLATION; MITOSIS; KINETOCHORES	Chromosome structure is dynamically regulated during cell division, and this regulation is dependent, in part, on condensin. The localization of condensin at chromosome arms is crucial for chromosome partitioning during anaphase. Condensin is also enriched at kinetochores but its precise role and loading machinery remain unclear. Here we show that fission yeast (Schizosaccharomyces pombe) kinetochore proteins Pcs1 and Mde4-homologues of budding yeast (Saccharomyces cerevisiae) monopolin subunits and known to prevent merotelic kinetochore orientation-act as a condensin 'recruiter' at kinetochores, and that condensin itself may act to clamp microtubule binding sites during metaphase. In addition to the regional recruitment factors, overall condensin association with chromatin is governed by the chromosomal passenger kinase Aurora B. Aurora-B-dependent phosphorylation of condensin promotes its association with histone H2A and H2A.Z, which we identify as conserved chromatin 'receptors' of condensin. Condensin phosphorylation and its deposition onto chromosome arms reach a peak during anaphase, when Aurora B kinase relocates from centromeres to the spindle midzone, where the separating chromosome arms are positioned. Our results elucidate the molecular basis for the spatiotemporal regulation of mitotic chromosome architecture, which is crucial for chromosome partitioning.	[Tada, Kenji; Susumu, Hiroaki; Sakuno, Takeshi; Watanabe, Yoshinori] Univ Tokyo, Lab Chromosome Dynam, Inst Mol & Cellular Biosci, Tokyo 1130032, Japan; [Tada, Kenji; Susumu, Hiroaki; Watanabe, Yoshinori] Univ Tokyo, Grad Sch Sci, Grad Program Biophys & Biochem, Tokyo 1130032, Japan	University of Tokyo; University of Tokyo	Watanabe, Y (corresponding author), Univ Tokyo, Lab Chromosome Dynam, Inst Mol & Cellular Biosci, Tokyo 1130032, Japan.	ywatanab@iam.u-tokyo.ac.jp	Sakuno, Takeshi/Y-9478-2019	Watanabe, Yoshinori/0000-0002-5488-4812	Global COE Program(Integrative Life Science Based on the Study of Biosignaling Mechanisms); Special Coordination Funds for Promoting Science and Technology; MEXT, Japan; Grants-in-Aid for Scientific Research [21000010] Funding Source: KAKEN	Global COE Program(Integrative Life Science Based on the Study of Biosignaling Mechanisms)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Special Coordination Funds for Promoting Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank S. Hauf for critically reading the manuscript and K.-i. Noma, T. Hirano and the Yeast Genetic Resource Center (YGRC) for yeast strains or reagents. We also thank S. Hauf and M. Yanagida for communicating unpublished results, and all the members of our laboratory for their support and discussion. This work was supported in part by Global COE Program(Integrative Life Science Based on the Study of Biosignaling Mechanisms) (to K.T. and H.S.), Special Coordination Funds for Promoting Science and Technology (to T.S.) and a Grant-in-Aid for Specially Promoted Research, MEXT, Japan (to Y.W.).	Aono N, 2002, NATURE, V417, P197, DOI 10.1038/417197a; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Bazile F, 2010, CELL CYCLE, V9, P3243, DOI 10.4161/cc.9.16.12620; Brito IL, 2010, GENETICS, V185, P55, DOI 10.1534/genetics.110.115139; Buchanan L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000726; Corbett KD, 2010, CELL, V142, P556, DOI 10.1016/j.cell.2010.07.017; D'Ambrosio C, 2008, GENE DEV, V22, P2215, DOI 10.1101/gad.1675708; DOUGHERTY WG, 1989, VIROLOGY, V171, P356, DOI 10.1016/0042-6822(89)90603-X; Fuller BG, 2008, NATURE, V453, P1132, DOI 10.1038/nature06923; Gerlich D, 2006, CURR BIOL, V16, P333, DOI 10.1016/j.cub.2005.12.040; Giet R, 2001, J CELL BIOL, V152, P669, DOI 10.1083/jcb.152.4.669; Gregan J, 2007, CURR BIOL, V17, P1190, DOI 10.1016/j.cub.2007.06.044; Haeusler RA, 2008, GENE DEV, V22, P2204, DOI 10.1101/gad.1675908; Hagstrom KA, 2002, GENE DEV, V16, P729, DOI 10.1101/gad.968302; Hauf S, 2007, EMBO J, V26, P4475, DOI 10.1038/sj.emboj.7601880; Hirano T, 2005, CURR BIOL, V15, pR265, DOI 10.1016/j.cub.2005.03.037; HIRAOKA Y, 1984, CELL, V39, P349, DOI 10.1016/0092-8674(84)90013-8; Hsu JY, 2000, CELL, V102, P279, DOI 10.1016/S0092-8674(00)00034-9; Hudson DF, 2008, MOL BIOL CELL, V19, P3070, DOI 10.1091/mbc.E08-01-0057; Hudson DF, 2009, CHROMOSOME RES, V17, P131, DOI 10.1007/s10577-008-9009-7; Iwasaki O, 2010, MOL BIOL CELL, V21, P254, DOI 10.1091/mbc.E09-09-0790; Johzuka K, 2009, MOL CELL, V34, P26, DOI 10.1016/j.molcel.2009.02.021; Kaitna S, 2002, CURR BIOL, V12, P798, DOI 10.1016/S0960-9822(02)00820-5; Kawashima SA, 2007, GENE DEV, V21, P420, DOI 10.1101/gad.1497307; Kim HS, 2009, NAT STRUCT MOL BIOL, V16, P1286, DOI 10.1038/nsmb.1688; Kitajima TS, 2006, NATURE, V441, P46, DOI 10.1038/nature04663; Koch A, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001588; Koshland D, 1996, ANNU REV CELL DEV BI, V12, P305, DOI 10.1146/annurev.cellbio.12.1.305; Lavoie BD, 2004, GENE DEV, V18, P76, DOI 10.1101/gad.1150404; Lipp JJ, 2007, J CELL SCI, V120, P1245, DOI 10.1242/jcs.03425; Liu W, 2010, NATURE, V466, P508, DOI 10.1038/nature09272; Miller KM, 2003, MOL CELL, V11, P303, DOI 10.1016/S1097-2765(03)00041-8; Mora-Bermudez F, 2007, NAT CELL BIOL, V9, P822, DOI 10.1038/ncb1606; Murnion ME, 2001, J BIOL CHEM, V276, P26656, DOI 10.1074/jbc.M102288200; Nakazawa N, 2008, J CELL BIOL, V180, P1115, DOI 10.1083/jcb.200708170; Nasmyth K, 2009, ANNU REV GENET, V43, P525, DOI 10.1146/annurev-genet-102108-134233; Neurohr G, 2011, SCIENCE, V332, P465, DOI 10.1126/science.1201578; Nonaka N, 2002, NAT CELL BIOL, V4, P89, DOI 10.1038/ncb739; Oliveira RA, 2005, MOL CELL BIOL, V25, P8971, DOI 10.1128/MCB.25.20.8971-8984.2005; Ono T, 2004, MOL BIOL CELL, V15, P3296, DOI 10.1091/mbc.E04-03-0242; Parra MA, 2007, MOL CELL BIOL, V27, P7641, DOI 10.1128/MCB.00742-07; Petersen J, 2003, CURR BIOL, V13, P590, DOI 10.1016/S0960-9822(03)00205-7; Petronczki M, 2006, CELL, V126, P1049, DOI 10.1016/j.cell.2006.07.029; Rabitsch KP, 2003, DEV CELL, V4, P535, DOI 10.1016/S1534-5807(03)00086-8; Rangasamy D, 2004, NAT STRUCT MOL BIOL, V11, P650, DOI 10.1038/nsmb786; Renshaw MJ, 2010, DEV CELL, V19, P232, DOI 10.1016/j.devcel.2010.07.013; Ribeiro SA, 2009, MOL BIOL CELL, V20, P2371, DOI 10.1091/mbc.E08-11-1127; Ruchaud S, 2007, NAT REV MOL CELL BIO, V8, P798, DOI 10.1038/nrm2257; SAKA Y, 1994, EMBO J, V13, P4938, DOI 10.1002/j.1460-2075.1994.tb06821.x; Sakuno T, 2009, NATURE, V458, P852, DOI 10.1038/nature07876; Samoshkin A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006831; Takayama Y, 2008, MOL BIOL CELL, V19, P682, DOI 10.1091/mbc.E07-05-0504; Takemoto A, 2007, NUCLEIC ACIDS RES, V35, P2403, DOI 10.1093/nar/gkm157; Takemoto A, 2009, NAT STRUCT MOL BIOL, V16, P1302, DOI 10.1038/nsmb.1708; Talbert PB, 2010, NAT REV MOL CELL BIO, V11, P264, DOI 10.1038/nrm2861; Tanaka TU, 2010, EMBO J, V29, P4070, DOI 10.1038/emboj.2010.294; Yokobayashi S, 2003, MOL CELL BIOL, V23, P3965, DOI 10.1128/MCB.23.11.3965-3973.2003; Yokobayashi S, 2005, CELL, V123, P803, DOI 10.1016/j.cell.2005.09.013	58	142	142	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 23	2011	474	7352					477	U105		10.1038/nature10179	http://dx.doi.org/10.1038/nature10179			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	781NJ	21633354				2022-12-24	WOS:000291939700041
J	Patel, MM; Lopez-Collada, VR; Bulhoes, MM; De Oliveira, LH; Marquez, AB; Flannery, B; Esparza-Aguilar, M; Renoiner, EIM; Luna-Cruz, ME; Sato, HK; Hernandez-Hernandez, LD; Toledo-Cortina, G; Ceron-Rodriguez, M; Osnaya-Romero, N; Martinez-Alcazar, M; Aguinaga-Villasenor, RG; Plascencia-Hernandez, A; Fojaco-Gonzalez, F; Rezk, GHP; Gutierrez-Ramirez, SF; Dorame-Castillo, R; Tinajero-Pizano, R; Mercado-Villegas, B; Barbosa, MR; Maluf, EMC; Ferreira, LB; de Carvalho, FM; dos Santos, AR; Cesar, ED; de Oliveira, MEP; Silva, CLO; Cortes, MD; Matus, CR; Tate, J; Gargiullo, P; Parashar, UD				Patel, Manish M.; Richardson Lopez-Collada, Vesta; Bulhoes, Marilia Mattos; Helena De Oliveira, Lucia; Bautista Marquez, Aurora; Flannery, Brendan; Esparza-Aguilar, Marcelino; Montenegro Renoiner, Ernesto Isaac; Edilia Luna-Cruz, Maria; Sato, Helena Keico; del Carmen Hernandez-Hernandez, Luz; Toledo-Cortina, Gerardo; Ceron-Rodriguez, Magdalena; Osnaya-Romero, Neydi; Martinez-Alcazar, Mario; Gabriela Aguinaga-Villasenor, Rocio; Plascencia-Hernandez, Arturo; Fojaco-Gonzalez, Francisco; Hernandez-Peredo Rezk, Guillermo; Fortino Gutierrez-Ramirez, Sixto; Dorame-Castillo, Roberto; Tinajero-Pizano, Rogelio; Mercado-Villegas, Bernice; Barbosa, Marilia Reichelt; Cesario Maluf, Eliane Mara; Ferreira, Lucimar Bozza; de Carvalho, Francisca Maria; dos Santos, Ana Rosa; Cesar, Eduardo Dolabella; Paula de Oliveira, Maria Elisa; Osterno Silva, Carmem Lucia; de los Angeles Cortes, Maria; Ruiz Matus, Cuauhtemoc; Tate, Jacqueline; Gargiullo, Paul; Parashar, Umesh D.			Intussusception Risk and Health Benefits of Rotavirus Vaccination in Mexico and Brazil	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CHILDHOOD DIARRHEA; CASE SERIES; SAFETY; INFANTS; EFFICACY; CHILDREN; GASTROENTERITIS; IMMUNIZATION; VACCINES	Background Because postlicensure surveillance determined that a previous rotavirus vaccine, RotaShield, caused intussusception in 1 of every 10,000 recipients, we assessed the association of the new monovalent rotavirus vaccine (RV1) with intussusception after routine immunization of infants in Mexico and Brazil. Methods We used case-series and case-control methods to assess the association between RV1 and intussusception. Infants with intussusception were identified through active surveillance at 69 hospitals (16 in Mexico and 53 in Brazil), and age-matched infants from the same neighborhood were enrolled as controls. Vaccination dates were verified by a review of vaccination cards or clinic records. Results We enrolled 615 case patients (285 in Mexico and 330 in Brazil) and 2050 controls. An increased risk of intussusception 1 to 7 days after the first dose of RV1 was identified among infants in Mexico with the use of both the case-series method (incidence ratio, 5.3; 95% confidence interval [CI], 3.0 to 9.3) and the case-control method (odds ratio, 5.8; 95% CI, 2.6 to 13.0). No significant risk was found after the first dose among infants in Brazil, but an increased risk, albeit smaller than that seen after the first dose in Mexico - an increase by a factor of 1.9 to 2.6 - was seen 1 to 7 days after the second dose. A combined annual excess of 96 cases of intussusception in Mexico (approximately 1 per 51,000 infants) and in Brazil (approximately 1 per 68,000 infants) and of 5 deaths due to intussusception was attributable to RV1. However, RV1 prevented approximately 80,000 hospitalizations and 1300 deaths from diarrhea each year in these two countries. Conclusions RV1 was associated with a short-term risk of intussusception in approximately 1 of every 51,000 to 68,000 vaccinated infants. The absolute number of deaths and hospitalizations averted because of vaccination far exceeded the number of intussusception cases that may have been associated with vaccination. (Funded in part by the GAVI Alliance and the U. S. Department of Health and Human Services.)	[Patel, Manish M.; Tate, Jacqueline; Gargiullo, Paul; Parashar, Umesh D.] Ctr Dis Control & Prevent, Atlanta, GA 30333 USA; [Richardson Lopez-Collada, Vesta; Bautista Marquez, Aurora; Esparza-Aguilar, Marcelino; Edilia Luna-Cruz, Maria; del Carmen Hernandez-Hernandez, Luz] Minist Hlth, Natl Ctr Child & Adolescent Hlth, Mexico City, DF, Mexico; [Toledo-Cortina, Gerardo] Hosp Pediat Moctezuma, Mexico City, DF, Mexico; [Ceron-Rodriguez, Magdalena] Hosp Infantil Mexico Dr Federico Gomez, Mexico City, DF, Mexico; [Osnaya-Romero, Neydi] Inst Nacl Pediat, Mexico City, DF, Mexico; [Bulhoes, Marilia Mattos; Montenegro Renoiner, Ernesto Isaac; dos Santos, Ana Rosa] Minist Hlth, Secretariat Hlth Surveillance, Brasilia, DF, Brazil; [Montenegro Renoiner, Ernesto Isaac] Univ Brasilia, Nucleo Med Trop, Brasilia, DF, Brazil; [Flannery, Brendan] Pan Amer Hlth Org, Brasilia, DF, Brazil; [Sato, Helena Keico] Secretaria Estado Saude Sao Paulo, Sao Paulo, Brazil; [Ferreira, Lucimar Bozza] Secretaria Municipal Saude Curitiba, Curitiba, Parana, Brazil; [de Carvalho, Francisca Maria] Secretaria Estado Saude Rio de Janeiro, Rio De Janeiro, Brazil; [Cesar, Eduardo Dolabella] Secretaria Estado Saude Minas Gerais, Belo Horizonte, MG, Brazil; [Osterno Silva, Carmem Lucia] Secretaria Estado Saude Curitiba, Ceara, Brazil; [Helena De Oliveira, Lucia; de los Angeles Cortes, Maria; Ruiz Matus, Cuauhtemoc] Pan Amer Hlth Org, Washington, DC USA; [Osnaya-Romero, Neydi] Hosp Nino Morelense, Cuernavaca, Morelos, Mexico; [Martinez-Alcazar, Mario; Gabriela Aguinaga-Villasenor, Rocio] Hosp Infantil Morelia Eva Samano de Lopez Mateos, Morelia, Michoacan, Mexico; [Plascencia-Hernandez, Arturo] Hosp Civil Reg Guadalajara Fray Antonio Alcalde, Guadalajara, Jalisco, Mexico; [Plascencia-Hernandez, Arturo] Hosp Civil Nuevo Guadalajara Juan I Menchaca, Guadalajara, Jalisco, Mexico; [Fojaco-Gonzalez, Francisco] Hosp Alta Especialidad Nino Dr Rodolfo Nieto Padr, Villahermosa, Tabasco, Mexico; [Hernandez-Peredo Rezk, Guillermo] Ctr Especialidades Med Veracruz, Xalapa, Veracruz, Mexico; [Fortino Gutierrez-Ramirez, Sixto] Hosp Metropolitano Dr Bernardo Sepulveda, Monterrey, Nuevo Leon, Mexico; [Dorame-Castillo, Roberto] Hosp Infantil Estado Sonora, Hermosillo, Sonora, Mexico; [Tinajero-Pizano, Rogelio] Hosp Gen Reg Leon, Guanajuato, Mexico; [Mercado-Villegas, Bernice] Hosp Civil Tepic Dr Antonio Gonzalez Guevara, Tepic, Nayarit, Mexico	Centers for Disease Control & Prevention - USA; Hospital Infantil de Mexico Federico Gomez; Universidade de Brasilia; Pan American Health Organization; Pan American Health Organization	Patel, MM (corresponding author), Ctr Dis Control & Prevent, 1600 Clifton Rd,MS A-47, Atlanta, GA 30333 USA.	mpatel@cdc.gov	Hernandez, Arturo Plascencia/K-9659-2017; Osnaya-Romero, Neydi/AAI-2458-2020	Hernandez, Arturo Plascencia/0000-0002-7950-3019; /0000-0003-1486-3651	GAVI Alliance; U.S. Department of Health and Human Services	GAVI Alliance; U.S. Department of Health and Human Services	Funded in part by the GAVI Alliance under a collaborative agreement with the Program for Appropriate Technology in Health (PATH) and in part by the U.S. Department of Health and Human Services.	[Anonymous], 2009, Wkly Epidemiol Rec, V84, P533; [Anonymous], 2011, Wkly Epidemiol Rec, V86, P38; [Anonymous], 2009, Wkly Epidemiol Rec, V84, P325; [Anonymous], 45 INT C ANT AG CHEM; Araujo EC, 2007, J PEDIAT-BRAZIL, V83, P217, DOI [10.2223/JPED.1600, 10.1590/S0021-75572007000400006]; Bines JE, 2004, VACCINE, V22, P569, DOI 10.1016/j.vaccine.2003.09.016; Buttery JP, 2011, VACCINE, V29, P3061, DOI 10.1016/j.vaccine.2011.01.088; Cortese M, ESTIMATES BENEFITS P; Cortese Margaret M., 2010, Morbidity and Mortality Weekly Report, V59, P1074; Cortese Margaret M., 2009, Morbidity and Mortality Weekly Report, V58, P1; de Palma O, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2825; Farrington CP, 2009, BIOSTATISTICS, V10, P3, DOI 10.1093/biostatistics/kxn013; Farrington CP, 2004, VACCINE, V22, P2064, DOI 10.1016/j.vaccine.2004.01.017; FARRINGTON CP, 1995, BIOMETRICS, V51, P228, DOI 10.2307/2533328; Linhares AC, 2008, LANCET, V371, P1181, DOI 10.1016/S0140-6736(08)60524-3; Moser CA, 2001, J INFECT DIS, V183, P1108, DOI 10.1086/319294; Murphy TV, 2001, NEW ENGL J MED, V344, P564, DOI 10.1056/NEJM200102223440804; Musonda P, 2006, STAT MED, V25, P2618, DOI 10.1002/sim.2477; Patel M, 2009, J INFECT DIS, V200, pS39, DOI 10.1086/605035; Patel M, 2009, JAMA-J AM MED ASSOC, V301, P2243, DOI 10.1001/jama.2009.756; Patel MM, 2011, PEDIATR INFECT DIS J, V30, pS1, DOI 10.1097/INF.0b013e3181fefa1f; Patel MM, 2009, VACCINE, V27, P2916, DOI 10.1016/j.vaccine.2009.03.016; Peter G, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.6.e67; Richardson V, 2010, NEW ENGL J MED, V362, P299, DOI 10.1056/NEJMoa0905211; Ruiz-Palacios GM, 2006, NEW ENGL J MED, V354, P11, DOI 10.1056/NEJMoa052434; Salinas M, 2005, PEDIATR INFECT DIS J, V24, P807, DOI 10.1097/01.inf.0000178294.13954.a1; Simonsen L, 2001, LANCET, V358, P1224, DOI 10.1016/S0140-6736(01)06346-2; Steele AD, 2010, VACCINE, V28, P6542, DOI 10.1016/j.vaccine.2008.08.034; Vesikari T, 2006, NEW ENGL J MED, V354, P23, DOI 10.1056/NEJMoa052664; World Health Organization, 2007, Wkly Epidemiol Rec, V82, P285	30	272	288	0	27	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 16	2011	364	24					2283	2292		10.1056/NEJMoa1012952	http://dx.doi.org/10.1056/NEJMoa1012952			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	777RZ	21675888	Bronze			2022-12-24	WOS:000291643800006
J	Sander, LE; Davis, MJ; Boekschoten, MV; Amsen, D; Dascher, CC; Ryffel, B; Swanson, JA; Muller, M; Blander, JM				Sander, Leif E.; Davis, Michael J.; Boekschoten, Mark V.; Amsen, Derk; Dascher, Christopher C.; Ryffel, Bernard; Swanson, Joel A.; Mueller, Michael; Blander, J. Magarian			Detection of prokaryotic mRNA signifies microbial viability and promotes immunity	NATURE			English	Article							TOLL-LIKE RECEPTORS; T-CELL RESPONSES; TRANSCRIPTION FACTORS; PROTECTIVE IMMUNITY; INNATE; INFLAMMASOME; RECOGNITION; ACTIVATION; REGULATORS; PHAGOSOME	Live vaccines have long been known to trigger far more vigorous immune responses than their killed counterparts(1-6). This has been attributed to the ability of live microorganisms to replicate and express specialized virulence factors that facilitate invasion and infection of their hosts(7). However, protective immunization can often be achieved with a single injection of live, but not dead, attenuated microorganisms stripped of their virulence factors. Pathogen-associated molecular patterns (PAMPs), which are detected by the immune system(8,9), are present in both live and killed vaccines, indicating that certain poorly characterized aspects of live microorganisms, not incorporated in dead vaccines, are particularly effective at inducing protective immunity. Here we show that the mammalian innate immune system can directly sense microbial viability through detection of a special class of viability-associated PAMPs (vita-PAMPs). We identify prokaryotic messenger RNA as a vita-PAMP present only in viable bacteria, the recognition of which elicits a unique innate response and a robust adaptive antibody response. Notably, the innate response evoked by viability and prokaryotic mRNA was thus far considered to be reserved for pathogenic bacteria, but we show that even non-pathogenic bacteria in sterile tissues can trigger similar responses, provided that they are alive. Thus, the immune system actively gauges the infectious risk by searching PAMPs for signatures of microbial life and thus infectivity. Detection of vita-PAMPs triggers a state of alert not warranted for dead bacteria. Vaccine formulations that incorporate vita-PAMPs could thus combine the superior protection of live vaccines with the safety of dead vaccines.	[Sander, Leif E.; Dascher, Christopher C.; Blander, J. Magarian] Mt Sinai Sch Med, Inst Immunol, Dept Med, New York, NY 10029 USA; [Davis, Michael J.; Swanson, Joel A.] Univ Michigan, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; [Boekschoten, Mark V.; Mueller, Michael] Wageningen Univ, Div Human Nutr, Nutr Metab & Genom Grp, NL-6703 HD Wageningen, Netherlands; [Amsen, Derk] Univ Amsterdam, Acad Med Ctr, Dept Cell Biol & Histol, NL-1105 AZ Amsterdam, Netherlands; [Ryffel, Bernard] Univ Orleans, Lab Mol Immunol & Embryol, F-45071 Orleans, France; [Ryffel, Bernard] CNRS, F-45071 Orleans, France	Icahn School of Medicine at Mount Sinai; University of Michigan System; University of Michigan; Wageningen University & Research; University of Amsterdam; Academic Medical Center Amsterdam; Universite de Orleans; Centre National de la Recherche Scientifique (CNRS)	Blander, JM (corresponding author), Mt Sinai Sch Med, Inst Immunol, Dept Med, 1425 Madison Ave, New York, NY 10029 USA.	julie.blander@mssm.edu	Sander, Leif Erik/AAI-8619-2020; Boekschoten, Mark V/A-2458-2011; Boekschoten, Mark/AAS-4597-2021; Muller, Michael/M-5724-2019; Muller, Michael/B-5795-2008; Swanson, Joel A/P-4362-2014	Boekschoten, Mark V/0000-0002-2139-0795; Boekschoten, Mark/0000-0002-2139-0795; Muller, Michael/0000-0002-5930-9905; Muller, Michael/0000-0002-5930-9905; Swanson, Joel A/0000-0003-0900-8212; Blander, Julie Magarian/0000-0001-9207-1700; Sander, Leif Erik/0000-0002-0476-9947; Davis, Michael/0000-0002-3970-2208	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI095245, R21AI080959, R01AI064668] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI064668, R21 AI080959-01A1, R21 AI080959, AI080959A, R01 AI095245] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Anderson BR, 2010, NUCLEIC ACIDS RES, V38, P5884, DOI 10.1093/nar/gkq347; Belasco JG, 2010, NAT REV MOL CELL BIO, V11, P467, DOI 10.1038/nrm2917; Blander JM, 2004, SCIENCE, V304, P1014, DOI 10.1126/science.1096158; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brockstedt DG, 2005, NAT MED, V11, P853, DOI 10.1038/nm1276; BUCHMEIER NA, 1990, SCIENCE, V248, P730, DOI 10.1126/science.1970672; Cheers C, 1996, TRENDS MICROBIOL, V4, P453, DOI 10.1016/0966-842X(96)10067-6; Coll RC, 2010, J INNATE IMMUN, V2, P406, DOI 10.1159/000315469; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Davis MJ, 2010, J LEUKOCYTE BIOL, V88, P813, DOI 10.1189/jlb.0310159; Detmer A, 2006, MICROB CELL FACT, V5, DOI 10.1186/1475-2859-5-23; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gripenland J, 2010, NAT REV MICROBIOL, V8, P857, DOI 10.1038/nrmicro2457; Haraga A, 2008, NAT REV MICROBIOL, V6, P53, DOI 10.1038/nrmicro1788; Herskovits AA, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030051; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Kanneganti TD, 2006, NATURE, V440, P233, DOI 10.1038/nature04517; Kariko K, 2005, IMMUNITY, V23, P165, DOI 10.1016/j.immuni.2005.06.008; KAWAMURA I, 1994, INFECT IMMUN, V62, P4396, DOI 10.1128/IAI.62.10.4396-4403.1994; KUIDA K, 1995, SCIENCE, V267, P2000, DOI 10.1126/science.7535475; Lauvau G, 2001, SCIENCE, V294, P1735, DOI 10.1126/science.1064571; Lim So-Yon, 2006, J Immune Based Ther Vaccines, V4, P5, DOI 10.1186/1476-8518-4-5; Mariathasan S, 2007, NAT REV IMMUNOL, V7, P31, DOI 10.1038/nri1997; MAURELLI AT, 1985, INFECT IMMUN, V49, P164, DOI 10.1128/IAI.49.1.164-171.1985; Medzhitov R, 2009, IMMUNITY, V30, P766, DOI 10.1016/j.immuni.2009.06.004; Monroe KM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000665; Nallagatla SR, 2008, RNA BIOL, V5, P140, DOI 10.4161/rna.5.3.6839; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Pang IK, 2011, TRENDS IMMUNOL, V32, P34, DOI 10.1016/j.it.2010.11.004; Piekna-Przybylska D, 2008, NUCLEIC ACIDS RES, V36, pD178, DOI 10.1093/nar/gkm855; Raskin DM, 2006, CELL, V124, P703, DOI 10.1016/j.cell.2006.02.002; Rehwinkel J, 2010, SCIENCE, V327, P284, DOI 10.1126/science.1185068; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Samarajiwa SA, 2009, NUCLEIC ACIDS RES, V37, pD852, DOI 10.1093/nar/gkn732; Sartor MA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-538; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Schnupf P, 2007, MICROBES INFECT, V9, P1176, DOI 10.1016/j.micinf.2007.05.005; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Shimada T, 2010, CELL HOST MICROBE, V7, P38, DOI 10.1016/j.chom.2009.12.008; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Sutterwala FS, 2006, IMMUNITY, V24, P317, DOI 10.1016/j.immuni.2006.02.004; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Torchinsky MB, 2009, NATURE, V458, P78, DOI 10.1038/nature07781; Vance RE, 2009, CELL HOST MICROBE, V6, P10, DOI 10.1016/j.chom.2009.06.007; VONKOENIG CHW, 1982, NATURE, V297, P233, DOI 10.1038/297233a0; Wing HJ, 2004, J BACTERIOL, V186, P699, DOI 10.1128/JB.186.3.699-705.2004; Woodward JJ, 2010, SCIENCE, V328, P1703, DOI 10.1126/science.1189801; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	51	296	300	0	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 16	2011	474	7351					385	+		10.1038/nature10072	http://dx.doi.org/10.1038/nature10072			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777TD	21602824	Green Accepted			2022-12-24	WOS:000291647100047
J	Yu, YH; Yoon, SO; Poulogiannis, G; Yang, Q; Ma, XJM; Villen, J; Kubica, N; Hoffman, GR; Cantley, LC; Gygi, SP; Blenis, J				Yu, Yonghao; Yoon, Sang-Oh; Poulogiannis, George; Yang, Qian; Ma, Xiaoju Max; Villen, Judit; Kubica, Neil; Hoffman, Gregory R.; Cantley, Lewis C.; Gygi, Steven P.; Blenis, John			Phosphoproteomic Analysis Identifies Grb10 as an mTORC1 Substrate That Negatively Regulates Insulin Signaling	SCIENCE			English	Article							INHIBITION; DISRUPTION; RESISTANCE; ACTIVATION; KINASE; LEADS	The evolutionarily conserved serine-threonine kinase mammalian target of rapamycin (mTOR) plays a critical role in regulating many pathophysiological processes. Functional characterization of the mTOR signaling pathways, however, has been hampered by the paucity of known substrates. We used large-scale quantitative phosphoproteomics experiments to define the signaling networks downstream of mTORC1 and mTORC2. Characterization of one mTORC1 substrate, the growth factor receptor-bound protein 10 (Grb10), showed that mTORC1-mediated phosphorylation stabilized Grb10, leading to feedback inhibition of the phosphatidylinositol 3-kinase (PI3K) and extracellular signal-regulated, mitogen-activated protein kinase (ERK-MAPK) pathways. Grb10 expression is frequently down-regulated in various cancers, and loss of Grb10 and loss of the well-established tumor suppressor phosphatase PTEN appear to be mutually exclusive events, suggesting that Grb10 might be a tumor suppressor regulated by mTORC1.	[Yu, Yonghao; Yoon, Sang-Oh; Yang, Qian; Ma, Xiaoju Max; Villen, Judit; Kubica, Neil; Hoffman, Gregory R.; Gygi, Steven P.; Blenis, John] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Poulogiannis, George; Cantley, Lewis C.] Beth Israel Deaconess Med Ctr, Div Signal Transduct, Boston, MA 02215 USA; [Yang, Qian] Harvard Univ, Sch Dent Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard School of Dental Medicine	Gygi, SP (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.	Steven_gygi@hms.harvard.edu; john_blenis@hms.harvard.edu	Poulogiannis, George/AAE-1966-2019; Poulogiannis, George/AAY-2210-2021; Cantley, Lewis C/D-1800-2014	Poulogiannis, George/0000-0002-0529-8614; Cantley, Lewis C/0000-0002-1298-7653; Villen, Judit/0000-0002-1005-1739	Tuberous Sclerosis Alliance [ID-146]; NIH [GM051405, CA46595, HG3456, R00CA140789]; NATIONAL CANCER INSTITUTE [R37CA046595, R00CA140789, R01CA046595] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003456] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056203, R01GM051405, R01GM041890] Funding Source: NIH RePORTER	Tuberous Sclerosis Alliance; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Blenis and Gygi laboratories for critical discussion. This work was supported by a postdoctoral fellowship from the Tuberous Sclerosis Alliance (grant ID-146 to Y.Y.), and NIH grants GM051405 and CA46595 (J.B.), HG3456 (S. P. G.), and R00CA140789 (J.V.). J.B. is an Established Investigator of the LAM Foundation. A provisional patent on the phosphorylation sites identified and the participation of Grb10 in the feedback loop was filed on 9/23/2010 (no. 61/403, 932 to J.B., S. P. G. and Y.Y.).	Alessi DR, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.267pe27; Carracedo A, 2008, J CLIN INVEST, V118, P3065, DOI [10.1172/jCI34739, 10.1172/JCI34739]; Charalambous M, 2003, P NATL ACAD SCI USA, V100, P8292, DOI 10.1073/pnas.1532175100; Choo AY, 2008, P NATL ACAD SCI USA, V105, P17414, DOI 10.1073/pnas.0809136105; Choo AY, 2010, MOL CELL, V38, P487, DOI 10.1016/j.molcel.2010.05.007; Choo AY, 2009, CELL CYCLE, V8, P567, DOI 10.4161/cc.8.4.7659; Cloughesy TF, 2008, PLOS MED, V5, P139, DOI 10.1371/journal.pmed.0050008; Guertin DA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.267pe24; Langlais P, 2005, BIOCHEMISTRY-US, V44, P8890, DOI 10.1021/bi050413i; Lim MA, 2004, FRONT BIOSCI-LANDMRK, V9, P387, DOI 10.2741/1226; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Saal LH, 2005, CANCER RES, V65, P2554, DOI 10.1158/0008-5472-CAN-04-3913; Shah OJ, 2004, CURR BIOL, V14, P1650, DOI 10.1016/j.cub.2004.08.026; Tzatsos A, 2006, MOL CELL BIOL, V26, P63, DOI 10.1128/MCB.26.1.63-76.2006; Wang L, 2007, MOL CELL BIOL, V27, P6497, DOI 10.1128/MCB.00679-07	16	628	645	1	92	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 10	2011	332	6035					1322	1326		10.1126/science.1199484	http://dx.doi.org/10.1126/science.1199484			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	775EP	21659605	Green Accepted			2022-12-24	WOS:000291441700045
J	Cohen, NM; Kenigsberg, E; Tanay, A				Cohen, Netta Mendelson; Kenigsberg, Ephraim; Tanay, Amos			Primate CpG Islands Are Maintained by Heterogeneous Evolutionary Regimes Involving Minimal Selection	CELL			English	Article							BIASED GENE CONVERSION; DIFFERENTIALLY METHYLATED REGIONS; PLURIPOTENT STEM-CELLS; DNA METHYLATION; HUMAN GENOME; BINDING SITES; HYPERMETHYLATION; PATTERNS; FREQUENCIES; SEQUENCES	Mammalian CpG islands are key epigenomic elements that were first characterized experimentally as genomic fractions with low levels of DNA methylation. Currently, CpG islands are defined based on their genomic sequences alone. Here, we develop evolutionary models to show that several distinct evolutionary processes generate and maintain CpG islands. One central evolutionary regime resulting in enriched CpG content is driven by low levels of DNA methylation and consequentially low rates of CpG deamination. Another major force forming CpG islands is biased gene conversion that stabilizes constitutively methylated CpG islands by balancing rapid deamination with CpG fixation. Importantly, evolutionary analysis and population genetics data suggest that selection for high CpG content is not a significant factor contributing to conservation of CpGs in differentially methylated regions. The heterogeneous, but not selective, origins of CpG islands have direct implications for the understanding of DNA methylation patterns in healthy and diseased cells.	[Cohen, Netta Mendelson; Kenigsberg, Ephraim; Tanay, Amos] Weizmann Inst Sci, Dept Comp Sci & Appl Math, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Tanay, A (corresponding author), Weizmann Inst Sci, Dept Comp Sci & Appl Math, IL-76100 Rehovot, Israel.	amos.tanay@weizmann.ac.il	Kenigsberg, Ephraim/AAM-5690-2020		Israeli Science foundation [1372/08]; EU EPIGENESYS NoE	Israeli Science foundation(Israel Science Foundation); EU EPIGENESYS NoE	We'd like to thank members of the Tanay group for discussions and critical reading of the manuscript. A. T. wishes to thank Tim Bestor, Peter Jones, and Einav Nili Gal-Yam for discussions. Research in A.T.'s lab was supported by the Israeli Science foundation (1372/08) and the EU EPIGENESYS NoE program.	Arndt PF, 2007, GENE, V390, P75, DOI 10.1016/j.gene.2006.11.022; Baele G, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-244; Bartke T, 2010, CELL, V143, P470, DOI 10.1016/j.cell.2010.10.012; Baylin S, 2002, CANCER CELL, V1, P299, DOI 10.1016/S1535-6108(02)00061-2; Baylin SB, 2000, TRENDS GENET, V16, P168, DOI 10.1016/S0168-9525(99)01971-X; BIRD A, 1985, CELL, V40, P91, DOI 10.1016/0092-8674(85)90312-5; BIRD AP, 1980, NUCLEIC ACIDS RES, V8, P1499, DOI 10.1093/nar/8.7.1499; BROWN TC, 1987, CELL, V50, P945, DOI 10.1016/0092-8674(87)90521-6; Cohen NM, 2009, GENOME RES, V19, P2193, DOI 10.1101/gr.096685.109; Cohn I, 2010, J MACH LEARN RES, V11, P2745; Dindot SV, 2009, GENOME RES, V19, P1374, DOI 10.1101/gr.089185.108; Doi A, 2009, NAT GENET, V41, P1350, DOI 10.1038/ng.471; Dreszer TR, 2007, GENOME RES, V17, P1420, DOI 10.1101/gr.6395807; Duret L, 2009, ANNU REV GENOM HUM G, V10, P285, DOI 10.1146/annurev-genom-082908-150001; Edwards JR, 2010, GENOME RES, V20, P972, DOI 10.1101/gr.101535.109; EYREWALKER A, 1993, P ROY SOC B-BIOL SCI, V252, P237, DOI 10.1098/rspb.1993.0071; Gal-Yam EN, 2008, P NATL ACAD SCI USA, V105, P12979, DOI 10.1073/pnas.0806437105; Galtier N, 2001, GENETICS, V159, P907; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Hwang DG, 2004, P NATL ACAD SCI USA, V101, P13994, DOI 10.1073/pnas.0404142101; Illingworth RS, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001134; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Ji H, 2010, NATURE, V467, P338, DOI 10.1038/nature09367; Jorgensen HF, 2002, MENT RETARD DEV D R, V8, P87, DOI 10.1002/mrdd.10021; Kenigsberg E, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001039; Keshet I, 2006, NAT GENET, V38, P149, DOI 10.1038/ng1719; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; KSCHISCHANG FR, 2001, IEEE T INFORM THEORY, V47, P21; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Rakyan VK, 2008, GENOME RES, V18, P1518, DOI 10.1101/gr.077479.108; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Schulz R, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001214; Straussman R, 2009, NAT STRUCT MOL BIOL, V16, P564, DOI 10.1038/nsmb.1594; Takai D, 2002, P NATL ACAD SCI USA, V99, P3740, DOI 10.1073/pnas.052410099; Tanay A, 2007, P NATL ACAD SCI USA, V104, P5521, DOI 10.1073/pnas.0609746104; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990	39	104	104	0	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 27	2011	145	5					773	786		10.1016/j.cell.2011.04.024	http://dx.doi.org/10.1016/j.cell.2011.04.024			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	769MR	21620139	Bronze			2022-12-24	WOS:000291018600016
J	Treasure, T; Hasan, A; Yacoub, M				Treasure, Tom; Hasan, Asif; Yacoub, Magdi			Is there a risk in avoiding risk for younger patients with aortic valve disease?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ROOT REPLACEMENT; ROSS PROCEDURE; HEART-VALVES; OUTCOMES; DURABILITY; AUTOGRAFT; SURVIVAL; MODELS; AGE		[Treasure, Tom] UCL, Dept Math, Clin Operat Res Unit, London WC1H 0BT, England; [Hasan, Asif] Freeman Rd Hosp, Newcastle Upon Tyne, Tyne & Wear, England; [Yacoub, Magdi] Harefield Hosp, Heart Sci Ctr, Harefield UB9 6JH, Middx, England	University of London; University College London; Newcastle Freeman Hospital; Newcastle University - UK; Royal Brompton & Harefield NHS Foundation Trust; Harefield Hospital	Treasure, T (corresponding author), UCL, Dept Math, Clin Operat Res Unit, London WC1H 0BT, England.	tom.treasure@gmail.com						Banbury MK, 2001, ANN THORAC SURG, V72, P753, DOI 10.1016/S0003-4975(01)02992-7; Berwick DM, 2008, JAMA-J AM MED ASSOC, V299, P1182, DOI 10.1001/jama.299.10.1182; Bridgewater B, 2009, 6 NATL ADULT CARDIAC; El-Hamamsy I, 2010, LANCET, V376, P524, DOI 10.1016/S0140-6736(10)60828-8; El-Hamamsy I, 2010, J AM COLL CARDIOL, V55, P368, DOI 10.1016/j.jacc.2009.09.030; Hasan A, 2000, BRIT MED J, V320, P171, DOI 10.1136/bmj.320.7228.171; Hirsh J, 2009, LANCET, V374, P273, DOI 10.1016/S0140-6736(09)60787-X; Kvidal P, 2000, J AM COLL CARDIOL, V35, P747, DOI 10.1016/S0735-1097(99)00584-7; Mokhles MM, 2011, CIRCULATION, V123, P31, DOI 10.1161/CIRCULATIONAHA.110.947341; Murday AJ, 2003, ANN THORAC SURG, V76, P66, DOI 10.1016/S0003-4975(03)00118-8; ROSS DN, 1967, LANCET, V2, P956; Royston G, 1999, BMJ-BRIT MED J, V318, P360; Society for Cardiothoracic Surgery in Great Britain and Ireland, 2011, CARD SURG DAT; Stoica S, 2010, HEART, V96, P1730, DOI 10.1136/hrt.2010.201939; Takkenberg JJM, 2004, J AM COLL CARDIOL, V44, P1142, DOI 10.1016/j.jacc.2004.06.010; Takkenberg JJM, 2003, ANN THORAC SURG, V75, P1372, DOI 10.1016/S0003-4975(02)04996-2; Takkenberg JJM, 2010, HEART, V96, P1691, DOI 10.1136/hrt.2010.207050; Takkenberg JJM, 2009, CIRCULATION, V119, P222, DOI 10.1161/CIRCULATIONAHA.107.726349; TREASURE T, 1990, LANCET, V336, P1115, DOI 10.1016/0140-6736(90)92583-4; TREASURE T, 1994, LANCET, V343, P1308, DOI 10.1016/S0140-6736(94)92463-5; Vink R, 2003, J AM COLL CARDIOL, V42, P2042, DOI 10.1016/j.jacc.2003.07.029	21	24	24	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 26	2011	342								d2466	10.1136/bmj.d2466	http://dx.doi.org/10.1136/bmj.d2466			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	771KG	21622509				2022-12-24	WOS:000291155000001
J	Innocenti, P; Morrow, EH; Dowling, DK				Innocenti, Paolo; Morrow, Edward H.; Dowling, Damian K.			Experimental Evidence Supports a Sex-Specific Selective Sieve in Mitochondrial Genome Evolution	SCIENCE			English	Article							POPULATION VIABILITY; MALE-STERILITY; MOTHERS CURSE; NUCLEAR; GENES; CONSEQUENCES; INHERITANCE; MUTATIONS; WOLBACHIA; CONFLICT	Mitochondria are maternally transmitted; hence, their genome can only make a direct and adaptive response to selection through females, whereas males represent an evolutionary dead end. In theory, this creates a sex-specific selective sieve, enabling deleterious mutations to accumulate in mitochondrial genomes if they exert male-specific effects. We tested this hypothesis, expressing five mitochondrial variants alongside a standard nuclear genome in Drosophila melanogaster, and found striking sexual asymmetry in patterns of nuclear gene expression. Mitochondrial polymorphism had few effects on nuclear gene expression in females but major effects in males, modifying nearly 10% of transcripts. These were mostly male-biased in expression, with enrichment hotspots in the testes and accessory glands. Our results suggest an evolutionary mechanism that results in mitochondrial genomes harboring male-specific mutation loads.	[Dowling, Damian K.] Monash Univ, Sch Biol Sci, Clayton, Vic 3800, Australia; [Innocenti, Paolo; Morrow, Edward H.] Uppsala Univ, Evolutionary Biol Ctr, Dept Ecol & Genet, S-75236 Uppsala, Sweden	Monash University; Uppsala University	Dowling, DK (corresponding author), Monash Univ, Sch Biol Sci, Clayton, Vic 3800, Australia.	damian.dowling@monash.edu	Morrow, Edward/C-2358-2011; Morrow, Edward H/Q-6730-2019; Dowling, Damian/C-9016-2009	Morrow, Edward/0000-0002-1853-7469; Morrow, Edward H/0000-0002-1853-7469; Dowling, Damian/0000-0003-2209-3458; Innocenti, Paolo/0000-0003-2082-0586	Australian Research Council [DP1092897]; Monash University; Swedish Research Council [2008-5533]	Australian Research Council(Australian Research Council); Monash University(Monash University); Swedish Research Council(Swedish Research CouncilEuropean Commission)	Funded by grants from the Australian Research Council (Discovery Project and Australian Research Fellowship, number DP1092897) and Monash University to D. K. D.; P. I. and E. H. M. were supported by the Swedish Research Council (grant 2008-5533 to E. H. M.). We thank D. Clancy for fly strains; U. Friberg for discussion; M. Norgate for sequencing; G. Arnqvist, U. Friberg, and J. Abbott for comments on the manuscript; and the Uppsala Array Platform. Microarray data have been deposited on the Gene Expression Omnibus database, accession no. GSE24729.	ADAMS MD, 2000, Insect Mol Biol, V287, P263; Charlat S, 2003, TRENDS GENET, V19, P217, DOI 10.1016/S0168-9525(03)00024-6; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Clancy DJ, 2008, AGING CELL, V7, P795, DOI 10.1111/j.1474-9726.2008.00428.x; Dowling DK, 2007, J EVOLUTION BIOL, V20, P358, DOI 10.1111/j.1420-9101.2006.01189.x; Dowling DK, 2008, TRENDS ECOL EVOL, V23, P546, DOI 10.1016/j.tree.2008.05.011; Dowling DK, 2010, AM NAT, V176, P131, DOI 10.1086/653671; Frank SA, 1996, NATURE, V383, P224, DOI 10.1038/383224a0; Gemmell NJ, 2004, TRENDS ECOL EVOL, V19, P238, DOI 10.1016/j.tree.2004.02.002; Gemmell NJ, 2001, TRENDS ECOL EVOL, V16, P115, DOI 10.1016/S0169-5347(00)02087-5; Innocenti P, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000335; Lee HY, 2008, CELL, V135, P1065, DOI 10.1016/j.cell.2008.10.047; Lemos B, 2008, SCIENCE, V319, P91, DOI 10.1126/science.1148861; Lemos B, 2010, P NATL ACAD SCI USA, V107, P15826, DOI 10.1073/pnas.1010383107; Lynch M, 1997, MOL BIOL EVOL, V14, P914, DOI 10.1093/oxfordjournals.molbev.a025834; Michaud J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-363; Moran NA, 1996, P NATL ACAD SCI USA, V93, P2873, DOI 10.1073/pnas.93.7.2873; Rand DM, 2004, TRENDS ECOL EVOL, V19, P645, DOI 10.1016/j.tree.2004.10.003; Rhoades MM, 1931, SCIENCE, V73, P340, DOI 10.1126/science.73.1891.340; Ruiz-Pesini E, 2000, AM J HUM GENET, V67, P682, DOI 10.1086/303040; Schnable PS, 1998, TRENDS PLANT SCI, V3, P175, DOI 10.1016/S1360-1385(98)01235-7; Smith S, 2010, MOL ECOL, V19, P36, DOI 10.1111/j.1365-294X.2009.04444.x; de Moraes VCS, 2009, BIOCHEM BIOPH RES CO, V381, P210, DOI 10.1016/j.bbrc.2009.02.014; Wade MJ, 2009, EVOLUTION, V63, P1084, DOI 10.1111/j.1558-5646.2009.00614.x; Werren John H, 2008, Nat Rev Microbiol, V6, P741, DOI 10.1038/nrmicro1969; Woodson JD, 2008, NAT REV GENET, V9, P383, DOI 10.1038/nrg2348; Zeh JA, 2005, TRENDS GENET, V21, P281, DOI 10.1016/j.tig.2005.03.006	27	198	201	5	109	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 13	2011	332	6031					845	848		10.1126/science.1201157	http://dx.doi.org/10.1126/science.1201157			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763CD	21566193				2022-12-24	WOS:000290529900047
J	Wagner, DE; Wang, IE; Reddien, PW				Wagner, Daniel E.; Wang, Irving E.; Reddien, Peter W.			Clonogenic Neoblasts Are Pluripotent Adult Stem Cells That Underlie Planarian Regeneration	SCIENCE			English	Article							SCHMIDTEA-MEDITERRANEA; SELF-RENEWAL; MARROW-CELLS; GENE; PLASTICITY; PROTEIN; DIFFERENTIATION; IDENTIFICATION; REPOPULATION; CULTURE	Pluripotent cells in the embryo can generate all cell types, but lineage-restricted cells are generally thought to replenish adult tissues. Planarians are flatworms and regenerate from tiny body fragments, a process requiring a population of proliferating cells (neoblasts). Whether regeneration is accomplished by pluripotent cells or by the collective activity of multiple lineage-restricted cell types is unknown. We used ionizing radiation and single-cell transplantation to identify neoblasts that can form large descendant-cell colonies in vivo. These clonogenic neoblasts (cNeoblasts) produce cells that differentiate into neuronal, intestinal, and other known postmitotic cell types and are distributed throughout the body. Single transplanted cNeoblasts restored regeneration in lethally irradiated hosts. We conclude that broadly distributed, adult pluripotent stem cells underlie the remarkable regenerative abilities of planarians.	[Wagner, Daniel E.; Wang, Irving E.; Reddien, Peter W.] MIT, Dept Biol, Howard Hughes Med Inst, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Whitehead Institute	Wagner, DE (corresponding author), MIT, Dept Biol, Howard Hughes Med Inst, Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	reddien@wi.mit.edu		/0000-0002-5569-333X; Wagner, Daniel/0000-0002-2983-635X	NIH [R01GM080639]; Keck Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080639] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Keck Foundation(W.M. Keck Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Kim for manuscript comments; S. Lapan for neuronal and intestinal markers; M. Srivastava for phylogenetics advice; D. Wenemoser for SMEDWI-1 antibody purification; J. Owen for Illumina data; M. Griffin for flow cytometry assistance; and P. Hsu, G. Bell, R. Young, and all members of the Reddien Lab for extensive comments and discussion. P. W. R. is an early career scientist of the Howard Hughes Medical Institute and an associate member of the Broad Institute of Harvard and MIT. We acknowledge support from the NIH (grant R01GM080639) and the Keck Foundation.	BAGUNA J, 1976, J EXP ZOOL, V195, P53, DOI 10.1002/jez.1401950106; BAGUNA J, 1989, DEVELOPMENT, V107, P77; Bardeen CR, 1904, J EXP ZOOL, V1, P191, DOI 10.1002/jez.1400010107; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; BECKER AJ, 1963, NATURE, V197, P452, DOI 10.1038/197452a0; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; BRAVO R, 1987, NATURE, V326, P515, DOI 10.1038/326515a0; Dubois F, 1949, B BIOL FR BELG, V83, P213; Eisenhoffer GT, 2008, CELL STEM CELL, V3, P327, DOI 10.1016/j.stem.2008.07.002; ERIKSSON S, 1984, J BIOL CHEM, V259, P1695; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; EVANS MJ, 1972, J EMBRYOL EXP MORPH, V28, P163; Guo TX, 2006, DEV CELL, V11, P159, DOI 10.1016/j.devcel.2006.06.004; Hayashi T, 2006, DEV GROWTH DIFFER, V48, P371, DOI 10.1111/j.1440-169x.2006.00876.x; Hewitson Tim D, 2006, Methods Mol Biol, V326, P219; Keller J., 1894, JENA F R MED NAT, V28, P370; LANGE CS, 1968, INT J RADIAT BIOL RE, V14, P373, DOI 10.1080/09553006814551221; LENDER T, 1965, CR HEBD ACAD SCI, V260, P4095; Morgan TH, 1898, ARCH ENTW MECH ORG, V7, P364; Morrisey EE, 1998, GENE DEV, V12, P3579, DOI 10.1101/gad.12.22.3579; Newmark PA, 2000, DEV BIOL, V220, P142, DOI 10.1006/dbio.2000.9645; Nishimura K, 2010, NEUROSCIENCE, V168, P18, DOI 10.1016/j.neuroscience.2010.03.038; Ohlstein B, 2006, NATURE, V439, P470, DOI 10.1038/nature04333; Pearson BJ, 2010, DEVELOPMENT, V137, P213, DOI 10.1242/dev.044297; Reddien PW, 2005, SCIENCE, V310, P1327, DOI 10.1126/science.1116110; Reddien PW, 2005, DEV CELL, V8, P635, DOI 10.1016/j.devcel.2005.02.014; Reddien PW, 2004, ANNU REV CELL DEV BI, V20, P725, DOI 10.1146/annurev.cellbio.20.010403.095114; Salvetti A, 2009, DEV BIOL, V328, P305, DOI 10.1016/j.ydbio.2009.01.029; Scimone ML, 2010, DEVELOPMENT, V137, P1231, DOI 10.1242/dev.042051; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; TILL JE, 1961, RADIAT RES, V14, P213, DOI 10.2307/3570892; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; Wagers AJ, 2004, CELL, V116, P639, DOI 10.1016/S0092-8674(04)00208-9; Wagers AJ, 2002, SCIENCE, V297, P2256, DOI 10.1126/science.1074807; Weissman IL, 2000, CELL, V100, P157, DOI 10.1016/S0092-8674(00)81692-X; Wenemoser D, 2010, DEV BIOL, V344, P979, DOI 10.1016/j.ydbio.2010.06.017; WOLFF ETIENNE, 1948, REV SUISSE ZOOL, V55, P218	37	408	424	0	103	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 13	2011	332	6031					811	816		10.1126/science.1203983	http://dx.doi.org/10.1126/science.1203983			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763CD	21566185	Green Accepted, Green Published			2022-12-24	WOS:000290529900038
J	Tan, YH; Luo, ZQ				Tan, Yunhao; Luo, Zhao-Qing			Legionella pneumophila SidD is a deAMPylase that modifies Rab1	NATURE			English	Article							EFFECTOR PROTEIN DRRA; AMPYLATION; SYSTEM; PHOSPHATASE; BINDING; FAMILY	Legionella pneumophila actively modulates host vesicle trafficking pathways to facilitate its intracellular replication with effectors translocated by the Dot/Icm type IV secretion system (T4SS)(1). The SidM/DrrA protein functions by locking the small GTPase Rab1 into an active form by its guanine nucleotide exchange factor (GEF) and AMPylation activity(2-4). Here we demonstrate that the L. pneumophila protein SidD preferably deAMPylates Rab1. We found that the deAMPylation activity of SidD could suppress the toxicity of SidM to yeast and is required to release Rab1 from bacterial phagosomes efficiently. A molecular mechanism for the temporal control of Rab1 activity in different phases of L. pneumophila infection is thus established. These observations indicate that AMPylation-mediated signal transduction is a reversible process regulated by specific enzymes.	[Tan, Yunhao; Luo, Zhao-Qing] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Luo, ZQ (corresponding author), Purdue Univ, Dept Biol Sci, 915 W State St, W Lafayette, IN 47907 USA.	luoz@purdue.edu	Tan, Yunhao/K-7442-2016; YAN, JING/J-7233-2015	Tan, Yunhao/0000-0002-5516-4980; Luo, Zhao-Qing/0000-0001-8890-6621	NIH-NIAID [R01AI069344, K02AI085403, R21AI092043]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K02AI085403, R01AI069344, R21AI092043] Funding Source: NIH RePORTER	NIH-NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank R. Isberg for the antibody against SidM and A. Aronson and A. Tao for critical reading of the manuscript and for discussions. This work was supported by NIH-NIAID grants R01AI069344, K02AI085403 and R21AI092043 (Z.-Q.L).	Belyi Y, 2008, J BACTERIOL, V190, P3026, DOI 10.1128/JB.01798-07; BERGER KH, 1993, MOL MICROBIOL, V7, P7, DOI 10.1111/j.1365-2958.1993.tb01092.x; Brombacher E, 2009, J BIOL CHEM, V284, P4846, DOI 10.1074/jbc.M807505200; Chien MC, 2004, SCIENCE, V305, P1966, DOI 10.1126/science.1099776; Conover GM, 2003, MOL MICROBIOL, V48, P305, DOI 10.1046/j.1365-2958.2003.03400.x; Ensminger AW, 2009, CURR OPIN MICROBIOL, V12, P67, DOI 10.1016/j.mib.2008.12.004; Fan HY, 1996, GENETICS, V142, P749; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; Ingmundson A, 2007, NATURE, V450, P365, DOI 10.1038/nature06336; Isberg RR, 2009, NAT REV MICROBIOL, V7, P12, DOI 10.1038/nrmicro1967; Kinch LN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005818; Kubori T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001216; Liu YC, 2008, P NATL ACAD SCI USA, V105, P9385, DOI 10.1073/pnas.0801055105; Luo ZQ, 2004, P NATL ACAD SCI USA, V101, P841, DOI 10.1073/pnas.0304916101; Machner MP, 2006, DEV CELL, V11, P47, DOI 10.1016/j.devcel.2006.05.013; Muller MP, 2010, SCIENCE, V329, P946, DOI 10.1126/science.1192276; Murata T, 2006, NAT CELL BIOL, V8, P971, DOI 10.1038/ncb1463; Pan XX, 2008, SCIENCE, V320, P1651, DOI 10.1126/science.1158160; Rantanen MK, 2007, FEBS J, V274, P3128, DOI 10.1111/j.1742-4658.2007.05845.x; Roy CR, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.262pe14; Schlicker C, 2008, J MOL BIOL, V376, P570, DOI 10.1016/j.jmb.2007.11.097; Seabra MC, 2004, CURR OPIN CELL BIOL, V16, P451, DOI 10.1016/j.ceb.2004.06.014; Shen XH, 2009, CELL MICROBIOL, V11, P911, DOI 10.1111/j.1462-5822.2009.01301.x; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Woolery AR, 2010, FRONT MICROBIOL, V1, DOI 10.3389/fmicb.2010.00113; Worby CA, 2009, MOL CELL, V34, P93, DOI 10.1016/j.molcel.2009.03.008; Xu L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000822; Yarbrough ML, 2009, SCIENCE, V323, P269, DOI 10.1126/science.1166382; Zhu WH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017638	29	164	169	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 28	2011	475	7357					506	U102		10.1038/nature10307	http://dx.doi.org/10.1038/nature10307			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	797ZA	21734656	Green Accepted			2022-12-24	WOS:000293167900042
J	Heaphy, CM; de Wilde, RF; Jiao, YC; Klein, AP; Edil, BH; Shi, CJ; Bettegowda, C; Rodriguez, FJ; Eberhart, CG; Hebbar, S; Offerhaus, GJ; McLendon, R; Rasheed, BA; He, YP; Yan, H; Bigner, DD; Oba-Shinjo, SM; Marie, SKN; Riggins, GJ; Kinzler, KW; Vogelstein, B; Hruban, RH; Maitra, A; Papadopoulos, N; Meeker, AK				Heaphy, Christopher M.; de Wilde, Roeland F.; Jiao, Yuchen; Klein, Alison P.; Edil, Barish H.; Shi, Chanjuan; Bettegowda, Chetan; Rodriguez, Fausto J.; Eberhart, Charles G.; Hebbar, Sachidanand; Offerhaus, G. Johan; McLendon, Roger; Rasheed, B. Ahmed; He, Yiping; Yan, Hai; Bigner, Darell D.; Oba-Shinjo, Sueli Mieko; Marie, Suely Kazue Nagahashi; Riggins, Gregory J.; Kinzler, Kenneth W.; Vogelstein, Bert; Hruban, Ralph H.; Maitra, Anirban; Papadopoulos, Nickolas; Meeker, Alan K.			Altered Telomeres in Tumors with ATRX and DAXX Mutations	SCIENCE			English	Article							CELLS; H3.3		[Heaphy, Christopher M.; de Wilde, Roeland F.; Klein, Alison P.; Rodriguez, Fausto J.; Eberhart, Charles G.; Hebbar, Sachidanand; Hruban, Ralph H.; Maitra, Anirban; Meeker, Alan K.] Johns Hopkins Med Inst, Dept Pathol, Sol Goldman Pancreat Canc Res Ctr, Baltimore, MD 21231 USA	Johns Hopkins University; Johns Hopkins Medicine		npapado1@jhmi.edu; ameeker1@jhmi.edu	Papadopoulos, Nickolas/K-7272-2012; Oba-Shinjo, Sueli M./C-4017-2012; jiao, yuchen/H-6313-2011; Marie, Suely Kazue Nagahashi/D-1870-2012	Oba-Shinjo, Sueli M./0000-0002-1650-5973; Marie, Suely Kazue Nagahashi/0000-0003-4419-7928; Heaphy, Christopher/0000-0003-4264-1810; Jiao, Yuchen/0000-0001-7917-8810	Caring for Carcinoid Foundation; NATIONAL CANCER INSTITUTE [R01CA113669, R01CA121113, P01CA134292, R37CA011898, R01CA140316, P50CA062924] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055089, P50NS020023] Funding Source: NIH RePORTER	Caring for Carcinoid Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	N.P., K.W.K., and B.V. are Founding Scientific Advisors of Personal Genome Diagnostics, Incorporated, a company focused on the identification of genetic alterations in human cancer for diagnostic and therapeutic purposes. N.P., K. W. K., and B. V. are members of the Scientific Advisory Board of Inostics, a company that is developing technologies for the molecular diagnosis of cancer. N.P., B. V., and K. W. K. also own stock in Inostics. The authors are entitled to a share of the royalties received by the university on sales of products related to genes described in this manuscript. The terms of these arrangements are being managed by the university in accordance with their conflict-of-interest policies. Johns Hopkins University has filed a patent application relating to the use of DAXX and ATRX mutations as diagnostic markers. Financial support came from the Caring for Carcinoid Foundation.	Azzalin CM, 2007, SCIENCE, V318, P798, DOI 10.1126/science.1147182; Bryan TM, 1997, NAT MED, V3, P1271, DOI 10.1038/nm1197-1271; Elsaesser SJ, 2010, COLD SH Q B, V75, P27, DOI 10.1101/sqb.2010.75.008; Goldberg AD, 2010, CELL, V140, P678, DOI 10.1016/j.cell.2010.01.003; Jiao YC, 2011, SCIENCE, V331, P1199, DOI 10.1126/science.1200609; Law MJ, 2010, CELL, V143, P367, DOI 10.1016/j.cell.2010.09.023; Lewis PW, 2010, P NATL ACAD SCI USA, V107, P14075, DOI 10.1073/pnas.1008850107; Wong LH, 2010, GENOME RES, V20, P351, DOI 10.1101/gr.101477.109; Wong LH, 2009, GENOME RES, V19, P404, DOI 10.1101/gr.084947.108; Xue YT, 2003, P NATL ACAD SCI USA, V100, P10635, DOI 10.1073/pnas.1937626100; Yeager TR, 1999, CANCER RES, V59, P4175	11	706	729	2	95	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 22	2011	333	6041					425	425		10.1126/science.1207313	http://dx.doi.org/10.1126/science.1207313			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	795FR	21719641	Green Accepted			2022-12-24	WOS:000292959600036
J	Qian, BZ; Li, JF; Zhang, H; Kitamura, T; Zhang, JH; Campion, LR; Kaiser, EA; Snyder, LA; Pollard, JW				Qian, Bin-Zhi; Li, Jiufeng; Zhang, Hui; Kitamura, Takanori; Zhang, Jinghang; Campion, Liam R.; Kaiser, Elizabeth A.; Snyder, Linda A.; Pollard, Jeffrey W.			CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis	NATURE			English	Article							CHEMOATTRACTANT PROTEIN-1; BLOOD MONOCYTES; EXPRESSION; MODEL; PROGRESSION; SURVIVAL; SUBSETS; CELLS	Macrophages, which are abundant in the tumour microenvironment, enhance malignancy(1). At metastatic sites, a distinct population of metastasis-associated macrophages promotes the extravasation, seeding and persistent growth of tumour cells(2). Here we define the origin of these macrophages by showing that Gr1-positive inflammatory monocytes are preferentially recruited to pulmonary metastases but not to primary mammary tumours in mice. This process also occurs for human inflammatory monocytes in pulmonary metastases of human breast cancer cells. The recruitment of these inflammatory monocytes, which express CCR2 (the receptor for chemokine CCL2), as well as the subsequent recruitment of metastasis-associated macrophages and their interaction with metastasizing tumour cells, is dependent on CCL2 synthesized by both the tumour and the stroma. Inhibition of CCL2-CCR2 signalling blocks the recruitment of inflammatory monocytes, inhibits metastasis in vivo and prolongs the survival of tumour-bearing mice. Depletion of tumour-cell-derived CCL2 also inhibits metastatic seeding. Inflammatory monocytes promote the extravasation of tumour cells in a process that requires monocyte-derived vascular endothelial growth factor. CCL2 expression and macrophage infiltration are correlated with poor prognosis and metastatic disease in human breast cancer(3-6). Our data provide the mechanistic link between these two clinical associations and indicate new therapeutic targets for treating metastatic breast cancer.	[Qian, Bin-Zhi; Li, Jiufeng; Zhang, Hui; Kitamura, Takanori; Pollard, Jeffrey W.] Albert Einstein Coll Med, Ctr Study Reprod Biol & Womens Hlth, Dept Dev & Mol Biol, Bronx, NY 10461 USA; [Zhang, Jinghang] Albert Einstein Coll Med, Flow Cytometry Core Facil, Bronx, NY 10461 USA; [Campion, Liam R.; Kaiser, Elizabeth A.; Snyder, Linda A.] Ortho Biotech Oncol R&D, Radnor, PA 19087 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Johnson & Johnson; Johnson & Johnson USA	Pollard, JW (corresponding author), Albert Einstein Coll Med, Ctr Study Reprod Biol & Womens Hlth, Dept Dev & Mol Biol, Bronx, NY 10461 USA.	pollard@aecom.yu.edu		Kitamura, Takanori/0000-0003-2032-3918	NIH [NIH PO1 CA100324, RO1 CA131270]; Albert Einstein Cancer Center Core [P30 CA 13330]; MRC [G1002033] Funding Source: UKRI; Medical Research Council [G1002033] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R01CA131270, P30CA013330, P01CA100324] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Albert Einstein Cancer Center Core; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the NIH to J.W.P.(NIH PO1 CA100324 and RO1 CA131270) and to the Albert Einstein Cancer Center Core (P30 CA 13330). We thank J. Massague for 4173 cells and N. Ferrara for the Vegfa<SUP>flox/flox</SUP> mice. We also thank P. Marsters for statistical analyses and M. Thompson, F. Shi, C. Ferrante, F. McCabe, H. Millar-Quinn and D. Wiley for discussions and technical assistance.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Al-Mehdi AB, 2000, NAT MED, V6, P100, DOI 10.1038/71429; Borowsky AD, 2005, CLIN EXP METASTAS, V22, P47, DOI 10.1007/s10585-005-2908-5; Brandt B, 2005, SEMIN CANCER BIOL, V15, P387, DOI 10.1016/j.semcancer.2005.06.006; Carton JM, 2007, PROTEIN EXPRES PURIF, V55, P279, DOI 10.1016/j.pep.2007.05.017; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Geissmann F, 2008, IMMUNOL CELL BIOL, V86, P398, DOI 10.1038/icb.2008.19; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Gerber HP, 1999, DEVELOPMENT, V126, P1149; Getts DR, 2008, J EXP MED, V205, P2319, DOI 10.1084/jem.20080421; Havens A, 2008, NEOPLASIA, V10, P371, DOI 10.1593/neo.08154; Huang YJ, 2009, CANCER RES, V69, P7529, DOI 10.1158/0008-5472.CAN-08-4382; Im JH, 2004, CANCER RES, V64, P8613, DOI 10.1158/0008-5472.CAN-04-2078; Ma Chaoyu, 2008, CSH Protoc, V2008, DOI 10.1101/pdb.prot5034; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Nielsen BS, 2001, AM J PATHOL, V158, P1997, DOI 10.1016/S0002-9440(10)64671-8; Palframan RT, 2001, J EXP MED, V194, P1361, DOI 10.1084/jem.194.9.1361; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Qian BZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006562; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Saji H, 2001, CANCER, V92, P1085, DOI 10.1002/1097-0142(20010901)92:5<1085::AID-CNCR1424>3.0.CO;2-K; Stern P, 2008, P NATL ACAD SCI USA, V105, P13895, DOI 10.1073/pnas.0806907105; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; Tsui Ping, 2007, Human Antibodies, V16, P117; Ueno T, 2000, CLIN CANCER RES, V6, P3282; Valkovic T, 1998, PATHOL RES PRACT, V194, P335, DOI 10.1016/S0344-0338(98)80057-5	26	1784	1850	11	335	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 14	2011	475	7355					222	U129		10.1038/nature10138	http://dx.doi.org/10.1038/nature10138			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791UA	21654748	Green Accepted			2022-12-24	WOS:000292690500049
J	Puente, XS; Pinyol, M; Quesada, V; Conde, L; Ordonez, GR; Villamor, N; Escaramis, G; Jares, P; Bea, S; Gonzalez-Diaz, M; Bassaganyas, L; Baumann, T; Juan, M; Lopez-Guerra, M; Colomer, D; Tubio, JMC; Lopez, C; Navarro, A; Tornador, C; Aymerich, M; Rozman, M; Hernandez, JM; Puente, DA; Freije, JMP; Velasco, G; Gutierrez-Fernandez, A; Costa, D; Carrio, A; Guijarro, S; Enjuanes, A; Hernandez, L; Yague, J; Nicolas, P; Romeo-Casabona, CM; Himmelbauer, H; Castillo, E; Dohm, JC; de Sanjose, S; Piris, MA; de Alava, E; Miguel, JS; Royo, R; Gelpi, JL; Torrents, D; Orozco, M; Pisano, DG; Valencia, A; Guigo, R; Bayes, M; Heath, S; Gut, M; Klatt, P; Marshall, J; Raine, K; Stebbings, LA; Futreal, PA; Stratton, MR; Campbell, PJ; Gut, I; Lopez-Guillermo, A; Estivill, X; Montserrat, E; Lopez-Otin, C; Campo, E				Puente, Xose S.; Pinyol, Magda; Quesada, Victor; Conde, Laura; Ordonez, Gonzalo R.; Villamor, Neus; Escaramis, Georgia; Jares, Pedro; Bea, Silvia; Gonzalez-Diaz, Marcos; Bassaganyas, Laia; Baumann, Tycho; Juan, Manel; Lopez-Guerra, Monica; Colomer, Dolors; Tubio, Jose M. C.; Lopez, Cristina; Navarro, Alba; Tornador, Cristian; Aymerich, Marta; Rozman, Maria; Hernandez, Jesus M.; Puente, Diana A.; Freije, Jose M. P.; Velasco, Gloria; Gutierrez-Fernandez, Ana; Costa, Dolors; Carrio, Anna; Guijarro, Sara; Enjuanes, Anna; Hernandez, Lluis; Yaguee, Jordi; Nicolas, Pilar; Romeo-Casabona, Carlos M.; Himmelbauer, Heinz; Castillo, Ester; Dohm, Juliane C.; de Sanjose, Silvia; Piris, Miguel A.; de Alava, Enrique; Miguel, Jesus San; Royo, Romina; Gelpi, Josep L.; Torrents, David; Orozco, Modesto; Pisano, David G.; Valencia, Alfonso; Guigo, Roderic; Bayes, Monica; Heath, Simon; Gut, Marta; Klatt, Peter; Marshall, John; Raine, Keiran; Stebbings, Lucy A.; Futreal, P. Andrew; Stratton, Michael R.; Campbell, Peter J.; Gut, Ivo; Lopez-Guillermo, Armando; Estivill, Xavier; Montserrat, Emili; Lopez-Otin, Carlos; Campo, Elias			Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia	NATURE			English	Article							CANCER GENOME; B-CLL; EXPRESSION; NOTCH1; CELLS; HYPERMUTATION; NETWORK	Chronic lymphocytic leukaemia (CLL), the most frequent leukaemia in adults in Western countries, is a heterogeneous disease with variable clinical presentation and evolution(1,2). Two major molecular subtypes can be distinguished, characterized respectively by a high or low number of somatic hypermutations in the variable region of immunoglobulin genes(3,4). The molecular changes leading to the pathogenesis of the disease are still poorly understood. Here we performed whole-genome sequencing of four cases of CLL and identified 46 somatic mutations that potentially affect gene function. Further analysis of these mutations in 363 patients with CLL identified four genes that are recurrently mutated: notch 1 (NOTCH1), exportin 1 (XPO1), myeloid differentiation primary response gene 88 (MYD88) and kelch-like 6 (KLHL6). Mutations in MYD88 and KLHL6 are predominant in cases of CLL with mutated immunoglobulin genes, whereas NOTCH1 and XPO1 mutations are mainly detected in patients with unmutated immunoglobulins. The patterns of somatic mutation, supported by functional and clinical analyses, strongly indicate that the recurrent NOTCH1, MYD88 and XPO1 mutations are oncogenic changes that contribute to the clinical evolution of the disease. To our knowledge, this is the first comprehensive analysis of CLL combining whole-genome sequencing with clinical characteristics and clinical outcomes. It highlights the usefulness of this approach for the identification of clinically relevant mutations in cancer.	[Conde, Laura; Villamor, Neus; Jares, Pedro; Bea, Silvia; Lopez-Guerra, Monica; Colomer, Dolors; Lopez, Cristina; Navarro, Alba; Aymerich, Marta; Rozman, Maria; Costa, Dolors; Carrio, Anna; Guijarro, Sara; Enjuanes, Anna; Hernandez, Lluis; Campo, Elias] Univ Barcelona, IDIBAPS, Hosp Clin, Serv Anat Patol,Unidad Hematopatol, E-08036 Barcelona, Spain; [Puente, Xose S.; Quesada, Victor; Ordonez, Gonzalo R.; Puente, Diana A.; Freije, Jose M. P.; Velasco, Gloria; Gutierrez-Fernandez, Ana; Lopez-Otin, Carlos] Univ Oviedo, Inst Univ Oncol, Dept Bioquim & Biol Mol, E-33006 Oviedo, Spain; [Pinyol, Magda] IDIBAPS, Unidad Genom, Barcelona 08036, Spain; [Escaramis, Georgia; Bassaganyas, Laia; Tubio, Jose M. C.; Tornador, Cristian; Estivill, Xavier] Pompeu Fabra Univ, Ctr Genom Regulat, Genes & Dis Programme, Barcelona 08003, Spain; [Gonzalez-Diaz, Marcos; Hernandez, Jesus M.; de Alava, Enrique; Miguel, Jesus San] Univ Salamanca, Ctr Invest Canc IBMCC USAL CSIC, Univ Hosp, Serv Hematol, Salamanca 37007, Spain; [Baumann, Tycho; Lopez-Guillermo, Armando; Montserrat, Emili] Univ Barcelona, IDIBAPS, Hosp Clin, Serv Hematol, E-08036 Barcelona, Spain; [Juan, Manel; Yaguee, Jordi] IDIBAPS, Hosp Clin, Serv Inmunol, Barcelona 08036, Spain; [Tubio, Jose M. C.] Hosp Clin Univ Santiago de Compostela, Santiago De Compostela 15706, Spain; [Nicolas, Pilar; Romeo-Casabona, Carlos M.] Univ Basque Country, Univ Deusto, Catedra Interuniv Derechoy Genoma Humano, Bilbao 48007, Spain; [Himmelbauer, Heinz; Castillo, Ester; Dohm, Juliane C.] Pompeii Fabra Univ, Ctr Genom Regulat, Ultrasequencing Unit, Barcelona 08003, Spain; [de Sanjose, Silvia] IDIBELL, Inst Catala Oncol, Unidad Infecc & Canc, Lhospitalet De Llobregat 08907, Spain; [Piris, Miguel A.] Spanish Natl Canc Res Ctr CNIO, Mol Pathol Programme, Madrid 28029, Spain; [Royo, Romina; Gelpi, Josep L.; Torrents, David; Orozco, Modesto] Univ Barcelona, Spanish Natl Bioinformat Inst, IRB, Programa Conjunto Biol Computac,BSC, E-08028 Barcelona, Spain; [Pisano, David G.; Valencia, Alfonso] Spanish Natl Bioinformat Inst, Spanish Natl Canc Res Ctr CNIO, Struct Biol & Biocomp Programme, Madrid 28029, Spain; [Guigo, Roderic] Pompeu Fabra Univ, Ctr Genom Regulat, Spanish Natl Bioinformat Inst, Genom Bioinformat Programme, Barcelona 08003, Spain; [Bayes, Monica; Heath, Simon; Gut, Marta; Gut, Ivo] Ctr Nacl Anal Genom, Barcelona 08028, Spain; [Klatt, Peter] CSIC, Ctr Nacl Biotecnol, E-28049 Madrid, Spain; [Marshall, John; Raine, Keiran; Stebbings, Lucy A.; Futreal, P. Andrew; Stratton, Michael R.; Campbell, Peter J.] Wellcome Trust Sanger Inst, Hinxton CB10 1SA, England	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Oviedo; Instituto Universitario de Oncologia de Asturias; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion del Cancer (CIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Complexo Hospitalario Universitario de Santiago de Compostela; University of Basque Country; University of Deusto; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Centro Nacional de Investigaciones Oncologicas (CNIO); Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; University of Barcelona; Centro Nacional de Investigaciones Oncologicas (CNIO); Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Wellcome Trust Sanger Institute	Campo, E (corresponding author), Univ Barcelona, IDIBAPS, Hosp Clin, Serv Anat Patol,Unidad Hematopatol, E-08036 Barcelona, Spain.	clo@uniovi.es; ecampo@clinic.ub.es	Lopez-Guillermo, Armando/Z-5684-2019; Hernandez, Luis/D-4684-2018; Juan, Manel/Q-2931-2019; Gutierrez-Fernandez, Ana/AAS-9954-2021; López, Cristina/W-4621-2017; Estivill, Xavier/E-2957-2012; de Sanjosé Llongueras, Silvia/H-6339-2014; IBIS, SARCOMAS/O-1893-2015; Velasco, Gloria/AAS-5842-2021; Tornador, Cristian/S-2197-2018; López-Otín, Carlos/AAB-2106-2020; Campo, Elias/AAC-5593-2019; Pisano, David/N-5817-2014; Gelpí, Josep Ll./M-6401-2013; Tubio, Jose M.C./H-5076-2015; Heath, Simon C/J-4138-2012; de Alava, Enrique/GOH-0368-2022; COLOMER, DOLORS/ABG-6894-2020; Piris, Miguel A/AAP-1445-2020; Gutierrez-Fernandez, Ana/ABG-6678-2020; Hernández, Jesus M/B-5459-2017; bea, silvia/K-7699-2014; Freije, José M.P./A-6535-2008; Navarro, Alba/H-2611-2015; San-Miguel, Jesús F./V-8977-2018; Piris, Miguel A/B-7067-2008; López, Cristina/ABB-3519-2020; Quesada, Víctor/B-6557-2014; Escaramis, Georgia/B-2997-2015; Jares, Pedro/T-3778-2019; Puente, Xosé S./ADB-0672-2022; Valencia, Alfonso/I-3127-2015; Gut, Ivo/ABF-3188-2020; Guigo, Roderic/D-1303-2010; Estivill, Xavier/A-3125-2013; Escaramis, Georgia/AAR-5586-2020; Tubio, Jose/AAG-7345-2019; ENJUANES, Anna/H-3245-2015; Torrents, David/G-5785-2015	Hernandez, Luis/0000-0002-4854-3069; Gutierrez-Fernandez, Ana/0000-0002-9287-8843; López, Cristina/0000-0001-6644-1659; Velasco, Gloria/0000-0001-8032-5056; Tornador, Cristian/0000-0002-6437-9270; López-Otín, Carlos/0000-0001-6964-1904; Campo, Elias/0000-0001-9850-9793; Pisano, David/0000-0002-4895-4124; Gelpí, Josep Ll./0000-0002-0566-7723; Tubio, Jose M.C./0000-0003-3540-2459; Heath, Simon C/0000-0002-9550-0897; de Alava, Enrique/0000-0001-8400-046X; Piris, Miguel A/0000-0001-5839-3634; Hernández, Jesus M/0000-0002-9661-9371; bea, silvia/0000-0001-7192-2385; Freije, José M.P./0000-0002-4688-8266; Navarro, Alba/0000-0002-4041-0974; San-Miguel, Jesús F./0000-0002-9183-4857; Piris, Miguel A/0000-0001-5839-3634; López, Cristina/0000-0001-6644-1659; Quesada, Víctor/0000-0002-8398-3457; Escaramis, Georgia/0000-0002-5416-3177; Puente, Xosé S./0000-0001-9525-1483; Valencia, Alfonso/0000-0002-8937-6789; Gut, Ivo/0000-0001-7219-632X; Guigo, Roderic/0000-0002-5738-4477; Estivill, Xavier/0000-0002-0723-2256; Tubio, Jose/0000-0003-3540-2459; ENJUANES, Anna/0000-0002-4679-6687; Royo, Romina/0000-0003-3493-0874; Carrio, Ana/0000-0002-8394-2321; Baumann, Tycho Stephan/0000-0003-4421-0088; Raine, Keiran/0000-0002-5634-1539; BASSAGANYAS, LAIA/0000-0002-4575-0214; COLOMER, DOLORS/0000-0001-7486-8484; Rozman, Maria/0000-0002-2641-1110; Juan, Manel/0000-0002-3064-1648; JARES, PEDRO/0000-0002-8401-579X; Gonzalez Diaz, Marcos/0000-0001-6637-1072; Torrents, David/0000-0002-6086-9037; Orozco Lopez, Modesto/0000-0002-8608-3278; Himmelbauer, Heinz/0000-0001-8897-2928; NICOLAS JIMENEZ, MARIA PILAR/0000-0003-4166-5941	Spanish Ministry of Science and Innovation (MICINN) through the Institut de Salud Carlos III (ISCIII); Red Tematica de Investigacion del Cancer (RTICC) del ISCIII	Spanish Ministry of Science and Innovation (MICINN) through the Institut de Salud Carlos III (ISCIII)(Instituto de Salud Carlos IIIMinistry of Science and Innovation, Spain (MICINN)Spanish Government); Red Tematica de Investigacion del Cancer (RTICC) del ISCIII	This work was funded by the Spanish Ministry of Science and Innovation (MICINN) through the Institut de Salud Carlos III (ISCIII) and Red Tematica de Investigacion del Cancer (RTICC) del ISCIII. C.L.-O. is an Investigator of the Botin Foundation and D.T., of the ICREA program. We thank E Santos for his support of this project, A. Carracedo and J. Benitez for genotyping studies, C. Fortuny for the supply of samples and N. Villahoz and M. C. Muro for their work in the coordination of the CLL-ICGC Consortium. We are also grateful to all patients with CLL who participated in this study.	Aqeilan RI, 2010, CELL DEATH DIFFER, V17, P215, DOI 10.1038/cdd.2009.69; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Burger JA, 2009, BLOOD, V113, P3050, DOI 10.1182/blood-2008-07-170415; Coste I, 2010, J CLIN INVEST, V120, P3663, DOI 10.1172/JCI42771; Damle RN, 1999, BLOOD, V94, P1840, DOI 10.1182/blood.V94.6.1840; Ferrigno P, 1998, EMBO J, V17, P5606, DOI 10.1093/emboj/17.19.5606; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Hamblin TJ, 1999, BLOOD, V94, P1848, DOI 10.1182/blood.V94.6.1848; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Kroll J, 2005, MOL CELL BIOL, V25, P8531, DOI 10.1128/MCB.25.19.8531-8540.2005; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Moreno-Bueno G, 2003, ONCOGENE, V22, P6115, DOI 10.1038/sj.onc.1206868; Muzio M, 2009, BRIT J HAEMATOL, V144, P507, DOI 10.1111/j.1365-2141.2008.07475.x; Ngo VN, 2011, NATURE, V470, P115, DOI 10.1038/nature09671; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Palomero T, 2006, P NATL ACAD SCI USA, V103, P18261, DOI 10.1073/pnas.0606108103; Pasqualucci L, 2001, NATURE, V412, P341, DOI 10.1038/35085588; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Rosati E, 2009, BLOOD, V113, P856, DOI 10.1182/blood-2008-02-139725; ROZMAN C, 1995, NEW ENGL J MED, V333, P1052, DOI 10.1056/NEJM199510193331606; Spencer J, 2005, J IMMUNOL, V175, P5170, DOI 10.4049/jimmunol.175.8.5170; Sportoletti P, 2010, BRIT J HAEMATOL, V151, P404, DOI 10.1111/j.1365-2141.2010.08368.x; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Zenz T, 2010, NAT REV CANCER, V10, P37, DOI 10.1038/nrc2764	26	1131	1170	3	158	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 7	2011	475	7354					101	105		10.1038/nature10113	http://dx.doi.org/10.1038/nature10113			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	788RE	21642962	Green Published, Green Accepted, hybrid			2022-12-24	WOS:000292461300053
J	Viviani, D; Charlet, A; van den Burg, E; Robinet, C; Hurni, N; Abatis, M; Magara, F; Stoop, R				Viviani, Daniele; Charlet, Alexandre; van den Burg, Erwin; Robinet, Camille; Hurni, Nicolas; Abatis, Marios; Magara, Fulvio; Stoop, Ron			Oxytocin Selectively Gates Fear Responses Through Distinct Outputs from the Central Amygdala	SCIENCE			English	Article							RAT CENTRAL NUCLEUS; CONDITIONED FEAR; NEURONS; POPULATIONS; BRAIN	Central amygdala (CeA) projections to hypothalamic and brain stem nuclei regulate the behavioral and physiological expression of fear, but it is unknown whether these different aspects of the fear response can be separately regulated by the CeA. We combined fluorescent retrograde tracing of CeA projections to nuclei that modulate fear-related freezing or cardiovascular responses with in vitro electrophysiological recordings and with in vivo monitoring of related behavioral and physiological parameters. CeA projections emerged from separate neuronal populations with different electrophysiological characteristics and different response properties to oxytocin. In vivo, oxytocin decreased freezing responses in fear-conditioned rats without affecting the cardiovascular response. Thus, neuropeptidergic signaling can modulate the CeA outputs through separate neuronal circuits and thereby individually steer the various aspects of the fear response.	[Viviani, Daniele; Charlet, Alexandre; van den Burg, Erwin; Robinet, Camille; Hurni, Nicolas; Abatis, Marios; Magara, Fulvio; Stoop, Ron] Univ Lausanne, Lausanne Univ Hosp Ctr, Dept Psychiat, Ctr Psychiat Neurosci, CH-1015 Lausanne, Switzerland; [Stoop, Ron] Univ Lausanne, Dept Physiol, CH-1015 Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne	Stoop, R (corresponding author), Univ Lausanne, Lausanne Univ Hosp Ctr, Dept Psychiat, Ctr Psychiat Neurosci, CH-1015 Lausanne, Switzerland.	rstoop@unil.ch	Charlet, Alexandre/D-5179-2016	Charlet, Alexandre/0000-0003-4837-3706	Swiss National Science Foundation [3100A0-116462]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	We thank E. Welker for outstanding scientific advice; H. Markram and R. Perin for expert help with multiple patch recordings; R. Daniel and D. Rainnie for feedback on the manuscript; and O. Bussard, V. Martin, N. Pochon and L. Bonsignore for technical support. Supported by Swiss National Science Foundation grant 3100A0-116462.	Bisetti A, 2006, NEUROSCIENCE, V142, P999, DOI 10.1016/j.neuroscience.2006.07.018; Bosch OJ, 2005, J NEUROSCI, V25, P6807, DOI 10.1523/JNEUROSCI.1342-05.2005; Champagne FA, 2006, BIOL PSYCHIAT, V59, P1227, DOI 10.1016/j.biopsych.2005.10.016; Chieng BCH, 2006, J COMP NEUROL, V497, P910, DOI 10.1002/cne.21025; Ciocchi S, 2010, NATURE, V468, P277, DOI 10.1038/nature09559; DAVIS M, 1992, P255; Day HEW, 1999, J COMP NEUROL, V413, P113; Dumont EC, 2002, EUR J NEUROSCI, V15, P545, DOI 10.1046/j.0953-816x.2001.01879.x; GOMEZ TMD, 1995, BRAIN RES, V689, P21, DOI 10.1016/0006-8993(95)00525-U; Gozzi A, 2010, NEURON, V67, P656, DOI 10.1016/j.neuron.2010.07.008; Haubensak W, 2010, NATURE, V468, P270, DOI 10.1038/nature09553; Huber D, 2005, SCIENCE, V308, P245, DOI 10.1126/science.1105636; KATZ LC, 1984, NATURE, V310, P498, DOI 10.1038/310498a0; LeDoux J, 2003, CELL MOL NEUROBIOL, V23, P727, DOI 10.1023/A:1025048802629; LEDOUX JE, 1988, J NEUROSCI, V8, P2517; Loewy AD., 1990, CENTRAL REGULATION A, P88; Paton JJ, 2006, NATURE, V439, P865, DOI 10.1038/nature04490; Porges SW, 2003, ANN NY ACAD SCI, V1008, P31, DOI 10.1196/annals.1301.004; Rainville P, 2006, INT J PSYCHOPHYSIOL, V61, P5, DOI 10.1016/j.ijpsycho.2005.10.024; Sajdyk TJ, 2004, NEUROPEPTIDES, V38, P225, DOI 10.1016/j.npep.2004.05.006; Sansone Randy A, 2009, Psychiatry (Edgmont), V6, P33; SCHWABER JS, 1982, J NEUROSCI, V2, P1424, DOI 10.1523/jneurosci.02-10-01424.1982; Tye KM, 2008, NATURE, V453, P1253, DOI 10.1038/nature06963; Tye KM, 2011, NATURE, V471, P358, DOI 10.1038/nature09820; Vianna EPM, 2006, INT J PSYCHOPHYSIOL, V61, P70, DOI 10.1016/j.ijpsycho.2005.10.019; Waldherr M, 2007, P NATL ACAD SCI USA, V104, P16681, DOI 10.1073/pnas.0705860104; Ziemann AE, 2009, CELL, V139, P1012, DOI 10.1016/j.cell.2009.10.029	28	262	265	5	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 1	2011	333	6038					104	107		10.1126/science.1201043	http://dx.doi.org/10.1126/science.1201043			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	785UF	21719680				2022-12-24	WOS:000292255400060
J	Hrecka, K; Hao, CL; Gierszewska, M; Swanson, SK; Kesik-Brodacka, M; Srivastava, S; Florens, L; Washburn, MP; Skowronski, J				Hrecka, Kasia; Hao, Caili; Gierszewska, Magda; Swanson, Selene K.; Kesik-Brodacka, Malgorzata; Srivastava, Smita; Florens, Laurence; Washburn, Michael P.; Skowronski, Jacek			Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein	NATURE			English	Article							AICARDI-GOUTIERES SYNDROME; UBIQUITIN LIGASE; INNATE; GENE; ASSOCIATION; USURPS; CELLS	Macrophages and dendritic cells have key roles in viral infections, providing virus reservoirs that frequently resist antiviral therapies and linking innate virus detection to antiviral adaptive immune responses(1,2). Human immunodeficiency virus 1 (HIV-1) fails to transduce dendritic cells and has a reduced ability to transduce macrophages, due to an as yet uncharacterized mechanism that inhibits infection by interfering with efficient synthesis of viral complementary DNA(3,4). In contrast, HIV-2 and related simian immunodeficiency viruses (SIVsm/mac) transduce myeloid cells efficiently owing to their virion-associated Vpx accessory proteins, which counteract the restrictive mechanism(5,6). Here we show that the inhibition of HIV-1 infection in macrophages involves the cellular SAM domain HD domain-containing protein 1 (SAMHD1). Vpx relieves the inhibition of lentivirus infection in macrophages by loading SAMHD1 onto the CRL4(DCAF1) E3 ubiquitin ligase, leading to highly efficient proteasome-dependent degradation of the protein. Mutations in SAMHD1 cause Aicardi-Goutieres syndrome, a disease that produces a phenotype that mimics the effects of a congenital viral infection(7,8). Failure to dispose of endogenous nucleic acid debris in Aicardi-Goutieres syndrome results in inappropriate triggering of innate immune responses via cytosolic nucleic acids sensors(9,10). Thus, our findings show that macrophages are defended from HIV-1 infection by a mechanism that prevents an unwanted interferon response triggered by self nucleic acids, and uncover an intricate relationship between innate immune mechanisms that control response to self and to retroviral pathogens.	[Hrecka, Kasia; Hao, Caili; Kesik-Brodacka, Malgorzata; Skowronski, Jacek] Case Sch Med, Dept Mol Biol & Microbiol, Cleveland, OH 44106 USA; [Hrecka, Kasia; Gierszewska, Magda; Srivastava, Smita; Skowronski, Jacek] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Swanson, Selene K.; Florens, Laurence; Washburn, Michael P.] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Washburn, Michael P.] Univ Kansas, Dept Pathol & Lab Med, Med Ctr, Kansas City, KS 66160 USA	Case Western Reserve University; Cold Spring Harbor Laboratory; Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center	Skowronski, J (corresponding author), Case Sch Med, Dept Mol Biol & Microbiol, Cleveland, OH 44106 USA.	jacek.skowronski@case.edu	Kęsik-Brodacka, Małgorzata/ABG-7355-2021	Washburn, Michael/0000-0001-7568-2585; Florens, Laurence/0000-0002-9310-6650	NIH [R01 AI077459, R21 AI084694]; Case CFAR developmental funds; Stowers Institute for Medical Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI084694, R01AI077459] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Case CFAR developmental funds; Stowers Institute for Medical Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank the Karn, McDonald and Bernstein laboratories, C. Carlin, R. Asaad, M. Reuter and A. Valentin-Torres, for reagents and help at various stages of this project. We acknowledge the excellent assistance of C. Wang with fluorescence microscopy. We also thank M. Emerman and N. Manel for HIV-2 Rod proviral constructs, F. Kirchhoff for the SIVmac 239-GFP proviral clone, M. Lederman and D. McDonald for discussions, J. Karn and M. Greenberg for discussions and comments on the manuscript. We are grateful to L. Van Aelst and D. Littman for advice, discussions and critical reading of the manuscript. This work in the J. S. laboratory was supported by NIH grants R01 AI077459 and R21 AI084694 and by Case CFAR developmental funds. S. K. S., L. F. and M. P. W. are supported by The Stowers Institute for Medical Research.	Ahn J, 2010, J BIOL CHEM, V285, P37333, DOI 10.1074/jbc.M110.133181; Angers S, 2006, NATURE, V443, P590, DOI 10.1038/nature05175; Bergamaschi A, 2009, J VIROL, V83, P4854, DOI 10.1128/JVI.00187-09; Blankson JN, 2002, ANNU REV MED, V53, P557, DOI 10.1146/annurev.med.53.082901.104024; Butler SL, 2001, NAT MED, V7, P631, DOI 10.1038/87979; Crow YJ, 2009, HUM MOL GENET, V18, pR130, DOI 10.1093/hmg/ddp293; Florens Laurence, 2006, V328, P159; GIBBS JS, 1995, J VIROL, V69, P2378, DOI 10.1128/JVI.69.4.2378-2383.1995; Goujon C, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-2; GUYADER M, 1989, EMBO J, V8, P1169, DOI 10.1002/j.1460-2075.1989.tb03488.x; Hirsch VM, 1998, NAT MED, V4, P1401, DOI 10.1038/3992; HORTON R, 1994, VIROLOGY, V199, P453, DOI 10.1006/viro.1994.1144; Hrecka K, 2007, P NATL ACAD SCI USA, V104, P11778, DOI 10.1073/pnas.0702102104; Kaushik R, 2009, CELL HOST MICROBE, V6, P68, DOI 10.1016/j.chom.2009.05.022; Kewalramani VN, 1996, VIROLOGY, V218, P159, DOI 10.1006/viro.1996.0176; Le Rouzic E, 2007, CELL CYCLE, V6, P182, DOI 10.4161/cc.6.2.3732; Manel N, 2010, NATURE, V467, P214, DOI 10.1038/nature09337; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Negre D, 2000, GENE THER, V7, P1613, DOI 10.1038/sj.gt.3301292; Pick E, 2007, MOL CELL BIOL, V27, P4708, DOI 10.1128/MCB.02432-06; Rice GI, 2009, NAT GENET, V41, P829, DOI 10.1038/ng.373; Srivastava S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000059; Steinman RM, 2006, CURR TOP MICROBIOL, V311, P17; Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032; Yamashita M, 2007, PLOS PATHOG, V3, P1502, DOI 10.1371/journal.ppat.0030156; Yamashita M, 2009, J VIROL, V83, P9835, DOI 10.1128/JVI.01084-09; Yan N, 2010, NAT IMMUNOL, V11, P1005, DOI 10.1038/ni.1941; Yang YG, 2007, CELL, V131, P873, DOI 10.1016/j.cell.2007.10.017; YU XF, 1991, J VIROL, V65, P5088, DOI 10.1128/JVI.65.9.5088-5091.1991; Zhang Y, 2010, ANAL CHEM, V82, P2272, DOI 10.1021/ac9023999	30	882	910	2	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 30	2011	474	7353					658	U137		10.1038/nature10195	http://dx.doi.org/10.1038/nature10195			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	785CF	21720370	Green Accepted			2022-12-24	WOS:000292204300043
J	Lu, DP; Lin, WW; Gao, XQ; Wu, SJ; Cheng, C; Avila, J; Heese, A; Devarenne, TP; He, P; Shan, LB				Lu, Dongping; Lin, Wenwei; Gao, Xiquan; Wu, Shujing; Cheng, Cheng; Avila, Julian; Heese, Antje; Devarenne, Timothy P.; He, Ping; Shan, Libo			Direct Ubiquitination of Pattern Recognition Receptor FLS2 Attenuates Plant Innate Immunity	SCIENCE			English	Article							LIGASE ACTIVITY; CELL-DEATH; KINASE; ARABIDOPSIS; DEFENSE; FLAGELLIN; BAK1; PHOSPHORYLATION; PERCEPTION; RESISTANCE	Innate immune responses are triggered by the activation of pattern-recognition receptors (PRRs). The Arabidopsis PRR FLAGELLIN-SENSING 2 (FLS2) senses bacterial flagellin and initiates immune signaling through association with BAK1. The molecular mechanisms underlying the attenuation of FLS2 activation are largely unknown. We report that flagellin induces recruitment of two closely related U-box E3 ubiquitin ligases, PUB12 and PUB13, to FLS2 receptor complex in Arabidopsis. BAK1 phosphorylates PUB12 and PUB13 and is required for FLS2-PUB12/13 association. PUB12 and PUB13 polyubiquitinate FLS2 and promote flagellin-induced FLS2 degradation, and the pub12 and pub13 mutants displayed elevated immune responses to flagellin treatment. Our study has revealed a unique regulatory circuit of direct ubiquitination and turnover of FLS2 by BAK1-mediated phosphorylation and recruitment of specific E3 ligases for attenuation of immune signaling.	[Lu, Dongping; Gao, Xiquan; Cheng, Cheng; Avila, Julian; Devarenne, Timothy P.; He, Ping] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA; [Lin, Wenwei; Wu, Shujing; Shan, Libo] Texas A&M Univ, Dept Plant Pathol & Microbiol, College Stn, TX 77843 USA; [Lu, Dongping; Lin, Wenwei; Gao, Xiquan; Wu, Shujing; Cheng, Cheng; He, Ping; Shan, Libo] Texas A&M Univ, Inst Plant Genom & Biotechnol, College Stn, TX 77843 USA; [Lin, Wenwei] Fujian Agr & Forestry Univ, Minist Educ, Key Lab Biopesticide & Chem Biol, Fuzhou 350002, Peoples R China; [Heese, Antje] Univ Missouri, Dept Biochem, Columbia, MO 65211 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Fujian Agriculture & Forestry University; University of Missouri System; University of Missouri Columbia	He, P (corresponding author), Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA.	pinghe@tamu.edu; lshan@tamu.edu	Lu, Dongping/GGB-4016-2022	Lu, Dongping/0000-0002-4888-0532; Avila, Julian/0000-0001-9388-3946; wu, shujing/0000-0002-1912-7699; He, Ping/0000-0002-5926-8349; Devarenne, Timothy/0000-0001-6032-8049; LIN, WENWEI/0000-0003-0098-6386	NSF [IOS-1030250]; NIH [R01GM092893]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM092893, R01GM097247] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank F. Ausubel, J. Alfano, M. Dickman, and H. Scholthof for critical reading of the manuscript and F. Rolland for the yeast two-hybrid vectors. We also thank the Salk Institute and Arabidopsis Biological Resource Center for the Arabidopsis T-DNA insertion lines. This work was supported by NSF (IOS-1030250) to L.S. and NIH (R01GM092893) to P.H.	Azevedo C, 2001, TRENDS PLANT SCI, V6, P354, DOI 10.1016/S1360-1385(01)01960-4; Boller T, 2009, ANNU REV PLANT BIOL, V60, P379, DOI 10.1146/annurev.arplant.57.032905.105346; Chinchilla D, 2007, NATURE, V448, P497, DOI 10.1038/nature05999; Chuang TH, 2004, NAT IMMUNOL, V5, P495, DOI 10.1038/ni1066; Craig A, 2009, J EXP BOT, V60, P1123, DOI 10.1093/jxb/erp059; Dodds PN, 2010, NAT REV GENET, V11, P539, DOI 10.1038/nrg2812; Goehre V, 2008, CURR BIOL, V18, P1824, DOI 10.1016/j.cub.2008.10.063; Gomez-Gomez L, 2000, MOL CELL, V5, P1003, DOI 10.1016/S1097-2765(00)80265-8; Gonzalez-Lamothe R, 2006, PLANT CELL, V18, P1067, DOI 10.1105/tpc.106.040998; Heese A, 2007, P NATL ACAD SCI USA, V104, P12217, DOI 10.1073/pnas.0705306104; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Levkowitz G, 1999, MOL CELL, V4, P1029, DOI 10.1016/S1097-2765(00)80231-2; Li J, 2002, CELL, V110, P213, DOI 10.1016/S0092-8674(02)00812-7; Lu DP, 2010, P NATL ACAD SCI USA, V107, P496, DOI 10.1073/pnas.0909705107; Nam KH, 2002, CELL, V110, P203, DOI 10.1016/S0092-8674(02)00814-0; Robatzek S, 2006, GENE DEV, V20, P537, DOI 10.1101/gad.366506; Schulze B, 2010, J BIOL CHEM, V285, P9444, DOI 10.1074/jbc.M109.096842; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Trujillo M, 2008, CURR BIOL, V18, P1396, DOI 10.1016/j.cub.2008.07.085; Trujillo M, 2010, CURR OPIN PLANT BIOL, V13, P402, DOI 10.1016/j.pbi.2010.04.002; Wang YS, 2006, PLANT CELL, V18, P3635, DOI 10.1105/tpc.106.046730; Yang CW, 2006, PLANT CELL, V18, P1084, DOI 10.1105/tpc.105.039198; Yee D, 2009, J EXP BOT, V60, P1109, DOI 10.1093/jxb/ern369; Zeng LR, 2004, PLANT CELL, V16, P2795, DOI 10.1105/tpc.104.025171; Zhang J, 2010, CELL HOST MICROBE, V7, P290, DOI 10.1016/j.chom.2010.03.007	26	400	427	18	236	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 17	2011	332	6036					1439	1442		10.1126/science.1204903	http://dx.doi.org/10.1126/science.1204903			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778FT	21680842	Green Accepted			2022-12-24	WOS:000291689000044
J	Luo, WB; Hu, HX; Chang, R; Zhong, J; Knabel, M; O'Meally, R; Cole, RN; Pandey, A; Semenza, GL				Luo, Weibo; Hu, Hongxia; Chang, Ryan; Zhong, Jun; Knabel, Matthew; O'Meally, Robert; Cole, Robert N.; Pandey, Akhilesh; Semenza, Gregg L.			Pyruvate Kinase M2 Is a PHD3-Stimulated Coactivator for Hypoxia-Inducible Factor 1	CELL			English	Article							TUMOR-GROWTH; CANCER-THERAPY; OXYGEN SENSOR; HIF; HYDROXYLATION; GENE; TRANSACTIVATION; HIF-1-ALPHA; METABOLISM; TENSION	The pyruvate kinase isoforms PKM1 and PKM2 are alternatively spliced products of the PKM2 gene. PKM2, but not PKM1, alters glucose metabolism in cancer cells and contributes to tumorigenesis by mechanisms that are not explained by its known biochemical activity. We show that PKM2 gene transcription is activated by hypoxia-inducible factor 1 (HIF-1). PKM2 interacts directly with the HIF-1 alpha subunit and promotes transactivation of HIF-1 target genes by enhancing HIF-1 binding and p300 recruitment to hypoxia response elements, whereas PKM1 fails to regulate HIF-1 activity. Interaction of PKM2 with prolyl hydroxylase 3 (PHD3) enhances PKM2 binding to HIF-1 alpha and PKM2 coactivator function. Mass spectrometry and anti-hydroxyproline antibody assays demonstrate PKM2 hydroxylation on proline-403/408. PHD3 knockdown inhibits PKM2 coactivator function, reduces glucose uptake and lactate production, and increases O(2) consumption in cancer cells. Thus, PKM2 participates in a positive feedback loop that promotes HIF-1 transactivation and reprograms glucose metabolism in cancer cells.	[Luo, Weibo; Hu, Hongxia; Chang, Ryan; Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, Vasc Program, Inst Cell Engn, Baltimore, MD 21205 USA; [Luo, Weibo; Hu, Hongxia; Knabel, Matthew; Pandey, Akhilesh; Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA; [Zhong, Jun; O'Meally, Robert; Cole, Robert N.; Pandey, Akhilesh; Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA; [Pandey, Akhilesh; Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [Pandey, Akhilesh] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; [Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, Dept Radiat Oncol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Semenza, GL (corresponding author), Johns Hopkins Univ, Sch Med, Vasc Program, Inst Cell Engn, Baltimore, MD 21205 USA.	gsemenza@jhmi.edu	Zhong, Jun/D-1662-2010; Pandey, Akhilesh/B-4127-2009; Hu, Hongxia/Q-7765-2016	Zhong, Jun/0000-0003-3148-4143; Pandey, Akhilesh/0000-0001-9943-6127; Luo, Weibo/0000-0002-1992-0320	NHLBI [N01-HV28180, HHS-N268201000032C]; Japan Science and Technology Agency; DIVISION OF HEART AND VASCULAR DISEASES [N01HV028180] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); DIVISION OF HEART AND VASCULAR DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank Karen Padgett (Novus Biologicals) for providing antibodies against HIF-1 beta, HIF-2 alpha, PKM2, PHD2, PHD3, GLUT1, PDK1, LDHA, histone H3, p300, and rabbit IgG; Vickram Srinivas (Thomas Jefferson University) for FLAG-PHD1 vector; Frank S. Lee (University of Pennsylvania) for FLAG-PHD2 vector; Ted Dawson (The Johns Hopkins University) for shNT vector; and Kevin Bittman (Seahorse Bioscience, Inc) for assistance with OCR assays. G. L. S. is the C. Michael Armstrong Professor at The Johns Hopkins University School of Medicine. This work was supported, in part, by contracts N01-HV28180 and HHS-N268201000032C from NHLBI and an International Cooperative Research Project award from the Japan Science and Technology Agency.	Arany Z, 1996, P NATL ACAD SCI USA, V93, P12969, DOI 10.1073/pnas.93.23.12969; Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; David CJ, 2010, NATURE, V463, P364, DOI 10.1038/nature08697; Dombrauckas JD, 2005, BIOCHEMISTRY-US, V44, P9417, DOI 10.1021/bi0474923; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Fukuda R, 2007, CELL, V129, P111, DOI 10.1016/j.cell.2007.01.047; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Hitosugi T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000431; Jiang BH, 1997, J BIOL CHEM, V272, P19253, DOI 10.1074/jbc.272.31.19253; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Koditz J, 2007, BLOOD, V110, P3610, DOI 10.1182/blood-2007-06-094441; Lando D, 2002, SCIENCE, V295, P858, DOI 10.1126/science.1068592; Li DX, 2004, J BIOL CHEM, V279, P55051, DOI 10.1074/jbc.M410287200; Luo WB, 2010, J BIOL CHEM, V285, P3651, DOI 10.1074/jbc.M109.068577; Melillo G, 2007, CANCER METAST REV, V26, P341, DOI 10.1007/s10555-007-9059-x; NOGUCHI T, 1986, J BIOL CHEM, V261, P3807; Pescador N, 2005, BIOCHEM J, V390, P189, DOI 10.1042/BJ20042121; Seagroves TN, 2001, MOL CELL BIOL, V21, P3436, DOI 10.1128/MCB.21.10.3436-3444.2001; Semenza GL, 2010, ONCOGENE, V29, P625, DOI 10.1038/onc.2009.441; Semenza GL, 1996, J BIOL CHEM, V271, P32529, DOI 10.1074/jbc.271.51.32529; SEMENZA GL, 1994, J BIOL CHEM, V269, P23757; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wheaton WW, 2011, AM J PHYSIOL-CELL PH, V300, pC385, DOI 10.1152/ajpcell.00485.2010; Xie L, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000444; Zhang HF, 2008, P NATL ACAD SCI USA, V105, P19579, DOI 10.1073/pnas.0809763105	28	936	982	10	178	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 27	2011	145	5					732	744		10.1016/j.cell.2011.03.054	http://dx.doi.org/10.1016/j.cell.2011.03.054			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	769MR	21620138	Green Accepted, Bronze			2022-12-24	WOS:000291018600013
J	Lee, JM; Lee, YK; Mamrosh, JL; Busby, SA; Griffin, PR; Pathak, MC; Ortlund, EA; Moore, DD				Lee, Jae Man; Lee, Yoon Kwang; Mamrosh, Jennifer L.; Busby, Scott A.; Griffin, Patrick R.; Pathak, Manish C.; Ortlund, Eric A.; Moore, David D.			A nuclear-receptor-dependent phosphatidylcholine pathway with antidiabetic effects	NATURE			English	Article							ORPHAN RECEPTORS; LIVER; IDENTIFICATION; LRH-1; PHOSPHOLIPIDS; HOMOLOG-1; BINDING; DEFICIENCY; ACTIVATION; PROMOTER	Nuclear hormone receptors regulate diverse metabolic pathways and the orphan nuclear receptor LRH-1 (also known as NR5A2) regulates bile acid biosynthesis(1,2). Structural studies have identified phospholipids as potential LRH-1 ligands(3-5), but their functional relevance is unclear. Here we show that an unusual phosphatidylcholine species with two saturated 12 carbon fatty acid acyl side chains (dilauroyl phosphatidylcholine (DLPC)) is an LRH-1 agonist ligand in vitro. DLPC treatment induces bile acid biosynthetic enzymes in mouse liver, increases bile acid levels, and lowers hepatic triglycerides and serum glucose. DLPC treatment also decreases hepatic steatosis and improves glucose homeostasis in two mouse models of insulin resistance. Both the antidiabetic and lipotropic effects are lost in liver-specific Lrh-1 knockouts. These findings identify an LRH-1 dependent phosphatidylcholine signalling pathway that regulates bile acid metabolism and glucose homeostasis.	[Lee, Jae Man; Moore, David D.] Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; [Lee, Yoon Kwang; Mamrosh, Jennifer L.; Moore, David D.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Lee, Yoon Kwang] Northeastern Ohio Univ Coll Med & Pharm, Dept Integrat Med Sci, Coll Med, Rootstown, OH 44272 USA; [Lee, Yoon Kwang] Northeastern Ohio Univ Coll Med & Pharm, Coll Pharm, Rootstown, OH 44272 USA; [Busby, Scott A.; Griffin, Patrick R.] Scripps Res Inst, Scripps Res Mol Screening Ctr, Jupiter, FL 33458 USA; [Pathak, Manish C.; Ortlund, Eric A.] Emory Univ, Dept Biochem, Sch Med, Atlanta, GA 30322 USA	Baylor College of Medicine; Baylor College of Medicine; Northeast Ohio Medical University (NEOMED); Northeast Ohio Medical University (NEOMED); Scripps Research Institute; Emory University	Moore, DD (corresponding author), Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA.	moore@bcm.edu	Ortlund, Eric Anthony/P-3121-2019; Ortlund, Eric Anthony/F-4672-2014	Ortlund, Eric Anthony/0000-0001-8855-3029; Ortlund, Eric Anthony/0000-0001-8855-3029	NIH [DK-079638, DK068804, R01 CA134873]; USDA [ARS 6250-52000-055]; Alkek Foundation; Robert R. P. Doherty Jr-Welch Chair in Science; NATIONAL CANCER INSTITUTE [R01CA134873] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007696, R01DK068804, P30DK079638, R01DK083572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH084512] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USDA(United States Department of Agriculture (USDA)); Alkek Foundation; Robert R. P. Doherty Jr-Welch Chair in Science; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank S. A. Kliewer and D. J. Mangelsdorf (UT Southwestern Medical Center) for the gift of Lrh-1<SUP>f/f</SUP> mice, A. J. Cooney for the OCT4 promoter constructs, C. Mills and D. Kuruvilla for experimental assistance, the Baylor College of Medicine Diabetes Endocrine Research Center (supported by NIH DK-079638 and USDA ARS 6250-52000-055) and the services of the Mouse Metabolism Core for hyperinsulinaemic clamp studies, and the current and previous members of the D.D.M. laboratory for discussions and technical support. Supported by NIH R01 DK068804, the Alkek Foundation and the Robert R. P. Doherty Jr-Welch Chair in Science to D.D.M., and NIH R01 CA134873 to P.R.G.	Amemiya-Kudo M, 2000, J BIOL CHEM, V275, P31078, DOI 10.1074/jbc.M005353200; Chakravarthy MV, 2009, CELL, V138, P476, DOI 10.1016/j.cell.2009.05.036; Chalkiadaki A, 2005, MOL CELL BIOL, V25, P5095, DOI 10.1128/MCB.25.12.5095-5105.2005; Cusi K, 2009, CURR OPIN ENDOCRINOL, V16, P141, DOI 10.1097/MED.0b013e3283293015; Dobrzyn P, 2004, P NATL ACAD SCI USA, V101, P6409, DOI 10.1073/pnas.0401627101; Dong B, 2009, P NATL ACAD SCI USA, V106, P18831, DOI 10.1073/pnas.0909731106; Gu PL, 2005, MOL CELL BIOL, V25, P3492, DOI 10.1128/MCB.25.9.3492-3505.2005; Hunt AN, 2006, J CELL BIOCHEM, V97, P244, DOI 10.1002/jcb.20691; Kanayama T, 2007, J BIOL CHEM, V282, P10290, DOI 10.1074/jbc.M700270200; Kang HW, 2010, TRENDS ENDOCRIN MET, V21, P449, DOI 10.1016/j.tem.2010.02.001; Kim KH, 1997, ANNU REV NUTR, V17, P77, DOI 10.1146/annurev.nutr.17.1.77; Krylova IN, 2005, CELL, V120, P343, DOI 10.1016/j.cell.2005.01.024; Lee H, 2000, CIRC RES, V87, P516; Lee YK, 2006, J BIOL CHEM, V281, P7850, DOI 10.1074/jbc.M509115200; Lee YK, 1999, J BIOL CHEM, V274, P20869, DOI 10.1074/jbc.274.30.20869; Lee YK, 2008, MOL ENDOCRINOL, V22, P1345, DOI 10.1210/me.2007-0565; Li DH, 2007, MOL CELL BIOL, V27, P6669, DOI 10.1128/MCB.00355-07; Li SJ, 2010, P NATL ACAD SCI USA, V107, P3441, DOI 10.1073/pnas.0914798107; Li Y, 2005, MOL CELL, V17, P491, DOI 10.1016/j.molcel.2005.02.002; Ma K, 2006, J CLIN INVEST, V116, P1102, DOI 10.1172/JCI25604; Mataki C, 2007, MOL CELL BIOL, V27, P8330, DOI 10.1128/MCB.00852-07; MCGARRY JD, 1992, SCIENCE, V258, P766, DOI 10.1126/science.1439783; McIntyre TM, 2003, P NATL ACAD SCI USA, V100, P131, DOI 10.1073/pnas.0135855100; Ortlund EA, 2005, NAT STRUCT MOL BIOL, V12, P357, DOI 10.1038/nsmb910; Sablin EP, 2009, MOL ENDOCRINOL, V23, P25, DOI 10.1210/me.2007-0508; Savage DB, 2006, J CLIN INVEST, V116, P817, DOI 10.1172/JCI27300; Shimomura L, 1999, P NATL ACAD SCI USA, V96, P13656, DOI 10.1073/pnas.96.24.13656; Urs AN, 2006, ENDOCRINOLOGY, V147, P5249, DOI 10.1210/en.2006-0355; Vidovic D, 2011, CHEMMEDCHEM, V6, P94, DOI 10.1002/cmdc.201000428; Wang W, 2005, P NATL ACAD SCI USA, V102, P7505, DOI 10.1073/pnas.0409482102; Watanabe M, 2004, J CLIN INVEST, V113, P1408, DOI 10.1172/JCI200421025; Whitby RJ, 2006, J MED CHEM, V49, P6652, DOI 10.1021/jm060990k	32	162	167	0	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 23	2011	474	7352					506	U135		10.1038/nature10111	http://dx.doi.org/10.1038/nature10111			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	781NJ	21614002	Green Accepted			2022-12-24	WOS:000291939700048
J	Pickhardt, PJ; Lawrence, EM; Pooler, BD; Bruce, RJ				Pickhardt, Perry J.; Lawrence, Edward M.; Pooler, B. Dustin; Bruce, Richard J.			Diagnostic Performance of Multidetector Computed Tomography for Suspected Acute Appendicitis	ANNALS OF INTERNAL MEDICINE			English	Article							LOWER-QUADRANT PAIN; NEGATIVE APPENDECTOMY RATE; HELICAL CT; ORAL CONTRAST; ADULTS; IMPACT; US; ULTRASONOGRAPHY; ACCURACY; SCAN	Background: Use of preoperative computed tomography for suspected acute appendicitis has dramatically increased since the introduction of multidetector CT (MDCT) scanners. Objective: To evaluate the diagnostic performance of MDCT for suspected acute appendicitis in adults. Design: Analysis of MDCT findings and clinical outcomes of consecutive adults referred for MDCT for suspected appendicitis from January 2000 to December 2009. Setting: Single academic medical center in the United States. Patients: 2871 adults. Measurements: Interpretation of nonfocused abdominopelvic MDCT scans by radiologists who were aware of the study indication. Posttest assessment of diagnostic performance of MDCT for acute appendicitis, according to the reference standard of final combined clinical, surgical, and pathology findings. Results: 675 of 2871 patients (23.5%) had confirmed acute appendicitis. The sensitivity, specificity, and negative and positive predictive values of MDCT were 98.5% (95% CI, 97.3% to 99.2%) (665 of 675 patients), 98.0% (CI, 97.4% to 98.6%) (2153 of 2196 patients), 99.5% (CI, 99.2% to 99.8%) (2153 of 2163 patients), and 93.9% (CI, 91.9% to 95.5%) (665 of 708 patients), respectively. Positive and negative likelihood ratios were 51.3 (CI, 38.1 to 69.0) and 0.015 (CI, 0.008 to 0.028), respectively. The overall rate of negative findings at appendectomy was 7.5% (CI, 5.8% to 9.7%) (54 of 716 patients), but would have decreased to 4.1% (28 of 690 patients) had surgery been avoided in 26 cases with true-negative findings on MDCT. The overall perforation rate was 17.8% (120 of 675 patients) but progressively decreased from 28.9% in 2000 to 11.5% in 2009. Multidetector computed tomography provided or suggested an alternative diagnosis in 893 of 2122 patients (42.1%) without appendicitis or appendectomy. Limitation: Possible referral bias, because some patients whose appendicitis was difficult to diagnose on clinical grounds may not have been referred for MDCT for evaluation of suspected appendicitis. Conclusion: Multidetector computed tomography is a useful test for routine evaluation of suspected appendicitis in adults.	[Pickhardt, Perry J.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Radiol, Clin Sci Ctr E3 311, Madison, WI 53792 USA	University of Wisconsin System; University of Wisconsin Madison	Pickhardt, PJ (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Radiol, Clin Sci Ctr E3 311, 600 Highland Ave, Madison, WI 53792 USA.	ppickhardt2@uwhealth.org						ADDISS DG, 1990, AM J EPIDEMIOL, V132, P910, DOI 10.1093/oxfordjournals.aje.a115734; Agresti A, 1998, AM STAT, V52, P119, DOI 10.2307/2685469; Anderson BA, 2005, AM J SURG, V190, P474, DOI 10.1016/j.amjsurg.2005.03.037; [Anonymous], 1996, RAD RISK PERSPECTIVE; BALTHAZAR EJ, 1986, AM J ROENTGENOL, V147, P705, DOI 10.2214/ajr.147.4.705; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Coursey CA, 2010, RADIOLOGY, V254, P460, DOI 10.1148/radiol.09082298; Doria AS, 2006, RADIOLOGY, V241, P83, DOI 10.1148/radiol.2411050913; Flum DR, 2001, JAMA-J AM MED ASSOC, V286, P1748, DOI 10.1001/jama.286.14.1748; GALE ME, 1985, J COMPUT ASSIST TOMO, V9, P34, DOI 10.1097/00004728-198501000-00007; Ganguli S, 2006, RADIOLOGY, V241, P175, DOI 10.1148/radiol.2411050191; Hara AK, 2009, AM J ROENTGENOL, V193, P764, DOI 10.2214/AJR.09.2397; Hlibczuk V, 2010, ANN EMERG MED, V55, P51, DOI 10.1016/j.annemergmed.2009.06.509; Hu H, 1999, MED PHYS, V26, P5, DOI 10.1118/1.598470; Jacobs JE, 2001, RADIOLOGY, V220, P683, DOI 10.1148/radiol.2202001557; Johnson PT, 2009, AM J ROENTGENOL, V192, P893, DOI 10.2214/AJR.08.1685; KALENDER WA, 1990, RADIOLOGY, V176, P181, DOI 10.1148/radiology.176.1.2353088; Keyzer C, 2004, RADIOLOGY, V232, P164, DOI 10.1148/radiol.2321031115; Keyzer C, 2009, AM J ROENTGENOL, V193, P1272, DOI 10.2214/AJR.08.1959; Klingenbeck-Regn K, 1999, EUR J RADIOL, V31, P110, DOI 10.1016/S0720-048X(99)00086-8; Lane MJ, 1999, RADIOLOGY, V213, P341, DOI 10.1148/radiology.213.2.r99nv44341; Lee CC, 2007, ACAD EMERG MED, V14, P117, DOI 10.1197/j.aem.2006.08.007; Lubner MG, 2011, RADIOLOGY; McCollough CH, 2009, RADIOL CLIN N AM, V47, P27, DOI 10.1016/j.rcl.2008.10.006; Mun S, 2006, EMERG RADIOL, V12, P99, DOI 10.1007/s10140-005-0456-6; Nathan RO, 2008, AM J ROENTGENOL, V191, P1102, DOI 10.2214/AJR.07.3466; Nikolaidis P, 2004, AM J ROENTGENOL, V183, P889, DOI 10.2214/ajr.183.4.1830889; Oto A, 2005, RADIOLOGY, V234, P445, DOI 10.1148/radiol.2341032002; Paulson EK, 2005, RADIOLOGY, V235, P879, DOI 10.1148/radiol.2353041231; Paulson EK, 2009, AM J ROENTGENOL, V193, P1268, DOI 10.2214/AJR.09.3313; Pedrosa I, 2006, RADIOLOGY, V238, P891, DOI 10.1148/radiol.2383050146; Raja AS, 2010, RADIOLOGY, V256, P460, DOI 10.1148/radiol.10091570; Raman SS, 2008, NEW ENGL J MED, V358, P972, DOI 10.1056/NEJMc0707000; Rao PM, 1999, ANN SURG, V229, P344, DOI 10.1097/00000658-199903000-00007; Rao PM, 1997, RADIOLOGY, V202, P139, DOI 10.1148/radiology.202.1.8988203; Rao PM, 1997, J COMPUT ASSIST TOMO, V21, P686, DOI 10.1097/00004728-199709000-00002; Rao PM, 1998, NEW ENGL J MED, V338, P141, DOI 10.1056/NEJM199801153380301; Rybkin AV, 2007, RADIOL CLIN N AM, V45, P411, DOI 10.1016/j.rcl.2007.04.003; Seo H, 2009, AM J ROENTGENOL, V193, P96, DOI 10.2214/AJR.08.1237; Stengel JW, 2010, RADIOLOGY, V256, P119, DOI 10.1148/radiol.10091229; Terasawa T, 2004, ANN INTERN MED, V141, P537, DOI 10.7326/0003-4819-141-7-200410050-00011; van Randen A, 2010, EUR RADIOL, V20, P1657, DOI 10.1007/s00330-009-1706-x; van Randen A, 2008, RADIOLOGY, V249, P97, DOI 10.1148/radiol.2483071652; Wagner PL, 2008, SURGERY, V144, P276, DOI 10.1016/j.surg.2008.03.040; Weston AR, 2005, INT J TECHNOL ASSESS, V21, P368, DOI 10.1017/S0266462305050488; Wijetunga R, 2001, RADIOLOGY, V221, P747, DOI 10.1148/radiol.2213001581; WOLVERSON MK, 1979, AM J ROENTGENOL, V133, P1089, DOI 10.2214/ajr.133.6.1089	47	128	129	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 21	2011	154	12					789	796		10.7326/0003-4819-154-12-201106210-00006	http://dx.doi.org/10.7326/0003-4819-154-12-201106210-00006			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	779SA	21690593				2022-12-24	WOS:000291800500014
J	Dupont, S; Morsut, L; Aragona, M; Enzo, E; Giulitti, S; Cordenonsi, M; Zanconato, F; Le Digabel, J; Forcato, M; Bicciato, S; Elvassore, N; Piccolo, S				Dupont, Sirio; Morsut, Leonardo; Aragona, Mariaceleste; Enzo, Elena; Giulitti, Stefano; Cordenonsi, Michelangelo; Zanconato, Francesca; Le Digabel, Jimmy; Forcato, Mattia; Bicciato, Silvio; Elvassore, Nicola; Piccolo, Stefano			Role of YAP/TAZ in mechanotransduction	NATURE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; CELL SELF-RENEWAL; CONTACT INHIBITION; ACTIN DYNAMICS; GROWTH-CONTROL; BREAST-CANCER; HIPPO PATHWAY; METASTASIS; TAZ; FORCE	Cells perceive their microenvironment not only through soluble signals but also through physical and mechanical cues, such as extracellular matrix (ECM) stiffness or confined adhesiveness. By mechanotransduction systems, cells translate these stimuli into biochemical signals controlling multiple aspects of cell behaviour, including growth, differentiation and cancer malignant progression, but how rigidity mechanosensing is ultimately linked to activity of nuclear transcription factors remains poorly understood. Here we report the identification of the Yorkie-homologues YAP (Yes-associated protein) and TAZ (transcriptional coactivator with PDZ-binding motif, also known as WWTR1) as nuclear relays of mechanical signals exerted by ECM rigidity and cell shape. This regulation requires Rho GTPase activity and tension of the actomyosin cytoskeleton, but is independent of the Hippo/LATS cascade. Crucially, YAP/TAZ are functionally required for differentiation of mesenchymal stem cells induced by ECM stiffness and for survival of endothelial cells regulated by cell geometry; conversely, expression of activated YAP overrules physical constraints in dictating cell behaviour. These findings identify YAP/TAZ as sensors and mediators of mechanical cues instructed by the cellular microenvironment.	[Dupont, Sirio; Morsut, Leonardo; Aragona, Mariaceleste; Enzo, Elena; Cordenonsi, Michelangelo; Zanconato, Francesca; Piccolo, Stefano] Univ Padua, Sch Med, Dept Histol Microbiol & Med Biotechnol, I-35131 Padua, Italy; [Giulitti, Stefano; Elvassore, Nicola] Univ Padua, Dept Chem Engn DIPIC, I-35131 Padua, Italy; [Le Digabel, Jimmy] Univ Paris Diderot, Lab MSC, F-75205 Paris, France; [Le Digabel, Jimmy] CNRS, UMR 7057, F-75205 Paris, France; [Forcato, Mattia; Bicciato, Silvio] Univ Modena & Reggio Emilia, Dept Biomed Sci, Ctr Genome Res, I-41100 Modena, Italy	University of Padua; University of Padua; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Universite Paris Cite; Universita di Modena e Reggio Emilia	Dupont, S (corresponding author), Univ Padua, Sch Med, Dept Histol Microbiol & Med Biotechnol, Viale Colombo 3, I-35131 Padua, Italy.	dupont@bio.unipd.it; piccolo@bio.unipd.it	Aragona, Mariaceleste/AAB-7307-2021; Dupont, Sirio/AAP-8133-2021; BICCIATO, Silvio/J-4466-2019; Forcato, Mattia/B-7733-2015; Bicciato, Silvio/C-9825-2009; CORDENONSI, MICHELANGELO/K-7692-2016	Aragona, Mariaceleste/0000-0002-2239-3541; BICCIATO, Silvio/0000-0002-1944-7078; Forcato, Mattia/0000-0002-7383-6576; Bicciato, Silvio/0000-0002-1944-7078; Dupont, Sirio/0000-0002-6869-1966; Enzo, Elena/0000-0001-9768-6368; PICCOLO, STEFANO/0000-0002-2037-0004; CORDENONSI, MICHELANGELO/0000-0002-8253-5724	Telethon and Progetti di Eccellenza; AIRC (Italian Association for Cancer Research); University of Padua; IIT; Telethon; MIUR (Italian Minister of University)	Telethon and Progetti di Eccellenza(Fondazione Telethon); AIRC (Italian Association for Cancer Research)(Fondazione AIRC per la ricerca sul cancro); University of Padua; IIT(Istituto Italiano di Tecnologia - IIT); Telethon(Fondazione Telethon); MIUR (Italian Minister of University)(Ministry of Education, Universities and Research (MIUR))	We thank G. Scita for advice and gift of reagents; X. Yang for 5SA-YAP1 plasmid; I. Farrance for 4xGTIIC-lux plasmid; H. Miyoshi for pCSII-EF-MCS vector; L. Naldini for pMD2-VSVG vector; R. Treisman for Delta N1+C mDIA, R26D and V159N Actin plasmids; G. Posern for SRF-lux reporter; mouse TAZ and psPAX2 were Addgene plasmid 19025 and 12260. This work was supported by: Telethon and Progetti di Eccellenza CARIPARO grants to N.E.; AIRC (Italian Association for Cancer Research) PI and AIRC Special Program Molecular Clinical Oncology "5 per mille'', University of Padua Strategic grant, IIT Excellence grant and Telethon to S.P.; AIRC PI and MIUR (Italian Minister of University) grants to S.D.	Adorno M, 2009, CELL, V137, P87, DOI 10.1016/j.cell.2009.01.039; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425; CHEN Z, 1994, GENE DEV, V8, P2293, DOI 10.1101/gad.8.19.2293; Descot A, 2009, MOL CELL, V35, P291, DOI 10.1016/j.molcel.2009.07.015; Dimeo TA, 2009, CANCER RES, V69, P5364, DOI 10.1158/0008-5472.CAN-08-4135; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; du Roure O, 2005, P NATL ACAD SCI USA, V102, P2390, DOI 10.1073/pnas.0408482102; Dupont S, 2009, CELL, V136, P123, DOI 10.1016/j.cell.2008.10.051; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Fu JP, 2010, NAT METHODS, V7, P733, DOI 10.1038/nmeth.1487; Galbraith CG, 2002, J CELL BIOL, V159, P695, DOI 10.1083/jcb.200204153; Giannone G, 2003, J CELL BIOL, V163, P409, DOI 10.1083/jcb.200302001; Gilbert PM, 2010, SCIENCE, V329, P1078, DOI 10.1126/science.1191035; Hong JH, 2005, SCIENCE, V309, P1074, DOI 10.1126/science.1110955; Jaalouk DE, 2009, NAT REV MOL CELL BIO, V10, P63, DOI 10.1038/nrm2597; Lei QY, 2008, MOL CELL BIOL, V28, P2426, DOI 10.1128/MCB.01874-07; Mackay A, 2003, ONCOGENE, V22, P2680, DOI 10.1038/sj.onc.1206349; Mahoney WM, 2005, BIOCHEM J, V388, P217, DOI 10.1042/BJ20041434; Makita R, 2008, AM J PHYSIOL-RENAL, V294, pF542, DOI 10.1152/ajprenal.00201.2007; Mammoto T, 2010, DEVELOPMENT, V137, P1407, DOI 10.1242/dev.024166; Martello G, 2010, CELL, V141, P1195, DOI 10.1016/j.cell.2010.05.017; Mazzone M, 2010, P NATL ACAD SCI USA, V107, P5012, DOI 10.1073/pnas.1000896107; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Morin-Kensicki EM, 2006, MOL CELL BIOL, V26, P77, DOI 10.1128/MCB.26.1.77-87.2006; Morsut L, 2010, DEVELOPMENT, V137, P2571, DOI 10.1242/dev.053801; Nienhaus U, 2009, MECH DEVELOP, V126, P942, DOI 10.1016/j.mod.2009.09.002; Oka T, 2008, J BIOL CHEM, V283, P27534, DOI 10.1074/jbc.M804380200; Olson EN, 2010, NAT REV MOL CELL BIO, V11, P353, DOI 10.1038/nrm2890; Ota M, 2008, DEVELOPMENT, V135, P4059, DOI 10.1242/dev.027151; Padua D, 2008, CELL, V133, P66, DOI 10.1016/j.cell.2008.01.046; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Park BK, 2007, NAT MED, V13, P62, DOI 10.1038/nm1519; Provenzano PP, 2009, ONCOGENE, V28, P4326, DOI 10.1038/onc.2009.299; Schwank G, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001669; Schwartz MA, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a005066; Selvaraj A, 2004, BMC MOL BIOL, V5, DOI 10.1186/1471-2199-5-13; Skouloudaki K, 2009, P NATL ACAD SCI USA, V106, P8579, DOI 10.1073/pnas.0811691106; Tse J.R., 2010, CURR PROTOC CELL BIO, V47; Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890; Zhang H, 2009, J BIOL CHEM, V284, P13355, DOI 10.1074/jbc.M900843200; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907	44	3148	3223	39	925	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 9	2011	474	7350					179	U212		10.1038/nature10137	http://dx.doi.org/10.1038/nature10137			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774PE	21654799				2022-12-24	WOS:000291397800042
J	Leproult, R; Van Cauter, E				Leproult, Rachel; Van Cauter, Eve			Effect of 1 Week of Sleep Restriction on Testosterone Levels in Young Healthy Men	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							OLDER MEN		[Leproult, Rachel; Van Cauter, Eve] Univ Chicago, Dept Med, Chicago, IL 60637 USA	University of Chicago	Leproult, R (corresponding author), Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA.	evcauter@medicine.bsd.uchicago.edu			NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000055] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL072694] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020595] Funding Source: NIH RePORTER; NCRR NIH HHS [M01 RR000055, MO1-RR-00055] Funding Source: Medline; NHLBI NIH HHS [R01 HL072694, 5R01HL72694-5] Funding Source: Medline; NIDDK NIH HHS [P60DK-020595, P60 DK020595] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Andersen ML, 2008, SLEEP MED REV, V12, P365, DOI 10.1016/j.smrv.2007.12.003; Axelsson J, 2005, J CLIN ENDOCR METAB, V90, P4530, DOI 10.1210/jc.2005-0520; Bremner WJ, 2010, NEW ENGL J MED, V363, P189, DOI 10.1056/NEJMe1006197; Harman SM, 2001, J CLIN ENDOCR METAB, V86, P724, DOI 10.1210/jc.86.2.724; MONK TH, 1989, PSYCHIAT RES, V27, P89, DOI 10.1016/0165-1781(89)90013-9; Penev PD, 2007, SLEEP, V30, P427, DOI 10.1093/sleep/30.4.427	6	150	157	1	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 1	2011	305	21					2173	2174		10.1001/jama.2011.710	http://dx.doi.org/10.1001/jama.2011.710			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	770RN	21632481	Green Accepted			2022-12-24	WOS:000291106300017
J	D'Agostino, RB				D'Agostino, Ralph B., Sr.			Changing End Points in Breast-Cancer Drug Approval - The Avastin Story	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PACLITAXEL		Boston Univ, Dept Math & Stat, Boston, MA 02215 USA	Boston University	D'Agostino, RB (corresponding author), Boston Univ, Dept Math & Stat, Boston, MA 02215 USA.							*FDA ONC DRUG ADV, 2010, JUL 20 M; *FDA ONC DRUGS ADV, 2007, DEC 5 M; Muggia FM, 2000, J CLIN ONCOL, V18, P106, DOI 10.1200/JCO.2000.18.1.106; Panageas KS, 2007, J NATL CANCER I, V99, P428, DOI 10.1093/jnci/djk091; Sledge GW, 2003, J CLIN ONCOL, V21, P588, DOI 10.1200/JCO.2003.08.013	5	66	68	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 14	2011	365	2								10.1056/nejmp1106984	http://dx.doi.org/10.1056/nejmp1106984			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	791SP	21707384				2022-12-24	WOS:000292685500005
J	Khan, AI; Dinh, DM; Schneider, D; Lenski, RE; Cooper, TF				Khan, Aisha I.; Dinh, Duy M.; Schneider, Dominique; Lenski, Richard E.; Cooper, Tim F.			Negative Epistasis Between Beneficial Mutations in an Evolving Bacterial Population	SCIENCE			English	Article							TERM EXPERIMENTAL EVOLUTION; ESCHERICHIA-COLI; FITNESS LANDSCAPES; RNA VIRUS; ADAPTATION; YEAST; SEX; EVOLVABILITY; GENERATIONS; SELECTION	Epistatic interactions between mutations play a prominent role in evolutionary theories. Many studies have found that epistasis is widespread, but they have rarely considered beneficial mutations. We analyzed the effects of epistasis on fitness for the first five mutations to fix in an experimental population of Escherichia coli. Epistasis depended on the effects of the combined mutations-the larger the expected benefit, the more negative the epistatic effect. Epistasis thus tended to produce diminishing returns with genotype fitness, although interactions involving one particular mutation had the opposite effect. These data support models in which negative epistasis contributes to declining rates of adaptation over time. Sign epistasis was rare in this genome-wide study, in contrast to its prevalence in an earlier study of mutations in a single gene.	[Khan, Aisha I.; Dinh, Duy M.; Cooper, Tim F.] Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA; [Schneider, Dominique] Univ Grenoble 1, Inst Jean Roget, Lab Adaptat & Pathogenie Microorganismes, F-38041 Grenoble, France; [Schneider, Dominique] CNRS, UMR5163, F-38041 Grenoble, France; [Lenski, Richard E.] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA	University of Houston System; University of Houston; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Michigan State University	Cooper, TF (corresponding author), Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA.	tfcooper@uh.edu	Schneider, Dominique/M-6019-2014	Cooper, Timothy/0000-0001-5038-9366; Lenski, Richard/0000-0002-1064-8375	NSF [DEB-1019989, DEB-0844355]; James S. McDonnell Foundation [220020174]; Agence Nationale de la Recherche [ANR-08-GENM-023-001]; Defense Advanced Research Projects Agency [HR0011-09-1-0055]	NSF(National Science Foundation (NSF)); James S. McDonnell Foundation; Agence Nationale de la Recherche(French National Research Agency (ANR)); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA))	This work was supported by grants from the NSF (DEB-1019989 to R.E.L. and DEB-0844355 to T.F.C.), the James S. McDonnell Foundation (220020174 to T.F.C.), the Agence Nationale de la Recherche (Program Genomique, Grant ANR-08-GENM-023-001 to D.S.) and the Defense Advanced Research Projects Agency "Fun Bio" Program (HR0011-09-1-0055 to R.E.L. and T.F.C.). We thank R. Azevedo, T. Paixao, and D. Stoebel for valuable discussions and helpful comments on the manuscript. R. E. L. will make the ancestral and evolved strains used in this study available to qualified recipients, subject to completion of a material transfer agreement that can be found at http://technologies.msu.edu/forms.html. T.F.C. will make the strains constructed in this study available to qualified recipients. Competition experiment counts, summary input data, and analysis scripts that pertain to the experiments and analyses reported in this paper have been deposited at http://dx.doi.org/10.5061/dryad.5rv40.	Barrick JE, 2009, NATURE, V461, P1243, DOI 10.1038/nature08480; Blount ZD, 2008, P NATL ACAD SCI USA, V105, P7899, DOI 10.1073/pnas.0803151105; Burch CL, 2000, NATURE, V406, P625, DOI 10.1038/35020564; Chou HH, 2011, SCIENCE, V332, P1190, DOI 10.1126/science.1203799; Cooper TF, 2003, P NATL ACAD SCI USA, V100, P1072, DOI 10.1073/pnas.0334340100; Cooper VS, 2000, NATURE, V407, P736, DOI 10.1038/35037572; da Silva J, 2010, GENETICS, V185, P293, DOI 10.1534/genetics.109.112458; de Visser JAGM, 2002, BMC EVOL BIOL, V2, DOI 10.1186/1471-2148-2-19; de Visser JAGM, 2009, AM NAT, V174, pS15, DOI 10.1086/599081; Draghi JA, 2010, NATURE, V463, P353, DOI 10.1038/nature08694; Elena SF, 1997, NATURE, V390, P395, DOI 10.1038/37108; Gerrish PJ, 1998, GENETICA, V102-3, P127, DOI 10.1023/A:1017067816551; Goddard MR, 2005, NATURE, V434, P636, DOI 10.1038/nature03405; Jasnos L, 2008, GENETICS, V178, P2105, DOI 10.1534/genetics.107.084533; Jasnos L, 2007, NAT GENET, V39, P550, DOI 10.1038/ng1986; KONDRASHOV AS, 1994, NATURE, V369, P99, DOI 10.1038/369099a0; KORONA R, 1994, P NATL ACAD SCI USA, V91, P9037, DOI 10.1073/pnas.91.19.9037; Kryazhimskiy S, 2009, P NATL ACAD SCI USA, V106, P18638, DOI 10.1073/pnas.0905497106; LENSKI RE, 1991, AM NAT, V138, P1315, DOI 10.1086/285289; LENSKI RE, 1994, P NATL ACAD SCI USA, V91, P6808, DOI 10.1073/pnas.91.15.6808; Lunzer M, 2005, SCIENCE, V310, P499, DOI 10.1126/science.1115649; Montville R, 2005, PLOS BIOL, V3, P1939, DOI 10.1371/journal.pbio.0030381; Moore FBG, 2000, P ROY SOC B-BIOL SCI, V267, P515, DOI 10.1098/rspb.2000.1030; Orr HA, 2003, GENETICS, V163, P1519; Orr HA, 2001, EVOLUTION, V55, P1085; Pepin KM, 2007, EVOLUTION, V61, P1710, DOI 10.1111/j.1558-5646.2007.00143.x; Sanjuan R, 2005, GENETICS, V170, P1001, DOI 10.1534/genetics.105.040741; Sanjuan R, 2007, PLOS GENET, V3, P939, DOI 10.1371/journal.pgen.0030093; Sanjuan R, 2006, P NATL ACAD SCI USA, V103, P14402, DOI 10.1073/pnas.0604543103; Schoustra SE, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000250; Silander OK, 2007, PLOS BIOL, V5, P922, DOI 10.1371/journal.pbio.0050094; TRAVISANO M, 1995, EVOLUTION, V49, P189, DOI 10.2307/2410304; Weinreich DM, 2006, SCIENCE, V312, P111, DOI 10.1126/science.1123539; Weinreich DM, 2005, EVOLUTION, V59, P1165; Woods R, 2006, P NATL ACAD SCI USA, V103, P9107, DOI 10.1073/pnas.0602917103; Woods RJ, 2011, SCIENCE, V331, P1433, DOI 10.1126/science.1198914	36	338	338	3	95	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 3	2011	332	6034					1193	1196		10.1126/science.1203801	http://dx.doi.org/10.1126/science.1203801			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	772BO	21636772				2022-12-24	WOS:000291205200047
J	Rowe, TB; Macrini, TE; Luo, ZX				Rowe, Timothy B.; Macrini, Thomas E.; Luo, Zhe-Xi			Fossil Evidence on Origin of the Mammalian Brain	SCIENCE			English	Article							EVOLUTION; DIVERSIFICATION; CYNODONTIA; THERAPSIDA; EAR	Many hypotheses have been postulated regarding the early evolution of the mammalian brain. Here, x-ray tomography of the Early Jurassic mammaliaforms Morganucodon and Hadrocodium sheds light on this history. We found that relative brain size expanded to mammalian levels, with enlarged olfactory bulbs, neocortex, olfactory (pyriform) cortex, and cerebellum, in two evolutionary pulses. The initial pulse was probably driven by increased resolution in olfaction and improvements in tactile sensitivity (from body hair) and neuromuscular coordination. A second pulse of olfactory enhancement then enlarged the brain to mammalian levels. The origin of crown Mammalia saw a third pulse of olfactory enhancement, with ossified ethmoid turbinals supporting an expansive olfactory epithelium in the nasal cavity, allowing full expression of a huge odorant receptor genome.	[Rowe, Timothy B.] Univ Texas Austin, Jackson Sch Geosci, Austin, TX 78712 USA; [Macrini, Thomas E.] St Marys Univ, Dept Biol Sci, San Antonio, TX 78228 USA; [Luo, Zhe-Xi] Carnegie Museum Nat Hist, Sect Vertebrate Paleontol, Pittsburgh, PA 15213 USA	University of Texas System; University of Texas Austin	Rowe, TB (corresponding author), Univ Texas Austin, Jackson Sch Geosci, C1100, Austin, TX 78712 USA.	rowe@mail.utexas.edu	Luo, Zhe-XI/AAU-2263-2021; Macrini, Thomas E./H-4577-2019	Macrini, Thomas E./0000-0001-9488-1512	NSF [DEB 0309369, EAR-0948842, AToL 0531767, DEB 0316558, EF0129959]; University of Texas Jackson School of Geosciences; NSF of China; Humboldt Foundation (Germany); National Geographic Society	NSF(National Science Foundation (NSF)); University of Texas Jackson School of Geosciences; NSF of China(National Natural Science Foundation of China (NSFC)); Humboldt Foundation (Germany)(Alexander von Humboldt Foundation); National Geographic Society(National Geographic Society)	This research was funded by NSF DEB 0309369 (T.E.M. and T.R.), NSF EAR-0948842 (T.R.), AToL 0531767 (T.R.), the University of Texas Jackson School of Geosciences (T.R. and T.E.M.), and funded by NSF DEB 0316558 and EF0129959, NSF of China, Humboldt Foundation (Germany), and National Geographic Society to Z.-X.L. Endocasts and computed tomography imagery are online at www.DigiMorph.org.	Aboitiz F, 2007, ADV ANAT EMBRYOL CEL, V193, P1; Allman J., 1990, Seminars in the Neurosciences, V2, P257; Bottorff W., 1995, THRINAXODON DIGITAL; CATANIA KC, 2009, EVOLUTIONARY NEUROSC, P697; GAUTHIER J, 1988, CLADISTICS, V4, P105, DOI 10.1111/j.1096-0031.1988.tb00514.x; Hopson J.A., 1979, P39; Hulbert A.J., 1988, P148; Jerison H.J., 2009, EVOLUTIONARY NEUROSC, P497; Jerison HJ., 1973, EVOLUTION BRAIN INTE; Ji Q, 2006, SCIENCE, V311, P1123, DOI 10.1126/science.1123026; Kemp TS, 2009, J VERTEBR PALEONTOL, V29, P1188, DOI 10.1671/039.029.0430; Kielan-Jaworowska Z., 2005, MAMMALS AGE DINOSAUR; Krubitzer L, 2009, EVOLUTIONARY NEUROSC, P545; Luo ZX, 2007, NATURE, V450, P1011, DOI 10.1038/nature06277; Luo ZX, 2011, P ROY SOC B-BIOL SCI, V278, P28, DOI 10.1098/rspb.2010.1148; Luo ZX, 2001, SCIENCE, V292, P1535, DOI 10.1126/science.1058476; Macrini TE, 2006, THESIS U TEXAS AUSTI; Macrini TE, 2007, J MORPHOL, V268, P844, DOI 10.1002/jmor.10556; Nieuwenhuys R., 1998, CENTRAL NERVOUS SYST; Niimura Y, 2009, GENOME BIOL EVOL, V1, P34, DOI 10.1093/gbe/evp003; NORTHCUTT RG, 1995, TRENDS NEUROSCI, V18, P373; QUIROGA JC, 1984, J HIRNFORSCH, V25, P285; QUIROGA JC, 1980, J HIRNFORSCH, V21, P299; Rowe T., 1988, Journal of Vertebrate Paleontology, V8, P241; Rowe T, 1996, SCIENCE, V273, P651, DOI 10.1126/science.273.5275.651; ROWE T, 1996, CALIFORNIA ACAD SCI, V20, P71; Rowe T, 2008, P NATL ACAD SCI USA, V105, P1238, DOI 10.1073/pnas.0706385105; Rowe Timothy B., 2005, Journal of Mammalian Evolution, V12, P303, DOI 10.1007/s10914-005-5731-5; Zelena J, 1994, NERVES MECHANORECEPT; [No title captured]	30	214	216	1	73	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 20	2011	332	6032					955	957		10.1126/science.1203117	http://dx.doi.org/10.1126/science.1203117			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766FO	21596988				2022-12-24	WOS:000290766600040
J	Fleishman, SJ; Whitehead, TA; Ekiert, DC; Dreyfus, C; Corn, JE; Strauch, EM; Wilson, IA; Baker, D				Fleishman, Sarel J.; Whitehead, Timothy A.; Ekiert, Damian C.; Dreyfus, Cyrille; Corn, Jacob E.; Strauch, Eva-Maria; Wilson, Ian A.; Baker, David			Computational Design of Proteins Targeting the Conserved Stem Region of Influenza Hemagglutinin	SCIENCE			English	Article							RECOGNITION; ANTIBODIES; INTERFACE; DOCKING; SURFACE; PAIR	We describe a general computational method for designing proteins that bind a surface patch of interest on a target macromolecule. Favorable interactions between disembodied amino acid residues and the target surface are identified and used to anchor de novo designed interfaces. The method was used to design proteins that bind a conserved surface patch on the stem of the influenza hemagglutinin (HA) from the 1918 H1N1 pandemic virus. After affinity maturation, two of the designed proteins, HB36 and HB80, bind H1 and H5 HAs with low nanomolar affinity. Further, HB80 inhibits the HA fusogenic conformational changes induced at low pH. The crystal structure of HB36 in complex with 1918/H1 HA revealed that the actual binding interface is nearly identical to that in the computational design model. Such designed binding proteins may be useful for both diagnostics and therapeutics.	[Fleishman, Sarel J.; Whitehead, Timothy A.; Corn, Jacob E.; Strauch, Eva-Maria; Baker, David] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Ekiert, Damian C.; Dreyfus, Cyrille; Wilson, Ian A.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Ekiert, Damian C.; Dreyfus, Cyrille; Wilson, Ian A.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Baker, David] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Scripps Research Institute; Scripps Research Institute; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Baker, D (corresponding author), Univ Washington, Dept Biochem, Seattle, WA 98195 USA.	dabaker@uw.edu	Baker, David/K-8941-2012	Baker, David/0000-0001-7896-6217; Fleishman, Sarel/0000-0003-3177-7560; Ekiert, Damian/0000-0002-2570-0404	Human Frontier Science Program; Jane Coffin Childs Memorial Fund; National Institute of Allergy and Infectious Diseases, NIH [AI057141]; Defense Advanced Research Projects Agency; NIH yeast resource center; Defense Threat Reduction Agency; Howard Hughes Medical Institute; NIH [AI058113, GM080209]; Achievement Rewards for College Scientists Foundation; Skaggs Institute for Chemical Biology; National Cancer Institute [Y1-CO-1020]; National Institute of General Medical Science, NIH [Y1-GM-1104]; U.S. Department of Energy, Basic Energy Sciences, Office of Science [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI058113, U54AI057141] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM080209] Funding Source: NIH RePORTER	Human Frontier Science Program(Human Frontier Science Program); Jane Coffin Childs Memorial Fund; National Institute of Allergy and Infectious Diseases, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NIH yeast resource center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Achievement Rewards for College Scientists Foundation(General Electric); Skaggs Institute for Chemical Biology; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Science, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); U.S. Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Computational designs were generated on resources generously provided by participants of Rosetta @ Home and the Argonne National Leadership Computing Facility. We thank J. L. Gallaher for protein preparation. S. J. F. was supported by a long-term fellowship from the Human Frontier Science Program, J. E. C. was supported by the Jane Coffin Childs Memorial Fund, and E. M. S. by a career development award from the National Institute of Allergy and Infectious Diseases, NIH, AI057141. Research in the Baker laboratory was supported by grants from the Defense Advanced Research Projects Agency, the NIH yeast resource center, the Defense Threat Reduction Agency, and the Howard Hughes Medical Institute and in the Wilson laboratory by NIH AI058113, predoctoral fellowships from the Achievement Rewards for College Scientists Foundation and the NIH Molecular Evolution Training Program GM080209 (D. C. E.), and the Skaggs Institute for Chemical Biology. X-ray diffraction data sets were collected at the Stanford Synchrotron Radiation Lightsource beamline 9-2 and at the Advanced Photon Source (APS) beamline 23ID-B (GM/CA-CAT). The GM/CA CAT 23-ID-B beamline has been funded in whole or in part with federal funds from National Cancer Institute (Y1-CO-1020) and the National Institute of General Medical Science, NIH (Y1-GM-1104). Use of the APS was supported by the U.S. Department of Energy, Basic Energy Sciences, Office of Science, under contract no. DE-AC02-06CH11357. Coordinates and structure factors were deposited in the Protein Data Bank as entry 3R2X.	[Anonymous], 2010, NEW ENGL J MED, V362, P1708; Chao G, 2006, NAT PROTOC, V1, P755, DOI 10.1038/nprot.2006.94; Chen J, 1999, P NATL ACAD SCI USA, V96, P8967, DOI 10.1073/pnas.96.16.8967; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; Das R, 2008, ANNU REV BIOCHEM, V77, P363, DOI 10.1146/annurev.biochem.77.062906.171838; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Gray JJ, 2003, J MOL BIOL, V331, P281, DOI 10.1016/S0022-2836(03)00670-3; Huang PS, 2007, PROTEIN SCI, V16, P2770, DOI 10.1110/ps.073125207; Jha RK, 2010, J MOL BIOL, V400, P257, DOI 10.1016/j.jmb.2010.05.006; Karanicolas J, 2011, MOL CELL, V42, P250, DOI 10.1016/j.molcel.2011.03.010; Kortemme T, 2004, NAT STRUCT MOL BIOL, V11, P371, DOI 10.1038/nsmb749; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; Ledford H, 2008, NATURE, V455, P437, DOI 10.1038/455437a; Lerner RA, 2006, ANGEW CHEM INT EDIT, V45, P8106, DOI 10.1002/anie.200603381; Lo Conte L, 1999, J MOL BIOL, V285, P2177; ROSSMANN MG, 1989, J BIOL CHEM, V264, P14587; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; Liu S, 2007, P NATL ACAD SCI USA, V104, P5330, DOI 10.1073/pnas.0606198104; Stevenson CEM, 2006, PROTEINS, V65, P1041, DOI 10.1002/prot.21136; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566	20	414	442	4	176	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 13	2011	332	6031					816	821		10.1126/science.1202617	http://dx.doi.org/10.1126/science.1202617			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763CD	21566186	Green Accepted			2022-12-24	WOS:000290529900039
J	Yoon, HS; Price, DC; Stepanauskas, R; Rajah, VD; Sieracki, ME; Wilson, WH; Yang, EC; Duffy, S; Bhattacharya, D				Yoon, Hwan Su; Price, Dana C.; Stepanauskas, Ramunas; Rajah, Veeran D.; Sieracki, Michael E.; Wilson, William H.; Yang, Eun Chan; Duffy, Siobain; Bhattacharya, Debashish			Single-Cell Genomics Reveals Organismal Interactions in Uncultivated Marine Protists	SCIENCE			English	Article							EUKARYOTES; PHYLOGENY; OCEAN; TIME	Whole-genome shotgun sequence data from three individual cells isolated from seawater, followed by analysis of ribosomal DNA, indicated that the cells represented three divergent clades of picobiliphytes. In contrast with the recent description of this phylum, we found no evidence of plastid DNA nor of nuclear-encoded plastid-targeted proteins, which suggests that these picobiliphytes are heterotrophs. Genome data from one cell were dominated by sequences from a widespread single-stranded DNA virus. This virus was absent from the other two cells, both of which contained non-eukaryote DNA derived from marine Bacteroidetes and large DNA viruses. By using shotgun sequencing of uncultured marine picobiliphytes, we revealed the distinct interactions of individual cells.	[Price, Dana C.; Rajah, Veeran D.; Duffy, Siobain; Bhattacharya, Debashish] Rutgers State Univ, Dept Ecol Evolut & Nat Resources, New Brunswick, NJ 08901 USA; [Yoon, Hwan Su; Stepanauskas, Ramunas; Sieracki, Michael E.; Wilson, William H.; Yang, Eun Chan] Bigelow Lab Ocean Sci, W Boothbay Harbor, ME 04575 USA; [Yoon, Hwan Su] Sungkyunkwan Univ, Dept Biol Sci, Suwon 440746, South Korea	Rutgers State University New Brunswick; Bigelow Laboratory for Ocean Sciences; Sungkyunkwan University (SKKU)	Bhattacharya, D (corresponding author), Rutgers State Univ, Dept Ecol Evolut & Nat Resources, New Brunswick, NJ 08901 USA.	bhattacharya@aesop.rutgers.edu	Yoon, Hwan Su/A-2974-2013; t, lf/AAJ-4924-2020; Duffy, Siobain/A-9104-2009	Duffy, Siobain/0000-0003-0753-223X; Stepanauskas, Ramunas/0000-0003-4458-3108; Yoon, Hwan Su/0000-0001-9507-0105; Yang, Eun Chan/0000-0001-8211-8130	NSF [EF-0827023, DEB-0936884, OCE-0821374, OCE-0623288]; Rural Development Administration, South Korea	NSF(National Science Foundation (NSF)); Rural Development Administration, South Korea(Rural Development Administration (RDA), Republic of Korea)	This project was supported by NSF grants EF-0827023, DEB-0936884, OCE-0821374, and OCE-0623288, and by Nest Generation BioGreen 21 (SSAC, 2011), Rural Development Administration, South Korea. The authors thank J. Heywood and N. Poulton for technical support. The genome sequence of the MS584-5 virus is available in GenBank under the accession number HQ322117, whereas the 454 sequence data from SAG MS584-5 and 454 + Illumina reads from MS584-11 and MS584-22 are available at the NCBI Sequence Read Archive under the accession numbers SRR068243.1, SRR068244.2, and SRR068245.2, respectively. The assembled contigs for each SAG, the phylogenomic results (alignments and trees), singleton hit lists, annotations for the 8334 proteins in the MS584-11 joint assembly, protein alignments used for the trees presented in the paper, and the Paulinella caromatophora plastid sequence and Illumina genome data used to determine the frequency of plastid genes recovered from these reads are freely available at http://dbdata.rutgers.edu/data/pico.	Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Baker BJ, 2010, P NATL ACAD SCI USA, V107, P8806, DOI 10.1073/pnas.0914470107; Bodaker I, 2010, ISME J, V4, P399, DOI 10.1038/ismej.2009.141; Cuvelier ML, 2008, ENVIRON MICROBIOL, V10, P1621, DOI 10.1111/j.1462-2920.2008.01580.x; Evans C, 2008, LIMNOL OCEANOGR, V53, P2035, DOI 10.4319/lo.2008.53.5.2035; Heywood JL, 2011, ISME J, V5, P674, DOI 10.1038/ismej.2010.155; Kim E, 2011, P NATL ACAD SCI USA, V108, P1496, DOI 10.1073/pnas.1013337108; Lovejoy C, 2006, APPL ENVIRON MICROB, V72, P3085, DOI 10.1128/AEM.72.5.3085-3095.2006; Marcy Y, 2007, P NATL ACAD SCI USA, V104, P11889, DOI 10.1073/pnas.0704662104; Moon DA, 1997, CURR GENET, V32, P132, DOI 10.1007/s002940050257; Moustafa A, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-6; Moustafa A, 2009, SCIENCE, V324, P1724, DOI 10.1126/science.1172983; Not F, 2007, SCIENCE, V315, P253, DOI 10.1126/science.1136264; Okamoto N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007080; Reyes-Prieto A, 2008, CURR BIOL, V18, P956, DOI 10.1016/j.cub.2008.05.042; Rodrigue S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006864; Shirai Y, 2008, APPL ENVIRON MICROB, V74, P4022, DOI 10.1128/AEM.00509-08; Stepanauskas R, 2007, P NATL ACAD SCI USA, V104, P9052, DOI 10.1073/pnas.0700496104; Vaishampayan PA, 2010, GENOME BIOL EVOL, V2, P53, DOI 10.1093/gbe/evp057; Williamson SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001456; Worden AZ, 2009, SCIENCE, V324, P268, DOI 10.1126/science.1167222; Woyke T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005299; Zhang K, 2006, NAT BIOTECHNOL, V24, P680, DOI 10.1038/nbt1214	23	213	219	1	93	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 6	2011	332	6030					714	717		10.1126/science.1203163	http://dx.doi.org/10.1126/science.1203163			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759RK	21551060				2022-12-24	WOS:000290265800042
J	Stuber, GD; Sparta, DR; Stamatakis, AM; van Leeuwen, WA; Hardjoprajitno, JE; Cho, S; Tye, KM; Kempadoo, KA; Zhang, F; Deisseroth, K; Bonci, A				Stuber, Garret D.; Sparta, Dennis R.; Stamatakis, Alice M.; van Leeuwen, Wieke A.; Hardjoprajitno, Juanita E.; Cho, Saemi; Tye, Kay M.; Kempadoo, Kimberly A.; Zhang, Feng; Deisseroth, Karl; Bonci, Antonello			Excitatory transmission from the amygdala to nucleus accumbens facilitates reward seeking	NATURE			English	Article							MIDBRAIN DOPAMINE NEURONS; BASOLATERAL AMYGDALA; COCAINE-SEEKING; BEHAVIOR; CORE; RELEASE; DISCONNECTION; INVOLVEMENT; MOTIVATION; INTERFACE	The basolateral amygdala (BLA) has a crucial role in emotional learning irrespective of valence(1-5,21-23). The BLA projection to the nucleus accumbens (NAc) is thought to modulate cue-triggered motivated behaviours(4,6,7,24,25), but our understanding of the interaction between these two brain regions has been limited by the inability to manipulate neural-circuit elements of this pathway selectively during behaviour. To circumvent this limitation, we used in vivo optogenetic stimulation or inhibition of glutamatergic fibres from the BLA to the NAc, coupled with intracranial pharmacology and ex vivo electrophysiology. Here we show that optical stimulation of the pathway from the BLA to the NAc in mice reinforces behavioural responding to earn additional optical stimulation of these synaptic inputs. Optical stimulation of these glutamatergic fibres required intra-NAc dopamine D1-type receptor signalling, but not D2-type receptor signalling. Brief optical inhibition of fibres from the BLA to the NAc reduced cue-evoked intake of sucrose, demonstrating an important role of this specific pathway in controlling naturally occurring reward-related behaviour. Moreover, although optical stimulation of glutamatergic fibres from the medial prefrontal cortex to the NAc also elicited reliable excitatory synaptic responses, optical self-stimulation behaviour was not observed by activation of this pathway. These data indicate that whereas the BLA is important for processing both positive and negative affect, the glutamatergic pathway from the BLA to the NAc, in conjunction with dopamine signalling in the NAc, promotes motivated behavioural responding. Thus, optogenetic manipulation of anatomically distinct synaptic inputs to the NAc reveals functionally distinct properties of these inputs in controlling reward-seeking behaviours.	[Stuber, Garret D.; Sparta, Dennis R.; Stamatakis, Alice M.] Univ N Carolina, UNC Neurosci Ctr, Dept Psychiat, Chapel Hill, NC 27599 USA; [Stuber, Garret D.; Sparta, Dennis R.; Stamatakis, Alice M.] Univ N Carolina, UNC Neurosci Ctr, Dept Cell & Mol Physiol, Chapel Hill, NC 27599 USA; [Stuber, Garret D.; Sparta, Dennis R.; van Leeuwen, Wieke A.; Hardjoprajitno, Juanita E.; Cho, Saemi; Tye, Kay M.; Kempadoo, Kimberly A.; Bonci, Antonello] Univ Calif San Francisco, Wheeler Ctr Neurobiol Drug Addict, Dept Neurol, Ernest Gallo Clin & Res Ctr, San Francisco, CA 94608 USA; [Tye, Kay M.; Zhang, Feng; Deisseroth, Karl] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Tye, Kay M.; Zhang, Feng; Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Bonci, Antonello] NIDA, Intramural Res Program, Baltimore, MD 21224 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center; Stanford University; Stanford University; National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA)	Stuber, GD (corresponding author), Univ N Carolina, UNC Neurosci Ctr, Dept Psychiat, Chapel Hill, NC 27599 USA.	gstuber@med.unc.edu	Macrae, Rhiannon/AAX-1536-2020; , UNC Neuroscience Microscopy Core/AAE-8305-2022; Stuber, Garret/E-1160-2011; Tye, Kay/J-6158-2013; Core, Vector/CAF-4832-2022	Tye, Kay/0000-0002-2435-0182; Stuber, Garret/0000-0003-1730-4855	NARSAD; ABMRF; Foundation of Hope; NIDA [DA029325]; Psychiatry Department at UNC Chapel Hill; State of California through the University of California at San Francisco;  [F32AA018610]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [DP2DK102256] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [F32AA018610] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA032750, R21DA029325] Funding Source: NIH RePORTER	NARSAD(NARSAD); ABMRF; Foundation of Hope; NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Psychiatry Department at UNC Chapel Hill; State of California through the University of California at San Francisco; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank J. Phillips, V. Kharazia, A. Adamantidis and H.-C. Tsai for assistance and advice. We also thank V. Gukassyan and the UNC Neuroscience Center microscopy core facility. This study was supported by funds from NARSAD, ABMRF, The Foundation of Hope, and NIDA (DA029325), by startup funds provided by the Psychiatry Department at UNC Chapel Hill (G. D. S.) and by the State of California through the University of California at San Francisco (A. B.). D. R. S. was supported by F32AA018610.	Ambroggi F, 2008, NEURON, V59, P648, DOI 10.1016/j.neuron.2008.07.004; Aravanis AM, 2007, J NEURAL ENG, V4, pS143, DOI 10.1088/1741-2560/4/3/S02; Balleine BW, 2006, TRENDS NEUROSCI, V29, P272, DOI 10.1016/j.tins.2006.03.002; Bromberg-Martin ES, 2009, NEURON, V63, P119, DOI 10.1016/j.neuron.2009.06.009; CADOR M, 1989, NEUROSCIENCE, V30, P77, DOI 10.1016/0306-4522(89)90354-0; Di Ciano P, 2004, J NEUROSCI, V24, P7167, DOI 10.1523/JNEUROSCI.1581-04.2004; Di Ciano P, 2001, J NEUROSCI, V21, P9471, DOI 10.1523/JNEUROSCI.21-23-09471.2001; Floresco SB, 1998, EUR J NEUROSCI, V10, P1241, DOI 10.1046/j.1460-9568.1998.00133.x; Gradinaru V, 2010, CELL, V141, P154, DOI 10.1016/j.cell.2010.02.037; Jones JL, 2010, BIOL PSYCHIAT, V67, P737, DOI 10.1016/j.biopsych.2009.11.006; Kalivas PW, 2005, NEURON, V45, P647, DOI 10.1016/j.neuron.2005.02.005; LeDoux J, 2003, CELL MOL NEUROBIOL, V23, P727, DOI 10.1023/A:1025048802629; Maren S, 2004, NAT REV NEUROSCI, V5, P844, DOI 10.1038/nrn1535; McFarland K, 2003, J NEUROSCI, V23, P3531; Paton JJ, 2006, NATURE, V439, P865, DOI 10.1038/nature04490; Phillips PEM, 2003, NATURE, V422, P614, DOI 10.1038/nature01566; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Setlow B, 2002, BEHAV NEUROSCI, V116, P267, DOI 10.1037//0735-7044.116.2.267; Shabel SJ, 2009, P NATL ACAD SCI USA, V106, P15031, DOI 10.1073/pnas.0905580106; Shiflett MW, 2010, EUR J NEUROSCI, V32, P1735, DOI 10.1111/j.1460-9568.2010.07439.x; Stuber GD, 2008, SCIENCE, V321, P1690, DOI 10.1126/science.1160873; Tsai HC, 2009, SCIENCE, V324, P1080, DOI 10.1126/science.1168878; Tye KM, 2008, NATURE, V453, P1253, DOI 10.1038/nature06963; Tye KM, 2011, NATURE, V471, P358, DOI 10.1038/nature09820; WRIGHT CI, 1995, J COMP NEUROL, V361, P383, DOI 10.1002/cne.903610304; Zhang F, 2006, NAT METHODS, V3, P785, DOI 10.1038/nmeth936	26	563	579	1	109	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 21	2011	475	7356					377	U129		10.1038/nature10194	http://dx.doi.org/10.1038/nature10194			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794PA	21716290	Green Accepted, Green Submitted			2022-12-24	WOS:000292911200042
J	Garner, EC; Bernard, R; Wang, WQ; Zhuang, XW; Rudner, DZ; Mitchison, T				Garner, Ethan C.; Bernard, Remi; Wang, Wenqin; Zhuang, Xiaowei; Rudner, David Z.; Mitchison, Tim			Coupled, Circumferential Motions of the Cell Wall Synthesis Machinery and MreB Filaments in B. subtilis	SCIENCE			English	Article							ACTIN-LIKE PROTEINS; BACILLUS-SUBTILIS; ESCHERICHIA-COLI; CAULOBACTER-CRESCENTUS; CYTOSKELETON; MORPHOGENESIS; SHAPE; MBL; LOCALIZATION; SEGREGATION	Rod-shaped bacteria elongate by the action of cell wall synthesis complexes linked to underlying dynamic MreB filaments. To understand how the movements of these filaments relate to cell wall synthesis, we characterized the dynamics of MreB and the cell wall elongation machinery using high-precision particle tracking in Bacillus subtilis. We found that MreB and the elongation machinery moved circumferentially around the cell, perpendicular to its length, with nearby synthesis complexes and MreB filaments moving independently in both directions. Inhibition of cell wall synthesis by various methods blocked the movement of MreB. Thus, bacteria elongate by the uncoordinated, circumferential movements of synthetic complexes that insert radial hoops of new peptidoglycan during their transit, possibly driving the motion of the underlying MreB filaments.	[Garner, Ethan C.; Mitchison, Tim] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Bernard, Remi; Rudner, David Z.] Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA; [Wang, Wenqin; Zhuang, Xiaowei] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Zhuang, Xiaowei] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Zhuang, Xiaowei] Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard University; Harvard University; Howard Hughes Medical Institute	Garner, EC (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA.	ethan.garner@hms.harvard.edu; zhuang@chemistry.harvard.edu; rudner@hms.harvard.edu; timothy_mitchison@hms.harvard.edu	Garner, Ethan/J-4025-2014; Wang, Wenqin/E-9418-2012	Garner, Ethan/0000-0003-0141-3555; 	NIH [R01-GM073831, R01-GM096450, R01-GM39565]; Helen Hay Whitney Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073831, R01GM039565, R01GM096450] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Helen Hay Whitney Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank P. Graumman, J. Errington, R. Carballido-Lopez, D. Kearns, D. Popham, and D. Scheffers for strains; D. Kahne, S. Walker, T. Bernhardt, and T. Uehara for discussions; Q. Justman for editing; S. Layer for inspiration; T. Emonet for MicrobeTracker; and the HMS Nikon Imaging Center for the use of their facilites. Funding was provided by NIH grants R01-GM073831 (D.Z.R.), R01-GM096450 (X.Z.), and R01-GM39565 (T.M.). X.Z. is a Howard Hughes Medical Investigator. E.C.G. was supported by the Helen Hay Whitney Foundation.	Bendezu FO, 2009, EMBO J, V28, P193, DOI 10.1038/emboj.2008.264; Carballido-Lopez R, 2003, DEV CELL, V4, P19, DOI 10.1016/S1534-5807(02)00403-3; Carballido-Lopez R, 2006, MICROBIOL MOL BIOL R, V70, P888, DOI 10.1128/MMBR.00014-06; Daniel RA, 2003, CELL, V113, P767, DOI 10.1016/S0092-8674(03)00421-5; Figge RM, 2004, MOL MICROBIOL, V51, P1321, DOI 10.1111/j.1365-2958.2003.03936.x; Gital Z, 2005, CELL, V120, P329, DOI 10.1016/j.cell.2005.01.007; Hayhurst EJ, 2008, P NATL ACAD SCI USA, V105, P14603, DOI 10.1073/pnas.0804138105; Jones LJF, 2001, CELL, V104, P913, DOI 10.1016/S0092-8674(01)00287-2; Kawai Y, 2009, MOL MICROBIOL, V73, P719, DOI 10.1111/j.1365-2958.2009.06805.x; Kim SY, 2006, P NATL ACAD SCI USA, V103, P10929, DOI 10.1073/pnas.0604503103; Kruse T, 2005, MOL MICROBIOL, V55, P78, DOI 10.1111/j.1365-2958.2004.04367.x; Kruse T, 2003, EMBO J, V22, P5283, DOI 10.1093/emboj/cdg504; Mayer JA, 2009, CELL MOTIL CYTOSKEL, V66, P109, DOI 10.1002/cm.20332; Soufo HJD, 2006, MOL MICROBIOL, V62, P1340, DOI 10.1111/j.1365-2958.2006.05457.x; Soufo HJD, 2003, CURR BIOL, V13, P1916, DOI 10.1016/j.cub.2003.10.024; Thompson RE, 2002, BIOPHYS J, V82, P2775, DOI 10.1016/S0006-3495(02)75618-X; Uehara T, 2008, J BACTERIOL, V190, P3914, DOI 10.1128/JB.00207-08; van den Ent F, 2001, NATURE, V413, P39, DOI 10.1038/35092500; White CL, 2010, MOL MICROBIOL, V76, P616, DOI 10.1111/j.1365-2958.2010.07108.x	19	374	379	2	79	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 8	2011	333	6039					222	225		10.1126/science.1203285	http://dx.doi.org/10.1126/science.1203285			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	789GG	21636745	Green Accepted			2022-12-24	WOS:000292502700050
J	Tadmor, AD; Ottesen, EA; Leadbetter, JR; Phillips, R				Tadmor, Arbel D.; Ottesen, Elizabeth A.; Leadbetter, Jared R.; Phillips, Rob			Probing Individual Environmental Bacteria for Viruses by Using Microfluidic Digital PCR	SCIENCE			English	Article							DNA PACKAGING MOTOR; MICROBIAL COMMUNITIES; MOLECULAR ANALYSIS; SEQUENCE; DYNAMICS; TERMITE; ACETOGENESIS; DIVERSITY; SAMPLE; GUT	Viruses may very well be the most abundant biological entities on the planet. Yet neither metagenomic studies nor classical phage isolation techniques have shed much light on the identity of the hosts of most viruses. We used a microfluidic digital polymerase chain reaction (PCR) approach to physically link single bacterial cells harvested from a natural environment with a viral marker gene. When we implemented this technique on the microbial community residing in the termite hindgut, we found genus-wide infection patterns displaying remarkable intragenus selectivity. Viral marker allelic diversity revealed restricted mixing of alleles between hosts, indicating limited lateral gene transfer of these alleles despite host proximity. Our approach does not require culturing hosts or viruses and provides a method for examining virus-bacterium interactions in many environments.	[Tadmor, Arbel D.] CALTECH, Dept Biochem & Mol Biophys, Pasadena, CA 91125 USA; [Ottesen, Elizabeth A.] MIT, Dept Civil & Environm Engn, Cambridge, MA 02139 USA; [Leadbetter, Jared R.] CALTECH, Ronald & Maxine Linde Ctr Global Environm Sci, Pasadena, CA 91125 USA; [Phillips, Rob] CALTECH, Dept Appl Phys, Pasadena, CA 91125 USA; [Phillips, Rob] CALTECH, Dept Bioengn, Pasadena, CA 91125 USA	California Institute of Technology; Massachusetts Institute of Technology (MIT); California Institute of Technology; California Institute of Technology; California Institute of Technology	Tadmor, AD (corresponding author), CALTECH, Dept Biochem & Mol Biophys, Pasadena, CA 91125 USA.	arbel@caltech.edu; phillips@pboc.caltech.edu		Leadbetter, Jared/0000-0002-7033-0844	NIH [R01 GM085286-01S]; U.S. Department of Energy [DE-FG02-07ER64484]; NSF [EF-0523267, CMMI-0758343]; Davidow Family Research Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098465, R01GM085286] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000217] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Energy(United States Department of Energy (DOE)); NSF(National Science Foundation (NSF)); Davidow Family Research Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We wish to thank D. Baltimore, S. Casjens, D. S. Fisher, R. W. Hendrix, H. J. Lee, M. Linden, E. G. Matson, R. Milo, V. J. Orphan, S. R. Quake, A. Z. Rosenthal, E. M. Rubin and colleagues at JGI, D. Z. Soghoian, N. D. Wolfe, D. Wu, X. Zhang, and the anonymous referees for their advice and feedback. We also wish to thank E. G. M. and A. Z. R for their assistance in collection of specimens and E. G. M. for ZAS genomic DNA. This project was supported by the NIH Director's Pioneer Award, NIH American Recovery and Reinvestment Act grant number R01 GM085286-01S, U.S. Department of Energy grant no. DE-FG02-07ER64484, and NSF grant nos. EF-0523267 and CMMI-0758343 and by the Davidow Family Research Fund. GenBank accession numbers are given in table S10.	Acinas SG, 2005, APPL ENVIRON MICROB, V71, P8966, DOI 10.1128/AEM.71.12.8966-8969.2005; Andersson AF, 2008, SCIENCE, V320, P1047, DOI 10.1126/science.1157358; Angly FE, 2006, PLOS BIOL, V4, P2121, DOI 10.1371/journal.pbio.0040368; [Anonymous], 2000, GLOBAL CHANGE HUM HL, DOI [DOI 10.1023/A:1011519513354, 10.1023/A:1011519513354.]; Casjens S, 2003, MOL MICROBIOL, V49, P277, DOI 10.1046/j.1365-2958.2003.03580.x; Casjens SR, 2005, J BACTERIOL, V187, P1091, DOI 10.1128/JB.187.3.1091-1104.2005; CHAI S, 1992, J MOL BIOL, V224, P87, DOI 10.1016/0022-2836(92)90578-8; Dinsdale EA, 2008, NATURE, V452, P629, DOI 10.1038/nature06810; Dube S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002876; Edwards RA, 2005, NAT REV MICROBIOL, V3, P504, DOI 10.1038/nrmicro1163; EPPLER K, 1991, VIROLOGY, V183, P519, DOI 10.1016/0042-6822(91)90981-G; Hamady M, 2010, ISME J, V4, P17, DOI 10.1038/ismej.2009.97; Hongoh Y, 2003, FEMS MICROBIOL ECOL, V44, P231, DOI 10.1016/S0168-6496(03)00026-6; Hugenholtz P, 2002, GENOME BIOL, V3; Kristensen DM, 2010, TRENDS MICROBIOL, V18, P11, DOI 10.1016/j.tim.2009.11.003; Leadbetter JR, 1999, SCIENCE, V283, P686, DOI 10.1126/science.283.5402.686; Lilburn TC, 2001, SCIENCE, V292, P2495, DOI 10.1126/science.1060281; Lindell D, 2007, NATURE, V449, P83, DOI 10.1038/nature06130; Marcy Y, 2007, P NATL ACAD SCI USA, V104, P11889, DOI 10.1073/pnas.0704662104; Martin AP, 2002, APPL ENVIRON MICROB, V68, P3673, DOI 10.1128/AEM.68.8.3673-3682.2002; Mitchell MS, 2002, NUCLEIC ACIDS RES, V30, P4009, DOI 10.1093/nar/gkf524; Moore LR, 1998, NATURE, V393, P464, DOI 10.1038/30965; Moore SD, 2002, CURR BIOL, V12, pR96, DOI 10.1016/S0960-9822(02)00670-X; Ottesen EA, 2006, SCIENCE, V314, P1464, DOI 10.1126/science.1131370; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; Rao VB, 2008, ANNU REV GENET, V42, P647, DOI 10.1146/annurev.genet.42.110807.091545; Rohwer F, 2002, J BACTERIOL, V184, P4529, DOI 10.1128/JB.184.16.4529-4535.2002; Rose TM, 1998, NUCLEIC ACIDS RES, V26, P1628, DOI 10.1093/nar/26.7.1628; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Sullivan MB, 2010, ENVIRON MICROBIOL, V12, P3035, DOI 10.1111/j.1462-2920.2010.02280.x; Sun S, 2008, CELL, V135, P1251, DOI 10.1016/j.cell.2008.11.015; Suttle CA, 2007, NAT REV MICROBIOL, V5, P801, DOI 10.1038/nrmicro1750; Tholen A, 1997, FEMS MICROBIOL ECOL, V24, P137, DOI 10.1016/S0168-6496(97)00053-6; Thompson JR, 2004, APPL ENVIRON MICROB, V70, P4103, DOI 10.1128/AEM.70.7.4103-4110.2004; Warnecke F, 2007, NATURE, V450, P560, DOI 10.1038/nature06269; Warren L, 2006, P NATL ACAD SCI USA, V103, P17807, DOI 10.1073/pnas.0608512103; Williamson SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001456; Zare RN, 2010, ANNU REV BIOMED ENG, V12, P187, DOI 10.1146/annurev-bioeng-070909-105238	38	160	175	1	176	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 1	2011	333	6038					58	62		10.1126/science.1200758	http://dx.doi.org/10.1126/science.1200758			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	785UF	21719670	Green Accepted			2022-12-24	WOS:000292255400046
J	Avrani, S; Wurtzel, O; Sharon, I; Sorek, R; Lindell, D				Avrani, Sarit; Wurtzel, Omri; Sharon, Itai; Sorek, Rotem; Lindell, Debbie			Genomic island variability facilitates Prochlorococcus-virus coexistence	NATURE			English	Article							PHAGE; EVOLUTION; BACTERIAL; ATLANTIC; ECOTYPES; COMMUNITIES; RESISTANCE; ELEMENTS	Prochlorococcus cyanobacteria are extremely abundant in the oceans, as are the viruses that infect them. How hosts and viruses coexist in nature remains unclear, although the presence of both susceptible and resistant cells may allow this coexistence. Combined whole-genome sequencing and PCR screening technology now enables us to investigate the effect of resistance on genome evolution and the genomic mechanisms behind the long-term coexistence of Prochlorococcus and their viruses. Here we present a genome analysis of 77 substrains selected for resistance to ten viruses, revealing mutations primarily in non-conserved, horizontally transferred genes that localize to a single hypervariable genomic island. Mutations affected viral attachment to the cell surface and imposed a fitness cost to the host, manifested by significantly lower growth rates or a previously unknown mechanism of more rapid infection by other viruses. The mutant genes are generally uncommon in nature yet some carry polymorphisms matching those found experimentally. These data are empirical evidence indicating that viral-attachment genes are preferentially located in genomic islands and that viruses are a selective pressure enhancing the diversity of both island genes and island gene content. This diversity emerges as a genomic mechanism that reduces the effective host population size for infection by a given virus, thus facilitating long-term coexistence between viruses and their hosts in nature.	[Avrani, Sarit; Sharon, Itai; Lindell, Debbie] Technion Israel Inst Technol, Fac Biol, IL-32000 Haifa, Israel; [Wurtzel, Omri; Sorek, Rotem] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel	Technion Israel Institute of Technology; Weizmann Institute of Science	Lindell, D (corresponding author), Technion Israel Inst Technol, Fac Biol, IL-32000 Haifa, Israel.	dlindell@tx.technion.ac.il	Wurtzel, Omri/AAG-3985-2019; Sharon, Itai/M-4472-2019	Wurtzel, Omri/0000-0002-6865-5914; Sharon, Itai/0000-0003-0705-2316; Lindell, Debbie/0000-0003-0612-4517	European Commission ERC [203406]; ISF [1504/06]; Technion Russell Berrie Nanotechnology Institute; ISF-FIRST [1615/09]; ERC; Azrieli fellowship	European Commission ERC(European CommissionEuropean Commission Joint Research CentreEuropean Research Council (ERC)); ISF(Israel Science Foundation); Technion Russell Berrie Nanotechnology Institute; ISF-FIRST; ERC(European Research Council (ERC)European Commission); Azrieli fellowship	We thank E. Zinser for the bacterial helper strain; I. Pekarsky for help with adsorption assays; I. Izhaki for advice on statistical analyses; O. Beja, Y. Mandel-Gutfreund, K. Kozek, U. Qimron and Lindell lab members for comments on the manuscript; and T. Dagan for coining the term 'susceptibility region'. Genome sequencing was carried out at the genome sequencing units at the Weizmann Institute of Science and the Technion - Israel Institute of Technology. This work was supported by a European Commission ERC Starting Grant (no. 203406), an ISF Morasha grant (no. 1504/06) and the Technion Russell Berrie Nanotechnology Institute (D. L.); and by an ISF-FIRST grant (no. 1615/09) and an ERC Starting Grant (R. S.). O. W. was supported by an Azrieli fellowship and D. L. is a Shillman fellow.	Bohannan BJM, 2000, ECOL LETT, V3, P362, DOI 10.1046/j.1461-0248.2000.00161.x; Bouman HA, 2006, SCIENCE, V312, P918, DOI 10.1126/science.1122692; Charlebois RL, 2004, GENOME RES, V14, P2469, DOI 10.1101/gr.3024704; Coleman ML, 2006, SCIENCE, V311, P1768, DOI 10.1126/science.1122050; Comeau AM, 2005, CURR OPIN MICROBIOL, V8, P488, DOI 10.1016/j.mib.2005.06.004; Dobrindt U, 2004, NAT REV MICROBIOL, V2, P414, DOI 10.1038/nrmicro884; Dufresne A, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-r90; Fuhrman JA, 2006, P NATL ACAD SCI USA, V103, P13104, DOI 10.1073/pnas.0602399103; Hsiao WWL, 2005, PLOS GENET, V1, P540, DOI 10.1371/journal.pgen.0010062; Johnson ZI, 2006, SCIENCE, V311, P1737, DOI 10.1126/science.1118052; Kettler GC, 2007, PLOS GENET, V3, P2515, DOI 10.1371/journal.pgen.0030231; Langille MGI, 2010, NAT REV MICROBIOL, V8, P372, DOI 10.1038/nrmicro2350; LENSKI RE, 1985, AM NAT, V125, P585, DOI 10.1086/284364; Luria SE, 1943, GENETICS, V28, P491; Lythgoe KA, 2003, ECOL LETT, V6, P326, DOI 10.1046/j.1461-0248.2003.00433.x; Malmstrom RR, 2010, ISME J, V4, P1252, DOI 10.1038/ismej.2010.60; Moore LR, 1998, NATURE, V393, P464, DOI 10.1038/30965; Palenik B, 2003, NATURE, V424, P1037, DOI 10.1038/nature01943; Parsons YN, 2003, ARCH MICROBIOL, V179, P214, DOI 10.1007/s00203-003-0518-7; Partensky F, 1999, MICROBIOL MOL BIOL R, V63, P106, DOI 10.1128/MMBR.63.1.106-127.1999; Rocap G, 2003, NATURE, V424, P1042, DOI 10.1038/nature01947; Rodriguez-Valera F, 2009, NAT REV MICROBIOL, V7, P828, DOI 10.1038/nrmicro2235; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Somova A G, 1966, Biull Eksp Biol Med, V31, P99; Stern A, 2011, BIOESSAYS, V33, P43, DOI 10.1002/bies.201000071; Stoddard LI, 2007, APPL ENVIRON MICROB, V73, P5516, DOI 10.1128/AEM.00356-07; Sullivan MB, 2010, ENVIRON MICROBIOL, V12, P3035, DOI 10.1111/j.1462-2920.2010.02280.x; Sullivan MB, 2003, NATURE, V424, P1047, DOI 10.1038/nature01929; Suttle CA, 2005, NATURE, V437, P356, DOI 10.1038/nature04160; Thingstad TF, 2000, LIMNOL OCEANOGR, V45, P1320, DOI 10.4319/lo.2000.45.6.1320; Walker CB, 2009, ENVIRON MICROBIOL, V11, P2244, DOI 10.1111/j.1462-2920.2009.01946.x; WATERBURY JB, 1993, APPL ENVIRON MICROB, V59, P3393, DOI 10.1128/AEM.59.10.3393-3399.1993; Yooseph S, 2007, PLOS BIOL, V5, P432, DOI 10.1371/journal.pbio.0050016; Zwirglmaier K, 2007, ENVIRON MICROBIOL, V9, P1278, DOI 10.1111/j.1462-2920.2007.01246.x	34	192	197	5	90	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 30	2011	474	7353					604	608		10.1038/nature10172	http://dx.doi.org/10.1038/nature10172			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	785CF	21720364				2022-12-24	WOS:000292204300031
J	Kwon, HB; Sabatini, BL				Kwon, Hyung-Bae; Sabatini, Bernardo L.			Glutamate induces de novo growth of functional spines in developing cortex	NATURE			English	Article							HIPPOCAMPAL SLICE CULTURES; SINGLE DENDRITIC SPINES; SYNAPSE FORMATION; PYRAMIDAL NEURONS; ADULT CORTEX; IN-VIVO; PLASTICITY; SYNAPTOGENESIS; ACTIVATION; MATURATION	Mature cortical pyramidal neurons receive excitatory inputs onto small protrusions emanating from their dendrites called spines. Spines undergo activity-dependent remodelling, stabilization and pruning during development, and similar structural changes can be triggered by learning and changes in sensory experiences(1-4). However, the biochemical triggers and mechanisms of de novo spine formation in the developing brain and the functional significance of new spines to neuronal connectivity are largely unknown. Here we develop an approach to induce and monitor de novo spine formation in real time using combined two-photon laser-scanning microscopy and two-photon laser uncaging of glutamate. Our data demonstrate that, in mouse cortical layer 2/3 pyramidal neurons, glutamate is sufficient to trigger de novo spine growth from the dendrite shaft in a location-specific manner. We find that glutamate-induced spinogenesis requires opening of NMDARs (N-methyl-D-aspartate-type glutamate receptors) and activation of protein kinase A (PKA) but is independent of calcium-calmodulin-dependent kinase II (CaMKII) and tyrosine kinase receptor B (TrkB) receptors. Furthermore, newly formed spines express glutamate receptors and are rapidly functional such that they transduce presynaptic activity into postsynaptic signals. Together, our data demonstrate that early neural connectivity is shaped by activity in a spatially precise manner and that nascent dendrite spines are rapidly functionally incorporated into cortical circuits.	[Kwon, Hyung-Bae; Sabatini, Bernardo L.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Sabatini, BL (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Neurobiol, Boston, MA 02115 USA.	bsabatini@hms.harvard.edu			Simons Foundation; National Institute of Neurological Disorders and Stroke [NS046579]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046579] Funding Source: NIH RePORTER	Simons Foundation; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank members of the Sabatini laboratory for their comments on the manuscript and assistance with data analysis. We are grateful to S. Nazia for technical support and for acting as the blind evaluator. This work was supported by a SFARI grant from the Simons Foundation and the National Institute of Neurological Disorders and Stroke (NS046579).	Busetto G, 2008, J PHYSIOL-LONDON, V586, P1519, DOI 10.1113/jphysiol.2007.149336; Chalifoux JR, 2010, NEURON, V66, P101, DOI 10.1016/j.neuron.2010.03.012; Dalva MB, 2007, NAT REV NEUROSCI, V8, P206, DOI 10.1038/nrn2075; De Roo M, 2008, CEREB CORTEX, V18, P151, DOI 10.1093/cercor/bhm041; Di Cristo G, 2001, SCIENCE, V292, P2337, DOI 10.1126/science.1059075; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Fiala JC, 1998, J NEUROSCI, V18, P8900; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; HAMORI J, 1973, BRAIN RES, V62, P337, DOI 10.1016/0006-8993(73)90694-X; Harvey CD, 2008, SCIENCE, V321, P136, DOI 10.1126/science.1159675; Harvey CD, 2007, NATURE, V450, P1195, DOI 10.1038/nature06416; Hofer SB, 2009, NATURE, V457, P313, DOI 10.1038/nature07487; Knott GW, 2006, NAT NEUROSCI, V9, P1117, DOI 10.1038/nn1747; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; MILLER M, 1981, J COMP NEUROL, V203, P555, DOI 10.1002/cne.902030402; Nagerl UV, 2007, J NEUROSCI, V27, P8149, DOI 10.1523/JNEUROSCI.0511-07.2007; RAKIC P, 1986, SCIENCE, V232, P232, DOI 10.1126/science.3952506; Richards DA, 2005, P NATL ACAD SCI USA, V102, P6166, DOI 10.1073/pnas.0501881102; Scheiffele P, 2003, ANNU REV NEUROSCI, V26, P485, DOI 10.1146/annurev.neuro.26.043002.094940; Skeberdis VA, 2006, NAT NEUROSCI, V9, P501, DOI 10.1038/nn1664; Sorra KE, 1998, J COMP NEUROL, V398, P225; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Tanaka JI, 2008, SCIENCE, V319, P1683, DOI 10.1126/science.1152864; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Yasuda H, 2003, NAT NEUROSCI, V6, P15, DOI 10.1038/nn985; Yuste R, 2004, NAT REV NEUROSCI, V5, P24, DOI 10.1038/nrn1300; Zaccolo M, 2002, SCIENCE, V295, P1711, DOI 10.1126/science.1069982; Zito K, 2009, NEURON, V61, P247, DOI 10.1016/j.neuron.2008.10.054; Zuo Y, 2005, NATURE, V436, P261, DOI 10.1038/nature03715	30	249	251	0	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 2	2011	474	7349					100	104		10.1038/nature09986	http://dx.doi.org/10.1038/nature09986			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	771KV	21552280	Green Accepted			2022-12-24	WOS:000291156700046
J	Muller, J; Hipsley, CA; Head, JJ; Kardjilov, N; Hilger, A; Wuttke, M; Reisz, RR				Mueller, Johannes; Hipsley, Christy A.; Head, Jason J.; Kardjilov, Nikolay; Hilger, Andre; Wuttke, Michael; Reisz, Robert R.			Eocene lizard from Germany reveals amphisbaenian origins	NATURE			English	Article							SQUAMATE REPTILES; BODY-FORM; PHYLOGENETIC ANALYSIS; MIDDLE-EOCENE; EVOLUTION; SNAKES; SYSTEMATICS; RESOLUTION; POSITION	Amphisbaenia is a speciose clade of fossorial lizards characterized by a snake-like body and a strongly reinforced skull adapted for head-first burrowing(1,2). The evolutionary origins of amphisbaenians are controversial, with molecular data uniting them with lacertids(3,4), a clade of Old World terrestrial lizards, whereas morphology supports a grouping with snakes and other limbless squamates(5-9). Reports of fossil stem amphisbaenians(10) have been falsified(11), and no fossils have previously tested these competing phylogenetic hypotheses or shed light on ancestral amphisbaenian ecology. Here we report the discovery of a new lacertid-like lizard from the Eocene Messel locality of Germany that provides the first morphological evidence for lacertid-amphisbaenian monophyly on the basis of a reinforced, akinetic skull roof and braincase, supporting the view that body elongation and limblessness in amphisbaenians and snakes evolved independently. Morphometric analysis of body shape and ecology in squamates indicates that the postcranial anatomy of the new taxon is most consistent with opportunistically burrowing habits, which in combination with cranial reinforcement indicates that head-first burrowing evolved before body elongation and may have been a crucial first step in the evolution of amphisbaenian fossoriality.	[Mueller, Johannes; Hipsley, Christy A.] Humboldt Univ, Leibniz Inst Evolut & Biodiversitatsforsch, Museum Nat Kunde, D-10115 Berlin, Germany; [Hipsley, Christy A.] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA; [Head, Jason J.; Reisz, Robert R.] Univ Toronto, Dept Biol, Mississauga, ON L5L 1C6, Canada; [Kardjilov, Nikolay; Hilger, Andre] Helmholtz Zentrum Berlin Mat & Energie, D-14109 Berlin, Germany; [Wuttke, Michael] Gen Direkt Kulturelles Erbe RLP, Direkt Landesarchaol, D-55116 Mainz, Germany	Humboldt University of Berlin; Leibniz Institut fur Evolutions und Biodiversitatsforschung; University of California System; University of California Santa Cruz; University of Toronto; University Toronto Mississauga; Helmholtz Association; Helmholtz-Zentrum fuer Materialien und Energie GmbH (HZB)	Muller, J (corresponding author), Humboldt Univ, Leibniz Inst Evolut & Biodiversitatsforsch, Museum Nat Kunde, Invalidenstr 43, D-10115 Berlin, Germany.	johannes.mueller@mfn-berlin.de	Müller, Johannes/A-6293-2017; Kardjilov, Nikolay/AAX-9855-2021	Müller, Johannes/0000-0001-5801-856X; Kardjilov, Nikolay/0000-0002-0980-1440; Hilger, Andre/0000-0002-6454-7967; Hipsley, Christy/0000-0002-5740-9363	Natural Sciences and Engineering Research Council of Canada; Alexander von Humboldt-Stiftung	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Alexander von Humboldt-Stiftung(Alexander von Humboldt Foundation)	We thank S. Schaal for making the specimen available for study, J. J. Wiens for providing his morphometric data set of extant squamates, J. L. Conrad for providing his morphological data set of fossil and extant squamates, I. Manke for technical and administrative support, H. Mewis, H. Stohr and A. Paulke for technical support, C. Bell and D. Evans for discussion, and P. Holroyd, M. Kroniger, M. Cunningham, M.-O. Rodel, K. Seymour, H.-D. Sues and F. Tillack for access to specimens. J.J.H. was funded by Natural Sciences and Engineering Research Council of Canada Discovery and Research Tools and Instruments grants, R.R.R. was funded by a Natural Sciences and Engineering Research Council of Canada Discovery grant and the Alexander von Humboldt-Stiftung.	BERMAN DS, 1977, J PALEONTOL, V51, P986; BERMAN DS, 1973, COPEIA, P704; Brandley MC, 2008, EVOLUTION, V62, P2042, DOI 10.1111/j.1558-5646.2008.00430.x; Conrad JL, 2008, B AM MUS NAT HIST, P1, DOI 10.1206/310.1; Estes R., 1988, P119; Estes R., 1983, HDB PALAOHERPETOL 10; Evans SE, 1998, ZOOL J LINN SOC-LOND, V124, P235, DOI 10.1006/zjls.1997.0139; Franzen J. L., 1982, COUR FORSCH I SENCKE, V54, P12; GANS C, 1975, AM ZOOL, V15, P455; Gans C., 2008, BIOL REPTILIA MORPHO, P621; GREER AE, 1991, J HERPETOL, V25, P166, DOI 10.2307/1564644; Hallermann J, 1998, ZOOL J LINN SOC-LOND, V122, P385, DOI 10.1006/zjls.1996.0109; Hipsley CA, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-151; Kearney M, 2005, J MORPHOL, V264, P1, DOI 10.1002/jmor.10210; Kearney M, 2003, HERPETOL MONOGR, V17, P1, DOI 10.1655/0733-1347(2003)017[0001:SOTALB]2.0.CO;2; Kearney M, 2003, J VERTEBR PALEONTOL, V23, P394, DOI 10.1671/0272-4634(2003)023[0394:TPPOSH]2.0.CO;2; Lee MSY, 2009, J EVOLUTION BIOL, V22, P1308, DOI 10.1111/j.1420-9101.2009.01751.x; Lee MSY, 1998, BIOL J LINN SOC, V65, P369, DOI 10.1111/j.1095-8312.1998.tb01148.x; Muller J, 2001, J VERTEBR PALEONTOL, V21, P261, DOI 10.1671/0272-4634(2001)021[0261:OAROER]2.0.CO;2; Popov S.V., 2004, COUR FORSCH I SENCKE, V250, P1; RIEPPEL O, 1988, EVOL BIOL, V22, P37; Rieppel O, 2007, J PALEONTOL, V81, P760, DOI 10.1666/pleo0022-3360(2007)081[0760:NMDFEK]2.0.CO;2; The Deep Scaly Project, 2008, RHIN FLOR FLOR WORM; Townsend TM, 2004, SYST BIOL, V53, P735, DOI 10.1080/10635150490522340; Vidal N, 2005, CR BIOL, V328, P1000, DOI 10.1016/j.crvi.2005.10.001; Weber Sinje, 2004, Abhandlungen der Senckenbergischen Naturforschenden Gesellschaft, V561, P1; Wiens JJ, 2006, EVOLUTION, V60, P123, DOI 10.1111/j.0014-3820.2006.tb01088.x; Wiens JJ, 2001, EVOLUTION, V55, P2303; Wiens JJ, 2010, SYST BIOL, V59, P674, DOI 10.1093/sysbio/syq048; WU XC, 1993, NATURE, V366, P57, DOI 10.1038/366057a0	30	72	76	0	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 19	2011	473	7347					364	367		10.1038/nature09919	http://dx.doi.org/10.1038/nature09919			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765QA	21593869				2022-12-24	WOS:000290722400046
J	Liu, YY; Slotine, JJ; Barabasi, AL				Liu, Yang-Yu; Slotine, Jean-Jacques; Barabasi, Albert-Laszlo			Controllability of complex networks	NATURE			English	Article							CONTRACTION ANALYSIS; PERCOLATION	The ultimate proof of our understanding of natural or technological systems is reflected in our ability to control them. Although control theory offers mathematical tools for steering engineered and natural systems towards a desired state, a framework to control complex self-organized systems is lacking. Here we develop analytical tools to study the controllability of an arbitrary complex directed network, identifying the set of driver nodes with time-dependent control that can guide the system's entire dynamics. We apply these tools to several real networks, finding that the number of driver nodes is determined mainly by the network's degree distribution. We show that sparse inhomogeneous networks, which emerge in many real complex systems, are the most difficult to control, but that dense and homogeneous networks can be controlled using a few driver nodes. Counterintuitively, we find that in both model and real systems the driver nodes tend to avoid the high-degree nodes.	[Liu, Yang-Yu; Barabasi, Albert-Laszlo] Northeastern Univ, Ctr Complex Network Res, Boston, MA 02115 USA; [Liu, Yang-Yu; Barabasi, Albert-Laszlo] Northeastern Univ, Dept Phys, Boston, MA 02115 USA; [Liu, Yang-Yu; Barabasi, Albert-Laszlo] Northeastern Univ, Dept Comp Sci & Biol, Boston, MA 02115 USA; [Liu, Yang-Yu; Barabasi, Albert-Laszlo] Dana Farber Canc Inst, Ctr Canc Syst Biol, Boston, MA 02115 USA; [Slotine, Jean-Jacques] MIT, Nonlinear Syst Lab, Cambridge, MA 02139 USA; [Slotine, Jean-Jacques] MIT, Dept Mech Engn, Cambridge, MA 02139 USA; [Slotine, Jean-Jacques] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Barabasi, Albert-Laszlo] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA	Northeastern University; Northeastern University; Northeastern University; Harvard University; Dana-Farber Cancer Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Brigham & Women's Hospital; Harvard Medical School	Barabasi, AL (corresponding author), Northeastern Univ, Ctr Complex Network Res, Boston, MA 02115 USA.	alb@neu.edu	Barabasi, Albert-Laszlo/S-6474-2017; Liu, Yang-Yu/G-8885-2011	Liu, Yang-Yu/0000-0003-2728-4907; Barabasi, Albert/0000-0002-4028-3522	US Army Research Laboratory [W911NF-09-2-0053]; Office of Naval Research [N000141010968]; Defense Threat Reduction Agency [WMD BRBAA07-J-2-0035, BRBAA08-Per4-C-2-0033]; James S. McDonnell Foundation 21st Century Initiative in Studying Complex Systems	US Army Research Laboratory(United States Department of DefenseUS Army Research Laboratory (ARL)); Office of Naval Research(Office of Naval Research); Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); James S. McDonnell Foundation 21st Century Initiative in Studying Complex Systems	We thank C. Song, G. Bianconi, H. Zhou, L. Vepstas, N. Gulbahce, H. Jeong, Y.-Y. Ahn, B. Barzel, N. Blumm, D. Wang, Z. Qu and Y. Li for discussions. This work was supported by the Network Science Collaborative Technology Alliance sponsored by the US Army Research Laboratory under Agreement Number W911NF-09-2-0053; the Office of Naval Research under Agreement Number N000141010968; the Defense Threat Reduction Agency awards WMD BRBAA07-J-2-0035 and BRBAA08-Per4-C-2-0033; and the James S. McDonnell Foundation 21st Century Initiative in Studying Complex Systems.	Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; [Anonymous], [No title captured]; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bauer M, 2001, EUR PHYS J B, V24, P339, DOI 10.1007/s10051-001-8683-4; Boguna M, 2004, EUR PHYS J B, V38, P205, DOI 10.1140/epjb/e2004-00038-8; Bollobas B., 2001, RANDOM GRAPHS; Caldarelli G., 2007, SCALE FREE NETWORKS; Callaway DS, 2000, PHYS REV LETT, V85, P5468, DOI 10.1103/PhysRevLett.85.5468; Chiang M, 2007, P IEEE, V95, P255, DOI 10.1109/JPROC.2006.887322; Chung F., 2002, ANN COMB, V6, P125, DOI [10.1007/PL00012580, 10.1007/PL00012580.pdf, DOI 10.1007/PL00012580.PDF]; Cohen R, 2000, PHYS REV LETT, V85, P4626, DOI 10.1103/PhysRevLett.85.4626; Dorogovtsev SN, 2003, EVOLUTION NETWORKS B; ERDOS P, 1960, B INT STATIST INST, V38, P343; Goh KI, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.278701; Hopcroft J. E., 1973, SIAM Journal on Computing, V2, P225, DOI 10.1137/0202019; Kalman R. E., 1963, SIAM J CONTROL     A, V1, P152, DOI [DOI 10.1137/0301010, 10.1137/0301010]; Kelly FP, 1998, J OPER RES SOC, V49, P237, DOI 10.1057/palgrave.jors.2600523; Kim DH, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/11/113047; Lezon TR, 2006, P NATL ACAD SCI USA, V103, P19033, DOI 10.1073/pnas.0609152103; LIN CT, 1974, IEEE T AUTOMAT CONTR, VAC19, P201, DOI 10.1109/TAC.1974.1100557; Liu B, 2008, IEEE T AUTOMAT CONTR, V53, P1009, DOI 10.1109/TAC.2008.919548; Lohmiller W, 1998, AUTOMATICA, V34, P683, DOI 10.1016/S0005-1098(98)00019-3; Lombardi A, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.056110; Lovasz Laszlo, 2009, MATCHING THEORY, V367; Luenberger D. G., 1979, INTRO DYNAMIC SYSTEM; Marucci L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008083; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Mesbahi M, 2010, GRAPH THEORETIC METHODS IN MULTIAGENT NETWORKS, P1; Mezard M, 2001, EUR PHYS J B, V20, P217, DOI 10.1007/PL00011099; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Motter AE, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.1; Newman MEJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.208701; Nishikawa T, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.014101; Ou-Yang Zhong-can, 2003, MAXIMUM MATCHING RAN; Pastor-Satorras R, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.258701; Pastor-Satorras R, 2001, PHYS REV LETT, V86, P3200, DOI 10.1103/PhysRevLett.86.3200; Pastor-Satorras R, 2004, EVOLUTION STRUCTURE; Rahman A, 2009, SIAM J CONTROL OPTIM, V48, P162, DOI 10.1137/060674909; SHIELDS RW, 1976, IEEE T AUTOMAT CONTR, V21, P203, DOI 10.1109/TAC.1976.1101198; Slotine J.J.E., 1991, APPL NONLINEAR CONTR; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725; Tanner HG, 2004, IEEE DECIS CONTR P, P2467, DOI 10.1109/CDC.2004.1428782; Wang W, 2005, BIOL CYBERN, V92, P38, DOI 10.1007/s00422-004-0527-x; Wang XF, 2002, PHYSICA A, V310, P521, DOI 10.1016/S0378-4371(02)00772-0; Yu WW, 2010, IEEE T SYST MAN CY B, V40, P881, DOI 10.1109/TSMCB.2009.2031624; Yu WW, 2009, AUTOMATICA, V45, P429, DOI 10.1016/j.automatica.2008.07.016; Zdeborova L, 2006, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2006/05/P05003	50	1980	2071	28	720	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 12	2011	473	7346					167	173		10.1038/nature10011	http://dx.doi.org/10.1038/nature10011			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	762NT	21562557				2022-12-24	WOS:000290487200029
J	Velasquez, SM; Ricardi, MM; Dorosz, JG; Fernandez, PV; Nadra, AD; Pol-Fachin, L; Egelund, J; Gille, S; Harholt, J; Ciancia, M; Verli, H; Pauly, M; Bacic, A; Olsen, CE; Ulvskov, P; Petersen, BL; Somerville, C; Iusem, ND; Estevez, JM				Velasquez, Silvia M.; Ricardi, Martiniano M.; Dorosz, Javier Gloazzo; Fernandez, Paula V.; Nadra, Alejandro D.; Pol-Fachin, Laercio; Egelund, Jack; Gille, Sascha; Harholt, Jesper; Ciancia, Marina; Verli, Hugo; Pauly, Markus; Bacic, Antony; Olsen, Carl Erik; Ulvskov, Peter; Petersen, Bent Larsen; Somerville, Chris; Iusem, Norberto D.; Estevez, Jose M.			O-Glycosylated Cell Wall Proteins Are Essential in Root Hair Growth	SCIENCE			English	Article							MOLECULAR CHARACTERIZATION; PROLYL 4-HYDROXYLASE; ARABIDOPSIS; EXTENSIN; GENES; CODES; IDENTIFICATION; REQUIRES; MUTANTS; TOBACCO	Root hairs are single cells that develop by tip growth and are specialized in the absorption of nutrients. Their cell walls are composed of polysaccharides and hydroxyproline-rich glycoproteins (HRGPs) that include extensins (EXTs) and arabinogalactan-proteins (AGPs). Proline hydroxylation, an early posttranslational modification of HRGPs that is catalyzed by prolyl 4-hydroxylases (P4Hs), defines the subsequent O-glycosylation sites in EXTs (which are mainly arabinosylated) and AGPs (which are mainly arabinogalactosylated). We explored the biological function of P4Hs, arabinosyltransferases, and EXTs in root hair cell growth. Biochemical inhibition or genetic disruption resulted in the blockage of polarized growth in root hairs and reduced arabinosylation of EXTs. Our results demonstrate that correct O-glycosylation on EXTs is essential for cell-wall self-assembly and, hence, root hair elongation in Arabidopsis thaliana.	[Velasquez, Silvia M.; Ricardi, Martiniano M.; Dorosz, Javier Gloazzo; Iusem, Norberto D.; Estevez, Jose M.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Consejo Nacl Invest Cient & Tecn IFIByNE CONICET, Inst Fisiol Biol Mol & Neurociencias, Buenos Aires, DF, Argentina; [Fernandez, Paula V.; Ciancia, Marina] Univ Buenos Aires, Fac Agron, Ctr Invest Hidratos Carbono CONICET, Dept Biol Aplicada & Alimentos,Catedra Quim Biomo, Buenos Aires, DF, Argentina; [Nadra, Alejandro D.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Biol, Buenos Aires, DF, Argentina; [Pol-Fachin, Laercio; Verli, Hugo] Univ Fed Rio Grande do Sul, Fac Farm, BR-90610000 Porto Alegre, RS, Brazil; [Egelund, Jack; Harholt, Jesper; Ulvskov, Peter; Petersen, Bent Larsen] Univ Copenhagen, Fac Life Sci, Dept Plant Biol & Biotechnol, DK-1871 Copenhagen, Denmark; [Gille, Sascha; Pauly, Markus; Somerville, Chris] Univ Calif Berkeley, Energy Biosci Inst, Berkeley, CA 94720 USA; [Bacic, Antony] Univ Melbourne, Sch Bot, Plant Cell Biol Res Ctr, Melbourne, Vic 3010, Australia; [Olsen, Carl Erik] Univ Copenhagen, Fac Life Sci, Dept Nat Sci, DK-1871 Copenhagen, Denmark; [Iusem, Norberto D.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, LFBM, Dept Fisiol Biol Mol & Celular, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; University of Buenos Aires; Universidade Federal do Rio Grande do Sul; University of Copenhagen; University of California System; University of California Berkeley; University of Melbourne; University of Copenhagen; University of Buenos Aires	Estevez, JM (corresponding author), Univ Buenos Aires, Fac Ciencias Exactas & Nat, Consejo Nacl Invest Cient & Tecn IFIByNE CONICET, Inst Fisiol Biol Mol & Neurociencias, C1428EGA, Buenos Aires, DF, Argentina.	jestevez@fbmc.fcen.uba.ar	Estevez, Jose Manuel/AAZ-9261-2020; Harholt, Jesper/F-3760-2011; Pauly, Markus/B-5895-2008; Estevez, Jose Manuel/C-2915-2018; Olsen, Carl E/H-3031-2014; Harholt, Jesper/F-6865-2014; Verli, Hugo/AAZ-2148-2021; Nadra, Alejandro/A-5668-2009; Ulvskov, Peter/I-1228-2014; Petersen, Bent/H-9437-2014; Verli, Hugo/G-8703-2012; Somerville, Christopher R/A-4048-2009	Estevez, Jose Manuel/0000-0001-6332-7738; Pauly, Markus/0000-0002-3116-2198; Estevez, Jose Manuel/0000-0001-6332-7738; Olsen, Carl E/0000-0002-2275-0596; Harholt, Jesper/0000-0002-7984-0066; Nadra, Alejandro/0000-0002-7860-3245; Ulvskov, Peter/0000-0003-3776-818X; Petersen, Bent/0000-0002-2004-9077; Verli, Hugo/0000-0002-4796-8620; Somerville, Christopher R/0000-0003-4647-0094; Ricardi, Martiniano/0000-0002-7904-6305; Iusem, Norberto/0000-0002-3052-2489; Bacic, Tony/0000-0001-7483-8605	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) [PICT2007-732, PICT2006-983]; CONICET [PIP2812, PIP0890, PIP0071]; Danish Agency for Science Technology and Innovation [274-09-0082, 2101-07-0071]; Australian Research Council; Conselho Nacional de Desinvolvimento Cientific e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); U.S. Department of Energy [DOE-FG02-03ER20133]; Energy Biosciences Institute; Villum Fonden [00007173] Funding Source: researchfish	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT)(ANPCyT); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Danish Agency for Science Technology and Innovation; Australian Research Council(Australian Research Council); Conselho Nacional de Desinvolvimento Cientific e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); U.S. Department of Energy(United States Department of Energy (DOE)); Energy Biosciences Institute; Villum Fonden(Villum Fonden)	We thank R. A. Fernandez for his assistance in confocal microscopy, S. Maldonado and S. Petrucelli for providing the access to a stereoscope, and A. Nebenfuhr for providing vectors of the ER and Golgi markers. This work was supported by grants from Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) (PICT2007-732 and PICT2006-983) and CONICET (PIP2812, PIP0890, and PIP0071) to A.D.N., N.D.I., and J.M.E.; from the Danish Agency for Science Technology and Innovation from the Danish Agency for Science Technology and Innovation (274-09-0082, 2101-07-0071) to J.E, P.U., and B.L.P; from the Australian Research Council to A.B.; and Conselho Nacional de Desinvolvimento Cientific e Tecnologico (CNPq) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) to L.F. and H.V. We thank Arabidopsis Biological Resource Center (Ohio University) for providing T-DNA lines seed lines. Thanks to K. Kobayashi and M. Otegui for critical reading of the manuscript. This work was partially supported by a grant from the U.S. Department of Energy (DOE-FG02-03ER20133) and funding from the Energy Biosciences Institute to C.S. S.M.V. performed most of the experiments. M.M.R. analyzed and performed some of the experiments and analyzed the data. J.G.D. performed some of the experiments. P.V.F and M.C. quantified Hyp in mutants and transgenic lines. S.G. and M.P. provided the XEG113-GFP data and xeg113-2 mutant. A.D.N. performed molecular modeling of P4Hs. L.F. and H.V. measured the molecular dynamics of EXT peptides. J.E. and A.B. assessed the Golgi localization of RRAs proteins. C.E.O., P.U., and B.L.P. characterized rra3 and xeg113 EXTs using ESI-MS, and P.U. and B.L.P. isolated rra1-3 RNAi and rra3 mutants. C.S. analyzed the data. N.D.I. analyzed the data and wrote the paper. J.M.E. designed research, performed most of the experiments, analyzed the data, supervised the project, and wrote the paper. The authors declare no competing financial interests.	BARNETT NM, 1970, PLANT PHYSIOL, V45, P188, DOI 10.1104/pp.45.2.188; Baumberger N, 2003, PLANT PHYSIOL, V131, P1313, DOI 10.1104/pp.102.014928; Baumberger N, 2003, PLANT J, V35, P71, DOI 10.1046/j.1365-313X.2003.01784.x; Birnbaum K, 2003, SCIENCE, V302, P1956, DOI 10.1126/science.1090022; Brady SM, 2007, SCIENCE, V318, P801, DOI 10.1126/science.1146265; Cannon MC, 2008, P NATL ACAD SCI USA, V105, P2226, DOI 10.1073/pnas.0711980105; Cosgrove DJ, 2005, NAT REV MOL CELL BIO, V6, P850, DOI 10.1038/nrm1746; Egelund J, 2007, PLANT MOL BIOL, V64, P439, DOI 10.1007/s11103-007-9162-y; Estevez JM, 2006, PLANT PHYSIOL, V142, P458, DOI 10.1104/pp.106.084244; Gille S, 2009, P NATL ACAD SCI USA, V106, P14699, DOI 10.1073/pnas.0905434106; Held MA, 2004, J BIOL CHEM, V279, P55474, DOI 10.1074/jbc.M408396200; Immerzeel P, 2006, PHYSIOL PLANTARUM, V128, P18, DOI 10.1111/j.1399-3054.2006.00712.x; KIELISZEWSKI MJ, 1994, PLANT J, V5, P157, DOI 10.1046/j.1365-313X.1994.05020157.x; Kieliszewski MJ, 2001, PHYTOCHEMISTRY, V57, P319, DOI 10.1016/S0031-9422(01)00029-2; Lamport DTA, 2011, PLANT PHYSIOL, V156, P11, DOI 10.1104/pp.110.169011; MAJAMAA K, 1986, J BIOL CHEM, V261, P7819; Owens NW, 2010, J AM CHEM SOC, V132, P5036, DOI 10.1021/ja905724d; Petersen B. L., 2011, ANN PLANT REV, V41, P305; Price NJ, 2003, J BIOL CHEM, V278, P41389, DOI 10.1074/jbc.M304519200; Ringli C, 2010, PLANT J, V63, P662, DOI 10.1111/j.1365-313X.2010.04270.x; Ritzenthaler C, 2002, PLANT CELL, V14, P237, DOI 10.1105/tpc.010237; Showalter AM, 2010, PLANT PHYSIOL, V153, P485, DOI 10.1104/pp.110.156554; Shpak E, 1999, P NATL ACAD SCI USA, V96, P14736, DOI 10.1073/pnas.96.26.14736; Somerville C, 2004, SCIENCE, V306, P2206, DOI 10.1126/science.1102765; STAFSTROM JP, 1986, PLANT PHYSIOL, V81, P242, DOI 10.1104/pp.81.1.242; Tiainen P, 2005, J BIOL CHEM, V280, P1142, DOI 10.1074/jbc.M411109200; Valentin R, 2010, LANGMUIR, V26, P9891, DOI 10.1021/la100265d; Won SK, 2009, PLANT PHYSIOL, V150, P1459, DOI 10.1104/pp.109.140905; Xu JF, 2008, PHYTOCHEMISTRY, V69, P1631, DOI 10.1016/j.phytochem.2008.02.006; Yi K, 2010, NAT GENET, V42, P264, DOI 10.1038/ng.529; Yuasa K, 2005, PLANT J, V41, P81, DOI 10.1111/j.1365-313X.2004.02279.x	31	202	219	6	116	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 17	2011	332	6036					1401	1403		10.1126/science.1206657	http://dx.doi.org/10.1126/science.1206657			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778FT	21680836				2022-12-24	WOS:000291689000033
J	Clements, WK; Kim, AD; Ong, KG; Moore, JC; Lawson, ND; Traver, D				Clements, Wilson K.; Kim, Albert D.; Ong, Karen G.; Moore, John C.; Lawson, Nathan D.; Traver, David			A somitic Wnt16/Notch pathway specifies haematopoietic stem cells	NATURE			English	Article							AORTIC ENDOTHELIUM; DEFINITIVE HEMATOPOIESIS; EMBRYONIC HEMATOPOIESIS; GENE-EXPRESSION; ZEBRAFISH; NOTCH; FATE; DIFFERENTIATION; PROLIFERATION; LEUKEMIA	Haematopoietic stem cells (HSCs) are a self-renewing population of cells that continuously replenish all blood and immune cells during the lifetime of an individual(1,2). HSCs are used clinically to treat a wide array of diseases, including acute leukaemias and congenital blood disorders, but obtaining suitable numbers of cells and finding immune-compatible donors remain serious problems. These difficulties have led to an interest in the conversion of embryonic stem cells or induced pluripotent stem cells into HSCs, which is not possible using current methodologies. To accomplish this goal, it is critical to understand the native mechanisms involved in the specification of HSCs during embryonic development. Here we demonstrate in zebrafish that Wnt16 controls a novel genetic regulatory network required for HSC specification. Non-canonical signalling by Wnt16 is required for somitic expression of the Notch ligands deltaC (dlc) and deltaD (dld), and these ligands are, in turn, required for the establishment of definitive haematopoiesis. Notch signalling downstream of Dlc and Dld is earlier than, and distinct from, known cell-autonomous requirements for Notch, strongly suggesting that novel Notch-dependent relay signal(s) induce the first HSCs in parallel to other established pathways. Our results demonstrate that somite-specific gene expression is required for the production of haemogenic endothelium.	[Clements, Wilson K.; Kim, Albert D.; Ong, Karen G.; Traver, David] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Clements, Wilson K.; Kim, Albert D.; Ong, Karen G.; Traver, David] Univ Calif San Diego, Sect Cell & Dev Biol, La Jolla, CA 92093 USA; [Moore, John C.; Lawson, Nathan D.] Univ Massachusetts, Sch Med, Program Gene Funct & Express, Worcester, MA 01605 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of Massachusetts System; University of Massachusetts Worcester	Traver, D (corresponding author), Univ Calif San Diego, Dept Cellular & Mol Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	dtraver@ucsd.edu	Clements, Wilson/C-9617-2015; Clements, Wilson/D-4153-2011	Clements, Wilson/0000-0003-4365-9553; Lawson, Nathan/0000-0001-7788-9619	AHA [0725086Y, 0815732D]; NIH [R01-HL093467, R01-DK074482]; CIRM; March of Dimes [6-FY09-508]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093467] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074482] Funding Source: NIH RePORTER	AHA(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIRM(California Institute for Regenerative Medicine); March of Dimes(March of Dimes); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors wish to thank L. Zon, K. Poss, D. Kimelman, M. Lardelli, B. Appel, C. Burns, J. Campos-Ortega, D. Ransom, N. Trede, J. Lewis, M. Pack, S. Holley, C. Moens, B. Paw, R. Karlstrom and J. Waxman for probe constructs. L. Zon, R. Dorsky, S. Lin and S. Holley provided transgenic and mutant zebrafish lines. C. Weaver, K. Willert, K. J. P. Griffin, J. Bertrand, D. Stachura and Y. Lee provided critical evaluation of the manuscript. This research was funded by an AHA Postdoctoral Fellowship 0725086Y to W.K.C., an AHA Predoctoral Founders Affiliate Fellowship 0815732D to J.C.M., NIH R01-HL093467 to N.L. and NIH R01-DK074482, CIRM New Investigator Award, and March of Dimes 6-FY09-508 to D.T.	Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Bertrand JY, 2008, DEVELOPMENT, V135, P1853, DOI 10.1242/dev.015297; Bertrand JY, 2007, DEVELOPMENT, V134, P4147, DOI 10.1242/dev.012385; Bertrand JY, 2010, NATURE, V464, P108, DOI 10.1038/nature08738; Boisset JC, 2010, NATURE, V464, P116, DOI 10.1038/nature08764; Burns CE, 2005, GENE DEV, V19, P2331, DOI 10.1101/gad.1337005; Cirone P, 2008, ANGIOGENESIS, V11, P347, DOI 10.1007/s10456-008-9116-2; Clements WK, 2009, DEV DYNAM, V238, P1788, DOI 10.1002/dvdy.21977; Clements WK, 2005, DEV BIOL, V283, P322, DOI 10.1016/j.ydbio.2005.04.026; Corrigan PM, 2009, STEM CELLS DEV, V18, P759, DOI 10.1089/scd.2008.0270; Gering M, 2010, J CELL PHYSIOL, V222, P11, DOI 10.1002/jcp.21905; Goessling W, 2009, CELL, V136, P1136, DOI 10.1016/j.cell.2009.01.015; Hadland BK, 2004, BLOOD, V104, P3097, DOI 10.1182/blood-2004-03-1224; Holley SA, 2002, DEVELOPMENT, V129, P1175; Julich D, 2005, DEV BIOL, V286, P391, DOI 10.1016/j.ydbio.2005.06.040; Kemp C, 2005, DEV DYNAM, V233, P1064, DOI 10.1002/dvdy.20408; Kissa K, 2008, BLOOD, V111, P1147, DOI 10.1182/blood-2007-07-099499; Kissa K, 2010, NATURE, V464, P112, DOI 10.1038/nature08761; Kumano K, 2003, IMMUNITY, V18, P699, DOI 10.1016/S1074-7613(03)00117-1; Lele Z, 2001, GENESIS, V30, P190, DOI 10.1002/gene.1063; Lin HF, 2005, BLOOD, V106, P3803, DOI 10.1182/blood-2005-01-0179; McWhirter JR, 1999, P NATL ACAD SCI USA, V96, P11464, DOI 10.1073/pnas.96.20.11464; Nusslein-Volhard C, 2002, ZEBRAFISH; Nygren MK, 2009, EXP HEMATOL, V37, P225, DOI 10.1016/j.exphem.2008.10.007; Parsons MJ, 2009, MECH DEVELOP, V126, P898, DOI 10.1016/j.mod.2009.07.002; Ren X, 2010, BLOOD, V115, P5338, DOI 10.1182/blood-2009-09-244640; Robert-Moreno A, 2005, DEVELOPMENT, V132, P1117, DOI 10.1242/dev.01660; Robert-Moreno A, 2008, EMBO J, V27, P1886, DOI 10.1038/emboj.2008.113; Scheer N, 2001, DEVELOPMENT, V128, P1099; Scheer N, 1999, MECH DEVELOP, V80, P153, DOI 10.1016/S0925-4773(98)00209-3; Staal FJT, 2010, J CELL BIOCHEM, V109, P844, DOI 10.1002/jcb.22467; TAKADA S, 1994, GENE DEV, V8, P174, DOI 10.1101/gad.8.2.174; Teh MT, 2007, J CELL SCI, V120, P330, DOI 10.1242/jcs.03329; TURNER DL, 1994, GENE DEV, V8, P1434, DOI 10.1101/gad.8.12.1434; Westerfield M, 2004, ZEBRAFISH BOOK GUIDE; Yokota T, 2006, DEVELOPMENT, V133, P2041, DOI 10.1242/dev.02349	36	166	173	1	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 9	2011	474	7350					220	U262		10.1038/nature10107	http://dx.doi.org/10.1038/nature10107			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774PE	21654806	Green Accepted			2022-12-24	WOS:000291397800052
J	Grigoryan, G; Kim, YH; Acharya, R; Axelrod, K; Jain, RM; Willis, L; Drndic, M; Kikkawa, JM; DeGrado, WF				Grigoryan, Gevorg; Kim, Yong Ho; Acharya, Rudresh; Axelrod, Kevin; Jain, Rishabh M.; Willis, Lauren; Drndic, Marija; Kikkawa, James M.; DeGrado, William F.			Computational Design of Virus-Like Protein Assemblies on Carbon Nanotube Surfaces	SCIENCE			English	Article							DE-NOVO DESIGN; PEPTIDES; DNA; BINDING; INDUCTION; DOMAIN; MODEL	There is a general need for the engineering of protein-like molecules that organize into geometrically specific superstructures on molecular surfaces, directing further functionalization to create richly textured, multilayered assemblies. Here we describe a computational approach whereby the surface properties and symmetry of a targeted surface define the sequence and superstructure of surface-organizing peptides. Computational design proceeds in a series of steps that encode both surface recognition and favorable intersubunit packing interactions. This procedure is exemplified in the design of peptides that assemble into a tubular structure surrounding single-walled carbon nanotubes (SWNTs). The geometrically defined, virus-like coating created by these peptides converts the smooth surfaces of SWNTs into highly textured assemblies with long-scale order, capable of directing the assembly of gold nanoparticles into helical arrays along the SWNT axis.	[Grigoryan, Gevorg; Acharya, Rudresh; DeGrado, William F.] Univ Penn, Dept Biochem & Biophys, Philadelphia, PA 19104 USA; [Kim, Yong Ho; DeGrado, William F.] Univ Penn, Dept Chem, Philadelphia, PA 19104 USA; [Axelrod, Kevin; Jain, Rishabh M.; Willis, Lauren; Drndic, Marija; Kikkawa, James M.] Univ Penn, Dept Phys & Astron, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	DeGrado, WF (corresponding author), Univ Penn, Dept Biochem & Biophys, Philadelphia, PA 19104 USA.	wdegrado@mail.med.upenn.edu	Acharya, Rudresh/AAD-1247-2021; Jain, Rishabh/D-7797-2013	Acharya, Rudresh/0000-0002-9012-9849; 	NSF Materials Research Science and Engineering Center [DMR05-20020]; NIH [GM54616, 5F32GM084631-02]; NSF National Science and Engineering Center [DMR-0425780]; NSF [DMR-0907226, DGE-0221664]; Roy and Diana Vagelos Program in the Molecular Life Sciences; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM084631, R37GM054616, R01GM054616] Funding Source: NIH RePORTER; Direct For Mathematical & Physical Scien [0907266] Funding Source: National Science Foundation	NSF Materials Research Science and Engineering Center(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF National Science and Engineering Center; NSF(National Science Foundation (NSF)); Roy and Diana Vagelos Program in the Molecular Life Sciences; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported by the NSF Materials Research Science and Engineering Center DMR05-20020 grant (to J.M.K., M. D., and W. F. D.), NIH grant no. GM54616 (to W. F. D.), a NSF National Science and Engineering Center grant no. DMR-0425780 (to W. F. D. and M. D.), NSF grant no. DMR-0907226 (to J.M.K.), and NIH grant no. 5F32GM084631-02 (to G. G.). K. A. acknowledges support from the Roy and Diana Vagelos Program in the Molecular Life Sciences, and L. W. acknowledges funding from the NSF-Integrative Graduate Education and Research Traineeship program (grant DGE-0221664). We would like to thank K. A. McAllister for training Y.H.K. in peptide synthesis, and A. E. Keating for comments on the manuscript.	Ashworth J, 2006, NATURE, V441, P656, DOI 10.1038/nature04818; Calhoun JR, 2005, BIOPOLYMERS, V80, P264, DOI 10.1002/bip.20230; Capriotti LA, 2007, J AM CHEM SOC, V129, P5281, DOI 10.1021/ja070356b; Chakraborty AK, 2001, ANNU REV PHYS CHEM, V52, P537, DOI 10.1146/annurev.physchem.52.1.537; Cordes MHJ, 1996, CURR OPIN STRUC BIOL, V6, P3, DOI 10.1016/S0959-440X(96)80088-1; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dahiyat BI, 1997, SCIENCE, V278, P82, DOI 10.1126/science.278.5335.82; DEGRADO WF, 1985, J AM CHEM SOC, V107, P7684, DOI 10.1021/ja00311a076; Dieckmann GR, 2003, J AM CHEM SOC, V125, P1770, DOI 10.1021/ja029084x; Fairman R, 2005, CURR OPIN STRUC BIOL, V15, P453, DOI 10.1016/j.sbi.2005.07.005; Ghirlanda G, 2002, J MOL BIOL, V319, P243, DOI 10.1016/S0022-2836(02)00233-4; Ghirlanda G, 1998, J MOL BIOL, V281, P379, DOI 10.1006/jmbi.1998.1912; Ghosh D, 2005, CURR OPIN CHEM BIOL, V9, P97, DOI 10.1016/j.cbpa.2005.02.005; Golberg D, 2007, ADV MATER, V19, P2413, DOI 10.1002/adma.200700179; Grigoryan G, 2011, J MOL BIOL, V405, P1079, DOI 10.1016/j.jmb.2010.08.058; Grigoryan G, 2009, NATURE, V458, P859, DOI 10.1038/nature07885; Haring D, 2001, BIOCONJUGATE CHEM, V12, P385, DOI 10.1021/bc000117c; Jiang L, 2008, SCIENCE, V319, P1387, DOI 10.1126/science.1152692; Kaplan J, 2004, P NATL ACAD SCI USA, V101, P11566, DOI 10.1073/pnas.0404387101; Katz E, 2004, CHEMPHYSCHEM, V5, P1085, DOI 10.1002/cphc.200400193; Kim JS, 1998, P NATL ACAD SCI USA, V95, P2812, DOI 10.1073/pnas.95.6.2812; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; Masica DL, 2010, J AM CHEM SOC, V132, P12252, DOI 10.1021/ja1001086; Nygren P, 2008, NANO LETT, V8, P1844, DOI 10.1021/nl080386s; O'Connell MJ, 2002, SCIENCE, V297, P593, DOI 10.1126/science.1072631; Ortiz-Acevedo A, 2005, J AM CHEM SOC, V127, P9512, DOI 10.1021/ja050507f; Rapaport H, 2006, SUPRAMOL CHEM, V18, P445, DOI 10.1080/10610270600665905; Reina J, 2002, NAT STRUCT BIOL, V9, P621, DOI 10.1038/nsb815; Rothlisberger D, 2008, NATURE, V453, P190, DOI 10.1038/nature06879; Segman S, 2010, ANGEW CHEM INT EDIT, V49, P716, DOI 10.1002/anie.200904566; Torrens ON, 2006, NANO LETT, V6, P2864, DOI 10.1021/nl062071n; Tu XM, 2009, NATURE, V460, P250, DOI 10.1038/nature08116; Wang SQ, 2003, NAT MATER, V2, P196, DOI 10.1038/nmat833; Zheng M, 2003, SCIENCE, V302, P1545, DOI 10.1126/science.1091911	34	161	171	0	178	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 27	2011	332	6033					1071	1076		10.1126/science.1198841	http://dx.doi.org/10.1126/science.1198841			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769FN	21617073	Green Accepted			2022-12-24	WOS:000290996700041
J	Hansen, SG; Ford, JC; Lewis, MS; Ventura, AB; Hughes, CM; Coyne-Johnson, L; Whizin, N; Oswald, K; Shoemaker, R; Swanson, T; Legasse, AW; Chiuchiolo, MJ; Parks, CL; Axthelm, MK; Nelson, JA; Jarvis, MA; Piatak, M; Lifson, JD; Picker, LJ				Hansen, Scott G.; Ford, Julia C.; Lewis, Matthew S.; Ventura, Abigail B.; Hughes, Colette M.; Coyne-Johnson, Lia; Whizin, Nathan; Oswald, Kelli; Shoemaker, Rebecca; Swanson, Tonya; Legasse, Alfred W.; Chiuchiolo, Maria J.; Parks, Christopher L.; Axthelm, Michael K.; Nelson, Jay A.; Jarvis, Michael A.; Piatak, Michael, Jr.; Lifson, Jeffrey D.; Picker, Louis J.			Profound early control of highly pathogenic SIV by an effector memory T-cell vaccine	NATURE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; IMMUNODEFICIENCY VIRUS SIVMAC239; PRIMARY HIV-1 INFECTION; IMMUNE-RESPONSES; RHESUS-MONKEYS; MACAQUE MODEL; REPLICATION; CHALLENGE; PROTECTION; AIDS	The acquired immunodeficiency syndrome (AIDS)-causing lentiviruses human immunodeficiency virus (HIV) and simian immunodeficiency virus (SIV) effectively evade host immunity and, once established, infections with these viruses are only rarely controlled by immunological mechanisms(1-3). However, the initial establishment of infection in the first few days after mucosal exposure, before viral dissemination and massive replication, may be more vulnerable to immune control(4). Here we report that SIV vaccines that include rhesus cytomegalovirus (RhCMV) vectors(5) establish indefinitely persistent, high-frequency, SIV-specific effector memory T-cell (T(EM)) responses at potential sites of SIV replication in rhesus macaques and stringently control highly pathogenic SIV(MAC239) infection early after mucosal challenge. Thirteen of twenty-four rhesus macaques receiving either RhCMV vectors alone or RhCMV vectors followed by adenovirus 5 (Ad5) vectors (versus 0 of 9 DNA/Ad5-vaccinated rhesus macaques) manifested early complete control of SIV (undetectable plasma virus), and in twelve of these thirteen animals we observed long-term (>= 1 year) protection. This was characterized by: occasional blips of plasma viraemia that ultimately waned; predominantly undetectable cell-associated viral load in blood and lymph node mononuclear cells; no depletion of effector-site CD4(+) memory T cells; no induction or boosting of SIV Env-specific antibodies; and induction and then loss of T-cell responses to an SIV protein (Vif) not included in the RhCMV vectors. Protection correlated with the magnitude of the peak SIV-specific CD8(+) T-cell responses in the vaccine phase, and occurred without anamnestic T-cell responses. Remarkably, long-term RhCMV vector-associated SIV control was insensitive to either CD8(+) or CD4(+) lymphocyte depletion and, at necropsy, cell-associated SIV was only occasionally measurable at the limit of detection with ultrasensitive assays, observations that indicate the possibility of eventual viral clearance. Thus, persistent vectors such as CMV and their associated TEM responses might significantly contribute to an efficacious HIV/AIDS vaccine.	[Hansen, Scott G.; Ford, Julia C.; Lewis, Matthew S.; Ventura, Abigail B.; Hughes, Colette M.; Coyne-Johnson, Lia; Whizin, Nathan; Swanson, Tonya; Legasse, Alfred W.; Axthelm, Michael K.; Nelson, Jay A.; Jarvis, Michael A.; Picker, Louis J.] Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Dept Mol Microbiol & Immunol, Beaverton, OR 97006 USA; [Hansen, Scott G.; Ford, Julia C.; Lewis, Matthew S.; Ventura, Abigail B.; Hughes, Colette M.; Coyne-Johnson, Lia; Whizin, Nathan; Swanson, Tonya; Legasse, Alfred W.; Axthelm, Michael K.; Nelson, Jay A.; Jarvis, Michael A.; Picker, Louis J.] Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Dept Pathol, Beaverton, OR 97006 USA; [Hansen, Scott G.; Ford, Julia C.; Lewis, Matthew S.; Ventura, Abigail B.; Hughes, Colette M.; Coyne-Johnson, Lia; Whizin, Nathan; Swanson, Tonya; Legasse, Alfred W.; Axthelm, Michael K.; Nelson, Jay A.; Jarvis, Michael A.; Picker, Louis J.] Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Beaverton, OR 97006 USA; [Oswald, Kelli; Shoemaker, Rebecca; Piatak, Michael, Jr.; Lifson, Jeffrey D.] NCI, AIDS & Canc Virus Program, SAIC Frederick Inc, Frederick, MD 21702 USA; [Chiuchiolo, Maria J.; Parks, Christopher L.] Int AIDS Vaccine Initiat, Vaccine Design & Dev Lab, Brooklyn, NY 11220 USA	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon National Primate Research Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; International AIDS Vaccine Initiative	Picker, LJ (corresponding author), Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Dept Mol Microbiol & Immunol, Beaverton, OR 97006 USA.	pickerl@ohsu.edu		Jarvis, Michael A/0000-0002-0124-4061	National Institute of Allergy and Infectious Diseases [RO1 AI060392, HHSN272200900037C]; International AIDS Vaccine Initiative (IAVI); United States Agency for International Development (USAID); Bill & Melinda Gates Foundation; National Center for Research Resources [P51 RR00163, R24 RR016001]; National Cancer Institute [HHSN261200800001E]; NATIONAL CENTER FOR RESEARCH RESOURCES [R24RR016001, P51RR000163] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI060392, R01AI060392] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [U24OD010850] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); International AIDS Vaccine Initiative (IAVI); United States Agency for International Development (USAID)(United States Agency for International Development (USAID)CGIAR); Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institute of Allergy and Infectious Diseases (RO1 AI060392; contract #HHSN272200900037C); the International AIDS Vaccine Initiative (IAVI) and its donors, particularly the United States Agency for International Development (USAID); the Bill & Melinda Gates Foundation-supported Collaboration for AIDS Vaccine Discovery; the National Center for Research Resources (P51 RR00163; R24 RR016001); and the National Cancer Institute (contract HHSN261200800001E). We thank A. Sylwester, D. Seiss, R. Lum, H. Park and A. Okoye for specialized technical assistance; P. Barry, G. Pavlakis, G. Franchini, C. Miller, N. Wilson, and K. Reimann and Nonhuman Primate Reagent Resource for provision of crucial constructs or reagents; D. Watkins for MHC typing; D. Montefiori for neutralizing antibody assays; N. Letvin and L. Shen for TRIM5a typing; S. Mongoue-Tchokote and M. Mori for statistical assistance; A. Townsend and T. Schroyer for figure preparation; and K. Fruh, D. Watkins, B. Beresford, A. McDermott, R. King and W. Koff for discussion and advice.	Anton PA, 2003, AIDS, V17, P53, DOI 10.1097/00002030-200301030-00008; Bachmann MF, 1997, P NATL ACAD SCI USA, V94, P640, DOI 10.1073/pnas.94.2.640; Blankson JN, 2007, J VIROL, V81, P2508, DOI 10.1128/JVI.02165-06; Casimiro DR, 2005, J VIROL, V79, P15547, DOI 10.1128/JVI.79.24.15547-15555.2005; Chang WLW, 2003, J VIROL, V77, P5073, DOI 10.1128/JVI.77.9.5073-5083.2003; Chun TW, 1998, P NATL ACAD SCI USA, V95, P8869, DOI 10.1073/pnas.95.15.8869; Cline AN, 2005, J MED PRIMATOL, V34, P303; Dinoso JB, 2009, J VIROL, V83, P9247, DOI 10.1128/JVI.00840-09; Friedrich TC, 2007, J VIROL, V81, P3465, DOI 10.1128/JVI.02392-06; Goulder PJR, 2008, NAT REV IMMUNOL, V8, P619, DOI 10.1038/nri2357; Grovit-Ferbas K, 1999, PERSISTENT VIRAL INF, P3; Haase AT, 2010, NATURE, V464, P217, DOI 10.1038/nature08757; Haase AT, 2005, NAT REV IMMUNOL, V5, P783, DOI 10.1038/nri1706; Hansen SG, 2009, NAT MED, V15, P293, DOI 10.1038/nm.1935; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Kulkarni V, 2011, VACCINE, V29, P6742, DOI 10.1016/j.vaccine.2010.12.056; Letvin NL, 2006, SCIENCE, V312, P1530, DOI 10.1126/science.1124226; Mittereder N, 1996, J VIROL, V70, P7498, DOI 10.1128/JVI.70.11.7498-7509.1996; MONTEFIORI DC, 2005, CURR PROTOC IMMUNOL, V12; North TW, 2010, J VIROL, V84, P2913, DOI 10.1128/JVI.02356-09; Ochsenbein AF, 1999, P NATL ACAD SCI USA, V96, P9293, DOI 10.1073/pnas.96.16.9293; Okoye A, 2009, J EXP MED, V206, P1575, DOI 10.1084/jem.20090356; Pitcher CJ, 2002, J IMMUNOL, V168, P29, DOI 10.4049/jimmunol.168.1.29; Reynolds MR, 2008, J EXP MED, V205, P2537, DOI 10.1084/jem.20081524; Robinson HL, 2005, NAT MED, V11, pS25, DOI 10.1038/nm1212; Rosati M, 2005, J VIROL, V79, P8480, DOI 10.1128/JVI.79.13.8480-8492.2005; Rosati M, 2009, P NATL ACAD SCI USA, V106, P15831, DOI 10.1073/pnas.0902628106; ROSENFELD MA, 1992, CELL, V68, P143, DOI 10.1016/0092-8674(92)90213-V; Ruiz L, 1999, AIDS, V13, pF1, DOI 10.1097/00002030-199901140-00001; Schmitz JE, 2000, J IMMUNOL, V164, P6015, DOI 10.4049/jimmunol.164.11.6015; Shen AD, 2003, J VIROL, V77, P4938, DOI 10.1128/JVI.77.8.4938-4949.2003; Shen AD, 2007, J VIROL, V81, P1660, DOI 10.1128/JVI.01396-06; Vaccari M, 2008, J VIROL, V82, P9629, DOI 10.1128/JVI.00893-08; Veazey RS, 1998, SCIENCE, V280, P427, DOI 10.1126/science.280.5362.427; Venneti S, 2008, AM J PATHOL, V172, P1603, DOI 10.2353/ajpath.2008.070967; Wilson NA, 2006, J VIROL, V80, P5875, DOI 10.1128/JVI.00171-06	36	757	785	1	102	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 26	2011	473	7348					523	U270		10.1038/nature10003	http://dx.doi.org/10.1038/nature10003			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	768QM	21562493	Green Submitted, Green Accepted			2022-12-24	WOS:000290951300043
J	Larson, HJ; Cooper, LZ; Eskola, J; Katz, SL; Ratzan, S				Larson, Heidi J.; Cooper, Louis Z.; Eskola, Juhani; Katz, Samuel L.; Ratzan, Scott			New Decade of Vaccines 5 Addressing the vaccine confidence gap	LANCET			English	Article							ADVERSE EVENTS; TRUST; RISK; AUTISM; SAFETY; IMMUNIZATION; EXPERIENCE; RESISTANCE; INDIA	Vaccines-often lauded as one of the greatest public health interventions are losing public confidence. Some vaccine experts have referred to this decline in confidence as a crisis. We discuss some of the characteristics of the changing global environment that are contributing to increased public questioning of vaccines, and outline some of the specific determinants of public trust. Public decision making related to vaccine acceptance is neither driven by scientific nor economic evidence alone, but is also driven by a mix of psychological, sociocultural, and political factors, all of which need to be understood and taken into account by policy and other decision makers. Public trust in vaccines is highly variable and building trust depends on understanding perceptions of vaccines and vaccine risks, historical experiences, religious or political affiliations, and socioeconomic status. Although provision of accurate, scientifically based evidence on the risk benefit ratios of vaccines is crucial, it is not enough to redress the gap between current levels of public confidence in vaccines and levels of trust needed to ensure adequate and sustained vaccine coverage. We call for more research not just on individual determinants of public trust, but on what mix of factors are most likely to sustain public trust. The vaccine community demands rigorous evidence on vaccine efficacy and safety and technical and operational feasibility when introducing a new vaccine, but has been negligent in demanding equally rigorous research to understand the psychological, social, and political factors that affect public trust in vaccines.	[Larson, Heidi J.] Univ London London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London WC1E 7HT, England; [Cooper, Louis Z.] Columbia Univ, Coll Phys & Surg, Dept Paediat, New York, NY USA; [Eskola, Juhani] Natl Inst Hlth & Welf THL, Helsinki, Finland; [Katz, Samuel L.] Duke Univ, Dept Paediat, Durham, NC USA; [Ratzan, Scott] Johnson & Johnson, Govt Affairs & Policy, New Brunswick, NJ USA	University of London; London School of Hygiene & Tropical Medicine; Columbia University; Finland National Institute for Health & Welfare; Duke University; Johnson & Johnson; Johnson & Johnson USA	Larson, HJ (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, Keppel St, London WC1E 7HT, England.	heidi.larson@lshtm.ac.uk	Larson, Heidi J./N-1018-2017	Larson, Heidi J./0000-0002-8477-7583	Bill & Melinda Gates Foundation; Novartis	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); Novartis(Novartis)	HJL is funded by the Bill & Melinda Gates Foundation as principal investigator for research on public confidence in immunisation. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of their employers. We thank David Salisbury for providing data for figure 2 and for useful discussion on the paper; Anne Louise-Kinmonth for reviewing subsquent drafts; and Pauline Brocard, Lee Barker, Caitlin Jarret, Isaac Ghinai, Jay Dowle, Larry Madoff, Melissa Cumming, and Louise Paushter for researching case studies.; JE received funding from Novartis for a pneumococcal advisory meeting and as a data and safety monitoring board member for meningococcal and typhoid vaccines. SR edits the Journal of Health Communication, with faculty appointments at Tufts School of Medicine and George Washington School of Public Health and Health Services. SR contributed independently of his principal employer, Johnson & Johnson. Some technical work, travel (LZC and SLK), and meetings relevant to this work were funded by the Bill & Melinda Gates Foundation. The funding organisation had no role in the drafting or direction of this report. HJL declares that she has no conflicts of interest.	Akehurst C, 1998, EURO SURVEILL, V2; Alesina A, 2002, J PUBLIC ECON, V85, P207, DOI 10.1016/S0047-2727(01)00084-6; Andrus JK, 2007, PUBLIC HEALTH REP, V122, P811; [Anonymous], WHO VACC PREV DIS MO; [Anonymous], MMWR, V581, P357; [Anonymous], J MCCARTHY JOINS DEF; [Anonymous], PROJECT SUPPORT PUBL; Autran B, 2009, EXPERT REV VACCINES, V8, P705, DOI [10.1586/erv.09.40, 10.1586/ERV.09.40]; Bean SJ, 2011, VACCINE, V29, P1874, DOI 10.1016/j.vaccine.2011.01.003; Bedford H, 2000, BMJ-BRIT MED J, V320, P240, DOI 10.1136/bmj.320.7229.240; Bingham A., 2009, OPEN VACCINE J, V2, P1, DOI DOI 10.2174/1875035400902010001; Black S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001738; Campbell P, PHIL T RO A IN PRESS; Centers for Disease Control and Prevention, IMP 1999 AAP USPHS J; Centers for Disease Control and Prevention, THIM VACC JOINT STAT; Chaturvedi S, 2009, INDIAN PEDIATR, V46, P963; Clements CJ, 2003, J MED ETHICS, V29, P22, DOI 10.1136/jme.29.1.22; Closser S, 2010, CHASING POLIO PAKIST; Cooper LZ, 2008, PEDIATRICS, V122, P149, DOI 10.1542/peds.2008-0987; Covello VT, 2003, J HEALTH COMMUN, V8, P5, DOI 10.1080/10810730390224802; Das J, 2003, SOC SCI MED, V57, P97, DOI 10.1016/S0277-9536(02)00302-7; Davis MM, 2010, VACCINE, V28, P1353, DOI 10.1016/j.vaccine.2009.11.007; Facebook, PRESS ROOM; FLYNN J, 1992, RISK ANAL, V12, P417, DOI 10.1111/j.1539-6924.1992.tb00694.x; Fombonne E, 2008, ARCH GEN PSYCHIAT, V65, P15, DOI 10.1001/archgenpsychiatry.2007.2; Fowler GL, 2007, VACCINE, V25, P3536, DOI 10.1016/j.vaccine.2007.01.082; Freed GL, 2010, PEDIATRICS, V125, P654, DOI 10.1542/peds.2009-1962; GALAZKA AM, 1995, EUR J EPIDEMIOL, V11, P95, DOI 10.1007/BF01719954; Gangarosa EJ, 1998, LANCET, V351, P356, DOI 10.1016/S0140-6736(97)04334-1; Global Polio Eradication Initiative, REP WHO SECR 60 WORL; Honda H, 2005, J CHILD PSYCHOL PSYC, V46, P572, DOI 10.1111/j.1469-7610.2005.01425.x; Institute of Medicine, 2004, IMM SAF REV VACC AUT; John J, 2010, INDIAN J MED RES, V132, P463; Kasperson J.X., 2003, SOC CONTOURS RISK, p217.; Kirby D, 2005, EVIDENCE HARM MERCUR; Larson HJ, 2010, LANCET, V376, P572, DOI 10.1016/S0140-6736(10)60881-1; Larson HJ, 2010, JAMA-J AM MED ASSOC, V303, P271, DOI 10.1001/jama.2009.2023; Lone Z, 2010, INDIAN J MED RES, V132, P1; Lopalco PL, 2009, BUNDESGESUNDHEITSBLA, V52, P1095, DOI 10.1007/s00103-009-0960-z; Martin R, 2009, 4 ANN GLOB IMM M NEW; MCALISTER A, 1982, AM J PUBLIC HEALTH, V72, P43, DOI 10.2105/AJPH.72.1.43; Milstien J, 1995, REPROD HEALTH MATTER, V3, P24; Mnookin S., 2011, PANIC VIRUS; Mudur G, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c3508; Murch SH, 2004, LANCET, V363, P750, DOI 10.1016/S0140-6736(04)15715-2; Offit Paul A., 2011, DEADLY CHOICES ANTIV; [Anonymous], 2008, Bull World Health Organ, V86, P425; Peters RG, 1997, RISK ANAL, V17, P43, DOI 10.1111/j.1539-6924.1997.tb00842.x; Pidgeon N, 2011, NAT CLIM CHANGE, V1, P35, DOI [10.1038/NCLIMATE1080, 10.1038/nclimate1080]; Poland GA, 2011, NEW ENGL J MED, V364, P97, DOI 10.1056/NEJMp1010594; Poland GA, 2010, VACCINE, V28, P6549, DOI 10.1016/j.vaccine.2010.08.032; Puliyel J, 2010, INDIAN J MED RES, V131, P588; Puliyel J, 2010, GUARDIAN LONDON 1027; PULIYEL JM, 2010, BMJ-BRIT MED J, V341, P266; SAVAGE I, 1993, RISK ANAL, V13, P413, DOI 10.1111/j.1539-6924.1993.tb00741.x; Saxena KB, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c4001; Schechter R, 2008, ARCH GEN PSYCHIAT, V65, P19, DOI 10.1001/archgenpsychiatry.2007.1; Shetty P, 2010, LANCET, V375, P970, DOI 10.1016/S0140-6736(10)60421-7; Spier RE, 2001, VACCINE, V20, pS78, DOI 10.1016/S0264-410X(01)00306-1; Stephens J, 2009, WASHINGTON POST 0731; Stern P. C., 1996, UNDERSTANDING RISK I; Streefland P, 1999, SOC SCI MED, V49, P1705, DOI 10.1016/S0277-9536(99)00239-7; Streefland PH, 2001, HEALTH POLICY, V55, P159, DOI 10.1016/S0168-8510(00)00132-9; TALWAR GP, 1994, P NATL ACAD SCI USA, V91, P8532, DOI 10.1073/pnas.91.18.8532; Taylor S, 2010, J HEALTH COMMUN, V15, P48, DOI 10.1080/10810731003698585; Tollefson J, 2010, NATURE, V466, P24, DOI 10.1038/466024a; UK National Health Service, INCR MMR VACC COV EN; UNICEF, COMB ANT RUM LESS LE; United Nations Educational Scientific and Cultural Organization, 2005, PREC PRINC; US Food and Drug Administration, COMPL LIST VACC LIC; Viral hepatitis prevention board, 1999, VACCINE, V17, P2473; WHO, POL VIR RESP NO BORD; World Health Organization, 2009, STAT WORLDS VACC IMM; World Health Organization, WHO PREQ VACC; Wright JA, 2006, EUR J PUBLIC HEALTH, V16, P137, DOI 10.1093/eurpub/cki194; Wroe AL, 2005, VACCINE, V23, P1428, DOI 10.1016/j.vaccine.2004.10.004; Yahya M., 2006, 261 I DEV STUD	77	478	482	2	103	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 6	2011	378	9790					526	535		10.1016/S0140-6736(11)60678-8	http://dx.doi.org/10.1016/S0140-6736(11)60678-8			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	809SO	21664679				2022-12-24	WOS:000294077200032
J	van de Veerdonk, FL; Plantinga, TS; Hoischen, A; Smeekens, SP; Joosten, LAB; Gilissen, C; Arts, P; Rosentul, DC; Carmichael, AJ; Smits-van der Graaf, CAA; Kullberg, BJ; van der Meer, JWM; Lilic, D; Veltman, JA; Netea, MG				van de Veerdonk, Frank L.; Plantinga, Theo S.; Hoischen, Alexander; Smeekens, Sanne P.; Joosten, Leo A. B.; Gilissen, Christian; Arts, Peer; Rosentul, Diana C.; Carmichael, Andrew J.; Smits-van der Graaf, Chantal A. A.; Kullberg, Bart Jan; van der Meer, Jos W. M.; Lilic, Desa; Veltman, Joris A.; Netea, Mihai G.			STAT1 Mutations in Autosomal Dominant Chronic Mucocutaneous Candidiasis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DEFICIENCY; IMMUNITY; AUTOANTIBODIES; INFLAMMATION; RECOGNITION; CARCINOMA; ALBICANS; CELLS; IL-17	Background Chronic mucocutaneous candidiasis (CMC) is characterized by susceptibility to candida infection of skin, nails, and mucous membranes. Patients with recessive CMC and autoimmunity have mutations in the autoimmune regulator AIRE. The cause of autosomal dominant CMC is unknown. Methods We evaluated 14 patients from five families with autosomal dominant CMC. We incubated their peripheral-blood mononuclear cells with different combinations of stimuli to test the integrity of pathways that mediate immunity, which led to the selection of 100 genes that were most likely to contain the genetic defect. We used an array-based sequence-capture assay, followed by next-generation sequencing, to identify mutations. Results The mononuclear cells from the affected patients were characterized by poor production of interferon-gamma, interleukin-17, and interleukin-22, suggesting that the defect lay within the interleukin-12 receptor and interleukin-23 receptor signaling pathways. We identified heterozygous missense mutations in the DNA sequence encoding the coiled-coil (CC) domain of signal transducer and activator of transcription 1 (STAT1) in the patients. These mutations lead to defective responses in type 1 and type 17 helper T cells (Th1 and Th17). The interferon-gamma receptor pathway was intact in these patients. Conclusions Mutations in the CC domain of STAT1 underlie autosomal dominant CMC and lead to defective Th1 and Th17 responses, which may explain the increased susceptibility to fungal infection.	[van de Veerdonk, Frank L.; Plantinga, Theo S.; Smeekens, Sanne P.; Joosten, Leo A. B.; Rosentul, Diana C.; Smits-van der Graaf, Chantal A. A.; Kullberg, Bart Jan; van der Meer, Jos W. M.; Netea, Mihai G.] Radboud Univ Nijmegen, Med Ctr, Dept Med, NL-6500 HB Nijmegen, Netherlands; [Hoischen, Alexander; Gilissen, Christian; Arts, Peer; Veltman, Joris A.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands; [Smits-van der Graaf, Chantal A. A.] Radboud Univ Nijmegen, Med Ctr, Dept Pulm Dis, NL-6500 HB Nijmegen, Netherlands; [van de Veerdonk, Frank L.; Plantinga, Theo S.; Smeekens, Sanne P.; Joosten, Leo A. B.; Rosentul, Diana C.; Smits-van der Graaf, Chantal A. A.; Kullberg, Bart Jan; van der Meer, Jos W. M.; Netea, Mihai G.] Nijmegen Inst Infect Inflammat & Immun, Nijmegen, Netherlands; [Carmichael, Andrew J.] James Cook Univ Hosp, Dept Dermatol, Middlesbrough, Cleveland, England; [Lilic, Desa] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; James Cook University Hospital; Newcastle University - UK	van der Meer, JWM (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Med, POB 9101, NL-6500 HB Nijmegen, Netherlands.	j.vandermeer@aig.umcn.nl	Smeekens, Sanne/AAZ-2061-2021; Joosten, Leo AB/H-3138-2015; Smeekens, Sanne/G-8307-2011; Gilissen, Christian/E-5246-2012; Hoischen, Alexander/AGF-7293-2022; Arts, Peer/Q-4139-2019; Hoischen, Alexander/D-1282-2013; Plantinga, Theo S./A-6895-2015; Veltman, Joris A/F-5128-2010; Smits-van der Graaf, Chantal/E-8652-2018; Netea, Mihai/N-5155-2014; van de Veerdonk, Frank L/C-7256-2008; van der Meer, Jos W.M./C-8521-2013; Kullberg, BJ/C-8520-2013	Smeekens, Sanne/0000-0002-7835-914X; Joosten, Leo AB/0000-0001-6166-9830; Smeekens, Sanne/0000-0002-7835-914X; Gilissen, Christian/0000-0003-1693-9699; Hoischen, Alexander/0000-0002-8072-4476; Arts, Peer/0000-0002-6742-6239; Hoischen, Alexander/0000-0002-8072-4476; Plantinga, Theo S./0000-0003-4990-6084; Veltman, Joris A/0000-0002-3218-8250; van de Veerdonk, Frank L/0000-0002-1121-4894; van der Meer, Jos W.M./0000-0001-5120-3690; Kullberg, BJ/0000-0002-6813-8167	Netherlands Organization for Scientific Research; Primary Immunodeficiency Association UK; European Union [Health-F5-2009-223143]; Aneuploidy Project [LSHG-CT-2006-37627]; Netherlands Organization for Health Research and Development (ZonMW) [917.66.36]	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Primary Immunodeficiency Association UK; European Union(European Commission); Aneuploidy Project; Netherlands Organization for Health Research and Development (ZonMW)(Netherlands Organization for Health Research and Development)	Supported by grants from the Netherlands Organization for Scientific Research (to Dr. Netea), the Primary Immunodeficiency Association UK (to Dr. Lilic), the Techgene Project funded by the European Union (Health-F5-2009-223143, to Drs. Veltman and Arts), the Aneuploidy Project (LSHG-CT-2006-37627, to Drs. Hoischen and Veltman), and the Netherlands Organization for Health Research and Development (ZonMW grant 917.66.36, to Dr. Veltman).	Aaltonen J, 1997, NAT GENET, V17, P399, DOI 10.1038/ng1297-399; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Cetani F, 2001, J CLIN ENDOCR METAB, V86, P4747, DOI 10.1210/jc.86.10.4747; Chapgier A, 2006, PLOS GENET, V2, P1193, DOI 10.1371/journal.pgen.0020131; Chapgier A, 2006, J IMMUNOL, V176, P5078, DOI 10.4049/jimmunol.176.8.5078; Conti HR, 2009, J EXP MED, V206, P299, DOI 10.1084/jem.20081463; Dupuis S, 2003, NAT GENET, V33, P388, DOI 10.1038/ng1097; Dupuis S, 2001, SCIENCE, V293, P300, DOI 10.1126/science.1061154; Eyerich K, 2008, J INVEST DERMATOL, V128, P2640, DOI 10.1038/jid.2008.139; Ferwerda B, 2009, NEW ENGL J MED, V361, P1760, DOI 10.1056/NEJMoa0901053; Glocker EO, 2009, NEW ENGL J MED, V361, P1727, DOI 10.1056/NEJMoa0810719; Hoischen A, 2010, NAT GENET, V42, P483, DOI 10.1038/ng.581; Hoshino A, 2006, BIOCHEM BIOPH RES CO, V346, P1062, DOI 10.1016/j.bbrc.2006.06.026; Kaganoi J, 2007, ANN SURG ONCOL, V14, P1405, DOI 10.1245/s10434-006-9274-7; Kimura HJ, 2009, ENDOCRINOLOGY, V150, P3409, DOI 10.1210/en.2008-1769; KIRKPATRICK CH, 1994, J AM ACAD DERMATOL, V31, pS14, DOI 10.1016/S0190-9622(08)81260-1; Koch D, 2009, CLIN EXP DERMATOL, V34, pE818, DOI 10.1111/j.1365-2230.2009.03561.x; Meloni A, 2008, J CLIN ENDOCR METAB, V93, P4389, DOI 10.1210/jc.2008-0935; Milner JD, 2008, NATURE, V452, P773, DOI 10.1038/nature06764; Netea MG, 2008, NAT REV MICROBIOL, V6, P67, DOI 10.1038/nrmicro1815; Netea MG, 2006, J CLIN INVEST, V116, P1642, DOI 10.1172/JCI27114; Ng WF, 2010, J ALLERGY CLIN IMMUN, V126, P1006, DOI 10.1016/j.jaci.2010.08.027; Park ES, 2000, MOL ENDOCRINOL, V14, P440, DOI 10.1210/me.14.3.440; Pfitzner E, 2004, CURR PHARM DESIGN, V10, P2839; Puel A, 2010, J EXP MED, V207, P291, DOI 10.1084/jem.20091983; van der Graaf CAA, 2003, NETH J MED, V61, P365; Vissers LELM, 2010, NAT GENET, V42, P1109, DOI 10.1038/ng.712; Watanabe G, 2001, CANCER J, V7, P132; Xing JC, 2008, GENOMICS, V92, P452, DOI 10.1016/j.ygeno.2008.08.007; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Zhong MH, 2005, P NATL ACAD SCI USA, V102, P3966, DOI 10.1073/pnas.0501063102	31	441	446	0	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 7	2011	365	1					54	61		10.1056/NEJMoa1100102	http://dx.doi.org/10.1056/NEJMoa1100102			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	788QL	21714643				2022-12-24	WOS:000292459400009
J	Skarnes, WC; Rosen, B; West, AP; Koutsourakis, M; Bushell, W; Iyer, V; Mujica, AO; Thomas, M; Harrow, J; Cox, T; Jackson, D; Severin, J; Biggs, P; Fu, J; Nefedov, M; de Jong, PJ; Stewart, AF; Bradley, A				Skarnes, William C.; Rosen, Barry; West, Anthony P.; Koutsourakis, Manousos; Bushell, Wendy; Iyer, Vivek; Mujica, Alejandro O.; Thomas, Mark; Harrow, Jennifer; Cox, Tony; Jackson, David; Severin, Jessica; Biggs, Patrick; Fu, Jun; Nefedov, Michael; de Jong, Pieter J.; Stewart, A. Francis; Bradley, Allan			A conditional knockout resource for the genome-wide study of mouse gene function	NATURE			English	Article							EMBRYONIC STEM-CELLS; HOMOLOGOUS RECOMBINATION; CAENORHABDITIS-ELEGANS; NEGATIVE SELECTION; RAT BLASTOCYSTS; EXPRESSION; TRAP; MICE; REPORTER; VECTOR	Gene targeting in embryonic stem cells has become the principal technology for manipulation of the mouse genome, offering unrivalled accuracy in allele design and access to conditional mutagenesis. To bring these advantages to the wider research community, large-scale mouse knockout programmes are producing a permanent resource of targeted mutations in all protein-coding genes. Here we report the establishment of a high-throughput gene-targeting pipeline for the generation of reporter-tagged, conditional alleles. Computational allele design, 96-well modular vector construction and high-efficiency gene-targeting strategies have been combined to mutate genes on an unprecedented scale. So far, more than 12,000 vectors and 9,000 conditional targeted alleles have been produced in highly germline-competent C57BL/6N embryonic stem cells. High-throughput genome engineering highlighted by this study is broadly applicable to rat and human stem cells and provides a foundation for future genome-wide efforts aimed at deciphering the function of all genes encoded by the mammalian genome.	[Skarnes, William C.; Rosen, Barry; West, Anthony P.; Koutsourakis, Manousos; Bushell, Wendy; Iyer, Vivek; Mujica, Alejandro O.; Thomas, Mark; Harrow, Jennifer; Cox, Tony; Jackson, David; Severin, Jessica; Biggs, Patrick; Bradley, Allan] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Fu, Jun; Stewart, A. Francis] Tech Univ Dresden, Biotechnol Zentrum, D-01062 Dresden, Germany; [Nefedov, Michael; de Jong, Pieter J.] Childrens Hosp, Oakland Res Inst, Oakland, CA 94609 USA	Wellcome Trust Sanger Institute; Technische Universitat Dresden; Children's Hospital Los Angeles; Children's Hospital Oakland Research Institute	Skarnes, WC (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge CB10 1SA, England.	skarnes@sanger.ac.uk	Severin, Jessica/AAQ-2723-2020; Stewart, A. Francis/E-7789-2010; Fu, Jun/C-9133-2011; Biggs, Patrick Jon/H-3355-2014	Severin, Jessica/0000-0003-1274-208X; Biggs, Patrick Jon/0000-0002-0285-4101; Mott, Richard/0000-0002-1022-9330; Jackson, David/0000-0002-8090-9462; Thomas, Mark/0000-0001-7267-6884; Bradley, Allan/0000-0002-2349-8839; Harrow, Jennifer/0000-0003-0338-3070	Wellcome Trust Sanger Institute; National Institutes of Health (KOMP) [U01-HG004080]; EU; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004080] Funding Source: NIH RePORTER	Wellcome Trust Sanger Institute(Wellcome Trust); National Institutes of Health (KOMP)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EU(European Commission); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank the following people for technical assistance: D. Klose, D. Oakley, W. Yang and L. Stebbings for informatics/vector design; R. Bennett, A. Horton and A. van Brunt for manual gene annotation/vector design; L. Cho, R. Li, J.-F. Popoff, M. Sharma and Y. Zhang for recombineering; G. Belteki, P. Tate, Y. Bekele and S. Borchia for targeting vectors; D. Fraser, J. Greystrong, N. Gueorguieva, M. Jackson, P. Ramagiri, I. Walczak, J. Woodward, E. Stebbings, M. Martinez, A. Tsang and Y. Yoshinaga for vector/ES quality control; and D. Edwards, S. Harris, N. Krishnappa, R. Leah and A. Tait for ES cells. We are grateful for advice on the Gateway system from J. Chesnut of Invitrogen. Finally, we wish to thank W. Wurst, K. Lloyd, and our EUCOMM and KOMP colleagues who are contributing to the production and distribution of the conditional knockout resource. This work was funded by the Wellcome Trust Sanger Institute, grants from the National Institutes of Health (KOMP, U01-HG004080 to W. C. S., P.J.d.J. and A. B.) from the EU Sixth Framework Programme (EUCOMM, to W.C.S., A.F.S. and A.B.).	Bozdech Z, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-r9; BRADLEY A, 1984, NATURE, V309, P255, DOI 10.1038/309255a0; Branda CS, 2004, DEV CELL, V6, P7, DOI 10.1016/S1534-5807(03)00399-X; Buehr M, 2008, CELL, V135, P1287, DOI 10.1016/j.cell.2008.12.007; Collins FS, 2007, CELL, V128, P9, DOI 10.1016/j.cell.2006.12.018; Collins SR, 2007, MOL CELL PROTEOMICS, V6, P439, DOI 10.1074/mcp.M600381-MCP200; de Felipe P, 2010, BIOTECHNOL J, V5, P213, DOI 10.1002/biot.200900134; DENG CX, 1992, MOL CELL BIOL, V12, P3365, DOI 10.1128/MCB.12.8.3365; Friedel RH, 2005, P NATL ACAD SCI USA, V102, P13188, DOI 10.1073/pnas.0505474102; Gertsenstein M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011260; Glaser S, 2005, NAT GENET, V37, P1187, DOI 10.1038/ng1668; GOSSLER A, 1989, SCIENCE, V244, P463, DOI 10.1126/science.2497519; Hansen GM, 2008, GENOME RES, V18, P1670, DOI 10.1101/gr.078352.108; HASTY P, 1991, MOL CELL BIOL, V11, P5586, DOI 10.1128/MCB.11.11.5586; Hope IA, 2004, GENOME RES, V14, P2070, DOI 10.1101/gr.2463804; KAST P, 1994, GENE, V138, P109, DOI 10.1016/0378-1119(94)90790-0; Lay JM, 1998, TRANSGENIC RES, V7, P135, DOI 10.1023/A:1008876526826; Lettice LA, 2002, P NATL ACAD SCI USA, V99, P7548, DOI 10.1073/pnas.112212199; Li P, 2008, CELL, V135, P1299, DOI 10.1016/j.cell.2008.12.006; Liang Q, 2008, P NATL ACAD SCI USA, V105, P17453, DOI 10.1073/pnas.0805638105; MANSOUR SL, 1988, NATURE, V336, P348, DOI 10.1038/336348a0; Mitchell KJ, 2001, NAT GENET, V28, P241, DOI 10.1038/90074; Osoegawa K, 2000, GENOME RES, V10, P116; Pettitt SJ, 2009, NAT METHODS, V6, P493, DOI 10.1038/nmeth.1342; Poser I, 2008, NAT METHODS, V5, P409, DOI 10.1038/NMETH.1199; Poueymirou WT, 2007, NAT BIOTECHNOL, V25, P91, DOI 10.1038/nbt1263; RIELE HT, 1992, P NATL ACAD SCI USA, V89, P5128, DOI 10.1073/pnas.89.11.5128; Ringwald M, 2011, NUCLEIC ACIDS RES, V39, pD849, DOI 10.1093/nar/gkq879; ROBERTSON E, 1986, NATURE, V323, P445, DOI 10.1038/323445a0; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Sarov M, 2006, NAT METHODS, V3, P839, DOI 10.1038/nmeth933; Skarnes WC, 2005, P NATL ACAD SCI USA, V102, P13001, DOI 10.1073/pnas.0506279102; Skarnes WC, 2004, NAT GENET, V36, P543, DOI 10.1038/ng0604-543; SKARNES WC, 1992, GENE DEV, V6, P903, DOI 10.1101/gad.6.6.903; SKARNES WC, 1995, P NATL ACAD SCI USA, V92, P6592, DOI 10.1073/pnas.92.14.6592; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Testa G, 2004, GENESIS, V38, P151, DOI 10.1002/gene.20012; THOMAS KR, 1987, CELL, V51, P503, DOI 10.1016/0092-8674(87)90646-5; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Valenzuela DM, 2003, NAT BIOTECHNOL, V21, P652, DOI 10.1038/nbt822; Van der Weyden L, 2002, PHYSIOL GENOMICS, V11, P133, DOI 10.1152/physiolgenomics.00074.2002; Wang JP, 2006, MOL BIOTECHNOL, V32, P43, DOI 10.1385/MB:32:1:043; Wilming LG, 2008, NUCLEIC ACIDS RES, V36, pD753, DOI 10.1093/nar/gkm987; YAGI T, 1990, P NATL ACAD SCI USA, V87, P9918, DOI 10.1073/pnas.87.24.9918; Yanagawa Y, 1999, TRANSGENIC RES, V8, P215, DOI 10.1023/A:1008914020843; Yang SH, 2009, TRANSGENIC RES, V18, P483, DOI 10.1007/s11248-008-9237-9; Zambrowicz BP, 2003, P NATL ACAD SCI USA, V100, P14109, DOI 10.1073/pnas.2336103100; Zuniga AE, 2004, GENE DEV, V18, P1553, DOI 10.1101/gad.299904	48	1118	1165	1	138	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 16	2011	474	7351					337	U361		10.1038/nature10163	http://dx.doi.org/10.1038/nature10163			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777TD	21677750	Green Accepted			2022-12-24	WOS:000291647100037
J	Zhao, TB; Zhang, ZN; Rong, ZL; Xu, Y				Zhao, Tongbiao; Zhang, Zhen-Ning; Rong, Zhili; Xu, Yang			Immunogenicity of induced pluripotent stem cells	NATURE			English	Article							GENERATION; FIBROBLASTS; EXPRESSION	Induced pluripotent stem cells (iPSCs), reprogrammed from somatic cells with defined factors, hold great promise for regenerative medicine as the renewable source of autologous cells(1-5). Whereas it has been generally assumed that these autologous cells should be immune-tolerated by the recipient from whom the iPSCs are derived, their immunogenicity has not been vigorously examined. We show here that, whereas embryonic stem cells (ESCs) derived from inbred C57BL/6 (B6) mice can efficiently form teratomas in B6 mice without any evident immune rejection, the allogeneic ESCs from 129/SvJ mice fail to form teratomas in B6 mice due to rapid rejection by recipients. B6 mouse embryonic fibroblasts (MEFs) were reprogrammed into iPSCs by either retroviral approach (ViPSCs) or a novel episomal approach (EiPSCs) that causes no genomic integration. In contrast to B6 ESCs, teratomas formed by B6 ViPSCs were mostly immune-rejected by B6 recipients. In addition, the majority of teratomas formed by B6 EiPSCs were immunogenic in B6 mice with T cell infiltration, and apparent tissue damage and regression were observed in a small fraction of teratomas. Global gene expression analysis of teratomas formed by B6 ESCs and EiPSCs revealed a number of genes frequently over-expressed in teratomas derived from EiPSCs, and several such gene products were shown to contribute directly to the immunogenicity of the B6 EiPSC-derived cells in B6 mice. These findings indicate that, in contrast to derivatives of ESCs, abnormal gene expression in some cells differentiated from iPSCs can induce T-cell-dependent immune response in syngeneic recipients. Therefore, the immunogenicity of therapeutically valuable cells derived from patient-specific iPSCs should be evaluated before any clinical application of these autologous cells into the patients.	[Zhao, Tongbiao; Zhang, Zhen-Ning; Rong, Zhili; Xu, Yang] Univ Calif San Diego, Div Biol Sci, Mol Biol Sect, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Xu, Y (corresponding author), Univ Calif San Diego, Div Biol Sci, Mol Biol Sect, 9500 Gilman Dr, La Jolla, CA 92093 USA.	yangxu@ucsd.edu	liang, yan/H-3894-2011; Rong, Zhili/H-7561-2014; Zhao, Tongbiao/C-5761-2011	Rong, Zhili/0000-0002-1699-7074; Zhao, Tongbiao/0000-0003-1429-5818; Xu, Yang/0000-0001-5574-921X; Zhang, Zhen-Ning/0000-0003-3798-7104	NIH; California Institute for Regenerative Medicine [ET-01277]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine)	We thank M. Abe, S. Ding and K. Hochedlinger for their generous supply of integration-free mouse iPSCs. We thank N. Shastri for his advice on how to identify antigen-specific T cells. We thank J. Fink and Blue Lake of Xu laboratory as well as UCSD Cancer Center pathologic core for technical support. This work was supported by a NIH grant and an Early Translational Award from California Institute for Regenerative Medicine to Y.X. (ET-01277).	Chen Yao-Tseng, 2005, Cancer Immun, V5, P9; Chin MH, 2009, CELL STEM CELL, V5, P111, DOI 10.1016/j.stem.2009.06.008; Dhodapkar KM, 2010, P NATL ACAD SCI USA, V107, P8718, DOI 10.1073/pnas.0915086107; Doi A, 2009, NAT GENET, V41, P1350, DOI 10.1038/ng.471; Gore A, 2011, NATURE, V471, P63, DOI 10.1038/nature09805; Guermonprez P, 2002, ANNU REV IMMUNOL, V20, P621, DOI 10.1146/annurev.immunol.20.100301.064828; Jincho Y, 2010, J BIOL CHEM, V285, P26384, DOI 10.1074/jbc.M110.115915; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Kont V, 2008, MOL IMMUNOL, V45, P25, DOI 10.1016/j.molimm.2007.05.014; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Liu L, 2010, J BIOL CHEM, V285, P19483, DOI 10.1074/jbc.M110.131995; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Song H, 2007, NAT CELL BIOL, V9, P573, DOI 10.1038/ncb1571; Song H, 2010, CELL STEM CELL, V6, P80, DOI 10.1016/j.stem.2009.11.016; Stadtfeld M, 2008, SCIENCE, V322, P945, DOI 10.1126/science.1162494; Stadtfeld M, 2010, NATURE, V465, P175, DOI 10.1038/nature09017; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhao TBA, 2010, TRENDS CELL BIOL, V20, P170, DOI 10.1016/j.tcb.2009.12.004; Zhou HY, 2009, CELL STEM CELL, V4, P381, DOI 10.1016/j.stem.2009.04.005	23	1002	1053	3	256	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 9	2011	474	7350					212	U251		10.1038/nature10135	http://dx.doi.org/10.1038/nature10135			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774PE	21572395	Green Published			2022-12-24	WOS:000291397800050
J	Bendall, SC; Simonds, EF; Qiu, P; Amir, EAD; Krutzik, PO; Finck, R; Bruggner, RV; Melamed, R; Trejo, A; Ornatsky, OI; Balderas, RS; Plevritis, SK; Sachs, K; Pe'er, D; Tanner, SD; Nolan, GP				Bendall, Sean C.; Simonds, Erin F.; Qiu, Peng; Amir, El-ad D.; Krutzik, Peter O.; Finck, Rachel; Bruggner, Robert V.; Melamed, Rachel; Trejo, Angelica; Ornatsky, Olga I.; Balderas, Robert S.; Plevritis, Sylvia K.; Sachs, Karen; Pe'er, Dana; Tanner, Scott D.; Nolan, Garry P.			Single-Cell Mass Cytometry of Differential Immune and Drug Responses Across a Human Hematopoietic Continuum	SCIENCE			English	Article							TYROSINE KINASE INHIBITOR; FLOW-CYTOMETRY; SIGNALING NETWORKS; QUANTITATIVE-ANALYSIS; MYELOGENOUS LEUKEMIA; STEM-CELLS; IDENTIFICATION; LYMPHOCYTE; DASATINIB; ACTIVATION	Flow cytometry is an essential tool for dissecting the functional complexity of hematopoiesis. We used single-cell "mass cytometry" to examine healthy human bone marrow, measuring 34 parameters simultaneously in single cells (binding of 31 antibodies, viability, DNA content, and relative cell size). The signaling behavior of cell subsets spanning a defined hematopoietic hierarchy was monitored with 18 simultaneous markers of functional signaling states perturbed by a set of ex vivo stimuli and inhibitors. The data set allowed for an algorithmically driven assembly of related cell types defined by surface antigen expression, providing a superimposable map of cell signaling responses in combination with drug inhibition. Visualized in this manner, the analysis revealed previously unappreciated instances of both precise signaling responses that were bounded within conventionally defined cell subsets and more continuous phosphorylation responses that crossed cell population boundaries in unexpected manners yet tracked closely with cellular phenotype. Collectively, such single-cell analyses provide system-wide views of immune signaling in healthy human hematopoiesis, against which drug action and disease can be compared for mechanistic studies and pharmacologic intervention.	[Bendall, Sean C.; Simonds, Erin F.; Krutzik, Peter O.; Finck, Rachel; Bruggner, Robert V.; Trejo, Angelica; Sachs, Karen; Nolan, Garry P.] Stanford Univ, Dept Microbiol & Immunol, Baxter Lab Stem Cell Biol, Stanford, CA 94305 USA; [Qiu, Peng; Plevritis, Sylvia K.] Stanford Univ, Dept Radiol, Stanford, CA 94305 USA; [Amir, El-ad D.; Melamed, Rachel; Pe'er, Dana] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Ornatsky, Olga I.; Tanner, Scott D.] Univ Toronto, Toronto, ON M5S 3H6, Canada; [Ornatsky, Olga I.; Tanner, Scott D.] DVS Sci, Markham, ON L3R 6E7, Canada; [Balderas, Robert S.] BD Biosci, San Diego, CA 95131 USA; [Bruggner, Robert V.] Stanford Univ, Biomed Informat Program, Stanford, CA 94305 USA	Stanford University; Stanford University; Columbia University; University of Toronto; Stanford University	Nolan, GP (corresponding author), Stanford Univ, Dept Microbiol & Immunol, Baxter Lab Stem Cell Biol, Stanford, CA 94305 USA.	gnolan@stanford.edu	Nolan, Garry/AAE-7903-2019; Bendall, Sean/AGG-0126-2022	Bendall, Sean/0000-0003-1341-2453; Melamed, Rachel/0000-0003-3089-9806; Pe'er, Dana/0000-0002-9259-8817; Simonds, Erin/0000-0002-3497-4861; Nolan, Garry/0000-0002-8862-9043; Altan-Bonnet, Gregoire/0000-0002-7283-3162	Damon Runyon Cancer Research Foundation [DRG-2017-09]; NIH [U19 AI057229, P01 CA034233, 272200700038C, 1R01CA130826, U54 CA149145, 5U54 CA143907, RB2-01592, PN2 EY018228, NOI-HV-00242]; European Commission [HEALTH.2010.1.2-1]; California Institute for Regenerative Medicine [RB2-01592, DR-01477]; Genome Canada via the Ontario Genomics Institute for Cancer Research; Ontario Research Fund [ORF-GL2-01-003]; Burroughs Wellcome Fund; Packard Fellowship for Science and Engineering; NATIONAL CANCER INSTITUTE [P01CA034233, R01CA130826, U54CA143907, U54CA149145] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [PN2EY018228] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI057229] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007033] Funding Source: NIH RePORTER	Damon Runyon Cancer Research Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Commission(European CommissionEuropean Commission Joint Research Centre); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); Genome Canada via the Ontario Genomics Institute for Cancer Research; Ontario Research Fund; Burroughs Wellcome Fund(Burroughs Wellcome Fund); Packard Fellowship for Science and Engineering; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	The authors thank W. J. Fantl for critical reading of the. manuscript. S.C.B. is supported by the Damon Runyon Cancer Research Foundation Fellowship (DRG-2017-09). This work was supported by NIH grants, U19 AI057229, P01 CA034233, 272200700038C, 1R01CA130826, U54 CA149145, 5U54 CA143907, RB2-01592, PN2 EY018228, NOI-HV-00242, and HEALTH.2010.1.2-1 (European Commission grant to the Sweden Diatools Consortium), as well as California Institute for Regenerative Medicine (DR-01477, RB2-01592) to G.P.N. G.P.N. is supported by an endowed chair from Rachtford and Carlota A. Harris. S.D.T. was supported by Genome Canada via the Ontario Genomics Institute for Cancer Research and by the Ontario Research Fund ORF-GL2-01-003. D.P. holds a Career Award at the Scientific Interface from the Burroughs Wellcome Fund and Packard Fellowship for Science and Engineering. Some antibodies were a gift from Becton Dickinson Biosciences. B.B. is a paid employee of Becton Dickinson, and G.P.N. and P.K. are paid consultants for Becton Dickinson Biosciences. G.P.N. is a member of the Board of Directors and a consultant for DVS Sciences. O.O., G.P.N., and S.T. have equity holdings in DVS Biosciences, and S.T. is an employee of DVS Sciences A patent has been applied for on the SPADE algorithm on behalf of Stanford University. Raw data and SPADE trees can be downloaded open access at www.cytobank.org/nolanlab.	Albeck JG, 2008, MOL CELL, V30, P11, DOI 10.1016/j.molcel.2008.02.012; Autissier P, 2010, CYTOM PART A, V77A, P410, DOI 10.1002/cyto.a.20859; Bandura DR, 2009, ANAL CHEM, V81, P6813, DOI 10.1021/ac901049w; Chang JT, 2007, SCIENCE, V315, P1687, DOI 10.1126/science.1139393; Dohse M, 2010, DRUG METAB DISPOS, V38, P1371, DOI 10.1124/dmd.109.031302; Druker BJ, 2008, BLOOD, V112, P4808, DOI 10.1182/blood-2008-07-077958; Fraser IDC, 2009, NAT IMMUNOL, V10, P327, DOI 10.1038/ni.1711; Frisa PS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007064; FULWYLER MJ, 1965, SCIENCE, V150, P910, DOI 10.1126/science.150.3698.910; Gibbs KD, 2011, BLOOD, V117, P4226, DOI 10.1182/blood-2010-07-298232; Hardy RR, 2007, IMMUNITY, V26, P703, DOI 10.1016/j.immuni.2007.05.013; HERZENBERG LA, 1973, J EXP MED, V137, P1311, DOI 10.1084/jem.137.6.1311; Irish JM, 2004, CELL, V118, P217, DOI 10.1016/j.cell.2004.06.028; Irish JM, 2010, P NATL ACAD SCI USA, V107, P12747, DOI 10.1073/pnas.1002057107; Janes KA, 2006, CELL, V124, P1225, DOI 10.1016/j.cell.2006.01.041; Janes KA, 2003, MOL CELL PROTEOMICS, V2, P463, DOI 10.1074/mcp.M300045-MCP200; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; KONDO M, 2003, Nat Med, V21, P2; Kornblau SM, 2010, CLIN CANCER RES, V16, P3721, DOI 10.1158/1078-0432.CCR-10-0093; Kotecha N, 2008, CANCER CELL, V14, P335, DOI 10.1016/j.ccr.2008.08.014; KRASNOW MA, 1991, SCIENCE, V251, P81, DOI 10.1126/science.1898782; Krutzik PO, 2008, NAT CHEM BIOL, V4, P132, DOI 10.1038/nchembio.2007.59; Krutzik PO, 2006, NAT METHODS, V3, P361, DOI 10.1038/NMETH872; Krutzik PO, 2003, CYTOM PART A, V55A, P61, DOI 10.1002/cyto.a.10072; Kurosaki T, 2010, ANNU REV IMMUNOL, V28, P21, DOI 10.1146/annurev.immunol.021908.132541; LeBien TW, 2008, BLOOD, V112, P1570, DOI 10.1182/blood-2008-02-078071; Lemischka IR, 2005, ANN NY ACAD SCI, V1044, P132, DOI 10.1196/annals.1349.017; Lindauer M, 2010, RECENT RESULTS CANC, V184, P83, DOI 10.1007/978-3-642-01222-8_7; Lou XD, 2007, ANGEW CHEM INT EDIT, V46, P6111, DOI 10.1002/anie.200700796; Majeti R, 2007, CELL STEM CELL, V1, P635, DOI 10.1016/j.stem.2007.10.001; Monroe JG, 2006, NAT REV IMMUNOL, V6, P283, DOI 10.1038/nri1808; Nam S, 2007, MOL CANCER THER, V6, P1400, DOI 10.1158/1535-7163.MCT-06-0446; O'Brien CA, 2009, SEMIN RADIAT ONCOL, V19, P71, DOI 10.1016/j.semradonc.2008.11.001; Oh ST, 2010, BLOOD, V116, P988, DOI 10.1182/blood-2010-02-270108; Ornatsky OI, 2008, ANAL CHEM, V80, P2539, DOI 10.1021/ac702128m; Ornatsky O, 2010, J IMMUNOL METHODS, V361, P1, DOI 10.1016/j.jim.2010.07.002; Perfetto SP, 2004, NAT REV IMMUNOL, V4, P648, DOI 10.1038/nri1416; Quintas-Cardama A, 2009, BLOOD, V114, P261, DOI 10.1182/blood-2008-09-180604; Robinson JP, 2005, CYTOM PART A, V67A, P61, DOI 10.1002/cyto.a.20183; Roederer M, 1997, Semin Immunol, V9, P389, DOI 10.1006/smim.1997.0097; Rosen DB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013543; Russwurm G, 2010, BLOOD, V116, P2617, DOI 10.1182/blood-2010-04-279786; Sachs K, 2005, SCIENCE, V308, P523, DOI 10.1126/science.1105809; Schade AE, 2008, BLOOD, V111, P1366, DOI 10.1182/blood-2007-04-084814; Shapiro HM, 2003, PRACTICAL FLOW CYTOM; Sillaber C, 2009, EUR J CLIN INVEST, V39, P1098, DOI 10.1111/j.1365-2362.2009.02206.x; Surh CD, 2008, IMMUNITY, V29, P848, DOI 10.1016/j.immuni.2008.11.002; Takano K, 2000, INT J HEMATOL, V72, P48; Tan JT, 2001, P NATL ACAD SCI USA, V98, P8732, DOI 10.1073/pnas.161126098; Tarnok A, 2010, CYTOM PART A, V77A, P6, DOI 10.1002/cyto.a.20844; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; ULEVITCH RJ, 1995, ANNU REV IMMUNOL, V13, P437, DOI 10.1146/annurev.iy.13.040195.002253; van Lochem EG, 2004, CYTOM PART B-CLIN CY, V60B, P1, DOI 10.1002/cyto.b.20008; Yang C, 2008, LEUKEMIA, V22, P1755, DOI 10.1038/leu.2008.163	54	1578	1659	30	656	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 6	2011	332	6030					687	696		10.1126/science.1198704	http://dx.doi.org/10.1126/science.1198704			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759RK	21551058	Green Accepted, Green Submitted			2022-12-24	WOS:000290265800035
J	Wood, AJ; Lo, TW; Zeitler, B; Pickle, CS; Ralston, EJ; Lee, AH; Amora, R; Miller, JC; Leung, E; Meng, XD; Zhang, L; Rebar, EJ; Gregory, PD; Urnov, FD; Meyer, BJ				Wood, Andrew J.; Lo, Te-Wen; Zeitler, Bryan; Pickle, Catherine S.; Ralston, Edward J.; Lee, Andrew H.; Amora, Rainier; Miller, Jeffrey C.; Leung, Elo; Meng, Xiangdong; Zhang, Lei; Rebar, Edward J.; Gregory, Philip D.; Urnov, Fyodor D.; Meyer, Barbara J.			Targeted Genome Editing Across Species Using ZFNs and TALENs	SCIENCE			English	Article									[Wood, Andrew J.; Lo, Te-Wen; Pickle, Catherine S.; Ralston, Edward J.; Meyer, Barbara J.] Univ Calif Berkeley, Howard Hughes Med Inst, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Zeitler, Bryan; Lee, Andrew H.; Amora, Rainier; Miller, Jeffrey C.; Leung, Elo; Meng, Xiangdong; Zhang, Lei; Rebar, Edward J.; Gregory, Philip D.; Urnov, Fyodor D.] Sangamo BioSci Inc, Richmond, CA 94804 USA	Howard Hughes Medical Institute; University of California System; University of California Berkeley; Sangamo Therapeutics, Inc.	Meyer, BJ (corresponding author), Univ Calif Berkeley, Howard Hughes Med Inst, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.	bjmeyer@berkeley.edu		Wood, Andrew/0000-0002-0653-2070; Meyer, Barbara/0000-0002-6530-4588; Gregory, Philip/0000-0001-9249-2468	NIH [GM30702]; HHMI; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM030702, R01GM030702] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	A.J.W. is a Sir Henry Wellcome Post-Doctoral Fellow. NIH (GM30702) and HHMI funded these studies.	Bogdanove AJ, 2010, CURR OPIN PLANT BIOL, V13, P394, DOI 10.1016/j.pbi.2010.04.010; Meyer BJ, 2010, CURR OPIN GENET DEV, V20, P179, DOI 10.1016/j.gde.2010.03.008; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Morton J, 2006, P NATL ACAD SCI USA, V103, P16370, DOI 10.1073/pnas.0605633103; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842	5	441	613	4	128	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 15	2011	333	6040					307	307		10.1126/science.1207773	http://dx.doi.org/10.1126/science.1207773			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	792HF	21700836	Green Accepted			2022-12-24	WOS:000292732000032
J	Autry, AE; Adachi, M; Nosyreva, E; Na, ES; Los, MF; Cheng, PF; Kavalali, ET; Monteggia, LM				Autry, Anita E.; Adachi, Megunai; Nosyreva, Elena; Na, Elisa S.; Los, Maarten F.; Cheng, Peng-fei; Kavalali, Ege T.; Monteggia, Lisa M.			NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses	NATURE			English	Article							NEUROTROPHIC FACTOR; PROTEIN-SYNTHESIS; PRESYNAPTIC FUNCTION; DEPRESSION; KETAMINE; BDNF; NEUROTRANSMISSION; MODELS; PHARMACOKINETICS; ANTAGONIST	Clinical studies consistently demonstrate that a single sub-psychomimetic dose of ketamine, an ionotropic glutamatergic NMDAR (N-methyl-D-aspartate receptor) antagonist, produces fast-acting antidepressant responses in patients suffering from major depressive disorder, although the underlying mechanism is unclear(1-3). Depressed patients report the alleviation of major depressive disorder symptoms within two hours of a single, low-dose intravenous infusion of ketamine, with effects lasting up to two weeks(1-3), unlike traditional antidepressants (serotonin re-uptake inhibitors), which take weeks to reach efficacy. This delay is a major drawback to current therapies for major depressive disorder and faster-acting antidepressants are needed, particularly for suicide-risk patients'. The ability of ketamine to produce rapidly acting, long-lasting antidepressant responses in depressed patients provides a unique opportunity to investigate underlying cellular mechanisms. Here we show that ketamine and other NMDAR antagonists produce fast-acting behavioural antidepressant-like effects in mouse models, and that these effects depend on the rapid synthesis of brain-derived neurotrophic factor. We find that the ketamine-mediated blockade of NMDAR at rest deactivates eukaryotic elongation factor 2 (eEF2) kinase (also called CaMKIII), resulting in reduced eEF2 phosphorylation and de-suppression of translation of brain-derived neurotrophic factor. Furthermore, we find that inhibitors of eEF2 kinase induce fast-acting behavioural antidepressant-like effects. Our findings indicate that the regulation of protein synthesis by spontaneous neurotransmission may serve as a viable therapeutic target for the development of fast-acting antidepressants.	[Autry, Anita E.; Adachi, Megunai; Na, Elisa S.; Los, Maarten F.; Cheng, Peng-fei; Monteggia, Lisa M.] Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA; [Nosyreva, Elena; Kavalali, Ege T.] Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Kavalali, ET (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Psychiat, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	ege.kavalali@utsouthwestern.edu	Ferrua, Camila/F-5439-2015; Adachi, Megumi/M-7746-2017; Autry, Anita/ABF-9006-2021	Ferrua, Camila/0000-0001-8071-377X; Adachi, Megumi/0000-0003-3404-6640; Na, Elisa/0000-0001-7236-9868	UT Southwestern Medical Center;  [MH070727];  [MH066198];  [T32 MH 76690-02]; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH076690, R01MH066198, R01MH070727] Funding Source: NIH RePORTER	UT Southwestern Medical Center; ; ; ; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank M. A. Mahgoub for assistance with the animal experiments, S. Birnbaum and A Pettersen for assistance with the behavioural testing and members of the Monteggia and Kavalali laboratories for discussions and cornments on the manuscript. This work was supported by grant MH070727 (L.M.M.), grant MH066198 (E.T.K.) and the Division of Basic Sciences Training Program at UT Southwestern Medical Center, T32 MH 76690-02 (A.E.A.). E.T.K. is an Established Investigator of the American Heart Association.	Adachi M, 2008, BIOL PSYCHIAT, V63, P642, DOI 10.1016/j.biopsych.2007.09.019; Akbarian S, 2002, J NEUROSCI, V22, P4153, DOI 10.1523/JNEUROSCI.22-10-04153.2002; Atasoy D, 2008, J NEUROSCI, V28, P10151, DOI 10.1523/JNEUROSCI.2432-08.2008; Berman RM, 2000, BIOL PSYCHIAT, V47, P351, DOI 10.1016/S0006-3223(99)00230-9; Berton O, 2006, SCIENCE, V311, P864, DOI 10.1126/science.1120972; Capasso A, 1996, GEN PHARMACOL, V27, P707, DOI 10.1016/0306-3623(95)02077-2; Chen B, 2001, BIOL PSYCHIAT, V50, P260, DOI 10.1016/S0006-3223(01)01083-6; Cleary C, 2008, BRAIN RES BULL, V76, P469, DOI 10.1016/j.brainresbull.2008.03.005; Detke MJ, 1997, EXP CLIN PSYCHOPHARM, V5, P107, DOI 10.1037/1064-1297.5.2.107; Duman CH, 2007, BIOL PSYCHIAT, V61, P661, DOI 10.1016/j.biopsych.2006.05.047; Espinosa F, 2009, J NEUROPHYSIOL, V101, P2290, DOI 10.1152/jn.90754.2008; Fernandez F, 2007, NAT NEUROSCI, V10, P411, DOI 10.1038/nn1860; Hoshaw BA, 2005, BRAIN RES, V1037, P204, DOI 10.1016/j.brainres.2005.01.007; Jakawich SK, 2010, NEURON, V68, P1143, DOI 10.1016/j.neuron.2010.11.034; Kavalali ET, 2011, PHYSIOLOGY, V26, P45, DOI 10.1152/physiol.00040.2010; Kavalali ET, 1999, P NATL ACAD SCI USA, V96, P12893, DOI 10.1073/pnas.96.22.12893; KRISTENSEN JD, 1995, BRIT J ANAESTH, V74, P193, DOI 10.1093/bja/74.2.193; Lattal KM, 2001, J NEUROSCI, V21, P5773, DOI 10.1523/JNEUROSCI.21-15-05773.2001; Li NX, 2010, SCIENCE, V329, P959, DOI 10.1126/science.1190287; Lindskog M, 2010, P NATL ACAD SCI USA, V107, P21806, DOI 10.1073/pnas.1016399107; Maeng S, 2008, BIOL PSYCHIAT, V63, P349, DOI 10.1016/j.biopsych.2007.05.028; Monteggia LM, 2004, P NATL ACAD SCI USA, V101, P10827, DOI 10.1073/pnas.0402141101; Park S, 2008, NEURON, V59, P70, DOI 10.1016/j.neuron.2008.05.023; Poleszak E, 2007, PHARMACOL BIOCHEM BE, V88, P158, DOI 10.1016/j.pbb.2007.07.018; PORSOLT RD, 1977, NATURE, V266, P730, DOI 10.1038/266730a0; Price RB, 2009, BIOL PSYCHIAT, V66, P522, DOI 10.1016/j.biopsych.2009.04.029; SCHWARTZ PH, 1991, RES COMMUN CHEM PATH, V73, P181; Shirayama Y, 2002, J NEUROSCI, V22, P3251, DOI 10.1523/JNEUROSCI.22-08-03251.2002; Sinner B., 2008, V182, P313, DOI 10.1007/978-3-540-74806-9_15; Sutton MA, 2007, NEURON, V55, P648, DOI 10.1016/j.neuron.2007.07.030; Sutton MA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.265pe19; Tanaka JI, 2008, SCIENCE, V319, P1683, DOI 10.1126/science.1152864; Zarate CA, 2006, ARCH GEN PSYCHIAT, V63, P856, DOI 10.1001/archpsyc.63.8.856	33	1231	1294	8	306	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 7	2011	475	7354					91	U109		10.1038/nature10130	http://dx.doi.org/10.1038/nature10130			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	788RE	21677641	Green Accepted			2022-12-24	WOS:000292461300051
J	Langevin, F; Crossan, GP; Rosado, IV; Arends, MJ; Patel, KJ				Langevin, Frederic; Crossan, Gerry P.; Rosado, Ivan V.; Arends, Mark J.; Patel, Ketan J.			Fancd2 counteracts the toxic effects of naturally produced aldehydes in mice	NATURE			English	Article							FETAL ALCOHOL SYNDROME; FANCONI-ANEMIA; DNA-ADDUCTS; CHILDHOOD LEUKEMIA; KNOCKOUT MICE; BONE-MARROW; ACETALDEHYDE; ETHANOL; CONSUMPTION; METABOLISM	Reactive aldehydes are common carcinogens. They are also by-products of several metabolic pathways and, without enzymatic catabolism, may accumulate and cause DNA damage. Ethanol, which is metabolished to acetaldehyde, is both carcinogenic and teratogenic in humans. Here we find that the Fanconi anaemia DNA repair pathway counteracts acetaldehyde-induced genotoxicity in mice. Our results show that the acetaldehyde-catabolising enzyme Aldh2 is essential for the development of Fancd2(-/-) embryos. Nevertheless, acetaldehyde-catabolism-competent mothers (Aldh2(+/-)) can support the development of double-mutant (Aldh2(-/-)Fancd2(-/-)) mice. However, these embryos are usually sensitive to ethanol exposure in utero, and ethanol consumption by postnatal double-deficient mice rapidly precipitates bone marrow failure. Lastly, Aldh2(-/-)Fancd2(-/-) mice spontaneously develop acute leukaemia. Acetaldehyde-mediated DNA damage may critically contribute to the genesis of fetal alcohol syndrome in fetuses, as well as to abnormal development, haematopoietic failure and cancer predisposition in Fanconi anaemia patients.	[Langevin, Frederic; Crossan, Gerry P.; Rosado, Ivan V.; Patel, Ketan J.] MRC Lab Mol Biol, Cambridge CB2 0QH, England; [Arends, Mark J.] Univ Cambridge, Addenbrookes Hosp, Dept Pathol, Cambridge CB2 2QQ, England; [Patel, Ketan J.] Univ Cambridge, Addenbrookes Hosp, Dept Med, Cambridge CB2 0QQ, England	MRC Laboratory Molecular Biology; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Patel, KJ (corresponding author), MRC Lab Mol Biol, Hills Rd, Cambridge CB2 0QH, England.	kjp@mrc-lmb.cam.ac.uk	Rosado, Ivan/AAZ-9068-2020	Rosado, Ivan/0000-0001-7409-7341; Crossan, Gerry/0000-0002-7974-009X	Children's Leukaemia Trust; Fanconi Anaemia Research Fund; MRC [MC_U105178811] Funding Source: UKRI; Medical Research Council [MC_U105178811] Funding Source: researchfish	Children's Leukaemia Trust; Fanconi Anaemia Research Fund; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank M. Grompe for Fancd2 knockout mice, J. Sale and S. Takeda for DT40 strains, N. Sugimura and F. Gergely for comments on the manuscript. We are grateful to T. Langford, R. Berks, V. Smith, J. Wiles, C. Shepherd, M. Kidd, M. Brown, A. Mead, R. Pannell, J. Garaycoechea and A. Shortland for their assistance with animal experiments and husbandry. We thank N. Grant and P. Banks from the Visual Aids department for photographic images and W. Zhao of the Human Research Tissue Bank (NIHR Cambridge Biomedical Research Centre) for processing histology. F.L. and I.V.R. are funded by the Children's Leukaemia Trust and Fanconi Anaemia Research Fund, respectively. K.J.P. acknowledges M. Neuberger, N. McIntyre and C. Decal for support.	ABEL EL, 1991, ALCOHOL CLIN EXP RES, V15, P514, DOI 10.1111/j.1530-0277.1991.tb00553.x; Alpi A, 2007, MOL CELL BIOL, V27, P8421, DOI 10.1128/MCB.00504-07; Alter BP, 2005, ARCH OTOLARYNGOL, V131, P635, DOI 10.1001/archotol.131.7.635; Brooks PJ, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000050; Chen CH, 2008, SCIENCE, V321, P1493, DOI 10.1126/science.1158554; Chen L, 2007, CHEM RES TOXICOL, V20, P108, DOI 10.1021/tx060232x; Cheng G, 2003, CHEM RES TOXICOL, V16, P145, DOI 10.1021/tx025614r; Crossan GP, 2011, NAT GENET, V43, P147, DOI 10.1038/ng.752; Hazen SL, 1998, BIOCHEMISTRY-US, V37, P6864, DOI 10.1021/bi972449j; Houghtaling S, 2003, GENE DEV, V17, P2021, DOI 10.1101/gad.1103403; King G, 1998, J EXP ZOOL, V282, P12; Knipscheer P, 2009, SCIENCE, V326, P1698, DOI 10.1126/science.1182372; Kunitoh S, 1997, J PHARMACOL EXP THER, V280, P527; Latino-Martel P, 2010, CANCER EPIDEM BIOMAR, V19, P1238, DOI 10.1158/1055-9965.EPI-09-1110; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; MacArthur AC, 2008, CANCER CAUSE CONTROL, V19, P283, DOI 10.1007/s10552-007-9091-8; Marc N, 2000, BIOCHEM GENET, V38, P297, DOI 10.1023/A:1002057000788; Marietta C, 2009, MUTAT RES-FUND MOL M, V664, P77, DOI 10.1016/j.mrfmmm.2009.03.011; Matsuda T, 2007, CARCINOGENESIS, V28, P2363, DOI 10.1093/carcin/bgm057; McKay JD, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001333; MEAGHER RC, 1982, NEW ENGL J MED, V307, P845, DOI 10.1056/NEJM198209303071402; MICHOT F, 1987, ACTA HAEMATOL-BASEL, V78, P252, DOI 10.1159/000205888; Nagayoshi H, 2009, MUTAT RES-GEN TOX EN, V673, P74, DOI 10.1016/j.mrgentox.2008.11.009; NAKAO S, 1991, AM J HEMATOL, V37, P120, DOI 10.1002/ajh.2830370210; Niedzwiedz W, 2004, MOL CELL, V15, P607, DOI 10.1016/j.molcel.2004.08.009; O'Brien PJ, 2005, CRIT REV TOXICOL, V35, P609, DOI 10.1080/10408440591002183; OSHEA KS, 1979, J ANAT, V128, P65; Pappa A, 2003, BIOCHEM J, V376, P615, DOI 10.1042/BJ20030810; Parmar K, 2009, MUTAT RES-FUND MOL M, V668, P133, DOI 10.1016/j.mrfmmm.2009.03.015; Patel KJ, 2007, DNA REPAIR, V6, P885, DOI 10.1016/j.dnarep.2007.02.002; Perez-Miller S, 2010, NAT STRUCT MOL BIOL, V17, P159, DOI 10.1038/nsmb.1737; Ridpath JR, 2007, CANCER RES, V67, P11117, DOI 10.1158/0008-5472.CAN-07-3028; Riveros-Rosas H, 1997, ARCH MED RES, V28, P453; Seitz HK, 2007, NAT REV CANCER, V7, P599, DOI 10.1038/nrc2191; Stein S, 2006, MUTAT RES-GEN TOX EN, V608, P1, DOI 10.1016/j.mrgentox.2006.01.009; SULIK KK, 1981, SCIENCE, V214, P936, DOI 10.1126/science.6795717; Vasiliou V, 2004, DRUG METAB REV, V36, P279, DOI 10.1081/DMR-120034001; VASILIOU V, 1989, COMP BIOCHEM PHYS C, V94, P671, DOI 10.1016/0742-8413(89)90130-8; Wang M, 2000, CHEM RES TOXICOL, V13, P1149, DOI 10.1021/tx000118t; WEBSTER WS, 1983, TERATOLOGY, V27, P231, DOI 10.1002/tera.1420270211; Yu HS, 2009, TOXICOL MECH METHOD, V19, P535, DOI 10.3109/15376510903401708	41	357	364	3	70	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 7	2011	475	7354					53	U67		10.1038/nature10192	http://dx.doi.org/10.1038/nature10192			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	788RE	21734703				2022-12-24	WOS:000292461300043
J	de Jager, M; Weissing, FJ; Herman, PMJ; Nolet, BA; van de Koppel, J				de Jager, Monique; Weissing, Franz J.; Herman, Peter M. J.; Nolet, Bart A.; van de Koppel, Johan			Levy Walks Evolve Through Interaction Between Movement and Environmental Complexity	SCIENCE			English	Article							RANDOM SEARCHES; PATTERNS; ANIMALS; STRATEGIES; FLIGHTS; SUCCESS	Ecological theory predicts that animal movement is shaped by its efficiency of resource acquisition. Focusing solely on efficiency, however, ignores the fact that animal activity can affect resource availability and distribution. Here, we show that feedback between individual behavior and environmental complexity can explain movement strategies in mussels. Specifically, experiments show that mussels use a Levy walk during the formation of spatially patterned beds, and models reveal that this Levy movement accelerates pattern formation. The emergent patterning in mussel beds, in turn, improves individual fitness. These results suggest that Levy walks evolved as a result of the selective advantage conferred by autonomously generated, emergent spatial patterns in mussel beds. Our results emphasize that an interaction between individual selection and habitat complexity shapes animal movement in natural systems.	[de Jager, Monique; Herman, Peter M. J.; van de Koppel, Johan] Netherlands Inst Ecol NIOO KNAW, Spatial Ecol Dept, NL-4400 AC Yerseke, Netherlands; [Weissing, Franz J.] Univ Groningen, Theoret Biol Grp, Ctr Ecol & Evolutionary Studies, NL-9747 AG Groningen, Netherlands; [Nolet, Bart A.] Netherlands Inst Ecol NIOO KNAW, Dept Anim Ecol, NL-6700 AB Wageningen, Netherlands; [Nolet, Bart A.; van de Koppel, Johan] Netherlands Inst Ecol NIOO KNAW, Project Grp Movement Ecol, NL-6700 AB Wageningen, Netherlands	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); University of Groningen; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW)	de Jager, M (corresponding author), Netherlands Inst Ecol NIOO KNAW, Spatial Ecol Dept, POB 140, NL-4400 AC Yerseke, Netherlands.	m.dejager@nioo.knaw.nl	Van de Koppel, Johan/E-7266-2010; Nolet, Bart A/C-1416-2008; de Jager, Monique/ABC-8594-2020; Herman, Peter M.J./A-9018-2011	Nolet, Bart A/0000-0002-7437-4879; Herman, Peter M.J./0000-0003-2188-6341; de Jager, Monique/0000-0001-5271-6957; Weissing, Franz J./0000-0003-3281-663X	Netherlands Organization of Scientific Research-Earth and Life Sciences (NWO-ALW); KNAW	Netherlands Organization of Scientific Research-Earth and Life Sciences (NWO-ALW)(Netherlands Organization for Scientific Research (NWO)); KNAW	For assistance, we thank S. Benhamou, A. Kolzsch, J. Powell, G. Theraulaz, W. Mooij, A. van den Berg, and J. van Soelen. We thank S. Kefi, F. Bartumeus, B. Silliman, and M. Rietkerk for comments on manuscript drafts. M.d.J. and J.v.d.K. designed the study. Experimental data were collected by M.d.J. and J.v.d.K. B.A.N. introduced the topic of Levy walks, and F.J.W. suggested the evolutionary invasion analysis. All analyses and modeling were done by M.d.J., assisted by J.v.d.K., P.M.J.H., and F.J.W. The paper was written by M.d.J. and J.v.d.K., and all authors contributed to the subsequent drafts. The authors declare no competing financial interests. M.d.J. is supported by a grant from the Netherlands Organization of Scientific Research-Earth and Life Sciences (NWO-ALW), and Project Group Movement Ecology by the KNAW Strategic Fund. This is publication 5033 of the Netherlands Institute of Ecology (NIOO-KNAW).	Adler PB, 2001, OECOLOGIA, V128, P465, DOI 10.1007/s004420100737; Bartumeus F, 2005, ECOLOGY, V86, P3078, DOI 10.1890/04-1806; Bartumeus F, 2009, OIKOS, V118, P488, DOI 10.1111/j.1600-0706.2009.17313.x; Benhamou S, 2008, ECOLOGY, V89, P2351, DOI 10.1890/08-0313.1; Benhamou S, 2007, ECOLOGY, V88, P1962, DOI 10.1890/06-1769.1; Boyer D, 2009, J PHYS A-MATH THEOR, V42, DOI 10.1088/1751-8113/42/43/434014; Codling EA, 2008, J R SOC INTERFACE, V5, P813, DOI 10.1098/rsif.2008.0014; Dercole F, 2008, PRINC SER THEOR COMP, P1; Geesteranus R. A. M., 1942, Archives Neerlandaises de Zoologie, V6, P283; Geritz SAH, 1998, EVOL ECOL, V12, P35, DOI 10.1023/A:1006554906681; Hauert C, 2006, ADV COMPLEX SYST, V9, P315, DOI 10.1142/S0219525906000847; Humphries NE, 2010, NATURE, V465, P1066, DOI 10.1038/nature09116; JONES CG, 1994, OIKOS, V69, P373, DOI 10.2307/3545850; Nolet BA, 2002, J ANIM ECOL, V71, P451, DOI 10.1046/j.1365-2656.2002.00610.x; Ramos-Fernandez G, 2004, BEHAV ECOL SOCIOBIOL, V55, P223, DOI 10.1007/s00265-003-0700-6; Reynolds AM, 2009, J THEOR BIOL, V260, P98, DOI 10.1016/j.jtbi.2009.05.033; Reynolds AM, 2009, ECOLOGY, V90, P877, DOI 10.1890/08-0153.1; Reynolds AM, 2007, ECOLOGY, V88, P1955, DOI 10.1890/06-1916.1; Reynolds A, 2008, ECOLOGY, V89, P2347, DOI 10.1890/07-1688.1; Sims DW, 2008, NATURE, V451, P1098, DOI 10.1038/nature06518; van de Koppel J, 2005, AM NAT, V165, pE66; van de Koppel J, 2008, SCIENCE, V322, P739, DOI 10.1126/science.1163952; Viswanathan GM, 2010, NATURE, V465, P1018, DOI 10.1038/4651018a; Viswanathan GM, 1999, NATURE, V401, P911, DOI 10.1038/44831; Viswanathan GM, 2000, PHYSICA A, V282, P1, DOI 10.1016/S0378-4371(00)00071-6	25	194	195	3	86	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 24	2011	332	6037					1551	1553		10.1126/science.1201187	http://dx.doi.org/10.1126/science.1201187			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782EE	21700872	Green Published, Green Submitted			2022-12-24	WOS:000291990000043
J	Liu, N; Hentschel, M; Weiss, T; Alivisatos, AP; Giessen, H				Liu, Na; Hentschel, Mario; Weiss, Thomas; Alivisatos, A. Paul; Giessen, Harald			Three-Dimensional Plasmon Rulers	SCIENCE			English	Article							ELECTROMAGNETICALLY INDUCED TRANSPARENCY; GOLD NANOPARTICLES; MOLECULAR RULER; DNA; ANALOG; METAMATERIALS; DESIGN	Plasmon rulers can be used to determine nanoscale distances within chemical or biological species. They are based on the spectral shift of the scattering spectrum when two plasmonic nanoparticles approach one another. However, the one-dimensionality of current plasmon rulers hampers the comprehensive understanding of many intriguing processes in soft matter, which take place in three dimensions. We demonstrated a three-dimensional plasmon ruler that is based on coupled plasmonic oligomers in combination with high-resolution plasmon spectroscopy. This enables retrieval of the complete spatial configuration of complex macromolecular and biological processes as well as their dynamic evolution.	[Liu, Na; Alivisatos, A. Paul] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Liu, Na; Alivisatos, A. Paul] Lawrence Berkeley Natl Lab, Div Mat Sci, Berkeley, CA 94720 USA; [Hentschel, Mario; Weiss, Thomas; Giessen, Harald] Univ Stuttgart, Inst Phys 4, D-70569 Stuttgart, Germany; [Hentschel, Mario; Weiss, Thomas; Giessen, Harald] Univ Stuttgart, Res Ctr Scope, D-70569 Stuttgart, Germany; [Weiss, Thomas] Univ Clermont Ferrand, LASMEA, F-63177 Clermont Ferrand, France	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of Stuttgart; University of Stuttgart	Liu, N (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	nliu@lbl.gov	Liu, Na/C-8190-2014; Hentschel, Mario/N-2093-2015; Alivisatos, Paul/N-8863-2015; Weiss, Thomas/AAS-9946-2021; Giessen, Harald/AAG-7586-2019	Liu, Na/0000-0001-5831-3382; Alivisatos, Paul/0000-0001-6895-9048; Weiss, Thomas/0000-0002-4991-6779; Giessen, Harald/0000-0002-4270-3850; Hentschel, Mario/0000-0002-6882-4183	NIH [NIH NOT-OD-09-056]; Deutsche Forschungsgemeinschaft (DFG) [SPP1391, FOR557, GI 269/11-1]; German Ministry of Science [13N9048, 13N10146]; Landesstiftung B; Deutsch-Franzosische Hochschule-Universite franco-allemande	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); German Ministry of Science; Landesstiftung B; Deutsch-Franzosische Hochschule-Universite franco-allemande	We thank T. Pfau and M. Dressel for useful discussions and comments and S. Hein for his material visualizations. N.L. and A.P.A. were supported by the NIH Plasmon Rulers Project, grant NIH NOT-OD-09-056. M.H., T.W., and H.G. were financially supported by the Deutsche Forschungsgemeinschaft (DFG) (grants SPP1391 and FOR557), by The German Ministry of Science (grants 13N9048 and 13N10146), and by Landesstiftung B. W.T.W. were also supported by the DFG (grant GI 269/11-1) and by Deutsch-Franzosische Hochschule-Universite franco-allemande.	Alzar CLG, 2002, AM J PHYS, V70, P37, DOI 10.1119/1.1412644; Cigler P, 2010, NAT MATER, V9, P918, DOI [10.1038/NMAT2877, 10.1038/nmat2877]; Fan JA, 2010, SCIENCE, V328, P1135, DOI 10.1126/science.1187949; Fleischhauer M, 2005, REV MOD PHYS, V77, P633, DOI 10.1103/RevModPhys.77.633; Granet G, 2002, J OPT A-PURE APPL OP, V4, pS145, DOI 10.1088/1464-4258/4/5/362; Han DR, 2011, SCIENCE, V332, P342, DOI 10.1126/science.1202998; Hentschel M, 2010, NANO LETT, V10, P2721, DOI 10.1021/nl101938p; Jones MR, 2010, NAT MATER, V9, P913, DOI [10.1038/NMAT2870, 10.1038/nmat2870]; Jun YW, 2009, P NATL ACAD SCI USA, V106, P17735, DOI 10.1073/pnas.0907367106; Lassiter JB, 2010, NANO LETT, V10, P3184, DOI 10.1021/nl102108u; Liu GL, 2006, NAT NANOTECHNOL, V1, P47, DOI 10.1038/nnano.2006.51; Liu N, 2008, NAT MATER, V7, P31, DOI 10.1038/nmat2072; Liu N, 2010, NANO LETT, V10, P1103, DOI 10.1021/nl902621d; Liu N, 2009, NAT MATER, V8, P758, DOI [10.1038/NMAT2495, 10.1038/nmat2495]; Mao CD, 1997, NATURE, V386, P137, DOI 10.1038/386137b0; Mastroianni AJ, 2009, J AM CHEM SOC, V131, P8455, DOI 10.1021/ja808570g; ORDAL MA, 1983, APPL OPTICS, V22, P1099, DOI 10.1364/AO.22.001099; Papasimakis N, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.253903; Sharma J, 2009, SCIENCE, V323, P112, DOI 10.1126/science.1165831; Sonnichsen C, 2005, NANO LETT, V5, P301, DOI 10.1021/nl048089k; Sonnichsen C, 2005, NAT BIOTECHNOL, V23, P741, DOI 10.1038/nbt1100; STRYER L, 1978, ANNU REV BIOCHEM, V47, P819, DOI 10.1146/annurev.bi.47.070178.004131; Tan SJ, 2011, NAT NANOTECHNOL, V6, P268, DOI [10.1038/nnano.2011.49, 10.1038/NNANO.2011.49]; Tassin P, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.053901; Winfree E, 1998, NATURE, V394, P539, DOI 10.1038/28998; Xu H, 2010, OPT EXPRESS, V18, P17736, DOI 10.1364/OE.18.017736; Zhang S, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.047401; Zheng JP, 2009, NATURE, V461, P74, DOI 10.1038/nature08274; Zheng JW, 2006, NANO LETT, V6, P1502, DOI 10.1021/nl060994c	29	484	490	15	430	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 17	2011	332	6036					1407	1410		10.1126/science.1199958	http://dx.doi.org/10.1126/science.1199958			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778FT	21680838				2022-12-24	WOS:000291689000035
J	Duy, C; Hurtz, C; Shojaee, S; Cerchietti, L; Geng, HM; Swaminathan, S; Klemm, L; Kweon, SM; Nahar, R; Braig, M; Park, E; Kim, YM; Hofmann, WK; Herzog, S; Jumaa, H; Koeffler, HP; Yu, JJ; Heisterkamp, N; Graeber, TG; Wu, H; Ye, BH; Melnick, A; Muschen, M				Duy, Cihangir; Hurtz, Christian; Shojaee, Seyedmehdi; Cerchietti, Leandro; Geng, Huimin; Swaminathan, Srividya; Klemm, Lars; Kweon, Soo-mi; Nahar, Rahul; Braig, Melanie; Park, Eugene; Kim, Yong-mi; Hofmann, Wolf-Karsten; Herzog, Sebastian; Jumaa, Hassan; Koeffler, H. Phillip; Yu, J. Jessica; Heisterkamp, Nora; Graeber, Thomas G.; Wu, Hong; Ye, B. Hilda; Melnick, Ari; Mueschen, Markus			BCL6 enables Ph+ acute lymphoblastic leukaemia cells to survive BCR-ABL1 kinase inhibition	NATURE			English	Article							CHRONIC MYELOID-LEUKEMIA; GERMINAL-CENTER FORMATION; IMATINIB RESISTANCE; INITIATING CELLS; IN-VITRO; B-CELLS; EXPRESSION; STAT5; PROLIFERATION; INFLAMMATION	Tyrosine kinase inhibitors (TKIs) are widely used to treat patients with leukaemia driven by BCR-ABL1 (ref. 1) and other oncogenic tyrosine kinases(2,3). Recent efforts have focused on developing more potent TKIs that also inhibit mutant tyrosine kinases(4,5). However, even effective TKIs typically fail to eradicate leukaemia-initiating cells (LICs)(6-8), which often cause recurrence of leukaemia after initially successful treatment. Here we report the discovery of a novel mechanism of drug resistance, which is based on protective feedback signalling of leukaemia cells in response to treatment with TKI. We identify BCL6 as a central component of this drug-resistance pathway and demonstrate that targeted inhibition of BCL6 leads to eradication of drug-resistant and leukaemia-initiating subclones.	[Duy, Cihangir; Hurtz, Christian; Shojaee, Seyedmehdi; Swaminathan, Srividya; Klemm, Lars; Nahar, Rahul; Mueschen, Markus] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Duy, Cihangir; Kweon, Soo-mi; Nahar, Rahul; Park, Eugene; Kim, Yong-mi; Heisterkamp, Nora; Mueschen, Markus] Univ So Calif, Dept Pediat, Childrens Hosp Los Angeles, Los Angeles, CA 90027 USA; [Cerchietti, Leandro; Geng, Huimin; Melnick, Ari] Weill Cornell Med Coll, Dept Med, New York, NY 10065 USA; [Cerchietti, Leandro; Geng, Huimin; Melnick, Ari] Weill Cornell Med Coll, Dept Pharmacol, New York, NY 10065 USA; [Braig, Melanie] Univ Klinikum Hamburg Eppendorf, Dept Hematol & Oncol, Hamburg, Germany; [Hofmann, Wolf-Karsten] Heidelberg Univ, Klinikum Mannheim, Dept Hematol & Oncol, Mannheim, Germany; [Hurtz, Christian; Herzog, Sebastian; Jumaa, Hassan] Univ Freiburg, Fac Biol, BIOSS Ctr Biol Signalling Studies, Freiburg, Germany; [Hurtz, Christian; Herzog, Sebastian; Jumaa, Hassan] Max Planck Inst Immunobiol, Freiburg, Germany; [Koeffler, H. Phillip] Cedars Sinai Med Ctr, Div Hematol & Oncol, Los Angeles, CA 90095 USA; [Yu, J. Jessica; Ye, B. Hilda] Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA; [Graeber, Thomas G.; Wu, Hong] Univ Calif Los Angeles, Dept Mol Pharmacol, Los Angeles, CA 90095 USA	University of California System; University of California San Francisco; Children's Hospital Los Angeles; University of Southern California; Cornell University; Cornell University; University of Hamburg; University Medical Center Hamburg-Eppendorf; Ruprecht Karls University Heidelberg; University of Freiburg; Max Planck Society; Cedars Sinai Medical Center; Yeshiva University; Albert Einstein College of Medicine; University of California System; University of California Los Angeles	Muschen, M (corresponding author), Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA.	markus.muschen@ucsf.edu	kim, y/AAR-6095-2020; Heisterkamp, Nora/C-1698-2012; Melnick, Ari/AAA-5763-2020; Duy, Cihangir/AAD-7735-2022	Heisterkamp, Nora/0000-0003-2769-2273; Duy, Cihangir/0000-0001-9150-9379; Herzog, Sebastian/0000-0001-7167-3489; Kim, Yong-Mi/0000-0003-3793-6438; Graeber, Thomas/0000-0001-8574-9181; Cerchietti, Leandro/0000-0003-0608-1350	National Institutes of Health/National Cancer Institute [R01CA104348, R01CA085573, R01CA026038, R01CA090321, R01CA137060, R01CA139032, R01CA157664, R21CA152497]; Leukemia and Lymphoma Society [SCOR 7005-11]; Alex's Lemonade Stand Foundation for Pediatric Cancer Research; California Institute for Regenerative Medicine [TR02-1816]; William Laurence and Blanche Hughes Foundation; Stand Up To Cancer-American Association for Cancer Research [IRG00909]; NATIONAL CANCER INSTITUTE [R01CA090321, R21CA152497, R01CA085573, R01CA157644, R01CA026038, R01CA104348, R01CA137060, R01CA157664, R01CA139032] Funding Source: NIH RePORTER	National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Alex's Lemonade Stand Foundation for Pediatric Cancer Research; California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); William Laurence and Blanche Hughes Foundation; Stand Up To Cancer-American Association for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank R. Dalla-Favera and L. Hennighausen for sharing BCL6<SUP>-/-</SUP> and STAT5<SUP>fl/fl</SUP> mice and wild-type controls with us. We thank A. L. Shaffer and L. M. Staudt for sharing their inducible BCL6 constructs. This work was supported by grants from the National Institutes of Health/National Cancer Institute through R01CA104348 (to A. M.), R01CA085573 (to B.H.Y.), R01CA026038 (to H. P. K.), R01CA090321 (to N.H.), R01CA137060 (to M. M.), R01CA139032 (to M. M.), R01CA157664 (to M. M.) and R21CA152497 (to M. M.), grants from the Leukemia and Lymphoma Society (to M. M.) Leukemia and Lymphoma Society SCOR 7005-11 (PI B. J. Druker), a grant from the Alex's Lemonade Stand Foundation for Pediatric Cancer Research (to M. M.), the California Institute for Regenerative Medicine through TR02-1816 (to M. M.), the William Laurence and Blanche Hughes Foundation and a Stand Up To Cancer-American Association for Cancer Research Innovative Research Grant IRG00909 (to M. M.). A. M. and M. M. are Scholars of the Leukemia and Lymphoma Society.	Ahmad KF, 2003, MOL CELL, V12, P1551, DOI 10.1016/S1097-2765(03)00454-4; Armstrong SA, 2003, CANCER CELL, V3, P173, DOI 10.1016/S1535-6108(03)00003-5; Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841; Cerchietti LC, 2010, CANCER CELL, V17, P400, DOI 10.1016/j.ccr.2009.12.050; Cerchietti LC, 2009, BLOOD, V113, P3397, DOI 10.1182/blood-2008-07-168773; Chakravarti Laha, 1967, HDB METHODS APPL STA, V1, P392; Choudhary C, 2009, MOL CELL, V36, P326, DOI 10.1016/j.molcel.2009.09.019; Ci WM, 2009, BLOOD, V113, P5536, DOI 10.1182/blood-2008-12-193037; Cui Y, 2004, MOL CELL BIOL, V24, P8037, DOI 10.1128/MCB.24.18.8037-8047.2004; de Mattos SF, 2004, MOL CELL BIOL, V24, P10058, DOI 10.1128/MCB.24.22.10058-10071.2004; Dent AL, 1997, SCIENCE, V276, P589, DOI 10.1126/science.276.5312.589; Druker BJ, 2001, NEW ENGL J MED, V344, P1038, DOI 10.1056/NEJM200104053441402; Duy C, 2010, J EXP MED, V207, P1209, DOI 10.1084/jem.20091299; Ghetu AF, 2008, MOL CELL, V29, P384, DOI 10.1016/j.molcel.2007.12.026; Godar S, 2008, CELL, V134, P62, DOI 10.1016/j.cell.2008.06.006; Goldberg Z, 2004, CELL CYCLE, V3, P1188; Graham SM, 2002, BLOOD, V99, P319, DOI 10.1182/blood.V99.1.319; Groszer M, 2001, SCIENCE, V294, P2186, DOI 10.1126/science.1065518; Gruber TA, 2010, CANCER RES, V70, P7411, DOI 10.1158/0008-5472.CAN-10-1438; Janes MR, 2010, NAT MED, V16, P205, DOI 10.1038/nm.2091; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; Krause DS, 2006, NAT MED, V12, P1175, DOI 10.1038/nm1489; Kumar MS, 2009, GENE DEV, V23, P2700, DOI 10.1101/gad.1848209; Meydan N, 1996, NATURE, V379, P645, DOI 10.1038/379645a0; Mullighan CG, 2008, SCIENCE, V322, P1377, DOI 10.1126/science.1164266; Naka K, 2010, NATURE, V463, P676, DOI 10.1038/nature08734; O'Hare T, 2009, CANCER CELL, V16, P401, DOI 10.1016/j.ccr.2009.09.028; Onishi M, 1998, MOL CELL BIOL, V18, P3871, DOI 10.1128/MCB.18.7.3871; Oravecz-Wilson KI, 2009, CANCER CELL, V16, P137, DOI 10.1016/j.ccr.2009.06.007; Pear WS, 1998, BLOOD, V92, P3780, DOI 10.1182/blood.V92.10.3780.422k15_3780_3792; Phan RT, 2004, NATURE, V432, P635, DOI 10.1038/nature03147; Polo JM, 2004, NAT MED, V10, P1329, DOI 10.1038/nm1134; Polo JM, 2007, P NATL ACAD SCI USA, V104, P3207, DOI 10.1073/pnas.0611399104; Pratilas CA, 2009, P NATL ACAD SCI USA, V106, P4519, DOI 10.1073/pnas.0900780106; Saito M, 2007, CANCER CELL, V12, P280, DOI 10.1016/j.ccr.2007.08.011; Shaffer AL, 2000, IMMUNITY, V13, P199, DOI 10.1016/S1074-7613(00)00020-0; Shah NP, 2004, SCIENCE, V305, P399, DOI 10.1126/science.1099480; Skorta I, 2009, CANCER RES, V69, P9337, DOI 10.1158/0008-5472.CAN-09-0548; SONEOKA Y, 1995, NUCLEIC ACIDS RES, V23, P628, DOI 10.1093/nar/23.4.628; Trageser D, 2009, J EXP MED, V206, P1739, DOI 10.1084/jem.20090004; Walker SR, 2007, ONCOGENE, V26, P224, DOI 10.1038/sj.onc.1209775; Wendel HG, 2006, P NATL ACAD SCI USA, V103, P7444, DOI 10.1073/pnas.0602402103; Williams RT, 2007, GENE DEV, V21, P2283, DOI 10.1101/gad.1588607; Williams RT, 2006, P NATL ACAD SCI USA, V103, P6688, DOI 10.1073/pnas.0602030103; Ye BH, 1997, NAT GENET, V16, P161, DOI 10.1038/ng0697-161	45	147	153	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 19	2011	473	7347					384	U572		10.1038/nature09883	http://dx.doi.org/10.1038/nature09883			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765QA	21593872	Green Accepted, Green Submitted			2022-12-24	WOS:000290722400051
J	Imasaki, T; Calero, G; Cai, G; Tsai, KL; Yamada, K; Cardelli, F; Erdjument-Bromage, H; Tempst, P; Berger, I; Kornberg, GL; Asturias, FJ; Kornberg, RD; Takagi, Y				Imasaki, Tsuyoshi; Calero, Guillermo; Cai, Gang; Tsai, Kuang-Lei; Yamada, Kentaro; Cardelli, Francesco; Erdjument-Bromage, Hediye; Tempst, Paul; Berger, Imre; Kornberg, Guy Lorch; Asturias, Francisco J.; Kornberg, Roger D.; Takagi, Yuichiro			Architecture of the Mediator head module	NATURE			English	Article							RNA-POLYMERASE-II; REPEAT DOMAIN; COMPLEX; YEAST; PROTEIN; INITIATION; SUBUNIT; BINDING; SYSTEM; CTD	Mediator is a key regulator of eukaryotic transcription(1), connecting activators and repressors bound to regulatory DNA elements with RNA polymerase II1-4 (Pol II). In the yeast Saccharomyces cerevisiae, Mediator comprises 25 subunits with a total mass of more than one megadalton (refs 5, 6) and is organized into three modules, called head, middle/arm and tail(7-9). Our understanding of Mediator assembly and its role in regulating transcription has been impeded so far by limited structural information. Here we report the crystal structure of the essential Mediator head module (seven subunits, with a mass of 223 kilodaltons) at a resolution of 4.3 angstroms. Our structure reveals three distinct domains, with the integrity of the complex centred on a bundle of ten helices from five different head subunits. An intricate pattern of interactions within this helical bundle ensures the stable assembly of the head subunits and provides the binding sites for general transcription factors and Pol II. Our structural and functional data suggest that the head module juxtaposes transcription factor IIH and the carboxy-terminal domain of the largest subunit of Pol II, thereby facilitating phosphorylation of the carboxy-terminal domain of Pol II. Our results reveal architectural principles underlying the role of Mediator in the regulation of gene expression.	[Imasaki, Tsuyoshi; Yamada, Kentaro; Cardelli, Francesco; Takagi, Yuichiro] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Calero, Guillermo; Kornberg, Guy Lorch; Kornberg, Roger D.] Stanford Univ, Dept Biol Struct, Sch Med, Stanford, CA 94350 USA; [Cai, Gang; Tsai, Kuang-Lei; Asturias, Francisco J.] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; [Erdjument-Bromage, Hediye; Tempst, Paul] Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10021 USA; [Berger, Imre] European Mol Biol Lab, Grenoble Outstn, F-38042 Grenoble 9, France	Indiana University System; Indiana University Bloomington; Stanford University; Scripps Research Institute; Memorial Sloan Kettering Cancer Center; European Molecular Biology Laboratory (EMBL)	Takagi, Y (corresponding author), Indiana Univ Sch Med, Dept Biochem & Mol Biol, 635 Barnhill Dr, Indianapolis, IN 46202 USA.	ytakagi@iupui.edu	Cai, Gang/B-1103-2012; Cai, Gang/AAA-4439-2020	Cai, Gang/0000-0001-8622-3907; Cai, Gang/0000-0001-8622-3907; Tempst, Paul/0000-0002-6680-3987; Imasaki, Tsuyoshi/0000-0001-5462-1820; Berger, Imre/0000-0001-7518-9045; Erdjument-Bromage, Hediye/0000-0003-0224-3594	NCI [Y1-CO-1020]; NIGMS [Y1-GM-1104]; US National Science Foundation [MCB 0843026]; American Heart Association [0735395N]; Human Frontier Science Program; NIH [Y1-CO-1020, Y1-GM-1104, R01 GM67167, GM36659]; NCI Cancer Center [P30 CA08748]; European Commission; DOE [DE-AC02-06CH11357, DE-AC02-05CH11231]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067167, R37GM036659, R01GM036659] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); US National Science Foundation(National Science Foundation (NSF)); American Heart Association(American Heart Association); Human Frontier Science Program(Human Frontier Science Program); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); European Commission(European CommissionEuropean Commission Joint Research Centre); DOE(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank L. Messerle for providing the Ta<INF>6</INF>Br<INF>14</INF> metal cluster, T. Hurley for reading the manuscript, M. Georgiadis for discussions, C. Kaplan for his advice on yeast genetics, T. Earnest for giving us beam time and L. Fabrizio for assisting with the N-terminal sequence analysis. We thank the CCP4 summer school, funded by the NCI (Y1-CO-1020), and NIGMS (Y1-GM-1104) for their assistance with the twinning data analysis. Y.T. thanks the instructors on 'The X-Ray Methods Course' at Cold Spring Harbor Laboratory. This work was supported by US National Science Foundation grant MCB 0843026 (Y.T.); the American Heart Association 0735395N (Y.T.); a Human Frontier Science Program long-term fellowship (T.I.); NIH grants R01 GM67167 (F.J.A.) and GM36659 (R.D.K.); NCI Cancer Center Support Grant P30 CA08748 (to the MSKCC Microchemistry and Proteomics Core Laboratory); and the European Commission Framework Program 7 projects INSTRUCT and P-CUBE (I.B.). X-ray data were collected at the GM/CA-CAT at the Advanced Photon Source, Argonne National Laboratory. GM/CA-CAT is funded by the NIH (Y1-CO-1020 and Y1-GM-1104) and the Advanced Photon Source is supported by the DOE (DE-AC02-06CH11357). Portions of this research were carried out at the Stanford Synchrotron Radiation Lightsource, supported by the DOE and the NIH, and at the Advanced Light Source, supported by the DOE (DE-AC02-05CH11231).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Asturias FJ, 1999, SCIENCE, V283, P985, DOI 10.1126/science.283.5404.985; Bjorklund S, 2005, TRENDS BIOCHEM SCI, V30, P240, DOI 10.1016/j.tibs.2005.03.008; Boube M, 2002, CELL, V110, P143, DOI 10.1016/S0092-8674(02)00830-9; Brignole EJ, 2009, NAT STRUCT MOL BIOL, V16, P190, DOI 10.1038/nsmb.1532; Bryson K, 2005, NUCLEIC ACIDS RES, V33, pW36, DOI 10.1093/nar/gki410; Cai G, 2010, NAT STRUCT MOL BIOL, V17, P273, DOI 10.1038/nsmb.1757; Cai G, 2009, STRUCTURE, V17, P559, DOI 10.1016/j.str.2009.01.016; Conaway RC, 2005, TRENDS BIOCHEM SCI, V30, P250, DOI 10.1016/j.tibs.2005.03.002; Cowtan K, 1998, ACTA CRYSTALLOGR D, V54, P750, DOI 10.1107/S0907444997016247; Cowtan K, 2010, ACTA CRYSTALLOGR D, V66, P470, DOI 10.1107/S090744490903947X; Davis JA, 2002, MOL CELL, V10, P409, DOI 10.1016/S1097-2765(02)00598-1; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Esnault C, 2008, MOL CELL, V31, P337, DOI 10.1016/j.molcel.2008.06.021; Fitzgerald DJ, 2006, NAT METHODS, V3, P1021, DOI 10.1038/nmeth983; Guglielmi B, 2004, NUCLEIC ACIDS RES, V32, P5379, DOI 10.1093/nar/gkh878; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Kang JS, 2001, J BIOL CHEM, V276, P42003, DOI 10.1074/jbc.M105961200; KIM YJ, 1994, CELL, V77, P599, DOI 10.1016/0092-8674(94)90221-6; KOLESKE AJ, 1992, CELL, V69, P883, DOI 10.1016/0092-8674(92)90298-Q; Kornberg RD, 2005, TRENDS BIOCHEM SCI, V30, P235, DOI 10.1016/j.tibs.2005.03.011; Lariviere L, 2006, NAT STRUCT MOL BIOL, V13, P895, DOI 10.1038/nsmb1143; Li MZ, 2007, NAT METHODS, V4, P251, DOI 10.1038/NMETH1010; Malik S, 2010, NAT REV GENET, V11, P761, DOI 10.1038/nrg2901; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; NONET ML, 1989, GENETICS, V123, P715; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PAYNE JM, 1989, J BIOL CHEM, V264, P19621; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Scheres SHW, 2005, J MOL BIOL, V348, P139, DOI 10.1016/j.jmb.2005.02.031; Schroder GF, 2010, NATURE, V464, P1218, DOI 10.1038/nature08892; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Sogaard TMM, 2007, J BIOL CHEM, V282, P14113, DOI 10.1074/jbc.M701345200; Sorzano COS, 2004, J STRUCT BIOL, V148, P194, DOI 10.1016/j.jsb.2004.06.006; STOFFLER G, 1983, ULTRASTRUCTURE MACRO, P409; Svejstrup JQ, 1997, P NATL ACAD SCI USA, V94, P6075, DOI 10.1073/pnas.94.12.6075; Takagi Y, 2006, J BIOL CHEM, V281, P80, DOI 10.1074/jbc.M508253200; Takagi Y, 2006, MOL CELL, V23, P355, DOI 10.1016/j.molcel.2006.06.007; Tempst Paul, 1994, Methods (Orlando), V6, P248, DOI 10.1006/meth.1994.1027; THOMPSON CM, 1993, CELL, V73, P1361, DOI 10.1016/0092-8674(93)90362-T; THOMPSON CM, 1995, P NATL ACAD SCI USA, V92, P4587, DOI 10.1073/pnas.92.10.4587; TISCHENDORF GW, 1974, MOL GEN GENET, V134, P187, DOI 10.1007/BF00267715	42	89	95	1	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 14	2011	475	7355					240	U45		10.1038/nature10162	http://dx.doi.org/10.1038/nature10162			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791UA	21725323	Green Accepted			2022-12-24	WOS:000292690500053
J	Dominguez-Escobar, J; Chastanet, A; Crevenna, AH; Fromion, V; Wedlich-Soldner, R; Carballido-Lopez, R				Dominguez-Escobar, Julia; Chastanet, Arnaud; Crevenna, Alvaro H.; Fromion, Vincent; Wedlich-Soeldner, Roland; Carballido-Lopez, Rut			Processive Movement of MreB-Associated Cell Wall Biosynthetic Complexes in Bacteria	SCIENCE			English	Article							PENICILLIN-BINDING PROTEINS; ACTIN-LIKE PROTEINS; BACILLUS-SUBTILIS; ESCHERICHIA-COLI; SYNTHETIC COMPLEXES; SHAPE DETERMINATION; MORPHOGENESIS; LOCALIZATION; CYTOSKELETON; ELONGATION	The peptidoglycan cell wall and the actin-like MreB cytoskeleton are major determinants of cell shape in rod-shaped bacteria. The prevailing model postulates that helical, membrane-associated MreB filaments organize elongation-specific peptidoglycan-synthesizing complexes along sidewalls. We used total internal reflection fluorescence microscopy to visualize the dynamic relation between MreB isoforms and cell wall synthesis in live Bacillus subtilis cells. During exponential growth, MreB proteins did not form helical structures. Instead, together with other morphogenetic factors, they assembled into discrete patches that moved processively along peripheral tracks perpendicular to the cell axis. Patch motility was largely powered by cell wall synthesis, and MreB polymers restricted diffusion of patch components in the membrane and oriented patch motion.	[Dominguez-Escobar, Julia; Crevenna, Alvaro H.; Wedlich-Soeldner, Roland] Max Planck Inst Biochem, D-82152 Martinsried, Germany; [Chastanet, Arnaud; Carballido-Lopez, Rut] INRA, Micalis UMR1319, F-78352 Jouy En Josas, France; [Chastanet, Arnaud; Carballido-Lopez, Rut] AgroParisTech, UMR Micalis, F-78350 Jouy En Josas, France; [Fromion, Vincent] INRA, Math Informat & Genomes UR1077, F-78352 Jouy En Josas, France	Max Planck Society; INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Wedlich-Soldner, R (corresponding author), Max Planck Inst Biochem, Klopferspitz 18, D-82152 Martinsried, Germany.	wedlich@biochem.mpg.de; rut.carballido-lopez@jouy.inra.fr	Crevenna, Alvaro/Q-4476-2019; Crevenna, Alvaro/E-9125-2016; LOPEZ, RUT CARBALLIDO/G-2283-2015	Crevenna, Alvaro/0000-0002-5580-3711; Crevenna, Alvaro/0000-0002-5580-3711; LOPEZ, RUT CARBALLIDO/0000-0001-9383-8811; CHASTANET, Arnaud/0000-0003-0320-4861	Human Frontier Science Program (HFSP) [HFSP-RGY0067/2009-C]; European Molecular Biology Organization; French National Research Agency (ANR) [ANR-08-JCJC-0024-01]; Max Planck society	Human Frontier Science Program (HFSP)(Human Frontier Science Program); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); French National Research Agency (ANR)(French National Research Agency (ANR)); Max Planck society(Max Planck Society)	We thank R. Daniel and L. J. Wu for sharing unpublished strains and for helpful suggestions, D.-J. Scheffers for strains, N. Campo for the antibody against GFP, and P. Hardy for manuscript editing. This work was supported by a Human Frontier Science Program (HFSP) Young Investigator grant (R.C.-L. and R.W.-S., HFSP-RGY0067/2009-C); a European Molecular Biology Organization short-term fellowship (R.C.-L), The French National Research Agency (ANR) (R.C.-L., ANR-08-JCJC-0024-01), and the Max Planck society (R.W.-S.).	Barrett D, 2007, J BIOL CHEM, V282, P31964, DOI 10.1074/jbc.M705440200; BROWN ED, 1995, J BACTERIOL, V177, P4194, DOI 10.1128/jb.177.14.4194-4197.1995; Cabeen MT, 2010, ANNU REV GENET, V44, P365, DOI 10.1146/annurev-genet-102108-134845; Carballido-Lopez R, 2003, DEV CELL, V4, P19, DOI 10.1016/S1534-5807(02)00403-3; Carballido-Lopez R, 2007, CURR OPIN MICROBIOL, V10, P611, DOI 10.1016/j.mib.2007.09.008; Carballido-Lopez R, 2006, MICROBIOL MOL BIOL R, V70, P888, DOI 10.1128/MMBR.00014-06; Carballido-Lopez R, 2006, DEV CELL, V11, P399, DOI 10.1016/j.devcel.2006.07.017; Claessen D, 2008, MOL MICROBIOL, V68, P1029, DOI 10.1111/j.1365-2958.2008.06210.x; Daniel RA, 2003, CELL, V113, P767, DOI 10.1016/S0092-8674(03)00421-5; Divakaruni AV, 2007, MOL MICROBIOL, V66, P174, DOI 10.1111/j.1365-2958.2007.05910.x; Fleming TC, 2010, GENE DEV, V24, P1160, DOI 10.1101/gad.1925210; Henriques AO, 1998, MOL MICROBIOL, V28, P235, DOI 10.1046/j.1365-2958.1998.00766.x; Holtje JV, 1998, MICROBIOL MOL BIOL R, V62, P181; Kahne D, 2005, CHEM REV, V105, P425, DOI 10.1021/cr030103a; Kim SY, 2006, P NATL ACAD SCI USA, V103, P10929, DOI 10.1073/pnas.0604503103; Margolin W, 2009, CURR BIOL, V19, pR812, DOI 10.1016/j.cub.2009.06.033; Murray T, 1997, J BACTERIOL, V179, P3021, DOI 10.1128/jb.179.9.3021-3029.1997; Paredez AR, 2006, SCIENCE, V312, P1491, DOI 10.1126/science.1126551; Scheffers DJ, 2004, MOL MICROBIOL, V51, P749, DOI 10.1046/j.1365-2958.2003.03854.x; Soufo HJD, 2006, MOL MICROBIOL, V62, P1340, DOI 10.1111/j.1365-2958.2006.05457.x; Soufo HJD, 2004, EMBO REP, V5, P789, DOI 10.1038/sj.embor.7400209; Uehara T, 2008, J BACTERIOL, V190, P3914, DOI 10.1128/JB.00207-08; Wei YP, 2003, J BACTERIOL, V185, P4717, DOI 10.1128/JB.185.16.4717-4726.2003; White CL, 2010, MOL MICROBIOL, V76, P616, DOI 10.1111/j.1365-2958.2010.07108.x; Yu JH, 2011, J CELL SCI, V124, P1533, DOI 10.1242/jcs.079038	25	365	371	3	82	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 8	2011	333	6039					225	228		10.1126/science.1203466	http://dx.doi.org/10.1126/science.1203466			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	789GG	21636744	Bronze, Green Published			2022-12-24	WOS:000292502700051
J	Kim, N; Huang, SYN; Williams, JS; Li, YC; Clark, AB; Cho, JE; Kunkel, TA; Pommier, Y; Jinks-Robertson, S				Kim, Nayun; Huang, Shar-yin N.; Williams, Jessica S.; Li, Yue C.; Clark, Alan B.; Cho, Jang-Eun; Kunkel, Thomas A.; Pommier, Yves; Jinks-Robertson, Sue			Mutagenic Processing of Ribonucleotides in DNA by Yeast Topoisomerase I	SCIENCE			English	Article							MISMATCH REPAIR PROTEINS; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTION; CAMPTOTHECIN; INSTABILITY; ANTICANCER; SEQUENCE; H2	The ribonuclease (RNase) H class of enzymes degrades the RNA component of RNA:DNA hybrids and is important in nucleic acid metabolism. RNase H2 is specialized to remove single ribonucleotides [ribonucleoside monophosphates (rNMPs)] from duplex DNA, and its absence in budding yeast has been associated with the accumulation of deletions within short tandem repeats. Here, we demonstrate that rNMP-associated deletion formation requires the activity of Top1, a topoisomerase that relaxes supercoils by reversibly nicking duplex DNA. The reported studies extend the role of Top1 to include the processing of rNMPs in genomic DNA into irreversible single-strand breaks, an activity that can have distinct mutagenic consequences and may be relevant to human disease.	[Kim, Nayun; Li, Yue C.; Cho, Jang-Eun; Jinks-Robertson, Sue] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA; [Huang, Shar-yin N.; Pommier, Yves] NCI, Lab Mol Pharmacol, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Williams, Jessica S.; Clark, Alan B.; Kunkel, Thomas A.] NIEHS, Lab Mol Genet, NIH, Res Triangle Pk, NC 27709 USA; [Williams, Jessica S.; Clark, Alan B.; Kunkel, Thomas A.] NIEHS, Struct Biol Lab, NIH, Res Triangle Pk, NC 27709 USA	Duke University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Jinks-Robertson, S (corresponding author), Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA.	sue.robertson@duke.edu	Kunkel, Thomas A./D-5088-2019	Kunkel, Thomas A./0000-0002-9900-1788	NIH [R01 GM38464, R01 GM93197]; Center for Cancer Research, National Cancer Institute, NIH; Division of Intramural Research of the NIH, National Institute of Environmental Health Sciences [Z01 ES065070, Z01 ES065089]; NATIONAL CANCER INSTITUTE [ZIABC006161, ZIABC006150] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES065070] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Cancer Research, National Cancer Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Division of Intramural Research of the NIH, National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	S.J.-R. was supported by NIH grants R01 GM38464 and R01 GM93197; Y.P. was supported by the Intramural Program, Center for Cancer Research, National Cancer Institute, NIH; and T.A.K. was supported by Projects Z01 ES065070 and Z01 ES065089 from the Division of Intramural Research of the NIH, National Institute of Environmental Health Sciences.	Chen JJZ, 2000, NUCLEIC ACIDS RES, V28, P3649, DOI 10.1093/nar/28.18.3649; Clark AB, 2011, DNA REPAIR, V10, P476, DOI 10.1016/j.dnarep.2011.02.001; Clark AB, 2010, CELL CYCLE, V9, P4422, DOI 10.4161/cc.9.22.14052; Crow YJ, 2006, NAT GENET, V38, P910, DOI 10.1038/ng1842; Greene CN, 1997, MOL CELL BIOL, V17, P2844, DOI 10.1128/MCB.17.5.2844; Harfe BD, 1999, MOL CELL BIOL, V19, P4766; HSIANG YH, 1988, CANCER RES, V48, P1722; JAXEL C, 1991, J BIOL CHEM, V266, P20418; Jeong HS, 2004, NUCLEIC ACIDS RES, V32, P407, DOI 10.1093/nar/gkh209; Lippert MJ, 2011, P NATL ACAD SCI USA, V108, P698, DOI 10.1073/pnas.1012363108; McElhinny SAN, 2010, NAT CHEM BIOL, V6, P774, DOI [10.1038/NCHEMBIO.424, 10.1038/nchembio.424]; Pommier Y, 2006, PROG NUCLEIC ACID RE, V81, P179, DOI 10.1016/S0079-6603(06)81005-6; Pommier Y, 2010, CHEM BIOL, V17, P421, DOI 10.1016/j.chembiol.2010.04.012; PORTER SE, 1989, MOL CELL BIOL, V9, P541, DOI 10.1128/MCB.9.2.541; Sekiguchi J, 1997, MOL CELL, V1, P89, DOI 10.1016/S1097-2765(00)80010-6; Takahashi T, 2011, P NATL ACAD SCI USA, V108, P692, DOI 10.1073/pnas.1012582108; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831	17	219	219	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 24	2011	332	6037					1561	1564		10.1126/science.1205016	http://dx.doi.org/10.1126/science.1205016			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782EE	21700875	Green Accepted			2022-12-24	WOS:000291990000046
J	Schafer, RJ; Moore, T				Schafer, Robert J.; Moore, Tirin			Selective Attention from Voluntary Control of Neurons in Prefrontal Cortex	SCIENCE			English	Article							FRONTAL EYE FIELDS	Animals can learn to voluntarily control neuronal activity within various brain areas through operant conditioning, but the relevance of that control to cognitive functions is unknown. We found that rhesus monkeys can control the activity of neurons within the frontal eye field (FEF), an oculomotor area of the prefrontal cortex. However, operantly driven FEF activity was primarily associated with selective visual attention, and not oculomotor preparation. Attentional effects were untrained and were observed both behaviorally and neurophysiologically. Furthermore, selective attention correlated with voluntary, but not spontaneous, fluctuations in FEF activity. Our results reveal a specific association of voluntarily driven neuronal activity with "top-down" attention and suggest a basis for the use of neurofeedback training to treat disorders of attention.	[Schafer, Robert J.; Moore, Tirin] Stanford Univ, Dept Neurobiol, Sch Med, Stanford, CA 94305 USA; [Moore, Tirin] Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA	Stanford University; Howard Hughes Medical Institute; Stanford University	Moore, T (corresponding author), Stanford Univ, Dept Neurobiol, Sch Med, Stanford, CA 94305 USA.	tirin@stanford.edu		Schafer, Robert/0000-0002-0874-830X	NIH [EY14924]; National Defense Science and Engineering Graduate fellowship; National Research Service Award [F31MH078490]; NATIONAL EYE INSTITUTE [R56EY014924, R01EY014924] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH078490] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Defense Science and Engineering Graduate fellowship; National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank D. Aldrich for technical assistance, and E. I. Knudsen and K. V. Shenoy for comments on the manuscript. Supported by NIH grant EY14924, a National Defense Science and Engineering Graduate fellowship, and National Research Service Award F31MH078490 (R.J.S.).	BRUCE CJ, 1985, J NEUROPHYSIOL, V54, P714, DOI 10.1152/jn.1985.54.3.714; BRUCE CJ, 1985, J NEUROPHYSIOL, V53, P603, DOI 10.1152/jn.1985.53.3.603; Carmena JM, 2003, PLOS BIOL, V1, P193, DOI 10.1371/journal.pbio.0000042; Cerf M, 2010, NATURE, V467, P1104, DOI 10.1038/nature09510; Chapin JK, 1999, NAT NEUROSCI, V2, P664, DOI 10.1038/10223; Fetz EE, 2007, J PHYSIOL-LONDON, V579, P571, DOI 10.1113/jphysiol.2006.127142; FETZ EE, 1969, SCIENCE, V163, P955, DOI 10.1126/science.163.3870.955; FETZ EE, 1975, EXP BRAIN RES, V23, P217; Gevensleben H, 2009, J CHILD PSYCHOL PSYC, V50, P780, DOI 10.1111/j.1469-7610.2008.02033.x; Gregoriou GG, 2009, SCIENCE, V324, P1207, DOI 10.1126/science.1171402; Kobayashi S, 2010, J NEUROPHYSIOL, V103, P1843, DOI 10.1152/jn.00173.2009; Loo SK, 2005, APPL NEUROPSYCHOL, V12, P64, DOI 10.1207/s15324826an1202_2; Moore T, 2006, CURR OPIN NEUROBIOL, V16, P159, DOI 10.1016/j.conb.2006.03.009; Sommer MA, 2000, J NEUROPHYSIOL, V83, P1979, DOI 10.1152/jn.2000.83.4.1979; Taylor DM, 2002, SCIENCE, V296, P1829, DOI 10.1126/science.1070291; Tehovnik EJ, 2000, BRAIN RES REV, V32, P413, DOI 10.1016/S0165-0173(99)00092-2; Thompson KG, 2005, J NEUROSCI, V25, P9479, DOI 10.1523/JNEUROSCI.0741-05.2005	17	107	111	1	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 24	2011	332	6037					1568	1571		10.1126/science.1199892	http://dx.doi.org/10.1126/science.1199892			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782EE	21617042	Green Accepted, Green Submitted			2022-12-24	WOS:000291990000048
J	Wang, D; Garcia-Bassets, I; Benner, C; Li, WB; Su, X; Zhou, YM; Qiu, JS; Liu, W; Kaikkonen, MU; Ohgi, KA; Glass, CK; Rosenfeld, MG; Fu, XD				Wang, Dong; Garcia-Bassets, Ivan; Benner, Chris; Li, Wenbo; Su, Xue; Zhou, Yiming; Qiu, Jinsong; Liu, Wen; Kaikkonen, Minna U.; Ohgi, Kenneth A.; Glass, Christopher K.; Rosenfeld, Michael G.; Fu, Xiang-Dong			Reprogramming transcription by distinct classes of enhancers functionally defined by eRNA	NATURE			English	Article							FORKHEAD BOX A1; PROSTATE-CANCER; GENE-EXPRESSION; ANDROGEN RECEPTOR; HISTONE MODIFICATIONS; NUCLEAR RECEPTORS; HUMAN GENOME; IN-VIVO; CHROMATIN; SIGNATURES	Mammalian genomes are populated with thousands of transcriptional enhancers that orchestrate cell-type-specific gene expression programs(1-4), but how those enhancers are exploited to institute alternative, signal-dependent transcriptional responses remains poorly understood. Here we present evidence that cell-lineage-specific factors, such as FoxA1, can simultaneously facilitate and restrict key regulated transcription factors, exemplified by the androgen receptor (AR), to act on structurally and functionally distinct classes of enhancer. Consequently, FoxA1 downregulation, an unfavourable prognostic sign in certain advanced prostate tumours, triggers dramatic reprogramming of the hormonal response by causing a massive switch in AR binding to a distinct cohort of pre-established enhancers. These enhancers are functional, as evidenced by the production of enhancer-templated non-coding RNA (eRNA(5)) based on global nuclear run-on sequencing (GRO-seq) analysis(6), with a unique class apparently requiring no nucleosome remodelling to induce specific enhancer-promoter looping and gene activation. GRO-seq data also suggest that liganded AR induces both transcription initiation and elongation. Together, these findings reveal a large repository of active enhancers that can be dynamically tuned to elicit alternative gene expression programs, which may underlie many sequential gene expression events in development, cell differentiation and disease progression.	[Wang, Dong; Benner, Chris; Qiu, Jinsong; Kaikkonen, Minna U.; Glass, Christopher K.; Fu, Xiang-Dong] Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Garcia-Bassets, Ivan; Li, Wenbo; Su, Xue; Liu, Wen; Ohgi, Kenneth A.; Rosenfeld, Michael G.] Univ Calif San Diego, Sch Med, Howard Hughes Med Inst, Dept Med, La Jolla, CA 92093 USA; [Garcia-Bassets, Ivan] Univ Calif San Diego, Sch Med, Dept Med, Div Endocrinol & Metab, La Jolla, CA 92093 USA; [Su, Xue; Liu, Wen] Univ Calif San Diego, Sch Med, Grad Program Biol, La Jolla, CA 92093 USA; [Zhou, Yiming] Digomics LLC, Malden, MA 02148 USA	University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Fu, XD (corresponding author), Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	ibassets@ucsd.edu; mrosenfeld@ucsd.edu; xdfu@ucsd.edu	Kaikkonen, Minna U/AAK-3612-2020; Wang, Dong/AAH-5611-2020; li, wenbo/GZM-8930-2022; Qiu, Jinsong/K-2325-2013; Glass, Christopher/AAI-3933-2021; Wang, Dong/C-8775-2013; Garcia-Bassets, Ivan/F-5075-2010	Kaikkonen, Minna U/0000-0001-6294-0979; Wang, Dong/0000-0001-7877-7440; Glass, Christopher/0000-0003-4344-3592; Benner, Christopher/0000-0002-4618-0719; Garcia-Bassets, Ivan/0000-0002-6941-9585; Wang, Dong/0000-0002-3656-329X	Howard Hughes Medical Institute Funding Source: Medline; NCI NIH HHS [R01 CA097134, R01 CA097134-10] Funding Source: Medline; NHGRI NIH HHS [R01 HG004659, HG004659, R01 HG004659-03] Funding Source: Medline; NHLBI NIH HHS [R01 HL065445-12, R01 HL065445] Funding Source: Medline; NIDDK NIH HHS [P01 DK074868, R01 DK039949-30, R37 DK039949, R01 DK018477-35, R01 DK091183, DK074868, P01 DK074868-05, DK01847, R37 DK039949-28, R01 DK018477, R01 DK039949, DK37949] Funding Source: Medline; NIGMS NIH HHS [R01 GM049369-17, R01 GM049369, GM049369] Funding Source: Medline; NINDS NIH HHS [R01 NS034934-23, R01 NS034934, NS34934] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA097134] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065445] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004659] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK018477, R01DK091183, R37DK039949, R01DK039949, P01DK074868] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049369] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034934] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Chandran UR, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-64; Cirillo LA, 2002, MOL CELL, V9, P279, DOI 10.1016/S1097-2765(02)00459-8; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Crowe AJ, 1999, J BIOL CHEM, V274, P25113, DOI 10.1074/jbc.274.35.25113; Gao N, 2005, DEVELOPMENT, V132, P3431, DOI 10.1242/dev.01917; Gao N, 2003, MOL ENDOCRINOL, V17, P1484, DOI 10.1210/me.2003-0020; Garcia-Bassets I, 2007, CELL, V128, P505, DOI 10.1016/j.cell.2006.12.038; Glinsky GV, 2004, J CLIN INVEST, V113, P913, DOI 10.1172/JCI200420032; He HSHS, 2010, NAT GENET, V42, P343, DOI 10.1038/ng.545; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Holbro T, 2003, P NATL ACAD SCI USA, V100, P8933, DOI 10.1073/pnas.1537685100; Holmqvist PH, 2005, EXP CELL RES, V304, P593, DOI 10.1016/j.yexcr.2004.12.002; Hu Q, 2008, P NATL ACAD SCI USA, V105, P19199, DOI 10.1073/pnas.0810634105; Hurtado A, 2011, NAT GENET, V43, P27, DOI 10.1038/ng.730; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kang ZG, 2004, MOL ENDOCRINOL, V18, P2633, DOI 10.1210/me.2004-0245; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Laitinen S, 2002, GENE CHROMOSOME CANC, V35, P66, DOI 10.1002/gcc.10097; Lee HJ, 2008, BIOCHEM BIOPH RES CO, V367, P481, DOI 10.1016/j.bbrc.2007.12.162; Lee TI, 2000, ANNU REV GENET, V34, P77, DOI 10.1146/annurev.genet.34.1.77; Legrier ME, 2009, INT J CANCER, V124, P1103, DOI 10.1002/ijc.24073; Linhart C, 2008, GENOME RES, V18, P1180, DOI 10.1101/gr.076117.108; Lupien M, 2008, CELL, V132, P958, DOI 10.1016/j.cell.2008.01.018; Mirosevich J, 2005, PROSTATE, V62, P339, DOI 10.1002/pros.20131; Ogawa S, 2005, CELL, V122, P707, DOI 10.1016/j.cell.2005.06.029; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; Rosenfeld MG, 2006, GENE DEV, V20, P1405, DOI 10.1101/gad.1424806; Shim EY, 1998, GENE DEV, V12, P5, DOI 10.1101/gad.12.1.5; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Thomsen MK, 2010, CANCER RES, V70, P979, DOI 10.1158/0008-5472.CAN-09-2370; Varambally S, 2005, CANCER CELL, V8, P393, DOI 10.1016/j.ccr.2005.10.001; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Wang H, 2008, CANCER RES, V68, P1625, DOI 10.1158/0008-5472.CAN-07-5915; Wang QB, 2009, CELL, V138, P245, DOI 10.1016/j.cell.2009.04.056; Yu YP, 2004, J CLIN ONCOL, V22, P2790, DOI 10.1200/JCO.2004.05.158	40	620	634	2	86	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 16	2011	474	7351					390	+		10.1038/nature10006	http://dx.doi.org/10.1038/nature10006			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777TD	21572438	Green Accepted			2022-12-24	WOS:000291647100048
J	Sang, LY; Miller, JJ; Corbit, KC; Giles, RH; Brauer, MJ; Otto, EA; Baye, LM; Wen, XH; Scales, SJ; Kwong, M; Huntzicker, EG; Sfakianos, MK; Sandoval, W; Bazan, JF; Kulkarni, P; Garcia-Gonzalo, FR; Seol, AD; O'Toole, JF; Held, S; Reutter, HM; Lane, WS; Rafiq, MA; Noor, A; Ansar, M; Devi, ARR; Sheffield, VC; Slusarski, DC; Vincent, JB; Doherty, DA; Hildebrandt, F; Reiter, JF; Jackson, PK				Sang, Liyun; Miller, Julie J.; Corbit, Kevin C.; Giles, Rachel H.; Brauer, Matthew J.; Otto, Edgar A.; Baye, Lisa M.; Wen, Xiaohui; Scales, Suzie J.; Kwong, Mandy; Huntzicker, Erik G.; Sfakianos, Mindan K.; Sandoval, Wendy; Bazan, J. Fernando; Kulkarni, Priya; Garcia-Gonzalo, Francesc R.; Seol, Allen D.; O'Toole, John F.; Held, Susanne; Reutter, Heiko M.; Lane, William S.; Rafiq, Muhammad Arshad; Noor, Abdul; Ansar, Muhammad; Devi, Akella Radha Rama; Sheffield, Val C.; Slusarski, Diane C.; Vincent, John B.; Doherty, Daniel A.; Hildebrandt, Friedhelm; Reiter, Jeremy F.; Jackson, Peter K.			Mapping the NPHP-JBTS-MKS Protein Network Reveals Ciliopathy Disease Genes and Pathways	CELL			English	Article							MECKEL-SYNDROME; PRIMARY CILIA; TRANSITION ZONE; INTRAFLAGELLAR TRANSPORT; RETINAL DEGENERATION; KIDNEY-DISEASE; NEPHRONOPHTHISIS; NEPHROCYSTIN; MOUSE; CILIOGENESIS	Nephronophthisis (NPHP), Joubert (JBTS), and Meckel-Gruber (MKS) syndromes are autosomal-recessive ciliopathies presenting with cystic kidneys, retinal degeneration, and cerebellar/neural tube malformation. Whether defects in kidney, retinal, or neural disease primarily involve ciliary, Hedgehog, or cell polarity pathways remains unclear. Using high-confidence proteomics, we identified 850 interactors copurifying with nine NPHP/JBTS/MKS proteins and discovered three connected modules: "NPHP1-4-8" functioning at the apical surface, "NPHP5-6" at centrosomes, and "MKS" linked to Hedgehog signaling. Assays for ciliogenesis and epithelial morphogenesis in 3D renal cultures link renal cystic disease to apical organization defects, whereas ciliary and Hedgehog pathway defects lead to retinal or neural deficits. Using 38 interactors as candidates, linkage and sequencing analysis of 250 patients identified ATXN10 and TCTN2 as new NPHP-JBTS genes, and our Tctn2 mouse knockout shows neural tube and Hedgehog signaling defects. Our study further illustrates the power of linking proteomic networks and human genetics to uncover critical disease pathways.	[Sang, Liyun; Brauer, Matthew J.; Wen, Xiaohui; Scales, Suzie J.; Kwong, Mandy; Huntzicker, Erik G.; Sfakianos, Mindan K.; Sandoval, Wendy; Bazan, J. Fernando; Kulkarni, Priya; Jackson, Peter K.] Genentech Inc, San Francisco, CA 94080 USA; [Miller, Julie J.] Stanford Univ, Dept Chem & Syst Biol, Sch Med, Stanford, CA 94305 USA; [Corbit, Kevin C.; Garcia-Gonzalo, Francesc R.; Seol, Allen D.; Reiter, Jeremy F.] Univ Calif San Francisco, Dept Biochem & Biophys, Cardiovasc Res Inst, San Francisco, CA 94158 USA; [Giles, Rachel H.] Univ Med Ctr Utrecht, Dept Med Oncol, NL-3584 CX Utrecht, Netherlands; [Giles, Rachel H.] Univ Med Ctr Utrecht, Dept Hypertens & Nephrol, NL-3584 CX Utrecht, Netherlands; [Otto, Edgar A.; O'Toole, John F.; Held, Susanne; Hildebrandt, Friedhelm] Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA; [Otto, Edgar A.; O'Toole, John F.; Held, Susanne; Hildebrandt, Friedhelm] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; [Baye, Lisa M.; Slusarski, Diane C.] Univ Iowa, Dept Biol, Iowa City, IA 52242 USA; [Sheffield, Val C.] Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA; [Reutter, Heiko M.] Univ Bonn, Childrens Hosp, Inst Human Genet, D-53111 Bonn, Germany; [Reutter, Heiko M.] Univ Bonn, Childrens Hosp, Dept Neonatol, D-53111 Bonn, Germany; [Lane, William S.] Harvard Univ, Mass Spectrometry & Prote Resource Lab, Ctr Syst Biol, Cambridge, MA 02138 USA; [Rafiq, Muhammad Arshad; Noor, Abdul; Vincent, John B.] Ctr Addict & Mental Hlth, Mol Neuropsychiat & Dev Lab, Neurogenet Sect, Toronto, ON M5T 1R8, Canada; [Ansar, Muhammad] Quaid i Azam Univ, Dept Biochem, Islamabad 45320, Pakistan; [Devi, Akella Radha Rama] Rainbow Childrens Hosp, Hyderabad 500034, Andhra Pradesh, India; [Vincent, John B.] Univ Toronto, Dept Psychiat, Toronto, ON M5T 1R8, Canada; [Doherty, Daniel A.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Sheffield, Val C.; Hildebrandt, Friedhelm] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Roche Holding; Genentech; Stanford University; University of California System; University of California San Francisco; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Iowa; University of Iowa; University of Bonn; University of Bonn; Harvard University; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; Quaid I Azam University; University of Toronto; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute	Jackson, PK (corresponding author), Genentech Inc, San Francisco, CA 94080 USA.	pjackson@gene.com	Ansar, Muhammad/F-4808-2015; Ansar, Muhammad/H-5967-2011; Noor, Abdul/J-2345-2016; Garcia-Gonzalo, Francesc/W-2639-2017; Scales, Suzie J./H-4507-2019	Ansar, Muhammad/0000-0001-5891-7063; Garcia-Gonzalo, Francesc/0000-0002-9152-2191; Scales, Suzie J./0000-0003-2544-0283; Miller, Julie/0000-0002-1288-593X; Sheffield, Val/0000-0002-6282-0835; Slusarski, Diane/0000-0003-3793-8636; Jackson, Peter/0000-0002-1742-2539; Otto, Edgar/0000-0002-2387-9973; Giles, Rachel/0000-0001-9133-2008	NIH [GM07365-33, DK071108, CA112369, R01-AR054396, R01-EY11298, R01-EY017168, DK1068306, DK1069274, DK090917]; Netherlands Organisation for Scientific Research VIDI [016.066.354]; EU [241955]; Cardiovascular Center Interdisciplinary Research Fellowship, University of Iowa; Canadian Institutes of Health Research [MOP-102758, KL2RR025015, R01NS064077]; March of Dimes; Burroughs Wellcome Fund; Packard Foundation; Sandler Family Supporting Foundation; Roy J. Carver Charitable Trust; Carver Endowment for Molecular Ophthalmology, and Research to Prevent Blindness; NATIONAL CANCER INSTITUTE [R01CA112369] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR025015] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY011298, R01EY017168] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007121] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR054396] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068306, RC4DK090917, K08DK071108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007365, R01GM095941] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064077] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Netherlands Organisation for Scientific Research VIDI(Netherlands Organization for Scientific Research (NWO)); EU(European Commission); Cardiovascular Center Interdisciplinary Research Fellowship, University of Iowa; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); March of Dimes(March of Dimes); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Packard Foundation(The David & Lucile Packard Foundation); Sandler Family Supporting Foundation; Roy J. Carver Charitable Trust; Carver Endowment for Molecular Ophthalmology, and Research to Prevent Blindness; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors acknowledge expert advice and contributions from Chris Westlake, Guowei Fang, Ben Chih, Andy Peterson, Cecile Chalouni, John S. Beck, Darryl Y. Nishimura, Charles C. Searby, Martin Griebel, John Neveu, Bogdan Budnik, Renee Robinson, Alex Loktev, Jorge Torres, Saikat Mukhopadhyay, Dirk Siepe, and Kevin Wright. We acknowledge the following support: J.J.M., NIH Medical Scientist Training Program Grant GM07365-33; R. H. G., the Netherlands Organisation for Scientific Research VIDI grant 016.066.354 and the EU FP7 "Syscilia" project 241955; L. M. B., the Cardiovascular Center Interdisciplinary Research Fellowship, University of Iowa; J.F.O., NIH grant DK071108; D. C. S., NIH Grant CA112369; J.B.V., Canadian Institutes of Health Research grant MOP-102758; D. A. D., KL2RR025015 and R01NS064077; J.F.R., NIH Grant R01-AR054396, the March of Dimes, the Burroughs Wellcome Fund, the Packard Foundation, and the Sandler Family Supporting Foundation; V. C. S., NIH Grants R01-EY11298, R01-EY017168, the Roy J. Carver Charitable Trust, Carver Endowment for Molecular Ophthalmology, and Research to Prevent Blindness. V. C. S. is an HHMI investigator. F. H. is an HHMI Investigator, a Doris Duke Distinguished Clinical Scientist, and a Frederick G. L. Huetwell Professor. F. H. acknowledges support from the NIH grants (DK1068306, DK1069274, and DK090917). L. S., M. J. B., X. W., S. J. S., M. K., E. G. H., M. K. S., W. S., J. F. B., P. K., and P. K. J. are employees of Genentech, Inc.	Baala L, 2007, AM J HUM GENET, V81, P170, DOI 10.1086/519494; Benzing T, 2001, P NATL ACAD SCI USA, V98, P9784, DOI 10.1073/pnas.171269898; Bialas NJ, 2009, J CELL SCI, V122, P611, DOI 10.1242/jcs.028621; Chang B, 2006, HUM MOL GENET, V15, P1847, DOI 10.1093/hmg/ddl107; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; Craige B, 2010, J CELL BIOL, V190, P927, DOI 10.1083/jcb.201006105; Davenport JR, 2007, CURR BIOL, V17, P1586, DOI 10.1016/j.cub.2007.08.034; Delous M, 2009, HUM MOL GENET, V18, P4711, DOI 10.1093/hmg/ddp434; Donaldson JC, 2000, EXP CELL RES, V256, P168, DOI 10.1006/excr.2000.4822; Essner JJ, 2005, DEVELOPMENT, V132, P1247, DOI 10.1242/dev.01663; Fliegauf M, 2006, J AM SOC NEPHROL, V17, P2424, DOI 10.1681/ASN.2005121351; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Hildebrandt F, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000353; Hildebrandt F, 2009, J AM SOC NEPHROL, V20, P23, DOI 10.1681/ASN.2008050456; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; Lee JH, 2010, NEUROBIOL DIS, V38, P167, DOI 10.1016/j.nbd.2009.12.022; Lim J, 2006, CELL, V125, P801, DOI 10.1016/j.cell.2006.03.032; Matsuura T, 2000, NAT GENET, V26, P191, DOI 10.1038/79911; Mollet G, 2005, HUM MOL GENET, V14, P645, DOI 10.1093/hmg/ddi061; Mollet G, 2002, NAT GENET, V32, P300, DOI 10.1038/ng996; Mougou-Zerelli S, 2009, HUM MUTAT, V30, P1574, DOI 10.1002/humu.21116; Murga-Zamalloa CA, 2010, MOL VIS, V16, P1373; Nachury MV, 2007, CELL, V129, P1201, DOI 10.1016/j.cell.2007.03.053; Olbrich H, 2003, NAT GENET, V34, P455, DOI 10.1038/ng1216; Oteiza P, 2008, DEVELOPMENT, V135, P2807, DOI 10.1242/dev.022228; Otto EA, 2003, NAT GENET, V34, P413, DOI 10.1038/ng1217; Parisi MA, 2007, EUR J HUM GENET, V15, P511, DOI 10.1038/sj.ejhg.5201648; Pazour GJ, 2000, J CELL BIOL, V151, P709, DOI 10.1083/jcb.151.3.709; Reiter JF, 2006, GENE DEV, V20, P22, DOI 10.1101/gad.1363606; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; Salonen R, 1998, J MED GENET, V35, P497, DOI 10.1136/jmg.35.6.497; SASAKI H, 1994, CELL, V76, P103, DOI 10.1016/0092-8674(94)90176-7; Schafer T, 2008, HUM MOL GENET, V17, P3655, DOI 10.1093/hmg/ddn260; Scholtens D, 2005, BIOINFORMATICS, V21, P3548, DOI 10.1093/bioinformatics/bti567; SCHOLTENS D, 2004, APCOMPLEX ESTIMATE P; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shiba D, 2010, CYTOSKELETON, V67, P112, DOI 10.1002/cm.20428; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Tallila J, 2008, AM J HUM GENET, V82, P1361, DOI 10.1016/j.ajhg.2008.05.004; Torres JZ, 2009, PROTEOMICS, V9, P2888, DOI 10.1002/pmic.200800873; Waragai M, 2006, J NEUROSCI RES, V83, P1170, DOI 10.1002/jnr.20807; Weatherbee SD, 2009, HUM MOL GENET, V18, P4565, DOI 10.1093/hmg/ddp422; Williams CL, 2008, MOL BIOL CELL, V19, P2154, DOI 10.1091/mbc.E07-10-1070; Winkelbauer ME, 2005, J CELL SCI, V118, P5575, DOI 10.1242/jcs.02665; Zaghloul NA, 2009, J CLIN INVEST, V119, P428, DOI 10.1172/JCI37041; Zuo XF, 2009, MOL BIOL CELL, V20, P2522, DOI 10.1091/mbc.E08-07-0772	46	414	440	1	70	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 13	2011	145	4					513	528		10.1016/j.cell.2011.04.019	http://dx.doi.org/10.1016/j.cell.2011.04.019			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	763MF	21565611	Green Accepted, Bronze			2022-12-24	WOS:000290560800006
J	Allen, AE; Dupont, CL; Obornik, M; Horak, A; Nunes-Nesi, A; McCrow, JP; Zheng, H; Johnson, DA; Hu, HH; Fernie, AR; Bowler, C				Allen, Andrew E.; Dupont, Christopher L.; Obornik, Miroslav; Horak, Ales; Nunes-Nesi, Adriano; McCrow, John P.; Zheng, Hong; Johnson, Daniel A.; Hu, Hanhua; Fernie, Alisdair R.; Bowler, Chris			Evolution and metabolic significance of the urea cycle in photosynthetic diatoms	NATURE			English	Article							CARBAMOYL-PHOSPHATE SYNTHETASE; PHYLOGENETIC ANALYSIS; SEQUENCE ALIGNMENT; TREE; INFERENCE; ACCURATE; INSIGHTS; HISTORY; MRBAYES; GENOME	Diatoms dominate the biomass of phytoplankton in nutrient-rich conditions and form the basis of some of the world's most productive marine food webs(1-4). The diatom nuclear genome contains genes with bacterial and plastid origins as well as genes of the secondary endosymbiotic host (the exosymbiont(5))(1,6-10), yet little is known about the relative contribution of each gene group to diatom metabolism. Here we show that the exosymbiont-derived ornithine-urea cycle, which is similar to that of metazoans but is absent in green algae and plants, facilitates rapid recovery from prolonged nitrogen limitation. RNA-interference-mediated knockdown of a mitochondrial carbamoyl phosphate synthase impairs the response of nitrogen-limited diatoms to nitrogen addition. Metabolomic analyses indicate that intermediates in the ornithine-urea cycle are particularly depleted and that both the tricarboxylic acid cycle and the glutamine synthetase/glutamate synthase cycles are linked directly with the ornithine-urea cycle. Several other depleted metabolites are generated from ornithine-urea cycle intermediates by the products of genes laterally acquired from bacteria. This metabolic coupling of bacterial-and exosymbiont-derived proteins seems to be fundamental to diatom physiology because the compounds affected include the major diatom osmolyte proline(12) and the precursors for long-chain polyamines required for silica precipitation during cell wall formation(11). So far, the ornithine-urea cycle is only known for its essential role in the removal of fixed nitrogen in metazoans. In diatoms, this cycle serves as a distribution and repackaging hub for inorganic carbon and nitrogen and contributes significantly to the metabolic response of diatoms to episodic nitrogen availability. The diatom ornithine-urea cycle therefore represents a key pathway for anaplerotic carbon fixation into nitrogenous compounds that are essential for diatom growth and for the contribution of diatoms to marine productivity.	[Allen, Andrew E.; Dupont, Christopher L.; McCrow, John P.; Zheng, Hong; Johnson, Daniel A.] J Craig Venter Inst, San Diego, CA 92121 USA; [Allen, Andrew E.; Hu, Hanhua; Bowler, Chris] Ecole Normale Super, Inst Biol, Environm & Evolutionary Genom Sect, CNRS,UMR8197,INSERM,U1024, F-75005 Paris, France; [Obornik, Miroslav; Horak, Ales] Biol Ctr ASCR, Inst Parasitol, Ceske Budejovice 37005, Czech Republic; [Obornik, Miroslav; Horak, Ales] Univ S Bohemia, Fac Sci, Ceske Budejovice 37005, Czech Republic; [Nunes-Nesi, Adriano; Fernie, Alisdair R.] Max Planck Insitut Mol Pfanzenphysiol, D-14476 Potsdam, Germany	J. Craig Venter Institute; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice; Max Planck Society	Allen, AE (corresponding author), J Craig Venter Inst, San Diego, CA 92121 USA.	aallen@jcvi.org	Obornik, Miroslav/G-9350-2014; Horak, Ales/H-6723-2012; Allen, Andrew E/C-4896-2012; Nunes-Nesi, Adriano/D-6430-2013; Bowler, Chris/AAC-6256-2019	Horak, Ales/0000-0002-3364-7383; Allen, Andrew E/0000-0001-5911-6081; McCrow, John/0000-0002-7014-5040; Nunes-Nesi, Adriano/0000-0002-9581-9355; Bowler, Chris/0000-0003-3835-6187	National Science Foundation [NSF-OCE-0722374, NSF-OCE-0727997, NSF-MCB-1024913]; JCVI; European Commission; Agence Nationale de la Recherche (France); Czech Science Foundation [206/08/1423]	National Science Foundation(National Science Foundation (NSF)); JCVI; European Commission(European CommissionEuropean Commission Joint Research Centre); Agence Nationale de la Recherche (France)(French National Research Agency (ANR)); Czech Science Foundation(Grant Agency of the Czech Republic)	We thank A. Meichenin and C. Lichtle for assistance with electron microscropy, J. C. Thomas for CPS purification and activity experiments, A. Falciatore for advice on RNAi constructs and A. Main for screening and evaluation of RNAi lines. This study was supported by the National Science Foundation (NSF-OCE-0722374, NSF-OCE-0727997, NSF-MCB-1024913) and JCVI internal funding to A.E.A., the European Commission Diatomics project and Agence Nationale de la Recherche (France) (C.B.) and the Czech Science Foundation (206/08/1423) (M.O.).	Allen AE, 2008, P NATL ACAD SCI USA, V105, P10438, DOI 10.1073/pnas.0711370105; Allen AE, 2006, CURR OPIN PLANT BIOL, V9, P264, DOI 10.1016/j.pbi.2006.03.013; ANDERSON PM, 1980, SCIENCE, V208, P291, DOI 10.1126/science.6245445; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; Ast M, 2009, P NATL ACAD SCI USA, V106, P3621, DOI 10.1073/pnas.0808862106; Benton MJ, 2007, MOL BIOL EVOL, V24, P26, DOI 10.1093/molbev/msl150; Berney C, 2006, P ROY SOC B-BIOL SCI, V273, P1867, DOI 10.1098/rspb.2006.3537; Bowler C, 2008, NATURE, V456, P239, DOI 10.1038/nature07410; Bowler C, 2010, ANNU REV MAR SCI, V2, P333, DOI 10.1146/annurev-marine-120308-081051; De Riso V, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp448; Esteban-Pretel G, 2010, J NUTR, V140, P792, DOI 10.3945/jn.109.119388; Falciatore A, 1999, MAR BIOTECHNOL, V1, P239, DOI 10.1007/PL00011773; Falkowski PG, 2007, NAT REV MICROBIOL, V5, P813, DOI 10.1038/nrmicro1751; Falkowski PG, 2004, SCIENCE, V305, P354, DOI 10.1126/science.1095964; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; GUPPY M, 1986, TRENDS BIOCHEM SCI, V11, P274, DOI 10.1016/0968-0004(86)90022-8; Hamm Christian, 2007, P311, DOI 10.1016/B978-012370518-1/50015-1; Holden HM, 1999, CELL MOL LIFE SCI, V56, P507, DOI 10.1007/s000180050448; HONG J, 1994, J MOL BIOL, V243, P131, DOI 10.1006/jmbi.1994.1638; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Krell A, 2007, J PHYCOL, V43, P753, DOI 10.1111/j.1529-8817.2007.00366.x; Kroger N, 2008, ANNU REV GENET, V42, P83, DOI 10.1146/annurev.genet.41.110306.130109; Lartillot N, 2004, MOL BIOL EVOL, V21, P1095, DOI 10.1093/molbev/msh112; Lartillot N, 2009, BIOINFORMATICS, V25, P2286, DOI 10.1093/bioinformatics/btp368; Lawson FS, 1996, MOL BIOL EVOL, V13, P970, DOI 10.1093/oxfordjournals.molbev.a025665; Lee B, 2000, P NATL ACAD SCI USA, V97, P8021, DOI 10.1073/pnas.140082197; Lisec J, 2006, NAT PROTOC, V1, P387, DOI 10.1038/nprot.2006.59; Maheswari U, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r85; MOMMSEN TP, 1989, SCIENCE, V243, P72, DOI 10.1126/science.2563172; Morris SM, 2002, ANNU REV NUTR, V22, P87, DOI 10.1146/annurev.nutr.22.110801.140547; Moustafa A, 2009, SCIENCE, V324, P1724, DOI 10.1126/science.1172983; NELSON DM, 1995, GLOBAL BIOGEOCHEM CY, V9, P359, DOI 10.1029/95GB01070; Nunes-Nesi A, 2010, MOL PLANT, V3, P973, DOI 10.1093/mp/ssq049; Parker MS, 2008, ANNU REV GENET, V42, P619, DOI 10.1146/annurev.genet.42.110807.091417; Quang LS, 2008, BIOINFORMATICS, V24, P2317, DOI 10.1093/bioinformatics/btn445; R Core Team, 2022, R LANG ENV STAT COMP; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sanderson MJ, 2002, MOL BIOL EVOL, V19, P101, DOI 10.1093/oxfordjournals.molbev.a003974; Sanderson MJ, 1997, MOL BIOL EVOL, V14, P1218, DOI 10.1093/oxfordjournals.molbev.a025731; Schauer N, 2005, FEBS LETT, V579, P1332, DOI 10.1016/j.febslet.2005.01.029; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Siaut M, 2007, GENE, V406, P23, DOI 10.1016/j.gene.2007.05.022; Smetacek V, 1999, PROTIST, V150, P25, DOI 10.1016/S1434-4610(99)70006-4; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Thorne JL, 1998, MOL BIOL EVOL, V15, P1647, DOI 10.1093/oxfordjournals.molbev.a025892; Young EB, 2003, J PHYCOL, V39, P897, DOI 10.1046/j.1529-8817.2003.03042.x	49	309	320	18	333	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 12	2011	473	7346					203	+		10.1038/nature10074	http://dx.doi.org/10.1038/nature10074			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	762NT	21562560	Green Published			2022-12-24	WOS:000290487200036
J	Moxon, ER; Siegrist, CA				Moxon, E. Richard; Siegrist, Claire-Anne			New Decade of Vaccines 1 The next decade of vaccines: societal and scientific challenges	LANCET			English	Article							INVASIVE PNEUMOCOCCAL DISEASE; INFLUENZA VACCINE; HIV VACCINE; BELLS-PALSY; ANTIBODIES; EFFICACY; ADULTS; IMMUNOLOGY; IMMUNITY; DESIGN	Vaccines against microbial diseases have improved the health of millions of people. In the next decade and beyond, many conceptual and technological scientific advances offer extraordinary opportunities to expand the portfolio of immunisations against viral and bacterial diseases and to pioneer the first vaccines against human parasitic and fungal diseases. Scientists in the public and private sectors are motivated as never before to bring about these innovations in immunisation. Many societal factors threaten to compromise realisation of the public health gains that immunisation can achieve in the next decade and beyond understanding these factors is imperative. Vaccines are typically given to healthy individuals and safety issues loom high on the list of public concerns. The public needs to regain confidence in immunisation and trust the organisations responsible for the research, development, and implementation of vaccines. In the past, by use of a judicious amalgam of knowledge and empiricism, successful vaccines were largely developed by microbiologists who identified antigens that induced immune responses to conserved pathogen components. In the future, vaccines need to be developed against deadly diseases for which this strategy is often not feasible because of the extensive antigenic variability of relevant pathogens. High microbial diversity means that immunity after natural infection is often ineffective for prevention of disease on subsequent exposure, for example in HIV infection and malaria. Additionally, vaccines need to be generated to protect the people who are most vulnerable because of age or underlying diseases. Thus, in the future, a much deeper understanding of the immunological challenges including the diversifying role of host genetics and environmental factors, leading perhaps to more personalised approaches will be the touchstone for rational design and development of adjuvants that result in novel safe and effective vaccines.	[Moxon, E. Richard] Univ Oxford, John Radcliffe Hosp, Dept Paediat, Oxford OX3 9DU, England; [Siegrist, Claire-Anne] Univ Hosp Geneva, Ctr Vaccinol, Geneva, Switzerland; [Siegrist, Claire-Anne] Univ Geneva, Fac Med, Geneva, Switzerland	University of Oxford; University of Geneva; University of Geneva	Moxon, ER (corresponding author), Univ Oxford, John Radcliffe Hosp, Dept Paediat, Oxford OX3 9DU, England.	richard.moxon@paediatrics.ox.ac.uk			GlaxoSmithKline; Sanofi Pasteur; Nasvax; DBV Technologies	GlaxoSmithKline(GlaxoSmithKline); Sanofi Pasteur; Nasvax; DBV Technologies	ERM has received honoraria for work as a board member for Novartis and GlycoVaxyn, and as a consultant for Novartis. C-AS's institution has received grants from GlaxoSmithKline, Sanofi Pasteur, Nasvax, and DBV Technologies; and travel and accommodation expenses from GlaxoSmithKline and Sanofi Pasteur. C-AS and C-AS's institution have received royalties for the patent for Viavac; and C-AS has patents, which have not generated royalties, with Sanofi Pasteur and DBV Technologies.	Alcais A, 2009, J CLIN INVEST, V119, P2506, DOI 10.1172/JCI38111; Baumgartner CK, 2010, IMMUNOLOGY, V130, P16, DOI 10.1111/j.1365-2567.2010.03265.x; Bayer R, 2007, EMBO REP, V8, P1099, DOI 10.1038/sj.embor.7401134; Bekker A, 2009, CURR OPIN PEDIATR, V21, P122, DOI 10.1097/MOP.0b013e32832185af; Belshe RB, 2007, NEW ENGL J MED, V356, P685, DOI 10.1056/NEJMoa065368; Boisier P, 2007, CLIN INFECT DIS, V44, P657, DOI 10.1086/511646; Bonanni P, 2007, HUM VACCINES, V3, P217, DOI 10.4161/hv.3.5.4351; Burton DR, 2010, SCIENCE, V329, P770, DOI 10.1126/science.1194693; Castellino F, 2009, EUR J IMMUNOL, V39, P2100, DOI 10.1002/eji.200939550; Chen WH, 2009, TRENDS IMMUNOL, V30, P351, DOI 10.1016/j.it.2009.05.002; Chow J, 2010, ADV IMMUNOL, V107, P243, DOI [10.1016/B978-0-12-381300-8.00008-3, 10.1016/S0065-2776(10)07001-X]; Cohen SA, 2011, J AM GERIATR SOC, V59, P327, DOI 10.1111/j.1532-5415.2010.03271.x; CRAIG A, 2003, ANTIGENIC VARIATION, P432; De Flora S, 2011, CARCINOGENESIS, V32, P787, DOI 10.1093/carcin/bgr054; Deans GD, 2010, J INTERN MED, V267, P220, DOI 10.1111/j.1365-2796.2009.02201.x; Dejnirattisai W, 2010, SCIENCE, V328, P745, DOI 10.1126/science.1185181; DOBZHANSKY T, 1973, AM BIOL TEACH, V35, P125, DOI 10.2307/4444260; Donnelly J, 2010, P NATL ACAD SCI USA, V107, P19490, DOI 10.1073/pnas.1013758107; Eskola J, 2001, NEW ENGL J MED, V344, P403, DOI 10.1056/NEJM200102083440602; FARRINGTON CP, 1993, INT J EPIDEMIOL, V22, P742, DOI 10.1093/ije/22.4.742; FINNE J, 1983, LANCET, V2, P355; Fujinami RS, 2006, CLIN MICROBIOL REV, V19, P80, DOI 10.1128/CMR.19.1.80-94.2006; Gilca V, 2006, PEDIATR INFECT DIS J, V25, P372, DOI 10.1097/01.inf.0000207468.04665.ad; Giuliani MM, 2006, P NATL ACAD SCI USA, V103, P10834, DOI 10.1073/pnas.0603940103; Granoff DM, 2010, CLIN INFECT DIS, V50, pS54, DOI 10.1086/648966; Gupta S, 1999, PARASITOL TODAY, V15, P497, DOI 10.1016/S0169-4758(99)01559-8; Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460; HALSTEAD SB, 1977, J EXP MED, V146, P201, DOI 10.1084/jem.146.1.201; Hammarlund E, 2003, NAT MED, V9, P1131, DOI 10.1038/nm917; Hanage WP, 2008, FUTURE MICROBIOL, V3, P23, DOI 10.2217/17460913.3.1.23; Harrison LH, 2009, VACCINE, V27, pB51, DOI 10.1016/j.vaccine.2009.04.063; Hausdorff WP, 2001, LANCET, V357, P950, DOI 10.1016/S0140-6736(00)04222-7; Hay SI, 2005, NAT REV MICROBIOL, V3, P81, DOI 10.1038/nrmicro1069; Heath PT, 1998, PEDIATR INFECT DIS J, V17, pS117, DOI 10.1097/00006454-199809001-00005; Huss A, 2009, CAN MED ASSOC J, V180, P48, DOI 10.1503/cmaj.080734; Jackson LA, 2008, CLIN INFECT DIS, V47, P1328, DOI 10.1086/592691; JEFFERSON T, 2010, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD004876.PUB3; Jegouic S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000412; Johnston MI, 2008, NEW ENGL J MED, V359, P888, DOI 10.1056/NEJMp0806162; Kasturi SP, 2011, NATURE, V470, P543, DOI 10.1038/nature09737; Khurana S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000624; Kyes S, 2001, ANNU REV MICROBIOL, V55, P673, DOI 10.1146/annurev.micro.55.1.673; Ladhani S, 2008, LANCET INFECT DIS, V8, P275, DOI 10.1016/S1473-3099(08)70078-1; Lang PO, 2011, AGEING RES REV, V10, P389, DOI 10.1016/j.arr.2010.09.005; Levine OS, 2011, LANCET, V378, P439, DOI 10.1016/S0140-6736(11)60406-6; Levy O, 2007, NAT REV IMMUNOL, V7, P379, DOI 10.1038/nri2075; Lewis DJM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006999; Malik B, 2010, CURR MOL MED, V10, P47, DOI 10.2174/156652410791065417; Malley R, 2010, J MOL MED, V88, P135, DOI 10.1007/s00109-009-0579-4; Manzoli L, 2009, LANCET INFECT DIS, V9, P482, DOI 10.1016/S1473-3099(09)70153-7; Moberley S, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000422.pub3; Mosca F, 2008, P NATL ACAD SCI USA, V105, P10501, DOI 10.1073/pnas.0804699105; Mouquet H, 2010, NATURE, V467, P591, DOI 10.1038/nature09385; Mutsch M, 2004, NEW ENGL J MED, V350, P896, DOI 10.1056/NEJMoa030595; Nicolas JF, 2008, EXPERT REV VACCINES, V7, P1201, DOI 10.1586/14760584.7.8.1201; Offit PA, 2008, VACCINES-BASEL, V2, P17, DOI 10.1016/b978-1-4557-0090-5.00004-5; Olszewska W, 2000, VIROLOGY, V272, P98, DOI 10.1006/viro.2000.0285; Pace D, 2009, VACCINE, V27, pB30, DOI 10.1016/j.vaccine.2009.05.003; Palmer DC, 2009, TRENDS IMMUNOL, V30, P592, DOI 10.1016/j.it.2009.09.009; Panda A, 2010, J IMMUNOL, V184, P2518, DOI 10.4049/jimmunol.0901022; Patel M, 2009, J INFECT DIS, V200, pS39, DOI 10.1086/605035; Pichichero ME, 2009, PEDIATRICS, V124, P1633, DOI 10.1542/peds.2008-3645; PITTMAN MARGARET, 1931, JOUR EXP MED, V53, P471, DOI 10.1084/jem.53.4.471; Poland GA, 2009, PHARMACOGENOMICS, V10, P837, DOI [10.2217/pgs.09.25, 10.2217/PGS.09.25]; Prausnitz MR, 2009, CURR TOP MICROBIOL, V333, P369, DOI 10.1007/978-3-540-92165-3_18; Prymula R, 2009, LANCET, V374, P1339, DOI 10.1016/S0140-6736(09)61208-3; Pulendran B, 2010, IMMUNITY, V33, P516, DOI 10.1016/j.immuni.2010.10.006; Ramsay ME, 2003, J INFECT DIS, V188, P481, DOI 10.1086/376997; Rappuoli R, 2011, LANCET, V378, P360, DOI 10.1016/S0140-6736(11)60440-6; Rinaudo CD, 2009, J CLIN INVEST, V119, P2515, DOI 10.1172/JCI38330; SABIN AB, 1954, J EXP MED, V99, P551, DOI 10.1084/jem.99.6.551; Sambhara S, 2009, CURR TOP MICROBIOL, V333, P413, DOI 10.1007/978-3-540-92165-3_20; SCHULMAN JL, 1969, P NATL ACAD SCI USA, V63, P326, DOI 10.1073/pnas.63.2.326; Sette A, 2010, IMMUNITY, V33, P530, DOI 10.1016/j.immuni.2010.09.017; Siegrist CA, 2009, NAT REV IMMUNOL, V9, P185, DOI 10.1038/nri2508; Smith J, 2011, LANCET, V378, P428, DOI 10.1016/S0140-6736(11)60478-9; Stratton K, 2001, IMMUNIZATION SAFETY; Takala SL, 2009, PARASITE IMMUNOL, V31, P560, DOI 10.1111/j.1365-3024.2009.01138.x; Trotter CL, 2009, EXPERT REV VACCINES, V8, P851, DOI [10.1586/erv.09.48, 10.1586/ERV.09.48]; TURK DC, 1967, HAEMOPHILUS INFLUENZ, P1; [United Nations Department of Economics and Social Affairs Population division], 2009, WORLD POP PROSP 2008; *US CDCP, 2009, MMWR-MORBID MORTAL W, V58, P1091; Virgin HW, 2010, NATURE, V464, P224, DOI 10.1038/nature08898; Walker LM, 2010, CURR OPIN IMMUNOL, V22, P358, DOI 10.1016/j.coi.2010.02.012; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823; *WHO SAF INJ GLOB, 2010, SAF INJ GLOB NETW 20; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659	88	43	46	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 23	2011	378	9788					348	359		10.1016/S0140-6736(11)60407-8	http://dx.doi.org/10.1016/S0140-6736(11)60407-8			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	803XL	21664685				2022-12-24	WOS:000293615800033
J	Anthony, RM; Kobayashi, T; Wermeling, F; Ravetch, JV				Anthony, Robert M.; Kobayashi, Toshihiko; Wermeling, Fredrik; Ravetch, Jeffrey V.			Intravenous gammaglobulin suppresses inflammation through a novel T(H)2 pathway	NATURE			English	Article							DC-SIGN; ANTIINFLAMMATORY ACTIVITY; DENDRITIC CELL; IN-VIVO; BONE-MARROW; IMMUNE-RESPONSES; IL-4; INTERLEUKIN-4; ANTIBODIES; RECEPTORS	High-dose intravenous immunoglobulin is a widely used therapeutic preparation of highly purified immunoglobulin G (IgG) antibodies. It is administered at high doses (1-2 grams per kilogram) for the suppression of autoantibody-triggered inflammation in a variety of clinical settings'. This anti-inflammatory activity of intravenous immunoglobulin is triggered by a minor population of IgG crystallizable fragments (Fcs), with glycans terminating in alpha 2,6 sialic acids (sFc) that target myeloid regulatory cells expressing the lectin dendritic-cell-specific ICAM-3 grabbing non-integrin (DC-SIGN; also known as CD209)(2-4). Here, to characterize this response in detail, we generated humanized DC-SIGN mice (hDC-SIGN), and demonstrate that the anti-inflammatory activity of intravenous immunoglobulin can be recapitulated by the transfer of bone-marrow-derived sFc-treated hDC-SIGN(+) macrophages or dendritic cells into naive recipients. Furthermore, sFc administration results in the production of IL-33, which, in turn, induces expansion of IL-4-producing basophils that promote increased expression of the inhibitory Fc receptor Fc gamma RIIB on effector macrophages. Systemic administration of the T(H)2 cytokines IL-33 or IL-4 upregulates Fc gamma RIIB on macrophages, and suppresses serum-induced arthritis. Consistent with these results, transfer of IL-33-treated basophils suppressed induced arthritic inflammation. This novel DC-SIGN-T(H)2 pathway initiated by an endogenous ligand, sFc, provides an intrinsic mechanism for maintaining immune homeostasis that could be manipulated to provide therapeutic benefit in autoimmune diseases.	[Anthony, Robert M.; Kobayashi, Toshihiko; Wermeling, Fredrik; Ravetch, Jeffrey V.] Rockefeller Univ, Lab Mol Genet & Immunol, New York, NY 10065 USA	Rockefeller University	Ravetch, JV (corresponding author), Rockefeller Univ, Lab Mol Genet & Immunol, 1230 York Ave, New York, NY 10065 USA.	ravetch@rockefeller.edu	Ravetch, Jeffrey/Z-1596-2019; Wermeling, Fredrik/AAA-6391-2019	Ravetch, Jeffrey/0000-0003-2024-9041; Wermeling, Fredrik/0000-0001-9633-677X	Wenner-Gren Foundations, Sweden; Virdante Pharmaceuticals; NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI035875, K22AI091684] Funding Source: NIH RePORTER	Wenner-Gren Foundations, Sweden; Virdante Pharmaceuticals; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors thank P. Smith, M. Kibe, J. Brown and K. Velinzon for technical support K. L. Jeffrey, C. Cheong, R. Steinman and J. J. Lee for discussions, M. Pack for providing human spleen sections, A. McKenzie for providing SIGN-R1<SUP>-/-</SUP> mice, T. Sparwasser for providing CD11c-hDC-SIGN mice, C. G. Park for providing hDC-SIGN and hDC-SIGN-R expressing cell lines, and H. Watarai for providing anti-IL-25R antibodies. R.M.A. is an Irvington Institute fellow of the Cancer Research Institute. F.W. is supported by the Wenner-Gren Foundations, Sweden. This work was performed with support from Virdante Pharmaceuticals and NIH grants to J.V.R.	Anthony RM, 2008, SCIENCE, V320, P373, DOI 10.1126/science.1154315; Anthony RM, 2008, P NATL ACAD SCI USA, V105, P19571, DOI 10.1073/pnas.0810163105; Bruhns P, 2003, IMMUNITY, V18, P573, DOI 10.1016/S1074-7613(03)00080-3; Cheong C, 2010, J IMMUNOL METHODS, V360, P66, DOI 10.1016/j.jim.2010.06.006; Finkelman F., 2003, CURR PROTOC IMMUNOL, P6281; FINKELMAN FD, 1993, J IMMUNOL, V151, P1235; Fort MM, 2001, IMMUNITY, V15, P985, DOI 10.1016/S1074-7613(01)00243-6; Geijtenbeek TBH, 2009, NAT REV IMMUNOL, V9, P465, DOI 10.1038/nri2569; Granelli-Piperno A, 2005, J IMMUNOL, V175, P4265, DOI 10.4049/jimmunol.175.7.4265; Gringhuis SI, 2007, IMMUNITY, V26, P605, DOI 10.1016/j.immuni.2007.03.012; Hodges A, 2007, NAT IMMUNOL, V8, P569, DOI 10.1038/ni1470; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Jeffrey KL, 2006, NAT IMMUNOL, V7, P274, DOI 10.1038/ni1310; Kaneko Y, 2006, SCIENCE, V313, P670, DOI 10.1126/science.1129594; Korganow AS, 1999, IMMUNITY, V10, P451, DOI 10.1016/S1074-7613(00)80045-X; Lanoue A, 2004, J EXP MED, V200, P1383, DOI 10.1084/jem.20040795; Min B, 2004, J EXP MED, V200, P507, DOI 10.1084/jem.20040590; Mohrs M, 2001, IMMUNITY, V15, P303, DOI 10.1016/S1074-7613(01)00186-8; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Nimmerjahn F, 2008, ANNU REV IMMUNOL, V26, P513, DOI 10.1146/annurev.immunol.26.021607.090232; Obata K, 2007, BLOOD, V110, P913, DOI 10.1182/blood-2007-01-068718; Ohmori K, 2009, J IMMUNOL, V182, P2835, DOI 10.4049/jimmunol.0802870; Ohmura K, 2005, ARTHRITIS RHEUM-US, V52, P1866, DOI 10.1002/art.21104; Paul WE, 2010, NAT REV IMMUNOL, V10, P225, DOI 10.1038/nri2735; Pricop L, 2001, J IMMUNOL, V166, P531, DOI 10.4049/jimmunol.166.1.531; Saenz SA, 2010, NATURE, V464, P1362, DOI 10.1038/nature08901; Samuelsson A, 2001, SCIENCE, V291, P484, DOI 10.1126/science.291.5503.484; Schaefer M, 2008, J IMMUNOL, V180, P6836, DOI 10.4049/jimmunol.180.10.6836; Scherer HU, 2010, ARTHRITIS RHEUM-US, V62, P1620, DOI 10.1002/art.27414; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; SEDER RA, 1991, P NATL ACAD SCI USA, V88, P2835, DOI 10.1073/pnas.88.7.2835; SEDER RA, 1991, INT ARCH ALLER A IMM, V94, P137, DOI 10.1159/000235345; Shinkai K, 2002, NATURE, V420, P825, DOI 10.1038/nature01202; Soilleux EJ, 2002, J LEUKOCYTE BIOL, V71, P445; Sokol CL, 2008, NAT IMMUNOL, V9, P310, DOI 10.1038/ni1558; Soumelis V, 2002, NAT IMMUNOL, V3, P673, DOI 10.1038/ni805; Takai T, 1996, NATURE, V379, P346, DOI 10.1038/379346a0; van de Geijn FE, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2892; Wang M, 1999, CLIN IMMUNOL, V90, P47, DOI 10.1006/clim.1998.4628; Wang YH, 2007, J EXP MED, V204, P1837, DOI 10.1084/jem.20070406; Xu DM, 2010, J IMMUNOL, V184, P2620, DOI 10.4049/jimmunol.0902685	41	434	452	2	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 7	2011	475	7354					110	U133		10.1038/nature10134	http://dx.doi.org/10.1038/nature10134			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	788RE	21685887	Green Accepted			2022-12-24	WOS:000292461300055
J	Paprotka, T; Delviks-Frankenberry, KA; Cingoz, O; Martinez, A; Kung, HJ; Tepper, CG; Hu, WS; Fivash, MJ; Coffin, JM; Pathak, VK				Paprotka, Tobias; Delviks-Frankenberry, Krista A.; Cingoez, Oya; Martinez, Anthony; Kung, Hsing-Jien; Tepper, Clifford G.; Hu, Wei-Shau; Fivash, Matthew J., Jr.; Coffin, John M.; Pathak, Vinay K.			Recombinant Origin of the Retrovirus XMRV	SCIENCE			English	Article							MURINE LEUKEMIA-VIRUS; CHRONIC-FATIGUE-SYNDROME; PROSTATE-CANCER; MOUSE DNA; IN-VIVO; CONTAMINATION; INFECTION; SEQUENCES; ANDROGEN; BLOOD	The retrovirus XMRV (xenotropic murine leukemia virus-related virus) has been detected in human prostate tumors and in blood samples from patients with chronic fatigue syndrome, but these findings have not been replicated. We hypothesized that an understanding of when and how XMRV first arose might help explain the discrepant results. We studied human prostate cancer cell lines CWR22Rv1 and CWR-R1, which produce XMRV virtually identical to the viruses recently found in patient samples, as well as their progenitor human prostate tumor xenograft (CWR22) that had been passaged in mice. We detected XMRV infection in the two cell lines and in the later passage xenografts, but not in the early passages. In particular, we found that the host mice contained two proviruses, PreXMRV-1 and PreXMRV-2, which share 99.92% identity with XMRV over >3.2-kilobase stretches of their genomes. We conclude that XMRV was not present in the original CWR22 tumor but was generated by recombination of two proviruses during tumor passaging in mice. The probability that an identical recombinant was generated independently is negligible (similar to 10(-12)); our results suggest that the association of XMRV with human disease is due to contamination of human samples with virus originating from this recombination event.	[Paprotka, Tobias; Delviks-Frankenberry, Krista A.; Pathak, Vinay K.] NCI, HIV Drug Resistance Program, Viral Mutat Sect, Frederick, MD 21702 USA; [Hu, Wei-Shau] NCI, HIV Drug Resistance Program, Viral Recombinat Sect, Frederick, MD 21702 USA; [Cingoez, Oya; Coffin, John M.] Tufts Univ, Sch Med, Dept Mol Biol & Microbiol, Boston, MA 02111 USA; [Cingoez, Oya; Coffin, John M.] Tufts Univ, Sch Med, Genet Program, Boston, MA 02111 USA; [Martinez, Anthony; Kung, Hsing-Jien; Tepper, Clifford G.] Univ Calif Davis, Dept Biochem & Mol Med, Sacramento, CA 95817 USA; [Kung, Hsing-Jien] Univ Calif Davis, Dept Urol, Sacramento, CA 95817 USA; [Fivash, Matthew J., Jr.] NCI, Data Management Serv Inc, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Tufts University; Tufts University; University of California System; University of California Davis; University of California System; University of California Davis; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Pathak, VK (corresponding author), NCI, HIV Drug Resistance Program, Viral Mutat Sect, Frederick, MD 21702 USA.	vinay.pathak@nih.gov	Cingöz, Oya/AAN-1739-2021; Tepper, Clifford G/H-6527-2011; Kung, Hsing-Jien/C-7651-2013; Delviks-Frankenberry, Krista A/M-4822-2013	Cingöz, Oya/0000-0002-0096-4948; Delviks-Frankenberry, Krista A/0000-0003-3370-8542; Pathak, Vinay/0000-0003-2441-8412	Center for Cancer Research, National Cancer Institute, NIH; Bench-to-Bedside Award [R37 CA 089441, R01CA150197]; F.M. Kirby Foundation; NATIONAL CANCER INSTITUTE [ZIABC011436, P30CA093373, R37CA089441, ZIABC010504, ZIABC011339, R01CA150197] Funding Source: NIH RePORTER	Center for Cancer Research, National Cancer Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Bench-to-Bedside Award; F.M. Kirby Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank W. Shao for analysis of MLV diversity, and E. Freed and S. Hughes for helpful discussions. This research was supported in part by the Intramural Research Program of the Center for Cancer Research, National Cancer Institute, NIH. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. government. This work was also supported in part by a Bench-to-Bedside Award to V.K.P., research grant R37 CA 089441 to J.M.C., and R01CA150197 to H.J.K. J.M.C. was a Research Professor of the American Cancer Society with support from the F.M. Kirby Foundation.	Arnold RS, 2010, UROLOGY, V75, P755, DOI 10.1016/j.urology.2010.01.038; Bogerd HP, 2011, VIROLOGY, V410, P234, DOI 10.1016/j.virol.2010.11.011; Chaipan C, 2011, J VIROL, V85, P4888, DOI 10.1128/JVI.00046-11; Courgnaud V, 2010, P NATL ACAD SCI USA, V107, P15666, DOI 10.1073/pnas.1007944107; Gregory CW, 2001, CANCER RES, V61, P2892; Groom HCT, 2010, P NATL ACAD SCI USA, V107, P5166, DOI 10.1073/pnas.0913650107; Hue S, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-111; Knouf EC, 2009, J VIROL, V83, P7353, DOI 10.1128/JVI.00546-09; Lo SC, 2010, P NATL ACAD SCI USA, V107, P15874, DOI 10.1073/pnas.1006901107; Lombardi VC, 2009, SCIENCE, V326, P585, DOI 10.1126/science.1179052; Nagabhushan M, 1996, CANCER RES, V56, P3042; Oakes B, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-109; Paprotka T, 2010, J VIROL, V84, P5719, DOI 10.1128/JVI.00134-10; PATHAK VK, 1990, P NATL ACAD SCI USA, V87, P6019, DOI 10.1073/pnas.87.16.6019; PRETLOW TG, 1993, J NATL CANCER I, V85, P394, DOI 10.1093/jnci/85.5.394; Qiu XX, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-68; Robinson MJ, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-108; Schlaberg R, 2009, P NATL ACAD SCI USA, V106, P16351, DOI 10.1073/pnas.0906922106; Sramkoski RM, 1999, IN VITRO CELL DEV-AN, V35, P403; Stieler K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011738; Urisman A, 2006, PLOS PATHOG, V2, P211, DOI 10.1371/journal.ppat.0020025; van Bokhoven A, 2003, PROSTATE, V57, P205, DOI 10.1002/pros.10290; van der Kuyl AC, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2010.00147; Weiss RA, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-124; Zhuang JL, 2006, J VIROL, V80, P6706, DOI 10.1128/JVI.00273-06	25	185	192	0	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 1	2011	333	6038					97	101		10.1126/science.1205292	http://dx.doi.org/10.1126/science.1205292			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	785UF	21628392	Green Accepted			2022-12-24	WOS:000292255400058
J	Isakova, T; Xie, HL; Yang, W; Xie, DW; Anderson, AH; Scialla, J; Wahl, P; Gutierrez, OM; Steigerwalt, S; He, J; Schwartz, S; Lo, J; Ojo, A; Sondheimer, J; Hsu, CY; Lash, J; Leonard, M; Kusek, JW; Feldman, HI; Wolf, M				Isakova, Tamara; Xie, Huiliang; Yang, Wei; Xie, Dawei; Anderson, Amanda Hyre; Scialla, Julia; Wahl, Patricia; Gutierrez, Orlando M.; Steigerwalt, Susan; He, Jiang; Schwartz, Stanley; Lo, Joan; Ojo, Akinlolu; Sondheimer, James; Hsu, Chi-yuan; Lash, James; Leonard, Mary; Kusek, John W.; Feldman, Harold I.; Wolf, Myles		CRIC Study Grp	Fibroblast Growth Factor 23 and Risks of Mortality and End-Stage Renal Disease in Patients With Chronic Kidney Disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							VASCULAR DYSFUNCTION; PARATHYROID-HORMONE; FGF RECEPTOR; HEMODIALYSIS; CALCITRIOL; DEATH; FIBROBLAST-GROWTH-FACTOR-23; PROGRESSION; PHOSPHORUS; PREDICTION	Context A high level of the phosphate-regulating hormone fibroblast growth factor 23 (FGF-23) is associated with mortality in patients with end-stage renal disease, but little is known about its relationship with adverse outcomes in the much larger population of patients with earlier stages of chronic kidney disease. Objective To evaluate FGF-23 as a risk factor for adverse outcomes in patients with chronic kidney disease. Design, Setting, and Participants A prospective study of 3879 participants with chronic kidney disease stages 2 through 4 who enrolled in the Chronic Renal Insufficiency Cohort between June 2003 and September 2008. Main Outcome Measures All-cause mortality and end-stage renal disease. Results At study enrollment, the mean (SD) estimated glomerular filtration rate (GFR) was 42.8 (13.5) mL/min/1.73 m(2), and the median FGF-23 level was 145.5 RU/mL (interquartile range [IQR], 96-239 reference unit [RU]/mL). During a median follow-up of 3.5 years (IQR, 2.5-4.4 years), 266 participants died (20.3/1000 person-years) and 410 reached end-stage renal disease (33.0/1000 person-years). In adjusted analyses, higher levels of FGF-23 were independently associated with a greater risk of death (hazard ratio [HR], per SD of natural log-transformed FGF-23, 1.5; 95% confidence interval [CI], 1.3-1.7). Mortality risk increased by quartile of FGF-23: the HR was 1.3 (95% CI, 0.8-2.2) for the second quartile, 2.0 (95% CI, 1.2-3.3) for the third quartile, and 3.0 (95% CI, 1.8-5.1) for the fourth quartile. Elevated fibroblast growth factor 23 was independently associated with significantly higher risk of endstage renal disease among participants with an estimated GFR between 30 and 44 mL/min/1.73 m(2) (HR, 1.3 per SD of FGF-23 natural log-transformed FGF-23; 95% CI, 1.04-1.6) and 45 mL/min/1.73 m(2) or higher (HR, 1.7; 95% CI, 1.1-2.4), but not less than 30 mL/min/1.73 m(2). Conclusion Elevated FGF-23 is an independent risk factor for end-stage renal disease in patients with relatively preserved kidney function and for mortality across the spectrum of chronic kidney disease. JAMA. 2011;305(23):2432-2439 www.jama.com	[Isakova, Tamara; Wahl, Patricia; Wolf, Myles] Univ Miami, Miller Sch Med, Dept Med, Div Nephrol & Hypertens, Miami, FL 33136 USA; [Xie, Huiliang] Univ Miami, Miller Sch Med, Dept Epidemiol & Publ Hlth, Div Nephrol & Hypertens, Miami, FL 33136 USA; [Xie, Huiliang; Yang, Wei; Anderson, Amanda Hyre; Feldman, Harold I.] Childrens Hosp Philadelphia, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; [Leonard, Mary] Childrens Hosp Philadelphia, Dept Pediat, Philadelphia, PA 19104 USA; [Schwartz, Stanley; Feldman, Harold I.] Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA; [Scialla, Julia] Johns Hopkins Univ, Sch Med, Dept Med, Div Nephrol, Baltimore, MD 21205 USA; [Gutierrez, Orlando M.] Univ Alabama Birmingham, Dept Med, Div Nephrol, Birmingham, AL USA; [Steigerwalt, Susan] St Johns Hlth Syst, Detroit, MI USA; [He, Jiang] Tulane Univ, Hlth Sci Ctr, Dept Med, New Orleans, LA 70118 USA; [Lo, Joan] Kaiser Permanente, Oakland, CA USA; [Ojo, Akinlolu] Univ Michigan Hlth Syst, Dept Med, Div Nephrol, Ann Arbor, MI USA; [Sondheimer, James] Wayne State Univ, Sch Med, Dept Med, Div Nephrol, Detroit, MI 48201 USA; [Hsu, Chi-yuan] Univ Calif San Francisco, Dept Med, Div Nephrol, San Francisco, CA 94143 USA; [Lash, James] Univ Illinois, Dept Med, Div Nephrol, Chicago, IL USA; [Kusek, John W.] NIDDK, Div Kidney Urol & Hematol Dis, Bethesda, MD USA	University of Miami; University of Miami; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Johns Hopkins University; University of Alabama System; University of Alabama Birmingham; Tulane University; Kaiser Permanente; University of Michigan System; University of Michigan; Wayne State University; University of California System; University of California San Francisco; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Wolf, M (corresponding author), Univ Miami, Miller Sch Med, Dept Med, Div Nephrol & Hypertens, 1120 NW 14th St,CRB 819, Miami, FL 33136 USA.	mwolf2@med.miami.edu	Yang, Wei/A-9223-2009; He, Jiang/AAF-5303-2020; Schwartz, S/I-9628-2019	Yang, Wei/0000-0001-8984-4389; He, Jiang/0000-0002-8286-9652; Hsu, Chi-yuan/0000-0001-8182-1238; Scialla, Julia/0000-0003-1707-691X	National Institutes of Health [R01DK081374, K23DK087858, R01DK077128, UL1RR024134, UL1RR025005, M01RR16500, UL1RR024989, M01RR000042, UL1RR024986, UL1RR029879, RR05096, UL1RR024131]; National Institute of Diabetes and Digestive and Kidney Diseases [5U01DK060990, 5U01DK060984, 5U01DK06102, 5U01DK061021, 5U01DK061028, 5U01DK60980, 5U01DK060963, 5U01DK060902]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024989, UL1RR024986, M01RR005096, M01RR013987, UL1RR024131, UL1RR029879, UL1RR025005, M01RR000042, UL1RR024134, M01RR016500] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK060990, R01DK076116, R01DK072231, U01DK060980, K23DK087858, R56DK072231, K24DK062234, U01DK060902, U01DK061021, U01DK061028, R01DK077128, R01DK081374, U01DK060984, U01DK060963] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This CRIC ancillary study was supported by National Institutes of Health grants R01DK081374 (Dr Wolf), K23DK087858 (Dr Isakova), and R01DK077128 (Dr Leonard). The CRIC Study is supported by cooperative agreement project grants 5U01DK060990, 5U01DK060984, 5U01DK06102, 5U01DK061021, 5U01DK061028, 5U01DK60980, 5U01DK060963, and 5U01DK060902 from the National Institute of Diabetes and Digestive and Kidney Diseases, and by grants UL1RR024134, UL1RR025005, M01RR16500, UL1RR024989, M01RR000042, UL1RR024986, UL1RR029879, RR05096, and UL1RR024131 from the National Institutes of Health.	Feldman HI, 2003, J AM SOC NEPHROL, V14, pS148, DOI 10.1097/01.ASN.0000070149.78399.CE; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Fliser D, 2007, J AM SOC NEPHROL, V18, P2600, DOI 10.1681/ASN.2006080936; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Gutierrez O, 2005, J AM SOC NEPHROL, V16, P2205, DOI 10.1681/ASN.2005010052; Gutierrez OM, 2008, NEW ENGL J MED, V359, P584, DOI 10.1056/NEJMoa0706130; Gutierrez OM, 2009, CIRCULATION, V119, P2545, DOI 10.1161/CIRCULATIONAHA.108.844506; Hu MC, 2011, J AM SOC NEPHROL, V22, P124, DOI 10.1681/ASN.2009121311; Isakova T, 2011, KIDNEY INT, V79, P1370, DOI 10.1038/ki.2011.47; Isakova T, 2009, J AM SOC NEPHROL, V20, P388, DOI 10.1681/ASN.2008060609; Jean G, 2009, NEPHROL DIAL TRANSPL, V24, P2792, DOI 10.1093/ndt/gfp191; Juppner H, 2010, J BONE MINER RES, V25, P2091, DOI 10.1002/jbmr.170; Kestenbaum B, 2005, J AM SOC NEPHROL, V16, P520, DOI 10.1681/ASN.2004070602; Komaba H, 2010, KIDNEY INT, V77, P232, DOI 10.1038/ki.2009.414; Landray MJ, 2010, AM J KIDNEY DIS, V56, P1082, DOI 10.1053/j.ajkd.2010.07.016; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Mirza MAI, 2009, ATHEROSCLEROSIS, V207, P546, DOI 10.1016/j.atherosclerosis.2009.05.013; Mirza MAI, 2009, NEPHROL DIAL TRANSPL, V24, P3125, DOI 10.1093/ndt/gfp205; Mirza MAI, 2009, ATHEROSCLEROSIS, V205, P385, DOI 10.1016/j.atherosclerosis.2009.01.001; Norris KC, 2006, J AM SOC NEPHROL, V17, P2928, DOI 10.1681/ASN.2005101101; Oliveira RB, 2010, CLIN J AM SOC NEPHRO, V5, P286, DOI 10.2215/CJN.05420709; Palmer SC, 2011, JAMA-J AM MED ASSOC, V305, P1119, DOI 10.1001/jama.2011.308; Parker BD, 2010, ANN INTERN MED, V152, P640, DOI 10.7326/0003-4819-152-10-201005180-00004; Shimada T, 2010, J CLIN ENDOCR METAB, V95, P578, DOI 10.1210/jc.2009-1603; Teng M, 2003, NEW ENGL J MED, V349, P446, DOI 10.1056/NEJMoa022536; Titan SM, 2011, CLIN J AM SOC NEPHRO, V6, P241, DOI 10.2215/CJN.04250510; Urakawa I, 2006, NATURE, V444, P770, DOI 10.1038/nature05315; US Renal Data System, 2010, USRDS 2010 ANN DAT R; Wesseling-Perry K, 2011, KIDNEY INT, V79, P112, DOI 10.1038/ki.2010.352; Wolf M, 2011, J AM SOC NEPHROL, V22, P956, DOI 10.1681/ASN.2010080894; Wolf M, 2010, J AM SOC NEPHROL, V21, P1427, DOI 10.1681/ASN.2009121293; Yilmaz MI, 2010, KIDNEY INT, V78, P679, DOI 10.1038/ki.2010.194	32	768	812	1	31	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 15	2011	305	23					2432	2439		10.1001/jama.2011.826	http://dx.doi.org/10.1001/jama.2011.826			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	777EB	21673295	Bronze, Green Accepted			2022-12-24	WOS:000291597300023
J	Zwilling, D; Huang, SY; Sathyasaikumar, KV; Notarangelo, FM; Guidetti, P; Wu, HQ; Lee, J; Truong, J; Andrews-Zwilling, Y; Hsieh, EW; Louie, JY; Wu, T; Scearce-Levie, K; Patrick, C; Adame, A; Giorgini, F; Moussaoui, S; Laue, G; Rassoulpour, A; Flik, G; Huang, YD; Muchowski, JM; Masliah, E; Schwarcz, R; Muchowski, PJ				Zwilling, Daniel; Huang, Shao-Yi; Sathyasaikumar, Korrapati V.; Notarangelo, Francesca M.; Guidetti, Paolo; Wu, Hui-Qiu; Lee, Jason; Truong, Jennifer; Andrews-Zwilling, Yaisa; Hsieh, Eric W.; Louie, Jamie Y.; Wu, Tiffany; Scearce-Levie, Kimberly; Patrick, Christina; Adame, Anthony; Giorgini, Flaviano; Moussaoui, Saliha; Laue, Grit; Rassoulpour, Arash; Flik, Gunnar; Huang, Yadong; Muchowski, Joseph M.; Masliah, Eliezer; Schwarcz, Robert; Muchowski, Paul J.			Kynurenine 3-Monooxygenase Inhibition in Blood Ameliorates Neurodegeneration	CELL			English	Article							QUINOLINIC ACID; MOUSE MODEL; TRYPTOPHAN-METABOLISM; ALZHEIMERS-DISEASE; GLUTAMATE UPTAKE; PATHWAY; EXPRESSION; AMINOTRANSFERASE; NEUROTOXICITY; INFLAMMATION	Metabolites in the kynurenine pathway, generated by tryptophan degradation, are thought to play an important role in neurodegenerative disorders, including Alzheimer's and Huntington's diseases. In these disorders, glutamate receptor-mediated excitotoxicity and free radical formation have been correlated with decreased levels of the neuroprotective metabolite kynurenic acid. Here, we describe the synthesis and characterization of JM6, a smallmolecule prodrug inhibitor of kynurenine 3-monooxygenase (KMO). Chronic oral administration of JM6 inhibits KMO in the blood, increasing kynurenic acid levels and reducing extracellular glutamate in the brain. In a transgenic mouse model of Alzheimer's disease, JM6 prevents spatial memory deficits, anxiety-related behavior, and synaptic loss. JM6 also extends life span, prevents synaptic loss, and decreases microglial activation in a mouse model of Huntington's disease. These findings support a critical link between tryptophan metabolism in the blood and neurodegeneration, and they provide a foundation for treatment of neurodegenerative diseases.	[Zwilling, Daniel; Huang, Shao-Yi; Lee, Jason; Truong, Jennifer; Andrews-Zwilling, Yaisa; Hsieh, Eric W.; Louie, Jamie Y.; Wu, Tiffany; Scearce-Levie, Kimberly; Huang, Yadong; Muchowski, Joseph M.; Muchowski, Paul J.] Univ Calif San Francisco, Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA; [Muchowski, Paul J.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Muchowski, Paul J.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA; [Huang, Shao-Yi; Muchowski, Paul J.] Taube Koret Ctr Huntingtons Dis Res, San Francisco, CA 94158 USA; [Huang, Shao-Yi; Muchowski, Paul J.] Hellman Family Fdn Program Alzheimers Dis Res, San Francisco, CA 94158 USA; [Sathyasaikumar, Korrapati V.; Notarangelo, Francesca M.; Guidetti, Paolo; Wu, Hui-Qiu; Schwarcz, Robert] Univ Maryland, Maryland Psychiat Res Ctr, Sch Med, Baltimore, MD 21228 USA; [Patrick, Christina; Adame, Anthony; Masliah, Eliezer] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Giorgini, Flaviano] Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England; [Moussaoui, Saliha; Laue, Grit] Novartis Inst BioMed Res, CH-4002 Basel, Switzerland; [Rassoulpour, Arash; Flik, Gunnar] Brains On Line BV, NL-9713 AV Groningen, Netherlands	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University System of Maryland; University of Maryland Baltimore; University of California System; University of California San Diego; University of Leicester; Novartis	Muchowski, PJ (corresponding author), Univ Calif San Francisco, Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA.	pmuchowski@gladstone.ucsf.edu	Schwarcz, Robert/P-3134-2018	Wu, Tiffany/0000-0002-9273-0574; Giorgini, Flaviano/0000-0001-7881-9508	J. David Gladstone Institutes; National Institutes of Health [AG022074, NS057715]; Taube-Koret Center for Huntington's Disease Research; Hellman Family Foundation; American Health Assistance Foundation; National Center for Research Resources [RR18928-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR018928] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS057715, P30NS065780] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG022074] Funding Source: NIH RePORTER	J. David Gladstone Institutes(University of California System); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Taube-Koret Center for Huntington's Disease Research; Hellman Family Foundation; American Health Assistance Foundation; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by the J. David Gladstone Institutes (P.J.M.), National Institutes of Health grants AG022074 (P.J.M., Y.H., and E.M.) and NS057715 (P.J.M. and R.S.), the Taube-Koret Center for Huntington's Disease Research and the Hellman Family Foundation Program in Alzheimer's Disease Research (P.J.M.), and a postdoctoral fellowship from the American Health Assistance Foundation (D.Z.). The J. David Gladstone Institutes received support from a National Center for Research Resources Grant RR18928-01. The authors thank S. Ordway and G. Howard for editorial assistance and S. Finkbeiner for helpful discussions. This study is dedicated in loving memory to Dr. Paolo Guidetti (June 5, 1966-December 28, 2007), who tragically passed away during the course of this study after a battle with cancer.	ANDINE P, 1988, NEUROSCI LETT, V90, P208, DOI 10.1016/0304-3940(88)90813-0; BEAL MF, 1992, J NEUROL SCI, V108, P80; Bjorkqvist M, 2008, J EXP MED, V205, P1869, DOI 10.1084/jem.20080178; BOEGMAN RJ, 1985, NEUROBIOL AGING, V6, P331, DOI 10.1016/0197-4580(85)90012-0; Campesan S, 2011, CURR BIOL, V21, P961, DOI 10.1016/j.cub.2011.04.028; Carpenedo R, 2001, EUR J NEUROSCI, V13, P2141, DOI 10.1046/j.0953-816x.2001.01592.x; Carrillo-Mora P, 2010, BEHAV BRAIN RES, V210, P240, DOI 10.1016/j.bbr.2010.02.041; Cepeda C, 2003, J NEUROSCI, V23, P961; Chin J, 2005, J NEUROSCI, V25, P9694, DOI 10.1523/JNEUROSCI.2980-05.2005; Clark CJ, 2005, INFECT IMMUN, V73, P5249, DOI 10.1128/IAI.73.8.5249-5251.2005; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Dziewczapolski G, 2009, J NEUROSCI, V29, P8805, DOI 10.1523/JNEUROSCI.6159-08.2009; Eckstein JA, 2008, J MASS SPECTROM, V43, P782, DOI 10.1002/jms.1376; FILLIT H, 1991, NEUROSCI LETT, V129, P318, DOI 10.1016/0304-3940(91)90490-K; FOSTER AC, 1984, NEUROSCI LETT, V48, P273, DOI 10.1016/0304-3940(84)90050-8; FUKUI S, 1991, J NEUROCHEM, V56, P2007, DOI 10.1111/j.1471-4159.1991.tb03460.x; Giorgini F, 2005, NAT GENET, V37, P526, DOI 10.1038/ng1542; Gregoire L, 2008, BEHAV BRAIN RES, V186, P161, DOI 10.1016/j.bbr.2007.08.007; Guidetti P, 2004, NEUROBIOL DIS, V17, P455, DOI 10.1016/j.nbd.2004.07.006; Guidetti P, 2007, J NEUROCHEM, V102, P103, DOI 10.1111/j.1471-4159.2007.04556.x; Guidetti P, 2006, NEUROBIOL DIS, V23, P190, DOI 10.1016/j.nbd.2006.02.011; Gulaj E, 2010, ADV MED SCI-POLAND, V55, P204, DOI 10.2478/v10039-010-0023-6; Harris JA, 2010, J NEUROSCI, V30, P372, DOI 10.1523/JNEUROSCI.5341-09.2010; HEYES MP, 1992, BRAIN, V115, P1249, DOI 10.1093/brain/115.5.1249; HEYES MP, 1992, BIOCHEM J, V283, P633, DOI 10.1042/bj2830633; Hilmas C, 2001, J NEUROSCI, V21, P7463, DOI 10.1523/JNEUROSCI.21-19-07463.2001; Hockly E, 2002, ANN NEUROL, V51, P235, DOI 10.1002/ana.10094; KESSLER M, 1989, J NEUROCHEM, V52, P1319, DOI 10.1111/j.1471-4159.1989.tb01881.x; Lievens JC, 2001, NEUROBIOL DIS, V8, P807, DOI 10.1006/nbdi.2001.0430; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Masliah E, 1996, ANN NEUROL, V40, P759, DOI 10.1002/ana.410400512; MASLIAH E, 1989, NEUROSCI LETT, V103, P234, DOI 10.1016/0304-3940(89)90582-X; Miller BR, 2008, NEUROSCIENCE, V153, P329, DOI 10.1016/j.neuroscience.2008.02.004; Misztal M, 1996, NEUROPHARMACOLOGY, V35, P449, DOI 10.1016/0028-3908(96)00005-6; Moroni F, 1999, ADV EXP MED BIOL, V467, P199; Moroni F, 2005, NEUROPHARMACOLOGY, V48, P788, DOI 10.1016/j.neuropharm.2004.10.019; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; NOZAKI K, 1992, J CEREBR BLOOD F MET, V12, P400, DOI 10.1038/jcbfm.1992.57; Okuda S, 1996, P NATL ACAD SCI USA, V93, P12553, DOI 10.1073/pnas.93.22.12553; Pellicciari R, 2006, CHEMMEDCHEM, V1, P528, DOI 10.1002/cmdc.200500095; PERKINS MN, 1982, BRAIN RES, V247, P184, DOI 10.1016/0006-8993(82)91048-4; Rassoulpour A, 2005, J NEUROCHEM, V93, P762, DOI 10.1111/j.1471-4159.2005.03134.x; Rodgers J, 2009, BRAIN, V132, P1259, DOI 10.1093/brain/awp074; Romani L, 2008, J IMMUNOL, V180, P5157, DOI 10.4049/jimmunol.180.8.5157; Rover S, 1997, J MED CHEM, V40, P4378, DOI 10.1021/jm970467t; Sapko MT, 2006, EXP NEUROL, V197, P31, DOI 10.1016/j.expneurol.2005.07.004; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; SCHWARCZ R, 1983, SCIENCE, V219, P316, DOI 10.1126/science.6849138; Silva-Adaya D, 2011, NEUROTOXICOL TERATOL, V33, P303, DOI 10.1016/j.ntt.2010.10.002; Simmons DA, 2007, GLIA, V55, P1074, DOI 10.1002/glia.20526; Stoy N, 2005, J NEUROCHEM, V93, P611, DOI 10.1111/j.1471-4159.2005.03070.x; Wacker JL, 2009, J NEUROSCI, V29, P9104, DOI 10.1523/JNEUROSCI.2250-09.2009; Wang JH, 2006, J BIOL CHEM, V281, P22021, DOI 10.1074/jbc.M603503200; Yamamoto M, 2007, AM J PATHOL, V170, P680, DOI 10.2353/ajpath.2007.060378	54	352	362	0	56	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 10	2011	145	6					863	874		10.1016/j.cell.2011.05.020	http://dx.doi.org/10.1016/j.cell.2011.05.020			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	775LS	21640374	Bronze, Green Accepted			2022-12-24	WOS:000291461600014
J	Oldham, ML; Chen, J				Oldham, Michael L.; Chen, Jue			Crystal Structure of the Maltose Transporter in a Pretranslocation Intermediate State	SCIENCE			English	Article							MALTODEXTRIN-BINDING-PROTEIN; BOVINE HEART-MITOCHONDRIA; ABC-TRANSPORTER; ATP-BINDING; ESCHERICHIA-COLI; CASSETTE TRANSPORTER; ALTERNATING ACCESS; ACTIVE-TRANSPORT; MECHANISM; CONFORMATION	Adenosine triphosphate (ATP)-binding cassette (ABC) transporters convert chemical energy from ATP hydrolysis to mechanical work for substrate translocation. They function by alternating between two states, exposing the substrate-binding site to either side of the membrane. A key question that remains to be addressed is how substrates initiate the transport cycle. Using x-ray crystallography, we have captured the maltose transporter in an intermediate step between the inward- and outward-facing states. We show that interactions with substrate-loaded maltose-binding protein in the periplasm induce a partial closure of the MalK dimer in the cytoplasm. ATP binding to this conformation then promotes progression to the outward-facing state. These results, interpreted in light of biochemical and functional studies, provide a structural basis to understand allosteric communication in ABC transporters.	[Oldham, Michael L.; Chen, Jue] Purdue Univ, Howard Hughes Med Inst, Dept Biol Sci, W Lafayette, IN 47907 USA	Howard Hughes Medical Institute; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Chen, J (corresponding author), Purdue Univ, Howard Hughes Med Inst, Dept Biol Sci, W Lafayette, IN 47907 USA.	chenjue@purdue.edu			NIH [GM070515]; American Heart Association; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070515, R56GM070515] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Davidson for providing the MBP(G69C/S337C) construct and comments on this manuscript and staff at the Advanced Photon Source beamline 23-ID for assistance with data collection. We are also especially grateful for thoughtful and constructive comments from the anonymous reviewers. This work was supported by an NIH grant (GM070515 to J.C.) and a postdoctoral fellowship from the American Heart Association (to M.L.O). J.C. is an investigator of the Howard Hughes Medical Institute. Coordinates and structure factors have been deposited in the Protein Data Bank under accession nos. 3PV0, 3PUY, and 3PUZ.	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; Boudker O, 2007, NATURE, V445, P387, DOI 10.1038/nature05455; Bowler MW, 2007, J BIOL CHEM, V282, P14238, DOI 10.1074/jbc.M700203200; Chen J, 2003, MOL CELL, V12, P651, DOI 10.1016/j.molcel.2003.08.004; Chen J, 2001, P NATL ACAD SCI USA, V98, P1525, DOI 10.1073/pnas.041542498; COVITZ KMY, 1994, EMBO J, V13, P1752, DOI 10.1002/j.1460-2075.1994.tb06439.x; Davidson AL, 2004, ANNU REV BIOCHEM, V73, P241, DOI 10.1146/annurev.biochem.73.011303.073626; DAVIDSON AL, 1992, P NATL ACAD SCI USA, V89, P2360, DOI 10.1073/pnas.89.6.2360; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Evenas J, 2001, J MOL BIOL, V309, P961, DOI 10.1006/jmbi.2001.4695; Haffke M, 2010, ACTA CRYSTALLOGR D, V66, P979, DOI 10.1107/S0907444910028593; Hall JA, 1997, J BIOL CHEM, V272, P17610, DOI 10.1074/jbc.272.28.17610; Hollenstein K, 2007, NATURE, V446, P213, DOI 10.1038/nature05626; Hung LW, 1998, NATURE, V396, P703, DOI 10.1038/25393; Hunke S, 2000, J BACTERIOL, V182, P1432, DOI 10.1128/JB.182.5.1432-1436.2000; Hvorup RN, 2007, SCIENCE, V317, P1387, DOI 10.1126/science.1145950; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Jones PM, 2009, TRENDS BIOCHEM SCI, V34, P520, DOI 10.1016/j.tibs.2009.06.004; Kadaba NS, 2008, SCIENCE, V321, P250, DOI 10.1126/science.1157987; Karpowich N, 2001, STRUCTURE, V9, P571, DOI 10.1016/S0969-2126(01)00617-7; Khare D, 2009, MOL CELL, V33, P528, DOI 10.1016/j.molcel.2009.01.035; Lewis HA, 2004, EMBO J, V23, P282, DOI 10.1038/sj.emboj.7600040; Lu G, 2005, P NATL ACAD SCI USA, V102, P17969, DOI 10.1073/pnas.0506039102; Oldham ML, 2007, NATURE, V450, P515, DOI 10.1038/nature06264; Oldham ML, 2008, CURR OPIN STRUC BIOL, V18, P726, DOI 10.1016/j.sbi.2008.09.007; Orelle C, 2008, P NATL ACAD SCI USA, V105, P12837, DOI 10.1073/pnas.0803799105; Orelle C, 2010, P NATL ACAD SCI USA, V107, P20293, DOI 10.1073/pnas.1006544107; Oswald C, 2006, N-S ARCH PHARMACOL, V372, P385, DOI 10.1007/s00210-005-0031-4; Pinkett HW, 2007, SCIENCE, V315, P373, DOI 10.1126/science.1133488; Reyes N, 2009, NATURE, V462, P880, DOI 10.1038/nature08616; Shaffer PL, 2009, SCIENCE, V325, P1010, DOI 10.1126/science.1176088; SHARFF AJ, 1992, BIOCHEMISTRY-US, V31, P10657, DOI 10.1021/bi00159a003; Shilton BH, 2008, BBA-BIOMEMBRANES, V1778, P1772, DOI 10.1016/j.bbamem.2007.09.005; Singh SK, 2008, SCIENCE, V322, P1655, DOI 10.1126/science.1166777; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; SPURLINO JC, 1991, J BIOL CHEM, V266, P5202; Tang C, 2007, NATURE, V449, P1078, DOI 10.1038/nature06232; Verdon G, 2003, J MOL BIOL, V330, P343, DOI 10.1016/S0022-2836(03)00575-8; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; Ye JQ, 2004, BBA-BIOENERGETICS, V1659, P1, DOI 10.1016/j.bbabio.2004.06.003; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018; Zhang YH, 1996, J BIOL CHEM, V271, P17881, DOI 10.1074/jbc.271.30.17881	43	170	172	0	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 3	2011	332	6034					1202	1205		10.1126/science.1200767	http://dx.doi.org/10.1126/science.1200767			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	772BO	21566157				2022-12-24	WOS:000291205200049
J	Yeretssian, G; Correa, RG; Doiron, K; Fitzgerald, P; Dillon, CP; Green, DR; Reed, JC; Saleh, M				Yeretssian, Garabet; Correa, Ricardo G.; Doiron, Karine; Fitzgerald, Patrick; Dillon, Christopher P.; Green, Douglas R.; Reed, John C.; Saleh, Maya			Non-apoptotic role of BID in inflammation and innate immunity	NATURE			English	Article							FAMILY-MEMBER; CELL-DEATH; KAPPA-B; PROTEIN; ACTIVATION; NOD1; BCL-2; RECOGNITION; MECHANISM; BINDING	Innate immunity is a fundamental defence response that depends on evolutionarily conserved pattern recognition receptors for sensing infections or danger signals(1,2). Nucleotide-binding and oligomerization domain (NOD) proteins are cytosolic pattern-recognition receptors of paramount importance in the intestine, and their dysregulation is associated with inflammatory bowel disease(3,4). They sense peptidoglycans from commensal microorganisms and pathogens and coordinate signalling events that culminate in the induction of inflammation and anti-microbial responses(2). However, the signalling mechanisms involved in this process are not fully understood. Here, using genome-wide RNA interference, we identify candidate genes that modulate the NOD1 inflammatory response in intestinal epithelial cells. Our results reveal a significant crosstalk between innate immunity and apoptosis and identify BID, a BCL2 family protein, as a critical component of the inflammatory response. Colonocytes depleted of BID or macrophages from Bid(-/-) mice are markedly defective in cytokine production in response to NOD activation. Furthermore, Bid(-/-) mice are unresponsive to local or systemic exposure to NOD agonists or their protective effect in experimental colitis. Mechanistically, BID interacts with NOD1, NOD2 and the I kappa B kinase (IKK) complex, impacting NF-kappa B and extracellular signal-regulated kinase (ERK) signalling. Our results define a novel role of BID in inflammation and immunity independent of its apoptotic function, furthering the mounting evidence of evolutionary conservation between the mechanisms of apoptosis and immunity.	[Yeretssian, Garabet; Doiron, Karine; Saleh, Maya] McGill Univ, Dept Med, Montreal, PQ H3G 0B1, Canada; [Correa, Ricardo G.; Reed, John C.] Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA; [Fitzgerald, Patrick; Dillon, Christopher P.; Green, Douglas R.] St Jude Childrens Res Hosp, Memphis, TN 38105 USA	McGill University; Sanford Burnham Prebys Medical Discovery Institute; St Jude Children's Research Hospital	Saleh, M (corresponding author), McGill Univ, Dept Med, Montreal, PQ H3G 0B1, Canada.	maya.saleh@mcgill.ca	Correa, Ricardo G/G-7613-2012; Dillon, Christopher/P-4457-2014; Green, Douglas R/N-8083-2018	Correa, Ricardo G/0000-0001-6940-7034; Dillon, Christopher/0000-0002-9458-0266; Green, Douglas R/0000-0002-7332-1417; Saleh, Maya/0000-0003-1538-9146	Canadian Institutes for Health Research [CIHR-MOP 82801]; Burroughs Wellcome Fund; McGill University Health Center; SASS Foundation for Medical Research	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Burroughs Wellcome Fund(Burroughs Wellcome Fund); McGill University Health Center; SASS Foundation for Medical Research	We thank A. Strasser for providing Bid<SUP>-/-</SUP> mice, G. Shore for BID antibodies and the McGill University high throughput/high content screening facility. We also thank D. Zhai for BID purification. This work was supported by grants from the Canadian Institutes for Health Research (CIHR-MOP 82801) and the Burroughs Wellcome Fund to M.S. M.S. is a Canadian Institutes for Health Research New Investigator. G.Y. is supported by a PDF-Fellowship from the McGill University Health Center. C.P.D. is supported by a fellowship grant from the SASS Foundation for Medical Research.	Abbott DW, 2004, CURR BIOL, V14, P2217, DOI 10.1016/j.cub.2004.12.032; Bertin J, 1999, J BIOL CHEM, V274, P12955, DOI 10.1074/jbc.274.19.12955; Bertrand MJM, 2009, IMMUNITY, V30, P789, DOI 10.1016/j.immuni.2009.04.011; Boutros M, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r66; Bruey JM, 2007, CELL, V129, P45, DOI 10.1016/j.cell.2007.01.045; Chen CM, 2004, J BIOL CHEM, V279, P25876, DOI 10.1074/jbc.M400682200; Cho JH, 2008, NAT REV IMMUNOL, V8, P458, DOI 10.1038/nri2340; Conradt B, 1998, CELL, V93, P519, DOI 10.1016/S0092-8674(00)81182-4; Desagher S, 2001, MOL CELL, V8, P601, DOI 10.1016/S1097-2765(01)00335-5; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Faustin B, 2007, MOL CELL, V25, P713, DOI 10.1016/j.molcel.2007.01.032; Faustin B, 2009, P NATL ACAD SCI USA, V106, P3935, DOI 10.1073/pnas.0809414106; Garrett WS, 2010, CELL, V140, P859, DOI 10.1016/j.cell.2010.01.023; Girardin SE, 2003, SCIENCE, V300, P1584, DOI 10.1126/science.1084677; Hasegawa M, 2008, EMBO J, V27, P373, DOI 10.1038/sj.emboj.7601962; Hsu YMS, 2007, NAT IMMUNOL, V8, P198, DOI 10.1038/ni1426; Inohara N, 1999, J BIOL CHEM, V274, P14560, DOI 10.1074/jbc.274.21.14560; Kim JG, 2004, INFECT IMMUN, V72, P1487, DOI 10.1128/IAI.72.3.1487-1495.2004; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; Luo W, 2010, CURR CANCER DRUG TAR, V10, P96, DOI 10.2174/156800910790980160; Masumoto J, 2006, J EXP MED, V203, P203, DOI 10.1084/jem.20051229; Mi HY, 2005, NUCLEIC ACIDS RES, V33, pD284, DOI 10.1093/nar/gki078; Ogura Y, 2001, J BIOL CHEM, V276, P4812, DOI 10.1074/jbc.M008072200; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Petros AM, 2004, BBA-MOL CELL RES, V1644, P83, DOI 10.1016/j.bbamcr.2003.08.012; Rivals I, 2007, BIOINFORMATICS, V23, P401, DOI 10.1093/bioinformatics/btl633; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Strasser A, 2005, NAT REV IMMUNOL, V5, P189, DOI 10.1038/nri1568; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Vijay-Kumar M, 2007, INFLAMM BOWEL DIS, V13, P856, DOI 10.1002/ibd.20142; Wang K, 1996, GENE DEV, V10, P2859, DOI 10.1101/gad.10.22.2859; Watanabe T, 2008, J CLIN INVEST, V118, P545, DOI [10.1172/JC133145, 10.1172/JCI33145]; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Zhai DY, 2005, J BIOL CHEM, V280, P15815, DOI 10.1074/jbc.M411902200; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	36	84	85	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 2	2011	474	7349					96	U126		10.1038/nature09982	http://dx.doi.org/10.1038/nature09982			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	771KV	21552281				2022-12-24	WOS:000291156700045
J	Thigpen, MC; Whitney, CG; Messonnier, NE; Zell, ER; Lynfield, R; Hadler, JL; Harrison, LH; Farley, MM; Reingold, A; Bennett, NM; Craig, AS; Schaffner, W; Thomas, A; Lewis, MM; Scallan, E; Schuchat, A				Thigpen, Michael C.; Whitney, Cynthia G.; Messonnier, Nancy E.; Zell, Elizabeth R.; Lynfield, Ruth; Hadler, James L.; Harrison, Lee H.; Farley, Monica M.; Reingold, Arthur; Bennett, Nancy M.; Craig, Allen S.; Schaffner, William; Thomas, Ann; Lewis, Melissa M.; Scallan, Elaine; Schuchat, Anne		Emerging Infections Programs Netw	Bacterial Meningitis in the United States, 1998-2007	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PNEUMOCOCCAL CONJUGATE VACCINE; DISEASE; EPIDEMIOLOGY; SURVEILLANCE; LISTERIOSIS; ILLNESS; ADULTS	BACKGROUND The rate of bacterial meningitis declined by 55% in the United States in the early 1990s, when the Haemophilus influenzae type b (Hib) conjugate vaccine for infants was introduced. More recent prevention measures such as the pneumococcal conjugate vaccine and universal screening of pregnant women for group B streptococcus (GBS) have further changed the epidemiology of bacterial meningitis. METHODS We analyzed data on cases of bacterial meningitis reported among residents in eight surveillance areas of the Emerging Infections Programs Network, consisting of approximately 17.4 million persons, during 1998-2007. We defined bacterial meningitis as the presence of H. influenzae, Streptococcus pneumoniae, GBS, Listeria monocytogenes, or Neisseria meningitidis in cerebrospinal fluid or other normally sterile site in association with a clinical diagnosis of meningitis. RESULTS We identified 3188 patients with bacterial meningitis; of 3155 patients for whom outcome data were available, 466 (14.8%) died. The incidence of meningitis changed by -31% (95% confidence interval [CI], -33 to -29) during the surveillance period, from 2.00 cases per 100,000 population (95% CI, 1.85 to 2.15) in 1998-1999 to 1.38 cases per 100,000 population (95% CI 1.27 to 1.50) in 2006-2007. The median age of patients increased from 30.3 years in 1998-1999 to 41.9 years in 2006-2007 (P<0.001 by the Wilcoxon rank-sum test). The case fatality rate did not change significantly: it was 15.7% in 1998-1999 and 14.3% in 2006-2007 (P=0.50). Of the 1670 cases reported during 2003-2007, S. pneumoniae was the predominant infective species (58.0%), followed by GBS (18.1%), N. meningitidis (13.9%), H. influenzae (6.7%), and L. monocytogenes (3.4%). An estimated 4100 cases and 500 deaths from bacterial meningitis occurred annually in the United States during 2003-2007. CONCLUSIONS The rates of bacterial meningitis have decreased since 1998, but the disease still often results in death. With the success of pneumococcal and Hib conjugate vaccines in reducing the risk of meningitis among young children, the burden of bacterial meningitis is now borne more by older adults. (Funded by the Emerging Infections Programs, Centers for Disease Control and Prevention.)	[Thigpen, Michael C.; Whitney, Cynthia G.; Messonnier, Nancy E.; Zell, Elizabeth R.; Lewis, Melissa M.; Scallan, Elaine; Schuchat, Anne] Ctr Dis Control & Prevent, Atlanta, GA USA; [Farley, Monica M.] Georgia Dept Human Resources, Atlanta, GA USA; [Lynfield, Ruth] Minnesota Dept Hlth, Minneapolis, MN USA; [Hadler, James L.] Connecticut Dept Publ Hlth & Addict Serv, Hartford, CT 06106 USA; [Harrison, Lee H.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Reingold, Arthur] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; [Bennett, Nancy M.] Univ Rochester, Sch Med & Dent, Rochester, NY USA; [Craig, Allen S.; Schaffner, William] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA; [Thomas, Ann] Oregon Publ Hlth Div, Portland, OR USA	Centers for Disease Control & Prevention - USA; Minnesota Department of Health (MHD); Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of California System; University of California Berkeley; University of Rochester; Vanderbilt University	Thigpen, MC (corresponding author), 3150 Rampart Rd, Ft Collins, CO 80521 USA.	mthigpen@cdc.gov	Walter, Elaine Scallan/AAG-4278-2020		Centers for Disease Control and Prevention, Atlanta	Centers for Disease Control and Prevention, Atlanta(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	Supported by the Emerging Infections Programs, Centers for Disease Control and Prevention, Atlanta.	Advisory Committee on Immunization Practices, 2009, ADV COMM IMM PRACT S, P59; [Anonymous], 2000, MMWR Recomm Rep, V49, P1; Anonymous, 2010, Morbidity and Mortality Weekly Report, V59, P258; Centers for Disease Control and Prevention, ACT BACT COR SURV AB; Centers for Disease Control and Prevention (CDC), 2006, MMWR Morb Mortal Wkly Rep, V55, P392; Centers for Disease Control and Prevention (CDC), 2005, MMWR Morb Mortal Wkly Rep, V54, P893; Centers for Disease Control and Prevention (CDC), 2010, ACT BACT COR SURV AB; Cohn AC, 2010, CLIN INFECT DIS, V50, P184, DOI 10.1086/649209; DURAND ML, 1993, NEW ENGL J MED, V328, P21, DOI 10.1056/NEJM199301073280104; Flannery B, 2006, ANN INTERN MED, V144, P1, DOI 10.7326/0003-4819-144-1-200601030-00004; Food Safety and Inspection Service, 2000, REV ACT PLAN CONTR L; Food Safety and Inspection Service, 2008, FSIS REG TEST LM RTE; FRASER DW, 1975, AM J EPIDEMIOL, V102, P394, DOI 10.1093/oxfordjournals.aje.a112178; FRASER DW, 1974, AM J EPIDEMIOL, V100, P29, DOI 10.1093/oxfordjournals.aje.a112005; Gottlieb SL, 2006, CLIN INFECT DIS, V42, P29, DOI 10.1086/498113; Hall HI, 2008, JAMA-J AM MED ASSOC, V300, P520, DOI 10.1001/jama.300.5.520; Hardnett FP, 2004, CLIN INFECT DIS, V38, pS121, DOI 10.1086/381602; Hsu HE, 2009, NEW ENGL J MED, V360, P244, DOI 10.1056/NEJMoa0800836; Jackson KA, 2010, EPIDEMIOL INFECT, V138, P1503, DOI 10.1017/S0950268810000294; Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; National Association of State Public Health Veterinarians Inc. (NASPHV), 2005, MMWR Recomm Rep, V54, P1; Phares CR, 2008, JAMA-J AM MED ASSOC, V299, P2056, DOI 10.1001/jama.299.17.2056; SCHLECH WF, 1985, JAMA-J AM MED ASSOC, V253, P1749, DOI 10.1001/jama.253.12.1749; Schrag Stephanie, 2002, MMWR Recomm Rep, V51, P1; Schuchat A, 1997, NEW ENGL J MED, V337, P970, DOI 10.1056/NEJM199710023371404; Schuchat A, 2001, EMERG INFECT DIS, V7, P92, DOI 10.3201/eid0701.010114; Tsai CJ, 2008, CLIN INFECT DIS, V46, P1664, DOI 10.1086/587897; Tunkel AR, 2004, CLIN INFECT DIS, V39, P1267, DOI 10.1086/425368; Varma JK, 2007, CLIN INFECT DIS, V44, P521, DOI 10.1086/509920; Voetsch AC, 2007, CLIN INFECT DIS, V44, P513, DOI 10.1086/511006; WENGER JD, 1990, J INFECT DIS, V162, P1316, DOI 10.1093/infdis/162.6.1316; Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823	32	527	569	2	55	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 26	2011	364	21					2016	2025		10.1056/NEJMoa1005384	http://dx.doi.org/10.1056/NEJMoa1005384			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	768QR	21612470				2022-12-24	WOS:000290952000006
J	Banks, JA; Nishiyama, T; Hasebe, M; Bowman, JL; Gribskov, M; dePamphilis, C; Albert, VA; Aono, N; Aoyama, T; Ambrose, BA; Ashton, NW; Axtell, MJ; Barker, E; Barker, MS; Bennetzen, JL; Bonawitz, ND; Chapple, C; Cheng, CY; Correa, LGG; Dacre, M; DeBarry, J; Dreyer, I; Elias, M; Engstrom, EM; Estelle, M; Feng, L; Finet, C; Floyd, SK; Frommer, WB; Fujita, T; Gramzow, L; Gutensohn, M; Harholt, J; Hattori, M; Heyl, A; Hirai, T; Hiwatashi, Y; Ishikawa, M; Iwata, M; Karol, KG; Koehler, B; Kolukisaoglu, U; Kubo, M; Kurata, T; Lalonde, S; Li, KJ; Li, Y; Litt, A; Lyons, E; Manning, G; Maruyama, T; Michael, TP; Mikami, K; Miyazaki, S; Morinaga, S; Murata, T; Mueller-Roeber, B; Nelson, DR; Obara, M; Oguri, Y; Olmstead, RG; Onodera, N; Petersen, BL; Pils, B; Prigge, M; Rensing, SA; Riano-Pachon, DM; Roberts, AW; Sato, Y; Scheller, HV; Schulz, B; Schulz, C; Shakirov, EV; Shibagaki, N; Shinohara, N; Shippen, DE; Sorensen, I; Sotooka, R; Sugimoto, N; Sugita, M; Sumikawa, N; Tanurdzic, M; Theissen, G; Ulvskov, P; Wakazuki, S; Weng, JK; Willats, WWGT; Wipf, D; Wolf, PG; Yang, LX; Zimmer, AD; Zhu, QH; Mitros, T; Hellsten, U; Loque, D; Otillar, R; Salamov, A; Schmutz, J; Shapiro, H; Lindquist, E; Lucas, S; Rokhsar, D; Grigoriev, IV				Banks, Jo Ann; Nishiyama, Tomoaki; Hasebe, Mitsuyasu; Bowman, John L.; Gribskov, Michael; dePamphilis, Claude; Albert, Victor A.; Aono, Naoki; Aoyama, Tsuyoshi; Ambrose, Barbara A.; Ashton, Neil W.; Axtell, Michael J.; Barker, Elizabeth; Barker, Michael S.; Bennetzen, Jeffrey L.; Bonawitz, Nicholas D.; Chapple, Clint; Cheng, Chaoyang; Correa, Luiz Gustavo Guedes; Dacre, Michael; DeBarry, Jeremy; Dreyer, Ingo; Elias, Marek; Engstrom, Eric M.; Estelle, Mark; Feng, Liang; Finet, Cedric; Floyd, Sandra K.; Frommer, Wolf B.; Fujita, Tomomichi; Gramzow, Lydia; Gutensohn, Michael; Harholt, Jesper; Hattori, Mitsuru; Heyl, Alexander; Hirai, Tadayoshi; Hiwatashi, Yuji; Ishikawa, Masaki; Iwata, Mineko; Karol, Kenneth G.; Koehler, Barbara; Kolukisaoglu, Uener; Kubo, Minoru; Kurata, Tetsuya; Lalonde, Sylvie; Li, Kejie; Li, Ying; Litt, Amy; Lyons, Eric; Manning, Gerard; Maruyama, Takeshi; Michael, Todd P.; Mikami, Koji; Miyazaki, Saori; Morinaga, Shin-ichi; Murata, Takashi; Mueller-Roeber, Bernd; Nelson, David R.; Obara, Mari; Oguri, Yasuko; Olmstead, Richard G.; Onodera, Naoko; Petersen, Bent Larsen; Pils, Birgit; Prigge, Michael; Rensing, Stefan A.; Mauricio Riano-Pachon, Diego; Roberts, Alison W.; Sato, Yoshikatsu; Scheller, Henrik Vibe; Schulz, Burkhard; Schulz, Christian; Shakirov, Eugene V.; Shibagaki, Nakako; Shinohara, Naoki; Shippen, Dorothy E.; Sorensen, Iben; Sotooka, Ryo; Sugimoto, Nagisa; Sugita, Mamoru; Sumikawa, Naomi; Tanurdzic, Milos; Theissen, Guenter; Ulvskov, Peter; Wakazuki, Sachiko; Weng, Jing-Ke; Willats, William W. G. T.; Wipf, Daniel; Wolf, Paul G.; Yang, Lixing; Zimmer, Andreas D.; Zhu, Qihui; Mitros, Therese; Hellsten, Uffe; Loque, Dominique; Otillar, Robert; Salamov, Asaf; Schmutz, Jeremy; Shapiro, Harris; Lindquist, Erika; Lucas, Susan; Rokhsar, Daniel; Grigoriev, Igor V.			The Selaginella Genome Identifies Genetic Changes Associated with the Evolution of Vascular Plants	SCIENCE			English	Article							SMALL RNAS; MESSENGER-RNAS; ARABIDOPSIS; MOELLENDORFFII; MECHANISM; LAND; PERSPECTIVE; SIRNAS	Vascular plants appeared similar to 410 million years ago, then diverged into several lineages of which only two survive: the euphyllophytes (ferns and seed plants) and the lycophytes. We report here the genome sequence of the lycophyte Selaginella moellendorffii (Selaginella), the first nonseed vascular plant genome reported. By comparing gene content in evolutionarily diverse taxa, we found that the transition from a gametophyte- to a sporophyte-dominated life cycle required far fewer new genes than the transition from a nonseed vascular to a flowering plant, whereas secondary metabolic genes expanded extensively and in parallel in the lycophyte and angiosperm lineages. Selaginella differs in posttranscriptional gene regulation, including small RNA regulation of repetitive elements, an absence of the trans-acting small interfering RNA pathway, and extensive RNA editing of organellar genes.	[Banks, Jo Ann] Purdue Univ, Dept Bot & Plant Pathol, W Lafayette, IN 47907 USA; [Nishiyama, Tomoaki] Kanazawa Univ, Adv Sci Res Ctr, Kanazawa, Ishikawa 9200934, Japan; [Nishiyama, Tomoaki; Hasebe, Mitsuyasu; Cheng, Chaoyang; Hirai, Tadayoshi; Ishikawa, Masaki; Iwata, Mineko; Kubo, Minoru; Kurata, Tetsuya; Obara, Mari; Oguri, Yasuko; Onodera, Naoko; Sato, Yoshikatsu; Shinohara, Naoki; Sugimoto, Nagisa; Wakazuki, Sachiko] Japan Sci & Technol Agcy, ERATO, Okazaki, Aichi 4448585, Japan; [Hasebe, Mitsuyasu; Aono, Naoki; Aoyama, Tsuyoshi; Hiwatashi, Yuji; Miyazaki, Saori; Morinaga, Shin-ichi; Murata, Takashi; Sumikawa, Naomi] Natl Inst Nat Sci, Natl Inst Basic Biol, Okazaki, Aichi 4448585, Japan; [Hasebe, Mitsuyasu; Aoyama, Tsuyoshi; Hiwatashi, Yuji; Murata, Takashi] Grad Univ Adv Studies, Sch Life Sci, Dept Basic Sci, Okazaki, Aichi 4448585, Japan; [Bowman, John L.; Floyd, Sandra K.] Monash Univ, Sch Biol Sci, Melbourne, Vic 3800, Australia; [Bowman, John L.] Univ Calif Davis, Plant Biol Sect, Davis, CA 95616 USA; [Gribskov, Michael; Li, Kejie; Li, Ying] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; [dePamphilis, Claude; Axtell, Michael J.] Penn State Univ, Dept Biol, University Pk, PA 16802 USA; [dePamphilis, Claude; Axtell, Michael J.] Penn State Univ, Huck Inst Life Sci, University Pk, PA 16802 USA; [dePamphilis, Claude] Penn State Univ, Grad Program Plant Biol, University Pk, PA 16802 USA; [dePamphilis, Claude] Penn State Univ, Inst Mol Evolutionary Genet, University Pk, PA 16802 USA; [Albert, Victor A.] SUNY Buffalo, Dept Biol Sci, Buffalo, NY 14260 USA; [Ambrose, Barbara A.; Karol, Kenneth G.; Litt, Amy] New York Bot Garden, Bronx, NY 10458 USA; [Ashton, Neil W.; Barker, Elizabeth] Univ Regina, Dept Biol, Regina, SK S4S 0A2, Canada; [Barker, Michael S.] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA; [Bennetzen, Jeffrey L.; DeBarry, Jeremy; Yang, Lixing; Zhu, Qihui] Univ Georgia, Dept Genet, Athens, GA 30602 USA; [Bonawitz, Nicholas D.; Chapple, Clint; Weng, Jing-Ke] Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA; [Correa, Luiz Gustavo Guedes; Koehler, Barbara] Univ Potsdam, Dept Mol Biol, D-14476 Potsdam, Germany; [Dacre, Michael; Manning, Gerard] Salk Inst Biol Studies, Razavi Newman Ctr Bioinformat, La Jolla, CA 92037 USA; [Dreyer, Ingo] Univ Potsdam, Heisenberg Grp Biophys & Mol Plant Biol, D-14476 Potsdam, Germany; [Elias, Marek] Charles Univ Prague, Dept Bot, Fac Sci, Prague 12801 2, Czech Republic; [Elias, Marek] Univ Prague, Fac Sci, Ostrava 71000, Czech Republic; [Engstrom, Eric M.] Coll William & Mary, Dept Biol, Williamsburg, VA 23187 USA; [Estelle, Mark; Prigge, Michael] Univ Calif San Diego, Sect Cell & Dev Biol, La Jolla, CA 92093 USA; [Feng, Liang] Univ Georgia, Inst Bioinformat, Athens, GA 30602 USA; [Finet, Cedric] Ecole Normale Super Lyon, Lab Reprod & Dev Plantes, F-69364 Lyon, France; [Frommer, Wolf B.; Lalonde, Sylvie] Carnegie Inst Sci, Dept Plant Biol, Stanford, CA 94305 USA; [Fujita, Tomomichi] Hokkaido Univ, Fac Sci, Sapporo, Hokkaido 0600810, Japan; [Gramzow, Lydia; Theissen, Guenter] Univ Jena, Dept Genet, D-07743 Jena, Germany; [Gutensohn, Michael; Schulz, Burkhard] Purdue Univ, Dept Hort & Landscape Architecture, W Lafayette, IN 47907 USA; [Gutensohn, Michael] Univ Halle Wittenberg, Inst Biol, D-06120 Halle, Germany; [Harholt, Jesper; Petersen, Bent Larsen; Sorensen, Iben; Ulvskov, Peter; Willats, William W. G. T.] Univ Copenhagen, Dept Plant Biol & Biotechnol, DK-1871 Frederiksberg C, Denmark; [Hattori, Mitsuru; Sugita, Mamoru] Nagoya Univ, Ctr Gene Res, Nagoya, Aichi 4648602, Japan; [Hattori, Mitsuru] Univ Tokyo, Sch Sci, Dept Chem, Bunkyo Ku, Tokyo 1130033, Japan; [Heyl, Alexander] Free Univ Berlin, Dahlem Ctr Plant Sci, Inst Biol Appl Genet, D-14195 Berlin, Germany; [Hirai, Tadayoshi] Univ Tsukuba, Ctr Gene Res, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan; [Kolukisaoglu, Uener] Univ Rostock, Ctr Life Sci Automat, D-18119 Rostock, Germany; [Kolukisaoglu, Uener] Univ Tubingen, Studiengangskoordinat Nanosci, D-72076 Tubingen, Germany; [Kurata, Tetsuya] Nara Inst Sci & Technol, Grad Sch Biol Sci, Plant Global Educ Project, Nara 6300192, Japan; [Li, Ying] Mayo Clin, Div Biomed Stat & Informat, Rochester, MN 55905 USA; [Lyons, Eric; Scheller, Henrik Vibe] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; [Maruyama, Takeshi] Hokkaido Univ, Grad Sch Life Sci, Sapporo, Hokkaido 0600810, Japan; [Michael, Todd P.] Rutgers State Univ, Dept Plant Biol & Pathol, Piscataway, NJ 08854 USA; [Michael, Todd P.] Waksman Inst Microbiol, Piscataway, NJ 08854 USA; [Michael, Todd P.] Monsanto Co, Genome Anal Ctr, St Louis, MO 63167 USA; [Mikami, Koji] Hokkaido Univ, Fac Fisheries Sci, Hakodate, Hokkaido 0418611, Japan; [Miyazaki, Saori] Natl Inst Genet, Mishima, Shizuoka 4118540, Japan; [Morinaga, Shin-ichi] Univ Tokyo, Grad Sch Arts & Sci, Tokyo 1538902, Japan; [Mueller-Roeber, Bernd] Bernd Max Planck Inst Mol Plant Physiol, D-14476 Potsdam, Germany; [Nelson, David R.] Univ Tennessee, Dept Microbiol Immunol & Biochem, Memphis, TN 38163 USA; [Obara, Mari] Japan Sci & Technol Agcy, Sapporo, Hokkaido 0600819, Japan; [Olmstead, Richard G.] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Onodera, Naoko] Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS B3H 4R2, Canada; [Pils, Birgit] Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Pils, Birgit] Sias AG, CH-8634 Hombrechtikon, Switzerland; [Rensing, Stefan A.; Zimmer, Andreas D.] Univ Freiburg, Fac Biol, D-79104 Freiburg, Germany; [Rensing, Stefan A.] Univ Freiburg, BIOSS Ctr Biol Signaling Studies, D-79104 Freiburg, Germany; [Rensing, Stefan A.] Univ Freiburg, Freiburg Initiat Syst Biol FRISYS, D-79104 Freiburg, Germany; [Mauricio Riano-Pachon, Diego] Max Planck Inst Mol Plant Physiol, Bioinformat Grp, GabiPD Team, D-14476 Potsdam, Germany; [Mauricio Riano-Pachon, Diego] Univ Los Andes, Dept Ciencias Biol, Bogota, Colombia; [Roberts, Alison W.] Univ Rhode Isl, Dept Biol Sci, Kingston, RI 02881 USA; [Scheller, Henrik Vibe; Loque, Dominique] Joint BioEnergy Inst, Feedstocks Div, Emeryville, CA 94608 USA; [Schulz, Christian] Ruhr Univ Bochum, Dept Evolut & Biodivers Plants, D-44780 Bochum, Germany; [Shakirov, Eugene V.; Shippen, Dorothy E.] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA; [Shibagaki, Nakako] Osaka Univ, Grad Sch Engn, Suita, Osaka 5650871, Japan; [Shinohara, Naoki; Sotooka, Ryo] Hokkaido Univ, Sch Sci, Sapporo, Hokkaido 0600810, Japan; [Sorensen, Iben] Cornell Univ, Dept Plant Biol, Ithaca, NY 14850 USA; [Tanurdzic, Milos] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Weng, Jing-Ke] Salk Inst Biol Studies, Jack H Skirball Ctr Chem Biol & Prote, La Jolla, CA 92037 USA; [Wipf, Daniel] Univ Bourgogne, INRA, UMR 1088, CNRS 5184, F-21065 Dijon, France; [Wolf, Paul G.] Utah State Univ, Dept Biol, Logan, UT 84322 USA; [Mitros, Therese; Rokhsar, Daniel] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Hellsten, Uffe; Otillar, Robert; Salamov, Asaf; Schmutz, Jeremy; Shapiro, Harris; Lindquist, Erika; Lucas, Susan; Rokhsar, Daniel; Grigoriev, Igor V.] US DOE, Joint Genome Inst, Walnut Creek, CA 94598 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Kanazawa University; Japan Science & Technology Agency (JST); National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Graduate University for Advanced Studies - Japan; Monash University; University of California System; University of California Davis; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; New York Botanical Garden; University of Regina; University of Arizona; University System of Georgia; University of Georgia; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Potsdam; Salk Institute; University of Potsdam; Charles University Prague; William & Mary; University of California System; University of California San Diego; University System of Georgia; University of Georgia; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); Carnegie Institution for Science; Hokkaido University; Friedrich Schiller University of Jena; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Martin Luther University Halle Wittenberg; University of Copenhagen; Nagoya University; University of Tokyo; Free University of Berlin; University of Tsukuba; University of Rostock; Eberhard Karls University of Tubingen; Nara Institute of Science & Technology; Mayo Clinic; University of California System; University of California Berkeley; Hokkaido University; Rutgers State University New Brunswick; Monsanto; Hokkaido University; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; University of Tokyo; Max Planck Society; University of Tennessee System; University of Tennessee Health Science Center; Japan Science & Technology Agency (JST); University of Washington; University of Washington Seattle; Dalhousie University; University of Oxford; Wellcome Centre for Human Genetics; University of Freiburg; University of Freiburg; University of Freiburg; Max Planck Society; Universidad de los Andes (Colombia); University of Rhode Island; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Ruhr University Bochum; Texas A&M University System; Texas A&M University College Station; Osaka University; Hokkaido University; Cornell University; Cold Spring Harbor Laboratory; Salk Institute; Centre National de la Recherche Scientifique (CNRS); INRAE; Universite de Bourgogne; Utah System of Higher Education; Utah State University; University of California System; University of California Berkeley; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI	Banks, JA (corresponding author), Purdue Univ, Dept Bot & Plant Pathol, W Lafayette, IN 47907 USA.	banksj@purdue.edu	Riaño-Pachón, Diego M/A-1755-2010; Li, Kejie/D-3595-2013; Manning, Gerard/C-8308-2009; Riaño-Pachón, Diego Mauricio/B-4891-2014; Weng, Jing-Ke/V-5934-2019; Heyl, Alexander/ABD-2145-2020; Harholt, Jesper/F-3760-2011; Barker, Mike/AAE-7891-2019; Petersen, Bent/H-9437-2014; Sato, Yoshikatsu/I-6129-2014; dePamphilis, Claude W/P-6652-2016; Elias, Marek/D-6851-2014; Frommer, Wolf B/K-5042-2017; Loque, Dominique/A-8153-2008; Chapple, Clint CS/Q-5456-2017; Kubo, Minoru/AAH-1689-2019; Weng, Jing-Ke/E-7343-2013; Schmutz, Jeremy/N-3173-2013; Dacre, Michael/C-1131-2008; Tanurdzic, Milos/A-5712-2012; Feng, Liang/I-5010-2014; Harholt, Jesper/F-6865-2014; Ishikawa, Masaki/AAC-8162-2022; Dreyer, Ingo/N-4747-2014; Ulvskov, Peter/I-1228-2014; Estelle, Mark/ABD-6742-2021; Weng, Jing-Ke/A-6900-2015; Wolf, Paul/F-7664-2010; Mikami, Koji/A-9825-2012; Mueller-Roeber, Bernd/Z-4052-2019; Yang, Lixing/A-7073-2013; Ye, Mingli/G-4909-2012; Scheller, Henrik/AAH-4770-2020; Zhu, Qihui/N-2625-2013; Shakirov, Eugene V/A-1363-2012; Gribskov, Michael/AAH-5905-2021; Frommer, Wolf B/A-8256-2008; Kolukisaoglu, Üner/J-8831-2014; Ishikawa, Masaki/Q-7598-2018	Riaño-Pachón, Diego M/0000-0001-9803-3465; Riaño-Pachón, Diego Mauricio/0000-0001-9803-3465; Weng, Jing-Ke/0000-0003-3059-0075; Barker, Mike/0000-0001-7173-1319; Petersen, Bent/0000-0002-2004-9077; Elias, Marek/0000-0003-0066-6542; Frommer, Wolf B/0000-0001-6465-0115; Chapple, Clint CS/0000-0002-5195-562X; Kubo, Minoru/0000-0001-8691-6252; Weng, Jing-Ke/0000-0003-1079-3668; Schmutz, Jeremy/0000-0001-8062-9172; Dacre, Michael/0000-0002-5561-1656; Tanurdzic, Milos/0000-0002-7564-0868; Harholt, Jesper/0000-0002-7984-0066; Ishikawa, Masaki/0000-0002-6491-5539; Dreyer, Ingo/0000-0002-2781-0359; Ulvskov, Peter/0000-0003-3776-818X; Weng, Jing-Ke/0000-0003-3059-0075; Wolf, Paul/0000-0002-4317-6976; Mikami, Koji/0000-0003-3811-0072; Scheller, Henrik/0000-0002-6702-3560; Shakirov, Eugene V/0000-0003-2689-7410; Frommer, Wolf B/0000-0001-6465-0115; Kolukisaoglu, Üner/0000-0002-8656-5963; Ishikawa, Masaki/0000-0002-6491-5539; Gramzow, Lydia/0000-0003-1919-6077; Nelson, David/0000-0003-0583-5421; Rokhsar, Daniel/0000-0002-8704-2224; Prigge, Michael/0000-0003-0671-2538; Shinohara, Naoki/0000-0002-4029-239X; Sorensen, Iben/0000-0002-9768-620X; DeBarry, Jeremy/0000-0001-5718-2675; Schulz, Christian/0000-0002-2708-0632; Wipf, Daniel/0000-0001-7197-5612; Bowman, John/0000-0001-7347-3691; Hasebe, Mitsuyasu/0000-0001-7425-8758; Lyons, Eric/0000-0002-3348-8845; Michael, Todd/0000-0001-6272-2875; Aoyama, Tsuyoshi/0000-0002-4184-167X; Gribskov, Michael/0000-0002-1718-0242; HIWATASHI, YUJI/0000-0002-3996-0549; Zimmer, Andreas/0000-0002-5595-9388; Grigoriev, Igor/0000-0002-3136-8903; Nishiyama, Tomoaki/0000-0003-1279-7806; Willats, William/0000-0003-2064-4025; Manning, Gerard/0000-0002-5087-9151	Office of Science of the U.S. DOE [DE-AC02-05CH11231]; NSF [0844413, 0515435, 0519970, 0638595, 0922742, 1020443, 0607123, 0744800, 1020660, 1036466, 0735191, 0228660, 0421604]; Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science, and Technology, Japan; Australian Research Council [FF0561326]; Lewis B and Dorothy Cullman Program; Natural Sciences and Engineering Research Council of Canada (NSERC) [2982]; NIH [GM84051, T32 GM007757, T32-HG00035, GM065383]; Life Sciences Research Foundation; National Human Genome Research Institute (NHGRI) [HG004164]; German Science Foundation (Deutsche Forschungsgemeinschaft, DFG) [DR 430/4-2]; Czech Ministry of Education [21620828]; Jeffress Memorial Trust [J-938]; DOE [DE-FG02-04ER15542]; Danish Council for Independent Research, Technology and Production Sciences [009-066624/274-09-0314]; Villum Kann Rasmussen Foundation; U.S. Department of Agriculture (USDA) [DE-FG02-08ER64630]; Danish Council for Strategic Research [09-063090]; Marie Curie FP6 RTN ZOONET; DFG [RE 837/10-2, BMBF FRISYS 0313921]; Bundesministerium fuer Bildung und Forschung, Germany [0315046]; USDA NRI [2007-35318-18389]; Burgundy Regional Council [20100112095254682-1]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004164, T32HG000035] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065383, T32GM007757, R01GM043644, R01GM084051] Funding Source: NIH RePORTER; Direct For Biological Sciences [1020443] Funding Source: National Science Foundation; Division Of Integrative Organismal Systems [0922742, 0844413] Funding Source: National Science Foundation; Villum Fonden [00007173] Funding Source: researchfish	Office of Science of the U.S. DOE(United States Department of Energy (DOE)); NSF(National Science Foundation (NSF)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Australian Research Council(Australian Research Council); Lewis B and Dorothy Cullman Program; Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Life Sciences Research Foundation; National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); German Science Foundation (Deutsche Forschungsgemeinschaft, DFG)(German Research Foundation (DFG)); Czech Ministry of Education(Ministry of Education, Youth & Sports - Czech Republic); Jeffress Memorial Trust; DOE(United States Department of Energy (DOE)); Danish Council for Independent Research, Technology and Production Sciences(Det Frie Forskningsrad (DFF)); Villum Kann Rasmussen Foundation(Villum Fonden); U.S. Department of Agriculture (USDA)(United States Department of Agriculture (USDA)); Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF)); Marie Curie FP6 RTN ZOONET(European Commission); DFG(German Research Foundation (DFG)); Bundesministerium fuer Bildung und Forschung, Germany; USDA NRI(United States Department of Agriculture (USDA)); Burgundy Regional Council(Region Bourgogne-Franche-Comte); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Villum Fonden(Villum Fonden)	Selaginella sequences were deposited at GenBank with the accession numbers GL377566 to GL378322.1 and HM173080. Genome sequencing and analysis were performed by the U.S. Department of Energy (DOE), Joint Genome Institute, supported by the Office of Science of the U.S. DOE, Contract DE-AC02-05CH11231 (I.V.G., U.H., D.L., E.L., S.L., T.M., R.O., D.R., A.S., J.S., H.V.S.). Support was provided by NSF 0844413 (J.A.B.); Japan Society for the Promotion of Science (M.H., T.N., T.F., K.M., T.M., M.S.); Ministry of Education, Culture, Sports, Science, and Technology, Japan (M.H., T.N., T.F.); NSF 0515435 and Australian Research Council FF0561326 (J.L.B.); NSF 0519970 (M.G.); NSF 0638595 (C.D.); NSF 0922742 (V.A.A.); The Lewis B and Dorothy Cullman Program (B.A.A., A.L.); NSF 1020443 (B.A.A.); Natural Sciences and Engineering Research Council of Canada (NSERC) 2982 (N.W.A.); NIH GM84051 (M.J.A.); NSERC (E.I.B.); NIH T32 GM007757 and NSERC PGS-D (M.S.B.); NSF 0607123 (J.L.B.); Life Sciences Research Foundation (NDB); National Human Genome Research Institute (NHGRI) HG004164 (M.D.); German Science Foundation (Deutsche Forschungsgemeinschaft, DFG) DR 430/4-2 (I.D.); Czech Ministry of Education 21620828 (M.E.); Jeffress Memorial Trust J-938 (E.M.E.); NSF 0744800 (M.E. and M.P.); DOE DE-FG02-04ER15542 (W.B.F. and S.L.); The Danish Council for Independent Research, Technology and Production Sciences 009-066624/274-09-0314 (J.H.); The Villum Kann Rasmussen Foundation (J.H., I.S., B.P., P.U., W.W.); NIH T32-HG00035, NSF 1020660, and NSF 1036466 (K.G.K.); NSF 0735191 (E.L.); NHGRI HG004164 (G.M); U.S. Department of Agriculture (USDA) DE-FG02-08ER64630 (T.P.M.); NSF 0228660 (R.G.O.); The Danish Council for Strategic Research 09-063090 (B.L.P. and P.U.); Marie Curie FP6 RTN ZOONET (B.P.); DFG RE 837/10-2, BMBF FRISYS 0313921 (S.A.R.); Bundesministerium fuer Bildung und Forschung, Germany, GABI-FUTURE grant 0315046 (D.M.R.); USDA NRI 2007-35318-18389 (A.W.R.); NSF 0421604 (C.S.); NIH GM065383 (D.E.S.); Burgundy Regional Council 20100112095254682-1 (D.W.); and DFG RE 837/10-2 (A.D.Z.). K. Wall, D. Hurley, and S. Hentel provided computational assistance.	Axtell MJ, 2007, PLANT CELL, V19, P1750, DOI 10.1105/tpc.107.051706; Barker MS, 2009, GENOME BIOL EVOL, V1, P391, DOI 10.1093/gbe/evp040; Bonke M, 2003, NATURE, V426, P181, DOI 10.1038/nature02100; Bourc'his D, 2010, SCIENCE, V330, P617, DOI 10.1126/science.1194776; Cao Y, 2010, FITOTERAPIA, V81, P253, DOI 10.1016/j.fitote.2009.09.007; Chen DJ, 2010, BIOINFORMATICS, V26, P1391, DOI 10.1093/bioinformatics/btq150; Chitwood DH, 2009, GENE DEV, V23, P549, DOI 10.1101/gad.1770009; Cho SH, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000314; Demura T, 2007, TRENDS PLANT SCI, V12, P64, DOI 10.1016/j.tplants.2006.12.006; Floyd SK, 2006, CURR BIOL, V16, P1911, DOI 10.1016/j.cub.2006.07.067; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Grewe F, 2011, NUCLEIC ACIDS RES, V39, P2890, DOI 10.1093/nar/gkq1227; Harrison CJ, 2005, NATURE, V434, P509, DOI 10.1038/nature03410; Hirano K, 2007, PLANT CELL, V19, P3058, DOI 10.1105/tpc.107.051524; Kasschau KD, 2007, PLOS BIOL, V5, P479, DOI 10.1371/journal.pbio.0050057; Kenrick P, 1997, NATURE, V389, P33, DOI 10.1038/37918; Knoop V, 2011, CELL MOL LIFE SCI, V68, P567, DOI 10.1007/s00018-010-0538-9; Nobuta K, 2007, NAT BIOTECHNOL, V25, P473, DOI 10.1038/nbt1291; Peragine A, 2004, GENE DEV, V18, P2368, DOI 10.1101/gad.1231804; Tang HB, 2008, SCIENCE, V320, P486, DOI 10.1126/science.1153917; Tang HB, 2008, GENOME RES, V18, P1944, DOI 10.1101/gr.080978.108; Tsuji S, 2007, J PLANT RES, V120, P281, DOI 10.1007/s10265-006-0055-y; Wang WM, 2005, BMC PLANT BIOL, V5, DOI 10.1186/1471-2229-5-10; Xie ZX, 2005, P NATL ACAD SCI USA, V102, P12984, DOI 10.1073/pnas.0506426102; Yasumura Y, 2007, CURR BIOL, V17, P1225, DOI 10.1016/j.cub.2007.06.037	25	583	653	5	260	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 20	2011	332	6032					960	963		10.1126/science.1203810	http://dx.doi.org/10.1126/science.1203810			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766FO	21551031	Green Accepted			2022-12-24	WOS:000290766600042
J	Dunkle, JA; Wang, LY; Feldman, MB; Pulk, A; Chen, VB; Kapral, GJ; Noeske, J; Richardson, JS; Blanchard, SC; Cate, JHD				Dunkle, Jack A.; Wang, Leyi; Feldman, Michael B.; Pulk, Arto; Chen, Vincent B.; Kapral, Gary J.; Noeske, Jonas; Richardson, Jane S.; Blanchard, Scott C.; Cate, Jamie H. Doudna			Structures of the Bacterial Ribosome in Classical and Hybrid States of tRNA Binding	SCIENCE			English	Article							AMINOACYL-TRANSFER-RNA; CRYSTAL-STRUCTURE; RECYCLING FACTOR; INTERMEDIATE STATES; MESSENGER-RNA; 70S RIBOSOME; TRANSLOCATION; DYNAMICS; SITE; TRANSLATION	During protein synthesis, the ribosome controls the movement of tRNA and mRNA by means of large-scale structural rearrangements. We describe structures of the intact bacterial ribosome from Escherichia coli that reveal how the ribosome binds tRNA in two functionally distinct states, determined to a resolution of similar to 3.2 angstroms by means of x-ray crystallography. One state positions tRNA in the peptidyl-tRNA binding site. The second, a fully rotated state, is stabilized by ribosome recycling factor and binds tRNA in a highly bent conformation in a hybrid peptidyl/exit site. The structures help to explain how the ratchet-like motion of the two ribosomal subunits contributes to the mechanisms of translocation, termination, and ribosome recycling.	[Dunkle, Jack A.; Pulk, Arto; Noeske, Jonas; Cate, Jamie H. Doudna] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Dunkle, Jack A.; Pulk, Arto; Noeske, Jonas; Cate, Jamie H. Doudna] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Wang, Leyi; Feldman, Michael B.; Blanchard, Scott C.] Cornell Univ, Weill Cornell Med Coll, Dept Physiol & Biophys, New York, NY 10065 USA; [Feldman, Michael B.] Weill Cornell Rockefeller Univ Sloan Kettering Tr, New York, NY 10065 USA; [Chen, Vincent B.; Kapral, Gary J.; Richardson, Jane S.] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; [Cate, Jamie H. Doudna] Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Cornell University; Duke University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Cate, JHD (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	jcate@lbl.gov	Blanchard, Scott C./A-5804-2009; Richardson, Jane/Q-6478-2019; Dunkle, Jack/ABB-9713-2020; Classen, Scott/AAY-8176-2020	Blanchard, Scott C./0000-0003-2717-9365; Richardson, Jane/0000-0002-3311-2944; Dunkle, Jack/0000-0001-6252-0587; Feldman, Michael/0000-0001-7364-5211; Pulk, Arto/0000-0001-8793-3038; Chen, Vincent/0000-0003-2492-979X; Noeske, Jonas/0000-0002-8750-2008	National Institutes of Health [GM65050, GM079238, GM074127-04S1, GM088674, P01-GM63210, GM07739]; National Cancer Institute [CA92584]; National Center for Research Resources [RR-15301]; U.S. Department of Energy [DE-AC03 76SF00098, DE-AC02-06CH11357]; Human Frontiers in Science Program; NATIONAL CANCER INSTITUTE [P01CA092584] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079238, P01GM063210, T32GM007739, R01GM065050, R01GM074127, R01GM088674] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); U.S. Department of Energy(United States Department of Energy (DOE)); Human Frontiers in Science Program(Human Frontier Science Program); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank K. Hamadani for purified RRF; K. Nierhaus for tRNAPhe overexpression plasmids; K. Frankel, S. Classen, and G. Meigs for help with data measurement at the SIBYLS and 8.3.1 beamlines at the Advanced Light Source (ALS); R. Kanagalaghatta, D. Neau, F. Murphy, and I. Kourinov for help with data measurement at ID-24 at the Advanced Photon Source (APS); J. Headd for help with Phenix refinement; and J. Holton for useful crystallographic discussions. We also thank J. Doudna and H. Noller for helpful comments on the manuscript. Atomic coordinates and structure factors are deposited in the Protein Data Bank (accession codes 3R8N and 3R8S for the fully rotated state R<INF>F</INF>, 3R8O and 3R8T for the unrotated state R<INF>0</INF>). This work was funded by the National Institutes of Health (GM65050 to J.H.D.C., GM079238 to S.C.B, and GM074127-04S1, GM088674, and P01-GM63210 project IV to J. S. R.), National Cancer Institute grant CA92584 for the SIBYLS and 8.3.1 beam lines at the ALS, and National Center for Research Resources grant RR-15301 for the Northeastern Collaborative Access Team beam lines at 24-ID at APS, and by the U.S. Department of Energy (DE-AC03 76SF00098 for the SIBYLS and 8.3.1 beamlines at the ALS, and DE-AC02-06CH11357 for the APS). M.B.F. is a trainee in the Weill Cornell/Rockefeller University/SloanKettering Tri-Institutional MD-PhD Program supported by NIH Medical Scientist Training Program grant GM07739. J.N. is supported by a Human Frontiers in Science Program Postdoctoral Fellowship.	Agrawal RK, 2004, P NATL ACAD SCI USA, V101, P8900, DOI 10.1073/pnas.0401904101; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Ben-Shem A, 2010, SCIENCE, V330, P1203, DOI 10.1126/science.1194294; Bokov K, 2009, NATURE, V457, P977, DOI 10.1038/nature07749; Cannone JJ, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-2; Cate JH, 1996, SCIENCE, V273, P1678, DOI 10.1126/science.273.5282.1678; Connell SR, 2007, MOL CELL, V25, P751, DOI 10.1016/j.molcel.2007.01.027; Cornish PV, 2008, MOL CELL, V30, P578, DOI 10.1016/j.molcel.2008.05.004; Cukras AR, 2005, J MOL BIOL, V349, P47, DOI 10.1016/j.jmb.2005.03.075; Dunkle JA, 2010, ANNU REV BIOPHYS, V39, P227, DOI 10.1146/annurev.biophys.37.032807.125954; Ermolenko DN, 2007, NAT STRUCT MOL BIOL, V14, P493, DOI 10.1038/nsmb1243; Feinberg JS, 2001, P NATL ACAD SCI USA, V98, P11120, DOI 10.1073/pnas.211184098; Feldman MB, 2010, NAT CHEM BIOL, V6, P54, DOI [10.1038/NCHEMBIO.274, 10.1038/nchembio.274]; Fischer N, 2010, NATURE, V466, P329, DOI 10.1038/nature09206; Frank J, 2000, NATURE, V406, P318, DOI 10.1038/35018597; Frank J, 2007, P NATL ACAD SCI USA, V104, P19671, DOI 10.1073/pnas.0708517104; Gao N, 2005, MOL CELL, V18, P663, DOI 10.1016/j.molcel.2005.05.005; GAVRILOVA LP, 1976, J MOL BIOL, V101, P537, DOI 10.1016/0022-2836(76)90243-6; Janosi L, 2000, J MOL BIOL, V295, P815, DOI 10.1006/jmbi.1999.3401; Joseph S, 1998, EMBO J, V17, P3478, DOI 10.1093/emboj/17.12.3478; Komoda T, 2006, J BIOL CHEM, V281, P32303, DOI 10.1074/jbc.M607058200; Lancaster L, 2002, CELL, V111, P129, DOI 10.1016/S0092-8674(02)00938-8; Li W, 2007, P NATL ACAD SCI USA, V104, P16540, DOI 10.1073/pnas.0708094104; LILL R, 1989, EMBO J, V8, P3933, DOI 10.1002/j.1460-2075.1989.tb08574.x; MOAZED D, 1989, NATURE, V342, P142, DOI 10.1038/342142a0; Munro JB, 2009, TRENDS BIOCHEM SCI, V34, P390, DOI 10.1016/j.tibs.2009.04.004; Ratje AH, 2010, NATURE, V468, P713, DOI 10.1038/nature09547; Savelsbergh A, 2009, RNA, V15, P772, DOI 10.1261/rna.1592509; Schmeing TM, 2009, SCIENCE, V326, P688, DOI 10.1126/science.1179700; Schmeing TM, 2009, NATURE, V461, P1234, DOI 10.1038/nature08403; Schmeing TM, 2003, RNA, V9, P1345, DOI 10.1261/rna.5120503; Schuwirth BS, 2005, SCIENCE, V310, P827, DOI 10.1126/science.1117230; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; Semenkov YP, 2000, NAT STRUCT BIOL, V7, P1027; Shenvi CL, 2005, RNA, V11, P1898, DOI 10.1261/rna.2192805; Spahn CMT, 2004, EMBO J, V23, P1008, DOI 10.1038/sj.emboj.7600102; Spirin AS, 2009, J BIOL CHEM, V284, P21103, DOI 10.1074/jbc.X109.001552; Stanley RE, 2010, NAT STRUCT MOL BIOL, V17, P289, DOI 10.1038/nsmb.1755; Sternberg SH, 2009, NAT STRUCT MOL BIOL, V16, P861, DOI 10.1038/nsmb.1622; Valle M, 2003, CELL, V114, P123, DOI 10.1016/S0092-8674(03)00476-8; Valle M, 2003, NAT STRUCT BIOL, V10, P899, DOI 10.1038/nsb1003; Valle M, 2002, EMBO J, V21, P3557, DOI 10.1093/emboj/cdf326; Voorhees RM, 2010, SCIENCE, V330, P835, DOI 10.1126/science.1194460; Weixlbaumer A, 2007, NAT STRUCT MOL BIOL, V14, P733, DOI 10.1038/nsmb1282; Zavialov AV, 2003, CELL, V114, P113, DOI 10.1016/S0092-8674(03)00478-1; Zhang W, 2009, SCIENCE, V325, P1014, DOI 10.1126/science.1175275	46	261	267	2	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 20	2011	332	6032					981	984		10.1126/science.1202692	http://dx.doi.org/10.1126/science.1202692			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766FO	21596992	Green Accepted			2022-12-24	WOS:000290766600048
J	He, FL; Hubbell, SP				He, Fangliang; Hubbell, Stephen P.			Species-area relationships always overestimate extinction rates from habitat loss	NATURE			English	Article							DEFORESTATION; PATTERNS	Extinction from habitat loss is the signature conservation problem of the twenty-first century(1). Despite its importance, estimating extinction rates is still highly uncertain because no proven direct methods or reliable data exist for verifying extinctions. The most widely used indirect method is to estimate extinction rates by reversing the species-area accumulation curve, extrapolating backwards to smaller areas to calculate expected species loss. Estimates of extinction rates based on this method are almost always much higher than those actually observed(2-5). This discrepancy gave rise to the concept of an 'extinction debt', referring to species 'committed to extinction' owing to habitat loss and reduced population size but not yet extinct during a non-equilibrium period(6,7). Here we show that the extinction debt as currently defined is largely a sampling artefact due to an unrecognized difference between the underlying sampling problems when constructing a species-area relationship (SAR) and when extrapolating species extinction from habitat loss. The key mathematical result is that the area required to remove the last individual of a species (extinction) is larger, almost always much larger, than the sample area needed to encounter the first individual of a species, irrespective of species distribution and spatial scale. We illustrate these results with data from a global network of large, mapped forest plots and ranges of passerine bird species in the continental USA; and we show that overestimation can be greater than 160%. Although we conclude that extinctions caused by habitat loss require greater loss of habitat than previously thought, our results must not lead to complacency about extinction due to habitat loss, which is a real and growing threat.	[He, Fangliang] Sun Yat Sen Univ, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China; [He, Fangliang] Sun Yat Sen Univ, Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China; [He, Fangliang] Univ Alberta, Dept Renewable Resources, Edmonton, AB T6G 2H1, Canada; [Hubbell, Stephen P.] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA 90095 USA; [Hubbell, Stephen P.] Smithsonian Trop Res Inst, Ctr Trop Forest Sci, Unit 0948, APO, AA 34002 USA	Sun Yat Sen University; Sun Yat Sen University; University of Alberta; University of California System; University of California Los Angeles; Smithsonian Institution; Smithsonian Tropical Research Institute	He, FL (corresponding author), Sun Yat Sen Univ, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China.	fhe@mail.sysu.edu.cn; shubbell@eeb.ucla.edu			Sun Yat-sen University; Natural Sciences and Engineering Research Council (Canada); NASA (National Aeronautics and Space Administration); US National Science Foundation	Sun Yat-sen University; Natural Sciences and Engineering Research Council (Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NASA (National Aeronautics and Space Administration)(National Aeronautics & Space Administration (NASA)); US National Science Foundation(National Science Foundation (NSF))	We acknowledge the work of the principal investigators and their field assistants for collecting the field data on the large plots of the Center for Tropical Forest Science network. We are grateful to P. Gowaty, K. Gaston and M. Rosenzweig for their comments on the paper. We thank R. Condit, R. Perez and S. Agular for Barro Colorado Island, R. Valencia for Yasuni, N. Supardi Noor and R. Kassim for Pasoh, D. Thomas, D. Kenfack and G. Chuyong for Korup, W.-H. Ye for Dinghushan, I.-F. Sun and C.-F. Hseih for Fushan, X.-H. Wang for Tiantong, Z.-Q. Hao for Changbaishan and X.-L. Wang for processing the passerine data. This work was supported by Sun Yat-sen University, the Natural Sciences and Engineering Research Council (Canada), NASA (National Aeronautics and Space Administration) and the US National Science Foundation.	Achard F, 2002, SCIENCE, V297, P999, DOI 10.1126/science.1070656; Arrhenius O, 1921, J ECOL, V9, P95, DOI 10.2307/2255763; Barnosky AD, 2011, NATURE, V471, P51, DOI 10.1038/nature09678; Brooks T, 1996, NATURE, V380, P115, DOI 10.1038/380115a0; Brooks TM, 1999, CONSERV BIOL, V13, P1140, DOI 10.1046/j.1523-1739.1999.98341.x; COLEMAN BD, 1981, MATH BIOSCI, V54, P191, DOI 10.1016/0025-5564(81)90086-9; Condit R, 2000, SCIENCE, V288, P1414, DOI 10.1126/science.288.5470.1414; DIAL R, 1994, NATURE, V370, P104, DOI 10.1038/370104b0; Ehrlich P.R., 1981, EXTINCTION; Green JL, 2003, ECOLOGY, V84, P3090, DOI 10.1890/02-3096; Harte J, 2004, NATURE, V430, DOI 10.1038/nature02718; He FL, 2002, ECOLOGY, V83, P1185, DOI 10.1890/0012-9658(2002)083[1185:SDPDFS]2.0.CO;2; HEYWOOD VH, 1992, TROPICAL DEFORESTATION AND SPECIES EXTINCTION, P91; HEYWOOD VH, 1994, NATURE, V368, P105, DOI 10.1038/368105a0; Kinzig AP, 2000, ECOLOGY, V81, P3305, DOI 10.1890/0012-9658(2000)081[3305:IOEARF]2.0.CO;2; Lovejoy T.E, 1980, GLOBAL 2000 REPORT P, V2, P328; Lugo A.E., 1988, P58; May Robert M., 1995, P1; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING BI; Myers N, 1979, SINKING ARK NEW LOOK; Myers N., 1983, TROPICAL RAIN FOREST, P325; National Research Council, 1980, RES PRIOR TROP BIOL; PIMM SL, 1995, SCIENCE, V269, P347, DOI 10.1126/science.269.5222.347; Pimm SL, 2000, NATURE, V403, P843, DOI 10.1038/35002708; PIMM SL, 1995, P NATL ACAD SCI USA, V92, P9343, DOI 10.1073/pnas.92.20.9343; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; SIMBERLOFF D, 1992, TROPICAL DEFORESTATION AND SPECIES EXTINCTION, P75; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; TILMAN D, 1994, NATURE, V371, P65, DOI 10.1038/371065a0; WCMC-World Conservation Monitoring Centre, 1992, GLOB BIOD STAT EARTH	30	273	289	11	434	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 19	2011	473	7347					368	371		10.1038/nature09985	http://dx.doi.org/10.1038/nature09985			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765QA	21593870				2022-12-24	WOS:000290722400047
J	Kim, BH; Shenoy, AR; Kumar, P; Das, R; Tiwari, S; MacMicking, JD				Kim, Bae-Hoon; Shenoy, Avinash R.; Kumar, Pradeep; Das, Rituparna; Tiwari, Sangeeta; MacMicking, John D.			A Family of IFN-gamma-Inducible 65-kD GTPases Protects Against Bacterial Infection	SCIENCE			English	Article							BINDING; IMMUNITY; AUTOPHAGY	Immune interferon gamma (IFN-gamma) is essential for mammalian host defense against intracellular pathogens. IFN-gamma induces nearly 2000 host genes, yet few have any assigned function. Here, we examined a complete mouse 65-kilodalton (kD) guanylate-binding protein (Gbp) gene family as part of a 43-member IFN-gamma-inducible guanosine triphosphatase (GTPase) superfamily in mouse and human genomes. Family-wide loss-of-function analysis found that at least four Gbps-Gbp1, Gbp6, Gbp7, and Gbp10-conferred cell-autonomous immunity to listerial or mycobacterial infection within macrophages and gene-deficient animals. These Gbps solicited host defense proteins, including the phagocyte oxidase, antimicrobial peptides, and autophagy effectors, to kill intracellular bacteria. Thus, specific 65-kD Gbps coordinate a potent oxidative and vesicular trafficking program to protect the host from infection.	[Kim, Bae-Hoon; Shenoy, Avinash R.; Kumar, Pradeep; Das, Rituparna; Tiwari, Sangeeta; MacMicking, John D.] Yale Univ, Sch Med, Boyer Ctr Mol Med, Sect Microbial Pathogenesis, New Haven, CT 06510 USA; [Das, Rituparna] Yale Univ, Sch Med, Dept Internal Med, Div Infect Dis, New Haven, CT 06510 USA	Yale University; Yale University	MacMicking, JD (corresponding author), Yale Univ, Sch Med, Boyer Ctr Mol Med, Sect Microbial Pathogenesis, 333 Cedar St, New Haven, CT 06510 USA.	john.macmicking@yale.edu	hongbo, yi/G-9615-2011; Tiwari, Sangeeta/GWV-0350-2022; Kim, Bae-Hoon/A-8847-2014; Kim, Bae-Hoon/F-3289-2012; tiwari, sangeeta/T-5810-2019	Shenoy, Avinash/0000-0001-6228-9303; Kim, Bae-Hoon/0000-0001-6866-7248	NIH National Institute of Allergy and Infectious Diseases [R01 AI068041-01A1]; Burroughs Wellcome Fund; Searle Scholars Program; Cancer Research Institute; W.W. Winchester Foundation; Browne-Cox Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068041] Funding Source: NIH RePORTER	NIH National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Searle Scholars Program; Cancer Research Institute; W.W. Winchester Foundation; Browne-Cox Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Y. Matsuura (NS34A DN cells); S. Ivanov (Ub-K63-GFP cells); R. Medzhitov (MyD88<SUP>-/-</SUP> Trif<SUP>-/-</SUP> mice); M. Pypaert (electron microscopy); and P. Cresswell, W. Mothes, C. Roy, G. Superti-Furga, T. Yoshimori, and H. Zhu (plasmids and antibodies). Supported by NIH National Institute of Allergy and Infectious Diseases (R01 AI068041-01A1), Burroughs Wellcome Fund Investigator in Pathogenesis of Infectious Disease Award, Searle Scholars Program, Cancer Research Institute Investigator Award, W.W. Winchester Foundation (to J.D.M.) and Browne-Cox Fellowship (to A.R.S.).	Alonso S, 2007, P NATL ACAD SCI USA, V104, P6031, DOI 10.1073/pnas.0700036104; Bekpen C, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-11-r92; Bustamante J, 2011, NAT IMMUNOL, V12, P213, DOI 10.1038/ni.1992; Degrandi D, 2007, J IMMUNOL, V179, P7729, DOI 10.4049/jimmunol.179.11.7729; Fujita N, 2008, MOL BIOL CELL, V19, P4651, DOI 10.1091/mbc.E08-03-0312; Hunn JP, 2008, EMBO J, V27, P2495, DOI 10.1038/emboj.2008.176; Itakura E, 2011, J CELL BIOL, V192, P17, DOI 10.1083/jcb.201009067; Itsui Y, 2009, HEPATOLOGY, V50, P1727, DOI 10.1002/hep.23195; MacMicking JD, 2003, SCIENCE, V302, P654, DOI 10.1126/science.1088063; Martens S, 2006, ANNU REV CELL DEV BI, V22, P559, DOI 10.1146/annurev.cellbio.22.010305.104619; Modiano N, 2005, P NATL ACAD SCI USA, V102, P8680, DOI 10.1073/pnas.0503227102; Myers JT, 2003, J IMMUNOL, V171, P5447, DOI 10.4049/jimmunol.171.10.5447; Olszewski MA, 2006, J INTERF CYTOK RES, V26, P328, DOI 10.1089/jir.2006.26.328; Philips JA, 2008, P NATL ACAD SCI USA, V105, P3070, DOI 10.1073/pnas.0707206105; Ponpuak M, 2010, IMMUNITY, V32, P329, DOI 10.1016/j.immuni.2010.02.009; Prakash B, 2000, NATURE, V403, P567, DOI 10.1038/35000617; Rupper AC, 2008, INFECT IMMUN, V76, P2304, DOI 10.1128/IAI.01437-07; Sever S, 1999, NATURE, V398, P481, DOI 10.1038/19024; Shenoy AR, 2007, IMMUNOBIOLOGY, V212, P771, DOI 10.1016/j.imbio.2007.09.018; Singh SB, 2006, SCIENCE, V313, P1438, DOI 10.1126/science.1129577; Singh SB, 2010, NAT CELL BIOL, V12, P1154, DOI 10.1038/ncb2119; Tietzel I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006499; Tiwari S, 2009, NAT IMMUNOL, V10, P907, DOI 10.1038/ni.1759; Zhang SY, 2008, IMMUNOL REV, V226, P29, DOI 10.1111/j.1600-065X.2008.00698.x	24	320	333	0	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 6	2011	332	6030					717	721		10.1126/science.1201711	http://dx.doi.org/10.1126/science.1201711			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759RK	21551061				2022-12-24	WOS:000290265800043
J	Valouev, A; Johnson, SM; Boyd, SD; Smith, CL; Fire, AZ; Sidow, A				Valouev, Anton; Johnson, Steven M.; Boyd, Scott D.; Smith, Cheryl L.; Fire, Andrew Z.; Sidow, Arend			Determinants of nucleosome organization in primary human cells	NATURE			English	Article							HIGH-RESOLUTION; HUMAN GENOME; SACCHAROMYCES-CEREVISIAE; C. ELEGANS; IN-VIVO; CHROMATIN; DNA; SEQUENCE; YEAST; METHYLATIONS	Nucleosomes are the basic packaging units of chromatin, modulating accessibility of regulatory proteins to DNA and thus influencing eukaryotic gene regulation. Elaborate chromatin remodelling mechanisms have evolved that govern nucleosome organization at promoters, regulatory elements, and other functional regions in the genome(1). Analyses of chromatin landscape have uncovered a variety of mechanisms, including DNA sequence preferences, that can influence nucleosome positions(2-4). To identify major determinants of nucleosome organization in the human genome, we used deep sequencing to map nucleosome positions in three primary human cell types and in vitro. A majority of the genome showed substantial flexibility of nucleosome positions, whereas a small fraction showed reproducibly positioned nucleosomes. Certain sites that position in vitro can anchor the formation of nucleosomal arrays that have cell type-specific spacing in vivo. Our results unveil an interplay of sequence-based nucleosome preferences and non-nucleosomal factors in determining nucleosome organization within mammalian cells.	[Valouev, Anton; Boyd, Scott D.; Smith, Cheryl L.; Fire, Andrew Z.; Sidow, Arend] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA; [Johnson, Steven M.] Brigham Young Univ, Dept Microbiol & Mol Biol, Provo, UT 84602 USA; [Fire, Andrew Z.; Sidow, Arend] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA	Stanford University; Brigham Young University; Stanford University	Sidow, A (corresponding author), Stanford Univ, Dept Pathol, Sch Med, 300 Pasteur Dr, Stanford, CA 94305 USA.	afire@stanford.edu; arend@stanford.edu	Johnson, Steven M/B-3940-2013	Johnson, Steven/0000-0002-7399-8153; Smith, Cheryl/0000-0003-4323-6382; Fire, Andrew/0000-0001-6217-8312	NIGMS [R01GM37706]; NHGRI [U01HG004695, T32HG00044]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000044, U01HG004695] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037706] Funding Source: NIH RePORTER	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Stanford Genetics/Pathology Sequencing Initiative. We thank G. Narlikar for help with in vitro experiments, Life Technologies, especially J. Briggs, for help with generating sequencing data, P. Lacroute for help with sequence alignment, S. Galli for valuable discussions, L. Gracey for critical reading of the manuscript, and members of the Sidow and Fire labs for valuable feedback and discussions. Work in the Fire lab was partially supported by NIGMS (R01GM37706). A.V. was partially supported by an ENCODE subcontract to A.S. (NHGRI U01HG004695). S.M.J. was partially supported by the Stanford Genome Training program (NHGRI T32HG00044).	Albert I, 2007, NATURE, V446, P572, DOI 10.1038/nature05632; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bernstein BE, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r62; Cuddapah S, 2009, GENOME RES, V19, P24, DOI 10.1101/gr.082800.108; Fan YH, 2005, CELL, V123, P1199, DOI 10.1016/j.cell.2005.10.028; Field Y, 2009, NAT GENET, V41, P438, DOI 10.1038/ng.324; Fu YT, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000138; Guoping S, 2010, CHROMOSOMA, V119, P73, DOI 10.1007/s00412-009-0235-3; Hughes Amanda, 2009, J Biol, V8, P96, DOI 10.1186/jbiol207; Johnson SM, 2006, GENOME RES, V16, P1505, DOI 10.1101/gr.5560806; Kaplan N, 2009, NATURE, V458, P362, DOI 10.1038/nature07667; KORNBERG RD, 1977, ANNU REV BIOCHEM, V46, P931, DOI 10.1146/annurev.bi.46.070177.004435; Lee W, 2007, NAT GENET, V39, P1235, DOI 10.1038/ng2117; Luger K, 1999, METHOD ENZYMOL, V304, P3; Mavrich TN, 2008, GENOME RES, V18, P1073, DOI 10.1101/gr.078261.108; Mavrich TN, 2008, NATURE, V453, P358, DOI 10.1038/nature06929; Mellor J, 2005, MOL CELL, V19, P147, DOI 10.1016/j.molcel.2005.06.023; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Radman-Livaja M, 2010, DEV BIOL, V339, P258, DOI 10.1016/j.ydbio.2009.06.012; Sasaki S, 2009, SCIENCE, V323, P401, DOI 10.1126/science.1163183; SATCHWELL SC, 1986, J MOL BIOL, V191, P659, DOI 10.1016/0022-2836(86)90452-3; SCHLEGEL RA, 1980, BIOCHIM BIOPHYS ACTA, V606, P316, DOI 10.1016/0005-2787(80)90041-6; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; Sha K, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-465; Tillo D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009129; TRIFONOV EN, 1980, P NATL ACAD SCI-BIOL, V77, P3816, DOI 10.1073/pnas.77.7.3816; Valouev A, 2008, NAT METHODS, V5, P829, DOI 10.1038/NMETH.1246; Valouev A, 2008, GENOME RES, V18, P1051, DOI 10.1101/gr.076463.108; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Wellinger RE, 1997, EMBO J, V16, P5046, DOI 10.1093/emboj/16.16.5046; WIDOM J, 1992, P NATL ACAD SCI USA, V89, P1095, DOI 10.1073/pnas.89.3.1095; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178; Zhang Y, 2009, NAT STRUCT MOL BIOL, V16, P847, DOI 10.1038/nsmb.1636	34	427	433	0	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 23	2011	474	7352					516	U148		10.1038/nature10002	http://dx.doi.org/10.1038/nature10002			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	781NJ	21602827	Green Accepted			2022-12-24	WOS:000291939700050
J	Mendes, R; Kruijt, M; de Bruijn, I; Dekkers, E; van der Voort, M; Schneider, JHM; Piceno, YM; DeSantis, TZ; Andersen, GL; Bakker, PAHM; Raaijmakers, JM				Mendes, Rodrigo; Kruijt, Marco; de Bruijn, Irene; Dekkers, Ester; van der Voort, Menno; Schneider, Johannes H. M.; Piceno, Yvette M.; DeSantis, Todd Z.; Andersen, Gary L.; Bakker, Peter A. H. M.; Raaijmakers, Jos M.			Deciphering the Rhizosphere Microbiome for Disease-Suppressive Bacteria	SCIENCE			English	Article							PATHOGENS	Disease-suppressive soils are exceptional ecosystems in which crop plants suffer less from specific soil-borne pathogens than expected owing to the activities of other soil microorganisms. For most disease-suppressive soils, the microbes and mechanisms involved in pathogen control are unknown. By coupling PhyloChip-based metagenomics of the rhizosphere microbiome with culture-dependent functional analyses, we identified key bacterial taxa and genes involved in suppression of a fungal root pathogen. More than 33,000 bacterial and archaeal species were detected, with Proteobacteria, Firmicutes, and Actinobacteria consistently associated with disease suppression. Members of the gamma-Proteobacteria were shown to have disease-suppressive activity governed by nonribosomal peptide synthetases. Our data indicate that upon attack by a fungal root pathogen, plants can exploit microbial consortia from soil for protection against infections.	[Mendes, Rodrigo; Kruijt, Marco; de Bruijn, Irene; Dekkers, Ester; van der Voort, Menno; Raaijmakers, Jos M.] Wageningen Univ, Phytopathol Lab, NL-6700 EE Wageningen, Netherlands; [Schneider, Johannes H. M.] Inst Sugar Beet Res, NL-4611 HL Bergen Op Zoom, Netherlands; [Piceno, Yvette M.; DeSantis, Todd Z.; Andersen, Gary L.] Lawrence Berkeley Natl Lab, Dept Ecol, Berkeley, CA 94720 USA; [DeSantis, Todd Z.] Second Genome Inc, San Francisco, CA 94158 USA; [Bakker, Peter A. H. M.] Univ Utrecht, Dept Biol, NL-3584 CH Utrecht, Netherlands	Wageningen University & Research; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Utrecht University	Raaijmakers, JM (corresponding author), Wageningen Univ, Phytopathol Lab, Droevendaalsesteeg 1, NL-6700 EE Wageningen, Netherlands.	jos.raaijmakers@wur.nl	Bakker, Peter A.H.M./B-9355-2011; Mendes, Rodrigo/F-1534-2010; rolshausen, philippe/F-7999-2011; de Bruijn, Irene/A-7437-2014; Piceno, Yvette/I-6738-2016; Raaijmakers, Jos M/D-1574-2014; Mendes, Rodrigo/AAV-6490-2020; Andersen, Gary/G-2792-2015	Mendes, Rodrigo/0000-0002-9817-4118; de Bruijn, Irene/0000-0002-4889-3253; Piceno, Yvette/0000-0002-7915-4699; Raaijmakers, Jos M/0000-0003-1608-6614; Mendes, Rodrigo/0000-0002-9817-4118; Andersen, Gary/0000-0002-1618-9827	Netherlands Science Organisation (NWO) [838.06.101]; Netherlands Genomics Initiative-Ecogenomics, Netherlands; Lawrence Berkeley National Laboratory (LBNL) [DE-AC02-05CH11231]; U.S. Department of Energy	Netherlands Science Organisation (NWO)(Netherlands Organization for Scientific Research (NWO)); Netherlands Genomics Initiative-Ecogenomics, Netherlands(Netherlands Government); Lawrence Berkeley National Laboratory (LBNL); U.S. Department of Energy(United States Department of Energy (DOE))	We thank T. Bisseling for critical reading and valuable suggestions. We acknowledge assistance by L. Sibbel-Wagemakers, N. Pangesti, M. de Milliano, N. Sharma, R. de Vries, P. M. S. van Oorschot, A. H. L. Schoone, and Y. Bakker. This work was financially supported by grants from Netherlands Science Organisation (NWO)-ERGO (#838.06.101) and Netherlands Genomics Initiative-Ecogenomics, Netherlands. Additional work was performed at Lawrence Berkeley National Laboratory (LBNL) (contract DE-AC02-05CH11231 with the U.S. Department of Energy). The 16S rDNA sequences are available on GenBank under accessions HQ848634 to HQ848643, and the thaABCD sequences under accession HQ888764. LBNL has a patent on the PhyloChip assay and Second Genome has licensed this assay from LBNL. Although the G3 PhyloChip is under patent (and under exclusive license to Second Genome), the data generated from the use of the chip are not patented or restricted. T.Z.dS. owns stock in Second Genome valued at under $10,000.	Bisseling T, 2009, SCIENCE, V324, P691, DOI 10.1126/science.1174404; COOK RJ, 1995, P NATL ACAD SCI USA, V92, P4197, DOI 10.1073/pnas.92.10.4197; DeAngelis KM, 2009, ISME J, V3, P168, DOI 10.1038/ismej.2008.103; Feil H, 2005, P NATL ACAD SCI USA, V102, P11064, DOI 10.1073/pnas.0504930102; Garbeva P, 2011, ISME J; Haas D, 2005, NAT REV MICROBIOL, V3, P307, DOI 10.1038/nrmicro1129; Hazen TC, 2010, SCIENCE, V330, P204, DOI 10.1126/science.1195979; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Marschner H., 1995, MINERAL NUTR HIGHER, V2nd ed.; Postma J, 2010, SOIL BIOL BIOCHEM, V42, P804, DOI 10.1016/j.soilbio.2010.01.017; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Schloss PD, 2006, PLOS COMPUT BIOL, V2, P786, DOI 10.1371/journal.pcbi.0020092; Scott JJ, 2008, SCIENCE, V322, P63, DOI 10.1126/science.1160423; Weller DM, 2002, ANNU REV PHYTOPATHOL, V40, P309, DOI 10.1146/annurev.phyto.40.030402.110010	14	1354	1472	87	1148	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 27	2011	332	6033					1097	1100		10.1126/science.1203980	http://dx.doi.org/10.1126/science.1203980			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769FN	21551032	Green Published			2022-12-24	WOS:000290996700048
J	Brady, CA; Jiang, D; Mello, SS; Johnson, TM; Jarvis, LA; Kozak, MM; Broz, DK; Basak, S; Park, EJ; McLaughlin, ME; Karnezis, AN; Attardi, LD				Brady, Colleen A.; Jiang, Dadi; Mello, Stephano S.; Johnson, Thomas M.; Jarvis, Lesley A.; Kozak, Margaret M.; Broz, Daniela Kenzelmann; Basak, Shashwati; Park, Eunice J.; McLaughlin, Margaret E.; Karnezis, Anthony N.; Attardi, Laura D.			Distinct p53 Transcriptional Programs Dictate Acute DNA-Damage Responses and Tumor Suppression	CELL			English	Article							RADIATION-INDUCED APOPTOSIS; P53-DEPENDENT APOPTOSIS; DEFICIENT MUTANT; ONCOGENIC RAS; ONLY PROTEIN; ACTIVATION; DOMAIN; SENESCENCE; BINDING; TARGET	The molecular basis for p53-mediated tumor suppression remains unclear. Here, to elucidate mechanisms of p53 tumor suppression, we use knockin mice expressing an allelic series of p53 transcriptional activation mutants. Microarray analysis reveals that one mutant, p53(25,26), is severely compromised for transactivation of most p53 target genes, and, moreover, p53(25,26) cannot induce G(1)-arrest or apoptosis in response to acute DNA damage. Surprisingly, p(5325,26) retains robust activity in senescence and tumor suppression, indicating that efficient transactivation of the majority of known p53 targets is dispensable for these pathways. In contrast, the transactivation-dead p53(25,26,53,54) mutant cannot induce senescence or inhibit tumorigenesis, like p53 nullizygosity. Thus, p53 transactivation is essential for tumor suppression but, intriguingly, in association with a small set of novel p53 target genes. Together, our studies distinguish the p53 transcriptional programs involved in acute DNA-damage responses and tumor suppression-a critical goal for designing therapeutics that block p53-dependent side effects of chemotherapy without compromising p53 tumor suppression.	[Brady, Colleen A.; Jiang, Dadi; Mello, Stephano S.; Johnson, Thomas M.; Jarvis, Lesley A.; Kozak, Margaret M.; Broz, Daniela Kenzelmann; Basak, Shashwati; Park, Eunice J.; Attardi, Laura D.] Stanford Univ, Dept Radiat Oncol, Div Radiat & Canc Biol, Sch Med, Stanford, CA 94305 USA; [Attardi, Laura D.] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; [Kozak, Margaret M.] MIT, Ctr Canc Res, Cambridge, MA 02142 USA; [Karnezis, Anthony N.] Univ Calif San Francisco, Canc Res Inst, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Karnezis, Anthony N.] Univ Calif San Francisco, Dept Pathol, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA	Stanford University; Stanford University; Massachusetts Institute of Technology (MIT); University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center	Attardi, LD (corresponding author), Stanford Univ, Dept Radiat Oncol, Div Radiat & Canc Biol, Sch Med, Stanford, CA 94305 USA.	attardi@stanford.edu	Mello, Stephano Spano/ABF-9477-2020	Mello, Stephano Spano/0000-0002-2484-086X; Kozak, Margaret/0000-0001-9111-1942	Smith Stanford Graduate Fellowship; Lucille P. Markey Biomedical Research Stanford Graduate Fellowship; National Science Foundation; Gerald Lieberman Dissertation Fellowship; C.A.P.E.S; Swiss National Science Foundation; American Cancer Society; Leukemia and Lymphoma Society; National Institutes of Health [CA140875]; NATIONAL CANCER INSTITUTE [R21CA141087, R01CA140875] Funding Source: NIH RePORTER	Smith Stanford Graduate Fellowship; Lucille P. Markey Biomedical Research Stanford Graduate Fellowship; National Science Foundation(National Science Foundation (NSF)); Gerald Lieberman Dissertation Fellowship; C.A.P.E.S(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); American Cancer Society(American Cancer Society); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Microarray analyses were performed using BRB-ArrayTools developed by Dr. Richard Simon and the BRB-ArrayTools Development Team. We thank T. Jacks for providing the Rosa26CreER<SUP>T2</SUP> mice, S. Lowe for the pWZL-HrasV12 plasmid and Pml antibody, S. Artandi for the 3xHA expression plasmid, and W. Hahn and A. Schinzel and the Dana Farber RNAi facility for the lentiviral shRNA constructs; D. Burkhart, A. Krieg, J. Sage, and L. Sayles for technical assistance; and S. Artandi, A. Brunet, A. Giaccia, and J. Sage for critical reading of the manuscript. This work was supported by a Smith Stanford Graduate Fellowship to C. A. B., a Lucille P. Markey Biomedical Research Stanford Graduate Fellowship to T. M. J., National Science Foundation Graduate Research Fellowships to C. A. B. and T. M. J., a Gerald Lieberman Dissertation Fellowship to C. A. B., a C.A.P.E.S Fellowship to S. S. M., a Swiss National Science Foundation Fellowship to D. K. B., and funding from the American Cancer Society, the Leukemia and Lymphoma Society, and the National Institutes of Health (CA140875) to LD.A.	Attardi LD, 2004, ONCOGENE, V23, P973, DOI 10.1038/sj.onc.1207026; Baptiste-Okoh N, 2008, P NATL ACAD SCI USA, V105, P1937, DOI 10.1073/pnas.0711800105; Barboza JA, 2006, P NATL ACAD SCI USA, V103, P19842, DOI 10.1073/pnas.0606343104; Brady CA, 2010, J CELL SCI, V123, P2527, DOI 10.1242/jcs.064501; Brown JP, 1997, SCIENCE, V277, P831, DOI 10.1126/science.277.5327.831; Broz DK, 2010, CARCINOGENESIS, V31, P1311, DOI 10.1093/carcin/bgp331; Bugni JM, 2009, ONCOGENE, V28, P734, DOI 10.1038/onc.2008.426; Candau R, 1997, ONCOGENE, V15, P807, DOI 10.1038/sj.onc.1201244; Chao C, 2000, EMBO J, V19, P4967, DOI 10.1093/emboj/19.18.4967; Chi SW, 2005, J BIOL CHEM, V280, P38795, DOI 10.1074/jbc.M508578200; Christophorou MA, 2006, NATURE, V443, P214, DOI 10.1038/nature05077; de Stanchina E, 2004, MOL CELL, V13, P523, DOI 10.1016/S1097-2765(04)00062-0; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Duxbury MS, 2005, BIOCHEM BIOPH RES CO, V331, P459, DOI 10.1016/j.bbrc.2005.03.199; Efeyan A, 2007, ONCOGENE, V26, P1645, DOI 10.1038/sj.onc.1209972; Efeyan A, 2006, NATURE, V443, P159, DOI 10.1038/443159a; Ferbeyre G, 2000, GENE DEV, V14, P2015; Gaidarenko O, 2009, ONCOGENE, V28, P4397, DOI 10.1038/onc.2009.290; Gamper AM, 2008, MOL CELL BIOL, V28, P2517, DOI 10.1128/MCB.01461-07; Gao JL, 2010, BIOCHEM BIOPH RES CO, V402, P588, DOI 10.1016/j.bbrc.2010.09.133; Green DR, 2009, NATURE, V458, P1127, DOI 10.1038/nature07986; Gudkov AV, 2003, NAT REV CANCER, V3, P117, DOI 10.1038/nrc992; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Hemann MT, 2004, P NATL ACAD SCI USA, V101, P9333, DOI 10.1073/pnas.0403286101; Ihrie RA, 2003, CURR BIOL, V13, P1985, DOI 10.1016/j.cub.2003.10.055; Jackson EL, 2005, CANCER RES, V65, P10280, DOI 10.1158/0008-5472.CAN-05-2193; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Johnson TM, 2005, NAT GENET, V37, P145, DOI 10.1038/ng1498; KASTAN MB, 1992, CELL, V71, P587, DOI 10.1016/0092-8674(92)90593-2; Kawase T, 2009, CELL, V136, P535, DOI 10.1016/j.cell.2008.12.002; Kennedy AL, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-16; Kodadek T, 2006, CELL, V127, P261, DOI 10.1016/j.cell.2006.10.002; Kortlever RM, 2006, NAT CELL BIOL, V8, P877, DOI 10.1038/ncb1448; LIN JY, 1994, GENE DEV, V8, P1235, DOI 10.1101/gad.8.10.1235; Liu J, 2008, NEUROPHARMACOLOGY, V54, P1, DOI 10.1016/j.neuropharm.2007.05.020; LOWE SW, 1993, NATURE, V362, P847, DOI 10.1038/362847a0; Lozano G, 2005, J PATHOL, V205, P206, DOI 10.1002/path.1704; Lu WJ, 2006, CELL DEATH DIFFER, V13, P909, DOI 10.1038/sj.cdd.4401922; Melotte V, 2009, JNCI-J NATL CANCER I, V101, P916, DOI 10.1093/jnci/djp131; MERRITT AJ, 1994, CANCER RES, V54, P614; Miller LD, 2005, P NATL ACAD SCI USA, V102, P13550, DOI 10.1073/pnas.0506230102; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Teufel DP, 2007, P NATL ACAD SCI USA, V104, P7009, DOI 10.1073/pnas.0702010104; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Tuveson DA, 2004, CANCER CELL, V5, P375, DOI 10.1016/S1535-6108(04)00085-6; van Ham M, 2003, GENES CELLS, V8, P631, DOI 10.1046/j.1365-2443.2003.00660.x; Venot C, 1999, ONCOGENE, V18, P2405, DOI 10.1038/sj.onc.1202539; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043; Zhu JH, 1998, J BIOL CHEM, V273, P13030, DOI 10.1074/jbc.273.21.13030	57	374	381	1	50	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 13	2011	145	4					571	583		10.1016/j.cell.2011.03.035	http://dx.doi.org/10.1016/j.cell.2011.03.035			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	763MF	21565614	Green Accepted, Bronze			2022-12-24	WOS:000290560800010
J	Cirimotich, CM; Dong, YM; Clayton, AM; Sandiford, SL; Souza-Neto, JA; Mulenga, M; Dimopoulos, G				Cirimotich, Chris M.; Dong, Yuemei; Clayton, April M.; Sandiford, Simone L.; Souza-Neto, Jayme A.; Mulenga, Musapa; Dimopoulos, George			Natural Microbe-Mediated Refractoriness to Plasmodium Infection in Anopheles gambiae	SCIENCE			English	Article							MALARIA PARASITE INFECTION; GRAM-NEGATIVE BACTERIA; SPOROGONIC DEVELOPMENT; POPULATION-DYNAMICS; NITRIC-OXIDE; MOSQUITO; STEPHENSI; FALCIPARUM; RESISTANCE; IMMUNITY	Malaria parasite transmission depends on the successful transition of Plasmodium through discrete developmental stages in the lumen of the mosquito midgut. Like the human intestinal tract, the mosquito midgut contains a diverse microbial flora, which may compromise the ability of Plasmodium to establish infection. We have identified an Enterobacter bacterium isolated from wild mosquito populations in Zambia that renders the mosquito resistant to infection with the human malaria parasite Plasmodium falciparum by interfering with parasite development before invasion of the midgut epithelium. Phenotypic analyses showed that the anti-Plasmodium mechanism requires small populations of replicating bacteria and is mediated through a mosquito-independent interaction with the malaria parasite. We show that this anti-Plasmodium effect is largely caused by bacterial generation of reactive oxygen species.	[Cirimotich, Chris M.; Dong, Yuemei; Clayton, April M.; Sandiford, Simone L.; Souza-Neto, Jayme A.; Dimopoulos, George] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA; [Mulenga, Musapa] Malaria Inst Macha, Choma, Zambia	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Dimopoulos, G (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Microbiol & Immunol, 615 N Wolfe St, Baltimore, MD 21205 USA.	gdimopou@jhsph.edu	Souza-Neto, Jayme A/E-7841-2010	Souza-Neto, Jayme A/0000-0001-9281-894X; Cirimotich, Chris/0000-0002-7636-0542; Dimopoulos, George/0000-0001-6755-8111; Dong, Yuemei/0000-0002-7902-2899	National Institutes of Health/National Institute of Allergy and Infectious Disease [R01AI061576]; Johns Hopkins Malaria Research Institute (JHMRI); Bloomberg Family Foundation; Calvin A. and Helen H. Lang fellowship; NSF; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007417, R01AI061576] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Johns Hopkins Malaria Research Institute (JHMRI); Bloomberg Family Foundation; Calvin A. and Helen H. Lang fellowship; NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work has been supported by the National Institutes of Health/National Institute of Allergy and Infectious Disease R01AI061576 and a Johns Hopkins Malaria Research Institute (JHMRI) Pilot Grant (to G. D.), the Bloomberg Family Foundation, the Calvin A. and Helen H. Lang fellowship (to C. M. C.), a JHMRI postdoctoral fellowship (to J.S.-N.), and a fellowship from the NSF (to A. M. C.). The authors thank the mosquito collection team at the Malaria Institute at Macha, Zambia; the JHMRI Parasitology and Insectary Core facilities; Sanaria Inc.; E. Nelson (Cornell University) for providing mutant bacteria strains; and D. McClellan for editorial services. We performed all experiments according to Johns Hopkins Institutional Animal Care and Use Committee guidelines. Human landing catches were performed according to the approved protocol UNZA REC 011-02-04 with consent of participants. GenBank accession numbers generated for bacterial 16S rDNA sequences are listed in table S1, SOM.	Alavi Y, 2003, INT J PARASITOL, V33, P933, DOI 10.1016/S0020-7519(03)00112-7; Blandin SA, 2009, SCIENCE, V326, P147, DOI 10.1126/science.1175241; Cirimotich CM, 2010, DEV COMP IMMUNOL, V34, P387, DOI 10.1016/j.dci.2009.12.005; Dong YM, 2006, PLOS PATHOG, V2, P513, DOI 10.1371/journal.ppat.0020052; Dong YM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000423; Garver LS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000335; Gonzalez-Ceron L, 2003, J MED ENTOMOL, V40, P371, DOI 10.1603/0022-2585-40.3.371; Kumar S, 2003, P NATL ACAD SCI USA, V100, P14139, DOI 10.1073/pnas.2036262100; Kumar S, 2010, SCIENCE, V327, P1644, DOI 10.1126/science.1184008; Luckhart S, 1998, P NATL ACAD SCI USA, V95, P5700, DOI 10.1073/pnas.95.10.5700; Mai-Prochnow A, 2008, J BACTERIOL, V190, P5493, DOI 10.1128/JB.00549-08; Meister S, 2005, P NATL ACAD SCI USA, V102, P11420, DOI 10.1073/pnas.0504950102; Meister S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000542; Molina-Cruz A, 2008, J BIOL CHEM, V283, P3217, DOI 10.1074/jbc.M705873200; Niare O, 2002, SCIENCE, V298, P213, DOI 10.1126/science.1073420; Peterson TML, 2007, FREE RADICAL BIO MED, V42, P132, DOI 10.1016/j.freeradbiomed.2006.10.037; Pumpuni CB, 1996, AM J TROP MED HYG, V54, P214, DOI 10.4269/ajtmh.1996.54.214; PUMPUNI CB, 1993, EXP PARASITOL, V77, P195, DOI 10.1006/expr.1993.1076; Riehle MM, 2006, SCIENCE, V312, P577, DOI 10.1126/science.1124153; Terenius O, 2008, J MED ENTOMOL, V45, P172, DOI 10.1603/0022-2585(2008)45[172:SRGSFB]2.0.CO;2; van Dijk K, 2000, APPL ENVIRON MICROB, V66, P5340, DOI 10.1128/AEM.66.12.5340-5347.2000; VAUGHAN JA, 1992, J PARASITOL, V78, P716, DOI 10.2307/3283550; VAUGHAN JA, 1994, AM J TROP MED HYG, V51, P233, DOI 10.4269/ajtmh.1994.51.233	23	389	403	4	112	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 13	2011	332	6031					855	858		10.1126/science.1201618	http://dx.doi.org/10.1126/science.1201618			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763CD	21566196	Green Accepted			2022-12-24	WOS:000290529900050
J	Sievers, SA; Karanicolas, J; Chang, HW; Zhao, A; Jiang, L; Zirafi, O; Stevens, JT; Munch, J; Baker, D; Eisenberg, D				Sievers, Stuart A.; Karanicolas, John; Chang, Howard W.; Zhao, Anni; Jiang, Lin; Zirafi, Onofrio; Stevens, Jason T.; Muench, Jan; Baker, David; Eisenberg, David			Structure-based design of non-natural amino-acid inhibitors of amyloid fibril formation	NATURE			English	Article							PAIRED HELICAL FILAMENTS; TAU-PROTEIN; PEPTIDE INHIBITORS; ALZHEIMERS-DISEASE; AGGREGATION; BINDING; MECHANISM; TOXICITY; MODEL	Many globular and natively disordered proteins can convert into amyloid fibrils. These fibrils are associated with numerous pathologies(1) as well as with normal cellular functions(2,3), and frequently form during protein denaturation(4,5). Inhibitors of pathological amyloid fibril formation could be useful in the development of therapeutics, provided that the inhibitors were specific enough to avoid interfering with normal processes. Here we show that computer-aided, structure-based design can yield highly specific peptide inhibitors of amyloid formation. Using known atomic structures of segments of amyloid fibrils as templates, we have designed and characterized an all-D-amino-acid inhibitor of the fibril formation of the tau protein associated with Alzheimer's disease, and a non-natural L.-amino-acid inhibitor of an amyloid fibril that enhances sexual transmission of human immunodeficiency virus. Our results indicate that peptides from structure-based designs can disrupt the fibril formation of full-length proteins, including those, such as tau protein, that lack fully ordered native structures. Because the inhibiting peptides have been designed on structures of dual-beta-sheet 'steric zippers', the successful inhibition of amyloid fibril formation strengthens the hypothesis that amyloid spines contain steric zippers.	[Sievers, Stuart A.; Chang, Howard W.; Zhao, Anni; Jiang, Lin; Eisenberg, David] Univ Calif Los Angeles, Howard Hughes Med Inst, Dept Biol Chem, Los Angeles, CA 90095 USA; [Sievers, Stuart A.; Chang, Howard W.; Zhao, Anni; Jiang, Lin; Eisenberg, David] Univ Calif Los Angeles, Howard Hughes Med Inst, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Karanicolas, John; Baker, David] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Karanicolas, John; Baker, David] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Karanicolas, John; Stevens, Jason T.] Univ Kansas, Ctr Bioinformat, Lawrence, KS 66045 USA; [Karanicolas, John; Stevens, Jason T.] Univ Kansas, Dept Mol Biosci, Lawrence, KS 66045 USA; [Zirafi, Onofrio; Muench, Jan] Univ Hosp Ulm, Inst Mol Virol, D-89081 Ulm, Germany	Howard Hughes Medical Institute; University of California System; University of California Los Angeles; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Kansas; University of Kansas; Ulm University	Eisenberg, D (corresponding author), Univ Calif Los Angeles, Howard Hughes Med Inst, Dept Biol Chem, Los Angeles, CA 90095 USA.	david@mbi.ucla.edu	Eisenberg, David/E-2447-2011; Jiang, Lin/G-1575-2010; Baker, David/K-8941-2012	Baker, David/0000-0001-7896-6217; Jan, Munch/0000-0001-7316-7141	Damon Runyon Cancer Research Foundation; Ruth L. Kirschstein National Research Service Award; Ministry of Science, Baden-Wurttemberg; UCLA-IGERT; NATIONAL INSTITUTE ON AGING [R01AG029430, P50AG016570] Funding Source: NIH RePORTER	Damon Runyon Cancer Research Foundation; Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Science, Baden-Wurttemberg; UCLA-IGERT; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank M. I. Ivanova, J. Corn, T. Kortemme, D. Anderson, M. R. Sawaya, M. Phillips, S. Sambashivan, J. Park, M. Landau, A. Laganowsky, Q. Zhang, R. Clubb, F. Guo, T. Yeates, J. Nowick, J. Zheng and M. J. Thompson for discussions; the HHMI, NIH, NSF, Gates Foundation and Joint Center for Translational Medicine for support; R. Peterson for help with NMR experiments; E. Mandelkow for providing tau constructs; R. Rick for providing amyloid-beta; and J. Stroud for amyloid-beta preparation. Support came from the Damon Runyon Cancer Research Foundation (J.K.), the Ruth L. Kirschstein National Research Service Award (H.W.C.), the programme for junior professors by the Ministry of Science, Baden-Wurttemberg (J.M.), and a UCLA-IGERT bioinformatics traineeship (S.A.S.).	ASTBURY WILLIAM THOMAS, 1935, BIOCHEM JOUR, V29, P2351; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barghorn Stefan, 2004, V299, P35; BIERNAT J, 1992, EMBO J, V11, P1593, DOI 10.1002/j.1460-2075.1992.tb05204.x; Calamai M, 2005, BIOPHYS J, V89, P4201, DOI 10.1529/biophysj.105.068726; Chen ZJ, 2005, J MOL BIOL, V354, P760, DOI 10.1016/j.jmb.2005.09.055; DeLano W.L., 2002, PYMOL MOL VIEWER; EISENBERG D, 1989, CHEM SCRIPTA, V29A, P217; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Findeis Mark A., 2002, Current Topics in Medicinal Chemistry, V2, P417, DOI 10.2174/1568026024607508; Fleishman SJ, 2011, SCIENCE, V332, P816, DOI 10.1126/science.1202617; Fowler DM, 2007, TRENDS BIOCHEM SCI, V32, P217, DOI 10.1016/j.tibs.2007.03.003; Friedhoff P, 1998, P NATL ACAD SCI USA, V95, P15712, DOI 10.1073/pnas.95.26.15712; Friedhoff P, 1998, BIOCHEMISTRY-US, V37, P10223, DOI 10.1021/bi980537d; Goldschmidt L, 2010, P NATL ACAD SCI USA, V107, P3487, DOI 10.1073/pnas.0915166107; Goux WJ, 2004, J BIOL CHEM, V279, P26868, DOI 10.1074/jbc.M402379200; Kokkoni N, 2006, BIOCHEMISTRY-US, V45, P9906, DOI 10.1021/bi060837s; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; Larbig G, 2007, CURR ALZHEIMER RES, V4, P315; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Maji SK, 2009, SCIENCE, V325, P328, DOI 10.1126/science.1173155; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Morris AM, 2008, BIOCHEMISTRY-US, V47, P2413, DOI 10.1021/bi701899y; Munch J, 2007, CELL, V131, P1059, DOI 10.1016/j.cell.2007.10.014; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nelson R, 2005, NATURE, V435, P773, DOI 10.1038/nature03680; Papkalla A, 2002, J VIROL, V76, P8455, DOI 10.1128/JVI.76.16.8455-8459.2002; Perez M, 1996, J NEUROCHEM, V67, P1183; Petrassi HM, 2000, J AM CHEM SOC, V122, P2178, DOI 10.1021/ja993309v; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; Quijano FAR, 2006, BIOCHEMISTRY-US, V45, P4638, DOI 10.1021/bi052226q; R Core Team, 2022, R LANG ENV STAT COMP; Roan NR, 2009, J VIROL, V83, P73, DOI 10.1128/JVI.01366-08; Sato T, 2006, BIOCHEMISTRY-US, V45, P5503, DOI 10.1021/bi052485f; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Schmidt K, 1999, J NEUROSCI METH, V87, P195, DOI 10.1016/S0165-0270(99)00003-5; SCHWEERS O, 1995, P NATL ACAD SCI USA, V92, P8463, DOI 10.1073/pnas.92.18.8463; SCHWEERS O, 1994, J BIOL CHEM, V269, P24290; Sciarretta KL, 2006, METHOD ENZYMOL, V413, P273, DOI 10.1016/S0076-6879(06)13015-3; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Soto C, 1996, BIOCHEM BIOPH RES CO, V226, P672, DOI 10.1006/bbrc.1996.1413; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; Thompson MJ, 2006, P NATL ACAD SCI USA, V103, P4074, DOI 10.1073/pnas.0511295103; Tjernberg LO, 1996, J BIOL CHEM, V271, P8545, DOI 10.1074/jbc.271.15.8545; von Bergen M, 2000, P NATL ACAD SCI USA, V97, P5129, DOI 10.1073/pnas.97.10.5129; Westermark P, 2007, AMYLOID, V14, P179, DOI 10.1080/13506120701460923; Wiesehan K, 2003, CHEMBIOCHEM, V4, P748, DOI 10.1002/cbic.200300631; WILLE H, 1992, J CELL BIOL, V118, P573, DOI 10.1083/jcb.118.3.573; Wiltzius JJW, 2009, NAT STRUCT MOL BIOL, V16, P973, DOI 10.1038/nsmb.1643	49	341	354	2	272	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 7	2011	475	7354					96	U117		10.1038/nature10154	http://dx.doi.org/10.1038/nature10154			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	788RE	21677644	Green Accepted, Green Submitted			2022-12-24	WOS:000292461300052
J	Qian, L; Winfree, E				Qian, Lulu; Winfree, Erik			Scaling Up Digital Circuit Computation with DNA Strand Displacement Cascades	SCIENCE			English	Article							AMPLIFICATION; EXPRESSION; LANGUAGE; MACHINE	To construct sophisticated biochemical circuits from scratch, one needs to understand how simple the building blocks can be and how robustly such circuits can scale up. Using a simple DNA reaction mechanism based on a reversible strand displacement process, we experimentally demonstrated several digital logic circuits, culminating in a four-bit square-root circuit that comprises 130 DNA strands. These multilayer circuits include thresholding and catalysis within every logical operation to perform digital signal restoration, which enables fast and reliable function in large circuits with roughly constant switching time and linear signal propagation delays. The design naturally incorporates other crucial elements for large-scale circuitry, such as general debugging tools, parallel circuit preparation, and an abstraction hierarchy supported by an automated circuit compiler.	[Qian, Lulu; Winfree, Erik] CALTECH, Pasadena, CA 91125 USA	California Institute of Technology	Winfree, E (corresponding author), CALTECH, Pasadena, CA 91125 USA.	winfree@caltech.edu	Winfree, Erik/L-4002-2013	Winfree, Erik/0000-0002-5899-7523	NSF [0728703, 0832824]; Human Frontier Science Program [RGY0074/2006-C]	NSF(National Science Foundation (NSF)); Human Frontier Science Program(Human Frontier Science Program)	We thank D. Y. Zhang for providing useful comments on the manuscript. Supported by NSF grants 0728703 and 0832824 (Molecular Programming Project) and Human Frontier Science Program award RGY0074/2006-C.	ADLEMAN LM, 1994, SCIENCE, V266, P1021, DOI 10.1126/science.7973651; BAUM EB, 1995, SCIENCE, V268, P583, DOI 10.1126/science.7725109; Benenson Y, 2004, NATURE, V429, P423, DOI 10.1038/nature02551; Bois J. S., 2007, THESIS CALTECH; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Chiniforooshan E, 2011, LECT NOTES COMPUT SC, V6518, P25, DOI 10.1007/978-3-642-18305-8_3; Choi HMT, 2010, NAT BIOTECHNOL, V28, P1208, DOI 10.1038/nbt.1692; Dirks RM, 2004, P NATL ACAD SCI USA, V101, P15275, DOI 10.1073/pnas.0407024101; Dittmer WU, 2004, ANGEW CHEM INT EDIT, V43, P3550, DOI 10.1002/anie.200353537; Eckhoff G., 2010, J SYST CHEM, V1, P13, DOI DOI 10.1186/1759-2208-1-13; Elbaz J, 2010, NAT NANOTECHNOL, V5, P417, DOI [10.1038/NNANO.2010.88, 10.1038/nnano.2010.88]; Goel A, 2009, LECT NOTES COMPUT SC, V5877, P67, DOI 10.1007/978-3-642-10604-0_7; Gu HZ, 2010, NATURE, V465, P202, DOI 10.1038/nature09026; Hucka M, 2003, BIOINFORMATICS, V19, P524, DOI 10.1093/bioinformatics/btg015; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Lund K, 2010, NATURE, V465, P206, DOI 10.1038/nature09012; Muller D. E., 1963, SWITCHING THEORY SPA, P289; Phillips A, 2009, J R SOC INTERFACE, V6, DOI 10.1098/rsif.2009.0072.focus; Qian L, 2011, J R SOC INTERFACE, V8, P1281, DOI 10.1098/rsif.2010.0729; Qian L, 2011, LECT NOTES COMPUT SC, V6518, P123, DOI 10.1007/978-3-642-18305-8_12; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; Seelig G, 2006, SCIENCE, V314, P1585, DOI 10.1126/science.1132493; Soloveichik D, 2010, P NATL ACAD SCI USA, V107, P5393, DOI 10.1073/pnas.0909380107; Stojanovic MN, 2003, NAT BIOTECHNOL, V21, P1069, DOI 10.1038/nbt862; Tian JD, 2009, MOL BIOSYST, V5, P714, DOI 10.1039/b822268c; Turberfield AJ, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.118102; Venkataraman S, 2010, P NATL ACAD SCI USA, V107, P16777, DOI 10.1073/pnas.1006377107; Yin P, 2008, NATURE, V451, P318, DOI 10.1038/nature06451; Yurke B, 2000, NATURE, V406, P605, DOI 10.1038/35020524; Yurke B., 2003, Genetic Programming and Evolvable Machines, V4, P111, DOI 10.1023/A:1023928811651; Zhang DY, 2007, SCIENCE, V318, P1121, DOI 10.1126/science.1148532; Zhang DY, 2009, J AM CHEM SOC, V131, P17303, DOI 10.1021/ja906987s	32	923	980	41	578	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 3	2011	332	6034					1196	1201		10.1126/science.1200520	http://dx.doi.org/10.1126/science.1200520			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	772BO	21636773				2022-12-24	WOS:000291205200048
J	Schwartz, AV; Vittinghoff, E; Bauer, DC; Hillier, TA; Strotmeyer, ES; Ensrud, KE; Donaldson, MG; Cauley, JA; Harris, TB; Koster, A; Womack, CR; Palermo, L; Black, DM				Schwartz, Ann V.; Vittinghoff, Eric; Bauer, Douglas C.; Hillier, Teresa A.; Strotmeyer, Elsa S.; Ensrud, Kristine E.; Donaldson, Meghan G.; Cauley, Jane A.; Harris, Tamara B.; Koster, Annemarie; Womack, Catherine R.; Palermo, Lisa; Black, Dennis M.		SOF Res Grp; Osteoporotic Fractures Men MrOS Re; Hlth ABC Res Grp	Association of BMD and FRAX Score With Risk of Fracture in Older Adults With Type 2 Diabetes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BONE-MINERAL DENSITY; OSTEOPOROTIC FRACTURES; BODY-COMPOSITION; WOMEN; MEN; PREDICTION; HEALTH; HIP; THIAZOLIDINEDIONES; METAANALYSIS	Context Type 2 diabetes mellitus (DM) is associated with higher bone mineral density (BMD) and paradoxically with increased fracture risk. It is not known if low BMD, central to fracture prediction in older adults, identifies fracture risk in patients with DM. Objective To determine if femoral neck BMD T score and the World Health Organization Fracture Risk Algorithm (FRAX) score are associated with hip and nonspine fracture risk in older adults with type 2 DM. Design, Setting, and Participants Data from 3 prospective observational studies with adjudicated fracture outcomes (Study of Osteoporotic Fractures [December 1998-July 2008]; Osteoporotic Fractures in Men Study [March 2000-March 2009]; and Health, Aging, and Body Composition study [April 1997-June 2007]) were analyzed in older community-dwelling adults (9449 women and 7436 men) in the United States. Main Outcome Measure Self-reported incident fractures, which were verified by radiology reports. Results Of 770 women with DM, 84 experienced a hip fracture and 262 a nonspine fracture during a mean (SD) follow-up of 12.6 (5.3) years. Of 1199 men with DM, 32 experienced a hip fracture and 133 a nonspine fracture during a mean (SD) follow-up of 7.5 (2.0) years. Age-adjusted hazard ratios (HRs) for 1-unit decrease in femoral neck BMD T score in women with DM were 1.88 (95% confidence interval [CI], 1.43-2.48) for hip fracture and 1.52 (95% CI, 1.31-1.75) for nonspine fracture, and in men with DM were 5.71 (95% CI, 3.42-9.53) for hip fracture and 2.17 (95% CI, 1.75-2.69) for nonspine fracture. The FRAX score was also associated with fracture risk in participants with DM (HRs for 1-unit increase in FRAX hip fracture score, 1.05; 95% CI, 1.03-1.07, for women with DM and 1.16; 95% CI, 1.07-1.27, for men with DM; HRs for 1-unit increase in FRAX osteoporotic fracture score, 1.04; 95% CI, 1.02-1.05, for women with DM and 1.09; 95% CI, 1.04-1.14, for men with DM). However, for a given T score and age or for a given FRAX score, participants with DM had a higher fracture risk than those without DM. For a similar fracture risk, participants with DM had a higher T score than participants without DM. For hip fracture, the estimated mean difference in T score for women was 0.59 (95% CI, 0.31-0.87) and for men was 0.38 (95% CI, 0.09-0.66). Conclusions Among older adults with type 2 DM, femoral neck BMD T score and FRAX score were associated with hip and nonspine fracture risk; however, in these patients compared with participants without DM, the fracture risk was higher for a given T score and age or for a given FRAX score. JAMA. 2011;305(21):2184-2192 www.jama.com	[Schwartz, Ann V.; Vittinghoff, Eric; Bauer, Douglas C.; Palermo, Lisa; Black, Dennis M.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94107 USA; [Bauer, Douglas C.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94107 USA; [Hillier, Teresa A.] Kaiser Permanente Ctr Hlth Res, Portland, OR USA; [Strotmeyer, Elsa S.; Cauley, Jane A.] Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15261 USA; [Ensrud, Kristine E.] Univ Minnesota, VA Med Ctr, Minneapolis, MN 55455 USA; [Ensrud, Kristine E.] Univ Minnesota, Div Epidemiol & Community Hlth, Minneapolis, MN 55455 USA; [Donaldson, Meghan G.] Calif Pacific Med Ctr, Res Inst, San Francisco, CA USA; [Harris, Tamara B.; Koster, Annemarie] NIA, Intramural Res Program, Bethesda, MD 20892 USA; [Koster, Annemarie] Maastricht Univ, Dept Hlth Care Studies, Maastricht, Netherlands; [Womack, Catherine R.] Univ Tennessee, Hlth Sci Ctr, Dept Prevent Med, Memphis, TN USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Kaiser Permanente; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Minnesota System; University of Minnesota Twin Cities; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; University of Minnesota System; University of Minnesota Twin Cities; California Pacific Medical Center; California Pacific Medical Center Research Institute; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Maastricht University; University of Tennessee System; University of Tennessee Health Science Center	Schwartz, AV (corresponding author), Univ Calif San Francisco, Dept Epidemiol & Biostat, 185 Berry St,Lobby 5,Ste 5700, San Francisco, CA 94107 USA.	aschwartz@psg.ucsf.edu	Koster, Annemarie/E-7438-2010; Strotmeyer, Elsa S/F-3015-2014; Newman, Anne B./C-6408-2013	Koster, Annemarie/0000-0003-1583-7391; Newman, Anne B./0000-0002-0106-1150; Strotmeyer, Elsa/0000-0002-4093-6036; Ensrud, Kristine/0000-0002-9069-3036; Cauley, Jane A/0000-0003-0752-4408	Amgen; Novartis; Roche; Merck; National Institutes of Health; National Institute on Aging [R01 AG005407, R01 AR35582, R01 AR35583, R01 AR35584, R01 AG005394, R01 AG027574, R01 AG027576, N01-AG-6-2101, N01-AG-6-2103, N01-AG-6-2106, R01-AG028050]; American Diabetes Association [1-04-JF-46]; National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institutes of Health Roadmap for Medical Research [U01 AR45580, U01 AR45614, U01 AR45632, U01 AR45647, U01 AR45654, U01 AR45583, U01 AG18197, U01-AG027810, UL1 RR024140]; National Institute of Nursing Research [R01-NR012459]; National Institutes of Health, National Institute on Aging; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024140] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR035584, U01AR045654, R01AR035583, U01AR045614, U01AR045632, K24AR051895, U01AR045647, R01AR035582, U01AR045583, U01AR045580] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR012459] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG028050, N01AG062103, U01AG018197, N01AG062101, N01AG062106, R01AG005407, R01AG027576, R01AG027574, R01AG005394, U01AG027810, U01AG042140] Funding Source: NIH RePORTER	Amgen(Amgen); Novartis(Novartis); Roche(Roche Holding); Merck(Merck & Company); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); American Diabetes Association(American Diabetes Association); National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institutes of Health Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Nursing Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); National Institutes of Health, National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Schwartz reported receiving honorarium from Amgen. Dr Bauer reported receiving research support from Amgen and Novartis. Dr Ensrud reported receiving travel support from Merck and Pfizer. Ms Palermo reported that she is a consultant for Nycomed. Dr Black reported receiving research support from Novartis, Roche, Merck, and Amgen. No other authors reported any disclosures.; This study was funded by an investigator-initiated grant from Amgen (Dr Schwartz). The Study of Osteoporotic Fractures is supported by National Institutes of Health funding. The National Institute on Aging provides support under the following grants: R01 AG005407, R01 AR35582, R01 AR35583, R01 AR35584, R01 AG005394, R01 AG027574, and R01 AG027576. The Osteoporotic Fractures in Men study is supported by National Institutes of Health funding and by grant 1-04-JF-46 from the American Diabetes Association (Dr Strotmeyer). The National Institute of Arthritis and Musculoskeletal and Skin Diseases, the National Institute on Aging, the National Center for Research Resources, and the National Institutes of Health Roadmap for Medical Research provided support under the following grants: U01 AR45580, U01 AR45614, U01 AR45632, U01 AR45647, U01 AR45654, U01 AR45583, U01 AG18197, U01-AG027810, and UL1 RR024140. The Health, Aging, and Body Composition study is supported by contracts N01-AG-6-2101, N01-AG-6-2103, and N01-AG-6-2106 from the National Institute on Aging; grant R01-AG028050 from the National Institute on Aging; grant R01-NR012459 from the National Institute of Nursing Research; and by the Intramural Research Program of the National Institutes of Health, National Institute on Aging.	[Anonymous], 2010, CLIN GUID PREV TREAT; Blank JB, 2005, CONTEMP CLIN TRIALS, V26, P557, DOI 10.1016/j.cct.2005.05.005; Bonds DE, 2006, J CLIN ENDOCR METAB, V91, P3404, DOI 10.1210/jc.2006-0614; Cowie CC, 2009, DIABETES CARE, V32, P287, DOI 10.2337/dc08-1296; CUMMINGS SR, 1993, LANCET, V341, P72, DOI 10.1016/0140-6736(93)92555-8; Dawson-Hughes B, 2008, OSTEOPOROSIS INT, V19, P449, DOI 10.1007/s00198-008-0559-5; Donaldson MG, 2010, J BONE MINER RES, V25, P1506, DOI 10.1002/jbmr.55; Ensrud KE, 2009, ARCH INTERN MED, V169, P2087, DOI 10.1001/archinternmed.2009.404; Johnell O, 2005, J BONE MINER RES, V20, P1185, DOI 10.1359/JBMR.050304; Kanis JA, 2008, OSTEOPOROSIS INT, V19, P385, DOI 10.1007/s00198-007-0543-5; Kanis JA, 2007, OSTEOPOROSIS INT, V18, P1033, DOI 10.1007/s00198-007-0343-y; Kanis JA, 2005, OSTEOPOROSIS INT, V16, P581, DOI 10.1007/s00198-004-1780-5; Loke YK, 2009, CAN MED ASSOC J, V180, P32, DOI 10.1503/cmaj.080486; Looker AC, 1998, OSTEOPOROSIS INT, V8, P468, DOI 10.1007/s001980050093; Meier C, 2008, ARCH INTERN MED, V168, P820, DOI 10.1001/archinte.168.8.820; Melton LJ, 2008, J BONE MINER RES, V23, P1334, DOI 10.1359/JBMR.080323; Newman AB, 2003, J AM GERIATR SOC, V51, P323, DOI 10.1046/j.1532-5415.2003.51105.x; Orwoll E, 2005, CONTEMP CLIN TRIALS, V26, P569, DOI 10.1016/j.cct.2005.05.006; Patel S, 2008, CALCIFIED TISSUE INT, V82, P87, DOI 10.1007/s00223-007-9082-5; Schwartz AV, 2002, DIABETES CARE, V25, P1749, DOI 10.2337/diacare.25.10.1749; Schwartz AV, 2001, J CLIN ENDOCR METAB, V86, P32, DOI 10.1210/jc.86.1.32; Strotmeyer ES, 2005, ARCH INTERN MED, V165, P1612, DOI 10.1001/archinte.165.14.1612; Vashishth Deepak, 2007, Curr Osteoporos Rep, V5, P62; Vestergaard P, 2007, OSTEOPOROSIS INT, V18, P427, DOI 10.1007/s00198-006-0253-4; World Health Organization, FRAX WHO FRACT RISK; Yamamoto M, 2007, CALCIFIED TISSUE INT, V80, P353, DOI 10.1007/s00223-007-9003-7	26	435	468	0	18	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 1	2011	305	21					2184	2192		10.1001/jama.2011.715	http://dx.doi.org/10.1001/jama.2011.715			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	770RN	21632482	Bronze, Green Accepted			2022-12-24	WOS:000291106300021
J	Nguitragool, W; Bokhari, AAB; Pillai, AD; Rayavara, K; Sharma, P; Turpin, B; Aravind, L; Desai, SA				Nguitragool, Wang; Bokhari, Abdullah A. B.; Pillai, Ajay D.; Rayavara, Kempaiah; Sharma, Paresh; Turpin, Brad; Aravind, L.; Desai, Sanjay A.			Malaria Parasite clag3 Genes Determine Channel-Mediated Nutrient Uptake by Infected Red Blood Cells	CELL			English	Article							SURFACE ANION CHANNEL; PLASMODIUM-FALCIPARUM; ERYTHROCYTE INVASION; MULTIGENE FAMILY; RHOPTRY PROTEIN; EXPRESSION; CYTOADHERENCE; PERMEABILITY; TRANSPORT; VIRULENCE	Development of malaria parasites within vertebrate erythrocytes requires nutrient uptake at the host cell membrane. The plasmodial surface anion channel (PSAC) mediates this transport and is an antimalarial target, but its molecular basis is unknown. We report a parasite gene family responsible for PSAC activity. We used high-throughput screening for nutrient uptake inhibitors to identify a compound highly specific for channels from the Dd2 line of the human pathogen P. falciparum. Inheritance of this compound's affinity in a Dd2xHB3 genetic cross maps to a single parasite locus on chromosome 3. DNA transfection and in vitro selections indicate that PSAC-inhibitor interactions are encoded by two clag3 genes previously assumed to function in cytoadherence. These genes are conserved in plasmodia, exhibit expression switching, and encode an integral protein on the host membrane, as predicted by functional studies. This protein increases host cell permeability to diverse solutes.	[Nguitragool, Wang; Bokhari, Abdullah A. B.; Pillai, Ajay D.; Rayavara, Kempaiah; Sharma, Paresh; Desai, Sanjay A.] NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD 20852 USA; [Turpin, Brad] Natl Instruments Inc, Austin, TX 78730 USA; [Aravind, L.] NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM)	Desai, SA (corresponding author), NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD 20852 USA.	sdesai@niaid.nih.gov		Aravind, L/0000-0003-0771-253X; Desai, Sanjay/0000-0003-2150-2483; Nguitragool, Wang/0000-0002-5484-7130	Medicines for Malaria Venture (MMV); National Institutes of Health, National Institute of Allergy and Infectious Diseases, and the National Library of Medicine; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000882] Funding Source: NIH RePORTER	Medicines for Malaria Venture (MMV); National Institutes of Health, National Institute of Allergy and Infectious Diseases, and the National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)NIH National Library of Medicine (NLM)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank John Adams, Alan Cowman, and Thomas Wellems for providing reagents; Mehreen Baakza, Kent Barbian, Yasmin El-Sayed, Juraj Kabat, Glenn Nardone, Son Nguyen, Norton Peet, Steve Porcella, Jose Riberio, Lattha Souvannaseng, Kurt Wollenberg, and Albert Youn for technical help; and the NIAID Scientific Director's office for providing required temporary laboratory space. We thank Edwin McCleskey and Thomas Wellems for critical reading of the manuscript. S. D. is a named inventor on a provisional patent application describing the PSAC antimalarial target identified in this article. B. T. is an employee and shareholder of National Instruments, Inc., which markets data analysis software used in this study. This research was supported by the Medicines for Malaria Venture (MMV) and the Intramural Research Program of the National Institutes of Health, National Institute of Allergy and Infectious Diseases, and the National Library of Medicine.	Alkhalil A, 2004, BLOOD, V104, P4279, DOI 10.1182/blood-2004-05-2047; Alkhalil A, 2007, CELL MICROBIOL, V9, P851, DOI 10.1111/j.1462-5822.2006.00834.x; Anantharaman V, 2007, INT REV CYTOL, V262, P1, DOI 10.1016/S0074-7696(07)62001-4; Balu B, 2005, P NATL ACAD SCI USA, V102, P16391, DOI 10.1073/pnas.0504679102; Balu B, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-83; Baumeister S, 2006, MOL MICROBIOL, V60, P493, DOI 10.1111/j.1365-2958.2006.05112.x; Boddey JA, 2010, NATURE, V463, P627, DOI 10.1038/nature08728; Bokhari A, 2008, J MEMBRANE BIOL, V226, P27, DOI 10.1007/s00232-008-9136-2; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Chen QJ, 1998, NATURE, V394, P392, DOI 10.1038/28660; Cohn JV, 2003, MOL BIOCHEM PARASIT, V132, P27, DOI 10.1016/j.molbiopara.2003.08.001; Cortes A, 2007, PLOS PATHOG, V3, P1023, DOI 10.1371/journal.ppat.0030107; CRAIG A, 2000, PARASITOL TODAY REGU, V16, P405; Craig AG, 2000, PARASITOL TODAY, V16, P366, DOI 10.1016/S0169-4758(00)01744-0; DAY KP, 1993, P NATL ACAD SCI USA, V90, P8292, DOI 10.1073/pnas.90.17.8292; Decherf G, 2004, BLOOD CELL MOL DIS, V32, P366, DOI 10.1016/j.bcmd.2004.01.008; Desai SA, 2000, NATURE, V406, P1001, DOI 10.1038/35023000; Duranton C, 2004, J GEN PHYSIOL, V123, P417, DOI 10.1085/jgp.200308919; Freitas-Junior LH, 2000, NATURE, V407, P1018, DOI 10.1038/35039531; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; GINSBURG H, 1985, MOL BIOCHEM PARASIT, V14, P313, DOI 10.1016/0166-6851(85)90059-3; Ginsburg H, 1988, Prog Clin Biol Res, V252, P317; Goel S, 2010, P NATL ACAD SCI USA, V107, P16643, DOI 10.1073/pnas.1002568107; Hill DA, 2007, P NATL ACAD SCI USA, V104, P1063, DOI 10.1073/pnas.0610353104; Holt DC, 1999, INT J PARASITOL, V29, P939, DOI 10.1016/S0020-7519(99)00046-6; HOMEWOOD CA, 1974, NATURE, V252, P718, DOI 10.1038/252718a0; Howitt CA, 2009, MOL MICROBIOL, V73, P1171, DOI 10.1111/j.1365-2958.2009.06846.x; Iriko H, 2008, MOL BIOCHEM PARASIT, V158, P11, DOI 10.1016/j.molbiopara.2007.11.004; Kaneko O, 2005, MOL BIOCHEM PARASIT, V143, P20, DOI 10.1016/j.molbiopara.2005.05.003; Kaneko O, 2001, MOL BIOCHEM PARASIT, V118, P223, DOI 10.1016/S0166-6851(01)00391-7; Kaneko O, 2007, PARASITOL INT, V56, P255, DOI 10.1016/j.parint.2007.05.003; KILEJIAN A, 1991, MOL BIOCHEM PARASIT, V44, P175, DOI 10.1016/0166-6851(91)90003-O; KIRK K, 1994, J BIOL CHEM, V269, P3339; Lavazec C, 2007, MOL MICROBIOL, V64, P1621, DOI 10.1111/j.1365-2958.2007.05767.x; Ling IT, 2004, MOL MICROBIOL, V52, P107, DOI 10.1111/j.1365-2958.2003.03969.x; Lisk G, 2005, EUKARYOT CELL, V4, P2153, DOI 10.1128/EC.4.12.2153-2159.2005; Lisk G, 2008, ANTIMICROB AGENTS CH, V52, P2346, DOI 10.1128/AAC.00057-08; Marti M, 2004, SCIENCE, V306, P1930, DOI 10.1126/science.1102452; Pillai AD, 2010, MOL PHARMACOL, V77, P724, DOI 10.1124/mol.109.062711; Richard D, 2010, J BIOL CHEM, V285, P14815, DOI 10.1074/jbc.M109.080770; Rungruang T, 2005, MOL BIOCHEM PARASIT, V140, P13, DOI 10.1016/j.molbiopara.2004.11.017; Russo I, 2010, NATURE, V463, P632, DOI 10.1038/nature08726; Saliba KJ, 1998, J BIOL CHEM, V273, P10190, DOI 10.1074/jbc.273.17.10190; Scherf A, 2008, ANNU REV MICROBIOL, V62, P445, DOI 10.1146/annurev.micro.61.080706.093134; SCHMIDT JA, 1982, J CLIN INVEST, V70, P379, DOI 10.1172/JCI110627; Spielmann T, 2010, TRENDS PARASITOL, V26, P6, DOI 10.1016/j.pt.2009.10.001; Staines HM, 2007, INT J PARASITOL, V37, P475, DOI 10.1016/j.ijpara.2006.12.013; Staines HM, 2000, BBA-BIOMEMBRANES, V1463, P88, DOI 10.1016/S0005-2736(99)00187-X; Trenholme KR, 2000, P NATL ACAD SCI USA, V97, P4029, DOI 10.1073/pnas.040561197; UPSTON JM, 1995, BBA-BIOMEMBRANES, V1236, P249, DOI 10.1016/0005-2736(95)00055-8; Verloo P, 2004, J BIOL CHEM, V279, P10316, DOI 10.1074/jbc.M311540200; Vincensini L, 2008, MOL BIOCHEM PARASIT, V160, P81, DOI 10.1016/j.molbiopara.2008.04.002; Wagner MA, 2003, BIOPHYS J, V84, P116, DOI 10.1016/S0006-3495(03)74836-X; WELLEMS TE, 1990, NATURE, V345, P253, DOI 10.1038/345253a0; WELLEMS TE, 1988, REV BRAS GENET, V11, P813	55	173	177	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 27	2011	145	5					665	677		10.1016/j.cell.2011.05.002	http://dx.doi.org/10.1016/j.cell.2011.05.002			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	769MR	21620134	Green Accepted, Bronze			2022-12-24	WOS:000291018600008
J	Zhang, ZH; Wippo, CJ; Wal, M; Ward, E; Korber, P; Pugh, BF				Zhang, Zhenhai; Wippo, Christian J.; Wal, Megha; Ward, Elissa; Korber, Philipp; Pugh, B. Franklin			A Packing Mechanism for Nucleosome Organization Reconstituted Across a Eukaryotic Genome	SCIENCE			English	Article							POSITIONS IN-VIVO; SACCHAROMYCES-CEREVISIAE; REMODELING FACTOR; DNA-SEQUENCE; PROMOTER; YEAST; TRANSCRIPTION; POLY(DA-DT); VITRO; ISWI	Near the 5' end of most eukaryotic genes, nucleosomes form highly regular arrays that begin at canonical distances from the transcriptional start site. Determinants of this and other aspects of genomic nucleosome organization have been ascribed to statistical positioning, intrinsically DNA-encoded positioning, or some aspect of transcription initiation. Here, we provide evidence for a different explanation. Biochemical reconstitution of proper nucleosome positioning, spacing, and occupancy levels was achieved across the 5' ends of most yeast genes by adenosine triphosphate-dependent trans-acting factors. These transcription-independent activities override DNA-intrinsic positioning and maintain uniform spacing at the 5' ends of genes even at low nucleosome densities. Thus, an active, nonstatistical nucleosome packing mechanism creates chromatin organizing centers at the 5' ends of genes where important regulatory elements reside.	[Wippo, Christian J.; Korber, Philipp] Univ Munich, Adolf Butenandt Inst, D-80336 Munich, Germany; [Zhang, Zhenhai; Wal, Megha; Ward, Elissa; Pugh, B. Franklin] Penn State Univ, Dept Biochem & Mol Biol, Ctr Eukaryot Gene Regulat, University Pk, PA 16802 USA	University of Munich; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Korber, P (corresponding author), Univ Munich, Adolf Butenandt Inst, D-80336 Munich, Germany.	pkorber@lmu.de; bfp2@psu.edu	Korber, Philipp/AAN-7633-2021; Zhang, Zhenhai/GRX-5887-2022; Wal, Megha/J-3607-2019	Korber, Philipp/0000-0001-7526-6549; Zhang, Zhenhai/0000-0002-4310-0525; 	National Institutes of Health [HG004160]; German Research Community [SFB/TR5]; European Community; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004160] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Research Community(German Research Foundation (DFG)); European Community(European Commission); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank the members of the Penn State Center for Eukaryotic Gene Regulation and of the Molecular Biology Unit of the Adolf-Butenandt-Institut for valuable discussion and support. We are grateful to D. Blaschke for technical assistance and to S. Holmberg for the gift of the S. cerevisiae library. This work was supported by grant HG004160 from the National Institutes of Health to B.F.P.; and by the German Research Community (SFB/TR5) and the Epigenome Network of Excellence in the Sixth Framework Programme of the European Community (NET grant), both to P.K. Sequencing data are available at ArrayExpress under accession number: SRA030538.1.	Albert I, 2007, NATURE, V446, P572, DOI 10.1038/nature05632; Anderson JD, 2001, MOL CELL BIOL, V21, P3830, DOI 10.1128/MCB.21.11.3830-3839.2001; Dion MF, 2007, SCIENCE, V315, P1405, DOI 10.1126/science.1134053; Flaus A, 2003, MOL CELL BIOL, V23, P7767, DOI 10.1128/MCB.23.21.7767-7779.2003; Hartley PD, 2009, CELL, V137, P445, DOI 10.1016/j.cell.2009.02.043; Hughes Amanda, 2009, J Biol, V8, P96, DOI 10.1186/jbiol207; Ito T, 1997, CELL, V90, P145, DOI 10.1016/S0092-8674(00)80321-9; IYER V, 1995, EMBO J, V14, P2570, DOI 10.1002/j.1460-2075.1995.tb07255.x; Kaplan N, 2009, NATURE, V458, P362, DOI 10.1038/nature07667; Korber P, 2004, J BIOL CHEM, V279, P35113, DOI 10.1074/jbc.M405446200; KORNBERG RD, 1988, NUCLEIC ACIDS RES, V16, P6677, DOI 10.1093/nar/16.14.6677; LeRoy G, 1998, SCIENCE, V282, P1900, DOI 10.1126/science.282.5395.1900; Luger K, 1999, METHOD ENZYMOL, V304, P3; Mavrich TN, 2008, GENOME RES, V18, P1073, DOI 10.1101/gr.078261.108; Mobius W, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000891; Raisner RM, 2005, CELL, V123, P233, DOI 10.1016/j.cell.2005.10.002; Rufiange A, 2007, MOL CELL, V27, P393, DOI 10.1016/j.molcel.2007.07.011; Schnitzler GR, 2008, CELL BIOCHEM BIOPHYS, V51, P67, DOI 10.1007/s12013-008-9015-6; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; Segal E, 2009, TRENDS GENET, V25, P335, DOI 10.1016/j.tig.2009.06.002; Stein A, 2010, NUCLEIC ACIDS RES, V38, P709, DOI 10.1093/nar/gkp1043; Tsukiyama T, 1999, GENE DEV, V13, P686, DOI 10.1101/gad.13.6.686; Vaillant C, 2010, GENOME RES, V20, P59, DOI 10.1101/gr.096644.109; VargaWeisz PD, 1997, NATURE, V388, P598, DOI 10.1038/41587; Weiner A, 2010, GENOME RES, V20, P90, DOI 10.1101/gr.098509.109; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178; Zhang Y, 2009, NAT STRUCT MOL BIOL, V16, P847, DOI 10.1038/nsmb.1636	27	230	231	1	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 20	2011	332	6032					977	980		10.1126/science.1200508	http://dx.doi.org/10.1126/science.1200508			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	766FO	21596991	Green Accepted			2022-12-24	WOS:000290766600047
J	Petersen, CP; Reddien, PW				Petersen, Christian P.; Reddien, Peter W.			Polarized notum Activation at Wounds Inhibits Wnt Function to Promote Planarian Head Regeneration	SCIENCE			English	Article							WINGLESS MORPHOGEN GRADIENT; REQUIREMENT; SHAPE	Regeneration requires initiation of programs tailored to the identity of missing parts. Head-versus-tail regeneration in planarians presents a paradigm for study of this phenomenon. After injury, Wnt signaling promotes tail regeneration. We report that wounding elicits expression of the Wnt inhibitor notum preferentially at anterior-facing wounds. This expression asymmetry occurs at essentially any wound, even if the anterior pole is intact. Inhibition of notum with RNA interference (RNAi) causes regeneration of an anterior-facing tail instead of a head, and double-RNAi experiments indicate that notum inhibits Wnt signaling to promote head regeneration. notum expression is itself controlled by Wnt signaling, suggesting that regulation of feedback inhibition controls the binary head-tail regeneration outcome. We conclude that local detection of wound orientation with respect to tissue axes results in distinct signaling environments that initiate appropriate regeneration responses.	[Petersen, Christian P.; Reddien, Peter W.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Reddien, Peter W.] MIT, Dept Biol, Cambridge, MA 02138 USA; [Reddien, Peter W.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute	Reddien, PW (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	reddien@wi.mit.edu	Petersen, Christian P./GZG-4541-2022	Petersen, Christian P./0000-0001-7552-6865; /0000-0002-5569-333X	NIH [R01GM080639]; ACS [RSG-07-180-01-DDC]; Keck Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080639] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ACS(American Cancer Society); Keck Foundation(W.M. Keck Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Reddien Lab for discussions and S. Lapan for hedgehog constructs. P. W. R. is a Howard Hughes Medical Institute early career scientist. We acknowledge support by NIH R01GM080639, ACS RSG-07-180-01-DDC, the Keck Foundation, and an American Cancer Society postdoctoral fellowship to C. P. P. C. P. P. and P. W. R. are inventors on a pending patent on the use of Notum inhibitors to enhance regeneration.	Adell T, 2009, DEVELOPMENT, V136, P905, DOI 10.1242/dev.033761; Brandman O, 2008, SCIENCE, V322, P390, DOI 10.1126/science.1160617; Gerlitz O, 2002, GENE DEV, V16, P1055, DOI 10.1101/gad.991802; Giraldez AJ, 2002, DEV CELL, V2, P667, DOI 10.1016/S1534-5807(02)00180-6; Goessling W, 2008, DEV BIOL, V320, P161, DOI 10.1016/j.ydbio.2008.05.526; Gurley KA, 2008, SCIENCE, V319, P323, DOI 10.1126/science.1150029; Gurley KA, 2010, DEV BIOL, V347, P24, DOI 10.1016/j.ydbio.2010.08.007; Han C, 2005, DEVELOPMENT, V132, P667, DOI 10.1242/dev.01636; Iglesias M, 2008, DEVELOPMENT, V135, P1215, DOI 10.1242/dev.020289; Kim JB, 2007, J BONE MINER RES, V22, P1913, DOI 10.1359/JBMR.070802; Kreuger J, 2004, DEV CELL, V7, P503, DOI 10.1016/j.devcel.2004.08.005; Lin G, 2008, DEV BIOL, V316, P323, DOI 10.1016/j.ydbio.2008.01.032; Morgan TH, 1898, ARCH ENTW MECH ORG, V7, P364; Parker DS, 2008, MOL CELL BIOL, V28, P1815, DOI 10.1128/MCB.01230-07; Petersen CP, 2008, SCIENCE, V319, P327, DOI 10.1126/science.1149943; Petersen CP, 2009, CELL, V139, P1056, DOI 10.1016/j.cell.2009.11.035; Petersen CP, 2009, P NATL ACAD SCI USA, V106, P17061, DOI 10.1073/pnas.0906823106; Reddien PW, 2004, ANNU REV CELL DEV BI, V20, P725, DOI 10.1146/annurev.cellbio.20.010403.095114; Rink JC, 2009, SCIENCE, V326, P1406, DOI 10.1126/science.1178712; Stoick-Cooper CL, 2007, DEVELOPMENT, V134, P479, DOI 10.1242/dev.001123; Torisu Y, 2008, CANCER SCI, V99, P1139, DOI 10.1111/j.1349-7006.2008.00814.x; TRAISTER A, 2007, BIOCHEM J; Yan D, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002493; Yazawa S, 2009, P NATL ACAD SCI USA, V106, P22329, DOI 10.1073/pnas.0907464106; Yokoyama H, 2007, DEV BIOL, V306, P170, DOI 10.1016/j.ydbio.2007.03.014	25	152	163	4	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 13	2011	332	6031					852	855		10.1126/science.1202143	http://dx.doi.org/10.1126/science.1202143			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763CD	21566195	Green Accepted, Green Submitted			2022-12-24	WOS:000290529900049
J	Wild, P; Farhan, H; McEwan, DG; Wagner, S; Rogov, VV; Brady, NR; Richter, B; Korac, J; Waidmann, O; Choudhary, C; Dotsch, V; Bumann, D; Dikic, I				Wild, Philipp; Farhan, Hesso; McEwan, David G.; Wagner, Sebastian; Rogov, Vladimir V.; Brady, Nathan R.; Richter, Benjamin; Korac, Jelena; Waidmann, Oliver; Choudhary, Chunaram; Doetsch, Volker; Bumann, Dirk; Dikic, Ivan			Phosphorylation of the Autophagy Receptor Optineurin Restricts Salmonella Growth	SCIENCE			English	Article							UBIQUITIN; TBK1; BINDING; DEGRADATION; P62/SQSTM1; INTEGRITY; BACTERIA; ADAPTER; NDP52	Selective autophagy can be mediated via receptor molecules that link specific cargoes to the autophagosomal membranes decorated by ubiquitin-like microtubule-associated protein light chain 3 (LC3) modifiers. Although several autophagy receptors have been identified, little is known about mechanisms controlling their functions in vivo. In this work, we found that phosphorylation of an autophagy receptor, optineurin, promoted selective autophagy of ubiquitin-coated cytosolic Salmonella enterica. The protein kinase TANK binding kinase 1 (TBK1) phosphorylated optineurin on serine-177, enhancing LC3 binding affinity and autophagic clearance of cytosolic Salmonella. Conversely, ubiquitin-or LC3-binding optineurin mutants and silencing of optineurin or TBK1 impaired Salmonella autophagy, resulting in increased intracellular bacterial proliferation. We propose that phosphorylation of autophagy receptors might be a general mechanism for regulation of cargo-selective autophagy.	[Wild, Philipp; McEwan, David G.; Richter, Benjamin; Waidmann, Oliver; Dikic, Ivan] Goethe Univ Frankfurt, Sch Med, Frankfurt Inst Mol Life Sci, D-60590 Frankfurt, Main, Germany; [Wild, Philipp; McEwan, David G.; Richter, Benjamin; Waidmann, Oliver; Dikic, Ivan] Goethe Univ Frankfurt, Sch Med, Inst Biochem 2, D-60590 Frankfurt, Main, Germany; [Farhan, Hesso; Bumann, Dirk] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland; [Wagner, Sebastian; Choudhary, Chunaram] Univ Copenhagen, Fac Hlth Sci, Ctr Prot Res, Novo Nordisk Fdn, DK-2200 Copenhagen, Denmark; [Rogov, Vladimir V.; Doetsch, Volker] Goethe Univ Frankfurt, Inst Biophys Chem, D-60439 Frankfurt, Main, Germany; [Rogov, Vladimir V.; Doetsch, Volker] Goethe Univ Frankfurt, Ctr Biomol Magnet Resonance, D-60439 Frankfurt, Main, Germany; [Rogov, Vladimir V.] Inst Prot Res, Pushchino 142290, Russia; [Brady, Nathan R.] German Canc Res Ctr, D-69120 Heidelberg, Germany; [Korac, Jelena; Dikic, Ivan] Univ Split, Sch Med, Dept Immunol & Med Genet, Split 21000, Croatia	Goethe University Frankfurt; Goethe University Frankfurt; University of Basel; Novo Nordisk Foundation; University of Copenhagen; Goethe University Frankfurt; Goethe University Frankfurt; Helmholtz Association; German Cancer Research Center (DKFZ); University of Split	Dikic, I (corresponding author), Goethe Univ Frankfurt, Sch Med, Frankfurt Inst Mol Life Sci, Theodor Stern Kai 7, D-60590 Frankfurt, Main, Germany.	ivan.dikic@biochem2.de	Wild, Philipp S./M-2106-2019; Choudhary, Chunaram/E-9819-2011; McEwan, David/AAY-6264-2020; Wagner, Sebastian/B-9056-2012; Dikic, Ivan/O-4650-2015; Prlic, Jelena Korac/I-7988-2012; Brady, Nathan/H-2452-2013; Farhan, Hesso/C-7997-2012; McEwan, David/A-3754-2015; Prlic, Jelena Korac/AAJ-1029-2021; choudhary, chunaram/ABE-6634-2020	Choudhary, Chunaram/0000-0002-9863-433X; Dikic, Ivan/0000-0001-8156-9511; Prlic, Jelena Korac/0000-0002-7840-9979; Farhan, Hesso/0000-0002-0889-8463; McEwan, David/0000-0003-0353-6532; Prlic, Jelena Korac/0000-0002-7840-9979; choudhary, chunaram/0000-0002-9863-433X; Brady, Nathan/0000-0002-1901-5996; Dotsch, Volker/0000-0001-5720-212X	Deutsche Forschungsgemeinschaft; Goethe University Frankfurt [EXC115]; Landes-Offensive zur Entwicklung Wissentschaftlich-okonomischer Exzellenz; European Research Council (ERC) under the European Union [250241-LineUb]; Swiss National Fonds [3100A0-121834/1]; Novo Nordisk Foundation; Split, Croatia, government; Danish Council for Independent Research [FSS: 10-085134]; Helmholtz Association; Swiss National Science Foundation [31003A-121834]; Novo Nordisk Foundation Center for Protein Research [PI Chunaram Choudhary] Funding Source: researchfish	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Goethe University Frankfurt; Landes-Offensive zur Entwicklung Wissentschaftlich-okonomischer Exzellenz; European Research Council (ERC) under the European Union(European Research Council (ERC)); Swiss National Fonds(Swiss National Science Foundation (SNSF)); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Split, Croatia, government; Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Helmholtz Association(Helmholtz Association); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Novo Nordisk Foundation Center for Protein Research	We thank P. Cohen, S. Mueller, K. Rajalingam, C. Behrends, and the members of Dikic laboratory for constructive comments and critical reading of the manuscript; P. Cohen for OPTN and TBK1 reagents; and V. Kirkin for the initial yeast two-hybrid screens. This work was supported by grants from Deutsche Forschungsgemeinschaft, the Cluster of Excellence "Macromolecular Complexes" of the Goethe University Frankfurt (EXC115), the Landes-Offensive zur Entwicklung Wissentschaftlich-okonomischer Exzellenz-funded Onkogene Signaltransduktion Frankfurt network, and the European Research Council (ERC) under the European Union's Seventh Framework Programme (FP7/2007-2013)/ERC grant agreement no. (250241-LineUb) to I. D. and partly by Swiss National Fonds (3100A0-121834/1) to D. B. The Center for Protein Research is funded by a generous grant from the Novo Nordisk Foundation. J.K. is supported by a scholarship from the Split, Croatia, government, S. W. by a postdoctoral fellowship from the Danish Council for Independent Research (FSS: 10-085134), N.R.B. by the Initiative and Networking Fund of the Helmholtz Association, and H. F. by Swiss National Science Foundation (31003A-121834).	Behrends C, 2010, NATURE, V466, P68, DOI 10.1038/nature09204; Beuzon CR, 2000, EMBO J, V19, P3235, DOI 10.1093/emboj/19.13.3235; Cemma M, 2011, AUTOPHAGY, V7, P341, DOI 10.4161/auto.7.3.14046; Cherra SJ, 2010, J CELL BIOL, V190, P533, DOI 10.1083/jcb.201002108; Clark K, 2009, J BIOL CHEM, V284, P14136, DOI 10.1074/jbc.M109.000414; Deretic V, 2010, CURR OPIN CELL BIOL, V22, P252, DOI 10.1016/j.ceb.2009.12.009; Ikeda F, 2010, CELL, V143, P677, DOI 10.1016/j.cell.2010.10.026; Jiang HB, 2010, BIOCHEM BIOPH RES CO, V395, P471, DOI 10.1016/j.bbrc.2010.04.030; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Kirkin V, 2009, MOL CELL, V33, P505, DOI 10.1016/j.molcel.2009.01.020; Knodler LA, 2010, P NATL ACAD SCI USA, V107, P17733, DOI 10.1073/pnas.1006098107; Kraft C, 2010, NAT CELL BIOL, V12, P836, DOI 10.1038/ncb0910-836; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; McEwan DG, 2011, TRENDS CELL BIOL, V21, P195, DOI 10.1016/j.tcb.2010.12.006; Morton S, 2008, FEBS LETT, V582, P997, DOI 10.1016/j.febslet.2008.02.047; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; Novak I, 2010, EMBO REP, V11, P45, DOI 10.1038/embor.2009.256; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Perrin AJ, 2004, CURR BIOL, V14, P806, DOI 10.1016/j.cub.2004.04.033; Radtke AL, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030029; Stehmeier P, 2009, MOL CELL, V33, P400, DOI 10.1016/j.molcel.2009.01.013; Thurston TLM, 2009, NAT IMMUNOL, V10, P1215, DOI 10.1038/ni.1800; Wagner S, 2008, ONCOGENE, V27, P3739, DOI 10.1038/sj.onc.1211042; Yang ZF, 2010, CURR OPIN CELL BIOL, V22, P124, DOI 10.1016/j.ceb.2009.11.014; Zheng YT, 2009, J IMMUNOL, V183, P5909, DOI 10.4049/jimmunol.0900441	25	913	942	6	137	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 8	2011	333	6039					228	233		10.1126/science.1205405	http://dx.doi.org/10.1126/science.1205405			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	789GG	21617041	Green Accepted			2022-12-24	WOS:000292502700052
J	Bejar, R; Stevenson, K; Abdel-Wahab, O; Galili, N; Nilsson, B; Garcia-Manero, G; Kantarjian, H; Raza, A; Levine, RL; Neuberg, D; Ebert, BL				Bejar, Rafael; Stevenson, Kristen; Abdel-Wahab, Omar; Galili, Naomi; Nilsson, Bjoern; Garcia-Manero, Guillermo; Kantarjian, Hagop; Raza, Azra; Levine, Ross L.; Neuberg, Donna; Ebert, Benjamin L.			Clinical Effect of Point Mutations in Myelodysplastic Syndromes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PROGNOSTIC SCORING SYSTEM; TP53 MUTATIONS; OF-FUNCTION; GENE; RISK; CBL; EPIDEMIOLOGY; LEUKEMIA; RUNX1; IDH1	BACKGROUND Myelodysplastic syndromes are clinically heterogeneous disorders characterized by clonal hematopoiesis, impaired differentiation, peripheral-blood cytopenias, and a risk of progression to acute myeloid leukemia. Somatic mutations may influence the clinical phenotype but are not included in current prognostic scoring systems. METHODS We used a combination of genomic approaches, including next-generation sequencing and mass spectrometry-based genotyping, to identify mutations in samples of bone marrow aspirate from 439 patients with myelodysplastic syndromes. We then examined whether the mutation status for each gene was associated with clinical variables, including specific cytopenias, the proportion of blasts, and overall survival. RESULTS We identified somatic mutations in 18 genes, including two, ETV6 and GNAS, that have not been reported to be mutated in patients with myelodysplastic syndromes. A total of 51% of all patients had at least one point mutation, including 52% of the patients with normal cytogenetics. Mutations in RUNX1, TP53, and NRAS were most strongly associated with severe thrombocytopenia (P < 0.001 for all comparisons) and an increased proportion of bone marrow blasts (P < 0.006 for all comparisons). In a multivariable Cox regression model, the presence of mutations in five genes retained independent prognostic significance: TP53 (hazard ratio for death from any cause, 2.48; 95% confidence interval [CI], 1.60 to 3.84), EZH2 (hazard ratio, 2.13; 95% CI, 1.36 to 3.33), ETV6 (hazard ratio, 2.04; 95% CI, 1.08 to 3.86), RUNX1 (hazard ratio, 1.47; 95% CI, 1.01 to 2.15), and ASXL1 (hazard ratio, 1.38; 95% CI, 1.00 to 1.89). CONCLUSIONS Somatic point mutations are common in myelodysplastic syndromes and are associated with specific clinical features. Mutations in TP53, EZH2, ETV6, RUNX1, and ASXL1 are predictors of poor overall survival in patients with myelodysplastic syndromes, independently of established risk factors. (Funded by the National Institutes of Health and others.)	[Bejar, Rafael; Nilsson, Bjoern; Ebert, Benjamin L.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Bejar, Rafael; Nilsson, Bjoern; Ebert, Benjamin L.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Bejar, Rafael; Ebert, Benjamin L.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Stevenson, Kristen; Neuberg, Donna] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Abdel-Wahab, Omar; Levine, Ross L.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10021 USA; [Abdel-Wahab, Omar; Levine, Ross L.] Mem Sloan Kettering Canc Ctr, Leukemia Serv, Dept Med, New York, NY 10021 USA; [Galili, Naomi; Raza, Azra] Columbia Univ, New York Presbyterian Hosp, Med Ctr, Dept Hematol, New York, NY USA; [Garcia-Manero, Guillermo; Kantarjian, Hagop] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Columbia University; NewYork-Presbyterian Hospital; University of Texas System; UTMD Anderson Cancer Center	Ebert, BL (corresponding author), Brigham & Womens Hosp, Karp Res Bldg,CHRB 05-211,1 Blackfan Cir, Boston, MA 02115 USA.	bebert@partners.org	levine, ross/AAE-7658-2019	Bejar, Rafael/0000-0002-5603-4598; Abdel-Wahab, Omar/0000-0002-3907-6171	National Institutes of Health (NIH) [5R01 HL082945, P01 CA108631, T32 HL007623]; Starr Cancer Consortium; Burroughs-Wellcome Fund; Huber-Foster Fellowship; NATIONAL CANCER INSTITUTE [P01CA108631] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082945, T32HL007623] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Starr Cancer Consortium; Burroughs-Wellcome Fund(Burroughs Wellcome Fund); Huber-Foster Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by grants from the National Institutes of Health (NIH) (5R01 HL082945 and P01 CA108631), the Starr Cancer Consortium, and the Burroughs-Wellcome Fund (Career Awards for Medical Scientists) (all to Dr. Ebert) and a grant from the NIH (T32 HL007623) and a Huber-Foster Fellowship (both to Dr. Bejar).	Badalian-Very G, 2010, BLOOD, V116, P1919, DOI 10.1182/blood-2010-04-279083; Bejar R, 2011, J CLIN ONCOL, V29, P504, DOI 10.1200/JCO.2010.31.1175; Chen CY, 2007, BRIT J HAEMATOL, V139, P405, DOI 10.1111/j.1365-2141.2007.06811.x; Ebert BL, 2008, NATURE, V451, P335, DOI 10.1038/nature06494; Ernst T, 2010, NAT GENET, V42, P722, DOI 10.1038/ng.621; Fisher CL, 2010, BLOOD, V115, P38, DOI 10.1182/blood-2009-07-230698; Garcia-Manero G, 2008, LEUKEMIA, V22, P538, DOI 10.1038/sj.leu.2405070; Grand FH, 2009, BLOOD, V113, P6182, DOI 10.1182/blood-2008-12-194548; Greenberg P, 1997, BLOOD, V89, P2079, DOI 10.1182/blood.V89.6.2079; Haase D, 2007, BLOOD, V110, P4385, DOI 10.1182/blood-2007-03-082404; Horiike S, 2003, LEUKEMIA LYMPHOMA, V44, P915, DOI 10.1080/1042819031000067620; Kalfa N, 2006, J UROLOGY, V176, P891, DOI 10.1016/j.juro.2006.04.023; Kan ZY, 2010, NATURE, V466, P869, DOI 10.1038/nature09208; KANEKO H, 1995, BLOOD, V85, P2189, DOI 10.1182/blood.V85.8.2189.bloodjournal8582189; Kita-Sasai Y, 2001, BRIT J HAEMATOL, V115, P309, DOI 10.1046/j.1365-2141.2001.03073.x; Ko M, 2010, NATURE, V468, P839, DOI 10.1038/nature09586; Kosmider O, 2010, LEUKEMIA, V24, P1094, DOI 10.1038/leu.2010.52; Kosmider O, 2009, BLOOD, V114, P3285, DOI 10.1182/blood-2009-04-215814; MacConaill LE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007887; Malcovati L, 2007, J CLIN ONCOL, V25, P3503, DOI 10.1200/JCO.2006.08.5696; Odero MD, 2002, GENE CHROMOSOME CANC, V35, P11, DOI 10.1002/gcc.10090; Padua RA, 1998, LEUKEMIA, V12, P887, DOI 10.1038/sj.leu.2401044; PAQUETTE RL, 1993, BLOOD, V82, P590, DOI 10.1182/blood.V82.2.590.bloodjournal822590; Pardanani A, 2010, LEUKEMIA, V24, P1370, DOI 10.1038/leu.2010.98; Pedersen-Bjergaard J, 2008, LEUKEMIA, V22, P240, DOI 10.1038/sj.leu.2405078; Rocquain J, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-401; Rollison DE, 2008, BLOOD, V112, P45, DOI 10.1182/blood-2008-01-134858; Sanada M, 2009, NATURE, V460, P904, DOI 10.1038/nature08240; Sekeres MA, 2010, HEMATOL ONCOL CLIN N, V24, P287, DOI 10.1016/j.hoc.2010.02.011; Sekeres MA, 2008, JNCI-J NATL CANCER I, V100, DOI 10.1093/jnci/djn349; Silva FPG, 2008, LEUKEMIA, V22, P1639, DOI 10.1038/leu.2008.34; Smith AE, 2010, BLOOD, V116, P3923, DOI 10.1182/blood-2010-03-274704; Steensma DP, 2005, EUR J HAEMATOL, V74, P47, DOI 10.1111/j.1600-0609.2004.00363.x; SUAREZ HG, 1991, ONCOGENE, V6, P677; Thomas RK, 2007, NAT GENET, V39, P347, DOI 10.1038/ng1975; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720	36	1130	1184	4	74	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 30	2011	364	26					2496	2506		10.1056/NEJMoa1013343	http://dx.doi.org/10.1056/NEJMoa1013343			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	785AM	21714648	Green Accepted			2022-12-24	WOS:000292199800005
J	Jain, A; Liu, RJ; Ramani, B; Arauz, E; Ishitsuka, Y; Ragunathan, K; Park, J; Chen, J; Xiang, YK; Ha, T				Jain, Ankur; Liu, Ruijie; Ramani, Biswarathan; Arauz, Edwin; Ishitsuka, Yuji; Ragunathan, Kaushik; Park, Jeehae; Chen, Jie; Xiang, Yang K.; Ha, Taekjip			Probing cellular protein complexes using single-molecule pull-down	NATURE			English	Article							RESONANCE ENERGY-TRANSFER; LIVING CELLS; ESCHERICHIA-COLI; GENE-EXPRESSION; LIVE CELLS; STOICHIOMETRY; MTOR; FRET; DNA; MICROSCOPY	Proteins perform most cellular functions in macromolecular complexes. The same protein often participates in different complexes to exhibit diverse functionality. Current ensemble approaches of identifying cellular protein interactions cannot reveal physiological permutations of these interactions. Here we describe a single-molecule pull-down (SiMPull) assay that combines the principles of a conventional pull-down assay with single-molecule fluorescence microscopy and enables direct visualization of individual cellular protein complexes. SiMPull can reveal how many proteins and of which kinds are present in the in vivo complex, as we show using protein kinase A. We then demonstrate a wide applicability to various signalling proteins found in the cytosol, membrane and cellular organelles, and to endogenous protein complexes from animal tissue extracts. The pulled-down proteins are functional and are used, without further processing, for single-molecule biochemical studies. SiMPull should provide a rapid, sensitive and robust platform for analysing protein assemblies in biological pathways.	[Jain, Ankur; Ragunathan, Kaushik; Park, Jeehae; Ha, Taekjip] Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL 61801 USA; [Jain, Ankur; Ragunathan, Kaushik; Park, Jeehae; Ha, Taekjip] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; [Liu, Ruijie; Ramani, Biswarathan; Xiang, Yang K.] Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL 61801 USA; [Arauz, Edwin; Chen, Jie] Univ Illinois, Dept Cell & Dev Biol, Urbana, IL 61801 USA; [Ishitsuka, Yuji; Ha, Taekjip] Univ Illinois, Dept Phys, Urbana, IL 61801 USA; [Ishitsuka, Yuji; Ha, Taekjip] Univ Illinois, Ctr Phys Living Cells, Urbana, IL 61801 USA; [Ishitsuka, Yuji; Ha, Taekjip] Howard Hughes Med Inst, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Howard Hughes Medical Institute	Ha, T (corresponding author), Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL 61801 USA.	kevinyx@illinois.edu; tjha@illinois.edu	Ishitsuka, Yuji/J-1921-2014; Diaz, Edwin Arauz/AAI-5457-2021; Ha, Taekjip/B-9506-2009	Ishitsuka, Yuji/0000-0002-6780-7154; Ha, Taekjip/0000-0003-2195-6258; Chen, Jie/0000-0002-7887-3747; liu, ruijie/0000-0002-2468-0579	NIH [AI083025, GM065367, HL082846, AR048914]; NSF [0646550, 0822613]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082846] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI083025] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR048914] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065367] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Myong, P. Jena, S. Arslan and R. Vafabakhsh for discussions. The expression vector encoding the YFP-MAVS gene was a gift from D. Lamarre. This work was funded by NIH grants (AI083025, GM065367 to T.H.; HL082846 to Y.K.X.; AR048914 to J.C.). Additional support was provided by NSF grants (0646550, 0822613 to T.H.). T.H. is an investigator with the Howard Hughes Medical Institute.	Alberts B, 1998, CELL, V92, P291, DOI 10.1016/S0092-8674(00)80922-8; Angers S, 2000, P NATL ACAD SCI USA, V97, P3684, DOI 10.1073/pnas.060590697; Baril M, 2009, J VIROL, V83, P1299, DOI 10.1128/JVI.01659-08; Barrios-Rodiles M, 2005, SCIENCE, V307, P1621, DOI 10.1126/science.1105776; Carriba P, 2008, NAT METHODS, V5, P727, DOI 10.1038/nmeth.1229; Chen I, 2005, CURR OPIN BIOTECH, V16, P35, DOI 10.1016/j.copbio.2004.12.003; COLLINS S, 1991, ANNU REV PHYSIOL, V53, P497, DOI 10.1146/annurev.physiol.53.1.497; Eyckerman S, 2001, NAT CELL BIOL, V3, P1114, DOI 10.1038/ncb1201-1114; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Gingras AC, 2007, NAT REV MOL CELL BIO, V8, P645, DOI 10.1038/nrm2208; Kerppola TK, 2008, ANNU REV BIOPHYS, V37, P465, DOI 10.1146/annurev.biophys.37.032807.125842; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Leake MC, 2008, P NATL ACAD SCI USA, V105, P15376, DOI 10.1073/pnas.0806338105; Leake MC, 2006, NATURE, V443, P355, DOI 10.1038/nature05135; Levene MJ, 2003, SCIENCE, V299, P682, DOI 10.1126/science.1079700; Lopez-Gimenez JF, 2007, MOL PHARMACOL, V71, P1015, DOI 10.1124/mol.106.033035; Maeder CI, 2007, NAT CELL BIOL, V9, P1319, DOI 10.1038/ncb1652; Mashanov GI, 2003, METHODS, V29, P142, DOI 10.1016/S1046-2023(02)00305-5; Mercier JF, 2002, J BIOL CHEM, V277, P44925, DOI 10.1074/jbc.M205767200; Myong S, 2005, NATURE, V437, P1321, DOI 10.1038/nature04049; Papin JA, 2005, NAT REV MOL CELL BIO, V6, P99, DOI 10.1038/nrm1570; Park J, 2010, CELL, V142, P544, DOI 10.1016/j.cell.2010.07.016; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Reyes-Lamothe R, 2010, SCIENCE, V328, P498, DOI 10.1126/science.1185757; Roy R, 2008, NAT METHODS, V5, P507, DOI 10.1038/NMETH.1208; Sabatini DM, 2006, NAT REV CANCER, V6, P729, DOI 10.1038/nrc1974; Schulte R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002061; Schwarzenbacher M, 2008, NAT METHODS, V5, P1053, DOI 10.1038/nmeth.1268; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Slaughter BD, 2007, P NATL ACAD SCI USA, V104, P20320, DOI 10.1073/pnas.0710336105; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308; Taylor SS, 2004, BBA-PROTEINS PROTEOM, V1697, P259, DOI 10.1016/j.bbapap.2003.11.029; Tunquist BJ, 2008, P NATL ACAD SCI USA, V105, P12557, DOI [10.1073/pnas.0805922105, 10.1073/pnas.0B05922105]; Ulbrich MH, 2008, P NATL ACAD SCI USA, V105, P14163, DOI 10.1073/pnas.0802075105; Ulbrich MH, 2007, NAT METHODS, V4, P319, DOI 10.1038/NMETH1024; Wallrabe H, 2005, CURR OPIN BIOTECH, V16, P19, DOI 10.1016/j.copbio.2004.12.002; Yamada T, 2009, NAT REV MOL CELL BIO, V10, P791, DOI 10.1038/nrm2787; Yip CK, 2010, MOL CELL, V38, P768, DOI 10.1016/j.molcel.2010.05.017; Yu J, 2006, SCIENCE, V311, P1600, DOI 10.1126/science.1119623; Yu Y, 2009, P NATL ACAD SCI USA, V106, P11558, DOI 10.1073/pnas.0903684106; Zamir E, 2010, NAT METHODS, V7, P295, DOI [10.1038/nmeth.1441, 10.1038/NMETH.1441]	42	283	286	0	174	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 26	2011	473	7348					484	U322		10.1038/nature10016	http://dx.doi.org/10.1038/nature10016			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	768QM	21614075	Green Accepted, Green Submitted			2022-12-24	WOS:000290951300034
J	Lowy, FD				Lowy, Franklin D.			How Staphylococcus aureus Adapts to Its Host	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Columbia Univ, Coll Phys & Surg, New York, NY 10027 USA	Columbia University	Lowy, FD (corresponding author), Columbia Univ, Coll Phys & Surg, New York, NY 10027 USA.							Diep BA, 2010, P NATL ACAD SCI USA, V107, P5587, DOI 10.1073/pnas.0912403107; Herron-Olson L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001120; Loffler B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000715; Lowder BV, 2009, P NATL ACAD SCI USA, V106, P19545, DOI 10.1073/pnas.0909285106; Pishchany G, 2010, CELL HOST MICROBE, V8, P544, DOI 10.1016/j.chom.2010.11.002	5	36	36	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 26	2011	364	21					1987	1990		10.1056/NEJMp1100251	http://dx.doi.org/10.1056/NEJMp1100251			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	768QR	21612466				2022-12-24	WOS:000290952000002
J	Chang, CH; Stukel, TA; Flood, AB; Goodman, DC				Chang, Chiang-Hua; Stukel, Therese A.; Flood, Ann Barry; Goodman, David C.			Primary Care Physician Workforce and Medicare Beneficiaries' Health Outcomes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							US PRIMARY-CARE; REGIONAL-VARIATIONS; MORTALITY; STATES; CHALLENGE; QUALITY; REFORM; RATES; LIFE	Context Despite a widespread interest in increasing the numbers of primary care physicians to improve care and to moderate costs, the relationship of the primary care physician workforce to patient-level outcomes remains poorly understood. Objective To measure the association between the adult primary care physician workforce and individual patient outcomes. Design, Setting, and Participants A cross-sectional analysis of the outcomes of a 2007 20% sample of fee-for-service Medicare beneficiaries aged 65 years or older (N=5 132 936), which used 2 measures of adult primary care physicians (general internists and family physicians) across Primary Care Service Areas (N=6542): (1) American Medical Association (AMA) Masterfile nonfederal, office-based physicians per total population and (2) office-based primary care clinical full-time equivalents (FTEs) per Medicare beneficiary derived from Medicare claims. Main Outcome Measures Annual individual-level outcomes (mortality, ambulatory care sensitive condition [ACSC] hospitalizations, and Medicare program spending), adjusted for individual patient characteristics and geographic area variables. Results Marked variation was observed in the primary care physician workforce across areas, but low correlation was observed between the 2 primary care workforce measures (Spearman r=0.056; P<.001). Compared with areas with the lowest quintile of primary care physician measure using AMA Masterfile counts, beneficiaries in the highest quintile had fewer ACSC hospitalizations (74.90 vs 79.61 per 1000 beneficiaries; relative rate [RR], 0.94; 95% confidence interval [CI], 0.93-0.95), lower mortality (5.38 vs 5.47 per 100 beneficiaries; RR, 0.98; 95% CI, 0.97-0.997), and no significant difference in total Medicare spending ($8722 vs $8765 per beneficiary; RR, 1.00; 95% CI, 0.99-1.00). Beneficiaries residing in areas with the highest quintile of primary care clinician FTEs compared with those in the lowest quintile had lower mortality (5.19 vs 5.49 per 100 beneficiaries; RR, 0.95; 95% CI, 0.93-0.96), fewer ACSC hospitalizations (72.53 vs 79.48 per 1000 beneficiaries; RR, 0.91; 95% CI, 0.90-0.92), and higher overall Medicare spending ($8857 vs $8769 per beneficiary; RR, 1.01; 95% CI, 1.004-1.02). Conclusion A higher level of primary care physician workforce, particularly with an FTE measure that may more accurately reflect ambulatory primary care, was generally associated with favorable patient outcomes. JAMA. 2011; 305(20): 2096-2105	[Chang, Chiang-Hua] Ctr Hlth Policy Res, Dartmouth Med Sch, Dartmouth Inst Hlth Policy & Clin Practice, Lebanon, NH 03766 USA; [Goodman, David C.] Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Dept Pediat, Hanover, NH 03756 USA; [Flood, Ann Barry] Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Dept Community & Family Med, Hanover, NH 03756 USA; [Stukel, Therese A.] Univ Toronto, Inst Clin Evaluat Sci, Toronto, ON, Canada; [Stukel, Therese A.] Univ Toronto, Dept Hlth Policy Management & Evaluat, Toronto, ON, Canada	Dartmouth College; Dartmouth College; Dartmouth College; University of Toronto; University of Toronto	Chang, CH (corresponding author), Ctr Hlth Policy Res, Dartmouth Med Sch, Dartmouth Inst Hlth Policy & Clin Practice, 35 Centerra Pkwy, Lebanon, NH 03766 USA.	chiang-hua.chang@dartmouth.edu	Goodman, David/AAG-7497-2020	Stukel, Therese/0000-0002-2951-1360	Texas Medical Association; Health Action Council, Cincinnati; Richard Stockton College of New Jersey; Iowa Health Business Alliance; Alliance for Academic Internal Medicine; American Medical Association; Connecticut Children's Hospital; Mt Sinai Hospital, New York; World Congress; Rutgers University; Baystate Medical Center; Brigham and Women's Hospital; ESRI Inc; Illinois Hospital Association; National Hospice Workgroup; National Association of Health Data Organizations; St. Peters University Hospital, New Brunswick, New Jersey; Massachusetts Hospital Association; Cooper Health System, Camden, New Jersey; Organizzato dal Laboratorio Management e Sanita Scuola Superiore Sant'Anna di Pisa; Kentucky Academy of Family Physicians; Southern Illinois University Health Policy Institute; Ohio University College of Osteopathic Medicine; Institute for Clinical Quality and Value; Marwood Group; American Society of Clinical Oncologists; OR Manager; Delta Health Alliance; SUNY Upstate University; Intermountain Healthcare; Vermont Department of Banking, Insurance, Securities and Health Care Administration; HealthDialog; Colorado Foundation for Medical Care; Seyferth Blumenthal and Harris; American Medical Forensic Specialists; Robert Wood Johnson Foundation; National Institute on Aging [P01 AG19783]; NATIONAL INSTITUTE ON AGING [P01AG019783] Funding Source: NIH RePORTER	Texas Medical Association; Health Action Council, Cincinnati; Richard Stockton College of New Jersey; Iowa Health Business Alliance; Alliance for Academic Internal Medicine; American Medical Association; Connecticut Children's Hospital; Mt Sinai Hospital, New York; World Congress; Rutgers University; Baystate Medical Center; Brigham and Women's Hospital; ESRI Inc; Illinois Hospital Association; National Hospice Workgroup; National Association of Health Data Organizations; St. Peters University Hospital, New Brunswick, New Jersey; Massachusetts Hospital Association; Cooper Health System, Camden, New Jersey; Organizzato dal Laboratorio Management e Sanita Scuola Superiore Sant'Anna di Pisa; Kentucky Academy of Family Physicians; Southern Illinois University Health Policy Institute; Ohio University College of Osteopathic Medicine; Institute for Clinical Quality and Value; Marwood Group; American Society of Clinical Oncologists; OR Manager; Delta Health Alliance; SUNY Upstate University; Intermountain Healthcare; Vermont Department of Banking, Insurance, Securities and Health Care Administration; HealthDialog; Colorado Foundation for Medical Care; Seyferth Blumenthal and Harris; American Medical Forensic Specialists; Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Goodman reported speaking fees from Texas Medical Association; Health Action Council, Cincinnati; Richard Stockton College of New Jersey; Iowa Health Business Alliance; Alliance for Academic Internal Medicine; American Medical Association; Connecticut Children's Hospital; Mt Sinai Hospital, New York; World Congress; Rutgers University; Baystate Medical Center; Brigham and Women's Hospital; ESRI Inc; Illinois Hospital Association; National Hospice Workgroup; National Association of Health Data Organizations; St. Peters University Hospital, New Brunswick, New Jersey; Massachusetts Hospital Association; Cooper Health System, Camden, New Jersey; Organizzato dal Laboratorio Management e Sanita Scuola Superiore Sant'Anna di Pisa; Kentucky Academy of Family Physicians; Southern Illinois University Health Policy Institute; Ohio University College of Osteopathic Medicine; Institute for Clinical Quality and Value; The Marwood Group; American Society of Clinical Oncologists; OR Manager; Delta Health Alliance; SUNY Upstate University; and Intermountain Healthcare; and consulting fees from Vermont Department of Banking, Insurance, Securities and Health Care Administration; HealthDialog; Colorado Foundation for Medical Care; Seyferth Blumenthal and Harris; and American Medical Forensic Specialists. Drs Chang, Stukel, and Flood reported no disclosures.; This research was supported in part by the Robert Wood Johnson Foundation and grant P01 AG19783 from the National Institute on Aging.	Billings J, 2003, USING ADM DATA MONIT; Bodenheimer T, 2010, HEALTH AFFAIR, V29, P799, DOI 10.1377/hlthaff.2010.0026; Center for the Evaluative Clinical Sciences at Dartmouth, 1996, QUAL MED CAR US REP; Chernew ME, 2009, HEALTH AFFAIR, V28, P1327, DOI 10.1377/hlthaff.28.5.1327; Collwill JM, 2008, HEALTH AFFAIR, V27, pW232, DOI 10.1377/hlthaff.27.3.w232; Council on Graduate Medical Education, 2010, 20 REP ADV PRIM CAR; Fisher ES, 2003, ANN INTERN MED, V138, P288, DOI 10.7326/0003-4819-138-4-200302180-00007; Fisher ES, 2003, ANN INTERN MED, V138, P273, DOI 10.7326/0003-4819-138-4-200302180-00006; Fisher ES, 2003, PERSPECT BIOL MED, V46, P69, DOI 10.1353/pbm.2003.0004; Franks P, 1999, HEALTH SERV RES, V34, P323; Goodman DC, 2006, HEALTH AFFAIR, V25, P521, DOI 10.1377/hlthaff.25.2.521; Goodman DC, 1996, JAMA-J AM MED ASSOC, V276, P1811, DOI 10.1001/jama.276.22.1811; Goodman DC, 2003, HEALTH SERV RES, V38, P287, DOI 10.1111/1475-6773.00116; Goodman DC., 2010, REGIONAL RACIAL VARI; Gottlieb DJ, 2010, HEALTH AFFAIR, V29, P537, DOI 10.1377/hlthaff.2009.0609; GRUMBACH K, 1995, AM J PUBLIC HEALTH, V85, P1402, DOI 10.2105/AJPH.85.10.1402; Guttmann A, 2010, PEDIATRICS, V125, P1119, DOI 10.1542/peds.2009-2821; Krakauer H, 1996, HEALTH SERV RES, V31, P191; Laditka JN, 2005, HEALTH SERV RES, V40, P1148, DOI 10.1111/j.1475-6773.2005.00403.x; Phillips RL, 2004, AM FAM PHYSICIAN, V70, P440; Ricketts TC, 2007, HEALTH SERV RES, V42, P2233, DOI 10.1111/j.1475-6773.2007.00728.x; Rittenhouse DR, 2009, NEW ENGL J MED, V361, P2301, DOI 10.1056/NEJMp0909327; Rittenhouse DR, 2009, JAMA-J AM MED ASSOC, V301, P2038, DOI 10.1001/jama.2009.691; Rosser WW, 2010, NEW ENGL J MED, V362, DOI 10.1056/NEJMp0911519; Salsberg E, 2008, JAMA-J AM MED ASSOC, V300, P1174, DOI 10.1001/jama.300.10.1174; Sandy LG, 2009, HEALTH AFFAIR, V28, P1136, DOI 10.1377/hlthaff.28.4.1136; Shi LY, 2005, SOC SCI MED, V61, P65, DOI 10.1016/j.socscimed.2004.11.056; Shi LY, 2003, J AM BOARD FAM PRACT, V16, P412, DOI 10.3122/jabfm.16.5.412; Starfield B, 2005, MILBANK Q, V83, P457, DOI 10.1111/j.1468-0009.2005.00409.x; Starfield B, 2005, HLTH AFF MILLWOOD S; Steinbrook R, 2009, NEW ENGL J MED, V360, P2696, DOI 10.1056/NEJMp0903460; Wennberg JE, 2004, BMJ-BRIT MED J, V328, P607, DOI 10.1136/bmj.328.7440.607; Wennberg JE, 2008, TRACKING CARE PATIEN	33	120	121	2	18	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 25	2011	305	20					2096	2105		10.1001/jama.2011.665	http://dx.doi.org/10.1001/jama.2011.665			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	768AC	21610242	Green Accepted, Bronze			2022-12-24	WOS:000290901700023
J	van de Kamp, T; Vagovic, P; Baumbach, T; Riedel, A				van de Kamp, Thomas; Vagovic, Patrik; Baumbach, Tilo; Riedel, Alexander			A Biological Screw in a Beetle's Leg	SCIENCE			English	Article									[van de Kamp, Thomas; Riedel, Alexander] State Museum Nat Hist SMNK, D-76133 Karlsruhe, Germany; [van de Kamp, Thomas; Vagovic, Patrik; Baumbach, Tilo] Karlsruhe Inst Technol, ANKA Inst Synchrotron Radiat, D-76344 Eggenstein Leopoldshafen, Germany; [van de Kamp, Thomas] Univ Dusseldorf, Inst Zool 2, D-40225 Dusseldorf, Germany	Helmholtz Association; Karlsruhe Institute of Technology; Heinrich Heine University Dusseldorf	Riedel, A (corresponding author), State Museum Nat Hist SMNK, D-76133 Karlsruhe, Germany.	riedel@smnk.de	Vagovic, Patrik/H-1193-2013; Baumbach, Tilo Gerd/K-5355-2013; van de Kamp, Thomas/G-1440-2016; Riedel, Alexander/V-2608-2019	van de Kamp, Thomas/0000-0001-7390-1318; Riedel, Alexander/0000-0002-8291-4425	German Research Foundation [RI 1817/3-1]	German Research Foundation(German Research Foundation (DFG))	We are grateful to F. Glaw encouraging us to prepare the initial manuscript, to S. Scharf for performing the segmentation of mu CT scans, and to D. Pelliccia for his assistance during the scans. M. Balke, O. Betz, and M. Spies kindly revised earlier drafts. The specimens examined are deposited at SMNK. The image data are stored at www. morphdbase. de?A_Riedel_20110523-M-4.1. This work was supported by grant RI 1817/3-1 from the German Research Foundation.	Betz O, 2007, J MICROSC-OXFORD, V227, P51, DOI 10.1111/j.1365-2818.2007.01785.x; Bogelsack G, 2000, THEOR BIOSCI, V119, P104, DOI 10.1078/1431-7613-00008; Chamorro-Lacayo ML, 2004, ZOOTAXA, P1; Frantsevich L, 2009, ARTHROPOD STRUCT DEV, V38, P16, DOI 10.1016/j.asd.2008.06.002; Larsen O., 1966, Opuscula Entomologica Suppl, V30, P1; Reuleaux F., 1900, LEHRBUCH KINEMATIK, V2, P723; Riedel A, 2010, ZOOL SCR, V39, P63, DOI 10.1111/j.1463-6409.2009.00404.x	7	39	40	2	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 1	2011	333	6038					52	52		10.1126/science.1204245	http://dx.doi.org/10.1126/science.1204245			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	785UF	21719669				2022-12-24	WOS:000292255400044
J	Lizak, C; Gerber, S; Numao, S; Aebi, M; Locher, KP				Lizak, Christian; Gerber, Sabina; Numao, Shin; Aebi, Markus; Locher, Kaspar P.			X-ray structure of a bacterial oligosaccharyltransferase	NATURE			English	Article							N-LINKED GLYCOSYLATION; HYDROXY AMINO-ACID; PROTEIN GLYCOSYLATION; COMPLEX; TRANSFERASE; GLYCOPROTEIN; PEPTIDE; SPECIFICITY; BIOLOGY; SYSTEM	Asparagine-linked glycosylation is a post-translational modification of proteins containing the conserved sequence motif Asn-X-Ser/Thr. The attachment of oligosaccharides is implicated in diverse processes such as protein folding and quality control, organism development or host-pathogen interactions. The reaction is catalysed by oligosaccharyltransferase (OST), a membrane protein complex located in the endoplasmic reticulum. The central, catalytic enzyme of OST is the STT3 subunit, which has homologues in bacteria and archaea. Here we report the X-ray structure of a bacterial OST, the PglB protein of Campylobacter lari, in complex with an acceptor peptide. The structure defines the fold of STT3 proteins and provides insight into glycosylation sequon recognition and amide nitrogen activation, both of which are prerequisites for the formation of the N-glycosidic linkage. We also identified and validated catalytically important, acidic amino acid residues. Our results provide the molecular basis for understanding the mechanism of N-linked glycosylation.	[Lizak, Christian; Gerber, Sabina; Locher, Kaspar P.] ETH, Dept Biol, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland; [Lizak, Christian; Numao, Shin; Aebi, Markus] ETH, Dept Biol, Inst Microbiol, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Locher, KP (corresponding author), ETH, Dept Biol, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland.	locher@mol.biol.ethz.ch		Numao, Shin/0000-0002-6204-7117	NCCR Structural Biology Zurich; Swiss National Science Foundation [SNF 31003A-127098/1, SNF 31003A-131075/1]	NCCR Structural Biology Zurich; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	We thank the beamline staff at the Swiss Light Source for assistance with data collection, S. Fleurkens and M. Bucher for technical assistance, and D. Arigoni for discussions. E. coli SCM6 was provided by C. Marolda and M. Valvano. C. L. was affiliated with the Life Science Zurich Graduate School. This research was supported by the NCCR Structural Biology Zurich (grant to K. P. L.) and Swiss National Science Foundation grants to M. A. (SNF 31003A-127098/1) and K. P. L. (SNF 31003A-131075/1).	Abu-Qarn M, 2006, MOL MICROBIOL, V61, P511, DOI 10.1111/j.1365-2958.2006.05252.x; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Apweiler R, 1999, BBA-GEN SUBJECTS, V1473, P4, DOI 10.1016/S0304-4165(99)00165-8; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BAUSE E, 1981, BIOCHEM J, V195, P639, DOI 10.1042/bj1950639; BAUSE E, 1984, BIOCHEM SOC T, V12, P514, DOI 10.1042/bst0120514; Breton C, 1999, CURR OPIN STRUC BIOL, V9, P563, DOI 10.1016/S0959-440X(99)00006-8; Breuer W, 2001, FEBS LETT, V501, P106, DOI 10.1016/S0014-5793(01)02641-2; Charnock SJ, 1999, BIOCHEMISTRY-US, V38, P6380, DOI 10.1021/bi990270y; Chen MM, 2007, BIOCHEMISTRY-US, V46, P5579, DOI 10.1021/bi602633n; Chen WJ, 2000, TERR ATMOS OCEAN SCI, V11, P765, DOI 10.3319/TAO.2000.11.4.765(A); CLELAND WW, 1994, SCIENCE, V264, P1887, DOI 10.1126/science.8009219; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Igura M, 2008, EMBO J, V27, P234, DOI 10.1038/sj.emboj.7601940; IMPERIALI B, 1995, P NATL ACAD SCI USA, V92, P97, DOI 10.1073/pnas.92.1.97; IMPERIALI B, 1992, J AM CHEM SOC, V114, P7942, DOI 10.1021/ja00046a068; Izquierdo L, 2009, EMBO J, V28, P2650, DOI 10.1038/emboj.2009.203; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kelleher DJ, 2006, GLYCOBIOLOGY, V16, p47R, DOI 10.1093/glycob/cwj066; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; Kowarik M, 2006, SCIENCE, V314, P1148, DOI 10.1126/science.1134351; Kowarik M, 2006, EMBO J, V25, P1957, DOI 10.1038/sj.emboj.7601087; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Lazarus MB, 2011, NATURE, V469, P564, DOI 10.1038/nature09638; Lefebre MD, 2002, APPL ENVIRON MICROB, V68, P5956, DOI 10.1128/AEM.68.12.5956-5964.2002; Li H, 2008, STRUCTURE, V16, P432, DOI 10.1016/j.str.2007.12.013; Li L, 2010, BIOCHEM BIOPH RES CO, V394, P1069, DOI 10.1016/j.bbrc.2010.03.126; Liu J, 2003, PROTEIN SCI, V12, P1418, DOI 10.1110/ps.0302103; Lizak C, 2011, BIOCONJUGATE CHEM, V22, P488, DOI 10.1021/bc100511k; Maeda Y, 2001, EMBO J, V20, P250, DOI 10.1093/emboj/20.1.250; Maita N, 2010, J BIOL CHEM, V285, P4941, DOI 10.1074/jbc.M109.081752; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MESCHER MF, 1976, J BIOL CHEM, V251, P2005; Nasab FP, 2008, MOL BIOL CELL, V19, P3758, DOI 10.1091/mbc.E08-05-0467; Petrescu AJ, 2004, GLYCOBIOLOGY, V14, P103, DOI 10.1093/glycob/cwh008; Ruiz-Canada C, 2009, CELL, V136, P272, DOI 10.1016/j.cell.2008.11.047; Schulz BL, 2009, P NATL ACAD SCI USA, V106, P11061, DOI 10.1073/pnas.0812515106; Schwarz F, 2011, GLYCOBIOLOGY, V21, P45, DOI 10.1093/glycob/cwq130; SHARMA C, 1981, EUR J BIOCHEM, V116, P101, DOI 10.1111/j.1432-1033.1981.tb05306.x; Silberstein S, 1996, FASEB J, V10, P849, DOI 10.1096/fasebj.10.8.8666161; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Szymanski CM, 2005, NAT REV MICROBIOL, V3, P225, DOI 10.1038/nrmicro1100; Szymanski CM, 1999, MOL MICROBIOL, V32, P1022, DOI 10.1046/j.1365-2958.1999.01415.x; Unligil UM, 2000, CURR OPIN STRUC BIOL, V10, P510, DOI 10.1016/S0959-440X(00)00124-X; Valliere-Douglass JF, 2009, J BIOL CHEM, V284, P32493, DOI 10.1074/jbc.M109.014803; VARKI A, 1993, GLYCOBIOLOGY, V3, P97, DOI 10.1093/glycob/3.2.97; Wacker M, 2002, SCIENCE, V298, P1790, DOI 10.1126/science.298.5599.1790; Whitley P, 1996, J BIOL CHEM, V271, P6241, DOI 10.1074/jbc.271.11.6241; WIBERG KB, 1992, J AM CHEM SOC, V114, P831, DOI 10.1021/ja00029a005; Wilson CM, 2007, J CELL SCI, V120, P648, DOI 10.1242/jcs.000729; Zielinska DF, 2010, CELL, V141, P897, DOI 10.1016/j.cell.2010.04.012; ZUFFEREY R, 1995, EMBO J, V14, P4949, DOI 10.1002/j.1460-2075.1995.tb00178.x	53	266	276	2	81	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 16	2011	474	7351					350	U377		10.1038/nature10151	http://dx.doi.org/10.1038/nature10151			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777TD	21677752				2022-12-24	WOS:000291647100039
J	Bonadona, V; Bonaiti, B; Olschwang, S; Grandjouan, S; Huiart, L; Longy, M; Guimbaud, R; Buecher, B; Bignon, YJ; Caron, O; Colas, C; Nogues, C; Lejeune-Dumoulin, S; Olivier-Faivre, L; Polycarpe-Osaer, F; Nguyen, TD; Desseigne, F; Saurin, JC; Berthet, P; Leroux, D; Duffour, J; Manouvrier, S; Frebourg, T; Sobol, H; Lasset, C; Bonaiti-Pellie, C				Bonadona, Valerie; Bonaiti, Bernard; Olschwang, Sylviane; Grandjouan, Sophie; Huiart, Laetitia; Longy, Michel; Guimbaud, Rosine; Buecher, Bruno; Bignon, Yves-Jean; Caron, Olivier; Colas, Chrystelle; Nogues, Catherine; Lejeune-Dumoulin, Sophie; Olivier-Faivre, Laurence; Polycarpe-Osaer, Florence; Nguyen, Tan Dat; Desseigne, Francoise; Saurin, Jean-Christophe; Berthet, Pascaline; Leroux, Dominique; Duffour, Jacqueline; Manouvrier, Sylvie; Frebourg, Thierry; Sobol, Hagay; Lasset, Christine; Bonaiti-Pellie, Catherine		French Canc Genetics Network	Cancer Risks Associated With Germline Mutations in MLH1, MSH2, and MSH6 Genes in Lynch Syndrome	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NONPOLYPOSIS COLORECTAL-CANCER; CUMULATIVE LIFETIME INCIDENCE; AGE-OF-ONSET; ESTIMATING PENETRANCE; ENDOMETRIAL CANCER; PROVEN MUTATIONS; 121 FAMILIES; GRL METHOD; CARRIERS; HNPCC	Context Providing accurate estimates of cancer risks is a major challenge in the clinical management of Lynch syndrome. Objective To estimate the age-specific cumulative risks of developing various tumors using a large series of families with mutations of the MLH1, MSH2, and MSH6 genes. Design, Setting, and Participants Families with Lynch syndrome enrolled between January 1, 2006, and December 31, 2009, from 40 French cancer genetics clinics participating in the ERISCAM (Estimation des Risques de Cancer chez les porteurs de mutation des genes MMR) study; 537 families with segregating mutated genes (248 with MLH1; 256 with MSH2; and 33 with MSH6) were analyzed. Main Outcome Measure Age-specific cumulative cancer risks estimated using the genotype restricted likelihood (GRL) method accounting for ascertainment bias. Results Significant differences in estimated cumulative cancer risk were found between the 3 mutated genes (P=.01). The estimated cumulative risks of colorectal cancer by age 70 years were 41% (95% confidence intervals [CI], 25%-70%) for MLH1 mutation carriers, 48% (95% CI, 30%-77%) for MSH2, and 12% (95% CI, 8%-22%) for MSH6. For endometrial cancer, corresponding risks were 54% (95% CI, 20%-80%), 21% (95% CI, 8%-77%), and 16% (95% CI, 8%-32%). For ovarian cancer, they were 20% (95% CI, 1%-65%), 24% (95% CI, 3%-52%), and 1% (95% CI, 0%-3%). The estimated cumulative risks by age 40 years did not exceed 2% (95% CI, 0%-7%) for endometrial cancer nor 1% (95% CI, 0%-3%) for ovarian cancer, irrespective of the gene. The estimated lifetime risks for other tumor types did not exceed 3% with any of the gene mutations. Conclusions MSH6 mutations are associated with markedly lower cancer risks than MLH1 or MSH2 mutations. Lifetime ovarian and endometrial cancer risks associated with MLH1 or MSH2 mutations were high but do not increase appreciably until after the age of 40 years. JAMA. 2011;305(22):2304-2310 www.jama.com	[Lasset, Christine] Ctr Leon Berard, Prevent & Genet Epidemiol Unit, F-69373 Lyon 08, France; [Bonadona, Valerie; Lasset, Christine] Univ Lyon 1, CNRS, UMR 5558, F-69622 Villeurbanne, France; [Bonaiti, Bernard; Bonaiti-Pellie, Catherine] INSERM, U669, Villejuif, France; [Bonaiti, Bernard] INRA, GABI, Jouy En Josas, France; [Olschwang, Sylviane; Huiart, Laetitia; Sobol, Hagay] Inst J Paoli I Calmettes, F-13009 Marseille, France; [Olschwang, Sylviane; Sobol, Hagay] INSERM, U891, F-13258 Marseille, France; [Grandjouan, Sophie] APHP, Paris, France; [Huiart, Laetitia] INSERM, UMR 912, F-13258 Marseille, France; [Longy, Michel] Inst Bergonie, Bordeaux, France; [Guimbaud, Rosine] Inst Claudius Regaud, Toulouse, France; [Guimbaud, Rosine] Ctr Hosp Univ, Toulouse, France; [Buecher, Bruno] CHU Nantes, F-44035 Nantes 01, France; [Bignon, Yves-Jean] Ctr Jean Perrin, Clermont Ferrand, France; [Caron, Olivier] Inst Gustave Roussy, Villejuif, France; [Colas, Chrystelle] Grp Hosp Pitie Salpetriere, APHP, INSERM, UMRS 938, F-75634 Paris, France; [Colas, Chrystelle] Univ Paris 06, Paris, France; [Nogues, Catherine] Hop Rene Huguenin, Inst Curie, St Cloud, France; [Lejeune-Dumoulin, Sophie; Manouvrier, Sylvie] CHRU, Lille, France; [Lejeune-Dumoulin, Sophie; Manouvrier, Sylvie] Univ Lille 2, Lille, France; [Olivier-Faivre, Laurence] Hop Enfants, Dijon, France; [Polycarpe-Osaer, Florence] Ctr Paul Strauss, Strasbourg, France; [Nguyen, Tan Dat] Inst Jean Godinot, Reims, France; [Saurin, Jean-Christophe] Hop Edouard Herriot, Lyon, France; [Berthet, Pascaline] Ctr Francois Baclesse, F-14021 Caen, France; [Leroux, Dominique] CHU Grenoble, F-38043 Grenoble, France; [Duffour, Jacqueline] Ctr Val Aurelle, Montpellier, France; [Frebourg, Thierry] INSERM, U614, Rouen, France; [Frebourg, Thierry] CHU, Rouen, France; [Sobol, Hagay] Univ Mediterranee, Marseille, France; [Bonaiti-Pellie, Catherine] Univ Paris Sud, Villejuif, France	UNICANCER; Centre Leon Berard; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; VetAgro Sup; Institut National de la Sante et de la Recherche Medicale (Inserm); AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Institut Paoli-Calmette (IPC); Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); UNICANCER; Institut Bergonie; UNICANCER; Institut Claudius Regaud; CHU de Toulouse; Nantes Universite; CHU de Nantes; UNICANCER; Centre Jean Perrin; UNICANCER; Gustave Roussy; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Rene Huguenin Hospital; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Universite de Lille - ISITE; CHU Lille; Universite de Lille - ISITE; Universite de Lille; CHU Dijon Bourgogne; UNICANCER; Centre Paul Strauss; UNICANCER; Institut Jean Godinot; CHU Lyon; UNICANCER; Centre Francois Baclesse; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); UNICANCER; Universite de Montpellier; Institut Regional du Cancer Montpellier / Val d'Aurelle (ICM); Institut National de la Sante et de la Recherche Medicale (Inserm); CHU de Rouen; UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Universite Paris Saclay	Lasset, C (corresponding author), Ctr Leon Berard, Prevent & Genet Epidemiol Unit, 28 Rue Laennec, F-69373 Lyon 08, France.	lasset@lyon.fnclcc.fr	, bignon/Y-3243-2019; Huiart, Laetitia/GQB-4064-2022; Olschwang, Sylviane/G-2716-2013; Laurent-Puig, Pierre/K-3641-2019; saurin, jean christophe/AAB-4077-2020; Frebourg, Thierry/AAK-8390-2020; Colas, Chrystelle/ABA-3212-2020; laurent-puig, pierre/B-2226-2013; GUIMBAUD, Rosine/M-7503-2014; Leroux, Dominique/G-7309-2014	Olschwang, Sylviane/0000-0001-7078-3029; Laurent-Puig, Pierre/0000-0001-8475-5459; laurent-puig, pierre/0000-0001-8475-5459; Faivre, Laurence/0000-0001-9770-444X; Frebourg, Thierry/0000-0003-0399-4007; BAERT-DESURMONT, Stephanie/0000-0002-1172-4157; Bonneau, Dominique/0000-0002-6886-0969	Fondation de France	Fondation de France(Fondation de France)	This work was supported by the Fondation de France.	Aarnio M, 1999, INT J CANCER, V81, P214, DOI 10.1002/(SICI)1097-0215(19990412)81:2<214::AID-IJC8>3.3.CO;2-C; Alarcon F, 2007, EUR J HUM GENET, V15, P831, DOI 10.1038/sj.ejhg.5201843; Baglietto L, 2010, JNCI-J NATL CANCER I, V102, P193, DOI 10.1093/jnci/djp473; Barrow E, 2008, CLIN GENET, V74, P233, DOI 10.1111/j.1399-0004.2008.01035.x; Barrow E, 2009, CLIN GENET, V75, P141, DOI 10.1111/j.1399-0004.2008.01125.x; Belot A, 2008, REV EPIDEMIOL SANTE, V56, P159, DOI 10.1016/j.respe.2008.03.117; Bonaiti B, 2011, EUR J HUM GENET, V19, P173, DOI 10.1038/ejhg.2010.158; Capelle LG, 2010, GASTROENTEROLOGY, V138, P487, DOI 10.1053/j.gastro.2009.10.051; Carayol J, 2004, GENET EPIDEMIOL, V27, P109, DOI 10.1002/gepi.20007; Carayol J, 2002, J MED GENET, V39, P335, DOI 10.1136/jmg.39.5.335; Chen SN, 2007, J CLIN ONCOL, V25, P1329, DOI 10.1200/JCO.2006.09.1066; Choi YH, 2009, HERED CANCER CLIN PR, V7, DOI 10.1186/1897-4287-7-14; DEVATHAIRE F, 1996, ESTIMATION INCIDENCE; Dunlop MG, 1997, HUM MOL GENET, V6, P105, DOI 10.1093/hmg/6.1.105; Green J, 2002, DIS COLON RECTUM, V45, P1223, DOI 10.1007/s10350-004-6397-4; Hampel H, 2005, GASTROENTEROLOGY, V129, P415, DOI 10.1053/j.gastro.2005.05.011; Hendriks YMC, 2004, GASTROENTEROLOGY, V127, P17, DOI 10.1053/j.gastro.2004.03.068; Jarvinen HJ, 2000, GASTROENTEROLOGY, V118, P829, DOI 10.1016/S0016-5085(00)70168-5; Jenkins MA, 2006, CLIN GASTROENTEROL H, V4, P489, DOI 10.1016/j.cgh.2006.01.002; Kastrinos F, 2009, JAMA-J AM MED ASSOC, V302, P1790, DOI 10.1001/jama.2009.1529; Kauff ND, 2007, J CLIN ONCOL, V25, P2921, DOI 10.1200/JCO.2007.11.3449; Lindor NM, 2006, JAMA-J AM MED ASSOC, V296, P1507, DOI 10.1001/jama.296.12.1507; Lynch HT, 2003, NEW ENGL J MED, V348, P919, DOI 10.1056/NEJMra012242; Offit K, 2006, NEW ENGL J MED, V354, P293, DOI 10.1056/NEJMe058284; Olschwang S, 2004, B CANCER, V91, P303; Plaschke J, 2004, J CLIN ONCOL, V22, P4486, DOI 10.1200/JCO.2004.02.033; Quehenberger F, 2005, J MED GENET, V42, P491, DOI 10.1136/jmg.2004.024299; RodriguezBigas MA, 1997, J NATL CANCER I, V89, P1758, DOI 10.1093/jnci/89.23.1758; Schmeler KM, 2006, NEW ENGL J MED, V354, P261, DOI 10.1056/NEJMoa052627; Stoffel E, 2009, GASTROENTEROLOGY, V137, P1621, DOI 10.1053/j.gastro.2009.07.039; Terdiman JP, 2001, GASTROENTEROLOGY, V120, P21, DOI 10.1053/gast.2001.20874; Vasen HFA, 2007, J MED GENET, V44, P353, DOI 10.1136/jmg.2007.048991; Vasen HFA, 2010, FAM CANCER, V9, P109, DOI 10.1007/s10689-009-9291-3; Vasen HFA, 1999, GASTROENTEROLOGY, V116, P1453, DOI 10.1016/S0016-5085(99)70510-X; Vasen HFA, 2001, J CLIN ONCOL, V19, P4074, DOI 10.1200/JCO.2001.19.20.4074; Watson P, 2008, INT J CANCER, V123, P444, DOI 10.1002/ijc.23508	36	655	686	3	51	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 8	2011	305	22					2304	2310		10.1001/jama.2011.743	http://dx.doi.org/10.1001/jama.2011.743			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	773YV	21642682				2022-12-24	WOS:000291349100023
J	Watanabe, T; Tomizawa, S; Mitsuya, K; Totoki, Y; Yamamoto, Y; Kuramochi-Miyagawa, S; Iida, N; Hoki, Y; Murphy, PJ; Toyoda, A; Gotoh, K; Hiura, H; Arima, T; Fujiyama, A; Sado, T; Shibata, T; Nakano, T; Lin, HF; Ichiyanagi, K; Soloway, PD; Sasaki, H				Watanabe, Toshiaki; Tomizawa, Shin-ichi; Mitsuya, Kohzoh; Totoki, Yasushi; Yamamoto, Yasuhiro; Kuramochi-Miyagawa, Satomi; Iida, Naoko; Hoki, Yuko; Murphy, Patrick J.; Toyoda, Atsushi; Gotoh, Kengo; Hiura, Hitoshi; Arima, Takahiro; Fujiyama, Asao; Sado, Takashi; Shibata, Tatsuhiro; Nakano, Toru; Lin, Haifan; Ichiyanagi, Kenji; Soloway, Paul D.; Sasaki, Hiroyuki			Role for piRNAs and Noncoding RNA in de Novo DNA Methylation of the Imprinted Mouse Rasgrf1 Locus	SCIENCE			English	Article							GERM-CELL DEVELOPMENT; MAMMALIAN DEVELOPMENT; DROSOPHILA; TRANSCRIPTION; FAMILY; GENES; PIWI; MILI	Genomic imprinting causes parental origin-specific monoallelic gene expression through differential DNA methylation established in the parental germ line. However, the mechanisms underlying how specific sequences are selectively methylated are not fully understood. We have found that the components of the PIWI-interacting RNA (piRNA) pathway are required for de novo methylation of the differentially methylated region (DMR) of the imprinted mouse Rasgrf1 locus, but not other paternally imprinted loci. A retrotransposon sequence within a noncoding RNA spanning the DMR was targeted by piRNAs generated from a different locus. A direct repeat in the DMR, which is required for the methylation and imprinting of Rasgrf1, served as a promoter for this RNA. We propose a model in which piRNAs and a target RNA direct the sequence-specific methylation of Rasgrf1.	[Watanabe, Toshiaki; Tomizawa, Shin-ichi; Yamamoto, Yasuhiro; Iida, Naoko; Hoki, Yuko; Sado, Takashi; Ichiyanagi, Kenji; Sasaki, Hiroyuki] Res Org Informat & Syst, Natl Inst Genet, Div Human Genet, Mishima, Shizuoka 4118540, Japan; [Watanabe, Toshiaki; Tomizawa, Shin-ichi; Yamamoto, Yasuhiro; Iida, Naoko; Hoki, Yuko; Sado, Takashi; Ichiyanagi, Kenji; Sasaki, Hiroyuki] Res Org Informat & Syst, Natl Inst Genet, Dept Integrated Genet, Mishima, Shizuoka 4118540, Japan; [Watanabe, Toshiaki; Lin, Haifan] Yale Univ, Sch Med, New Haven, CT 06520 USA; [Tomizawa, Shin-ichi] Babraham Inst, Lab Dev Genet & Imprinting, Cambridge CB22 3AT, England; [Mitsuya, Kohzoh] Univ Texas Hlth Sci Ctr San Antonio, Dept Obstet & Gynecol, Ctr Pregnancy & Newborn Res, San Antonio, TX 78229 USA; [Totoki, Yasushi; Shibata, Tatsuhiro] Natl Canc Ctr, Res Inst, Div Canc Genom, Chuo Ku, Tokyo 1040045, Japan; [Yamamoto, Yasuhiro; Hoki, Yuko; Sado, Takashi; Ichiyanagi, Kenji; Sasaki, Hiroyuki] Kyushu Univ, Med Inst Bioregulat, Div Epigenom, Higashi Ku, Fukuoka 8128582, Japan; [Kuramochi-Miyagawa, Satomi; Gotoh, Kengo; Nakano, Toru] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan; [Iida, Naoko] Res Org Informat & Syst, Natl Inst Genet, Dept Mol Genet, Div Mutagenesis, Mishima, Shizuoka 4118540, Japan; [Murphy, Patrick J.; Soloway, Paul D.] Cornell Univ, Coll Agr & Life Sci, Div Nutr Sci, Ithaca, NY 14853 USA; [Toyoda, Atsushi; Fujiyama, Asao] Res Org Informat & Syst, Natl Inst Genet, Ctr Genet Resource Informat, Comparat Genom Lab, Mishima, Shizuoka 4118540, Japan; [Hiura, Hitoshi; Arima, Takahiro] Tohoku Univ, Grad Sch Med, Environm & Genome Res Ctr, Dept Informat Genet,Aoba Ku, Sendai, Miyagi 9808575, Japan; [Fujiyama, Asao] Natl Inst Informat, Principle Informat Res Div, Chiyoda Ku, Tokyo 1018430, Japan	Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Yale University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; University of Texas System; University of Texas Health San Antonio; National Cancer Center - Japan; Kyushu University; Osaka University; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Cornell University; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Tohoku University; Research Organization of Information & Systems (ROIS); National Institute of Informatics (NII) - Japan	Watanabe, T (corresponding author), Res Org Informat & Syst, Natl Inst Genet, Div Human Genet, Mishima, Shizuoka 4118540, Japan.	toshwatatoshiakiwatanabe@gmail.com; hsasaki@bioreg.kyushu-u.ac.jp	Mitsuya, Kohzoh/F-4437-2010; Ichiyanagi, Kenji/J-2141-2015; Shibata, Tatsuhiro/ABA-8234-2020; Sado, Takashi/AAI-1689-2019; Shibata, Tatsuhiro/AAO-1278-2021; Tomizawa, Shinichi/AAT-7149-2020; Soloway, Paul/T-8243-2019	Tomizawa, Shinichi/0000-0002-8291-6623; Ichiyanagi, Kenji/0000-0002-6831-6525; Sado, Takashi/0000-0002-1232-0250; Mitsuya, Kohzoh/0000-0002-0950-5406; Soloway, Paul/0000-0003-1967-0437	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Grants-in-Aid for Scientific Research [23659768, 23013003, 23390385, 19061001] Funding Source: KAKEN; NATIONAL CANCER INSTITUTE [R01CA098597] Funding Source: NIH RePORTER	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank M. Kaneda, S. Chuma, V. Shteyn, and J. Peng for comments on the manuscript and H. Horiike, H. Furuumi, T. Ichiyanagi, Y. Amakawa, H. Chiba, and Y. Li for sample preparation. The accession number for the small RNA sequences is GSE20327. This work was supported in part by Grants-in-Aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan to H. S. and K.M.	Aravin AA, 2008, MOL CELL, V31, P785, DOI 10.1016/j.molcel.2008.09.003; Aravin AA, 2007, SCIENCE, V316, P744, DOI 10.1126/science.1142612; Bartolomei MS, 2009, GENE DEV, V23, P2124, DOI 10.1101/gad.1841409; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Buhler M, 2006, CELL, V125, P873, DOI 10.1016/j.cell.2006.04.025; Carmell MA, 2007, DEV CELL, V12, P503, DOI 10.1016/j.devcel.2007.03.001; Chotalia M, 2009, GENE DEV, V23, P105, DOI 10.1101/gad.495809; de la Puente A, 2002, GENE, V291, P287, DOI 10.1016/S0378-1119(02)00601-7; Drake NM, 2009, MAMM GENOME, V20, P654, DOI 10.1007/s00335-009-9192-7; Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494; Hirasawa R, 2008, GENE DEV, V22, P1607, DOI 10.1101/gad.1667008; Irvine DV, 2006, SCIENCE, V313, P1134, DOI 10.1126/science.1128813; Kato Y, 2007, HUM MOL GENET, V16, P2272, DOI 10.1093/hmg/ddm179; Koerner MV, 2009, DEVELOPMENT, V136, P1771, DOI 10.1242/dev.030403; Kuramochi-Miyagawa S, 2008, GENE DEV, V22, P908, DOI 10.1101/gad.1640708; Lindroth AM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000145; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; Malone CD, 2009, CELL, V137, P522, DOI 10.1016/j.cell.2009.03.040; MOORE T, 1991, TRENDS GENET, V7, P45, DOI 10.1016/0168-9525(91)90230-N; Pane A, 2007, DEV CELL, V12, P851, DOI 10.1016/j.devcel.2007.03.022; Pearsall RS, 1999, GENOMICS, V55, P194, DOI 10.1006/geno.1998.5660; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Saito K, 2009, NATURE, V461, P1296, DOI 10.1038/nature08501; Sasaki H, 2008, NAT REV GENET, V9, P129, DOI 10.1038/nrg2295; Schaefer CB, 2007, SCIENCE, V316, P398, DOI 10.1126/science.1137544; Tomizawa S, 2011, DEVELOPMENT, V138, P811, DOI 10.1242/dev.061416; Watanabe T, 2011, DEV CELL, V20, P364, DOI 10.1016/j.devcel.2011.01.005; Wierzbicki AT, 2009, NAT GENET, V41, P630, DOI 10.1038/ng.365; Yoon BJ, 2002, NAT GENET, V30, P92, DOI 10.1038/ng795	29	281	294	0	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 13	2011	332	6031					848	852		10.1126/science.1203919	http://dx.doi.org/10.1126/science.1203919			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763CD	21566194	Green Accepted			2022-12-24	WOS:000290529900048
J	Klinakis, A; Lobry, C; Abdel-Wahab, O; Oh, P; Haeno, H; Buonamici, S; van De Walle, I; Cathelin, S; Trimarchi, T; Araldi, E; Liu, C; Ibrahim, S; Beran, M; Zavadil, J; Efstratiadis, A; Taghon, T; Michor, F; Levine, RL; Aifantis, I				Klinakis, Apostolos; Lobry, Camille; Abdel-Wahab, Omar; Oh, Philmo; Haeno, Hiroshi; Buonamici, Silvia; van De Walle, Inge; Cathelin, Severine; Trimarchi, Thomas; Araldi, Elisa; Liu, Cynthia; Ibrahim, Sherif; Beran, Miroslav; Zavadil, Jiri; Efstratiadis, Argiris; Taghon, Tom; Michor, Franziska; Levine, Ross L.; Aifantis, Iannis			A novel tumour-suppressor function for the Notch pathway in myeloid leukaemia	NATURE			English	Article							T-CELL DEVELOPMENT; MICE; DIFFERENTIATION; SPECIFICATION; ACTIVATION; EXPRESSION; PROGENITOR; COMPLEX	Notch signalling is a central regulator of differentiation in a variety of organisms and tissue types(1). Its activity is controlled by the multisubunit gamma-secretase (gamma SE) complex(2). Although Notch signalling can play both oncogenic and tumour-suppressor roles in solid tumours, in the haematopoietic system it is exclusively oncogenic, notably in T-cell acute lymphoblastic leukaemia, a disease characterized by Notch1-activating mutations(3). Here we identify novel somatic-inactivating Notch pathway mutations in a fraction of patients with chronic myelomonocytic leukaemia (CMML). Inactivation of Notch signalling in mouse haematopoietic stem cells (HSCs) results in an aberrant accumulation of granulocyte/monocyte progenitors (GMPs), extramedullary haematopoieisis and the induction of CMML-like disease. Transcriptome analysis revealed that Notch signalling regulates an extensive myelomonocytic-specific gene signature, through the direct suppression of gene transcription by the Notch target Hes1. Our studies identify a novel role for Notch signalling during early haematopoietic stem cell differentiation and suggest that the Notch pathway can play both tumour-promoting and -suppressive roles within the same tissue.	[Lobry, Camille; Oh, Philmo; Buonamici, Silvia; Cathelin, Severine; Trimarchi, Thomas; Araldi, Elisa; Liu, Cynthia; Ibrahim, Sherif; Aifantis, Iannis] NYU, Sch Med, Howard Hughes Med Inst, New York, NY 10016 USA; [Lobry, Camille; Oh, Philmo; Buonamici, Silvia; Cathelin, Severine; Trimarchi, Thomas; Araldi, Elisa; Liu, Cynthia; Ibrahim, Sherif; Aifantis, Iannis] NYU, Sch Med, Dept Pathol, New York, NY 10016 USA; [Klinakis, Apostolos; Efstratiadis, Argiris] Acad Athens, Biomed Res Fdn, Athens, Greece; [Abdel-Wahab, Omar; Levine, Ross L.] Mem Sloan Kettering Canc Ctr, Dept Med, Human Oncol & Pathogenesis Program, New York, NY 10016 USA; [Abdel-Wahab, Omar; Levine, Ross L.] Mem Sloan Kettering Canc Ctr, Dept Med, Leukemia Serv, New York, NY 10016 USA; [Haeno, Hiroshi; Michor, Franziska] Harvard Univ, Sch Publ Hlth, Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Haeno, Hiroshi; Michor, Franziska] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [van De Walle, Inge; Taghon, Tom] Univ Ghent, State Univ Ghent Hosp, Dept Clin Chem Microbiol & Immunol, B-9000 Ghent, Belgium; [Beran, Miroslav] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA; [Zavadil, Jiri] NYU Canc Inst, Dept Pathol, New York, NY 10016 USA; [Zavadil, Jiri] NYU Langone Med Ctr, Ctr Hlth Informat & Bioinformat, New York, NY 10016 USA; [Buonamici, Silvia] Novartis Inst Biomed Res, Cambridge, MA 02139 USA	Howard Hughes Medical Institute; New York University; New York University; Academy of Athens; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Harvard University; Dana-Farber Cancer Institute; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Ghent University; Ghent University Hospital; University of Texas System; UTMD Anderson Cancer Center; New York University; NYU Langone Medical Center; Novartis	Aifantis, I (corresponding author), NYU, Sch Med, Howard Hughes Med Inst, New York, NY 10016 USA.	aklinakis@bioacademy.gr; iannis.aifantis@nyumc.org	lobry, camille/A-6188-2015; Taghon, Tom/M-9111-2018; levine, ross/AAE-7658-2019; Zavadil, Jiri/ABG-1780-2020; Araldi, Elisa/AAZ-5946-2021	lobry, camille/0000-0003-0550-4921; Zavadil, Jiri/0000-0003-0640-5562; Taghon, Tom/0000-0002-5781-0288; Araldi, Elisa/0000-0002-6596-6784; Van de Walle, Inge/0000-0002-7631-399X; Abdel-Wahab, Omar/0000-0002-3907-6171	National Institutes of Health [RO1CA133379, RO1CA105129, R21CA141399, RO1CA149655, R01CA1328234, U54CA143798]; Leukemia & Lymphoma Society; American Cancer Society; Irma T. Hirschl Trust; Dana Foundation; Mallinckrodt Foundation; Alex's Lemonade Stand Foundation; Fund for Scientific Research Flanders (Fonds Wetenschappelijk Onderzoek); National Cancer Institute [1P01CA97403]; EU; Institute for the Promotion of Innovation by Science and Technology in Flanders (Agentschap voor Innovatie door Wetenschap en Technologie); Hope Street Kids Foundations; New York University; Fonds Wetenschappelijk Onderzoek; Memorial Sloan Kettering Cancer Center; American Society of Hematology; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [R01CA149655, R21CA141399, U54CA143798, R01CA105129, R01CA133379, P01CA097403] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); American Cancer Society(American Cancer Society); Irma T. Hirschl Trust; Dana Foundation; Mallinckrodt Foundation; Alex's Lemonade Stand Foundation; Fund for Scientific Research Flanders (Fonds Wetenschappelijk Onderzoek)(FWO); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); EU(European Commission); Institute for the Promotion of Innovation by Science and Technology in Flanders (Agentschap voor Innovatie door Wetenschap en Technologie)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Hope Street Kids Foundations; New York University; Fonds Wetenschappelijk Onderzoek(FWO); Memorial Sloan Kettering Cancer Center; American Society of Hematology; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank G. Fishel, F. Radtke and R. Kopan for donating mouse strains; P. Lopez and the New York University Flow Facility for cell sorting; and A. Heguy and the Geoffrey Beene Translational Core laboratory for assistance with DNA resequencing. The New York University Cancer Institute Genomics Facility helped with micro-array processing. This work was supported by the National Institutes of Health (RO1CA133379, RO1CA105129, R21CA141399, RO1CA149655 to I.A.; R01CA1328234 to R.L.L. and F.M.; U54CA143798 to F.M.), the Leukemia & Lymphoma Society (to I.A.), the American Cancer Society (to I.A.), the Irma T. Hirschl Trust, the Dana Foundation, The Mallinckrodt Foundation, the Alex's Lemonade Stand Foundation (to I.A.), and the Fund for Scientific Research Flanders (Fonds Wetenschappelijk Onderzoek) and its Odysseus Research Program (to T.T.). A.E. was supported by the National Cancer Institute (1P01CA97403, Project 2) and a gift from the Berrie Foundation. A.K. was supported by an EU Marie Curie International Re-integration Grant. I.v.D.W. was supported by the Institute for the Promotion of Innovation by Science and Technology in Flanders (Agentschap voor Innovatie door Wetenschap en Technologie). S.C. was supported by the Hope Street Kids Foundations and P.O. by the New York University Medical Scientist Training Program. T.T. was supported by the Fonds Wetenschappelijk Onderzoek). O.A.W. was supported by the Clinical Scholars Program at Memorial Sloan Kettering Cancer Center and by the American Society of Hematology. R.L.L. is an Early Career Award recipient of the Howard Hughes Medical Institute and is the Geoffrey Beene Junior Chair at Memorial Sloan Kettering Cancer Center. I.A. is a Howard Hughes Medical Institute Early Career Scientist.	Aifantis I, 1999, J EXP MED, V190, P141, DOI 10.1084/jem.190.1.141; Aifantis I, 2008, NAT REV IMMUNOL, V8, P380, DOI 10.1038/nri2304; Buonamici S, 2009, NATURE, V459, P1000, DOI 10.1038/nature08020; Challen GA, 2010, CELL STEM CELL, V6, P265, DOI 10.1016/j.stem.2010.02.002; De Strooper B, 2005, CELL, V122, P318, DOI 10.1016/j.cell.2005.07.021; Demehri S, 2008, PLOS BIOL, V6, P992, DOI 10.1371/journal.pbio.0060123; Dumortier A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009258; Emanuel PD, 2008, LEUKEMIA, V22, P1335, DOI 10.1038/leu.2008.162; GRABHER C, 2006, NAT REV CANCER, V6, P1; Hurlbut GD, 2007, CURR OPIN CELL BIOL, V19, P166, DOI 10.1016/j.ceb.2007.02.012; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Leighton PA, 2001, NATURE, V410, P174, DOI 10.1038/35065539; Mercher T, 2008, CELL STEM CELL, V3, P314, DOI 10.1016/j.stem.2008.07.010; Mitchell KJ, 2001, NAT GENET, V28, P241, DOI 10.1038/90074; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Ng SYM, 2009, IMMUNITY, V30, P493, DOI 10.1016/j.immuni.2009.01.014; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Robert-Moreno A, 2008, EMBO J, V27, P1886, DOI 10.1038/emboj.2008.113; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Rothenberg EV, 2005, ANNU REV IMMUNOL, V23, P601, DOI 10.1146/annurev.immunol.23.021704.115737; Saito T, 2003, IMMUNITY, V18, P675, DOI 10.1016/S1074-7613(03)00111-0; Santaguida M, 2009, CANCER CELL, V15, P341, DOI 10.1016/j.ccr.2009.02.016; Stadtfeld M, 2005, DEVELOPMENT, V132, P203, DOI 10.1242/dev.01558; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Taghon TN, 2005, GENE DEV, V19, P965, DOI 10.1101/gad.1298305; Taghon T, 2009, BLOOD, V113, P3254, DOI 10.1182/blood-2008-07-168906; Tefferi A, 2010, LEUKEMIA, V24, P1128, DOI 10.1038/leu.2010.69; Thompson BJ, 2008, J EXP MED, V205, P1395, DOI 10.1084/jem.20080277; Van de Walle I, 2009, BLOOD, V113, P2988, DOI 10.1182/blood-2008-06-164871; Yang XD, 2004, DEV BIOL, V269, P81, DOI 10.1016/j.ydbio.2004.01.014; Zuniga-Pflucker JC, 2004, NAT REV IMMUNOL, V4, P67, DOI 10.1038/nri1257	32	284	295	1	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 12	2011	473	7346					230	+		10.1038/nature09999	http://dx.doi.org/10.1038/nature09999			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	762NT	21562564	Green Accepted			2022-12-24	WOS:000290487200042
J	Caiazzo, M; Dell'Anno, MT; Dvoretskova, E; Lazarevic, D; Taverna, S; Leo, D; Sotnikova, TD; Menegon, A; Roncaglia, P; Colciago, G; Russo, G; Carninci, P; Pezzoli, G; Gainetdinov, RR; Gustincich, S; Dityatev, A; Broccoli, V				Caiazzo, Massimiliano; Dell'Anno, Maria Teresa; Dvoretskova, Elena; Lazarevic, Dejan; Taverna, Stefano; Leo, Damiana; Sotnikova, Tatyana D.; Menegon, Andrea; Roncaglia, Paola; Colciago, Giorgia; Russo, Giovanni; Carninci, Piero; Pezzoli, Gianni; Gainetdinov, Raul R.; Gustincich, Stefano; Dityatev, Alexander; Broccoli, Vania			Direct generation of functional dopaminergic neurons from mouse and human fibroblasts	NATURE			English	Article							EMBRYONIC STEM-CELLS; EXPRESSION; TRANSPLANTATION	Transplantation of dopaminergic neurons can potentially improve the clinical outcome of Parkinson's disease, a neurological disorder resulting from degeneration of mesencephalic dopaminergic neurons(1,2). In particular, transplantation of embryonic-stem-cell-derived dopaminergic neurons has been shown to be efficient in restoring motor symptoms in conditions of dopamine deficiency(3,4). However, the use of pluripotent-derived cells might lead to the development of tumours if not properly controlled(5). Here we identified a minimal set of three transcription factors-Mash1 (also known as Ascl1), Nurr1 (also known as Nr4a2) and Lmx1a-that are able to generate directly functional dopaminergic neurons from mouse and human fibroblasts without reverting to a progenitor cell stage. Induced dopaminergic (iDA) cells release dopamine and show spontaneous electrical activity organized in regular spikes consistent with the pacemaker activity featured by brain dopaminergic neurons. The three factors were able to elicit dopaminergic neuronal conversion in prenatal and adult fibroblasts from healthy donors and Parkinson's disease patients. Direct generation of iDA cells from somatic cells might have significant implications for understanding critical processes for neuronal development, in vitro disease modelling and cell replacement therapies.	[Caiazzo, Massimiliano; Dell'Anno, Maria Teresa; Colciago, Giorgia; Broccoli, Vania] Ist Sci San Raffaele, Stem Cells & Neurogenesis Unit, Div Neurosci, I-20132 Milan, Italy; [Dvoretskova, Elena; Taverna, Stefano; Leo, Damiana; Sotnikova, Tatyana D.; Russo, Giovanni; Pezzoli, Gianni; Gainetdinov, Raul R.; Dityatev, Alexander] Ist Italiano Tecnol, Dept Neurosci & Brain Technol, I-16163 Genoa, Italy; [Lazarevic, Dejan] CBM Srl, I-34149 Trieste, Italy; [Lazarevic, Dejan; Roncaglia, Paola; Gustincich, Stefano] Int Sch Adv Studies SISSA, Neurobiol Sect, I-34136 Trieste, Italy; [Menegon, Andrea] Ist Sci San Raffaele, Expt Imaging Ctr, Adv Light & Electron Microscopy Bioimaging Ctr, I-20132 Milan, Italy; [Carninci, Piero] RIKEN Yokohama Inst, Omics Sci Ctr, Tsurumi Ku, Kanagawa 2300045, Japan; [Pezzoli, Gianni] Ist Clin Perfezionamento, Parkinson Inst, I-20126 Milan, Italy; [Gustincich, Stefano] Giovanni Armenise Harvard Fdn Lab, I-34136 Trieste, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Istituto Italiano di Tecnologia - IIT; International School for Advanced Studies (SISSA); Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; RIKEN	Broccoli, V (corresponding author), Ist Sci San Raffaele, Stem Cells & Neurogenesis Unit, Div Neurosci, I-20132 Milan, Italy.	broccoli.vania@hsr.it	Broccoli, Vania/K-3464-2016; Taverna, Stefano/AAN-1938-2020; Gainetdinov, Raul R/G-5875-2011; menegon, andrea/AAN-3736-2020; Caiazzo, Massimiliano/C-1722-2016; Sotnikova, Tatyana D/T-9992-2017; Carninci, Piero/K-1568-2014; Colciago, Giorgia/AAN-2698-2020; Dityatev, Alexander/A-4034-2008; Lazarevic, Dejan/AAN-1861-2020	Broccoli, Vania/0000-0003-4050-0926; Taverna, Stefano/0000-0003-1871-8662; Gainetdinov, Raul R/0000-0003-2951-6038; menegon, andrea/0000-0002-2396-756X; Caiazzo, Massimiliano/0000-0002-8975-3257; Carninci, Piero/0000-0001-7202-7243; Colciago, Giorgia/0000-0003-0476-8861; Dityatev, Alexander/0000-0002-0472-0553; Dell'Anno, Maria Teresa/0000-0003-1825-671X; Pezzoli, Gianni/0000-0003-4665-6710; Leo, Damiana/0000-0001-9219-5498; lazarevic, dejan/0000-0003-4527-290X; Gustincich, Stefano/0000-0002-2749-2514; Roncaglia, Paola/0000-0002-2825-0621	Fondazione Grigioni per il Morbo di Parkinson [FGBRCVNI10310-001-V.B.]; Eranet Neuron; Cariplo Foundation; Ministry of Health; Italian Institute of Technology; Fondazione Telethon Funding Source: Custom	Fondazione Grigioni per il Morbo di Parkinson; Eranet Neuron; Cariplo Foundation(Fondazione Cariplo); Ministry of Health; Italian Institute of Technology(Istituto Italiano di Tecnologia - IIT); Fondazione Telethon(Fondazione Telethon)	We are thankful to D. Bonanomi, S.-L. Ang, S. El Mestikawy, M. P. Smidt, M. German and F. Valtorta for providing valuable antibodies. We thank A. Sessa and V. B. laboratory members for helpful discussion. M. Wernig is acknowledged for providing the iN-inducing lentiviral vectors. We are thankful to S. Nicolis for sharing Sox2<SUP>beta-geo</SUP> mice. L. Muzio, C. Laterza and G. Martino are acknowledged for the generation of Sox2<SUP>beta-geo</SUP> induced pluripotent stem cells. M. Bacigaluppi is acknowledged for advice on stereological countings. We thank the "Cell Line and DNA Biobank" (G. Gaslini Institute) and "Human Genetic Bank of Patients affected by Parkinson Disease and parkinsonism" (Parkinson Institute of Milan) of the Telethon Genetic Biobank Network for human fibroblast samples. This study was supported by the "Fondazione Grigioni per il Morbo di Parkinson" (grant no. FGBRCVNI10310-001-V.B.), Eranet Neuron (V. B.), Cariplo Foundation (V. B.), Ministry of Health (Giovani ricercatori Award) (V. B.) and Italian Institute of Technology (V.B., A.D., S.G., T.S., R.G.).	Amariglio N, 2009, PLOS MED, V6, P221, DOI 10.1371/journal.pmed.1000029; Ang SL, 2006, DEVELOPMENT, V133, P3499, DOI 10.1242/dev.02501; Bacigaluppi M, 2009, BRAIN, V132, P2239, DOI 10.1093/brain/awp174; Barberi T, 2003, NAT BIOTECHNOL, V21, P1200, DOI 10.1038/nbt870; Biagioli M, 2009, P NATL ACAD SCI USA, V106, P15454, DOI 10.1073/pnas.0813216106; Broccoli V, 1999, NATURE, V401, P164, DOI 10.1038/43670; Colasante G, 2008, J NEUROSCI, V28, P10674, DOI 10.1523/JNEUROSCI.1283-08.2008; GRACE AA, 1984, J NEUROSCI, V4, P2866; GRACE AA, 1989, J NEUROSCI, V9, P3463; Heins N, 2002, NAT NEUROSCI, V5, P308, DOI 10.1038/nn828; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Kim JH, 2002, NATURE, V418, P50, DOI 10.1038/nature00900; Lindvall Olle, 2004, NeuroRx, V1, P382; Menegon A, 2006, J NEUROSCI, V26, P11670, DOI 10.1523/JNEUROSCI.3321-06.2006; Mundroff M. L., 2002, CURR PROTOC NEUROSCI; Pang ZPP, 2011, NATURE, V476, P220, DOI 10.1038/nature10202; Perlmann T, 2004, CELL TISSUE RES, V318, P45, DOI 10.1007/s00441-004-0974-7; Pfisterer U, 2011, P NATL ACAD SCI USA, V108, P10343, DOI 10.1073/pnas.1105135108; Politis M, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000976; Pothos E, 1996, J NEUROCHEM, V66, P629; Pothos EN, 1998, J NEUROSCI, V18, P4106; Pruszak J., 2009, CURR PROTOC STEM CEL; Sawamoto K, 2001, P NATL ACAD SCI USA, V98, P6423, DOI 10.1073/pnas.111152398; Simeone A, 2005, TRENDS NEUROSCI, V28, P62, DOI 10.1016/j.tins.2004.11.007; Sironi F, 2008, PARKINSONISM RELAT D, V14, P326, DOI 10.1016/j.parkreldis.2007.10.003; Sironi F, 2010, PARKINSONISM RELAT D, V16, P228, DOI 10.1016/j.parkreldis.2009.09.008; Smidt MP, 2007, NAT REV NEUROSCI, V8, P21, DOI 10.1038/nrn2039; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Staal RGW, 2004, NAT NEUROSCI, V7, P341, DOI 10.1038/nn1205; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Wernig M, 2008, P NATL ACAD SCI USA, V105, P5856, DOI 10.1073/pnas.0801677105; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Zappone MV, 2000, DEVELOPMENT, V127, P2367	36	730	774	4	196	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 11	2011	476	7359					224	U151		10.1038/nature10284	http://dx.doi.org/10.1038/nature10284			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	805MU	21725324				2022-12-24	WOS:000293731900040
J	Willeit, P; Willeit, J; Kloss-Brandstatter, A; Kronenberg, F; Kiechl, S				Willeit, Peter; Willeit, Johann; Kloss-Brandstaetter, Anita; Kronenberg, Florian; Kiechl, Stefan			Fifteen-Year Follow-up of Association Between Telomere Length and Incident Cancer and Cancer Mortality	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Willeit, Peter] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England; [Willeit, Johann; Kiechl, Stefan] Innsbruck Med Univ, Dept Neurol, Innsbruck, Austria; [Kloss-Brandstaetter, Anita; Kronenberg, Florian] Innsbruck Med Univ, Dept Med Genet Mol & Clin Pharmacol, Innsbruck, Austria	University of Cambridge; Medical University of Innsbruck; Medical University of Innsbruck	Willeit, P (corresponding author), Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England.	stefan.kiechl@i-med.ac.at	Kronenberg, Florian/B-1736-2008; Willeit, Peter/HCI-7091-2022	Kronenberg, Florian/0000-0003-2229-1120; Willeit, Peter/0000-0002-1866-7159; Kloss-Brandstatter, Anita/0000-0002-0873-6704	British Heart Foundation [RG/08/014/24067] Funding Source: Medline	British Heart Foundation(British Heart Foundation)		Calado RT, 2009, NEW ENGL J MED, V361, P2353, DOI 10.1056/NEJMra0903373; Farzaneh-Far R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008612; Houben JMJ, 2011, J GERONTOL A-BIOL, V66, P38, DOI 10.1093/gerona/glq164; Lin J, 2010, J IMMUNOL METHODS, V352, P71, DOI 10.1016/j.jim.2009.09.012; Willeit P, 2010, JAMA-J AM MED ASSOC, V304, P69, DOI 10.1001/jama.2010.897; Wood AM, 2009, STAT MED, V28, P1067, DOI 10.1002/sim.3530	6	74	75	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 6	2011	306	1					42	44		10.1001/jama.2011.901	http://dx.doi.org/10.1001/jama.2011.901			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	787LV	21730239				2022-12-24	WOS:000292378700018
J	Donlea, JM; Thimgan, MS; Suzuki, Y; Gottschalk, L; Shaw, PJ				Donlea, Jeffrey M.; Thimgan, Matthew S.; Suzuki, Yasuko; Gottschalk, Laura; Shaw, Paul J.			Inducing Sleep by Remote Control Facilitates Memory Consolidation in Drosophila	SCIENCE			English	Article							VISUAL-PATTERN MEMORY; CENTRAL COMPLEX; NEURONS; BRAIN; DEPRIVATION; PLASTICITY; BEHAVIOR; NEUROPEPTIDES; MELANOGASTER; WAKEFULNESS	Sleep is believed to play an important role in memory consolidation. We induced sleep on demand by expressing the temperature-gated nonspecific cation channel Transient receptor potential cation channel (UAS-TrpA1) in neurons, including those with projections to the dorsal fan-shaped body (FB). When the temperature was raised to 31 degrees C, flies entered a quiescent state that meets the criteria for identifying sleep. When sleep was induced for 4 hours after a massed-training protocol for courtship conditioning that is not capable of inducing long-term memory (LTM) by itself, flies develop an LTM. Activating the dorsal FB in the absence of sleep did not result in the formation of LTM after massed training.	[Donlea, Jeffrey M.; Thimgan, Matthew S.; Suzuki, Yasuko; Gottschalk, Laura; Shaw, Paul J.] Washington Univ, Dept Anat & Neurobiol, St Louis, MO 63110 USA	Washington University (WUSTL)	Shaw, PJ (corresponding author), Washington Univ, Dept Anat & Neurobiol, 660 S Euclid Ave, St Louis, MO 63110 USA.	shawp@pcg.wustl.edu			NIH [R01-NS051305-01A1, NS057105, T32GM008151, 5F31NS063514-02]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008151] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051305, P30NS057105, F31NS063514] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank P. Taghert, E. Herzog, P. Gray, L. Seugnet, A. Diantonio, W. Vanderheyden, and B. van Swinderen for discussions. This work was supported by NIH grants R01-NS051305-01A1, NS057105, T32GM008151, and 5F31NS063514-02.	Al-Anzi B, 2010, CURR BIOL, V20, P969, DOI 10.1016/j.cub.2010.04.039; Andretic R, 2005, METHOD ENZYMOL, V393, P759, DOI 10.1016/S0076-6879(05)93040-1; Appelbaum L, 2010, NEURON, V68, P87, DOI 10.1016/j.neuron.2010.09.006; BERGMANN BM, 1989, SLEEP, V12, P5, DOI 10.1093/sleep/12.1.5; Cirelli C, 2004, NEURON, V41, P35, DOI 10.1016/S0896-6273(03)00814-6; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Donlea JM, 2009, SCIENCE, V324, P105, DOI 10.1126/science.1166657; GAILEY DA, 1985, GENETICS, V111, P795; GAILEY DA, 1982, GENETICS, V102, P771; Ganguly-Fitzgerald I, 2006, SCIENCE, V313, P1775, DOI 10.1126/science.1130408; Gilestro GF, 2009, SCIENCE, V324, P109, DOI 10.1126/science.1166673; Graves LA, 2003, LEARN MEMORY, V10, P168, DOI 10.1101/lm.48803; Hamada FN, 2008, NATURE, V454, P217, DOI 10.1038/nature07001; Hendricks JC, 2000, NEURON, V25, P129, DOI 10.1016/S0896-6273(00)80877-6; Kahsai L, 2011, J COMP NEUROL, V519, P290, DOI 10.1002/cne.22520; Kahsai L, 2010, J EXP BIOL, V213, P2256, DOI 10.1242/jeb.043190; Liu G, 2006, NATURE, V439, P551, DOI 10.1038/nature04381; Luan HJ, 2006, J NEUROSCI, V26, P573, DOI 10.1523/JNEUROSCI.3916-05.2006; Marella S, 2006, NEURON, V49, P285, DOI 10.1016/j.neuron.2005.11.037; Nitabach MN, 2006, J NEUROSCI, V26, P479, DOI 10.1523/JNEUROSCI.3915-05.2006; Pan YF, 2009, LEARN MEMORY, V16, P289, DOI 10.1101/lm.1331809; Rechtschaffen A, 1998, PERSPECT BIOL MED, V41, P359, DOI 10.1353/pbm.1998.0051; Seugnet L, 2008, CURR BIOL, V18, P1110, DOI 10.1016/j.cub.2008.07.028; Shaw PJ, 2000, SCIENCE, V287, P1834, DOI 10.1126/science.287.5459.1834; Shaw PJ, 2002, NATURE, V417, P287, DOI 10.1038/417287a; Siegel JM, 2005, NATURE, V437, P1264, DOI 10.1038/nature04285; SIEGEL RW, 1979, P NATL ACAD SCI USA, V76, P3430, DOI 10.1073/pnas.76.7.3430; Tononi G, 2006, SLEEP MED REV, V10, P49, DOI 10.1016/j.smrv.2005.05.002; Vyazovskiy VV, 2009, NEURON, V63, P865, DOI 10.1016/j.neuron.2009.08.024; Walker MP, 2005, NEUROSCIENCE, V133, P911, DOI 10.1016/j.neuroscience.2005.04.007; Wang ZP, 2008, LEARN MEMORY, V15, P133, DOI 10.1101/lm.873008; Winther AME, 2006, MOL CELL NEUROSCI, V31, P399, DOI 10.1016/j.mcn.2005.10.010; Young JM, 2010, J COMP NEUROL, V518, P1500, DOI 10.1002/cne.22284	33	222	224	2	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 24	2011	332	6037					1571	1576		10.1126/science.1202249	http://dx.doi.org/10.1126/science.1202249			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782EE	21700877	Green Accepted			2022-12-24	WOS:000291990000049
J	Chou, HH; Chiu, HC; Delaney, NF; Segre, D; Marx, CJ				Chou, Hsin-Hung; Chiu, Hsuan-Chao; Delaney, Nigel F.; Segre, Daniel; Marx, Christopher J.			Diminishing Returns Epistasis Among Beneficial Mutations Decelerates Adaptation	SCIENCE			English	Article							ESCHERICHIA-COLI; EVOLUTION; FITNESS; ARCHITECTURE; LANDSCAPE; DYNAMICS; PROTEIN	Epistasis has substantial impacts on evolution, in particular, the rate of adaptation. We generated combinations of beneficial mutations that arose in a lineage during rapid adaptation of a bacterium whose growth depended on a newly introduced metabolic pathway. The proportional selective benefit for three of the four loci consistently decreased when they were introduced onto more fit backgrounds. These three alleles all reduced morphological defects caused by expression of the foreign pathway. A simple theoretical model segregating the apparent contribution of individual alleles to benefits and costs effectively predicted the interactions between them. These results provide the first evidence that patterns of epistasis may differ for within- and between-gene interactions during adaptation and that diminishing returns epistasis contributes to the consistent observation of decelerating fitness gains during adaptation.	[Chou, Hsin-Hung; Delaney, Nigel F.; Marx, Christopher J.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Chiu, Hsuan-Chao; Segre, Daniel] Boston Univ, Grad Program Bioinformat, Boston, MA 02215 USA; [Segre, Daniel] Boston Univ, Dept Biol, Boston, MA 02215 USA; [Segre, Daniel] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; [Marx, Christopher J.] Harvard Univ, Ctr Syst Biol, Fac Arts & Sci, Cambridge, MA 02138 USA	Harvard University; Boston University; Boston University; Boston University; Harvard University	Marx, CJ (corresponding author), Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA.	cmarx@oeb.harvard.edu	Chiu, Hsuan-Chao/F-8963-2011; Segrè, Daniel/A-1993-2009	Chiu, Hsuan-Chao/0000-0001-9828-2955; Segrè, Daniel/0000-0003-4859-1914; CHOU, HSIN-HUNG/0000-0001-6003-5609	NIH [R01 GM078209]; NSF [DEB-0845893]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078209] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Kryazhminskiy, D. Weinreich, J. Weitz, C. Wilke, R. Whitaker, and members of the Marx and Segre labs for suggestions and discussions. Supported by NIH grant R01 GM078209, and NSF grant DEB-0845893. The resulting single-end 36-bp read data have been deposited in the NCBI Short Read Archive with accession no. SRA030695.1.	Applebee MK, 2008, J BACTERIOL, V190, P5087, DOI 10.1128/JB.01976-07; Barrick JE, 2009, NATURE, V461, P1243, DOI 10.1038/nature08480; Bridgham JT, 2006, SCIENCE, V312, P97, DOI 10.1126/science.1123348; Chistoserdova L, 1998, SCIENCE, V281, P99, DOI 10.1126/science.281.5373.99; Chou HH, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000652; Cordell HJ, 2002, HUM MOL GENET, V11, P2463, DOI 10.1093/hmg/11.20.2463; Dekel E, 2005, NATURE, V436, P588, DOI 10.1038/nature03842; Elena SF, 2003, NAT REV GENET, V4, P457, DOI 10.1038/nrg1088; Khan AI, 2011, SCIENCE, V332, P1193, DOI 10.1126/science.1203801; Kryazhimskiy S, 2009, P NATL ACAD SCI USA, V106, P18638, DOI 10.1073/pnas.0905497106; Kurland CG, 1996, MOL MICROBIOL, V21, P1, DOI 10.1046/j.1365-2958.1996.5901313.x; Kvitek DJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002056; Lunzer M, 2005, SCIENCE, V310, P499, DOI 10.1126/science.1115649; Martin G, 2007, NAT GENET, V39, P555, DOI 10.1038/ng1998; Marx CJ, 2003, J BACTERIOL, V185, P7160, DOI 10.1128/JB.185.23.7160-7168.2003; Phillips PC, 2008, NAT REV GENET, V9, P855, DOI 10.1038/nrg2452; Sanjuan R, 2004, P NATL ACAD SCI USA, V101, P15376, DOI 10.1073/pnas.0404125101; Segre D, 2005, NAT GENET, V37, P77, DOI 10.1038/ng1489; Weinreich DM, 2006, SCIENCE, V312, P111, DOI 10.1126/science.1123539	19	315	318	0	69	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 3	2011	332	6034					1190	1192		10.1126/science.1203799	http://dx.doi.org/10.1126/science.1203799			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	772BO	21636771	Green Accepted			2022-12-24	WOS:000291205200046
J	Chen, XW; Leischner, U; Rochefort, NL; Nelken, I; Konnerth, A				Chen, Xiaowei; Leischner, Ulrich; Rochefort, Nathalie L.; Nelken, Israel; Konnerth, Arthur			Functional mapping of single spines in cortical neurons in vivo	NATURE			English	Article							MOUSE AUDITORY-CORTEX; PYRAMIDAL NEURONS; DENDRITIC SPINES; FLUORESCENCE MICROSCOPY; VISUAL-CORTEX; ORGANIZATION; EXCITATION; DYNAMICS; SIGNALS; SPIKES	The individual functional properties and spatial arrangement of afferent synaptic inputs on dendrites have a critical role in the processing of information by neurons in the mammalian brain(1-4). Although recent work has identified visually-evoked local dendritic calcium signals in the rodent visual cortex(5), sensory-evoked signalling on the level of dendritic spines, corresponding to individual afferent excitatory synapses, remains unexplored(6). Here we used a new variant of high-resolution two-photon imaging(7) to detect sensory-evoked calcium transients in single dendritic spines of mouse cortical neurons in vivo. Calcium signals evoked by sound stimulation required the activation of NMDA (N-methyl-D-aspartate) receptors. Active spines are widely distributed on basal and apical dendrites and pure-tone stimulation at different frequencies revealed both narrowly and widely tuned spines. Notably, spines tuned for different frequencies were highly interspersed on the same dendrites: even neighbouring spines were mostly tuned to different frequencies. Thus, our results demonstrate that NMDA-receptor-dependent single-spine synaptic inputs to the same dendrite are highly heterogeneous. Furthermore, our study opens the way for in vivo mapping of functionally defined afferent sensory inputs with single-synapse resolution.	[Chen, Xiaowei; Leischner, Ulrich; Rochefort, Nathalie L.; Konnerth, Arthur] Tech Univ Munich, Inst Neurosci, D-80802 Munich, Germany; [Chen, Xiaowei; Leischner, Ulrich; Rochefort, Nathalie L.; Konnerth, Arthur] Tech Univ Munich, Ctr Integrated Prot Sci, D-80802 Munich, Germany; [Nelken, Israel] Hebrew Univ Jerusalem, Dept Neurobiol, Silberman Inst Life Sci, IL-91904 Jerusalem, Israel; [Nelken, Israel] Hebrew Univ Jerusalem, Edmond & Lily Safra Ctr Brain Sci, IL-91904 Jerusalem, Israel	Technical University of Munich; Technical University of Munich; University of Munich; Hebrew University of Jerusalem; Hebrew University of Jerusalem	Konnerth, A (corresponding author), Tech Univ Munich, Inst Neurosci, Biedersteinerstr 29, D-80802 Munich, Germany.	arthur.konnerth@lrz.tum.de	Nelken, Israel/B-7753-2011; Leischner, Ulrich/H-9936-2012	Nelken, Israel/0000-0002-6645-107X; Rochefort, Nathalie/0000-0002-3498-6221; Leischner, Ulrich/0000-0001-7771-2135	Schiedel Foundation; German-Israeli Foundation (GIF) [1002/2008]; Deutsche Forschungsgemeinschaft [IRTG 1373]; Bundesministerium fur Bildung und Forschung (BMBF)	Schiedel Foundation; German-Israeli Foundation (GIF)(German-Israeli Foundation for Scientific Research and Development); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF))	We thank J. Lou for technical assistance, D. Bayer, F. Bayer and W. Zeitz for building the scanning device, A. Fohr for software support and Y. Kovalchuk and H. Adelsberger for help during the initial experiments. This work was supported by the Schiedel Foundation, the German-Israeli Foundation (GIF grant 1002/2008 to I.N. and A. K.), the Deutsche Forschungsgemeinschaft (IRTG 1373) and the Bundesministerium fur Bildung und Forschung (BMBF) in the frame of ERA-NET NEURON. A. K. is a Carl-von-Linde senior fellow of the Institute for Advanced Study of the Technische Universitat Munchen.	Bandyopadhyay S, 2010, NAT NEUROSCI, V13, P361, DOI 10.1038/nn.2490; Berretta N, 1996, NEUROSCIENCE, V75, P339, DOI 10.1016/0306-4522(96)00301-6; Bloodgood BL, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000190; Branco T, 2010, CURR OPIN NEUROBIOL, V20, P494, DOI 10.1016/j.conb.2010.07.009; Busche MA, 2008, SCIENCE, V321, P1686, DOI 10.1126/science.1162844; Cash S, 1999, NEURON, V22, P383, DOI 10.1016/S0896-6273(00)81098-3; Chadderton P, 2009, J NEUROSCI, V29, P14127, DOI 10.1523/JNEUROSCI.2061-09.2009; de Kock CPJ, 2008, J PHYSIOL-LONDON, V586, P3353, DOI 10.1113/jphysiol.2008.155580; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Donnert G, 2007, NAT METHODS, V4, P81, DOI 10.1038/NMETH986; Franklin K. B. J., 2001, MOUSE BRAIN STEREOTA; GERIG JS, 1964, P IEEE, V52, P1753, DOI 10.1109/PROC.1964.3500; Holthoff K, 2004, J PHYSIOL-LONDON, V560, P27, DOI 10.1113/jphysiol.2004.072678; Holtmaat AJGD, 2005, NEURON, V45, P279, DOI 10.1016/j.neuron.2005.01.003; Ji N, 2008, NAT METHODS, V5, P197, DOI 10.1038/NMETH.1175; Jia HB, 2011, NAT PROTOC, V6, P28, DOI 10.1038/nprot.2010.169; Jia HB, 2010, NATURE, V464, P1307, DOI 10.1038/nature08947; Kawaguchi Y, 2006, CEREB CORTEX, V16, P696, DOI 10.1093/cercor/bhj015; Kerlin AM, 2010, NEURON, V67, P858, DOI 10.1016/j.neuron.2010.08.002; Kitamura K, 2008, NAT METHODS, V5, P61, DOI 10.1038/NMETH1150; Kovalchuk Y, 2000, J NEUROSCI, V20, P1791; Kremer Y, 2008, OPT EXPRESS, V16, P10066, DOI 10.1364/OE.16.010066; Larkum ME, 2008, CURR OPIN NEUROBIOL, V18, P321, DOI 10.1016/j.conb.2008.08.013; Lechleiter JD, 2002, BIOPHYS J, V83, P2292, DOI 10.1016/S0006-3495(02)73989-1; Linden JF, 2003, J NEUROPHYSIOL, V90, P2660, DOI 10.1152/jn.00751.2002; London M, 2005, ANNU REV NEUROSCI, V28, P503, DOI 10.1146/annurev.neuro.28.061604.135703; Mainen ZF, 1999, NATURE, V399, P151, DOI 10.1038/20187; Noguchi J, 2005, NEURON, V46, P609, DOI 10.1016/j.neuron.2005.03.015; Peters A., 1984, CEREBRAL CORTEX FUNC, P107, DOI [10.1007/978-3-662-03733-1_15, DOI 10.1007/978-3-662-03733-1_15]; Polsky A, 2004, NAT NEUROSCI, V7, P621, DOI 10.1038/nn1253; Roorda RD, 2004, J NEUROPHYSIOL, V92, P609, DOI 10.1152/jn.00087.2004; Rothschild G, 2010, NAT NEUROSCI, V13, P353, DOI 10.1038/nn.2484; Sabatini BL, 2001, CURR OPIN NEUROBIOL, V11, P349, DOI 10.1016/S0959-4388(00)00218-X; Schiller J, 2000, NATURE, V404, P285, DOI 10.1038/35005094; Scholl B, 2010, NEURON, V65, P412, DOI 10.1016/j.neuron.2010.01.020; Sohya K, 2007, J NEUROSCI, V27, P2145, DOI 10.1523/JNEUROSCI.4641-06.2007; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; Svoboda K, 1999, NAT NEUROSCI, V2, P65, DOI 10.1038/4569; Waters J, 2003, J NEUROSCI, V23, P8558; WONG EHF, 1986, P NATL ACAD SCI USA, V83, P7104, DOI 10.1073/pnas.83.18.7104; Wu GY, 2006, NEURON, V52, P705, DOI 10.1016/j.neuron.2006.10.009; Yuste R, 2000, NAT NEUROSCI, V3, P653, DOI 10.1038/76609; YUSTE R, 1995, NATURE, V375, P682, DOI 10.1038/375682a0	43	262	268	3	73	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 28	2011	475	7357					501	U97		10.1038/nature10193	http://dx.doi.org/10.1038/nature10193			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	797ZA	21706031				2022-12-24	WOS:000293167900041
J	Peter, IS; Davidson, EH				Peter, Isabelle S.; Davidson, Eric H.			A gene regulatory network controlling the embryonic specification of endoderm	NATURE			English	Article							SEA-URCHIN EMBRYO; NUCLEAR BETA-CATENIN; STRONGYLOCENTROTUS-PURPURATUS; CELL FATES; EXPRESSION; IDENTIFICATION; BLASTOMERES; LINEAGES; FAMILY	Specification of endoderm is the prerequisite for gut formation in the embryogenesis of bilaterian organisms. Modern lineage labelling studies(1-3) have shown that in the sea urchin embryo model system, descendants of the veg1 and veg2 cell lineages produce the endoderm, and that the veg2 lineage also gives rise to mesodermal cell types. It is known that Wnt/beta-catenin signalling is required for endoderm specification(4-6) and Delta/Notch signalling is required for mesoderm specification(7-9). Some directcis-regulatory targets of these signals have been found(10,11) and various phenomenological patterns of gene expression have been observed in the pre-gastrular endomesoderm. However, no comprehensive, causal explanation of endoderm specification has been conceived for sea urchins, nor for any other deuterostome. Here we propose a model, on the basis of the underlying genomic control system, that provides such an explanation, built at several levels of biological organization. The hardwired core of the control system consists of the cis-regulatory apparatus of endodermal regulatory genes, which determine the relationship between the inputs to which these genes are exposed and their outputs. The architecture of the network circuitry controlling the dynamic process of endoderm specification then explains, at the system level, a sequence of developmental logic operations, which generate the biological process. The control system initiates non-interacting endodermal and mesodermal gene regulatory networks in veg2-derived cells and extinguishes the endodermal gene regulatory network in mesodermal precursors. It also generates a cross-regulatory network that specifies future anterior endoderm in veg2 descendants and institutes a distinct network specifying posterior endoderm in veg1-derived cells. The network model provides an explanatory framework that relates endoderm specification to the genomic regulatory code.	[Peter, Isabelle S.; Davidson, Eric H.] CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology	Davidson, EH (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	ipeter@caltech.edu; davidson@caltech.edu		Peter, Isabelle/0000-0003-3685-3147	Swiss National Science Foundation; National Institutes of Health [HD37105]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD037105] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We acknowledge technical assistance from J. Yun, who executed much of the perturbation analysis matrix, and from A. Puszynska and E. Erkenbrack, who contributed to whole-mount in situ hybridization results. We are grateful to E. Rothenberg for a detailed critique of the manuscript. I. S. P. was the recipient of a fellowship from the Swiss National Science Foundation in the initial stages of this work. The research was supported by National Institutes of Health grant HD37105 to E.H.D.	Byrum CA, 2009, DEV DYNAM, V238, P1649, DOI 10.1002/dvdy.21978; CAMERON RA, 1991, DEVELOPMENT, V113, P1085; Croce JC, 2010, DEVELOPMENT, V137, P83, DOI 10.1242/dev.044149; Davidson EH, 2010, NATURE, V468, P911, DOI 10.1038/nature09645; De-Leon SBT, 2010, P NATL ACAD SCI USA, V107, P10103, DOI 10.1073/pnas.1004824107; Howard-Ashby M, 2006, DEV BIOL, V300, P90, DOI 10.1016/j.ydbio.2006.08.033; Howard-Ashby M, 2006, DEV BIOL, V300, P74, DOI 10.1016/j.ydbio.2006.08.039; Livi CB, 2007, GENE EXPR PATTERNS, V7, P1, DOI 10.1016/j.modgep.2006.04.009; Logan CY, 1999, DEVELOPMENT, V126, P345; Logan CY, 1997, DEVELOPMENT, V124, P2213; Longabaugh WJR, 2009, BBA-GENE REGUL MECH, V1789, P363, DOI 10.1016/j.bbagrm.2008.07.014; Materna SC, 2006, DEV BIOL, V300, P108, DOI 10.1016/j.ydbio.2006.08.032; Materna SC, 2008, NAT PROTOC, V3, P1876, DOI 10.1038/nprot.2008.187; Minokawa T, 2005, DEV BIOL, V288, P545, DOI 10.1016/j.ydbio.2005.09.047; Oliveri P, 2008, P NATL ACAD SCI USA, V105, P5955, DOI 10.1073/pnas.0711220105; Peter IS, 2010, DEV BIOL, V340, P188, DOI 10.1016/j.ydbio.2009.10.037; Peter IS, 2009, FEBS LETT, V583, P3948, DOI 10.1016/j.febslet.2009.11.060; Ransick A, 2004, METHOD CELL BIOL, V74, P601; Ransick A, 1998, DEV BIOL, V195, P38, DOI 10.1006/dbio.1997.8814; Ransick A, 2006, DEV BIOL, V297, P587, DOI 10.1016/j.ydbio.2006.05.037; Rast JP, 2000, DEV BIOL, V228, P270, DOI 10.1006/dbio.2000.9941; Revilla-I-Domingo R, 2007, P NATL ACAD SCI USA, V104, P12383, DOI 10.1073/pnas.0705324104; Rizzo F, 2006, DEV BIOL, V300, P35, DOI 10.1016/j.ydbio.2006.08.012; Sherwood DR, 1999, DEVELOPMENT, V126, P1703; Smith J, 2008, DEV BIOL, V313, P863, DOI 10.1016/j.ydbio.2007.10.042; Smith J, 2007, SCIENCE, V318, P794, DOI 10.1126/science.1146524; Sweet HC, 2002, DEVELOPMENT, V129, P1945; Sweet HC, 1999, DEVELOPMENT, V126, P5255; Tu Q, 2006, DEV BIOL, V300, P49, DOI 10.1016/j.ydbio.2006.09.031; Wikramanayake AH, 2004, GENESIS, V39, P194, DOI 10.1002/gene.20045	30	158	160	1	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 30	2011	474	7353					635	U110		10.1038/nature10100	http://dx.doi.org/10.1038/nature10100			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	785CF	21623371	Green Accepted			2022-12-24	WOS:000292204300038
J	Voineagu, I; Wang, XC; Johnston, P; Lowe, JK; Tian, Y; Horvath, S; Mill, J; Cantor, RM; Blencowe, BJ; Geschwind, DH				Voineagu, Irina; Wang, Xinchen; Johnston, Patrick; Lowe, Jennifer K.; Tian, Yuan; Horvath, Steve; Mill, Jonathan; Cantor, Rita M.; Blencowe, Benjamin J.; Geschwind, Daniel H.			Transcriptomic analysis of autistic brain reveals convergent molecular pathology	NATURE			English	Article							COMMON GENETIC-VARIANTS; SPECTRUM DISORDERS; NETWORK ANALYSIS; CANDIDATE GENE; COPY NUMBER; ASSOCIATION; EXPRESSION; PATHWAYS; PACKAGE; DISEASE	Autism spectrum disorder (ASD) is a common, highly heritable neurodevelopmental condition characterized by marked genetic heterogeneity(1-3). Thus, a fundamental question is whether autism represents an aetiologically heterogeneous disorder in which the myriad genetic or environmental risk factors perturb common underlying molecular pathways in the brain(4). Here, we demonstrate consistent differences in transcriptome organization between autistic and normal brain by gene co-expression network analysis. Remarkably, regional patterns of gene expression that typically distinguish frontal and temporal cortex are significantly attenuated in the ASD brain, suggesting abnormalities in cortical patterning. We further identify discrete modules of co-expressed genes associated with autism: a neuronal module enriched for known autism susceptibility genes, including the neuronal specific splicing factor A2BP1 (also known as FOX1), and a module enriched for immune genes and glial markers. Using high-throughput RNA sequencing we demonstrate dysregulated splicing of A2BP1-dependent alternative exons in the ASD brain. Moreover, using a published autism genome-wide association study (GWAS) data set, we show that the neuronal module is enriched for genetically associated variants, providing independent support for the causal involvement of these genes in autism. In contrast, the immune-glial module showed no enrichment for autism GWAS signals, indicating a non-genetic aetiology for this process. Collectively, our results provide strong evidence for convergent molecular abnormalities in ASD, and implicate transcriptional and splicing dysregulation as underlying mechanisms of neuronal dysfunction in this disorder.	[Voineagu, Irina; Lowe, Jennifer K.; Tian, Yuan; Geschwind, Daniel H.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Program Neurogenet & Neurobehav Genet, Los Angeles, CA 90095 USA; [Voineagu, Irina; Lowe, Jennifer K.; Tian, Yuan; Geschwind, Daniel H.] Univ Calif Los Angeles, David Geffen Sch Med, Semel Inst, Los Angeles, CA 90095 USA; [Wang, Xinchen; Blencowe, Benjamin J.] Univ Toronto, Donnelly Ctr, Banting & Best Dept Med Res, Toronto, ON M5G 1L6, Canada; [Johnston, Patrick; Mill, Jonathan] Kings Coll London, Inst Psychiat, London SE5 8AF, England; [Horvath, Steve; Cantor, Rita M.; Geschwind, Daniel H.] Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Toronto; University of London; King's College London; University of California System; University of California Los Angeles	Geschwind, DH (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Program Neurogenet & Neurobehav Genet, Los Angeles, CA 90095 USA.	dhg@mednet.ucla.edu	Mill, Jonathan/B-5678-2014; Mill, Jonathan S/B-3276-2010	Mill, Jonathan/0000-0003-1115-3224; Mill, Jonathan S/0000-0003-1115-3224; Wang, Xinchen/0000-0002-5198-6581; Voineagu, Irina/0000-0003-4162-3872	CIHR Funding Source: Medline; NIMH NIH HHS [R37 MH060233-12, R37 MH060233, R37 MH060233-11, R01 MH081754-03, R01 MH081754, R37MH060233, R01 MH081754-04, R01 MH094714, R01 MH081754-02, 5R01MH081754-03, R01 MH081754-01, R01 MH081754-05] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH081754, R37MH060233, R01MH094714] Funding Source: NIH RePORTER; Medical Research Council [G9817803B] Funding Source: researchfish	CIHR(Canadian Institutes of Health Research (CIHR)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Abrahams BS, 2008, NAT REV GENET, V9, P341, DOI 10.1038/nrg2346; Alarcon M, 2008, AM J HUM GENET, V82, P150, DOI 10.1016/j.ajhg.2007.09.005; Albright AV, 2004, J NEUROIMMUNOL, V157, P27, DOI 10.1016/j.jneuroim.2004.09.007; Amaral DG, 2008, TRENDS NEUROSCI, V31, P137, DOI 10.1016/j.tins.2007.12.005; Babatz TD, 2009, AUTISM RES, V2, P359, DOI 10.1002/aur.107; Boulanger LM, 2009, NEURON, V64, P93, DOI 10.1016/j.neuron.2009.09.001; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Castermans D, 2010, HUM MOL GENET, V19, P1368, DOI 10.1093/hmg/ddq013; Chen YQ, 2008, NATURE, V452, P429, DOI 10.1038/nature06757; Cooper GM, 2008, BLOOD, V112, P1022, DOI 10.1182/blood-2008-01-134247; Durand CM, 2007, NAT GENET, V39, P25, DOI 10.1038/ng1933; Garbett K, 2008, NEUROBIOL DIS, V30, P303, DOI 10.1016/j.nbd.2008.01.012; Geschwind DH, 2008, CELL, V135, P391, DOI 10.1016/j.cell.2008.10.016; Han JL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000074; Johnson MB, 2009, NEURON, V62, P494, DOI 10.1016/j.neuron.2009.03.027; Langfelder P, 2008, BIOINFORMATICS, V24, P719, DOI 10.1093/bioinformatics/btm563; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lee JA, 2009, GENE DEV, V23, P2284, DOI 10.1101/gad.1837009; Luco RF, 2010, SCIENCE, V327, P996, DOI 10.1126/science.1184208; Martin CL, 2007, AM J MED GENET B, V144B, P869, DOI 10.1002/ajmg.b.30530; Miller JA, 2010, P NATL ACAD SCI USA, V107, P12698, DOI 10.1073/pnas.0914257107; Morgan JT, 2010, BIOL PSYCHIAT, V68, P368, DOI 10.1016/j.biopsych.2010.05.024; Moy SS, 2009, BEHAV BRAIN RES, V205, P123, DOI 10.1016/j.bbr.2009.06.021; Oldham MC, 2008, NAT NEUROSCI, V11, P1271, DOI 10.1038/nn.2207; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Plaisier CL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000642; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Underwood JG, 2005, MOL CELL BIOL, V25, P10005, DOI 10.1128/MCB.25.22.10005-10016.2005; Wang K, 2007, AM J HUM GENET, V81, P1278, DOI 10.1086/522374; Wang K, 2009, NATURE, V459, P528, DOI 10.1038/nature07999; Wintle RF, 2011, AUTISM RES, V4, P89, DOI 10.1002/aur.173; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zhang CL, 2008, GENE DEV, V22, P2550, DOI 10.1101/gad.1703108; Zhang KL, 2010, NUCLEIC ACIDS RES, V38, pW90, DOI 10.1093/nar/gkq324; Zhao XZ, 2006, BIOL PSYCHIAT, V59, P747, DOI 10.1016/j.biopsych.2005.10.023; Zikopoulos B, 2010, J NEUROSCI, V30, P14595, DOI 10.1523/JNEUROSCI.2257-10.2010	37	1181	1205	6	255	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 16	2011	474	7351					380	+		10.1038/nature10110	http://dx.doi.org/10.1038/nature10110			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777TD	21614001	Green Accepted, Green Submitted			2022-12-24	WOS:000291647100046
J	Mineur, YS; Abizaid, A; Rao, Y; Salas, R; DiLeone, RJ; Gundisch, D; Diano, S; De Biasi, M; Horvath, TL; Gao, XB; Picciotto, MR				Mineur, Yann S.; Abizaid, Alfonso; Rao, Yan; Salas, Ramiro; DiLeone, Ralph J.; Guendisch, Daniela; Diano, Sabrina; De Biasi, Mariella; Horvath, Tamas L.; Gao, Xiao-Bing; Picciotto, Marina R.			Nicotine Decreases Food Intake Through Activation of POMC Neurons	SCIENCE			English	Article							CENTRAL-NERVOUS-SYSTEM; BODY-WEIGHT; SMOKING; RECEPTOR; BRAIN; OBESITY; MICE	Smoking decreases appetite, and smokers often report that they smoke to control their weight. Understanding the neurobiological mechanisms underlying the anorexic effects of smoking would facilitate the development of novel treatments to help with smoking cessation and to prevent or treat obesity. By using a combination of pharmacological, molecular genetic, electrophysiological, and feeding studies, we found that activation of hypothalamic alpha 3 beta 4 nicotinic acetylcholine receptors leads to activation of pro-opiomelanocortin (POMC) neurons. POMC neurons and subsequent activation of melanocortin 4 receptors were critical for nicotinic-induced decreases in food intake in mice. This study demonstrates that nicotine decreases food intake and body weight by influencing the hypothalamic melanocortin system and identifies critical molecular and synaptic mechanisms involved in nicotine-induced decreases in appetite.	[Mineur, Yann S.; DiLeone, Ralph J.; Picciotto, Marina R.] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06508 USA; [Abizaid, Alfonso; Rao, Yan; Diano, Sabrina; Horvath, Tamas L.; Gao, Xiao-Bing] Yale Univ, Sch Med, Dept Comparat Med, New Haven, CT 06508 USA; [Salas, Ramiro; De Biasi, Mariella] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Guendisch, Daniela] Univ Hawaii, Coll Pharm, Dept Pharmaceut Sci, Hilo, HI 96720 USA	Yale University; Yale University; Baylor College of Medicine; University of Hawaii System; University Hawaii Hilo	Picciotto, MR (corresponding author), Yale Univ, Sch Med, Dept Psychiat, 34 Pk St,3rd Floor Res, New Haven, CT 06508 USA.	marina.picciotto@yale.edu	Gao, Xiao-Bing/C-3121-2011; Mineur, Yann/E-2487-2018; Picciotto, Marina R./F-8747-2012; De Biasi, Mariella/M-7646-2017; Salas, Ramiro/A-9602-2015	Gao, Xiao-Bing/0000-0002-2035-4936; Mineur, Yann/0000-0002-8030-6776; Picciotto, Marina R./0000-0002-4404-1280; De Biasi, Mariella/0000-0002-0687-8872; DiLeone, Ralph/0000-0002-4770-2590; Abizaid, Alfonso/0000-0001-9303-3511	NIH [DA14241, DA00436, AA15632]; Transdisciplinary Tobacco Use Research Center; Natural Science and Engineering Research Council of Canada; American Diabetes Association [1-08-RA-36, DK070039];  [DK070723];  [RR016467];  [DA017173];  [OD006850];  [DK080000]; NATIONAL CANCER INSTITUTE [U19CA148127] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016467] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070723, R01DK080000, R01DK070039] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P50AA015632] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA014241, K02DA000436, R01DA017173] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006850] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Transdisciplinary Tobacco Use Research Center; Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); American Diabetes Association(American Diabetes Association); ; ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	These studies were supported by grants DA14241, DA00436, and AA15632 from the NIH. X.-B.G. was supported by DK070723. Y.M. was supported by a Transdisciplinary Tobacco Use Research Center young investigator pilot grant. Alfonso Abizaid was supported by a postdoctoral fellowship from the Natural Science and Engineering Research Council of Canada. D. G. was supported by RR016467. Y.R., X.-B.G., and S. D. were supported by American Diabetes Association grants 1-08-RA-36 and DK070039. M. D. was supported by DA017173. T. L. H. was supported by OD006850 and DK080000. The authors gratefully acknowledge U. Hochgeschwender (Oklahoma Medical Research Foundation) for providing heterozygous POMC breeding pairs.	ALBANES D, 1987, AM J PUBLIC HEALTH, V77, P439, DOI 10.2105/AJPH.77.4.439; Backberg M, 2004, SYNAPSE, V52, P245, DOI 10.1002/syn.20024; Filozof C, 2004, Obes Rev, V5, P95, DOI 10.1111/j.1467-789X.2004.00131.x; Freeman M E, 2008, NEUROSCIENCE MED, P301; Fulkerson JA, 2003, J ADOLESCENT HEALTH, V32, P306, DOI 10.1016/S1054-139X(02)00566-9; Garfield AS, 2009, TRENDS ENDOCRIN MET, V20, P203, DOI 10.1016/j.tem.2009.02.002; GRUNBERG NE, 1987, PSYCHOPHARMACOLOGY, V91, P221; Jo YH, 2002, J NEUROBIOL, V53, P618, DOI 10.1002/neu.10147; Krude H, 2003, J CLIN ENDOCR METAB, V88, P4633, DOI 10.1210/jc.2003-030502; Majkutewicz I, 2010, ACTA NEUROBIOL EXP, V70, P28; Meister B, 2006, EUR J NEUROSCI, V24, P2731, DOI 10.1111/j.1460-9568.2006.05157.x; Phillis J. W., 2005, Critical Reviews in Neurobiology, V17, P161; PICCIOTTO MR, 1995, NATURE, V374, P65, DOI 10.1038/374065a0; Pistelli F, 2009, Monaldi Arch Chest Dis, V71, P81; Schafer MKH, 1998, NEUROSCIENCE, V84, P331, DOI 10.1016/S0306-4522(97)00516-2; Smart JL, 2003, ANN NY ACAD SCI, V994, P202, DOI 10.1111/j.1749-6632.2003.tb03181.x; Tao YX, 2010, ENDOCR REV, V31, P506, DOI 10.1210/er.2009-0037; Voorhees CC, 2002, PREV MED, V34, P616, DOI 10.1006/pmed.2002.1026; WACK JT, 1982, AM J CLIN NUTR, V35, P366, DOI 10.1093/ajcn/35.2.366; Williams DL, 2005, AM J PHYSIOL-REG I, V289, pR2, DOI 10.1152/ajpregu.00226.2005; WOOLF NJ, 1991, PROG NEUROBIOL, V37, P475, DOI 10.1016/0301-0082(91)90006-M	21	273	281	1	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 10	2011	332	6035					1330	1332		10.1126/science.1201889	http://dx.doi.org/10.1126/science.1201889			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	775EP	21659607	Green Accepted			2022-12-24	WOS:000291441700047
J	Zaslaver, A; Baugh, LR; Sternberg, PW				Zaslaver, Alon; Baugh, L. Ryan; Sternberg, Paul W.			Metazoan Operons Accelerate Recovery from Growth-Arrested States	CELL			English	Article							ELEGANS DAUER LARVA; CAENORHABDITIS-ELEGANS; GENE-EXPRESSION; GLOBAL ANALYSIS; GENOME; ORGANIZATION; PROMOTERS; DYNAMICS; SEQUENCE; CHORDATE	Existing theories explain why operons are advantageous in prokaryotes, but their occurrence in metazoans is an enigma. Nematode operon genes, typically consisting of growth genes, are significantly upregulated during recovery from growth-arrested states. This expression pattern is anticorrelated to nonoperon genes, consistent with a competition for transcriptional resources. We find that transcriptional resources are initially limiting during recovery and that recovering animals are highly sensitive to any additional decrease in transcriptional resources. We provide evidence that operons become advantageous because, by clustering growth genes into operons, fewer promoters compete for the limited transcriptional machinery, effectively increasing the concentration of transcriptional resources and accelerating recovery. Mathematical modeling reveals how a moderate increase in transcriptional resources can substantially enhance transcription rate and recovery. This design principle occurs in different nematodes and the chordate C. intestinalis. As transition from arrest to rapid growth is shared by many metazoans, operons could have evolved to facilitate these processes.	[Zaslaver, Alon; Sternberg, Paul W.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; [Zaslaver, Alon; Sternberg, Paul W.] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Baugh, L. Ryan] Duke Univ, Dept Biol, Durham, NC 27708 USA; [Baugh, L. Ryan] Duke Univ, IGSP Ctr Syst Biol, Durham, NC 27708 USA	California Institute of Technology; Howard Hughes Medical Institute; California Institute of Technology; Duke University; Duke University	Sternberg, PW (corresponding author), CALTECH, Howard Hughes Med Inst, 1200 E Calif Blvd, Pasadena, CA 91125 USA.	pws@caltech.edu	Baugh, L. Ryan/GRS-0507-2022	Baugh, L. Ryan/0000-0003-2148-5492; Sternberg, Paul/0000-0002-7699-0173	Genome Canada; European Molecular Biology Organization (EMBO); Human Frontier Science Program (HFSP); Caltech Center for Biological Circuit Design; HHMI	Genome Canada(Genome Canada); European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO)); Human Frontier Science Program (HFSP)(Human Frontier Science Program); Caltech Center for Biological Circuit Design; HHMI(Howard Hughes Medical Institute)	We are grateful to Tom Blumenthal, Erich Schwarz, Hillel Schwartz, Shalev Itzkovitz, Ronen Zaidel-Bar, and Ron Milo for critical review and helpful comments. We thank Elodie Ghedin for sharing the list of operon genes in B. malayi, the Mitani laboratory and the Caenorhabditis Genetics Center for deletion strains, WormBase, and the Genome BC C. elegans Gene Expression Consortium http://elegans.bcgsc.bc.ca/ for SAGE data (produced at the Michael Smith Genome Sciences Centre with funding from Genome Canada). A.Z. was supported by the European Molecular Biology Organization (EMBO), the Human Frontier Science Program (HFSP), and the Caltech Center for Biological Circuit Design. L.R.B. was an ACS postdoctoral fellow. P.W.S. is an Investigator with the HHMI, which supported this work. A.Z. conceived the idea of this study, designed and performed all of the experiments and the mathematical modeling, and carried out all of the data and bioinformatics analyses. L.R.B. contributed experimental tools, shared unpublished data, and helped to analyze and interpret the data. A.Z. and P.W.S. wrote the paper.	Abad P, 2008, NAT BIOTECHNOL, V26, P909, DOI 10.1038/nbt.1482; Alon U., 2006, INTRO SYSTEMS BIOL D; Azumi K, 2007, DEV BIOL, V308, P572, DOI 10.1016/j.ydbio.2007.05.022; Barriere A, 2005, CURR BIOL, V15, P1176, DOI 10.1016/j.cub.2005.06.022; Baugh LR, 2009, SCIENCE, V324, P92, DOI 10.1126/science.1169628; Baugh LR, 2003, DEVELOPMENT, V130, P889, DOI 10.1242/dev.00302; BLACKWELL TK, 2006, TRANSCRIPTION MECH, P1; Blumenthal T, 2002, NATURE, V417, P851, DOI 10.1038/nature00831; Blumenthal Thomas, 2003, Nature Reviews Genetics, V4, P112; Carey M, 1998, CELL, V92, P5, DOI 10.1016/S0092-8674(00)80893-4; CASSADA RC, 1975, DEV BIOL, V46, P326, DOI 10.1016/0012-1606(75)90109-8; Chen NS, 2006, GENOME RES, V16, P606, DOI 10.1101/gr.4515306; Chubb JR, 2006, CURR BIOL, V16, P1018, DOI 10.1016/j.cub.2006.03.092; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; DALLEY BK, 1992, DEV BIOL, V151, P80, DOI 10.1016/0012-1606(92)90215-3; Dieterich C, 2008, NAT GENET, V40, P1193, DOI 10.1038/ng.227; Ganot P, 2004, MOL CELL BIOL, V24, P7795, DOI 10.1128/MCB.24.17.7795-7805.2004; Ghedin E, 2007, SCIENCE, V317, P1756, DOI 10.1126/science.1145406; GOLDEN JW, 1984, DEV BIOL, V102, P368, DOI 10.1016/0012-1606(84)90201-X; Golding I, 2005, CELL, V123, P1025, DOI 10.1016/j.cell.2005.09.031; Guiliano DB, 2006, PLOS GENET, V2, P1871, DOI 10.1371/journal.pgen.0020198; Hillier LW, 2005, GENOME RES, V15, P1651, DOI 10.1101/gr.3729105; Huang PM, 2007, GENOME RES, V17, P1478, DOI 10.1101/gr.6824707; JACOB F, 1960, CR HEBD ACAD SCI, V250, P1727; JOHNSON TE, 1984, MECH AGEING DEV, V28, P23, DOI 10.1016/0047-6374(84)90150-7; KLASS M, 1976, NATURE, V260, P523, DOI 10.1038/260523a0; Lawrence JG, 2003, ANNU REV MICROBIOL, V57, P419, DOI 10.1146/annurev.micro.57.030502.090816; Lercher MJ, 2003, GENOME RES, V13, P238, DOI 10.1101/gr.553803; Lewis K, 2007, NAT REV MICROBIOL, V5, P48, DOI 10.1038/nrmicro1557; Mayer MG, 2011, P ROY SOC B-BIOL SCI, V278, P2784, DOI 10.1098/rspb.2010.2760; Opperman CH, 2008, P NATL ACAD SCI USA, V105, P14802, DOI 10.1073/pnas.0805946105; Price MN, 2005, GENOME RES, V15, P809, DOI 10.1101/gr.3368805; Qian WF, 2008, GENOME RES, V18, P412, DOI 10.1101/gr.7112608; Reinke V, 2004, DEVELOPMENT, V131, P311, DOI 10.1242/dev.00914; Reinke V, 2009, GENETICS, V181, P1219, DOI 10.1534/genetics.108.099283; SANFORD T, 1983, J BIOL CHEM, V258, P2804; Satou Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r152; Schrimpf SP, 2009, PLOS BIOL, V7, P616, DOI 10.1371/journal.pbio.1000048; Scott M, 2010, SCIENCE, V330, P1099, DOI 10.1126/science.1192588; Stein LD, 2003, PLOS BIOL, V1, P166, DOI 10.1371/journal.pbio.0000045; Wang J, 2003, DEVELOPMENT, V130, P1621, DOI 10.1242/dev.00363; Whittle CM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000187; Zaslaver A, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000545; ZORIO DAR, 1994, NATURE, V372, P270, DOI 10.1038/372270a0	44	35	38	1	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 10	2011	145	6					981	992		10.1016/j.cell.2011.05.013	http://dx.doi.org/10.1016/j.cell.2011.05.013			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	775LS	21663799	Green Accepted, Green Submitted, Bronze			2022-12-24	WOS:000291461600023
